PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Oguin, TH; Sharma, S; Stuart, AD; Duan, S; Scott, SA; Jones, CK; Daniels, JS; Lindsley, CW; Thomas, PG; Brown, HA				Oguin, Thomas H., III; Sharma, Shalini; Stuart, Amanda D.; Duan, Susu; Scott, Sarah A.; Jones, Carrie K.; Daniels, J. Scott; Lindsley, Craig W.; Thomas, Paul G.; Brown, H. Alex			Phospholipase D Facilitates Efficient Entry of Influenza Virus, Allowing Escape from Innate Immune Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID; CHEMICAL MODULATION; MEMBRANE; ENDOCYTOSIS; INFECTION; DESIGN	Lipid metabolism plays a fundamental role during influenza virus replication, although key regulators of lipid-dependent trafficking and virus production remain inadequately defined. This report demonstrates that infection by influenza virus stimulates phospholipase D (PLD) activity and that PLD co-localizes with influenza during infection. Both chemical inhibition and RNA interference of PLD delayed viral entry and reduced viral titers in vitro. Although there may be contributions by both major isoenzymes, the effects on viral infectivity appear to be more dependent on the PLD2 isoenzyme. In vivo, PLD2 inhibition reduced virus titer and correlated with significant increases in transcription of innate antiviral effectors. The reduction in viral titer downstream of PLD2 inhibition was dependent on Rig-I (retinoic acid-inducible gene-1), IRF3, and MxA (myxovirus resistance gene A) but not IRF7. Inhibition of PLD2 accelerated the accumulation of MxA in foci as early as 30 min postinfection. Together these data suggest that PLD facilitates the rapid endocytosis of influenza virus, permitting viral escape from innate immune detection and effectors that are capable of limiting lethal infection.	[Oguin, Thomas H., III; Duan, Susu; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Oguin, Thomas H., III] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Sharma, Shalini] Lala Lajpat Rai Univ Vet & Anim Sci, Dept Vet Physiol & Biochem, Hisar 125004, Haryana, India; [Stuart, Amanda D.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Scott, Sarah A.; Jones, Carrie K.; Daniels, J. Scott; Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Brown, H. Alex] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Jones, Carrie K.; Daniels, J. Scott; Lindsley, Craig W.] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA	St Jude Children's Research Hospital; University of Memphis; Lala Lajpat Rai University of Veterinary & Animal Sciences; University of Cambridge; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Thomas, PG (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Paul.Thomas@stjude.org; alex.brown@vanderbilt.edu	Thomas, Paul G./H-1063-2018	Thomas, Paul G./0000-0001-7955-0256; Oguin, Thomas/0000-0001-8959-4025	National Institutes of Health [U54MH084659, P01ESO013125]; NIAID [HHSN2722008000058C, HHSN266200700005C]; Medical Research Council [RG53985]; NATIONAL CANCER INSTITUTE [T32CA009592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES013125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants U54MH084659, P01ESO013125, and HHSN2722008000058C and HHSN266200700005C from the NIAID. This work was also supported by Medical Research Council Grant RG53985.	Antonescu CN, 2010, MOL BIOL CELL, V21, P2944, DOI 10.1091/mbc.E10-05-0421; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; Carrasco M, 2004, TRAFFIC, V5, P979, DOI 10.1111/j.1600-0854.2004.00237.x; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Czarny M, 2000, FEBS LETT, V467, P326, DOI 10.1016/S0014-5793(00)01174-1; Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; Lakadamyali M, 2004, MICROBES INFECT, V6, P929, DOI 10.1016/j.micinf.2004.05.002; Lam V, 2005, BIOTECHNOL BIOENG, V90, P793, DOI 10.1002/bit.20467; Lavieri RR, 2010, J MED CHEM, V53, P6706, DOI 10.1021/jm100814g; Liu STH, 2011, P NATL ACAD SCI USA, V108, P12869, DOI 10.1073/pnas.1109796108; Mahankali M, 2011, CELL SIGNAL, V23, P1291, DOI 10.1016/j.cellsig.2011.03.010; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Munck A, 2005, FEBS J, V272, P1718, DOI 10.1111/j.1742-4658.2005.04601.x; Myers DS, 2011, BBA-MOL CELL BIOL L, V1811, P748, DOI 10.1016/j.bbalip.2011.05.015; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Padron D, 2006, MOL BIOL CELL, V17, P598, DOI 10.1091/mbc.E05-05-0389; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Scott SA, 2014, BBA-MOL CELL BIOL L, V1841, P1060, DOI 10.1016/j.bbalip.2014.01.009; Scott SA, 2013, J BIOL CHEM, V288, P20477, DOI 10.1074/jbc.M113.451708; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Sieczkarski SB, 2003, J VIROL, V77, P460, DOI 10.1128/JVI.77.1.460-469.2003; Skehel JJ, 2001, BIOCHEM SOC T, V29, P623, DOI 10.1042/BST0290623; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12; Yang LQ, 2010, MOL PHARMACOL, V78, P105, DOI 10.1124/mol.109.063107	35	37	38	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25405	25417		10.1074/jbc.M114.558817	http://dx.doi.org/10.1074/jbc.M114.558817			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25065577	Green Published, hybrid			2022-12-25	WOS:000342130800002
J	Giovagnetti, V; Flori, S; Tramontano, F; Lavaud, J; Brunet, C				Giovagnetti, Vasco; Flori, Serena; Tramontano, Ferdinando; Lavaud, Johann; Brunet, Christophe			The Velocity of Light Intensity Increase Modulates the Photoprotective Response in Coastal Diatoms	PLOS ONE			English	Article							PHAEODACTYLUM-TRICORNUTUM; DIADINOXANTHIN CYCLE; CHLOROPHYLL FLUORESCENCE; PHYTOPLANKTON GROWTH; VERTICAL VARIABILITY; PLANKTONIC DIATOMS; ENERGY-DISSIPATION; PHOTOSYNTHESIS; ACCLIMATION; MODEL	In aquatic ecosystems, the superimposition of mixing events to the light diel cycle exposes phytoplankton to changes in the velocity of light intensity increase, from diurnal variations to faster mixing-related ones. This is particularly true in coastal waters, where diatoms are dominant. This study aims to investigate if coastal diatoms differently activate the photoprotective responses, xanthophyll cycle (XC) and non-photochemical fluorescence quenching (NPQ), to cope with predictable light diel cycle and unpredictable mixing-related light variations. We compared the effect of two fast light intensity increases (simulating mixing events) with that of a slower increase (corresponding to the light diel cycle) on the modulation of XC and NPQ in the planktonic coastal diatom Pseudo-nitzschia multistriata. During each light treatment, the photon flux density (PFD) progressively increased from darkness to five peaks, ranging from 100 to 650 mu mol photons m(-2) s(-1). Our results show that the diel cycle-related PFD increase strongly activates XC through the enhancement of the carotenoid biosynthesis and induces a moderate and gradual NPQ formation over the light gradient. In contrast, during mixing-related PFD increases, XC is less activated, while higher NPQ rapidly develops at moderate PFD. We observe that together with the light intensity and its increase velocity, the saturation light for photosynthesis (Ek) is a key parameter in modulating photoprotection. We propose that the capacity to adequately regulate and actuate alternative photoprotective 'safety valves' in response to changing velocity of light intensity increase further enhances the photophysiological flexibility of diatoms. This might be an evolutionary outcome of diatom adaptation to turbulent marine ecosystems characterized by unpredictable mixing-related light changes over the light diel cycle.	[Giovagnetti, Vasco; Flori, Serena; Tramontano, Ferdinando; Brunet, Christophe] Stn Zool Anton Dohrn, Naples, Italy; [Lavaud, Johann] Univ La Rochelle, Unite Mixte Rech 7266, La Rochelle, France	Stazione Zoologica Anton Dohrn di Napoli; La Rochelle Universite	Brunet, C (corresponding author), Stn Zool Anton Dohrn, Naples, Italy.	christophe.brunet@szn.it	brunet, christophe/AAD-7817-2021; Flori, Serena/GPP-7017-2022; Lavaud, Johann/N-6185-2014	Flori, Serena/0000-0003-3407-2785; Lavaud, Johann/0000-0002-4704-2502; Giovagnetti, Vasco/0000-0002-3298-4310				Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Brunet C, 2003, J PLANKTON RES, V25, P1413, DOI 10.1093/plankt/fbg091; Brunet C, 2008, J PLANKTON RES, V30, P645, DOI 10.1093/plankt/fbn028; Brunet C, 2007, MAR ECOL PROG SER, V346, P15, DOI 10.3354/meps07017; Brunet C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087015; Brunet C, 2010, J PLANKTON RES, V32, P1609, DOI 10.1093/plankt/fbq104; Chukhutsina VU, 2014, BBA-BIOENERGETICS, V1837, P899, DOI 10.1016/j.bbabio.2014.02.021; Costa BS, 2013, J EXP BOT, V64, P483, DOI 10.1093/jxb/ers340; D'Alelio D, 2010, LIMNOL OCEANOGR, V55, P106, DOI 10.4319/lo.2010.55.1.0106; Dambek M, 2012, J EXP BOT, V63, P5607, DOI 10.1093/jxb/ers211; Dimier C, 2007, J PHYCOL, V43, P937, DOI 10.1111/j.1529-8817.2007.00381.x; Dimier C, 2009, PROTIST, V160, P397, DOI 10.1016/j.protis.2009.03.001; Dimier C, 2009, LIMNOL OCEANOGR, V54, P823, DOI 10.4319/lo.2009.54.3.0823; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Eisenstadt D, 2008, ENVIRON MICROBIOL, V10, P1997, DOI 10.1111/j.1462-2920.2008.01616.x; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Finazzi G, 2010, TRENDS PLANT SCI, V15, P565, DOI 10.1016/j.tplants.2010.07.004; Geider RJ, 2009, PLANT ECOL DIVERS, V2, P165, DOI 10.1080/17550870903300949; Geider RJ, 1997, MAR ECOL PROG SER, V148, P187, DOI 10.3354/meps148187; Giovagnetti V, 2012, EUR J PHYCOL, V47, P408, DOI 10.1080/09670262.2012.733030; Giovagnetti V, 2010, J PLANKTON RES, V32, P1501, DOI 10.1093/plankt/fbq074; Goss R, 2006, J PLANT PHYSIOL, V163, P1008, DOI 10.1016/j.jplph.2005.09.008; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Gundermann K, 2012, BBA-BIOENERGETICS, V1817, P1044, DOI 10.1016/j.bbabio.2012.03.008; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kooistra Wiebe H. C. F., 2007, P207; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Lavaud J, 2004, J PHYCOL, V40, P130, DOI 10.1046/j.1529-8817.2004.03026.x; Lavaud J, 2002, PLANT PHYSIOL, V129, P1398, DOI 10.1104/pp.002014; Lavaud J, 2002, PHOTOSYNTH RES, V74, P51, DOI 10.1023/A:1020890625141; Lavaud J, 2014, ADV PHOTOSY IN PRESS; Lavaud J, 2007, LIMNOL OCEANOGR, V52, P1188, DOI 10.4319/lo.2007.52.3.1188; Lavaud J, 2006, PLANT CELL PHYSIOL, V47, P1010, DOI 10.1093/pcp/pcj058; Lavaud J, 2013, BBA-BIOENERGETICS, V1827, P294, DOI 10.1016/j.bbabio.2012.11.012; Lavaud J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036806; Lawrenz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058137; Lepetit B, 2013, PLANT PHYSIOL, V161, P853, DOI 10.1104/pp.112.207811; Lepetit B, 2012, PHOTOSYNTH RES, V111, P245, DOI 10.1007/s11120-011-9633-5; Lepetit B, 2010, PLANT PHYSIOL, V154, P1905, DOI 10.1104/pp.110.166454; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Lohr M, 2011, PHYTOPLANKTON PIGMEN, P113, DOI DOI 10.1017/CB09780511732263.006; MacIntyre HL, 2002, J PHYCOL, V38, P17, DOI 10.1046/j.1529-8817.2002.00094.x; MacIntyre HL, 2000, TRENDS PLANT SCI, V5, P12, DOI 10.1016/S1360-1385(99)01504-6; Miloslavina Y, 2009, BBA-BIOENERGETICS, V1787, P1189, DOI 10.1016/j.bbabio.2009.05.012; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nymark M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007743; OWENS TG, 1986, PHOTOCHEM PHOTOBIOL, V43, P535, DOI 10.1111/j.1751-1097.1986.tb09532.x; Polimene L, 2014, J PLANKTON RES, V36, P214, DOI 10.1093/plankt/fbt086; Polimene L, 2012, J PLANKTON RES, V34, P196, DOI 10.1093/plankt/fbr102; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Ruban AV, 2004, PHOTOSYNTH RES, V82, P165, DOI 10.1007/s11120-004-1456-1; Schumann A, 2007, PHYCOLOGIA, V46, P113, DOI 10.2216/06-30.1; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Talmy D, 2013, LIMNOL OCEANOGR, V58, P1802, DOI 10.4319/lo.2013.58.5.1802; Tassan S, 1995, LIMNOL OCEANOGR, V40, P1358, DOI 10.4319/lo.1995.40.8.1358; Trainer VL, 2012, HARMFUL ALGAE, V14, P271, DOI 10.1016/j.hal.2011.10.025; van Leeuwe MA, 2005, MAR ECOL PROG SER, V288, P9, DOI 10.3354/meps288009; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Wu HY, 2012, PLANT PHYSIOL, V160, P464, DOI 10.1104/pp.112.203067	61	21	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103782	10.1371/journal.pone.0103782	http://dx.doi.org/10.1371/journal.pone.0103782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083713	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800079
J	Cristescu, ME; Demiri, B; Altshuler, I; Crease, TJ				Cristescu, Melania E.; Demiri, Bora; Altshuler, Ianina; Crease, Teresa J.			Gene Expression Variation in Duplicate Lactate dehydrogenase Genes: Do Ecological Species Show Distinct Responses?	PLOS ONE			English	Article							DAPHNIA-PULEX GROUP; CLONAL DIVERSITY; ENZYME GENOTYPE; B GENE; POPULATIONS; SPECIATION; EVOLUTION; HYPOXIA; PCR; REPRODUCTION	Lactate dehydrogenase (LDH) has been shown to play an important role in adaptation of several aquatic species to different habitats. The genomes of Daphnia pulex, a pond species, and Daphnia pulicaria, a lake inhabitant, encode two L-LDH enzymes, LDHA and LDHB. We estimated relative levels of Ldh gene expression in these two closely related species and their hybrids in four environmental settings, each characterized by one of two temperatures (10 degrees C or 20 degrees C), and one of two concentrations of dissolved oxygen (DO; 6.5-7 mg/l or 2-3 mg/l). We found that levels of LdhA expression were 4 to 48 times higher than LdhB expression (p<0.005) in all three groups (the two parental species and hybrids). Moreover, levels of LdhB expression differed significantly (p<0.05) between D. pulex and D. pulicaria, but neither species differed from the hybrid. Consistently higher expression of LdhA relative to LdhB in both species and the hybrid suggests that the two isozymes could be performing different functions. No significant differences in levels of gene expression were observed among the four combinations of temperature and dissolved oxygen (p>0.1). Given that Daphnia dwell in environments characterized by fluctuating conditions with long periods of low dissolved oxygen concentration, we suggest that these species could employ regulated metabolic depression to survive in such environments.	[Cristescu, Melania E.; Demiri, Bora] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; [Crease, Teresa J.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Cristescu, Melania E.; Altshuler, Ianina] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Windsor; University of Guelph; McGill University	Cristescu, ME (corresponding author), Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada.	melania.cristescu@mcgill.ca	Crease, Teresa/E-2932-2015; Altshuler, Ianina/O-3206-2019	Crease, Teresa/0000-0001-8074-8024; Cristescu, Melania/0000-0002-0854-4040; Altshuler, Ianina/0000-0003-2235-1664	NSERC Canada; NSERC CREATE grant	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC CREATE grant	This work was supported by NSERC Canada Discovery grants to TJC and MEC and by an NSERC CREATE grant to MEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colbourne John K., 1997, P163; CRAWFORD DL, 1992, MOL BIOL EVOL, V9, P806; Crease TJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-212; Crease TJ, 1997, HEREDITY, V79, P242; Cristescu ME, 2012, MOL ECOL, V21, P1411, DOI 10.1111/j.1365-294X.2011.05465.x; Cristescu ME, 2009, J MOL EVOL, V69, P276, DOI 10.1007/s00239-009-9274-x; Cristescu ME, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-268; Cristescu MEA, 2006, GENOMICS, V88, P415, DOI 10.1016/j.ygeno.2006.03.007; Dahlhoff EP, 2000, P NATL ACAD SCI USA, V97, P10056, DOI 10.1073/pnas.160277697; Dudycha JL, 2004, FRESHWATER BIOL, V49, P505, DOI 10.1111/j.1365-2427.2004.01201.x; Dudycha JL, 2003, OECOLOGIA, V135, P555, DOI 10.1007/s00442-003-1230-7; Dudycha JL, 1999, EVOLUTION, V53, P1744, DOI 10.1111/j.1558-5646.1999.tb04559.x; Eanes WF, 1999, ANNU REV ECOL SYST, V30, P301, DOI 10.1146/annurev.ecolsys.30.1.301; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; EVERSE J, 1973, ADV ENZYMOL RAMB, V37, P61; Gorr TA, 2004, INT CONGR SER, V1275, P55, DOI 10.1016/j.ics.2004.08.068; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; HEBERT PDN, 1989, EVOLUTION, V43, P1004, DOI 10.1111/j.1558-5646.1989.tb02546.x; HEBERT PDN, 1983, HEREDITY, V51, P353, DOI 10.1038/hdy.1983.40; Hebert PDN, 2001, HEREDITY, V87, P153, DOI 10.1046/j.1365-2540.2001.00885.x; Heier CR, 2009, LIMNOL OCEANOGR, V54, P492, DOI 10.4319/lo.2009.54.2.0492; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; INNES DJ, 1986, HEREDITY, V57, P345, DOI 10.1038/hdy.1986.134; Johns GC, 2004, MOL BIOL EVOL, V21, P314, DOI 10.1093/molbev/msh021; Karl I, 2009, ECOGRAPHY, V32, P488, DOI 10.1111/j.1600-0587.2008.05660.x; Lopez J.A., 2007, TOTAL RNA EXTRACTION; Lynch M, 2000, GENETICS, V154, P459; MARKERT CL, 1975, SCIENCE, V189, P102, DOI 10.1126/science.1138367; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Paul RJ, 1998, COMP BIOCHEM PHYS A, V120, P519, DOI 10.1016/S1095-6433(98)10062-4; Pfrender ME, 2000, MOL ECOL, V9, P1717, DOI 10.1046/j.1365-294x.2000.01062.x; POWERS DA, 1991, ANNU REV GENET, V25, P629; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rees BB, 2001, BIOL BULL, V200, P247, DOI 10.2307/1543505; Rossignol F, 2003, J CELL BIOCHEM, V89, P67, DOI 10.1002/jcb.10484; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schulte PM, 2000, P NATL ACAD SCI USA, V97, P6597, DOI 10.1073/pnas.97.12.6597; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Spanier KI, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-50; THRELKELD ST, 1979, ECOLOGY, V60, P165, DOI 10.2307/1936478; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; WRIGHT D, 1990, FRESHWATER BIOL, V24, P43, DOI 10.1111/j.1365-2427.1990.tb00306.x; Xu S, 2013, MOL ECOL, V22, P4549, DOI 10.1111/mec.12407	45	2	2	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103964	10.1371/journal.pone.0103964	http://dx.doi.org/10.1371/journal.pone.0103964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080082	Green Submitted, gold, Green Published			2022-12-25	WOS:000339954800100
J	Van Biesen, W; van der Veer, SN; Murphey, M; Loblova, O; Davies, S				Van Biesen, Wim; van der Veer, Sabine N.; Murphey, Mark; Loblova, Olga; Davies, Simon			Patients' Perceptions of Information and Education for Renal Replacement Therapy: An Independent Survey by the European Kidney Patients' Federation on Information and Support on Renal Replacement Therapy	PLOS ONE			English	Article							SHARED DECISION-MAKING; DIALYSIS MODALITY SELECTION; PERITONEAL-DIALYSIS; REFERRAL PATTERN; DISEASE PATIENTS; ESRD PATIENTS; HEALTH-CARE; EXPERIENCE; INITIATION; CONTRAINDICATIONS	Background: Selection of an appropriate renal replacement modality is of utmost importance for patients with end stage renal disease. Previous studies showed provision of information to and free modality choice by patients to be suboptimal. Therefore, the European Kidney Patients' Federation (CEAPIR) explored European patients' perceptions regarding information, education and involvement on the modality selection process. Methods: CEAPIR developed a survey, which was disseminated by the national kidney patient organisations in Europe. Results: In total, 3867 patients from 36 countries completed the survey. Respondents were either on in-centre haemodialysis (53%) or had a functioning graft (38%) at the time of survey. The majority (78%) evaluated the general information about kidney disease and treatment as helpful, but 39% did not recall being told about alternative treatment options than their current one. Respondents were more often satisfied with information provided on in-centre haemodialysis (90%) and transplantation (87%) than with information provided on peritoneal dialysis (79%) or home haemodialysis (61%), and were more satisfied with information from health care professionals vs other sources such as social media. Most (75%) felt they had been involved in treatment selection, 29% perceived they had no free choice. Involvement in modality selection was associated with enhanced satisfaction with treatment (OR 3.13; 95% CI 2.72-3.60). Many respondents (64%) could not remember receiving education on how to manage their kidney disease in daily life. Perceptions on information seem to differ between countries. Conclusions: Kidney patients reported to be overall satisfied with the information they received on their disease and treatment, although information seemed mostly to have been focused on one modality. Patients involved in modality selection were more satisfied with their treatment. However, in the perception of the patients, the freedom to choose an alternative modality showed room for improvement.	[Van Biesen, Wim] Ghent Univ Hosp, Div Renal, Ghent, Belgium; [van der Veer, Sabine N.] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, NL-1105 AZ Amsterdam, Netherlands; [Murphey, Mark] Irish Kidney Assoc, Dublin, Ireland; [Loblova, Olga] A&R Edelman, London, England; [Loblova, Olga] Cent European Univ, Dept Publ Policy, Budapest, Hungary; [Davies, Simon] Univ Hosp North Staffordshire, Dept Nephrol, Stoke On Trent, Staffs, England	Ghent University; Ghent University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Central European University	Van Biesen, W (corresponding author), Ghent Univ Hosp, Div Renal, Ghent, Belgium.	wim.vanbiesen@ugent.be		Davies, Simon/0000-0001-5127-4755; van der Veer, Sabine/0000-0003-0929-436X; Loblova, Olga/0000-0003-2481-8440	Baxter Healthcare	Baxter Healthcare	Baxter Healthcare provided logistical and financial support for this initiative through an unrestricted scientific grant to CEAPIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameling JM, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-140; Caring for Australians with Renal Impairment (CARI), 2005, ACC ONT DIAL GUID; Chewning B, 2012, PATIENT EDUC COUNS, V86, P9, DOI 10.1016/j.pec.2011.02.004; Covic A, 2010, NEPHROL DIAL TRANSPL, V25, P1757, DOI 10.1093/ndt/gfq206; Crow R, 2002, Health Technol Assess, V6, P1; Curtin R B, 2001, Nephrol Nurs J, V28, P385; Curtin RB, 2001, NEPHROL NURS J, V28, P393; Fadem SZ, 2011, CLIN J AM SOC NEPHRO, V6, P605, DOI 10.2215/CJN.06970810; Finkelstein FO, 2008, KIDNEY INT, V74, P1178, DOI 10.1038/ki.2008.376; Flynn KE, 2006, SOC SCI MED, V63, P1158, DOI 10.1016/j.socscimed.2006.03.030; Hingwala J, 2013, NEPHROL DIAL TRANSPL, V28, P732, DOI 10.1093/ndt/gfs323; Jager KJ, 2004, AM J KIDNEY DIS, V43, P891, DOI 10.1053/j.ajkd.2003.12.051; Kurella Tamura M, 2013, KIDNEY INT; Lameire N, 1999, NEPHROL DIAL TRANSPL, V14, P16, DOI 10.1093/ndt/14.suppl_6.16; Lameire N, 2002, KIDNEY INT, V61, pS27, DOI 10.1046/j.1523-1755.61.s80.6.x; Lee A, 2008, NEPHROL DIAL TRANSPL, V23, P3953, DOI 10.1093/ndt/gfn365; Lobbedez T, 2008, NEPHROL DIAL TRANSPL, V23, P3290, DOI 10.1093/ndt/gfn213; Lobbedez T, 2013, NEPHROL DIAL TRANSPL, V28, P1276, DOI 10.1093/ndt/gft018; Mehrotra R, 2005, KIDNEY INT, V68, P378; Morton RL, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c112; Morton RL, 2012, AM J KIDNEY DIS, V60, P102, DOI 10.1053/j.ajkd.2011.12.030; Moss AH, 2001, AM J KIDNEY DIS, V37, P1081; Muthalagappan S, 2013, NEPHROL DIAL TRANSPL, V28, P2717, DOI 10.1093/ndt/gft245; Oliver MJ, 2010, NEPHROL DIAL TRANSPL, V25, P2737, DOI 10.1093/ndt/gfq085; Povlsen JV, 2009, CONTRIB NEPHROL, V163, P261, DOI 10.1159/000223808; Song MK, 2013, NEPHROL DIAL TRANSPL, V28, P2815, DOI 10.1093/ndt/gft238; Stehman-Breen CO, 2000, KIDNEY INT, V57, P639, DOI 10.1046/j.1523-1755.2000.t01-1-00885.x; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Tennankore KK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-192; Van Biesen W, 1999, PERITON DIALYSIS INT, V19, pS273; Van Biesen W, 2013, NEPHROL DIAL TRANSPL, V28, P1980, DOI 10.1093/ndt/gft291; van der Veer SN, 2012, NEPHROL DIAL TRANSPL, V27, P4188, DOI 10.1093/ndt/gfs351; van der Veer SN, 2012, NEPHROL DIAL TRANSPL, V27, P3284, DOI 10.1093/ndt/gfs023; van der Weijden T, 2013, BMJ QUAL SAF, V22, P855, DOI 10.1136/bmjqs-2012-001502; Winterbottom A, 2007, NEPHROL DIAL TRANSPL, V22, P2291, DOI 10.1093/ndt/gfm095; Winterbottom AE, 2012, NEPHROL DIAL TRANSPL, V27, P325, DOI 10.1093/ndt/gfr266; Wright JA, 2011, AM J KIDNEY DIS, V57, P387, DOI 10.1053/j.ajkd.2010.09.018	38	52	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103914	10.1371/journal.pone.0103914	http://dx.doi.org/10.1371/journal.pone.0103914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079071	Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800094
J	Goodreau, SM; Carnegie, NB; Vittinghoff, E; Lama, JR; Fuchs, JD; Sanchez, J; Buchbinder, SP				Goodreau, Steven M.; Carnegie, Nicole B.; Vittinghoff, Eric; Lama, Javier R.; Fuchs, Jonathan D.; Sanchez, Jorge; Buchbinder, Susan P.			Can Male Circumcision Have an Impact on the HIV Epidemic in Men Who Have Sex with Men?	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; HOMOSEXUAL ROLE SEPARATION; RISK; ACQUISITION; PREVENTION; SURVEILLANCE; SPREAD; PERU	Background: Three trials have demonstrated the prophylactic effect of male circumcision (MC) for HIV acquisition among heterosexuals, and MC interventions are underway throughout sub-Saharan Africa. Similar efforts for men who have sex with men (MSM) are stymied by the potential for circumcised MSM to acquire HIV easily through receptive sex and transmit easily through insertive sex. Existing work suggests that MC for MSM should reach its maximum potential in settings where sexual role segregation is historically high and relatively stable across the lifecourse; HIV incidence among MSM is high; reported willingness for prophylactic circumcision is high; and pre-existing circumcision rates are low. We aim to identify the likely public health impact that MC interventions among MSM would have in one setting that fulfills these conditions-Peru-as a theoretical upper bound for their effectiveness among MSM generally. Methods and Findings: We use a dynamic, stochastic sexual network model based in exponential-family random graph modeling and parameterized from multiple behavioral surveys of Peruvian MSM. We consider three enrollment criteria (insertive during 100%, >80% or >60% of UAI) and two levels of uptake (25% and 50% of eligible men); we explore sexual role proportions from two studies and different frequencies of switching among role categories. Each scenario is simulated 10 times. We estimate that efficiency could reach one case averted per 6 circumcisions. However, the population-level impact of an optimistic MSM-MC intervention in this setting would likely be at most similar to 5-10% incidence and prevalence reductions over 25 years. Conclusions: Roll-out of MC for MSM in Peru would not result in a substantial reduction in new HIV infections, despite characteristics in this population that could maximize such effects. Additional studies are needed to confirm these results for other MSM populations, and providers may consider the individual health benefits of offering MC to their MSM patients.	[Goodreau, Steven M.] Univ Washington, Seattle, WA 98195 USA; [Carnegie, Nicole B.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Vittinghoff, Eric] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Lama, Javier R.; Sanchez, Jorge] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Fuchs, Jonathan D.; Buchbinder, Susan P.] San Francisco Dept Publ Hlth, San Francisco, CA USA	University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; San Francisco Department of Public Health	Goodreau, SM (corresponding author), Univ Washington, Seattle, WA 98195 USA.	goodreau@uw.edu	Goodreau, Steven/P-2366-2017	Carnegie, Nicole/0000-0001-7664-6682; Goodreau, Steven/0000-0003-1009-5763	US National Institutes of Health [R01 AI083060, R01 HD068395, R01 AI52054]; US Naval Medical Research Unit 6 [62787A S17 H B0002]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068395, R24HD042828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069496, R37AI051164, UM1AI069496, R01AI083060, R01AI052054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Naval Medical Research Unit 6; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding came from the US National Institutes of Health (R01 AI083060, R01 HD068395, R01 AI52054) and by US Naval Medical Research Unit 6 (Work Unit Number 62787A S17 H B0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J, 2009, J INFECT DIS, V200, P1803, DOI 10.1086/648472; Armbruster B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070043; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Caceres C F, 1999, Cult Health Sex, V1, P261, DOI 10.1080/136910599301012; Carrier J, 1995, OTROS INTIMACY HOMOS, Vxxii; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Chariyalertsak S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024295; Goodreau SM, 2005, J INFECT DIS, V191, pS147, DOI 10.1086/425268; Goodreau SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050522; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Guanira J, 2007, 4 INT AIDS SOC C HIV; Hunter David R, 2008, J Stat Softw, V24, pnihpa54860; Instituto Nacional de Estadistica e Informatica, 2011, B ANAL DEM, V36; Krivitsky PN, 2011, STAT METHODOL, V8, P319, DOI 10.1016/j.stamet.2011.01.005; Krivitsky PN, 2010, ARXIV10111937V1; Lama JR, 2006, JAIDS-J ACQ IMM DEF, V42, P501, DOI 10.1097/01.qai.0000221677.29693.dd; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Lau JTF, 2011, AIDS CARE, V23, P1472, DOI 10.1080/09540121.2011.565018; Lau JTF, 2012, J SEX MED, V9, P1904, DOI 10.1111/j.1743-6109.2010.02050.x; Londish GJ, 2010, SEX HEALTH, V7, P463, DOI 10.1071/SH09080; McDaid LM, 2010, SEX TRANSM INFECT, V86, P404, DOI 10.1136/sti.2010.042895; Millett GA, 2008, JAMA-J AM MED ASSOC, V300, P1674, DOI 10.1001/jama.300.14.1674; Murray S. O., 1995, LATIN AM MALE HOMOSE; Peinado J, 2007, J SEX RES, V44, P233, DOI 10.1080/00224490701443676; Rogers JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061725; Sanchez J, 2011, AIDS, V25, P519, DOI 10.1097/QAD.0b013e328340fd81; Sanchez J, 2009, JAIDS-J ACQ IMM DEF, V51, pS47, DOI 10.1097/QAI.0b013e3181a2671d; Soto RJ, 2007, JAIDS-J ACQ IMM DEF, V46, P101; Templeton DJ, 2010, CURR OPIN INFECT DIS, V23, P45, DOI 10.1097/QCO.0b013e328334e54d; Thornton AC, 2011, SEX TRANSM DIS, V38, P928, DOI 10.1097/OLQ.0b013e318221562a; TRICHOPOULOS D, 1988, LANCET, V2, P965; VANDRUTEN H, 1992, J SEX RES, V29, P477, DOI 10.1080/00224499209551663; Wasserman S, 1996, PSYCHOMETRIKA, V61, P401, DOI 10.1007/BF02294547; Wei CY, 2011, SEX TRANSM DIS, V38, P353, DOI 10.1097/OLQ.0b013e3181fe6523; WHO UNAIDS, 2011, PROGR SCAL MAL CIRC; Wiysonge CS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007496.pub2	38	19	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102960	10.1371/journal.pone.0102960	http://dx.doi.org/10.1371/journal.pone.0102960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076493	Green Submitted, Green Published, gold			2022-12-25	WOS:000340028800021
J	Ojikutu, B; Higgins-Biddle, M; Greeson, D; Phelps, BR; Amzel, A; Okechukwu, E; Kolapo, U; Cabral, H; Cooper, E; Hirschhorn, LR				Ojikutu, Bisola; Higgins-Biddle, Molly; Greeson, Dana; Phelps, Benjamin R.; Amzel, Anouk; Okechukwu, Emeka; Kolapo, Usman; Cabral, Howard; Cooper, Ellen; Hirschhorn, Lisa R.			The Association between Quality of HIV Care, Loss to Follow-Up and Mortality in Pediatric and Adolescent Patients Receiving Antiretroviral Therapy in Nigeria	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1-INFECTED CHILDREN; TREATMENT OUTCOMES; CLINICAL CARE; HEALTH-CARE; SCALE-UP; OF-CARE; PROGRAM; IMPROVEMENT; INITIATION	Access to pediatric HIV treatment in resource-limited settings has risen significantly. However, little is known about the quality of care that pediatric or adolescent patients receive. The objective of this study is to explore quality of HIV care and treatment in Nigeria and to determine the association between quality of care, loss-to-follow-up and mortality. A retrospective cohort study was conducted including patients <= 18 years of age who initiated ART between November 2002 and December 2011 at 23 sites across 10 states. 1,516 patients were included. A quality score comprised of 6 process indicators was calculated for each patient. More than half of patients (55.5%) were found to have a high quality score, using the median score as the cut-off. Most patients were screened for tuberculosis at entry into care (81.3%), had adherence measurement and counseling at their last visit (88.7% and 89.7% respectively), and were prescribed co-trimoxazole at some point during enrollment in care (98.8%). Thirty-seven percent received a CD4 count in the six months prior to chart review. Mortality within 90 days of ART initiation was 1.9%. A total of 4.2% of patients died during the period of follow-up (mean: 27 months) with 19.0% lost to follow-up. In multivariate regression analyses, weight for age z-score (Adjusted Hazard Ratio (AHR): 0.90; 95% CI: 0.85, 0.95) and high quality indicator score (compared a low score, AHR: 0.43; 95% CI: 0.26, 0.73) had a protective effect on mortality. Patients with a high quality score were less likely to be lost to follow-up (Adjusted Odds Ratio (AOR): 0.42; 95% CI: 0.32, 0.56), compared to those with low score. These findings indicate that providing high quality care to children and adolescents living with HIV is important to improve outcomes, including lowering loss to follow-up and decreasing mortality in this age group.	[Ojikutu, Bisola; Higgins-Biddle, Molly] John Snow Inc, Boston, MA 02210 USA; [Ojikutu, Bisola] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Greeson, Dana] Columbia Univ, Dept Epidemiol, New York, NY USA; [Phelps, Benjamin R.; Amzel, Anouk] US Agcy Int Dev, Washington, DC 20523 USA; [Okechukwu, Emeka] US Agcy Int Dev, Abuja, Nigeria; [Kolapo, Usman] Indepth Precis, Abuja, Nigeria; [Cabral, Howard] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Cooper, Ellen] Boston Univ, Sch Med, Boston, MA 02118 USA; [Hirschhorn, Lisa R.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Columbia University; United States Agency for International Development (USAID); United States Agency for International Development (USAID); Boston University; Boston University; Harvard University; Harvard Medical School	Ojikutu, B (corresponding author), John Snow Inc, Boston, MA 02210 USA.	bojikutu@jsi.com	Okechukwu, Emeka Franklin/AAH-1130-2020	Hirschhorn, Lisa/0000-0002-4355-7437; Ojikutu, Bisola/0000-0001-7957-8881	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development [GHH-I-00-07-00059-00]	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development under the terms of contract no. GHH-I-00-07-00059-00. Bisola Ojikutu and Molly-Higgins Biddle are employed by John Snow Inc. Usman Kolapo is employed by Indepth Precision. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EJ, 2012, JAIDS-J ACQ IMM DEF, V60, pS105, DOI 10.1097/QAI.0b013e31825cf4f5; Alemayehu YK, 2009, INT J QUAL HEALTH C, V21, P356, DOI 10.1093/intqhc/mzp030; Anigilaje EA, 2013, ISRN PEDIATR; Arrive E, 2008, JAIDS-J ACQ IMM DEF, V49, P523, DOI 10.1097/QAI.0b013e31818aadce; Braitstein P, 2011, JAIDS-J ACQ IMM DEF, V57, pE40, DOI 10.1097/QAI.0b013e3182167f0d; Brennan AT, 2011, AIDS, V25, P2027, DOI 10.1097/QAD.0b013e32834b6480; Brook RH, 1996, NEW ENGL J MED, V335, P966, DOI 10.1056/NEJM199609263351311; BROOK RH, 1977, MED CARE, V15, P1; Bygrave H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052856; Campbell SM, 2000, SOC SCI MED, V51, P1611, DOI 10.1016/S0277-9536(00)00057-5; Ciampa PJ, 2012, JAIDS-J ACQ IMM DEF, V60, pE46, DOI 10.1097/QAI.0b013e31824c0267; Davies MA, 2013, PEDIAT INFECT DIS J; Doherty T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-406; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; DONABEDIAN A, 1988, INQUIRY-J HEALTH CAR, V25, P173; Ekouevi DK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-519; Emdin CA, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18445; Evans D, 2013, AIDS RES HUM RETROV, V29, P892, DOI [10.1089/aid.2012.0215, 10.1089/AID.2012.0215]; Fayorsey RN, 2013, JAIDS-J ACQ IMM DEF, V62, pE124, DOI 10.1097/QAI.0b013e3182869558; Federal Ministry of Health of Nigeria, 2010, NAT GUID PED HIV AID; George E, 2007, J INFECT DIS, V195, P1411, DOI 10.1086/514823; Horberg M, 2011, AIDS PATIENT CARE ST, V25, P21, DOI 10.1089/apc.2010.0315; Kline MW, 2006, PEDIATRICS, V117, P1388, DOI 10.1542/peds.2005-1348; Lamb MR, 2014, AIDS, V28, P559, DOI 10.1097/QAD.0000000000000054; Leatherman S, 2010, INT J QUAL HEALTH C, V22, P237, DOI 10.1093/intqhc/mzq028; Leroy V, 2013, JAIDS-J ACQ IMM DEF, V62, P208, DOI 10.1097/QAI.0b013e31827b70bf; Lolekha R, 2010, JT COMM J QUAL PATIE, V36, P541, DOI 10.1016/S1553-7250(10)36082-X; Mainz J, 2003, INT J QUAL HEALTH C, V15, P523, DOI 10.1093/intqhc/mzg081; Marazzi MC, 2014, PEDIATR INFECT DIS J, V33, P295, DOI 10.1097/INF.0b013e3182a0994b; Meyers T, 2007, J INFECT DIS, V196, pS474, DOI 10.1086/521116; Moon TD, 2011, INT J STD AIDS, V22, P621, DOI 10.1258/ijsa.2011.010442; Morris MB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-5; Mukhtar-Yola Mariya, 2006, Afr J AIDS Res, V5, P141, DOI 10.2989/16085900609490374; Nyandiko W, 2013, JAIDS-J ACQ IMM DEF, V63, pE49, DOI 10.1097/QAI.0b013e31828e1e2c; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Sripipatana T, 2007, AM J OBSTET GYNECOL, V197, pS107, DOI 10.1016/j.ajog.2007.03.069; Sutcliffe CG, 2010, PEDIATR INFECT DIS J, V29, P849, DOI 10.1097/INF.0b013e3181e753a8; Thanprasertsuk S, 2012, INT J QUAL HEALTH C, V24, P338, DOI 10.1093/intqhc/mzs008; The Institute of Medicine, 1998, CROSS QUAL CHASM IOM; UNAIDS, 2011, GLOB HIV AIDS RESP E; UNAIDS, COUNTR PROF NIG; Virga PH, 2012, INT J MED INFORM, V81, pE39, DOI 10.1016/j.ijmedinf.2012.06.006; Walker AS, 2012, CLIN INFECT DIS, V55, P1707, DOI 10.1093/cid/cis797; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; Were MC, 2013, PEDIATRICS, V131, pE789, DOI 10.1542/peds.2012-2072; World Health Organization, 2013, TREATM HIV CHILDR; World Health Organization, 2011, GUID INT CAS FIND PE; World Health Organization, 2010, ANT THER HIV INF INF; Zanoni BC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022706; Zhao Y, 2013, CLIN INFECT DIS, V56, P735, DOI 10.1093/cid/cis941	50	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e100039	10.1371/journal.pone.0100039	http://dx.doi.org/10.1371/journal.pone.0100039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM7EZ	25075742	Green Published, Green Submitted, gold			2022-12-25	WOS:000340028800004
J	Wang, C; Yu, YQ; Zhang, XY; Li, Y; Kou, CG; Li, B; Tao, YC; Zhen, Q; He, H; Kanu, JS; Huang, XF; Han, M; Liu, YW				Wang, Chang; Yu, Yaqin; Zhang, Xiangyang; Li, Yong; Kou, Changgui; Li, Bo; Tao, Yuchun; Zhen, Qing; He, Huan; Kanu, Joseph Sam; Huang, Xufeng; Han, Mei; Liu, Yawen			Awareness, Treatment, Control of Diabetes Mellitus and the Risk Factors: Survey Results from Northeast China	PLOS ONE			English	Article							INADEQUATE GLYCEMIC CONTROL; UNITED-STATES; SELF-CARE; PREVALENCE; ADULTS; HEALTH	Background: The awareness, treatment and control of diabetes mellitus (DM) can effectively reflect on the social status of diabetes conditions. Although several researchers have investigated the awareness, treatment and control rates of diabetes mellitus in China, little is known about their association with risk factors. This study aims to examine the relationship between risk factors and awareness, treatment and control of diabetes mellitus in northeast China. Methods: A cross-sectional survey was conducted in 2012. Multistage stratified random duster sampling design was used to select participants aged 18 to 79 years old. The analysis was based on a representative sample of 1,854 adult subjects. Multivariable logistic regression analysis was used to examine socio-demographic factors associated with the levels of awareness, treatment and control of diabetes mellitus. Results:The awareness, treatment, and control rates of diabetes mellitus were 64.1%, 52.9% and 44.2%, respectively. In the multivariable logistic regression analysis, family history of diabetes was significantly positively associated with awareness (OR, 2.145; 95% CI, 1.600-2.875) and treatment (OR, 2.021; 95% Cl, 1.559-2.619) of diabetes mellitus, while negatively associated with control (OR, 0.671; 95% CI, 0.529-0.951). Cigarette smokers and alcohol drinkers were less likely than nonsmokers and non-drinkers to be aware of their blood glucose levels (OR, 0.895, 0.614; 95% CI, 0.659-1.216, 0.446-0.844, respectively). Participants who frequently exercise were more likely to be aware of their diabetic conditions than people who never or rarely exercise (OR, 2.003; 95% CI, 1.513-2.651). Conclusions: We found that the awareness and treatment of diabetes mellitus were positively associated with age and were high in participants with a family history of diabetes and those who exercise frequently, but low for cigarette smokers and alcohol drinkers. Participants with a family history of diabetes had their diabetic condition poorly controlled.	[Wang, Chang; Yu, Yaqin; Li, Yong; Kou, Changgui; Li, Bo; Tao, Yuchun; Zhen, Qing; He, Huan; Kanu, Joseph Sam; Liu, Yawen] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Changchun, Jilin Province, Peoples R China; [Zhang, Xiangyang] Peking Univ, Beijing Hui Long Guan Hosp, Beijing 100871, Peoples R China; [Huang, Xufeng; Han, Mei] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia	Jilin University; Peking University; University of Wollongong	Liu, YW (corresponding author), Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Changchun, Jilin Province, Peoples R China.	ywliu@jlu.edu.cn	He, Huan/AAF-9644-2019; Huang, Xu-Feng/D-6053-2013; Li, Bo/AAA-8968-2020; Huang, Xu-Feng/H-7408-2015; liu, yawen/J-2471-2014	Huang, Xu-Feng/0000-0002-5895-2253; Li, Bo/0000-0002-7294-6888; Huang, Xu-Feng/0000-0002-5895-2253; Kanu, Joseph Sam/0000-0003-0799-6907; He, Huan/0000-0001-8123-5765	Scientific Research Foundation of the Health Bureau of Jilin Province, China [2011Z116]	Scientific Research Foundation of the Health Bureau of Jilin Province, China	This work was supported by the Scientific Research Foundation of the Health Bureau of Jilin Province, China (Grant Number 2011Z116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkerwi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057920; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; Cai L, 2011, TROP MED INT HEALTH, V16, P1070, DOI 10.1111/j.1365-3156.2011.02805.x; Chen R, 2012, PLOS ONE, V7, P1; Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035; Fox KM, 2006, CLIN THER, V28, P388, DOI 10.1016/j.clinthera.2006.03.005; Hu DS, 2008, DIABETES RES CLIN PR, V81, P250, DOI 10.1016/j.diabres.2008.04.008; Kaiser A, 2012, DIABETIC MED, V29, P190, DOI 10.1111/j.1464-5491.2011.03422.x; Lou P, 2010, ZHONG HUA XIAN DAI H, V16, P2371; McDonald M, 2009, J GERONTOL A-BIOL, V64, P256, DOI 10.1093/gerona/gln016; Nyenwe EA, 2003, DIABETES RES CLIN PR, V62, P177, DOI 10.1016/j.diabres.2003.07.002; Ong KL, 2008, ANN EPIDEMIOL, V18, P222, DOI 10.1016/j.annepidem.2007.10.007; Shah BR, 2005, J EVAL CLIN PRACT, V11, P568, DOI 10.1111/j.1365-2753.2005.00582.x; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sims M, 2011, ANN EPIDEMIOL, V21, P892, DOI 10.1016/j.annepidem.2011.05.006; Toljamo M, 2001, J ADV NURS, V34, P780, DOI 10.1046/j.1365-2648.2001.01808.x; Mendes ABV, 2010, ACTA DIABETOL, V47, P137, DOI 10.1007/s00592-009-0138-z; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wong CKH, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-142; Wu Yang-feng, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P564; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yifeng L, 2008, J MED FORUM, V29; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; Zhou YJ, 2013, EXP THER MED, V5, P1137, DOI 10.3892/etm.2013.945	25	48	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103594	10.1371/journal.pone.0103594	http://dx.doi.org/10.1371/journal.pone.0103594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068894	gold, Green Submitted, Green Published			2022-12-25	WOS:000339993700081
J	Borre, L; Andreassen, TF; Shi, L; Weinstein, H; Gether, U				Borre, Lars; Andreassen, Thorvald F.; Shi, Lei; Weinstein, Harel; Gether, Ulrik			The Second Sodium Site in the Dopamine Transporter Controls Cation Permeation and Is Regulated by Chloride	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEROTONIN TRANSPORTER; PLASMA-MEMBRANE; BINDING-SITES; ION-BINDING; NEUROTRANSMITTER; SUBSTRATE; RELEASE; LEUT; NA+; AMPHETAMINE	The dopamine transporter (DAT) belongs to the family of neurotransmitter: sodium symporters and controls dopamine (DA) homeostasis by mediating Na+- and Cl--dependent reuptake of DA. Here we used two-electrode voltage clamp measurements in Xenopus oocytes together with targeted mutagenesis to investigate the mechanistic relationship between DAT ion binding sites and transporter conductances. In Li+, DAT displayed a cocaine-sensitive cation leak current similar to 10-fold larger than the substrate-induced current in Na+. Mutation of Na+ coordinating residues in the first (Na1) and second (Na2) binding sites suggested that the Li+ leak depends on Li+ interaction with Na2 rather than Na1. DA caused a marked inhibition of the Li+ leak, consistent with the ability of the substrate to interact with the Li+-occupied state of the transporter. The leak current in Li+ was also potently inhibited by low millimolar concentrations of Na+, which according to our mutational data conceivably depended on high affinity binding to Na1. The Li+ leak was further regulated by Cl- that most likely increases Li+ permeation by allosterically lowering Na2 affinity. Interestingly, mutational lowering of Na2 affinity by substituting Asp-420 with asparagine dramatically increased cation permeability in Na+ to a level higher than seen in Li+. In addition to reveal a functional link between the bound Cl- and the cation bound in the Na2 site, the data support a key role of Na2 in determining cation permeability of the transporter and thereby possibly in regulating the opening probability of the inner gate.	[Borre, Lars; Andreassen, Thorvald F.; Gether, Ulrik] Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, Dept Neurosci & Pharmacol, Mol Neuropharmacol Lab,Fac Hlth & Med Sci,Panum I, DK-2200 Copenhagen N, Denmark; [Shi, Lei; Weinstein, Harel] Cornell Univ, Dept Physiol & Biophys, Weill Med Coll, New York, NY 10021 USA; [Shi, Lei; Weinstein, Harel] Cornell Univ, Inst Computat Biomed, Weill Med Coll, New York, NY 10021 USA	Lundbeckfonden; University of Copenhagen; Cornell University; Cornell University	Borre, L (corresponding author), Panum Inst 18 6, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark.	lbo29917134@gmail.com; gether@sund.ku.dk	WEINSTEIN, HAREL/O-8245-2019; Shi, Lei/AAV-1321-2020	WEINSTEIN, HAREL/0000-0003-3473-9818; Shi, Lei/0000-0002-4137-096X; Gether, Ulrik/0000-0002-0020-3807	National Institutes of Health [P01 DA 12408]; Danish Medical Research Council; University of Copenhagen BioScaRT Program of Excellence; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Novo Nordisk Foundation; Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; Lundbeck Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Copenhagen BioScaRT Program of Excellence; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DA 12408 (to U. G. and H. W.). This work was also supported by the Danish Medical Research Council (to U. G.), University of Copenhagen BioScaRT Program of Excellence (to U. G.), Lundbeck Foundation Center for Biomembranes in Nanomedicine (to U. G.), the Novo Nordisk Foundation (to U. G.), Fabrikant Vilhelm Pedersen og Hustrus Mindelegat (to U. G.), and The Lundbeck Foundation (to L. B.).	Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Caplan DA, 2008, BIOPHYS J, V95, P4613, DOI 10.1529/biophysj.108.139741; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; Chen NH, 2000, EUR J PHARMACOL, V405, P329, DOI 10.1016/S0014-2999(00)00563-X; COSTA PF, 1989, J PHYSIOL-LONDON, V413, P199, DOI 10.1113/jphysiol.1989.sp017649; Erreger K, 2008, J NEUROSCI, V28, P976, DOI 10.1523/JNEUROSCI.2796-07.2008; Felts B, 2014, J BIOL CHEM, V289, P1825, DOI 10.1074/jbc.M113.504654; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Galli A, 1997, J NEUROSCI, V17, P3401; Galli A, 1996, P NATL ACAD SCI USA, V93, P8671, DOI 10.1073/pnas.93.16.8671; GIROS B, 1992, MOL PHARMACOL, V42, P383; GU H, 1994, J BIOL CHEM, V269, P7124; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hamilton PJ, 2013, MOL PSYCHIATR, V18, P1315, DOI 10.1038/mp.2013.102; Hansen FH, 2014, J CLIN INVEST, V124, P3107, DOI 10.1172/JCI73778; Henry LK, 2011, J BIOL CHEM, V286, P30823, DOI 10.1074/jbc.M111.250308; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; KRUEGER BK, 1990, J NEUROCHEM, V55, P260, DOI 10.1111/j.1471-4159.1990.tb08847.x; Kurian MA, 2011, LANCET NEUROL, V10, P721, DOI 10.1016/S1474-4422(11)70141-7; Lin F, 1996, BIOPHYS J, V71, P3126, DOI 10.1016/S0006-3495(96)79506-1; MacAulay N, 2002, J PHYSIOL-LONDON, V544, P447, DOI 10.1113/jphysiol.2002.022897; Mager S, 1996, J NEUROSCI, V16, P5405; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Mazei-Robison MS, 2008, J NEUROSCI, V28, P7040, DOI 10.1523/JNEUROSCI.0473-08.2008; Meinild AK, 2004, J BIOL CHEM, V279, P49671, DOI 10.1074/jbc.M407660200; Meinild AK, 2012, AM J PHYSIOL-CELL PH, V302, pC1661, DOI 10.1152/ajpcell.00446.2011; Ni YG, 2001, J BIOL CHEM, V276, P30942, DOI 10.1074/jbc.M104653200; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Porzgen P, 2001, MOL PHARMACOL, V59, P83; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Schmitt KC, 2013, J PHARMACOL EXP THER, V346, P2, DOI 10.1124/jpet.111.191056; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sonders MS, 1997, J NEUROSCI, V17, P960; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; WALL SC, 1995, MOL PHARMACOL, V47, P544; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao CF, 2011, BIOCHEMISTRY-US, V50, P1848, DOI 10.1021/bi101454f; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	52	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25764	25773		10.1074/jbc.M114.574269	http://dx.doi.org/10.1074/jbc.M114.574269			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25063810	Green Published, hybrid			2022-12-25	WOS:000342130800034
J	Jagannathan, S; Hsu, JCC; Reid, DW; Chen, Q; Thompson, WJ; Moseley, AM; Nicchitta, CV				Jagannathan, Sujatha; Hsu, Jack C. -C.; Reid, David W.; Chen, Qiang; Thompson, Will J.; Moseley, Arthur M.; Nicchitta, Christopher V.			Multifunctional Roles for the Protein Translocation Machinery in RNA Anchoring to the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; MEMBRANE-PROTEINS; MICROSOMAL-MEMBRANES; RIBOSOME RECEPTOR; DIRECT ASSOCIATION; STATISTICAL-MODEL; BINDING PROTEINS; LOCALIZATION; TRANSLATION; IDENTIFICATION	Signal sequence-encoding mRNAs undergo translation-dependent localization to the endoplasmic reticulum (ER) and at the ER are anchored via translation on Sec61-bound ribosomes. Recent investigations into the composition and membrane association characteristics of ER-associated mRNAs have, however, revealed both ribosome-dependent (indirect) and ribosome-independent (direct) modes of mRNA association with the ER. These findings raise important questions regarding our understanding of how mRNAs are selected, localized, and anchored to the ER. Using semi-intact tissue culture cells, we performed a polysome solubilization screen and identified conditions that distinguish polysomes engaged in the translation of distinct cohorts of mRNAs. To gain insight into the molecular basis of direct mRNA anchoring to the ER, we performed RNA-protein UV photocross-linking studies in rough microsomes and demonstrate that numerous ER integral membrane proteins display RNA binding activity. Quantitative proteomic analyses of HeLa cytosolic and ER-bound polysome fractions identified translocon components as selective polysome-interacting proteins. Notably, the Sec61 complex was highly enriched in polysomes engaged in the translation of endomembrane organelle proteins, whereas translocon accessory proteins, such as ribophorin I, were present in all subpopulations of ER-associated polysomes. Analyses of the protein composition of oligo(dT)-selected UV photocross-linked ER protein-RNA adducts identified Sec61 alpha,beta and ribophorin I as ER-poly(A) mRNA-binding proteins, suggesting unexpected roles for the protein translocation and modification machinery in mRNA anchoring to the ER. In summary, we propose that multiple mechanisms of mRNA and ribosome association with ER operate to enable an mRNA transcriptome-wide function for the ER in protein synthesis.	[Jagannathan, Sujatha; Chen, Qiang; Nicchitta, Christopher V.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Hsu, Jack C. -C.; Reid, David W.; Nicchitta, Christopher V.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Thompson, Will J.; Moseley, Arthur M.] Duke Univ, Med Ctr, Duke Prote Core Facil, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Nicchitta, CV (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3709, Durham, NC 27710 USA.	christopher.nicchitta@duke.edu		Hsu, Chun Chieh/0000-0003-4380-8723; Jagannathan, Sujatha/0000-0001-9039-2631	National Institutes of Health [GM101533]; Duke University School of Medicine; National Institutes of Health, NCRR, Shared Instrumentation Grant [1S10RR027528-0]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University School of Medicine; National Institutes of Health, NCRR, Shared Instrumentation Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM101533 (to C. V. N.). This work was also supported by a bridge-funding award from the Duke University School of Medicine (to C. V. N.). The DeltaVision system was purchased with funding from National Institutes of Health, NCRR, Shared Instrumentation Grant 1S10RR027528-0.	Axelsson MAB, 2004, MOL BIOL CELL, V15, P1843, DOI 10.1091/mbc.E03-07-0459; Bai JZ, 2008, CELL BIOL INT, V32, P473, DOI 10.1016/j.cellbi.2007.10.002; BECKERS CJM, 1987, CELL, V50, P523, DOI 10.1016/0092-8674(87)90025-0; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Blobel G, 1979, Symp Soc Exp Biol, V33, P9; Blobel G, 2000, BIOSCIENCE REP, V20, P303, DOI 10.1023/A:1010318832604; Blower MD, 2013, INT REV CEL MOL BIO, V302, P1, DOI 10.1016/B978-0-12-407699-0.00001-7; BORDIER C, 1981, J BIOL CHEM, V256, P1604; CARDELLI J, 1976, J CELL BIOL, V70, P47, DOI 10.1083/jcb.70.1.47; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen Q, 2011, MOL BIOL CELL, V22, P2646, DOI 10.1091/mbc.E11-03-0239; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Cui XYA, 2013, J BIOL CHEM, V288, P29633, DOI 10.1074/jbc.M113.482505; Cui XYA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001336; Dejgaard K, 2010, J PROTEOME RES, V9, P1763, DOI 10.1021/pr900900x; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Dimitrov L, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013243; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Dowell JA, 2008, ANAL CHEM, V80, P6715, DOI 10.1021/ac8007994; FREIDLIN PJ, 1980, BIOCHEM BIOPH RES CO, V93, P521, DOI 10.1016/0006-291X(80)91108-0; Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042; Gilar M, 2005, ANAL CHEM, V77, P6426, DOI 10.1021/ac050923i; Gilar M, 2005, J SEP SCI, V28, P1694, DOI 10.1002/jssc.200500116; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Guth S, 2004, EUR J BIOCHEM, V271, P3200, DOI 10.1111/j.1432-1033.2004.04252.x; Hamilton RS, 2011, METHODS MOL BIOL, V714, P447, DOI 10.1007/978-1-61779-005-8_27; HARTMANN E, 1993, EUR J BIOCHEM, V214, P375, DOI 10.1111/j.1432-1033.1993.tb17933.x; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Jagannathan S, 2011, METHODS MOL BIOL, V714, P301, DOI 10.1007/978-1-61779-005-8_19; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KIKUCHI Y, 1978, P NATL ACAD SCI USA, V75, P1270, DOI 10.1073/pnas.75.3.1270; Kraut-Cohen J, 2013, MOL BIOL CELL, V24, P3069, DOI 10.1091/mbc.E13-01-0038; Kraut-Cohen J, 2010, TRENDS BIOCHEM SCI, V35, P459, DOI 10.1016/j.tibs.2010.02.006; KREIBICH G, 1978, J CELL BIOL, V77, P464, DOI 10.1083/jcb.77.2.464; KRUPPA J, 1977, J CELL BIOL, V74, P414, DOI 10.1083/jcb.74.2.414; LANDE MA, 1975, J CELL BIOL, V65, P513, DOI 10.1083/jcb.65.3.513; Langley R, 1998, DNA CELL BIOL, V17, P449, DOI 10.1089/dna.1998.17.449; Lerner RS, 2003, RNA, V9, P1123, DOI 10.1261/rna.5610403; LODISH HF, 1977, J CELL BIOL, V74, P358, DOI 10.1083/jcb.74.2.358; LONGUET M, 1979, BIOCHIMIE, V61, P1113; Loya A, 2008, RNA, V14, P1352, DOI 10.1261/rna.867208; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mathias RA, 2011, METHODS, V54, P396, DOI 10.1016/j.ymeth.2011.01.006; Medioni C, 2012, DEVELOPMENT, V139, P3263, DOI 10.1242/dev.078626; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Milam SL, 2012, BIOPHYS J, V103, P59, DOI 10.1016/j.bpj.2012.05.035; Morgan DG, 2002, J MOL BIOL, V324, P871, DOI 10.1016/S0022-2836(02)01111-7; Morris AR, 2010, WIRES SYST BIOL MED, V2, P162, DOI 10.1002/wsbm.54; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Nicchitta CV, 2005, BIOCHEM CELL BIOL, V83, P687, DOI 10.1139/O05-147; NICCHITTA CV, 1993, CELL, V73, P989, DOI 10.1016/0092-8674(93)90276-V; Ogawa-Goto K, 2002, J VIROL, V76, P2350, DOI 10.1128/JVI.76.5.2350-2362.2002; Ogawa-Goto K, 2007, MOL BIOL CELL, V18, P3741, DOI 10.1091/mbc.E06-12-1125; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PASHEV IG, 1991, TRENDS BIOCHEM SCI, V16, P323, DOI 10.1016/0968-0004(91)90133-G; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Pyhtila B, 2008, RNA, V14, P445, DOI 10.1261/rna.721108; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; RAPOPORT TA, 1989, BIOCHEM SOC T, V17, P325, DOI 10.1042/bst0170325; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; SAVITZ AJ, 1990, NATURE, V346, P540, DOI 10.1038/346540a0; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P589, DOI 10.1074/mcp.M500321-MCP200; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Song YP, 2010, J PROTEOME RES, V9, P1195, DOI 10.1021/pr900146t; Stalder L, 2013, EMBO J, V32, P1115, DOI 10.1038/emboj.2013.52; Stephens SB, 2008, MOL BIOL CELL, V19, P623, DOI 10.1091/mbc.E07-07-0677; Stephens Samuel B., 2008, V419, P197, DOI 10.1007/978-1-59745-033-1_14; Stephens S, 2007, THEATER HEUTE, P47; Suh J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-333; Trcek T, 2013, GENE DEV, V27, P541, DOI 10.1101/gad.209635.112; Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671; Ueno T, 2012, NUCLEIC ACIDS RES, V40, P3006, DOI 10.1093/nar/gkr1197; Ueno T, 2010, J BIOL CHEM, V285, P29941, DOI 10.1074/jbc.M109.094607; VEIS A, 1985, P NATL ACAD SCI USA, V82, P3693, DOI 10.1073/pnas.82.11.3693; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Weil D, 2013, BBA-GENE REGUL MECH, V1829, P725, DOI 10.1016/j.bbagrm.2013.01.002; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	96	28	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25907	25924		10.1074/jbc.M114.580688	http://dx.doi.org/10.1074/jbc.M114.580688			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25063809	Green Published, hybrid			2022-12-25	WOS:000342130800046
J	Kannangara, TS; Bostrom, CA; Ratzlaff, A; Thompson, L; Cater, RM; Gil-Mohapel, J; Christie, BR				Kannangara, Timal S.; Bostrom, Crystal A.; Ratzlaff, Andrea; Thompson, Lee; Cater, Robyn M.; Gil-Mohapel, Joana; Christie, Brian R.			Deletion of the NMDA Receptor GluN2A Subunit Significantly Decreases Dendritic Growth in Maturing Dentate Granule Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; POSTNATAL HIPPOCAMPAL NEUROGENESIS; ADULT HIPPOCAMPUS; SPINE DENSITY; RAT-BRAIN; IN-VITRO; FUNCTIONAL-PROPERTIES; DEPENDENT REGULATION; CELL-PROLIFERATION; EPSILON-1 SUBUNIT	It is known that NMDA receptors can modulate adult hippocampal neurogenesis, but the contribution of specific regulatory GluN2 subunits has been difficult to determine. Here we demonstrate that mice lacking GluN2A (formerly NR2A) do not show altered cell proliferation or neuronal differentiation, but present significant changes in neuronal morphology in dentate granule cells. Specifically, GluN2A deletion significantly decreased total dendritic length and dendritic complexity in DG neurons located in the inner granular zone. Furthermore, the absence of GluN2A also resulted in a localized increase in spine density in the middle molecular layer, a region innervated by the medial perforant path. Interestingly, alterations in dendritic morphology and spine density were never seen in dentate granule cells located in the outer granular zone, a region that has been hypothesized to contain older, more mature, neurons. These results indicate that although the GluN2A subunit is not critical for the cell proliferation and differentiation stages of the neurogenic process, it does appear to play a role in establishing synaptic and dendritic morphology in maturing dentate granule cells localized in the inner granular zone.	[Kannangara, Timal S.; Bostrom, Crystal A.; Ratzlaff, Andrea; Thompson, Lee; Cater, Robyn M.; Gil-Mohapel, Joana; Christie, Brian R.] Univ Victoria, Div Med Sci, Victoria, BC, Canada; [Bostrom, Crystal A.; Ratzlaff, Andrea; Thompson, Lee; Cater, Robyn M.; Christie, Brian R.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Christie, Brian R.] Univ Victoria, Grad Program Neurosci, Victoria, BC, Canada; [Kannangara, Timal S.; Christie, Brian R.] Univ British Columbia, Dept Cellular & Physiol Sci, Victoria, BC, Canada; [Kannangara, Timal S.; Christie, Brian R.] Univ British Columbia, Grad Program Neurosci, Victoria, BC, Canada; [Kannangara, Timal S.; Christie, Brian R.] Univ British Columbia, Brain Res Ctr, Victoria, BC, Canada	University of Victoria; University of Victoria; University of Victoria; University of British Columbia; University of British Columbia; University of British Columbia	Christie, BR (corresponding author), Univ Victoria, Div Med Sci, Victoria, BC, Canada.	brain64@uvic.ca	Christie, Brian Ross/AAF-3766-2019; Gil-Mohapel, Joana/AAP-8871-2021	Christie, Brian Ross/0000-0002-6830-0160; Gil-Mohapel, Joana/0000-0003-4982-1662; Kannangara, Timal/0000-0003-1893-7961	Canadian Institutes for Health Research (CIHR MOP) [125888]; Fragile-X Research Foundation of Canada	Canadian Institutes for Health Research (CIHR MOP)(Canadian Institutes of Health Research (CIHR)); Fragile-X Research Foundation of Canada	This work was supported by the Canadian Institutes for Health Research (CIHR MOP 125888) and Fragile-X Research Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2009, J NEUROSCI, V29, P10869, DOI 10.1523/JNEUROSCI.5531-08.2009; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Arvidsson A, 2001, EUR J NEUROSCI, V14, P10, DOI 10.1046/j.0953-816x.2001.01611.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRAMHAM CR, 1991, BRAIN RES, V567, P42, DOI 10.1016/0006-8993(91)91433-2; BREWER GJ, 1989, NEUROSCI LETT, V99, P268, DOI 10.1016/0304-3940(89)90458-8; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Brunet JF, 1999, BIOESSAYS, V21, P313, DOI 10.1002/(SICI)1521-1878(199904)21:4<313::AID-BIES7>3.0.CO;2-C; Cameron HA, 1998, NEUROSCIENCE, V82, P349; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Chancey JH, 2013, J NEUROSCI, V33, P6614, DOI 10.1523/JNEUROSCI.0781-13.2013; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P19, DOI 10.1113/jphysiol.1983.sp014477; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Espinosa JS, 2009, NEURON, V62, P205, DOI 10.1016/j.neuron.2009.03.006; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Ewald RC, 2008, J NEUROSCI, V28, P850, DOI 10.1523/JNEUROSCI.5078-07.2008; Ewald RC, 2009, FRONT NEUROSCI, P1; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Gambrill AC, 2011, P NATL ACAD SCI USA, V108, P5855, DOI 10.1073/pnas.1012676108; Gao C, 2011, J NEUROSCI, V31, P8533, DOI 10.1523/JNEUROSCI.1300-11.2011; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Gil-Mohapel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075125; Gould E, 1997, J NEUROSCI, V17, P2492; Gray JA, 2011, NEURON, V71, P1085, DOI 10.1016/j.neuron.2011.08.007; Henle F, 2012, N-S ARCH PHARMACOL, V385, P171, DOI 10.1007/s00210-011-0701-3; Hu M, 2009, EUR J PHARMACOL, V622, P37, DOI 10.1016/j.ejphar.2009.09.031; Ino H, 2000, MOL BRAIN RES, V78, P163, DOI 10.1016/S0169-328X(00)00092-9; Jiang W, 2004, BRAIN RES, V1020, P154, DOI 10.1016/j.brainres.2004.06.028; Kannangara TS, 2011, NEUROBIOL AGING, V32, P2279, DOI 10.1016/j.neurobiolaging.2009.12.025; Kannangara TS, 2009, HIPPOCAMPUS, V19, P889, DOI 10.1002/hipo.20514; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; KEMPERMANN G, 2006, ADULT NEUROGENESIS S; Kitamura T, 2003, NEUROSCI RES, V47, P55, DOI 10.1016/S0168-0102(03)00171-8; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Lee LJ, 2005, J NEUROSCI, V25, P2304, DOI 10.1523/JNEUROSCI.4902-04.2005; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Nacher J, 2007, NEUROSCIENCE, V144, P855, DOI 10.1016/j.neuroscience.2006.10.021; Nacher J, 2006, HIPPOCAMPUS, V16, P267, DOI 10.1002/hipo.20160; Nacher J, 2003, NEUROBIOL AGING, V24, P273, DOI 10.1016/S0197-4580(02)00096-9; Nacher J, 2001, EUR J NEUROSCI, V13, P512, DOI 10.1046/j.0953-816x.2000.01424.x; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; Nixon K, 2004, J NEUROSCI, V24, P9714, DOI 10.1523/JNEUROSCI.3063-04.2004; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petrus DS, 2009, EUR J NEUROSCI, V29, P244, DOI 10.1111/j.1460-9568.2008.06579.x; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Redila VA, 2006, NEUROSCIENCE, V137, P1299, DOI 10.1016/j.neuroscience.2005.10.050; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Schmidt-Salzmann C, 2014, J PHYSIOL-LONDON, V592, P125, DOI 10.1113/jphysiol.2013.267203; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sepulveda FJ, 2010, J NEUROPHYSIOL; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SHOLL D A, 1956, Prog Neurobiol, P324; Simpson JM, 2011, NEUROBIOL DIS, V41, P249, DOI 10.1016/j.nbd.2010.09.012; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Tovar KR, 1999, J NEUROSCI, V19, P4180; Townsend M, 2003, P NATL ACAD SCI USA, V100, P1340, DOI 10.1073/pnas.0335786100; Tronel S, 2010, P NATL ACAD SCI USA, V107, P7963, DOI 10.1073/pnas.0914613107; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Ven TJV, 2005, J NEUROSCI, V25, P9488, DOI 10.1523/JNEIROSCI.2450-05.2005; Vlachos A, 2013, NEUROBIOL DIS, V59, P267, DOI 10.1016/j.nbd.2013.07.018; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Wenzel A, 1997, J NEUROCHEM, V68, P469; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	83	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103155	10.1371/journal.pone.0103155	http://dx.doi.org/10.1371/journal.pone.0103155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083703	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800019
J	Lee, EY; Kim, SS; Lee, JS; Kim, IJ; Song, SH; Cha, SK; Park, KS; Kang, JS; Chung, CH				Lee, Eun Young; Kim, Sang Soo; Lee, Ji-Sung; Kim, In Joo; Song, Sang Heon; Cha, Seung-Kuy; Park, Kyu-Sang; Kang, Jeong Suk; Chung, Choon Hee			Soluble alpha-Klotho as a Novel Biomarker in the Early Stage of Nephropathy in Patients with Type 2 Diabetes	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; TRPV5 CHANNEL; MICE; EXCRETION; URINARY; PROTEIN	Objective: Although alpha-klotho is known as an anti-aging, antioxidant, and cardio-renal protective protein, the clinical implications of soluble alpha-klotho levels in patients with diabetes have not been evaluated. Therefore, this study evaluated whether plasma and urinary alpha-klotho levels are associated with albuminuria in kidney disease in diabetes. Research Design and Methods: A total of 147 patients with type 2 diabetes and 25 healthy control subjects were enrolled. The plasma and urine concentrations of alpha-klotho were analyzed by enzyme-linked immunosorbent assay. Results: Plasma alpha-klotho (572.4 pg/mL [95% CI, 541.9-604.6 pg/mL] vs. 476.9 pg/mL [95% CI, 416.9-545.5 pg/mL]) and urinary alpha-klotho levels (59.8 pg/mg creatinine [95% CI, 43.6-82.0 pg/mg creatinine] vs. 21.0 pg/mg creatinine [95% CI, 9.7-45.6 pg/mg creatinine]) were significantly higher in diabetic patients than non-diabetic controls. Among diabetic patients, plasma alpha-klotho concentration was inversely associated with albuminuria stages (normoalbuminuria, 612.6 pg/mL [95% CI, 568.9-659.6 pg/mL], microalbuminuria, 551.8 pg/mL [95% CI, 500.5-608.3 pg/mL], and macroalbuminuria, 505.7 pg/mL [95% CI, 439.7-581.7 pg/mL] (p for trend = 0.0081), while urinary alpha-klotho levels were remained constantly high with increasing urinary albumin excretion. Conclusions: Soluble alpha-klotho levels in plasma and urine may be novel and useful early markers of diabetic renal injury.	[Lee, Eun Young; Kang, Jeong Suk] Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea; [Kim, Sang Soo; Kim, In Joo; Song, Sang Heon] Pusan Natl Univ Hosp, Dept Internal Med, Pusan, South Korea; [Lee, Ji-Sung] Soonchunhyang Univ, Med Ctr, Biostat Consulting Unit, Seoul, South Korea; [Cha, Seung-Kuy; Park, Kyu-Sang] Yonsei Univ, Wonju Coll Med, Dept Physiol, Wonju, South Korea; [Chung, Choon Hee] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea	Soonchunhyang University; Pusan National University; Pusan National University Hospital; Soonchunhyang University; Yonsei University; Yonsei University	Lee, EY (corresponding author), Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea.	eylee@sch.ac.kr	Park, Kyong Soo/C-2265-2008; Lee, Eun Young/Q-6592-2019	Park, Kyong Soo/0000-0003-3597-342X; Lee, Eun Young/0000-0002-4513-9888; Chung, Choon/0000-0003-1144-7206; Park, Kyu-Sang/0000-0003-0322-9807	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2012R1A1A2044121]; Soonchunhyang University [20130626]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology; Soonchunhyang University	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2012R1A1A2044121) and the Soonchunhyang University Research Fund (No. 20130626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetunji OR, 2009, DIABETES RES CLIN PR, V85, P179, DOI 10.1016/j.diabres.2009.04.028; Akimoto T, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-155; Asai O, 2012, KIDNEY INT, V81, P539, DOI 10.1038/ki.2011.423; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Devaraj S, 2012, AM J CLIN PATHOL, V137, P479, DOI 10.1309/AJCPGPMAF7SFRBO4; Hu MC, 2012, NEPHROL DIAL TRANSPL, V27, P2650, DOI 10.1093/ndt/gfs160; Hu MC, 2012, ADV EXP MED BIOL, V728, P126, DOI 10.1007/978-1-4614-0887-1_9; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2012, NAT REV NEPHROL, V8, P423, DOI 10.1038/nrneph.2012.92; Kacso IM, 2012, CLIN BIOCHEM, V45, P1415, DOI 10.1016/j.clinbiochem.2012.07.098; Karalliedde J, 2013, CLIN J AM SOC NEPHRO, V8, P1899, DOI 10.2215/CJN.02700313; Kempe DS, 2009, PFLUG ARCH EUR J PHY, V458, P503, DOI 10.1007/s00424-009-0636-4; Kim HR, 2013, AM J KIDNEY DIS, V61, P899, DOI 10.1053/j.ajkd.2013.01.024; Kuro-O M, 2012, CURR OPIN NEPHROL HY, V21, P362, DOI 10.1097/MNH.0b013e32835422ad; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lang F, 2012, TRANSFUS MED HEMOTH, V39, P308, DOI 10.1159/000342534; Lim SC, 2013, J RENIN ANGIOTENSIN; Lin Y, 2013, ENDOCRINOLOGY, V154, P3855, DOI 10.1210/en.2013-1053; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Zhao YH, 2011, DIABETES, V60, P1907, DOI 10.2337/db10-1262	23	46	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e102984	10.1371/journal.pone.0102984	http://dx.doi.org/10.1371/journal.pone.0102984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084095	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800013
J	Sughrue, T; Brody, JP				Sughrue, Trevor; Brody, James P.			Breast Tumor Laterality in the United States Depends Upon the Country of Birth, but Not Race	PLOS ONE			English	Article							CANCER LATERALITY; AGE-PERIOD; MORTALITY; COHORT; RISK; ORIGINS; DISEASE; RATES; SIZE	More breast cancers are diagnosed in the left breast than the right. The ratio (l/r) is called the laterality ratio. We analyzed 1.2 million cases of breast cancer diagnosed in the US between 1973 and 2010 and recorded by the Surveillance, Epidemiology, and End Results (SEER) program. We found that the laterality ratio depends upon the country of birth, but not race of the patient. We identified five countries of birth that had p-values larger than 0.995, while we expected to see less than 1. Those born in Japan (l/r = 1.14, p = 0.997), the Ryukyu Islands (l/r = 2.6, p = 0.998), Laos (l/r = 1.62, p = 0.9999) and Algeria (l/r = 2.1 p = 0.9959) had significantly larger laterality ratios compared to the overall SEER population (l/r = 1.04). Those born in Poland (l/r = 0.92, p = 0.997) had a laterality ratio significantly less than expected. We compared the laterality ratio calculated for tumors occurring in each quadrant of the breast for two immigrant populations: those born in Japan and those born in Poland. We found the only significant difference was in the laterality ratio of the upper outer quadrant. Thus, the birthplace effect appears to only occur in the upper outer quadrant of the breast. Finally, we found a small, but statistically significant, increase in the breast cancer laterality ratio with age, and decrease with birth year and year of diagnosis.	[Sughrue, Trevor; Brody, James P.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA	University of California System; University of California Irvine	Brody, JP (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA.	jpbrody@uci.edu		Brody, James/0000-0002-7995-5197	University of California	University of California(University of California System)	This study was funded solely by internal University of California funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUSK T, 1947, BRIT J CANCER, V1, P345, DOI 10.1038/bjc.1947.31; CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; EKBOM A, 1994, CANCER CAUSE CONTROL, V5, P510, DOI 10.1007/BF01831378; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Harding C, 2012, CANCER-AM CANCER SOC, V118, P1371, DOI 10.1002/cncr.26376; HARTVEIT F, 1983, CLIN ONCOL, V9, P135; Hilakivi-Clarke L, 2006, TRENDS ENDOCRIN MET, V17, P340, DOI 10.1016/j.tem.2006.09.002; Holford T R, 1992, Stat Methods Med Res, V1, P317, DOI 10.1177/096228029200100306; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; ING R, 1977, LANCET, V2, P124; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Lagiou P, 2008, PLOS MED, V5, P1306, DOI 10.1371/journal.pmed.0050194; LOUGHRY CW, 1989, ANN PLAS SURG, V22, P380, DOI 10.1097/00000637-198905000-00002; Michels KB, 1996, LANCET, V348, P1542, DOI 10.1016/S0140-6736(96)03102-9; National Cancer Institute, 2013, SURV EP END RES SEER; Perkins CI, 2004, CANCER CAUSE CONTROL, V15, P637, DOI 10.1023/B:CACO.0000036171.44162.5f; Roychoudhuri R, 2006, CANCER CAUSE CONTROL, V17, P655, DOI 10.1007/s10552-005-0615-9; RUTQVIST LE, 1990, BRIT J CANCER, V61, P866, DOI 10.1038/bjc.1990.193; Silva ID, 2008, PLOS MED, V5, P1372, DOI 10.1371/journal.pmed.0050193; Soto-Ortiz L, 2012, THEORY CANC AGE SPEC; TRICHOPOULOS D, 1992, EPIDEMIOLOGY, V3, P523, DOI 10.1097/00001648-199211000-00011; TRICHOPOULOS D, 1990, LANCET, V335, P939, DOI 10.1016/0140-6736(90)91000-Z; Trichopoulos D, 1990, Epidemiology, V1, P95; Tu YK, 2012, EPIDEMIOLOGY, V23, P583, DOI 10.1097/EDE.0b013e31824d57a9; Weiss HA, 1996, CANCER CAUSE CONTROL, V7, P539, DOI 10.1007/BF00051887	26	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103313	10.1371/journal.pone.0103313	http://dx.doi.org/10.1371/journal.pone.0103313			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083708	Green Published, gold			2022-12-25	WOS:000339819800029
J	Voros, A; Simm, R; Slamti, L; Mckay, MJ; Hegna, IK; Nielsen-LeRoux, C; Hassan, KA; Paulsen, IT; Lereclus, D; Okstad, OA; Molloy, MP; Kolsto, AB				Voros, Aniko; Simm, Roger; Slamti, Leyla; Mckay, Matthew J.; Hegna, Ida K.; Nielsen-LeRoux, Christina; Hassan, Karl A.; Paulsen, Ian T.; Lereclus, Didier; Okstad, Ole Andreas; Molloy, Mark P.; Kolsto, Anne-Brit			SecDF as Part of the Sec-Translocase Facilitates Efficient Secretion of Bacillus cereus Toxins and Cell Wall-Associated Proteins	PLOS ONE			English	Article							PLCR VIRULENCE REGULON; HEMOLYSIN BL; EFFLUX PUMP; COMPREHENSIVE ANALYSIS; MULTIDRUG-RESISTANCE; ENTEROTOXIN COMPLEX; GENE-EXPRESSION; EXPORT; THURINGIENSIS; SUBTILIS	The aim of this study was to explore the role of SecDF in protein secretion in Bacillus cereus ATCC 14579 by in-depth characterization of a markerless secDF knock out mutant. Deletion of secDF resulted in pleiotropic effects characterized by a moderately slower growth rate, aberrant cell morphology, enhanced susceptibility to xenobiotics, reduced virulence and motility. Most toxins, including food poisoning-associated enterotoxins Nhe, Hbl, and cytotoxin K, as well as phospholipase C were less abundant in the secretome of the Delta secDF mutant as determined by label-free mass spectrometry. Global transcriptome studies revealed profound transcriptional changes upon deletion of secDF indicating cell envelope stress. Interestingly, the addition of glucose enhanced the described phenotypes. This study shows that SecDF is an important part of the Sec-translocase mediating efficient secretion of virulence factors in the Gram-positive opportunistic pathogen B. cereus, and further supports the notion that B. cereus enterotoxins are secreted by the Sec-system.	[Voros, Aniko; Simm, Roger; Hegna, Ida K.; Okstad, Ole Andreas; Kolsto, Anne-Brit] Univ Oslo, Sch Pharm, Dept Pharma Biosci, Lab Microbial Dynam LaMDa, N-0514 Oslo, Norway; [Mckay, Matthew J.; Molloy, Mark P.] Macquarie Univ, APAF, Sydney, NSW 2109, Australia; [Slamti, Leyla; Lereclus, Didier] UMR1319 Micalis, INRA, Guyancourt, France; [Lereclus, Didier] UMR Micalis, AgroParistech, Jouy En Josas, France; [Paulsen, Ian T.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW, Australia	University of Oslo; Macquarie University; INRAE; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Macquarie University	Kolsto, AB (corresponding author), Univ Oslo, Sch Pharm, Dept Pharma Biosci, Lab Microbial Dynam LaMDa, N-0514 Oslo, Norway.	a.b.kolsto@farmasi.uio.no	Okstad, Ole Andreas/ABE-4202-2020; Nielsen-Leroux, Christina/GRS-3334-2022; Lereclus, Didier/AAD-8293-2019; Simm, Roger/AAN-8965-2020; Hassan, Karl/B-2802-2013; Paulsen, Ian/K-3832-2012	Simm, Roger/0000-0001-5187-2456; McKay, Matthew/0000-0002-3430-2467; Lereclus, Didier/0000-0001-9047-9104; Hassan, Karl/0000-0003-2031-9679; Paulsen, Ian/0000-0001-9015-9418; Molloy, Mark/0000-0003-4679-5868; Okstad, Ole Andreas/0000-0001-9351-8535	Norwegian Research Council (FUGE II); EU [IRSES-GA-2009_247634]	Norwegian Research Council (FUGE II); EU(European Commission)	The work was funded by The Norwegian Research Council (FUGE II) and EU grant IRSES-GA-2009_247634. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebusuyi AA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-252; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Aubry A, 2012, INFECT IMMUN, V80, P3521, DOI 10.1128/IAI.00224-12; Bazzini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018902; BEECHER DJ, 1995, INFECT IMMUN, V63, P4423, DOI 10.1128/IAI.63.11.4423-4428.1995; Bergholz TM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-97; Bohnert JA, 2008, J BACTERIOL, V190, P8225, DOI 10.1128/JB.00912-08; Bolhuis A, 1998, J BIOL CHEM, V273, P21217, DOI 10.1074/jbc.273.33.21217; Bouillaut L, 2005, APPL ENVIRON MICROB, V71, P8903, DOI 10.1128/AEM.71.12.8903-8910.2005; Burg-Golani T, 2013, J BACTERIOL, V195, P5262, DOI 10.1128/JB.00697-13; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Clair G, 2010, MOL CELL PROTEOMICS, V9, P1486, DOI 10.1074/mcp.M000027-MCP201; Daniels C, 2009, CLIN MICROBIOL INFEC, V15, P32, DOI 10.1111/j.1469-0691.2008.02693.x; DeLisa MP, 2004, J BACTERIOL, V186, P366, DOI 10.1128/JB.186.2.366-373.2004; Dietrich R, 1999, APPL ENVIRON MICROB, V65, P4470; Dietrich R, 2005, APPL ENVIRON MICROB, V71, P8214, DOI 10.1128/AEM.71.12.8214-8220.2005; Fagerlund A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-304; Fedhila S, 2010, J INVERTEBR PATHOL, V103, P24, DOI 10.1016/j.jip.2009.09.005; Fedhila S, 2006, MOL MICROBIOL, V62, P339, DOI 10.1111/j.1365-2958.2006.05362.x; GARDEL C, 1987, J BACTERIOL, V169, P1286, DOI 10.1128/jb.169.3.1286-1290.1987; Ghelardi E, 2002, J BACTERIOL, V184, P6424, DOI 10.1128/JB.184.23.6424-6433.2002; Ghelardi E, 2007, APPL ENVIRON MICROB, V73, P4089, DOI 10.1128/AEM.02345-06; Gilois N, 2007, PROTEOMICS, V7, P1719, DOI 10.1002/pmic.200600502; Gohar M, 2005, PROTEOMICS, V5, P3696, DOI 10.1002/pmic.200401225; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Gominet M, 2001, MOL MICROBIOL, V40, P963, DOI 10.1046/j.1365-2958.2001.02440.x; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; Grenha R, 2013, P NATL ACAD SCI USA, V110, P1047, DOI 10.1073/pnas.1213770110; Guillemet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055085; Guillemet E, 2010, J BACTERIOL, V192, P286, DOI 10.1128/JB.00264-09; Hansmeier N, 2006, PROTEOMICS, V6, P2465, DOI 10.1002/pmic.200500360; HARTMANN E, 1994, NATURE, V367, P654, DOI 10.1038/367654a0; Hecker M, 1998, MOL MICROBIOL, V29, P1129, DOI 10.1046/j.1365-2958.1998.00977.x; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Ho TD, 2012, CURR OPIN MICROBIOL, V15, P182, DOI 10.1016/j.mib.2012.01.001; ISOBE M, 1995, BIOORG MED CHEM LETT, V5, P2855, DOI 10.1016/0960-894X(95)00503-L; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x; Kaakoush NO, 2013, HELICOBACTER, V18, P316, DOI 10.1111/hel.12045; Kaakoush NO, 2010, FEBS J, V277, P1606, DOI 10.1111/j.1742-4658.2010.07587.x; Kesel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053457; Kinsinger RF, 2003, J BACTERIOL, V185, P5627, DOI 10.1128/JB.185.18.5627-5631.2003; KLEEREBEZEM M, 1993, MOL MICROBIOL, V7, P947, DOI 10.1111/j.1365-2958.1993.tb01186.x; Knyazev DG, 2013, J BIOL CHEM, V288, P17941, DOI 10.1074/jbc.M113.477893; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; LAVALLIE ER, 1989, J BACTERIOL, V171, P3085, DOI 10.1128/jb.171.6.3085-3094.1989; Li H, 2011, MOL MICROBIOL, V80, P886, DOI 10.1111/j.1365-2958.2011.07557.x; Lippolis R, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-28; Lund T, 2000, MOL MICROBIOL, V38, P254, DOI 10.1046/j.1365-2958.2000.02147.x; Lund T, 1996, FEMS MICROBIOL LETT, V141, P151, DOI 10.1016/0378-1097(96)00208-X; Mckay MJ, 2007, PROTEOM CLIN APPL, V1, P1570, DOI 10.1002/prca.200700305; Meneses N, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-51; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Milani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050323; Minagawa S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-70; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Nelson SS, 2006, J BACTERIOL, V188, P348, DOI 10.1128/JB.188.1.348-351.2006; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Niu C, 2005, J MICROBIOL METH, V62, P129, DOI 10.1016/j.mimet.2005.01.013; Nouwen N, 2005, J BACTERIOL, V187, P6852, DOI 10.1128/JB.187.19.6852-6855.2005; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; POGLIANO JA, 1994, EMBO J, V13, P554, DOI 10.1002/j.1460-2075.1994.tb06293.x; Pos KM, 2009, BBA-PROTEINS PROTEOM, V1794, P782, DOI 10.1016/j.bbapap.2008.12.015; Provenano M, 2007, ADV EXP MED BIOL, V593, P66; Quiblier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063513; Quiblier C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-72; Raddadi N, 2005, J APPL MICROBIOL, V99, P1070, DOI 10.1111/j.1365-2672.2005.02713.x; Ramarao N, 2012, JOVE-J VIS EXP, DOI 10.3791/4392; Ravagnani A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-39; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Salamitou S, 2000, MICROBIOL-UK, V146, P2825, DOI 10.1099/00221287-146-11-2825; Salvetti S, 2011, APPL ENV MICROBIOL; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Shah IM, 2010, MOL MICROBIOL, V75, P1232, DOI 10.1111/j.1365-2958.2010.07046.x; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Slamti L, 2002, EMBO J, V21, P4550, DOI 10.1093/emboj/cdf450; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stahler FN, 2006, INFECT IMMUN, V74, P3845, DOI 10.1128/IAI.02025-05; STARK MJR, 1987, GENE, V51, P255, DOI 10.1016/0378-1119(87)90314-3; Tang WH, 2008, J PROTEOME RES, V7, P3661, DOI 10.1021/pr070492f; Terashima H, 2008, INT REV CEL MOL BIO, V270, P39, DOI 10.1016/S1937-6448(08)01402-0; Thay B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054661; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; van der Voort M, 2009, J APPL MICROBIOL, V107, P795, DOI 10.1111/j.1365-2672.2009.04252.x; van Schaik W, 2004, J BACTERIOL, V186, P4100, DOI 10.1128/JB.186.13.4100-4109.2004; van Schaik W, 2004, J BACTERIOL, V186, P316, DOI 10.1128/JB.186.2.316-325.2004; van Schaik W, 2007, J BACTERIOL, V189, P4384, DOI 10.1128/JB.00313-07; Verheust C, 2005, J BACTERIOL, V187, P1966, DOI 10.1128/JB.187.6.1966-1973.2005; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Voros A, 2013, MICROBIOLOGY; Watt SA, 2005, PROTEOMICS, V5, P153, DOI 10.1002/pmic.200400905; Webber MA, 2001, ANTIMICROB AGENTS CH, V45, P1550, DOI 10.1128/AAC.45.5.1550-1552.2001; Wolf D, 2010, J BACTERIOL, V192, P4680, DOI 10.1128/JB.00543-10; Yang CK, 2011, J BACTERIOL, V193, P5607, DOI 10.1128/JB.05897-11; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	101	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103326	10.1371/journal.pone.0103326	http://dx.doi.org/10.1371/journal.pone.0103326			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083861	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800031
J	Zhang, XT; Wang, Y; Hu, WJ; Li, DY; Zhou, ZM; Pan, DF; Wu, WL; Xu, TD				Zhang, Xiaotian; Wang, Yi; Hu, Wenjing; Li, Dongye; Zhou, Zhongmin; Pan, Defeng; Wu, Wanling; Xu, Tongda			Interleukin-1/Toll-Like Receptor-Induced Nuclear Factor Kappa B Signaling Participates in Intima Hyperplasia after Carotid Artery Balloon Injury in Goto-Kakizaki Rats: A Potential Target Therapy Pathway	PLOS ONE			English	Article							IN-STENT RESTENOSIS; DIABETES-MELLITUS; DOWN-REGULATION; BETA-CELL; CORONARY; ANGIOPLASTY; EXPRESSION; IMPLANTATION; GLUCOKINASE; ACTIVATION	The value of restenosis after percutaneous coronary intervention (PCI) is recognized worldwide, especially for diabetic patients. Interleukin-1/Toll-like receptor (IL-1/TLR) signaling is involved in innate and adaptive immune responses, but whether and how the IL-1/TLR-induced nuclear factor kappa B (NF kappa B) pathway plays key roles in intimal formation is unclear. The underlying mechanism of intima hyperplasia was investigated with a model of carotid balloon injury in Goto-Kakizaki (GK) and Wistar rats and with lipopolysaccharide-stimulated macrophages. Elastic-van Gieson staining showed the medial area peakedon Day 3 post-injury and decreased by Day 7 post-injury in both GK and Wistar rats. The N/M at Day 7 in GK rats was significantly higher than in Wistar rats (p<0.001). The percent of 5-ethynyl-29-deoxyuridine (EdU) staining-positive cells on Day 3 post-injury was greater than seen on Day 7 post-injury in GK and Wistar rats. The percent of EdU-positive cells on Days 3 and 7 post-injury in Wistar rats was less than that found in GK rats (p<0.01; p<0.05). NF kappa Bp65 immunostaining had increased by Day 7 post-injury. Agilent Whole Genome Oligo Microarray verified that the IL-1/TLR-induced NF kappa B pathway was activated by carotid balloon injury. TLR4, IL-1 receptor associated kinase, inhibitors a of NF kappa B, human antigen R, c-Myc (Proto-Oncogene Proteins), EGF-like module-containing mucin-like hormone receptor-like 1 and Interleukin-6 were up-regulated or down-regulated according to immunochemistry, quantitative real-time PCR, Western blotting and Enzyme linked immunosorbent assay. Overall, we conclude that the IL-1/TLR-induced NF kappa B pathway participates in the intimal hyperplasia after carotid injury in GK and Wistar rats and that GK rats respond more intensely to the inflammation than Wistar rats.	[Zhang, Xiaotian; Wang, Yi; Hu, Wenjing; Li, Dongye] Xuzhou Med Coll, Inst Cardiovasc Dis Res, Xuzhou, Jiangsu, Peoples R China; [Zhou, Zhongmin] Northeast Ohio Med Univ, Aultman Hosp, Dept Internal Med, Canton, OH USA; [Zhou, Zhongmin] Northeast Ohio Med Univ, Canton Med Educ Fdn, Canton, OH USA; [Pan, Defeng; Wu, Wanling; Xu, Tongda] Xuzhou Med Coll, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Northeast Ohio Medical University (NEOMED); Northeast Ohio Medical University (NEOMED); Xuzhou Medical University	Li, DY (corresponding author), Xuzhou Med Coll, Inst Cardiovasc Dis Res, Xuzhou, Jiangsu, Peoples R China.; Xu, TD (corresponding author), Xuzhou Med Coll, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China.	dongyelichina@gmail.com; xtd3004@aliyun.com	李, 东/GYA-4703-2022; 李, 东野/AAY-6410-2020	Xu, Tongda/0000-0002-5594-3992	Academic Degrees Committee; Department of Education of Jiangsu province [CXLX11-0732]	Academic Degrees Committee; Department of Education of Jiangsu province	This work was supported by the Academic Degrees Committee and the Department of Education of Jiangsu province (grant number CXLX11-0732). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown MR, 1999, CIRC RES, V85, P524, DOI 10.1161/01.RES.85.6.524; Bu DX, 2005, FASEB J, V19, P1293, DOI 10.1096/fj.04-2645fje; Christopher T, 2012, PLOS GENET, V8; Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050; Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44; Fraczek J, 2008, J BIOL CHEM, V283, P31697, DOI 10.1074/jbc.M804779200; Frese T, 2007, HORM METAB RES, V39, P567, DOI 10.1055/s-2007-984471; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; Goto Y, 1988, Adv Exp Med Biol, V246, P29; Grewe PH, 2000, J AM COLL CARDIOL, V35, P157, DOI 10.1016/S0735-1097(99)00486-6; Guo JS, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-150; Hatao F, 2004, J LEUKOCYTE BIOL, V76, P904, DOI 10.1189/jlb.0504277; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hurst RT, 2003, ANN INTERN MED, V139, P824, DOI 10.7326/0003-4819-139-10-200311180-00010; Jensen LO, 2008, EUR HEART J, V29, P2733, DOI 10.1093/eurheartj/ehn434; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kong JY, 2013, INFLAMM RES, V62, P173, DOI 10.1007/s00011-012-0568-x; Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6; Landry DB, 1997, AM J PATHOL, V151, P1085; Laybutt DR, 2002, DIABETES, V51, P1793, DOI 10.2337/diabetes.51.6.1793; Li Y, 2011, J MOL MED, V89, P545, DOI 10.1007/s00109-011-0729-3; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2630, DOI 10.1161/01.ATV.0000247259.01257.b3; Liu Xiaoshun, 2004, Expert Rev Cardiovasc Ther, V2, P653, DOI 10.1586/14779072.2.5.653; Lu C, 2011, J IMMUNOL, V187, P1458, DOI 10.4049/jimmunol.1003428; Ma XD, 2010, INT J CLIN EXP MED, V3, P192; Majid Abdul, 2009, Acta Med Indones, V41, P41; Martin DM, 2011, MED ENG PHYS, V33, P148, DOI 10.1016/j.medengphy.2010.10.009; Marz W, 2004, CIRCULATION, V109, P2844, DOI 10.1161/01.CIR.0000129306.44085.C4; Murthy SN, 2010, DIABETES, V59, P3240, DOI 10.2337/db09-1761; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Ohtani K, 2004, GENE THER, V11, P1273, DOI 10.1038/sj.gt.3302288; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Ozer N, 2008, HEART VESSELS, V23, P75, DOI 10.1007/s00380-007-1020-y; Portha B, 2005, DIABETES-METAB RES, V21, P495, DOI 10.1002/dmrr.566; Rosano GMC, 2006, AM J CARDIOL, V98, p14J, DOI 10.1016/j.amjcard.2006.07.004; Schachinger V, 2006, CLIN RES CARDIOL, V95, P18, DOI 10.1007/s00392-006-1115-y; Schillinger M, 2001, J ENDOVASC THER, V8, P477, DOI 10.1583/1545-1550(2001)008<0477:RAPTAI>2.0.CO;2; Schillinger M, 2005, VASC HEALTH RISK MAN, V1, P73, DOI 10.2147/vhrm.1.1.73.58932; Soran O, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-012-0323-5; Stella, 2002, CELL, V109, P21; Suganamia Ta, 2007, BIOCHEM BIOPH RES CO, V354, P5; Tran H, 2003, MOL CELL BIOL, V23, P7177, DOI 10.1128/MCB.23.20.7177-7188.2003; Wei YZ, 2008, AM J PHYSIOL-REG I, V294, pR673, DOI 10.1152/ajpregu.00561.2007; Yu CM, 2012, INT J CARDIOL; Zhang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012323; Zhou ZM, 2002, ATHEROSCLEROSIS, V161, P153, DOI 10.1016/S0021-9150(01)00640-2	47	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103794	10.1371/journal.pone.0103794	http://dx.doi.org/10.1371/journal.pone.0103794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083789	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800080
J	Corniani, N; Velini, ED; Silva, FML; Nanayakkara, NPD; Witschel, M; Dayan, FE				Corniani, Natalia; Velini, Edivaldo D.; Silva, Ferdinando M. L.; Nanayakkara, N. P. Dhammika; Witschel, Matthias; Dayan, Franck E.			Novel Bioassay for the Discovery of Inhibitors of the 2-C-Methyl-D-erythritol 4-Phosphate (MEP) and Terpenoid Pathways Leading to Carotenoid Biosynthesis	PLOS ONE			English	Article							1-DEOXY-D-XYLULOSE 5-PHOSPHATE SYNTHASE; MEVALONATE ISOPRENOID BIOSYNTHESIS; NONMEVALONATE PATHWAY; STATISTICAL PARAMETER; PHOSPHATE-PATHWAY; HIGHER-PLANTS; CLOMAZONE; HERBICIDES; ANTIMALARIAL; METABOLISM	The 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway leads to the synthesis of isopentenyl diphosphate in plastids. It is a major branch point providing precursors for the synthesis of carotenoids, tocopherols, plastoquinone and the phytyl chain of chlorophylls, as well as the hormones abscisic acid and gibberellins. Consequently, disruption of this pathway is harmful to plants. We developed an in vivo bioassay that can measure the carbon flow through the carotenoid pathway. Leaf cuttings are incubated in the presence of a phytoene desaturase inhibitor to induce phytoene accumulation. Any compound reducing the level of phytoene accumulation is likely to interfere with either one of the steps in the MEP pathway or the synthesis of geranylgeranyl diphosphate. This concept was tested with known inhibitors of steps of the MEP pathway. The specificity of this in vivo bioassay was also verified by testing representative herbicides known to target processes outside of the MEP and carotenoid pathways. This assay enables the rapid screen of new inhibitors of enzymes preceding the synthesis of phytoene, though there are some limitations related to the non-specific effect of some inhibitors on this assay.	[Corniani, Natalia; Velini, Edivaldo D.; Silva, Ferdinando M. L.] Sao Paulo State Univ, Fac Agron Sci, Botucatu, SP, Brazil; [Nanayakkara, N. P. Dhammika] Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res, University, MS 38677 USA; [Witschel, Matthias] BASF SE, GVA HC B009, Ludwigshafen, Germany; [Dayan, Franck E.] USDA ARS, Nat Prod Utilizat Res Unit, University, MS 38677 USA	Universidade Estadual Paulista; University of Mississippi; BASF; United States Department of Agriculture (USDA)	Dayan, FE (corresponding author), USDA ARS, Nat Prod Utilizat Res Unit, University, MS 38677 USA.	franck.dayan@ars.usda.gov	Dayan, Franck E/AAB-6565-2022; Dayan, Franck/A-7592-2009	Dayan, Franck E/0000-0001-6964-2499; Dayan, Franck/0000-0001-6964-2499; Corniani, Natalia/0000-0001-7342-5171	Brazilian Agency CAPES (Coordination for the Improvement of Higher Education Personnel) [BEX 0226/12-2]	Brazilian Agency CAPES (Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Grant# BEX 0226/12-2 from the Brazilian Agency CAPES (Coordination for the Improvement of Higher Education Personnel) that supported the research of N. Corniani in a USDA laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RL, 1990, WEED TECHNOL, V4, P606, DOI 10.1017/S0890037X00026063; Baerg RJ, 1996, PESTIC BIOCHEM PHYS, V55, P10, DOI 10.1006/pest.1996.0030; BARTLEY GE, 1995, PLANT CELL, V7, P1027, DOI 10.1105/tpc.7.7.1027; Botella-Pavia P, 2004, PLANT J, V40, P188, DOI 10.1111/j.1365-313X.2004.02198.x; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; CHANG JH, 1987, ACS SYM SER, V355, P10; Chang WC, 2013, CURR OPIN CHEM BIOL, V17, P571, DOI 10.1016/j.cbpa.2013.06.020; Cordoba E, 2011, J EXP BOT, V62, P2023, DOI 10.1093/jxb/erq393; Cordoba E, 2009, J EXP BOT, V60, P2933, DOI 10.1093/jxb/erp190; CROTEAU R, 1992, PLANT PHYSIOL, V98, P1515, DOI 10.1104/pp.98.4.1515; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Culpepper AS, 2001, WEED SCI, V49, P613, DOI 10.1614/0043-1745(2001)049[0613:EOIOCA]2.0.CO;2; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Dayan FE, 2003, ENCY AGROCHEMICALS, V2, P744; Dayan FE, 2014, WEED SCI, DOI [10.1614/WS-D-1613-00063.00061, DOI 10.1614/WS-D-1613-00063.00061]; Dayan FE, 2010, WEED SCI, V58, P340, DOI 10.1614/WS-09-092.1; De Mendiburu F., 2014, **DATA OBJECT**; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; DENO NC, 1947, J AM CHEM SOC, V69, P2233, DOI 10.1021/ja01201a505; Duke SO, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 4: AGRICULTURAL AND RELATED BIOTECHNOLOGIES, 2ND EDITION, P23; DUKE SO, 1985, WEED SCI, V33, P786, DOI 10.1017/S0043174500083351; DUKE SO, 1991, WEED SCI, V39, P339, DOI 10.1017/S0043174500073033; Duke SO, 2012, PEST MANAG SCI, V68, P505, DOI 10.1002/ps.2333; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; ELNAGGAR SF, 1992, J AGR FOOD CHEM, V40, P880, DOI 10.1021/jf00017a036; Ershov YV, 2007, APPL BIOCHEM MICRO+, V43, P115, DOI 10.1134/S0003683807020019; Fellermeier M, 1999, TETRAHEDRON LETT, V40, P2743, DOI 10.1016/S0040-4039(99)00361-5; Fellermeier M, 2001, EUR J BIOCHEM, V268, P6302, DOI 10.1046/j.0014-2956.2001.02585.x; Ferhatoglu Y, 2006, PESTIC BIOCHEM PHYS, V85, P7, DOI 10.1016/j.pestbp.2005.10.002; Ferhatoglu Y, 2005, PESTIC BIOCHEM PHYS, V81, P59, DOI 10.1016/j.pestbp.2004.09.002; Ge X, 2012, PESTIC BIOCHEM PHYS, V104, P187, DOI 10.1016/j.pestbp.2012.07.009; Ge X, 2011, PEST MANAG SCI, V67, P1215, DOI 10.1002/ps.2169; Gong YF, 2006, PLANTA MED, V72, P329, DOI 10.1055/s-2005-916234; Hale I, 2012, MEDCHEMCOMM, V3, P418, DOI 10.1039/c2md00298a; Hayashi D, 2013, CHEM COMMUN, V49, P5535, DOI 10.1039/c3cc40758f; Hess FD, 2000, WEED SCI, V48, P160, DOI 10.1614/0043-1745(2000)048[0160:LDHAO]2.0.CO;2; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Koyama T., 1999, COMPREHENSIVE NATURA, V2, P69, DOI DOI 10.1016/B978-0-08-091283-7.00037-0; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Lee DL, 1997, WEED SCI, V45, P601; Lichtenthaler HK, 2010, ADV PHOTOSYNTH RESP, V31, P95; Lichtenthaler HK, 2000, Z NATURFORSCH C, V55, P305; Lichtenthaler HK, 2000, BIOCHEM SOC T, V28, P785, DOI 10.1042/BST0280785; Lichtenthaler HK, 1997, PHYSIOL PLANTARUM, V101, P643, DOI 10.1111/j.1399-3054.1997.tb01049.x; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Lichtenthaler HK, 1997, FEBS LETT, V400, P271, DOI 10.1016/S0014-5793(96)01404-4; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; Malkin R., 2000, BIOCH MOL BIOL PLANT, P568; Mueller C, 2000, BIOCHEM SOC T, V28, P792, DOI 10.1042/BST0280792; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Ritz C, 2005, J STAT SOFTW, V12, P1; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Rohdich F, 2000, P NATL ACAD SCI USA, V97, P6451, DOI 10.1073/pnas.97.12.6451; Rohmer M, 1998, PROG DRUG RES, V50, P135; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Rohmer Michel, 2004, Curr Opin Investig Drugs, V5, P154; Sandmann G., 1989, Target sites of herbicide action., P25; Schuhr Christoph A., 2003, Phytochemistry Reviews, V2, P3, DOI 10.1023/B:PHYT.0000004180.25066.62; Schwender J, 1997, FEBS LETT, V414, P129, DOI 10.1016/S0014-5793(97)01002-8; SEEFELDT SS, 1995, WEED TECHNOL, V9, P218, DOI 10.1017/S0890037X00023253; Service RF, 2007, SCIENCE, V316, P1114, DOI 10.1126/science.316.5828.1114; Service RF, 2013, SCIENCE, V341, P1329, DOI 10.1126/science.341.6152.1329; Singh N, 2007, CURR PHARM DESIGN, V13, P1161, DOI 10.2174/138161207780618939; Sprecher SL, 1998, J AQUAT PLANT MANAGE, V36, P111; Sui YX, 2007, J BIOMOL SCREEN, V12, P229, DOI 10.1177/1087057106296498; Vranova E, 2013, ANNU REV PLANT BIOL, V64, P665, DOI 10.1146/annurev-arplant-050312-120116; WEIMER MR, 1991, WEED SCI, V39, P529, DOI 10.1017/S0043174500088317; WEIMER MR, 1992, PLANT PHYSIOL, V98, P427, DOI 10.1104/pp.98.2.427; Weinberg T, 2003, WEED SCI, V51, P663, DOI 10.1614/P2002-106; Withers ST, 2007, APPL MICROBIOL BIOT, V73, P980, DOI 10.1007/s00253-006-0593-1; Witschel M, 2013, PEST MANAG SCI, V69, P559, DOI 10.1002/ps.3479; Yasuor H, 2010, PLANT PHYSIOL, V153, P319, DOI 10.1104/pp.110.153296; Zamponi GW, 2003, J MED CHEM, V46, P87, DOI 10.1021/jm020354w; Zeidler J, 2000, BIOCHEM SOC T, V28, P796, DOI 10.1042/BST0280796; Zeidler J, 1998, Z NATURFORSCH C, V53, P980; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao LS, 2013, ANNU REV BIOCHEM, V82, P497, DOI 10.1146/annurev-biochem-052010-100934	77	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103704	10.1371/journal.pone.0103704	http://dx.doi.org/10.1371/journal.pone.0103704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077957	Green Published, gold, Green Submitted			2022-12-25	WOS:000339954800066
J	de Andrade, L; Lynch, C; Carvalho, E; Rodrigues, CG; Vissoci, JRN; Passos, GF; Pietrobon, R; Nihei, OK; Carvalho, MDD				de Andrade, Luciano; Lynch, Catherine; Carvalho, Elias; Rodrigues, Clarissa Garcia; Nickenig Vissoci, Joao Ricardo; Passos, Guttenberg Ferreira; Pietrobon, Ricardo; Nihei, Oscar Kenji; de Barros Carvalho, Maria Dalva			System Dynamics Modeling in the Evaluation of Delays of Care in ST-Segment Elevation Myocardial Infarction Patients within a Tiered Health System	PLOS ONE			English	Article							QUALITATIVE COMPARATIVE-ANALYSIS; DOOR-OUT TIME; INTERHOSPITAL TRANSFER; PRIMARY ANGIOPLASTY; REPERFUSION; CARDIOLOGISTS; ASSOCIATION; GUIDELINES; MANAGEMENT; MORTALITY	Background: Mortality rates amongst ST segment elevation myocardial infarction (STEMI) patients remain high, especially in developing countries. The aim of this study was to evaluate the factors related with delays in the treatment of STEMI patients to support a strategic plan toward structural and personnel modifications in a primary hospital aligning its process with international guidelines. Methods and Findings: The study was conducted in a primary hospital localized in Foz do Iguacu, Brazil. We utilized a qualitative and quantitative integrated analysis including on-site observations, interviews, medical records analysis, Qualitative Comparative Analysis (QCA) and System Dynamics Modeling (SD). Main cause of delays were categorized into three themes: a) professional, b) equipment and c) transportation logistics. QCA analysis confirmed four main stages of delay to STEMI patient's care in relation to the 'Door-in-Door-out' time at the primary hospital. These stages and their average delays in minutes were: a) First Medical Contact (From Door-In to the first contact with the nurse and/or physician): 7 minutes; b) Electrocardiogram acquisition and review by a physician: 28 minutes; c) ECG transmission and Percutaneous Coronary Intervention Center team feedback time: 76 minutes; and d) Patient's Transfer Waiting Time: 78 minutes. SD baseline model confirmed the system's behavior with all occurring delays and the need of improvements. Moreover, after model validation and sensitivity analysis, results suggested that an overall improvement of 40% to 50% in each of these identified stages would reduce the delay. Conclusions: This evaluation suggests that investment in health personnel training, diminution of bureaucracy, and management of guidelines might lead to important improvements decreasing the delay of STEMI patients' care. In addition, this work provides evidence that SD modeling may highlight areas where health system managers can implement and evaluate the necessary changes in order to improve the process of care.	[de Andrade, Luciano; de Barros Carvalho, Maria Dalva] Univ Estadual Maringa, Dept Hlth Sci, Maringa, Parana, Brazil; [Lynch, Catherine] Duke Univ, Duke Global Hlth Inst, Dept Surg, Div Emergency Med, Durham, NC USA; [Carvalho, Elias] Univ Estadual Maringa, Maringa, Parana, Brazil; [Carvalho, Elias] Pontificia Univ Catolica PUC PR, Knowledge Discovery & Machine Learning Grp, Grad Program Informat PPGIA, Curitiba, Parana, Brazil; [de Andrade, Luciano; Nihei, Oscar Kenji] State Univ West Parana, Dept Nursing, Foz Do Iguacu, Parana, Brazil; [Rodrigues, Clarissa Garcia] Fundacao Univ Cardiol, Inst Cardiol Rio Grande do Sul, Porto Alegre, RS, Brazil; [Nickenig Vissoci, Joao Ricardo] Fac Inga, Dept Med, Maringa, Parana, Brazil; [Passos, Guttenberg Ferreira] Univ Brasilia, Dept Informat, Brasilia, DF, Brazil; [Pietrobon, Ricardo] Duke Univ Hlth Syst, Dept Surg, Durham, NC USA	Universidade Estadual de Maringa; Duke University; Universidade Estadual de Maringa; Universidade Estadual do Oeste do Parana; Fundacao Universitaria de Cardiologia; Centro Universitario Inga (UNINGA); Universidade de Brasilia; Duke University	Carvalho, MDD (corresponding author), Univ Estadual Maringa, Dept Hlth Sci, Maringa, Parana, Brazil.	kiracarva@gmail.com	Carvalho, Maria Dalva/AAK-8411-2021; Carvalho, Elias/J-7086-2012	Carvalho, Maria Dalva/0000-0002-1377-3331; Carvalho, Elias/0000-0002-2638-7202; Staton, Catherine/0000-0002-6468-2894	Science Without Borders Program, Brazilian Government	Science Without Borders Program, Brazilian Government	LA and JRNV were funded by the Science Without Borders Program, Brazilian Government (http://www.cienciasemfronteiras.gov.br/web/csf-eng/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre FV, 2008, CIRCULATION, V117, P1145, DOI 10.1161/CIRCULATIONAHA.107.728519; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Bardin L., 1977, ANAL OF CONTENT, P70; Beltrame RL, 2006, FORMACAO MED DEBATE; Brazil. Ministry of Health, 2011, RED URG EM LINH CUID; Carneiro JKR, 2005, REV BRAS CARDIOL INV, V13, P32; Clemmensen P, 2005, J ELECTROCARDIOL, V38, P194, DOI 10.1016/j.jelectrocard.2005.06.035; Cronqvist L., 2009, CONFIGURATIONAL COMP; de Andrade L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059363; De Luca G, 2008, ANN EMERG MED, V52, P665, DOI 10.1016/j.annemergmed.2008.08.033; Dusa A, 2010, QUAL QUANT, V44, P99, DOI 10.1007/s11135-008-9183-x; Feitosa-Filho GS, 2012, REV BRAS CLIN MED, V10, P91; Fiss PC, 2007, ACAD MANAGE REV, V32, P1180, DOI 10.5465/AMR.2007.26586092; Forrester J.W., 1969, URBAN DYNAMICS; Franco B, 2008, REV LAT-AM ENFERM, V16, P414, DOI 10.1590/S0104-11692008000300013; Frigotto G, 1996, NEW CULTURAL MAPS NE; GASKELL G., 2002, PESQUISA QUALITATIVA; Giuliani E, 2010, J EVAL CLIN PRACT, V16, P1071, DOI 10.1111/j.1365-2753.2009.01254.x; Goldberg RJ, 2002, AM J CARDIOL, V89, P791, DOI 10.1016/S0002-9149(02)02186-0; Herrin J, 2011, ARCH INTERN MED, V171, P1879, DOI 10.1001/archinternmed.2011.481; Hines J., 2005, MOL STRUCTURE BUILDI; Hug S, 2013, POLIT ANAL, V21, P252, DOI 10.1093/pan/mps061; Hutchison AW, 2009, CIRC-CARDIOVASC INTE, V2, P528, DOI 10.1161/CIRCINTERVENTIONS.109.892372; Jollis JG, 2012, CIRC-CARDIOVASC QUAL, V5, P423, DOI 10.1161/CIRCOUTCOMES.111.964668; Khan SA, 2007, STUD HEALTH TECHNOL, V129, P247; Khraim FM, 2009, PATIENT EDUC COUNS, V75, P155, DOI 10.1016/j.pec.2008.09.019; Lacerda A, 2012, REV MED RES, V14, P193; Larson David M, 2008, Curr Cardiol Rep, V10, P415, DOI 10.1007/s11886-008-0065-6; Lassen JF, 2013, NAT REV CARDIOL, V10, P41, DOI 10.1038/nrcardio.2012.156; Lino MM, 2008, REV ESC ENFERM USP, V42, P771, DOI 10.1590/S0080-62342008000400022; Loch A, 2013, POSTGRAD MED J, V89, P335, DOI 10.1136/postgradmedj-2012-131174; Mahmoud KD, 2013, EUR HEART J-ACUTE CA, V2, P166, DOI 10.1177/2048872613481449; Marcolino MS, 2013, ARQ BRAS CARDIOL, V100, P307, DOI 10.5935/abc.20130054; Marx A., 2011, METHODOLOGICAL INNOV, V6, P103, DOI [10.4256/mio.2010.0037, DOI 10.4256/MIO.2010.0037]; Miedema MD, 2011, CIRCULATION, V124, P1636, DOI 10.1161/CIRCULATIONAHA.111.033118; Minayo M. S., 1996, PESQUISA SOCIAL TEOR; Nielsen PH, 2010, CIRCULATION, V121, P1484, DOI 10.1161/CIRCULATIONAHA.109.873224; NVivo, 2012, QUAL DAT AN SOFTW VE; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Oliva R, 2003, EUR J OPER RES, V151, P552, DOI 10.1016/S0377-2217(02)00622-7; Park YH, 2012, J KOREAN MED SCI, V27, P864, DOI 10.3346/jkms.2012.27.8.864; Peacock WF, 2008, TEX HEART I J, V35, P152; Ragin C. C, 2008, REDESIGNING SOCIAL I; Ragin C.C., 1987, COMPUT METHOD BIOMEC; Rathore SS, 2006, J AM COLL CARDIOL, V47, P1346, DOI 10.1016/j.jacc.2005.11.053; Rihoux B, 2006, INT SOCIOL, V21, P679, DOI 10.1177/0268580906067836; Saltelli A., 2000, WILEY SERIES PROBABI; Seegmuller EF, 2008, CIENC CULT, V39, P9; Sejersten M, 2008, AM J CARDIOL, V101, P941, DOI 10.1016/j.amjcard.2007.11.038; Silverman D., 2006, INTERPRETING QUALITA, V3a; Soares JD, 2009, ARQ BRAS CARDIOL, V92, P430; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Sterman J, 2004, DYNAMICA, V10, P51; Sterman J., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Thiem A, 2013, R J, V5, P87; Thilo C, 2013, CLIN RES CARDIOL, V102, P905, DOI 10.1007/s00392-013-0608-8; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; VANDENBELT M, 2004, MEDIATED MODELING SY; Ventana Systems Inc, 2011, VENS DSS; Victor Suma M, 2012, Indian Heart J, V64, P582, DOI 10.1016/j.ihj.2012.09.007; Wang TY, 2011, JAMA-J AM MED ASSOC, V305, P2540, DOI 10.1001/jama.2011.862; World Health Organization (WHO), 2013, TOP 10 CAUS DEATH	63	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103577	10.1371/journal.pone.0103577	http://dx.doi.org/10.1371/journal.pone.0103577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079362	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800056
J	Hickey, C; Chelazzi, L; Theeuwes, J				Hickey, Clayton; Chelazzi, Leonardo; Theeuwes, Jan			Reward-Priming of Location in Visual Search	PLOS ONE			English	Article							POP-OUT; SELECTIVE ATTENTION; NEURAL BASIS; CAPTURE; STIMULI; DOPAMINE; TARGET	Existing visual search research has demonstrated that the receipt of reward will be beneficial for subsequent perceptual and attentional processing of features that have characterized targets, but detrimental for processing of features that have characterized irrelevant distractors. Here we report a similar effect of reward on location. Observers completed a visual search task in which they selected a target, ignored a salient distractor, and received random-magnitude reward for correct performance. Results show that when target selection garnered rewarding outcome attention is subsequently a.) primed to return to the target location, and b.) biased away from the location that was occupied by the salient, task-irrelevant distractor. These results suggest that in addition to priming features, reward acts to guide visual search by priming contextual locations of visual stimuli.	[Hickey, Clayton; Theeuwes, Jan] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [Hickey, Clayton] Univ Trento, Ctr Mind Brain Sci CIMeC, Trento, Trento, Italy; [Chelazzi, Leonardo] Univ Verona, Dept Neurol & Visual Sci, I-37100 Verona, Italy; [Chelazzi, Leonardo] Italian Inst Neurosci, Verona, Italy	Vrije Universiteit Amsterdam; University of Trento; University of Verona	Hickey, C (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	clayton.hickey@unitn.it	Theeuwes, Jan/ABF-3771-2020; Hickey, Clayton/ABA-6126-2021; Chelazzi, Leonardo/B-6084-2011	Hickey, Clayton/0000-0002-4162-5643; Chelazzi, Leonardo/0000-0001-8566-0611; Theeuwes, Jan/0000-0002-5849-7721	Netherlands Organization for Scientific Research (NWO) VENI [016-125-283]; European Research Council (ERC) [2012-AdG-323413]; Fondazione Cariverona	Netherlands Organization for Scientific Research (NWO) VENI(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC)); Fondazione Cariverona(Fondazione Cariverona)	This work was made possible by a Netherlands Organization for Scientific Research (NWO) VENI grant (016-125-283) to CH and a European Research Council (ERC) advanced grant (2012-AdG-323413) to JT. LC is supported by Fondazione Cariverona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BA, 2012, VIS COGN, V20, P647, DOI 10.1080/13506285.2012.679711; Anderson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027926; Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Arsenault JT, 2013, NEURON, V77, P1174, DOI 10.1016/j.neuron.2013.01.008; Atas A, 2014, PSYCHOL SCI, V25, P113, DOI 10.1177/0956797613499591; Awh E, 2012, TRENDS COGN SCI, V16, P437, DOI 10.1016/j.tics.2012.06.010; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Buschschulte A, 2014, J COGNITIVE NEUROSCI, V26, P1049, DOI 10.1162/jocn_a_00539; Camara E, 2013, EXP BRAIN RES, V230, P291, DOI 10.1007/s00221-013-3654-6; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Chelazzi L, 2013, VISION RES, V85, P58, DOI 10.1016/j.visres.2012.12.005; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Della Libera C, 2006, PSYCHOL SCI, V17, P222; Della Libera C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019460; Della Libera C, 2009, PSYCHOL SCI, V20, P778, DOI 10.1111/j.1467-9280.2009.02360.x; Geyer T, 2007, J EXP PSYCHOL HUMAN, V33, P788, DOI 10.1037/0096-1523.33.4.788; Hickey C, 2006, J COGNITIVE NEUROSCI, V18, P604, DOI 10.1162/jocn.2006.18.4.604; Hickey C, 2013, VISION RES, V92, P67, DOI 10.1016/j.visres.2013.09.008; Hickey C, 2012, CURR BIOL, V22, pR219, DOI 10.1016/j.cub.2012.02.007; Hickey C, 2011, VIS COGN, V19, P117, DOI 10.1080/13506285.2010.503946; Hickey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014087; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Hickey C, 2010, EXP BRAIN RES, V201, P789, DOI 10.1007/s00221-009-2094-9; Hickey C, 2009, J COGNITIVE NEUROSCI, V21, P760, DOI 10.1162/jocn.2009.21039; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Kristjansson A, 2007, CEREB CORTEX, V17, P1612, DOI 10.1093/cercor/bhl072; Kristjansson A, 2010, ATTEN PERCEPT PSYCHO, V72, P1229, DOI 10.3758/APP.72.5.1229; Kumada T, 2002, PERCEPT PSYCHOPHYS, V64, P493, DOI 10.3758/BF03194720; Lee J, 2013, J NEUROSCI, V33, P10625, DOI 10.1523/JNEUROSCI.5575-12.2013; Maljkovic V, 1996, PERCEPT PSYCHOPHYS, V58, P977, DOI 10.3758/BF03206826; Mastropasqua T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053683; PARK JY, 1994, J EXP PSYCHOL HUMAN, V20, P613, DOI 10.1037/0096-1523.20.3.613; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Qi SQ, 2013, BRAIN RES, V1532, P32, DOI 10.1016/j.brainres.2013.07.044; RABBITT P, 1979, Q J EXP PSYCHOL, V31, P305, DOI 10.1080/14640747908400729; Raymond JE, 2009, PSYCHOL SCI, V20, P981, DOI 10.1111/j.1467-9280.2009.02391.x; Roelfsema PR, 2010, TRENDS COGN SCI, V14, P64, DOI 10.1016/j.tics.2009.11.005; Roelfsema PR, 2005, NEURAL COMPUT, V17, P2176, DOI 10.1162/0899766054615699; Rothkirch M, 2013, EXP BRAIN RES, V224, P35, DOI 10.1007/s00221-012-3284-4; Rutherford HJV, 2010, PSYCHON B REV, V17, P536, DOI 10.3758/PBR.17.4.536; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; Serences JT, 2008, NEURON, V60, P1169, DOI 10.1016/j.neuron.2008.10.051; Shomstein S, 2013, PSYCHOL SCI, V24, P2369, DOI 10.1177/0956797613490743; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; TREISMAN A, 1992, AM PSYCHOL, V47, P862, DOI 10.1037/0003-066X.47.7.862; Wang LH, 2013, J VISION, V13, DOI 10.1167/13.3.5	49	42	44	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103372	10.1371/journal.pone.0103372	http://dx.doi.org/10.1371/journal.pone.0103372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6EF	25080218	Green Published, gold, Green Submitted			2022-12-25	WOS:000339954800041
J	Nilsson, MI; Macneil, LG; Kitaoka, Y; Alqarni, F; Suri, R; Akhtar, M; Haikalis, ME; Dhaliwal, P; Saeed, M; Tarnopolsky, MA				Nilsson, Mats I.; Macneil, Lauren G.; Kitaoka, Yu; Alqarni, Fatimah; Suri, Rahul; Akhtar, Mahmood; Haikalis, Maria E.; Dhaliwal, Pavneet; Saeed, Munim; Tarnopolsky, Mark A.			Redox State and Mitochondrial Respiratory Chain Function in Skeletal Muscle of LGMD2A Patients	PLOS ONE			English	Article							CALPAIN-3 GENE; OXIDATIVE STRESS; CAPN3 GENE; MUTATIONS; DIAGNOSIS; EXERCISE; FEATURES; 2A	Background: Calpain-3 deficiency causes oxidative and nitrosative stress-induced damage in skeletal muscle of LGMD2A patients, but mitochondrial respiratory chain function and anti-oxidant levels have not been systematically assessed in this clinical population previously. Methods: We identified 14 patients with phenotypes consistent with LGMD2A and performed CAPN3 gene sequencing, CAPN3 expression/autolysis measurements, and in silico predictions of pathogenicity. Oxidative damage, anti-oxidant capacity, and mitochondrial enzyme activities were determined in a subset of muscle biopsies. Results: Twenty-one disease-causing variants were detected along the entire CAPN3 gene, five of which were novel (c. 338 T>C, c.500 T>C, c.1525-1 G>T, c.2115+4 T>G, c.2366 T>A). Protein-and mRNA-based tests confirmed in silico predictions and the clinical diagnosis in 75% of patients. Reductions in antioxidant defense mechanisms (SOD-1 and NRF-2, but not SOD-2), coupled with increased lipid peroxidation and protein ubiquitination, were observed in calpain-3 deficient muscle, indicating a redox imbalance primarily affecting non-mitochondrial compartments. Although ATP synthase levels were significantly lower in LGMD2A patients, citrate synthase, cytochrome c oxidase, and complex I+III activities were not different from controls. Conclusions: Despite significant oxidative damage and redox imbalance in cytosolic/myofibrillar compartments, mitochondrial respiratory chain function is largely maintained in skeletal muscle of LGMD2A patients.	[Nilsson, Mats I.; Macneil, Lauren G.; Kitaoka, Yu; Alqarni, Fatimah; Suri, Rahul; Akhtar, Mahmood; Haikalis, Maria E.; Dhaliwal, Pavneet; Saeed, Munim; Tarnopolsky, Mark A.] McMaster Univ Hosp, Neuromuscular Clin, Dept Pediat & Med, Hamilton, ON, Canada	McMaster University	Tarnopolsky, MA (corresponding author), McMaster Univ Hosp, Neuromuscular Clin, Dept Pediat & Med, Hamilton, ON, Canada.	tarnopol@mcmaster.ca	Nilsson, Mats/AAG-2068-2021	Nilsson, Mats/0000-0001-5656-5578; Kitaoka, Yu/0000-0001-6932-2735	Jessica Heikoop and family; Jay's Drive Fore MD Golf Tournament	Jessica Heikoop and family; Jay's Drive Fore MD Golf Tournament	Work was supported with private donations from Jessica Heikoop and family and Jay's Drive Fore MD Golf Tournament. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini C.F.M., 2005, CALPAINOPATHY SEATTL; Ankala A, 2013, MUSCLE NERVE, V47, P931, DOI 10.1002/mus.23763; Beckmann JS, 1996, CURR OPIN NEUROL, V9, P389, DOI 10.1097/00019052-199610000-00013; Chae J, 2001, NEUROMUSCULAR DISORD, V11, P547, DOI 10.1016/S0960-8966(01)00197-3; Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Duguez S, 2006, FEBS J, V273, P3427, DOI 10.1111/j.1742-4658.2006.05351.x; Fanin M, 2007, J MED GENET, V44, P38, DOI 10.1136/jmg.2006.044859; Fanin M, 2004, HUM MUTAT, V24, P52, DOI 10.1002/humu.20058; Fanin M, 2013, NEUROPATH APPL NEURO, V39, P762, DOI 10.1111/nan.12034; Fanin M, 2003, AM J PATHOL, V163, P1929, DOI 10.1016/S0002-9440(10)63551-1; Fanin M, 2009, EUR J HUM GENET, V17, P598, DOI 10.1038/ejhg.2008.193; Fardeau M, 1996, NEUROMUSCULAR DISORD, V6, P447, DOI 10.1016/S0960-8966(96)00387-2; Grover GJ, 2008, INT J BIOCHEM CELL B, V40, P2698, DOI 10.1016/j.biocel.2008.06.013; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Kawai H, 1998, MUSCLE NERVE, V21, P1493, DOI 10.1002/(SICI)1097-4598(199811)21:11<1493::AID-MUS19>3.0.CO;2-1; Kitaoka Y, 2013, MOL GENET METAB, V110, P297, DOI 10.1016/j.ymgme.2013.06.022; Kolski HK, 2008, NEUROPATHOLOGY, V28, P264, DOI 10.1111/j.1440-1789.2007.00871.x; Krahn M, 2006, CLIN GENET, V69, P444, DOI 10.1111/j.1399-0004.2006.00603.x; Kramerova I, 2012, HUM MOL GENET, V21, P3193, DOI 10.1093/hmg/dds144; Kramerova I, 2008, HUM MOL GENET, V17, P3271, DOI 10.1093/hmg/ddn223; Kramerova I, 2007, BBA-MOL BASIS DIS, V1772, P128, DOI 10.1016/j.bbadis.2006.07.002; Kramerova I, 2009, HUM MOL GENET, V18, P3194, DOI 10.1093/hmg/ddp257; McKenzie S, 2000, AM J PHYSIOL-ENDOC M, V278, pE580, DOI 10.1152/ajpendo.2000.278.4.E580; Milic A, 2007, NEUROMUSCULAR DISORD, V17, P148, DOI 10.1016/j.nmd.2006.11.001; Murphy RM, 2006, AM J PHYSIOL-CELL PH, V290, pC116, DOI 10.1152/ajpcell.00291.2005; Murphy RM, 2007, J APPL PHYSIOL, V103, P926, DOI 10.1152/japplphysiol.01422.2006; Nilsson MI, 2014, GENE, V537, P41, DOI 10.1016/j.gene.2013.12.033; Nilsson MI, 2013, MUSCLE NERVE, V47, P740, DOI 10.1002/mus.23666; Nilsson MI, 2012, MOL GENET METAB, V107, P469, DOI 10.1016/j.ymgme.2012.09.010; Ojima K, 2012, J CLIN INVEST, V120, P2672; Ojima K, 2007, J BIOL CHEM, V282, P14493, DOI 10.1074/jbc.M610806200; Ojima K, 2011, J MOL BIOL, V407, P439, DOI 10.1016/j.jmb.2011.01.057; Ono Y, 2010, J BIOL CHEM, V285, P22984, DOI 10.1074/jbc.M110.126946; Piluso G, 2005, J MED GENET, V42, P686, DOI 10.1136/jmg.2004.028738; Rajakumar D, 2013, NEUROCHEM RES, P1; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Saenz A, 2005, BRAIN, V128, P732, DOI 10.1093/brain/awh408; Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Todorova A, 2005, CLIN GENET, V67, P356, DOI 10.1111/j.1399-0004.2005.00398.x; Whitehead NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015354; Wu Y, 2011, MOL GENET METAB, V104, P587, DOI 10.1016/j.ymgme.2011.08.012	43	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102549	10.1371/journal.pone.0102549	http://dx.doi.org/10.1371/journal.pone.0102549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079074	gold, Green Submitted, Green Published			2022-12-25	WOS:000339954800014
J	Wiens, O; Xia, D; von Schubert, C; Wastling, JM; Dobbelaere, DAE; Heussler, VT; Woods, KL				Wiens, Olga; Xia, Dong; von Schubert, Conrad; Wastling, Jonathan M.; Dobbelaere, Dirk A. E.; Heussler, Volker T.; Woods, Kerry L.			Cell Cycle-Dependent Phosphorylation of Theileria annulata Schizont Surface Proteins	PLOS ONE			English	Article							NF-KAPPA-B; PARVA; SURVIVAL; PATHWAY; JUN; PROLIFERATION; ACTIVATION; INFECTION; KINASE; TOOLS	The invasion of Theileria sporozoites into bovine leukocytes is rapidly followed by the destruction of the surrounding host cell membrane, allowing the parasite to establish its niche within the host cell cytoplasm. Theileria infection induces host cell transformation, characterised by increased host cell proliferation and invasiveness, and the activation of anti-apoptotic genes. This process is strictly dependent on the presence of a viable parasite. Several host cell kinases, including PI3-K, JNK, CK2 and Src-family kinases, are constitutively activated in Theileria-infected cells and contribute to the transformed phenotype. Although a number of host cell molecules, including IkB kinase and polo-like kinase 1 (Plk1), are recruited to the schizont surface, very little is known about the schizont molecules involved in host-parasite interactions. In this study we used immunofluorescence to detect phosphorylated threonine (p-Thr), serine (p-Ser) and threonine-proline (p-Thr-Pro) epitopes on the schizont during host cell cycle progression, revealing extensive schizont phosphorylation during host cell interphase. Furthermore, we established a quick protocol to isolate schizonts from infected macrophages following synchronisation in S-phase or mitosis, and used mass spectrometry to detect phosphorylated schizont proteins. In total, 65 phosphorylated Theileria proteins were detected, 15 of which are potentially secreted or expressed on the surface of the schizont and thus may be targets for host cell kinases. In particular, we describe the cell cycle-dependent phosphorylation of two T. annulata surface proteins, TaSP and p104, both of which are highly phosphorylated during host cell S-phase. TaSP and p104 are involved in mediating interactions between the parasite and the host cell cytoskeleton, which is crucial for the persistence of the parasite within the dividing host cell and the maintenance of the transformed state.	[Wiens, Olga; von Schubert, Conrad; Dobbelaere, Dirk A. E.; Woods, Kerry L.] Univ Bern, Vetsuisse Fac, Div Mol Pathobiol, Bern, Switzerland; [Xia, Dong; Wastling, Jonathan M.] Univ Liverpool, Inst Infect & Global Hlth, Dept Infect Biol, Liverpool L69 3BX, Merseyside, England; [Xia, Dong; Wastling, Jonathan M.] Univ Liverpool, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England; [Wastling, Jonathan M.] Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 3BX, Merseyside, England; [Heussler, Volker T.] Univ Bern, Inst Cell Biol, Bern, Switzerland	University of Bern; University of Liverpool; University of Liverpool; University of Liverpool; University of Bern	Woods, KL (corresponding author), Univ Bern, Vetsuisse Fac, Div Mol Pathobiol, Bern, Switzerland.	kerry.woods@vetsuisse.unibe.ch	Heussler, Volker/H-9322-2019	Heussler, Volker/0000-0001-8028-9825; Xia, Dong/0000-0003-4571-2776	Swiss National Science Foundation [SNF_31003A_130780]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation (grant SNF_31003A_130780). http://www.snf.ch/en/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson R, 1997, PARASITOL TODAY, V13, P390, DOI 10.1016/S0169-4758(97)01127-7; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Aurrecoechea C, 2013, NUCLEIC ACIDS RES, V41, pD684, DOI 10.1093/nar/gks1113; Baumgartner M, 2000, CELL MICROBIOL, V2, P329, DOI 10.1046/j.1462-5822.2000.00062.x; Baumgartner M, 1999, MICROBES INFECT, V1, P1181, DOI 10.1016/S1286-4579(99)00244-0; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Botteron C, 1998, BIOCHEM BIOPH RES CO, V246, P418, DOI 10.1006/bbrc.1998.8635; Chaussepied M, 1998, MOL BIOCHEM PARASIT, V94, P215, DOI 10.1016/S0166-6851(98)00070-X; Chaussepied M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001197; Daubenberger C, 1997, MOL BIOCHEM PARASIT, V85, P265, DOI 10.1016/S0166-6851(97)02831-4; Dessauge F, 2005, PARASITOLOGY, V130, pS37, DOI 10.1017/S0031182005008140; Dessauge F, 2005, TRENDS PARASITOL, V21, P377, DOI 10.1016/j.pt.2005.06.003; Dessauge G, 2005, ONCOGENE, V24, P1075, DOI 10.1038/sj.onc.1208314; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Dobbelaere D., 2009, INTRACELLULAR NICHES, P613, DOI [10.1002/9783527629176., DOI 10.1002/9783527629176]; DOBBELAERE DAE, 1988, P NATL ACAD SCI USA, V85, P4730, DOI 10.1073/pnas.85.13.4730; Dulla K, 2010, MOL CELL PROTEOMICS, V9, P1167, DOI 10.1074/mcp.M900335-MCP200; Galley Y, 1997, P NATL ACAD SCI USA, V94, P5119, DOI 10.1073/pnas.94.10.5119; Guergnon J, 2003, CELL MICROBIOL, V5, P709, DOI 10.1046/j.1462-5822.2003.00314.x; Guergnon J, 2006, APOPTOSIS, V11, P1263, DOI 10.1007/s10495-006-7702-6; Heussler VT, 2001, CELL MICROBIOL, V3, P537, DOI 10.1046/j.1462-5822.2001.00134.x; Heussler VT, 2002, SCIENCE, V298, P1033, DOI 10.1126/science.1075462; IRVIN AD, 1982, RES VET SCI, V33, P298, DOI 10.1016/S0034-5288(18)32305-1; IVANOV V, 1989, MOL CELL BIOL, V9, P4677, DOI 10.1128/MCB.9.11.4677; Jackson AP, 2014, NUCL ACIDS RES; Kinnaird JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066833; Kuhni-Boghenbor K, 2012, CELL MICROBIOL, V14, P1867, DOI 10.1111/cmi.12006; Kuenzi P, 2003, J IMMUNOL, V171, P1224, DOI 10.4049/jimmunol.171.3.1224; Lizundia R, 2006, CANCER RES, V66, P6105, DOI 10.1158/0008-5472.CAN-05-3861; Malik R, 2010, PROTEOMICS, V10, P1270, DOI 10.1002/pmic.200900365; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; OLEMOIYOI OK, 1993, EMBO J, V12, P1621, DOI 10.1002/j.1460-2075.1993.tb05807.x; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Seitzer U, 2007, PARASITOL RES, V101, pS217, DOI 10.1007/s00436-007-0685-6; Seitzer U, 2010, PARASITOL RES, V106, P1085, DOI 10.1007/s00436-010-1747-8; Shiels B, 2006, INT J PARASITOL, V36, P9, DOI 10.1016/j.ijpara.2005.09.002; SHIELS B, 1992, J CELL SCI, V101, P99; STABEL JR, 1995, VET IMMUNOL IMMUNOP, V45, P211, DOI 10.1016/0165-2427(94)05348-V; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; von Schubert C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000499; Weir W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-42; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Witschi M, 2013, INT J PARASITOL, V43, P173, DOI 10.1016/j.ijpara.2012.10.017; Woods K., 2014, Protein phosphorylation in parasites: novel targets for antiparasitic intervention, P181; Woods KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003346	48	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103821	10.1371/journal.pone.0103821	http://dx.doi.org/10.1371/journal.pone.0103821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077614	Green Published, gold, Green Accepted			2022-12-25	WOS:000339954800084
J	Wood, KA; Stillman, RA; Daunt, F; O'Hare, MT				Wood, Kevin A.; Stillman, Richard A.; Daunt, Francis; O'Hare, Matthew T.			Can Sacrificial Feeding Areas Protect Aquatic Plants from Herbivore Grazing? Using Behavioural Ecology to Inform Wildlife Management	PLOS ONE			English	Article							WHITE-FRONTED GEESE; SWANS CYGNUS-OLOR; FOOD SUPPLEMENTATION; REDUCE PREDATION; STANDING CROP; DUCK NESTS; CONSERVATION; CONFLICT; IMPACT; PATTERNS	Effective wildlife management is needed for conservation, economic and human well-being objectives. However, traditional population control methods are frequently ineffective, unpopular with stakeholders, may affect non-target species, and can be both expensive and impractical to implement. New methods which address these issues and offer effective wildlife management are required. We used an individual-based model to predict the efficacy of a sacrificial feeding area in preventing grazing damage by mute swans (Cygnus olor) to adjacent river vegetation of high conservation and economic value. The accuracy of model predictions was assessed by a comparison with observed field data, whilst prediction robustness was evaluated using a sensitivity analysis. We used repeated simulations to evaluate how the efficacy of the sacrificial feeding area was regulated by (i) food quantity, (ii) food quality, and (iii) the functional response of the forager. Our model gave accurate predictions of aquatic plant biomass, carrying capacity, swan mortality, swan foraging effort, and river use. Our model predicted that increased sacrificial feeding area food quantity and quality would prevent the depletion of aquatic plant biomass by swans. When the functional response for vegetation in the sacrificial feeding area was increased, the food quantity and quality in the sacrificial feeding area required to protect adjacent aquatic plants were reduced. Our study demonstrates how the insights of behavioural ecology can be used to inform wildlife management. The principles that underpin our model predictions are likely to be valid across a range of different resource-consumer interactions, emphasising the generality of our approach to the evaluation of strategies for resolving wildlife management problems.	[Wood, Kevin A.; Daunt, Francis; O'Hare, Matthew T.] Ctr Ecol & Hydrol, Edinburgh, Midlothian, Scotland; [Wood, Kevin A.; Stillman, Richard A.] Bournemouth Univ, Fac Sci & Technol, Poole BH12 5BB, Dorset, England	UK Centre for Ecology & Hydrology (UKCEH); Bournemouth University	Wood, KA (corresponding author), Ctr Ecol & Hydrol, Edinburgh, Midlothian, Scotland.	kevinwoodecology@hotmail.co.uk	Wood, Kevin/C-7312-2012; O'Hare, Matthew T/F-3648-2011; Daunt, Francis/K-6688-2012	Wood, Kevin/0000-0001-9170-6129; Daunt, Francis/0000-0003-4638-3388	Centre for Ecology & Hydrology Algorithm (Natural Environment Research Council) [NEC3579]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Centre for Ecology & Hydrology Algorithm (Natural Environment Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded through a Centre for Ecology & Hydrology Algorithm (Grant Number NEC3579; Natural Environment Research Council, http://www.nerc.ac.uk/) studentship awarded to KW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2004, J APPL ECOL, V41, P675, DOI 10.1111/j.0021-8901.2004.00923.x; Amano T, 2007, J APPL ECOL, V44, P506, DOI 10.1111/j.1365-2664.2007.01314.x; Amano T, 2012, ECOL RES, V27, P495, DOI 10.1007/s11284-012-0928-6; Ankney CD, 1996, J WILDLIFE MANAGE, V60, P217, DOI 10.2307/3802219; BECH C, 1980, J COMP PHYSIOL, V136, P61, DOI 10.1007/BF00688623; BLOKPOEL H, 1989, WILDLIFE SOC B, V17, P435; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Brunckhorst H., 1996, OKOLOGIE ENERGETIK P; Bullock J. M., 2000, Grazing management: the principles and practice of grazing, for profit and environmental gain, within temperate grassland systems. Proceedings of the British Grassland Society Conference held at the Cairn Hotel, Harrogate, 29 February-2 March 2000., P17; Conover M., 2002, RESOLVING HUMAN WILD; Conover MR, 2005, WILDLIFE SOC B, V33, P1330, DOI 10.2193/0091-7648(2005)33[1330:EOSFTR]2.0.CO;2; Cooper SM, 2000, WILDLIFE SOC B, V28, P660; Decker DJ, 1997, WILDLIFE SOC B, V25, P788; Delany S, 2005, DUCKS GEESE SWANS, P231; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Gayet G, 2011, AQUAT BOT, V95, P110, DOI 10.1016/j.aquabot.2011.04.003; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; GOSLING LM, 1989, BIOL J LINN SOC, V38, P39, DOI 10.1111/j.1095-8312.1989.tb01561.x; Greenwood RJ, 1998, WILDLIFE SOC B, V26, P219; GROSS JE, 1993, ECOLOGY, V74, P778, DOI 10.2307/1940805; Hairston N. G., 1989, ECOLOGICAL EXPT PURP; HANSEN LP, 1979, J MAMMAL, V60, P335, DOI 10.2307/1379805; Heydon MJ, 2010, WILDLIFE RES, V37, P731, DOI 10.1071/WR10006; Hodder KH, 1997, J APPL ECOL, V34, P547, DOI 10.2307/2404906; Jozkowicz Alicja, 1996, Acta Ornithologica (Warsaw), V31, P45; Kear J, 1988, MUTE SWAN; KERSTEN M, 1987, ARDEA, V75, P175; Lopez-Bao JV, 2010, ANIM CONSERV, V13, P35, DOI 10.1111/j.1469-1795.2009.00300.x; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; McKay HV, 2001, AGR ECOSYST ENVIRON, V84, P99, DOI 10.1016/S0167-8809(00)00207-3; McLane AJ, 2011, ECOL MODEL, V222, P1544, DOI 10.1016/j.ecolmodel.2011.01.020; Meissner Wlodzimierz, 2007, Ornis Svecica, V17, P148; Nolet BA, 2002, J ANIM ECOL, V71, P979, DOI 10.1046/j.1365-2656.2002.00662.x; Nolet BA, 2005, OIKOS, V111, P302, DOI 10.1111/j.0030-1299.2005.14043.x; O'Hare MT, 2007, FRESHWATER BIOL, V52, P2463, DOI 10.1111/j.1365-2427.2007.01841.x; Orr RJ, 1997, APPL ANIM BEHAV SCI, V52, P65, DOI 10.1016/S0168-1591(96)01120-3; OWEN M, 1990, IBIS, V132, P238, DOI 10.1111/j.1474-919X.1990.tb01042.x; Owen M., 1975, Wildfowl, V26, P31; OWEN M, 1977, Biological Conservation, V11, P209, DOI 10.1016/0006-3207(77)90005-2; PANDIT AK, 1984, J ENVIRON MANAGE, V18, P73; Percival SM, 1997, BIOL CONSERV, V82, P273, DOI 10.1016/S0006-3207(97)00041-4; Perry G, 1997, TRENDS ECOL EVOL, V18, P228; RATTRAY PV, 1974, NEW ZEAL J AGR RES, V17, P401, DOI 10.1080/00288233.1974.10421024; Redpath SM, 2001, J APPL ECOL, V38, P1157, DOI 10.1046/j.0021-8901.2001.00683.x; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; REES EC, 1990, J APPL ECOL, V27, P939, DOI 10.2307/2404388; Ringelman KM, 2014, ECOL MODEL, V272, P141, DOI 10.1016/j.ecolmodel.2013.09.028; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Sahlsten J, 2010, WILDLIFE BIOL, V16, P85, DOI 10.2981/08-085; Sih A, 2001, ANIM BEHAV, V61, P379, DOI 10.1006/anbe.2000.1592; Spray C.J., 2002, Aspects of Applied Biology, V67, P67; Stephens D.W., 1986, pi; Stillman RA, 2008, ECOL MODEL, V216, P265, DOI 10.1016/j.ecolmodel.2008.04.014; Stillman RA, 2010, BIOL REV, V85, P413, DOI 10.1111/j.1469-185X.2009.00106.x; Sutherland WJ, 1998, ANIM BEHAV, V56, P801, DOI 10.1006/anbe.1998.0896; Takatsuki S, 2009, BIOL CONSERV, V142, P1922, DOI 10.1016/j.biocon.2009.02.011; Tatu KS, 2007, J WILDLIFE MANAGE, V71, P1431, DOI 10.2193/2006-130; Thirgood S, 2005, CONSERV BIOL SER, V9, P13; van Eerden M. R., 1996, Gibier Faune Sauvage, V13, P681; VanVuren D, 1996, BIOL AGRIC HORTIC, V13, P39, DOI 10.1080/01448765.1996.9754765; VICKERY JA, 1994, J APPL ECOL, V31, P371, DOI 10.2307/2404551; Vickery JA, 1999, BIOL CONSERV, V89, P93, DOI 10.1016/S0006-3207(98)00134-7; Watola GV, 2003, J APPL ECOL, V40, P565, DOI 10.1046/j.1365-2664.2003.00811.x; Wood K.A, 2012, THESIS BOURNEMOUTH U; Wood Kevin A., 2014, British Wildlife, V25, P171; Wood KA, 2013, OIKOS, V122, P1720, DOI 10.1111/j.1600-0706.2013.00592.x; Wood KA, 2013, BIRD STUDY, V60, P229, DOI 10.1080/00063657.2013.776003; Wood KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056287; Wood KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049824; Wood KA, 2012, AQUAT BOT, V102, P28, DOI 10.1016/j.aquabot.2012.04.006; Wood Kevin A., 2012, P339; Wood KA, 2012, HYDROBIOLOGIA, V686, P157, DOI 10.1007/s10750-012-1007-2; Woodroffe R, 2005, CONSERV BIOL SER, V9, P1	73	13	13	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e104034	10.1371/journal.pone.0104034	http://dx.doi.org/10.1371/journal.pone.0104034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077615	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000339954800104
J	Botman, D; Rottinger, E; Martindale, MQ; de Jong, J; Kaandorp, JA				Botman, Daniel; Roettinger, Eric; Martindale, Mark Q.; de Jong, Johann; Kaandorp, Jaap A.			A Computational Approach towards a Gene Regulatory Network for the Developing Nematostella vectensis Gut	PLOS ONE			English	Article							SEA-ANEMONE; POSITIONAL INFORMATION; EXPRESSION; CNIDARIAN; SPECIFICATION; SENSITIVITY; PATTERN; MODEL; AXIS	Background: The starlet sea anemone Nematostella vectensis is a diploblastic cnidarian that expresses a set of conserved genes for gut formation during its early development. During the last decade, the spatial distribution of many of these genes has been visualized with RNA hybridization or protein immunolocalization techniques. However, due to N. vectensis' curved and changing morphology, quantification of these spatial data is problematic. A method is developed for two-dimensional gene expression quantification, which enables a numerical analysis and dynamic modeling of these spatial patterns. Methods/Result: In this work, first standardized gene expression profiles are generated from publicly available N. vectensis embryo images that display mRNA and/or protein distributions. Then, genes expressed during gut formation are clustered based on their expression profiles, and further grouped based on temporal appearance of their gene products in embryonic development. Representative expression profiles are manually selected from these clusters, and used as input for a simulation-based optimization scheme. This scheme iteratively fits simulated profiles to the selected profiles, leading to an optimized estimation of the model parameters. Finally, a preliminary gene regulatory network is derived from the optimized model parameters. Outlook: While the focus of this study is N. vectensis, the approach outlined here is suitable for inferring gene regulatory networks in the embryonic development of any animal, thus allowing to comparatively study gene regulation of gut formation in silico across various species.	[Botman, Daniel; Kaandorp, Jaap A.] Univ Amsterdam, Amsterdam, Netherlands; [Roettinger, Eric] Univ Nice Sophia Antipolis, Inst Res Canc & Aging, Nice IRCAN, UMR 7284, F-06189 Nice, France; [Roettinger, Eric] CNRS, Inst Res Canc & Aging, Nice IRCAN, UMR 7284, F-06034 Nice, France; [Roettinger, Eric] Fac Med Nice, INSERM, Inst Res Canc & Aging, Nice IRCAN,U1081, F-06034 Nice, France; [Martindale, Mark Q.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL USA; [de Jong, Johann] Netherlands Canc Inst, Computat Canc Biol Grp, Div Mol Carcinogenesis, Amsterdam, Netherlands	University of Amsterdam; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; State University System of Florida; University of Florida; Netherlands Cancer Institute	Kaandorp, JA (corresponding author), Univ Amsterdam, Amsterdam, Netherlands.	j.a.kaandorp@uva.nl	Röttinger, Eric/AAX-6277-2021	Rottinger, Eric/0000-0002-2938-6774; de Jong, Johann/0000-0002-2097-0915	Knowledge Based Bio-Economy (KBBE) EU grant [289434]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093116] Funding Source: NIH RePORTER	Knowledge Based Bio-Economy (KBBE) EU grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is part of the BioPreDyn project (www.biopredyn.eu). BioPreDyn is a Cooperation project of the Knowledge Based Bio-Economy (KBBE) EU grant, with the number 289434. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botman Daniel, 2012, BMC Res Notes, V5, P555, DOI 10.1186/1756-0500-5-555; Crombach A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046658; Crombach A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002589; Darling JA, 2005, BIOESSAYS, V27, P211, DOI 10.1002/bies.20181; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Egea JA, 2010, COMPUT OPER RES, V37, P315, DOI 10.1016/j.cor.2009.05.003; Egea JA, 2009, IND ENG CHEM RES, V48, P4388, DOI 10.1021/ie801717t; Fomekong-Nanfack Y, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-94; Fritzenwanker JH, 2007, DEV BIOL, V310, P264, DOI 10.1016/j.ydbio.2007.07.029; Fritzenwanker JH, 2004, DEV BIOL, V275, P389, DOI 10.1016/j.ydbio.2004.08.014; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2012, CURR OPIN GENET DEV, V22, P533, DOI 10.1016/j.gde.2012.10.005; Jaeger J, 2009, MOL BIOSYST, V5, P1549, DOI 10.1039/b904722k; Lee PN, 2007, DEV BIOL, V310, P169, DOI 10.1016/j.ydbio.2007.05.040; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Magie CR, 2007, DEV BIOL, V305, P483, DOI 10.1016/j.ydbio.2007.02.044; Maly T, 1996, APPL NUMER MATH, V20, P57, DOI 10.1016/0168-9274(95)00117-4; Manu, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000303; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; Martindale MQ, 2009, DEV CELL, V17, P162, DOI 10.1016/j.devcel.2009.07.024; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; MJOLSNESS E, 1991, J THEOR BIOL, V152, P429, DOI 10.1016/S0022-5193(05)80391-1; Ormestad M, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-17; Pennisi E, 2005, SCIENCE, V309, P80, DOI 10.1126/science.309.5731.80; Peter IS, 2011, NATURE, V474, P635, DOI 10.1038/nature10100; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reeves GT, 2006, DEV CELL, V11, P289, DOI 10.1016/j.devcel.2006.08.006; Rottinger E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003164; Ryan JF, 2003, NUCLEIC ACIDS RES, V31, P159, DOI 10.1093/nar/gkg116; Song L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-328; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	31	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103341	10.1371/journal.pone.0103341	http://dx.doi.org/10.1371/journal.pone.0103341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076223	Green Published, Green Submitted, gold			2022-12-25	WOS:000340028800039
J	Carlos, CP; Sonehara, NM; Oliani, SM; Burdmann, EA				Carlos, Carla Patricia; Sonehara, Nathalia Martins; Oliani, Sonia Maria; Burdmann, Emmanuel A.			Predictive Usefulness of Urinary Biomarkers for the Identification of Cyclosporine A-Induced Nephrotoxicity in a Rat Model	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; KIDNEY INJURY MOLECULE-1; INTERSTITIAL FIBROSIS; DIAGNOSTIC MARKER; ANGIOTENSIN-II; OSTEOPONTIN; INFLAMMATION; NEPHROPATHY; EXPRESSION; OVEREXPRESSION	The main side effect of cyclosporine A (CsA), a widely used immunosuppressive drug, is nephrotoxicity. Early detection of CsA-induced acute nephrotoxicity is essential for stop or minimize kidney injury, and timely detection of chronic nephrotoxicity is critical for halting the drug and preventing irreversible kidney injury. This study aimed to identify urinary biomarkers for the detection of CsA-induced nephrotoxicity. We allocated salt-depleted rats to receive CsA or vehicle for 7, 14 or 21 days and evaluated renal function and hemodynamics, microalbuminuria, renal macrophage infiltration, tubulointerstitial fibrosis and renal tissue and urinary biomarkers for kidney injury. Kidney injury molecule-1 (KIM-1), tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (IL-6), fibronectin, neutrophil gelatinase-associated lipocalin (NGAL), TGF-beta, osteopontin, and podocin were assessed in urine. TNF-alpha, IL-6, fibronectin, osteopontin, TGF-beta, collagen IV, alpha smooth muscle actin (alpha -SMA) and vimentin were assessed in renal tissue. CsA caused early functional renal dysfunction and microalbuminuria, followed by macrophage infiltration and late tubulointerstitial fibrosis. Urinary TNF-alpha, KIM-1 and fibronectin increased in the early phase, and urinary TGF-beta and osteopontin increased in the late phase of CsA nephrotoxicity. Urinary biomarkers correlated consistently with renal tissue cytokine expression. In conclusion, early increases in urinary KIM-1, TNF-alpha, and fibronectin and elevated microalbuminuria indicate acute CsA nephrotoxicity. Late increases in urinary osteopontin and TGF-beta indicate chronic CsA nephrotoxicity. These urinary kidney injury biomarkers correlated well with the renal tissue expression of injury markers and with the temporal development of CsA nephrotoxicity.	[Carlos, Carla Patricia; Burdmann, Emmanuel A.] Sao Jose Do Rio Preto Med Sch, Div Nephrol, Sao Jose Do Rio Preto, SP, Brazil; [Carlos, Carla Patricia; Sonehara, Nathalia Martins; Oliani, Sonia Maria] Sao Paulo State Univ, Inst Biociencias Letras & Ciencias Exatas, Dept Biol, Sao Jose Do Rio Preto, SP, Brazil; [Burdmann, Emmanuel A.] Univ Sao Paulo, Sch Med, Div Nephrol, LIM 12, Sao Paulo, Brazil	Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade Estadual Paulista; Universidade de Sao Paulo	Burdmann, EA (corresponding author), Sao Jose Do Rio Preto Med Sch, Div Nephrol, Sao Jose Do Rio Preto, SP, Brazil.	burdmann@usp.br	Burdmann, Emmanuel/B-7023-2009; Carlos, Carla P/K-1403-2014; Burdmann, Emmanuel/AAY-1966-2020; Oliani, Sonia Maria/E-3476-2012	Burdmann, Emmanuel/0000-0002-7644-8579; Carlos, Carla P/0000-0003-0516-4533; Oliani, Sonia Maria/0000-0003-0918-2130	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, SP, Brazil (FAPESP) [09/17100-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq), Brazil [150954/2009-3, 302768/2010-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, SP, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, SP, Brazil (FAPESP); grant 09/17100-2 to EAB) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq), Brazil; grants 150954/2009-3 to CPC and 302768/2010-6 to SMO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ban CR, 2008, VASC HEALTH RISK MAN, V4, P575; Barrera-Chimal J, 2012, BIOMARKERS, V17, P385, DOI 10.3109/1354750X.2012.680070; Bennett WM, 1996, KIDNEY INT, V50, P1089, DOI 10.1038/ki.1996.415; Bobadilla NA, 2007, AM J PHYSIOL-RENAL, V293, pF2, DOI 10.1152/ajprenal.00072.2007; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Burdmann EA, 2003, SEMIN NEPHROL, V23, P465, DOI 10.1016/S0270-9295(03)00090-1; Cai T, 2007, J UROLOGY, V178, P1906, DOI 10.1016/j.juro.2007.07.041; Camici M, 2007, BIOMED PHARMACOTHER, V61, P245, DOI 10.1016/j.biopha.2006.12.009; Carlos CP, 2010, TRANSPLANTATION, V89, P1362, DOI 10.1097/TP.0b013e3181da0587; Chen D, 2013, GENE, V531, P23, DOI 10.1016/j.gene.2013.08.047; Cherney DZI, 2012, DIABETIC MED, V29, P1297, DOI 10.1111/j.1464-5491.2012.03651.x; Devarajan P, 2008, AM J KIDNEY DIS, V52, P395, DOI 10.1053/j.ajkd.2008.07.008; Di Paolo S, 1999, CLIN EXP IMMUNOL, V117, P355; Disel U, 2004, TRANSPL P, V36, P1372, DOI 10.1016/j.transproceed.2004.05.078; Djamali A, 2009, AM J TRANSPLANT, V9, P74, DOI 10.1111/j.1600-6143.2008.02463.x; Esposito C, 2011, AM J NEPHROL, V33, P239, DOI 10.1159/000324577; Haas M, 1999, AM J KIDNEY DIS, V34, P69, DOI 10.1016/S0272-6386(99)70111-3; Hosgood SA, 2012, J SURG RES, V174, pE85, DOI 10.1016/j.jss.2011.10.024; Hudkins KL, 1999, J AM SOC NEPHROL, V10, P444; Idasiak-Piechocka I, 2010, NEPHRON CLIN PRACT, V116, pC47, DOI 10.1159/000314550; Ihara Y, 2011, J CELL BIOCHEM, V112, P2518, DOI 10.1002/jcb.23176; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Lim AI, 2013, J CELL PHYSIOL, V228, P917, DOI 10.1002/jcp.24267; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Lloberas N, 2008, NEPHROL DIAL TRANSPL, V23, P3111, DOI 10.1093/ndt/gfn223; Madsen KM, 1997, J AM SOC NEPHROL, V8, P1043; McMorrow T, 2005, NEPHROL DIAL TRANSPL, V20, P2215, DOI 10.1093/ndt/gfh967; Min W, 1998, KIDNEY INT, V53, P189, DOI 10.1046/j.1523-1755.1998.00745.x; Moresco RN, 2013, CLIN CHIM ACTA, V421, P17, DOI 10.1016/j.cca.2013.02.019; Persy VP, 2003, KIDNEY INT, V63, P543, DOI 10.1046/j.1523-1755.2003.00767.x; Petermann A, 2007, NEPHRON CLIN PRACT, V106, pC61, DOI 10.1159/000101799; PICHLER RH, 1995, J AM SOC NEPHROL, V6, P1186; Pruijm M, 2012, AM J NEPHROL, V35, P288, DOI 10.1159/000335934; Ramseyer VD, 2013, AM J PHYSIOL-RENAL, V304, pF1231, DOI 10.1152/ajprenal.00557.2012; Sabry A, 2006, ARCH MED RES, V37, P933, DOI 10.1016/j.arcmed.2006.07.001; Sanchez-Nino MD, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/182958; Shihab FS, 2000, KIDNEY INT, V58, P1174, DOI 10.1046/j.1523-1755.2000.00273.x; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Slattery C, 2005, AM J PATHOL, V167, P395, DOI 10.1016/S0002-9440(10)62984-7; Tesch GH, 2008, AM J PHYSIOL-RENAL, V294, pF697, DOI 10.1152/ajprenal.00016.2008; Upadhyay A, 2011, NEPHROL DIAL TRANSPL, V26, P920, DOI 10.1093/ndt/gfq471; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Vaidya VS, 2009, KIDNEY INT, V76, P108, DOI 10.1038/ki.2009.96; Vaidya VS, 2006, AM J PHYSIOL-RENAL, V290, pF517, DOI 10.1152/ajprenal.00291.2005; Vieira JM, 1999, TRANSPLANTATION, V68, P1746, DOI 10.1097/00007890-199912150-00019; Waanders F, 2010, J PATHOL, V220, P7, DOI 10.1002/path.2642; Wasilewska A, 2010, PEDIATR NEPHROL, V25, P889, DOI 10.1007/s00467-009-1397-1; Weekley CC, 2012, CURR OPIN NEPHROL HY, V21, P301, DOI 10.1097/MNH.0b013e328352132d; Wolak T, 2009, KIDNEY INT, V76, P32, DOI 10.1038/ki.2009.90; Xu DL, 2014, CELL BIOL INT, V38, P8, DOI 10.1002/cbin.10149; YOUNG BA, 1995, KIDNEY INT, V48, P439, DOI 10.1038/ki.1995.312	51	24	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103660	10.1371/journal.pone.0103660	http://dx.doi.org/10.1371/journal.pone.0103660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072153	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600077
J	Choi, DP; Oh, SM; Lee, JM; Cho, HM; Lee, WJ; Song, BM; Rhee, Y; Kim, HC				Choi, Dong Phil; Oh, Sun Min; Lee, Ju-Mi; Cho, Hye Min; Lee, Won Joon; Song, Bo-Mi; Rhee, Yumie; Kim, Hyeon Chang			Serum 25-Hydroxyvitamin D and Insulin Resistance in Apparently Healthy Adolescents	PLOS ONE			English	Article							VITAMIN-D INSUFFICIENCY; HYPOVITAMINOSIS-D; METABOLIC SYNDROME; OBESE CHILDREN; RISK; SENSITIVITY; ASSOCIATION; EXPRESSION; ETHNICITY; RECEPTOR	Purpose: Vitamin D deficiency is a common condition that is associated with diabetes and insulin resistance. However, the association between vitamin D and insulin resistance has not been fully studied, especially in the general adolescent population. Therefore, we assessed the association between serum 25-hydroxyvitamin D [25(OH)D] level and insulin resistance among apparently healthy Korean adolescents. Methods: A total of 260 (135 male and 125 female) adolescents in a rural high school were assessed for serum 25(OH)D, fasting plasma glucose, and insulin. All of the participants were aged 15 to 16 years old, and without known hypertension or diabetes. Serum 25(OH)D was analyzed both as a continuous and categorical variable in association with insulin resistance. Insulin resistance was estimated by homeostasis model assessment (HOMA-IR). Increased insulin resistance was operationally defined as a HOMA-IR value higher than the sex-specific 75th percentile. Results: In male adolescents, every 10 ng/ml decrease in 25(OH)D level was associated with a 0.25 unit increase in HOMA-IR (p = 0.003) after adjusting for age and BMI. Compared to those in the highest quartile, male adolescents in the lowest 25(OH)D quartile were at significantly higher risk for insulin resistance: unadjusted odds ratio 4.06 (95% CI, 1.26 to 13.07); age and BMI adjusted odds ratio 3.59 (95% CI, 1.03 to 12.57). However, 25(OH)D level, either in continuous or categorical measure, was not significantly associated with insulin resistance among female adolescents. Conclusions: This study suggests that serum 25(OH)D level may be inversely associated with insulin resistance in healthy male adolescents.	[Choi, Dong Phil; Song, Bo-Mi] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120749, South Korea; [Oh, Sun Min; Lee, Ju-Mi; Cho, Hye Min; Lee, Won Joon; Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul 120749, South Korea; [Rhee, Yumie] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea; [Choi, Dong Phil; Kim, Hyeon Chang] Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul 120749, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, HC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, Seoul 120749, South Korea.	hckim@yuhs.ac	Rhee, Yumie/L-8020-2019; Kim, Hyeon Chang/F-8796-2019	Rhee, Yumie/0000-0003-4227-5638; Kim, Hyeon Chang/0000-0001-7867-1240	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST) [2010-0007860]; Yonsei University College of Medicine [6-2010-0164]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST); Yonsei University College of Medicine(General Electric)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (MEST) (No. 2010-0007860) and by a faculty research grant of Yonsei University College of Medicine for 2010 (6-2010-0164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemzadeh R, 2008, METABOLISM, V57, P183, DOI 10.1016/j.metabol.2007.08.023; Alvarez JA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/351385; [Anonymous], 2009, KOR NAT HLTH NUTR EX; Belenchia AM, 2013, AM J CLIN NUTR, V97, P774, DOI 10.3945/ajcn.112.050013; Bland R, 2004, J STEROID BIOCHEM, V89-90, P121, DOI 10.1016/j.jsbmb.2004.03.115; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Del Gobbo LC, 2011, J NUTR, V141, P290, DOI 10.3945/jn.110.129619; Erdonmez D, 2011, J CLIN RES PEDIATR E, V3, P198, DOI 10.4274/jcrpe.507; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Godsland IF, 2005, DIABETOLOGIA, V48, P2213, DOI 10.1007/s00125-005-1930-0; Grimnes G, 2010, DIABETIC MED, V27, P1107, DOI 10.1111/j.1464-5491.2010.03092.x; Gulseth HL, 2010, DIABETES CARE, V33, P923, DOI 10.2337/dc09-1692; Heaney RP, 2013, ADV NUTR, V4, P303, DOI 10.3945/an.113.003731; Hoffman RP, 2000, PEDIATR RES, V48, P384, DOI 10.1203/00006450-200009000-00022; Isaia G, 2001, DIABETES CARE, V24, P1496, DOI 10.2337/diacare.24.8.1496; JOHNSON JA, 1994, AM J PHYSIOL, V267, pE356, DOI 10.1152/ajpendo.1994.267.3.E356; Kayaniyil S, 2010, DIABETES CARE, V33, P1379, DOI 10.2337/dc09-2321; Kelishadi R, 2014, J PEDIAT-BRAZIL, V90, P28, DOI 10.1016/j.jped.2013.06.006; Kelly A, 2011, ARCH DIS CHILD, V96, P447, DOI 10.1136/adc.2010.187591; Knekt P, 2008, EPIDEMIOLOGY, V19, P666, DOI 10.1097/EDE.0b013e318176b8ad; Lee M, 2003, NEW DIR CHILD ADOLES, V99, P9, DOI 10.1002/cd.63; Liu E, 2009, J NUTR, V139, P329, DOI 10.3945/jn.108.093831; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Maestro B, 2000, ENDOCR J, V47, P383, DOI 10.1507/endocrj.47.383; Mattila C, 2007, DIABETES CARE, V30, P2569, DOI 10.2337/dc07-0292; Moran A, 2008, CIRCULATION, V117, P2361, DOI 10.1161/CIRCULATIONAHA.107.704569; Muszkat P, 2010, ARQ BRAS ENDOCRINOL, V54, P110, DOI 10.1590/S0004-27302010000200005; Olson ML, 2012, J CLIN ENDOCR METAB, V97, P279, DOI 10.1210/jc.2011-1507; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; SIMPSON RU, 1985, J BIOL CHEM, V260, P8882; Zhao GX, 2010, DIABETES CARE, V33, P344, DOI 10.2337/dc09-0924; 이종국, 2008, Clinical and Experimental Pediatrics, V51, P33	32	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103108	10.1371/journal.pone.0103108	http://dx.doi.org/10.1371/journal.pone.0103108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072652	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600023
J	Calegaro-Marques, C; Amato, SB				Calegaro-Marques, Claudia; Amato, Suzana B.			Urbanization Breaks Up Host-Parasite Interactions: A Case Study on Parasite Community Ecology of Rufous-Bellied Thrushes (Turdus rufiventris) along a Rural-Urban Gradient	PLOS ONE			English	Article							POPULATION INTERACTIONS; SPECIES RICHNESS; CONSERVATION; HELMINTHS; BIODIVERSITY; STABILITY; ABUNDANCE; RESPONSES; PATTERNS; BRAZIL	Urbanization drastically alters natural ecosystems and the structure of their plant and animal communities. Whereas some species cope successfully with these environmental changes, others may go extinct. In the case of parasite communities, the expansion of urban areas has a critical effect by changing the availability of suitable substrates for the eggs or free-larval stages of those species with direct life cycles or for the range of hosts of those species with complex cycles. In this study we investigated the influence of the degree of urbanization and environmental heterogeneity on helminth richness, abundance and community structure of rufous-bellied thrushes (Turdus rufiventris) along a rural-urban gradient in the metropolitan region of Porto Alegre, State of Rio Grande do Sul, Brazil. This common native bird species of southern Brazil hosts 15 endoparasite species at the study region. A total of 144 thrushes were collected with mist nets at 11 sites. The degree of urbanization and environmental heterogeneity were estimated by quantifying five landscape elements: buildings, woodlands, fields, bare lands, and water. Landscape analyses were performed at two spatial scales (10 and 100 ha) taking into account home range size and the potential dispersal distance of thrushes and their prey (intermediate hosts). Mean parasite richness showed an inverse relationship with the degree of urbanization, but a positive relationship with environmental heterogeneity. Changes in the structure of component communities along the rural-urban gradient resulted from responses to the availability of particular landscape elements that are compatible with the parasites' life cycles. We found that the replacement of natural environments with buildings breaks up host-parasite interactions, whereas a higher environmental (substrate) diversity allows the survival of a wider range of intermediate hosts and vectors and their associated parasites.	[Calegaro-Marques, Claudia; Amato, Suzana B.] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Zool, BR-90049 Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Calegaro-Marques, C (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Zool, BR-90049 Porto Alegre, RS, Brazil.	calegaromarques@gmail.com	Calegaro-Marques, Claudia/D-8838-2013		Brazilian Higher Education Authority (CAPES; Brazilian National Research Council (CNPq); CAPES post-doctoral fellowship [23038.8306/2010-62]	Brazilian Higher Education Authority (CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES post-doctoral fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by doctoral scholarships from the Brazilian Higher Education Authority (CAPES) and the Brazilian National Research Council (CNPq) to CCM. During the writing of this paper CCM was supported by a CAPES post-doctoral fellowship (project # 23038.8306/2010-62). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti Marina, 2001, P89; Amato J. F. R., 2010, ORNITOLOGIA CONSERVA, P369; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; AYRES M., 2007, BIOESTAT; Biamonte E, 2011, LANDSCAPE ECOL, V26, P183, DOI 10.1007/s10980-010-9564-0; BirdLife International, 2012, IUCN 2013 IUCN RED L; Blouin M, 2013, EUR J SOIL SCI, V64, P161, DOI 10.1111/ejss.12025; Buczkowski G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041729; Calegaro-Marques C, 2013, J PARASITOL, V99, P1, DOI 10.1645/GE-3087.1; Calegaro-Marques C, 2010, REV MEX BIODIVERS, V81, P801; Calegaro-Marques C, 2010, IHERINGIA SER ZOOL, V100, P73, DOI 10.1590/S0073-47212010000100010; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Christe P, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P593, DOI 10.1007/978-4-431-36025-4_27; Coimbra MAA, 2009, J PARASITOL, V95, P1011, DOI 10.1645/GE-1948.1; Combes Claude., 2001, PARASITISM ECOLOGY E; Delgado CA, 2012, LANDSCAPE URBAN PLAN, V105, P5, DOI 10.1016/j.landurbplan.2011.12.019; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; EFE MA, 2001, GUIA ILUSTRADO AVES; Fair J., 2010, ORNITHOLOGICAL COUNC; Fontana CS, 2011, URBAN ECOSYST, V14, P341, DOI 10.1007/s11252-011-0156-9; Fontana Carla Suertegaray, 2005, Comunicacoes do Museu de Ciencias e Tecnologia da PUCRS Serie Zoologia, V18, P161; FONTANA CS, 2001, FLORA FAUNA PARQUE N, P82; Foronda P, 2004, PARASITE, V11, P311, DOI 10.1051/parasite/2004113311; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Isaac B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091049; Lafferty Kevin D., 2005, P113; MacGregor-Fors I, 2010, CONDOR, V112, P711, DOI 10.1525/cond.2010.100062; Magura T, 2008, COMMUNITY ECOL, V9, P115, DOI 10.1556/ComEc.9.2008.1.13; Magura T, 2010, LANDSCAPE ECOL, V25, P621, DOI 10.1007/s10980-009-9445-6; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marzluff John M., 2001, P19; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; MCDONNELL MJ, 1990, ECOLOGY, V71, P1232, DOI 10.2307/1938259; McKay DM, 2006, PARASITOLOGY, V132, P1, DOI 10.1017/S003118200500884X; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Mennechez G, 2006, ACTA OECOL, V30, P182, DOI 10.1016/j.actao.2006.03.002; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Monello RJ, 2011, OIKOS, V120, P1427, DOI 10.1111/j.1600-0706.2011.19260.x; Pena M.R. de la, 1998, BIRDS SO S AM ANTARC; Penone C, 2013, INSECT CONSERV DIVER, V6, P319, DOI 10.1111/j.1752-4598.2012.00217.x; Pietersen DW, 2010, OSTRICH, V81, P211, DOI 10.2989/00306525.2010.519879; Reis RE, 2003, LIVRO VERMELHO FAUNA; Rook GAW, 2009, IMMUNOLOGY, V126, P3, DOI 10.1111/j.1365-2567.2008.03007.x; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Silveira LF., 2008, LIVRO VERMELHO FAUNA, P378; Sures B, 2004, TRENDS PARASITOL, V20, P170, DOI 10.1016/j.pt.2004.01.014; Tietz Marques Sandra Marcia, 2007, Parasitologia Latinoamericana, V62, P183; Toro H, 1999, AVIAN PATHOL, V28, P619, DOI 10.1080/03079459994416; Tothmeresz B, 2011, LANDSCAPE URBAN PLAN, V101, P330, DOI 10.1016/j.landurbplan.2011.02.038; Wobeser Gary A., 2008, P3	55	43	43	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103144	10.1371/journal.pone.0103144	http://dx.doi.org/10.1371/journal.pone.0103144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068271	gold, Green Published, Green Submitted			2022-12-25	WOS:000339993700039
J	Fu, YJ; Chang, H; Peng, XL; Bai, Q; Yi, L; Zhou, Y; Zhu, JD; Mi, MT				Fu, Yujie; Chang, Hui; Peng, Xiaoli; Bai, Qian; Yi, Long; Zhou, Yong; Zhu, Jundong; Mi, Mantian			Resveratrol Inhibits Breast Cancer Stem-Like Cells and Induces Autophagy via Suppressing Wnt/beta-Catenin Signaling Pathway	PLOS ONE			English	Article							IN-VITRO; APOPTOSIS; RESISTANCE; CURCUMIN	Resveratrol, a natural polyphenolic compound, is abundantly found in plant foods and has been extensively studied for its anti-cancer properties. Given the important role of CSCs (Cancer Stem Cells) in breast tumorigenesis and progression, it is worth investigating the effects of resveratrol on CSCs. The article is an attempt to investigate the effects of resveratrol on breast CSCs. Resveratrol significantly inhibits the proliferation of BCSCs (breast cancer stem-like cells) isolated from MCF-7 and SUM159, and decreased the percentage of BCSCs population, consequently reduced the size and number of mammospheres in non-adherent spherical clusters. Accordingly, the injection of resveratrol (100 mg/kg/d) in NOD/SCID (nonobese diabetic/severe combined immunodeficient) mice effectively inhibited the growth of xenograft tumors and reduced BCSC population in tumor cells. After the reimplantation of primary tumor cells into the secondary mice for 30 d, all 6 control inoculations produced tumors, while tumor cells derived from resveratrol-treated mice only caused 1 tumor of 6 inoculations. Further studies by TEM (Transmission electron microscopy) analysis, GFP-LC3-II puncta formation assay and western blot for LC3-II, Beclin1 and Atg 7, showed that resveratrol induces autophagy in BCSCs. Moreover, resveratrol suppresses Wnt/beta-catenin signaling pathway in BCSCs; over-expression of beta-catenin by transfecting the plasmid markedly reduced resveratrol-induced cytotoxicity and autophagy in BCSCs. Our findings indicated that resveratrol inhibits BCSCs and induces autophagy via suppressing Wnt/beta-catenin signaling pathway.	[Fu, Yujie; Chang, Hui; Peng, Xiaoli; Bai, Qian; Yi, Long; Zhou, Yong; Zhu, Jundong; Mi, Mantian] Third Mil Med Univ, Res Ctr Nutr & Food Safety, Chongqing Key Lab Nutr & Food Safety, Chongqing, Peoples R China; [Fu, Yujie] Chongqing Univ Technol, Inst Pharm & Bioengn, Chongqing, Peoples R China; [Peng, Xiaoli] Chengdu Med Coll, Sch Preclin Med, Dept Publ Hlth, Chengdu, Peoples R China	Army Medical University; Chongqing University of Technology; Chengdu Medical College	Zhou, Y (corresponding author), Third Mil Med Univ, Res Ctr Nutr & Food Safety, Chongqing Key Lab Nutr & Food Safety, Chongqing, Peoples R China.	zhuy72@126.com; mimt2007@126.com			National Basic Research Program of China (973 Program) [2010CB529403]; Chongqing Natural Science Foundation [cstc2011jjA10092]; special fund of Chongqing key laboratory (CSTC)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing); special fund of Chongqing key laboratory (CSTC)(Natural Science Foundation Project of CQ CSTC)	This study was supported by the National Basic Research Program of China (973 Program, No 2010CB529403), Chongqing Natural Science Foundation (cstc2011jjA10092) and the special fund of Chongqing key laboratory (CSTC). In addition to the source of financial support, the funders contributed to the study design, conduct of the study, analysis of samples, interpretation of findings.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alayev A, 2014, CELL CYCLE, V13, P371, DOI 10.4161/cc.27355; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Chang H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3194; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen Q, 2010, PLOS ONE, V12; Chuthapisith S, 2010, SURG ONCOL, V19, P27, DOI 10.1016/j.suronc.2009.01.004; Cufi S, 2011, CELL CYCLE, V10, P3871, DOI 10.4161/cc.10.22.17976; de Beca FF, 2013, J CLIN PATHOL, V66, P187, DOI 10.1136/jclinpath-2012-201169; Filippi-Chiela EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020849; Fillmore C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1673; Fukui M, 2010, MOL CARCINOGEN, V49, P750, DOI 10.1002/mc.20650; Ge J, 2013, BIOMED ENVIRON SCI, V26, P902, DOI 10.3967/bes2013.019; Gunther S, 2007, CANCER LETT, V250, P25, DOI 10.1016/j.canlet.2006.09.014; Harikumar KB, 2010, INT J CANCER, V127, P257, DOI 10.1002/ijc.25041; Hope C, 2008, MOL NUTR FOOD RES, V52, pS52, DOI 10.1002/mnfr.200700448; Hu YP, 2012, AM J CANCER RES, V2, P340; Kaminski BM, 2012, CURR PHARM BIOTECHNO, V13, P137; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Li Z, 2008, CELL BIOL TOXICOL, V24, P401, DOI 10.1007/s10565-008-9054-1; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Lindeman GJ, 2010, ASIA-PAC J CLIN ONCO, V6, P89, DOI 10.1111/j.1743-7563.2010.01279.x; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Nicolini A, 2011, CURR PHARM BIOTECHNO, V12, P196, DOI 10.2174/138920111794295657; Oi N, 2010, CANCER RES, V70, P9755, DOI 10.1158/0008-5472.CAN-10-2858; Pandey PR, 2011, BREAST CANCER RES TR, V130, P387, DOI 10.1007/s10549-010-1300-6; Patel KR, 2010, CANCER RES, V70, P7392, DOI 10.1158/0008-5472.CAN-10-2027; Patel VB, 2010, NUTR CANCER, V62, P958, DOI 10.1080/01635581.2010.510259; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Preffer F, 2009, CYTOM PART B-CLIN CY, V76B, P295, DOI 10.1002/cyto.b.20480; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Teiten MH, 2011, INT J ONCOL, V38, P603, DOI 10.3892/ijo.2011.905; Mai TT, 2012, CANCER LETT, V321, P144, DOI 10.1016/j.canlet.2012.01.045; Vergara D, 2012, MOL BIOSYST, V8, P1078, DOI 10.1039/c2mb05486h	38	185	194	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102535	10.1371/journal.pone.0102535	http://dx.doi.org/10.1371/journal.pone.0102535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068516	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993700010
J	Harbour, VL; Weigl, Y; Robinson, B; Amir, S				Harbour, Valerie L.; Weigl, Yuval; Robinson, Barry; Amir, Shimon			Phase Differences in Expression of Circadian Clock Genes in the Central Nucleus of the Amygdala, Dentate Gyrus, and Suprachiasmatic Nucleus in the Rat	PLOS ONE			English	Article							OVAL NUCLEUS; BED NUCLEUS; STRIA TERMINALIS; FACTOR DBP; PROTEIN; PERIOD2; RHYTHM; PER2	We performed a high temporal resolution analysis of the transcript level of two core clock genes, Period2 (Per2) and Bmal1, and a clock output gene, Dbp, in the suprachiasmatic nucleus (SCN), the master circadian clock, and in two forebrain regions, the lateral part of the central nucleus of the amygdala (CEAl), and dentate gyrus (DG), in rats. These regions, as we have shown previously, exhibit opposite rhythms in expression of the core clock protein, PERIOD2 (PER2). We found that the expression of Per2, Bmal1 and Dbp follow a diurnal rhythm in all three regions but the phase and amplitude of the rhythms of each gene vary across regions, revealing important regional differences in temporal dynamics underlying local daily rhythm generation in the mammalian forebrain. These findings underscore the complex temporal organization of subordinate circadian oscillators in the forebrain and raise interesting questions about the functional connection of these oscillators with the master SCN clock.	[Harbour, Valerie L.; Weigl, Yuval; Robinson, Barry; Amir, Shimon] Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Grp Rech Neurobiol Comportementale, Montreal, PQ H3G 1M8, Canada	Concordia University - Canada	Amir, S (corresponding author), Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Grp Rech Neurobiol Comportementale, Montreal, PQ H3G 1M8, Canada.	shimon.amir@concordia.ca	Amir, Shimon/AAE-4635-2022		Canadian Institutes of Health Research [MOP 13625]; le Fonds de la recherche en sante Quebec; Concordia University Research Chair Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); le Fonds de la recherche en sante Quebec; Concordia University Research Chair Program	This work was supported by grants from the Canadian Institutes of Health Research (Grant # MOP 13625), le Fonds de la recherche en sante Quebec, and the Concordia University Research Chair Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2004, J NEUROSCI, V24, P781, DOI 10.1523/JNEUROSCI.4488-03.2004; Amir S, 2006, NEUROSCI LETT, V407, P254, DOI 10.1016/j.neulet.2006.08.057; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; D'Agostino R.B., 1986, TESTS NORMAL DISTRIB; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Harbour VL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076391; Harbour VL, 2011, J MOL NEUROSCI, V45, P154, DOI 10.1007/s12031-010-9469-z; Klugmann M, 2006, MOL CELL NEUROSCI, V31, P303, DOI 10.1016/j.mcn.2005.09.019; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Nakabayashi H, 2013, BIOCHEM BIOPH RES CO, V434, P370, DOI 10.1016/j.bbrc.2013.03.084; Perrin JS, 2006, P NATL ACAD SCI USA, V103, P5591, DOI 10.1073/pnas.0601310103; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2000, GENE DEV, V14, P679; Segall LA, 2006, NEUROSCIENCE, V140, P753, DOI 10.1016/j.neuroscience.2006.03.037; Segall LA, 2009, NEUROSCI LETT, V457, P58, DOI 10.1016/j.neulet.2009.03.083; Segall LA, 2010, J MOL NEUROSCI, V42, P168, DOI 10.1007/s12031-010-9341-1; Segall LA, 2010, J MOL NEUROSCI, V42, P176, DOI 10.1007/s12031-010-9375-4; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; Weigl Y, 2013, CHRONOBIOL INT, V30, P559, DOI 10.3109/07420528.2012.754451; WUARIN J, 1990, CELL, V63, P1257, DOI 10.1016/0092-8674(90)90421-A; Xu Z, 2011, MOL CELL ENDOCRINOL, V339, P90, DOI 10.1016/j.mce.2011.03.020; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000	27	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103309	10.1371/journal.pone.0103309	http://dx.doi.org/10.1371/journal.pone.0103309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068868	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000339993700058
J	van Oosterhout, F; Goitom, E; Roessink, I; Lurling, M				van Oosterhout, Frank; Goitom, Eyerusalem; Roessink, Ivo; Lurling, Miquel			Lanthanum from a Modified Clay Used in Eutrophication Control Is Bioavailable to the Marbled Crayfish (Procambarus fallax f. virginalis)	PLOS ONE			English	Article							COPPER-NICKEL SMELTERS; RARE-EARTH-ELEMENTS; FRESH-WATER; PHOSPHORUS; ACCUMULATION; PHOSLOCK(R); TOXICITY; SEDIMENT; LAKES; BIOACCUMULATION	To mitigate eutrophication in fresh standing waters the focus is on phosphorus (P) control, i.e. on P inflows to a lake as well as a lake's sediment as internal P source. The in-lake application of the lanthanum (La) modified clays - i.e. La modified bentonite (Phoslock) or La modified kaolinite, aim at dephosphatising the water column and at reducing the release of P from a lake's sediment. Application of these clays raises the question whether La from these clays can become bioavailable to biota. We investigated the bioavailability of La from Phoslock in a controlled parallel groups experiment in which we measured the La in carapace, gills, ovaries, hepatopancreas and abdominal muscle after 0, 14 and 28 days of exposure to Phoslock. Expressing the treatment effect as the difference of the median concentration between the two treatment groups (Phoslock minus control group) yield the following effects, the plus sign (+) indicating an increase, concentrations in mu g g(-1) dry weight: Day 14: carapace +10.5 mu g g(-1), gills +112 mu g g(-1), ovaries +2.6 mu g g(-1), hepatopancreas +32.9 mu g g(-1) and abodminal muscle +3.2 mu g g(-1). Day 28: carapace +17.9 mu g g(-1); gills +182 mu g g(-1); ovaries +2.2 mu g g(-1); hepatopancreas +41.9 mu g g(-1) and abodminal muscle +7.6 mu g g(-1), all effects were statistically significant. As La from Phoslock is bio-available to and taken up by the marbled crayfishes (Procambarus fallax f. virginalis), we advocate that the application of in-lake chemical water treatments to mitigate eutrophication should be accompanied by a thorough study on potential side effects.	[van Oosterhout, Frank; Goitom, Eyerusalem; Lurling, Miquel] Wageningen Univ, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, NL-6700 AP Wageningen, Netherlands; [Roessink, Ivo] Wageningen UR, Alterra, Wageningen, Netherlands; [Lurling, Miquel] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	van Oosterhout, F (corresponding author), Wageningen Univ, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, NL-6700 AP Wageningen, Netherlands.	jean.vanoosterhout@wur.nl	Roessink, Ivo/O-9350-2014; KNAW, NIOO-KNAW/A-4320-2012	KNAW, NIOO-KNAW/0000-0002-3835-159X	Wageningen University (WUR)	Wageningen University (WUR)	The research was funded internally by Wageningen University (WUR; www.wur.nl) and externally by the Regional Water Authority De Dommel (www.dommel.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst D, 2004, MAR FRESHWATER RES, V55, P715, DOI 10.1071/MF03181; ALIKHAN MA, 1990, WATER RES, V24, P1069, DOI 10.1016/0043-1354(90)90168-6; [Anonymous], 2006, OFFICIAL J EUROPEA L, V64, P37; Azevedo SMFO, 2002, TOXICOLOGY, V181, P441, DOI 10.1016/S0300-483X(02)00491-2; BAGATTO G, 1987, B ENVIRON CONTAM TOX, V38, P1076, DOI 10.1007/BF01609098; BAGATTO G, 1987, B ENVIRON CONTAM TOX, V38, P540, DOI 10.1007/BF01606626; Barry MJ, 2000, CHEMOSPHERE, V41, P1669, DOI 10.1016/S0045-6535(00)00091-6; BROWN BE, 1982, BIOL REV, V57, P621, DOI 10.1111/j.1469-185X.1982.tb00375.x; BRYAN GW, 1971, PROC R SOC SER B-BIO, V177, P389, DOI 10.1098/rspb.1971.0037; Carpenter SR, 2005, P NATL ACAD SCI USA, V102, P10002, DOI 10.1073/pnas.0503959102; Carpenter SR, 2008, P NATL ACAD SCI USA, V105, P11039, DOI 10.1073/pnas.0806112105; Clearwater SJ, 2004, AUS2004005 NIWA; Codd GA, 2005, AQUAT ECOL SER, V3, P1; Codd GA, 1999, EUR J PHYCOL, V34, P405, DOI 10.1080/09670269910001736462; Codd GA., 1994, REV MED MICROBIOL, V5, P256, DOI [DOI 10.1097/00013542-199410000-00005, 10.1097/00013542-199410000-00005]; Cullen JJ, 2008, MAR ECOL PROG SER, V364, P295, DOI 10.3354/meps07551; DAS T, 1988, BIOL TRACE ELEM RES, V18, P201, DOI 10.1007/BF02917504; Douglas GB, 2008, MAR FRESHWATER RES, V59, P836, DOI 10.1071/MF07183; Douglas G. B., 2004, PHOSPHORUS ENV TECHN, P291; Douglas GB., 2002, US Patent, Patent No. [6,350,383, 6350383]; Faria M, 2010, CHEMOSPHERE, V78, P232, DOI 10.1016/j.chemosphere.2009.11.003; Groves S, 2010, 02209 PWS TR; Gulati RD, 2002, HYDROBIOLOGIA, V478, P73, DOI 10.1023/A:1021092427559; Haghseresht F, 2009, APPL CLAY SCI, V46, P369, DOI 10.1016/j.clay.2009.09.009; Hu X, 2002, B ENVIRON CONTAM TOX, V69, P727, DOI 10.1007/s00128-002-0121-7; Hubschman J.H., 1967, CRUSTACEANA, V12, P141; HUBSHMAN JERRY H., 1967, CRUSTACEANA, V12, P33, DOI 10.1163/156854067X00684; JOHANNESSON KH, 1994, LIMNOL OCEANOGR, V39, P1141, DOI 10.4319/lo.1994.39.5.1141; Kouba A, 2010, WATER AIR SOIL POLL, V211, P5, DOI 10.1007/s11270-009-0273-8; Landman M, 2007, LAKE OKAREKA TIKITAP; Liu XW, 1997, GEOCHIM COSMOCHIM AC, V61, P1625, DOI 10.1016/S0016-7037(97)00037-9; LOBEL PB, 1991, ARCH ENVIRON CON TOX, V21, P118, DOI 10.1007/BF01055566; Lurling M, 2010, WATER RES, V44, P309, DOI 10.1016/j.watres.2009.09.034; Marsden ID, 2004, J EXP MAR BIOL ECOL, V300, P373, DOI 10.1016/j.jembe.2003.12.009; Martin P, 2010, CONTRIB ZOOL, V79, P107, DOI 10.1163/18759866-07903003; Meade ME, 1995, J SHELLFISH RES, V14, P341; NICNAS, 2001, NA89928 NICNAS; NNI, 1997, 13395 NNI NENENISO; NNI, 1986, 6663 NNI NEN; NNI, 1990, 6646 NNI NEN; Oosterhout JFXv, 2010, H20, V19, P23; Powell ML, 2006, COMP BIOCHEM PHYS A, V144, P211, DOI 10.1016/j.cbpa.2006.02.032; Rainbow PS, 2007, ENVIRON INT, V33, P576, DOI 10.1016/j.envint.2006.05.007; Reitzel K, 2013, HYDROBIOLOGIA, V703, P189, DOI 10.1007/s10750-012-1358-8; Robb M, 2003, HYDROBIOLOGIA, V494, P237, DOI 10.1023/A:1025478618611; Ross G, 2008, HARMFUL ALGAE, V7, P545, DOI 10.1016/j.hal.2007.12.007; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Seitz R, 2005, J EXP ZOOL PART A, V303A, P393, DOI 10.1002/jez.a.143; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Solutions PW, 2014, SCI INFORM; Sondergaard M, 2001, ScientificWorldJournal, V1, P427; Spears BM, 2013, WATER RES, V47, P5930, DOI 10.1016/j.watres.2013.07.016; Sun H, 1996, CHEMOSPHERE, V33, P1475; Traunspurger W, 1996, HYDROBIOLOGIA, V328, P215, DOI 10.1007/BF00017632; Trouilhe MC, 2007, AQUAT CONSERV, V17, P520, DOI 10.1002/aqc.793; TU Q, 1994, ENVIRON POLLUT, V85, P345, DOI 10.1016/0269-7491(94)90057-4; Tyler G, 2004, PLANT SOIL, V267, P191, DOI 10.1007/s11104-005-4888-2; van Griethuysen C, 2004, ENVIRON TOXICOL CHEM, V23, P668, DOI 10.1897/02-583; van Oosterhout F, 2013, HYDROBIOLOGIA, V710, P265, DOI 10.1007/s10750-012-1206-x; Verweij W, 2013, CHEAQS PROGRAM CALCU; Vonk HJ, 1960, PHYSL CRUSTACEA; Wang WX, 1996, MAR ECOL PROG SER, V140, P91, DOI 10.3354/meps140091; Watson-Lung T, 2009, PHOSLOCK TOXICITY TE; Welch EB, 2005, LAKE RESERV MANAGE, V21, P209, DOI 10.1080/07438140509354430; Yang XY, 1999, CHEMOSPHERE, V39, P2443, DOI 10.1016/S0045-6535(99)00172-1; Yuan XZ, 2009, ECOL ENG, V35, P1599, DOI 10.1016/j.ecoleng.2008.08.002	67	31	31	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102410	10.1371/journal.pone.0102410	http://dx.doi.org/10.1371/journal.pone.0102410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068309	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700007
J	Park, JT; Johnson, N; Liu, S; Levesque, M; Wang, YJ; Ho, H; Huso, D; Maitra, A; Parsons, MJ; Prescott, JD; Leach, SD				Park, J. T.; Johnson, N.; Liu, S.; Levesque, M.; Wang, Y. J.; Ho, H.; Huso, D.; Maitra, A.; Parsons, M. J.; Prescott, J. D.; Leach, S. D.			Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey	ONCOGENE			English	Article							K-RAS CODON-12; ZEBRAFISH; CANCER; INDUCTION; NEOPLASIA; ONCOGENES; ABLATION; TUMORS; MICE	Somatic activation of the KRAS proto-oncogene is evident in almost all pancreatic cancers, and appears to represent an initiating event. These mutations occur primarily at codon 12 and less frequently at codons 13 and 61. Although some studies have suggested that different KRAS mutations may have variable oncogenic properties, to date there has been no comprehensive functional comparison of multiple KRAS mutations in an in vivo vertebrate tumorigenesis system. We generated a Gal4/UAS-based zebrafish model of pancreatic tumorigenesis in which the pancreatic expression of UAS-regulated oncogenes is driven by a ptf1a: Gal4-VP16 driver line. This system allowed us to rapidly compare the ability of 12 different KRAS mutations (G12A, G12C, G12D, G12F, G12R, G12S, G12V, G13C, G13D, Q61L, Q61R and A146T) to drive pancreatic tumorigenesis in vivo. Among fish injected with one of five KRAS mutations reported in other tumor types but not in human pancreatic cancer, 2/79 (2.5%) developed pancreatic tumors, with both tumors arising in fish injected with A146T. In contrast, among fish injected with one of seven KRAS mutations known to occur in human pancreatic cancer, 22/106 (20.8%) developed pancreatic cancer. All eight tumorigenic KRAS mutations were associated with downstream MAPK/ERK pathway activation in preneoplastic pancreatic epithelium, whereas nontumorigenic mutations were not. These results suggest that the spectrum of KRAS mutations observed in human pancreatic cancer reflects selection based on variable tumorigenic capacities, including the ability to activate MAPK/ERK signaling.	[Park, J. T.; Johnson, N.; Liu, S.; Levesque, M.; Parsons, M. J.; Prescott, J. D.; Leach, S. D.] Johns Hopkins Med Inst, Dept Surg, Baltimore, MD 21205 USA; [Wang, Y. J.; Parsons, M. J.; Leach, S. D.] Johns Hopkins Med Inst, Grad Program Human Genet, Baltimore, MD 21205 USA; [Ho, H.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Huso, D.] Johns Hopkins Med Inst, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Parsons, M. J.; Leach, S. D.] Johns Hopkins Med Inst, Inst Med Genet, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Leach, SD (corresponding author), Mem Sloan Kettering Canc Ctr, David M Rubenstein Ctr Pancreat Canc Res, 1275 York Ave,Box 20, New York, NY 10065 USA.	leachs@mskcc.org	Wang, Julia/M-4516-2016	Wang, Julia/0000-0003-2641-6904	NCI [P01 CA134292]; Paul K Neumann Professorship in Pancreatic Cancer at Johns Hopkins University; NATIONAL CANCER INSTITUTE [P01CA134292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Paul K Neumann Professorship in Pancreatic Cancer at Johns Hopkins University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Mary Chico, Mara Swaim, Anzer Habibullah and Frazer Matthews for expert administrative and technical support. This work was supported by NCI P01 CA134292. SDL was further supported by the Paul K Neumann Professorship in Pancreatic Cancer at Johns Hopkins University.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; BARBACID M, 1990, EUR J CLIN INVEST, V20, P225, DOI 10.1111/j.1365-2362.1990.tb01848.x; Charbel C, 2014, J INVEST DERMATOL, V134, P1067, DOI 10.1038/jid.2013.429; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Er TK, 2014, CANCER LETT, V343, P1, DOI 10.1016/j.canlet.2013.09.012; Fukahori M, 2012, THYROID, V22, P683, DOI 10.1089/thy.2011.0261; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Guerrero S, 2000, CANCER RES, V60, P6750; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hu G, 2011, DEV DYNAM, V240, P2101, DOI 10.1002/dvdy.22699; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Krasinskas AM, 2013, MODERN PATHOL, V26, P1346, DOI 10.1038/modpathol.2013.71; Kraus MC, 2006, INT J ONCOL, V29, P957; Leach SD, 2009, ZEBRAFISH, V6, P317, DOI 10.1089/zeb.2009.9988; Martin P, 2013, J THORAC ONCOL, V8, P530, DOI 10.1097/JTO.0b013e318283d958; Morelli MP, 2012, J CLIN ONCOL, V30, P3565, DOI 10.1200/JCO.2012.43.6535; Mosimann C, 2013, DEV DYNAM, V242, P949, DOI 10.1002/dvdy.23989; Parikh C, 2006, BLOOD, V108, P2349, DOI 10.1182/blood-2004-08-009498; Park SW, 2008, GASTROENTEROLOGY, V134, P2080, DOI 10.1053/j.gastro.2008.02.084; Pisharath Harshan, 2009, V546, P133, DOI 10.1007/978-1-60327-977-2_9; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; Roberts JA, 2014, DEVELOPMENT, V141, P715, DOI 10.1242/dev.100347; Yen J, 2014, CURR OPIN GENET DEV, V24, P38, DOI 10.1016/j.gde.2013.11.003; Yoo J, 2000, ARCH PATHOL LAB MED, V124, P836; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	26	27	27	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2015	34	21					2801	2806		10.1038/onc.2014.223	http://dx.doi.org/10.1038/onc.2014.223			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI7XN	25065594	Green Accepted			2022-12-25	WOS:000354979500012
J	Ribeiro-Rodrigues, TM; Catarino, S; Marques, C; Ferreira, JV; Martins-Marques, T; Pereira, P; Girao, H				Ribeiro-Rodrigues, Teresa M.; Catarino, Steve; Marques, Carla; Ferreira, Joao V.; Martins-Marques, Tania; Pereira, Paulo; Girao, Henrique			AMSH-mediated deubiquitination of Cx43 regulates internalization and degradation of gap junctions	FASEB JOURNAL			English	Article						connexin43; DUB; ubiquitin; endocytosis	INTRACELLULAR-TRANSPORT; UBIQUITIN ISOPEPTIDASE; CONNEXIN DEGRADATION; SORTING MACHINERY; PLASMA-MEMBRANE; AUTOPHAGY; ACTIVATION; PATHWAY; PROTEINS; SIGNAL	Gap junctions (GJs) are specialized cell-cell contacts formed by connexins (Cxs), which provide direct intercellular communication between eukaryotic cells. Although Cx43 has long been known to be a substrate for ubiquitination, the reversal of this modification by deubiquitylases (DUBs) has never been described. Here we report that the DUB-associated molecule with the SH3 domain of STAM (AMSH) interacts with Cx43 and mediates its deubiquitination. In this study, we demonstrate that Cx43 is modified with lysine 63-linked polyubiquitin chains and that these increase the interaction between Cx43 and AMSH. We also show that AMSH is recruited to GJ plaque sites at the plasma membrane, where it mediates the deubiquitination of Cx43. Using siRNA depletion or overexpression of a catalytically inactive mutant of AMSH, we show that by decreasing Cx43 deubiquitination, both the internalization and degradation rate of Cx43 are increased. Overall, these data strongly suggest that AMSH-mediated deubiquitination of Cx43 protects GJs from degradation.Ribeiro-Rodrigues, T. M., Catarino, S., Marques, C., Ferreira, J. V., Martins-Marques, T., Pereira, P., GirAo, H. AMSH-mediated deubiquitination of Cx43 regulates internalization and degradation of gap junctions.	[Ribeiro-Rodrigues, Teresa M.; Catarino, Steve; Marques, Carla; Ferreira, Joao V.; Martins-Marques, Tania; Pereira, Paulo; Girao, Henrique] Univ Coimbra, Inst Biomed Imaging & Life Sci IBILI, Ctr Ophthalmol & Vis Sci, Fac Med, P-3000354 Coimbra, Portugal; [Ribeiro-Rodrigues, Teresa M.] Univ Coimbra, Dept Fis, CFC, P-3000354 Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Girao, H (corresponding author), Univ Coimbra, Inst Biomed Imaging & Life Sci IBILI, Ctr Ophthalmol & Vis Sci, Fac Med, Azinhaga Sta Comba, P-3000354 Coimbra, Portugal.	hmgirao@fmed.uc.pt	Pereira, Paulo/AAD-8375-2022; Girao, H/I-7591-2012; Marques, Carla/AAC-9838-2019; Catarino, Steve/GQI-2873-2022; Rodrigues, Teresa/GYU-8199-2022; Martins-Marques, Tania/AAJ-6686-2020; Ribeiro-Rodrigues, Teresa M/A-1585-2018; Ferreira, João Vasco/E-1753-2015	Pereira, Paulo/0000-0002-9908-2290; Girao, H/0000-0002-5786-8447; Catarino, Steve/0000-0001-9644-6960; Martins-Marques, Tania/0000-0001-5798-3923; Ribeiro-Rodrigues, Teresa M/0000-0002-5169-6090; Ferreira, João Vasco/0000-0001-5897-7461; Marques, Carla/0000-0002-1817-4813	Portuguese Foundation for Science and (FCT) [PTDC/SAU-ORG/119290/2010, PEST-C/SAU/U13282/2013-COMPETE]; FCT [SFRH/BPD/68749/2010]; FCT Ph.D. grant [SFRH/BD/52294/2013]; FCT grant [PTDC/SAU-ORG/119290/2010, PTDC/SAU-ORG/113542/2009]	Portuguese Foundation for Science and (FCT); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT Ph.D. grant(Portuguese Foundation for Science and Technology); FCT grant(Portuguese Foundation for Science and Technology)	This work was supported by Portuguese Foundation for Science and (FCT) grants PTDC/SAU-ORG/119290/2010 and PEST-C/SAU/U13282/2013-COMPETE. S.C. was supported by FCT postdoctoral grant SFRH/BPD/68749/2010. T.M.R.-R. was supported by FCT Ph.D. grant SFRH/BD/52294/2013. T.M.-M. was supported by FCT grant PTDC/SAU-ORG/119290/2010. J.V.E. was supported by FCT grant PTDC/SAU-ORG/113542/2009.	Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Auth T, 2009, EXP CELL RES, V315, P1053, DOI 10.1016/j.yexcr.2008.12.025; Barriere H, 2007, MOL BIOL CELL, V18, P3952, DOI 10.1091/mbc.E07-07-0678; Bejarano E, 2012, MOL BIOL CELL, V23, P2156, DOI 10.1091/mbc.E11-10-0844; Catarino S, 2011, BIOCHEM J, V437, P255, DOI 10.1042/BJ20102059; Davies CW, 2013, BIOCHEMISTRY-US, V52, P7818, DOI 10.1021/bi401106b; Fong JT, 2012, AUTOPHAGY, V8, P794, DOI 10.4161/auto.19390; Girao H, 2009, EXP CELL RES, V315, P3587, DOI 10.1016/j.yexcr.2009.10.003; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Leithe E, 2009, J CELL SCI, V122, P3883, DOI 10.1242/jcs.053801; Lichtenstein A, 2011, J CELL SCI, V124, P910, DOI 10.1242/jcs.073072; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Sierra MI, 2010, J BIOL CHEM, V285, P13990, DOI 10.1074/jbc.M109.061309; Taillebourg E, 2012, AUTOPHAGY, V8, P767, DOI 10.4161/auto.19381; Tanaka N, 1999, J BIOL CHEM, V274, P19129, DOI 10.1074/jbc.274.27.19129; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933	29	32	32	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4629	4641		10.1096/fj.13-248963	http://dx.doi.org/10.1096/fj.13-248963			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25070368				2022-12-25	WOS:000344050900005
J	Cavaretta, JP; Sherer, KR; Lee, KY; Kim, EH; Issema, RS; Chung, HJ				Cavaretta, John P.; Sherer, Kaitlyn R.; Lee, Kwan Young; Kim, Edward H.; Issema, Rodal S.; Chung, Hee Jung			Polarized Axonal Surface Expression of Neuronal KCNQ Potassium Channels Is Regulated by Calmodulin Interaction with KCNQ2 Subunit	PLOS ONE			English	Article							RECEPTOR-MEDIATED INHIBITION; ENDOPLASMIC-RETICULUM; K+ CHANNELS; INITIAL SEGMENT; RETIGABINE EZOGABINE; KV7 CHANNELS; C-TERMINUS; ANKYRIN-G; PROTEIN; EXCITABILITY	KCNQ potassium channels composed of KCNQ2 and KCNQ3 subunits give rise to the M-current, a slow-activating and non-inactivating voltage-dependent potassium current that limits repetitive firing of action potentials. KCNQ channels are enriched at the surface of axons and axonal initial segments, the sites for action potential generation and modulation. Their enrichment at the axonal surface is impaired by mutations in KCNQ2 carboxy-terminal tail that cause benign familial neonatal convulsion and myokymia, suggesting that their correct surface distribution and density at the axon is crucial for control of neuronal excitability. However, the molecular mechanisms responsible for regulating enrichment of KCNQ channels at the neuronal axon remain elusive. Here, we show that enrichment of KCNQ channels at the axonal surface of dissociated rat hippocampal cultured neurons is regulated by ubiquitous calcium sensor calmodulin. Using immunocytochemistry and the cluster of differentiation 4 (CD4) membrane protein as a trafficking reporter, we demonstrate that fusion of KCNQ2 carboxy-terminal tail is sufficient to target CD4 protein to the axonal surface whereas inhibition of calmodulin binding to KCNQ2 abolishes axonal surface expression of CD4 fusion proteins by retaining them in the endoplasmic reticulum. Disruption of calmodulin binding to KCNQ2 also impairs enrichment of heteromeric KCNQ2/KCNQ3 channels at the axonal surface by blocking their trafficking from the endoplasmic reticulum to the axon. Consistently, hippocampal neuronal excitability is dampened by transient expression of wild-type KCNQ2 but not mutant KCNQ2 deficient in calmodulin binding. Furthermore, coexpression of mutant calmodulin, which can interact with KCNQ2/KCNQ3 channels but not calcium, reduces but does not abolish their enrichment at the axonal surface, suggesting that apo calmodulin but not calcium-bound calmodulin is necessary for their preferential targeting to the axonal surface. These findings collectively reveal calmodulin as a critical player that modulates trafficking and enrichment of KCNQ channels at the neuronal axon.	[Cavaretta, John P.; Sherer, Kaitlyn R.; Lee, Kwan Young; Kim, Edward H.; Issema, Rodal S.; Chung, Hee Jung] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Sherer, Kaitlyn R.; Chung, Hee Jung] Univ Illinois, Neurosci Program, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Chung, HJ (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	chunghj@life.illinois.edu		Kim, Edward/0000-0003-4098-1002; Issema, Rodal/0000-0001-8818-2803; Chung, Hee Jung/0000-0002-5555-9907; Lee, Kwan Young/0000-0003-2890-0580	March of Dimes Foundation [5-FY11-105]; Roy J. Carver Charitable Trust [11-3887]; University of Illinois at Urbana Champaign	March of Dimes Foundation(March of Dimes); Roy J. Carver Charitable Trust; University of Illinois at Urbana Champaign	This work is supported by Basil O'Connor New Investigator Award 5-FY11-105 (H.J.C.) from March of Dimes Foundation (www.marchofdimes.com), New Investigator Grant 11-3887 (H.J.C.) from Roy J. Carver Charitable Trust (www.carvertrust.org), and ICR Start-up fund from the University of Illinois at Urbana Champaign (H.J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaimo A, 2009, J BIOL CHEM, V284, P20668, DOI 10.1074/jbc.M109.019539; Bal M, 2010, J NEUROSCI, V30, P2311, DOI 10.1523/JNEUROSCI.5175-09.2010; Borgatti R, 2004, NEUROLOGY, V63, P57, DOI 10.1212/01.WNL.0000132979.08394.6D; BROWN DA, 1981, FED PROC, V40, P2625; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Chung HJ, 2006, P NATL ACAD SCI USA, V103, P8870, DOI 10.1073/pnas.0603376103; Chung HJ, 2009, P NATL ACAD SCI USA, V106, P629, DOI 10.1073/pnas.0811615106; Clark BD, 2009, NEUROSCIENTIST, V15, P651, DOI 10.1177/1073858409341973; Cooper EC, 2000, P NATL ACAD SCI USA, V97, P4914, DOI 10.1073/pnas.090092797; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; Dencker D, 2008, EPILEPSY BEHAV, V12, P49, DOI 10.1016/j.yebeh.2007.09.023; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Duflocq A, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-66; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Etzioni A, 2011, J NEUROSCI, V31, P14158, DOI 10.1523/JNEUROSCI.2666-11.2011; Fache MP, 2004, J CELL BIOL, V166, P571, DOI 10.1083/jcb.200312155; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Garrido JJ, 2003, BIOL CELL, V95, P437, DOI 10.1016/S0248-4900(03)00091-1; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Geiger J, 2006, NEUROSCI LETT; Gomez-Posada JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025508; Goraya TA, 2005, CELL SIGNAL, V17, P789, DOI 10.1016/j.cellsig.2004.12.017; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; Gunthorpe MJ, 2012, EPILEPSIA, V53, P412, DOI 10.1111/j.1528-1167.2011.03365.x; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Halling D Brent, 2006, Sci STKE, V2006, per1; Hansen HH, 2007, EUR J PHARMACOL, V570, P77, DOI 10.1016/j.ejphar.2007.05.029; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Higashida H, 2005, NEUROSCI RES, V51, P231, DOI 10.1016/j.neures.2004.11.009; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Korsgaard MPG, 2005, J PHARMACOL EXP THER, V314, P282, DOI 10.1124/jpet.105.083923; Kosenko A, 2012, EMBO J, V31, P3147, DOI 10.1038/emboj.2012.156; KRIJNSELOCKER J, 1995, MOL BIOL CELL, V6, P1315, DOI 10.1091/mbc.6.10.1315; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Large CH, 2012, EPILEPSIA, V53, P425, DOI 10.1111/j.1528-1167.2011.03364.x; Lewis TL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001021; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Liu WJ, 2014, MOL CELL NEUROSCI, V58, P40, DOI 10.1016/j.mcn.2013.12.005; Liu XB, 2012, EPILEPSIA, V53, P45, DOI 10.1111/j.1528-1167.2012.03474.x; Maljevic S, 2003, J PHYSIOL-LONDON, V548, P353, DOI 10.1113/jphysiol.2003.040980; Maljevic S, 2010, PFLUG ARCH EUR J PHY, V460, P277, DOI 10.1007/s00424-010-0831-3; Maylie J, 2004, J PHYSIOL-LONDON, V554, P255, DOI 10.1113/jphysiol.2003.049072; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mruk K, 2012, P NATL ACAD SCI USA, V109, P13579, DOI 10.1073/pnas.1207606109; Munro G, 2007, J MED CHEM, V50, P2576, DOI 10.1021/jm060989l; Nunez JL, 2009, NEUROSCIENCE, V158, P623, DOI 10.1016/j.neuroscience.2008.09.061; Orth CB, 2007, J COMP NEUROL, V504, P441, DOI 10.1002/cne.21445; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Rasmussen HB, 2007, J CELL SCI, V120, P953, DOI 10.1242/jcs.03396; Regev N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006586; Richards MC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013938; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Roche JP, 2002, BRIT J PHARMACOL, V137, P1173, DOI 10.1038/sj.bjp.0704989; Roderick HL, 1997, FEBS LETT, V405, P181, DOI 10.1016/S0014-5793(97)00183-X; Saitsu H, 2012, ANN NEUROL, V72, P298, DOI 10.1002/ana.23620; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sanchez-Ponce D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048557; Schmitt B, 2005, EPILEPSY RES, V65, P161, DOI 10.1016/j.eplepsyres.2005.05.009; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Shah MM, 2011, J PHYSIOL-LONDON, V589, P6029, DOI 10.1113/jphysiol.2011.220913; Shahidullah M, 2005, P NATL ACAD SCI USA, V102, P16454, DOI 10.1073/pnas.0503966102; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Terasaki M, 1996, DEV BIOL, V179, P320, DOI 10.1006/dbio.1996.0263; TERASAKI M, 1994, P NATL ACAD SCI USA, V91, P7510, DOI 10.1073/pnas.91.16.7510; Tzingounis AV, 2010, P NATL ACAD SCI USA, V107, P10232, DOI 10.1073/pnas.1004644107; Tzingounis AV, 2008, P NATL ACAD SCI USA, V105, P19974, DOI 10.1073/pnas.0810535105; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Weber YG, 2006, BRAIN RES; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu WW, 2008, J NEUROPHYSIOL, V100, P1897, DOI 10.1152/jn.90346.2008; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xu Q, 2013, J MOL BIOL, V425, P378, DOI 10.1016/j.jmb.2012.11.023; Yap CC, 2008, J CELL SCI, V121, P1514, DOI 10.1242/jcs.022442; Yap CC, 2008, J CELL BIOL, V180, P827, DOI 10.1083/jcb.200707143; Yue C, 2006, J NEUROPHYSIOL; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	99	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103655	10.1371/journal.pone.0103655	http://dx.doi.org/10.1371/journal.pone.0103655			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077630	Green Published, gold, Green Submitted			2022-12-25	WOS:000339954800064
J	Das, A; Barker, DA; Wang, T; Lau, CM; Lin, Y; Botchwey, EA				Das, Anusuya; Barker, Daniel A.; Wang, Tiffany; Lau, Cheryl M.; Lin, Yong; Botchwey, Edward A.			Delivery of Bioactive Lipids from Composite Microgel-Microsphere Injectable Scaffolds Enhances Stem Cell Recruitment and Skeletal Repair	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; ENDOTHELIAL GROWTH-FACTOR; IN-VITRO DEGRADATION; SPHINGOSINE 1-PHOSPHATE; DEFECT MODEL; REGENERATION; FTY720; TISSUE; SPHINGOSINE-1-PHOSPHATE; RABBIT	In this study, a microgel composed of chitosan and inorganic phosphates was used to deliver poly(lactic-co-glycolic acid) (PLAGA) microspheres loaded with sphingolipid growth factor FTY720 to critical size cranial defects in Sprague Dawley rats. We show that sustained release of FTY720 from injected microspheres used alone or in combination with recombinant human bone morphogenic protein-2 (rhBMP2) improves defect vascularization and bone formation in the presence and absence of rhBMP2 as evaluated by quantitative microCT and histological measurements. Moreover, sustained delivery of FTY720 from PLAGA and local targeting of sphingosine 1-phosphate (S1P) receptors reduces CD45+ inflammatory cell infiltration, promotes endogenous recruitment of CD29+CD90+ bone progenitor cells and enhances the efficacy of rhBMP2 from chitosan microgels. Companion in vitro studies suggest that selective activation of sphingosine receptor subtype-3 (S1P(3)) via FTY720 treatment induces smad-1 phosphorylation in bone-marrow stromal cells. Additionally, FTY720 enhances stromal cell-derived factor-1 (SDF-1) mediated chemotaxis of CD90+CD11B-CD45- bone progenitor cells in vitro after stimulation with rhBMP2. We believe that use of such small molecule delivery formulations to recruit endogenous bone progenitors may be an attractive alternative to exogenous cell-based therapy.	[Das, Anusuya] Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22903 USA; [Das, Anusuya; Lin, Yong] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Barker, Daniel A.] Univ Virginia, Dept Otolaryngol, Charlottesville, VA USA; [Wang, Tiffany; Lau, Cheryl M.; Botchwey, Edward A.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA	University of Virginia; University of Virginia; University of Virginia; University System of Georgia; Georgia Institute of Technology	Das, A (corresponding author), Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22903 USA.	ad8rt@virginia.edu; Edward.Botchwey@bme.gatech	Lin, Yong/I-4505-2016; , Yong/T-4079-2019	Lin, Yong/0000-0002-2839-5740; 	National Institutes of Health [R01 DE019935]; NIH [R01 AR056445]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health R01 DE019935 and NIH R01 AR056445. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita S, 2004, WOUND REPAIR REGEN, V12, P252, DOI 10.1111/j.1067-1927.2004.012118.x; Argraves KM, 2008, J BIOL CHEM, V283, P25074, DOI 10.1074/jbc.M801214200; Aronin CEP, 2010, BIOMATERIALS, V31, P6417, DOI 10.1016/j.biomaterials.2010.04.061; Aronin CEP, 2010, TISSUE ENG PT A, V16, P1801, DOI [10.1089/ten.tea.2009.0539, 10.1089/ten.TEA.2009.0539]; Awojoodu AO, 2013, P NATL ACAD SCI USA, V110, P13785, DOI 10.1073/pnas.1221309110; Bayless KJ, 2003, BIOCHEM BIOPH RES CO, V312, P903, DOI 10.1016/j.bbrc.2003.11.017; Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001; CAPLAN AI, 1983, CLIN ORTHOP RELAT R, P243; Cooper PR, 2010, J DENT, V38, P687, DOI 10.1016/j.jdent.2010.05.016; Das A, 2014, J BIOMED MATER RES A, V102, P1210, DOI 10.1002/jbm.a.34779; Das A, 2013, BIOMATERIALS, V34, P9853, DOI 10.1016/j.biomaterials.2013.08.015; DRUSHEL RF, 1985, CELL DIFFER DEV, V16, P13, DOI 10.1016/0045-6039(85)90603-7; Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264; Gomez G, 2006, J CRANIOFAC SURG, V17, P935; Hou R, 2005, ZHONGGUI XIU FU CHON, V19, P8818; Hou R, 2007, J BIOMED MATER RES A, V80A, P85, DOI 10.1002/jbm.a.30840; Huang C, 2012, CELL TISSUE RES, V347, P553, DOI 10.1007/s00441-011-1217-3; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Kalazic I, 2007, J BONE MINER RES, V22, pS61; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Keul P, 2011, CIRC RES, V108, P314, DOI 10.1161/CIRCRESAHA.110.235028; Kimura T, 2004, BLOOD, V103, P4478, DOI 10.1182/blood-2003-03-0875; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F; Mathews S, 2011, CELL PROLIFERAT, V44, P537, DOI 10.1111/j.1365-2184.2011.00788.x; Meno-Tetang GML, 2006, DRUG METAB DISPOS, V34, P1480, DOI 10.1124/dmd.105.009001; Mountziaris PM, 2008, TISSUE ENG PART B-RE, V14, P179, DOI 10.1089/ten.teb.2008.0038; Nair LS, 2007, BIOMACROMOLECULES, V8, P3779, DOI 10.1021/bm7006967; Nyangoga H, 2010, ACTA BIOMATER, V6, P3310, DOI 10.1016/j.actbio.2010.01.042; Oktay EO, 2010, J ORAL IMPLANTOL, V36, P175, DOI 10.1563/AAID-JOI-D-09-00023; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/00007632-200208151-00010; Ratajczak MZ, 2003, STEM CELLS, V21, P363, DOI 10.1634/stemcells.21-3-363; Ratanavaraporn J, 2012, BIOMATERIALS, V33, P304, DOI 10.1016/j.biomaterials.2011.09.050; Rau CR, 2011, AM J PATHOL, V178, P1770, DOI 10.1016/j.ajpath.2011.01.003; REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3; Roelofsen T, 2008, J CELL BIOCHEM, V105, P1128, DOI 10.1002/jcb.21915; Roviezzo F, 2011, J PHARMACOL EXP THER, V337, P830, DOI 10.1124/jpet.111.179168; Rumi MN, 2005, J ORTHOP RES, V23, P34, DOI 10.1016/j.orthres.2004.05.003; Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430; Sato C, 2012, BIOCHEM BIOPH RES CO, V423, P200, DOI 10.1016/j.bbrc.2012.05.130; Sefcik LS, 2011, TISSUE ENG PT A, V17, P617, DOI [10.1089/ten.tea.2010.0404, 10.1089/ten.TEA.2010.0404]; Shinohara K, 2011, J ORTHOP RES, V29, P1064, DOI 10.1002/jor.21374; Siu RK, 2012, TISSUE ENG PT A, V18, P252, DOI [10.1089/ten.tea.2011.0142, 10.1089/ten.TEA.2011.0142]; Stephan SJ, 2010, LARYNGOSCOPE, V120, P895, DOI 10.1002/lary.20624; TRUETA J, 1960, J BONE JOINT SURG BR, V42, P367, DOI 10.1302/0301-620X.42B2.367; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Volarevic V, 2011, STEM CELLS, V29, P5, DOI 10.1002/stem.556; Walker DH, 2007, ARTERIOSCLER THRMOB, V27, P275; Wang LM, 2010, BIOMATERIALS, V31, P3976, DOI 10.1016/j.biomaterials.2010.01.131; Woo EJ, 2013, CLIN ORTHOP RELAT R, V471, P1707, DOI 10.1007/s11999-012-2684-x; Xin CY, 2004, J BIOL CHEM, V279, P35255, DOI 10.1074/jbc.M312091200; Yonamine Y, 2010, ORAL SURG ORAL MED O, V109, P225, DOI 10.1016/j.tripleo.2009.09.010; Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510; Zhu W, 2007, J BIOL CHEM, V282, P18676, DOI 10.1074/jbc.M610232200	56	25	29	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e101276	10.1371/journal.pone.0101276	http://dx.doi.org/10.1371/journal.pone.0101276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077607	Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800004
J	Lin, JY; Li, ML; Brewer, G				Lin, Jing-Yi; Li, Mei-Ling; Brewer, Gary			mRNA Decay Factor AUF1 Binds the Internal Ribosomal Entry Site of Enterovirus 71 and Inhibits Virus Replication	PLOS ONE			English	Article							MOUTH-DISEASE; HOST FACTORS; HNRNP A1; PROTEIN; ELEMENT; TRANSLATION; INFECTION; INTERACTS; INITIATION; OUTBREAK	AU-rich element binding factor 1 (AUF1) has a role in the replication cycles of different viruses. Here we demonstrate that AUF1 binds the internal ribosome entry site (IRES) of enterovirus 71 (EV71) and negatively regulates IRES-dependent translation. During EV71 infection, AUF1 accumulates in the cytoplasm where viral replication occurs, whereas AUF1 localizes predominantly in the nucleus in mock-infected cells. AUF1 knockdown in infected cells increases IRES activity and synthesis of viral proteins. Taken together, the results suggest that AUF1 interacts with the EV71 IRES to negatively regulate viral translation and replication.	[Lin, Jing-Yi] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Li, Mei-Ling; Brewer, Gary] Rutgers Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Taipei Medical University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Brewer, G (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.	brewerga@rwjms.rutgers.edu		Lin, Jing-Yi/0000-0002-5692-5657	National Institutes of Health [R01 CA052443]; Taiwan NCS [102-2320-B-038-055-MY3]; Taipei Medical University [TMU102-AE1-B24]; NATIONAL CANCER INSTITUTE [R01CA052443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan NCS; Taipei Medical University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health, R01 CA052443; Taiwan NCS grant 102-2320-B-038-055-MY3; Taipei Medical University grant TMU102-AE1-B24. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Cathcart AL, 2014, J GEN VIROL IN PRESS; Cathcart AL, 2013, J VIROL, V87, P10423, DOI 10.1128/JVI.01049-13; Cook HL, 2004, MOL CELL BIOL, V24, P4522, DOI 10.1128/MCB.24.10.4522-4533.2004; Dempsey LA, 1998, J BIOL CHEM, V273, P29224, DOI 10.1074/jbc.273.44.29224; Fuentes-Panana EM, 2000, J VIROL, V74, P8166, DOI 10.1128/JVI.74.17.8166-8175.2000; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; Gratacos FM, 2010, WIRES RNA, V1, P457, DOI 10.1002/wrna.26; Hino K, 2013, J VIROL, V87, P6582, DOI 10.1128/JVI.02495-12; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang PN, 2011, NUCLEIC ACIDS RES, V39, P9633, DOI 10.1093/nar/gkr682; Hutin S, 2013, J VIROL, V87, P4672, DOI 10.1128/JVI.00159-13; Joachims M, 1999, J VIROL, V73, P718, DOI 10.1128/JVI.73.1.718-727.1999; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Knapinska AM, 2011, MOL CELL BIOL, V31, P1419, DOI 10.1128/MCB.00907-10; KRAUSSLICH HG, 1987, J VIROL, V61, P2711; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lee N, 2012, RNA, V18, P2073, DOI 10.1261/rna.034900.112; Lenarcic EM, 2013, J VIROL, V87, P8697, DOI 10.1128/JVI.00950-13; Levengood JD, 2013, RNA BIOL, V10, P1136, DOI 10.4161/rna.25107; Li ML, 2008, J VIROL, V82, P6880, DOI 10.1128/JVI.00517-08; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; Lin JY, 2008, J GEN VIROL, V89, P2540, DOI 10.1099/vir.0.2008/003673-0; Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08; Lin JY, 2009, NUCLEIC ACIDS RES, V37, P47, DOI 10.1093/nar/gkn901; Lu JY, 2006, RNA, V12, P883, DOI 10.1261/rna.2308106; Lund N, 2012, NUCLEIC ACIDS RES, V40, P3663, DOI 10.1093/nar/gkr1238; MCALLISTER RM, 1969, CANCER-AM CANCER SOC, V24, P520, DOI 10.1002/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Paek KY, 2008, J VIROL, V82, P12082, DOI 10.1128/JVI.01405-08; Rozovics JM, 2012, MBIO, V3, DOI 10.1128/mBio.00431-12; Rui E, 2001, VIRUS RES, V74, P59, DOI 10.1016/S0168-1702(00)00245-8; RUTKA JT, 1987, ACTA NEUROPATHOL, V75, P92, DOI 10.1007/BF00686798; Shih SR, 2011, J VIROL, V85, P9658, DOI 10.1128/JVI.05063-11; Shih SR, 2004, J BIOMED SCI, V11, P239, DOI 10.1159/000076036; Sinsimer KS, 2008, MOL CELL BIOL, V28, P5223, DOI 10.1128/MCB.00431-08; Sweeney TR, 2014, EMBO J, V33, P76, DOI 10.1002/embj.201386124; Thompson SR, 2003, VIROLOGY, V315, P259, DOI 10.1016/S0042-6822(03)00544-0; Wilson GM, 2003, J BIOL CHEM, V278, P33039, DOI 10.1074/jbc.M305775200; Wong J, 2013, FASEB J, V27, P2777, DOI 10.1096/fj.12-226498; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Yasumura Y., 1963, NIPPON RINSHO, V21, P9; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zucconi BE, 2010, J BIOL CHEM, V285, P39127, DOI 10.1074/jbc.M110.180182; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103827	10.1371/journal.pone.0103827	http://dx.doi.org/10.1371/journal.pone.0103827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077793	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800085
J	Seo, JH; Maki, T; Maeda, M; Miyamoto, N; Liang, AC; Hayakawa, K; Pham, LDD; Suwa, F; Taguchi, A; Matsuyama, T; Ihara, M; Kim, KW; Lo, EH; Arai, K				Seo, Ji Hae; Maki, Takakuni; Maeda, Mitsuyo; Miyamoto, Nobukazu; Liang, Anna C.; Hayakawa, Kazuhide; Pham, Loc-Duyen D.; Suwa, Fumihiko; Taguchi, Akihiko; Matsuyama, Tomohiro; Ihara, Masafumi; Kim, Kyu-Won; Lo, Eng H.; Arai, Ken			Oligodendrocyte Precursor Cells Support Blood-Brain Barrier Integrity via TGF-beta Signaling	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-BETA; CEREBRAL ENDOTHELIUM; NEUROVASCULAR NICHE; IN-VITRO; STROKE; MECHANISMS; PERICYTES; DISEASE; INJURY	Trophic coupling between cerebral endothelium and their neighboring cells is required for the development and maintenance of blood-brain barrier (BBB) function. Here we report that oligodendrocyte precursor cells (OPCs) secrete soluble factor TGF-beta 1 to support BBB integrity. Firstly, we prepared conditioned media from OPC cultures and added them to cerebral endothelial cultures. Our pharmacological experiments showed that OPC-conditioned media increased expressions of tight-junction proteins and decreased in vitro BBB permeability by activating TGB-b-receptor-MEK/ERK signaling pathway. Secondly, our immuno-electron microscopic observation revealed that in neonatal mouse brains, OPCs attach to cerebral endothelial cells via basal lamina. And finally, we developed a novel transgenic mouse line that TGF-beta 1 is knocked down specifically in OPCs. Neonates of these OPC-specific TGF-beta 1 deficient mice (OPC-specific TGF-beta 1 partial KO mice: Pdgfra(Cre)/Tgfb1(flox/wt) mice or OPC-specific TGF-beta 1 total KO mice: Pdgfra(Cre)/Tgfb1(flox/flox) mice) exhibited cerebral hemorrhage and loss of BBB function. Taken together, our current study demonstrates that OPCs increase BBB tightness by upregulating tight junction proteins via TGF-beta signaling. Although astrocytes and pericytes are well-known regulators of BBB maturation and maintenance, these findings indicate that OPCs also play a pivotal role in promoting BBB integrity.	[Seo, Ji Hae; Maki, Takakuni; Miyamoto, Nobukazu; Liang, Anna C.; Hayakawa, Kazuhide; Pham, Loc-Duyen D.; Lo, Eng H.; Arai, Ken] Massachusetts Gen Hosp, Dept Radiol, Neuroprotect Res Lab, Charlestown, MA 02129 USA; [Seo, Ji Hae; Maki, Takakuni; Miyamoto, Nobukazu; Liang, Anna C.; Hayakawa, Kazuhide; Pham, Loc-Duyen D.; Lo, Eng H.; Arai, Ken] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Seo, Ji Hae; Maki, Takakuni; Miyamoto, Nobukazu; Liang, Anna C.; Hayakawa, Kazuhide; Pham, Loc-Duyen D.; Lo, Eng H.; Arai, Ken] Harvard Univ, Sch Med, Charlestown, MA USA; [Seo, Ji Hae; Kim, Kyu-Won] Seoul Natl Univ, Coll Pharm, SNU Harvard NeuroVasc Protect Res Ctr, Seoul, South Korea; [Seo, Ji Hae; Kim, Kyu-Won] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Maeda, Mitsuyo; Suwa, Fumihiko] Osaka Dent Univ, Dept Anat, Osaka, Japan; [Maeda, Mitsuyo; Taguchi, Akihiko] Inst Biomed Res & Innovat, Dept Regenerat Med, Kobe, Hyogo, Japan; [Matsuyama, Tomohiro] Hyogo Coll Med, Inst Adv Med Sci, Lab Neurogenesis & CNS Repair, Nishinomiya, Hyogo, Japan; [Ihara, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Stroke & Cerebrovasc Dis, Osaka, Japan; [Kim, Kyu-Won] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Coll Med, Coll Pharm, Seoul, South Korea	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Seoul National University (SNU); Seoul National University (SNU); Institute for Biomedical Research & Innovation (IBRI); Hyogo College of Medicine; National Cerebral & Cardiovascular Center - Japan; Seoul National University (SNU); Seoul National University (SNU)	Lo, EH (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Neuroprotect Res Lab, Charlestown, MA 02129 USA.	lo@helix.mgh.harvard.edu; karai@partners.org	Kim, Kyu Won/AAJ-7213-2020; Ihara, Masafumi/O-5020-2019; 眞木, 崇州/AAO-1160-2020	Ihara, Masafumi/0000-0002-7102-4048; 	National Institutes of Health; National Research Foundation of Korea through the Global Research Laboratory Program [2011-0021874]; National Research Foundation of Korea through the Basic Science Research Program [2011-357-E00022]; Uehara Memorial Foundation; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055104, R37NS037074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea through the Global Research Laboratory Program(National Research Foundation of Korea); National Research Foundation of Korea through the Basic Science Research Program(National Research Foundation of Korea); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by the National Institutes of Health, National Research Foundation of Korea through the Global Research Laboratory Program (2011-0021874), Basic Science Research Program (2011-357-E00022), the Uehara Memorial Foundation, and the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; Arai K, 2009, BIOL PHARM BULL, V32, P1639, DOI 10.1248/bpb.32.1639; Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Arai K, 2009, J NEUROSCI, V29, P4351, DOI 10.1523/JNEUROSCI.0035-09.2009; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Carmichael ST, 2010, STROKE, V41, pS124, DOI 10.1161/STROKEAHA.110.597146; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Garcia CM, 2004, DEV BRAIN RES, V152, P25, DOI 10.1016/j.devbrainres.2004.05.008; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Hayakawa K, 2012, NEUROSCI LETT, V513, P42, DOI 10.1016/j.neulet.2012.02.004; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Madri JA, 2009, J PHYSIOL PHARMACOL, V60, P95; Maki T, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00275; Maki T, 2013, CNS NEUROL DISORD-DR, V12, P302, DOI 10.2174/1871527311312030004; Manole MD, 2011, CURR PHARM DESIGN, V17, P3854; Miyamoto N, 2014, CELL MOL LIFE SCI, V71, P1055, DOI 10.1007/s00018-013-1488-9; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Pallast S, 2009, J NEUROCHEM, V111, P882, DOI 10.1111/j.1471-4159.2009.06379.x; Pham LDD, 2012, GLIA, V60, P875, DOI 10.1002/glia.22320; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; Quaegebeur A, 2011, NEURON, V71, P406, DOI 10.1016/j.neuron.2011.07.013; Ronaldson PT, 2012, CURR PHARM DESIGN, V18, P3624; Seo JH, 2013, J CLIN INVEST, V123, P782, DOI 10.1172/JCI65863; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Zhang RL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00201; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	46	96	99	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103174	10.1371/journal.pone.0103174	http://dx.doi.org/10.1371/journal.pone.0103174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078775	Green Published, gold, Green Submitted			2022-12-25	WOS:000339954800032
J	Favaro, L; Ozella, L; Pessani, D				Favaro, Livio; Ozella, Laura; Pessani, Daniela			The Vocal Repertoire of the African Penguin (Spheniscus demersus): Structure and Function of Calls	PLOS ONE			English	Article							INDIVIDUAL RECOGNITION; BEHAVIOR; EMOTION; JITTER; BIRDS; FORM; AGE	The African Penguin (Spheniscus demersus) is a highly social and vocal seabird. However, currently available descriptions of the vocal repertoire of African Penguin are mostly limited to basic descriptions of calls. Here we provide, for the first time, a detailed description of the vocal behaviour of this species by collecting audio and video recordings from a large captive colony. We combine visual examinations of spectrograms with spectral and temporal acoustic analyses to determine vocal categories. Moreover, we used a principal component analysis, followed by signal classification with a discriminant function analysis, for statistical validation of the vocalisation types. In addition, we identified the behavioural contexts in which calls were uttered. The results show that four basic vocalisations can be found in the vocal repertoire of adult African Penguin, namely a contact call emitted by isolated birds, an agonistic call used in aggressive interactions, an ecstatic display song uttered by single birds, and a mutual display song vocalised by pairs, at their nests. Moreover, we identified two distinct vocalisations interpreted as begging calls by nesting chicks (begging peep) and unweaned juveniles (begging moan). Finally, we discussed the importance of specific acoustic parameters in classifying calls and the possible use of the source-filter theory of vocal production to study penguin vocalisations.	[Favaro, Livio; Ozella, Laura; Pessani, Daniela] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy	University of Turin	Favaro, L (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.	livio.favaro@unito.it	Ozella, Laura/ABD-9898-2020; Favaro, Livio/B-8337-2013	Favaro, Livio/0000-0002-8698-472X; Ozella, Laura/0000-0001-7371-3309	Fiat Group Automobiles S.p.A. (Verrone plant) research grant; University of Torino; Italian Ministry of Instruction University and Research	Fiat Group Automobiles S.p.A. (Verrone plant) research grant; University of Torino; Italian Ministry of Instruction University and Research(Ministry of Education, Universities and Research (MIUR))	Livio Favaro is a Postdoctoral Researcher at the University of Torino and was supported for part of this study by a Fiat Group Automobiles S.p.A. (Verrone plant) research grant. Laura Ozella is supported by the University of Torino and the Italian Ministry of Instruction University and Research with a PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstrom Per, 2003, Bulletin of the British Ornithologists' Club, V123A, P114; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; Aubin T, 2000, P ROY SOC B-BIOL SCI, V267, P1081, DOI 10.1098/rspb.2000.1112; Aubin T, 2004, AN ACAD BRAS CIENC, V76, P279, DOI 10.1590/S0001-37652004000200015; BACHOROWSKI JA, 1995, PSYCHOL SCI, V6, P219, DOI 10.1111/j.1467-9280.1995.tb00596.x; Baldo S, 2011, J FIELD ORNITHOL, V82, P249, DOI 10.1111/j.1557-9263.2011.00328.x; Barham PJ, 2006, OSTRICH, V77, P202, DOI 10.2989/00306520609485534; Barros KS, 2011, ETHOLOGY, V117, P83, DOI 10.1111/j.1439-0310.2010.01853.x; BIRDLIFE INTERNATIONAL, 2012, IUCN 2012 IUCN RED L; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Boersma P, 2004, STEM SPRAAK TAALPATH, V12, P237; Boersma P., 2013, PRAAT DOING PHONETIC; Boersma P, 2009, FOLIA PHONIATR LOGO, V61, P305, DOI 10.1159/000245159; Boersma PD, 1976, LIVING BIRD, V15, P43; Borker AL, 2014, CONSERV BIOL, V28, P1100, DOI 10.1111/cobi.12264; Brandes TS, 2008, BIRD CONSERV INT, V18, pS163, DOI 10.1017/S0959270908000415; Briefer EF, 2012, J ZOOL, V288, P1, DOI 10.1111/j.1469-7998.2012.00920.x; Brockmann M, 2011, J VOICE, V25, P44, DOI 10.1016/j.jvoice.2009.07.002; Budka M, 2013, ETHOLOGY, V119, P960, DOI 10.1111/eth.12141; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Charlton BD, 2009, J ACOUST SOC AM, V126, P2721, DOI 10.1121/1.3224720; Cheng JK, 2012, BIOACOUSTICS, V21, P157, DOI 10.1080/09524622.2012.669664; Crawford RJM, 2011, AFR J MAR SCI, V33, P139, DOI 10.2989/1814232X.2011.572377; Crawford RJM, 1995, S AFR J MARINE SCI, V16, P101; Deaux EC, 2013, BEHAVIOUR, V150, P75, DOI 10.1163/1568539X-00003038; EGGLETON P, 1979, OSTRICH, V50, P139, DOI 10.1080/00306525.1979.9634105; Fant G., 1960, ACOUSTIC THEORY SPEE; Farrus M., 2007, P 8 ANN C INT SPEECH, P778; Favaro L, 2014, ACTA ACUST UNITED AC, V100, P782, DOI 10.3813/AAA.918758; Fitch WT, 1999, J ZOOL, V248, P31, DOI 10.1017/S095283699900504X; Goller F, 1997, P NATL ACAD SCI USA, V94, P14787, DOI 10.1073/pnas.94.26.14787; Greenewalt C.H., 1968, BIRD SONG ACOUSTICS; HEATH RGM, 1985, J ZOOL, V205, P91; Jouventin P, 2002, ANIM BEHAV, V64, P747, DOI 10.1006/anbe.2002.4002; Jouventin P, 1982, ADV ETHOL, V58, P3; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Laiolo P, 2010, BIOL CONSERV, V143, P1635, DOI 10.1016/j.biocon.2010.03.025; Li X, 2007, INT CONF ACOUST SPEE, P1081, DOI 10.1109/ICMLC.2007.4370304; Midling Kjell, 2002, Bioacoustics, V12, P233; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Riede T, 2004, J EXP BIOL, V207, P4025, DOI 10.1242/jeb.01256; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Stachowicz JB, 2014, J ZOOL, V292, P1, DOI 10.1111/jzo.12083; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Thumser N. N., 1998, Marine Ornithology, V26, P41; TITZE IR, 1987, J SPEECH HEAR RES, V30, P252, DOI 10.1044/jshr.3002.252; TITZE IR, 1993, J SPEECH HEAR RES, V36, P1120, DOI 10.1044/jshr.3606.1120; WAZA, 2005, 60 ANN C WORLD ASS Z	49	30	30	1	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103460	10.1371/journal.pone.0103460	http://dx.doi.org/10.1371/journal.pone.0103460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076136	gold, Green Published, Green Submitted			2022-12-25	WOS:000340028800048
J	Horacio, AN; Lopes, JP; Ramirez, M; Melo-Cristino, J				Horacio, Andreia N.; Lopes, Joana P.; Ramirez, Mario; Melo-Cristino, Jose		Portuguese Grp Study Streptococcal	Non-Invasive Pneumococcal Pneumonia in Portugal-Serotype Distribution and Antimicrobial Resistance	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CONJUGATE VACCINE; POLYSACCHARIDE VACCINE; TYPING METHODS; ADULTS; INFECTIONS; DISEASE; MULTICENTER; COVERAGE	There is limited information on the serotypes causing non-invasive pneumococcal pneumonia (NIPP). Our aim was to characterize pneumococci causing NIPP in adults to determine recent changes in serotype prevalence, the potential coverage of pneumococcal vaccines and changes in antimicrobial resistance. Serotypes and antimicrobial susceptibility profiles of a sample of 1300 isolates recovered from adult patients (>= 18 yrs) between 1999 and 2011 (13 years) were determined. Serotype 3 was the most frequent cause of NIPP accounting for 18% of the isolates. The other most common serotypes were 11A (7%), 19F (7%), 19A (5%), 14 (4%), 22F (4%), 23F (4%) and 9N (4%). Between 1999 and 2011, there were significant changes in the proportion of isolates expressing vaccine serotypes, with a steady decline of the serotypes included in the 7-valent conjugate vaccine from 31% (1999-2003) to 11% (2011) (P<0.001). Taking together the most recent study years (2009-2011), the potential coverage of the 13-valent conjugate vaccine was 44% and of the 23-valent polysaccharide vaccine was 66%. While erythromycin resistance increased from 8% in 1999-2003 to 18% in 2011 (P<0.001), no significant trend was identified for penicillin non-susceptibility, which had an average value of 18.5%. The serotype distribution found in this study for NIPP was very different from the one previously described for IPD, with only two serotypes in common to the ones responsible for half of each presentation in 2009-2011 - serotypes 3 and 19A. In spite of these differences, the overall prevalence of resistant isolates was similar in NIPP and in IPD.	[Horacio, Andreia N.; Lopes, Joana P.; Ramirez, Mario; Melo-Cristino, Jose; Portuguese Grp Study Streptococcal] Univ Lisbon, Fac Med, Inst Mol Med, Inst Microbiol, P-1699 Lisbon, Portugal	Universidade de Lisboa	Ramirez, M (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, Inst Microbiol, P-1699 Lisbon, Portugal.	ramirez@fm.ul.pt	Ramirez, Mario/B-4993-2008; Melo-Cristino, Jose A G/H-3726-2013	Ramirez, Mario/0000-0002-4084-6233; Melo-Cristino, Jose A G/0000-0001-8643-1722; Goncalves, Elsa/0000-0003-2789-7068; Tome, Rui/0000-0001-5381-2705; Toscano, Cristina/0000-0002-4674-6065	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/81205/2011, PTDC/DTP-EPI/1759/2012]; Pfizer; GlaxoSmithKline	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline)	A.N. Horacio was supported by grant SFRH/BD/81205/2011, from Fundacao para a Ciencia e Tecnologia, Portugal. This work was partially supported by Fundacao para a Ciencia e Tecnologia, Portugal (PTDC/DTP-EPI/1759/2012) and unrestricted research grants from Pfizer and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2008, CLIN MICROBIOL INFEC, V14, P835, DOI 10.1111/j.1469-0691.2008.02031.x; Aguiar SI, 2014, EUROSURVEILLANCE, V19, P18, DOI 10.2807/1560-7917.ES2014.19.12.20750; Aguiar SI, 2010, VACCINE, V28, P5167, DOI 10.1016/j.vaccine.2010.06.008; Aguiar SI, 2010, J CLIN MICROBIOL, V48, P101, DOI 10.1128/JCM.00665-09; Almeida ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090974; Benfield T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072743; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonten M, 2014, PNEUMONIA, V3, P95; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Cilloniz C, 2012, J BRAS PNEUMOL, V38, P419, DOI 10.1590/S1806-37132012000400002; Clinical and Laboratory Standards Institute, 2007, PERF STAND ANT SUSC; Clinical and Laboratory Standards Institute, 2013, PERF STAND ANT SUSC; Domenech A, 2011, J ANTIMICROB CHEMOTH, V66, P487, DOI 10.1093/jac/dkq480; Fedson DS, 2011, EXPERT REV VACCINES, V10, P1143, DOI [10.1586/ERV.11.99, 10.1586/erv.11.99]; Grabenstein JD, 2012, CLIN INFECT DIS, V55, P255, DOI 10.1093/cid/cis354; Heron Melonie, 2013, Natl Vital Stat Rep, V62, P1; Horacio AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073704; Horacio AN, 2012, VACCINE, V30, P218, DOI 10.1016/j.vaccine.2011.11.022; Huijts SM, 2013, EUR RESPIR J, V42, P1283, DOI 10.1183/09031936.00137412; Melo-Cristino J, 2003, MICROB DRUG RESIST, V9, P73, DOI 10.1089/107662903764736364; Polverino E, 2013, THORAX, V68, P1007, DOI 10.1136/thoraxjnl-2013-203828; Regev-Yochay G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088406; Rodrigo C, 2014, THORAX, V69, P168, DOI 10.1136/thoraxjnl-2013-203987; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; Sherwin RL, 2013, J INFECT DIS, V208, P1813, DOI 10.1093/infdis/jit506; Smith AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003238; Smith KJ, 2012, JAMA-J AM MED ASSOC, V307, P804, DOI 10.1001/jama.2012.169; Steens A, 2013, VACCINE, V31, P6232, DOI 10.1016/j.vaccine.2013.10.032; Truck J, 2012, CLIN INFECT DIS, V55, P1577, DOI 10.1093/cid/cis700	31	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103092	10.1371/journal.pone.0103092	http://dx.doi.org/10.1371/journal.pone.0103092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075961	gold, Green Submitted, Green Published			2022-12-25	WOS:000340028800026
J	Al-Furoukh, N; Kardon, JR; Kruger, M; Szibor, M; Baker, TA; Braun, T				Al-Furoukh, Natalie; Kardon, Julia R.; Krueger, Marcus; Szibor, Marten; Baker, Tania A.; Braun, Thomas			NOA1, a Novel ClpXP Substrate, Takes an Unexpected Nuclear Detour Prior to Mitochondrial Import	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; BIOGENESIS; BINDING; GENE; YQEH; PHOSPHORYLATION; IDENTIFICATION; TRANSLOCATION; TRANSLATION; ACTIVATION	The mitochondrial matrix GTPase NOA1 is a nuclear encoded protein, essential for mitochondrial protein synthesis, oxidative phosphorylation and ATP production. Here, we demonstrate that newly translated NOA1 protein is imported into the nucleus, where it localizes to the nucleolus and interacts with UBF1 before nuclear export and import into mitochondria. Mutation of the nuclear localization signal (NLS) prevented both nuclear and mitochondrial import while deletion of the N-terminal mitochondrial targeting sequence (MTS) or the C-terminal RNA binding domain of NOA1 impaired mitochondrial import. Absence of the MTS resulted in accumulation of NOA1 in the nucleus and increased caspase-dependent apoptosis. We also found that export of NOA1 from the nucleus requires a leptomycin-B sensitive, Crm1-dependent nuclear export signal (NES). Finally, we show that NOA1 is a new substrate of the mitochondrial matrix protease complex ClpXP. Our results uncovered an unexpected, mandatory detour of NOA1 through the nucleolus before uptake into mitochondria. We propose that nucleo-mitochondrial translocation of proteins is more widespread than previously anticipated providing additional means to control protein bioavailability as well as cellular communication between both compartments.	[Al-Furoukh, Natalie; Krueger, Marcus; Szibor, Marten; Braun, Thomas] Max Planck Inst Heart & Lung Res Bad Nauheim, Dept Cardiac Dev & Remodeling, Bad Nauheim, Germany; [Kardon, Julia R.; Baker, Tania A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Braun, T (corresponding author), Max Planck Inst Heart & Lung Res Bad Nauheim, Dept Cardiac Dev & Remodeling, Bad Nauheim, Germany.	thomas.braun@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008	Kardon, Julia/0000-0002-6621-4461; Schindler, Natalie/0000-0001-7281-4597; Braun, Thomas/0000-0002-6165-4804	Max-Planck-Society	Max-Planck-Society(Max Planck Society)	Max-Planck-Society (URL: www.mpg.de) supported NA, MK, MS, and T. Braun. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Al-Furoukh N, 2013, BBA-MOL CELL RES, V1833, P2933, DOI 10.1016/j.bbamcr.2013.07.022; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Chuderland D, 2008, J BIOL CHEM, V283, P11176, DOI 10.1074/jbc.M709030200; Chung HK, 2003, J BIOL CHEM, V278, P28079, DOI 10.1074/jbc.M212835200; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257; Heidler J, 2011, J BIOL CHEM, V286, P32086, DOI 10.1074/jbc.M111.221986; Igwe EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-408; Kang HJ, 2010, J BIOL CHEM, V285, P21258, DOI 10.1074/jbc.M109.084590; Kang SG, 2002, J BIOL CHEM, V277, P21095, DOI 10.1074/jbc.M201642200; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kolanczyk M, 2011, MOL BIOL CELL, V22, P1, DOI 10.1091/mbc.E10-07-0643; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Li WG, 2005, J BIOL CHEM, V280, P28430, DOI 10.1074/jbc.M410601200; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Loh PC, 2007, GENES GENET SYST, V82, P281, DOI 10.1266/ggs.82.281; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Matsushima Y, 2012, BBA-GENE REGUL MECH, V1819, P1080, DOI 10.1016/j.bbagrm.2011.11.008; McKinsey TA, 2005, INHIBITION NUCL EXPO; Melchior F, 1998, METH MOL B, V88, P265; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Neher SB, 2003, GENE DEV, V17, P1084, DOI 10.1101/gad.1078003; Rossmanith W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019152; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; So HS, 2006, CELL DEATH DIFFER, V13, P1763, DOI 10.1038/sj.cdd.4401863; Sudhamsu J, 2008, J BIOL CHEM, V283, P32968, DOI 10.1074/jbc.M804837200; Tang TD, 2009, J BIOL CHEM, V284, P5414, DOI 10.1074/jbc.M807797200; Uicker WC, 2007, J BACTERIOL, V189, P2926, DOI 10.1128/JB.01654-06; Vongsamphanh R, 2001, MOL CELL BIOL, V21, P1647, DOI 10.1128/MCB.21.5.1647-1655.2001; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469; Yashiroda Y, 2003, CURR MED CHEM, V10, P741, DOI 10.2174/0929867033457791; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004	39	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103141	10.1371/journal.pone.0103141	http://dx.doi.org/10.1371/journal.pone.0103141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072814	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600025
J	McCollum, AM; Holman, RC; Hughes, CM; Mehal, JM; Folkema, AM; Redd, JT; Cheek, JE; Damon, IK; Reynolds, MG				McCollum, Andrea M.; Holman, Robert C.; Hughes, Christine M.; Mehal, Jason M.; Folkema, Arianne M.; Redd, John T.; Cheek, James E.; Damon, Inger K.; Reynolds, Mary G.			Molluscum Contagiosum in a Pediatric American Indian Population: Incidence and Risk Factors	PLOS ONE			English	Article							INFECTIOUS-DISEASE HOSPITALIZATIONS; ATOPIC-DERMATITIS; CHILDREN; ALASKA; EPIDEMIOLOGY; MANAGEMENT; HEALTH	Background: Molluscum contagiosum virus (MCV) causes an innocuous yet persistent skin infection in immunocompetent individuals and is spread by contact with lesions. Studies point to atopic dermatitis (AD) as a risk factor for MCV infection; however, there are no longitudinal studies that have evaluated this hypothesis. Methods: Outpatient visit data from fiscal years 2001-2009 for American Indian and Alaska Native (AI/AN) children were examined to describe the incidence of molluscum contagiosum (MC). We conducted a case-control study of patients <5 years old at an Indian Health Service (IHS) clinic to evaluate dermatological risk factors for infection. Results: The incidence rate for MC in children <5 years old was highest in the West and East regions. MC cases were more likely to have a prior or co-occurring diagnosis of eczema, eczema or dermatitis, impetigo, and scabies (p < 0.05) compared to controls; 51.4% of MC cases had a prior or co-occurring diagnosis of eczema or dermatitis. Conclusions: The present study is the first demonstration of an association between AD and MC using a case-control study design. It is unknown if the concurrent high incidence of eczema and MC is related, and this association deserves further investigation.	[McCollum, Andrea M.; Holman, Robert C.; Hughes, Christine M.; Mehal, Jason M.; Folkema, Arianne M.; Damon, Inger K.; Reynolds, Mary G.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA; [McCollum, Andrea M.] US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Sci Educ & Profess Dev Program Off, Atlanta, GA USA; [Redd, John T.; Cheek, James E.] Indian Hlth Serv, Off Publ Hlth Support, Div Epidemiol & Dis Prevent, Albuquerque, NM USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	McCollum, AM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA.	amccollum@cdc.gov		Reynolds, Mary/0000-0001-7882-4614	Centers for Disease Control and Prevention, Atlanta, Georgia	Centers for Disease Control and Prevention, Atlanta, Georgia(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding was provided for by the Centers for Disease Control and Prevention, Atlanta, Georgia. The findings and conclusions in this report are those of the author(s) and do not necessarily represent the views of the Centers for Disease Control and Prevention or the Indian Health Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, RED BOOK; [Anonymous], 2010, DIR CHS INP DAT FISC; [Anonymous], 2009, TRENDS IND HLTH 2002; Berger EM, 2012, ARCH DERMATOL, V148, P1257, DOI 10.1001/archdermatol.2012.2414; Boguniewicz M, 2010, J ALLERGY CLIN IMMUN, V125, P4, DOI 10.1016/j.jaci.2009.11.027; Braue A, 2005, PEDIATR DERMATOL, V22, P287, DOI 10.1111/j.1525-1470.2005.22401.x; CASTILLA MT, 1995, DERMATOLOGY, V191, P165, DOI 10.1159/000246540; Coloe J, 2009, PEDIATR ANN, V38, P321, DOI 10.3928/00904481-20090513-01; Seize MBDP, 2011, AN BRAS DERMATOL, V86, P663, DOI 10.1590/S0365-05962011000400006; Dohil MA, 2006, J AM ACAD DERMATOL, V54, P47, DOI 10.1016/j.jaad.2005.08.035; Ghura HS, 2001, BRIT J DERMATOL, V144, P1094, DOI 10.1046/j.1365-2133.2001.04211.x; Hayashida S, 2010, J DERMATOL SCI, V60, P173, DOI 10.1016/j.jdermsci.2010.09.003; Holman RC, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.2.e176; Holman RC, 2011, PUBLIC HEALTH REP, V126, P508, DOI 10.1177/003335491112600407; JANNIGER CK, 1993, CUTIS, V52, P194; KONING S, 1994, BRIT J GEN PRACT, V44, P417; Lee B, 2004, J AM ACAD DERMATOL, V51, P478, DOI 10.1016/j.jaad.2003.12.047; Lee R, 2010, CUTIS, V86, P230; Molino AC, 2004, PEDIATR DERMATOL, V21, P628, DOI 10.1111/j.0736-8046.2004.21602.x; Nelson KC, 2007, PEDIATR ANN, V36, P814, DOI 10.3928/0090-4481-20071201-13; Netchiporouk E, 2012, PEDIATRICS, V129, pE1072, DOI 10.1542/peds.2011-1054; NIIZEKI K, 1984, DERMATOLOGICA, V169, P197, DOI 10.1159/000249604; OVERFIELD TM, 1966, J PEDIATR-US, V69, P640, DOI 10.1016/S0022-3476(66)80053-7; POSTLETHWAITE R, 1967, J HYG-CAMB, V65, P281, DOI 10.1017/S0022172400045800; Reynolds MG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005255; Rich JD, 1999, CLIN INFECT DIS, V28, P1171, DOI 10.1086/517770; Shaw TE, 2011, J INVEST DERMATOL, V131, P67, DOI 10.1038/jid.2010.251; SOLOMON LM, 1966, CAN MED ASSOC J, V95, P978; STURT RJ, 1971, MED J AUSTRALIA, V2, P751, DOI 10.5694/j.1326-5377.1971.tb92526.x; Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668; Wollenberg A, 2003, J ALLERGY CLIN IMMUN, V112, P667, DOI 10.1016/j.jaci.2003.07.001; [No title captured]	33	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103419	10.1371/journal.pone.0103419	http://dx.doi.org/10.1371/journal.pone.0103419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072249	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600048
J	Moyersoen, B; Weiss, M				Moyersoen, Bernard; Weiss, Michael			New Neotropical Sebacinales Species from a Pakaraimaea dipterocarpacea Forest in the Guayana Region, Southern Venezuela: Structural Diversity and Phylogeography	PLOS ONE			English	Article							ECTOMYCORRHIZAL FUNGI; GENETIC DIVERSITY; NUCLEOTIDE-SEQUENCES; COMMUNITY STRUCTURE; RAIN-FOREST; HOST; SOIL; DNA; IDENTIFICATION; ORCHIDACEAE	Pakaraimaea dipterocarpacea, a member of the Dipterocarpaceae endemic in the Guayana region, is associated with a diverse community of ectomycorrhizal (ECM) fungi. Amongst the 41 ECM fungal species detected in a 400 m(2) P. dipterocarpacea ssp. nitida plot in Southern Venezuela, three species belonged to the Sebacinales. We tested whether ECM anatomotype characterization can be used as a feasible element in an integrative taxonomy in this diverse fungal group, where the relevance of fruitbody morphology for species delimitation seems limited. Using a combination of ECM morpho-anatomical characterizations and phylogenetic analyses based on nuclear ITS and LSU sequences, we report three new species. The main distinguishing features of Sebacina guayanensis are the yellowish cell walls together with conspicuous undifferentiated, uniform compact (type B) rhizomorphs. Staghorn-like hyphae are characteristic of S. tomentosa. The combination of clusters of thick-walled emanating hyphae, including hyphae similar to awl-shaped cystidia with basal dichotomous or trichotomous ramifications, and the presence of type B rhizomorphs were characteristic of a third, yet unnamed species. The three species belong to three different, possibly specifically tropical clades in Sebacinales Group A. The geographic distribution of phylogenetically related strains was wide, including a Dicymbe forest in Guyana and an Ecuadorian rainforest with Coccoloba species. We show that ECM morpho-anatomy can be used, in combination with other analyses, to delineate species within Sebacinales Group A. In addition to phylogenetic information, type B rhizomorphs observed in different Sebacinales clades have important ecological implications for this fungal group. The phylogeography of Sebacinales suggests that dispersion and host jump are important radiation mechanisms that shaped P. dipterocarpacea ECM fungal community. This study emphasizes the need for more sequence data to evaluate the hypothesis that phylogeographic relationships between neo- and paleotropical ECM fungal species could be attributed to the vicariance of cross-continental hosts such as the Dipterocarpacae.	[Moyersoen, Bernard] Univ Aberdeen, Sch Biol Sci, Aberdeen AB9 1FX, Scotland; [Weiss, Michael] Univ Tubingen, Dept Biol, Tubingen, Germany	University of Aberdeen; Eberhard Karls University of Tubingen	Weiss, M (corresponding author), Univ Tubingen, Dept Biol, Tubingen, Germany.	michael.weiss@uni-tuebingen.de			Instituto Venezolano de Investigaciones Cientificas; University Simon Bolivar; University of Tubingen; 'Fonds de la Recherche Scientifique' (FNRS); German Research Foundation (DFG); University of Aberdeen	Instituto Venezolano de Investigaciones Cientificas; University Simon Bolivar; University of Tubingen; 'Fonds de la Recherche Scientifique' (FNRS)(Fonds de la Recherche Scientifique - FNRS); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Aberdeen	The Instituto Venezolano de Investigaciones Cientificas, the University Simon Bolivar and the University of Tubingen provided support including lab facilities. Costs for field trips were partially funded by the 'Fonds de la Recherche Scientifique' (FNRS). Financial support for the molecular analyses was provided by the German Research Foundation (DFG) and the University of Aberdeen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerer R, 2001, MYCORRHIZA, V11, P107, DOI 10.1007/s005720100108; AGERER R, 1991, METHOD MICROBIOL, V23, P25; Agerer R., 2004, DEEMY INFORM SYSTEM; Agerer R, 2006, MYCOL PROG, V5, P67, DOI 10.1007/s11557-006-0505-x; Alexander IJ, 2006, NEW PHYTOL, V172, P589, DOI 10.1111/j.1469-8137.2006.01930.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashton P. S., 1969, Biological Journal of the Linnean Society, V1, P155, DOI 10.1111/j.1095-8312.1969.tb01818.x; Azul Anabela Marisa, 2006, Descriptions of Ectomycorrhizae, V9-10, P87; Bandala VM, 2011, MYCOTAXON, V118, P147, DOI 10.5248/118.147; Bereau M, 1997, CAN J BOT, V75, P711, DOI 10.1139/b97-080; Brandbyge J., 1993, FLOWERING PLANTS DIC, P531, DOI [10.1007/978-3-662-02899-563, 10.1007/978-3-662-02899-5_63, DOI 10.1007/978-3-662-02899-5_63]; Brearley FQ, 2012, BIOTROPICA, V44, P637, DOI 10.1111/j.1744-7429.2012.00862.x; Ciferri R.\, 1961, QUADERNO, V19, P1; Dayanandan S, 1999, AM J BOT, V86, P1182, DOI 10.2307/2656982; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Roman M, 2005, MYCOL RES, V109, P1063, DOI 10.1017/S0953756205003564; Deshmukh S, 2006, P NATL ACAD SCI USA, V103, P18450, DOI 10.1073/pnas.0605697103; Diedhiou AG, 2014, ECTOMYCORRHIZAL SYMB, P1; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Garnica S, 2013, FEMS MICROBIOL ECOL, V83, P265, DOI 10.1111/j.1574-6941.2012.01473.x; Geml J, 2012, J BIOGEOGR, V39, P74, DOI 10.1111/j.1365-2699.2011.02588.x; Givnish TJ, 2004, INT J PLANT SCI, V165, pS1, DOI 10.1086/424022; Hambleton S, 2005, STUD MYCOL, P1; Hawksworth DL, 2012, MYCOSPHERE, V3, P143, DOI [10.5943/mycosphere/3/2/4, 10.5598/imafungus.2012.03.01.03]; Henkel TW, 2004, MYCOTAXON, V89, P433; Henkel TW, 2002, MYCOL RES, V106, P515, DOI 10.1017/S0953756202005919; Hibbett DS, 2013, NAT REV MICROBIOL, V11, P129, DOI 10.1038/nrmicro2963; Hynson NA, 2013, MOL ECOL, V22, P1473, DOI 10.1111/mec.12180; Jairus T, 2011, NEW PHYTOL, V192, P179, DOI 10.1111/j.1469-8137.2011.03775.x; Kass E, 1997, MOL PHYLOGENET EVOL, V8, P65, DOI 10.1006/mpev.1997.0410; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kennedy AH, 2011, MOL ECOL, V20, P1303, DOI 10.1111/j.1365-294X.2011.05000.x; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kropp BR, 2009, ADV MYCORRHIZAL SCI, P153; Lowy B, 1971, FLORA NEOTROP, V6, P1; MAGUIRE B, 1977, TAXON, V26, P341; MAGUIRE B, 1980, TAXON, V29, P225, DOI 10.2307/1220284; Maguire B, 1981, MEM NY BOT GARD, V32, P306; Matheny PB, 2009, J BIOGEOGR, V36, P577, DOI 10.1111/j.1365-2699.2008.02055.x; McGuire KL, 2010, OECOLOGIA, V164, P785, DOI 10.1007/s00442-010-1686-1; McNeill J., 2012, 18 INT BOT C MELB AU; Morris MH, 2008, MYCORRHIZA, V18, P375, DOI 10.1007/s00572-008-0186-1; Morris MH, 2009, FEMS MICROBIOL ECOL, V69, P274, DOI 10.1111/j.1574-6941.2009.00704.x; Moyersoen B, 2003, NEW PHYTOL, V160, P569, DOI 10.1046/j.1469-8137.2003.00908.x; Moyersoen B, 2012, DESCR ECTOMYC, V13, P16; Moyersoen B, 2014, ECTOMYCORRHIZAL SYMB, P79; Moyersoen B, 2012, DESCR ECTOMYC, V13, P42; Moyersoen B., 1993, SCI GUAIANAE, V3; Moyersoen B, 2006, NEW PHYTOL, V172, P753, DOI 10.1111/j.1469-8137.2006.01860.x; Moyersoen Bernard, 2012, Descriptions of Ectomycorrhizae, V13, P25; Moyersoen B, 2012, TROPICAL FORESTS, P93; Oberwinkler F, 2013, MYCOL PROG, V12, P1, DOI 10.1007/s11557-012-0880-4; Peay KG, 2013, ISME J, V7, P1852, DOI 10.1038/ismej.2013.66; Peay KG, 2010, NEW PHYTOL, V185, P529, DOI 10.1111/j.1469-8137.2009.03075.x; Phosri C, 2012, BIODIVERS CONSERV, V21, P2287, DOI 10.1007/s10531-012-0250-1; Pirozynski KA, 1998, AUST J BOT SUPPL SER, V10, P137; Rambaut A., 2009, FIGTREE VERSION 1 3; Riess K, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-102; Riviere T, 2007, MYCORRHIZA, V17, P415, DOI 10.1007/s00572-007-0117-6; Roy M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-51; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Selosse MA, 2002, MOL ECOL, V11, P1831, DOI 10.1046/j.1365-294X.2002.01553.x; Selosse MA, 2002, NEW PHYTOL, V155, P183, DOI 10.1046/j.1469-8137.2002.00442.x; Selosse MA, 2004, MICROB ECOL, V47, P416, DOI 10.1007/s00248-003-2034-3; Selosse MA, 2007, NEW PHYTOL, V174, P864, DOI 10.1111/j.1469-8137.2007.02064.x; Selosse MA, 2009, MYCOL RES, V113, P1062, DOI 10.1016/j.mycres.2009.07.004; Setaro Sabrina D, 2011, PLoS Curr, V3, pRRN1227, DOI 10.1371/currents.RRN1227; Setaro SD, 2012, BIODIVERS CONSERV, V21, P2269, DOI 10.1007/s10531-011-0205-y; SINGER R, 1979, Acta Amazonica, V9, P25; Smith ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055160; Smith ME, 2011, NEW PHYTOL, V192, P699, DOI 10.1111/j.1469-8137.2011.03844.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tedersoo L, 2003, NEW PHYTOL, V159, P153, DOI 10.1046/j.1469-8137.2003.00792.x; Tedersoo L, 2011, MOL ECOL, V20, P3071, DOI 10.1111/j.1365-294X.2011.05145.x; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tedersoo L, 2010, ISME J, V4, P465, DOI 10.1038/ismej.2009.131; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Tello SA, 2014, MYCOL PROG, V13, P471, DOI 10.1007/s11557-013-0928-0; Twieg B, 2009, MANUAL CONCISE DESCR, VCDE28; Urban A, 2003, MYCOL RES, V107, P3, DOI 10.1017/S0953756202007116; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wei J, 2011, MYCORRHIZA, V21, P105, DOI 10.1007/s00572-010-0312-8; Weiss M, 2004, MYCOL RES, V108, P1003, DOI 10.1017/S0953756204000772; Weiss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016793; WELLS K, 1982, MYCOLOGIA, V74, P325, DOI 10.2307/3792902; White T., 1990, PCR PROTOCOLS GUIDE, P315; ZAK B, 1978, CAN J BOT, V56, P1416, DOI 10.1139/b78-164	88	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103076	10.1371/journal.pone.0103076	http://dx.doi.org/10.1371/journal.pone.0103076			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072467	Green Submitted, Green Published, gold			2022-12-25	WOS:000341307600021
J	Wu, RD; Long, YC; Malanson, GP; Garber, PA; Zhang, S; Li, DQ; Zhao, P; Wang, LZ; Duo, HR				Wu, Ruidong; Long, Yongcheng; Malanson, George P.; Garber, Paul A.; Zhang, Shuang; Li, Diqiang; Zhao, Peng; Wang, Longzhu; Duo, Hairui			Optimized Spatial Priorities for Biodiversity Conservation in China: A Systematic Conservation Planning Perspective	PLOS ONE			English	Article							SCALE	By addressing several key features overlooked in previous studies, i.e. human disturbance, integration of ecosystem-and species-level conservation features, and principles of complementarity and representativeness, we present the first national-scale systematic conservation planning for China to determine the optimized spatial priorities for biodiversity conservation. We compiled a spatial database on the distributions of ecosystem-and species-level conservation features, and modeled a human disturbance index (HDI) by aggregating information using several socioeconomic proxies. We ran Marxan with two scenarios (HDI-ignored and HDI-considered) to investigate the effects of human disturbance, and explored the geographic patterns of the optimized spatial conservation priorities. Compared to when HDI was ignored, the HDI-considered scenario resulted in (1) a marked reduction (similar to 9%) in the total HDI score and a slight increase (similar to 7%) in the total area of the portfolio of priority units, (2) a significant increase (similar to 43%) in the total irreplaceable area and (3) more irreplaceable units being identified in almost all environmental zones and highly-disturbed provinces. Thus the inclusion of human disturbance is essential for cost-effective priority-setting. Attention should be targeted to the areas that are characterized as moderately-disturbed, <2,000 m in altitude, and/or intermediately-to extremely-rugged in terrain to identify potentially important regions for implementing cost-effective conservation. We delineated 23 primary large-scale priority areas that are significant for conserving China's biodiversity, but those isolated priority units in disturbed regions are in more urgent need of conservation actions so as to prevent immediate and severe biodiversity loss. This study presents a spatially optimized national-scale portfolio of conservation priorities - effectively representing the overall biodiversity of China while minimizing conflicts with economic development. Our results offer critical insights for current conservation and strategic land-use planning in China. The approach is transferable and easy to implement by end-users, and applicable for national- and local-scale systematic conservation prioritization practices.	[Wu, Ruidong] Yunnan Univ, Inst Int Rivers & Ecosecur, Kunming, Yunnan, Peoples R China; [Wu, Ruidong] Yunnan Univ, Yunnan Key Lab Int Rivers & Transboundary Eco Sec, Kunming, Yunnan, Peoples R China; [Long, Yongcheng; Zhang, Shuang; Zhao, Peng; Wang, Longzhu] Nat Conservancy China Program, Kunming, Yunnan, Peoples R China; [Malanson, George P.] Univ Iowa, Dept Geog, Iowa City, IA 52242 USA; [Garber, Paul A.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Li, Diqiang] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Duo, Hairui] Beijing Forestry Univ, Sch Nat Reserve, Beijing, Peoples R China	Yunnan University; Yunnan University; University of Iowa; University of Illinois System; University of Illinois Urbana-Champaign; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Beijing Forestry University	Wu, RD (corresponding author), Yunnan Univ, Inst Int Rivers & Ecosecur, Kunming, Yunnan, Peoples R China.	rdwu@ynu.edu.cn	Wu, Ruidong/H-6325-2019	Wu, Ruidong/0000-0002-9908-1802	National Natural Science Foundation of China [31260148]; National Key Technologies R&D Program of China [2011BAC09B07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program of China(National Key Technology R&D Program)	This study was funded by the National Natural Science Foundation of China (No. 31260148) and the National Key Technologies R&D Program of China (No. 2011BAC09B07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardon J.A., 2010, MARXAN GOOD PRACTICE, V2; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Carwardine J, 2008, P NATL ACAD SCI USA, V105, P11446, DOI 10.1073/pnas.0707157105; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chen C. D, 1998, BIODIVERSITY CHINA C; Chen L, 1993, CHINAS BIODIVERSITY; Crous CJ, 2013, J APPL ECOL, V50, P205, DOI 10.1111/1365-2664.12012; Fan J, 2009, J GEOGR SCI, V19, P515, DOI 10.1007/s11442-009-0515-0; Fu L.K., 1992, CHINA PLANT RED DATA; Groves C.R., 2003, DRAFTING CONSERVATIO; Institute of Botany, 2009, SUBJ DAT CHIN PLANTS; Institute of Zoology, 2009, DAT FAUN SIN; IUCN, 2022, IUCN RED LIST THREAT; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Lea C., 2010, NPS2010NRR2010204 US; [李炳元 Li Bingyuan], 2008, [第四纪研究, Quaternary Sciences], V28, P535; Li D., 2003, RES NATL FORESTRY NA; Linke S, 2012, J APPL ECOL, V49, P1036, DOI 10.1111/j.1365-2664.2012.02177.x; Liu J., 2013, ENCY BIODIVERSITY, P372, DOI DOI 10.1016/B978-0-12-384719-5.00335-X; Lu YH, 2013, ENVIRON SCI POLICY, V33, P346, DOI 10.1016/j.envsci.2013.05.007; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Ministry of Environment Protection of China, 2011, CHIN NAT BIOD CONS S; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Pan Jiahua, 2012, Science, V336, P1397, DOI 10.1126/science.1224009; Riley SJ., 1999, INTERMOUNT J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; State Forestry Administration of China, 2009, NAT KEY PROT WILD PL; State Forestry Administration of China, 2009, NAT KEY TERR WILDL R; Tang ZY, 2006, FRONT ECOL ENVIRON, V4, P347, DOI 10.1890/1540-9295(2006)004[0347:BICM]2.0.CO;2; The Ministry of Environmental Protection of China, 2011, ISS SICH BIOD CONS S; The State Council of China, 2011, CIRC STAT COUNC ISS; USGS, 2004, SHUTTL RAD TOP MISS; Venter O, 2013, CONSERV LETT, V6, P116, DOI 10.1111/j.1755-263X.2012.00287.x; Wang S., 1998, CHINA RED DATA BOOK; WCS, 2005, CHIN SPEC INF SERV; Withey JC, 2012, ECOL LETT, V15, P1249, DOI 10.1111/j.1461-0248.2012.01847.x; Wu RD, 2011, FRONT ECOL ENVIRON, V9, P383, DOI 10.1890/100093; Wu RD, 2011, ENVIRON SCI POLLUT R, V18, P800, DOI 10.1007/s11356-011-0440-5; [徐卫华 XU WeiHua], 2006, [生态学报, Acta Ecologica Sinica], V26, P271; Yang XH, 2009, INT J ENV RES PUB HE, V6, P3025, DOI 10.3390/ijerph6123025; Zhang RZ, 1997, DISTRIBUTIONS CHINA; Zhang YB, 2008, BIODIVERS CONSERV, V17, P1783, DOI 10.1007/s10531-008-9384-6; 马克平, 2001, 植物生态学报, V25	45	35	43	4	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103783	10.1371/journal.pone.0103783	http://dx.doi.org/10.1371/journal.pone.0103783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072933	Green Submitted, Green Published, gold			2022-12-25	WOS:000341307600086
J	Hill, KE; Motley, AK; Winfrey, VP; Burk, RF				Hill, Kristina E.; Motley, Amy K.; Winfrey, Virginia P.; Burk, Raymond F.			Selenoprotein P Is the Major Selenium Transport Protein in Mouse Milk	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE; DELETION; PLASMA; EXCRETION; SEPP1; MICE; RAT	Selenium is transferred from the mouse dam to its neonate via milk. Milk contains selenium in selenoprotein form as selenoprotein P (Sepp1) and glutathione peroxidase-3 (Gpx3) as well as in non-specific protein form as selenomethionine. Selenium is also present in milk in uncharacterized small-molecule form. We eliminated selenomethionine from the mice in these experiments by feeding a diet that contained sodium selenite as the source of selenium. Selenium-replete dams with deletion of Sepp1 or Gpx3 were studied to assess the effects of these genes on selenium transfer to the neonate. Sepp1 knockout caused a drop in milk selenium to 27% of the value in wild-type milk and a drop in selenium acquisition by the neonates to 35%. In addition to decreasing milk selenium by eliminating Sepp1, deletion of Sepp1 causes a decline in whole-body selenium, which likely also contributes to the decreased transfer of selenium to the neonate. Deletion of Gpx3 did not decrease milk selenium content or neonate selenium acquisition by measurable amounts. Thus, when the dam is fed selenium-adequate diet (0.25 mg selenium/kg diet), milk Sepp1 transfers a large amount of selenium to neonates but the transfer of selenium by Gpx3 is below detection by our methods.	[Hill, Kristina E.; Motley, Amy K.; Winfrey, Virginia P.; Burk, Raymond F.] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37235 USA	Vanderbilt University	Hill, KE (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, 221 Kirkland Hall, Nashville, TN 37235 USA.	kristina.hill@vanderbilt.edu			National Institues of Health [R37 ES02497, R01 DK82813, P30 ES00267]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES002497, P30ES000267] Funding Source: NIH RePORTER	National Institues of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding came from National Institues of Health grants R37 ES02497 (RFB), R01 DK82813 (RFB), and P30 ES00267. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISSAR N, 1991, J NUTR, V121, P1243, DOI 10.1093/jn/121.8.1243; Burk RF, 2006, BBA-GEN SUBJECTS, V1760, P1789, DOI 10.1016/j.bbagen.2006.08.010; Burk RF, 2013, FASEB J, V27, P3249, DOI 10.1096/fj.13-231852; Burk RF, 2001, BIOFACTORS, V14, P107, DOI 10.1002/biof.5520140115; Dudley HC, 1935, IND ENG CHEM, V7, P0003, DOI 10.1021/ac50093a002; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; Hill KE, 2012, J BIOL CHEM, V287, P40414, DOI 10.1074/jbc.M112.421404; Kobayashi Y, 2002, P NATL ACAD SCI USA, V99, P15932, DOI 10.1073/pnas.252610699; KOH TS, 1983, J ASSOC OFF ANA CHEM, V66, P918; Kurokawa S, 2014, FREE RADICAL BIO MED, V69, P67, DOI 10.1016/j.freeradbiomed.2014.01.010; Kurokawa S, 2012, J BIOL CHEM, V287, P28717, DOI 10.1074/jbc.M112.383521; MCCONNELL KP, 1948, J BIOL CHEM, V173, P653; MILNER JA, 1987, AM J CLIN NUTR, V45, P617, DOI 10.1093/ajcn/45.3.617; Olson GE, 2007, J BIOL CHEM, V282, P12290, DOI 10.1074/jbc.M611403200; Olson GE, 2010, AM J PHYSIOL-RENAL, V298, pF1244, DOI 10.1152/ajprenal.00662.2009; Schweizer U, 2004, BIOCHEM J, V378, P21, DOI 10.1042/BJ20031795; SHEEHAN TMT, 1990, CLIN CHEM, V36, P2124; SMITH AM, 1986, J NUTR, V116, P1068, DOI 10.1093/jn/116.6.1068; SMITH AM, 1987, J NUTR, V117, P725, DOI 10.1093/jn/117.4.725	20	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103486	10.1371/journal.pone.0103486	http://dx.doi.org/10.1371/journal.pone.0103486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068390	gold, Green Published, Green Submitted			2022-12-25	WOS:000339993700074
J	Xu, HY; Zhang, YQ; Lei, Y; Gao, XM; Zhai, HQ; Lin, N; Tang, SH; Liang, RX; Ma, Y; Li, DF; Zhang, Y; Zhu, GR; Yang, HJ; Huang, LQ				Xu, Haiyu; Zhang, Yanqiong; Lei, Yun; Gao, Xiumei; Zhai, Huaqiang; Lin, Na; Tang, Shihuan; Liang, Rixin; Ma, Yan; Li, Defeng; Zhang, Yi; Zhu, Guangrong; Yang, Hongjun; Huang, Luqi			A Systems Biology-Based Approach to Uncovering the Molecular Mechanisms Underlying the Effects of Dragon's Blood Tablet in Colitis, Involving the Integration of Chemical Analysis, ADME Prediction, and Network Pharmacology	PLOS ONE			English	Article							INTERACTION DATABASE; DAEMONOROPS-DRACO; ULCERATIVE-COLITIS; IDENTIFICATION; KNOWLEDGEBASE; PERMEABILITY; FLAVONOIDS; UPDATE; DRUGS; RESIN	Traditional Chinese medicine (TCM) is one of the oldest East Asian medical systems. The present study adopted a systems biology-based approach to provide new insights relating to the active constituents and molecular mechanisms underlying the effects of dragon's blood (DB) tablets for the treatment of colitis. This study integrated chemical analysis, prediction of absorption, distribution, metabolism, and excretion (ADME), and network pharmacology. Firstly, a rapid, reliable, and accurate ultra-performance liquid chromatography-electrospray ionization-tandem mass spectrometry method was employed to identify 48 components of DB tablets. In silico prediction of the passive absorption of these compounds, based on Caco-2 cell permeability, and their P450 metabolism enabled the identification of 22 potentially absorbed components and 8 metabolites. Finally, networks were constructed to analyze interactions between these DB components/metabolites absorbed and their putative targets, and between the putative DB targets and known therapeutic targets for colitis. This study provided a great opportunity to deepen the understanding of the complex pharmacological mechanisms underlying the effects of DB in colitis treatment.	[Xu, Haiyu; Zhang, Yanqiong; Lei, Yun; Gao, Xiumei; Lin, Na; Tang, Shihuan; Liang, Rixin; Ma, Yan; Li, Defeng; Zhang, Yi; Yang, Hongjun] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China; [Xu, Haiyu; Huang, Luqi] China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, Beijing, Peoples R China; [Lei, Yun; Zhai, Huaqiang] Beijing Univ Chinese Med, Beijing, Peoples R China; [Gao, Xiumei] Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China; [Zhu, Guangrong] Yunnan Datang Hanfang Pharm Co Ltd, Simao, Yunnan, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; China Academy of Chinese Medical Sciences; National Resource Center for Chinese Materia Medica, CACMS; Beijing University of Chinese Medicine; Tianjin University of Traditional Chinese Medicine	Yang, HJ (corresponding author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China.	hongjun0420@vip.sina.com; huangluqi@263.net	MA, YAN/HHN-2912-2022	Tang, Shihuan/0000-0003-0589-4499	Key Projects in the National Science Technology [2008BAI51B03]; National Natural Science Foundation of China [81202793]; Beijing Joint Project Specific Funds; Operational expenses for basic research of China Academy of Chinese Medical Sciences [Z02063]; Fundamental Research Funds for the Central public welfare research institutes [ZZ070819, ZZ070831, ZZ070830]	Key Projects in the National Science Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Joint Project Specific Funds; Operational expenses for basic research of China Academy of Chinese Medical Sciences; Fundamental Research Funds for the Central public welfare research institutes	Financial support was provided by Key Projects in the National Science & Technology Pillar Program during the 11th Five-Year Plan Period (No. 2008BAI51B03), the National Natural Science Foundation of China (No. 81202793), Beijing Joint Project Specific Funds and independent topics supported by Operational expenses for basic research of China Academy of Chinese Medical Sciences (No. Z02063), Beijing Joint Project Specific Funds and the Fundamental Research Funds for the Central public welfare research institutes (Nos. ZZ070819, ZZ070831 and ZZ070830). Support was also provided in the form of salary for Guangrong Zhu as an employee at Datang Hanfang Pharmacy co.ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; ARNONE A, 1990, J CHEM SOC PERK T 1, P2637, DOI 10.1039/p19900002637; ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Azuaje FJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00052; Badib AS, 1991, MED PLANTS YEMEN MAK, P15; Barnes Patricia M, 2004, Adv Data, P1; Baumer U, 2010, ANAL BIOANAL CHEM, V397, P1363, DOI 10.1007/s00216-010-3620-0; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S16; De Marino S, 2008, MOLECULES, V13, P1219, DOI 10.3390/molecules13061219; Feng SH, 2011, WORLD J INTEGRA TRAD, V6, P496; Guillarme D, 2010, TRAC-TREND ANAL CHEM, V29, P15, DOI 10.1016/j.trac.2009.09.008; Horwitz Bruce, 2005, J Pediatr Gastroenterol Nutr, V40 Suppl 1, pS22, DOI 10.1097/00005176-200504001-00012; Hu WB, 2011, J PRAC TRAD CHIN MED, V25, P56; Lehne Benjamin, 2009, Human Genomics, V3, P291; Li S, 2007, IET SYST BIOL, V1, P51, DOI 10.1049/iet-syb:20060032; Li S, 2011, HERBBIOMAP DATABASE; Lv RX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086692; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Milbum M., 1984, AFRICA, V39, P486; NASINI G, 1981, PHYTOCHEMISTRY, V20, P514, DOI 10.1016/S0031-9422(00)84180-1; National Medical Products Administration, 2006, NOT PRINT DISTR SPEC; PIOZZI F, 1974, PHYTOCHEMISTRY, V13, P2231, DOI 10.1016/0031-9422(74)85033-8; Ponce YM, 2004, J PHARM PHARM SCI, V7, P186; Ponce YM, 2003, INT J MOL SCI, V4, P512, DOI 10.3390/i4080512; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rubino SJ, 2012, CURR OPIN IMMUNOL, V24, P398, DOI 10.1016/j.coi.2012.04.010; Shen CC, 2007, NAT PROD RES, V21, P377, DOI 10.1080/14786410701194575; Shi JM, 2009, J SEP SCI, V32, P4040, DOI 10.1002/jssc.200900392; Sikander A, 2010, CLIN CHIM ACTA, V411, P59, DOI 10.1016/j.cca.2009.10.003; State Pharmacopoeia Committee, 2010, PHARM PEOPL REP CHIN, P133; Tao Y, 2013, J CHROMATOGR B, V935, P1, DOI 10.1016/j.jchromb.2013.07.015; The Editorial Committee, 1999, MAT MED CHIN, V8, P455; Theodoridis GA, 2012, ANAL CHIM ACTA, V711, P7, DOI 10.1016/j.aca.2011.09.042; Tomasello G, 2011, EUR J HISTOCHEM, V55, P210, DOI 10.4081/ejh.2011.e38; U.S. Department of Health and Human Services FDA, 2000, CTR DRUG EV RES CDER, P1; WANG Y, 2012, EVID-BASED COMPL ALT, V2012, DOI DOI 10.1155/2012/698531; Wangensteen H, 2013, NUTRIENTS, V5, P1757, DOI 10.3390/nu5051757; Wine E, 2013, J CROHNS COLITIS, V7, P916, DOI 10.1016/j.crohns.2012.12.012; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Wuchty S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-24; Xu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081135; Xu HY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/658531; Yazdanian M, 1998, PHARMACEUT RES, V15, P1490, DOI 10.1023/A:1011930411574; Yi T, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-116; Zhang B, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/456747; Zhang GB, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1016/J.MATCHAR.2013.04.007; Zhang J, 2010, BIOORG MED CHEM LETT, V20, P718, DOI 10.1016/j.bmcl.2009.11.073; Zhang Y., 2013, MATH PROB ENG, V2013, DOI DOI 10.4018/JIIT.2013010101; Zhou LM, 2009, INT J PHARMACEUT, V379, P109, DOI 10.1016/j.ijpharm.2009.06.016; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797; Zhu ZY, 2012, J CLIN MED PRAC, V16, P47	57	33	46	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e101432	10.1371/journal.pone.0101432	http://dx.doi.org/10.1371/journal.pone.0101432			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068885	gold, Green Submitted, Green Published			2022-12-25	WOS:000339993700002
J	Tang, BR; Cai, JJ; Sun, L; Li, YP; Qu, J; Snider, BJ; Wu, SZ				Tang, Bingrong; Cai, Jingjing; Sun, Lin; Li, Yiping; Qu, Jia; Snider, Barbara Joy; Wu, Shengzhou			Proteasome Inhibitors Activate Autophagy Involving Inhibition of PI3K-Akt-mTOR Pathway as an Anti-Oxidation Defense in Human RPE Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; DEATH; DEGRADATION; EXPRESSION; LIPOFUSCIN; PROTECTS; SURVIVAL; MERTK; GENE	The two major intracellular protein degradation systems, the ubiquitin-proteasome system (UPS) and autophagy, work collaboratively in many biological processes including development, apoptosis, aging, and countering oxidative injuries. We report here that, in human retinal pigment epithelial cells (RPE), ARPE-19 cells, proteasome inhibitors, clasto-lactacystin beta-lactone (LA) or epoxomicin (Epo), at non-lethal doses, increased the protein levels of autophagy-specific genes Atg5 and Atg7 and enhanced the conversion of microtubule-associated protein light chain (LC3) from LC3-I to its lipidative form, LC3-II, which was enhanced by co-addition of the saturated concentration of Bafilomycin A1 (Baf). Detection of co-localization for LC3 staining and labeled-lysosome further confirmed autophagic flux induced by LA or Epo. LA or Epo reduced the phosphorylation of the protein kinase B (Akt), a downstream target of phosphatidylinositol-3-kinases (PI3K), and mammalian target of rapamycin (mTOR) in ARPE-19 cells; by contrast, the induced changes of autophagy substrate, p62, showed biphasic pattern. The autophagy inhibitor, Baf, attenuated the reduction in oxidative injury conferred by treatment with low doses of LA and Epo in ARPE-19 cells exposed to menadione (VK3) or 4-hydroxynonenal (4-HNE). Knockdown of Atg7 with siRNA in ARPE-19 cells reduced the protective effects of LA or Epo against VK3. Overall, our results suggest that treatment with low levels of proteasome inhibitors confers resistance to oxidative injury by a pathway involving inhibition of the PI3K-Akt-mTOR pathway and activation of autophagy.	[Tang, Bingrong; Cai, Jingjing; Sun, Lin; Qu, Jia; Wu, Shengzhou] Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China; [Tang, Bingrong; Cai, Jingjing; Sun, Lin; Qu, Jia; Wu, Shengzhou] Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Tang, Bingrong; Cai, Jingjing; Sun, Lin; Qu, Jia; Wu, Shengzhou] Minist Hlth, State Key Lab Cultivat Base, Wenzhou, Zhejiang, Peoples R China; [Tang, Bingrong; Cai, Jingjing; Sun, Lin; Qu, Jia; Wu, Shengzhou] Minist Hlth, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China; [Tang, Bingrong; Cai, Jingjing; Sun, Lin; Qu, Jia; Wu, Shengzhou] Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Li, Yiping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China; [Snider, Barbara Joy] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Wenzhou Medical University; Wenzhou Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Washington University (WUSTL)	Wu, SZ (corresponding author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China.	wszlab@mail.eye.ac.cn	wu, shengzhou/ABG-8579-2021	wu, shengzhou/0000-0003-1154-2369; Cai, Jingjing/0000-0003-0708-3809	National Natural Science Foundation of China [81371027]; Chinese Ministry of Education [20133321120002]; Qianjiang Scholar Scheme [QJD1202020]; Wenzhou Medical University [89210001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Qianjiang Scholar Scheme; Wenzhou Medical University	The study was supported by National Natural Science Foundation of China (81371027), by Chinese Ministry of Education (20133321120002), by Qianjiang Scholar Scheme (QJD1202020), and by start-up funding (89210001) from Wenzhou Medical University to Dr. Shengzhou Wu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann M, 2004, FASEB J, V18, P562, DOI 10.1096/fj.03-0289fje; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Cadwell K, 2009, AUTOPHAGY, V5, P250, DOI 10.4161/auto.5.2.7560; Cai JJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-88; Cai JJ, 2012, INVEST OPHTH VIS SCI, V53, P5967, DOI 10.1167/iovs.12-10048; Cerquetti L, 2011, EXP CELL RES, V317, P1397, DOI 10.1016/j.yexcr.2011.02.014; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Keller JN, 2004, INT J BIOCHEM CELL B, V36, P2376, DOI 10.1016/j.biocel.2004.05.003; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kuang XL, 2014, J NEUROSCI RES, V92, P1319, DOI 10.1002/jnr.23413; Kundu M, 2011, ANTIOXID REDOX SIGN, V14, P1953, DOI 10.1089/ars.2010.3809; Kuusisto E, 2001, BIOCHEM BIOPH RES CO, V280, P223, DOI 10.1006/bbrc.2000.4107; Lamming DW, 2013, J CLIN INVEST, V123, P980, DOI 10.1172/JCI64099; Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X; Lu CB, 2002, J BIOL CHEM, V277, P24368, DOI 10.1074/jbc.M201924200; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rodrigues EB, 2007, OPHTHALMOLOGICA, V221, P143, DOI 10.1159/000099293; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Thompson HGR, 2003, ONCOGENE, V22, P2322, DOI 10.1038/sj.onc.1206325; van Schalkwyk DA, 2010, BIOCHEM PHARMACOL, V79, P1291, DOI 10.1016/j.bcp.2009.12.025; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang XJ, 2013, AUTOPHAGY, V9, P1500, DOI 10.4161/auto.25573; Wu J, 2013, ENDOCRINE, V44, P87, DOI 10.1007/s12020-012-9826-5; Wu SZ, 2009, J NEUROCHEM, V109, P1225, DOI 10.1111/j.1471-4159.2009.06037.x; Wu WKK, 2008, BIOCHEM BIOPH RES CO, V374, P258, DOI 10.1016/j.bbrc.2008.07.031; Wu YT, 2009, AUTOPHAGY, V5, P824, DOI 10.4161/auto.9099; Xiang Y, 2007, AUTOPHAGY, V3, P257, DOI 10.4161/auto.3847; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	39	25	26	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103364	10.1371/journal.pone.0103364	http://dx.doi.org/10.1371/journal.pone.0103364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	25062253	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992600063
J	Lin, CS; Uboldi, AD; Marapana, D; Czabotar, PE; Epp, C; Bujard, H; Taylor, NL; Perugini, MA; Hodder, AN; Cowman, AF				Lin, Clara S.; Uboldi, Alessandro D.; Marapana, Danushka; Czabotar, Peter E.; Epp, Christian; Bujard, Hermann; Taylor, Nicole L.; Perugini, Matthew A.; Hodder, Anthony N.; Cowman, Alan F.			The Merozoite Surface Protein 1 Complex Is a Platform for Binding to Human Erythrocytes by Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING; SERINE-PROTEASE; CELL INVASION; MALARIA; ANTIBODIES; PARASITE; ANTIGEN; IDENTIFICATION; RESPONSES; INHIBIT	Plasmodium falciparum is the causative agent of the most severe form of malaria in humans. The merozoite, an extracellular stage of the parasite lifecycle, invades erythrocytes in which they develop. The most abundant protein on the surface of merozoites is merozoite surface protein 1 (MSP1), which consists of four processed fragments. Studies indicate that MSP1 interacts with other peripheral merozoite surface proteins to form a large complex. Successful invasion of merozoites into host erythrocytes is dependent on this protein complex; however, the identity of all components and its function remain largely unknown. We have shown that the peripheral merozoite surface proteins MSPDBL1 and MSPDBL2 are part of the large MSP1 complex. Using surface plasmon resonance, we determined the binding affinities of MSPDBL1 and MSPDBL2 to MSP1 to be in the range of 2-4 x 10(-7) M. Both proteins bound to three of the four proteolytically cleaved fragments of MSP1 (p42, p38, and p83). In addition, MSPDBL1 and MSPDBL2, but not MSP1, bound directly to human erythrocytes. This demonstrates that the MSP1 complex acts as a platform for display of MSPDBL1 and MSPDBL2 on the merozoite surface for binding to receptors on the erythrocyte and invasion.	[Lin, Clara S.; Uboldi, Alessandro D.; Marapana, Danushka; Czabotar, Peter E.; Hodder, Anthony N.; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Lin, Clara S.; Marapana, Danushka; Czabotar, Peter E.; Hodder, Anthony N.; Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Epp, Christian] Heidelberg Univ, Dept Infect Dis, D-69120 Heidelberg, Germany; [Bujard, Hermann] Univ Heidelberg ZMBH, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Taylor, Nicole L.; Perugini, Matthew A.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic 3082, Australia	Walter & Eliza Hall Institute; University of Melbourne; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; La Trobe University	Hodder, AN (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	hodder@wehi.edu.au; cowman@wehi.edu.au		Czabotar, Peter/0000-0002-2594-496X	National Health and Medical Research Council of Australia [637406]; Victorian State Government Operational Infrastructure Support; Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council of Australia Grant 637406, by Victorian State Government Operational Infrastructure Support, and by the Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme.	Amambua-Ngwa A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002992; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; BLACKMAN MJ, 1992, MOL BIOCHEM PARASIT, V50, P307, DOI 10.1016/0166-6851(92)90228-C; BLACKMAN MJ, 1993, MOL BIOCHEM PARASIT, V62, P103, DOI 10.1016/0166-6851(93)90182-W; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; Boyle MJ, 2013, INT J PARASITOL, V43, P1, DOI 10.1016/j.ijpara.2012.11.002; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Burgess BR, 2005, J BIOL CHEM, V280, P37236, DOI 10.1074/jbc.M506753200; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; de Monerri NCS, 2011, INFECT IMMUN, V79, P1086, DOI 10.1128/IAI.00902-10; Demanga CG, 2010, INFECT IMMUN, V78, P486, DOI 10.1128/IAI.01359-08; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Fan YT, 2013, J PROTEOMICS, V78, P148, DOI 10.1016/j.jprot.2012.11.020; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Hodder AN, 2012, J BIOL CHEM, V287, P32922, DOI 10.1074/jbc.M112.350504; Holder AA, 2009, PARASITOLOGY, V136, P1445, DOI 10.1017/S0031182009990515; HOLDER AA, 1994, PARASITOL TODAY, V10, P182, DOI 10.1016/0169-4758(94)90025-6; Kadekoppala M, 2008, EUKARYOT CELL, V7, P2123, DOI 10.1128/EC.00274-08; Kauth CW, 2006, J BIOL CHEM, V281, P31517, DOI 10.1074/jbc.M604641200; Kauth CW, 2003, J BIOL CHEM, V278, P22257, DOI 10.1074/jbc.M302299200; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; NICHOLLS SC, 1988, MOL BIOCHEM PARASIT, V28, P11, DOI 10.1016/0166-6851(88)90174-0; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Ochola LI, 2010, MOL BIOL EVOL, V27, P2344, DOI 10.1093/molbev/msq119; OEUVRAY C, 1994, BLOOD, V84, P1594; Pachebat JA, 2001, MOL BIOCHEM PARASIT, V117, P83, DOI 10.1016/S0166-6851(01)00336-X; RILEY EM, 1992, PARASITE IMMUNOL, V14, P321, DOI 10.1111/j.1365-3024.1992.tb00471.x; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Sakamoto H, 2012, VACCINE, V30, P1972, DOI 10.1016/j.vaccine.2012.01.010; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Singh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005410; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; Stafford WHL, 1996, MOL BIOCHEM PARASIT, V80, P159, DOI 10.1016/0166-6851(96)02696-5; Tetteh KKA, 2013, INFECT IMMUN, V81, P3835, DOI 10.1128/IAI.00301-13; Tetteh KKA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005568; Tham WH, 2011, BLOOD, V118, P1923, DOI 10.1182/blood-2011-03-341305; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Trucco C, 2001, MOL BIOCHEM PARASIT, V112, P91, DOI 10.1016/S0166-6851(00)00350-9; Van Tyne D, 2013, ANTIMICROB AGENTS CH, V57, P2937, DOI 10.1128/AAC.02574-12; Van Tyne D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001383; Wickramarachchi T, 2009, INT J PARASITOL, V39, P763, DOI 10.1016/j.ijpara.2008.12.004; Woehlbier U, 2006, INFECT IMMUN, V74, P1313, DOI 10.1128/IAI.74.2.1313-1322.2006; Woehlbier U, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-77	50	35	35	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25655	25669		10.1074/jbc.M114.586495	http://dx.doi.org/10.1074/jbc.M114.586495			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074930	Green Published, hybrid			2022-12-25	WOS:000342130800025
J	Nguyen, KQN; Tsou, WI; Calarese, DA; Kimani, SG; Singh, S; Hsieh, S; Liu, YZ; Lu, B; Wu, Y; Garforth, SJ; Almo, SC; Kotenko, SV; Birge, RB				Nguyen, Khanh-Quynh N.; Tsou, Wen-I; Calarese, Daniel A.; Kimani, Stanley G.; Singh, Sukhwinder; Hsieh, Shelly; Liu, Yongzhang; Lu, Bin; Wu, Yi; Garforth, Scott J.; Almo, Steve C.; Kotenko, Sergei V.; Birge, Raymond B.			Overexpression of MERTK Receptor Tyrosine Kinase in Epithelial Cancer Cells Drives Efferocytosis in a Gain-of-Function Capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC CELLS; TAM RECEPTORS; MONOCLONAL-ANTIBODY; DENDRITIC CELLS; AXL; EXPRESSION; ACTIVATION; CLEARANCE; GROWTH; PHAGOCYTOSIS	MERTK, a member of the TAM (TYRO3, AXL, and MERTK) receptor tyrosine kinases, has complex and diverse roles in cell biology. On the one hand, knock-out of MERTK results in age-dependent autoimmunity characterized by failure of apoptotic cell clearance, while on the other, MERTK overexpression in cancer drives classical oncogene pathways leading to cell transformation. To better understand the interplay between cell transformation and efferocytosis, we stably expressed MERTK in human MCF10A cells, a non-tumorigenic breast epithelial cell line devoid of endogenous MERTK. While stable expression of MERTK in MCF10A resulted in enhanced motility and AKT-mediated chemoprotection, MERTK-10A cells did not form stable colonies in soft agar, or enhance proliferation compared with parental MCF10A cells. Concomitant to chemoresistance, MERTK also stimulated efferocytosis in a gain-of-function capacity. However, unlike AXL, MERTK activation was highly dependent on apoptotic cells, suggesting MERTK may preferentially interface with phosphatidylserine. Consistent with this idea, knockdown of MERTK in breast cancer cells MDA-MB 231 reduced efferocytosis, while transient or stable expression of MERTK stimulated apoptotic cell clearance in all cell lines tested. Moreover, human breast cancer cells with higher endogenous MERTK showed higher levels of efferocytosis that could be blocked by soluble TAM receptors. Finally, through MERTK, apoptotic cells induced PD-L1 expression, an immune checkpoint blockade, suggesting that cancer cells may adopt MERTK-driven efferocytosis as an immune suppression mechanism for their advantage. These data collectively identify MERTK as a significant link between cancer progression and efferocytosis, and a potentially unrealized tumor-promoting event when MERTK is overexpressed in epithelial cells.	[Nguyen, Khanh-Quynh N.; Tsou, Wen-I; Kimani, Stanley G.; Kotenko, Sergei V.; Birge, Raymond B.] Rutgers Biomed & Hlth Sci, Univ Hosp Canc Ctr, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Tsou, Wen-I; Kotenko, Sergei V.] Rutgers Biomed & Hlth Sci, Ctr Immun & Inflammat, New Jersey Med Sch, Newark, NJ 07103 USA; [Singh, Sukhwinder] Rutgers Biomed & Hlth Sci, Dept Pathol & Lab Med, Flow Cytometry & Immunol Core Lab, Newark, NJ 07103 USA; [Calarese, Daniel A.; Garforth, Scott J.; Almo, Steve C.] Yeshiva Univ, Dept Biochem, Albert Einstein Coll Med, Bronx, NY 10461 USA; [Hsieh, Shelly] Rutgers, Yeshiva Univ, New Jersey Med Sch, Newark, NJ 07103 USA; [Liu, Yongzhang; Lu, Bin] Wenzhou Med Univ, Inst Biophys, Wenzhou 325035, Peoples R China; [Liu, Yongzhang; Lu, Bin] Wenzhou Med Univ, Attardi Inst Mitochondrial Biomed, Sch Life Sci, Wenzhou 325035, Peoples R China; [Wu, Yi] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou 215123, Jiangsu, Peoples R China	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Yeshiva University; Albert Einstein College of Medicine; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Wenzhou Medical University; Wenzhou Medical University; Soochow University - China	Kotenko, SV (corresponding author), Rutgers, Dept Biochem & Mol Biol, Ctr Canc, New Jersey Med Sch, 205 South Orange Ave, Newark, NJ 07103 USA.	kotenkse@njms.rutgers.edu; birgera@njms.rutgers.edu		Hsieh, Shelly/0000-0002-2500-3860; Singh, Sukhwinder/0000-0002-7061-0096; Kimani, Stanley/0000-0003-3627-8162	National Institutes of Health [R01 165077]; NIH [R01 AI104669, GM094662, GM094665]; Rutgers-NJMS Translational Research Award; Bridge Research Grant; Albert Einstein College of Medicine Cancer Center [P30 CA013330]; National Natural Science Foundation of China [31070710]; Zhejiang Qianjiang Talent Project B Grant [2010R10045]; Key Science and Technology Innovation Team of Zhejiang Province Grant [2010R50048]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094662, U01GM094665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers-NJMS Translational Research Award; Bridge Research Grant; Albert Einstein College of Medicine Cancer Center; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Qianjiang Talent Project B Grant; Key Science and Technology Innovation Team of Zhejiang Province Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 165077 (to R. B. B.), NIH R01 AI104669 (to S. V. K.), the Rutgers-NJMS Translational Research Award and Bridge Research Grant (to R. B. B. and S. V. K.), NIH Grants GM094662 and GM094665 (to S. C. A.), the Albert Einstein College of Medicine Cancer Center P30 CA013330 Grant, the National Natural Science Foundation of China Grant (No. 31070710) and Zhejiang Qianjiang Talent Project B Grant (No. 2010R10045) (to B. L.), and the Key Science and Technology Innovation Team of Zhejiang Province Grant (2010R50048).	Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871; Basso D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054824; Behrens EM, 2003, EUR J IMMUNOL, V33, P2160, DOI 10.1002/eji.200324076; Berghoff AS, 2014, CLIN NEUROPATHOL, V33, P42, DOI 10.5414/NP300698; Braunger J, 1997, ONCOGENE, V14, P2619, DOI 10.1038/sj.onc.1201123; Burchert A, 1998, ONCOGENE, V16, P3177, DOI 10.1038/sj.onc.1201865; Caberoy NB, 2012, J CELL PHYSIOL, V227, P401, DOI 10.1002/jcp.22955; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Chen YM, 2009, REPRODUCTION, V138, P655, DOI 10.1530/REP-09-0101; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Cook RS, 2013, J CLIN INVEST, V123, P3231, DOI 10.1172/JCI67655; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DeRose P, 2011, IMMUNOTHERAPY-UK, V3, P933, DOI [10.2217/IMT.11.87, 10.2217/imt.11.87]; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Fisher PW, 2005, BIOCHEM J, V387, P727, DOI 10.1042/BJ20040859; Fridell YWC, 1996, MOL CELL BIOL, V16, P135; Gerber DE, 2011, CLIN CANCER RES, V17, P6888, DOI 10.1158/1078-0432.CCR-11-1074; Graham DK, 2006, CLIN CANCER RES, V12, P2662, DOI 10.1158/1078-0432.CCR-05-2208; GRAHAM DK, 1995, ONCOGENE, V10, P2349; Guttridge KL, 2002, J BIOL CHEM, V277, P24057, DOI 10.1074/jbc.M112086200; Haile ST, 2013, J IMMUNOL, V191, P2829, DOI 10.4049/jimmunol.1202777; He J, 2007, CLIN CANCER RES, V13, P5211, DOI 10.1158/1078-0432.CCR-07-0793; Helm O, 2014, INT J CANCER, V135, P843, DOI 10.1002/ijc.28736; Holland SJ, 2005, CANCER RES, V65, P9294, DOI 10.1158/0008-5472.CAN-05-0993; Ji R, 2013, J IMMUNOL, V191, P6165, DOI 10.4049/jimmunol.1302229; Karantza-Wadsworth V, 2008, METHOD ENZYMOL, V446, P61, DOI 10.1016/S0076-6879(08)01604-2; Keating AK, 2006, ONCOGENE, V25, P6092, DOI 10.1038/sj.onc.1209633; Nguyen KQ, 2013, AUTOIMMUNITY, V46, P294, DOI 10.3109/08916934.2013.794515; Lan ZD, 2000, BLOOD, V95, P633, DOI 10.1182/blood.V95.2.633; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Li QT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064812; Ling L, 1996, J BIOL CHEM, V271, P18355, DOI 10.1074/jbc.271.31.18355; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Maeda R, 2014, J THORAC ONCOL, V9, P179, DOI 10.1097/JTO.0000000000000044; Mahajan NP, 2003, J BIOL CHEM, V278, P42596, DOI 10.1074/jbc.M305817200; Mark MR, 1996, J BIOL CHEM, V271, P9785, DOI 10.1074/jbc.271.16.9785; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Nakano T, 2003, CLIN EXP METASTAS, V20, P665, DOI 10.1023/A:1027355610603; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Rahman ZSM, 2010, J IMMUNOL, V185, P5859, DOI 10.4049/jimmunol.1001187; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Rothlin CV, 2010, CURR OPIN IMMUNOL, V22, P740, DOI 10.1016/j.coi.2010.10.001; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; Sandahl M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-122; Sasaki T, 2006, EMBO J, V25, P80, DOI 10.1038/sj.emboj.7600912; Sasaki T, 2002, J BIOL CHEM, V277, P44164, DOI 10.1074/jbc.M207340200; Schlegel J, 2013, J CLIN INVEST, V123, P2257, DOI 10.1172/JCI67816; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Silva EAC, 2013, IMMUNITY, V39, P160, DOI 10.1016/j.immuni.2013.06.010; Soliman H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088557; Stenhoff J, 2004, BIOCHEM BIOPH RES CO, V319, P871, DOI 10.1016/j.bbrc.2004.05.070; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tibrewal N, 2008, J BIOL CHEM, V283, P3618, DOI 10.1074/jbc.M706906200; TOSHIMA J, 1995, BIOCHEM BIOPH RES CO, V209, P656, DOI 10.1006/bbrc.1995.1549; Tsou WI, 2014, J BIOL CHEM, V289, P25750, DOI 10.1074/jbc.M114.569020; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116; Wu CW, 2002, ANTICANCER RES, V22, P1071; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Wu YM, 2004, CANCER RES, V64, P7311, DOI 10.1158/0008-5472.CAN-04-0972	67	59	60	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25737	25749		10.1074/jbc.M114.570838	http://dx.doi.org/10.1074/jbc.M114.570838			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074939	hybrid, Green Published			2022-12-25	WOS:000342130800032
J	Beguy, D; Mumah, J; Gottschalk, L				Beguy, Donatien; Mumah, Joyce; Gottschalk, Lindsey			Unintended Pregnancies among Young Women Living in Urban Slums: Evidence from a Prospective Study in Nairobi City, Kenya	PLOS ONE			English	Article							SEXUAL RISK-TAKING; ADOLESCENT PREGNANCY; REPRODUCTIVE HEALTH; CONTRACEPTIVE USE; ADVERSE OUTCOMES; TRENDS; BEHAVIOR; CHILDBEARING; FERTILITY; PATTERNS	Background: Despite the significant proportion of young people residing in slum communities, little attention has been paid to the sexual and reproductive health (SRH) challenges they face during their transition to adulthood within this harsh environment. Little is known about the extent to which living in extreme environments, like slums, impact SRH outcomes, especially during this key developmental period. This paper aims to fill this research gap by examining the levels of and factors associated with unintended pregnancies among young women aged 15-22 in two informal settlements in Nairobi, Kenya. Methods: We use data from two waves of a 3-year prospective survey that collected information from adolescents living in the two slums in 2007-2010. In total, 849 young women aged 15-22 were considered for analysis. We employed Cox and logistic regression models to investigate factors associated with timing of pregnancy experience and unintended pregnancy among adolescents who were sexually active by Wave 1 or Wave 2. Findings: About two thirds of sexually experienced young women (69%) have ever been pregnant by Wave 2. For 41% of adolescents, the pregnancies were unintended, with 26% being mistimed and 15% unwanted. Multivariate analysis shows a significant association between a set of factors including age at first sex, schooling status, living arrangements and timing of pregnancy experience. In addition, marital status, schooling status, age at first sex and living arrangements are the only factors that are significantly associated with unintended pregnancy among the young women. Conclusions: Overall, this study underscores the importance of looking at reproductive outcomes of early sexual initiation, the serious health risks early fertility entail, especially among out-of school girls, and sexual activity in general among young women living in slum settlements. This provides greater impetus for addressing reproductive behaviors among young women living in resource-poor settings such as slums.	[Beguy, Donatien; Mumah, Joyce] African Populat & Hlth Res Ctr, Urbanizat & Wellbeing & Populat Dynam & Reprod Hl, Nairobi, Kenya; [Gottschalk, Lindsey] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA	African Population & Health Research Centre; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Beguy, D (corresponding author), African Populat & Hlth Res Ctr, Urbanizat & Wellbeing & Populat Dynam & Reprod Hl, Nairobi, Kenya.	dbeguy@aphrc.org		Mumah, Joyce/0000-0001-6181-6837; Gottschalk, Lindsey/0000-0001-5110-9493	Wellcome Trust; Strengthening Evidence for Programming on Unintended Pregnancy (STEP UP) Research Program Consortium through UK Department for International Development; Measurement, Learning and Evaluation project (MLE) through Bill and Melinda Gates Foundation; William and Flora Hewlett Foundation; Swedish International Development Agency (SIDA); Department for International Development (DFID) [201398] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Strengthening Evidence for Programming on Unintended Pregnancy (STEP UP) Research Program Consortium through UK Department for International Development; Measurement, Learning and Evaluation project (MLE) through Bill and Melinda Gates Foundation; William and Flora Hewlett Foundation; Swedish International Development Agency (SIDA); Department for International Development (DFID)	Collection of data used in this study is funded by the Wellcome Trust. Analysis and writing time was supported by funding from the Strengthening Evidence for Programming on Unintended Pregnancy (STEP UP) Research Program Consortium through a grant by UK Department for International Development and the Measurement, Learning and Evaluation project (MLE) through a grant from the Bill and Melinda Gates Foundation. This research was also made possible through the generous core funding to APHRC by the William and Flora Hewlett Foundation and dSwedish International Development Agency (SIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyinka DA, 2010, J MATERN-FETAL NEO M, V23, P785, DOI 10.3109/14767050903572166; African Population and Health Research Center, 2002, POP HLTH DYN NAIR IN; AHMAN E., 2011, UNSAFE ABORTION GLOB; Anand G., PLANNING CITIES AFRI; Babalola Stella, 2005, Afr J Reprod Health, V9, P49; Beguy D, 2011, J URBAN HEALTH, V88, P318, DOI 10.1007/s11524-011-9547-8; Beguy D, 2010, DEMOGR RES, V23, P549, DOI 10.4054/DemRes.2010.23.20; Blanc AK, 1998, STUD FAMILY PLANN, V29, P106, DOI 10.2307/172153; Chen N, 1998, MIGRATION, URBANIZATION, AND DEVELOPMENT : NEW DIRECTIONS AND ISSUES, P59; Cleves M., 2008, INTRO SURVIVAL ANAL; Cox D. R., 1984, ANAL SURVIVAL DATA; COX DR, 1972, J R STAT SOC B, V34, P187; Dodoo FNA, 2007, SOC SCI MED, V64, P1019, DOI 10.1016/j.socscimed.2006.10.007; Dodoo FNA, 2002, RURAL SOCIOL, V67, P46, DOI 10.1111/j.1549-0831.2002.tb00093.x; Emina J, 2011, J URBAN HEALTH, V88, P200, DOI 10.1007/s11524-011-9594-1; Erulkar A., 2007, ADOLESCENCE KIBERA S; Ezeh AC, 2010, STUD FAMILY PLANN, V41, P109, DOI 10.1111/j.1728-4465.2010.00231.x; Fotso JC, 2008, J URBAN HEALTH, V85, P428, DOI 10.1007/s11524-008-9263-1; Fotso JC, 2009, MATERN CHILD HLTH J, V13, P130, DOI 10.1007/s10995-008-0326-4; Gage AJ, 1998, STUD FAMILY PLANN, V29, P154, DOI 10.2307/172156; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; GLASIER A, 2006, LANCET, V368, P1595, DOI DOI 10.1016/S0140-6736(06)69478-6; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Gupta N, 2003, ARCH SEX BEHAV, V32, P41, DOI 10.1023/A:1021841312539; Gupta N, 2003, DEMOGR RES, V8, P93; Hussain R., 2012, GUTTMACHER I SERIES; Kabakyenga JK, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-73; Kabiru CW, 2010, J YOUTH STUD, V13, P453, DOI 10.1080/13676261003801754; Kennedy E, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-11; KIRAGU K, 1995, INT FAM PLAN PERSPEC, V21, P108, DOI 10.2307/2133184; Klein JD, 2005, PEDIATRICS, V116, P281, DOI 10.1542/peds.2005-0999; Kravdal O, 2002, DEMOGRAPHY, V39, P233, DOI 10.2307/3088337; Kumi-Kyereme Akwasi, 2007, Afr J Reprod Health, V11, P133, DOI 10.2307/25549736; Liran D, 2012, J MATERN-FETAL NEO M, P1; Magadi MA, 2000, SOC SCI MED, V51, P551, DOI 10.1016/S0277-9536(99)00495-5; MARQUES NM, 1991, J TROP PEDIATRICS, V37, P194, DOI 10.1093/tropej/37.4.194; Marston C, 2003, POP STUD-J DEMOG, V57, P77, DOI 10.1080/0032472032000061749; Muganda-Onyando R, 2008, DRAM COUNTING COST T; Ngom P, 2003, J ADOLESCENT HEALTH, V33, P369, DOI 10.1016/S1054-139X(03)00213-1; Ochako R, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-1; Olukoya Peju, 2004, Afr J Reprod Health, V8, P57, DOI 10.2307/3583306; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Place F, 2007, WORLD DEV, V35, P312, DOI 10.1016/j.worlddev.2006.10.005; Population Reference Bureau, 2012, PRB WORLD POP DAT SH; Rashid SF, 2006, REPROD HEALTH MATTER, V14, P151, DOI 10.1016/S0968-8080(06)27221-5; Rashid SF, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S3-S3; Ringheim K, 2010, IMPROVING REPROD HLT; Rodgers KB, 1999, J MARRIAGE FAM, V61, P99, DOI 10.2307/353886; Rogers W, 1993, STATA TECHNICAL B, V13; Shah L, 2004, REPROD HEALTH MATTER, V12, P9, DOI 10.1016/S0968-8080(04)24002-2; Singh S, 2000, FAM PLANN PERSPECT, V32, P14, DOI 10.2307/2648144; Singh S, 1998, STUD FAMILY PLANN, V29, P117, DOI 10.2307/172154; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Stata Corporation, 2011, STAT SE 12 WIND; Temin M., 2009, START GIRL NEW AGEND; UN-HABITAT, 2010, STAT AFR CIT 2010 GO; UN-HABITAT, 2003, SLUMS WORLD FAC URB; UN-Habitat, 2008, STAT WORLDS CIT 2008; UN-HABITAT, 2003, CHALL SLUMS GLOB REP; Uzun AK, 2012, J MATERN-FETAL NEO M, P1; WHO, 2010, SOCIAL DETERMINANTS; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Zulu EM, 2002, POP STUD-J DEMOG, V56, P311, DOI 10.1080/00324720215933	63	34	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e101034	10.1371/journal.pone.0101034	http://dx.doi.org/10.1371/journal.pone.0101034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6EF	25080352	Green Submitted, gold, Green Published			2022-12-25	WOS:000339954800002
J	Komiyama, T; Iwama, H; Osada, N; Nakamura, Y; Kobayashi, H; Tateno, Y; Gojobori, T				Komiyama, Tomoyoshi; Iwama, Hisakazu; Osada, Naoki; Nakamura, Yoji; Kobayashi, Hiroyuki; Tateno, Yoshio; Gojobori, Takashi			Dopamine Receptor Genes and Evolutionary Differentiation in the Domestication of Fighting Cocks and Long-Crowing Chickens	PLOS ONE			English	Article							EXON-III; PERSONALITY VARIATION; JAPANESE GAMECOCKS; ALLELE FREQUENCY; NOVELTY SEEKING; DRD4; POLYMORPHISMS; POPULATION; ASSOCIATION; IDENTIFICATION	The chicken domestication process represents a typical model of artificial selection, and gives significant insight into the general understanding of the influence of artificial selection on recognizable phenotypes. Two Japanese domesticated chicken varieties, the fighting cock (Shamo) and the long-crowing chicken (Naganakidori), have been selectively bred for dramatically different phenotypes. The former has been selected exclusively for aggressiveness and the latter for long crowing with an obedient sitting posture. To understand the particular mechanism behind these genetic changes during domestication, we investigated the degree of genetic differentiation in the aforementioned chickens, focusing on dopamine receptor D2, D3, and D4 genes. We studied other ornamental chickens such as Chabo chickens as a reference for comparison. When genetic differentiation was measured by an index of nucleotide differentiation (N-ST) newly devised in this study, we found that the N-ST value of DRD4 for Shamo (0.072) was distinctively larger than those of the other genes among the three populations, suggesting that aggressiveness has been selected for in Shamo by collecting a variety of single nucleotide polymorphisms. In addition, we found that in DRD4 in Naganakidori, there is a deletion variant of one proline at the 24th residue in the repeat of nine prolines of exon 1. We thus conclude that artificial selection has operated on these different kinds of genetic variation in the DRD4 genes of Shamo and Naganakidori so strongly that the two domesticated varieties have differentiated to obtain their present opposite features in a relatively short period of time.	[Komiyama, Tomoyoshi] Tokai Univ, Sch Med, Dept Clin Pharmacol, Isehara, Kanagawa 25911, Japan; [Komiyama, Tomoyoshi; Kobayashi, Hiroyuki] Tokai Univ, Sch Med, Dept Clin Pharmacol, Isehara, Kanagawa 25911, Japan; [Iwama, Hisakazu] Kagawa Univ, Life Sci Res Ctr, Takamatsu, Kagawa 760, Japan; [Osada, Naoki; Gojobori, Takashi] Natl Inst Genet, Shizuoka, Japan; [Nakamura, Yoji] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Kanagawa, Japan; [Tateno, Yoshio] Daegu Gyoungbuk Inst Sci & Technol, Sch New Biol, Taegu, South Korea; [Gojobori, Takashi] SOKENDAI, Dept Genet, Grad Sch Adv Studies, Hayama, Kanagawa, Japan; [Gojobori, Takashi] King Abdullah Univ Sci & Technol, BESE, CBRC, Thuwal, Saudi Arabia	Tokai University; Tokai University; Kagawa University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Fisheries Research & Education Agency (FRA); Graduate University for Advanced Studies - Japan; King Abdullah University of Science & Technology	Komiyama, T (corresponding author), Tokai Univ, Sch Med, Dept Clin Pharmacol, Isehara, Kanagawa 25911, Japan.	komiyama@tokai-u.jp; yt.tateno@gmail.com; tgojobor@nig.ac.jp	Osada, Naoki/J-3790-2019	Osada, Naoki/0000-0003-0180-5372; Komiyama, Tomoyoshi/0000-0003-2138-0084	KAKENHI [21570241]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (21570241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, J MOL EVOL, V72, P253, DOI 10.1007/s00239-011-9432-9; Bachner-Melman R, 2007, AM J MED GENET B, V144B, P748, DOI 10.1002/ajmg.b.30505; Benjamin J, 1996, NAT GENET, V12, P81, DOI 10.1038/ng0196-81; Boehmler W, 2007, GENES BRAIN BEHAV, V6, P155, DOI 10.1111/j.1601-183X.2006.00243.x; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; Bunzow JR, 1991, CLONING GENE HUMAN D; Daniel, 2000, CHICKEN BOOK; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Dundes A, 1994, HIST JAPANESE CHICKE; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Fidler AE, 2007, P ROY SOC B-BIOL SCI, V274, P1685, DOI 10.1098/rspb.2007.0337; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Grady DL, 2013, J NEUROSCI, V33, P286, DOI 10.1523/JNEUROSCI.3515-12.2013; Hejjas K, 2007, MAMM GENOME, V18, P871, DOI 10.1007/s00335-007-9070-0; HUDSON RR, 1992, GENETICS, V132, P583; Inoue-Murayama M, 2002, J VET MED SCI, V64, P747, DOI 10.1292/jvms.64.747; Isaac E., 1970, GEOGRAPHY DOMESTICAT; Ito H, 2004, J VET MED SCI, V66, P815, DOI 10.1292/jvms.66.815; Iwama H, 2002, MOL BIOL EVOL, V19, P1891, DOI 10.1093/oxfordjournals.molbev.a004013; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kiyohara C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-89; Komiyama T, 2004, MOL PHYLOGENET EVOL, V33, P16, DOI 10.1016/j.ympev.2004.04.019; Komiyama T, 2004, GENE, V333, P91, DOI 10.1016/j.gene.2004.02.035; Komiyama T, 2003, GENE, V317, P195, DOI 10.1016/S0378-1119(03)00703-0; Korsten P, 2010, MOL ECOL, V19, P832, DOI 10.1111/j.1365-294X.2009.04518.x; Kubikova L, 2010, J COMP NEUROL, V518, P741, DOI 10.1002/cne.22255; Larsen SA, 2005, DNA CELL BIOL, V24, P795, DOI 10.1089/dna.2005.24.795; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu YP, 2006, BIOCHEM GENET, V44, P18, DOI 10.1007/s10528-006-9012-7; Momozawa Y, 2005, MAMM GENOME, V16, P538, DOI 10.1007/s00335-005-0021-3; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Niimi Y, 2001, J HERED, V92, P433, DOI 10.1093/jhered/92.5.433; Oana H, 1951, HIST JAPANECE CHICKE, p[25, 48, 74]; Ptacek R, 2011, MED SCI MONITOR, V17, pRA215, DOI 10.12659/MSM.881925; Robertson D, 2011, PRIMER AUTONOMIC NER, P63; Sauer Carl O., 1952, AGR ORIGINS DISPERSA; Sokoloff P, 1990, MOL CLONIGN CHARACTE; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sugiyama A, 2004, ZOOL SCI, V21, P941, DOI 10.2108/zsj.21.941; Sweitzer MM, 2013, SOC COGN AFFECT NEUR, V8, P499, DOI 10.1093/scan/nss020; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Yamaguchi K, 1998, CHICKEN, P80; Yamaguchi K, 1968, ENCY CHICKEN, P12	46	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e101778	10.1371/journal.pone.0101778	http://dx.doi.org/10.1371/journal.pone.0101778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078403	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800009
J	Pongor, LS; Vera, R; Ligeti, B				Pongor, Loerinc S.; Vera, Roberto; Ligeti, Balazs			Fast and Sensitive Alignment of Microbial Whole Genome Sequencing Reads to Large Sequence Datasets on a Desktop PC: Application to Metagenomic Datasets and Pathogen Identification	PLOS ONE			English	Article							GENERATION; DOMAIN; BLAST; ALGORITHM; DATABASE; EGGNOG; TOOL	Next generation sequencing (NGS) of metagenomic samples is becoming a standard approach to detect individual species or pathogenic strains of microorganisms. Computer programs used in the NGS community have to balance between speed and sensitivity and as a result, species or strain level identification is often inaccurate and low abundance pathogens can sometimes be missed. We have developed Taxoner, an open source, taxon assignment pipeline that includes a fast aligner (e.g. Bowtie2) and a comprehensive DNA sequence database. We tested the program on simulated datasets as well as experimental data from Illumina, IonTorrent, and Roche 454 sequencing platforms. We found that Taxoner performs as well as, and often better than BLAST, but requires two orders of magnitude less running time meaning that it can be run on desktop or laptop computers. Taxoner is slower than the approaches that use small marker databases but is more sensitive due the comprehensive reference database. In addition, it can be easily tuned to specific applications using small tailored databases. When applied to metagenomic datasets, Taxoner can provide a functional summary of the genes mapped and can provide strain level identification. Taxoner is written in C for Linux operating systems. The code and documentation are available for research applications at http://code.google.com/p/taxoner.	[Pongor, Loerinc S.; Vera, Roberto; Ligeti, Balazs] Pazmany Peter Catholic Univ, Fac Informat Technol, Budapest, Hungary; [Pongor, Loerinc S.] Semmelweis Univ, Dept Pediat 2, H-1085 Budapest, Hungary; [Vera, Roberto] Int Ctr Genet Engn & Biotechnol, Prot Struct & Bioinformat Grp, I-34012 Trieste, Italy	Semmelweis University; International Center for Genetic Engineering & Biotechnology (ICGEB)	Pongor, LS (corresponding author), Pazmany Peter Catholic Univ, Fac Informat Technol, Budapest, Hungary.	pongorlorinc@gmail.com	Pongor, Lorinc/AAA-9835-2021	Pongor, Lorinc/0000-0001-5917-4628; Vera Alvarez, Roberto/0000-0002-4108-5982	Hungarian Academy of Sciences; Hungarian National Innovation Office [TET 10-1-2011-0058, TAMOP-4.2.1.B-11/2/KMR-2011-0002, TAMOP-4.2.2/B-10/1-2010-0014]; ICGEB	Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian National Innovation Office; ICGEB(Department of Biotechnology (DBT) India)	LSP was partially funded by a Lendulet grant from the Hungarian Academy of Sciences to Dr. B. Gyorffy (Lendulet Cancer Biomarker Research Group, Centre for Natural Sciences, Hungarian Academy of Sciences). The research at Pazmany Peter Catholic University, Budapest was partially supported by Hungarian National Innovation Office grants TET 10-1-2011-0058, TAMOP-4.2.1.B-11/2/KMR-2011-0002, and TAMOP-4.2.2/B-10/1-2010-0014. Funding for open access charge and for the services of a scientific writer/editor was provided by ICGEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bayer R., 1972, ACTA INFORM, V1, P173, DOI [10.1007/bf00288683, DOI 10.1007/BF00288683, 10.1007/BF00288683]; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Dhir S, 2010, CURR PROTEIN PEPT SC, V11, P538, DOI 10.2174/138920310794109148; Droge J, 2012, BRIEF BIOINFORM, V13, P646, DOI 10.1093/bib/bbs031; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Koslicki D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091784; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lu SY, 1999, J BIOL CHEM, V274, P20473, DOI 10.1074/jbc.274.29.20473; Maravic G, 2003, J MOL BIOL, V332, P99, DOI 10.1016/S0022-2836(03)00863-5; Maravic G, 2003, NUCLEIC ACIDS RES, V31, P4941, DOI 10.1093/nar/gkg666; Moore CB, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S2-S6; Murvai J, 1999, BIOINFORMATICS, V15, P343, DOI 10.1093/bioinformatics/15.4.343; Neelakanta Girish, 2013, Microbiol Insights, V6, P37, DOI 10.4137/MBI.S10819; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Shiryev SA, 2007, BIOINFORMATICS, V23, P2949, DOI 10.1093/bioinformatics/btm479; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Teeling H, 2012, BRIEF BIOINFORM, V13, P728, DOI 10.1093/bib/bbs039; Vera R, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat051; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	32	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103441	10.1371/journal.pone.0103441	http://dx.doi.org/10.1371/journal.pone.0103441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077800	Green Published, gold, Green Submitted			2022-12-25	WOS:000339954800045
J	Berumen, ML; Braun, CD; Cochran, JEM; Skomal, GB; Thorrold, SR				Berumen, Michael L.; Braun, Camrin D.; Cochran, Jesse E. M.; Skomal, Gregory B.; Thorrold, Simon R.			Movement Patterns of Juvenile Whale Sharks Tagged at an Aggregation Site in the Red Sea	PLOS ONE			English	Article							RHINCODON-TYPUS; SATELLITE TRACKING; NINGALOO REEF; VERTICAL MOVEMENTS; GENETIC-STRUCTURE; DIVING BEHAVIOR; FISHERIES; ECOLOGY; BIOLOGY; OCEAN	Conservation efforts aimed at the whale shark, Rhincodon typus, remain limited by a lack of basic information on most aspects of its ecology, including global population structure, population sizes and movement patterns. Here we report on the movements of 47 Red Sea whale sharks fitted with three types of satellite transmitting tags from 2009-2011. Most of these sharks were tagged at a single aggregation site near Al-Lith, on the central coast of the Saudi Arabian Red Sea. Individuals encountered at this site were all juveniles based on size estimates ranging from 2.5-7 m total length with a sex ratio of approximately 1:1. All other known aggregation sites for juvenile whale sharks are dominated by males. Results from tagging efforts showed that most individuals remained in the southern Red Sea and that some sharks returned to the same location in subsequent years. Diving data were recorded by 37 tags, revealing frequent deep dives to at least 500 m and as deep as 1360 m. The unique temperature-depth profiles of the Red Sea confirmed that several whale sharks moved out of the Red Sea while tagged. The wide-ranging horizontal movements of these individuals highlight the need for multinational, cooperative efforts to conserve R. typus populations in the Red Sea and Indian Ocean.	[Berumen, Michael L.; Braun, Camrin D.; Cochran, Jesse E. M.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Braun, Camrin D.; Thorrold, Simon R.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Skomal, Gregory B.] Massachusetts Div Marine Fisheries, New Bedford, MA USA	King Abdullah University of Science & Technology; Woods Hole Oceanographic Institution; Massachusetts Division of Marine Fisheries	Berumen, ML (corresponding author), King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia.	michael.berumen@kaust.edu.sa	Thorrold, Simon R/B-7565-2012; Berumen, Michael/F-7745-2011	Thorrold, Simon R/0000-0002-1533-7517; Braun, Camrin/0000-0002-9317-9489; Berumen, Michael/0000-0003-2463-2742	KAUST [USA00002, KSA 00011]; United States National Science Foundation [OCE 0825148]	KAUST(King Abdullah University of Science & Technology); United States National Science Foundation(National Science Foundation (NSF))	Financial support was provided in part by KAUST baseline research funds (to MLB), KAUST award nos. USA00002 and KSA 00011 (to SRT), and the United States National Science Foundation (OCE 0825148 to SRT and GBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhilesh KV, 2013, ENVIRON BIOL FISH, V96, P713, DOI 10.1007/s10641-012-0063-9; Alava MNR, 2002, FISHERY TRADE WHALE, P132; Beckley LE, 1997, ENVIRON BIOL FISH, V50, P343, DOI 10.1023/A:1007355709632; Berumen ML, 2013, CORAL REEFS, V32, P737, DOI 10.1007/s00338-013-1055-8; Borrell A, 2011, ENVIRON BIOL FISH, V92, P559, DOI 10.1007/s10641-011-9879-y; Borrell A, 2011, ICES J MAR SCI, V68, P547, DOI 10.1093/icesjms/fsq170; Bouwmeester J, 2011, CORAL REEFS, V30, P1011, DOI 10.1007/s00338-011-0796-5; Braun CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088170; Brunnschweiler JM, 2009, J FISH BIOL, V74, P706, DOI 10.1111/j.1095-8649.2008.02155.x; Castro ALF, 2007, MOL ECOL, V16, P5183, DOI 10.1111/j.1365-294X.2007.03597.x; Chen VY, 2002, MANAGEMENT TRADE WHA; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1111/j.1095-8649.1997.tb01138.x; Couturier LIE, 2013, LIPIDS, V48, P1029, DOI 10.1007/s11745-013-3829-8; Dingle Hugh, 2001, P247; Eckert SA, 2002, J ZOOL, V257, P111, DOI 10.1017/S0952836902000705; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Fowler SL, 2000, MANAGEMENT TRADE WHA; Galuardi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037829; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Gifford A, 2007, FISH RES, V84, P17, DOI 10.1016/j.fishres.2006.11.011; Graham RT, 2006, J ROY SOC INTERFACE, V3, P109, DOI 10.1098/rsif.2005.0082; Gudger AEW, 1938, COPEIA, V1938, P170; Gunn JS, 1999, MAR BIOL, V135, P553, DOI 10.1007/s002270050656; Hanfee F., 2001, TRADE WHALE SHARK IT; Hearn A.R., 2013, ANIM BIOTELEMETRY, V1, P1, DOI [10.1186/2050-3385-1-11, DOI 10.1186/2050-3385-1-11]; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Hsu HH, 2012, J FISH BIOL, V80, P1595, DOI 10.1111/j.1095-8649.2012.03234.x; Hsu HH, 2007, FISH RES, V84, P25, DOI 10.1016/j.fishres.2006.11.030; Hueter RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071883; Joung SJ, 1996, ENVIRON BIOL FISH, V46, P219, DOI 10.1007/BF00004997; Lam CH, 2010, MAR ECOL PROG SER, V419, P71, DOI 10.3354/meps08862; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Li W, 2012, J FISH BIOL, V80, P1608, DOI 10.1111/j.1095-8649.2012.03250.x; Maguire J. J., 2006, STATE WORLD HIGHLY M; Motta PJ, 2010, ZOOLOGY, V113, P199, DOI 10.1016/j.zool.2009.12.001; Musyl MK, 2011, MAR ECOL PROG SER, V433, P1, DOI 10.3354/meps09202; Newman HE, 2002, EL BIOD CONS MAN P I, P230; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Norman B, 2004, REV CURRENT CONSERVA; Norman B. M., 1999, ASPECTS BIOL ECOTOUR; R Development Core Team, 2014, R LANG ENV STAT COMP; Raitsos DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064909; Ramirez-Macias D, 2012, J FISH BIOL, V80, P1401, DOI 10.1111/j.1095-8649.2012.03258.x; Robinson DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058255; Rohner CA, 2013, MAR ECOL PROG SER, V493, P219, DOI 10.3354/meps10500; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; Rowat D, 2011, MAR FRESHWATER RES, V62, P621, DOI 10.1071/MF10135; Schmidt JV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004988; Sequeira AMM, 2013, J FISH BIOL, V82, P367, DOI 10.1111/jfb.12017; Sleeman JC, 2010, J EXP MAR BIOL ECOL, V390, P84, DOI 10.1016/j.jembe.2010.05.009; Spaet JLY, 2012, J FISH BIOL, V80, P952, DOI 10.1111/j.1095-8649.2011.03178.x; Spaet JLY, 2011, ZOOL MIDDLE EAST, V52, P118, DOI 10.1080/09397140.2011.10638488; Stevens JD, 2007, FISH RES, V84, P4, DOI 10.1016/j.fishres.2006.11.008; Stewart BS, 2005, ENVIRON BIOL FISH, V74, P184, DOI 10.1007/s10641-005-2229-1; Taylor G., 1994, WHALE SHARKS GIANTS; Taylor JG, 1996, MAR FRESHWATER RES, V47, P637, DOI 10.1071/MF9960637; Thums M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0477; Vignaud TM, 2014, MOL ECOL, V23, P2590, DOI 10.1111/mec.12754; Wang YM, 2012, INTEGR ZOOL, V7, P94, DOI [10.1111/j.1749-4877.2012.00279.x, 10.1111/j.1749-4877.2011.00278.x]; Wilson SG, 2007, FISH OCEANOGR, V16, P547, DOI 10.1111/j.1365-2419.2007.00450.x; Wilson SG, 2006, MAR BIOL, V148, P1157, DOI 10.1007/s00227-005-0153-8	62	42	42	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103536	10.1371/journal.pone.0103536	http://dx.doi.org/10.1371/journal.pone.0103536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076407	Green Published, gold, Green Submitted			2022-12-25	WOS:000340028800060
J	Holt, D; Okusanya, O; Judy, R; Venegas, O; Jiang, J; DeJesus, E; Eruslanov, E; Quatromoni, J; Bhojnagarwala, P; Deshpande, C; Albelda, S; Nie, S; Singhal, S				Holt, David; Okusanya, Olugbenga; Judy, Ryan; Venegas, Ollin; Jiang, Jack; DeJesus, Elizabeth; Eruslanov, Evgeniy; Quatromoni, Jon; Bhojnagarwala, Pratik; Deshpande, Charuhas; Albelda, Steven; Nie, Shuming; Singhal, Sunil			Intraoperative Near-Infrared Imaging Can Distinguish Cancer from Normal Tissue but Not Inflammation	PLOS ONE			English	Article							ENHANCED PERMEABILITY; IN-VIVO; SURGERY; RETENTION; ONCOLOGY; NANOTECHNOLOGY; RESECTION; MODELS	Introduction: Defining tumor from non-tumor tissue is one of the major challenges of cancer surgery. Surgeons depend on visual and tactile clues to select which tissues should be removed from a patient. Recently, we and others have hypothesized near-infrared (NIR) imaging can be used during surgery to differentiate tumors from normal tissue. Methods: We enrolled 8 canines and 5 humans undergoing cancer surgery for NIR imaging. The patients were injected with indocyanine green (ICG), an FDA approved non-receptor specific NIR dye that accumulates in hyperpermeable tissues, 16-24 hours prior to surgery. During surgery, NIR imaging was used to discriminate the tumor from non-tumor tissue. Results: NIR imaging identified all tumors with a mean signal-to-background ratio of 6.7. Optical images were useful during surgery in discriminating normal tissue from cancer. In 3 canine cases and 1 human case, the tissue surrounding the tumor was inflamed due to obstruction of the vascular supply due to mass effect. In these instances, NIR imaging could not distinguish tumor tissue from tissue that was congested, edematous and did not contain cancer. Conclusions: This study shows that NIR imaging can identify tumors from normal tissues, provides excellent tissue contrast, and it facilitates the resection of tumors. However, in situations where there is significant peritumoral inflammation, NIR imaging with ICG is not helpful. This suggests that non-targeted NIR dyes that accumulate in hyperpermeable tissues will have significant limitations in the future, and receptor-specific NIR dyes may be necessary to overcome this problem.	[Holt, David] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA; [Okusanya, Olugbenga; Judy, Ryan; Venegas, Ollin; Jiang, Jack; DeJesus, Elizabeth; Eruslanov, Evgeniy; Quatromoni, Jon; Bhojnagarwala, Pratik; Singhal, Sunil] Univ Penn, Perelman Sch Med, Dept Surg, Philadelphia, PA 19104 USA; [Deshpande, Charuhas] Univ Penn, Perelman Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; [Albelda, Steven] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Nie, Shuming] Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA; [Nie, Shuming] Emory Univ, Dept Chem, Atlanta, GA 30322 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Emory University; Emory University	Holt, D (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA.	dholt@vet.upenn.edu	Okusanya, Olugbenga/AAH-9534-2020; Eruslanov, Evgeniy/AAS-1277-2020; Nie, Shuming/E-4843-2011	Multhoff, Gabriele/0000-0002-2616-3137; Okusanya, Olugbenga/0000-0002-4304-9651	American Surgical Association; National Institutes of Health Transformative [R01 CA163256-01]; NATIONAL CANCER INSTITUTE [R01CA163256] Funding Source: NIH RePORTER	American Surgical Association; National Institutes of Health Transformative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the American Surgical Association (SS) and National Institutes of Health Transformative R01 CA163256-01 (DH, MW, SN, SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliperti LA, 2011, ANN SURG ONCOL, V18, P603, DOI 10.1245/s10434-010-1442-0; BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/NNANO.2009.314, 10.1038/nnano.2009.314]; Crane LMA, 2011, MOL IMAGING BIOL, V13, P1043, DOI 10.1007/s11307-010-0425-7; de Oliveira RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074942; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Frangioni JV, 2006, NAT BIOTECHNOL, V24, P909, DOI 10.1038/nbt0806-909; Greish K, 2007, J DRUG TARGET, V15, P457, DOI 10.1080/10611860701539584; Greish K, 2010, METHODS MOL BIOL, V624, P25, DOI 10.1007/978-1-60761-609-2_3; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hutteman M, 2011, EJSO-EUR J SURG ONC, V37, P252, DOI 10.1016/j.ejso.2010.12.014; Ignatius SH, 2008, CHEST, V133, P662, DOI 10.1378/chest.07-1306; Jackaman C, 2003, J IMMUNOL, V171, P5051, DOI 10.4049/jimmunol.171.10.5051; Judy BF, 2012, NEOPLASIA, V14, P352, DOI 10.1593/neo.12208; Klimberg VS, 1999, SURG ONCOL, V8, P77, DOI 10.1016/S0960-7404(99)00031-6; Madajewski B, 2012, CLIN CANCER RES, V18, P5741, DOI 10.1158/1078-0432.CCR-12-1188; Mohs AM, 2010, ANAL CHEM, V82, P9058, DOI 10.1021/ac102058k; NCI, 2009, SURV EP RES SEER PRO; Nguyen QT, 2013, NAT REV CANCER, V13, P653, DOI 10.1038/nrc3566; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Okusanya OT, 2013, TECHNOL CANC RES TRE; Polom K, 2011, CANCER-AM CANCER SOC, V117, P4812, DOI 10.1002/cncr.26087; Prabhakar U, 2013, CANCER RES, V73, P2412, DOI 10.1158/0008-5472.CAN-12-4561; Predina JD, 2011, CANCER GENE THER, V18, P871, DOI 10.1038/cgt.2011.56; Predina JD, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-34; Predina JD, 2012, CANCER BIOL THER, V13, P745, DOI 10.4161/cbt.20557; Predina JD, 2012, AM J TRANSL RES, V4, P206; Schaafsma B. E, 2011, J SURG ONCOL; Schulz MD, 2010, ANN THORAC SURG, V89, pS2188, DOI 10.1016/j.athoracsur.2010.02.111; Sevick-Muraca EM, 2012, ANNU REV MED, V63, P217, DOI 10.1146/annurev-med-070910-083323; Singhal S, 2010, ANNU REV MED, V61, P359, DOI 10.1146/annurev.med.60.052907.094936; Terwisscha van Scheltinga AG, 2011, J NUCL MED; Vaidya A, 2001, UROLOGY, V57, P949, DOI 10.1016/S0090-4295(01)00904-9; van der Vorst JR, 2013, CANCER-AM CANCER SOC, V119, P3411, DOI 10.1002/cncr.28203; Veiseh M, 2007, CANCER RES, V67, P6882, DOI 10.1158/0008-5472.CAN-06-3948	35	81	83	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103342	10.1371/journal.pone.0103342	http://dx.doi.org/10.1371/journal.pone.0103342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072388	Green Submitted, gold, Green Published			2022-12-25	WOS:000341307600040
J	Verma, M; Ghangal, R; Sharma, R; Sinha, AK; Jain, M				Verma, Mohit; Ghangal, Rajesh; Sharma, Raghvendra; Sinha, Alok K.; Jain, Mukesh			Transcriptome Analysis of Catharanthus roseus for Gene Discovery and Expression Profiling	PLOS ONE			English	Article							INDOLE ALKALOID BIOSYNTHESIS; MADAGASCAR PERIWINKLE; SSR-MARKERS; SEQUENCING TECHNOLOGIES; PATHWAY; IDENTIFICATION; VINDOLINE; CHICKPEA; TRANSFERABILITY; RESOURCE	The medicinal plant, Catharanthus roseus, accumulates wide range of terpenoid indole alkaloids, which are well documented therapeutic agents. In this study, deep transcriptome sequencing of C. roseus was carried out to identify the pathways and enzymes (genes) involved in biosynthesis of these compounds. About 343 million reads were generated from different tissues (leaf, flower and root) of C. roseus using Illumina platform. Optimization of de novo assembly involving a two-step process resulted in a total of 59,220 unique transcripts with an average length of 1284 bp. Comprehensive functional annotation and gene ontology (GO) analysis revealed the representation of many genes involved in different biological processes and molecular functions. In total, 65% of C. roseus transcripts showed homology with sequences available in various public repositories, while remaining 35% unigenes may be considered as C. roseus specific. In silico analysis revealed presence of 11,620 genic simple sequence repeats (excluding mono-nucleotide repeats) and 1820 transcription factor encoding genes in C. roseus transcriptome. Expression analysis showed roots and leaves to be actively participating in bisindole alkaloid production with clear indication that enzymes involved in pathway of vindoline and vinblastine biosynthesis are restricted to aerial tissues. Such large-scale transcriptome study provides a rich source for understanding plant-specialized metabolism, and is expected to promote research towards production of plant-derived pharmaceuticals.	[Verma, Mohit; Ghangal, Rajesh; Sharma, Raghvendra; Sinha, Alok K.; Jain, Mukesh] Natl Inst Plant Genome Res, Funct & Appl Genom Lab, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Jain, M (corresponding author), Natl Inst Plant Genome Res, Funct & Appl Genom Lab, Aruna Asaf Ali Marg, New Delhi, India.	mjain@nipgr.ac.in	Sharma, Raghvendra/M-3400-2013; Verma, Mohit/ABB-7093-2020; Jain, Mukesh/AAP-5816-2021	Sharma, Raghvendra/0000-0002-7612-6932; Verma, Mohit/0000-0002-0438-5396; Jain, Mukesh/0000-0002-7622-1083	National Institute of Plant Genome Research	National Institute of Plant Genome Research	This work was financially supported by the core grant of the National Institute of Plant Genome Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052443; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blasko G., 1990, ALKALOIDS CHEM PHARM, V37, P1; Broun Pierre, 2006, Phytochemistry Reviews, V5, P27, DOI 10.1007/s11101-006-9000-x; Carels N, 2000, GENETICS, V154, P1819; De Geyter N, 2012, TRENDS PLANT SCI, V17, P349, DOI 10.1016/j.tplants.2012.03.001; DECAROLIS E, 1990, PLANT PHYSIOL, V94, P1323, DOI 10.1104/pp.94.3.1323; DELUCA V, 1986, J PLANT PHYSIOL, V125, P147, DOI 10.1016/S0176-1617(86)80252-8; Dwivedi Samresh, 2001, Journal of Medicinal and Aromatic Plant Sciences, V23, P104; El-Domyati FM, 2012, LIFE SCI J, V9, P5949; El-Sayed Magdi, 2007, Phytochemistry Reviews, V6, P277, DOI 10.1007/s11101-006-9047-8; Facchini PJ, 2008, PLANT J, V54, P763, DOI 10.1111/j.1365-313X.2008.03438.x; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Geu-Flores F, 2012, NATURE, V492, P138, DOI 10.1038/nature11692; Ghangal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072516; Giddings LA, 2011, J BIOL CHEM, V286, P16751, DOI 10.1074/jbc.M111.225383; Goklany S, 2009, BIOTECHNOL PROGR, V25, P1289, DOI 10.1002/btpr.204; Gongora-Castillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052506; Guimaraes G, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls002; Jaggi M, 2011, APPL MICROBIOL BIOT, V90, P1005, DOI 10.1007/s00253-011-3131-8; Jain M, 2012, BRIEF FUNCT GENOMICS, V11, P63, DOI 10.1093/bfgp/elr038; Jain M, 2011, CURR SCI INDIA, V101, P1435; Jhanwar S, 2012, PLANT BIOTECHNOL J, V10, P690, DOI 10.1111/j.1467-7652.2012.00712.x; Kato N, 2007, PLANT CELL PHYSIOL, V48, P8, DOI 10.1093/pcp/pcl041; Kim SW, 2007, BIOTECHNOL BIOPROC E, V12, P646, DOI 10.1007/BF02931081; Kumar S, 2007, FEBS J, V274, P1290, DOI 10.1111/j.1742-4658.2007.05677.x; Kumar S, 2014, PLANT CELL REP, V33, P905, DOI 10.1007/s00299-014-1569-8; Lai ZX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-561; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Magnotta M, 2006, PHYTOCHEMISTRY, V67, P1758, DOI 10.1016/j.phytochem.2006.05.018; Mishra RK, 2011, PLANT OMICS, V4, P154; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; NAARANLAHTI T, 1991, PHYTOCHEMISTRY, V30, P1451, DOI 10.1016/0031-9422(91)84184-T; Nammi Srinivas, 2003, BMC Complement Altern Med, V3, P4, DOI 10.1186/1472-6882-3-4; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Patra B, 2013, BBA-GENE REGUL MECH, V1829, P1236, DOI 10.1016/j.bbagrm.2013.09.006; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Raina SK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-134; Rischer H, 2006, P NATL ACAD SCI USA, V103, P5614, DOI 10.1073/pnas.0601027103; Rohini G, 2014, DNA RES, V21, P69, DOI 10.1093/dnares/dst042; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shaw RK, 2009, CROP BREED APPL BIOT, V9, P52, DOI 10.12702/1984-7033.v09n01a08; Shokeen B, 2005, MOL ECOL NOTES, V5, P818, DOI 10.1111/j.1471-8286.2005.01074.x; Shokeen B, 2007, PLANT SCI, V172, P441, DOI 10.1016/j.plantsci.2006.10.010; Shukla AK, 2006, J EXP BOT, V57, P3921, DOI 10.1093/jxb/erl146; Simkin AJ, 2013, PHYTOCHEMISTRY, V85, P36, DOI 10.1016/j.phytochem.2012.09.014; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Singh VK, 2013, PLANT BIOTECHNOL J, V11, P691, DOI 10.1111/pbi.12059; St-Pierre B, 1999, PLANT CELL, V11, P887, DOI 10.1105/tpc.11.5.887; Suttipanta N, 2011, PLANT PHYSIOL, V157, P2081, DOI 10.1104/pp.111.181834; Svoboda G.H., 1975, CATHARANTHUS ALKALOI, P45; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; van der Heijden R, 2004, CURR MED CHEM, V11, P607; Van Moerkercke A, 2013, PLANT CELL PHYSIOL, V54, P673, DOI 10.1093/pcp/pct039; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066539; Wei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084105; Yang CQ, 2012, J INTEGR PLANT BIOL, V54, P703, DOI 10.1111/j.1744-7909.2012.01161.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang HT, 2011, PLANT J, V67, P61, DOI 10.1111/j.1365-313X.2011.04575.x	63	34	37	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103583	10.1371/journal.pone.0103583	http://dx.doi.org/10.1371/journal.pone.0103583			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072156	Green Submitted, Green Published, gold			2022-12-25	WOS:000341307600067
J	Viboud, C; Charu, V; Olson, D; Ballesteros, S; Gog, J; Khan, F; Grenfell, B; Simonsen, L				Viboud, Cecile; Charu, Vivek; Olson, Donald; Ballesteros, Sebastien; Gog, Julia; Khan, Farid; Grenfell, Bryan; Simonsen, Lone			Demonstrating the Use of High-Volume Electronic Medical Claims Data to Monitor Local and Regional Influenza Activity in the US	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; UNITED-STATES; PANDEMIC INFLUENZA; CHILDREN; MORTALITY; SURVEILLANCE; PNEUMONIA; EPIDEMICS; COVERAGE; ILLNESS	Introduction: Fine-grained influenza surveillance data are lacking in the US, hampering our ability to monitor disease spread at a local scale. Here we evaluate the performances of high-volume electronic medical claims data to assess local and regional influenza activity. Material and Methods: We used electronic medical claims data compiled by IMS Health in 480 US locations to create weekly regional influenza-like-illness (ILI) time series during 2003-2010. IMS Health captured 62% of US outpatient visits in 2009. We studied the performances of IMS-ILI indicators against reference influenza surveillance datasets, including CDC-ILI outpatient and laboratory-confirmed influenza data. We estimated correlation in weekly incidences, peak timing and seasonal intensity across datasets, stratified by 10 regions and four age groups (< 5, 5-29, 30-59, and 60+ years). To test IMS-Health performances at the city level, we compared IMS-ILI indicators to syndromic surveillance data for New York City. We also used control data on laboratory-confirmed Respiratory Syncytial Virus (RSV) activity to test the specificity of IMS-ILI for influenza surveillance. Results: Regional IMS-ILI indicators were highly synchronous with CDC's reference influenza surveillance data (Pearson correlation coefficients rho >= 0.89; range across regions, 0.80-0.97, P < 0.001). Seasonal intensity estimates were weakly correlated across datasets in all age data (rho <= 0.52), moderately correlated among adults (rho >= 0.64) and uncorrelated among school-age children. IMS-ILI indicators were more correlated with reference influenza data than control RSV indicators (rho = 0.93 with influenza v. rho = 0.33 with RSV, P < 0.05). City-level IMS-ILI indicators were highly consistent with reference syndromic data (rho >= 0.86). Conclusion: Medical claims-based ILI indicators accurately capture weekly fluctuations in influenza activity in all US regions during inter-pandemic and pandemic seasons, and can be broken down by age groups and fine geographical areas. Medical claims data provide more reliable and fine-grained indicators of influenza activity than other high-volume electronic algorithms and should be used to augment existing influenza surveillance systems.	[Viboud, Cecile; Charu, Vivek; Gog, Julia; Grenfell, Bryan; Simonsen, Lone] Fogarty Int Ctr, NIH, Bethesda, MD 20892 USA; [Charu, Vivek] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Olson, Donald] New York City Dept Hlth & Mental Hyg, New York, NY USA; [Ballesteros, Sebastien; Grenfell, Bryan] Princeton Univ, Dept Evolut Biol, Princeton, NJ 08544 USA; [Gog, Julia] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 9EW, England; [Khan, Farid] IMS Hlth, Plymouth, PA USA; [Simonsen, Lone] George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Johns Hopkins University; New York City Department of Health & Mental Hygiene; Princeton University; University of Cambridge; George Washington University	Viboud, C (corresponding author), Fogarty Int Ctr, NIH, Bethesda, MD 20892 USA.	viboudc@mail.nih.gov	Simonsen, Lone/K-4531-2014	Simonsen, Lone/0000-0003-1535-8526; Gog, Julia/0000-0003-1240-7214; Olson, Donald/0000-0002-5980-229X	Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security (to JG, LS, BG), and the in-house influenza program of the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Benoit SR, 2013, EPIDEMIOL INFECT, V141, P805, DOI 10.1017/S0950268812001549; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Brammer L, 2009, INFLUENZA OTHER RESP, V3, P51, DOI 10.1111/j.1750-2659.2009.00077.x; Butler D, 2013, NATURE, V494, P155, DOI 10.1038/494155a; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Cortese MM, 2010, PEDIATR INFECT DIS J, V29, P489, DOI 10.1097/INF.0b013e3181d95b53; COSTAGLIOLA D, 1991, AM J PUBLIC HEALTH, V81, P97, DOI 10.2105/AJPH.81.1.97; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fleming DM, 2005, J EPIDEMIOL COMMUN H, V59, P586, DOI 10.1136/jech.2004.026450; FLEMING DM, 1993, LANCET, V342, P1507, DOI 10.1016/S0140-6736(05)80082-0; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Gog J, 2013, PLOS COMPUT IN PRESS; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Haynes AK, 2013, MMWR-MORBID MORTAL W, V62, P141; Kalies H, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-82; Light M, 2008, PEDIATR INFECT DIS J, V27, P512, DOI 10.1097/INF.0b013e318168daf1; Nelson MI, 2011, J VIROL, V85, P828, DOI 10.1128/JVI.01762-10; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Olson Donald R, 2011, PLoS Curr, V3, pRRN1251, DOI 10.1371/currents.RRN1251; Ortiz JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018687; Plagianos MG, 2011, EMERG INFECT DIS, V17, P1724, DOI 10.3201/eid1709.101357; Rha B, 2013, EMERG INFECT DIS, V19, P1214, DOI 10.3201/eid1908.130483; Ritger K. A., 2009, Morbidity and Mortality Weekly Report, V58, P913; Schuck-Paim C, 2013, VACCINE, V31, P5983, DOI 10.1016/j.vaccine.2013.10.038; SERFLING RE, 1967, AM J EPIDEMIOL, V86, P433, DOI 10.1093/oxfordjournals.aje.a120753; Shaman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3837; Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109; United States Census Bureau, POP EST; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	36	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e102429	10.1371/journal.pone.0102429	http://dx.doi.org/10.1371/journal.pone.0102429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072598	Green Submitted, gold, Green Published			2022-12-25	WOS:000341307600012
J	Li, AH; Wang, DD; Yu, BZ; Yu, XM; Li, WQ				Li, Aihua; Wang, Dandan; Yu, Buzhu; Yu, Xiaomei; Li, Weiqi			Maintenance or Collapse: Responses of Extraplastidic Membrane Lipid Composition to Desiccation in the Resurrection Plant Paraisometrum mileense	PLOS ONE			English	Article							PHOSPHOLIPASE-D; HABERLEA-RHODOPENSIS; SPOROBOLUS-STAPFIANUS; XEROPHYTA-VISCOSA; CRATEROSTIGMA-PLANTAGINEUM; PHOSPHATIDIC-ACID; WATER-DEFICIT; MYROTHAMNUS-FLABELLIFOLIA; PHOTOSYNTHETIC ACTIVITY; PROTECTION MECHANISMS	Resurrection plants usually grow in specific or extreme habitats and have the capacity to survive almost complete water loss. We characterized the physiological and biochemical responses of Paraisometrum mileense to extreme desiccation and found that it is a resurrection plant. We profiled the changes in lipid molecular species during dehydration and rehydration in P. mileense, and compared these with corresponding changes in the desiccation-sensitive plant Arabidopsis thaliana. One day of desiccation was lethal for A. thaliana but not for P. mileense. After desiccation and subsequent rewatering, A. thaliana showed dramatic lipid degradation accompanied by large increases in levels of phosphatidic acid (PA) and diacylglycerol (DAG). In contrast, desiccation and rewatering of P. mileense significantly decreased the level of monogalactosyldiacylglycerol and increased the unsaturation of membrane lipids, without changing the level of extraplastidic lipids. Lethal desiccation in P. mileense caused massive lipid degradation, whereas the PA content remained at a low level similar to that of fresh leaves. Neither damage nor repair processes, nor increases in PA, occurred during non-lethal desiccation in P. mileense. The activity of phospholipase D, the main source of PA, was much lower in P. mileense than in A. thaliana under control conditions, or after either dehydration or rehydration. It was demonstrated that low rates of phospholipase D-mediated PA formation in P. mileense might limit its ability to degrade lipids to PA, thereby maintaining membrane integrity following desiccation.	[Li, Weiqi] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China; [Li, Aihua; Wang, Dandan; Yu, Buzhu; Yu, Xiaomei; Li, Weiqi] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming, Peoples R China; [Li, Aihua] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, WQ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China.	weiqili@mail.kib.ac.cn			National Natural Science Foundation of China [31070262]; Kunming Institute of Botany [KSCX2-EW-J-24]; Germplasm Bank of Wild Species; CAS Innovation Program of Kunming Institute [540806321211]; 100-Talents Program of CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Kunming Institute of Botany; Germplasm Bank of Wild Species; CAS Innovation Program of Kunming Institute; 100-Talents Program of CAS(Chinese Academy of Sciences)	This research was supported by grants from the National Natural Science Foundation of China (31070262), Kunming Institute of Botany (KSCX2-EW-J-24), the Germplasm Bank of Wild Species, the CAS Innovation Program of Kunming Institute (540806321211), as well as the 100-Talents Program of CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla KO, 2010, PLANT GROWTH REGUL, V62, P279, DOI 10.1007/s10725-010-9497-2; Apostolova E, 2012, PLANT PHYSIOL BIOCH, V55, P85, DOI 10.1016/j.plaphy.2012.03.015; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Beck JG, 2007, FASEB J, V21, P1714, DOI 10.1096/fj.06-7809com; Bewley J. D., 1982, Physiological plant ecology. II. Water relations and carbon assimilation., P325; BIANCHI G, 1993, PHYSIOL PLANTARUM, V87, P223, DOI 10.1111/j.1399-3054.1993.tb00146.x; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Committee AoSYACC, 2006, ANN SHIL YIZ AUT COU; Dalla Vecchia F, 1998, PLANT GROWTH REGUL, V24, P219; Denich TJ, 2003, J MICROBIOL METH, V52, P149, DOI 10.1016/S0167-7012(02)00155-0; DHINDSA RS, 1981, J EXP BOT, V32, P79, DOI 10.1093/jxb/32.1.79; Evelin RP, 2012, ACTA PHYSIOL PLANT, V34, P947; Farrant JM, 2003, PLANT CELL ENVIRON, V26, P1275, DOI 10.1046/j.0016-8025.2003.01052.x; Farrant JM, 2000, PLANT ECOL, V151, P29, DOI 10.1023/A:1026534305831; Farrant JM, 2007, PLANT STRESS, V1, P72, DOI [DOI 10.1002/9780470376881.CH3, DOI 10.1002/9780470376881.ch3]; Frank W, 2000, PLANT CELL, V12, P111, DOI 10.1105/tpc.12.1.111; GAFF DF, 1976, AUST J BOT, V24, P209, DOI 10.1071/BT9760209; GAFF DF, 1979, BIOL PLANTARUM, V21, P92, DOI 10.1007/BF02909453; Gaff DF, 1989, STRUCTURAL FUNCTIONA, P308; Gasulla F, 2013, PLANT J, V75, P726, DOI 10.1111/tpj.12241; Gechev TS, 2013, CELL MOL LIFE SCI, V70, P689, DOI 10.1007/s00018-012-1155-6; Gechev TS, 2012, CELL MOL LIFE SCI, V69, P3175, DOI 10.1007/s00018-012-1088-0; Georgieva K, 2005, PHOTOSYNTH RES, V85, P191, DOI 10.1007/s11120-005-2440-0; Georgieva K, 2007, PLANTA, V225, P955, DOI 10.1007/s00425-006-0396-8; Gigon A, 2004, ANN BOT-LONDON, V94, P345, DOI 10.1093/aob/mch150; Hong YY, 2008, PLANT CELL, V20, P803, DOI 10.1105/tpc.107.056390; Hong YY, 2009, PLANT J, V58, P376, DOI 10.1111/j.1365-313X.2009.03788.x; Ingle RA, 2007, PLANT CELL ENVIRON, V30, P435, DOI 10.1111/j.1365-3040.2006.01631.x; Ingle RA, 2008, PLANT CELL ENVIRON, V31, P1813, DOI 10.1111/j.1365-3040.2008.01887.x; Ingram J, 1997, PLANT PHYSIOL, V115, P113, DOI 10.1104/pp.115.1.113; Jia YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065687; Jiang GQ, 2007, PLANTA, V225, P1405, DOI 10.1007/s00425-006-0449-z; Jovanovic Z, 2011, PLANT GROWTH REGUL, V64, P231, DOI 10.1007/s10725-011-9563-4; Katagiri T, 2001, PLANT J, V26, P595, DOI 10.1046/j.1365-313x.2001.01060.x; Kotlova ER, 2005, RUSS J PLANT PHYSL+, V52, P35, DOI 10.1007/s11183-005-0006-9; Li W, 2008, J BIOL CHEM, V283, P461, DOI 10.1074/jbc.M706692200; LILJENBERG CS, 1992, PROG LIPID RES, V31, P335, DOI 10.1016/0163-7827(92)90012-8; Lynch DV, 2004, NEW PHYTOL, V161, P677, DOI 10.1111/j.1469-8137.2004.00992.x; Melvin JO, 2011, PLANT CELL, V23, P1231; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Moore JP, 2007, ANN BOT-LONDON, V99, P211, DOI 10.1093/aob/mcl269; Muller J, 1997, PHYSIOL PLANTARUM, V100, P153, DOI 10.1111/j.1399-3054.1997.tb03466.x; NAVARIIZZO F, 1995, PHYSIOL PLANTARUM, V94, P135, DOI 10.1111/j.1399-3054.1995.tb00794.x; Neale AD, 2000, PLANT CELL ENVIRON, V23, P265, DOI 10.1046/j.1365-3040.2000.00548.x; Oliver M., 1996, UNDERSTANDING DISABI; Oliver MJ, 2011, PHYTOCHEMISTRY, V72, P1273, DOI 10.1016/j.phytochem.2010.10.020; Pandey V, 2010, J PLANT PHYSIOL, V167, P1351, DOI 10.1016/j.jplph.2010.05.001; Pappan K, 1997, J BIOL CHEM, V272, P7048, DOI 10.1074/jbc.272.11.7048; Peters S, 2007, J EXP BOT, V58, P1947, DOI 10.1093/jxb/erm056; Porembski S, 2011, ECOL STUD-ANAL SYNTH, V215, P139, DOI 10.1007/978-3-642-19106-0_8; Proctor Michael C. F., 2002, P207, DOI 10.1079/9780851995342.0207; Quartacci MF, 1997, J EXP BOT, V48, P1269, DOI 10.1093/jxb/48.6.1269; Quartacci MF, 2002, J EXP BOT, V53, P2159, DOI 10.1093/jxb/erf076; Rascio N, 2005, CRIT REV PLANT SCI, V24, P209, DOI 10.1080/07352680591008583; Rawyler A, 1999, PLANT PHYSIOL, V120, P293, DOI 10.1104/pp.120.1.293; Shen A, 2007, S AFR J BOT, V73, P494, DOI 10.1016/j.sajb.2007.04.031; Sherwin HW, 1998, PLANT GROWTH REGUL, V24, P203, DOI 10.1023/A:1005801610891; Shui Y, 2007, SCIENCE, V1, P37; STEVANOVIC B, 1992, CAN J BOT, V70, P107, DOI 10.1139/b92-015; Strasser RJ, 2010, BBA-BIOENERGETICS, V1797, P1313, DOI 10.1016/j.bbabio.2010.03.008; Toumi I, 2008, BIOL PLANTARUM, V52, P161, DOI 10.1007/s10535-008-0035-2; Tuba Z, 1998, PLANT GROWTH REGUL, V24, P211, DOI 10.1023/A:1005951908229; TYMMS MJ, 1979, J EXP BOT, V30, P165, DOI 10.1093/jxb/30.1.165; Vander Willigen C, 2003, FUNCT PLANT BIOL, V30, P281, DOI 10.1071/FP02221; VERKLEIJ AJ, 1982, BIOCHIM BIOPHYS ACTA, V684, P255, DOI 10.1016/0005-2736(82)90014-1; Vicre M, 2004, PLANT CELL ENVIRON, V27, P1329, DOI 10.1111/j.1365-3040.2004.01212.x; Wang L, 2009, PLANT BIOLOGY, V11, P837, DOI 10.1111/j.1438-8677.2008.00187.x; Wang RH, 2008, PROG NAT SCI, V18, P1111; WANG XM, 1993, ARCH BIOCHEM BIOPHYS, V306, P486, DOI 10.1006/abbi.1993.1541; Wang XM, 2002, CURR OPIN PLANT BIOL, V5, P408, DOI 10.1016/S1369-5266(02)00283-2; Wang Z, 2009, PLANTA, V230, P1155, DOI 10.1007/s00425-009-1014-3; Weitzman AL, 1997, NOVON, P423; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Welti R, 2007, FRONT BIOSCI-LANDMRK, V12, P2494, DOI 10.2741/2250; Zhang X.H., 2012, BASED COMPLEMENT ALT, P1; Zhou ZG, 2011, LIPIDS, V46, P879, DOI 10.1007/s11745-011-3575-8	77	20	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103430	10.1371/journal.pone.0103430	http://dx.doi.org/10.1371/journal.pone.0103430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068901	gold, Green Published, Green Submitted			2022-12-25	WOS:000339993700070
J	Plana-Ripoll, O; Olsen, J; Andersen, PK; Gomez, G; Cnattingius, S; Li, J				Plana-Ripoll, Oleguer; Olsen, Jorn; Andersen, Per Kragh; Gomez, Guadalupe; Cnattingius, Sven; Li, Jiong			Prenatal Exposure to Maternal Bereavement and Childbirths in the Offspring: A Population-Based Cohort Study	PLOS ONE			English	Article							STRESS REDUCES FERTILITY; BEHAVIOR; PARENTS; DEATH; GLUCOCORTICOIDS; NATIONWIDE; MORTALITY; OUTCOMES; TRENDS; CANCER	Introduction: The decline in birth rates is a concern in public health. Fertility is partly determined before birth by the intrauterine environment and prenatal exposure to maternal stress could, through hormonal disturbance, play a role. There has been such evidence from animal studies but not from humans. We aimed to examine the association between prenatal stress due to maternal bereavement following the death of a relative and childbirths in the offspring. Materials and Methods: This population-based cohort study included all subjects born in Denmark after 1968 and in Sweden after 1973 and follow-up started at the age of 12 years. Subjects were categorized as exposed if their mothers lost a close relative during pregnancy or the year before and unexposed otherwise. The main outcomes were age at first child and age-specific mean numbers of childbirths. Data was analyzed using Cox Proportional Hazards models stratified by gender and adjusted for several covariates. Subanalyses were performed considering the type of relative deceased and timing of bereavement. Results: A total of 4,121,596 subjects were followed-up until up to 41 years of age. Of these subjects, 93,635 (2.3%) were exposed and 981,989 (23.8%) had at least one child during follow-up time. Compared to unexposed, the hazard ratio (HR) [95% confidence interval] of having at least one child for exposed males and females were 0.98 [0.96-1.01] and 1.01 [0.98-1.03], respectively. We found a slightly reduced probability of having children in females born to mothers who lost a parent with HR = 0.97 [0.94-0.99] and increased probability in females born to mothers who lost another child (HR = 1.09 [1.04-1.14]), the spouse (HR = 1.29 [1.12-1.48]) or a sibling (HR = 1.13 [1.01-1.27]). Conclusions: Our results suggested no overall association between prenatal exposure to maternal stress and having a child in early adulthood but a longer time of follow-up is necessary in order to reach a firmer conclusion.	[Plana-Ripoll, Oleguer; Olsen, Jorn; Li, Jiong] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Andersen, Per Kragh] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark; [Gomez, Guadalupe] Univ Politecn Cataluna, Dept Estadist & Invest Operat, Barcelona, Spain; [Cnattingius, Sven] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden	Aarhus University; University of California System; University of California Los Angeles; University of Copenhagen; Universitat Politecnica de Catalunya; Karolinska Institutet	Plana-Ripoll, O (corresponding author), Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark.	opr@ph.au.dk	Gomez, Guadalupe/K-5352-2014; Gomez, Guadalupe/AFS-1974-2022; li, jiong/L-6534-2014; Olsen, Jørn/F-8801-2015; Plana-Ripoll, Oleguer/E-1448-2015	Gomez, Guadalupe/0000-0003-4252-4884; Gomez, Guadalupe/0000-0003-4252-4884; li, jiong/0000-0002-1716-8067; Olsen, Jørn/0000-0001-7462-5140; Plana-Ripoll, Oleguer/0000-0002-6470-7465; li, jiong/0000-0003-1125-026X	European Research Council [ERC-2010-STG-260242-PROGEURO]; Swedish Council for Working Life and Social Research [2010-0092]; Aarhus University	European Research Council(European Research Council (ERC)European Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Aarhus University	The study was supported by the European Research Council (ERC-2010-STG-260242-PROGEURO) and the Swedish Council for Working Life and Social Research (2010-0092). Oleguer Plana-Ripoll is partly supported by a PhD fellowship from Aarhus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115092, 10.1371/journal.pone.0085013]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bermejo JL, 2007, CANCER EPIDEM BIOMAR, V16, P2204, DOI 10.1158/1055-9965.EPI-07-0638; Butler D, 2004, NATURE, V432, P38, DOI 10.1038/432038a; Cardenas SMC, 2013, INT J MORPHOL, V31, P754, DOI 10.4067/S0717-95022013000200065; Class QA, 2013, PSYCHOL SCI, V24, P1309, DOI 10.1177/0956797612468010; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; CRUMP CJ, 1989, HORM BEHAV, V23, P333, DOI 10.1016/0018-506X(89)90047-0; Dunn E, 2010, J PHYSIOL-LONDON, V588, P887, DOI 10.1113/jphysiol.2009.182139; Ekbom A, 2011, METHODS MOL BIOL, V675, P215, DOI 10.1007/978-1-59745-423-0_10; Ellis BJ, 2003, CHILD DEV, V74, P801, DOI 10.1111/1467-8624.00569; Entringer S, 2009, HORM BEHAV, V55, P292, DOI 10.1016/j.yhbeh.2008.11.006; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fowden AL, 2006, HORM RES, V65, P50, DOI 10.1159/000091506; Gerardin DCC, 2005, PHYSIOL BEHAV, V84, P97, DOI 10.1016/j.physbeh.2004.10.014; Gitau R, 1998, LANCET, V352, P707, DOI 10.1016/S0140-6736(05)60824-0; Goodkin K, 2001, HDB BEREAVEMENT RES, P671; Guibert F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2368; HERRENKOHL LR, 1979, SCIENCE, V206, P1097, DOI 10.1126/science.573923; HERRENKOHL LR, 1986, ANN NY ACAD SCI, V474, P120, DOI 10.1111/j.1749-6632.1986.tb28003.x; Holmes MC, 2006, J NEUROSCI, V26, P3840, DOI 10.1523/JNEUROSCI.4464-05.2006; Ingstrup KG, 2013, HUM REPROD, V28, P1092, DOI 10.1093/humrep/des434; Kapoor A, 2006, J PHYSIOL-LONDON, V572, P31, DOI 10.1113/jphysiol.2006.105254; Knudsen LB, 1998, DAN MED BULL, V45, P320; Lassen TH, 2012, HUM REPROD, V27, P2815, DOI 10.1093/humrep/des207; Li J, 2005, NEW ENGL J MED, V352, P1190, DOI 10.1056/NEJMoa033160; Li J, 2002, CANCER, V95, P2237, DOI 10.1002/cncr.10943; Li J, 2003, LANCET, V361, P363, DOI 10.1016/S0140-6736(03)12387-2; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043508; Li J, 2011, INT J EPIDEMIOL, V40, P1161, DOI 10.1093/ije/dyq127; Li JO, 2010, EUR CHILD ADOLES PSY, V19, P747, DOI 10.1007/s00787-010-0113-9; Li JO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011896; Lin DY, 2000, J ROY STAT SOC B, V62, P711, DOI 10.1111/1467-9868.00259; Lutz W, 2006, INT J ANDROL, V29, P25, DOI 10.1111/j.1365-2605.2005.00639.x; National Board of Health and Welfare Centre for Epidemiology, 2003, SWED MED BIRTH REG S; O'Connor TG, 2005, BIOL PSYCHIAT, V58, P211, DOI 10.1016/j.biopsych.2005.03.032; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Rubin DB, 2004, MULTIPLE IMPUTATION; Seckl JR, 2001, MOL CELL ENDOCRINOL, V185, P61, DOI 10.1016/S0303-7207(01)00633-5; Shamolina TS, 2010, NEUROSCIENCE BEHAV P, V40, P1017, DOI [10.1007/s11055-010-9362-9, DOI 10.1007/S11055-010-9362-9]; Sheppard P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089539; Sheppard P, 2012, BIOL LETTERS, V8, P237, DOI 10.1098/rsbl.2011.0747; SKODOL AE, 1989, AM J PSYCHIAT, V146, P61; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Stroebe MS, 1993, HDB BEREAVEMENT; Wadhwa PD, 2005, PSYCHONEUROENDOCRINO, V30, P724, DOI 10.1016/j.psyneuen.2005.02.004; WARD IL, 1972, SCIENCE, V175, P82, DOI 10.1126/science.175.4017.82; Whirledge S, 2010, MINERVA ENDOCRINOL, V35, P109	50	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103353	10.1371/journal.pone.0103353	http://dx.doi.org/10.1371/journal.pone.0103353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RZ	25068458	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700064
J	Kone, M; Sun, G; Ibberson, M; Martinez-Sanchez, A; Sayers, S; Nguyen-Tu, MS; Kantor, C; Swisa, A; Dor, Y; Gorman, T; Ferrer, J; Thorens, B; Reimann, F; Gribble, F; McGinty, JA; Chen, LL; French, PM; Birzele, F; Hildebrandt, T; Uphues, I; Rutter, GA				Kone, Marina; Sun, Gao; Ibberson, Mark; Martinez-Sanchez, Aida; Sayers, Sophie; Marie-Sophie Nguyen-Tu; Kantor, Chase; Swisa, Avital; Dor, Yuval; Gorman, Tracy; Ferrer, Jorge; Thorens, Bernard; Reimann, Frank; Gribble, Fiona; McGinty, James A.; Chen, Lingling; French, Paul M.; Birzele, Fabian; Hildebrandt, Tobias; Uphues, Ingo; Rutter, Guy A.			LKB1 and AMPK differentially regulate pancreatic beta-cell identity	FASEB JOURNAL			English	Article						islet; diabetes; insulin secretion; RNASeq	PROTEIN-KINASE; INSULIN-SECRETION; GLUCOSE-TOLERANCE; EXPRESSION; FAMILY; MASS; TRANSCRIPTOMES; MUTATIONS; BIOLOGY; SUBUNIT	Fully differentiated pancreatic cells are essential for normal glucose homeostasis in mammals. Dedifferentiation of these cells has been suggested to occur in type 2 diabetes, impairing insulin production. Since chronic fuel excess (glucotoxicity) is implicated in this process, we sought here to identify the potential roles in -cell identity of the tumor suppressor liver kinase B1 (LKB1/STK11) and the downstream fuel-sensitive kinase, AMP-activated protein kinase (AMPK). Highly -cell-restricted deletion of each kinase in mice, using an Ins1-controlled Cre, was therefore followed by physiological, morphometric, and massive parallel sequencing analysis. Loss of LKB1 strikingly (2.0-12-fold, E<0.01) increased the expression of subsets of hepatic (Alb, Iyd, Elovl2) and neuronal (Nptx2, Dlgap2, Cartpt, Pdyn) genes, enhancing glutamate signaling. These changes were partially recapitulated by the loss of AMPK, which also up-regulated -cell disallowed genes (Slc16a1, Ldha, Mgst1, Pdgfra) 1.8- to 3.4-fold (E<0.01). Correspondingly, targeted promoters were enriched for neuronal (Zfp206; P=1.3x10(-33)) and hypoxia-regulated (HIF1; P=2.5x10(-16)) transcription factors. In summary, LKB1 and AMPK, through only partly overlapping mechanisms, maintain -cell identity by suppressing alternate pathways leading to neuronal, hepatic, and other characteristics. Selective targeting of these enzymes may provide a new approach to maintaining -cell function in some forms of diabetes.Kone, M., Pullen, T. J., Sun, G., Ibberson, M., Martinez-Sanchez, A., Sayers, S., Nguyen-Tu, M.-S., Kantor, C., Swisa, A., Dor, Y., Gorman, T., Ferrer, J., Thorens, B., Reimann, F., Gribble, F., McGinty, J. A., Chen, L., French, P. M., Birzele, F., Hildebrandt, T., Uphues, I., Rutter, G. A. LKB1 and AMPK differentially regulate pancreatic -cell identity.	[Kone, Marina; Sun, Gao; Ibberson, Mark; Sayers, Sophie; Marie-Sophie Nguyen-Tu; Kantor, Chase; Swisa, Avital; Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Sect Cell Biol, London W12 ONN, England; [Ferrer, Jorge] Univ London Imperial Coll Sci Technol & Med, Sect Cell Dev, Div Diabet Endocrinol & Metab, Dept Med, London W12 ONN, England; [McGinty, James A.; Chen, Lingling; French, Paul M.] Univ London Imperial Coll Sci Technol & Med, Photon Grp, Dept Phys, London W12 ONN, England; [Ibberson, Mark] Univ Lausanne, Swiss Inst Bioinformat, Lausanne, Switzerland; [Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Swisa, Avital; Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel; [Gorman, Tracy] AstraZeneca Diabet & Obes Drug Discovery, Alderley Edge, England; [Reimann, Frank; Gribble, Fiona] Univ Cambridge, Metab Res Labs, Cambridge, England; [Birzele, Fabian; Hildebrandt, Tobias; Uphues, Ingo] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany	Imperial College London; Imperial College London; Imperial College London; Swiss Institute of Bioinformatics; University of Lausanne; University of Lausanne; Hebrew University of Jerusalem; AstraZeneca; University of Cambridge; Boehringer Ingelheim	Rutter, GA (corresponding author), Univ London Imperial Coll Sci Technol & Med, ICTEM, Hammersmith Hosp, 3rd Floor,du Cane Rd, London W12 ONN, England.	g.rutter@imperial.ac.uk	Sanchez, Aida Martinez/ABH-5957-2020; French, Paul/E-8649-2011; Pullen, Timothy J/H-2143-2011; Ferrer, Jorge/A-3176-2012; Chen, Ling-Ling/AAY-3547-2021	Sanchez, Aida Martinez/0000-0001-5142-2527; Pullen, Timothy J/0000-0002-6853-5701; Ferrer, Jorge/0000-0002-5959-5729; Gribble, Fiona/0000-0002-4232-2898; Reimann, Frank/0000-0001-9399-6377; Ibberson, Mark/0000-0003-3152-5670; Rutter, Guy/0000-0001-6360-0343; French, Paul/0000-0002-0478-6755	Medical Research Council (UK) [MR/J0003042/1]; Biotechnology and Biological Sciences Research Council (UK) [BB/J015873/1]; Royal Society for a Wolfson Research Merit Award; Wellcome Trust [WT098424AIA]; Imperial College/Wellcome Trust Institutional Strategic Support Funds (ISSF) grant; Diabetes Research and Wellness (DRWE) nonclinical fellowship; Innovative Medicines Initiative (IMIDIA) Joint Undertaking [155005]; European Union; European Federation of Pharmaceutical Industries and Associations (EFPLA); Biotechnology and Biological Sciences Research Council [BB/J015873/1] Funding Source: researchfish; Diabetes UK [11/0004210] Funding Source: researchfish; Medical Research Council [MR/K001981/1, MC_UU_12012/3, MR/L02036X/1, MC_UU_12012/5/B] Funding Source: researchfish; BBSRC [BB/J015873/1] Funding Source: UKRI; MRC [MR/K001981/1, MR/L02036X/1, MC_UU_12012/3] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society for a Wolfson Research Merit Award(Royal Society of London); Wellcome Trust(Wellcome TrustEuropean Commission); Imperial College/Wellcome Trust Institutional Strategic Support Funds (ISSF) grant; Diabetes Research and Wellness (DRWE) nonclinical fellowship; Innovative Medicines Initiative (IMIDIA) Joint Undertaking; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations (EFPLA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	G.A.R. thanks the Medical Research Council (UK) for programme grant MR/J0003042/1, the Biotechnology and Biological Sciences Research Council (UK) for project grant BB/J015873/1, the Royal Society for a Wolfson Research Merit Award, and the Wellcome Trust for Senior Investigator Award WT098424AIA. CAR. and P.F. received an Imperial College/Wellcome Trust Institutional Strategic Support Funds (ISSF) grant. T.J.P. was supported by a Diabetes Research and Wellness (DRWE) nonclinical fellowship, and M.K. by an Imperial College Ph. D. studentship. the work leading to this publication has received support from the Innovative Medicines Initiative (IMIDIA) Joint Undertaking under grant agreement no. 155005, resources of which are composed of a financial contribution from the European Union's Seventh framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations (EFPLA) member companies' in kind contribution (G.A.R., B.T.). The authors thank Dr. Gabriela da Silva Xavier for help with pancreatic morphology, Jane Srivastava for assistance with FACS analysis, and Dr. Isabelle Leclerc (Imperial College London) for useful discussions.	Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Beall C, 2010, BIOCHEM J, V429, P323, DOI 10.1042/BJ20100231; Bramswig NC, 2013, J CLIN INVEST, V123, P1275, DOI 10.1172/JCI66514; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Courtney M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003934; Crombag HS, 2009, NEUROPSYCHOPHARMACOL, V34, P857, DOI 10.1038/npp.2008.80; da Silva Xavier G, 2013, J DIABETES RES, V2013; de Lau WBM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-242; De Saedeleer CJ, 2014, ONCOGENE, V33, P4060, DOI 10.1038/onc.2013.454; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Ishii K, 2012, DEVELOPMENT, V139, P1734, DOI 10.1242/dev.076539; Jacob LS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001225; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kawashima H, 2012, INT J ONCOL, V40, P31, DOI 10.3892/ijo.2011.1234; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Martin Daniel, 2008, P51; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nie J, 2013, P NATL ACAD SCI USA, V110, P13857, DOI 10.1073/pnas.1307698110; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Partanen JI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0111; Pullen TJ, 2013, DIABETES OBES METAB, V15, P503, DOI 10.1111/dom.12029; Pullen TJ, 2012, DIABETES, V61, P1719, DOI 10.2337/db11-1531; Pullen TJ, 2010, ISLETS, V2, P89, DOI 10.4161/isl.2.2.11025; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Ravier MA, 2010, METHODS MOL BIOL, V633, P171, DOI 10.1007/978-1-59745-019-5_12; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Rother E, 2012, P NATL ACAD SCI USA, V109, P18132, DOI 10.1073/pnas.1206147109; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; Rutter GA, 2008, FRONT HORM RES, V36, P118, DOI 10.1159/000115360; Rutter Guy A., 2001, Molecular Aspects of Medicine, V22, P247, DOI 10.1016/S0098-2997(01)00013-9; Rutter GA, 2009, MOL CELL ENDOCRINOL, V297, P41, DOI 10.1016/j.mce.2008.05.020; Sakamaki JI, 2014, NAT CELL BIOL, V16, P234, DOI 10.1038/ncb2919; Scully Tony, 2012, Nature, V485, pS2; Sia GM, 2007, NEURON, V55, P87, DOI 10.1016/j.neuron.2007.06.020; Stange Geert, 2003, Methods Mol Med, V83, P15; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun G, 2010, DIABETOLOGIA, V53, P924, DOI 10.1007/s00125-010-1692-1; Sun G, 2011, DIS MODEL MECH, V4, P193, DOI 10.1242/dmm.006833; Sun G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1261, DOI 10.1152/ajpendo.00100.2010; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tamarina NA, 2014, ISLETS, V6, DOI 10.4161/isl.27685; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; Thorrez L, 2011, GENOME RES, V21, P95, DOI 10.1101/gr.109173.110; Upadhyay G, 2008, ONCOGENE, V27, P5845, DOI 10.1038/onc.2008.202; Vencio RZN, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-119; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Zambon AC, 2005, P NATL ACAD SCI USA, V102, P8561, DOI 10.1073/pnas.0503363102; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	65	59	60	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4972	4985		10.1096/fj.14-257667	http://dx.doi.org/10.1096/fj.14-257667			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25070369	Green Published, hybrid			2022-12-25	WOS:000344050900033
J	Sah, RP; Garg, SK; Dixit, AK; Dudeja, V; Dawra, RK; Saluja, AK				Sah, Raghuwansh P.; Garg, Sushil K.; Dixit, Ajay K.; Dudeja, Vikas; Dawra, Rajinder K.; Saluja, Ashok K.			Endoplasmic Reticulum Stress Is Chronically Activated in Chronic Pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); ER Stress; NF-kappa B (NF-KB); Pancreas; Unfolded Protein Response (UPR); Chronic Pancreatitis; Trypsinogen Activation	UNFOLDED PROTEIN RESPONSE; NF-KAPPA-B; ACINAR-CELLS; HEREDITARY PANCREATITIS; TRYPSINOGEN ACTIVATION; MESSENGER-RNA; ER STRESS; OXIDATIVE STRESS; CATHEPSIN-B; PATHOGENESIS	Background: The nature of endoplasmic reticulum (ER) stress in chronic pancreatitis (CP) is not known. Results: ER stress is activated early, independently of trypsinogen activation, and remains sustained in CP. Conclusion: Pathologic ER stress activation may be a novel pathogenic mechanism of CP. Significance: ER stress is a key event independent of the traditional central event of pancreatitis-trypsinogen activation. The pathogenesis of chronic pancreatitis (CP) is poorly understood. Endoplasmic reticulum (ER) stress has now been recognized as a pathogenic event in many chronic diseases. However, ER stress has not been studied in CP, although pancreatic acinar cells seem to be especially vulnerable to ER dysfunction because of their dependence on high ER volume and functionality. Here, we aim to investigate ER stress in CP, study its pathogenesis in relation to trypsinogen activation (widely regarded as the key event of pancreatitis), and explore its mechanism, time course, and downstream consequences during pancreatic injury. CP was induced in mice by repeated episodes of acute pancreatitis (AP) based on caerulein hyperstimulation. ER stress leads to activation of unfolded protein response components that were measured in CP and AP. We show sustained up-regulation of unfolded protein response components ATF4, CHOP, GRP78, and XBP1 in CP. Overexpression of GRP78 and ATF4 in human CP confirmed the experimental findings. We used novel trypsinogen-7 knock-out mice (T-/-), which lack intra-acinar trypsinogen activation, to clarify the relationship of ER stress to intra-acinar trypsinogen activation in pancreatic injury. Comparable activation of ER stress was seen in wild type and T-/- mice. Induction of ER stress occurred through pathologic calcium signaling very early in the course of pancreatic injury. Our results establish that ER stress is chronically activated in CP and is induced early in pancreatic injury through pathologic calcium signaling independent of trypsinogen activation. ER stress may be an important pathogenic mechanism in pancreatitis that needs to be explored in future studies.	[Sah, Raghuwansh P.; Garg, Sushil K.; Dixit, Ajay K.; Dudeja, Vikas; Dawra, Rajinder K.; Saluja, Ashok K.] Univ Minnesota, Div Basic & Translat Res, Dept Surg, Sch Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Saluja, AK (corresponding author), 420 Delaware St SE,Mayo Mail Code 195, Minneapolis, MN 55455 USA.	asaluja@umn.edu	Dixit, Ajay/AAH-7171-2021		National Institutes of Health [DK093047, DK058694, DK092145]; Department of Surgery, University of Minnesota; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093047, R01DK092145, R01DK058694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Surgery, University of Minnesota(University of Minnesota System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK093047, DK058694, and DK092145 (to A. K. S.) and intramural support from the Department of Surgery, University of Minnesota.	Archer H, 2006, GASTROENTEROLOGY, V131, P1844, DOI 10.1053/j.gastro.2006.09.049; Beer S, 2014, GUT, V63, P860, DOI 10.1136/gutjnl-2013-305981; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; Braganza JM, 2011, LANCET, V377, P1184, DOI 10.1016/S0140-6736(10)61852-1; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; CASE RM, 1978, BIOL REV, V53, P211, DOI 10.1111/j.1469-185X.1978.tb01437.x; Chen JM, 2009, ANNU REV GENOM HUM G, V10, P63, DOI 10.1146/annurev-genom-082908-150009; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; Dawra R, 2011, GASTROENTEROLOGY, V141, P2210, DOI 10.1053/j.gastro.2011.08.033; Dickhout JG, 2011, CIRC RES, V108, P629, DOI 10.1161/CIRCRESAHA.110.226803; Etemad B, 2001, GASTROENTEROLOGY, V120, P682, DOI 10.1053/gast.2001.22586; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Gaiser S, 2011, GUT, V60, P1379, DOI 10.1136/gut.2010.226175; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Gorelick FS, 2009, CLIN GASTROENTEROL H, V7, pS10, DOI 10.1016/j.cgh.2009.07.036; Guda Nalini M, 2011, Curr Gastroenterol Rep, V13, P140, DOI 10.1007/s11894-011-0176-x; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hasty AH, 2012, J CLIN INVEST, V122, P3859, DOI 10.1172/JCI65173; Hietaranta AJ, 2001, BIOCHEM BIOPH RES CO, V280, P388, DOI 10.1006/bbrc.2000.4120; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huang HJ, 2013, GASTROENTEROLOGY, V144, P202, DOI 10.1053/j.gastro.2012.09.059; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; KAISER AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1295, DOI 10.1152/ajpcell.1995.269.5.C1295; Kereszturi E, 2009, J BIOL CHEM, V284, P33392, DOI 10.1074/jbc.M109.056812; Kereszturi E, 2009, HUM MUTAT, V30, P575, DOI 10.1002/humu.20853; Kitamura M, 2009, ANTIOXID REDOX SIGN, V11, P2353, DOI 10.1089/ARS.2008.2391; Kitamura M, 2011, INT REV IMMUNOL, V30, P4, DOI 10.3109/08830185.2010.522281; Kubisch CH, 2007, AM J PHYSIOL-GASTR L, V292, pG1804, DOI 10.1152/ajpgi.00078.2007; Kubisch CH, 2006, AM J PHYSIOL-GASTR L, V291, pG238, DOI 10.1152/ajpgi.00471.2005; LaRusch J, 2011, CURR OPIN GASTROEN, V27, P467, DOI 10.1097/MOG.0b013e328349e2f8; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Lin JH, 2010, ADV EXP MED BIOL, V664, P115, DOI 10.1007/978-1-4419-1399-9_14; Lugea A, 2011, GASTROENTEROLOGY, V140, P987, DOI 10.1053/j.gastro.2010.11.038; Mahurkar S, 2006, GUT, V55, P1270, DOI 10.1136/gut.2005.087403; Ohmuraya M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00126; Ohmuraya M, 2011, EXP ANIM TOKYO, V60, P433; Paliwal S, 2013, GUT, V62, P1602, DOI 10.1136/gutjnl-2012-302448; Pandol SJ, 2010, DIGEST DIS, V28, P776, DOI 10.1159/000327212; Petersen OH, 2009, BRAZ J MED BIOL RES, V42, P9, DOI 10.1590/S0100-879X2009000100003; Petersen OH, 2005, CELL CALCIUM, V38, P171, DOI 10.1016/j.ceca.2005.06.024; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Rakonczay Z, 2008, GUT, V57, P259, DOI 10.1136/gut.2007.124115; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosendahl J, 2013, GUT, V62, P582, DOI 10.1136/gutjnl-2011-300645; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Sah RP, 2013, CURR OPIN GASTROEN, V29, P523, DOI 10.1097/MOG.0b013e328363e399; Sah RP, 2013, GASTROENTEROLOGY, V144, P1076, DOI 10.1053/j.gastro.2013.01.041; Sah RP, 2012, CURR OPIN GASTROEN, V28, P507, DOI 10.1097/MOG.0b013e3283567f52; Sah RP, 2011, CURR OPIN GASTROEN, V27, P444, DOI 10.1097/MOG.0b013e328349e346; Sahin-Toth M, 2006, ENDOCRIN METAB CLIN, V35, P303, DOI 10.1016/j.ecl.2006.02.002; Salminen A, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-41; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; Saluja AK, 2007, ANNU REV PHYSIOL, V69, P249, DOI 10.1146/annurev.physiol.69.031905.161253; Schnur A, 2014, GUT, V63, P337, DOI 10.1136/gutjnl-2012-304331; Szmola R, 2010, GUT, V59, P365, DOI 10.1136/gut.2009.198903; Tando Y, 1999, AM J PHYSIOL-GASTR L, V277, pG678, DOI 10.1152/ajpgi.1999.277.3.G678; Teich N, 2006, HUM MUTAT, V27, P721, DOI 10.1002/humu.20343; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Whitcomb DC, 2010, ANNU REV MED, V61, P413, DOI 10.1146/annurev.med.041608.121416; Witt H, 2013, NAT GENET, V45, P1216, DOI 10.1038/ng.2730; Yadav D, 2012, AM J GASTROENTEROL, V107, P1096, DOI 10.1038/ajg.2012.126; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	70	56	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27551	27561		10.1074/jbc.M113.528174	http://dx.doi.org/10.1074/jbc.M113.528174			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25077966	hybrid, Green Published			2022-12-25	WOS:000342852800017
J	de la Cruz-Herrera, CF; Campagna, M; Garcia, MA; Marcos-Villar, L; Lang, V; Baz-Martinez, M; Gutierrez, S; Vidal, A; Rodriguez, MS; Esteban, M; Rivas, C				de la Cruz-Herrera, Carlos F.; Campagna, Michela; Garcia, Maria A.; Marcos-Villar, Laura; Lang, Valerie; Baz-Martinez, Maite; Gutierrez, Sylvia; Vidal, Anxo; Rodriguez, Manuel S.; Esteban, Mariano; Rivas, Carmen			Activation of the Double-stranded RNA-dependent Protein Kinase PKR by Small Ubiquitin-like Modifier (SUMO)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR STOMATITIS-VIRUS; IN-VITRO; SUMOYLATION; BINDING; PHOSPHORYLATION; DIMERIZATION; INFECTION; UBC9; GENE; MUTATIONS	The dsRNA-dependent kinase PKR is an interferon-inducible protein with ability to phosphorylate the alpha subunit of the eukaryotic initiation factor (eIF)-2 complex, resulting in a shutoff of general translation, induction of apoptosis, and inhibition of virus replication. Here we analyzed the modification of PKR by the small ubiquitin-like modifiers SUMO1 and SUMO2 and evaluated the consequences of PKR SUMOylation. Our results indicate that PKR is modified by both SUMO1 and SUMO2, in vitro and in vivo. We identified lysine residues Lys-60, Lys-150, and Lys-440 as SUMOylation sites in PKR. We show that SUMO is required for efficient PKR-dsRNA binding, PKR dimerization, and eIF2 alpha phosphorylation. Furthermore, we demonstrate that SUMO potentiates the inhibition of protein synthesis induced by PKR in response to dsRNA, whereas a PKR SUMOylation mutant is impaired in its ability to inhibit protein synthesis and shows reduced capability to control vesicular stomatitis virus replication and to induce apoptosis in response to vesicular stomatitis virus infection. In summary, our data demonstrate the important role of SUMO in processes mediated by the activation of PKR.	[de la Cruz-Herrera, Carlos F.; Campagna, Michela; Marcos-Villar, Laura; Esteban, Mariano; Rivas, Carmen] CSIC, Ctr Nacl Biotecnol, Dept Biol Mol & Celular, E-28049 Madrid, Spain; [Garcia, Maria A.] Hosp Univ Virgen de la Nieves, Unidad Invest, Granada 18014, Spain; [Lang, Valerie; Rodriguez, Manuel S.] Inbiomed, Ubiquitylat & Canc Mol Biol Lab, San Sebastian 20009, Gipuzkoa, Spain; [Baz-Martinez, Maite; Vidal, Anxo; Rivas, Carmen] Univ Santiago de Compostela, Ctr Invest Med Mol CIMUS, Inst Invest Sanitarias IDIS, E-15782 Santiago De Compostela, Spain; [Gutierrez, Sylvia] CSIC, Confocal Serv, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Vidal, Anxo] Univ Santiago de Compostela, Dept Fisiol, Inst Invest Sanitarias IDIS, E-15782 Santiago De Compostela, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Hospital Universitario Virgen de las Nieves; Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Universidade de Santiago de Compostela	Rivas, C (corresponding author), Univ Santiago de Compostela, Ctr Invest Med Mol CIMUS, Inst Invest Sanitarias IDIS, E-15782 Santiago De Compostela, Spain.	crivas@cnb.csic.es	Vidal, Anxo/B-5010-2015; Rivas, Carmen/AAB-6278-2019; RODRIGUEZ, Manuel S./D-5439-2018; Rivas, Carmen/L-3162-2017; Garcia, Maria Angel MA/I-5116-2016; Gutierrez-Erlandsson, Sylvia/K-7551-2014; Esteban, Mariano/ABG-5375-2020; Baz-Martínez, Maite/L-4626-2017	Vidal, Anxo/0000-0002-0866-4202; Rivas, Carmen/0000-0002-0518-7199; Rivas, Carmen/0000-0002-0518-7199; Garcia, Maria Angel MA/0000-0003-2003-3769; Gutierrez-Erlandsson, Sylvia/0000-0002-5895-868X; Esteban, Mariano/0000-0003-0846-2827; Baz-Martínez, Maite/0000-0001-9160-7833; de la Cruz-Herrera, Carlos/0000-0002-7493-5154	Ministry of Economy and Competitiveness of Spain [BFU-2011-27064]; La Caixa fellowship; Juan de la Cierva Programme	Ministry of Economy and Competitiveness of Spain(Spanish Government); La Caixa fellowship(La Caixa Foundation); Juan de la Cierva Programme	This work was supported by Grant BFU-2011-27064 from the Ministry of Economy and Competitiveness of Spain.; Supported by a La Caixa fellowship.; Supported by the Juan de la Cierva Programme.	Anderson E, 2011, J MOL BIOL, V413, P973, DOI 10.1016/j.jmb.2011.09.025; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; Cai RR, 1998, J BIOL CHEM, V273, P11274, DOI 10.1074/jbc.273.18.11274; Campagna M, 2011, CELL DEATH DIFFER, V18, P72, DOI 10.1038/cdd.2010.77; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Durbin RK, 2002, VIRAL IMMUNOL, V15, P41, DOI 10.1089/088282402317340224; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gonzalez-Santamaria J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.135; Gonzalez-Santamaria J, 2011, J VIROL, V85, P12890, DOI 10.1128/JVI.05628-11; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Harashima A, 2010, GENE DEV, V24, P2640, DOI 10.1101/gad.1965010; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; HOVANESSIAN AG, 1987, EUR J BIOCHEM, V167, P467, DOI 10.1111/j.1432-1033.1987.tb13360.x; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kang JI, 2009, VIRUS RES, V142, P51, DOI 10.1016/j.virusres.2009.01.007; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; LEE SB, 1994, VIROLOGY, V199, P491, DOI 10.1006/viro.1994.1151; Marchal JA, 2014, FASEB J, V28, P1965, DOI 10.1096/fj.13-248294; Marcos-Villar L, 2013, CELL CYCLE, V12, P2809, DOI 10.4161/cc.25868; Marcos-Villar L, 2009, J VIROL, V83, P8849, DOI 10.1128/JVI.00339-09; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; MCMILLAN NAJ, 1995, J BIOL CHEM, V270, P2601, DOI 10.1074/jbc.270.6.2601; Okumura F, 2013, J BIOL CHEM, V288, P2839, DOI 10.1074/jbc.M112.401851; Palacios S, 2005, MOL BIOL CELL, V16, P2822, DOI 10.1091/mbc.E04-11-1005; PATEL RC, 1995, P NATL ACAD SCI USA, V92, P8283, DOI 10.1073/pnas.92.18.8283; Patel RC, 1996, J BIOL CHEM, V271, P25657, DOI 10.1074/jbc.271.41.25657; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Perkins DJ, 2010, MBIO, V1, DOI 10.1128/mBio.00239-10; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Stojdl DF, 2000, J VIROL, V74, P9580, DOI 10.1128/JVI.74.20.9580-9585.2000; Su QZ, 2006, P NATL ACAD SCI USA, V103, P63, DOI 10.1073/pnas.0508207103; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Wilson VG, 2012, BIOMOLECULES, V2, P203, DOI 10.3390/biom2020203; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yue ZY, 1997, VIROLOGY, V234, P364, DOI 10.1006/viro.1997.8664; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	44	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26357	26367		10.1074/jbc.M114.560961	http://dx.doi.org/10.1074/jbc.M114.560961			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25074923	hybrid, Green Published			2022-12-25	WOS:000342128800028
J	Gao, Y; Nelson, SW				Gao, Yang; Nelson, Scott W.			Autoinhibition of Bacteriophage T4 Mre11 by Its C-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; CRYSTAL-STRUCTURE; PROTEIN COMPLEX; DNA CLEAVAGE; NUCLEASE; RECOMBINATION; MECHANISM; INSIGHTS; REVEALS; CHECKPOINT	Mre11 and Rad50 form a stable complex (MR) and work cooperatively in repairing DNA double strand breaks. In the bacteriophage T4, Rad50 (gene product 46) enhances the nuclease activity of Mre11 (gene product 47), and Mre11 and DNA in combination stimulate the ATPase activity of Rad50. The structural basis for the cross-activation of the MR complex has been elusive. Various crystal structures of the MR complex display limited protein-protein interfaces that mainly exist between the C terminus of Mre11 and the coiled-coil domain of Rad50. To test the role of the C-terminal Rad50 binding domain (RBD) in Mre11 activation, we constructed a series of C-terminal deletions and mutations in bacteriophage T4 Mre11. Deletion of the RBD in Mre11 eliminates Rad50 binding but only has moderate effect on its intrinsic nuclease activity; however, the additional deletion of the highly acidic flexible linker that lies between RBD and the main body of Mre11 increases the nuclease activity of Mre11 by 20-fold. Replacement of the acidic residues in the flexible linker with alanine elevates the Mre11 activity to the level of the MR complex when combined with deletion of RBD. Nuclease activity kinetics indicate that Rad50 association and deletion of the C terminus of Mre11 both enhance DNA substrate binding. Additionally, a short peptide that contains the flexible linker and RBD of Mre11 acts as an inhibitor of Mre11 nuclease activity. These results support a model where the Mre11 RBD and linker domain act as an autoinhibitory domain when not in complex with Rad50. Complex formation with Rad50 alleviates this inhibition due to the tight association of the RBD and the Rad50 coiled-coil.	[Gao, Yang; Nelson, Scott W.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Nelson, SW (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	swn@iastate.edu	Gao, Yang/O-3445-2016		Carver Trust [10-3603]; Iowa State University; National Science Foundation [MCB-1121693]; Direct For Biological Sciences [1121693] Funding Source: National Science Foundation	Carver Trust; Iowa State University; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Carver Trust Young Investigator Grant 10-3603 (to S. W. N.), Iowa State University institutional support (to S. W. N), and National Science Foundation Grant MCB-1121693 (to S. W. N).	Albrecht DW, 2012, J BIOL CHEM, V287, P31371, DOI 10.1074/jbc.M112.392316; Almond JR, 2013, GENETICS, V195, P739, DOI 10.1534/genetics.113.154872; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; BLOOM LB, 1994, BIOCHEMISTRY-US, V33, P7576, DOI 10.1021/bi00190a010; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chen C, 2013, P NATL ACAD SCI USA, V110, P20605, DOI 10.1073/pnas.1306328110; Connelly JC, 1999, NUCLEIC ACIDS RES, V27, P1039, DOI 10.1093/nar/27.4.1039; Connelly JC, 2002, TRENDS BIOCHEM SCI, V27, P410, DOI 10.1016/S0968-0004(02)02144-8; Das D, 2010, J MOL BIOL, V397, P647, DOI 10.1016/j.jmb.2010.01.049; De la Rosa MB, 2011, J BIOL CHEM, V286, P26258, DOI 10.1074/jbc.M111.256305; Dery U, 2008, MOL CELL BIOL, V28, P3058, DOI 10.1128/MCB.02025-07; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Graves BJ, 1998, COLD SPRING HARB SYM, V63, P621, DOI 10.1101/sqb.1998.63.621; Herdendorf TJ, 2011, BIOCHEMISTRY-US, V50, P6030, DOI 10.1021/bi200184w; Herdendorf TJ, 2011, J BIOL CHEM, V286, P2382, DOI 10.1074/jbc.M110.178871; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lim HS, 2011, GENE DEV, V25, P1091, DOI 10.1101/gad.2037811; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; MICKELSON C, 1981, J VIROL, V40, P65, DOI 10.1128/JVI.40.1.65-77.1981; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Mockel C, 2012, NUCLEIC ACIDS RES, V40, P914, DOI 10.1093/nar/gkr749; Mosig G, 1998, ANNU REV GENET, V32, P379, DOI 10.1146/annurev.genet.32.1.379; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Park YB, 2011, STRUCTURE, V19, P1591, DOI 10.1016/j.str.2011.09.010; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Povirk LR, 2006, DNA REPAIR, V5, P1199, DOI 10.1016/j.dnarep.2006.05.016; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Sambrook J., 1989, MOL CLONING LAB MANU, V2, P32; Schiller CB, 2012, NAT STRUCT MOL BIOL, V19, P693, DOI 10.1038/nsmb.2323; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Szczepek M, 2009, MOL MICROBIOL, V72, P1011, DOI 10.1111/j.1365-2958.2009.06702.x; Taylor AMR, 2004, DNA REPAIR, V3, P1219, DOI 10.1016/j.dnarep.2004.04.009; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; van Noort J, 2003, P NATL ACAD SCI USA, V100, P7581, DOI 10.1073/pnas.1330706100; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Woodworth DL, 1996, GENETICS, V143, P1081; Wyman C, 2011, DNA REPAIR, V10, P1066, DOI 10.1016/j.dnarep.2011.07.008	51	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26505	26513		10.1074/jbc.M114.583625	http://dx.doi.org/10.1074/jbc.M114.583625			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25077970	hybrid, Green Published			2022-12-25	WOS:000342128800041
J	Guan, X; Duan, YH; Zeng, QW; Pan, HJ; Qian, Y; Li, DL; Cao, XH; Liu, MY				Guan, Xin; Duan, Yanhong; Zeng, Qingwen; Pan, Hongjie; Qian, Yu; Li, Dali; Cao, Xiaohua; Liu, Mingyao			Lgr4 Protein Deficiency Induces Ataxia-like Phenotype in Mice and Impairs Long Term Depression at Cerebellar Parallel Fiber-Purkinje Cell Synapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR 48; WNT/BETA-CATENIN; TRANSGENIC MICE; GENETIC ENHANCEMENT; DOWN-REGULATION; PLASTICITY; DEGENERATION; MEMORY; INACTIVATION; EXPRESSION	Cerebellar dysfunction causes ataxia characterized by loss of balance and coordination. Until now, the molecular and neuronal mechanisms of several types of inherited cerebellar ataxia have not been completely clarified. Here, we report that leucine-rich G protein-coupled receptor 4 (Lgr4/Gpr48) is highly expressed in Purkinje cells (PCs) in the cerebellum. Deficiency of Lgr4 leads to an ataxia-like phenotype in mice. Histologically, no obvious morphological changes were observed in the cerebellum of Lgr4 mutant mice. However, the number of PCs was slightly but significantly reduced in Lgr4(-/-) mice. In addition, in vitro electrophysiological analysis showed an impaired long term depression (LTD) at parallel fiber-PC (PF-PC) synapses in Lgr4(-/-) mice. Consistently, immunostaining experiments showed that the level of phosphorylated cAMP-responsive element-binding protein (Creb) was significantly decreased in Lgr4(-/-) PCs. Furthermore, treatment with forskolin, an adenylyl cyclase agonist, rescued phospho-Creb in PCs and reversed the impairment in PF-PC LTD in Lgr4(-/-) cerebellar slices, indicating that Lgr4 is an upstream regulator of Creb signaling, which is underlying PF-PC LTD. Together, our findings demonstrate for first time an important role for Lgr4 in motor coordination and cerebellar synaptic plasticity and provide a potential therapeutic target for certain types of inherited cerebellar ataxia.	[Guan, Xin; Pan, Hongjie; Qian, Yu; Li, Dali; Liu, Mingyao] E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Guan, Xin; Pan, Hongjie; Qian, Yu; Li, Dali; Liu, Mingyao] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Duan, Yanhong; Zeng, Qingwen; Cao, Xiaohua] E China Normal Univ, Key Lab Brain Funct Genom, Minist Educ, Shanghai 200241, Peoples R China; [Liu, Mingyao] Texas A&M Univ Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	East China Normal University; East China Normal University; East China Normal University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Li, DL (corresponding author), E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China.	dlli@bio.ecnu.edu.cn; xhcao@brain.ecnu.edu.cn; myliu@bio.ecnu.edu.cn		Liu, Mingyao/0000-0001-7339-5048; Li, Dali/0000-0002-0046-8493	State Key Development Programs of China [2012CB910400, 2010CB945403]; National Natural Science Foundation of China [31371455, 30930055, 31070993, 31271200]; Science and Technology Commission of Shanghai Municipality [12XD1406100, 14140900300]	State Key Development Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported in part by State Key Development Programs of China Grants 2012CB910400 (to M. L.) and 2010CB945403 (to D. L.), National Natural Science Foundation of China Grants 31371455, 30930055, 31070993, and 31271200, and Science and Technology Commission of Shanghai Municipality Grants 12XD1406100 and 14140900300.	Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; Barco A, 2011, MOL NEUROBIOL, V44, P330, DOI 10.1007/s12035-011-8209-x; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Blom JMC, 2002, NEUROPSYCHOPHARMACOL, V26, P605, DOI 10.1016/S0893-133X(01)00401-8; Brault V, 2001, DEVELOPMENT, V128, P1253; Cao XH, 2008, NEURON, V60, P353, DOI 10.1016/j.neuron.2008.08.027; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Carter RJ, 1999, J NEUROSCI, V19, P3248; Clark HB, 1997, J NEUROSCI, V17, P7385; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Cryan JF, 2004, P NATL ACAD SCI USA, V101, P8186, DOI 10.1073/pnas.0401080101; Dar MS, 2011, PHARMACOL BIOCHEM BE, V98, P341, DOI 10.1016/j.pbb.2010.12.020; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; Du B, 2013, J BIOL CHEM, V288, P15131, DOI 10.1074/jbc.M113.455535; Evans GJO, 2007, BIOL CELL, V99, P363, DOI 10.1042/BC20070010; FEDDERSEN RM, 1992, NEURON, V9, P955, DOI 10.1016/0896-6273(92)90247-B; FEDDERSEN RM, 1995, MOL CELL NEUROSCI, V6, P153, DOI 10.1006/mcne.1995.1014; Gilman S, 1996, ANN NEUROL, V39, P241, DOI 10.1002/ana.410390214; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Liu SJ, 2013, J BIOL CHEM, V288, P8794, DOI 10.1074/jbc.M112.436204; Lonchamp E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030180; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Luo J, 2009, DEVELOPMENT, V136, P2747, DOI 10.1242/dev.033571; Luo WJ, 2013, STEM CELLS, V31, P2492, DOI 10.1002/stem.1484; Maltecca F, 2009, J NEUROSCI, V29, P9244, DOI 10.1523/JNEUROSCI.1532-09.2009; Manto M, 2009, CURR OPIN NEUROL, V22, P419, DOI 10.1097/WCO.0b013e32832b9897; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; Nishihara E, 2003, J NEUROSCI, V23, P213; Qian Y, 2013, DEVELOPMENT, V140, P1751, DOI 10.1242/dev.093641; Schonewille M, 2010, NEURON, V67, P618, DOI 10.1016/j.neuron.2010.07.009; Schuller U, 2007, BRAIN RES, V1140, P161, DOI 10.1016/j.brainres.2006.05.105; Selvadurai HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023012; Song HP, 2008, J BIOL CHEM, V283, P36687, DOI 10.1074/jbc.M800721200; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STRICK PL, 1985, SCIENCE, V229, P547, DOI 10.1126/science.229.4713.547; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thomas JD, 1998, DEV BRAIN RES, V105, P159, DOI 10.1016/S0165-3806(97)00164-8; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; van Woerden GM, 2009, NAT NEUROSCI, V12, P823, DOI 10.1038/nn.2329; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Wang F, 2014, J MOL ENDOCRINOL, V52, P133, DOI 10.1530/JME-13-0042; Wang Y, 2013, STEM CELLS, V31, P1921, DOI 10.1002/stem.1438; Wen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064451; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Wexler EM, 2009, STEM CELLS, V27, P1130, DOI 10.1002/stem.36; Yi TF, 2014, J BIOL CHEM, V289, P8767, DOI 10.1074/jbc.M113.530816	56	11	11	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26492	26504		10.1074/jbc.M114.564138	http://dx.doi.org/10.1074/jbc.M114.564138			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25063812	Green Published, hybrid			2022-12-25	WOS:000342128800040
J	Trevitt, CR; Hosszu, LLP; Batchelor, M; Panico, S; Terry, C; Nicoll, AJ; Risse, E; Taylor, WA; Sandberg, MK; Al-Doujaily, H; Linehan, JM; Saibil, HR; Scott, DJ; Collinge, J; Waltho, JP; Clarke, AR				Trevitt, Clare R.; Hosszu, Laszlo L. P.; Batchelor, Mark; Panico, Silvia; Terry, Cassandra; Nicoll, Andrew J.; Risse, Emmanuel; Taylor, William A.; Sandberg, Malin K.; Al-Doujaily, Huda; Linehan, Jacqueline M.; Saibil, Helen R.; Scott, David J.; Collinge, John; Waltho, Jonathan P.; Clarke, Anthony R.			N-terminal Domain of Prion Protein Directs Its Oligomeric Association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; INTERMEDIATE STATES; SCRAPIE; CONVERSION; STABILITY; PRPSC; SUSCEPTIBILITY; CONFORMATION; POLYMORPHISM; TRANSITION	The self-association of prion protein (PrP) is a critical step in the pathology of prion diseases. It is increasingly recognized that small non-fibrillar beta-sheet-rich oligomers of PrP may be of crucial importance in the prion disease process. Here, we characterize the structure of a well defined beta-sheet-rich oligomer, containing similar to 12 PrP molecules, and often enclosing a central cavity, formed using full-length recombinant PrP. The N-terminal region of prion protein (residues 23-90) is required for the formation of this distinct oligomer; a truncated form comprising residues 91-231 forms a broad distribution of aggregated species. No infectivity or toxicity was found using cell and animal model systems. This study demonstrates that examination of the full repertoire of conformers and assembly states that can be accessed by PrP under specific experimental conditions should ideally be done using the full-length protein.	[Trevitt, Clare R.; Hosszu, Laszlo L. P.; Batchelor, Mark; Terry, Cassandra; Nicoll, Andrew J.; Risse, Emmanuel; Taylor, William A.; Sandberg, Malin K.; Al-Doujaily, Huda; Linehan, Jacqueline M.; Collinge, John; Clarke, Anthony R.] UCL Inst Neurol, MRC Prion Unit, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Panico, Silvia; Saibil, Helen R.] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England; [Scott, David J.] Univ Nottingham, Sch Biosci, Natl Ctr Macromol Hydrodynam, Loughborough LE12 5RD, Leics, England; [Scott, David J.] ISIS Spallat Neutron & Muon Source, Didcot OX11 0FA, Oxon, England; [Scott, David J.] Rutherford Appleton Lab, Didcot OX11 0FA, Oxon, England; [Waltho, Jonathan P.] Univ Sheffield, Krebs Inst Biomol Res, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of London; University College London; University of London; Birkbeck University London; University of Nottingham; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Sheffield	Clarke, AR (corresponding author), UCL Inst Neurol, MRC Prion Unit, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England.	a.r.clarke@prion.ucl.ac.uk	Terry, Cassandra/AAP-1280-2021	Panico, Silvia/0000-0002-2196-0727; Scott, David/0000-0002-6726-2078; Terry, Cassandra/0000-0002-8611-8821; Waltho, Jonathan/0000-0002-7402-5492	Medical Research Council; BBSRC [BB/K016245/1] Funding Source: UKRI; MRC [MC_U123192748, MC_U123160656] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K016245/1] Funding Source: researchfish; Medical Research Council [MC_U123192748, MC_U123160656] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council.	ARNOLD JE, 1995, J PATHOL, V176, P403, DOI 10.1002/path.1711760412; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2004, PROTEIN SCI, V13, P586, DOI 10.1110/ps.03457204; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Creighton T. E., 1993, PROTEINS STRUCTURES; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5; Deriziotis P, 2011, EMBO J, V30, P3065, DOI 10.1038/emboj.2011.224; Gerber R, 2008, J MOL BIOL, V381, P212, DOI 10.1016/j.jmb.2008.05.057; Gerber R, 2008, PROTEIN SCI, V17, P537, DOI 10.1110/ps.073163308; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Hosszu LLP, 2010, BIOCHEMISTRY-US, V49, P8729, DOI 10.1021/bi100572j; Hosszu LLP, 2009, J BIOL CHEM, V284, P21981, DOI 10.1074/jbc.M809173200; Hosszu LLP, 2005, BIOCHEMISTRY-US, V44, P16649, DOI 10.1021/bi051277k; Hosszu LLP, 2004, J BIOL CHEM, V279, P28515, DOI 10.1074/jbc.M313762200; Hosszu LLP, 1999, NAT STRUCT BIOL, V6, P740, DOI 10.1038/11507; Huang LQ, 2010, FASEB J, V24, P3536, DOI 10.1096/fj.09-150987; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Jansen K, 2001, BIOL CHEM, V382, P683, DOI 10.1515/BC.2001.081; Kachel N, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-16; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kazlauskaite J, 2005, BIOCHEM BIOPH RES CO, V328, P292, DOI 10.1016/j.bbrc.2004.12.172; Khalili-Shirazi A, 2005, J IMMUNOL, V174, P3256, DOI 10.4049/jimmunol.174.6.3256; Khan MQ, 2010, P NATL ACAD SCI USA, V107, P19808, DOI 10.1073/pnas.1005267107; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Krishnan R, 2012, P NATL ACAD SCI USA, V109, P11172, DOI 10.1073/pnas.1209527109; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Larda ST, 2013, J AM CHEM SOC, V135, P10533, DOI 10.1021/ja404584s; LASZLO L, 1992, J PATHOL, V166, P333, DOI 10.1002/path.1711660404; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leffers KW, 2005, BIOL CHEM, V386, P569, DOI 10.1515/BC.2005.067; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; LIBERSKI PP, 1991, J COMP PATHOL, V105, P377, DOI 10.1016/S0021-9975(08)80107-7; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Maiti NR, 2001, J BIOL CHEM, V276, P2427, DOI 10.1074/jbc.M007862200; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Milanesi L, 2012, P NATL ACAD SCI USA, V109, P19563, DOI 10.1073/pnas.1211764109; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Nicoll AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3416; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; O'Sullivan DBD, 2007, BIOCHEM J, V401, P533, DOI 10.1042/BJ20060668; PARKER MJ, 1995, J MOL BIOL, V253, P771, DOI 10.1006/jmbi.1995.0590; Pires RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044992; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Redfield Christina, 2004, Methods Mol Biol, V278, P233; Reed MAC, 2003, J MOL BIOL, V330, P1189, DOI 10.1016/S0022-2836(03)00625-9; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Sasaki K, 2008, PRION, V2, P118, DOI 10.4161/pri.2.3.7148; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Tattum MH, 2006, J MOL BIOL, V357, P975, DOI 10.1016/j.jmb.2006.01.052; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Vendrely C, 2005, BBA-GEN SUBJECTS, V1724, P355, DOI 10.1016/j.bbagen.2005.05.017; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Wadsworth Jonathan D. F., 2008, V459, P197, DOI 10.1007/978-1-59745-234-2_14; Walsh DM, 2012, PROG MOL BIOL TRANSL, V107, P101, DOI 10.1016/B978-0-12-385883-2.00012-6; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wells MA, 2006, BIOCHEM J, V399, P435, DOI 10.1042/BJ20060458; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	80	16	16	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25497	25508		10.1074/jbc.M114.566588	http://dx.doi.org/10.1074/jbc.M114.566588			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074940	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000342130800012
J	Tsou, WI; Nguyen, KQN; Calarese, DA; Garforth, SJ; Antes, AL; Smirnov, SV; Almo, SC; Birge, RB; Kotenko, SV				Tsou, Wen-I; Nguyen, Khanh-Quynh N.; Calarese, Daniel A.; Garforth, Scott J.; Antes, Anita L.; Smirnov, Sergey V.; Almo, Steve C.; Birge, Raymond B.; Kotenko, Sergei V.			Receptor Tyrosine Kinases, TYRO3, AXL, and MER, Demonstrate Distinct Patterns and Complex Regulation of Ligand-induced Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-S; APOPTOTIC CELLS; DENDRITIC CELLS; TAM RECEPTORS; GROWTH-FACTOR; GAS6; PHOSPHATIDYLSERINE; IDENTIFICATION; RECOGNITION; ADHESION	TYRO3, AXL, and MER receptors (TAMs) are three homologous type I receptor-tyrosine kinases that are activated by endogenous ligands, protein S (PROS1) and growth arrest-specific gene 6 (GAS6). These ligands can either activate TAMs as soluble factors, or, in turn, opsonize phosphatidylserine (PS) on apoptotic cells (ACs) and serve as bridging molecules between ACs and TAMs. Abnormal expression and activation of TAMs have been implicated in promoting proliferation and survival of cancer cells, as well as in suppressing anti-tumor immunity. Despite the fact that TAM receptors share significant similarity, little is known about the specificity of interaction between TAM receptors and their ligands, particularly in the context of ACs, and about the functional diversity of TAM receptors. To study ligand-mediated activation of TAMs, we generated a series of reporter cell lines expressing chimeric TAM receptors. Using this system, we found that each TAM receptor has a unique pattern of interaction with and activation by GAS6 and PROS1, which is also differentially affected by the presence of ACs, PS-containing lipid vesicles and enveloped virus. We also demonstrated that gamma-carboxylation of ligands is essential for the full activation of TAMs and that soluble immunoglobulin-like TAM domains act as specific ligand antagonists. These studies demonstrate that, despite their similarity, TYRO3, AXL, and MER are likely to perform distinct functions in both immunoregulation and the recognition and removal of ACs.	[Tsou, Wen-I; Nguyen, Khanh-Quynh N.; Antes, Anita L.; Smirnov, Sergey V.; Birge, Raymond B.; Kotenko, Sergei V.] Rutgers Biomed & Hlth Sci, Dept Biochem & Mol Biol, Univ Hosp Canc Ctr, New Jersey Med Sch, Newark, NJ 07103 USA; [Tsou, Wen-I; Smirnov, Sergey V.; Kotenko, Sergei V.] Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07103 USA; [Calarese, Daniel A.; Garforth, Scott J.; Almo, Steve C.] Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Almo, Steve C.] Yeshiva Univ, Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Birge, RB (corresponding author), Rutgers Biomed & Hlth Sci, Dept Biochem & Mol Biol, New Jersey Med Sch, 185 S Orange Ave, Newark, NJ 07103 USA.	birgera@njms.rutgers.edu; kotenkse@njms.rutgers.edu			National Institutes of Health [R01AI104669, R01NCI165077, GM094662, GM094665]; Rutgers University; NJMS translational research award bridge grant;  [P30CA013330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094662, U01GM094665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers University; NJMS translational research award bridge grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01AI104669 (to S. V. K.) and R01NCI165077 (to R. B. B.), Rutgers University, NJMS translational research award & bridge grant (to S. V. K. and R. B. B.), National Institutes of Health Grants GM094662 & GM094665 (to S. C. A.), and P30CA013330 to Cancer Center of the Albert Einstein College of Medicine.	Bandyopadhyay PK, 2008, VITAM HORM, V78, P157, DOI 10.1016/S0083-6729(07)00008-8; Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005; Burstyn-Cohen T, 2009, J CLIN INVEST, V119, P2942, DOI 10.1172/JCI39325; Caberoy NB, 2012, J CELL PHYSIOL, V227, P401, DOI 10.1002/jcp.22955; Caberoy NB, 2010, EMBO J, V29, P3898, DOI 10.1038/emboj.2010.265; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Chen J, 1997, ONCOGENE, V14, P2033, DOI 10.1038/sj.onc.1201039; DAHLBACK B, 1990, J BIOL CHEM, V265, P18481; Eken C, 2010, J BIOL CHEM, V285, P39914, DOI 10.1074/jbc.M110.126748; Ekman C, 2010, J THROMB HAEMOST, V8, P838, DOI 10.1111/j.1538-7836.2010.03752.x; Fridell YWC, 1996, MOL CELL BIOL, V16, P135; Gerber DE, 2011, CLIN CANCER RES, V17, P6888, DOI 10.1158/1078-0432.CCR-11-1074; Giorda KM, 2013, DNA CELL BIOL, V32, P557, DOI 10.1089/dna.2013.2159; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; GRIFFIN JH, 1992, BLOOD, V79, P3203; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Heiring C, 2004, J BIOL CHEM, V279, P6952, DOI 10.1074/jbc.M311750200; Hunt CL, 2011, J VIROL, V85, P334, DOI 10.1128/JVI.01278-09; Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232; Korshunov VA, 2006, CIRC RES, V98, P1446, DOI 10.1161/01.RES.0000223322.16149.9a; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; LAI C, 1994, ONCOGENE, V9, P2567; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Li RH, 1996, J NEUROSCI, V16, P2012; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Mercer J, 2011, CELL HOST MICROBE, V9, P255, DOI 10.1016/j.chom.2011.04.002; Moerdyk-Schauwecker M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-166; Morizono K, 2011, CELL HOST MICROBE, V9, P286, DOI 10.1016/j.chom.2011.03.012; Muthukumaran G, 1997, J BIOL CHEM, V272, P4993, DOI 10.1074/jbc.272.8.4993; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; Nguyen KQN, 2014, J BIOL CHEM, V289, P25737, DOI 10.1074/jbc.M114.570838; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; OHASHI K, 1995, J BIOL CHEM, V270, P22681, DOI 10.1074/jbc.270.39.22681; Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998; Rahman ZSM, 2010, J IMMUNOL, V185, P5859, DOI 10.4049/jimmunol.1001187; Recarte-Pelz P, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4199; Robins RS, 2013, BLOOD, V121, P692, DOI 10.1182/blood-2012-05-433730; Sadallah S, 2011, CLIN EXP IMMUNOL, V163, P26, DOI 10.1111/j.1365-2249.2010.04271.x; Sandahl M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-122; Sasaki T, 2006, EMBO J, V25, P80, DOI 10.1038/sj.emboj.7600912; Sasaki T, 2002, J BIOL CHEM, V277, P44164, DOI 10.1074/jbc.M207340200; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Scutera S, 2009, J IMMUNOL, V183, P3004, DOI 10.4049/jimmunol.0804384; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Shimojima M, 2007, J INFECT DIS, V196, pS259, DOI 10.1086/520594; Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06; SOH J, 1993, P NATL ACAD SCI USA, V90, P8737, DOI 10.1073/pnas.90.18.8737; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Suh CH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3088; Todt JC, 2004, J LEUKOCYTE BIOL, V75, P705, DOI 10.1189/jlb.0903439; Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003	57	137	142	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25750	25763		10.1074/jbc.M114.569020	http://dx.doi.org/10.1074/jbc.M114.569020			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074926	hybrid, Green Published			2022-12-25	WOS:000342130800033
J	Yu, HJ; Rathore, SS; Gulbranson, DR; Shen, JS				Yu, Haijia; Rathore, Shailendra S.; Gulbranson, Daniel R.; Shen, Jingshi			The N- and C-terminal Domains of Tomosyn Play Distinct Roles in Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor Binding and Fusion Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION; SNARE COMPLEX; NEUROTRANSMITTER RELEASE; T-SNARE; EXOCYTOSIS; MUNC18C; SYNTAXIN; MECHANISMS; REVEALS; RECONSTITUTION	Tomosyn negatively regulates SNARE-dependent exocytic pathways including insulin secretion, GLUT4 exocytosis, and neurotransmitter release. The molecular mechanism of tomosyn, however, has not been fully elucidated. Here, we reconstituted SNARE-dependent fusion reactions in vitro to recapitulate the tomosyn-regulated exocytic pathways. We then expressed and purified active full-length tomosyn and examined how it regulates the reconstituted SNARE-dependent fusion reactions. Using these defined fusion assays, we demonstrated that tomosyn negatively regulates SNARE-mediated membrane fusion by inhibiting the assembly of the ternary SNARE complex. Tomosyn recognizes the t-SNARE complex and prevents its pairing with the v-SNARE, therefore arresting the fusion reaction at a pre-docking stage. The inhibitory function of tomosyn is mediated by its C-terminal domain (CTD) that contains an R-SNARE-like motif, confirming previous studies carried out using truncated tomosyn fragments. Interestingly, the N-terminal domain (NTD) of tomosyn is critical (but not sufficient) to the binding of tomosyn to the syntaxin monomer, indicating that full-length tomosyn possesses unique features not found in the widely studied CTD fragment. Finally, we showed that the inhibitory function of tomosyn is dominant over the stimulatory activity of the Sec1/Munc18 protein in fusion. We suggest that tomosyn uses its CTD to arrest SNARE-dependent fusion reactions, whereas its NTD is required for the recruitment of tomosyn to vesicle fusion sites through syntaxin interaction.	[Yu, Haijia; Rathore, Shailendra S.; Gulbranson, Daniel R.; Shen, Jingshi] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Shen, JS (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	jingshi.shen@colorado.edu	Yu, Haijia/GXV-5159-2022; Gulbranson, Daniel/AAE-4807-2020; Gulbranson, Daniel/AAE-4338-2020	Yu, Haijia/0000-0002-7193-8034; YU, HAIJIA/0000-0002-3049-7850; SHEN, JINGSHI/0000-0001-9595-1148	National Institutes of Health [R01DK095367]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK095367 (to J. S.).	Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Bhatnagar S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002323; Bielopolski N, 2014, J BIOL CHEM, V289, P17087, DOI 10.1074/jbc.M113.515296; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Burdina AO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026185; Burgoyne RD, 2007, CURR BIOL, V17, pR255, DOI 10.1016/j.cub.2007.02.006; Chen KY, 2011, P NATL ACAD SCI USA, V108, P18482, DOI 10.1073/pnas.1110184108; Cheviet S, 2006, J CELL SCI, V119, P2912, DOI 10.1242/jcs.03037; D'Andrea-Merrins M, 2007, J BIOL CHEM, V282, P16553, DOI 10.1074/jbc.M610818200; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Dybbs M, 2005, PLOS GENET, V1, P6, DOI 10.1371/journal.pgen.0010002; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Gracheva EO, 2007, J PHYSIOL-LONDON, V585, P705, DOI 10.1113/jphysiol.2007.138321; Gracheva EO, 2007, J NEUROSCI, V27, P10176, DOI 10.1523/JNEUROSCI.2339-07.2007; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Gracheva Elena O, 2010, Front Synaptic Neurosci, V2, P141, DOI 10.3389/fnsyn.2010.00141; Groffen AJA, 2005, J NEUROCHEM, V92, P554, DOI 10.1111/j.1471-4159.2004.02890.x; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Hu Zhitao, 2013, Elife, V2, pe00967, DOI 10.7554/eLife.00967; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Masuda ES, 1998, NEURON, V21, P479, DOI 10.1016/S0896-6273(00)80559-0; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; Oh E, 2009, DIABETES, V58, P1165, DOI 10.2337/db08-1059; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rathore SS, 2011, MOL BIOL CELL, V22, P2612, DOI 10.1091/mbc.E11-03-0190; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; Schollmeier Y, 2011, J BIOL CHEM, V286, P30582, DOI 10.1074/jbc.M111.269886; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Scott BL, 2003, METHOD ENZYMOL, V372, P274; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Sheu L, 2003, J BIOL CHEM, V278, P27556, DOI 10.1074/jbc.M303203200; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Williams AL, 2011, J BIOL CHEM, V286, P14542, DOI 10.1074/jbc.M110.215624; Yamamoto Y, 2010, J BIOL CHEM, V285, P40943, DOI 10.1074/jbc.M110.156893; Yamamoto Y, 2010, BIOCHEM BIOPH RES CO, V399, P24, DOI 10.1016/j.bbrc.2010.07.026; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x; Yu HJ, 2013, P NATL ACAD SCI USA, V110, pE3271, DOI 10.1073/pnas.1311232110; Yu HJ, 2013, J BIOL CHEM, V288, P18885, DOI 10.1074/jbc.M113.465450; Yu HJ, 2013, MOL BIOL CELL, V24, P1176, DOI 10.1091/mbc.E12-11-0810; Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015	75	18	18	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25571	25580		10.1074/jbc.M114.591487	http://dx.doi.org/10.1074/jbc.M114.591487			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25063806	Green Published, hybrid			2022-12-25	WOS:000342130800018
J	Zhang, DQ; Tong, X; Arthurs, B; Guha, A; Rui, LY; Kamath, A; Inoki, K; Yin, L				Zhang, Deqiang; Tong, Xin; Arthurs, Blake; Guha, Anirvan; Rui, Liangyou; Kamath, Avani; Inoki, Ken; Yin, Lei			Liver Clock Protein BMAL1 Promotes de Novo Lipogenesis through Insulin-mTORC2-AKT Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC LIPID-METABOLISM; ROTATING SHIFT WORK; ARNT-LIKE PROTEIN-1; MTOR COMPLEX 2; CIRCADIAN CLOCK; FATTY LIVER; INSULIN-RESISTANCE; MUTANT MICE; RICTOR; DISEASE	The clock protein BMAL1 (brain and muscle Arnt-like protein 1) participates in circadian regulation of lipid metabolism, but its contribution to insulin AKT-regulated hepatic lipid synthesis is unclear. Here we used both Bmal1(-/-) and acute liver-specific Bmal1-depleted mice to study the role of BMAL1 in refeeding-induced de novo lipogenesis in the liver. Both global deficiency and acute hepatic depletion of Bmal1 reduced lipogenic gene expression in the liver upon refeeding. Conversely, Bmal1 overexpression in mouse liver by adenovirus was sufficient to elevate the levels of mRNA of lipogenic enzymes. Bmal1(-/-) primary mouse hepatocytes displayed decreased levels of de novo lipogenesis and lipogenic enzymes, supporting the notion that BMAL1 regulates lipid synthesis in hepatocytes in a cell-autonomous manner. Both refed mouse liver and insulin-treated primary mouse hepatocytes showed impaired AKT activation in the case of either Bmal1 deficiency or Bmal1 depletion by adenoviral shRNA. Restoring AKT activity by a constitutively active mutant of AKT nearly normalized de novo lipogenesis in Bmal1(-/-) hepatocytes. Finally, Bmal1 deficiency or knockdown decreased the protein abundance of RICTOR, the key component of the mTORC2 complex, without affecting the gene expression of key factors of insulin signaling. Thus, our study uncovered a novel metabolic function of hepatic BMAL1 that promotes de novo lipogenesis via the insulin-mTORC2-AKT signaling during refeeding.	[Zhang, Deqiang; Tong, Xin; Arthurs, Blake; Guha, Anirvan; Rui, Liangyou; Kamath, Avani; Inoki, Ken; Yin, Lei] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Yin, L (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	Leiyin@umich.edu	Zhang, Deqiang/J-9199-2016	Guha, Anirvan/0000-0001-6018-1438; TONG, XIN/0000-0002-4832-8940	National Institutes of Health from NIDDK [K99/R00 DK077449, R01 DK099593, 094014]; Michigan Gastrointestinal Hormone Research Core Center [5P3ODKO34933]; University of Michigan Diabetes and Research Training Center [P60DK020572]; STEP Program at the University of Michigan - National Institutes of Health [R25 DK088752]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, K99DK077449, R01DK099593, R01DK094014, P30DK020572, R00DK077449, R25DK088752] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Michigan Gastrointestinal Hormone Research Core Center; University of Michigan Diabetes and Research Training Center; STEP Program at the University of Michigan - National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K99/R00 DK077449 and R01 DK099593 (to L. Y.) and R01 Grant 094014 (to L. R.) from NIDDK, pilot grants from the Michigan Gastrointestinal Hormone Research Core Center (5P3ODKO34933) and from the University of Michigan Diabetes and Research Training Center (P60DK020572) (to L. Y.), and by a pilot grant from the University of Michigan Diabetes and Research Training Center P60DK020572 (to X. T.).; Supported by the STEP Program at the University of Michigan funded by National Institutes of Health Grant R25 DK088752 (NIDDK).	Abu-Elheiga L, 2012, J BIOL CHEM, V287, P12578, DOI 10.1074/jbc.M111.309559; Ahmadieh H, 2014, DIABETES RES CLIN PR, V104, P53, DOI 10.1016/j.diabres.2014.01.003; Akcakanat A, 2007, BIOCHEM BIOPH RES CO, V362, P330, DOI 10.1016/j.bbrc.2007.07.151; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bakan I, 2012, CURR OPIN LIPIDOL, V23, P226, DOI 10.1097/MOL.0b013e328352dd03; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Cheung O, 2010, CURR OPIN GASTROEN, V26, P202, DOI 10.1097/MOG.0b013e328337b0c4; Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; De Bacquer D, 2009, INT J EPIDEMIOL, V38, P848, DOI 10.1093/ije/dyn360; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Haas JT, 2012, CELL METAB, V15, P873, DOI 10.1016/j.cmet.2012.05.002; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hardin PE, 2004, J BIOL RHYTHM, V19, P348, DOI 10.1177/0748730404268052; He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Inoue I, 2005, J ATHEROSCLER THROMB, V12, P169, DOI 10.5551/jat.12.169; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Kennaway DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065255; Knebel B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031812; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Leavens KF, 2011, CRIT REV BIOCHEM MOL, V46, P200, DOI 10.3109/10409238.2011.562481; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Lee J, 2013, MOL CELL BIOL, V33, P2327, DOI 10.1128/MCB.01421-12; Liu SH, 2013, NATURE, V502, P550, DOI 10.1038/nature12710; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Postic C, 2008, DIABETES METAB, V34, P643, DOI 10.1016/S1262-3636(08)74599-3; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Shearn CT, 2013, FREE RADICAL BIO MED, V65, P680, DOI 10.1016/j.freeradbiomed.2013.07.011; Sheng L, 2011, J BIOL CHEM, V286, P38128, DOI 10.1074/jbc.M111.256677; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Sookoian S, 2007, J INTERN MED, V261, P285, DOI 10.1111/j.1365-2796.2007.01766.x; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tong X, 2013, J BIOL CHEM, V288, P5417, DOI 10.1074/jbc.M112.433482; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wan M, 2011, CELL METAB, V14, P516, DOI 10.1016/j.cmet.2011.09.001; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Weickert MO, 2006, DIABETOLOGIA, V49, P1732, DOI 10.1007/s00125-006-0295-3; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yuan MS, 2012, J BIOL CHEM, V287, P29579, DOI 10.1074/jbc.M112.386854; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	68	69	72	5	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25925	25935		10.1074/jbc.M114.567628	http://dx.doi.org/10.1074/jbc.M114.567628			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25063808	Green Published, hybrid			2022-12-25	WOS:000342130800047
J	Friedlander, AM; Ballesteros, E; Fay, M; Sala, E				Friedlander, Alan M.; Ballesteros, Enric; Fay, Michael; Sala, Enric			Marine Communities on Oil Platforms in Gabon, West Africa: High Biodiversity Oases in a Low Biodiversity Environment	PLOS ONE			English	Article							RIGS-TO-REEFS; SANTA-BARBARA CHANNEL; FLOWER GARDEN BANKS; OFFSHORE OIL; FISH ASSEMBLAGES; CONTINENTAL-SHELF; TROPHIC STRUCTURE; ARTIFICIAL REEFS; GULF; SEA	The marine biodiversity of Gabon, West Africa has not been well studied and is largely unknown. Our examination of marine communities associated with oil platforms in Gabon is the first scientific investigation of these structures and highlights the unique ecosystems associated with them. A number of species previously unknown to Gabonese waters were recorded during our surveys on these platforms. Clear distinctions in benthic communities were observed between older, larger platforms in the north and newer platforms to the south or closer to shore. The former were dominated by a solitary cup coral, Tubastraea sp., whereas the latter were dominated by the barnacle Megabalanus tintinnabulum, but with more diverse benthic assemblages compared to the northerly platforms. Previous work documented the presence of limited zooxanthellated scleractinian corals on natural rocky substrate in Gabon but none were recorded on platforms. Total estimated fish biomass on these platforms exceeded one ton at some locations and was dominated by barracuda (Sphyraena spp.), jacks (Carangids), and rainbow runner (Elagatis bipinnulata). Thirty-four percent of fish species observed on these platforms are new records for Gabon and 6% are new to tropical West Africa. Fish assemblages closely associated with platforms had distinct amphi-Atlantic affinities and platforms likely extend the distribution of these species into coastal West Africa. At least one potential invasive species, the snowflake coral (Carijoa riisei), was observed on the platforms. Oil platforms may act as stepping stones, increasing regional biodiversity and production but they may also be vectors for invasive species. Gabon is a world leader in terrestrial conservation with a network of protected areas covering >10% of the country. Oil exploration and biodiversity conservation currently co-exist in terrestrial and freshwater ecosystems in Gabon. Efforts to increase marine protection in Gabon may benefit by including oil platforms in the marine protected area design process.	[Friedlander, Alan M.] Univ Hawaii, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Friedlander, Alan M.; Fay, Michael; Sala, Enric] Natl Geog Soc, Pristine Seas, Washington, DC USA; [Ballesteros, Enric; Sala, Enric] CSIC, Ctr Estudis Avancats, Blanes, Spain; [Fay, Michael] Wildlife Conservat Soc, Bronx, NY USA	University of Hawaii System; National Geographic Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Wildlife Conservation Society	Friedlander, AM (corresponding author), Univ Hawaii, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA.	alan.friedlander@hawaii.edu			Waitt Foundation; Blancpain; Davidoff Cool Water; National Geographic Society; Wildlife Conservation Society	Waitt Foundation; Blancpain; Davidoff Cool Water; National Geographic Society(National Geographic Society); Wildlife Conservation Society	This work was funded by the Waitt Foundation, Blancpain, Davidoff Cool Water, National Geographic Society, and the Wildlife Conservation Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso Pedro, 1999, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V17A, P65; Almada VC., 2013, FRONT BIOGEOGR, V5, P1, DOI [10.21425/F5FBG14493, DOI 10.21425/F5FBG14493, 10.21425/F55114493, DOI 10.21425/F55114493]; Arnand F., 1976, Bulletin Mus natn Hist nat Paris (Ecol gen), VNo. 30, P49; Atchison AD, 2008, J EXP MAR BIOL ECOL, V365, P1, DOI 10.1016/j.jembe.2008.07.002; Baudin F, 2010, MAR PETROL GEOL, V27, P995, DOI 10.1016/j.marpetgeo.2010.02.006; Bentahila Y, 2006, MAR GEOL, V226, P323, DOI 10.1016/j.margeo.2005.11.014; BIANCHI G, 1992, MAR ECOL PROG SER, V85, P9, DOI 10.3354/meps085009; Bohnsack J.A., 1991, P61; BOHNSACK JA, 1989, B MAR SCI, V44, P631; BULL AS, 1994, B MAR SCI, V55, P1086; Caselle JE, 2002, ICES J MAR SCI, V59, pS258, DOI 10.1006/jmsc.2002.1264; Cebrian E, 2000, OCEANOL ACTA, V23, P311, DOI 10.1016/S0399-1784(00)00131-6; Clarke K., 2001, PRIMER VERSION 5 USE; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Ferreira CEL, 2004, J BIOGEOGR, V31, P1093, DOI 10.1111/j.1365-2699.2004.01044.x; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Floeter SR, 2004, J FISH BIOL, V64, P1680, DOI 10.1111/j.0022-1112.2004.00428.x; Friedlander AM, 2013, AQUAT CONSERV, V23, P515, DOI 10.1002/aqc.2333; Friedlander AM, 2012, REV BIOL TROP, V60, P321; Gallaway BJ, 1981, 10BS8227 FWS; Gonzalez-Correa JM, 2005, J EXP MAR BIOL ECOL, V320, P65, DOI 10.1016/j.jembe.2004.12.032; Hamzah BA, 2003, MAR POLICY, V27, P339, DOI 10.1016/S0308-597X(03)00040-X; Helvey M, 2002, ICES J MAR SCI, V59, pS266, DOI 10.1006/jmsc.2002.1226; Jernelov A, 2010, AMBIO, V39, P353, DOI 10.1007/s13280-010-0085-5; Jorgensen T, 2002, ICES J MAR SCI, V59, pS288, DOI 10.1006/jmsc.2001.1165; Kritzer J.P., 2010, MARINE METAPOPULATIO; Laborel J., 1974, P 2 INT COR REEF S, V1, P425; Le Loeuff P, 1998, ACTA OECOL, V19, P309; Lee Michelle E., 2006, Bulletin of the Biological Society of Washington, V12, P229; Longhurst AR, 1987, ECOLOGY TROPICAL OCE; Love MS, 2006, FISH B-NOAA, V104, P383; Love MS, 2000, FISH B-NOAA, V98, P96; Ludwig J. A., 1988, STAT ECOLOGY; Macreadie PI, 2012, FRONT ECOL ENVIRON, V10, P179, DOI 10.1890/12.WB.013; Macreadie PI, 2011, FRONT ECOL ENVIRON, V9, P455, DOI 10.1890/100112; MCGLADE JM, 2002, GULF GUINEA LARGE MA; OLSGARD F, 1995, MAR ECOL PROG SER, V122, P277, DOI 10.3354/meps122277; Ondreas H, 2005, GEO-MAR LETT, V25, P281, DOI 10.1007/s00367-005-0213-6; Page HM, 2006, MAR ECOL PROG SER, V325, P101, DOI 10.3354/meps325101; Parente V, 2006, ENERG POLICY, V34, P1992, DOI 10.1016/j.enpol.2005.02.008; POLOVINA JJ, 1989, B MAR SCI, V44, P997; Pradella N, 2014, J FISH BIOL, V84, P247, DOI 10.1111/jfb.12274; Reggio V. C., 1989, PETROLEUM STRUCTURES, P47; Reid Gordon Mcgregor, 1996, Proceedings of the Royal Society of Edinburgh Section B (Biological Sciences), V104, P285; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rooker JR, 1997, CORAL REEFS, V16, P83, DOI 10.1007/s003380050062; Roy KOL, 2007, MAR ECOL-EVOL PERSP, V28, P115, DOI 10.1111/j.1439-0485.2006.00145.x; Sala E, 2003, B MAR SCI, V72, P103; Sala E, 1997, MAR ECOL PROG SER, V152, P273, DOI 10.3354/meps152273; Sammarco PW, 2010, AQUAT INVASIONS, V5, P131, DOI 10.3391/ai.2010.5.2.02; Sammarco PW, 2004, MAR ECOL PROG SER, V280, P129, DOI 10.3354/meps280129; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SCHELTEMA RS, 1995, AM MALACOL BULL, V11, P99; Scheltema RS, 1971, 4 EUR MAR BIOL S, P7; Schroeder DM, 2002, CAL COOP OCEAN FISH, V43, P182; Schroeder DM, 2004, OCEAN COAST MANAGE, V47, P21, DOI 10.1016/j.ocecoaman.2004.03.002; Seranne M, 2008, B SOC GEOL FR, V179, P29, DOI 10.2113/gssgfbull.179.1.29; Shipp RL, 2009, REV FISH SCI, V17, P41, DOI 10.1080/10641260802104244; Sibuet M, 2009, DEEP-SEA RES PT II, V56, P2156, DOI 10.1016/j.dsr2.2009.04.015; Smilauer tBa, 2002, CANOCO REFERENCE MAN; Soldal AV, 2002, ICES J MAR SCI, V59, pS281, DOI 10.1006/jmsc.2002.1279; STANLEY DR, 1990, FISH B-NOAA, V88, P719; STANLEY DR, 1989, B MAR SCI, V44, P767; Street GT, 1996, MAR BIOL, V126, P271, DOI 10.1007/BF00347452; Sumaila UR, 2012, CAN J FISH AQUAT SCI, V69, P499, DOI [10.1139/F2011-171, 10.1139/f2011-171]; ter Braak CJF, 1994, ECOSCIENCE, V1, P127, DOI 10.1080/11956860.1994.11682237; tersBraak C., 1995, AQUAT SCI, V57, P1; Trevors JT, 2010, WATER AIR SOIL POLL, V211, P1, DOI 10.1007/s11270-010-0527-5; Vanden Bossche JP, 1990, 181 CIFA FAO, V2; Voituriez B, 1982, RAPPORTS PROCES VERB, V180, P114; Wauthy B, 1983, OCEANOGR TROP, V18, P103; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; Wirtz P, 2003, J MAR BIOL ASSOC UK, V83, P735, DOI 10.1017/S0025315403007720h; Wirtz P, 2007, ZOOTAXA, P1, DOI 10.11646/zootaxa.1523.1.1; Wirtz Peter, 2012, Arquipelago-Life and Marine Sciences, P77; Wirtz P, 2013, SPIXIANA, V36, P113; Wirtz Peter, 2001, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V18A, P81; Wirtz Peter, 2004, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, P83; WOLFSON A, 1979, MAR ECOL PROG SER, V1, P81, DOI 10.3354/meps001081; Yeo DCJ, 2010, BIOFOULING, V26, P179, DOI 10.1080/08927010903402438; Zar J.H., 1999, BIOSTATISTICAL ANAL, P4	81	67	69	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103709	10.1371/journal.pone.0103709	http://dx.doi.org/10.1371/journal.pone.0103709			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083704	Green Submitted, Green Published, gold			2022-12-25	WOS:000339819800069
J	Soares, CC; Georg, I; Lampe, E; Lewis, L; Morgado, MG; Nicol, AF; Pinho, AA; Salles, RCS; Teixeira, SLM; Vicente, ACP; Viscidi, RP; Gomes, SA				Soares, Caroline C.; Georg, Ingebourg; Lampe, Elisabeth; Lewis, Lia; Morgado, Mariza G.; Nicol, Alcina F.; Pinho, Adriana A.; Salles, Regina C. S.; Teixeira, Sylvia L. M.; Vicente, Ana Carolina P.; Viscidi, Raphael P.; Gomes, Selma A.			HIV-1, HBV, HCV, HTLV, HPV-16/18, and Treponema pallidum Infections in a Sample of Brazilian Men Who Have Sex with Men	PLOS ONE			English	Article							INJECTION-DRUG USERS; C VIRUS-INFECTION; HPV INFECTION; BEHAVIORAL SURVEILLANCE; HIDDEN POPULATIONS; HEPATITIS-B; PREVALENCE; SEROPREVALENCE; TRANSMISSION; TYPE-1	Background: Men who have sex with men (MSM) are more vulnerable to blood-borne infections and/or sexually-transmitted infections (STI). This study was conducted to estimate the prevalences of mono and co-infections of HIV-1 and other blood-borne/STIs in a sample of MSM in Campinas, Brazil. Methods: Responding Driven Sampling (RDS) was used for recruitment of MSM. Serum samples collected from 558 MSM were analyzed for the presence of serological markers for HIV-1, HBV, HCV, HTLV, HPV-16/18, and T. pallidum infections. Results: The highest prevalences of infection in serum samples were found for HPV-16 and 18 (31.9% and 20.3%, respectively). Approximately 8% of the study population showed infection with HIV-1, and within that group, 27.5% had recently become infected with HIV-1. HBV infection and syphilis were detected in 11.4% and 10% of the study population, respectively, and the rates of HTLV and HCV infection were 1.5% and 1%, respectively. With the exception of HTLV, all other studied infections were usually found as co-infections rather then mono-infections. The rates of co-infection for HCV, HPV-18, and HIV-1 were the highest among the studied infections (100%, 83%, and 85%, respectively). Interestingly, HTLV infection was usually found as a mono-infection in the study group, whereas HCV was found only as a co-infection. Conclusions: The present findings highlight the need to educate the MSM population concerning their risk for STIs infections and methods of prevention. Campaigns to encourage vaccination against HBV and HPV could decrease the rates of these infections in MSM.	[Soares, Caroline C.; Gomes, Selma A.] IOC, Lab Virol Mol, Rio De Janeiro, Brazil; [Georg, Ingebourg] IPEC, Lab Anal Clin, Rio De Janeiro, Brazil; [Lampe, Elisabeth; Lewis, Lia] IOC, Lab Ref Nacl Hepatites Virais, Rio De Janeiro, Brazil; [Morgado, Mariza G.; Teixeira, Sylvia L. M.] IOC, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil; [Nicol, Alcina F.] IOC, Lab Interdisclinar Pesquisas Med, Rio De Janeiro, Brazil; [Pinho, Adriana A.] Inst Oswaldo Cruz, Posdoutoranda Lab Educ & Ambinete, Rio De Janeiro, Brazil; [Salles, Regina C. S.] Lab Municipal Patol Clin Campinas, Sao Paulo, Brazil; [Vicente, Ana Carolina P.] IOC, Lab Genet Mol & Microorganismos, Rio De Janeiro, Brazil; [Viscidi, Raphael P.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Johns Hopkins University	Gomes, SA (corresponding author), IOC, Lab Virol Mol, Rio De Janeiro, Brazil.	selma@ioc.fiocruz.br	Soares, Caroline Cordeiro/ABM-8961-2022; gomes, selma A/D-2762-2015	Lewis-Ximenez, Lia Laura/0000-0002-3447-4621; Viscidi, Raphael/0000-0002-7906-8002; Gomes, Selma/0000-0003-0233-3370	Oswaldo Cruz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI106701] Funding Source: NIH RePORTER	Oswaldo Cruz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Oswaldo Cruz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2011, SEMIN LIVER DIS, V31, P340, DOI 10.1055/s-0031-1297923; Amon JJ, 2008, CLIN INFECT DIS, V46, P1852, DOI 10.1086/588297; Backes DM, 2009, CANCER CAUSE CONTROL, V20, P449, DOI 10.1007/s10552-008-9276-9; Carneiro-Proietti ABF, 2006, REV PANAM SALUD PUBL, V19, P44, DOI 10.1590/S1020-49892006000100007; Dona MG, 2012, J CLIN VIROL, V54, P185, DOI 10.1016/j.jcv.2012.02.014; Frank Ove, 2000, SURV METHODOL, V26, P87; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Grangeiro A, 2009, CAD SAUDE PUBLICA, V25, P2053, DOI 10.1590/S0102-311X2009000900019; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Kahn J, 2002, CLIN INFECT DIS, V35, P1382, DOI 10.1086/343044; Kendall C, 2008, AIDS BEHAV, V12, pS97, DOI 10.1007/s10461-008-9390-4; Kerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504; LEPKOWSKI JM, 1991, J NUTR, V121, P416, DOI 10.1093/jn/121.3.416; Lu BB, 2011, CANCER EPIDEM BIOMAR, V20, P990, DOI 10.1158/1055-9965.EPI-10-1160; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; MARGOLIS HS, 1991, SEMIN LIVER DIS, V11, P84, DOI 10.1055/s-2008-1040427; Mello M, 2008, RES REPORT ASSESSMEN; Ministerio da Saude, 2011, B EP AIDS DST AN 8 1; Ministerio da Saude, 2012, B EP HEP VIR AN 3 1; Miralles-Guri C, 2009, J CLIN PATHOL, V62, P870, DOI 10.1136/jcp.2008.063149; Moriuchi H, 2013, PEDIATR INFECT DIS J, V32, P175, DOI 10.1097/INF.0b013e31827efc39; Nicol AF, 2013, J CLIN VIROL, V57, P147, DOI 10.1016/j.jcv.2013.02.007; Nicol AF, 2010, J CLIN VIROL, V47, P208, DOI 10.1016/j.jcv.2009.12.005; Nyitray AG, 2011, SEX TRANSM DIS, V38, P932, DOI 10.1097/OLQ.0b013e31822154f9; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Pando MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039834; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Parisi SG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-150; Pinto MT, 2012, REV INST MED TROP SP, V54, P123, DOI 10.1590/S0036-46652012000300002; Ramirez-Valles J, 2005, AIDS BEHAV, V9, P387, DOI 10.1007/s10461-005-9012-3; Ribeiro D, 2012, SEX TRANSM INFECT, V88, P32, DOI 10.1136/sextrans-2011-050066; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Cavalcanti AMS, 2012, BRAZ J INFECT DIS, V16, P157, DOI [10.1590/S1413-86702012000200009, 10.1016/S1413-8670(12)70298-2]; Semaan Salaam, 2002, AIDS Reviews, V4, P213; Souza CA, 1993, REV INST MED TROP SP, V35, P45; SUDMAN S, 1988, SCIENCE, V240, P991, DOI 10.1126/science.240.4855.991; Viscidi RP, 2003, J INFECT DIS, V187, P194, DOI 10.1086/346052	37	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e102676	10.1371/journal.pone.0102676	http://dx.doi.org/10.1371/journal.pone.0102676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083768	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800010
J	DiMeglio, LM; Staudt, G; Yu, HR; Davis, TM				DiMeglio, Laura M.; Staudt, Guenter; Yu, Hongrun; Davis, Thomas M.			A Phylogenetic Analysis of the Genus Fragaria (Strawberry) Using Intron-Containing Sequence from the ADH-1 Gene	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACERS; DIPLOID STRAWBERRY; NUCLEAR GENES; LINKAGE MAP; DNA; ROSACEAE; EVOLUTION; MARKERS; UTILITY; ORIGIN	The genus Fragaria encompasses species at ploidy levels ranging from diploid to decaploid. The cultivated strawberry, Fragariaxananassa, and its two immediate progenitors, F. chiloensis and F. virginiana, are octoploids. To elucidate the ancestries of these octoploid species, we performed a phylogenetic analysis using intron-containing sequences of the nuclear ADH-1 gene from 39 germplasm accessions representing nineteen Fragaria species and one outgroup species, Dasiphora fruticosa. All trees from Maximum Parsimony and Maximum Likelihood analyses showed two major clades, Clade A and Clade B. Each of the sampled octoploids contributed alleles to both major clades. All octoploid-derived alleles in Clade A clustered with alleles of diploid F. vesca, with the exception of one octoploid allele that clustered with the alleles of diploid F. mandshurica. All octoploid-derived alleles in clade B clustered with the alleles of only one diploid species, F. iinumae. When gaps encoded as binary characters were included in the Maximum Parsimony analysis, tree resolution was improved with the addition of six nodes, and the bootstrap support was generally higher, rising above the 50% threshold for an additional nine branches. These results, coupled with the congruence of the sequence data and the coded gap data, validate and encourage the employment of sequence sets containing gaps for phylogenetic analysis. Our phylogenetic conclusions, based upon sequence data from the ADH-1 gene located on F. vesca linkage group II, complement and generally agree with those obtained from analyses of protein-encoding genes GBSSI-2 and DHAR located on F. vesca linkage groups V and VII, respectively, but differ from a previous study that utilized rDNA sequences and did not detect the ancestral role of F. iinumae.	[DiMeglio, Laura M.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Yu, Hongrun] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA; [Davis, Thomas M.] Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire; Loma Linda University; University System Of New Hampshire; University of New Hampshire	Davis, TM (corresponding author), Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA.	tom.davis@unh.edu			USDA-CSREES NRI Plant Genome Grant [2008-35300-04411]; New Hampshire Agricultural Experiment Station	USDA-CSREES NRI Plant Genome Grant(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); New Hampshire Agricultural Experiment Station	Partial funding in support of this research was provided by USDA-CSREES NRI Plant Genome Grant 2008-35300-04411, and also by the New Hampshire Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRINGHURST RS, 1990, HORTSCIENCE, V25, P879, DOI 10.21273/HORTSCI.25.8.879; BRINGHURST RS, 1970, AM J BOT, V57, P969, DOI 10.2307/2440994; Clegg MT, 1997, P NATL ACAD SCI USA, V94, P7791, DOI 10.1073/pnas.94.15.7791; Darrow G.M., 1966, STRAWBERRY; Davis TM, 2010, ACTA HORTIC, V859, P221; Davis TM, 2009, ACTA HORTIC, V842, P533; Davis TM, 2006, J AM SOC HORTIC SCI, V131, P506, DOI 10.21273/JASHS.131.4.506; Davis TM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-81; Davis TM, 1997, J HERED, V88, P215, DOI 10.1093/oxfordjournals.jhered.a023091; DAVIS TM, 2004, PLANT ANIMAL GENOME, V12; Deng C, 2001, THEOR APPL GENET, V103, P316, DOI 10.1007/s001220100648; DiMeglio L, 2003, RESOLVING RETICULTE; Eriksson T, 1998, PLANT SYST EVOL, V211, P155, DOI 10.1007/BF00985357; Eriksson T, 2003, INT J PLANT SCI, V164, P197, DOI 10.1086/346163; FEDOROVA N. J., 1946, Doklady Akademii nauk SSSR, V52, P545; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Folta KM, 2006, CRIT REV PLANT SCI, V25, P399, DOI 10.1080/07352680600824831; Fujita MK, 2004, MOL PHYLOGENET EVOL, V31, P1031, DOI 10.1016/j.ympev.2003.09.016; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hancock J.F., 1999, STRAWBERRIES, P25; HANFSTINGL U, 1994, GENETICS, V138, P811; Harrison RE, 1997, J AM SOC HORTIC SCI, V122, P63, DOI 10.21273/JASHS.122.1.63; Howarth DG, 2002, MOL PHYLOGENET EVOL, V23, P525, DOI 10.1016/S1055-7903(02)00035-0; Hummer KE, 2008, HORTSCIENCE, V43, P1623, DOI 10.21273/HORTSCI.43.5.1623; Hummer KE, 2006, HORTSCIENCE, V41, P993; Hummer Kim E., 2012, Journal of the Botanical Research Institute of Texas, V6, P9; Hummer KE, 2009, AM J BOT, V96, P713, DOI 10.3732/ajb.0800285; Ichijima K, 1926, GENETICS, V11, P590; Iketani H, 2010, JAP J BOT, V26, P13; Kawakita A, 2003, MOL BIOL EVOL, V20, P87, DOI 10.1093/molbev/msg007; Lei JJ, 2005, HORTSCIENCE, V40, P1194, DOI 10.21273/HORTSCI.40.5.1194; Lin J, 2000, THEOR APPL GENET, V101, P415, DOI 10.1007/s001220051498; Lin J, 2000, THESIS, P96; Liu B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-157; Lundberg M, 2009, MOL PHYLOGENET EVOL, V51, P269, DOI 10.1016/j.ympev.2009.02.020; Mahoney LL, 2010, ACTA HORTIC, V859, P301, DOI 10.17660/ActaHortic.2010.859.35; Monfort A, 2006, MOL ECOL NOTES, V6, P197, DOI 10.1111/j.1471-8286.2005.01191.x; MORGAN DR, 1994, AM J BOT, V81, P890, DOI 10.2307/2445770; Ogden TH, 2007, MOL PHYLOGENET EVOL, V42, P817, DOI 10.1016/j.ympev.2006.07.021; Oh SH, 2003, MOL PHYLOGENET EVOL, V29, P203, DOI 10.1016/S1055-7903(03)00093-9; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Potter D, 2000, SYST BOT, V25, P337, DOI 10.2307/2666646; Rousseau-Gueutin M, 2009, MOL PHYLOGENET EVOL, V51, P515, DOI 10.1016/j.ympev.2008.12.024; Sambrook J., 2001, MOL CLONING LAB MANU; Sang T, 2002, CRIT REV BIOCHEM MOL, V37, P121, DOI 10.1080/10409230290771474; Sang T, 1999, SYST BOT, V24, P148, DOI 10.2307/2419546; Sargent DJ, 2007, THEOR APPL GENET, V114, P373, DOI 10.1007/s00122-006-0441-9; Sargent DJ, 2006, THEOR APPL GENET, V112, P1349, DOI 10.1007/s00122-006-0237-y; Sargent DJ, 2004, ANN BOT-LONDON, V94, P787, DOI 10.1093/aob/mch217; Sargent DJ, 2004, THEOR APPL GENET, V109, P1385, DOI 10.1007/s00122-004-1767-9; Sargent DJ, 2009, GENETICS GENOMICS RO; SENANAYAKE YD, 1967, AM J BOT, V54, P221, DOI 10.2307/2440801; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Small RL, 1998, AM J BOT, V85, P1301, DOI 10.2307/2446640; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; STAUDT G, 1973, Willdenowia, V7, P101; Staudt G, 2009, ACTA HORTIC, V842, P71; Staudt G., 1999, U CALIFORNIA PUBLICA, V81; Staudt G., 2005, BOT JAHR SYST PFLANZ, V126, P163, DOI [10.1127/0006-8152/2005/0126-0163, DOI 10.1127/0006-8152/2005/0126-0163]; Staudt G., 1989, ACTA HORTIC, V265, P23, DOI [10.17660/ActaHortic.1989.265.1, DOI 10.17660/ACTAHORTIC.1989.265.1]; Staudt Guenter, 2003, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V124, P397, DOI 10.1127/0006-8152/2003/0124-0397; Staudt Guenter, 2001, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V123, P341; Staudt Guenter, 2008, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V127, P317, DOI 10.1127/0006-8152/2008/0127-0317; Staudt Guenter, 2006, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V126, P483, DOI 10.1127/0006-8152/2006/0126-0483; Staudt Gunter, 2003, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V125, P53, DOI 10.1127/0006-8152/2003/0125-0053; Swofford DL, 2001, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TORRES AM, 1993, THEOR APPL GENET, V85, P937, DOI 10.1007/BF00215032; Vilanova S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-67; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; WOLYN DJ, 1990, PLANT MOL BIOL, V14, P855, DOI 10.1007/BF00016518	73	30	34	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102237	10.1371/journal.pone.0102237	http://dx.doi.org/10.1371/journal.pone.0102237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078607	Green Published, gold			2022-12-25	WOS:000339954800011
J	Freeman, CM; Stolberg, VR; Crudgington, S; Martinez, FJ; Han, MK; Chensue, SW; Arenberg, DA; Meldrum, CA; McCloskey, L; Curtis, JL				Freeman, Christine M.; Stolberg, Valerie R.; Crudgington, Sean; Martinez, Fernando J.; Han, MeiLan K.; Chensue, Stephen W.; Arenberg, Douglas A.; Meldrum, Catherine A.; McCloskey, Lisa; Curtis, Jeffrey L.			Human CD56+Cytotoxic Lung Lymphocytes Kill Autologous Lung Cells in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							CD8(+) T-CELLS; VOLUME-REDUCTION SURGERY; SMOKE-INDUCED EMPHYSEMA; NATURAL-KILLER; MOUSE MODEL; NK CELLS; CYTOTOXIC FUNCTION; EFFECTOR FUNCTION; MEDICAL THERAPY; COPD	CD56+ natural killer (NK) and CD56+ T cells, from sputum or bronchoalveolar lavage of subjects with chronic obstructive pulmonary disease (COPD) are more cytotoxic to highly susceptible NK targets than those from control subjects. Whether the same is true in lung parenchyma, and if NK activity actually contributes to emphysema progression are unknown. To address these questions, we performed two types of experiments on lung tissue from clinically-indicated resections (n = 60). First, we used flow cytometry on fresh single-cell suspension to measure expression of cell-surface molecules (CD56, CD16, CD8, NKG2D and NKp44) on lung lymphocytes and of the 6D4 epitope common to MICA and MICB on lung epithelial (CD326+) cells. Second, we sequentially isolated CD56+, CD8+ and CD4+ lung lymphocytes, co-cultured each with autologous lung target cells, then determined apoptosis of individual target cells using Annexin-V and 7-AAD staining. Lung NK cells (CD56+ CD3-) and CD56+ T cells (CD56+ CD3+) were present in a range of frequencies that did not differ significantly between smokers without COPD and subjects with COPD. Lung NK cells had a predominantly "cytotoxic'' CD56+ CD16+ phenotype; their co-expression of CD8 was common, but the percentage expressing CD8 fell as FEV1 % predicted decreased. Greater expression by autologous lung epithelial cells of the NKG2D ligands, MICA/MICB, but not expression by lung CD56+ cells of the activating receptor NKG2D, correlated inversely with FEV1 % predicted. Lung CD56+ lymphocytes, but not CD4+ or CD8+ conventional lung T cells, rapidly killed autologous lung cells without additional stimulation. Such natural cytotoxicity was increased in subjects with severe COPD and was unexplained in multiple regression analysis by age or cancer as indication for surgery. These data show that as spirometry worsens in COPD, CD56+ lung lymphocytes exhibit spontaneous cytotoxicity of autologous structural lung cells, supporting their potential role in emphysema progression.	[Freeman, Christine M.; Stolberg, Valerie R.] VA Ann Arbor Healthcare Syst, Res Serv, Ann Arbor, MI 48105 USA; [Freeman, Christine M.; Crudgington, Sean; Martinez, Fernando J.; Han, MeiLan K.; Arenberg, Douglas A.; Meldrum, Catherine A.; McCloskey, Lisa; Curtis, Jeffrey L.] Univ Michigan Hlth Syst, Dept Internal Med, Dept Pulm & Crit Care Med, Ann Arbor, MI USA; [Chensue, Stephen W.; Curtis, Jeffrey L.] Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Chensue, Stephen W.] VA Ann Arbor Healthcare Syst, Pathol & Lab Med Serv, Ann Arbor, MI USA; [Chensue, Stephen W.] Univ Michigan Hlth Syst, Dept Pathol, Ann Arbor, MI USA; [Curtis, Jeffrey L.] VA Ann Arbor Healthcare Syst, Med Serv, Pulm & Crit Care Med Sect, Ann Arbor, MI USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Freeman, CM (corresponding author), VA Ann Arbor Healthcare Syst, Res Serv, Ann Arbor, MI 48105 USA.	cmfreema@umich.edu	Arenberg, Douglas/P-7251-2014	Arenberg, Douglas/0000-0001-7707-5092; Curtis, Jeffrey/0000-0001-5191-4847	Biomedical Laboratory Research & Development Service, Department of Veterans Affairs [1 I01 BX001389]; United States Public Health Service [R01 HL082480, K23 HL093351, K24 HL04212]; Tissue Procurement Core of the University of Michigan Comprehensive Cancer Center [P30 CA46952]; Lung Tissue Research Consortium (Clinical Centers) [N01 HR046162]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL093351, K24HL004212, R01HL082480] Funding Source: NIH RePORTER	Biomedical Laboratory Research & Development Service, Department of Veterans Affairs(US Department of Veterans Affairs); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Tissue Procurement Core of the University of Michigan Comprehensive Cancer Center; Lung Tissue Research Consortium (Clinical Centers); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Sources of support Merit Review Award 1 I01 BX001389 from the Biomedical Laboratory Research & Development Service, Department of Veterans Affairs (C.M.F.); R01 HL082480 (J.L.C.), K23 HL093351 (M.K.H.), and K24 HL04212 (F.J.M.) from the United States Public Health Service. These investigations were also supported in part by the Tissue Procurement Core of the University of Michigan Comprehensive Cancer Center, Grant P30 CA46952; and by the Lung Tissue Research Consortium (Clinical Centers), grant N01 HR046162. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar T, 2008, NATURAL KILLER T CEL; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Beziat V, 2011, J IMMUNOL, V186, P6753, DOI 10.4049/jimmunol.1100330; Borchers MT, 2007, EXP MOL PATHOL, V83, P301, DOI 10.1016/j.yexmp.2007.08.020; Borchers MT, 2006, AM J PHYSIOL-LUNG C, V291, pL222, DOI 10.1152/ajplung.00327.2005; Borchers MT, 2009, J CLIN INVEST, V119, P636, DOI 10.1172/JCI34462; Campbell KS, 2013, J ALLERGY CLIN IMMUN, V132, P536, DOI 10.1016/j.jaci.2013.07.006; Carbone E, 1999, EUR J IMMUNOL, V29, P4022, DOI 10.1002/(SICI)1521-4141(199912)29:12<4022::AID-IMMU4022>3.3.CO;2-F; Chi SY, 2012, RESPIROLOGY, V17, P486, DOI 10.1111/j.1440-1843.2011.02104.x; Culley FJ, 2009, IMMUNOLOGY, V128, P151, DOI 10.1111/j.1365-2567.2009.03167.x; Curtis Jeffrey L, 2007, Proc Am Thorac Soc, V4, P512, DOI 10.1513/pats.200701-002FM; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Esin S, 2008, INFECT IMMUN, V76, P1719, DOI 10.1128/IAI.00870-07; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Forsslund H, 2014, CHEST, V145, P711, DOI 10.1378/chest.13-0873; Freeman CM, 2007, AM J PATHOL, V171, P767, DOI 10.2353/ajpath.2007.061177; Freeman CM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-13; Freeman CM, 2010, J IMMUNOL, V184, P6504, DOI 10.4049/jimmunol.1000006; Gao B, 2011, HEPATOLOGY, V53, P1076, DOI 10.1002/hep.24275; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hodge G, 2013, RESPIROLOGY, V18, P369, DOI 10.1111/j.1440-1843.2012.02287.x; Hodge S, 2005, EUR RESPIR J, V25, P447, DOI 10.1183/09031936.05.00077604; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Imai K, 2005, EUR RESPIR J, V25, P250, DOI 10.1183/09031936.05.00023704; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Maeno T, 2007, J IMMUNOL, V178, P8090, DOI 10.4049/jimmunol.178.12.8090; Majo J, 2001, EUR RESPIR J, V17, P946, DOI 10.1183/09031936.01.17509460; Martinez FJ, 2008, AM J RESP CRIT CARE, V178, P491, DOI 10.1164/rccm.200709-1383OC; McCubbrey AL, 2012, J IMMUNOL, V189, P112, DOI 10.4049/jimmunol.1200984; Michel T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051230; Minino Arialdi M, 2010, Natl Vital Stat Rep, V59, P1; Morice WG, 2007, AM J CLIN PATHOL, V127, P881, DOI 10.1309/Q49CRJ030L22MHLF; Motz GT, 2010, AM J RESP CRIT CARE, V181, P1223, DOI 10.1164/rccm.200910-1485OC; Motz GT, 2010, J IMMUNOL, V184, P4460, DOI 10.4049/jimmunol.0903654; Motz GT, 2008, J IMMUNOL, V181, P8036, DOI 10.4049/jimmunol.181.11.8036; Naunheim KS, 2006, ANN THORAC SURG, V82, P431, DOI 10.1016/j.athoracsur.2006.05.069; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Piet B, 2011, J CLIN INVEST, V121, P2254, DOI 10.1172/JCI44675; Poggi A, 2005, J IMMUNOL, V175, P6352, DOI 10.4049/jimmunol.175.10.6352; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Roos-Engstrand E, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-128; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Shi FD, 2011, NAT REV IMMUNOL, V11, P658, DOI 10.1038/nri3065; Shimoda S, 2011, HEPATOLOGY, V53, P1270, DOI 10.1002/hep.24194; Solana R, 2000, VACCINE, V18, P1613, DOI 10.1016/S0264-410X(99)00495-8; Spaggiari GM, 2001, EUR J IMMUNOL, V31, P1656, DOI 10.1002/1521-4141(200106)31:6<1656::AID-IMMU1656>3.0.CO;2-V; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Stolberg VR, 2014, AM J PATHOL, V184, P454, DOI 10.1016/j.ajpath.2013.10.017; Sullivan AK, 2005, AM J RESP CRIT CARE, V172, P590, DOI 10.1164/rccm.200410-1332OC; Urbanowicz RA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-76; Urbanowicz RA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-53; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; Wortham BW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078735; Wortham BW, 2012, J IMMUNOL, V188, P4468, DOI 10.4049/jimmunol.1102643	58	35	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103840	10.1371/journal.pone.0103840	http://dx.doi.org/10.1371/journal.pone.0103840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078269	Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800088
J	Lee, JH; Pooley, NJ; Mohd-Adnan, A; Martin, SAM				Lee, Jun-Hoe; Pooley, Nicholas J.; Mohd-Adnan, Adura; Martin, Samuel A. M.			Cloning and Characterisation of Multiple Ferritin Isoforms in the Atlantic Salmon (Salmo salar)	PLOS ONE			English	Article							GENE-EXPRESSION; TREMATOMUS-BERNACCHII; IRON HOMEOSTASIS; EVOLUTION; PROTEIN; CELLS; PHYLOGENY; RESPONSES; IMMUNITY	Ferritin is a highly-conserved iron-storage protein that has also been identified as an acute phase protein within the innate immune system. The iron-storage function is mediated through complementary roles played by heavy (H)-chain subunit as well as the light (L) in mammals or middle (M)-chain in teleosts, respectively. In this study, we report the identification of five ferritin subunits (H1, H2, M1, M2, M3) in the Atlantic salmon that were supported by the presence of iron-regulatory regions, gene structure, conserved domains and phylogenetic analysis. Tissue distribution analysis across eight different tissues showed that each of these isoforms is differentially expressed. We also examined the expression of the ferritin isoforms in the liver and kidney of juvenile Atlantic salmon that was challenged with Aeromonas salmonicida as well as in muscle cell culture stimulated with interleukin-1 beta. We found that each isoform displayed unique expression profiles, and in certain conditions the expressions between the isoforms were completely diametrical to each other. Our study is the first report of multiple ferritin isoforms from both the H- and M-chains in a vertebrate species, as well as ferritin isoforms that showed decreased expression in response to infection. Taken together, the results of our study suggest the possibility of functional differences between the H- and M-chain isoforms in terms of tissue localisation, transcriptional response to bacterial exposure and stimulation by specific immune factors.	[Lee, Jun-Hoe; Pooley, Nicholas J.; Martin, Samuel A. M.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Lee, Jun-Hoe; Mohd-Adnan, Adura] Univ Kebangsaan, Fac Sci & Technol, Sch Biosci & Biotechnol, Selangor, Malaysia; [Mohd-Adnan, Adura] Minist Sci Technol & Innovat, Malaysia Genome Inst, Selangor, Malaysia	University of Aberdeen; Universiti Kebangsaan Malaysia	Martin, SAM (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.	sam.martin@abdn.ac.uk	Lee, Jun-Hoe/F-4197-2017	Lee, Jun-Hoe/0000-0002-6331-3472; Martin, Samuel/0000-0003-0289-6317	Malaysian Ministry of Science, Technology and Innovation [07-05-MGI-GMB009]; Universiti Kebangsaan Malaysia [UKM-DLP-2011-027]; Biotechnology and Biological Sciences Research Council, UK studentship at the University of Aberdeen	Malaysian Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Universiti Kebangsaan Malaysia; Biotechnology and Biological Sciences Research Council, UK studentship at the University of Aberdeen	This work was supported by a grant from the Malaysian Ministry of Science, Technology and Innovation (07-05-MGI-GMB009) and Universiti Kebangsaan Malaysia (UKM-DLP-2011-027). NJP was supported by a Biotechnology and Biological Sciences Research Council, UK studentship at the University of Aberdeen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN O, 1995, MOL MAR BIOL BIOTECH, V4, P164; Arosio P, 2010, BBA-GEN SUBJECTS, V1800, P783, DOI 10.1016/j.bbagen.2010.02.005; Bower NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011100; Burns M, 2008, EUR FOOD RES TECHNOL, V226, P1513, DOI 10.1007/s00217-007-0683-z; Bury N, 2003, COMP BIOCHEM PHYS C, V135, P97, DOI 10.1016/S1532-0456(03)00021-8; Campillos M, 2010, NUCLEIC ACIDS RES, V38, pW360, DOI 10.1093/nar/gkq371; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Ceciliani F, 2002, PROTEIN PEPTIDE LETT, V9, P211, DOI 10.2174/0929866023408779; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; DICKEY LF, 1987, J BIOL CHEM, V262, P7901; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Giorgi A, 2008, ARCH BIOCHEM BIOPHYS, V478, P69, DOI 10.1016/j.abb.2008.06.022; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hashimoto S, 1999, BLOOD, V94, P837, DOI 10.1182/blood.V94.3.837.413k02_837_844; Hilton KB, 2008, GENE, V415, P40, DOI 10.1016/j.gene.2008.02.016; Hu YH, 2010, FISH SHELLFISH IMMUN, V28, P678, DOI 10.1016/j.fsi.2010.01.001; Ingerslev HC, 2006, MOL IMMUNOL, V43, P1194, DOI 10.1016/j.molimm.2005.07.009; Jain S, 2011, J PHARM BIOALLIED SC, V3, P118, DOI 10.4103/0975-7406.76489; Ju Z, 2002, MOL GENET GENOMICS, V268, P87, DOI 10.1007/s00438-002-0727-9; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Lawson MJ, 2009, NUCLEIC ACIDS RES, V37, P4570, DOI 10.1093/nar/gkp421; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lee J-H, 2012, TRENDS EVOL BIOL, V4, pe3, DOI [10.4081/eb.2012.e3, DOI 10.4081/EB.2012.E3]; Marsden MJ, 1996, INFECT IMMUN, V64, P3863, DOI 10.1128/IAI.64.9.3863-3869.1996; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; MATSCHAK TW, 1995, EXPERIENTIA, V51, P260, DOI 10.1007/BF01931109; Mignogna G, 2002, EUR J BIOCHEM, V269, P1600, DOI 10.1046/j.1432-1327.2002.02762.x; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Neves JV, 2009, DEV COMP IMMUNOL, V33, P848, DOI 10.1016/j.dci.2009.02.001; Ong ST, 2006, IMMUNOBIOLOGY, V211, P295, DOI 10.1016/j.imbio.2006.02.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Pooley NJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-747; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Quaresima B, 1994, GENOME RES, V4, P85; Recalcati S, 2008, J AUTOIMMUN, V30, P84, DOI 10.1016/j.jaut.2007.11.003; Takezaki N, 2003, MOL BIOL EVOL, V20, P287, DOI 10.1093/molbev/msg040; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vegusdal A, 2004, LIPIDS, V39, P649, DOI 10.1007/s11745-004-1278-3; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Yamashita M, 1996, J BIOL CHEM, V271, P26908, DOI 10.1074/jbc.271.43.26908; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Ye JM, 2011, DEV COMP IMMUNOL, V35, P1273, DOI 10.1016/j.dci.2011.03.005; Zhang X, 2010, FISH SHELLFISH IMMUN, V28, P735, DOI 10.1016/j.fsi.2009.11.027; Zheng WJ, 2010, FISH SHELLFISH IMMUN, V28, P829, DOI 10.1016/j.fsi.2010.01.013	53	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103729	10.1371/journal.pone.0103729	http://dx.doi.org/10.1371/journal.pone.0103729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078784	gold, Green Published, Green Submitted			2022-12-25	WOS:000339954800072
J	Mahdavi-Arab, N; Meyer, ST; Mehrparvar, M; Weisser, WW				Mahdavi-Arab, Nafiseh; Meyer, Sebastian T.; Mehrparvar, Mohsen; Weisser, Wolfgang W.			Complex Effects of Fertilization on Plant and Herbivore Performance in the Presence of a Plant Competitor and Activated Carbon	PLOS ONE			English	Article							INSECT HERBIVORES; ANTAGONISTIC INTERACTIONS; NITROGEN-FERTILIZATION; CEREAL APHIDS; BOTTOM-UP; GROWTH; HOMOPTERA; REPRODUCTION; DEFOLIATION; PREDATORS	Plant-herbivore interactions are influenced by host plant quality which in turn is affected by plant growth conditions. Competition is the major biotic and nutrient availability a major abiotic component of a plant's growth environment. Yet, surprisingly few studies have investigated impacts of competition and nutrient availability on herbivore performance and reciprocal herbivore effects on plants. We studied growth of the specialist aphid, Macrosiphoniella tanacetaria, and its host plant tansy, Tanacetum vulgare, under experimental addition of inorganic and organic fertilizer crossed with competition by goldenrod, Solidago canadensis. Because of evidence that competition by goldenrod is mediated by allelopathic compounds, we also added a treatment with activated carbon. Results showed that fertilization increased, and competition with goldenrod decreased, plant biomass, but this was likely mediated by resource competition. There was no evidence from the activated carbon treatment that allelopathy played a role which instead had a fertilizing effect. Aphid performance increased with higher plant biomass and depended on plant growth conditions, with fertilization and AC increasing, and plant competition decreasing aphid numbers. Feedbacks of aphids on plant performance interacted with plant growth conditions in complex ways depending on the relative magnitude of the effects on plant biomass and aphid numbers. In the basic fertilization treatment, tansy plants profited from increased nutrient availability by accumulating more biomass than they lost due to an increased number of aphids under fertilization. When adding additional fertilizer, aphid numbers increased so high that tansy plants suffered and showed reduced biomass compared with controls without aphids. Thus, the ecological cost of an infestation with aphids depends on the balance of effects of growth conditions on plant and herbivore performance. These results emphasize the importance to investigate both perspectives in plant herbivore interactions and characterize the effects of growth conditions on plant and herbivore performance and their respective feedbacks.	[Mahdavi-Arab, Nafiseh] Univ Jena, Inst Ecol, Jena, Germany; [Mahdavi-Arab, Nafiseh; Meyer, Sebastian T.; Weisser, Wolfgang W.] Tech Univ Munich, Sch Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Germany; [Mehrparvar, Mohsen] Grad Univ Adv Technol, Inst Sci & High Technol & Environm Sci, Dept Biodivers, Kerman, Iran	Friedrich Schiller University of Jena; Technical University of Munich; Graduate University of Advanced Technology	Meyer, ST (corresponding author), Tech Univ Munich, Sch Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Germany.	sebastian.t.meyer@tum.de	Weisser, Wolfgang W/B-9718-2014; Meyer, Sebastian Tobias/AAH-3856-2021	Weisser, Wolfgang W/0000-0002-2757-8959; Meyer, Sebastian Tobias/0000-0003-0833-1472; Mehrparvar, Mohsen/0000-0002-6051-5845	TUM Diversity Scholarship; German Research Foundation (DFG); Technische Universitat Munchen;  [WE 3081/15-2]	TUM Diversity Scholarship; German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen; 	This study was financially supported by grant WE 3081/15-2 and by a TUM Diversity Scholarship to NMA. Publication of this work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding program open access publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilasha D, 2008, J ECOL, V96, P993, DOI 10.1111/j.1365-2745.2008.01413.x; ADDICOTT JF, 1978, CAN J ZOOL, V56, P2554, DOI 10.1139/z78-343; Agrawal AA, 2004, AM NAT, V164, P113, DOI 10.1086/420980; [Anonymous], 2015, SPRINGERPLUS, DOI DOI 10.1186/s40064-015-1263-5; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; BELSKY AJ, 1986, AM NAT, V127, P870, DOI 10.1086/284531; Bethke JA, 1998, ENTOMOL EXP APPL, V88, P41, DOI 10.1023/A:1003208222531; Blackman RL, 2006, APHIDS WORLDS HERBAC; Butcko VM, 2002, AM MIDL NAT, V148, P253, DOI 10.1674/0003-0031(2002)148[0253:EOTSAA]2.0.CO;2; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.2307/3868432; Cappuccino N, 2006, BIOL LETTERS, V2, P189, DOI 10.1098/rsbl.2005.0433; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; CHOUDHURY D, 1984, OIKOS, V43, P401, DOI 10.2307/3544159; Cisneros JJ, 2001, ENVIRON ENTOMOL, V30, P501, DOI 10.1603/0046-225X-30.3.501; CRAWLEY MJ, 1989, ANNU REV ENTOMOL, V34, P531, DOI 10.1146/annurev.en.34.010189.002531; de Sassi C, 2012, ECOLOGY, V93, P1892, DOI 10.1890/11-1839.1; Duffield SJ, 1997, ANN APPL BIOL, V130, P13, DOI 10.1111/j.1744-7348.1997.tb05779.x; EDELSTEINKESHET L, 1986, J MATH BIOL, V24, P25, DOI 10.1007/BF00275719; FOSTER WA, 1984, OIKOS, V42, P97, DOI 10.2307/3544614; FOWLER N, 1986, ANNU REV ECOL SYST, V17, P89, DOI 10.1146/annurev.es.17.110186.000513; Garratt MPD, 2010, AGR FOREST ENTOMOL, V12, P307, DOI 10.1111/j.1461-9563.2010.00480.x; Gash AFJ, 2012, AGRONOMY-BASEL, V2, P1, DOI 10.3390/agronomy2010001; Haag JJ, 2004, J ECOL, V92, P156, DOI 10.1111/j.1365-2745.2004.00847.x; Hartvigsen G, 1995, OIKOS, V74, P463, DOI 10.2307/3545991; Hassell MP., 1978, DYNAMICS ARTHROPOD P; Hierro JL, 2003, PLANT SOIL, V256, P29, DOI 10.1023/A:1026208327014; Holman J., 2009, HOST PLANT CATALOGUE; Inderjit, 2003, PLANT SOIL, V256, P1, DOI 10.1023/A:1026242418333; Inderjit, 2006, TRENDS PLANT SCI, V11, P574, DOI 10.1016/j.tplants.2006.10.004; Kleine S, 2013, PHYTOCHEMISTRY, V96, P123, DOI 10.1016/j.phytochem.2013.09.018; Ladner DT, 2005, ENTOMOL EXP APPL, V116, P9, DOI 10.1111/j.1570-7458.2005.00308.x; Lau JA, 2008, NEW PHYTOL, V178, P412, DOI 10.1111/j.1469-8137.2007.02360.x; LEE TD, 1980, J ECOL, V68, P813, DOI 10.2307/2259457; Louda S. M., 1990, Perspectives on plant competition., P413; LOUDA SM, 1992, ECOLOGY, V73, P153, DOI 10.2307/1938728; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; MCNAUGHTON SJ, 1986, AM NAT, V128, P765, DOI 10.1086/284602; MCNAUGHTON SJ, 1985, ECOLOGY, V66, P1617, DOI 10.2307/1938024; Mehrparvar M, 2013, BIOL CONTROL, V65, P142, DOI 10.1016/j.biocontrol.2012.12.009; Meyer GA, 1996, ECOL ENTOMOL, V21, P270, DOI 10.1111/j.1365-2311.1996.tb01244.x; MITICH LW, 1992, WEED TECHNOL, V6, P242, DOI 10.1017/S0890037X00034643; Muller CB, 2005, OECOLOGIA, V143, P419, DOI 10.1007/s00442-004-1795-9; Nevo E, 2001, J ECON ENTOMOL, V94, P27, DOI 10.1603/0022-0493-94.1.27; Newingham BA, 2006, OIKOS, V114, P397, DOI 10.1111/j.2006.0030-1299.14345.x; Nowak H, 2010, OECOLOGIA, V163, P973, DOI 10.1007/s00442-010-1652-y; Perkins MC, 2004, ARCH INSECT BIOCHEM, V55, P153, DOI 10.1002/arch.10133; Petermann JS, 2010, J ANIM ECOL, V79, P709, DOI 10.1111/j.1365-2656.2010.01674.x; Pietikainen J, 2000, OIKOS, V89, P231, DOI 10.1034/j.1600-0706.2000.890203.x; Pisula NL, 2010, AM MIDL NAT, V163, P161, DOI 10.1674/0003-0031-163.1.161; R Development Core Team, 2010, LANG ENV STAT COMP; Rebele F, 2000, PLANT ECOL, V147, P77, DOI 10.1023/A:1009808810378; Sarfraz RM, 2009, EUR J ENTOMOL, V106, P583, DOI 10.14411/eje.2009.073; Sarkar D., 2019, NLME LINEAR NONLINEA; Schadler M, 2007, ECOLOGY, V88, P1490, DOI 10.1890/06-0647; Stadler B, 2004, ECOL ENTOMOL, V29, P106, DOI 10.1111/j.0307-6946.2004.00577.x; Tsai JH, 2001, ENVIRON ENTOMOL, V30, P44, DOI 10.1603/0046-225X-30.1.44; Weisser WW, 2000, ENTOMOL EXP APPL, V97, P83, DOI 10.1023/A:1004096312093; Weisshuhn K, 2009, BASIC APPL ECOL, V10, P500, DOI 10.1016/j.baae.2008.10.009; Wurst S, 2010, PLANT ECOL, V211, P19, DOI 10.1007/s11258-010-9767-0; Zehnder CB, 2008, ECOL ENTOMOL, V33, P24, DOI 10.1111/j.1365-2311.2007.00945.x; Zvereva EL, 2010, OECOLOGIA, V163, P949, DOI 10.1007/s00442-010-1633-1	62	3	3	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103731	10.1371/journal.pone.0103731	http://dx.doi.org/10.1371/journal.pone.0103731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078980	Green Published, gold, Green Submitted			2022-12-25	WOS:000339954800073
J	Xu, JW; Liao, YM; Liu, H; Nie, RH; Havumaki, J				Xu, Jian-wei; Liao, Yuan-mei; Liu, Hui; Nie, Ren-hua; Havumaki, Joshua			Use of Bed Nets and Factors That Influence Bed Net Use among Jinuo Ethnic Minority in Southern China	PLOS ONE			English	Article							MALARIA ELIMINATION	Background: Insecticide-treated nets (ITNs) are an integral part of vector control recommendations for malaria elimination in China. This study investigated the extent to which bed nets were used and which factors influence bed net use among Jinuo Ethnic Minority in China-Myanmar-Laos border areas. Methods and Findings: This study combined a quantitative household questionnaire survey and qualitative semi-structured in-depth interviews (SDI). Questionnaires were administered to 352 heads of households. SDIs were given to 20 key informants. The bed net to person ratio was 1: 2.1 (i.e., nearly one net for every two people), however only 169 (48.0%) households owned at least one net and 623 (47.2%) residents slept under bed nets the prior night. The percentages of residents who regularly slept under nets (RSUN) and slept under nets the prior night (SUNPN) were similar (48.0% vs. 47.2%, P>0.05), however the percentage correct use of nets (CUN) was significantly lower (34.5%, P <0.0001). The annual cash income per person (ACIP) was an independent factor that influenced bed net use (P <0.0001), where families with an ACIP of CNY10000 or more were much more likely to use nets. House type was strongly associated with bed net use (OR: 4.71, 95% CI: 2.81, 7.91; P<0.0001), where those with traditional wood walls and terracotta roofs were significantly more likely to use nets, and the head of household's knowledge was an independent factor (OR: 5.04, 95% CI: 2.72, 9.35; P <0.0001), where those who knew bed nets prevent malaria were significantly more likely to use nets too. Conclusions: High bed net availability does not necessarily mean higher coverage or bed net use. Household income, house type and knowledge of the ability of bed nets to prevent malaria are all independent factors that influence bed net use among Jinuo Ethnic Minority.	[Xu, Jian-wei; Liu, Hui; Nie, Ren-hua] Yunnan Inst Parasit Dis, Puer, Peoples R China; [Liao, Yuan-mei] Hlth Sch Ganzhou, Ganzhou, Jiangxi, Peoples R China; [Havumaki, Joshua] Fdn Innovat New Diagnost, Cointrin Geneva, Switzerland	Foundation For Innovative New Diagnostics	Liu, H (corresponding author), Yunnan Inst Parasit Dis, Puer, Peoples R China.	liubible@126.com	Xu, Jian-wei/ABI-7923-2020	Xu, Jian-wei/0000-0003-2769-819X	China of the Global Fund to fight AIDS, Tuberculosis and Malaria	China of the Global Fund to fight AIDS, Tuberculosis and Malaria	The authors thank the fifth grant to China of the Global Fund to fight AIDS, Tuberculosis and Malaria for financial sponsorship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, FACTORS AFFECT SUCCE; [Anonymous], WHO GLOB MAL PROGR P; Atkinson JA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-119; China Centre for Diseases Control and Prevention, 2011, TECHN GUID MAL EL; COTTER C, 2013, LANCET; Dong XS, 2010, MOSQUITO FAUNA YUNNA, P49; Dong XueShu, 2000, Chinese Journal of Parasitic Disease Control, V13, P144; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Gai X, 1986, JINUO YU JIANZHI; Gosling RD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-346; Li BenFu, 2013, Zhongguo Bingyuan Shengwuxue Zazhi / Journal of Pathogen Biology, V8, P448; Ministry of Health People's Republic of China, 2010, MAL EL ACT PLAN 2010; Mishra RN, 2010, TROP MED INT HEALTH, V15, P36, DOI 10.1111/j.1365-3156.2010.02544.x; Ngo DT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007369; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Sochantha T, 2010, TROP MED INT HEALTH, V15, P336, DOI 10.1111/j.1365-3156.2009.02457.x; Tatem AJ, 2010, LANCET, V376, P1579, DOI 10.1016/S0140-6736(10)61301-3; Tsuang A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-211; Ward KA, 2011, EMERG INFECT DIS, V17, P1409, DOI 10.3201/eid1708.100842; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Xia Zhi-Gui, 2012, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V30, P419; Xu JW, 2012, SE ASIAN J TROP MED, V43, P819; Xu JianWei, 2010, Zhongguo Meijie Shengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V21, P527; Xu JianWei, 2004, China Tropical Medicine, V4, P319; Xu JianWei, 2004, Chinese Journal of Schistosomiasis Control, V16, P51; Xu Jianwei, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P456; Zhou HN, 1994, J PRACTICAL PARASIT, V2, P44; [周升 ZHOU Sheng], 2009, [中国媒介生物学及控制杂志, Chinese Journal of Vector Biology and Control], V20, P326; Zhu DF, 1997, J PRACTICAL PARASIT, V5, P45	29	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103780	10.1371/journal.pone.0103780	http://dx.doi.org/10.1371/journal.pone.0103780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080267	gold, Green Published, Green Submitted			2022-12-25	WOS:000339954800081
J	Abbott, DS; Chin-Smith, EC; Seed, PT; Chandiramani, M; Shennan, AH; Tribe, RM				Abbott, Danielle S.; Chin-Smith, Evonne C.; Seed, Paul T.; Chandiramani, Manju; Shennan, Andrew H.; Tribe, Rachel M.			Raised Trappin2/elafin Protein in Cervico-Vaginal Fluid Is a Potential Predictor of Cervical Shortening and Spontaneous Preterm Birth	PLOS ONE			English	Article							VITAMIN-D; NEUTROPHIL ELASTASE; INNATE IMMUNITY; ELAFIN; INHIBITOR; BIOMARKERS; TRAPPIN-2; INJURY	Early spontaneous preterm birth is associated with inflammation/infection and shortening of the cervix. We hypothesised that cervico-vaginal production of trappin2/elafin (peptidase inhibitor 3) and cathelicidin antimicrobial peptide (cathelicidin), key components of the innate immune system, are altered in women who have a spontaneous preterm birth. The aim was to determine the relationship between cervico-vaginal fluid (CVF) trappin2/elafin and cathelicidin protein concentrations with cervical length in woman at risk of spontaneous preterm birth. Trappin2/elafin and cathelicidin were measured using ELISA in longitudinal CVF samples (taken between 13 to 30 weeks' gestation) from 74 asymptomatic high risk women (based on obstetric history) recruited prospectively. Thirty six women developed a short cervix (<25 mm) by 24 weeks' and 38 women did not. Women who developed a short cervix had 2.71 times higher concentrations of CVF trappin2/ elafin from 14 weeks' versus those who did not (CI 1.94-3.79, p<0.0005). CVF trappin2/elafin before 24 weeks' was 1.79 times higher in women who had a spontaneous preterm birth <37 weeks' (CI: 1.05-3.05, p = 0.034). Trappin2/elafin (>200 ng/ml) measured between 14(+0) -14(+6) weeks' of pregnancy predicted women who subsequently developed a short cervix (n = 11, ROC area = 1.00, p = 0.008) within 8 weeks. Cathelicidin was not predictive of spontaneous delivery. Vitamin D status did not correlate with CVF antimicrobial peptide concentrations. Raised CVF trappin2/elafin has potential as an early pregnancy test for prediction of cervical shortening and spontaneous preterm birth. This justifies validation in a larger cohort.	[Abbott, Danielle S.; Chin-Smith, Evonne C.; Seed, Paul T.; Shennan, Andrew H.; Tribe, Rachel M.] Kings Coll London, Div Womens Hlth, Womens Hlth Acad Ctr Kings Hlth Partners, London WC2R 2LS, England; [Chandiramani, Manju] Univ London Imperial Coll Sci Technol & Med, Parturit Res Grp, Dept Surg & Canc, London, England; [Tribe, Rachel M.] Kings Coll London, Div Womens Hlth, Womens Hlth Acad Ctr KHP, London WC2R 2LS, England	King's Health Partners; University of London; King's College London; Imperial College London; King's Health Partners; University of London; King's College London	Tribe, RM (corresponding author), Kings Coll London, Div Womens Hlth, Womens Hlth Acad Ctr Kings Hlth Partners, London WC2R 2LS, England.	rachel.tribe@kcl.ac.uk	Chin-Smith, Evonne/AAQ-6957-2020; Seed, Paul T/C-4435-2008	Chin-Smith, Evonne/0000-0002-1935-2941; Seed, Paul T/0000-0001-7904-7933; Tribe, Rachel/0000-0003-3675-9978; Shennan, Andrew/0000-0001-5273-3132	Action Medical Research [S/P/4113]; Tommy's Charity; Sutton Place Foundation General Charitable Trust; Wellbeing of Women; British Maternal and Fetal Medicine Society	Action Medical Research; Tommy's Charity; Sutton Place Foundation General Charitable Trust; Wellbeing of Women(Wellbeing of Women (WoW)); British Maternal and Fetal Medicine Society	Action Medical Research, grant number S/P/4113 (Registered Charity No: 208701; www.action.org.uk) to RMT AHS. Tommy's Charity (Registered Charity No: 1060508; http://www.tommys.org/) to RMT AHS. The Sutton Place Foundation General Charitable Trust (Registered Charity No: 1136264) RMT AHS. Wellbeing of Women (Registered Charity No: 239281; http://www.wellbeingofwomen.org.uk) to DSA AHS RMT. British Maternal and Fetal Medicine Society (http://www.rcog.org.uk/ content/british-maternal-fetal-medicine-society) to DSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SR, 2012, BIOCHEM PHARMACOL, V83, P695, DOI 10.1016/j.bcp.2011.11.003; AMEMIYA T, 1973, ECONOMETRICA, V41, P997, DOI 10.2307/1914031; Baranger K, 2008, FEBS J, V275, P2008, DOI 10.1111/j.1742-4658.2008.06355.x; Bastek JA, 2013, OBSTET GYNECOL, V122, P283, DOI 10.1097/AOG.0b013e31829ab714; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Blencowe H, 2013, PEDIATR RES, V74, P4, DOI 10.1038/pr.2013.203; Bodnar LM, 2014, AM J EPIDEMIOL, V179, P168, DOI 10.1093/aje/kwt237; Chandiramani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052412; Chowdhury MA, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-49; Drannik AG, 2013, J VIROL, V87, P7526, DOI 10.1128/JVI.02243-12; Frew L, 2011, REPRODUCTION, V141, P725, DOI 10.1530/REP-10-0537; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Ginzberg HH, 2001, AM J PHYSIOL-GASTR L, V281, pG705, DOI 10.1152/ajpgi.2001.281.3.G705; Grundmann M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-146; Guyot N, 2008, J BIOL CHEM, V283, P32377, DOI 10.1074/jbc.M803707200; Henriksen PA, 2008, INT J BIOCHEM CELL B, V40, P1095, DOI 10.1016/j.biocel.2008.01.004; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; Horne AW, 2008, REPRODUCTION, V135, P739, DOI 10.1530/REP-07-0564; Hunt KK, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3374; Menon R, 2011, REPROD SCI, V18, P1046, DOI 10.1177/1933719111415548; Motta JP, 2011, GASTROENTEROLOGY, V140, P1272, DOI 10.1053/j.gastro.2010.12.050; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; Paczesny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000406; Patel MV, 2013, AM J REPROD IMMUNOL, V69, P463, DOI 10.1111/aji.12078; Scott A, 2011, BIOCHEM SOC T, V39, P1437, DOI 10.1042/BST0391437; Spong CY, 2007, OBSTET GYNECOL, V110, P405, DOI 10.1097/01.AOG.0000275287.08520.4a; Stock SJ, 2009, REPROD SCI, V16, P1125, DOI 10.1177/1933719109341998; Takahashi K, 2002, IMMUNOPHARM IMMUNOT, V24, P335, DOI 10.1081/IPH-120014721; Tejera P, 2009, AM J RESP CELL MOL, V41, P696, DOI 10.1165/rcmb.2008-0410OC; Tromp G, 2004, AM J OBSTET GYNECOL, V191, P1331, DOI 10.1016/j.ajog.2004.07.010; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009; Verrier T, 2012, INT J BIOCHEM CELL B, V44, P1377, DOI 10.1016/j.biocel.2012.05.007; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Wilkinson TS, 2011, BIOCHEM SOC T, V39, P1409, DOI 10.1042/BST0391409; Zhu Y, 2001, Respir Res, V2, P300, DOI 10.1186/rr73	35	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e100771	10.1371/journal.pone.0100771	http://dx.doi.org/10.1371/journal.pone.0100771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075964	Green Published, Green Submitted, gold			2022-12-25	WOS:000340028800006
J	Freeth, T				Freeth, Tony			Eclipse Prediction on the Ancient Greek Astronomical Calculating Machine Known as the Antikythera Mechanism	PLOS ONE			English	Article								The ancient Greek astronomical calculating machine, known as the Antikythera Mechanism, predicted eclipses, based on the 223-lunar month Saros cycle. Eclipses are indicated on a four-turn spiral Saros Dial by glyphs, which describe type and time of eclipse and include alphabetical index letters, referring to solar eclipse inscriptions. These include Index Letter Groups, describing shared eclipse characteristics. The grouping and ordering of the index letters, the organization of the inscriptions and the eclipse times have previously been unsolved. A new reading and interpretation of data from the back plate of the Antikythera Mechanism, including the glyphs, the index letters and the eclipse inscriptions, has resulted in substantial changes to previously published work. Based on these new readings, two arithmetical models are presented here that explain the complete eclipse prediction scheme. The first model solves the glyph distribution, the grouping and anomalous ordering of the index letters and the structure of the inscriptions. It also implies the existence of lost lunar eclipse inscriptions. The second model closely matches the glyph times and explains the four-turn spiral of the Saros Dial. Together, these models imply a surprisingly early epoch for the Antikythera Mechanism. The ancient Greeks built a machine that can predict, for many years ahead, not only eclipses but also a remarkable array of their characteristics, such as directions of obscuration, magnitude, colour, angular diameter of the Moon, relationship with the Moon's node and eclipse time. It was not entirely accurate, but it was an astonishing achievement for its era.	[Freeth, Tony] Antikythera Mech Res Project, London, England; [Freeth, Tony] Images First Ltd, London, England		Freeth, T (corresponding author), Antikythera Mech Res Project, London, England.	tony@images-first.com		Freeth, Tony/0000-0001-9375-4247				Anastasiou M, 2013, J HIST ASTRONOMY; [Anonymous], 1963, PAPHS, V107, P528; Brack-Bernsen L, 1999, DIBNER INST STUD HIS, P149; Brack-Bernsen L, 1997, PREDICTIONS LUNAR PH, P5; Cullen C, 2002, JHA, Vxxxiii; Edmunds MG, 2011, J HIST ASTRON, V42, P307, DOI 10.1177/002182861104200302; Epping J., 1890, STIMMEN MARIA-LAACH, V39, P225; Espenak F, 2013, ECLIPSE MAPS FIGURES; Evans James, 2006, GEMINOS INTRO PHENOM; Freeth T, 2006, NATURE, V444, P587, DOI 10.1038/nature05357; Freeth T., 2012, ISAW PAPERS; Freeth T, 2008, NATURE, V454, P614, DOI 10.1038/nature07130; Gautschy R, 2012, JHA, Vxliii; Goldstein BR, 2005, COLORS ECLIPSES MEDI, V5, P11; Gray SL, 2012, P ROY SOC A-MATH PHY, V468, P1839, DOI 10.1098/rspa.2012.0007; Hannah R., 2008, TIME ANTIQUITY; Heath TL., 1921, HIST GREEK MATH; Kent J. H., 1966, CORINTH RESULTS EX 3, P14; Malzbender T, 2001, COMP GRAPH, P519, DOI 10.1145/383259.383320; NEUGEBAUER O, 1948, B AM MATH SOC, V54, P1013, DOI 10.1090/S0002-9904-1948-09089-9; Neugebauer O, 1967, ASTRONOMICAL J, V72; Neugebauer O., 1955, ASTRONOMICAL CUNEIFO, V1-3; Neugebauer O., 1975, HIST ANCIENT MATH AS; Ossendrijver M., 2012, BABYLONIAN MATH ASTR; Price D, 1959, SCI AM, P60; Price D de S, 1974, T AM PHILOS SOC, V64, P1; Ramsey AT, 2003, INT S CT IM PROC IND; Schaefer BE, 1996, Q J ROY ASTRON SOC, V37, P759; Steele JM, 2000, ARCH HIST EXACT SCI, V54, P421, DOI 10.1007/s004070050007; Steele JM, 1997, J HIST ASTRON, V28, P119; Steele JM, 1997, J HIST ASTRON, V28, P133; Toomer G.J., 1974, CENTARUS, V18, P6, DOI [10.1111/j.1600-0498.1974.tb00205.x, DOI 10.1111/J.1600-0498.1974.TB00205.X]; Toomer Gerald J., 1984, PTOLEMYS ALMAGEST; Tracy StephenV., 1990, ATTIC LETT CUTTERS 2; Wright M. T., 2006, ANTIQUARIAN HOROLOGY, V29, P319; Wright MT, 2003, B SCI INSTRUM SOC, Vlxxx, P4	36	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103275	10.1371/journal.pone.0103275	http://dx.doi.org/10.1371/journal.pone.0103275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075747	Green Submitted, Green Published, gold			2022-12-25	WOS:000340028800034
J	Harper, DM; Else, BM; Bartley, MJ; Arey, AM; Barnett, AL; Rosemergey, BE; Paynter, CA; Verdenius, I; Harper, SM; Harris, GD; Groner, JA; Malnar, GJ; Wall, J; Bonham, AJ				Harper, Diane M.; Else, Britney M.; Bartley, Mitchell J.; Arey, Anne M.; Barnett, Angela L.; Rosemergey, Beth E.; Paynter, Christopher A.; Verdenius, Inge; Harper, Sean M.; Harris, George D.; Groner, Jennifer A.; Malnar, Gerard J.; Wall, Jeffrey; Bonham, Aaron J.			In a Safety Net Population HPV4 Vaccine Adherence Worsens as BMI Increases	PLOS ONE			English	Article							BODY-MASS INDEX; CERVICAL-CANCER; AFRICAN-AMERICAN; RISK-FACTORS; SEXUAL-BEHAVIOR; HISPANIC WOMEN; NEEDLE LENGTH; HEALTH-CARE; OBESITY; WEIGHT	Objectives: Obesity adversely inhibits antibody response to vaccination. Three doses of HPV4 may or may not provide adequate long term protection against HPV 16/18 in obese females. The aim of this study was to determine whether adherence to HPV4 vaccination in a safety net population was reduced with increasing body mass index (BMI). Methods: We designed a historical prospective study evaluating the number and dates of HPV4 dosing that occurred from July 1, 2006 through October 1, 2009 by the demographic characteristics of the 10-26 year old recipient females. The defined dosing intervals were adapted from the literature and obesity categories were defined by the WHO. Results: 1240 females with BMI measurements received at least one dose of HPV4; 38% were obese (class I, II and III) and 25% were overweight. Females with normal BMI received on-time triplet dosing significantly more often than did the obese class II and III females (30% vs. 18%, p<0.001). Obese class II/III females have a significant 45% less chance of completing the on-time triplet HPV4 series than normal women (OR = 0.55, 95% CI: 0.37, 0.83). Pregnancy history has a significant influence on BMI and HPV4 dosing compliance in this safety net population where 71% had been gravid. Hispanic females were less likely to complete HPV4 dosing regardless of BMI (aOR = 0.39, 95% CI: 0.16, 0.95). Conclusions: Obesity, as well as gravidity and Hispanic race, are risk factors for lack of HPV4 vaccine adherence among young females in a safety net population.	[Harper, Diane M.; Else, Britney M.; Bartley, Mitchell J.; Arey, Anne M.; Barnett, Angela L.; Rosemergey, Beth E.; Paynter, Christopher A.; Harris, George D.; Groner, Jennifer A.] Univ Missouri, Dept Community & Family Med, Sch Med, Kansas City, MO 64108 USA; [Harper, Diane M.; Malnar, Gerard J.; Wall, Jeffrey] Univ Missouri, Sch Med, Dept Obstet & Gynecol, Kansas City, MO 64108 USA; [Harper, Diane M.; Bonham, Aaron J.] Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64108 USA; [Verdenius, Inge] Radboud Univ Nijmegen, Dept Obstet & Gynecol, NL-6525 ED Nijmegen, Netherlands; [Harper, Sean M.] Hampshire Coll, Amherst, MA 01002 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Radboud University Nijmegen	Harper, DM (corresponding author), Univ Missouri, Dept Community & Family Med, Sch Med, Kansas City, MO 64108 USA.	diane.m.harper@gmail.com	Harper, Diane M./I-2180-2014	Harper, Diane M./0000-0001-7648-883X				Abrams B, 2013, OBESITY, V21, P1514, DOI 10.1002/oby.20503; American Cancer Society, 2008, CANC PREV EARL DET F; Amy NK, 2006, INT J OBESITY, V30, P147, DOI 10.1038/sj.ijo.0803105; Banerjea R, 2008, WOMEN HEALTH, V47, P1, DOI 10.1080/03630240802099261; Baylor NW, 2009, FDA APPROVAL LETT HU; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chang VW, 2010, JAMA-J AM MED ASSOC, V303, P1274, DOI 10.1001/jama.2010.339; Cokkinides VE, 2012, CA-CANCER J CLIN, V62, P353, DOI 10.3322/caac.21155; Coughlin SS, 2004, PREV CHRONIC DIS, V1, pA04; Datta GD, 2006, CANCER, V106, P664, DOI 10.1002/cncr.21660; Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625; Eliakim A, 2006, AUTOIMMUNITY, V39, P137, DOI 10.1080/08916930600597326; Fagan HB, 2011, J OBES, V2011, DOI 10.1155/2011/218250; Ferrante JM, 2007, AM J PREV MED, V32, P525, DOI 10.1016/j.amepre.2007.02.004; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fontaine KR, 1998, ARCH FAM MED, V7, P381, DOI 10.1001/archfami.7.4.381; Freeman HP, 2005, NIH PUB; GARFINKEL L, 1985, ANN INTERN MED, V103, P1034, DOI 10.7326/0003-4819-103-6-1034; Hall HI, 2002, CANCER EPIDEM BIOMAR, V11, P137; Harper DM, 2009, PUBLIC HEALTH GENOM, V12, P319, DOI 10.1159/000214922; Harper DM, 2010, J VACCINES VACCIN, V1; IBM Corp, 2011, IBM SPSS STAT WIND V; IBM Corp, 2012, COCHR ARM TEST TREND; Karlsson EA, 2010, EXP BIOL MED, V235, P1412, DOI 10.1258/ebm.2010.010227; Koster MP, 2009, PEDIATRICS, V124, P667, DOI 10.1542/peds.2008-1127; Kraschnewski JL, 2012, PREV MED, V54, P302, DOI 10.1016/j.ypmed.2012.02.010; Lee SK, 2005, OBES RES, V13, P1263, DOI 10.1038/oby.2005.150; Leone LA, 2012, J COMMUN HEALTH, V37, P299, DOI 10.1007/s10900-011-9445-8; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Marshall HS, 2013, VACCINE, V31, P2647, DOI 10.1016/j.vaccine.2013.03.037; Middleman AB, 2010, PEDIATRICS, V125, pE508, DOI 10.1542/peds.2009-1592; Miller R, 2014, INT J OBESITY, V38, P397, DOI 10.1038/ijo.2013.126; Mitchell RS, 2008, AM J PREV MED, V35, P127, DOI 10.1016/j.amepre.2008.03.031; Nagelkerke NJD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-199; Nelson JC, 2009, AM J PUBLIC HEALTH, V99, pS389, DOI 10.2105/AJPH.2008.151332; Nelson W, 2009, J WOMENS HEALTH, V18, P1759, DOI 10.1089/jwh.2009.1430; Neuzil KM, 2011, JAMA-J AM MED ASSOC, V305, P1424, DOI 10.1001/jama.2011.407; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Ostbye T, 2005, AM J PUBLIC HEALTH, V95, P1623, DOI 10.2105/AJPH.2004.047803; Paich HA, 2013, OBESITY, V21, P2377, DOI 10.1002/oby.20383; Park JK, 2012, ASIAN PAC J CANCER P, V13, P3271, DOI 10.7314/APJCP.2012.13.7.3271; Reuman PD, 1997, VACCINE, V15, P1157, DOI 10.1016/S0264-410X(96)00310-6; Scarinci IC, 2010, CANCER-AM CANCER SOC, V116, P2531, DOI 10.1002/cncr.25065; Segerstrom SC, 2012, BRAIN BEHAV IMMUN, V26, P747, DOI 10.1016/j.bbi.2011.10.009; Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208; Skelton JA, 2009, ACAD PEDIATR, V9, P322, DOI 10.1016/j.acap.2009.04.005; Smith AMA, 2011, J WOMENS HEALTH, V20, P1091, DOI 10.1089/jwh.2010.2585; Smolen KK, 2012, VACCINE, V30, P3572, DOI 10.1016/j.vaccine.2012.03.051; StatSoft Inc, 2010, STATISTICA; Verdenius I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071295; WEBER DJ, 1985, JAMA-J AM MED ASSOC, V254, P3187, DOI 10.1001/jama.254.22.3187; WEBER DJ, 1986, NEW ENGL J MED, V314, P1393; Wee CC, 2005, OBES RES, V13, P1275, DOI 10.1038/oby.2005.152; Wee CC, 2000, ANN INTERN MED, V132, P697, DOI 10.7326/0003-4819-132-9-200005020-00003; Wee CC, 2008, OBESITY, V16, P2552, DOI 10.1038/oby.2008.394; White SJ, 2013, VACCINE, V31, P1666, DOI 10.1016/j.vaccine.2013.01.032; Wolfe WS, 1997, INT J OBESITY, V21, P802, DOI 10.1038/sj.ijo.0800478; WOOD RC, 1993, JAMA-J AM MED ASSOC, V270, P2935, DOI 10.1001/jama.270.24.2935; World Health Organization (WHO), 2013, GLOB DAT BOD MASS IN; Wu HY, 2006, OBESITY, V14, P526; Young KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082779	61	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103172	10.1371/journal.pone.0103172	http://dx.doi.org/10.1371/journal.pone.0103172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM7EZ	25076128	Green Submitted, Green Published, gold			2022-12-25	WOS:000340028800028
J	Mohammadrezaei, M; Toghyani, M; Gheisari, A; Toghyani, M; Eghbalsaied, S				Mohammadrezaei, Mohammad; Toghyani, Majid; Gheisari, Abbasali; Toghyani, Mehdi; Eghbalsaied, Shahin			Synergistic Effect of Fadrozole and Insulin-Like Growth Factor-I on Female-To-Male Sex Reversal and Body Weight of Broiler Chicks	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; ESTROGEN-RECEPTOR-ALPHA; IGF-I; GRANULOSA-CELLS; AROMATASE EXPRESSION; GONADAL DEVELOPMENT; ANDROGEN RECEPTOR; GALLUS-DOMESTICUS; JAPANESE-QUAIL; LARON-SYNDROME	The aim of this study was to investigate the effects of Fadrozole hydrochloride and recombinant human insulin-like growth factor I (rhIGF-I) on female-to-male sex reversal, hatching traits, and body weight of broiler chickens. On the third day of incubation, fertile eggs were randomly assigned to five experimental groups comprising (i) Fadrozole (0.1 mg/egg), (ii) rhIGF-I (100 ng/egg), (iii) Fadrozole (0.1 mg/egg) + rhIGF-I (100 ng/egg), (iv) vehicle injection (10 mM acetic acid and 0.1% BSA), and (v) non-injected eggs. Eggs in the rhIGF-I-injected groups showed the mode of hatching time at the 480th hour of incubation, 12 hours earlier compared to the other groups, with no statistically significant difference in mortality and hatchability. On Day 1 and 42 of production, 90% of genetically female chicks were masculinized using Fadrozole treatment, while 100% female-to-male phenotypic sex reversal was observed in the Fadrozole+rhIGF-I group. Fadrozole equalized the body weight of both genders, although rhIGF-I was effective on the body weight of male chicks only. Interestingly, combined rhIGF-I and Fadrozole could increase the body weight in both sexes compared to the individual injections (P<0.05). These findings revealed that (i) IGF-I-treated chicken embryos were shown to be an effective option for overcoming the very long chicken deprivation period, (ii) the simultaneous treatment with Fadrozole and IGF-I could maximize the female-to-male sex reversal chance, (iii) the increase in the body weight of masculinized chickens via Fadrozole could be equal to their genetically male counterparts, and (iv) the IGF-I effectiveness, specifically along with the application of aromatase inhibitors in female chicks, indicates that estrogen synthesis could be a stumbling block for the IGF-I action mechanism in female embryos.	[Mohammadrezaei, Mohammad; Toghyani, Mehdi; Eghbalsaied, Shahin] Islamic Azad Univ, Khorasgan Isfahan Branch, Young Researchers & Elite Club, Esfahan, Iran; [Toghyani, Majid; Eghbalsaied, Shahin] Islamic Azad Univ, Khorasgan Isfahan Branch, Dept Anim Sci, Esfahan, Iran; [Gheisari, Abbasali] Isfahan Res Ctr Nat Resources & Agr, Dept Anim Sci, Esfahan, Iran; [Toghyani, Mehdi] Univ New England, Dept Anim Sci, Sch Environm & Rural Sci, Armidale, NSW, Australia	Islamic Azad University; Islamic Azad University; University of New England	Eghbalsaied, S (corresponding author), Islamic Azad Univ, Khorasgan Isfahan Branch, Young Researchers & Elite Club, Esfahan, Iran.	shahin.eghbal@khuisf.ac.ir	Eghbalsaied, Shahin/AAC-8686-2019; Toghyani, Mehdi/ABH-8543-2020; Toghyani, Majid/ABA-5571-2020; mohammadrezaei, mohammad/H-8385-2016; Toghyani, Majid/B-7766-2010	Eghbalsaied, Shahin/0000-0002-9030-8679; mohammadrezaei, mohammad/0000-0003-3855-3412; Toghyani, Majid/0000-0003-0470-856X; Toghyani, Mehdi/0000-0002-5065-1739				ADASHI EY, 1985, ENDOCR REV, V6, P400, DOI 10.1210/edrv-6-3-400; Agbaje IM, 2007, HUM REPROD, V22, P1871, DOI 10.1093/humrep/dem077; Andrews JE, 1997, GEN COMP ENDOCR, V108, P182, DOI 10.1006/gcen.1997.6978; Ayers KL, 2013, SEX DEV, V7, P80, DOI 10.1159/000342358; BALLARD FJ, 1990, GEN COMP ENDOCR, V79, P459, DOI 10.1016/0016-6480(90)90076-X; BASSAS L, 1987, J EXP ZOOL, P299; Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; Berensztein EB, 2006, PEDIATR RES, V60, P740, DOI 10.1203/01.pdr.0000246072.04663.bb; BICSAK TA, 1990, ENDOCRINOLOGY, V126, P2184, DOI 10.1210/endo-126-4-2184; Breier BH, 1996, ENDOCRINOLOGY, V137, P4061, DOI 10.1210/en.137.9.4061; Burke WH, 1999, POULTRY SCI, V78, P1019, DOI 10.1093/ps/78.7.1019; Cardinale M, 2006, J STRENGTH COND RES, V20, P103; Careghi C, 2005, POULTRY SCI, V84, P1314, DOI 10.1093/ps/84.8.1314; Casa AJ, 2012, BREAST CANCER RES TR, V132, P61, DOI 10.1007/s10549-011-1540-0; Chandrashekar V, 2004, BIOL REPROD, V71, P17, DOI 10.1095/biolreprod.103.027060; CHATELAIN PG, 1991, ENDOCRINOLOGY, V128, P1857, DOI 10.1210/endo-128-4-1857; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; DAVIS JG, 1971, BIOCHEMISTRY-US, V10, P39, DOI 10.1021/bi00777a006; Davis LG, 1986, INTRO BASICS MOL BIO, P2; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; Decuypere E, 2001, WORLD POULTRY SCI J, V57, P127, DOI 10.1079/WPS20010010; Deprem T, 2007, TURK J VET ANIM SCI, V31, P233; DUCLOS MJ, 1991, J ENDOCRINOL, V128, P35, DOI 10.1677/joe.0.1280035; ELBRECHT A, 1992, SCIENCE, V255, P467, DOI 10.1126/science.1734525; Elis S, 2011, DIS MODEL MECH, V4, P649, DOI 10.1242/dmm.006775; Ellegren H, 2011, NAT REV GENET, V12, P157, DOI 10.1038/nrg2948; ERICKSON GF, 1990, J CLIN ENDOCR METAB, V70, P894, DOI 10.1210/jcem-70-4-894; ERICKSON GF, 1989, J CLIN ENDOCR METAB, V69, P716, DOI 10.1210/jcem-69-4-716; ERICKSON GF, 1978, ENDOCRINOLOGY, V102, P1275, DOI 10.1210/endo-102-4-1275; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Fuxjager MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051482; Garcia-Segura LM, 2010, PROG BRAIN RES, V181, P251, DOI 10.1016/S0079-6123(08)81014-X; Hayashi RM, 2013, J APPL POULTRY RES, V22, P9, DOI 10.3382/japr.2012-00488; IMATAKA H, 1989, GEN COMP ENDOCR, V73, P69, DOI 10.1016/0016-6480(89)90056-7; KAJIMOTO Y, 1989, MOL ENDOCRINOL, V3, P1907, DOI 10.1210/mend-3-12-1907; KITAMOTO T, 1982, J BIOCHEM, V92, P1679, DOI 10.1093/oxfordjournals.jbchem.a134097; Klinger B, 1998, CLIN ENDOCRINOL, V48, P81; Kocamis H, 1998, POULTRY SCI, V77, P1913, DOI 10.1093/ps/77.12.1913; Kocamis H, 2000, POULTRY SCI, V79, P1345, DOI 10.1093/ps/79.9.1345; Lambeth LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068362; Laron Z, 1998, EUR J ENDOCRINOL, V138, P176, DOI 10.1530/eje.0.1380176; Lazaros L, 2012, HUM REPROD, V27, P3385, DOI 10.1093/humrep/des334; Lee IW, 2011, HUM REPROD, V26, P1585, DOI 10.1093/humrep/der062; Lee PLM, 2002, EVOLUTION, V56, P2548; Li WM, 2008, POULTRY SCI, V87, P2231, DOI 10.3382/ps.2008-00139; LINEWEAVER H, 1947, J BIOL CHEM, V171, P565; Liu HH, 2011, J APPL PHYSIOL, V111, P1789, DOI 10.1152/japplphysiol.00551.2011; Matsushita S, 2006, POULTRY SCI, V85, P1641, DOI 10.1093/ps/85.9.1641; Mattsson A, 2008, REPRODUCTION, V136, P175, DOI 10.1530/REP-08-0100; MCMURTRY JP, 1994, J ENDOCRINOL, V142, P225, DOI 10.1677/joe.0.1420225; McMurtry JP, 1997, DOMEST ANIM ENDOCRIN, V14, P199, DOI 10.1016/S0739-7240(97)00019-2; MEANS GD, 1991, MOL ENDOCRINOL, V5, P2005, DOI 10.1210/mend-5-12-2005; Mendoza RA, 2011, J ENDOCRINOL, V208, P1, DOI 10.1677/JOE-10-0235; NAGASE H, 1983, J BIOL CHEM, V258, P7481; Nakabayashi O, 1998, J MOL ENDOCRINOL, V20, P193, DOI 10.1677/jme.0.0200193; Philippou A, 2007, IN VIVO, V21, P45; Rappaport MS, 1996, BIOL REPROD, V54, P446, DOI 10.1095/biolreprod54.2.446; RAPPAPORT MS, 1995, BIOL REPROD, V52, P419, DOI 10.1095/biolreprod52.2.419; Rondini EA, 2011, MOL CARCINOGEN, V50, P370, DOI 10.1002/mc.20720; Saxena I, 1997, CELL MOL LIFE SCI, V53, P13, DOI 10.1007/PL00000575; SHOHAM Z, 1992, FERTIL STERIL, V57, P1044; Sirianni R, 2007, CANCER RES, V67, P8368, DOI 10.1158/0008-5472.CAN-06-4064; Smith CA, 2003, BIOL REPROD, V68, P560, DOI 10.1095/biolreprod.102.007294; Smith CA, 1997, J STEROID BIOCHEM, V60, P295, DOI 10.1016/S0960-0760(96)00196-3; STEINKAMPF MP, 1988, MOL CELL ENDOCRINOL, V59, P93, DOI 10.1016/0303-7207(88)90199-2; Vaillant S, 2003, MOL REPROD DEV, V65, P420, DOI 10.1002/mrd.10318; Vaillant S, 2001, J EXP ZOOL, V290, P727, DOI 10.1002/jez.1123; Wang Y, 2014, ANIMAL, V8, P610, DOI 10.1017/S175173111400007X; WARTENBERG H, 1992, ANDROLOGIA, V24, P1; Willemsen H, 2010, WORLD POULTRY SCI J, V66, P177, DOI 10.1017/S0043933910000243; Yang X, 2008, SEX DEV, V2, P309, DOI 10.1159/000195680; Zhao D, 2010, NATURE, V464, P237, DOI 10.1038/nature08852	72	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103570	10.1371/journal.pone.0103570	http://dx.doi.org/10.1371/journal.pone.0103570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075864	gold, Green Published, Green Submitted			2022-12-25	WOS:000340028800065
J	Puechmaille, SJ; Borissov, IM; Zsebok, S; Allegrini, B; Hizem, M; Kuenzel, S; Schuchmann, M; Teeling, EC; Siemers, BM				Puechmaille, Sebastien J.; Borissov, Ivailo M.; Zsebok, Sandor; Allegrini, Benjamin; Hizem, Mohammed; Kuenzel, Sven; Schuchmann, Maike; Teeling, Emma C.; Siemers, Bjoern M.			Female Mate Choice Can Drive the Evolution of High Frequency Echolocation in Bats: A Case Study with Rhinolophus mehelyi	PLOS ONE			English	Article							POLYMORPHIC MICROSATELLITE LOCI; GREATER HORSESHOE BATS; SEXUAL SELECTION; PAIRWISE RELATEDNESS; CONCOMITANT SHIFTS; CALL FREQUENCIES; ACOUSTIC-SIGNALS; MOUSTACHED BAT; SOCIAL CALLS; CHIROPTERA	Animals employ an array of signals (i.e. visual, acoustic, olfactory) for communication. Natural selection favours signals, receptors, and signalling behaviour that optimise the received signal relative to background noise. When the signal is used for more than one function, antagonisms amongst the different signalling functions may constrain the optimisation of the signal for any one function. Sexual selection through mate choice can strongly modify the effects of natural selection on signalling systems ultimately causing maladaptive signals to evolve. Echolocating bats represent a fascinating group in which to study the evolution of signalling systems as unlike bird songs or frog calls, echolocation has a dual role in foraging and communication. The function of bat echolocation is to generate echoes that the calling bat uses for orientation and food detection with call characteristics being directly related to the exploitation of particular ecological niches. Therefore, it is commonly assumed that echolocation has been shaped by ecology via natural selection. Here we demonstrate for the first time using a novel combined behavioural, ecological and genetic approach that in a bat species, Rhinolophus mehelyi: (1) echolocation peak frequency is an honest signal of body size; (2) females preferentially select males with high frequency calls during the mating season; (3) high frequency males sire more off-spring, providing evidence that echolocation calls may play a role in female mate choice. Our data refute the sole role of ecology in the evolution of echolocation and highlight the antagonistic interplay between natural and sexual selection in shaping acoustic signals.	[Puechmaille, Sebastien J.; Borissov, Ivailo M.; Zsebok, Sandor; Schuchmann, Maike; Siemers, Bjoern M.] Max Planck Inst Ornithol, Sensory Ecol Grp, Seewiesen, Germany; [Puechmaille, Sebastien J.; Teeling, Emma C.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Puechmaille, Sebastien J.; Borissov, Ivailo M.; Zsebok, Sandor; Schuchmann, Maike; Siemers, Bjoern M.] Tabachka Bat Res Stn, Tabachka, Bulgaria; [Zsebok, Sandor] MTA ELTE MTM Ecol Res Grp, Budapest, Hungary; [Allegrini, Benjamin] Naturalia Environm, Gallargues Le Montueux, France; [Hizem, Mohammed] Tunis Super Inst Biol Appl Sci, Tunis, Tunisia; [Kuenzel, Sven] Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany	Max Planck Society; University College Dublin; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Max Planck Society	Puechmaille, SJ (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Zool, Greifswald, Germany.	s.puechmaille@gmail.com	Zsebők, Sándor/H-4768-2015; Puechmaille, Sebastien/D-1612-2010	Zsebők, Sándor/0000-0003-4463-4753; Puechmaille, Sebastien/0000-0001-9517-5775; Teeling, Emma/0000-0002-3309-1346	IRCSET-Marie Curie International Mobility Fellowships in Science, Engineering and Technology; Max Planck Society; ERC Starting grant	IRCSET-Marie Curie International Mobility Fellowships in Science, Engineering and Technology; Max Planck Society(Max Planck SocietyFoundation CELLEX); ERC Starting grant(European Research Council (ERC))	The study was funded by an IRCSET-Marie Curie International Mobility Fellowships in Science, Engineering and Technology to S.J.P., by the Max Planck Society (B.M.S.) and an ERC Starting grant (E.C.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonduriansky R, 2011, AM NAT, V178, P729, DOI 10.1086/662665; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Canadian Council On Animal Care, 2003, CCAC SPEC SPEC REC B, P1; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; Clutton-Brock T, 2009, Q REV BIOL, V84, P3, DOI 10.1086/596461; Crichton E. G., 2000, REPROD BIOL BATS; DAVIES NB, 1978, NATURE, V274, P683, DOI 10.1038/274683a0; Dietz C, 2007, MAMM BIOL, V72, P129, DOI 10.1016/j.mambio.2006.07.005; Dietz C., 2009, BATS BRITAIN EUROPE; Ellers J, 2003, EVOLUTION, V57, P1100, DOI 10.1111/j.0014-3820.2003.tb00319.x; Fenton M.B., 1985, COMMUNICATION CHIROP; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; Francis Charles M., 1998, P169; Galeotti P, 2005, BEHAV ECOL, V16, P301, DOI 10.1093/beheco/arh165; Gray DA, 1997, ANIM BEHAV, V54, P1553, DOI 10.1006/anbe.1997.0584; Hayden S, 2010, GENOME RES, V20, P1, DOI 10.1101/gr.099416.109; HUFFMAN RF, 1993, J COMP PHYSIOL A, V171, P735, DOI 10.1007/BF00213070; HUFFMAN RF, 1993, J COMP PHYSIOL A, V171, P725, DOI 10.1007/BF00213069; Jacobs DS, 2007, OECOLOGIA, V152, P583, DOI 10.1007/s00442-007-0679-1; Jiang TL, 2013, ETHOLOGY, V119, P881, DOI 10.1111/eth.12130; JONES G, 1993, P ROY SOC B-BIOL SCI, V252, P125, DOI 10.1098/rspb.1993.0055; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Jones G, 1997, ADV STUD BEHAV, V26, P317, DOI 10.1016/S0065-3454(08)60383-6; Jones G, 2013, P I CIVIL ENG-ENERGY, V166, P1, DOI 10.1680/ener.2013.166.1.1; Knornschild M, 2012, P ROY SOC B-BIOL SCI, V279, P4827, DOI 10.1098/rspb.2012.1995; LI CC, 1993, HUM HERED, V43, P45, DOI 10.1159/000154113; Liu Y, 2013, CHINESE SCI BULL, V58, P2179, DOI 10.1007/s11434-013-5793-3; LYNCH M, 1988, MOL BIOL EVOL, V5, P584; Ma J, 2006, J COMP PHYSIOL A, V192, P535, DOI 10.1007/s00359-006-0094-9; MASTERS WM, 1995, ANIM BEHAV, V50, P1243, DOI 10.1016/0003-3472(95)80041-7; Milligan BG, 2003, GENETICS, V163, P1153; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Pfalzer G, 2003, J ZOOL, V261, P21, DOI 10.1017/S0952836903003935; Puechmaille S, 2005, MOL ECOL NOTES, V5, P941, DOI 10.1111/j.1471-8286.2005.01123.x; Puechmaille Sebastien J., 2012, Vespertilio, V16, P211; Puechmaille SJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1582; Puechmaille SJ, 2009, CONSERV GENET, V10, P1073, DOI 10.1007/s10592-008-9691-1; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Riede T, 1999, J EXP BIOL, V202, P2859; Rozen S, 2000, Methods Mol Biol, V132, P365; Russo D, 2007, J BIOGEOGR, V34, P2129, DOI 10.1111/j.1365-2699.2007.01762.x; Salsamendi E, 2005, J MAMMAL, V16, P149; SCHERRER JA, 1993, ANIM BEHAV, V46, P847, DOI 10.1006/anbe.1993.1270; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schuchmann M, 2012, ACTA CHIROPTEROL, V14, P161, DOI 10.3161/150811012X654376; Schuchmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012842; Schuchmann M, 2010, AM NAT, V176, P72, DOI 10.1086/652993; Sell A, 2010, P ROY SOC B-BIOL SCI, V277, P3509, DOI 10.1098/rspb.2010.0769; Servedio MR, 2011, TRENDS ECOL EVOL, V26, P389, DOI 10.1016/j.tree.2011.04.005; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Siemers BM, 2005, ACTA CHIROPTEROL, V7, P259, DOI 10.3161/1733-5329(2005)7[259:ISISAO]2.0.CO;2; Siemers BM, 2004, BEHAV ECOL SOCIOBIOL, V56, P464, DOI 10.1007/s00265-004-0807-4; SIMMONS LW, 1988, ANIM BEHAV, V36, P380, DOI 10.1016/S0003-3472(88)80009-5; SMITH JM, 1991, TRENDS ECOL EVOL, V6, P146, DOI 10.1016/0169-5347(91)90055-3; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Ulanovsky N, 2008, P NATL ACAD SCI USA, V105, P8491, DOI 10.1073/pnas.0703550105; Vallone PM, 2004, BIOTECHNIQUES, V37, P226, DOI 10.2144/04372ST03; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Voigt CC, 2008, J MAMMAL, V89, P1401, DOI 10.1644/08-MAMM-S-060.1; Thong VD, 2012, J MAMMAL, V93, P1, DOI 10.1644/11-MAMM-A-073.1; Wang J, 2007, GENET RES, V89, P135, DOI 10.1017/S0016672307008798; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Wang JL, 2002, GENETICS, V160, P1203; Ward HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087199; Wilkins MR, 2013, TRENDS ECOL EVOL, V28, P156, DOI 10.1016/j.tree.2012.10.002; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	72	53	54	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103452	10.1371/journal.pone.0103452	http://dx.doi.org/10.1371/journal.pone.0103452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075972	Green Published, Green Submitted, gold			2022-12-25	WOS:000340028800046
J	Shi, F; Shi, JK; Li, YF				Shi, Feng; Shi, Jikui; Li, Yongfu			Mechanochemical Phosphorylation and Solubilisation of beta-D-Glucan from Yeast Saccharomyces cerevisiae and Its Biological Activities	PLOS ONE			English	Article							MECHANICAL ACTIVATION; ANTITUMOR ACTIVITIES; PHYSICOCHEMICAL CHARACTERIZATION; CHAIN CONFORMATION; RESPONSE MODIFIER; ANTIOXIDANT; CELLULOSE; POLYSACCHARIDES; DERIVATIVES; PRODUCTS	To obtain a water-soluble beta-D-glucan derivative cleanly and conveniently, a highly efficient mechanochemical method, planetary ball milling, was used to phosphorylate beta-D-glucan isolated from yeast Saccharomyces cerevisiae in solid state. Soluble beta-D-glucan phosphate (GP) with a high degree of substitution (0.77-2.09) and an apparent PEAK molecular weight of 6.6-10.0 kDa was produced when beta-D-glucan was co-milled with sodium hexametaphosphate at 139.5-186.0 rad/s for 12-20 min. The energy transferred was 3.03-11.98 KJ/g. The phosphorylation of GPs was demonstrated by Fourier transform infrared spectroscopy and C-13 and P-31 Nuclear magnetic resonance spectroscopy. Three GP products with different degree of substitution (DS) and degree of polymerisation (DP) were able to upregulate the functional events mediated by activated murine macrophage RAW264.7 cells, among which GP-2 with a DS of 1.24 and DP of 30.5 exerted the highest immunostimulating activity. Our results indicate that mechanochemical processing is an efficient method for preparing water-soluble and biologically active GP with high DS.	[Shi, Feng; Shi, Jikui] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Shi, Feng; Shi, Jikui] Jiangnan Univ, Sch Biotechnol, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi, Peoples R China; [Shi, Feng; Shi, Jikui] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China; [Li, Yongfu] Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University; Jiangnan University	Shi, F (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	shifeng@jiangnan.edu.cn			Science and Technology Support Project of Jiangsu Province [BE2012428]; Fundamental Research Funds for the Central Universities [JUSRP 21109]	Science and Technology Support Project of Jiangsu Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by grants from Science and Technology Support Project of Jiangsu Province (BE2012428) and Fundamental Research Funds for the Central Universities (JUSRP 21109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avolio R, 2012, CARBOHYD POLYM, V87, P265, DOI 10.1016/j.carbpol.2011.07.047; Balaz P, 2009, MINER ENG, V22, P681, DOI 10.1016/j.mineng.2009.01.014; BROWDER W, 1990, ANN SURG, V211, P605; BURGIO N, 1991, NUOVO CIMENTO D, V13, P459, DOI 10.1007/BF02452130; Chen R, 2010, CARBOHYD POLYM, V81, P188, DOI 10.1016/j.carbpol.2010.02.012; Chen XY, 2009, CARBOHYD POLYM, V78, P581, DOI 10.1016/j.carbpol.2009.05.019; Colombo I, 2009, J PHARM SCI-US, V98, P3961, DOI 10.1002/jps.21733; Ding JZ, 2013, INT J FOOD SCI TECH, V48, P253, DOI 10.1111/j.1365-2621.2012.03181.x; Du ZJ, 2013, INT J BIOL MACROMOL, V58, P329, DOI 10.1016/j.ijbiomac.2013.04.037; GORIN PAJ, 1981, ADV CARBOHYDRATE CHE, V41; Ha TZ, 2006, AM J PHYSIOL-HEART C, V291, pH1910, DOI 10.1152/ajpheart.01264.2005; Huang QL, 2011, CARBOHYD POLYM, V83, P1363, DOI 10.1016/j.carbpol.2010.09.057; Huang ZQ, 2012, BIORESOURCE TECHNOL, V118, P624, DOI 10.1016/j.biortech.2012.05.082; Hunter KW, 2002, LETT APPL MICROBIOL, V35, P267, DOI 10.1046/j.1472-765X.2002.01201.x; James SL, 2012, CHEM SOC REV, V41, P413, DOI 10.1039/c1cs15171a; Kogan G, 2005, CARBOHYD POLYM, V61, P18, DOI 10.1016/j.carbpol.2005.02.010; Lee DY, 2002, BIOSCI BIOTECH BIOCH, V66, P233, DOI 10.1271/bbb.66.233; Lee JS, 2009, CARBOHYD POLYM, V78, P162, DOI 10.1016/j.carbpol.2009.04.036; Leyva A, 2008, BIOLOGICALS, V36, P134, DOI 10.1016/j.biologicals.2007.09.001; Liao ZD, 2011, BIORESOURCE TECHNOL, V102, P7953, DOI 10.1016/j.biortech.2011.05.067; Muller A, 1996, J IMMUNOL, V156, P3418; Passauer L, 2010, CARBOHYD POLYM, V82, P809, DOI 10.1016/j.carbpol.2010.05.050; Passauer L, 2009, STARCH-STARKE, V61, P621, DOI 10.1002/star.200900168; Qin F, 2012, CARBOHYD POLYM, V90, P1092, DOI 10.1016/j.carbpol.2012.06.048; Rahar S, 2011, J ADV PHARM TECHNOL, V2, P94, DOI 10.4103/2231-4040.82953; Roy A, 2012, BIORESOURCE TECHNOL, V107, P222, DOI 10.1016/j.biortech.2011.11.073; Sakai Y, 2007, J BIOSCI BIOENG, V103, P161, DOI 10.1263/jbb.103.161; Sandula J, 1999, CARBOHYD POLYM, V38, P247, DOI 10.1016/S0144-8617(98)00099-X; Sandula J, 1995, INT J BIOL MACROMOL, V17, P323, DOI 10.1016/0141-8130(96)81839-3; Shi YK, 2012, CARBOHYD POLYM, V87, P160, DOI 10.1016/j.carbpol.2011.07.032; SOLTES L, 1993, J APPL POLYM SCI, V48, P1313; Sun LQ, 2012, CARBOHYD POLYM, V87, P1206, DOI 10.1016/j.carbpol.2011.08.097; Sun ZW, 2009, CARBOHYD POLYM, V77, P628, DOI 10.1016/j.carbpol.2009.02.001; Synytsya A, 2013, CARBOHYD POLYM, V92, P792, DOI 10.1016/j.carbpol.2012.09.077; Trebichavsky I, 2001, FOLIA MICROBIOL, V46, P353, DOI 10.1007/BF02815626; Tsiapali E, 2001, FREE RADICAL BIO MED, V30, P393, DOI 10.1016/S0891-5849(00)00485-8; Medeiros SDV, 2012, INT J MOL SCI, V13, P8142, DOI 10.3390/ijms13078142; WILLIAMS DL, 1992, CARBOHYD RES, V235, P247, DOI 10.1016/0008-6215(92)80093-G; WILLIAMS DL, 1991, CARBOHYD RES, V219, P203, DOI 10.1016/0008-6215(91)89052-H; WILLIAMS DL, 1991, IMMUNOPHARMACOLOGY, V22, P139, DOI 10.1016/0162-3109(91)90039-2; Zhang LN, 2000, BIOSCI BIOTECH BIOCH, V64, P2172, DOI 10.1271/bbb.64.2172; Zhang M, 2003, CARBOHYD RES, V338, P2863, DOI 10.1016/j.carres.2003.08.013; Zhang W, 2008, COMPOS SCI TECHNOL, V68, P2479, DOI 10.1016/j.compscitech.2008.05.005; Zhang YJ, 2013, STARCH-STARKE, V65, P461, DOI 10.1002/star.201200174	44	16	17	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103494	10.1371/journal.pone.0103494	http://dx.doi.org/10.1371/journal.pone.0103494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075740	Green Submitted, gold, Green Published			2022-12-25	WOS:000340028800054
J	Narayanan, R; Ahn, S; Cheney, MD; Yepuru, M; Miller, DD; Steiner, MS; Dalton, JT				Narayanan, Ramesh; Ahn, Sunjoo; Cheney, Misty D.; Yepuru, Muralimohan; Miller, Duane D.; Steiner, Mitchell S.; Dalton, James T.			Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; PREVENTS BONE LOSS; PHYSICAL FUNCTION; DOUBLE-BLIND; EXPRESSION; TRANSCRIPTION; ACTIVATION; ENOBOSARM; TAMOXIFEN; THERAPY	Introduction: The androgen receptor (AR) is the most highly expressed steroid receptor in breast cancer with 75-95% of estrogen receptor (ER)-positive and 40-70% of ER-negative breast cancers expressing AR. Though historically breast cancers were treated with steroidal androgens, their use fell from favor because of their virilizing side effects and the emergence of tamoxifen. Nonsteroidal, tissue selective androgen receptor modulators (SARMs) may provide a novel targeted approach to exploit the therapeutic benefits of androgen therapy in breast cancer. Materials and Methods: Since MDA-MB-453 triple-negative breast cancer cells express mutated AR, PTEN, and p53, MDA-MB-231 triple-negative breast cancer cells stably expressing wildtype AR (MDA-MB-231-AR) were used to evaluate the in vitro and in vivo anti-proliferative effects of SARMs. Microarray analysis and epithelial: mesenchymal stem cell (MSC) co-culture signaling studies were performed to understand the mechanisms of action. Results: Dihydrotestosterone and SARMs, but not bicalutamide, inhibited the proliferation of MDA-MB-231-AR. The SARMs reduced the MDA-MB-231-AR tumor growth and tumor weight by greater than 90%, compared to vehicle-treated tumors. SARM treatment inhibited the intratumoral expression of genes and pathways that promote breast cancer development through its actions on the AR. SARM treatment also inhibited the metastasis-promoting paracrine factors, IL6 and MMP13, and subsequent migration and invasion of epithelial: MSC co-cultures. Conclusion: 1. AR stimulation inhibits paracrine factors that are important for MSC interactions and breast cancer invasion and metastasis. 2. SARMs may provide promise as novel targeted therapies to treat AR-positive triple-negative breast cancer.	[Narayanan, Ramesh; Ahn, Sunjoo; Cheney, Misty D.; Yepuru, Muralimohan; Miller, Duane D.; Steiner, Mitchell S.; Dalton, James T.] GTx Inc, Memphis, TN 38103 USA		Narayanan, R (corresponding author), GTx Inc, Memphis, TN 38103 USA.	rnaraya4@uthsc.edu; jdalton@gtxinc.com		Dalton, James T/0000-0002-3915-7326				ADAIR FE, 1946, ANN SURG, V123, P1023, DOI 10.1097/00000658-194606000-00006; Agoff SN, 2003, AM J CLIN PATHOL, V120, P725, DOI 10.1309/42F00D0DJD0J5EDT; American Cancer Society, 2014, CANC FACTS FIG 2014; Buchanan G, 2005, CANCER RES, V65, P8487, DOI 10.1158/0008-5472.CAN-04-3077; Chen JY, 2005, ENDOCRINOLOGY, V146, P5444, DOI 10.1210/en.2005-0732; Dalton JT, 2011, J CACHEXIA SARCOPENI, V2, P153, DOI 10.1007/s13539-011-0034-6; Dobs AS, 2013, LANCET ONCOL, V14, P335, DOI 10.1016/S1470-2045(13)70055-X; Dodson S, 2011, ANNU REV MED, V62, P265, DOI 10.1146/annurev-med-061509-131248; Elsawa SF, 2011, BLOOD, V118, P5540, DOI 10.1182/blood-2011-04-351742; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon KH, 2013, LANCET ONCOL, V14, P271, DOI 10.1016/S1470-2045(13)70068-8; Furuya K, 2012, BIOL PHARM BULL, V35, P1096, DOI 10.1248/bpb.b12-00054; Gao WQ, 2005, ENDOCRINOLOGY, V146, P4887, DOI 10.1210/en.2005-0572; Garay JP, 2012, AM J CANCER RES, V2, P434; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; GRATTAROLA R, 1974, AM J OBSTET GYNECOL, V118, P173, DOI 10.1016/0002-9378(74)90545-6; GRATTAROLA R, 1975, AM J OBSTET GYNECOL, V121, P169, DOI 10.1016/0002-9378(75)90633-X; Gucalp A, 2013, CLIN CANCER RES, V19, P5505, DOI 10.1158/1078-0432.CCR-12-3327; Hild SA, 2010, J ANDROL, V31, P472, DOI 10.2164/jandrol.109.009365; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kearbey JD, 2007, PHARM RES, V24, P328, DOI 10.1007/s11095-006-9152-9; Kearbey JD, 2009, PHARM RES-DORDR, V26, P2471, DOI 10.1007/s11095-009-9962-7; KENNEDY B. J., 1958, NEW ENGLAND JOUR MED, V259, P673, DOI 10.1056/NEJM195810022591404; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Liu Z, 2002, P NATL ACAD SCI USA, V99, P7940, DOI 10.1073/pnas.122225699; McGhan LJ, 2014, ANN SURG ONCOL, V21, P361, DOI 10.1245/s10434-013-3260-7; Narayanan R, 2005, MOL CELL BIOL, V25, P264, DOI 10.1128/MCB.25.1.264-277.2005; Narayanan R, 2008, MOL ENDOCRINOL, V22, P2448, DOI 10.1210/me.2008-0160; Narayanan R, 2010, CANCER RES, V70, P842, DOI 10.1158/0008-5472.CAN-09-3206; Narita D, 2006, NEOPLASMA, V53, P161; Narita D, 2006, FOLIA HISTOCHEM CYTO, V44, P165; Niemeier LA, 2010, MODERN PATHOL, V23, P205, DOI 10.1038/modpathol.2009.159; Peters KM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-132; Podo F, 2010, MOL ONCOL, V4, P209, DOI 10.1016/j.molonc.2010.04.006; Razandi M, 2013, ONCOGENE, V32, P3274, DOI 10.1038/onc.2012.335; Rizza P, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3619; Santagata S, 2014, J CLIN INVEST, V124, P859, DOI 10.1172/JCI70941; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Stebbing Justin, 2012, Br J Nurs, V21, pS18; Swamydas M, 2013, CELL ADHES MIGR, V7, P315, DOI 10.4161/cam.25138; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Yepuru M, 2013, CLIN CANC RES; YU H, 1995, CANCER RES, V55, P2104; Yu H, 1996, BREAST CANCER RES TR, V40, P171, DOI 10.1007/BF01806212	45	41	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103202	10.1371/journal.pone.0103202	http://dx.doi.org/10.1371/journal.pone.0103202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072326	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600029
J	Nigro, N; Wildi, K; Mueller, C; Schuetz, P; Mueller, B; Fluri, F; Christ-Crain, M; Katan, M				Nigro, Nicole; Wildi, Karin; Mueller, Christian; Schuetz, Philipp; Mueller, Beat; Fluri, Felix; Christ-Crain, Mirjam; Katan, Mira			BNP but Not s-cTnln Is Associated with Cardioembolic Aetiology and Predicts Short and Long Term Prognosis after Cerebrovascular Events	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; BRAIN NATRIURETIC PEPTIDE; CARDIAC TROPONIN ASSAYS; ATRIAL-FIBRILLATION; HEART-FAILURE; MYOCARDIAL-INFARCTION; EARLY-DIAGNOSIS; ARTERY-DISEASE; T ELEVATION; MORTALITY	Background: We analyzed the prognostic value of b-type natriuretic peptide (BNP) and sensitive cardiac Troponin (s-cTnI) in patients with ischemic stroke or transient ischemic attack (TIA) and their significance in predicting stroke aetiology. Methods: In a prospectively enrolled cohort we measured BNP and s-cTnI levels upon admission. Primary endpoints were mortality, unfavorable functional outcome and stroke recurrence after 90 days and after 12 months. Secondary endpoint was cardioembolic aetiology. Results: In 441 patients BNP but not s-cTnI remained an independent predictor for death with an adjusted HR of 1.2 (95% CI 1.1-1.4) after 90 days and 1.2 (95% CI 1.0-1.3) after one year. The comparison of the Area under Receiver Operating Characteristic (AUROC) of model A (age, NIHSS) and model B (age, NIHSS, BNP) showed an improvement in the prediction of mortality (0.85 (95% CI 0.79-0.90) vs. 0.86 (95% CI 0.81-0.92), Log Rank p = 0.004). Furthermore the category free net reclassification improvement (cfNRI) when adding BNP to the multivariate model was 57.5%, p < 0.0001. For the prediction of functional outcome or stroke recurrence both markers provided no incremental value. Adding BNP to a model including age, atrial fibrillation and heart failure lead to a higher discriminatory accuracy for identification of cardioembolic stroke than the model without BNP (AUC 0.75 (95% CI 0.70-0.80) vs. AUC 0.79, (95% CI 0.75-0.84), p = 0.008). Conclusion: BNP is an independent prognostic maker for overall mortality in patients with ischemic stroke or TIA and may improve the diagnostic accuracy to identify cardioembolic aetiology.	[Nigro, Nicole; Christ-Crain, Mirjam; Katan, Mira] Univ Basel Hosp, Dept Endocrinol, CH-4031 Basel, Switzerland; [Wildi, Karin; Mueller, Christian] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland; [Schuetz, Philipp; Mueller, Beat] Med Univ Clin, Aarau, Switzerland; [Schuetz, Philipp; Mueller, Beat] Kantonsspital Aarau, Div Endocrinol Diabetol & Metab, Aarau, Switzerland; [Katan, Mira] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Fluri, Felix] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Nigro, Nicole; Wildi, Karin; Mueller, Christian; Schuetz, Philipp; Mueller, Beat; Fluri, Felix; Christ-Crain, Mirjam; Katan, Mira] Univ Basel Hosp, Dept Clin Res, CH-4031 Basel, Switzerland	University of Basel; University of Basel; Kantonsspital Aarau AG (KSA); University of Zurich; University Zurich Hospital; University of Basel; University of Basel	Nigro, N (corresponding author), Univ Basel Hosp, Dept Endocrinol, CH-4031 Basel, Switzerland.	Nicole.Nigro@usb.ch	Wildi, Karin/AAN-3644-2020; Müller, Christian/AAB-4783-2022; Mueller, Beat/G-2662-2012; schuetz, philipp/C-8475-2013	Wildi, Karin/0000-0002-6520-2696; Müller, Christian/0000-0002-1120-6405; schuetz, philipp/0000-0001-6400-4949; Katan, Mira/0000-0002-9265-8066; Christ-Crain, Mirjam/0000-0002-6336-0965	Department of Endocrinology and Metabolism from the University Hospital of Basel; Swiss National Science Foundation [PP00P3_123346, PZ00P3_142422]; foundation Leduqc; Abbott	Department of Endocrinology and Metabolism from the University Hospital of Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); foundation Leduqc; Abbott(Abbott Laboratories)	This study was supported by an unrestricted research grant from Abbott. However Abbott was not involved in data collection, management, analysis and interpretation of the data. As well as grants from the Department of Endocrinology and Metabolism from the University Hospital of Basel. MCC was supported by a grant from the Swiss National Science Foundation (PP00P3_123346). MK was supported by a transatlantic career development award from the foundation Leduqc and a grant from the Swiss National Science Foundation (PZ00P3_142422). All supporting funders had no role in study design, data collection, management, analysis, interpretation of the data, the preparation or approval of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Christensen H, 2004, CEREBROVASC DIS, V18, P194, DOI 10.1159/000079941; Codognotto M, 2007, CLIN CHEM, V53, P2097, DOI 10.1373/clinchem.2007.089656; DAVIS M, 1994, LANCET, V343, P440, DOI 10.1016/S0140-6736(94)92690-5; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Di Angelantonio E, 2005, J NEUROL NEUROSUR PS, V76, P76, DOI 10.1136/jnnp.2004.041491; Etgen T, 2005, STROKE, V36, P270, DOI 10.1161/01.STR.0000151364.19066.a1; Faiz KW, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-96; Foerch C, 2009, NEUROLOGY, V73, P393, DOI 10.1212/WNL.0b013e3181b05ef9; Garcia-Berrocoso T, 2013, NEUROLOGY, V81, P1976, DOI 10.1212/01.wnl.0000436937.32410.32; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Hendrikx T, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-41; Idris I, 2010, AGE AGEING, V39, P752, DOI 10.1093/ageing/afq098; Jensen JK, 2012, EUR NEUROL, V68, P287, DOI 10.1159/000341340; Jensen JK, 2007, AM J CARDIOL, V99, P108, DOI 10.1016/j.amjcard.2006.07.071; Caballero PEJ, 2013, J STROKE CEREBROVASC, V22, pE214, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.014; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Katan M, 2011, EXPERT REV NEUROTHER, V11, P225, DOI 10.1586/ERN.10.200; Katan M, 2010, J AM COLL CARDIOL, V56, P1045, DOI 10.1016/j.jacc.2010.02.071; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Koenig IR, 2008, STROKE, V39, P1821, DOI 10.1161/STROKEAHA.107.505867; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Lainchbury JG, 2003, J AM COLL CARDIOL, V42, P728, DOI 10.1016/S0735-1097(03)00787-3; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Makikallio AM, 2005, STROKE, V36, P1016, DOI 10.1161/01.STR.0000162751.54349.ae; Mingels A, 2009, CLIN CHEM, V55, P101, DOI 10.1373/clinchem.2008.106427; Montaner J, 2012, CEREBROVASC DIS, V34, P240, DOI 10.1159/000341858; Montaner J, 2008, STROKE, V39, P2280, DOI 10.1161/STROKEAHA.107.505354; Mortezabeigi H R, 2013, Pak J Biol Sci, V16, P1393; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Reiter M, 2012, EUR HEART J, V33, P988, DOI 10.1093/eurheartj/ehr376; Rizos T, 2012, STROKE, V43, P2689, DOI 10.1161/STROKEAHA.112.654954; Rost NS, 2012, STROKE, V43, P441, DOI 10.1161/STROKEAHA.111.629212; Schnabel RB, 2010, CIRCULATION, V121, P200, DOI 10.1161/CIRCULATIONAHA.109.882241; Shibazaki K, 2011, EUR J NEUROL, V18, P165, DOI 10.1111/j.1468-1331.2010.03101.x; Shibazaki K, 2009, INTERNAL MED, V48, P1601, DOI 10.2169/internalmedicine.48.2166; Shibazaki K, 2009, INTERNAL MED, V48, P259, DOI 10.2169/internalmedicine.48.1475; Szabo K, 2001, STROKE, V32, P1323, DOI 10.1161/01.STR.32.6.1323; Tang WH, ARTERIOSCLER THROMB, V30, P634; Wright SP, 2003, J AM COLL CARDIOL, V42, P1793, DOI 10.1016/j.jacc.2003.05.011	42	23	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e102704	10.1371/journal.pone.0102704	http://dx.doi.org/10.1371/journal.pone.0102704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072816	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600015
J	Tulipani, DC; Lipcius, RN				Tulipani, Diane C.; Lipcius, Romuald N.			Evidence of Eelgrass (Zostera marina) Seed Dispersal by Northern Diamondback Terrapin (Malaclemys terrapin terrapin) in Lower Chesapeake Bay	PLOS ONE			English	Article							SEAGRASS MEADOWS; SALT-MARSH; GROWTH; GERMINATION; MACROPHYTE; INGESTION; TORTOISES; PATTERNS; TURTLES	The initial discovery in May 2009 of eelgrass (Zostera marina) seeds in fecal samples of wild-caught northern diamondback terrapins (Malaclemys terrapin terrapin) was the first field evidence of eelgrass seed ingestion in this species. This finding suggested the potential of terrapins as seed dispersers in eelgrass beds, which we sampled for two additional years (2010 and 2011). Seeds were only found in feces of terrapins captured prior to June 8 in all three years, coinciding with eelgrass seed maturation and release. Numbers of seeds in terrapin feces varied annually and decreased greatly in 2011 after an eelgrass die off in late 2010. The condition of seeds in terrapin feces was viable-mature, germinated, damaged, or immature. Of terrapins captured during time of seed release, 97% were males and juvenile females, both of which had head widths < 30 mm. The fraction of individuals with ingested seeds was 33% for males, 35% for small females, and only 6% for large (mature) females. Probability of seed ingestion decreased exponentially with increasing terrapin head width; only males and small females (head width <30 mm) were likely to be vectors of seed dispersal. The characteristic that diamondback terrapins have well-defined home ranges allowed us to estimate the number of terrapins potentially dispersing eelgrass seeds annually. In seagrass beds of the Goodwin Islands region (lower York River, Virginia), there were 559 to 799 terrapins, which could disperse between 1,341 and 1,677 eelgrass seeds annually. These would represent a small proportion of total seed production within a single seagrass bed. However, based on probable home range distances, terrapins can easily traverse eelgrass meadow boundaries, thereby dispersing seeds beyond the bed of origin. Given the relatively short dispersion distance of eelgrass seeds, the diamondback terrapin may be a major source of inter-bed seed dispersal and genetic diversity.	[Tulipani, Diane C.; Lipcius, Romuald N.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA	William & Mary; Virginia Institute of Marine Science	Tulipani, DC (corresponding author), Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA.	dctvims09@gmail.com			Virginia Institute of Marine Science; Chesapeake Bay National Estuarine Research Reserve in Virginia [NA10NOS4200026]; National Science Foundations [DGE-0840804]; Virginia Sea Grant; Diamondback Terrapin Working Group; National Oceanic and Atmospheric Administration-National Estuarine Research Reserve GRF	Virginia Institute of Marine Science; Chesapeake Bay National Estuarine Research Reserve in Virginia; National Science Foundations(National Science Foundation (NSF)); Virginia Sea Grant; Diamondback Terrapin Working Group; National Oceanic and Atmospheric Administration-National Estuarine Research Reserve GRF	Funding provided by Virginia Institute of Marine Science graduate student fellowship (2007-2010) http://www.vims.edu/gateways/prospectivestudents/index.php, National Oceanic and Atmospheric Administration-National Estuarine Research Reserve GRF with Chesapeake Bay National Estuarine Research Reserve in Virginia (NA10NOS4200026, 2010-2012) http://nerrs.noaa.gov/Fellowship.aspx, National Science Foundations GK-12 PERFECT fellowship (DGE-0840804, 2012-2013) http://www.vims.edu/education/graduate/gk12/, Virginia Sea Grant research grant http://vaseagrant.vims.edu/ and Diamondback Terrapin Working Group research grant (2009) http://www.dtwg.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D.R., 2008, MODEL BASED INFERENC; Birkhead RD, 2005, AM MIDL NAT, V154, P143, DOI 10.1674/0003-0031(2005)154[0143:POFASI]2.0.CO;2; Blake S, 2012, J BIOGEOGR, V39, P1961, DOI 10.1111/j.1365-2699.2011.02672.x; Bonin F, 2006, TURTLES WORLD; Butler J.A., 2002, POPULATION ECOLOGY H; CAGLE FRED R., 1939, COPEIA, V1939, P170, DOI 10.2307/1436818; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; Elbers JP, 2011, WETLANDS, V31, P757, DOI 10.1007/s13157-011-0192-5; Erazmus K. R., 2012, THESIS HOFSTRA U HEM; Ernst CH, 2009, TURTLES US CANADA; Gibbons J. Whitfield, 2001, Chelonian Conservation and Biology, V4, P66; Guzman A, 2008, AMPHIBIA-REPTILIA, V29, P463, DOI 10.1163/156853808786230442; Harden Leigh Anne, 2007, Journal of the North Carolina Academy of Science, V123, P154; Harwell MC, 2002, ECOLOGY, V83, P3319, DOI 10.2307/3072082; Heck KL, 2008, ECOSYSTEMS, V11, P1198, DOI 10.1007/s10021-008-9155-y; Holliday DK, 2009, ENVIRON TOXICOL CHEM, V28, P338, DOI 10.1897/08-145.1; HURD LE, 1979, ESTUARIES, V2, P28, DOI 10.2307/1352036; Jarvis JC, 2009, THESIS COLL WILLIAM; Jerozolimski A, 2009, OECOLOGIA, V161, P517, DOI 10.1007/s00442-009-1396-8; Kendrick GA, 2012, BIOSCIENCE, V62, P56, DOI 10.1525/bio.2012.62.1.10; Kimmons JB, 2010, CHELONIAN CONSERV BI, V9, P289, DOI 10.2744/CCB-0797.1; Liu H, 2004, OECOLOGIA, V138, P539, DOI 10.1007/s00442-003-1445-7; MOLL D, 1995, BIOTROPICA, V27, P121, DOI 10.2307/2388909; MOORE KA, 1993, AQUAT BOT, V45, P79, DOI 10.1016/0304-3770(93)90054-Z; Moore KA, 2014, ESTUARIES COASTS S1, pS20; Moore KA, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P361; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; OLIVIERI I, 1995, AM NAT, V146, P202, DOI 10.1086/285795; Orth R.J., 2011, 153 VIRG I MAR SCI; ORTH RJ, 1986, AQUAT BOT, V24, P335, DOI 10.1016/0304-3770(86)90100-2; ORTH RJ, 1994, ECOLOGY, V75, P1927, DOI 10.2307/1941597; Orth RJ, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P111; Orth RJ, 2012, MAR ECOL PROG SER, V448, P177, DOI 10.3354/meps09522; Rook MA, 2009, THESIS COLL WILLIAM; Roosenburg Willem M., 1999, Chelonian Conservation and Biology, V3, P425; SCHMIDTNIELSEN K, 1958, NATURE, V182, P783, DOI 10.1038/182783a0; SCHUPP EW, 1993, VEGETATIO, V108, P15; Sheridan CM, 2010, MOL ECOL, V19, P5497, DOI 10.1111/j.1365-294X.2010.04876.x; SILBERHORN GM, 1983, AQUAT BOT, V15, P133, DOI 10.1016/0304-3770(83)90024-4; Spivey P.B., 1998, THESIS U GEORGIA ATH; Sumoski SE, 2012, MAR ECOL PROG SER, V471, P1, DOI 10.3354/meps10145; THAYER GW, 1984, ESTUARIES, V7, P351, DOI 10.2307/1351619; TUCKER AD, 1995, HERPETOLOGICA, V51, P167; Tulipani D. C, 2013, THESIS COLL WILLIAM; VANMONTFRANS J, 1984, ESTUARIES, V7, P289, DOI 10.2307/1351615	45	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103346	10.1371/journal.pone.0103346	http://dx.doi.org/10.1371/journal.pone.0103346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072473	gold, Green Published			2022-12-25	WOS:000341307600041
J	Wen, Y; Zhang, F; Li, CY; He, SL; Tan, WH; Lei, YX; Zhang, Q; Yu, HJ; Zheng, JJ; Guo, X				Wen, Yan; Zhang, Feng; Li, Chunyan; He, Shulan; Tan, Wuhong; Lei, Yanxia; Zhang, Qiang; Yu, Hanjie; Zheng, Jingjing; Guo, Xiong			Gene Expression Analysis Suggests Bone Development-Related Genes GDF5 and DIO2 Are Involved in the Development of Kashin-Beck Disease in Children Rather than Adults	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; CHONDROCYTES; PROFILES; BETA	Objective: To investigate the differences in gene expression between children and adults with Kashin-Beck disease (KBD). Methods: 12 children with KBD and 12 healthy children were selected and divided into 4 KBD vs. control pairs matched according to age and gender, with each pair having 3 KBD children and 3 healthy children. Additionally, 15 adults with KBD and 15 healthy adults were selected and divided into 5 KBD vs. control pairs matched according to age and gender, with each pair having 3 KBD adults and 3 healthy adults. Total RNA was isolated from peripheral blood mononuclear cells (PBMCs) respectively. A total of 367 target genes were selected based on previous genome-wide gene expression profile analysis. Expression levels of the 367 genes were evaluated by customized oligonucleotide microarray and the differentially expressed genes were identified. Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) was conducted to validate the microarray data. Results: A total of 95 (25.9%) genes in KBD children and 158 (43.1%) genes in KBD adults were found to exhibit more than two-fold change in gene expression level relative to healthy controls. By comparing differentially expressed genes identified in KBD children to those of KBD adults, 42 genes were found to be differentially expressed only in KBD children. And 105 genes were found to be differentially expressed only in KBD adults. Further, 16 differentially expressed genes common to both KBD children and adults were found to be asynchronously expressed in KBD children compared to KBD adults. Conclusion: Significant differences in gene expression pattern were identified between KBD children and KBD adults, indicating different molecular mechanisms underlying cartilage lesions of KBD children and KBD adults. In addition, bone development-related genes GDF5 (expression ratio = 2.14 +/- 0.02) and DIO2 (expression ratio = 0.11 +/- 0.05) may contribute to the development of KBD in children rather than in adults.	[Wen, Yan; Zhang, Feng; Li, Chunyan; He, Shulan; Tan, Wuhong; Lei, Yanxia; Zheng, Jingjing; Guo, Xiong] Xi An Jiao Tong Univ, Sch Publ Hlth, Hlth Sci Ctr,Key Lab Trace Elements & Endem Dis,M, Key Lab Environm & Gene Related Dis,Minist Educ, Xian 710049, Peoples R China; [Zhang, Qiang] Qinghai Inst Endem Dis Control & Prevent, Dept Kashin Beck Dis, Xining, Qinghai, Peoples R China; [Yu, Hanjie] Northwest Univ, Natl Engn Res Ctr Miniaturized Detect Syst, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Northwest University Xi'an	Guo, X (corresponding author), Xi An Jiao Tong Univ, Sch Publ Hlth, Hlth Sci Ctr,Key Lab Trace Elements & Endem Dis,M, Key Lab Environm & Gene Related Dis,Minist Educ, Xian 710049, Peoples R China.	guox@mail.xjtu.edu.cn	Yu, Hanjie/E-7819-2016; He, Shulan/O-3614-2019	Yu, Hanjie/0000-0003-2684-8715; 	"13115'' major program of the Technology Science Innovation Project of Shaanxi Province [2009ZDKG-79]; National Natural Scientific Foundation of China [30972556]	"13115'' major program of the Technology Science Innovation Project of Shaanxi Province; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the "13115'' major program of the Technology Science Innovation Project of Shaanxi Province (2009ZDKG-79) and the National Natural Scientific Foundation of China (30972556). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Duan C, 2010, ARTHRITIS RHEUM-US, V62, P771, DOI 10.1002/art.27282; Francis-West PH, 1999, DEVELOPMENT, V126, P1305; Gao X-y, 2010, J XIAN JIAOTONG U ME, V4; Guo X, 2006, J BONE MINER METAB, V24, P319, DOI 10.1007/s00774-006-0690-3; Guo X., 1993, CHIN J CTRL ENDEM DI, V08, P82; Hinsenkamp M, 2001, INT ORTHOP, V25, P133, DOI 10.1007/s002640000177; KOLSTEREN P, 1992, ANN SOC BELG MED TR, V72, P81; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Moreno-Reyes R, 2001, INT ORTHOP, V25, P164, DOI 10.1007/s002640000216; Nishitoh H, 1996, J BIOL CHEM, V271, P21345, DOI 10.1074/jbc.271.35.21345; Schlegel W, 2009, J CELL MOL MED, V13, P3398, DOI 10.1111/j.1582-4934.2009.00953.x; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Wang L, 2010, J BONE MINER RES, V25, P1138, DOI 10.1002/jbmr.5; Wang S, 2012, GENES CELLS, V17, P619, DOI 10.1111/j.1365-2443.2012.01620.x; Wang SH, 2006, J RHEUMATOL, V33, P615; Wang Shi-jie, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P643; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028439; Wang W, 2013, OSTEOARTHR CARTILAGE, V21, P1781, DOI 10.1016/j.joca.2013.08.002; Wang WZ, 2009, OSTEOARTHR CARTILAGE, V17, P83, DOI 10.1016/j.joca.2008.05.008; Wang WZ, 2008, J RHEUMATOL, V35, P696; [吴泰相 WU Taixiang], 2008, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V8, P86; Xiong G, 2001, INT ORTHOP, V25, P147, DOI 10.1007/s002640100248; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022983	24	14	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103618	10.1371/journal.pone.0103618	http://dx.doi.org/10.1371/journal.pone.0103618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072641	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600072
J	Zhimulev, IF; Zykova, TY; Goncharov, FP; Khoroshko, VA; Demakova, OV; Semeshin, VF; Pokholkova, GV; Boldyreva, LV; Demidova, DS; Babenko, VN; Demakov, SA; Belyaeva, ES				Zhimulev, Igor F.; Zykova, Tatyana Yu.; Goncharov, Fyodor P.; Khoroshko, Varvara A.; Demakova, Olga V.; Semeshin, Valeriy F.; Pokholkova, Galina V.; Boldyreva, Lidiya V.; Demidova, Darya S.; Babenko, Vladimir N.; Demakov, Sergey A.; Belyaeva, Elena S.			Genetic Organization of Interphase Chromosome Bands and Interbands in Drosophila melanogaster	PLOS ONE			English	Article							POLYTENE CHROMOSOMES; FUNCTIONAL-ORGANIZATION; REVISED MAP; INTERCALARY HETEROCHROMATIN; X-CHROMOSOME; BINDING; IDENTIFICATION; TRANSCRIPTION; EXPRESSION; HYPOTHESIS	Drosophila melanogaster polytene chromosomes display specific banding pattern; the underlying genetic organization of this pattern has remained elusive for many years. In the present paper, we analyze 32 cytology-mapped polytene chromosome interbands. We estimated molecular locations of these interbands, described their molecular and genetic organization and demonstrate that polytene chromosome interbands contain the 59 ends of housekeeping genes. As a rule, interbands display preferential "head-to-head'' orientation of genes. They are enriched for "broad'' class promoters characteristic of housekeeping genes and associate with open chromatin proteins and Origin Recognition Complex (ORC) components. In two regions, 10A and 100B, coding sequences of genes whose 5'-ends reside in interbands map to constantly loosely compacted, early-replicating, so-called "grey'' bands. Comparison of expression patterns of genes mapping to late-replicating dense bands vs genes whose promoter regions map to interbands shows that the former are generally tissue-specific, whereas the latter are represented by ubiquitously active genes. Analysis of RNA-seq data (modENCODE-FlyBase) indicates that transcripts from interband-mapping genes are present in most tissues and cell lines studied, across most developmental stages and upon various treatment conditions. We developed a special algorithm to computationally process protein localization data generated by the modENCODE project and show that Drosophila genome has about 5700 sites that demonstrate all the features shared by the interbands cytologically mapped to date.	[Zhimulev, Igor F.; Zykova, Tatyana Yu.; Goncharov, Fyodor P.; Khoroshko, Varvara A.; Demakova, Olga V.; Semeshin, Valeriy F.; Pokholkova, Galina V.; Boldyreva, Lidiya V.; Demidova, Darya S.; Demakov, Sergey A.; Belyaeva, Elena S.] Russian Acad Sci, Inst Mol & Cellular Biol, Siberian Branch, Novosibirsk, Russia; [Zhimulev, Igor F.; Demidova, Darya S.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Babenko, Vladimir N.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia	Russian Academy of Sciences; Novosibirsk State University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Zhimulev, IF (corresponding author), Russian Acad Sci, Inst Mol & Cellular Biol, Siberian Branch, Novosibirsk, Russia.	zhimulev@mcb.nsc.ru	Boldyreva, Lidiya/N-6978-2015; Zykova (Vatolina), Tatyana/I-3897-2014; Goncharov, Fedor/C-8891-2018; Sidorenko, Darya S./N-9524-2015; Zhimulev, Igor F/N-7978-2015; Pokholkova, Galina/N-7554-2015; Demakova, Olga/N-7478-2015	Boldyreva, Lidiya/0000-0003-0716-4545; Goncharov, Fedor/0000-0001-9728-2670; Sidorenko, Darya S./0000-0002-1230-2722; Babenko, Vladimir/0000-0002-3077-9559; Zhimulev, Igor/0000-0002-6220-3028; Demakova, Olga/0000-0002-8538-7384; Demakov, Sergey/0000-0002-5526-6784	Russian Scientific Foundation [14-14- 00934]; Russian Science Foundation [14-14-00934] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This research was funded by grant of Russian Scientific Foundation #14-14- 00934(http://www.rscf.ru/sites/default/files/docfiles/Spisok_pobediteley.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyenkova NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083319; Ashburner M, 1972, INT C SER ENDOCRINOL, V273, P315; Ashburner M., 2004, DROSOPHILA LAB HDB; Babenko V N, 2013, Tsitologiia, V55, P181; BEERMANN W., 1965, Genetics today. Proceedings of the XI International Congress of Genetics, The Hague, the Netherlands, September, 1963., V2, P375; Beermann W, 1967, HERITAGE MENDEL, P179; Belyaeva ES, 2008, CHROMOSOMA, V117, P411, DOI 10.1007/s00412-008-0163-7; Belyaeva ES, 2012, PLOS ONE, V7, P352, DOI 10.1371/journal.pone.0030035; Belyakin SN, 2005, P NATL ACAD SCI USA, V102, P8269, DOI 10.1073/pnas.0502702102; Belyakin SN, 2010, CHROMOSOMA, V119, P589, DOI 10.1007/s00412-010-0280-y; Braunschweig U, 2009, EMBO J, V28, P3635, DOI 10.1038/emboj.2009.301; Bridges CB, 1938, J HERED, V29, P11, DOI 10.1093/oxfordjournals.jhered.a104399; Bridges CB, 1939, J HERED, V30, P475, DOI 10.1093/oxfordjournals.jhered.a104634; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Bridges PN, 1942, J HERED, V33, P403, DOI 10.1093/oxfordjournals.jhered.a105104; Bridges PN, 1941, J HERED, V32, P64, DOI 10.1093/oxfordjournals.jhered.a104998; Bridges PN, 1941, J HERED, V32, P299, DOI 10.1093/oxfordjournals.jhered.a105069; Calinski T., 1974, COMMUNICATIONS STAT, V3, P1, DOI [DOI 10.1080/03610927408827101, 10.1080/03610927408827101]; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; CRICK F, 1971, NATURE, V234, P25, DOI 10.1038/234025a0; DAVIDSON EH, 1973, Q REV BIOL, V48, P565, DOI 10.1086/407817; Demakov SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-566; Ding Y, 2009, DEV BIOL, V334, P253, DOI 10.1016/j.ydbio.2009.07.027; Eaton ML, 2011, GENOME RES, V21, P164, DOI 10.1101/gr.116038.110; Eggert H, 2004, J CELL SCI, V117, P4253, DOI 10.1242/jcs.01292; Feller C, 2012, NUCLEIC ACIDS RES, V40, P1509, DOI 10.1093/nar/gkr869; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; FUJITA S, 1965, NATURE, V206, P742, DOI 10.1038/206742a0; GERSH ES, 1975, J THEOR BIOL, V50, P413, DOI 10.1016/0022-5193(75)90090-9; Gortchakov AA, 2005, CHROMOSOMA, V114, P54, DOI 10.1007/s00412-005-0339-3; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Kaufmann BP, 1939, P NATL ACAD SCI USA, V25, P571, DOI 10.1073/pnas.25.11.571; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kolesnikova TD, 2011, FLY, V5, P181, DOI 10.4161/fly.5.3.16729; Koltzoff N., 1934, Science, V80, P312, DOI 10.1126/science.80.2075.312; KOSSWIG C, 1947, J HERED, V38, P235, DOI 10.1093/oxfordjournals.jhered.a105740; KOZLOVA TY, 1994, GENETICS, V136, P1063; Lam KC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002736; LEFEVRE G, 1971, GENETICS, V67, P497; Makunin IV, 2002, GENETICS, V160, P1023; Miele V, 2008, NUCLEIC ACIDS RES, V36, P3746, DOI 10.1093/nar/gkn262; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; MOJENA R, 1977, COMPUT J, V20, P359, DOI 10.1093/comjnl/20.4.359; Nordman J, 2011, GENOME RES, V21, P175, DOI 10.1101/gr.114611.110; PAUL J, 1972, NATURE, V238, P444, DOI 10.1038/238444a0; Petesch SJ, 2012, TRENDS GENET, V28, P285, DOI 10.1016/j.tig.2012.02.005; Pindyurin AV, 2007, J CELL SCI, V120, P2344, DOI 10.1242/jcs.006007; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; Rath U, 2004, J CELL BIOCHEM, V93, P1033, DOI 10.1002/jcb.20243; Semeshin VF, 2004, METH MOL B, V247, P305; SEMESHIN VF, 1979, CHROMOSOMA, V73, P163, DOI 10.1007/BF00331569; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sher N, 2012, GENOME RES, V22, P64, DOI 10.1101/gr.126003.111; Sokoloff S, 1977, THESIS U TUBINGEN; SORSA V, 1975, HEREDITAS, V81, P77; Sorsa V., 1968, Suomalaisen Tiedeakat Toim (Ser A 4 Biol), VNo. 134, P1; Sorsa V, 1984, INSECT ULTRASTRUCTUR, V2, P75; SPEISER C, 1974, THEOR APPL GENET, V44, P97, DOI 10.1007/BF02981919; Spradling AC, 2011, P NATL ACAD SCI USA, V108, P15948, DOI 10.1073/pnas.1112960108; Taramasco O, 2013, RHMM HIDDEN MARKOV M; Vatolina TY, 2011, RUSS J GENET+, V47, P521, DOI 10.1134/S1022795411040144; Vatolina TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025960; Wakano C, 2012, BBA-GENE REGUL MECH, V1819, P688, DOI 10.1016/j.bbagrm.2012.02.006; Weber CC, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r23; White R, 2012, BRIEF FUNCT GENOMICS, V11, P347, DOI 10.1093/bfgp/els020; Yao CF, 2012, CHROMOSOMA, V121, P209, DOI 10.1007/s00412-011-0355-4; Zhang P, 2012, NUCLEIC ACIDS RES, P1; ZHIMULEV IF, 1975, CHROMOSOMA, V49, P219, DOI 10.1007/BF00361067; Zhimulev IF, 2003, CHROMOSOMA, V111, P377, DOI 10.1007/s00412-002-0218-0; Zhimulev IF, 1999, ADV GENET, V39, P1, DOI 10.1016/S0065-2660(08)60476-9; ZHIMULEV IF, 1975, THEOR APPL GENET, V45, P335, DOI 10.1007/BF00277673; Zhimulev IF, 2012, BIOESSAYS, V34, P498, DOI 10.1002/bies.201100142	76	48	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e101631	10.1371/journal.pone.0101631	http://dx.doi.org/10.1371/journal.pone.0101631			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072930	Green Submitted, Green Published, gold			2022-12-25	WOS:000341307600006
J	Chau, M; Lui, JLC; Landman, EBM; Spath, SS; Vortkamp, A; Baron, J; Nilsson, O				Chau, Michael; Lui, Julian C.; Landman, Ellie B. M.; Spath, Stephan-Stanislaw; Vortkamp, Andrea; Baron, Jeffrey; Nilsson, Ola			Gene Expression Profiling Reveals Similarities between the Spatial Architectures of Postnatal Articular and Growth Plate Cartilage	PLOS ONE			English	Article							KNEE-JOINT; SYNOVIAL JOINT; CHONDROCYTES; CHONDROGENESIS; OSTEOARTHRITIS; IDENTIFICATION; CELLS; DIFFERENTIATION; NORMALIZATION; ANGIOGENESIS	Articular and growth plate cartilage are discrete tissues but arise from a common cartilaginous condensation and have comparable spatial architectures consisting of distinct layers of chondrocytes. To investigate similarities and differences between articular and growth plate cartilage and to explore transcriptional changes that occur during the onset of their divergence, we performed manual microdissection of 10-day-old rat proximal tibias, microarray analysis, bioinformatics, and real-time PCR to compare gene expression profiles in individual cartilage layers. We found that many genes that were spatially upregulated in the intermediate/deep zone of articular cartilage were also spatially upregulated in the resting zone of growth plate cartilage (overlap greater than expected by chance, P<0.001). Interestingly, the superficial zone of articular cartilage showed an expression profile with similarities to both the proliferative and hypertrophic zones of growth plate cartilage (P<0.001 each). Additionally, significant numbers of known proliferative zone markers (3 out of 6) and hypertrophic zone markers (27 out of 126) were spatially upregulated in the superficial zone (more than expected by chance, P<0.001 each). In conclusion, we provide evidence that the intermediate/deep zone of articular cartilage has a gene expression profile more similar to that of the resting zone of growth plate cartilage, whereas the superficial zone has a gene expression profile more similar to those of the proliferative and hypertrophic zones. These findings suggest that the superficial zone chondrocytes of articular cartilage differentiate according to a program that is not completely different from but instead has distinct similarities to the hypertrophic differentiation program of growth plate chondrocytes. We also present functional signaling pathways implicated by differential gene expression between articular and growth plate cartilage during their initial separation by the secondary ossification center.	[Chau, Michael; Landman, Ellie B. M.; Spath, Stephan-Stanislaw; Nilsson, Ola] Karolinska Inst, Dept Womens & Childrens Hlth, Pediat Endocrinol Unit, Stockholm, Sweden; [Chau, Michael; Landman, Ellie B. M.; Spath, Stephan-Stanislaw; Nilsson, Ola] Univ Hosp, Stockholm, Sweden; [Chau, Michael; Lui, Julian C.; Landman, Ellie B. M.; Spath, Stephan-Stanislaw; Baron, Jeffrey; Nilsson, Ola] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA; [Vortkamp, Andrea] Univ Duisburg Essen, Fac Biol, Dept Dev Biol, Essen, Germany; [Vortkamp, Andrea] Univ Duisburg Essen, Ctr Med Biotechnol, Essen, Germany	Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Duisburg Essen; University of Duisburg Essen	Nilsson, O (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Pediat Endocrinol Unit, Stockholm, Sweden.	ola.nilsson@ki.se	Lui, Julian/E-2253-2012	Lui, Julian/0000-0002-0611-4901; /0000-0002-5839-4626; Nilsson, Ola/0000-0002-9986-8138	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; NIH, Bethesda, MD, USA; Sallskapet Barnavard; Karolinska Institutet, Stockholm, SWE; Deutsche Forschungsgemeinschaft, Bonn, DEU [Vo-620/10]; ESPE Research Fellowship; Swedish Research Council; Stockholm County Council; Swedish Society of Medicine; HKH Kronprinsessan Lovisas forening for barnasjukvard; Stiftelsen Frimurare Barnhuset i Stockholm,; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000640] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sallskapet Barnavard; Karolinska Institutet, Stockholm, SWE; Deutsche Forschungsgemeinschaft, Bonn, DEU; ESPE Research Fellowship; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Swedish Society of Medicine; HKH Kronprinsessan Lovisas forening for barnasjukvard; Stiftelsen Frimurare Barnhuset i Stockholm,; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, USA. MC was supported by a grant from Sallskapet Barnavard and the Karolinska Institutet, Stockholm, SWE. AV was supported by a grant from the Deutsche Forschungsgemeinschaft (Vo-620/10), Bonn, DEU. ON was supported by an ESPE Research Fellowship Grant and grants from the Swedish Research Council, the Stockholm County Council, the Swedish Society of Medicine, HKH Kronprinsessan Lovisas forening for barnasjukvard, Sallskapet Barnavard, Stiftelsen Frimurare Barnhuset i Stockholm, and the Karolinska Institutet, Stockholm, SWE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad V, 2002, ENDOCRINOLOGY, V143, P1851, DOI 10.1210/en.143.5.1851; Amanatullah DF, 2014, J TISSUE ENG REGEN M, V8, P505, DOI 10.1002/term.1543; ANDERSEN H, 1961, ACTA ANAT, V46, P279; Bandyopadhyay A, 2008, DEV BIOL, V321, P162, DOI 10.1016/j.ydbio.2008.06.012; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cooper KL, 2013, NATURE, V495, P375, DOI 10.1038/nature11940; Darling EM, 2004, J ORTHOP RES, V22, P1182, DOI 10.1016/j.orthres.2004.03.001; De Luca F, 2001, ENDOCRINOLOGY, V142, P430, DOI 10.1210/en.142.1.430; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; GARDNER E, 1968, J ANAT, V102, P289; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Hattori S, 2007, BIOCHEM BIOPH RES CO, V358, P99, DOI 10.1016/j.bbrc.2007.04.142; Hayes AJ, 2001, ANAT EMBRYOL, V203, P469, DOI 10.1007/s004290100178; HEINRICHS C, 1994, ENDOCRINOLOGY, V135, P1113, DOI 10.1210/en.135.3.1113; Huber M, 2000, INVEST RADIOL, V35, P573, DOI 10.1097/00004424-200010000-00003; HUNZIKER EB, 1994, MICROSC RES TECHNIQ, V28, P505, DOI 10.1002/jemt.1070280606; Hyde G, 2008, J ANAT, V213, P531, DOI 10.1111/j.1469-7580.2008.00966.x; Hyde G, 2007, DEV BIOL, V304, P825, DOI 10.1016/j.ydbio.2007.01.026; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwamoto M, 1999, CRIT REV ORAL BIOL M, V10, P477, DOI 10.1177/10454411990100040401; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lausch E, 2009, AM J HUM GENET, V85, P168, DOI 10.1016/j.ajhg.2009.06.014; Leijten JCH, 2012, ARTHRITIS RHEUM-US, V64, P3302, DOI 10.1002/art.34535; Lui JCK, 2010, BONE, V46, P1380, DOI 10.1016/j.bone.2010.01.373; Luque A, 2003, J BIOL CHEM, V278, P23656, DOI 10.1074/jbc.M212964200; MINNS RJ, 1977, J ANAT, V123, P437; Nilsson O, 2007, J ENDOCRINOL, V193, P75, DOI 10.1677/joe.1.07099; Noback CR, 1954, AM J PHYS ANTHROP-NE, V12, P63, DOI 10.1002/ajpa.1330120118; Onyekwelu I, 2009, J CELL BIOCHEM, V107, P383, DOI 10.1002/jcb.22149; Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050; Pearle AD, 2005, CLIN SPORT MED, V24, P1, DOI 10.1016/j.csm.2004.08.007; Reboul P, 1996, J CLIN INVEST, V97, P2011, DOI 10.1172/JCI118636; Tavella S, 2004, J BONE MINER RES, V19, P1678, DOI 10.1359/JBMR.040706; Ulrich-Vinther Michael, 2003, J Am Acad Orthop Surg, V11, P421; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Zeggini E, 2012, LANCET, V380, P815, DOI 10.1016/S0140-6736(12)60681-3	40	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103061	10.1371/journal.pone.0103061	http://dx.doi.org/10.1371/journal.pone.0103061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068449	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700031
J	He, J; Xuan, T; Xin, TC; An, HB; Wang, JY; Zhao, GC; Li, MF				He, Jie; Xuan, Tao; Xin, Tianchi; An, Hongbo; Wang, Jinye; Zhao, Gengchun; Li, Mingfa			Evidence for Chromatin-Remodeling Complex PBAP-Controlled Maintenance of the Drosophila Ovarian Germline Stem Cells	PLOS ONE			English	Article							BAG-OF-MARBLES; SELF-RENEWAL; ASYMMETRIC DIVISION; GENETIC-ANALYSIS; DIFFERENTIATION; OOGENESIS; NICHE; NANOS; TRANSCRIPTION; EXPRESSION	In the Drosophila oogenesis, germline stem cells (GSCs) continuously self-renew and differentiate into daughter cells for consecutive germline lineage commitment. This developmental process has become an in vivo working platform for studying adult stem cell fate regulation. An increasing number of studies have shown that while concerted actions of extrinsic signals from the niche and intrinsic regulatory machineries control GSC self-renewal and germline differentiation, epigenetic regulation is implicated in the process. Here, we report that Brahma (Brm), the ATPase subunit of the Drosophila SWI/SNF chromatin-remodeling complexes, is required for maintaining GSC fate. Removal or knockdown of Brm function in either germline or niche cells causes a GSC loss, but does not disrupt normal germline differentiation within the germarium evidenced at the molecular and morphological levels. There are two Drosophila SWI/SNF complexes: the Brm-associated protein (BAP) complex and the polybromo-containing BAP (PBAP) complex. More genetic studies reveal that mutations in polybromo/bap180, rather than gene encoding Osa, the BAP complex-specific subunit, elicit a defect in GSC maintenance reminiscent of the brm mutant phenotype. Further genetic interaction test suggests a functional association between brm and polybromo in controlling GSC self-renewal. Taken together, studies in this paper provide the first demonstration that Brm in the form of the PBAP complex functions in the GSC fate regulation.	[He, Jie; Xuan, Tao; Xin, Tianchi; An, Hongbo; Zhao, Gengchun; Li, Mingfa] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Xuan, Tao; Wang, Jinye] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xuan, T (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	xuantao@sjtu.edu.cn; mfli@sjtu.edu.cn	Wang, Jin-Ye/H-1450-2011; Xin, Tianchi/AAU-6803-2020	Wang, Jin-Ye/0000-0002-0937-1508; Xin, Tianchi/0000-0002-6982-8610	National Basic Research Program of China [2012CB966903]; National Natural Science Foundation of China [J1210047]; Innovation Project of Shanghai Municipal Education Commission [12ZZ015]; Postdoctoral Research Foundation of Shanghai Jiao Tong University [13X100030030]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project of Shanghai Municipal Education Commission; Postdoctoral Research Foundation of Shanghai Jiao Tong University	This work was supported by National Basic Research Program of China (2012CB966903), National Natural Science Foundation of China (J1210047), Innovation Project of Shanghai Municipal Education Commission (12ZZ015) and Postdoctoral Research Foundation of Shanghai Jiao Tong University (13X100030030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables ET, 2010, CELL STEM CELL, V7, P581, DOI 10.1016/j.stem.2010.10.001; Bhat KM, 1999, GENETICS, V151, P1479; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brizuela BJ, 1997, MECH DEVELOP, V65, P209, DOI 10.1016/S0925-4773(97)00081-6; BRIZUELA BJ, 1994, GENETICS, V137, P803; Buszczak M, 2009, SCIENCE, V323, P248, DOI 10.1126/science.1165678; Carrera I, 2008, MOL CELL BIOL, V28, P5238, DOI 10.1128/MCB.00747-08; Chau J, 2012, P NATL ACAD SCI USA, V109, P9465, DOI 10.1073/pnas.1120473109; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; CHRISTERSON LB, 1994, GENE DEV, V8, P614, DOI 10.1101/gad.8.5.614; Clough E, 2014, DEV BIOL; Collins RT, 2000, GENE DEV, V14, P3140, DOI 10.1101/gad.854300; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Elfring LK, 1998, GENETICS, V148, P251; Eliazer S, 2011, P NATL ACAD SCI USA, V108, P7064, DOI 10.1073/pnas.1015874108; Forbes A, 1998, DEVELOPMENT, V125, P679; Gancz D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001202; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Horne-Badovinac S, 2005, DEV DYNAM, V232, P559, DOI 10.1002/dvdy.20286; Jin YY, 2013, ELIFE, V2, DOI 10.7554/eLife.00999; Jin ZG, 2007, CURR BIOL, V17, P539, DOI 10.1016/j.cub.2007.01.050; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; Kirilly D, 2011, DEVELOPMENT, V138, P5087, DOI 10.1242/dev.067850; Li Q, 2008, CELL RES, V18, P372, DOI 10.1038/cr.2008.25; Lin HF, 1997, DEVELOPMENT, V124, P2463; Maines JZ, 2007, DEVELOPMENT, V134, P1471, DOI 10.1242/dev.02810; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; Mohrmann L, 2004, MOL CELL BIOL, V24, P3077, DOI 10.1128/MCB.24.8.3077-3088.2004; Moshkin YM, 2007, MOL CELL BIOL, V27, P651, DOI 10.1128/MCB.01257-06; Parisi MJ, 2001, GENESIS, V29, P196, DOI 10.1002/gene.1024; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Rojas-Rios P, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001298; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Spradling Allan C., 1993, P1; Sugimura I, 2006, DEV CELL, V10, P127, DOI 10.1016/j.devcel.2005.10.018; Tastan OY, 2010, DEVELOPMENT, V137, P3167, DOI 10.1242/dev.050575; Tie F, 2012, MOL CELL BIOL, V32, P2323, DOI 10.1128/MCB.06392-11; Wang XX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002426; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Xie, 2008, GERMLINE STEM CELL N; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Xin TC, 2013, DEV BIOL, V384, P1, DOI 10.1016/j.ydbio.2013.10.001; Xuan T, 2013, DEV BIOL, V379, P167, DOI 10.1016/j.ydbio.2013.04.015; Yang LL, 2007, DEVELOPMENT, V134, P4265, DOI 10.1242/dev.009159; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zeng XK, 2013, DEVELOPMENT, V140, P3532, DOI 10.1242/dev.096891; Zraly CB, 2003, DEV BIOL, V253, P291, DOI 10.1016/S0012-1606(02)00011-8	50	14	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103473	10.1371/journal.pone.0103473	http://dx.doi.org/10.1371/journal.pone.0103473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068272	gold, Green Published, Green Submitted			2022-12-25	WOS:000339993700072
J	Rajenderan, S; Balaji, V; Anandan, S; Sahni, RD; Tansarli, GS; Falagas, ME				Rajenderan, Sangeetha; Balaji, Veeraraghavan; Anandan, Shalini; Sahni, Rani Diana; Tansarli, Giannoula S.; Falagas, Matthew E.			Determination of MIC Distribution of Arbekacin, Cefminox, Fosfomycin, Biapenem and Other Antibiotics against Gram-Negative Clinical Isolates in South India: A Prospective Study	PLOS ONE			English	Article							RESISTANT PSEUDOMONAS-AERUGINOSA; IN-VITRO ACTIVITY; URINARY-TRACT-INFECTIONS; MULTIDRUG-RESISTANT; ESCHERICHIA-COLI; ACINETOBACTER-BAUMANNII; CARBAPENEM; SUSCEPTIBILITY; AMINOGLYCOSIDE; EPIDEMIOLOGY	Objectives: To determine the in vitro activity of antibiotics, including arbekacin, cefminox, fosfomycin and biapenem which are all still unavailable in India, against Gram-negative clinical isolates. Methods: We prospectively collected and tested all consecutive isolates of Escherichia coli, Klebsiella spp., Pseudomonas aeruginosa and Acinetobacter spp. from blood, urine and sputum samples between March and November 2012. The minimum inhibition concentration (MIC) of 16 antibiotics was determined by the broth micro-dilution method. Results: Overall 925 isolates were included; 211 E. coli, 207 Klebsiella spp., 153 P. aeruginosa, and 354 Acinetobacter spp. The MIC50 and MIC90 were high for cefminox, biapenem and arbekacin for all pathogens but interpretative criteria were not available. The MIC50 was categorized as susceptible for a couple of antibiotics, including piperacillin/tazobactam, carbapenems and amikacin, for E. coli, Klebsiella spp. and P. aeruginosa. However, for Acinetobacter spp., the MIC50 was categorized as susceptible only for colistin. On the other hand, fosfomycin was the only antibiotic that inhibited 90% of E. coli and Klebsiella spp. isolates, while 90% of P. aeruginosa isolates were inhibited only by colistin. Finally, 90% of Acinetobacter spp. isolates were not inhibited by any antibiotic tested. Conclusion: Fosfomycin and colistin might be promising antibiotics for the treatment of infections due to E. coli or Klebsiella spp. and P. aeruginosa, respectively, in India; however, clinical trials should first corroborate the in vitro findings. The activity of tigecycline should be evaluated, as this is commonly used as last-resort option for the treatment of multidrug-resistant Acinetobacter infections.	[Rajenderan, Sangeetha; Balaji, Veeraraghavan; Anandan, Shalini; Sahni, Rani Diana] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Tansarli, Giannoula S.; Falagas, Matthew E.] Alfa Inst Biomed Sci, Athens, Greece; [Falagas, Matthew E.] Iaso Gen Hosp, Dept Internal Med Infect Dis, Iaso Grp, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Christian Medical College & Hospital (CMCH) Vellore; Alfa Institute Of Biomedical Sciences; Tufts University	Falagas, ME (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr	SAHNI, RANI DIANA/AAB-1007-2022	Veeraraghavan, Balaji/0000-0002-8662-4257	Educational and Research Grant of Meiji Seika Pharma Co, Ltd, Japan	Educational and Research Grant of Meiji Seika Pharma Co, Ltd, Japan	The study was performed from funding received from the Educational and Research Grant of Meiji Seika Pharma Co, Ltd, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Noriyuki, 2005, Japanese Journal of Antibiotics, V58, P445; Abhilash K P P, 2010, J Assoc Physicians India, V58 Suppl, P13; ALDRIDGE KE, 1994, ANTIMICROB AGENTS CH, V38, P889, DOI 10.1128/AAC.38.4.889; Amudhan SM, 2011, INDIAN J MED MICROBI, V29, P269, DOI 10.4103/0255-0857.83911; Anandan S, 2009, INDIAN PEDIATR, V46, P1106; [Anonymous], 2012, CLIN LAB STANDARDS I; APPELBAUM PC, 1993, J ANTIMICROB CHEMOTH, V32, P223, DOI 10.1093/jac/32.2.223; Araoka H, 2012, JPN J INFECT DIS, V65, P84; Behera B, 2009, INDIAN J MED RES, V129, P446; Ben-David D, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2011.03478.x; Bergen PJ, 2012, CURR OPIN INFECT DIS, V25, P626, DOI 10.1097/QCO.0b013e328358afe5; Chang HJ, 2011, J MICROBIOL IMMUNOL, V44, P125, DOI 10.1016/j.jmii.2010.06.001; Chaudhuri B N, 2011, J Assoc Physicians India, V59, P287; De AS, 2010, INDIAN J CRIT CARE M, V14, P217, DOI 10.4103/0972-5229.76089; Durakovic N, 2011, INTERNAL MED, V50, P1009, DOI 10.2169/internalmedicine.50.4270; Falagas ME, 2011, FUTURE MICROBIOL, V6, P653, DOI [10.2217/fmb.11.49, 10.2217/FMB.11.49]; Falagas ME, 2010, INT J ANTIMICROB AG, V35, P194, DOI 10.1016/j.ijantimicag.2009.10.005; Falagas ME, 2010, LANCET INFECT DIS, V10, P43, DOI 10.1016/S1473-3099(09)70325-1; Falagas ME, 2009, EXPERT OPIN INV DRUG, V18, P921, DOI 10.1517/13543780902967624; Gladstone P, 2005, Indian J Med Microbiol, V23, P189; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Hamada Y, 2011, J INFECT CHEMOTHER, V17, P876, DOI 10.1007/s10156-011-0262-x; Hoellman DB, 1998, ANTIMICROB AGENTS CH, V42, P495, DOI 10.1128/AAC.42.3.495; Hwang JH, 2012, EUR J CLIN MICROBIOL, V31, P1663, DOI 10.1007/s10096-011-1490-9; Lerma M, 2008, REV ESP QUIM, V21, P149; Livermore DM, 2013, J ANTIMICROB CHEMOTH, V68, P1825, DOI 10.1093/jac/dkt118; Maraki S, 2012, SURG INFECT, V13, P326, DOI 10.1089/sur.2011.115; Michalopoulos A, 2010, CLIN MICROBIOL INFEC, V16, P184, DOI 10.1111/j.1469-0691.2009.02921.x; Michalopoulos AS, 2005, CLIN MICROBIOL INFEC, V11, P115, DOI 10.1111/j.1469-0691.2004.01043.x; Pullukcu H, 2007, INT J ANTIMICROB AG, V29, P62, DOI 10.1016/j.ijantimicag.2006.08.039; Sahni RD, 2013, FUTURE MICR IN PRESS; Senol S, 2010, J CHEMOTHERAPY, V22, P355, DOI 10.1179/joc.2010.22.5.355; Sinha M, 2007, INDIAN J MED RES, V126, P63; Sinha N, 2013, INDIAN J MED MICROBI, V31, P60, DOI 10.4103/0255-0857.108724; Somily AM, 2012, SAUDI MED J, V33, P750; Taneja N, 2011, INDIAN J MED RES, V133, P681; Varaiya A, 2008, INDIAN J MED RES, V127, P398; Winn W, 2006, KONEMANS COLOR ATLAS, P309; Winn W, 2006, KONEMANS COLOR ATLAS, P213; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zapor MJ, 2010, ANTIMICROB AGENTS CH, V54, P3015, DOI 10.1128/AAC.01173-09	41	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103253	10.1371/journal.pone.0103253	http://dx.doi.org/10.1371/journal.pone.0103253			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068396	gold, Green Published, Green Submitted			2022-12-25	WOS:000339993700052
J	Riveiro-Barciela, M; Buti, M; Homs, M; Campos-Varela, I; Cantarell, C; Crespo, M; Castells, L; Tabernero, D; Quer, J; Esteban, R; Rodriguez-Frias, F				Riveiro-Barciela, Mar; Buti, Maria; Homs, Maria; Campos-Varela, Isabel; Cantarell, Carmen; Crespo, Manuel; Castells, Lluis; Tabernero, David; Quer, Josep; Esteban, Rafael; Rodriguez-Frias, Francisco			Cirrhosis, Liver Transplantation and HIV Infection Are Risk Factors Associated with Hepatitis E Virus Infection	PLOS ONE			English	Article							BLOOD-DONORS; IGG SEROPREVALENCE; SOUTHWEST ENGLAND; RECIPIENTS; TRANSFUSION; PREVALENCE; HEV; SPAIN; ANTIBODIES; RIBAVIRIN	Background: Acute and chronic hepatitis E have been associated with high mortality and development of cirrhosis, particularly in solid-organ recipients and patients infected by human immunodeficiency virus. However, data regarding the epidemiology of hepatitis E in special populations is still limited. Aims: Investigate seroprevalence and possible factors associated with HEV infection in a large cohort of immunosuppressed patients. Methods: Cross-sectional study testing IgG anti-HEV in serum samples from 1373 consecutive individuals: 332 liver-transplant, 296 kidney-transplant, 6 dual organ recipients, 301 non-transplanted patients with chronic liver disease, 238 HIV-infected patients and 200 healthy controls. Results: IgG anti-HEV was detected in 3.5% controls, 3.7% kidney recipients, 7.4% liver transplant without cirrhosis and 32.1% patients who developed post-transplant cirrhosis (p < 0.01). In patients with chronic liver disease, IgG anti-HEV was also statistically higher in those with liver cirrhosis (2% vs 17.5%, p < 0.01). HIV-infected patients showed an IgG anti-HEV rate of 9.2%, higher than those patients without HIV infection (p < 0.03). Multivariate analysis showed that the factors independently associated with anti-HEV detection were liver cirrhosis, liver transplantation and HIV infection (OR: 7.6, 3.1 and 2.4). HCV infection was a protective factor for HEV infection (OR: 0.4). Conclusions: HEV seroprevalence was high in liver transplant recipients, particularly those with liver cirrhosis. The difference in anti-HEV prevalence between Liver and Kidney transplanted cases suggests an association with advanced liver disease. Further research is needed to ascertain whether cirrhosis is a predisposing factor for HEV infection or whether HEV infection may play a role in the pathogeneses of cirrhosis.	[Riveiro-Barciela, Mar; Buti, Maria; Campos-Varela, Isabel; Castells, Lluis; Quer, Josep; Esteban, Rafael] Hosp Univ Vall Hebron, Dept Internal Med, Liver Unit, Barcelona, Spain; [Buti, Maria; Quer, Josep; Esteban, Rafael; Rodriguez-Frias, Francisco] Hosp Univ Vall Hebron, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Homs, Maria; Tabernero, David; Rodriguez-Frias, Francisco] Hosp Univ Vall Hebron, Liver Pathol Unit, Virol Unit, Dept Biochem, Barcelona, Spain; [Homs, Maria; Tabernero, David; Rodriguez-Frias, Francisco] Hosp Univ Vall Hebron, Liver Pathol Unit, Virol Unit, Dept Microbiol, Barcelona, Spain; [Cantarell, Carmen] Hosp Univ Vall Hebron, Dept Nephrol, Barcelona, Spain; [Crespo, Manuel] Hosp Univ Vall Hebron, Dept Infect Dis, Barcelona, Spain	Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron	Buti, M (corresponding author), Hosp Univ Vall Hebron, Dept Internal Med, Liver Unit, Barcelona, Spain.	mbuti@vhebron.net	Rodriguez-Frias, Francisco/AAC-3507-2020; Tabernero, David/AAB-3848-2019; Crespo, Manuel/H-8868-2015; Quer, Josep/A-6741-2012	Tabernero, David/0000-0002-1146-4084; Crespo, Manuel/0000-0001-9016-0515; Quer, Josep/0000-0003-0014-084X; esteban, rafael/0000-0001-5280-392X; rodriguez-frias, francisco/0000-0002-9128-7013; Homs, Maria/0000-0002-8370-8375; Campos Varela, Isabel/0000-0001-6597-3151; Buti Ferret, Maria/0000-0002-0732-3078; castells, lluis/0000-0002-6672-5931				Abravanel F, 2013, J CLIN VIROL, V58, P624, DOI 10.1016/j.jcv.2013.10.003; Acharya SK, 2007, J HEPATOL, V46, P387, DOI 10.1016/j.jhep.2006.09.016; Balayan MS, 1997, J VIRAL HEPATITIS, V4, P279, DOI 10.1046/j.1365-2893.1997.00050.x; Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Boutrouille A, 2007, J CLIN MICROBIOL, V45, P2009, DOI 10.1128/JCM.00235-07; Boxall E, 2006, TRANSFUSION MED, V16, P79, DOI 10.1111/j.1365-3148.2006.00652.x; Buti M, 2004, J HEPATOL, V41, P126, DOI 10.1016/j.jhep.2004.03.013; Buti M, 2008, CLIN VACCINE IMMUNOL, V15, P732, DOI 10.1128/CVI.00014-08; Buti M, 2006, CLIN VACCINE IMMUNOL, V13, P1328, DOI 10.1128/CVI.00255-06; Buti M, 2010, LIVER TRANSPLANT, V16, P106, DOI 10.1002/lt.21925; Chandra V, 2008, J VIROL, V82, P7100, DOI 10.1128/JVI.00403-08; CHUANG WL, 1991, DIGEST DIS SCI, V36, P299, DOI 10.1007/BF01318200; Cleland A, 2013, VOX SANG, V105, P283, DOI 10.1111/vox.12056; Clemente-Casares P, 2003, EMERG INFECT DIS, V9, P448; Colson P, 2007, EMERG INFECT DIS, V13, P648, DOI 10.3201/eid1304.061387; Dalton HR, 2008, EUR J GASTROEN HEPAT, V20, P784, DOI 10.1097/MEG.0b013e3282f5195a; Drobeniuc J, 2010, CLIN INFECT DIS, V51, pE24, DOI 10.1086/654801; Fainboim H, 1999, J VIRAL HEPATITIS, V6, P53, DOI 10.1046/j.1365-2893.1999.t01-1-6120135.x; Goyal R, 2012, ANTIVIR THER, V17, P1091, DOI 10.3851/IMP2317; Haagsma EB, 2009, LIVER TRANSPLANT, V15, P1225, DOI 10.1002/lt.21819; Haim-Boukobza S, 2012, J HEPATOL, V57, P1374, DOI 10.1016/j.jhep.2012.08.001; Hamid SS, 2002, HEPATOLOGY, V36, P474, DOI 10.1053/jhep.2002.34856; Harrison A, 2013, J MED VIROL, V85, P266, DOI 10.1002/jmv.23463; Jardi R, 2012, HIV MED, V13, P379, DOI 10.1111/j.1468-1293.2011.00985.x; Jeong WI, 2011, HEPATOLOGY, V53, P1342, DOI 10.1002/hep.24190; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2014, NEW ENGL J MED, V370, P1111, DOI 10.1056/NEJMoa1215246; Keane FE, 2012, HIV MED, V13, P83, DOI 10.1111/j.1468-1293.2011.00942.x; Kimura Y, 2014, BLOOD TRANSFUS-ITALY, V12, P103, DOI 10.2450/2013.0081-13; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; LAVANCHY D, 1994, LANCET, V344, P747, DOI 10.1016/S0140-6736(94)92235-7; Legrand-Abravanel F, 2011, EMERG INFECT DIS, V17, P30, DOI 10.3201/eid1701.100527; Mateos-Lindemann ML, 2014, J MED VIROL, V86, P71, DOI 10.1002/jmv.23804; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; Mateos ML, 1999, VOX SANG, V76, P78; Matsubayashi K, 2004, TRANSFUSION, V44, P934, DOI 10.1111/j.1537-2995.2004.03300.x; Matsubayashi K, 2008, TRANSFUSION, V48, P1368, DOI 10.1111/j.1537-2995.2008.01722.x; Maylin S, 2012, J CLIN VIROL, V53, P346, DOI 10.1016/j.jcv.2012.01.001; Mitsui T, 2004, J MED VIROL, V74, P563, DOI 10.1002/jmv.20215; Pas SD, 2013, J CLIN VIROL, V58, P629, DOI 10.1016/j.jcv.2013.10.010; Pas SD, 2012, EMERG INFECT DIS, V18, P869, DOI 10.3201/eid1805.111712; Peron JM, 2011, J HEPATOL, V54, P1323, DOI 10.1016/j.jhep.2011.01.009; Pischke S, 2012, AM J TRANSPLANT, V12, P3128, DOI 10.1111/j.1600-6143.2012.04200.x; Pischke S, 2010, J VIRAL HEPATITIS, V17, P598, DOI 10.1111/j.1365-2893.2009.01219.x; Pischke S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085330; Pischke S, 2013, LIVER INT, V33, P722, DOI 10.1111/liv.12114; Pischke S, 2010, LIVER TRANSPLANT, V16, P74, DOI 10.1002/lt.21958; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Renou C, 2010, AIDS, V24, P1493, DOI 10.1097/QAD.0b013e32833a29ab; Riveiro-Barciela M., 2014, J CLIN GASTROENTEROL; Rossi-Tamisier M, 2013, J CLIN VIROL, V56, P62, DOI 10.1016/j.jcv.2012.09.010; Surjit M, 2006, J BIOL CHEM, V281, P8135, DOI 10.1074/jbc.M509568200; Versluis J, 2013, BLOOD, V122, P1079, DOI 10.1182/blood-2013-03-492363	53	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103028	10.1371/journal.pone.0103028	http://dx.doi.org/10.1371/journal.pone.0103028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068388	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993700030
J	Wang, A; Landen, NX; Meisgen, F; Lohcharoenkal, W; Stahle, M; Sonkoly, E; Pivarcsi, A				Wang, Aoxue; Landen, Ning Xu; Meisgen, Florian; Lohcharoenkal, Warangkana; Stahle, Mona; Sonkoly, Eniko; Pivarcsi, Andor			MicroRNA-31 Is Overexpressed in Cutaneous Squamous Cell Carcinoma and Regulates Cell Motility and Colony Formation Ability of Tumor Cells	PLOS ONE			English	Article							MIR-31; EXPRESSION; CANCER; PROLIFERATION; METASTASIS; MIGRATION; SKIN	Cutaneous squamous cell carcinoma (cSCC) is a malignancy of epidermal keratinocytes that is responsible for approximately 20% of skin cancer-related death yearly. We have previously compared the microRNA (miRNA) expression profile of cSCC to healthy skin and found the dysregulation of miRNAs in human cSCC. In this study we show that miR-31 is overexpressed in cSCC (n = 68) compared to healthy skin (n = 34) and precancerous skin lesions (actinic keratosis, n = 12). LNA in situ hybridization revealed that miR-31 was specifically up-regulated in tumor cells. Mechanistic studies of inhibition of endogenous miR-31 in human metastatic cSCC cells revealed suppressed migration, invasion and colony forming ability, whereas overexpression of miR-31 induced these phenotypes. These results indicate that miR-31 regulates cancer-associated phenotypes of cSCC and identify miR-31 as a potential target for cSCC treatment.	[Wang, Aoxue; Landen, Ning Xu; Meisgen, Florian; Lohcharoenkal, Warangkana; Stahle, Mona; Sonkoly, Eniko; Pivarcsi, Andor] Karolinska Inst, Dept Med, Unit Dermatol & Venereol, Stockholm, Sweden	Karolinska Institutet	Pivarcsi, A (corresponding author), Karolinska Inst, Dept Med, Unit Dermatol & Venereol, Stockholm, Sweden.	Andor.Pivarcsi@ki.se	Pivarcsi, Andor/J-5801-2017; Landén, Ning Xu/AFL-2883-2022	Pivarcsi, Andor/0000-0003-2196-1102; Landén, Ning Xu/0000-0003-4868-3798; Lohcharoenkal, Warangkana/0000-0001-6541-1693; Sonkoly, Eniko/0000-0002-4909-5413	Swedish Research Council (Vetenskapsradet), Cancerfonden [CAN 2012/730]; Swedish Society of Medicine (Svenska Lakaresallskapet); Swedish Psoriasis Association (Psoriasisforbundet); European Skin Research Foundation; Welander and Finsens Foundation; Tore Nilssons Foundation; Lars Hierta Memorial Foundation; Sigurt and Elsa Golje Memorial Foundation; Centre of Excellence for Research on Inflammation and Cardiovascular Disease; Karolinska Institute; Stockholm County Council; Swedish Society for Medical Research; LEO Pharma Research Foundation	Swedish Research Council (Vetenskapsradet), Cancerfonden; Swedish Society of Medicine (Svenska Lakaresallskapet); Swedish Psoriasis Association (Psoriasisforbundet); European Skin Research Foundation; Welander and Finsens Foundation; Tore Nilssons Foundation; Lars Hierta Memorial Foundation; Sigurt and Elsa Golje Memorial Foundation; Centre of Excellence for Research on Inflammation and Cardiovascular Disease; Karolinska Institute(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Swedish Society for Medical Research; LEO Pharma Research Foundation(LEO Pharma)	This work was supported by the Swedish Research Council (Vetenskapsradet), Cancerfonden (CAN 2012/730), the Swedish Society of Medicine (Svenska Lakaresallskapet), the Swedish Psoriasis Association (Psoriasisforbundet), the European Skin Research Foundation, the Welander and Finsens Foundation, the Tore Nilssons Foundation, the Lars Hierta Memorial Foundation, the Sigurt and Elsa Golje Memorial Foundation, the Centre of Excellence for Research on Inflammation and Cardiovascular Disease, the Karolinska Institute, and the Stockholm County Council. N.X.L. was supported by the Swedish Society for Medical Research. A. P. was supported by the LEO Pharma Research Foundation. E. S. was supported by the Stockholm County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Augoff K, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-5; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bruegger C, 2013, EXP DERMATOL, V22, P426, DOI 10.1111/exd.12153; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hameetman L, 2013, BMC CANC IN PRESS, V3; Johansson N, 1997, AM J PATHOL, V151, P499; Lambert SR, 2014, BRIT J CANCER, V110, P520, DOI 10.1038/bjc.2013.760; Laurila EM, 2013, GENES CHROM IN PRESS; Lu ZD, 2012, ONCOL LETT, V4, P1027, DOI 10.3892/ol.2012.841; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Ratushny V, 2010, JCI, V122, P464; ROWE DE, 1992, J AM ACAD DERMATOL, V26, P976, DOI 10.1016/0190-9622(92)70144-5; Sand M, 2012, J DERMATOL SCI, V68, P119, DOI 10.1016/j.jdermsci.2012.09.004; Schmittgen TD, 2010, FUTURE ONCOL, V6, P17, DOI [10.2217/fon.09.150, 10.2217/FON.09.150]; Sossey-Alaoui K, 2011, INT J CANCER, V129, P1331, DOI 10.1002/ijc.25793; Sun DF, 2013, J BIOL CHEM, V288, P9508, DOI 10.1074/jbc.M112.367763; Tan XG, 2011, CLIN CANCER RES, V17, P6802, DOI 10.1158/1078-0432.CCR-11-0419; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Xu N, 2012, J BIOL CHEM, V287, P29899, DOI 10.1074/jbc.M112.391243; Xu N, 2011, J INVEST DERMATOL, V131, P1521, DOI 10.1038/jid.2011.55; Zhang TF, 2011, CLIN SCI, V121, P437, DOI 10.1042/CS20110207	24	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103206	10.1371/journal.pone.0103206	http://dx.doi.org/10.1371/journal.pone.0103206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068518	gold, Green Published, Green Submitted			2022-12-25	WOS:000339993700044
J	Lidsky, M; Antoun, G; Speicher, P; Adams, B; Turley, R; Augustine, C; Tyler, D; Ali-Osman, F				Lidsky, Michael; Antoun, Gamil; Speicher, Paul; Adams, Bartley; Turley, Ryan; Augustine, Christi; Tyler, Douglas; Ali-Osman, Francis			Mitogen-activated Protein Kinase (MAPK) Hyperactivation and Enhanced NRAS Expression Drive Acquired Vemurafenib Resistance in V600E BRAF Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						c-Jun N-terminal Kinase (JNK); Extracellular Signal-regulated Kinase (ERK); Melanoma; Mitogen-activated Protein Kinase (MAPK); p38; Acquired Drug Resistance; NRAS; Vemurafenib	GLUTATHIONE-S-TRANSFERASE; METASTATIC MELANOMA; MEDIATES RESISTANCE; IMPROVED SURVIVAL; MEK INHIBITION; B-RAF; PATHWAY; GROWTH; PHOSPHORYLATION; MUTATIONS	Background: The response to vemurafenib in V600E BRAF+ve melanoma is short lived due to acquisition of vemurafenib resistance. Results: NRAS expression and increased MAPK activation drive vemurafenib resistance in V600E BRAF+ve melanoma. Conclusion: Resistance to vemurafenib in melanoma is complex and can be mitigated by MAPK and NRAS inhibition. Significance: These findings could lead to improved therapy of V600E BRAF+ve melanoma by targeting MAPKs and NRAS. Although targeting the V600E activating mutation in the BRAF gene, the most common genetic abnormality in melanoma, has shown clinical efficacy in melanoma patients, response is, invariably, short lived. To better understand mechanisms underlying this acquisition of resistance to BRAF-targeted therapy in previously responsive melanomas, we induced vemurafenib resistance in two V600E BRAF+ve melanoma cell lines, A375 and DM443, by serial in vitro vemurafenib exposure. The resulting approximately 10-fold more vemurafenib-resistant cell lines, A375rVem and D443rVem, had higher growth rates and showed differential collateral resistance to cisplatin, melphalan, and temozolomide. The acquisition of vemurafenib resistance was associated with significantly increased NRAS levels in A375rVem and D443rVem, increased activation of the prosurvival protein, AKT, and the MAPKs, ERK, JNK, and P38, which correlated with decreased levels of the MAPK inhibitor protein, GSTP1. Despite the increased NRAS, whole exome sequencing showed no NRAS gene mutations. Inhibition of all three MAPKs and siRNA-mediated NRAS suppression both reversed vemurafenib resistance significantly in A375rVem and DM443rVem. Together, the results indicate a mechanism of acquired vemurafenib resistance in V600E BRAF+ve melanoma cells that involves increased activation of all three human MAPKs and the PI3K pathway, as well as increased NRAS expression, which, contrary to previous reports, was not associated with mutations in the NRAS gene. The data highlight the complexity of the acquired vemurafenib resistance phenotype and the challenge of optimizing BRAF-targeted therapy in this disease. They also suggest that targeting the MAPKs and/or NRAS may provide a strategy to mitigate such resistance in V600E BRAF+ve melanoma.	[Lidsky, Michael; Speicher, Paul; Turley, Ryan; Augustine, Christi; Tyler, Douglas] Duke Univ, Med Ctr, Dept Surg, Div Surg Oncol, Durham, NC 27710 USA; [Antoun, Gamil; Adams, Bartley; Ali-Osman, Francis] Duke Univ, Med Ctr, Dept Surg, Div Surg Sci, Durham, NC 27710 USA	Duke University; Duke University	Ali-Osman, F (corresponding author), Duke Univ, Med Ctr, Dept Surg, 421 Med Sci Res Bldg 1, Durham, NC 27710 USA.	francis.aliosman@duke.edu	Lidsky, Michael E./AAM-8307-2020	Lidsky, Michael E./0000-0003-0500-2016	National Institutes of Health [5R01CA153050, 1R01CA127872]; Veterans Affairs merit review grant; NATIONAL CANCER INSTITUTE [R01CA153050, T32CA093245, R01CA127872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit review grant(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01CA153050 and 1R01CA127872. This work was also supported by a Veterans Affairs merit review grant.	Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Ali-Osman Francis, 1996, P63; Anderson C M, 1995, Oncology (Williston Park), V9, P1149; Anderson C. M., 1995, ONCOLOGY HUNTINGT, V9, P1167; Anderson C. M., 1995, ONCOLOGY HUNTINGT, V9, P1163; Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; Bhatt RS, 2010, CANCER-AM CANCER SOC, V116, P1751, DOI 10.1002/cncr.24902; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buery RR, 2011, ONCOL REP, V26, P783, DOI 10.3892/or.2011.1385; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Estrada Y, 2009, PIGM CELL MELANOMA R, V22, P66, DOI 10.1111/j.1755-148X.2008.00520.x; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gopal YNV, 2010, CANCER RES, V70, P8736, DOI 10.1158/0008-5472.CAN-10-0902; Gray-Schopfer VC, 2005, CANCER METAST REV, V24, P165, DOI 10.1007/s10555-005-5865-1; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Jaiswal BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005717; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Johnson DB, 2013, CURR TREAT OPTION ON, V14, P280, DOI 10.1007/s11864-013-0226-8; Kim KB, 2013, J CLIN ONCOL, V31, P482, DOI 10.1200/JCO.2012.43.5966; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Lo HW, 2007, CURR OPIN PHARMACOL, V7, P367, DOI 10.1016/j.coph.2007.06.009; Lo HW, 2002, J CELL BIOCHEM, V87, P103, DOI 10.1002/jcb.10275; Lopez-Bergami P, 2010, J BIOL CHEM, V285, P903, DOI 10.1074/jbc.M109.075630; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Okamura T, 2009, J BIOL CHEM, V284, P16979, DOI 10.1074/jbc.M808153200; Qin JZ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-15; Satyamoorthy K, 2003, CANCER RES, V63, P756; Su F, 2012, CANCER RES, V72, P969, DOI 10.1158/0008-5472.CAN-11-1875; TEW KD, 1994, CANCER RES, V54, P4313; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200; Yadav V, 2012, J BIOL CHEM, V287, P28087, DOI 10.1074/jbc.M112.377218	44	34	34	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27714	27726		10.1074/jbc.M113.532432	http://dx.doi.org/10.1074/jbc.M113.532432			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25063807	hybrid, Green Published			2022-12-25	WOS:000342852800030
J	Cheng, W; Tian, J; Burgunder, JM; Hunziker, W; Eng, HL				Cheng, Wei; Tian, Jing; Burgunder, Jean-Marc; Hunziker, Walter; Eng, How-Lung			Myotonia Congenita-Associated Mutations in Chloride Channel-1 Affect Zebrafish Body Wave Swimming Kinematics	PLOS ONE			English	Article							LARVAL ZEBRAFISH; ONTOGENY; DOMINANT; TRACKING	Myotonia congenita is a human muscle disorder caused by mutations in CLCN1, which encodes human chloride channel 1 (CLCN1). Zebrafish is becoming an increasingly useful model for human diseases, including muscle disorders. In this study, we generated transgenic zebrafish expressing, under the control of a muscle specific promoter, human CLCN1 carrying mutations that have been identified in human patients suffering from myotonia congenita. We developed video analytic tools that are able to provide precise quantitative measurements of movement abnormalities in order to analyse the effect of these CLCN1 mutations on adult transgenic zebrafish swimming. Two new parameters for body-wave kinematics of swimming reveal changes in body curvature and tail offset in transgenic zebrafish expressing the disease-associated CLCN1 mutants, presumably due to their effect on muscle function. The capability of the developed video analytic tool to distinguish wild-type from transgenic zebrafish could provide a useful asset to screen for compounds that reverse the disease phenotype, and may be applicable to other movement disorders besides myotonia congenita.	[Cheng, Wei; Hunziker, Walter] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Epithelial Cell Biol Lab, Singapore, Singapore; [Tian, Jing; Eng, How-Lung] Agcy Sci Technol & Res, Inst Infocomm Res, Singapore, Singapore; [Burgunder, Jean-Marc] Univ Bern, Dept Neurol, Bern, Switzerland; [Burgunder, Jean-Marc] Univ Bern, Deparment Clin Res, Bern, Switzerland; [Hunziker, Walter] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Hunziker, Walter] Singapore Eye Res Inst, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); University of Bern; University of Bern; National University of Singapore; National University of Singapore; Singapore National Eye Center	Hunziker, W (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Epithelial Cell Biol Lab, Singapore, Singapore.	hunziker@imcb.a-star.edu.sg; howlungeng@zweec.com	Hunziker, Walter/GSM-8190-2022; Hunziker, Walter/B-3140-2010; Tian, Jing/ABI-2886-2020	Hunziker, Walter/0000-0002-5265-4933; Tian, Jing/0000-0002-4084-6911	Council Office of the Agency for Science Technology and Research (A*STAR), Singapore [10/03/EG/05/02, 1031C004]	Council Office of the Agency for Science Technology and Research (A*STAR), Singapore	This work was funded by grants 10/03/EG/05/02 and 1031C004 from the Joint Council Office of the Agency for Science Technology and Research (A*STAR), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Bassett DI, 2003, HUM MOL GENET, V12, pR265, DOI 10.1093/hmg/ddg279; Becker PE, 1973, NEW DEV ELECTROMYOGR, P407; Becker RE, 1977, TOPICS HUMAN GENETIC; Blaser R, 2006, BEHAV RES METHODS, V38, P456, DOI 10.3758/BF03192800; Budick SA, 2000, J EXP BIOL, V203, P2565; Burgunder JM, 2008, NEUROMUSCULAR DISORD, V18, P633, DOI 10.1016/j.nmd.2008.05.007; Cachat JM, 2011, NEUROMETHODS, V51, P191, DOI 10.1007/978-1-60761-953-6_16; Cario CL, 2011, J PHYSIOL-LONDON, V589, P3703, DOI 10.1113/jphysiol.2011.207308; Danos N, 2007, J EXP BIOL, V210, P3374, DOI 10.1242/jeb.007484; Fishman MC, 2001, SCIENCE, V294, P1290, DOI 10.1126/science.1066652; Flinn L, 2008, J NEUROCHEM, V106, P1991, DOI 10.1111/j.1471-4159.2008.05463.x; Fontaine E, 2008, J EXP BIOL, V211, P1305, DOI 10.1242/jeb.010272; GEORGE AL, 1993, NAT GENET, V3, P305, DOI 10.1038/ng0493-305; Green MH, 2011, J EXP BIOL, V214, P3111, DOI 10.1242/jeb.057497; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Jing Tian, 2011, 2011 IEEE 15th International Symposium on Consumer Electronics, P268, DOI 10.1109/ISCE.2011.5973830; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Levin ED, 2007, PHYSIOL BEHAV, V90, P54, DOI 10.1016/j.physbeh.2006.08.026; Liu TM, 2007, IEEE SIGNAL PROC MAG, V24, P126, DOI 10.1109/MSP.2007.273080; Lossin C, 2008, ADV GENET, V63, P25, DOI 10.1016/S0065-2660(08)01002-X; Martineau PR, 2013, METHODS, V62, P292, DOI 10.1016/j.ymeth.2013.05.002; McClenahan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032295; Mikut R, 2013, ZEBRAFISH, V10, P401, DOI 10.1089/zeb.2013.0886; Schaefer AT, 2012, CURR OPIN NEUROBIOL, V22, P170, DOI 10.1016/j.conb.2011.11.004; Stewart AM, 2012, BRAIN RES, V1451, P44, DOI 10.1016/j.brainres.2012.02.064; Suster Maximiliano L, 2009, Methods Mol Biol, V561, P41, DOI 10.1007/978-1-60327-019-9_3	27	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103445	10.1371/journal.pone.0103445	http://dx.doi.org/10.1371/journal.pone.0103445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083883	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800041
J	Vineretsky, KA; Karagas, MR; Kuriger-Laber, JK; Waterboer, T; Pawlita, M; Nelson, HH				Vineretsky, Karin A.; Karagas, Margaret R.; Kuriger-Laber, Jacquelyn K.; Waterboer, Tim; Pawlita, Michael; Nelson, Heather H.			HLA-C-35kb Expression SNP Is Associated with Differential Control of beta-HPV Infection in Squamous Cell Carcinoma Cases and Controls	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; DELTA T-CELLS; HUMAN-PAPILLOMAVIRUS INFECTION; HLA-C; EPIDERMODYSPLASIA-VERRUCIFORMIS; SKIN-CANCER; BASAL-CELL; IMMUNE-SURVEILLANCE; POPULATION; SYSTEM	A single nucleotide polymorphism (SNP) 35 kb upstream of the HLA-C gene is associated with HLA-C expression, and the high expressing genotype (CC) has been associated with HIV-1 control. HLA-C is unique among the classical MHC class I molecules for its role in the control of viral infections and recognition of abnormal or missing self. This immunosurveillance is central to the pathogenesis of non-melanoma skin cancer (NMSC) and of squamous cell carcinoma (SCC) in particular e sun exposure is a major risk factor for these cancers, cutaneous infections with genus beta-HPV have been implicated in the development of SCC. We hypothesized that the high expression HLA-C genotype is associated with beta-HPV infections. Therefore we investigated the association between beta-HPV serology and the -35 kb SNP (rs9264942) in a population-based case-control study of 510 SCC cases and 608 controls. Among controls the high expression -35 kb SNP genotype (CC) reduced the likelihood of positive serology for multiple (>= 2) beta-HPV infections (OR=0.49, 95% CI: 0.25-0.97), and beta-HPV species 2 infection (OR=0.43, 95% CI: 0.23-0.79). However, no association with beta-HPV status was observed among SCC cases. Our findings suggest that underlying immunogenotype plays an important role in differential control of beta-HPV in SCC cases and controls.	[Vineretsky, Karin A.] Univ Minnesota, Sch Publ Hlth, Dept Environm Hlth Sci, Minneapolis, MN 55455 USA; [Karagas, Margaret R.] Norris Cotton Canc Ctr, Geisel Sch Med Dartmouth, Dept Community & Family Med, Hanover, NH USA; [Waterboer, Tim; Pawlita, Michael] German Canc Res Ctr, Heidelberg, Germany; [Kuriger-Laber, Jacquelyn K.; Nelson, Heather H.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Kuriger-Laber, Jacquelyn K.; Nelson, Heather H.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Dartmouth College; Norris Cotton Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Nelson, HH (corresponding author), Univ Minnesota, Sch Publ Hlth, Dept Environm Hlth Sci, Minneapolis, MN 55455 USA.	hhnelson@umn.edu	Waterboer, Tim/G-1252-2010	Pawlita, Michael/0000-0002-4720-8306; Nelson, Heather/0000-0003-1901-9513	NIH [R01 CA 82354, R01 CA057494, R01 CA118443]; NATIONAL CANCER INSTITUTE [R01CA118443, R01CA057494, R01CA082354, P30CA023108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH R01 CA 82354, R01 CA057494, R01 CA118443. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], RS9264942 NAT CTR BI; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Athar M, 2011, ARCH BIOCHEM BIOPHYS, V508, P159, DOI 10.1016/j.abb.2011.01.004; Bernard HU, 2013, INFECT GENET EVOL, V18, P357, DOI 10.1016/j.meegid.2013.03.011; Blais ME, 2011, IMMUNOLOGY, V133, P1, DOI 10.1111/j.1365-2567.2011.03422.x; Boyman O, 2007, TRENDS IMMUNOL, V28, P51, DOI 10.1016/j.it.2006.12.005; Chen D, 2011, HUM MOL GENET, V20, P4714, DOI 10.1093/hmg/ddr383; Chen HY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002514; Christoph T, 2000, BRIT J DERMATOL, V142, P862, DOI 10.1046/j.1365-2133.2000.03464.x; Crequer A, 2013, J CLIN IMMUNOL, V33, P14, DOI 10.1007/s10875-012-9749-1; de Koning MNC, 2007, J GEN VIROL, V88, P1489, DOI 10.1099/vir.0.82732-0; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Dell'Oste V, 2009, J INVEST DERMATOL, V129, P1026, DOI 10.1038/jid.2008.317; Doorbar J., 2005, J CLIN VIROL, V32, pS7, DOI DOI 10.1016/j.jcv.2004.12.006; Ebert LM, 2006, J IMMUNOL, V176, P4331, DOI 10.4049/jimmunol.176.7.4331; Eisemann N, 2014, J INVEST DERMATOL, V134, P43, DOI 10.1038/jid.2013.304; Farzan SF, 2013, INT J CANCER, V133, P1713, DOI 10.1002/ijc.28176; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Ferrarini M, 2002, TRENDS IMMUNOL, V23, P14, DOI 10.1016/S1471-4906(01)02110-X; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Harwood CA, 2004, BRIT J DERMATOL, V150, P949, DOI 10.1111/j.1365-2133.2004.05847.x; Heath WR, 2013, NAT IMMUNOL, V14, P978, DOI 10.1038/ni.2680; Herman Sara, 2007, Skinmed, V6, P234, DOI 10.1111/j.1540-9740.2007.06174.x; Hundhausen C, 2012, J INVEST DERMATOL, V132, P635, DOI 10.1038/jid.2011.378; Iannacone MR, 2014, INT J CANCER, V134, P2231, DOI 10.1002/ijc.28552; Karagas MR, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c2986; Karagas MR, 2006, J NATL CANCER I, V98, P389, DOI 10.1093/jnci/djj092; Karagas MR, 1998, ENVIRON HEALTH PERSP, V106, P1047, DOI 10.1289/ehp.98106s41047; Karagas MR, 1999, INT J CANCER, V81, P555, DOI 10.1002/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R; Karagas MR, 2006, CANC EPIDEMIOLOGY PR, P1230, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0064; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Kulpa DA, 2011, IMMUNOLOGY, V134, P116, DOI 10.1111/j.1365-2567.2011.03474.x; Kuo IH, 2013, J ALLERGY CLIN IMMUN, V131, P266, DOI 10.1016/j.jaci.2012.12.1563; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Lazarczyk M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039995; MAJEWSKI S, 1990, J AM ACAD DERMATOL, V22, P423, DOI 10.1016/0190-9622(90)70058-P; Miller KL, 2006, CARCINOGENESIS, V27, P1670, DOI 10.1093/carcin/bgi376; Muehleisen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040754; Orth G, 2006, SEMIN IMMUNOL, V18, P362, DOI 10.1016/j.smim.2006.07.008; Patel AS, 2008, INT J CANCER, V122, P2377, DOI 10.1002/ijc.23377; Proby CM, 2011, AM J TRANSPLANT, V11, P1498, DOI 10.1111/j.1600-6143.2011.03589.x; Rees JR, 2007, J AM ACAD DERMATOL, V56, P781, DOI 10.1016/j.jaad.2006.11.038; Sehr P, 2002, J VIROL METHODS, V106, P61, DOI 10.1016/S0166-0934(02)00134-9; Sehr P, 2001, J IMMUNOL METHODS, V253, P153, DOI 10.1016/S0022-1759(01)00376-3; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Viarisio D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002125; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Zavattaro E, 2014, MODERN PATHOLOGY, DOI [10.1038/mod-pathol.2013.240, DOI 10.1038/MOD-PATHOL.2013.240]	48	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103710	10.1371/journal.pone.0103710	http://dx.doi.org/10.1371/journal.pone.0103710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083782	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800070
J	You, XX; Liu, LZ; Zeng, YH; Li, RH; He, J; Ma, XH; Jiang, CH; Zhu, CM; Chen, LS; Yu, MJ; Ou, GL; Wu, YM				You, Xiaoxing; Liu, Liangzhuan; Zeng, Yanhua; Li, Ranhui; He, Jun; Ma, Xiaohua; Jiang, Chuanhao; Zhu, Cuiming; Chen, Liesong; Yu, Minjun; Ou, Guangli; Wu, Yimou			Macrophage-Activating Lipopeptide-2 Requires Mal and PI3K for Efficient Induction of Heme Oxygenase-1	PLOS ONE			English	Article							MYD88 ADAPTER-LIKE; BRUTONS TYROSINE KINASE; MYCOPLASMA-GENITALIUM INFECTION; AIRWAY EPITHELIAL-CELLS; TOLL-LIKE RECEPTOR-2; NF-KAPPA-B; SIGNAL-TRANSDUCTION; HUMAN MONOCYTES; INFLAMMATORY RESPONSES; NEGATIVE REGULATION	Aims: This study is to investigate the mechanisms by which macrophage-activating lipopeptide-2 (MALP-2) induces heme oxygenase (HO)-1, a cytoprotective enzyme that catalyzes the degradation of heme, in human monocytes. Methods: Human monocytic THP-1 cells were cultured for transient transfection with plasmids and stimulation with MALP-2 for indicative time intervals. After incubation with MALP-2, cells were collected and disrupted, before being tested for promoter activity using luciferase assay. For analysis of proteins, immunoreactive bands were detected using an enhanced chemiluminescence Western blotting system, and the band intensity was measured by densitometryic analysis. For the detection of co-immunoprecipitation, SDS-PAGE was performed and the membranes were probed using respective antibodies. To investigate the cellular localization of NF-E2-related factor 2 (Nrf2), cells underwent immunofluorescence staining and confocal microscopy, and were analyzed using electrophoretic mobility shift assay. Results: MALP-2-induced HO-1 expression and promoter activity were abrogated by transfection with dominant negative (DN) plasmids of TLR2 and TLR6, or their neutralizing antibodies. However, inhibition of MyD88 or transfection with the DN-MyD88 was insufficient to attenuate HO-1 expression. In contrast, mutation or silencing of MyD88 adapter-like (Mal) by DN-Mal or siRNA almost completely blocked HO-1 induction. Btk, c-Src and PI3K were also involved in MALP-2-induced HO-1 expression, as revealed by specific inhibitors LFM-A13, PP1 and LY294002, or by transfection with siRNA of c-Src. MALP-2-induced activation of PI3K was attenuated by transfection with DN mutant of Mal, and by pretreatment with LFM-A13 or PP1. Furthermore, MALP-2 stimulated the translocation of Nrf2 from the cytosol to the nucleus and Nrf2 binding to the ARE site in the HO-1 promoter, which could also be inhibited by pretreatment with a PI3K inhibitor, LY294002. Conclusions: These results indicated that MALP-2 required TLR2/6, Btk, Mal and c-Src to activate PI3K, which in turn initiated the activation of Nrf2 for efficient HO-1 induction.	[You, Xiaoxing; Liu, Liangzhuan; Zeng, Yanhua; Li, Ranhui; He, Jun; Ma, Xiaohua; Jiang, Chuanhao; Zhu, Cuiming; Chen, Liesong; Yu, Minjun; Ou, Guangli; Wu, Yimou] Univ South China, Coll Med, Inst Pathogen Biol, Hengyang City, Peoples R China; [Ma, Xiaohua] Changsha Cent Hosp, Dept Clin Lab, Chagnsha City, Peoples R China; [He, Jun] Univ South China, Affiliated Nanhua Hosp, Dept Clin Lab, Hengyang City, Peoples R China	University of South China; University of South China	Wu, YM (corresponding author), Univ South China, Coll Med, Inst Pathogen Biol, Hengyang City, Peoples R China.	yimouwu82503@163.com	Chen, Liesong/GZK-2499-2022; MA, XIAO/HHN-5611-2022		National Natural Science Foundation of China [31000091]; Hunan Provincial Natural Science Foundation of China [14JJ2090]; Science and Technology Planning Project of Hunan Province [2013TT2013]; construct program of the key discipline in Hunan Province [2011-75]; Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control Foundation [2014-5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Science and Technology Planning Project of Hunan Province; construct program of the key discipline in Hunan Province; Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control Foundation	This work was supported by the National Natural Science Foundation of China (No. 31000091), Hunan Provincial Natural Science Foundation of China (No. 14JJ2090), the Science and Technology Planning Project of Hunan Province (Grant No. 2013TT2013), construct program of the key discipline in Hunan Province (No. 2011-75) and Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control Foundation (No. 2014-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo ECB, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-89; Bao Y, 2012, J BIOL CHEM, V287, P23769, DOI 10.1074/jbc.M112.372425; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Byeon SE, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/512926; Catrein I, 2011, PROTEOMICS, V11, P3614, DOI 10.1002/pmic.201100076; Chen HH, 2012, FREE RADICAL BIO MED, V52, P1054, DOI 10.1016/j.freeradbiomed.2011.12.012; Citti C, 2013, TRENDS MICROBIOL, V21, P196, DOI 10.1016/j.tim.2013.01.003; Dunne A, 2010, J BIOL CHEM, V285, P18276, DOI 10.1074/jbc.M109.098137; Gonzalez-Serrano ME, 2012, J CLIN IMMUNOL, V32, P967, DOI 10.1007/s10875-012-9706-z; Gao F, 2010, TOXICOL APPL PHARM, V247, P146, DOI 10.1016/j.taap.2010.06.007; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Honda F, 2012, NAT IMMUNOL, V13, P369, DOI 10.1038/ni.2234; Into T, 2007, INFECT IMMUN, V75, P2253, DOI 10.1128/IAI.00141-07; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kandasamy P, 2011, J BIOL CHEM, V286, P7841, DOI 10.1074/jbc.M110.170241; Kaufmann A, 1999, INFECT IMMUN, V67, P6303; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Lee IT, 2009, AM J PATHOL, V175, P519, DOI 10.2353/ajpath.2009.090016; Lee KE, 2013, J CLIN IMMUNOL, V33, P1117, DOI 10.1007/s10875-013-9909-y; Lijeroos M, 2007, CELL SIGNAL, V19, P625, DOI 10.1016/j.cellsig.2006.08.013; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Ma XH, 2013, CLIN VACCINE IMMUNOL, V20, P827, DOI 10.1128/CVI.00716-12; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; McGowin CL, 2013, J INFECT DIS, V207, P1857, DOI 10.1093/infdis/jit101; McGowin CL, 2012, INFECT IMMUN, V80, P3842, DOI 10.1128/IAI.00819-12; Mellett M, 2011, J IMMUNOL, V186, P4925, DOI 10.4049/jimmunol.1002739; Miao BC, 2010, P NATL ACAD SCI USA, V107, P20126, DOI 10.1073/pnas.1004522107; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Nishiguchi M, 2001, J IMMUNOL, V166, P2610, DOI 10.4049/jimmunol.166.4.2610; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; OSUSKY M, 1995, J BIOL CHEM, V270, P25729, DOI 10.1074/jbc.270.43.25729; Park SY, 2010, CHEM-BIOL INTERACT, V188, P437, DOI 10.1016/j.cbi.2010.09.007; Rawadi G, 1999, J IMMUNOL, V162, P2193; Rushworth SA, 2005, J IMMUNOL, V175, P4408, DOI 10.4049/jimmunol.175.7.4408; Rushworth SA, 2008, J IMMUNOL, V181, P6730, DOI 10.4049/jimmunol.181.10.6730; Rushworth SA, 2011, J IMMUNOL, V187, P702, DOI 10.4049/jimmunol.1004117; Sierra SS, 2009, EMBO J, V28, P2018, DOI 10.1038/emboj.2009.158; Singhal E, 2011, J BIOL CHEM, V286, P32054, DOI 10.1074/jbc.M111.271247; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11; Truchetet ME, 2011, J INFECT DIS, V204, P1796, DOI 10.1093/infdis/jir630; Ulrichts P, 2010, J CELL SCI, V123, P256, DOI 10.1242/jcs.056002; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Vijayan V, 2011, J IMMUNOL, V187, P817, DOI 10.4049/jimmunol.1003631; Waites KB, 2012, J MOL DIAGN, V14, P437, DOI 10.1016/j.jmoldx.2012.06.001; Wang Y, 2012, J IMMUNOL, V188, P3371, DOI 10.4049/jimmunol.1100573; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhang QH, 2012, J BIOL CHEM, V287, P6208, DOI 10.1074/jbc.M111.310375	52	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103433	10.1371/journal.pone.0103433	http://dx.doi.org/10.1371/journal.pone.0103433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077631	Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800044
J	Golden-Mason, L; Hahn, YS; Strong, M; Cheng, LL; Rosen, HR				Golden-Mason, Lucy; Hahn, Young S.; Strong, Michael; Cheng, Linling; Rosen, Hugo R.			Extracellular HCV-Core Protein Induces an Immature Regulatory Phenotype in NK Cells: Implications for Outcome of Acute Infection	PLOS ONE			English	Article							HEPATITIS-C VIRUS; NATURAL-KILLER-CELLS; ENVELOPE PROTEIN; EXPRESSION; CYTOTOXICITY; FREQUENCY; IMMUNITY; ALPHA; REPLICATION; PERSISTENCE	Background: Hepatitis C viral (HCV) proteins, including core, demonstrate immuno-modulatory properties; however, the effect of extracellular core on natural killer (NK) cells has not previously been investigated. Aims: To characterise NKs in acute HCV infection over time, and, to examine the effect of exogenous HCV-core protein on NK cell phenotype and function. Methods: Acute HCV patients (n = 22), including 10 subjects who spontaneously recovered, were prospectively studied. Flow-cytometry was used to measure natural cytotoxicity and to phenotype NKs directly ex vivo and after culture with HCV-core protein. Microarray analysis was used to identify pathways involved in the NK cell response to exogenous HCV-core. Results: Direct ex vivo analysis demonstrated an increased frequency of immature/regulatory CD56(bright) NKs early in acute HCV infection per se which normalized with viral clearance. Natural cytotoxicity was reduced and did not recover after viral clearance. There was a statistically significant correlation between the frequency of CD56(bright) NKs and circulating serum levels of HCV core protein. In vitro culture of purified CD56(bright) NK cells with HCV-core protein in the presence of IL-15 maintained a significant proportion of NKs in the CD56(bright) state. The in vitro effect of core closely correlates with NK characteristics measured directly ex vivo in acute HCV infection. Pathway analysis suggests that HCV-core protein attenuates NK interferon type I responses. Conclusions: Our data suggest that HCV-core protein alters NK cell maturation and may influence the outcome of acute infection.	[Golden-Mason, Lucy; Cheng, Linling; Rosen, Hugo R.] Univ Colorado, Div Gastroenterol & Hepatol, Aurora, CO 80045 USA; [Golden-Mason, Lucy; Cheng, Linling; Rosen, Hugo R.] Univ Colorado, Hepatitis Ctr C, Aurora, CO USA; [Hahn, Young S.] Univ Virginia, Dept Pathol & Microbiol, Beirne Carter Ctr Immunol Res, Charlottesville, VA USA; [Strong, Michael] Univ Colorado, Dept Med, Aurora, CO USA; [Rosen, Hugo R.] Denver Vet Affairs VA, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Virginia; University of Colorado System; University of Colorado Anschutz Medical Campus	Rosen, HR (corresponding author), Univ Colorado, Div Gastroenterol & Hepatol, Aurora, CO 80045 USA.	Hugo.Rosen@UCHSC.edu		Golden-Mason, Lucy/0000-0002-2087-4405; Golden-Mason, Lucy/0000-0003-3347-4192	HCV center grant [U19 A 1066328]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066328, R01AI098126] Funding Source: NIH RePORTER	HCV center grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U19 A 1066328 (HCV center grant, HRR and YSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2004, J LEUKOCYTE BIOL, V76, P743, DOI 10.1189/jlb.0304197; Alter G, 2011, J HEPATOL, V55, P278, DOI 10.1016/j.jhep.2010.11.030; Amadei B, 2010, GASTROENTEROLOGY, V138, P1536, DOI 10.1053/j.gastro.2010.01.006; Biggins SW, 2012, LIVER TRANSPLANT, V18, P1471, DOI 10.1002/lt.23551; Biron CA, 2012, P NATL ACAD SCI USA, V109, P1814, DOI 10.1073/pnas.1120528109; BONAVITA MS, 1993, INT J TISSUE REACT, V15, P11; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Bozzano F, 2011, EUR J IMMUNOL, V41, P2905, DOI 10.1002/eji.201041361; Chan A, 2007, J IMMUNOL, V179, P89, DOI 10.4049/jimmunol.179.1.89; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Corado J, 1997, CLIN EXP IMMUNOL, V109, P451, DOI 10.1046/j.1365-2249.1997.4581355.x; Crotta S, 2002, J EXP MED, V195, P35, DOI 10.1084/jem.20011124; De Maria A, 2007, EUR J IMMUNOL, V37, P445, DOI 10.1002/eji.200635989; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; Golden-Mason L, 2008, GUT, V57, P1121, DOI 10.1136/gut.2007.130963; Golden-Mason L, 2007, J VIROL, V81, P9292, DOI 10.1128/JVI.00834-07; Golden-Mason L, 2013, IMMUNOL REV, V255, P68, DOI 10.1111/imr.12090; Golden-Mason L, 2012, HEPATOLOGY, V56, P1214, DOI 10.1002/hep.25771; Golden-Mason L, 2010, HEPATOLOGY, V52, P1581, DOI 10.1002/hep.23896; Heeg M, 2012, HEPATOLOGY, V56, P1197, DOI 10.1002/hep.25858; Herzer K, 2003, J VIROL, V77, P8299, DOI 10.1128/JVI.77.15.8299-8309.2003; Jinushi M, 2004, J IMMUNOL, V173, P6072, DOI 10.4049/jimmunol.173.10.6072; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Kramer B, 2012, HEPATOLOGY, V56, P1201, DOI 10.1002/hep.25804; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Large MK, 1999, J IMMUNOL, V162, P931; Li Y, 2004, J LEUKOCYTE BIOL, V76, P1171, DOI 10.1189/jlb.0604372; Lunemann S, 2013, J INFECT DIS, V2013; Marras F, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/152430; Meier UC, 2005, J VIROL, V79, P12365, DOI 10.1128/JVI.79.19.12365-12374.2005; Mondelli MU, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00351; Moretta A, 2000, IMMUNOL TODAY, V21, P228, DOI 10.1016/S0167-5699(00)01596-6; Morishima C, 2006, HEPATOLOGY, V43, P573, DOI 10.1002/hep.21073; Nattermann J, 2006, GUT, V55, P869, DOI 10.1136/gut.2005.076463; Nattermann J, 2005, AM J PATHOL, V166, P443, DOI 10.1016/S0002-9440(10)62267-5; Oliviero B, 2013, J HEPATOL; Par G, 2002, J HEPATOL, V37, P514, DOI 10.1016/S0168-8278(02)00218-0; Pelletier S, 2010, J HEPATOL, V53, P805, DOI 10.1016/j.jhep.2010.05.013; Rehermann B, 2013, HEPATOLOGY, DOI 10.1002/hep.26353; Rosen HR, 2013, J CLIN INVEST, V123, P4121, DOI 10.1172/JCI67714; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Shilling HG, 2002, J IMMUNOL, V169, P239, DOI 10.4049/jimmunol.169.1.239; Stegmann KA, 2012, J INFECT DIS, V205, P1351, DOI 10.1093/infdis/jis210; Stegmann KA, 2010, GASTROENTEROLOGY, V138, P1885, DOI 10.1053/j.gastro.2010.01.051; Tseng CTK, 2002, J EXP MED, V195, P43, DOI 10.1084/jem.20011145; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Yao ZQ, 2004, J VIROL, V78, P6409, DOI 10.1128/JVI.78.12.6409-6419.2004	49	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103219	10.1371/journal.pone.0103219	http://dx.doi.org/10.1371/journal.pone.0103219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076408	gold, Green Published, Green Submitted			2022-12-25	WOS:000340028800030
J	Lundberg, M; Curbo, S; Reiser, K; Masterman, T; Braesch-Andersen, S; Arestrom, I; Ahlborg, N				Lundberg, Mathias; Curbo, Sophie; Reiser, Kathrin; Masterman, Thomas; Braesch-Andersen, Sten; Arestrom, Irene; Ahlborg, Niklas			Methodological Aspects of ELISA Analysis of Thioredoxin 1 in Human Plasma and Cerebrospinal Fluid	PLOS ONE			English	Article							OXIDATIVE STRESS MARKER; CIRCULATING ANTIBODIES; REDOX REGULATION; S-NITROSYLATION; INTERFERENCE; SPECIFICITY; DISEASE; SYSTEMS; IMMUNOGLOBULIN; IMMUNOASSAYS	Thioredoxin-1 (Trx1) is a protein antioxidant involved in major cellular processes. Increased plasma levels of Trx1 have been associated with human diseases suggesting that Trx1 is a marker for oxidative stress with putative clinical use. However, the reported mean levels of Trx1 in the control cohorts vary a hundred-fold between studies (0.8-87 ng/ml), possibly due to methodological differences between the capture ELISA used in the different studies. The aim of this study was to investigate methodological aspects related to the ELISA measurement of Trx1. ELISAs utilizing different capture and detection combinations of antibodies to Trx1 and as well as recombinant human (rh) Trx1 standards from two sources were characterized. The different ELISAs were subsequently used to measure Trx1 in human plasma and cerebrospinal fluid samples (CSF) from healthy donors and from patients with various neurological diagnoses. The Trx1 standards differed in their content of monomeric and oligomeric Trx1, which affected the ELISAs composed of different antibody combinations. Thus, the levels of Trx1 determined in human plasma and CSF samples varied depending on the antibody used in the ELISAs and on the rhTrx1 standard. Furthermore, the relevance of preventing interference by heterophilic antibodies (HA) in human plasma and CSF was investigated. The addition of a HA blocking buffer to human samples drastically reduced the ELISA signals in many samples showing that HA are likely to cause false positive results unless they are blocked. In conclusion, the study shows that the design of a Trx1 ELISA in regards to antibodies and standards used has an impact on the measured Trx1 levels. Importantly, analyses of human plasma and CSF without preventing HA interference may obscure the obtained data. Overall, the results of this study are crucial for the improvement of future studies on the association of Trx1 levels with various diseases.	[Lundberg, Mathias] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Curbo, Sophie; Reiser, Kathrin] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Masterman, Thomas] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Braesch-Andersen, Sten; Arestrom, Irene; Ahlborg, Niklas] Mabtech, Nacka, Sweden; [Ahlborg, Niklas] Stockholm Univ, Dept Immunol, S-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Stockholm University	Lundberg, M (corresponding author), Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden.	Mathias.Lundberg@ki.se	curbo, sophie/AAA-8614-2020	curbo, sophie/0000-0002-0964-0712	Karolinska Institutet research foundation; Soderstrom-Konigska Foundation	Karolinska Institutet research foundation(Karolinska Institutet); Soderstrom-Konigska Foundation	This work was generously supported by the Karolinska Institutet research foundation and the Soderstrom-Konigska Foundation. Mabtech provided support in the form of salaries for authors NA, IA & SB-A, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Arodin L, 2014, ALTERATION THIOREDOX; Berndt C, 2007, AM J PHYSIOL-HEART C, V292, pH1227, DOI 10.1152/ajpheart.01162.2006; BOSCATO LM, 1986, CLIN CHEM, V32, P1491; Callister ME, 2006, THORAX, V61, P521, DOI 10.1136/thx.2005.053041; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; Gil-Bea FJ, 2010, J ALZHEIMERS DIS, V22, P405, DOI 10.3233/JAD-2010-100795; Hashemy SI, 2008, J BIOL CHEM, V283, P21890, DOI 10.1074/jbc.M801047200; Hofer S, 2009, CRIT CARE MED, V37, P2155, DOI 10.1097/CCM.0b013e31819fff67; Hokamaki J, 2005, INT J CARDIOL, V99, P225, DOI 10.1016/j.ijcard.2004.01.010; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HUNTER WM, 1980, LANCET, V2, P1136; Jikimoto T, 2002, MOL IMMUNOL, V38, P765, DOI 10.1016/S0161-5890(01)00113-4; Kakisaka Y, 2002, HORM METAB RES, V34, P160, DOI 10.1055/s-2002-23201; Kondo N, 2006, ANTIOXID REDOX SIGN, V8, P1881, DOI 10.1089/ars.2006.8.1881; Kwon YW, 2003, BIOL CHEM, V384, P991, DOI 10.1515/BC.2003.111; Leoni V, 2004, CLIN CHEM LAB MED, V42, P186, DOI 10.1515/CCLM.2004.034; Lundberg M, 2004, BIOCHEM BIOPH RES CO, V319, P801, DOI 10.1016/j.bbrc.2004.04.199; Nakamura H, 1996, INT IMMUNOL, V8, P603, DOI 10.1093/intimm/8.4.603; Owe-Larsson B, 2011, PROG NEURO-PSYCHOPH, V35, P1117, DOI 10.1016/j.pnpbp.2011.03.012; PRINCE AM, 1973, LANCET, V1, P1346; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Sahaf B, 1997, EXP CELL RES, V236, P181, DOI 10.1006/excr.1997.3699; Sehlin D, 2010, J ALZHEIMERS DIS, V21, P1295, DOI 10.3233/JAD-2010-100609; Sengupta R, 2013, ANTIOXID REDOX SIGN, V18, P259, DOI 10.1089/ars.2012.4716; Takahashi KI, 2008, ANTIOXID REDOX SIGN, V10, P715, DOI 10.1089/ars.2007.1949; THOMPSON RJ, 1986, CLIN CHEM, V32, P476; Wahlgren CM, 2005, EUR J VASC ENDOVASC, V29, P281, DOI 10.1016/j.ejvs.2004.12.020; Zhang XY, 2009, SCHIZOPHR RES, V113, P151, DOI 10.1016/j.schres.2009.05.016; ZWEIG MH, 1987, CLIN CHEM, V33, P840	30	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103554	10.1371/journal.pone.0103554	http://dx.doi.org/10.1371/journal.pone.0103554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075746	gold, Green Published, Green Submitted			2022-12-25	WOS:000340028800064
J	Quarto, T; Blasi, G; Pallesen, KJ; Bertolino, A; Brattico, E				Quarto, Tiziana; Blasi, Giuseppe; Pallesen, Karen Johanne; Bertolino, Alessandro; Brattico, Elvira			Implicit Processing of Visual Emotions Is Affected by Sound-Induced Affective States and Individual Affective Traits	PLOS ONE			English	Article							FACIAL EXPRESSIONS; MUSIC-THERAPY; ATTENTION; MOOD; PERSONALITY; PERCEPTION; ANXIETY; FACES; DEPRESSION; STIMULI	The ability to recognize emotions contained in facial expressions are affected by both affective traits and states and varies widely between individuals. While affective traits are stable in time, affective states can be regulated more rapidly by environmental stimuli, such as music, that indirectly modulate the brain state. Here, we tested whether a relaxing or irritating sound environment affects implicit processing of facial expressions. Moreover, we investigated whether and how individual traits of anxiety and emotional control interact with this process. 32 healthy subjects performed an implicit emotion processing task (presented to subjects as a gender discrimination task) while the sound environment was defined either by a) a therapeutic music sequence (MusiCure), b) a noise sequence or c) silence. Individual changes in mood were sampled before and after the task by a computerized questionnaire. Additionally, emotional control and trait anxiety were assessed in a separate session by paper and pencil questionnaires. Results showed a better mood after the MusiCure condition compared with the other experimental conditions and faster responses to happy faces during MusiCure compared with angry faces during Noise. Moreover, individuals with higher trait anxiety were faster in performing the implicit emotion processing task during MusiCure compared with Silence. These findings suggest that sound-induced affective states are associated with differential responses to angry and happy emotional faces at an implicit stage of processing, and that a relaxing sound environment facilitates the implicit emotional processing in anxious individuals.	[Quarto, Tiziana; Brattico, Elvira] Univ Helsinki, Finland & Finnish Ctr Interdisciplinary Mus Res, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland; [Quarto, Tiziana; Blasi, Giuseppe; Bertolino, Alessandro] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Psychiat Neurosci Grp, Bari, Italy; [Pallesen, Karen Johanne] Aarhus Univ, Aarhus Univ Hosp, Res Clin Funct Disorders & Psychosomat, Aarhus, Denmark; [Pallesen, Karen Johanne] Aarhus Univ, Interacting Minds Ctr, Aarhus, Denmark; [Bertolino, Alessandro] Hoffman La Roche Ltd, Neurosci DTA, PRED, Basel, Switzerland; [Brattico, Elvira] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, Brain & Mind Lab, Helsinki, Finland	University of Helsinki; Universita degli Studi di Bari Aldo Moro; Aarhus University; Aarhus University; Roche Holding; Aalto University	Brattico, E (corresponding author), Univ Helsinki, Finland & Finnish Ctr Interdisciplinary Mus Res, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland.	elvira.brattico@helsinki.fi	Brattico, Elvira/M-1455-2019; Blasi, Giuseppe/HHS-5404-2022	Blasi, Giuseppe/0000-0003-0878-1131; Brattico, Elvira/0000-0003-0676-6464	University of Helsinki [490083]; Academy of Finland [133673]	University of Helsinki; Academy of Finland(Academy of Finland)	The present study has been financially supported by the 3-year grant of the University of Helsinki (project number 490083; URL:http://www.helsinki.fi/university/) and by the Academy of Finland (project number: 133673; URL:http://www.aka.fi/eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKISKAL HS, 1983, ARCH GEN PSYCHIAT, V40, P801; Alluri V, 2012, MUSIC PERCEPT, V29, P297, DOI 10.1525/MP.2012.29.3.297; Alluri V, 2012, NEUROIMAGE, V59, P3677, DOI 10.1016/j.neuroimage.2011.11.019; Alluri V, 2010, MUSIC PERCEPT, V27, P223, DOI 10.1525/mp.2010.27.3.223; Blasi G, 2009, J NEUROSCI, V29, P14812, DOI 10.1523/JNEUROSCI.3609-09.2009; Blasi G, 2009, BIOL PSYCHIAT, V66, P847, DOI 10.1016/j.biopsych.2009.06.017; BOUHUYS AL, 1995, J AFFECT DISORDERS, V33, P215, DOI 10.1016/0165-0327(94)00092-N; Brattico E, 2005, CLIN NEUROPHYSIOL, V116, P190, DOI 10.1016/j.clinph.2004.07.030; Brattico E, 2009, J COGNITIVE NEUROSCI, V21, P2230, DOI 10.1162/jocn.2008.21144; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Caprara G, 2003, J PERS SOC PSYCHOL, V84, P849, DOI 10.1037/0022-3514.84.4.849; Cavanagh K, 2001, J BEHAV THER EXP PSY, V32, P29, DOI 10.1016/S0005-7916(01)00021-0; Chanda ML, 2013, TRENDS COGN SCI, V17, P179, DOI 10.1016/j.tics.2013.02.007; Chien AJ, 1996, J PSYCHIAT RES, V30, P21, DOI 10.1016/0022-3956(95)00041-0; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.3.CO;2-Q; de Gelder B, 2000, BRAIN COGNITION, V44, P425, DOI 10.1006/brcg.1999.1203; Demenescu LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015058; EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037/0003-066X.48.4.384; Erkkila J, 2011, BRIT J PSYCHIAT, V199, P132, DOI 10.1192/bjp.bp.110.085431; Estes Z, 2008, PSYCHOL SCI, V19, P93, DOI 10.1111/j.1467-9280.2008.02051.x; Farne M, 1989, B SOC ITAL BIOL SPER, V6, P571; Feldmann-Wustefeld T, 2011, PSYCHOPHYSIOLOGY, V48, P697, DOI 10.1111/j.1469-8986.2010.01130.x; Fidell L.S., 2001, USING MULTIVARIATE S, V4th; Fitzgerald DA, 2011, NEUROIMAGE, V56, P1783, DOI 10.1016/j.neuroimage.2011.02.061; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Fredriksson Ann-Charlotte, 2009, Intensive Crit Care Nurs, V25, P208, DOI 10.1016/j.iccn.2009.04.002; Friedman RS, 2010, PSYCHOL BULL, V136, P875, DOI 10.1037/a0020495; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; GRAY MW, 1981, NUCLEIC ACIDS RES, V9, P3523, DOI 10.1093/nar/9.14.3523; Guetin S., 2009, Annals of Physical and Rehabilitation Medicine, V52, P30, DOI 10.1016/j.annrmp.2008.08.009; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hodsoll S, 2011, EMOTION, V11, P346, DOI 10.1037/a0022771; Holmes A, 2009, PSYCHOPHYSIOLOGY, V46, P62, DOI 10.1111/j.1469-8986.2008.00750.x; Huang YX, 2007, NEUROSCI LETT, V412, P134, DOI 10.1016/j.neulet.2006.10.061; Karch S, 2008, J PSYCHIATR RES, V42, P734, DOI 10.1016/j.jpsychires.2007.07.016; Kessler H, 2007, DEPRESS ANXIETY, V24, P223, DOI 10.1002/da.20223; Koster EHW, 2005, EMOTION, V5, P446, DOI 10.1037/1528-3542.5.4.446; Kreutz G, 2008, PSYCHOL MUSIC, V36, P101, DOI 10.1177/0305735607082623; Kujala T, 2009, BIOL PSYCHOL, V81, P135, DOI 10.1016/j.biopsycho.2009.03.010; LARSEN RJ, 1991, J PERS SOC PSYCHOL, V61, P132, DOI 10.1037/0022-3514.61.1.132; Lartillot O, 2008, P 11 INT C DIG AUD E; Lartillot O, 2007, MUSIC SCI, P281; Lesiuk T, 2010, J MUSIC THER, V47, P137, DOI 10.1093/jmt/47.2.137; Logeswaran N, 2009, NEUROSCI LETT, V455, P129, DOI 10.1016/j.neulet.2009.03.044; MACLEOD C, 1991, BEHAV RES THER, V29, P599, DOI 10.1016/0005-7967(91)90009-R; Maratos AS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004517.pub2; MATHEWS A, 1985, BEHAV RES THER, V23, P563, DOI 10.1016/0005-7967(85)90104-4; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; MCLACHLAN G, 1997, WILEY SERIES PROBABI; McNair D., 2005, PROFILE MOOD STATES; Miedema HME, 2001, ENVIRON HEALTH PERSP, V109, P409, DOI 10.2307/3454901; Nilsson U, 2009, HEART LUNG, V38, P201, DOI 10.1016/j.hrtlng.2008.07.008; North AC, 2010, AM J PSYCHOL, V123, P199, DOI 10.5406/amerjpsyc.123.2.0199; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Pallesen KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011120; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Saarikallio S., 2007, PSYCHOL MUSIC, V35, P88, DOI DOI 10.1177/0305735607068889; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Schaefer RS, 2013, NEUROIMAGE, V70, P317, DOI 10.1016/j.neuroimage.2012.12.064; Schafer JL, 1998, MULTIVAR BEHAV RES, V33, P545, DOI 10.1207/s15327906mbr3304_5; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Spreckelmeyer KN, 2006, BRAIN RES, V1070, P160, DOI 10.1016/j.brainres.2005.11.075; Stansfeld SA, 2003, BRIT MED BULL, V68, P243, DOI 10.1093/bmb/ldg033; THAYER RE, 1994, J PERS SOC PSYCHOL, V67, P910, DOI 10.1037/0022-3514.67.5.910; Thorgaard Per, 2005, Intensive Crit Care Nurs, V21, P220, DOI 10.1016/j.iccn.2004.10.008; Toiviainen P, 2003, PERCEPTION, V32, P741, DOI 10.1068/p3312; Toiviainen P, 2007, MUSIC SCI, P3; Toiviainen P, 2010, MUSIC PERCEPT, V28, P1, DOI 10.1525/MP.2010.28.1.1; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Vastfjall D, 2002, CYBERPSYCHOL BEHAV, V5, P19, DOI 10.1089/109493102753685854; Vuust P, 2012, NEUROPSYCHOLOGIA, V50, P1432, DOI 10.1016/j.neuropsychologia.2012.02.028	74	20	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103278	10.1371/journal.pone.0103278	http://dx.doi.org/10.1371/journal.pone.0103278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KU	25072162	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600037
J	Thomsen, O; Collin, R; Carrillo-Baltodano, A				Thomsen, Olaf; Collin, Rachel; Carrillo-Baltodano, Allan			The Effects of Experimentally Induced Adelphophagy in Gastropod Embryos	PLOS ONE			English	Article							NURSE EGGS; HATCHING SIZE; VERMETID GASTROPOD; CREPIDULA-DILATATA; LARVAL DEVELOPMENT; SEX-CHANGE; CALYPTRAEIDAE; REPRODUCTION; PROSOBRANCHIA; EVOLUTION	Adelphophagy, development where embryos grow large by consuming morphologically distinct nutritive embryos or their own normal siblings is widespread but uncommon among animal phyla. Among invertebrates it is particularly common in some families of marine gastropods and segmented worms, but rare or unknown in other closely related families. In calyptraeid gastropods phylogenetic analysis indicates that adelphophagy has arisen at least 9 times from species with planktotrophic larval development. This pattern of frequent parallel evolution of adelphophagy suggests that the embryos of planktotrophic species might be predisposed to evolve adelphophagy. Here we used embryos of three species of planktotrophic calyptraeids, one from each of three major genera in the family (Bostrycapulus, Crucibulum, and Crepidula), to answer the following 3 questions: (1) Can embryos of species with planktotrophic development benefit, in terms of pre-hatching growth, from the ingestion of yolk and tissue from experimentally damaged siblings? (2) Does ingestion of this material from damaged siblings increase variation in pre-hatching size? and (3) Does this experimentally induced adelphophagy alter the allometry between the velum and the shell, increasing morphological similarity to embryos of normally adelphophagic species? We found an overall increase in shell length and velum diameter when embryos feed on damaged siblings within their capsules. There was no detectable increase in variation in shell length or velum diameter, or changes in allometry. The overall effect of our treatment was small compared to the embryonic growth observed in naturally adelphophagic development. However each embryo in our experiment probably consumed less than one sibling on average, whereas natural adelphophages often each consume 10-30 or more siblings. These results suggest that the ability to consume, assimilate, and benefit from yolk and tissue of their siblings is widespread across calyptraeids.	[Thomsen, Olaf; Collin, Rachel; Carrillo-Baltodano, Allan] Smithsonian Trop Res Inst, Balboa, Panama; [Thomsen, Olaf] Carl von Ossietzky Univ Oldenburg, D-26111 Oldenburg, Germany	Smithsonian Institution; Smithsonian Tropical Research Institute; Carl von Ossietzky Universitat Oldenburg	Collin, R (corresponding author), Smithsonian Trop Res Inst, Balboa, Panama.	collinr@si.edu	Collin, Rachel/Q-7100-2019; Collin, Rachel/G-2001-2010; Carrillo-Baltodano, Allan Martin/HGE-5684-2022	Collin, Rachel/0000-0001-5103-4460; Carrillo-Baltodano, Allan Martin/0000-0001-6297-8782	United States National Science Foundation [IOS 1019727]; Smithsonian Tropical Research Institute; Division Of Integrative Organismal Systems [1019727] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by United States National Science Foundation grant IOS 1019727 to R. Collin and the Smithsonian Tropical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbuj A, 2014, INVERTEBR REPROD DEV, V58, P138, DOI 10.1080/07924259.2013.875949; Blake JA, 1999, HYDROBIOLOGIA, V402, P57, DOI 10.1023/A:1003784324125; Brante A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067050; Calvo M, 2004, INVERTEBR BIOL, V123, P289; Chaparro OR, 2002, BIOL BULL, V203, P80, DOI 10.2307/1543460; Chaparro OR, 1999, J EXP MAR BIOL ECOL, V232, P261, DOI 10.1016/S0022-0981(98)00115-4; Collin R, 2004, EVOLUTION, V58, P1488; Collin R, 2003, MAR ECOL PROG SER, V247, P103, DOI 10.3354/meps247103; Collin R, 2000, VELIGER, V43, P24; Collin R, 2007, BIOL BULL-US, V212, P83, DOI 10.2307/25066586; Collin R, 2013, BIOL BULL-US, V225, P8, DOI 10.1086/BBLv225n1p8; Collin R, 2012, BIOL BULL-US, V223, P268, DOI 10.1086/BBLv223n3p268; Collin R, 2012, BIOL J LINN SOC, V106, P763, DOI 10.1111/j.1095-8312.2012.01908.x; Collin R, 2012, INTEGR COMP BIOL, V52, P128, DOI 10.1093/icb/ics065; Collin R, 2010, MAR ECOL PROG SER, V410, P89, DOI 10.3354/meps08638; Cubillos VM, 2007, MAR FRESHWATER RES, V58, P1152, DOI 10.1071/MF07094; Fioroni P., 1982, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V108, P375; GALLARDO CS, 1987, INT J INVER REP DEV, V11, P239, DOI 10.1080/01688170.1987.10510284; Gibson G, 2012, INTEGR COMP BIOL, V52, P151, DOI 10.1093/icb/ics054; Henry JJ, 2010, BIOL BULL-US, V218, P211, DOI 10.1086/BBLv218n3p211; HOAGLAND KE, 1986, AM MALACOL BULL, V4, P173; Kamel SJ, 2010, INTEGR COMP BIOL, V50, P619, DOI 10.1093/icb/icq104; Klinzing MSE, 2000, J EXP MAR BIOL ECOL, V252, P255; Kohn A.J., 1994, LIFE HIST BIOGEOGRAP; Lesoway MP, 2014, INT J DEV B IN PRESS; McDonald KA, 2014, INVERTEBR BIOL, V133, P213, DOI 10.1111/ivb.12057; Merot C, 2012, MAR ECOL PROG SER, V449, P173, DOI 10.3354/meps09536; Oyarzun FX, 2011, INTEGR COMP BIOL, V51, P81, DOI 10.1093/icb/icr009; RIVEST BR, 1983, J EXP MAR BIOL ECOL, V69, P217, DOI 10.1016/0022-0981(83)90071-0; Smith KE, 2013, ECOLOGY, V94, P2263, DOI 10.1890/12-1701.1; Smith KE, 2013, HELGOLAND MARINE RES, P1; SPIGHT TM, 1975, OECOLOGIA, V21, P1, DOI 10.1007/BF00345889; SPIGHT TM, 1976, BIOL BULL, V150, P491, DOI 10.2307/1540687; Strathmann MF, 2006, PAC SCI, V60, P97, DOI 10.1353/psc.2005.0062; STRATHMANN RR, 1993, BIOL BULL, V185, P232, DOI 10.2307/1542003; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Veliz D, 2003, MAR BIOL, V143, P131, DOI 10.1007/s00227-003-1042-7; Veliz D, 2001, MAR BIOL, V139, P527, DOI 10.1007/s002270100601; Veliz D, 2012, MOLLUSCAN RES, V32, P145	41	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103366	10.1371/journal.pone.0103366	http://dx.doi.org/10.1371/journal.pone.0103366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072671	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600043
J	Wong, CM; Wang, YD; Lee, JTH; Huang, Z; Wu, DH; Xu, AM; Lam, KSL				Wong, Chi-Ming; Wang, Yudong; Lee, Jimmy Tsz Hang; Huang, Zhe; Wu, Donghai; Xu, Aimin; Lam, Karen Siu Ling			Adropin Is a Brain Membrane-bound Protein Regulating Physical Activity via the NB-3/Notch Signaling Pathway in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOGNITION MOLECULE NB-3; GESTATIONAL DIABETES-MELLITUS; ENDOTHELIAL FUNCTION; MOTOR COORDINATION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; PURKINJE-CELLS; DEFICIENCY; OBESITY; PLASMA	Adropin is a highly conserved polypeptide that has been suggested to act as an endocrine factor that plays important roles in metabolic regulation, insulin sensitivity, and endothelial functions. However, in this study, we provide evidence demonstrating that adropin is a plasma membrane protein expressed abundantly in the brain. Using a yeast two-hybrid screening approach, we identified NB-3/Contactin 6, a brain-specific, non-canonical, membrane-tethered Notch1 ligand, as an interaction partner of adropin. Furthermore, this interaction promotes NB3-induced activation of Notch signaling and the expression of Notch target genes. We also generated and characterized adropin knockout mice to explore the role of adropin in vivo. Adropin knockout mice exhibited decreased locomotor activity and impaired motor coordination coupled with defective synapse formation, a phenotype similar to NB-3 knockout mice. Taken together, our data suggest that adropin is a membrane-bound protein that interacts with the brain-specific Notch1 ligand NB3. It regulates physical activity and motor coordination via the NB-3/Notch signaling pathway and plays an important role in cerebellum development in mice.	[Wong, Chi-Ming; Wang, Yudong; Lee, Jimmy Tsz Hang; Huang, Zhe; Xu, Aimin; Lam, Karen Siu Ling] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Wong, Chi-Ming; Wang, Yudong; Lee, Jimmy Tsz Hang; Huang, Zhe; Xu, Aimin; Lam, Karen Siu Ling] Univ Hong Kong, Dept Med, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Wong, Chi-Ming; Xu, Aimin; Lam, Karen Siu Ling] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Wu, Donghai] Guangzhou Inst Biomed & Hlth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Wong, CM (corresponding author), Univ Hong Kong, Dept Med, Li Ka Shing Fac Med, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	wispwong@hku.hk; amxu@hkucc.hku.hk	Wong, Chi-Ming/A-7627-2013	Wong, Chi-Ming/0000-0002-0025-7135; Huang, Zhe/0000-0003-4943-3723; Lee, Jimmy Tsz Hang/0000-0003-1208-8356	RGC Collaborative Research Fund [HKU2/CRF/12R]; University of Hong Kong for the State Key Laboratory of Pharmaceutical Biotechnology; National 973 Basic Research Program of China [2011CB504004, 2010CB945500]	RGC Collaborative Research Fund(Hong Kong Research Grants Council); University of Hong Kong for the State Key Laboratory of Pharmaceutical Biotechnology; National 973 Basic Research Program of China(National Basic Research Program of China)	This work was supported by RGC Collaborative Research Fund Grant HKU2/CRF/12R, matching funds from the University of Hong Kong for the State Key Laboratory of Pharmaceutical Biotechnology, and by National 973 Basic Research Program of China (2011CB504004 and 2010CB945500).	Aydin S, 2013, PEPTIDES, V47, P66, DOI 10.1016/j.peptides.2013.07.001; Aydin S, 2013, MOL CELL BIOCHEM, V380, P73, DOI 10.1007/s11010-013-1660-4; Barski JJ, 2003, J NEUROSCI, V23, P3469; Bizzoca A, 2003, DEVELOPMENT, V130, P29, DOI 10.1242/dev.00183; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Butler AA, 2012, J CLIN ENDOCR METAB, V97, P3783, DOI 10.1210/jc.2012-2194; Celik A, 2013, CARDIOVASC THER, V31, P174, DOI 10.1111/1755-5922.12025; Celik E, 2013, J PERINAT MED, V41, P375, DOI 10.1515/jpm-2012-0227; Cui XY, 2004, J BIOL CHEM, V279, P25858, DOI 10.1074/jbc.M313505200; Gozal D, 2013, J PEDIATR-US, V163, P1122, DOI 10.1016/j.jpeds.2013.05.040; Hu QD, 2006, DEV NEUROSCI-BASEL, V28, P25, DOI 10.1159/000090750; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Imayoshi I, 2011, MOL NEUROBIOL, V44, P7, DOI 10.1007/s12035-011-8186-0; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Klein SM, 2012, J NEUROSCI METH, V203, P292, DOI 10.1016/j.jneumeth.2011.10.001; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar KG, 2012, OBESITY, V20, P1394, DOI 10.1038/oby.2012.31; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Lerman I, 2002, J APPL PHYSIOL, V92, P2245, DOI 10.1152/japplphysiol.01045.2001; Lian WL, 2011, INTERNAL MED, V50, P1523, DOI 10.2169/internalmedicine.50.5163; Lovren F, 2010, CIRCULATION, V122, pS185, DOI 10.1161/CIRCULATIONAHA.109.931782; Medof ME, 1996, FASEB J, V10, P574, DOI 10.1096/fasebj.10.5.8621057; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Qiu X, 2014, PEPTIDES, V52, P19, DOI 10.1016/j.peptides.2013.11.013; Sakurai K, 2010, NEUROSCI LETT, V473, P102, DOI 10.1016/j.neulet.2010.02.027; Sakurai K, 2009, DEV NEUROBIOL, V69, P811, DOI 10.1002/dneu.20742; Sayin O, 2014, J PEDIATR ENDOCR MET, V27, P479, DOI 10.1515/jpem-2013-0296; Shimoda Y, 2009, CELL ADHES MIGR, V3, P64, DOI 10.4161/cam.3.1.7764; St-Onge MP, 2014, OBESITY, V22, P1056, DOI 10.1002/oby.20631; Takeda Y, 2003, J NEUROBIOL, V56, P252, DOI 10.1002/neu.10222; Topuz M, 2013, J INVEST MED, V61, P1161, DOI 10.2310/JIM.0000000000000003; Wu LZ, 2014, CLIN CHEM LAB MED, V52, P751, DOI 10.1515/cclm-2013-0844; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Zhang XM, 2011, DIABETES, V60, P486, DOI 10.2337/db10-0650	38	69	71	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25976	25986		10.1074/jbc.M114.576058	http://dx.doi.org/10.1074/jbc.M114.576058			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074942	Green Published, hybrid			2022-12-25	WOS:000342130800051
J	Zhang, Z; Li, M; Lu, R; Alioua, A; Stefani, E; Toro, L				Zhang, Zhu; Li, Min; Lu, Rong; Alioua, Abderrahmane; Stefani, Enrico; Toro, Ligia			The Angiotensin II Type 1 Receptor (AT1R) Closely Interacts with Large Conductance Voltage- and Ca2+-activated K+ (BK) Channels and Inhibits Their Activity Independent of G-protein Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY SMOOTH-MUSCLE; SIGNAL-TRANSDUCTION; POTASSIUM CHANNELS; PHOSPHORYLATION; MODULATION; ARTERY; CA2+	Angiotensin II (ANG-II) and BK channels play important roles in the regulation of blood pressure. In arterial smooth muscle, ANG-II inhibits BK channels, but the underlying molecular mechanisms are unknown. Here, we first investigated whether ANG-II utilizes its type 1 receptor (AT1R) to modulate BK activity. Pharmacological, biochemical, and molecular evidence supports a role for AT1R. In renal arterial myocytes, the AT1R antagonist losartan (10 mu M) abolished the ANG-II (1 mu M)-induced reduction of whole cell BK currents, and BK channels and ANG-II receptors were found to co-localize at the cell periphery. We also found that BK inhibition via ANG-II-activated AT1R was independent of G-protein activation (assessed with 500 mu M GDP beta S). In BK-expressing HEK293T cells, ANG-II (1 mu M) also induced a reduction of BK currents, which was contingent on AT1R expression. The molecular mechanisms of AT1R and BK channel coupling were investigated in co-transfected cells. Co-immunoprecipitation showed formation of a macromolecular complex, and live immunolabeling demonstrated that both proteins co-localized at the plasma membrane with high proximity indexes as in arterial myocytes. Consistent with a close association, we discovered that the sole AT1R expression could decrease BK channel voltage sensitivity. Truncated BK proteins revealed that the voltage-sensing conduction cassette is sufficient for BK-AT1R association. Finally, C-terminal yellow and cyan fluorescent fusion proteins, AT1R-YFP and BK-CFP, displayed robust co-localized Forster resonance energy transfer, demonstrating intermolecular interactions at their C termini. Overall, our results strongly suggest that AT1R regulates BK channels through a close protein-protein interaction involving multiple BK regions and independent of G-protein activation.	[Zhang, Zhu; Li, Min; Lu, Rong; Alioua, Abderrahmane; Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Toro, Ligia] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Stefani, Enrico] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Cardiovasc Res Lab, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Toro, L (corresponding author), Univ Calif Los Angeles, Dept Anesthesiol, BH 528 CHS Box 957115, Los Angeles, CA 90095 USA.	ltoro@ucla.edu			National Institutes of Health [HL107418, HL096740, HL088640]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107418, R01HL088640, R01HL096740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL107418 and HL096740 (to L. T. and E. S.) and HL088640 (to E. S.).	Alioua A, 2002, P NATL ACAD SCI USA, V99, P14560, DOI 10.1073/pnas.222348099; Aurelie NDC, 2011, CURR HYPERTENS REP, V13, P122, DOI 10.1007/s11906-011-0187-x; Bascands JL, 2001, HYPERTENSION, V38, P1294, DOI 10.1161/hy1201.096540; Bollag WB, 2008, MOL CELL ENDOCRINOL, V296, P53, DOI 10.1016/j.mce.2008.08.022; Goette A, 2008, EUROPACE, V10, P238, DOI 10.1093/europace/eum283; Grimm PR, 2010, KIDNEY INT, V78, P956, DOI 10.1038/ki.2010.272; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Hachet-Haas M, 2006, MICROSC RES TECHNIQ, V69, P941, DOI 10.1002/jemt.20376; Hayabuchi Y, 2006, J MOL CELL CARDIOL, V41, P972, DOI 10.1016/j.yjmcc.2006.07.010; Hu XQ, 2012, DRUG DISCOV TODAY, V17, P974, DOI 10.1016/j.drudis.2012.04.002; Ji YY, 2009, CELL PHYSIOL BIOCHEM, V23, P265, DOI 10.1159/000218173; KUME H, 1992, P NATL ACAD SCI USA, V89, P11051, DOI 10.1073/pnas.89.22.11051; Li M, 2013, J BIOL CHEM, V288, P3668, DOI 10.1074/jbc.M112.426585; Li M, 2010, P NATL ACAD SCI USA, V107, P19096, DOI 10.1073/pnas.1002685107; Lu T, 2010, CIRC RES, V106, P1164, DOI 10.1161/CIRCRESAHA.109.209767; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; Matsumoto T, 2010, J PHARMACOL SCI, V112, P299, DOI 10.1254/jphs.09308FP; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Min LJ, 2009, AGEING RES REV, V8, P113, DOI 10.1016/j.arr.2008.12.002; Park WS, 2008, ARCH PHARM RES, V31, P1291, DOI 10.1007/s12272-001-2109-y; Perez GJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1769, DOI 10.1152/ajpcell.2001.281.6.C1769; RUILOPE LM, 1994, HYPERTENSION, V23, P3, DOI 10.1161/01.HYP.23.1.3; Sailer CA, 2006, EUR J NEUROSCI, V24, P442, DOI 10.1111/j.1460-9568.2006.04936.x; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; SCORNIK FS, 1993, AM J PHYSIOL, V265, pH1460, DOI 10.1152/ajpheart.1993.265.4.H1460; Sorensen CM, 2011, PFLUG ARCH EUR J PHY, V462, P655, DOI 10.1007/s00424-011-1018-2; Sumners C, 2002, CLIN EXP PHARMACOL P, V29, P483, DOI 10.1046/j.1440-1681.2002.03660.x; Sun JJ, 2008, LIFE SCI, V82, P600, DOI 10.1016/j.lfs.2007.12.015; TORO L, 1990, J GEN PHYSIOL, V96, P373, DOI 10.1085/jgp.96.2.373; TORO L, 1990, AM J PHYSIOL, V258, pH912, DOI 10.1152/ajpheart.1990.258.3.H912; Touyz RM, 1997, HYPERTENSION, V30, P222, DOI 10.1161/01.HYP.30.2.222; Touyz RM, 2000, PHARMACOL REV, V52, P639; TWITCHELL WA, 1994, MOL PHARMACOL, V46, P793; Wu Y, 2010, BIOPHYS J, V98, P493, DOI 10.1016/j.bpj.2009.10.037; Wynne BM, 2009, J AM SOC HYPERTENS, V3, P84, DOI 10.1016/j.jash.2008.09.002; Zhang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012323; Zhou XB, 2008, J BIOL CHEM, V283, P21036, DOI 10.1074/jbc.M800447200	38	20	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25678	25689		10.1074/jbc.M114.595603	http://dx.doi.org/10.1074/jbc.M114.595603			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070892	Green Published, hybrid			2022-12-25	WOS:000342130800027
J	Stracka, D; Jozefczuk, S; Rudroff, F; Sauer, U; Hall, MN				Stracka, Daniele; Jozefczuk, Szymon; Rudroff, Florian; Sauer, Uwe; Hall, Michael N.			Nitrogen Source Activates TOR (Target of Rapamycin) Complex 1 via Glutamine and Independently of Gtr/Rag Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE PHOSPHOPROTEOME REVEALS; YEAST SACCHAROMYCES-CEREVISIAE; AMINO-ACID; MASS-SPECTROMETRY; GROWTH-CONTROL; QUANTITATIVE METABOLOMICS; CATABOLITE REPRESSION; GENE-EXPRESSION; CELL-GROWTH; RAG GTPASES	The evolutionary conserved TOR complex 1 (TORC1) activates cell growth in response to nutrients. In yeast, TORC1 responds to the nitrogen source via a poorly understood mechanism. Leucine, and perhaps other amino acids, activates TORC1 via the small GTPases Gtr1 and Gtr2, orthologs of the mammalian Rag GTPases. Here we investigate the activation of TORC1 by the nitrogen source and how this might be related to TORC1 activation by Gtr/Rag. The quality of the nitrogen source, as defined by its ability to promote growth and glutamine accumulation, directly correlates with its ability to activate TORC1 as measured by Sch9 phosphorylation. Preferred nitrogen sources stimulate rapid, sustained Sch9 phosphorylation and glutamine accumulation. Inhibition of glutamine synthesis reduces TORC1 activity and growth. Poor nitrogen sources stimulate rapid but transient Sch9 phosphorylation. A Gtr1 deficiency prevents the transient stimulation of TORC1 but does not affect the sustained TORC1 activity in response to good nitrogen sources. These findings suggest that the nitrogen source must be converted to glutamine, the preferred nitrogen source in yeast, to sustain TORC1 activity. Furthermore, sustained TORC1 activity is independent of Gtr/Rag. Thus, the nitrogen source and Gtr/Rag activate TORC1 via different mechanisms.	[Stracka, Daniele; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Jozefczuk, Szymon; Rudroff, Florian; Sauer, Uwe] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	m.hall@unibas.ch	Sauer, Uwe/Y-3556-2019	Rudroff, Florian/0000-0002-6680-8200; Hall, Michael N/0000-0002-2998-0757	SystemsX.ch, Swiss National Science Foundation; Louis Jeantet Foundation; Canton of Basel	SystemsX.ch, Swiss National Science Foundation; Louis Jeantet Foundation; Canton of Basel	This work was supported by SystemsX.ch, Swiss National Science Foundation, The Louis Jeantet Foundation, and the Canton of Basel.	Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Binda M, 2010, CELL CYCLE, V9, P221, DOI 10.4161/cc.9.2.10585; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Buscher JM, 2009, ANAL CHEM, V81, P2135, DOI 10.1021/ac8022857; Canelas AB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1150; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; DeLuna A, 2001, J BIOL CHEM, V276, P43775, DOI 10.1074/jbc.M107986200; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Duran RV, 2013, ONCOGENE, V32, P4549, DOI 10.1038/onc.2012.465; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Ewald JC, 2009, ANAL CHEM, V81, P3623, DOI 10.1021/ac900002u; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; MAGASANIK B, 1992, MOL CELLULAR BIOL YE, V2, P283; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Smets B, 2010, CURR GENET, V56, P1, DOI 10.1007/s00294-009-0287-1; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Tennant DA, 2009, CARCINOGENESIS, V30, P1269, DOI 10.1093/carcin/bgp070; TERSCHURE EG, 1995, J BACTERIOL, V177, P6672, DOI 10.1128/jb.177.22.6672-6675.1995; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; TODA T, 1988, GENE DEV, V2, P517, DOI 10.1101/gad.2.5.517; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; VANDERPL.JB, 1974, BIOCHEM BIOPH RES CO, V56, P580, DOI 10.1016/0006-291X(74)90643-3; Wu L, 2005, ANAL BIOCHEM, V336, P164, DOI 10.1016/j.ab.2004.09.001; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	51	119	120	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25010	25020		10.1074/jbc.M114.574335	http://dx.doi.org/10.1074/jbc.M114.574335			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25063813	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000341985300025
J	Muletz, C; Caruso, NM; Fleischer, RC; McDiarmid, RW; Lips, KR				Muletz, Carly; Caruso, Nicholas M.; Fleischer, Robert C.; McDiarmid, Roy W.; Lips, Karen R.			Unexpected Rarity of the Pathogen Batrachochytrium dendrobatidis in Appalachian Plethodon Salamanders: 1957-2011	PLOS ONE			English	Article							AMPHIBIAN CHYTRID FUNGUS; NORTH-CAROLINA; LOW-PREVALENCE; WIDESPREAD; DISEASE; CHYTRIDIOMYCOSIS; INFECTION; DECLINES; POPULATIONS; MORBIDITY	Widespread population declines in terrestrial Plethodon salamanders occurred by the 1980s throughout the Appalachian Mountains, the center of global salamander diversity, with no evident recovery. We tested the hypothesis that the historic introduction and spread of the pathogenic fungus Batrachochytrium dendrobatidis (Bd) Plethodon population declines. We expected to detect elevated prevalence of Bd prior to population declines as observed for Central American plethodontids. We tested 1,498 Plethodon salamanders of 12 species (892 museum specimens, 606 wild individuals) for the presence of Bd, and tested 94 of those for Batrachochytrium salamandrivorans (Bs) and for ranavirus. Field samples were collected in 2011 from 48 field sites across a 767 km transect. Historic samples from museum specimens ere collected at five sites with the greatest number and longest duration of collection (1957-987), four of which were sampled in the field in 2011. None of the museum specimens were positive for Bd, but four P. cinereus from field surveys positive The overall Bd prevalence from 1957-2011 for 12 Plethodon species sampled across a 757 km transect was 0.2% (95% CI 0.1-0.7%). All 94 samples were negative for Bs and ranavirus. We conclude that known amphibian pathogens are unlikely causes for declines in these Plethodon populations. Furthermore, these exceptionally low levels of Bd, in a region known to harbor Bd, may indicate that Plethodon specific traits limit Bd infection.	[Muletz, Carly; Caruso, Nicholas M.; Lips, Karen R.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Caruso, Nicholas M.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [Muletz, Carly; Fleischer, Robert C.] Smithsonian Conservat Biol Inst, Ctr Conservat & Evolutionary Genet, Natl Zool Pk, Washington, DC USA; [McDiarmid, Roy W.] Smithsonian Inst, USGS Patuxent Wildlife Res Ctr, Natl Museum Nat Hist, Washington, DC 20560 USA	University System of Maryland; University of Maryland College Park; University of Alabama System; University of Alabama Tuscaloosa; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of the Interior; United States Geological Survey	Muletz, C (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	cmuletz@umd.edu	Muletz-Wolz, Carly/N-3816-2013	Muletz-Wolz, Carly/0000-0001-5047-9601; Lips, Karen/0000-0002-2719-1551; Caruso, Nicholas/0000-0002-1059-6907	National Science Foundation [DEB 0917653, 0213851, 0234386]; University of Maryland; Smithsonian Seed Grant Program; Direct For Biological Sciences [1120161] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Maryland; Smithsonian Seed Grant Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The National Science Foundation (http://www.nsf.gov/) provided support to KRL (DEB 0917653, 0213851, 0234386). Funding for this project was provided by the University of Maryland and Smithsonian Seed Grant Program (http://www.sgsi.umd.edu/) to KRL, RCF and RWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064347; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Becker MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010957; Becker RA, 2013, MAPS DRAW GEOGRAPHIC; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Brunner JL, 2009, EVOL ECOL RES, V11, P1169; Caruso NM, 2014, GLOBAL CHANGE BIOL, V20, P1751, DOI 10.1111/gcb.12550; Caruso NM, 2013, DIVERS DISTRIB, V19, P38, DOI 10.1111/j.1472-4642.2012.00938.x; Chatfield MWH, 2012, PLOS ONE, V7; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Chinnadurai SK, 2009, J WILDLIFE DIS, V45, P631, DOI 10.7589/0090-3558-45.3.631; Collins JP, 2003, DIVERSITY DISTRIBUTI, V9; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Gandon S, 2002, AM NAT, V159, P658, DOI 10.1086/339993; Grant EHC, 2008, APPL HERPETOL, V5, P233; Gratwicke B., 2011, Herpetological Review, V42, P217; Gray Matthew J., 2009, Herpetological Review, V40, P316; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; HANDT O, 1994, EXPERIENTIA, V50, P524, DOI 10.1007/BF01921720; Harrell FE., 2021, HMISC HARRELL MISCEL; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Highton R, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P34; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Kiemnec-Tyburczy Karen M., 2012, Herpetological Review, V43, P85; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JR, 2007, J WILDLIFE MANAGE, V71, P435, DOI 10.2193/2006-345; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Miller DAW, 2012, METHODS ECOL EVOL, V3, P850, DOI 10.1111/j.2041-210X.2012.00216.x; Muletz CR, 2012, BIOL CONSERV, V152, P119, DOI 10.1016/j.biocon.2012.03.022; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; R Core Team, 2021, R LANG ENV STAT COMP; Richards-Hrdlicka KL, 2013, DIS AQUAT ORGAN, V102, P169, DOI 10.3354/dao02552; Richards-Hrdlicka KL, 2012, METHODS ECOL EVOL, V3, P842, DOI 10.1111/j.2041-210X.2012.00228.x; Rodriguez D, 2014, MOL ECOL, V23, P774, DOI 10.1111/mec.12615; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Rovito SM, 2009, P NATL ACAD SCI USA, V106, P3231, DOI 10.1073/pnas.0813051106; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Vazquez VM, 2009, DIS AQUAT ORGAN, V84, P1, DOI 10.3354/dao02026; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Woodhams DC, 2006, J WILDLIFE DIS, V42, P207, DOI 10.7589/0090-3558-42.2.207	46	37	39	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103728	10.1371/journal.pone.0103728	http://dx.doi.org/10.1371/journal.pone.0103728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084159	Green Submitted, Green Published, gold			2022-12-25	WOS:000339819800074
J	Seong, CS; Varela-Ramirez, A; Tang, XL; Anchondo, B; Magallanes, D; Aguilera, RJ				Seong, Chang-Soo; Varela-Ramirez, Armando; Tang, Xiaolei; Anchondo, Brenda; Magallanes, Diego; Aguilera, Renato J.			Cloning and Characterization of a Novel Drosophila Stress Induced DNase	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; IMMUNE-RESPONSES; GENE-EXPRESSION; HOST-DEFENSE; MAMMALIAN DNA; ENDONUCLEASE; NUCLEASE; IDENTIFICATION; INFECTION; MELANOGASTER	Drosophila melanogaster flies mount an impressive immune response to a variety of pathogens with an efficient system comprised of both humoral and cellular responses. The fat body is the main producer of the anti-microbial peptides (AMPs) with anti-pathogen activity. During bacterial infection, an array of secreted peptidases, proteases and other enzymes are involved in the dissolution of debris generated by pathogen clearance. Although pathogen destruction should result in the release a large amount of nucleic acids, the mechanisms for its removal are still not known. In this report, we present the characterization of a nuclease gene that is induced not only by bacterial infection but also by oxidative stress. Expression of the identified protein has revealed that it encodes a potent nuclease that has been named Stress Induced DNase (SID). SID belongs to a family of evolutionarily conserved cation-dependent nucleases that degrade both single and double-stranded nucleic acids. Down-regulation of sid expression via RNA interference leads to significant reduction of fly viability after bacterial infection and oxidative stress. Our results indicate that SID protects flies from the toxic effects of excess DNA/RNA released by pathogen destruction and from oxidative damage.	[Seong, Chang-Soo; Varela-Ramirez, Armando; Anchondo, Brenda; Magallanes, Diego; Aguilera, Renato J.] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Seong, Chang-Soo; Varela-Ramirez, Armando; Anchondo, Brenda; Magallanes, Diego; Aguilera, Renato J.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Tang, Xiaolei] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; Loma Linda University	Aguilera, RJ (corresponding author), Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA.	raguilera@utep.edu	Tang, Xiaolei/AAT-7669-2021; Varela-Ramirez, Armando/ABI-4315-2020	Tang, Xiaolei/0000-0003-1492-9622; Varela-Ramirez, Armando/0000-0002-2071-4874; seong, changsoo/0000-0001-9426-9534	Research Centers for Minority Institutions grant from the National Institutes on Minority Health and Health Disparities (NIMHD) [5G12MD007592]; NIGMS SCORE Grants [1SC3GM088069, 1SC3GM103713]; RISE Scholars Program at UTEP through NIGMS [R25GM069621-10]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM103713, SC3GM088069, R25GM069621] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	Research Centers for Minority Institutions grant from the National Institutes on Minority Health and Health Disparities (NIMHD); NIGMS SCORE Grants; RISE Scholars Program at UTEP through NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The Biomolecule Analysis, Genomic Analysis and the Cytometry, Screening and Imaging Core Facilities that were used in this work were supported by a Research Centers for Minority Institutions grant 5G12MD007592 from the National Institutes on Minority Health and Health Disparities (NIMHD). The authors also acknowledge support from the NIGMS SCORE Grants 1SC3GM088069 and 1SC3GM103713 to RJA. DM was supported by the RISE Scholars Program at UTEP through NIGMS Grant No. R25GM069621-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova VE, 2008, GENE, V418, P41, DOI 10.1016/j.gene.2008.04.005; Ayres JS, 2008, GENETICS, V178, P1807, DOI 10.1534/genetics.107.083782; Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Benedik MJ, 1998, FEMS MICROBIOL LETT, V165, P1; Braun A, 1998, P NATL ACAD SCI USA, V95, P14337, DOI 10.1073/pnas.95.24.14337; Brun S, 2006, GENES CELLS, V11, P397, DOI 10.1111/j.1365-2443.2006.00953.x; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Calvo E, 2006, J EXP BIOL, V209, P2651, DOI 10.1242/jeb.02267; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chakrabarti S, 2012, CELL HOST MICROBE, V12, P60, DOI 10.1016/j.chom.2012.06.001; Chambers MC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002970; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; FRIEDHOFF P, 1994, NUCLEIC ACIDS RES, V22, P3280, DOI 10.1093/nar/22.16.3280; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; Holm CK, 2013, CURR OPIN IMMUNOL, V25, P13, DOI 10.1016/j.coi.2012.12.006; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kawane K, 2010, P NATL ACAD SCI USA, V107, P19432, DOI 10.1073/pnas.1010603107; Kwon SY, 2008, DEV BIOL, V316, P538, DOI 10.1016/j.ydbio.2008.01.033; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Liu X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042725; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luce-Fedrow A, 2009, INFECT IMMUN, V77, P4815, DOI 10.1128/IAI.00594-09; McIlroy D, 2000, GENE DEV, V14, P549; Miller MD, 1996, PROTEIN SCI, V5, P24; MILLER MD, 1994, NAT STRUCT BIOL, V1, P461, DOI 10.1038/nsb0794-461; Molthathong S, 2007, FISH SHELLFISH IMMUN, V22, P617, DOI 10.1016/j.fsi.2006.08.008; Mukae N, 2002, GENE DEV, V16, P2662, DOI 10.1101/gad.1022802; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Nunes LM, 2014, AAPS J, V16, P872, DOI 10.1208/s12248-014-9617-4; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Patterson RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061773; Rangarajan ES, 2001, FEMS MICROBIOL REV, V25, P583, DOI 10.1111/j.1574-6976.2001.tb00593.x; Robinson SW, 2013, NUCLEIC ACIDS RES, V41, pD744, DOI 10.1093/nar/gks1141; Robles-Escajeda E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073508; Schafer P, 2004, J MOL BIOL, V338, P217, DOI 10.1016/j.jmb.2004.02.069; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Scholz SR, 2003, BIOCHEMISTRY-US, V42, P9288, DOI 10.1021/bi0348765; Senger K, 2004, MOL CELL, V13, P19, DOI 10.1016/S1097-2765(03)00500-8; Senger K, 2006, P NATL ACAD SCI USA, V103, P15957, DOI 10.1073/pnas.0607608103; Seong CS, 2006, CELL IMMUNOL, V240, P5, DOI 10.1016/j.cellimm.2006.05.007; Silverman N, 2009, ISJ-INVERT SURVIV J, V6, P163; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Wang WY, 2000, BIOCHEM J, V346, P799, DOI 10.1042/0264-6021:3460799; Wertheim B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r94; Wertheim B, 2011, MOL ECOL, V20, P932, DOI 10.1111/j.1365-294X.2010.04911.x; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	59	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103564	10.1371/journal.pone.0103564	http://dx.doi.org/10.1371/journal.pone.0103564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083901	Green Submitted, gold, Green Published			2022-12-25	WOS:000339819800051
J	Gao, X; Wang, GJ; Yuan, YY; Xin, F; Han, MY; Lu, JQ; Zhao, H; Yu, F; Xu, JC; Zhang, MG; Dong, J; Lin, X; Dai, P				Gao, Xue; Wang, Guo-Jian; Yuan, Yong-Yi; Xin, Feng; Han, Ming-Yu; Lu, Jing-Qiao; Zhao, Hui; Yu, Fei; Xu, Jin-Cao; Zhang, Mei-Guang; Dong, Jiang; Lin, Xi; Dai, Pu			Novel Compound Heterozygous Mutations in MYO7A Associated with Usher Syndrome 1 in a Chinese Family	PLOS ONE			English	Article							MYOSIN VIIA GENE; SYNDROME TYPE-I; SYNDROME TYPE-1; DEAFNESS; FREQUENCY	Usher syndrome is an autosomal recessive disease characterized by sensorineural hearing loss, age-dependent retinitis pigmentosa (RP), and occasionally vestibular dysfunction. The most severe form is Usher syndrome type 1 (USH1). Mutations in the MYO7A gene are responsible for USH1 and account for 29-55% of USH1 cases. Here, we characterized a Chinese family (no. 7162) with USH1. Combining the targeted capture of 131 known deafness genes, next-generation sequencing, and bioinformatic analysis, we identified two deleterious compound heterozygous mutations in the MYO7A gene: a reported missense mutation c.73G>A (p.G25R) and a novel nonsense mutation c.462C>A (p.C154X). The two compound variants are absent in 219 ethnicity-matched controls, co-segregates with the USH clinical phenotypes, including hearing loss, vestibular dysfunction, and age-dependent penetrance of progressive RP, in family 7162. Therefore, we concluded that the USH1 in this family was caused by compound heterozygous mutations in MYO7A.	[Gao, Xue; Wang, Guo-Jian; Yuan, Yong-Yi; Xin, Feng; Han, Ming-Yu; Zhao, Hui; Yu, Fei; Dai, Pu] Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Gao, Xue; Wang, Guo-Jian; Han, Ming-Yu; Zhao, Hui; Dai, Pu] Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Otolaryngol, Sanya, Peoples R China; [Lu, Jing-Qiao; Lin, Xi] Emory Univ, Sch Med, Dept Otolaryngol, Atlanta, GA 30322 USA; [Gao, Xue; Xu, Jin-Cao; Zhang, Mei-Guang] Second Artillery Gen Hosp, Dept Otolaryngol, Beijing, Peoples R China; [Dong, Jiang] Xian Res Inst Hitech, Xian, Shaanxi, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Emory University	Lin, X (corresponding author), Emory Univ, Sch Med, Dept Otolaryngol, Atlanta, GA 30322 USA.	xlin2@emory.edu; daipu301@vip.sina.com	lin, xi/GZL-4959-2022	Yuan, Yongyi/0000-0002-7936-4776	National Natural Science Foundation of China [30801285, 81230020, 81200751, 81070792, 81000415, 81360159]; China Postdoctoral Science Foundation [2012M521878, 2013T60947]; State 863 High Technology R&D Key Project of China [2011AA02A112, 2012AA020101]; National Basic Research Program of China (973 Program) [2014CB541706]; Beijing technology new star project [2010B081]; NIH [R33 DC010476];  [2012BAI09B02];  [201202005]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R33DC010476] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); State 863 High Technology R&D Key Project of China(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Beijing technology new star project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the Project of the National Natural Science Foundation of China (Grant Nos. 30801285, 81230020, 81200751, 81070792, 81000415, 81360159), grants from China Postdoctoral Science Foundation (No. 2012M521878, No. 2013T60947), a grant from State 863 High Technology R&D Key Project of China (2011AA02A112, 2012AA020101), a grant from Minister of Science and Technology of China (2012BAI09B02), a grant from the National Basic Research Program of China (973 Program) (2014CB541706), a grant from Beijing technology new star project (2010B081) and a grant from Minister of Health of China (201202005). Work performed in the Lin lab was supported by a grant from NIH (R33 DC010476). We sincerely thank all the family members for their participation and cooperation in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Baux David, 2008, Hum Mutat, V29, pE76, DOI 10.1002/humu.20780; Bharadwaj AK, 2000, EXP EYE RES, V71, P173, DOI 10.1006/exer.2000.0863; Bonnet C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-21; Chen ZY, 1996, GENOMICS, V36, P440, DOI 10.1006/geno.1996.0489; Cohen M, 2007, INT J AUDIOL, V46, P82, DOI 10.1080/14992020600975279; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Jaijo T, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045377; Jaijo T, 2006, Hum Mutat, V27, P290, DOI 10.1002/humu.9404; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Kimberling WJ, 2010, GENET MED, V12, P512, DOI 10.1097/GIM.0b013e3181e5afb8; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kuhlenbaumer G, 2011, HUM MUTAT, V32, P144, DOI 10.1002/humu.21400; Levy G, 1997, HUM MOL GENET, V6, P111, DOI 10.1093/hmg/6.1.111; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Marmor MF, 2004, DOC OPHTHALMOL, V108, P107, DOI 10.1023/B:DOOP.0000036793.44912.45; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Nakanishi H, 2010, J HUM GENET, V55, P796, DOI 10.1038/jhg.2010.115; Ouyang XM, 2005, HUM GENET, V116, P292, DOI 10.1007/s00439-004-1227-2; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Rizel L, 2011, MOL VIS, V17, P3548; Roux AF, 2006, J MED GENET, V43, P763, DOI 10.1136/jmg.2006.041954; Simpson Claire L, 2011, BMC Proc, V5 Suppl 9, pS83, DOI 10.1186/1753-6561-5-S9-S83; Stabej PL, 2012, J MED GENET, V49, P27, DOI 10.1136/jmedgenet-2011-100468; Tang WX, 2012, GENET TEST MOL BIOMA, V16, P536, DOI 10.1089/gtmb.2011.0187; Tang WS, 2011, GENETIC TES IN PRESS; Udovichenko IP, 2002, J CELL SCI, V115, P445; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0	31	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103415	10.1371/journal.pone.0103415	http://dx.doi.org/10.1371/journal.pone.0103415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080338	Green Submitted, gold, Green Published			2022-12-25	WOS:000339954800042
J	Montory, JA; Pechenik, JA; Diederich, CM; Chaparro, OR				Montory, Jaime A.; Pechenik, Jan A.; Diederich, Casey M.; Chaparro, Oscar R.			Effects of Low Salinity on Adult Behavior and Larval Performance in the Intertidal Gastropod Crepipatella peruviana (Calyptraeidae)	PLOS ONE			English	Article							MARINE INVERTEBRATE LARVAE; VERTICAL-DISTRIBUTION; OXYGEN-CONSUMPTION; REDUCED SALINITY; TEMPORAL VARIABILITY; FECUNDA GASTROPODA; FOOD PATCHES; EGG CAPSULES; TEMPERATURE; CREPIDULA	Shallow-water coastal areas suffer frequent reductions in salinity due to heavy rains, potentially stressing the organisms found there, particularly the early stages of development (including pelagic larvae). Individual adults and newly hatched larvae of the gastropod Crepipatella peruviana were exposed to different levels of salinity stress (32(control), 25, 20 or 15), to quantify the immediate effects of exposure to low salinities on adult and larval behavior and on the physiological performance of the larvae. For adults we recorded the threshold salinity that initiates brood chamber isolation. For larvae, we measured the impact of reduced salinity on velar surface area, velum activity, swimming velocity, clearance rate (CR), oxygen consumption (OCR), and mortality (LC50); we also documented the impact of salinity discontinuities on the vertical distribution of veliger larvae in the water column. The results indicate that adults will completely isolate themselves from the external environment by clamping firmly against the substrate at salinities <= 24. Moreover, the newly hatched larvae showed increased mortality at lower salinities, while survivors showed decreased velum activity, decreased exposed velum surface area, and decreased mean swimming velocity. The clearance rates and oxygen consumption rates of stressed larvae were significantly lower than those of control individuals. Finally, salinity discontinuities affected the vertical distribution of larvae in the water column. Although adults can protect their embryos from low salinity stress until hatching, salinities < 24 clearly affect survival, physiology and behavior in early larval life, which will substantially affect the fitness of the species under declining ambient salinities.	[Montory, Jaime A.; Chaparro, Oscar R.] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Pechenik, Jan A.; Diederich, Casey M.] Tufts Univ, Dept Biol, Medford, MA 02155 USA; [Montory, Jaime A.] Univ Austral Chile, Programa Doctorado Ciencias Menc & Ecol & Evoluc, Valdivia, Chile	Universidad Austral de Chile; Tufts University; Universidad Austral de Chile	Montory, JA (corresponding author), Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	jaimemontory@gmail.com	Montory, Jaime/E-6077-2010; Montory, Jaime/AAL-5187-2020; Chaparro, Oscar R/A-5070-2009	Montory, Jaime/0000-0003-3383-7467; Montory, Jaime/0000-0003-3383-7467; 	Comision Nacional de Investigacion Cientifica y Tecnologica-Chile [24121345]; Fondo Nacional de Investigacion Cientifica y Tecnologica-Chile [1100335]	Comision Nacional de Investigacion Cientifica y Tecnologica-Chile; Fondo Nacional de Investigacion Cientifica y Tecnologica-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Comision Nacional de Investigacion Cientifica y Tecnologica-Chile Doctoral fellowship 24121345 JAM. Fondo Nacional de Investigacion Cientifica y Tecnologica-Chile grant 1100335 ORC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSET AV, 1990, MAR ECOL PROG SER, V58, P217; Allen JD, 2010, BIOL BULL-US, V218, P189, DOI 10.1086/BBLv218n2p189; ALMATAR SM, 1984, MAR BIOL, V80, P117, DOI 10.1007/BF02180178; Amado EM, 2011, COMP BIOCHEM PHYS A, V158, P542, DOI 10.1016/j.cbpa.2010.12.019; AMEYAWAKUMFI C, 1987, MAR ECOL PROG SER, V37, P153, DOI 10.3354/meps037153; Anger K, 1998, J EXP MAR BIOL ECOL, V220, P287, DOI 10.1016/S0022-0981(97)00110-X; Arellano SM, 2012, J EXP MAR BIOL ECOL, V414, P28, DOI 10.1016/j.jembe.2012.01.008; Barria A, 2012, REV BIOL MAR OCEANOG, V47, P461, DOI 10.4067/S0718-19572012000300009; Baylon J, 2007, AQUACULTURE, V269, P390, DOI 10.1016/j.aquaculture.2007.03.024; Berger VJ, 1997, HYDROBIOLOGIA, V355, P115, DOI 10.1023/A:1003023322263; Bodinier C, 2009, J ANAT, V214, P318, DOI 10.1111/j.1469-7580.2009.01050.x; BOUDREAU B, 1992, J EXP MAR BIOL ECOL, V162, P35, DOI 10.1016/0022-0981(92)90123-R; Chan HY, 2008, MAR BIOL, V153, P735, DOI 10.1007/s00227-007-0850-6; Chaparro OR, 2008, J EXP MAR BIOL ECOL, V365, P38, DOI 10.1016/j.jembe.2008.07.038; Chaparro OR, 2008, ESTUAR COAST SHELF S, V76, P861, DOI 10.1016/j.ecss.2007.08.014; Chaparro OR, 2009, MAR ECOL PROG SER, V374, P145, DOI 10.3354/meps07777; Chaparro OR, 1999, BIOL BULL, V197, P104, DOI 10.2307/1543001; Chaparro OR, 2005, J MAR BIOL ASSOC UK, V85, P157, DOI 10.1017/S0025315405010982h; Chaparro OR, 2004, MAR BIOL, V144, P79, DOI 10.1007/s00227-003-1176-7; Chaparro OR, 2002, BIOL BULL, V203, P80, DOI 10.2307/1543460; Chaparro OR, 2002, J SHELLFISH RES, V21, P233; CHAPMAN PM, 1982, AQUAT TOXICOL, V2, P47, DOI 10.1016/0166-445X(82)90005-4; Charmantier G, 2001, J EXP BIOL, V204, P967; COUGHLAN J, 1969, MAR BIOL, V2, P356, DOI 10.1007/BF00355716; Cubillos VM, 2007, MAR FRESHWATER RES, V58, P1152, DOI 10.1071/MF07094; Dahlhoff EP, 2002, INTEGR COMP BIOL, V42, P862, DOI 10.1093/icb/42.4.862; Daigle RM, 2011, J EXP MAR BIOL ECOL, V409, P89, DOI 10.1016/j.jembe.2011.08.008; Diederich CM, 2011, J EXP MAR BIOL ECOL, V397, P94, DOI 10.1016/j.jembe.2010.11.019; Fretter V., 1994, BRIT PROSOBRANCH MOL; Gallager SM, 1996, MAR BIOL, V124, P679, DOI 10.1007/BF00351049; GALLARDO CS, 1979, STUD NEOTROP FAUNA E, V14, P215, DOI 10.1080/01650527909360557; GALLARDO CS, 1977, MAR BIOL, V39, P241, DOI 10.1007/BF00390998; Genio L, 2008, J SEA RES, V59, P133, DOI 10.1016/j.seares.2007.09.001; HADFIELD MG, 1989, B MAR SCI, V45, P377; Iriarte JL, 2007, ESTUAR COAST SHELF S, V74, P471, DOI 10.1016/j.ecss.2007.05.015; Ismael D, 1997, COMP BIOCHEM PHYS A, V118, P871, DOI 10.1016/S0300-9629(97)00016-9; Kim WS, 2001, MAR BIOL, V138, P157, DOI 10.1007/s002270000430; Kinne O., 1966, Netherlands Journal of Sea Research, V3, P222, DOI 10.1016/0077-7579(66)90013-5; Kinne O., 1971, MARINE ECOLOGY 2, V1; Klinzing MSE, 2000, J EXP MAR BIOL ECOL, V252, P255; Liu JY, 2006, J APPL ICHTHYOL, V22, P244, DOI 10.1111/j.1439-0426.2007.00960.x; MANN R, 1991, MAR ECOL PROG SER, V68, P257; Mardones ML, 2013, J EXP MAR BIOL ECOL, V443, P141, DOI 10.1016/j.jembe.2013.02.041; Marsden ID, 2004, MAR ECOL PROG SER, V266, P157, DOI 10.3354/meps266157; MCFARLANE ID, 1980, MAR BEHAV PHYSIOL, V7, P95, DOI 10.1080/10236248009386974; Metaxas A, 1998, MAR BIOL, V130, P433, DOI 10.1007/s002270050264; Montory JA, 2009, MAR ECOL PROG SER, V374, P157, DOI 10.3354/meps07780; Morritt D, 1996, J EXP MAR BIOL ECOL, V207, P191, DOI 10.1016/S0022-0981(96)02634-2; Navarro JM, 1998, AQUACULTURE, V167, P315, DOI 10.1016/S0044-8486(98)00310-X; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; PECHENIK JA, 1983, J EXP MAR BIOL ECOL, V71, P165, DOI 10.1016/0022-0981(93)90071-U; PECHENIK JA, 1982, J EXP MAR BIOL ECOL, V63, P195, DOI 10.1016/0022-0981(82)90178-2; Przeslawski R, 2005, GLOBAL CHANGE BIOL, V11, P515, DOI 10.1111/j.1365-2486.2005.00918.x; Richmond CE, 1996, MAR ECOL PROG SER, V133, P167, DOI 10.3354/meps133167; Richmond CE, 1999, MAR BIOL, V134, P259, DOI 10.1007/s002270050544; ROBERTS MH, 1971, BIOL BULL, V140, P104, DOI 10.2307/1540030; ROLLER RA, 1989, J EXP MAR BIOL ECOL, V125, P235, DOI 10.1016/0022-0981(89)90099-3; Sameoto JA, 2008, BIOL BULL-US, V214, P329, DOI 10.2307/25470674; Sameoto JA, 2008, J EXP MAR BIOL ECOL, V367, P131, DOI 10.1016/j.jembe.2008.09.003; Saranchova OL, 2001, RUSS J MAR BIOL, V27, P87, DOI DOI 10.1023/A:1016643213691; SHUMWAY SE, 1977, J COMP PHYSIOL, V116, P269, DOI 10.1007/BF00689036; Sokolova IM, 2000, J COMP PHYSIOL B, V170, P91, DOI 10.1007/s003600050264; Spicer JI, 2003, SARSIA, V88, P302, DOI 10.1080/00364820310002263; STICKLE WB, 1976, MAR BIOL, V37, P125, DOI 10.1007/BF00389123; STRATHMANN RR, 1972, BIOL BULL-US, V142, P505, DOI 10.2307/1540326; STRATHMANN RR, 1979, BIOL BULL, V157, P524, DOI 10.2307/1541035; Studer A, 2012, J EXP MAR BIOL ECOL, V412, P110, DOI 10.1016/j.jembe.2011.11.008; Surbida KL, 2001, PHYSIOL BIOCHEM ZOOL, V74, P894, DOI 10.1086/324474; TEDENGREN M, 1988, MAR ECOL PROG SER, V47, P107, DOI 10.3354/meps047107; Torres G, 2002, J EXP MAR BIOL ECOL, V277, P43, DOI 10.1016/S0022-0981(02)00244-7; Torres G, 2006, J EXP MAR BIOL ECOL, V338, P134, DOI 10.1016/j.jembe.2006.07.003; Tsuzuki MY, 2008, BRAZ ARCH BIOL TECHN, V51, P563, DOI 10.1590/S1516-89132008000300017; Underwood A.J., 1979, Advances in Marine Biology, V16, P111, DOI 10.1016/S0065-2881(08)60293-X; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Veliz D, 2012, MOLLUSCAN RES, V32, P145; Verween A, 2007, J EXP MAR BIOL ECOL, V348, P111, DOI 10.1016/j.jembe.2007.04.011; WIDDOWS J, 1991, AQUACULTURE, V94, P147, DOI 10.1016/0044-8486(91)90115-N; Wuenschel MJ, 2004, J FISH BIOL, V64, P1088, DOI 10.1111/j.1095-8649.2004.00374.x; Yen PT, 2008, AQUACULTURE, V280, P124, DOI 10.1016/j.aquaculture.2008.04.035; Zhang HY, 2014, MAR POLLUT BULL, V79, P39, DOI 10.1016/j.marpolbul.2014.01.008; [No title captured]	81	17	18	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103820	10.1371/journal.pone.0103820	http://dx.doi.org/10.1371/journal.pone.0103820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077484	Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800083
J	Pavey, L; Churchill, S				Pavey, Louisa; Churchill, Sue			Promoting the Avoidance of High-Calorie Snacks: Priming Autonomy Moderates Message Framing Effects	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; LOSS-FRAMED MESSAGES; PHYSICAL-ACTIVITY; BEHAVIOR; RESPONSES; INTENTIONS	The beneficial effects of gain-framed vs. loss-framed messages promoting health protective behaviors have been found to be inconsistent, and consideration of potential moderating variables is essential if framed health promotion messages are to be effective. This research aimed to determine the influence of highlighting autonomy (choice and freedom) and heteronomy (coercion) on the avoidance of high-calorie snacks following reading gain-framed or loss-framed health messages. In Study 1 (N = 152) participants completed an autonomy, neutral, or heteronomy priming task, and read a gain-framed or loss-framed health message. In Study 2 (N = 242) participants read a gain-framed or loss-framed health message with embedded autonomy or heteronomy primes. In both studies, snacking intentions and behavior were recorded after seven days. In both studies, when autonomy was highlighted, the gain-framed message (compared to the loss-framed message) resulted in stronger intentions to avoid high-calorie snacks, and lower self-reported snack consumption after seven days. Study 2 demonstrated this effect occurred only for participants to whom the information was most relevant (BMI>25). The results suggest that messages promoting healthy dietary behavior may be more persuasive if the autonomy-supportive vs. coercive nature of the health information is matched to the message frame. Further research is needed to examine potential mediating processes.	[Pavey, Louisa] Univ Kingston, Kingston Upon Thames KT1 2EE, Surrey, England; [Churchill, Sue] Univ Chichester, Chichester, England	Kingston University; University of Chichester	Pavey, L (corresponding author), Univ Kingston, Kingston Upon Thames KT1 2EE, Surrey, England.	l.pavey@kingston.ac.uk	Pavey, Louisa/AAM-4375-2021	Pavey, Louisa/0000-0002-7646-099X				Akl EA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006777.pub2; Brug Johannes, 2003, Nutrition and Health (Bicester), V17, P9; Chatzisarantis NLD, 2012, BRIT J SOC PSYCHOL, V51, P690, DOI 10.1111/j.2044-8309.2011.02033.x; Chatzisarantis NLD, 2009, PSYCHOL HEALTH, V24, P29, DOI 10.1080/08870440701809533; Churchill S, 2013, BRIT J HEALTH PSYCH, V18, P610, DOI 10.1111/bjhp.12007; Covey J, 2014, HEALTH PSYCHOL, V33, P52, DOI 10.1037/a0029305; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Gallagher KM, 2012, ANN BEHAV MED, V43, P101, DOI 10.1007/s12160-011-9308-7; Gerend MA, 2008, ANN BEHAV MED, V35, P221, DOI 10.1007/s12160-008-9024-0; Gerend MA, 2011, HEALTH PSYCHOL, V30, P420, DOI 10.1037/a0021981; Hagger MS, 2006, PERS SOC PSYCHOL B, V32, P131, DOI 10.1177/0146167205279905; Hodgins HS, 2006, MOTIV EMOTION, V30, P283, DOI 10.1007/s11031-006-9036-7; Huang TTK, 2005, OBES RES, V13, P1205, DOI 10.1038/oby.2005.143; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kiene SM, 2005, HEALTH PSYCHOL, V24, P321, DOI 10.1037/0278-6133.24.3.321; Levesque C, 2003, PERS SOC PSYCHOL B, V29, P1570, DOI 10.1177/0146167203256877; McCall LA, 2004, J APPL BIOBEHAV RES, V9, P122; Millar MG, 2000, J APPL SOC PSYCHOL, V30, P853, DOI 10.1111/j.1559-1816.2000.tb02827.x; O'Keefe DJ, 2007, J HEALTH COMMUN, V12, P623, DOI 10.1080/10810730701615198; O'Keefe DJ, 2006, COMM YEARB, V30, P1, DOI 10.1207/s15567419cy3001_1; Pavey L, 2009, MOTIV EMOTION, V33, P277, DOI 10.1007/s11031-009-9137-1; Pavey LJ, 2008, EUR J SOC PSYCHOL, V38, P852, DOI 10.1002/ejsp.477; Pavey LJ, 2012, PSYCHOL HEALTH, V27, P259, DOI 10.1080/08870446.2011.556251; Pavey LJ, 2010, PSYCHOL HEALTH, V25, P855, DOI 10.1080/08870440902929528; Pears SL, 2012, APPETITE, V58, P1164, DOI 10.1016/j.appet.2012.02.017; Rains SA, 2007, HUM COMMUN RES, V33, P241, DOI 10.1111/j.1468-2958.2007.00298.x; Rothman A.J., 2010, PERSPECTIVES FRAMING, P257; Rothman AJ, 1999, PERS SOC PSYCHOL B, V25, P1355, DOI 10.1177/0146167299259003; Rothman AJ, 1997, PSYCHOL BULL, V121, P3, DOI 10.1037/0033-2909.121.1.3; ROTHMAN AJ, 1993, J EXP SOC PSYCHOL, V29, P408, DOI 10.1006/jesp.1993.1019; Rothman AJ, 2006, J COMMUN, V56, pS202, DOI 10.1111/j.1460-2466.2006.00290.x; Sherman DK, 2006, MOTIV EMOTION, V30, P165, DOI 10.1007/s11031-006-9001-5; Silva MN, 2010, J BEHAV MED, V33, P110, DOI 10.1007/s10865-009-9239-y; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Van't Riet J, 2009, HLTH ED RES, V23, P243; Werrij MQ, 2011, J HEALTH PSYCHOL, V16, P199, DOI 10.1177/1359105310374779; Williams GC, 1999, ARCH PEDIAT ADOL MED, V153, P959, DOI 10.1001/archpedi.153.9.959; Williams GC, 2007, HEALTH PSYCHOL, V26, P728, DOI 10.1037/0278-6133.26.6.728; Williams GC, 2009, ANN BEHAV MED, V37, P315, DOI 10.1007/s12160-009-9090-y; Yan CM, 2010, J COMMUN, V60, P344, DOI 10.1111/j.1460-2466.2010.01485.x	40	12	13	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103892	10.1371/journal.pone.0103892	http://dx.doi.org/10.1371/journal.pone.0103892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6EF	25078965	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000339954800093
J	Freeman, TCA; Leung, J; Wufong, E; Orchard-Mills, E; Carlile, S; Alais, D				Freeman, Tom C. A.; Leung, Johahn; Wufong, Ella; Orchard-Mills, Emily; Carlile, Simon; Alais, David			Discrimination Contours for Moving Sounds Reveal Duration and Distance Cues Dominate Auditory Speed Perception	PLOS ONE			English	Article							MOTION; MOVEMENT; DIRECTION; NEURONS; CORTEX; TIME; RESPONSES; PARIETAL; VELOCITY; POSITION	Evidence that the auditory system contains specialised motion detectors is mixed. Many psychophysical studies confound speed cues with distance and duration cues and present sound sources that do not appear to move in external space. Here we use the 'discrimination contours' technique to probe the probabilistic combination of speed, distance and duration for stimuli moving in a horizontal arc around the listener in virtual auditory space. The technique produces a set of motion discrimination thresholds that define a contour in the distance-duration plane for different combination of the three cues, based on a 3-interval oddity task. The orientation of the contour (typically elliptical in shape) reveals which cue or combination of cues dominates. If the auditory system contains specialised motion detectors, stimuli moving over different distances and durations but defining the same speed should be more difficult to discriminate. The resulting discrimination contours should therefore be oriented obliquely along iso-speed lines within the distance-duration plane. However, we found that over a wide range of speeds, distances and durations, the ellipses aligned with distance-duration axes and were stretched vertically, suggesting that listeners were most sensitive to duration. A second experiment showed that listeners were able to make speed judgements when distance and duration cues were degraded by noise, but that performance was worse. Our results therefore suggest that speed is not a primary cue to motion in the auditory system, but that listeners are able to use speed to make discrimination judgements when distance and duration cues are unreliable.	[Freeman, Tom C. A.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales; [Leung, Johahn; Carlile, Simon] Univ Sydney, Dept Physiol, Auditory Neurosci Lab, Sydney, NSW 2006, Australia; [Leung, Johahn; Carlile, Simon] Univ Sydney, Bosch Inst, Sch Med, Sydney, NSW 2006, Australia; [Wufong, Ella; Orchard-Mills, Emily; Alais, David] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	Cardiff University; University of Sydney; University of Sydney; University of Sydney	Freeman, TCA (corresponding author), Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales.	freeman@cardiff.ac.uk	Freeman, Tom/A-1587-2010	Freeman, Tom/0000-0002-5989-9183	Royal Society [CAR004]; Wellcome Trust [WT 081581MA]	Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust)	Funding provided by Royal Society Travel Grant to TF (CAR004) and Wellcome Trust Project Grant to TF (WT 081581MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHISSAR M, 1992, J NEUROPHYSIOL, V67, P203, DOI 10.1152/jn.1992.67.1.203; ALTMAN JA, 1968, EXP NEUROL, V22, P13, DOI 10.1016/0014-4886(68)90016-2; Anstis S, 1998, TRENDS COGN SCI, V2, P111, DOI 10.1016/S1364-6613(98)01142-5; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; Bompas A, 2013, SYSTEMATIC BIASES AD, V13, P1; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Carlile S, 2002, J ACOUST SOC AM, V111, P1026, DOI 10.1121/1.1436067; Champion RA, 2010, J VISION, V10, DOI 10.1167/10.6.14; Chandler DW, 1992, J ACOUSTICAL SOC AM, V91; Dong CJ, 2000, PERCEPT PSYCHOPHYS, V62, P1099, DOI 10.3758/BF03212091; Ernst MO, 2007, J VISION, V7, DOI 10.1167/7.5.7; Farina A, 2007, AUSIO ENG SOC CONVEN, P122; Freeman TCA, 2002, PERCEPTION, V31, P603, DOI 10.1068/p3256; GEGENFURTNER KR, 1995, VISION RES, V35, P1547, DOI 10.1016/0042-6989(94)00264-M; Getzmann S, 2011, EUR J NEUROSCI, V33, P1339, DOI 10.1111/j.1460-9568.2011.07617.x; Getzrnann S, 2011, HEARING RES, V272, P21, DOI 10.1016/j.heares.2010.11.005; GRANTHAM DW, 1989, PERCEPT PSYCHOPHYS, V45, P129, DOI 10.3758/BF03208047; Grantham DW, 1997, BINAURAL SPATIAL HEA; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; Grzeschik R, 2010, EXP BRAIN RES, V203, P159, DOI 10.1007/s00221-010-2221-7; Jenison RL, 2001, J NEUROSCI, V21, P4408, DOI 10.1523/JNEUROSCI.21-12-04408.2001; Jiang H, 2000, HEARING RES, V139, P69, DOI 10.1016/S0378-5955(99)00176-8; Kaczmarek T, 2005, J ACOUST SOC AM, V117, P3149, DOI 10.1121/1.1880832; LAPPIN JS, 1975, J EXP PSYCHOL HUMAN, V1, P383, DOI 10.1037/0096-1523.1.4.383; Lutfi RA, 1999, J ACOUST SOC AM, V106, P919, DOI 10.1121/1.428033; Magezi DA, 2013, J NEUROPHYSIOL, V109, P321, DOI 10.1152/jn.00625.2012; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Mollon JD, 1974, NEW SCI, V61, P479; NAKAYAMA K, 1985, VISION RES, V25, P625, DOI 10.1016/0042-6989(85)90171-3; Neelon MF, 2003, HEARING RES, V180, P57, DOI 10.1016/S0378-5955(03)00095-9; NOORLANDER C, 1980, J OPT SOC AM, V70, P1116, DOI 10.1364/JOSA.70.001116; Pavani F, 2002, CURR BIOL, V12, P1584, DOI 10.1016/S0960-9822(02)01143-0; PERROTT DR, 1993, J ACOUST SOC AM, V93, P1053, DOI 10.1121/1.405553; PERROTT DR, 1989, J ACOUST SOC AM, V85, P1773, DOI 10.1121/1.397968; Perrott DR, 1988, MINIMUM AUDIBLE MOVE, P1522; POIRSON AB, 1990, J OPT SOC AM A, V7, P783, DOI 10.1364/JOSAA.7.000783; Pralong D, 1996, VIRTUAL AUDITORY SPA; Reisbeck TE, 1999, VISION RES, V39, P3267, DOI 10.1016/S0042-6989(99)00017-6; SOVIJARVI AR, 1974, BRAIN RES, V73, P455, DOI 10.1016/0006-8993(74)90669-6; SPITZER MW, 1993, J NEUROPHYSIOL, V69, P1245, DOI 10.1152/jn.1993.69.4.1245; TORONCHUK JM, 1992, EXP BRAIN RES, V88, P169, DOI 10.1007/BF02259138; Wagner H, 1997, TRENDS NEUROSCI, V20, P583, DOI 10.1016/S0166-2236(97)01110-7; WANDELL BA, 1985, J OPT SOC AM A, V2, P62, DOI 10.1364/JOSAA.2.000062; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wuerger S, 2010, INFORM FUSION, V11, P45, DOI 10.1016/j.inffus.2009.04.005; Xiao X, 1997, J ACOUST SOC AM, V102, P1907, DOI 10.1121/1.421013; ZAKARAUSKAS P, 1991, HEARING RES, V52, P233, DOI 10.1016/0378-5955(91)90203-L	48	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102864	10.1371/journal.pone.0102864	http://dx.doi.org/10.1371/journal.pone.0102864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076211	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000340028800019
J	Kerkhoff, AD; Wood, R; Vogt, M; Lawn, SD				Kerkhoff, Andrew D.; Wood, Robin; Vogt, Monica; Lawn, Stephen D.			Prognostic Value of a Quantitative Analysis of Lipoarabinomannan in Urine from Patients with HIV-Associated Tuberculosis	PLOS ONE			English	Article							NEGATIVE PULMONARY TUBERCULOSIS; DIAGNOSTIC-ACCURACY; ANTIRETROVIRAL THERAPY; POSITIVE PATIENTS; LOW-COST; ASSAY; ANTIGEN; MORTALITY; INFECTION; PATHOLOGY	Background: Detection of the mycobacterial cell wall antigen lipoarabinomannan (LAM) in urine can be used to diagnose HIV-associated tuberculosis (TB) using a qualitative (positive/negative) read-out. However, it is not known whether the quantity of LAM present in urine provides additional prognostic information. Methods/Findings: Consecutively recruited adult outpatients initiating antiretroviral therapy (ART) in South Africa were investigated for TB regardless of clinical symptoms using sputum smear microscopy and liquid culture (reference standard). Urine samples were tested using the Clearview TB-ELISA for LAM and the Xpert MTB/RIF assay. The ELISA optical densities (OD) were used as a quantitative assessment of urine LAM. Among 514 patients with complete sputum and urine LAM OD results, culture-confirmed TB was diagnosed in 84 patients. Twenty-three (27.3%) were LAM-positive with a median LAM OD of 0.68 (IQR 0.16-2.43; range, 0.10-3.29) and 61 (72.6%) were LAM negative (LAM OD <0.1 above background). Higher LAM ODs were associated with a range of prognostic indices, including lower CD4 cell counts, lower haemoglobin levels, higher blood neutrophil counts and higher mycobacterial load as assessed using both sputum and urine samples. The median LAM OD among patients who died was more than 6.8-fold higher than that of patients who remained alive at 3 months (P<0.001). The small number of deaths, however, precluded adequate assessment of mortality risk stratified according to urine LAM OD. Conclusions: In patients with HIV-associated TB, concentrations of LAM in urine were strongly associated with a range of poor prognostic characteristics known to be associated with mortality risk. Urine LAM assays with a semi-quantitative (negative vs. low-positive vs. high-positive) read-out may have improved clinical utility over assays with a simple binary result.	[Kerkhoff, Andrew D.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Kerkhoff, Andrew D.; Wood, Robin; Vogt, Monica; Lawn, Stephen D.] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Kerkhoff, Andrew D.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Kerkhoff, Andrew D.] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Lawn, Stephen D.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England; [Lawn, Stephen D.] Univ Cape Town, Dept Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa	George Washington University; University of Cape Town; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of London; London School of Hygiene & Tropical Medicine; University of Cape Town	Lawn, SD (corresponding author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.	stephen.lawn@lshtm.ac.uk			Wellcome Trust [088590]; National Institutes of Health (NIH) [RO1 A1058736-01A1, 5UO1A1069519-02]	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	SDL is funded by the Wellcome Trust (Grant no 088590). RW is funded by the National Institutes of Health (NIH) through grants RO1 A1058736-01A1 and 5UO1A1069519-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Dawson R, 2010, INT J TUBERC LUNG D, V14, P52; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Gounder CR, 2011, JAIDS-J ACQ IMM DEF, V58, P219, DOI 10.1097/QAI.0b013e31822b75d4; Kerkhoff AD, 2014, JAIDS-J ACQ IMM DEF, V66, P33, DOI 10.1097/QAI.0000000000000091; Kerkhoff AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067956; Lanjewar D N, 2001, HIV Med, V2, P266, DOI 10.1046/j.1468-1293.2001.00079.x; Lawn SD, 2013, INT J TUBERC LUNG D, V17, P636, DOI 10.5588/ijtld.12.0811; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P1354, DOI 10.5588/ijtld.12.0174; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-231; Lawn SD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-407; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Lawn SD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-103; Lawn SD, 2012, AIDS, V26, P1635, DOI 10.1097/QAD.0b013e3283553685; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Lawn SD, 2011, J INFECT DIS, V204, pS1159, DOI 10.1093/infdis/jir411; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Lowe DM, 2013, EUR RESPIR J, V42, P1752, DOI 10.1183/09031936.00140913; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; Rylance J, 2010, LANCET INFECT DIS, V10, P886, DOI 10.1016/S1473-3099(10)70201-2; Shah M, 2010, J CLIN MICROBIOL, V48, P2972, DOI 10.1128/JCM.00363-10; Shah M, 2009, JAIDS-J ACQ IMM DEF, V52, P145, DOI 10.1097/QAI.0b013e3181b98430; Talbot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032876; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; World Health Organization, 2011, SER FERR CONC ASS IR; Zumla A, 2013, LANCET INFECT DIS, V13, P285, DOI 10.1016/S1473-3099(13)70039-2	35	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103285	10.1371/journal.pone.0103285	http://dx.doi.org/10.1371/journal.pone.0103285			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075867	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000340028800035
J	Devonshire, IM; Davis, J; Fairweather, S; Highfield, L; Thaker, C; Walsh, A; Wilson, R; Hathway, GJ				Devonshire, Ian M.; Davis, Jenny; Fairweather, Sophie; Highfield, Lauren; Thaker, Chandni; Walsh, Ashleigh; Wilson, Rachel; Hathway, Gareth J.			Risk-Based Learning Games Improve Long-Term Retention of Information among School Pupils	PLOS ONE			English	Article							COGNITIVE-DEVELOPMENT; TAKING BEHAVIOR; EDUCATION; NEUROSCIENCE; SCIENCE; BRAIN; CALIBRATION; REWARDS	Risk heightens motivation and, if used appropriately, may have the potential to improve engagement in the classroom. We have developed a risk-based learning game for school pupils in order to test whether such learning games can improve later recall of information. The study was performed during a series of public engagement workshops delivered by undergraduate students. Undergraduate neuroscience students delivered 90-minute science workshops to 9-10 year old school pupils (n = 448) that were divided into 'Risk', 'No risk' and 'Control' classes. 'Risk' classes received periodic multiple-choice questions (MCQs) during the workshops which required small teams of pupils to assign tokens to the answer(s) they believed to be correct. Tokens assigned to the correct answer were returned to the group and an equal number given back as a prize; tokens assigned to incorrect answers were lost. Participation was incentivised by the promise of a brain-related prize to the team with the most tokens at the end of the workshop. 'No risk' classes received MCQs without the risk component whilst the 'Control' classes received no MCQs. When presented with a neuroscience quiz based on workshop content at the end of the workshop, pupils in the 'Risk' classes exhibited significantly greater recall of information one week later. Quiz scores were higher than scores from the day of the workshop which suggested pupils may have discussed the workshop content outside of the classroom, thereby increasing knowledge over and above what was learned during the workshop. This is supported by feedback from pupils in 'Risk' classes which indicated that 'Risk' workshops were more interesting than 'No risk' and 'Control' workshops. These data suggest that there is a role for risk in the classroom but further investigations are required to elucidate the causal mechanisms of improved retention of information.	[Devonshire, Ian M.; Davis, Jenny; Fairweather, Sophie; Highfield, Lauren; Thaker, Chandni; Walsh, Ashleigh; Wilson, Rachel; Hathway, Gareth J.] Univ Nottingham, Sch Med, Sch Life Sci, Queens Med Ctr,Lab Dev Nocicept, Nottingham, England	University of Nottingham	Hathway, GJ (corresponding author), Univ Nottingham, Sch Med, Sch Life Sci, Queens Med Ctr,Lab Dev Nocicept, Nottingham, England.	gareth.hathway@nottingham.ac.uk		Hathway, Gareth/0000-0003-4347-9667; Devonshire, Ian/0000-0003-3250-3852	School of Life Sciences; University of Nottingham	School of Life Sciences; University of Nottingham	This project was funded by the School of Life Sciences teaching fund and a University of Nottingham 'Cascade Award'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliance for Useful Evidence, 2013, EV FRONTL; ATKINSON JW, 1957, PSYCHOL REV, V64, P359, DOI 10.1037/h0043445; Barr DA, 2013, J CHIPROPR EDUC, V27, P21, DOI 10.7899/JCE-12-018; Burgess AW, 2014, ACAD MED, V89, P678, DOI 10.1097/ACM.0000000000000162; Callan DE, 2008, HUM BRAIN MAPP, V29, P237, DOI 10.1002/hbm.20383; Cameron J, 2005, J EDUC PSYCHOL, V97, P641, DOI 10.1037/0022-0663.97.4.641; Cameron J., 2002, REWARDS INTRINSIC MO; Carew TJ, 2010, NEURON, V67, P685, DOI 10.1016/j.neuron.2010.08.028; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Curtis D, 2002, INT ED J, V3, P43; Della Salla S, 2012, NEUROSCIENCE ED GOOD; Dennison C, 2000, YOUNG PEOPLE GENDER; Devonshire IM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001761; Devonshire IM, 2010, NEUROSCIENTIST, V16, P349, DOI 10.1177/1073858410370900; Divjak B, 2011, J INF ORGAN SCI, V35, P15; Education Endowment Foundation, 2014, NEUR ED REV ED INT A; Egenfeldt-Nielsen S, 2006, NORD J DIGIT LIT, V1, P184; Erk S, 2003, NEUROIMAGE, V18, P439, DOI 10.1016/S1053-8119(02)00015-0; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Galdman-Rakic P, 1987, HDB PHYSL; Garris R., 2002, Simulation & Gaming, V33, P441, DOI 10.1177/1046878102238607; Gullone E, 2000, J ADOLESCENCE, V23, P393, DOI 10.1006/jado.2000.0327; HAYS RT, 2005, EFFECTIVENESS INSTRU; Hoffmann KF, 2009, TEACH TEACH EDUC, V25, P843, DOI 10.1016/j.tate.2008.12.004; Howard-Jones P, 2011, MIND BRAIN EDUC, V5, P33, DOI 10.1111/j.1751-228X.2011.01108.x; Howard-Jones PA, 2009, INSTR SCI, V37, P519, DOI 10.1007/s11251-008-9073-6; Leclercq D, 1983, EVALUATION ED, V6, P161, DOI [10.1016/0191-765X(82)90011-8, DOI 10.1016/0191-765X(82)90011-8]; Levin IP, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00015; Li MC, 2013, J SCI EDUC TECHNOL, V22, P877, DOI 10.1007/s10956-013-9436-x; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Malone T. W., 1981, COGNITIVE SCI, V4, P333, DOI DOI 10.1016/S0364-0213(81)80017-1; Matvey G, 2006, MEMORY, V14, P253, DOI 10.1080/09658210500216844; Moore S, 1996, J YOUTH ADOLESCENCE, V25, P343, DOI 10.1007/BF01537389; Pearson Education, 2012, LIT REV GAM ED; Pincham HL, 2014, TRENDS NEUROSCI EDUC, V3, P28, DOI 10.1016/j.tine.2014.02.002; Sandseter EBH, 2011, EVOL PSYCHOL-US, V9, P257, DOI 10.1177/147470491100900212; Sigman M, 2014, NAT NEUROSCI, V17, P497, DOI 10.1038/nn.3672; Slavin R.E., 2002, EDUC RES-UK, V31, P15, DOI [10.3102/0013189X031007015, DOI 10.3102/0013189X031007015]; Steinberg L, 2007, CURR DIR PSYCHOL SCI, V16, P55, DOI 10.1111/j.1467-8721.2007.00475.x; Stone NJ, 2000, EDUC PSYCHOL REV, V12, P437, DOI 10.1023/A:1009084430926; Studer B, 2011, COGN AFFECT BEHAV NE, V11, P144, DOI 10.3758/s13415-011-0025-2; TANG SH, 1995, APPL COGNITIVE PSYCH, V9, P365, DOI 10.1002/acp.2350090502; Tenney ER, 2011, DEV PSYCHOL, V47, P1065, DOI 10.1037/a0023273; Tymula A, 2012, P NATL ACAD SCI USA, V109, P17135, DOI 10.1073/pnas.1207144109; UK Government Cabinet Office, 2012, TEST LEARN AD DEV PU	45	7	7	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103640	10.1371/journal.pone.0103640	http://dx.doi.org/10.1371/journal.pone.0103640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KU	25072799	gold, Green Published, Green Submitted			2022-12-25	WOS:000341307600074
J	Knapp, AR; Wang, HY; Parthun, MR				Knapp, Amy R.; Wang, Huanyu; Parthun, Mark R.			The Yeast Histone Chaperone Hif1p Functions with RNA in Nucleosome Assembly	PLOS ONE			English	Article							HIR PROTEINS; SACCHAROMYCES-CEREVISIAE; CHROMATIN REPLICATION; DNA-REPLICATION; COMPLEX; SEQUENCE; ACETYLTRANSFERASE; ACID; NASP	Background: Hif1p is an H3/H4-specific histone chaperone that associates with the nuclear form of the Hat1p/Hat2p complex (NuB4 complex) in the yeast Saccharomyces cerevisiae. While not capable of depositing histones onto DNA on its own, Hif1p can act in conjunction with a yeast cytosolic extract to assemble nucleosomes onto a relaxed circular plasmid. Results: To identify the factor(s) that function with Hif1p to carry out chromatin assembly, multiple steps of column chromatography were carried out to fractionate the yeast cytosolic extract. Analysis of partially purified fractions indicated that Hif1p-dependent chromatin assembly activity resided in RNA rather than protein. Fractionation of isolated RNA indicated that the chromatin assembly activity did not simply purify with bulk RNA. In addition, the RNA-mediated chromatin assembly activity was blocked by mutations in the human homolog of Hif1p, sNASP, that prevent the association of this histone chaperone with histone H3 and H4 without altering its electrostatic properties. Conclusions: These results suggest that specific RNA species may function in concert with histone chaperones to assemble chromatin.	[Knapp, Amy R.; Wang, Huanyu; Parthun, Mark R.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Parthun, MR (corresponding author), Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	Parthun.1@osu.edu	Wang, Huanyu/W-3145-2019	Wang, Huanyu/0000-0002-5982-6371	National Institutes of Health [GM062970]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health (GM062970). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2004, MOL CELL, V14, P195, DOI 10.1016/S1097-2765(04)00184-4; Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; Froberg JE, 2013, J MOL BIOL, V425, P3698, DOI 10.1016/j.jmb.2013.06.031; Ge ZQ, 2011, J BIOL CHEM, V286, P16790, DOI 10.1074/jbc.M110.216846; Kaufman PD, 1998, MOL CELL BIOL, V18, P4793, DOI 10.1128/MCB.18.8.4793; Keller C, 2013, CHROMOSOME RES, V21, P627, DOI 10.1007/s10577-013-9390-8; KLEINSCHMIDT J, 1986, EMBO J, V5, P3547, DOI 10.1002/j.1460-2075.1986.tb04681.x; KLEINSCHMIDT JA, 1985, J BIOL CHEM, V260, P1166; LOWARY PT, 1989, P NATL ACAD SCI USA, V86, P8266, DOI 10.1073/pnas.86.21.8266; Marchese FP, 2013, EPIGENETICS, V9; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; NELSON T, 1981, BIOCHEMISTRY-US, V20, P2594, DOI 10.1021/bi00512a035; Ohsawa Ryosuke, 2013, Frontiers in Genetics, V4, P136, DOI 10.3389/fgene.2013.00136; ORAND MG, 1992, DEV BIOL, V154, P37, DOI 10.1016/0012-1606(92)90045-I; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; Poveda A, 2004, J BIOL CHEM, V279, P16033, DOI 10.1074/jbc.M314228200; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Richardson RT, 2000, J BIOL CHEM, V275, P30378, DOI 10.1074/jbc.M003781200; Saxena A, 2011, BIOESSAYS, V33, P830, DOI 10.1002/bies.201100084; Sharp JA, 2002, GENE DEV, V16, P85, DOI 10.1101/gad.925302; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Spitale RC, 2011, EPIGENETICS-US, V6, P539, DOI 10.4161/epi.6.5.15221; TATCHELL K, 1977, BIOCHEMISTRY-US, V16, P5295, DOI 10.1021/bi00643a021; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Verzijlbergen KF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002284; Wang HY, 2008, NUCLEIC ACIDS RES, V36, P5763, DOI 10.1093/nar/gkn574; Wang HY, 2012, NUCLEIC ACIDS RES, V40, P660, DOI 10.1093/nar/gkr781; WELCH JE, 1990, BIOL REPROD, V43, P559, DOI 10.1095/biolreprod43.4.559	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e100299	10.1371/journal.pone.0100299	http://dx.doi.org/10.1371/journal.pone.0100299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072697	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600003
J	Mauramo, M; Ramseier, AM; Buser, A; Tiercy, JM; Weiger, R; Waltimo, T				Mauramo, Matti; Ramseier, Adrian Markus; Buser, Andreas; Tiercy, Jean-Marie; Weiger, Roland; Waltimo, Tuomas			Associations of HLA-A, -B and-DRB1 Types with Oral Diseases in Swiss Adults	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; HUMAN-LEUKOCYTE ANTIGENS; CLASS-II ALLELES; TEMPOROMANDIBULAR-JOINT; MUTANS STREPTOCOCCI; AGGRESSIVE PERIODONTITIS; ANKYLOSING-SPONDYLITIS; DENTAL-CARIES; GENETICS; HLA-DR4	Human leukocyte antigens (HLA) are crucial components of host defense against microbial challenge but the associations of HLA types with oral infectious diseases have not been studied in detail. This prospective cross-sectional study examined associations of HLA-A, -B and -DRB1 types with common oral diseases in a healthy Swiss adult population. 257 subjects (107 m, 150 f, mean age: 43.5 yr; range: 21-58 yr) with known HLA-A, -B and -DRB1 profiles and comprehensive medical records were included. A thorough anamnesis was followed by oral examinations including saliva flow measurements, the DMFT score for cariological status, complete periodontal status with plaque and bleeding indexes as well as assessment of mucosal alterations and temporomandibular dysfunction (TMD). Student's t-test and Pearson chi-square test were utilized to compare the oral diseases between HLA positive and negative subjects. Bonferroni correction for multiple comparisons was used and P-Bonf<0.05 was considered statistically significant. HLA types -B15 (P-Bonf = 0.002), -B51 (P-Bonf = 0.02) and -DRB1*12 (P-Bonf = 0.02) were associated with less periodontal disease manifestations. HLA-A32 had a positive association with TMD dysfunction (P-Bonf = 0.012). No other statistically significant associations were observed. In conclusion, HLA types may contribute to the development of oral diseases in generally healthy Caucasian adults.	[Mauramo, Matti; Ramseier, Adrian Markus; Waltimo, Tuomas] Univ Basel, Sch Dent Med, Dept Prevent Dent & Oral Microbiol, Basel, Switzerland; [Mauramo, Matti] Univ Helsinki, Inst Dent, Helsinki, Finland; [Buser, Andreas] Blood Transfus Serv SRC Basel, Basel, Switzerland; [Tiercy, Jean-Marie] Univ Hosp Geneva, Natl Reference Lab Histocompatibil, Geneva, Switzerland; [Tiercy, Jean-Marie] Univ Geneva, Geneva, Switzerland; [Weiger, Roland] Univ Basel, Sch Dent Med, Clin Periodontol Endodontol & Cariol, Basel, Switzerland	University of Basel; University of Helsinki; University of Geneva; University of Geneva; University of Basel	Mauramo, M (corresponding author), Univ Basel, Sch Dent Med, Dept Prevent Dent & Oral Microbiol, Basel, Switzerland.	matti.mauramo@helsinki.fi	Buser, Andreas S/A-2660-2008; Buser, Andreas/AAL-8676-2020	Buser, Andreas S/0000-0002-7942-6746; Buser, Andreas/0000-0002-7942-6746; Mauramo, Matti/0000-0002-0107-4939	Swiss National Science Foundation [32003B-121582]; Schweizerische Zahnarzte-Gesellschaft [246-09]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Schweizerische Zahnarzte-Gesellschaft	This study (TW) was supported by Swiss National Science Foundation (32003B-121582) URL: www.snf.ch; and Schweizerische Zahnarzte-Gesellschaft (SSO Fonds 246-09) URL: www.sso.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton RT, 1999, HUM IMMUNOL, V60, P984, DOI 10.1016/S0198-8859(99)00088-9; AINAMO J, 1975, INT DENT J, V25, P229; Altun C, 2008, PEDIATR DENT, V30, P154; Bagherian A, 2008, J Indian Soc Pedod Prev Dent, V26, P18; BAINES M, 1992, MOL ASPECTS MED, V13, P263, DOI 10.1016/0098-2997(92)90003-I; BREWERTON DA, 1973, LANCET, V1, P904; Buhler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041400; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Dobr T, 2007, EUR J HAEMATOL, V78, P495, DOI 10.1111/j.1600-0609.2007.00841.x; Fischer GF, 2001, WIEN KLIN WOCHENSCHR, V113, P814; Helenius LMJ, 2004, SCAND J RHEUMATOL, V33, P24, DOI 10.1080/03009740310004603; Henry CH, 1999, J ORAL MAXIL SURG, V57, P683, DOI 10.1016/S0278-2391(99)90432-9; Henry CH, 2002, J ORAL MAXIL SURG, V60, P778, DOI 10.1053/joms.2002.33245; Kaner D, 2007, J PERIODONTOL, V78, P1201, DOI 10.1902/jop.2007.060437; Kim SJ, 2003, J ORAL MAXIL SURG, V61, P1156, DOI 10.1016/S0278-2391(03)00674-8; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; LEHNER T, 1981, NATURE, V292, P770, DOI 10.1038/292770a0; Machulla HKG, 2002, J CLIN PERIODONTOL, V29, P573, DOI 10.1034/j.1600-051X.2002.290614.x; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Meador Robert, 2002, Curr Rheumatol Rep, V4, P47, DOI 10.1007/s11926-002-0023-z; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Ozawa Y, 2001, ORAL MICROBIOL IMMUN, V16, P353, DOI 10.1034/j.1399-302X.2001.160606.x; POULTER LW, 1989, CLIN EXP IMMUNOL, V78, P189; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; SCHWARTZ RH, 1985, ANNU REV IMMUNOL, V3, P237, DOI 10.1146/annurev.iy.03.040185.001321; Sreebny LM., 2010, DRY MOUTH MALEVOLENT; Stein JM, 2008, J CLIN PERIODONTOL, V35, P183, DOI 10.1111/j.1600-051X.2007.01189.x; Sun A, 2000, J FORMOS MED ASSOC, V99, P290; Trowsdale J, 2013, ANNU REV GENOM HUM G, V14, P301, DOI 10.1146/annurev-genom-091212-153455; Wallengren ML, 1997, ACTA ODONTOL SCAND, V55, P296, DOI 10.3109/00016359709114967; WALLENGREN ML, 1991, ORAL MICROBIOL IMMUN, V6, P292, DOI 10.1111/j.1399-302X.1991.tb00495.x; Wallengren MLL, 2001, ORAL MICROBIOL IMMUN, V16, P45, DOI 10.1034/j.1399-302x.2001.160108.x; WHO, OR HLTH SRUV BAS MET, P4	33	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103527	10.1371/journal.pone.0103527	http://dx.doi.org/10.1371/journal.pone.0103527			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072155	gold, Green Published, Green Submitted			2022-12-25	WOS:000341307600057
J	Kim, KH; Jun, YW; Park, Y; Lee, JA; Suh, BC; Lim, CS; Lee, YS; Kaang, BK; Jang, DJ				Kim, Kun-Hyung; Jun, Yong-Woo; Park, Yongsoo; Lee, Jin-A; Suh, Byung-Chang; Lim, Chae-Seok; Lee, Yong-Seok; Kaang, Bong-Kiun; Jang, Deok-Jin			Intracellular Membrane Association of the Aplysia cAMP Phosphodiesterase Long and Short Forms via Different Targeting Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; TERMINAL SPLICE REGION; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; DROSOPHILA-MELANOGASTER; ELECTROSTATIC SWITCH; HIGH-AFFINITY; LOCALIZATION; UNIQUE; MEMORY	Phosphodiesterases (PDEs) play key roles in cAMP compartmentalization, which is required for intracellular signaling processes, through specific subcellular targeting. Previously, we showed that the long and short forms of Aplysia PDE4 (ApPDE4), which are localized to the membranes of distinct subcellular organelles, play key roles in 5-hydroxytryptamine-induced synaptic facilitation in Aplysia sensory and motor synapses. However, the molecular mechanism of the isoform-specific distinct membrane targeting was not clear. In this study, we further investigated the molecular mechanism of the membrane targeting of the ApPDE4 long and short forms. We found that the membrane targeting of the long form was mediated by hydrophobic interactions, mainly via 16 amino acids at the N-terminal region, whereas the short form was targeted solely to the plasma membrane, mainly by nonspecific electrostatic interactions between their N termini and the negatively charged lipids such as the phosphatidylinositol polyphosphates PI4P and PI(4,5) P2, which are embedded in the inner leaflet of the plasma membrane. Moreover, oligomerization of the long or short form by interaction of their respective upstream conserved region domains, UCR1 and UCR2, enhanced their plasma membrane targeting. These results suggest that the long and short forms of ApPDE4 are distinctly targeted to intracellular membranes through their direct association with the membranes via hydrophobic and electrostatic interactions, respectively.	[Kim, Kun-Hyung; Jun, Yong-Woo; Jang, Deok-Jin] Kyungpook Natl Univ, Dept Ecol Sci, Coll Ecol & Environm, Sangju Si 742711, Kyungbuk, South Korea; [Park, Yongsoo] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Lee, Jin-A] Hannam Univ, Dept Biotechnol, Coll Life Sci & Nanotechnol, Taejon 305811, South Korea; [Suh, Byung-Chang] Daegu Gyeongbuk Inst Sci & Technol DGIST, Dept Brain Sci, Taegu 711873, South Korea; [Lim, Chae-Seok; Kaang, Bong-Kiun] Seoul Natl Univ, Dept Biol Sci, Coll Nat Sci, Seoul 151747, South Korea; [Lee, Yong-Seok] Chung Ang Univ, Dept Life Sci, Coll Nat Sci, Seoul 156756, South Korea	Kyungpook National University; Max Planck Society; Hannam University; Daegu Gyeongbuk Institute of Science & Technology (DGIST); Seoul National University (SNU); Chung Ang University	Kaang, BK (corresponding author), 599 Gwanangno, Seoul 151747, South Korea.	kaang@snu.ac.kr; jangdj@knu.ac.kr	Park, Yongsoo/G-9285-2014	Park, Yongsoo/0000-0001-8336-8051	NRF - Ministry of Education, Science, and Technology [2013-R1A1A2012804]; National Honor Scientist Program of Korea; NRF [2011-0022813]; Korean Ministry of Education, Science, and Technology [2012R1A1A2044699]	NRF - Ministry of Education, Science, and Technology(National Research Foundation of Korea); National Honor Scientist Program of Korea; NRF; Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Basic Science Research Program through NRF Grant 2013-R1A1A2012804 funded by the Ministry of Education, Science, and Technology (to D. J. J.) and by the National Honor Scientist Program of Korea (to D. J. J. and B. K. K.).; Supported by Basic Science Research Program through the NRF Grant 2011-0022813.; Supported by Korean Ministry of Education, Science, and Technology 2012R1A1A2044699.	Baillie GS, 2002, J BIOL CHEM, V277, P28298, DOI 10.1074/jbc.M108353200; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Beard MB, 1999, FEBS LETT, V460, P173, DOI 10.1016/S0014-5793(99)01335-6; Beard MB, 2000, J BIOL CHEM, V275, P10349, DOI 10.1074/jbc.275.14.10349; BOLGER G, 1993, MOL CELL BIOL, V13, P6558, DOI 10.1128/MCB.13.10.6558; Bolger GB, 2003, J BIOL CHEM, V278, P49230, DOI 10.1074/jbc.M303772200; Bolger GB, 2003, J BIOL CHEM, V278, P33351, DOI 10.1074/jbc.M303269200; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; CADWALLADER KA, 1994, MOL CELL BIOL, V14, P4722, DOI 10.1128/MCB.14.7.4722; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Huston E, 2006, J CELL SCI, V119, P3799, DOI 10.1242/jcs.03106; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jang DJ, 2011, MOL CELLS, V31, P175, DOI 10.1007/s10059-011-0025-7; Jang DJ, 2010, LEARN MEMORY, V17, P469, DOI 10.1101/lm.1899410; Jun M. H., 2014, BMB REP IN PRESS; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; Lee SH, 2012, J NEUROSCI, V32, P16296, DOI 10.1523/JNEUROSCI.1872-12.2012; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; OConnell JC, 1996, BIOCHEM J, V318, P255, DOI 10.1042/bj3180255; Park H, 2005, J NEUROSCI, V25, P9037, DOI 10.1523/JNEUROSCI.1989-05.2005; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Richter W, 2002, J BIOL CHEM, V277, P40212, DOI 10.1074/jbc.M203585200; Richter W, 2013, EXPERT OPIN THER TAR, V17, P1011, DOI 10.1517/14728222.2013.818656; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Russwurm C, 2009, J BIOL CHEM, V284, P25782, DOI 10.1074/jbc.M109.017194; Rutten K, 2006, NEUROBIOL LEARN MEM, V85, P132, DOI 10.1016/j.nlm.2005.09.002; Shakur Y, 2000, J BIOL CHEM, V275, P38749, DOI 10.1074/jbc.M001734200; SHAKUR Y, 1993, BIOCHEM J, V292, P677, DOI 10.1042/bj2920677; Smith KJ, 1996, J BIOL CHEM, V271, P16703, DOI 10.1074/jbc.271.28.16703; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967	48	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25797	25811		10.1074/jbc.M114.572222	http://dx.doi.org/10.1074/jbc.M114.572222			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25077971	Green Published, hybrid			2022-12-25	WOS:000342130800037
J	Ledderose, C; Bao, Y; Lidicky, M; Zipperle, J; Li, LL; Strasser, K; Shapiro, NI; Junger, WG				Ledderose, Carola; Bao, Yi; Lidicky, Markus; Zipperle, Johannes; Li, Linglin; Strasser, Katharina; Shapiro, Nathan I.; Junger, Wolfgang G.			Mitochondria Are Gate-keepers of T Cell Function by Producing the ATP That Drives Purinergic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANNEXIN-1 HEMICHANNELS; IMMUNE SYNAPSE; ACTIVATION; CALCIUM; RECEPTORS; RELEASE; SEPSIS; IMMUNOSUPPRESSION; METABOLISM; EXPRESSION	T cells play a central role in host defense. ATP release and autocrine feedback via purinergic receptors has been shown to regulate T cell function. However, the sources of the ATP that drives this process are not known. We found that stimulation of T cells triggers a spike in cellular ATP production that doubles intracellular ATP levels in < 30 s and causes prolonged ATP release into the extracellular space. Cell stimulation triggered rapid mitochondrial Ca2+ uptake, increased oxidative phosphorylation, a drop in mitochondrial membrane potential (Delta psi(m)), and the accumulation of active mitochondria at the immune synapse of stimulated T cells. Inhibition of mitochondria with CCCP, KCN, or rotenone blocked intracellular ATP production, ATP release, intracellular Ca2+ signaling, induction of the early activation marker CD69, and IL-2 transcription in response to cell stimulation. These findings demonstrate that rapid activation of mitochondrial ATP production fuels the purinergic signaling mechanisms that regulate T cells and define their role in host defense.	[Ledderose, Carola; Bao, Yi; Lidicky, Markus; Zipperle, Johannes; Li, Linglin; Strasser, Katharina; Junger, Wolfgang G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA; [Shapiro, Nathan I.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Emergency Med, Boston, MA 02215 USA; [Lidicky, Markus] Paracelsus Med Univ, A-5020 Salzburg, Austria; [Junger, Wolfgang G.] Ludwig Boltzmann Inst Traumatol, A-1200 Vienna, Austria	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Paracelsus Private Medical University; Ludwig Boltzmann Institute	Junger, WG (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Feldberg 870,330 Brookline Ave, Boston, MA 02215 USA.	wjunger@bidmc.harvard.edu	Shapiro, Nathan/F-1718-2016; li, li/GPX-3938-2022; Bao, Yi/J-5418-2013; LI, LI/GVS-5344-2022; Li, Li/AEM-3636-2022; li, li/HII-4157-2022; Junger, Wolfgang G/I-1932-2013	Junger, Wolfgang G/0000-0003-3350-8452; Strasser, Katharina/0000-0001-6962-5285; Zipperle, Johannes/0000-0002-8222-3413; Bao, Yi/0000-0003-0748-1575	National Institutes of Health [GM-51477, GM-60475, AI-080582, T32GM103702]; Harvard Digestive Disease Center; German Research Foundation (DFG) [LE-3209/1-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM103702, R01GM060475, R01GM051477, R29GM051477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Disease Center; German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by Grants GM-51477, GM-60475, AI-080582, and T32GM103702 from the National Institutes of Health (to W. G. J.), by The Harvard Digestive Disease Center, and by a fellowship from the German Research Foundation (DFG), LE-3209/1-1 (to C. L.).	Baixauli F, 2011, EMBO J, V30, P1238, DOI 10.1038/emboj.2011.25; Belikova I, 2007, CRIT CARE MED, V35, P2702, DOI 10.1097/01.CCM.0000295593.25106.C4; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chaudry IH, 2009, BRIT J SURG, V96, P1097, DOI 10.1002/bjs.6697; Chida J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060561; Choi O, 2012, J IMMUNOL, V188, P3920, DOI 10.4049/jimmunol.1102587; Dehkordy SF, 2012, J CLIN IMMUNOL, V32, P1, DOI 10.1007/s10875-011-9593-8; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; FAIST E, 1993, J TRAUMA, V34, P846, DOI 10.1097/00005373-199306000-00016; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; HOYT DB, 1994, SHOCK, V2, P23, DOI 10.1097/00024382-199407000-00005; Japiassu AM, 2011, CRIT CARE MED, V39, P1056, DOI 10.1097/CCM.0b013e31820eda5c; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Kaminski MM, 2012, BBA-MOL CELL RES, V1823, P1041, DOI 10.1016/j.bbamcr.2012.03.003; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Kurishita Y, 2012, J AM CHEM SOC, V134, P18779, DOI 10.1021/ja308754g; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; MARKERT M L, 1991, Immunodeficiency Reviews, V3, P45; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Nyhan WL, 2005, MOL GENET METAB, V86, P25, DOI 10.1016/j.ymgme.2005.07.027; Ojida A, 2008, J AM CHEM SOC, V130, P12095, DOI 10.1021/ja803262w; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schwindling C, 2010, J IMMUNOL, V184, P184, DOI 10.4049/jimmunol.0902872; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Seror C, 2011, J EXP MED, V208, P1823, DOI 10.1084/jem.20101805; Tokunaga A, 2010, J BIOL CHEM, V285, P17406, DOI 10.1074/jbc.M110.112417; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Wang RN, 2012, IMMUNOL REV, V249, P14, DOI 10.1111/j.1600-065X.2012.01155.x; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Woehrle T, 2010, J LEUKOCYTE BIOL, V88, P1181, DOI 10.1189/jlb.0410211; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458; Zhang YF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005000	51	68	68	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25936	25945		10.1074/jbc.M114.575308	http://dx.doi.org/10.1074/jbc.M114.575308			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070895	Green Published, hybrid			2022-12-25	WOS:000342130800048
J	Parks, EE; Ceresa, BP				Parks, Eileen E.; Ceresa, Brian P.			Cell Surface Epidermal Growth Factor Receptors Increase Src and c-Cbl Activity and Receptor Ubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; EGF RECEPTOR; EPITHELIAL-CELLS; SIGNAL PROPAGATION; PLASMA-MEMBRANE; MICE LACKING; ACTIVATION; TYROSINE; MECHANISMS; KINASE	There is an established role for the endocytic pathway in regulation of epidermal growth factor receptor (EGFR) signaling to downstream effectors. However, because ligand-mediated EGFR endocytosis utilizes multiple "moving parts," dissecting the spatial versus temporal contributions has been challenging. Blocking all endocytic trafficking can have unintended effects on other receptors as well as give rise to compensatory mechanisms, both of which impact interpretation of EGFR signaling. To overcome these limitations, we used epidermal growth factor (EGF) conjugated to polystyrene beads (EGF beads). EGF beads simultaneously activate the EGFR while blocking its endocytosis and allow analysis of EGFR signaling from the plasma membrane. Human telomerase immortalized corneal epithelial (hTCEpi) cells were used to model normal epithelial cell biology. In hTCEpi cells, both cell surface and intracellular EGFRs exhibited dose-dependent increases in effector activity after 15 min of ligand stimulation, but only the serine phosphorylation of signal transducer and activator of transcription 3 (STAT3) was statistically significant when accounting for receptor phosphorylation. However, over time with physiological levels of receptor phosphorylation, cell surface receptors produced either enhanced or sustained mitogen-activated protein kinase kinase (MEK), Casitas B-lineage lymphoma (c-Cbl), and the pro-oncogene Src activity. These increases in effector communication by cell surface receptors resulted in an increase in EGFR ubiquitylation with sustained ligand incubation. Together, these data indicate that spatial regulation of EGFR signaling may be an important regulatory mechanism in receptor down-regulation.	[Parks, Eileen E.; Ceresa, Brian P.] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA	University of Louisville	Ceresa, BP (corresponding author), Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA.	brian.ceresa@louisville.edu			National Institutes of Health [R01GM092874, R01EY021497]; NATIONAL EYE INSTITUTE [R01EY021497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM092874 and R01EY021497 (to B. P. C.).	de Melker AA, 2004, J BIOL CHEM, V279, P55465, DOI 10.1074/jbc.M409765200; de Melker AA, 2001, J CELL SCI, V114, P2167; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Fry WHD, 2009, EXP CELL RES, V315, P697, DOI 10.1016/j.yexcr.2008.07.022; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Hansen LA, 1997, AM J PATHOL, V150, P1959; Hsueh YJ, 2011, INVEST OPHTH VIS SCI, V52, P4685, DOI 10.1167/iovs.10-6103; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Hyatt DC, 2008, EXP CELL RES, V314, P3415, DOI 10.1016/j.yexcr.2008.08.020; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Johannessen LE, 2000, EXP CELL RES, V260, P136, DOI 10.1006/excr.2000.5004; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kassenbrock CK, 2002, J BIOL CHEM, V277, P24967, DOI 10.1074/jbc.M201026200; Kopp R, 2003, RECENT RESULTS CANC, V162, P115; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Peterson JL, 2014, INVEST OPHTH VIS SCI, V55, P2870, DOI 10.1167/iovs.13-12943; Pines G, 2010, FEBS LETT, V584, P2699, DOI 10.1016/j.febslet.2010.04.019; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Rush JS, 2014, INVEST OPHTH VIS SCI, V55, P4691, DOI 10.1167/iovs.14-14133; Rush JS, 2013, MOL CELL ENDOCRINOL, V381, P188, DOI 10.1016/j.mce.2013.07.029; Rush JS, 2012, J BIOL CHEM, V287, P712, DOI 10.1074/jbc.M111.294470; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2013, EMBO J, V32, P2140, DOI 10.1038/emboj.2013.149; Singh AB, 2007, J BIOL CHEM, V282, P32890, DOI 10.1074/jbc.M702677200; Smit GDV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000217; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stefonek TJ, 2007, WOUND REPAIR REGEN, V15, P847, DOI 10.1111/j.1524-475X.2007.00288.x; Tullo AB, 2005, EYE, V19, P729, DOI 10.1038/sj.eye.6701630; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xu KP, 2006, INVEST OPHTH VIS SCI, V47, P2832, DOI 10.1167/iovs.05-1361; Zhang L, 2003, MOL VIS, V9, P584	41	7	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25537	25545		10.1074/jbc.M114.579581	http://dx.doi.org/10.1074/jbc.M114.579581			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074934	Green Published, hybrid			2022-12-25	WOS:000342130800015
J	Egede, LE; Gebregziabher, M; Zhao, YM; Dismuke, CE; Walker, RJ; Hunt, KJ; Axon, RN				Egede, Leonard E.; Gebregziabher, Mulugeta; Zhao, Yumin; Dismuke, Clara E.; Walker, Rebekah J.; Hunt, Kelly J.; Axon, R. Neal			Impact of Mental Health Visits on Healthcare Cost in Patients with Diabetes and Comorbid Mental Health Disorders	PLOS ONE			English	Article							RANDOMIZED-TRIAL; PSYCHOLOGICAL DISTRESS; MEDICAL-CARE; VETERANS; INDIVIDUALS; DEPRESSION; OUTCOMES; TELEPSYCHIATRY; MANAGEMENT; ILLNESS	Purpose: To assess the impact of mental health visits (MHV) on the cost of care for Veterans with diabetes and comorbid mental health conditions. Methods: A national cohort of 120,852 Veterans with diabetes and at least one mental health diagnosis (i.e., substance abuse, depression or psychoses) in 2002 was followed through 2006. Outcomes were pharmacy, inpatient and outpatient costs in 2012 dollars. Results: Least-square covariate adjusted estimates from the joint model of total VA costs of the number of MHV using December 31, 2012 value dollars indicate that relative to those with fewer MHV, those with 3+ MHV had the lowest mean inpatient cost ($21,406), but the highest mean outpatient and pharmacy cost ($9,727 and $2,015, respectively). If all Veterans who received zero MHV actually received 3+ MHV, we estimate through simulated scenarios that between $32,272,329 and $181,460,247 in inpatient costs would be saved. However, these savings would be offset by additional expenditures of between $1,166,017,547 and $1,166,224,787 in outpatient costs and between $151,604,683 and $161,439,632 in pharmacy costs. Conclusions: Among Veterans with diabetes and comorbid mental disorders having three or more mental health visits is associated with marginally decreased inpatient cost, but these potential savings seem to be offset by increased outpatient and pharmacy costs.	[Gebregziabher, Mulugeta; Zhao, Yumin; Dismuke, Clara E.; Walker, Rebekah J.; Hunt, Kelly J.; Axon, R. Neal] Ralph H Johnson Dept Vet Affairs Med Ctr, Hlth Equity & Rural Outreach Innovat Ctr, Charleston, SC USA; [Egede, Leonard E.; Zhao, Yumin; Dismuke, Clara E.; Walker, Rebekah J.; Axon, R. Neal] Med Univ S Carolina, Div Gen Internal Med, Ctr Hlth Dispar Res, Charleston, SC 29425 USA; [Gebregziabher, Mulugeta; Hunt, Kelly J.] Med Univ S Carolina, Div Biostat & Epidemiol, Charleston, SC 29425 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Medical University of South Carolina	Egede, LE (corresponding author), Med Univ S Carolina, Div Gen Internal Med, Ctr Hlth Dispar Res, Charleston, SC 29425 USA.	egedel@musc.edu		Gebregziabher, Mulugeta/0000-0002-4826-481X; Walker, Rebekah/0000-0002-7773-557X	VHA Health Services Research and Development (HSRD) program [IIR-06-219]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK093699] Funding Source: NIH RePORTER	VHA Health Services Research and Development (HSRD) program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grant #IIR-06-219 funded by the VHA Health Services Research and Development (HSR&D) program. The funding agency did not participate in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Dickerson F, 2008, PSYCHOSOMATICS, V49, P109, DOI 10.1176/appi.psy.49.2.109; Dieterich M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007906.pub2; Dixon LB, 2004, PSYCHIAT SERV, V55, P892, DOI 10.1176/appi.ps.55.8.892; Druss BG, 2010, AM J PSYCHIAT, V167, P151, DOI 10.1176/appi.ajp.2009.09050691; Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464; Egede LE, 2012, DIABETES CARE, V35, P2533, DOI 10.2337/dc12-0572; Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0; Egede LE, 2011, DIABETES CARE, V34, P938, DOI 10.2337/dc10-1504; Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024; Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x; Frueh BC, 2007, J TELEMED TELECARE, V13, P142, DOI 10.1258/135763307780677604; Germain V, 2010, CYBERPSYCH BEH SOC N, V13, P29, DOI 10.1089/cyber.2009.0139; Hultsjo SM, 2012, J PSYCHIATR MENT HLT, V19, P891, DOI 10.1111/j.1365-2850.2012.01874.x; Hutter N, 2010, DIABETOLOGIA, V53, P2470, DOI 10.1007/s00125-010-1873-y; Jimenez-Garcia R, 2012, PRIM CARE DIABETES, V6, P149, DOI 10.1016/j.pcd.2011.10.002; Kalsekar Iftekhar D, 2006, Manag Care Interface, V19, P39; Kreyenbuhl J, 2008, SCHIZOPHR RES, V101, P256, DOI 10.1016/j.schres.2008.02.004; Kreyenbuhl J, 2010, SCHIZOPHRENIA BULL, V36, P428, DOI 10.1093/schbul/sbn106; McGuire J, 2009, ADM POLICY MENT HLTH, V36, P255, DOI 10.1007/s10488-009-0210-6; Miller DR, 2004, DIABETES CARE, V27, pB10, DOI 10.2337/diacare.27.suppl_2.B10; Morland LA, 2010, J CLIN PSYCHIAT, V71, P855, DOI 10.4088/JCP.09m05604blu; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Pirraglia Paul A, 2012, Prev Chronic Dis, V9, pE51; Ruskin PE, 2004, AM J PSYCHIAT, V161, P1471, DOI 10.1176/appi.ajp.161.8.1471; Saxon AJ, 2006, MED CARE, V44, P334, DOI 10.1097/01.mlr.0000204052.95507.5c; West AN, 2010, J RURAL HEALTH, V26, P301, DOI 10.1111/j.1748-0361.2010.00298.x	26	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103804	10.1371/journal.pone.0103804	http://dx.doi.org/10.1371/journal.pone.0103804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4JL	25083903	Green Submitted, Green Published, gold			2022-12-25	WOS:000339819800081
J	Adriaanse, SM; Binnewijzend, MAA; Ossenkoppele, R; Tijms, BM; van der Flier, WM; Koene, T; Smits, LL; Wink, AM; Scheltens, P; van Berckel, BNM; Barkhof, F				Adriaanse, Sofie M.; Binnewijzend, Maja A. A.; Ossenkoppele, Rik; Tijms, Betty M.; van der Flier, Wiesje M.; Koene, Teddy; Smits, Lieke L.; Wink, Alle Meije; Scheltens, Philip; van Berckel, Bart N. M.; Barkhof, Frederik			Widespread Disruption of Functional Brain Organization in Early-Onset Alzheimer's Disease	PLOS ONE			English	Article							RESTING-STATE FMRI; CONNECTIVITY; NETWORK; PATTERNS; MEMORY; GREY	Early-onset Alzheimer's disease (AD) patients present a different clinical profile than late-onset AD patients. This can be partially explained by cortical atrophy, although brain organization might provide more insight. The aim of this study was to examine functional connectivity in early-onset and late-onset AD patients. Resting-state fMRI scans of 20 early-onset (<65 years old), 28 late-onset (>= 65 years old) AD patients and 15 "young'' (<65 years old) and 31 "old'' (>= 65 years old) age-matched controls were available. Resting-state network-masks were used to create subject-specific maps. Group differences were examined using a non-parametric permutation test, accounting for gray-matter. Performance on five cognitive domains were used in a correlation analysis with functional connectivity in AD patients. Functional connectivity was not different in any of the RSNs when comparing the two control groups (young vs. old controls), which implies that there is no general effect of aging on functional connectivity. Functional connectivity in early-onset AD was lower in all networks compared to age-matched controls, where late-onset AD showed lower functional connectivity in the default-mode network. Functional connectivity was lower in early-onset compared to late-onset AD in auditory-, sensory-motor, dorsal-visual systems and the default mode network. Across patients, an association of functional connectivity of the default mode network was found with visuoconstruction. Functional connectivity of the right dorsal visual system was associated with attention across patients. In late-onset AD patients alone, higher functional connectivity of the sensory-motor system was associated with poorer memory performance. Functional brain organization was more widely disrupted in early-onset AD when compared to late-onset AD. This could possibly explain different clinical profiles, although more research into the relationship of functional connectivity and cognitive performance is needed.	[Adriaanse, Sofie M.; Binnewijzend, Maja A. A.; Ossenkoppele, Rik; Tijms, Betty M.; Wink, Alle Meije; van Berckel, Bart N. M.; Barkhof, Frederik] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Binnewijzend, Maja A. A.; Tijms, Betty M.; van der Flier, Wiesje M.; Scheltens, Philip] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Alzheimerctr Amsterdam, Amsterdam, Netherlands; [van der Flier, Wiesje M.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Koene, Teddy; Smits, Lieke L.] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Amsterdam, Netherlands; [Adriaanse, Sofie M.; Binnewijzend, Maja A. A.; Ossenkoppele, Rik; Tijms, Betty M.; van der Flier, Wiesje M.; Smits, Lieke L.; Wink, Alle Meije; Scheltens, Philip; van Berckel, Bart N. M.; Barkhof, Frederik] Neurosci Campus Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam	Adriaanse, SM (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands.	s.adriaanse@vumc.nl	Ossenkoppele, Rik/J-5826-2013; Wink, Alle Meije/R-6403-2017; Tijms, Betty M./I-2218-2019; Barkhof, Frederik/AAJ-6226-2020; Scheltens, Philip/AAL-9631-2020	Wink, Alle Meije/0000-0002-8197-0118; Tijms, Betty M./0000-0002-2612-1797; Barkhof, Frederik/0000-0003-3543-3706; Scheltens, Philip/0000-0002-1046-6408; van der Flier, Wiesje/0000-0001-8766-6224; Ossenkoppele, Rik/0000-0003-1584-7477	Dutch Foundation for Brain Research (De Hersenstichting) [KS2011(1)-24]; Internationale Stichting Alzheimer Onderzoek (ISAO) [11539]; Alzheimer Nederland; Stichting VUmc fonds; Stichting Dioraphte	Dutch Foundation for Brain Research (De Hersenstichting); Internationale Stichting Alzheimer Onderzoek (ISAO); Alzheimer Nederland; Stichting VUmc fonds; Stichting Dioraphte	This work was supported by the Dutch Foundation for Brain Research (De Hersenstichting [grant number KS2011(1)-24]) and by the Internationale Stichting Alzheimer Onderzoek (ISAO) [grant number #11539]. The VUmc Alzheimer center is supported by Alzheimer Nederland and Stichting VUmc fonds. The clinical database structure was developed with funding from Stichting Dioraphte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2010, HUM BRAIN MAPP, V31, P515, DOI 10.1002/hbm.20883; Alzheimer's Disease International, LANCET, V366, P2112; Andersson J.L.R, 2007, TR07JA2 FMRIB; [Anonymous], NEURORADIOLOGY, V49, P967; Bear MF, 2007, NEUROSCIENCE EXPLORI; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Beckmann CF, 2009, OHBM 2011; Binnewijzend MAA, 2012, NEUROBIOL AGING, V33, P2018, DOI 10.1016/j.neurobiolaging.2011.07.003; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; de Waal H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.013; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Frisoni GB, 2007, BRAIN, V130, P720, DOI 10.1093/brain/awl377; Fujimori M, 1998, ALZ DIS ASSOC DIS, V12, P163, DOI 10.1097/00002093-199809000-00007; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gour N, 2014, HUM BRAIN MAPP, V35, P2978, DOI 10.1002/hbm.22379; Gour N, 2011, NEUROIMAGE, V58, P687, DOI 10.1016/j.neuroimage.2011.05.090; Hall DA, 2003, AUDIOL NEURO-OTOL, V8, P1, DOI 10.1159/000067894; Hodges JR, 2006, BRAIN, V129, P2811, DOI 10.1093/brain/awl275; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kalpouzos G, 2005, J NEUROL, V252, P548, DOI 10.1007/s00415-005-0685-3; Kim EJ, 2005, BRAIN, V128, P1790, DOI 10.1093/brain/awh539; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Koedam ELGE, 2010, J ALZHEIMERS DIS, V19, P1401, DOI 10.3233/JAD-2010-1337; Koss E, 1996, NEUROLOGY, V46, P136, DOI 10.1212/WNL.46.1.136; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Moller C, 2013, NEUROBIOL AGING, V34, P2014, DOI 10.1016/j.neurobiolaging.2013.02.013; Ossenkoppele R, 2012, BRAIN, V135, P2115, DOI 10.1093/brain/aws113; Rabinovici GD, 2010, BRAIN, V133, P512, DOI 10.1093/brain/awp326; Salmon E, 2008, NEUROPSYCHOLOGIA, V46, P1613, DOI 10.1016/j.neuropsychologia.2007.11.022; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Smits LL, 2012, J ALZHEIMERS DIS, V30, P101, DOI 10.3233/JAD-2012-111934; Verhage F., 1964, INTELLIGENCE AGE RES; WATSON RT, 1986, ARCH NEUROL-CHICAGO, V43, P787, DOI 10.1001/archneur.1986.00520080035016; Whitwell Jennifer L, 2005, Top Magn Reson Imaging, V16, P409, DOI 10.1097/01.rmr.0000245457.98029.e1; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	44	36	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102995	10.1371/journal.pone.0102995	http://dx.doi.org/10.1371/journal.pone.0102995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080229	gold, Green Submitted, Green Published			2022-12-25	WOS:000339954800021
J	Fukuda, K; Yatera, K; Ogawa, M; Kawanami, T; Yamasaki, K; Noguchi, S; Murphy, RS; Mukae, H; Taniguchi, H				Fukuda, Kazumasa; Yatera, Kazuhiro; Ogawa, Midori; Kawanami, Toshinori; Yamasaki, Kei; Noguchi, Shingo; Murphy, Robert S.; Mukae, Hiroshi; Taniguchi, Hatsumi			An Unclassified Microorganism: Novel Pathogen Candidate Lurking in Human Airways	PLOS ONE			English	Article							INTRACELLULAR GROWTH; GENOME SEQUENCE; IDENTIFICATION; MICROBIOME; DIVERSITY; ALIGNMENT; BACTERIA; LUNG	During the assessments of the correlation of the diseases and the microbiota of various clinical specimens, unique 16S ribosomal RNA (rRNA) gene sequences (less than 80% similarity to known bacterial type strains) were predominantly detected in a bronchoalveolar lavage fluid (BALF) specimen from a patient with chronic lower respiratory tract infection. The origin of this unique sequence is suspected to be the causative agent of the infection. We temporarily named the owner organism of this sequence "IOLA" (Infectious Organism Lurking in Airways). In order to evaluate the significance of IOLA in human lung disorders, we performed several experiments. IOLA-16S rRNA genes were detected in 6 of 386 clone libraries constructed from clinical specimens of patients with respiratory diseases (in our study series). The gene sequences (1,427 bp) are identical, and no significantly similar sequence was found in public databases (using NCBI blastn) except for the 8 shorter sequences detected from patients with respiratory diseases in other studies from 2 other countries. Phylogenetic analyses revealed that the 16S rRNA gene of IOLA is more closely related to eukaryotic mitochondria than bacteria. However, the size and shape of IOLA seen by fluorescent in-situ hybridization are similar to small bacteria (approximately 1 mm with a spherical shape). Furthermore, features of both bacteria and mitochondria were observed in the genomic fragment (about 19 kb) of IOLA, and the GC ratio of the sequence was extremely low (20.5%). Two main conclusions were reached: (1) IOLA is a novel bacteria-like microorganism that, interestingly, possesses features of eukaryotic mitochondria. (2) IOLA is a novel pathogen candidate, and it may be the causative agent of human lung or airway disease. IOLA exists in BALF specimens from patients with remarkable symptoms; this information is an important piece for helping solve the elusive etiology of chronic respiratory disorders.	[Fukuda, Kazumasa; Ogawa, Midori; Taniguchi, Hatsumi] Univ Occupat & Environm Hlth, Dept Microbiol, Kitakyushu, Fukuoka 807, Japan; [Yatera, Kazuhiro; Kawanami, Toshinori; Yamasaki, Kei; Noguchi, Shingo; Mukae, Hiroshi] Univ Occupat & Environm Hlth, Dept Resp Med, Kitakyushu, Fukuoka 807, Japan; [Murphy, Robert S.] Univ Kitakyushu, Ctr Fundamental Educ, Kitakyushu, Fukuoka, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Kitakyushu	Fukuda, K (corresponding author), Univ Occupat & Environm Hlth, Dept Microbiol, Kitakyushu, Fukuoka 807, Japan.	kfukuda@med.uoeh-u.ac.jp			University of Occupational and Environmental Health, Japan	University of Occupational and Environmental Health, Japan(University of Occupational & Environmental Health - Japan)	This work was supported by University of Occupational and Environmental Health, Japan. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Aoki R, 2013, OPHTHALMOLOGY, V120, P668, DOI 10.1016/j.ophtha.2012.10.001; Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Brindefalk B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024457; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Cardenas PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046803; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Dollive S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r60; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hotopp JCD, 2006, PLOS GENET, V2, P2176, DOI 10.1371/journal.pgen.0020213; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Kawanami T, 2011, CHEST, V139, P600, DOI 10.1378/chest.10-0460; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Kolesnikov AA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1424, DOI 10.1134/S0006297912130020; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lin MQ, 2009, NUCLEIC ACIDS RES, V37, P6076, DOI 10.1093/nar/gkp642; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lynch SV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009738; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Maruta K, 1998, AM J RESP CRIT CARE, V157, P1967, DOI 10.1164/ajrccm.157.6.9710108; Maughan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045791; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nakayama K, 2008, DNA RES, V15, P185, DOI 10.1093/dnares/dsn011; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Nomoto M, 2009, MICROBIOL IMMUNOL, V53, P550, DOI 10.1111/j.1348-0421.2009.00158.x; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Woo PCY, 2008, CLIN MICROBIOL INFEC, V14, P908, DOI 10.1111/j.1469-0691.2008.02070.x; Yamasaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063103; Yoshimura K, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.018; Yutin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036972	48	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103646	10.1371/journal.pone.0103646	http://dx.doi.org/10.1371/journal.pone.0103646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080337	gold, Green Published, Green Submitted			2022-12-25	WOS:000339954800062
J	Klein, DJ; Baym, M; Eckhoff, P				Klein, Daniel J.; Baym, Michael; Eckhoff, Philip			The Separatrix Algorithm for Synthesis and Analysis of Stochastic Simulations with Applications in Disease Modeling	PLOS ONE			English	Article							SENSITIVITY-ANALYSIS; GENETIC ALGORITHMS; MALARIA VACCINES; TRANSMISSION; OPTIMIZATION; STRATEGIES; REGRESSION; INFECTION; DESIGNS; POLIOMYELITIS	Decision makers in epidemiology and other disciplines are faced with the daunting challenge of designing interventions that will be successful with high probability and robust against a multitude of uncertainties. To facilitate the decision making process in the context of a goal-oriented objective (e.g., eradicate polio by 2018), stochastic models can be used to map the probability of achieving the goal as a function of parameters. Each run of a stochastic model can be viewed as a Bernoulli trial in which "success'' is returned if and only if the goal is achieved in simulation. However, each run can take a significant amount of time to complete, and many replicates are required to characterize each point in parameter space, so specialized algorithms are required to locate desirable interventions. To address this need, we present the Separatrix Algorithm, which strategically locates parameter combinations that are expected to achieve the goal with a user-specified probability of success (e.g. 95%). Technically, the algorithm iteratively combines density-corrected binary kernel regression with a novel information-gathering experiment design to produce results that are asymptotically correct and work well in practice. The Separatrix Algorithm is demonstrated on several test problems, and on a detailed individual-based simulation of malaria.	[Klein, Daniel J.; Baym, Michael; Eckhoff, Philip] Inst Dis Modeling, Bellevue, WA USA; [Baym, Michael] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Baym, Michael] MIT, Dept Math, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Klein, DJ (corresponding author), Inst Dis Modeling, Bellevue, WA USA.	dklein@intven.com		Baym, Michael/0000-0003-1303-5598	Bill and Melinda Gates through the Global Good Fund at Intellectual Ventures Laboratory	Bill and Melinda Gates through the Global Good Fund at Intellectual Ventures Laboratory	This work was supported by Bill and Melinda Gates through the Global Good Fund at Intellectual Ventures Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON IS, 1982, ANN STAT, V10, P1217, DOI 10.1214/aos/1176345986; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Ankenman B, 2008, 2008 WINTER SIMULATION CONFERENCE, VOLS 1-5, P362, DOI 10.1109/WSC.2008.4736089; Baesler FF, 2001, WSC'01: PROCEEDINGS OF THE 2001 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P1405, DOI 10.1109/WSC.2001.977463; Barton RR, 1998, 1998 WINTER SIMULATION CONFERENCE PROCEEDINGS, VOLS 1 AND 2, P167, DOI 10.1109/WSC.1998.744912; Barton RR, 2006, HBK OPERAT RES MANAG, V13, P535, DOI 10.1016/S0927-0507(06)13018-2; BERNARDO JM, 1979, ANN STAT, V7, P686, DOI 10.1214/aos/1176344689; BLANNING RW, 1975, SIMULATION, V24, P177, DOI 10.1177/003754977502400606; BOX GEP, 1951, J R STAT SOC B, V13, P1, DOI 10.1111/j.2517-6161.1951.tb00067.x; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Brown ST, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-353; Castiglione F, 2007, BIOINFORMATICS, V23, P3350, DOI 10.1093/bioinformatics/btm408; Chaloner K, 1995, STAT SCI, V10, P273, DOI 10.1214/ss/1177009939; Chick SE, 2002, PROCEEDINGS OF THE 2002 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P400, DOI 10.1109/WSC.2002.1172910; Chick SE, 2006, PROCEEDINGS OF THE 2006 WINTER SIMULATION CONFERENCE, VOLS 1-5, P96, DOI 10.1109/WSC.2006.323042; DeGroot M. H., 1970, OPTIMAL STAT DECISIO; DONOHUE JM, 1994, 1994 WINTER SIMULATION CONFERENCE PROCEEDINGS, P200; Eckhoff P, 2013, AM J TROP MED HYG, V88, P817, DOI 10.4269/ajtmh.12-0007; Eckhoff PA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-303; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Fang HB, 2006, ENG OPTIMIZ, V38, P407, DOI 10.1080/03052150500422294; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; HALL P, 1991, J AM STAT ASSOC, V86, P665; Hall P, 2001, ANN STAT, V29, P624; Hazelton ML, 2007, COMPUT STAT DATA AN, V51, P4393, DOI 10.1016/j.csda.2006.06.012; Helton JC, 2003, RELIAB ENG SYST SAFE, V81, P23, DOI 10.1016/S0951-8320(03)00058-9; HENDERSON RH, 1989, ANN NY ACAD SCI, V569, P69, DOI 10.1111/j.1749-6632.1989.tb27359.x; Jin RC, 2005, J STAT PLAN INFER, V134, P268, DOI 10.1016/j.jspi.2004.02.014; Jourdan A, 2010, ASTA-ADV STAT ANAL, V94, P341, DOI 10.1007/s10182-010-0145-y; Khuri AI, 2010, WIRES COMPUT STAT, V2, P128, DOI 10.1002/wics.73; Kleijnen JPC, 2009, EUR J OPER RES, V192, P707, DOI 10.1016/j.ejor.2007.10.013; Kleijnen JPC, 2004, J OPER RES SOC, V55, P876, DOI 10.1057/palgrave.jors.2601747; Kleijnen JPC, 2005, EUR J OPER RES, V164, P287, DOI 10.1016/j.ejor.2004.02.005; LINDLEY DV, 1956, ANN MATH STAT, V27, P986, DOI 10.1214/aoms/1177728069; Lollini PL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-352; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; MATLAB, 2012, MATLAB VERS 8 1 R201; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; McKenzie FE, 2002, AM J TROP MED HYG, V67, P571, DOI 10.4269/ajtmh.2002.67.571; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Pappalardo F, 2006, LECT NOTES ARTIF INT, V3849, P223; Patel R, 2005, J THEOR BIOL, V234, P201, DOI 10.1016/j.jtbi.2004.11.032; SABIN AB, 1960, JAMA-J AM MED ASSOC, V173, P1521, DOI 10.1001/jama.1960.03020320001001; Sabuncuoglu I, 2002, INT J PROD RES, V40, P2483, DOI 10.1080/00207540210135596; Sacks J., 1989, STAT SCIREV J I MATH, V4, P409, DOI [10.1214/ss/1177012413, DOI 10.1214/SS/1177012413]; SALK JE, 1955, JAMA-J AM MED ASSOC, V158, P1239, DOI 10.1001/jama.1955.02960140001001; SAUL AJ, 1990, J APPL ECOL, V27, P123, DOI 10.2307/2403572; Scott DW, 2005, HANDB STAT, V24, P229, DOI 10.1016/S0169-7161(04)24009-3; SMITH AFM, 1980, BIOMETRIKA, V67, P613, DOI 10.1093/biomet/67.3.613; Smith T, 2008, PARASITOLOGY, V135, P1507, DOI 10.1017/S0031182008000371; Smith T, 2006, AM J TROP MED HYG, V75, P1; Stover J, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010157; Stover J, 2011, CURR OPIN HIV AIDS, V6, P108, DOI 10.1097/COH.0b013e328343ac05; Tekin E, 2004, IIE TRANS, V36, P1067, DOI 10.1080/07408170490500654; Thompson KM, 2008, SYST DYNAM REV, V24, P433, DOI 10.1002/sdr.419; Van Beers W. C., 2004, SIM C 2004 P 2004 WI, V1; Wahba G., 1990, SPLINE MODELS OBSERV, V59; Wenger EA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-126	61	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103467	10.1371/journal.pone.0103467	http://dx.doi.org/10.1371/journal.pone.0103467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078087	Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800047
J	Pandey, R; Lucent, D; Kumari, K; Sharma, P; Lal, R; Oakeshott, JG; Pandey, G				Pandey, Rinku; Lucent, Del; Kumari, Kirti; Sharma, Pooja; Lal, Rup; Oakeshott, John G.; Pandey, Gunjan			Kinetic and Sequence-Structure-Function Analysis of LinB Enzyme Variants with beta- and delta-Hexachlorocyclohexane	PLOS ONE			English	Article							SPHINGOMONAS-PAUCIMOBILIS UT26; HALOALKANE DEHALOGENASE LINB; SITE-DIRECTED MUTAGENESIS; GAMMA-HEXACHLOROCYCLOHEXANE; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; DEGRADATION; SUBSTRATE; BACTERIUM; RESIDUES	Organochlorine insecticide hexachlorocyclohexane (HCH) has recently been classified as a 'Persistent Organic pollutant' by the Stockholm Convention. The LinB haloalkane dehalogenase is a key upstream enzyme in the recently evolved Lin pathway for the catabolism of HCH in bacteria. Here we report a sequence-structure-function analysis of ten naturally occurring and thirteen synthetic mutants of LinB. One of the synthetic mutants was found to have similar to 80 fold more activity for beta- and delta-hexachlorocyclohexane. Based on detailed biophysical calculations, molecular dynamics and ensemble docking calculations, we propose that the latter variant is more active because of alterations to the shape of its active site and increased conformational plasticity.	[Pandey, Rinku; Kumari, Kirti; Sharma, Pooja; Oakeshott, John G.; Pandey, Gunjan] CSIRO Ecosyst Sci, Acton, ACT, Australia; [Lucent, Del] CSIRO, Ctr Mat Sci & Engn, Parkville, Vic, Australia; [Lucent, Del] Wilkes Univ, Div Phys & Engn, Wilkes Barre, PA 18766 USA; [Kumari, Kirti; Sharma, Pooja; Lal, Rup] Univ Delhi, Dept Zool, Delhi 110007, India	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Wilkes University; University of Delhi	Pandey, G (corresponding author), CSIRO Ecosyst Sci, Acton, ACT, Australia.	gunjan.pandey@csiro.au	Lal, Rup/AFP-1009-2022; Oakeshott, John G/B-5365-2009; Pandey, Gunjan/B-8133-2009; Pandey, Gunjan/I-6993-2019	Oakeshott, John G/0000-0001-8324-7874; Pandey, Gunjan/0000-0002-3514-4624; 	Indian Australian Strategic Research Fund; Commonwealth Scientific and Industrial Research Organisation's Office of the Chief Executive Postdoctoral Fellowship scheme; Council of Scientific and Industrial Research-University Grants Commission, Government of India	Indian Australian Strategic Research Fund; Commonwealth Scientific and Industrial Research Organisation's Office of the Chief Executive Postdoctoral Fellowship scheme; Council of Scientific and Industrial Research-University Grants Commission, Government of India(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India)	Part of the work was supported by the Indian Australian Strategic Research Fund and Commonwealth Scientific and Industrial Research Organisation's Office of the Chief Executive Postdoctoral Fellowship scheme. KK and PS acknowledge Council of Scientific and Industrial Research-University Grants Commission, Government of India, for providing their research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohac M, 2002, BIOCHEMISTRY-US, V41, P14272, DOI 10.1021/bi026427v; Brittain DRB, 2011, CHEM COMMUN, V47, P976, DOI 10.1039/c0cc02925d; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Damborsky J, 1999, PROTEIN ENG, V12, P989, DOI 10.1093/protein/12.11.989; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynkova K, 1999, FEBS LETT, V446, P177, DOI 10.1016/S0014-5793(99)00199-4; Ito M, 2007, ARCH MICROBIOL, V188, P313, DOI 10.1007/s00203-007-0251-8; Jit S, 2011, ENVIRON SCI POLLUT R, V18, P586, DOI 10.1007/s11356-010-0401-4; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lal R, 2006, TRENDS BIOTECHNOL, V24, P121, DOI 10.1016/j.tibtech.2006.01.005; Lal R, 2010, MICROBIOL MOL BIOL R, V74, P58, DOI 10.1128/MMBR.00029-09; Lemmon G, 2012, METHODS MOL BIOL, V819, P143, DOI 10.1007/978-1-61779-465-0_10; Marek J, 2000, BIOCHEMISTRY-US, V39, P14082, DOI 10.1021/bi001539c; Nagata Y, 1997, APPL ENVIRON MICROB, V63, P3707, DOI 10.1128/AEM.63.9.3707-3710.1997; Nagata Y, 2007, APPL MICROBIOL BIOT, V76, P741, DOI 10.1007/s00253-007-1066-x; Oakley AJ, 2004, BIOCHEMISTRY-US, V43, P870, DOI 10.1021/bi034748g; Okai M, 2013, J BACTERIOL, V195, P2642, DOI 10.1128/JB.02020-12; Pavlova M, 2009, NAT CHEM BIOL, V5, P727, DOI 10.1038/nchembio.205; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sharma P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025128; Vijgen J, 2011, ENVIRON SCI POLLUT R, V18, P152, DOI 10.1007/s11356-010-0417-9; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weber R, 2008, ENVIRON SCI POLLUT R, V15, P363, DOI 10.1007/s11356-008-0024-1	28	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103632	10.1371/journal.pone.0103632	http://dx.doi.org/10.1371/journal.pone.0103632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076214	Green Published, Green Submitted, gold			2022-12-25	WOS:000340028800069
J	Abreu, PMV; Gaspar, CG; Buss, DS; Ventura, JA; Ferreira, PCG; Fernandes, PMB				Abreu, Paolla M. V.; Gaspar, Clicia G.; Buss, David S.; Ventura, Jose A.; Ferreira, Paulo C. G.; Fernandes, Patricia M. B.			Carica papaya MicroRNAs Are Responsive to Papaya meleira virus Infection	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; PLANT MICRORNAS; ARABIDOPSIS ARGONAUTE1; PROTEASOME SYSTEM; IDENTIFICATION; UBIQUITIN; DICER-LIKE1; BIOGENESIS; SUPPRESSOR; SEQUENCES	MicroRNAs are implicated in the response to biotic stresses. Papaya meleira virus (PMeV) is the causal agent of sticky disease, a commercially important pathology in papaya for which there are currently no resistant varieties. PMeV has a number of unusual features, such as residence in the laticifers of infected plants, and the response of the papaya to PMeV infection is not well understood. The protein levels of 20S proteasome subunits increase during PMeV infection, suggesting that proteolysis could be an important aspect of the plant defense response mechanism. To date, 10,598 plant microRNAs have been identified in the Plant miRNAs Database, but only two, miR162 and miR403, are from papaya. In this study, known plant microRNA sequences were used to search for potential microRNAs in the papaya genome. A total of 462 microRNAs, representing 72 microRNA families, were identified. The expression of 11 microRNAs, whose targets are involved in 20S and 26S proteasomal degradation and in other stress response pathways, was compared by real-time PCR in healthy and infected papaya leaf tissue. We found that the expression of miRNAs involved in proteasomal degradation increased in response to very low levels of PMeV titre and decreased as the viral titre increased. In contrast, miRNAs implicated in the plant response to biotic stress decreased their expression at very low level of PMeV and increased at high PMeV levels. Corroborating with this results, analysed target genes for this miRNAs had their expression modulated in a dependent manner. This study represents a comprehensive identification of conserved miRNAs inpapaya. The data presented here might help to complement the available molecular and genomic tools for the study of papaya. The differential expression of some miRNAs and identifying their target genes will be helpful for understanding the regulation and interaction of PMeV and papaya.	[Abreu, Paolla M. V.; Buss, David S.; Ventura, Jose A.; Fernandes, Patricia M. B.] Univ Fed Espirito Santo, Vitoria, Espirito Santo, Spain; [Gaspar, Clicia G.; Ferreira, Paulo C. G.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, Brazil; [Ventura, Jose A.] Inst Capixaba Pesquisa Assistencia Tecn & Extensa, Vitoria, Espirito Santo, Spain	Universidade Federal do Rio de Janeiro	Fernandes, PMB (corresponding author), Univ Fed Espirito Santo, Vitoria, Espirito Santo, Spain.	patricia.fernandes@ufes.br	Ferreira, Paulo C G/I-2836-2015; Fernandes, Patricia M B/AAL-5991-2021	Ferreira, Paulo C G/0000-0002-5510-999X; Fernandes, Patricia M B/0000-0003-2695-3638	FINEP (Financiadora de Estudos e Projetos); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAPES (Fundacao de Amparo a Pesquisa do Estado do Espirito Santo)	FINEP (Financiadora de Estudos e Projetos)(Financiadora de Inovacao e Pesquisa (Finep)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPES (Fundacao de Amparo a Pesquisa do Estado do Espirito Santo)	This work was supported by grants from FINEP (Financiadora de Estudos e Projetos), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and FAPES (Fundacao de Amparo a Pesquisa do Estado do Espirito Santo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu PMV, 2012, J VIROL METHODS, V180, P11, DOI 10.1016/j.jviromet.2011.12.003; Alcaide-Loridan C, 2012, PLANT PHYSIOL, V160, P72, DOI 10.1104/pp.112.201905; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; [Anonymous], 2013, J INTEGR AGR, DOI [DOI 10.1016/S2095-3119(13)60311-1, DOI 10.1007/s00425-009-0889-3]; Aryal R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-682; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; BECKER F, 1993, PLANT J, V3, P875, DOI 10.1111/j.1365-313X.1993.00875.x; Camborde L, 2010, PLANT CELL, V22, P3142, DOI 10.1105/tpc.109.072090; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Chenon M, 2012, EMBO J, V31, P741, DOI 10.1038/emboj.2011.424; Citovsky V, 2009, SEMIN CELL DEV BIOL, V20, P1048, DOI 10.1016/j.semcdb.2009.05.012; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dielen AS, 2010, MOL PLANT PATHOL, V11, P293, DOI 10.1111/j.1364-3703.2009.00596.x; El Moussaoui A, 2001, CELL MOL LIFE SCI, V58, P556, DOI 10.1007/PL00000881; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Gleave AP, 2008, TREE GENET GENOMES, V4, P343, DOI 10.1007/s11295-007-0113-1; Guo Q, 2007, CHINESE SCI BULL, V52, P2380, DOI 10.1007/s11434-007-0359-x; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Jagadeeswaran G, 2009, NEW PHYTOL, V184, P85, DOI 10.1111/j.1469-8137.2009.02915.x; Jin HL, 2006, PLANT PHYSIOL, V142, P651, DOI 10.1104/pp.106.083519; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jover-Gil S, 2005, INT J DEV BIOL, V49, P733, DOI 10.1387/ijdb.052015sj; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Kitajima E. W., 1993, Fitopatologia Brasileira, V18, P118; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Lang QL, 2011, MOL BIOL REP, V38, P1523, DOI 10.1007/s11033-010-0260-6; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Liang G, 2013, PLANTA, V238, P739, DOI 10.1007/s00425-013-1929-6; Lu YZ, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/128297; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Marino D, 2012, PLANT PHYSIOL, V160, P15, DOI 10.1104/pp.112.199281; Moissiard G, 2004, MOL PLANT PATHOL, V5, P71, DOI 10.1111/j.1364-3703.2004.00207.x; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rodrigues SP, 2012, J PROTEOMICS, V75, P3191, DOI 10.1016/j.jprot.2012.03.021; Rodrigues SP, 2011, PROTEOMICS, V11, P2592, DOI 10.1002/pmic.201000757; Rodrigues SP, 2009, PLANT CELL REP, V28, P861, DOI 10.1007/s00299-009-0673-7; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Simon-Mateo C, 2006, J VIROL, V80, P2429, DOI 10.1128/JVI.80.5.2429-2436.2006; Szczesniak MW, 2012, NUCLEIC ACIDS RES, V40, pD198, DOI 10.1093/nar/gkr1159; Tagami Y, 2007, DNA RES, V14, P227, DOI 10.1093/dnares/dsm022; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Ventura J. A., 2004, DIS FRUITS VEGETABLE, VII, P201; Wang MB, 2012, MOL PLANT MICROBE IN, V25, P1275, DOI 10.1094/MPMI-04-12-0093-CR; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zhu X, 2012, PLOS ONE, V7; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	63	22	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103401	10.1371/journal.pone.0103401	http://dx.doi.org/10.1371/journal.pone.0103401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072834	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600045
J	Rasakham, K; Schmidt, HD; Kay, K; Huizenga, MN; Calcagno, N; Pierce, RC; Spires-Jones, TL; Sadri-Vakili, G				Rasakham, Khampaseuth; Schmidt, Heath D.; Kay, Kevin; Huizenga, Megan N.; Calcagno, Narghes; Pierce, R. Christopher; Spires-Jones, Tara L.; Sadri-Vakili, Ghazaleh			Synapse Density and Dendritic Complexity Are Reduced in the Prefrontal Cortex following Seven Days of Forced Abstinence from Cocaine Self-Administration	PLOS ONE			English	Article							INDUCED STRUCTURAL PLASTICITY; DRUG-SEEKING BEHAVIOR; NUCLEUS-ACCUMBENS; INDUCED REINSTATEMENT; ORBITOFRONTAL CORTEX; FRONTAL-CORTEX; ALTERS; SPINES; NEURONS; SENSITIZATION	Chronic cocaine exposure in both human addicts and in rodent models of addiction reduces prefrontal cortical activity, which subsequently dysregulates reward processing and higher order executive function. The net effect of this impaired gating of behavior is enhanced vulnerability to relapse. Previously we have shown that cocaine-induced increases in brain-derived neurotrophic factor (BDNF) expression in the medial prefrontal cortex (PFC) is a neuroadaptive mechanism that blunts the reinforcing efficacy of cocaine. As BDNF is known to affect neuronal survival and synaptic plasticity, we tested the hypothesis that abstinence from cocaine self-administration would lead to alterations in neuronal morphology and synaptic density in the PFC. Using a novel technique, array tomography and Golgi staining, morphological changes in the rat PFC were analyzed following 14 days of cocaine self-administration and 7 days of forced abstinence. Our results indicate that overall dendritic branching and total synaptic density are significantly reduced in the rat PFC. In contrast, the density of thin dendritic spines are significantly increased on layer V pyramidal neurons of the PFC. These findings indicate that dynamic structural changes occur during cocaine abstinence that may contribute to the observed hypo-activity of the PFC in cocaine-addicted individuals.	[Rasakham, Khampaseuth; Kay, Kevin; Huizenga, Megan N.; Calcagno, Narghes; Spires-Jones, Tara L.; Sadri-Vakili, Ghazaleh] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Boston, MA 02114 USA; [Schmidt, Heath D.; Pierce, R. Christopher] Univ Penn, Ctr Neurobiol & Behav, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA	Harvard University; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine	Sadri-Vakili, G (corresponding author), Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Boston, MA 02114 USA.	gsadrivakili@partners.org	Spires-Jones, Tara/AAR-7697-2020	Spires-Jones, Tara/0000-0003-2530-0598; Thapa, Khampaseuth/0000-0001-6395-2891; Calcagno, Narghes/0000-0003-0615-891X	NIDA [DA22339, DA033641, DA18678];  [DA030445]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022339, R01DA033641, K01DA030445, K02DA018678] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIDA grants DA22339 and DA033641 (R. C. P. & G. S. V.) and DA18678 (R. C. P.). H. D. S. was supported by an individual K01 award (DA030445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Chen YI, 2011, EUR J NEUROSCI, V34, P800, DOI 10.1111/j.1460-9568.2011.07806.x; Dietz DM, 2009, PHARMACOPSYCHIATRY, V42, pS69, DOI 10.1055/s-0029-1202847; Dumitriu D, 2012, J NEUROSCI, V32, P6957, DOI 10.1523/JNEUROSCI.5718-11.2012; GABBOTT PL, 1984, J NEUROSCI METH, V11, P221, DOI 10.1016/0165-0270(84)90084-0; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; IZZO PN, 1987, NEUROSCIENCE, V20, P577, DOI 10.1016/0306-4522(87)90111-4; Jayaram P, 2005, EUR J NEUROSCI, V21, P2035, DOI 10.1111/j.1460-9568.2005.04000.x; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Lu HB, 2012, NEUROIMAGE, V62, P1857, DOI 10.1016/j.neuroimage.2012.05.076; Madayag A, 2007, J NEUROSCI, V27, P13968, DOI 10.1523/JNEUROSCI.2808-07.2007; McFarland K, 2003, J NEUROSCI, V23, P3531; McFarland K, 2001, J NEUROSCI, V21, P8655; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Miguens M, 2008, PSYCHOPHARMACOLOGY, V196, P303, DOI 10.1007/s00213-007-0958-x; Munoz-Cuevas FJ, 2013, NAT NEUROSCI, V16, P1367, DOI 10.1038/nn.3498; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; Pierce RC, 1998, NEUROSCIENCE, V82, P1103; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Robinson TE, 2001, SYNAPSE, V39, P257; Sadri-Vakili G, 2010, J NEUROSCI, V30, P11735, DOI 10.1523/JNEUROSCI.2328-10.2010; Sarti F, 2007, EUR J NEUROSCI, V26, P749, DOI 10.1111/j.1460-9568.2007.05689.x; Spires TL, 2004, EUR J NEUROSCI, V19, P2799, DOI 10.1111/j.0953-816X.2004.03374.x; Sun WL, 2006, J NEUROSCI, V26, P8004, DOI 10.1523/JNEUROSCI.1413-06.2006; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Trantham H, 2002, NEUROSCIENCE, V113, P749, DOI 10.1016/S0306-4522(02)00246-4; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; VOLKOW ND, 1988, BRIT J PSYCHIAT, V152, P641, DOI 10.1192/bjp.152.5.641; Winstanley CA, 2009, PHARMACOL BIOCHEM BE, V93, P278, DOI 10.1016/j.pbb.2008.12.007	36	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e102524	10.1371/journal.pone.0102524	http://dx.doi.org/10.1371/journal.pone.0102524			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072653	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600013
J	Bittencourt-Silva, GB; Silva, HR				Bittencourt-Silva, Gabriela B.; Silva, Helio R.			Effects of Fragmentation and Sea-Level Changes upon Frog Communities of Land-Bridge Islands off the Southeastern Coast of Brazil	PLOS ONE			English	Article							RIO-DE-JANEIRO; NESTED SUBSET PATTERNS; SPECIES RICHNESS; REPRODUCTIVE MODES; ATLANTIC FOREST; AMPHIBIA ANURA; DIVERSITY; AREA; EXTINCTION; SYSTEMS	We investigate the composition of anuran communities of land-bridge islands off the southeastern coast of Brazil. These islands provide natural long-term experiments on the effects of fragmentation in the Brazilian Atlantic Forest (BAF). We hypothesize that Pleistocene sea-level changes, in combination with other abiotic variables such as area and habitat diversity, has affected anuran species richness and community composition on these islands. Data from the literature and collections databases were used to produce species lists for eight land-bridge islands and for the mainland adjacent to the islands. We assess the effects of area, number of breeding habitats and distance to the mainland upon anuran species richness on land-bridge islands. Additionally we use nestedness analysis to quantify the extent to which the species on smaller and less habitat-diverse islands correspond to subsets of those on larger and more diverse ones. We found that area has both direct and indirect effects on anuran species richness on land-bridge islands, irrespective of distance to the mainland. However, on islands with comparable sizes, differences in species richness can be attributed to the number and quality of breeding habitats. Anuran communities on these islands display a nested pattern, possibly caused by selective extinction related to habitat loss. Common lowland pond-breeders were conspicuous by their absence. In the BAF, the conservation of fragments with a high diversity of breeding habitats could compensate for the generally negative effect of small area upon species richness. We suggest that sea-level changes have an important role in shaping composition of anuran species on coastal communities.	[Bittencourt-Silva, Gabriela B.; Silva, Helio R.] Univ Fed Rio de Janeiro, Dept Anim Biol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Bittencourt-Silva, GB (corresponding author), Univ Fed Rio de Janeiro, Dept Anim Biol, Rio De Janeiro, Brazil.	gabrielabitt.ufrrj@gmail.com		Bittencourt-Silva, Gabriela/0000-0002-7391-8408	CNPq research fellowship [474703/2010-6]	CNPq research fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding for this work was provided by a CNPq research fellowship (process no 474703/2010-6) to HRS. (http://efomento.cnpq.br/efomento/divulgacao/divulgacaoResultados.do?metodo=propostas&codigoLinhaFomento=366&seqChamada=2&idComite=ZO&codigoPeriodoSubmissao=1112&hf=1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'Saber A.N, 1977, GEOMORFOLOGIA, V52, P1, DOI DOI 10.3897/ZOOKEYS.150.2109; ABBOTT I, 1974, Emu, V74, P124; Almeida-Gomes M, 2014, CONSERV BIOL, V28, P616, DOI 10.1111/cobi.12196; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Alves-Silva R, 2009, J NAT HIST, V43, P205, DOI 10.1080/00222930802568808; Angulo RJ, 2006, QUATERNARY SCI REV, V25, P486, DOI 10.1016/j.quascirev.2005.03.008; [Anonymous], 2012, MAN TECN VEG BRAS; Bertoluci J, 2002, AMPHIBIA-REPTILIA, V23, P161, DOI 10.1163/156853802760061804; Bittencourt-Silva Gabriela Bueno, 2013, Check List, V9, P225; Blondel J., 1985, P477; Brasileiro CA, 2007, J HERPETOL, V41, P271, DOI 10.1670/0022-1511(2007)41[271:ANISOS]2.0.CO;2; Brasileiro CA, 2007, ZOOTAXA, P47, DOI 10.11646/zootaxa.1391.3; BROWN WALTER C., 1952, BULL MUS COMP ZOOL HARVARD UNIV, V107, P1; Brown WC, 1969, P CALIF ACAD SCI, V38, P105; Carvalho-e-Silva Ana Maria Telles de, 2008, Biota Neotrop., V8, P199, DOI 10.1590/S1676-06032008000100021; CEPAGRI, 2008, CTR PESQ MET CLIM AP; Cicchi Paulo José Pyles, 2007, Biota Neotrop., V7, P0, DOI 10.1590/S1676-06032007000200026; Cicchi Paulo José Pyles, 2009, Biota Neotrop., V9, P201, DOI 10.1590/S1676-06032009000200019; Clemente-Carvalho RBG, 2011, MOL PHYLOGENET EVOL, V61, P79, DOI 10.1016/j.ympev.2011.05.017; CONDE MMS, 2005, HIST NATURAL MARAMBA, P133; Conti LA, 2010, REV BRASILEIRA GEOMO, V10, P45; CUTLER A, 1991, CONSERV BIOL, V5, P496, DOI 10.1111/j.1523-1739.1991.tb00357.x; da Silva HR, 2011, BIOTROPICA, V43, P218, DOI 10.1111/j.1744-7429.2010.00656.x; Darlington P.J., 1957, ZOOGEOGRAPHY GEOGRAP; Dias GTM, 2009, LECT NOTES EARTH SCI, V107, P225; Foufopoulos J, 1999, AM NAT, V153, P1, DOI 10.1086/303149; Frost DR, 2013, AMPHIBIAN SPECIES WO; Fundacao SOS Mata INPE, 2011, ATL REM FLOR MAT ATL, P1; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; Haddad CFB, 1998, J HERPETOL, V32, P557, DOI 10.2307/1565210; HADDAD CFB, 1990, J HERPETOL, V24, P225, DOI 10.2307/1564239; Haddad CFB, 2000, BIOTROPICA, V32, P862; HEYER W R, 1990, Arquivos de Zoologia (Sao Paulo), V31, P231; Izecksohn E, 2001, ANFIBIOS MUNICIPIO R; Izecksohn E, 2008, REV BRAS ZOOL, V25, P100, DOI 10.1590/S0101-81752008000100014; KOHN DD, 1994, J ECOL, V82, P367, DOI 10.2307/2261304; LOMOLINO MV, 1994, J MAMMAL, V75, P39, DOI 10.2307/1382234; MAC ARTHUR ROBERT H., 1967; MATTOS CCL, 2005, HIST NATURAL MARAMBA, P55; Mello CEHV, 1987, APONTAMENTOS SERVIR; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nobrega LDA, 2004, REV U RURAL SER CIEN, V26, P115; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; PATTERSON BD, 1990, OIKOS, V59, P330, DOI 10.2307/3545143; R Core Team, 2012, R LANG ENV STAT COMP; Ricklefs RE, 1999, J ANIM ECOL, V68, P1142, DOI 10.1046/j.1365-2656.1999.00358.x; Rocha CFD, 2008, BRAZ J BIOL, V68, P101, DOI 10.1590/S1519-69842008000100014; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; Roncarati H., 2005, HIST NATURAL MARAMBA, P15; Salgado C, 2009, CLIMA AMBIENTE ILHA, P7; Shnberloff D.S., 1974, Annual Rev Ecol Syst, V5, P161; Silva-Soares T, 2010, BIOTA NEOTROP, V10, P225, DOI [10.1590/S1676-06032010000200025, 10.1590/S1676-06032010000300028]; SIMBERLOFF D, 1976, ECOLOGY, V57, P629, DOI 10.2307/1936179; Stocker T.F., 2013, CLIMATE CHANGE 2013, P1535; Suguio K, 1978, SPECIAL PUBLICATION, V1, P57; Triantis KA, 2003, J BIOGEOGR, V30, P19, DOI 10.1046/j.1365-2699.2003.00805.x; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Venables W.N., 2002, MODERN APPL STAT S P, Vfourth, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2_10]; Vences M, 2003, P ROY SOC B-BIOL SCI, V270, P2435, DOI 10.1098/rspb.2003.2516; Watson DM, 2002, J BIOGEOGR, V29, P823, DOI 10.1046/j.1365-2699.2002.00726.x; WEYGOLDT P, 1989, Amphibia-Reptilia, V10, P419, DOI 10.1163/156853889X00052; Williams C. B., 1964, PATTERNS BALANCE NAT; Wright DH, 1998, OECOLOGIA, V113, P1, DOI 10.1007/s004420050348; WRIGHT DH, 1992, OECOLOGIA, V92, P416, DOI 10.1007/BF00317469; WRIGHT S, 1960, BIOMETRICS, V16, P189, DOI 10.2307/2527551; Wynn A, 2001, TROP ZOOL, V14, P255, DOI 10.1080/03946975.2001.10531157; Yiming L, 1998, OECOLOGIA, V113, P557, DOI 10.1007/s004420050409; ZIMMERMAN BL, 1986, J BIOGEOGR, V13, P133, DOI 10.2307/2844988	69	7	7	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103522	10.1371/journal.pone.0103522	http://dx.doi.org/10.1371/journal.pone.0103522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068643	Green Submitted, gold, Green Published			2022-12-25	WOS:000339993700078
J	Fukuoka, M; Yoshida, M; Eda, A; Takahashi, M; Hohjoh, H				Fukuoka, Masashi; Yoshida, Mariko; Eda, Akiko; Takahashi, Masaki; Hohjoh, Hirohiko			Gene Silencing Mediated by Endogenous MicroRNAs under Heat Stress Conditions in Mammalian Cells	PLOS ONE			English	Article							SHOCK RESPONSE; ARGONAUTE 2; HSP90; PHOSPHORYLATION; EXPRESSION; ACTIVATION; MIRNA; MECHANISMS; REPRESSION; HSF1	Heat shock, sudden change in temperature, triggers various responses in cells for protecting the cells from such a severe circumstance. Here we investigated gene silencing mediated by endogenous microRNAs (miRNAs) in mammalian cells exposed to a mild hyperthermia, by means of miRNA activity assay using a luciferase reporter gene as well as miRNA expression analysis using a DNA microarray. Our findings indicated that the gene silencing activities involving miRNAs were enhanced without increasing in their expression levels under heat-stress conditions. Additionally, the gene silencing activity appeared to be independent of the cytoprotective action involving heat shock proteins that are immediately activated in heat-shocked cells and that function as molecular chaperons for restoring heat-denatured proteins to normal proteins. Our current findings suggested the possibility that gene silencing involving endogenous miRNAs might play a subsidiary role in heat-shocked cells for an aggressive inhibition of the expression of heat-denatured proteins.	[Fukuoka, Masashi; Yoshida, Mariko; Eda, Akiko; Takahashi, Masaki; Hohjoh, Hirohiko] Natl Inst Neurosci, NCNP, Dept Mol Pharmacol, Kodaira, Tokyo 187, Japan	National Center for Neurology & Psychiatry - Japan	Hohjoh, H (corresponding author), Natl Inst Neurosci, NCNP, Dept Mol Pharmacol, Kodaira, Tokyo 187, Japan.	hohjohh@ncnp.go.jp		Takahashi, Masaki/0000-0003-1190-2213	Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by research grants from the Ministry of Health, Labour and Welfare of Japan and by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bang OS, 2000, BIOCHEM BIOPH RES CO, V278, P306, DOI 10.1006/bbrc.2000.3805; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Eda A, 2011, GENE, V485, P46, DOI 10.1016/j.gene.2011.05.034; Eda A, 2009, BIOCHEM BIOPH RES CO, V388, P648, DOI 10.1016/j.bbrc.2009.08.040; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gorospe M, 2011, TRENDS GENET, V27, P233, DOI 10.1016/j.tig.2011.03.005; Hancock Michael K, 2009, Curr Chem Genomics, V3, P1, DOI 10.2174/1875397300903010001; HE L, 2004, NAT REV GENET, V5, P522; Hibio N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00996; HICKEY E, 1989, MOL CELL BIOL, V9, P2615, DOI 10.1128/MCB.9.6.2615; Hohjoh H, 2004, FEBS LETT, V557, P193, DOI 10.1016/S0014-5793(03)01492-3; Hohjoh H, 2007, BIOCHEM BIOPH RES CO, V362, P360, DOI 10.1016/j.bbrc.2007.07.189; Hohjoh H, 2007, GENE, V391, P39, DOI 10.1016/j.gene.2006.11.018; Hong DS, 2013, CANCER TREAT REV, V39, P375, DOI 10.1016/j.ctrv.2012.10.001; Horman SR, 2013, MOL CELL, V50, P356, DOI 10.1016/j.molcel.2013.03.015; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Johnston M, 2010, MOL BIOL CELL, V21, P1462, DOI 10.1091/mbc.E09-10-0885; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Madlener S, 2009, HUM MOL GENET, V18, P1990, DOI 10.1093/hmg/ddp123; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Ohnishi Y, 2010, NUCLEIC ACIDS RES, V38, P5141, DOI 10.1093/nar/gkq229; Oshlag JZ, 2013, INT J HYPERTHER, V29, P51, DOI 10.3109/02656736.2012.753471; Pare JM, 2009, MOL BIOL CELL, V20, P3273, DOI 10.1091/mbc.E09-01-0082; Park HG, 2005, CELL MOL LIFE SCI, V62, P10, DOI 10.1007/s00018-004-4208-7; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Shaw M, 1998, BIOCHEM J, V336, P241, DOI 10.1042/bj3360241; Shen J, 2013, NATURE, V497, P383, DOI 10.1038/nature12080; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Suzuki Y, 2009, J BIOL CHEM, V284, P35597, DOI 10.1074/jbc.M109.036285; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Takahashi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048974; Tamura Y, 2009, MOL BIOL REP, V36, P1413, DOI 10.1007/s11033-008-9330-4; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; Velichko AK, 2013, CELL MOL LIFE SCI, V70, P4229, DOI 10.1007/s00018-013-1348-7; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	48	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103130	10.1371/journal.pone.0103130	http://dx.doi.org/10.1371/journal.pone.0103130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068899	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993700037
J	Hutter, J; Eriksson, M; Johannssen, T; Klopfleisch, R; von Smolinski, D; Gruber, AD; Seeberger, PH; Lepenies, B				Huetter, Julia; Eriksson, Magdalena; Johannssen, Timo; Klopfleisch, Robert; von Smolinski, Dorthe; Gruber, Achim D.; Seeberger, Peter H.; Lepenies, Bernd			Role of the C-Type Lectin Receptors MCL and DCIR in Experimental Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PLASMACYTOID DENDRITIC CELLS; MANNAN-BINDING LECTIN; TOLL-LIKE RECEPTORS; T-CELLS; INTESTINAL INFLAMMATION; PATTERN-RECOGNITION; MOUSE MODELS; HOMEOSTASIS; IMMUNITY	Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract. Though its exact etiology is still unclear, it is proposed that an imbalance in the intestinal homeostasis leads to a disturbed interaction between commensal microbiota and the mucosal immune system. Previous studies have shown that both innate and adaptive immunity are involved in an overwhelming colon inflammation, and thus contribute to the pathogenesis of IBD. In innate immunity, several pattern recognition receptors such as Toll-like receptors, NOD-like receptors or C-type lectin receptors (CLRs) are involved in IBD pathogenesis. Myeloid CLRs are mainly expressed by antigen-presenting cells and bind to glycan structures present on self or foreign antigens. The Macrophage-restricted C-type lectin (MCL) and the Dendritic cell immunoreceptor (DCIR) are two poorly characterized members of the CLR family. In this study, we investigated the role of MCL and DCIR in the pathogenesis of murine colitis. Both CLRs bound to intestinal microbiota to a different extent. They modulated the production of pro-inflammatory cytokines by antigen-presenting cells upon stimulation with heat-killed microbiota and impacted subsequent T cell responses. To analyze whether MCL and DCIR contribute to the pathogenesis of IBD, the dextran sulfate sodium (DSS) murine colitis model was employed. MCL-/- as well as DCIR-/- mice exhibited only a slightly increased severity of disease compared to wild-type mice indicating a limited role for MCL and DCIR in the regulation of intestinal immunity	[Huetter, Julia; Eriksson, Magdalena; Johannssen, Timo; Seeberger, Peter H.; Lepenies, Bernd] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Potsdam, Germany; [Huetter, Julia; Eriksson, Magdalena; Johannssen, Timo; Seeberger, Peter H.; Lepenies, Bernd] Free Univ Berlin, Inst Chem & Biochem, Dept Biol Chem & Pharm, Berlin, Germany; [Klopfleisch, Robert; von Smolinski, Dorthe; Gruber, Achim D.] Free Univ Berlin, Dept Vet Pathol, Berlin, Germany	Max Planck Society; Free University of Berlin; Free University of Berlin	Lepenies, B (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Potsdam, Germany.	Bernd.Lepenies@mpikg.mpg.de	Lepenies, Bernd/C-6509-2009; Gruber, Achim D./ABA-4514-2021	Lepenies, Bernd/0000-0001-9033-5522; Klopfleisch, Robert/0000-0002-6308-0568	German Federal Ministry of Education and Research (BMBF) [Fkz.0315446];  [SFB 765]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); 	The authors thank the Max Planck Society for very generous support. Funding by the German Federal Ministry of Education and Research (BMBF, Fkz.0315446 to B.L.) and SFB 765 (to P.H.S. and B.L.) is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Arce I, 2004, EUR J IMMUNOL, V34, P210, DOI 10.1002/eji.200324230; Balch SG, 1998, J BIOL CHEM, V273, P18656, DOI 10.1074/jbc.273.29.18656; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bates EEM, 1999, J IMMUNOL, V163, P1973; Bernstein CN, 2008, GUT, V57, P1185, DOI 10.1136/gut.2007.122143; Bloem K, 2014, IMMUNOL LETT, V158, P33, DOI 10.1016/j.imlet.2013.11.007; Bloem K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066266; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Cerboni S, 2013, ADV IMMUNOL, V120, P211, DOI 10.1016/B978-0-12-417028-5.00008-9; COOPER HS, 1993, LAB INVEST, V69, P238; Drummond RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003417; Eriksson M, 2014, CHEMBIOCHEM, V15, P844, DOI 10.1002/cbic.201300764; Eriksson M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00196; Florentin J, 2012, BLOOD, V120, P4544, DOI 10.1182/blood-2012-02-413286; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Furukawa A, 2013, P NATL ACAD SCI USA, V110, P17438, DOI 10.1073/pnas.1312649110; Graham LM, 2012, J BIOL CHEM, V287, P25964, DOI 10.1074/jbc.M112.384164; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Holm C, 2003, APPL ENVIRON MICROB, V69, P2857, DOI 10.1128/AEM.69.5.2857-2863.2003; Hoving JC, 2014, CELL MICROBIOL, V16, P185, DOI 10.1111/cmi.12249; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Kanazawa N, 2007, J DERMATOL SCI, V45, P77, DOI 10.1016/j.jdermsci.2006.09.001; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Klechevsky E, 2010, BLOOD, V116, P1685, DOI 10.1182/blood-2010-01-264960; Krishnaswamy JK, 2013, TRENDS IMMUNOL, V34, P224, DOI 10.1016/j.it.2012.12.003; Lepenies B, 2013, ADV DRUG DELIVER REV, V65, P1271, DOI 10.1016/j.addr.2013.05.007; Lobato-Pascual A, 2013, EUR J IMMUNOL, V43, P3167, DOI 10.1002/eji.201343752; Fernandez EM, 2011, GUT, V60, P1444, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Maglinao M, 2014, J CONTROL RELEASE, V175, P36, DOI 10.1016/j.jconrel.2013.12.011; Maglinao M, 2013, J IMMUNOL, V191, P2551, DOI 10.4049/jimmunol.1203451; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Massoud AH, 2014, J ALLERGY CLIN IMMUN, V133, P853, DOI 10.1016/j.jaci.2013.09.029; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Meyer-Wentrup F, 2009, J LEUKOCYTE BIOL, V85, P518, DOI 10.1189/jlb.0608352; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Mo JY, 2012, J BIOL CHEM, V287, P23057, DOI 10.1074/jbc.M112.344283; Muller S, 2010, GUT, V59, P1493, DOI 10.1136/gut.2010.208348; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Saba K, 2009, AM J PATHOL, V174, P144, DOI 10.2353/ajpath.2009.080235; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Saunders SP, 2010, J IMMUNOL, V184, P2627, DOI 10.4049/jimmunol.0901970; Schlegel MK, 2011, CHEMBIOCHEM, V12, P2791, DOI 10.1002/cbic.201100511; Seibold F, 2004, GASTROENTEROLOGY, V127, P1076, DOI 10.1053/j.gastro.2004.07.056; Stagg AJ, 2003, GUT, V52, P1522, DOI 10.1136/gut.52.10.1522; Steichen AL, 2013, J LEUKOCYTE BIOL, V94, P393, DOI 10.1189/jlb.1212622; Stockinger B, 1996, J EXP MED, V183, P891, DOI 10.1084/jem.183.3.891; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yan HM, 2013, INT IMMUNOPHARMACOL, V16, P353, DOI 10.1016/j.intimp.2013.04.013	54	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103281	10.1371/journal.pone.0103281	http://dx.doi.org/10.1371/journal.pone.0103281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068517	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700054
J	Jetten, N; Roumans, N; Gijbels, MJ; Romano, A; Post, MJ; de Winther, MPJ; van der Hulst, RRWJ; Xanthoulea, S				Jetten, Nadine; Roumans, Nadia; Gijbels, Marion J.; Romano, Andrea; Post, Mark J.; de Winther, Menno P. J.; van der Hulst, Rene R. W. J.; Xanthoulea, Sofia			Wound Administration of M2-Polarized Macrophages Does Not Improve Murine Cutaneous Healing Responses	PLOS ONE			English	Article							GENETICALLY DIABETIC MOUSE; EX-VIVO; MICE; REPAIR; PHENOTYPE; MONOCYTES; POLARIZATION; REGENERATION; INFLAMMATION; ACTIVATION	Macrophages play a crucial role in all stages of cutaneous wound healing responses and dysregulation of macrophage function can result in derailed wound repair. The phenotype of macrophages is influenced by the wound microenvironment and evolves during healing from a more pro-inflammatory (M1) profile in early stages, to a less inflammatory pro-healing (M2) phenotype in later stages of repair. The aim of the current study was to investigate the potential of exogenous administration of M2 macrophages to promote wound healing in an experimental mouse model of cutaneous injury. Bone marrow derived macrophages were stimulated in-vitro with IL-4 or IL-10 to obtain two different subsets of M2-polarized cells, M2a or M2c respectively. Polarized macrophages were injected into full-thickness excisional skin wounds of either C57BL/6 or diabetic db/db mice. Control groups were injected with non-polarized (M0) macrophages or saline. Our data indicate that despite M2 macrophages exhibit an anti-inflammatory phenotype in-vitro, they do not improve wound closure in wild type mice while they delay healing in diabetic mice. Examination of wounds on day 15 post-injury indicated delayed re-epithelialization and persistence of neutrophils in M2 macrophage treated diabetic wounds. Therefore, topical application of ex-vivo generated M2 macrophages is not beneficial and contraindicated for cell therapy of skin wounds.	[Jetten, Nadine; Gijbels, Marion J.; de Winther, Menno P. J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, CARIM, Dept Mol Genet, Maastricht, Netherlands; [Roumans, Nadia; van der Hulst, Rene R. W. J.; Xanthoulea, Sofia] Maastricht Univ, Med Ctr, Sch Nutr Toxicol & Metab, Dept Plast Surg,NUTRIM, Maastricht, Netherlands; [Gijbels, Marion J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, CARIM, Dept Pathol, Maastricht, Netherlands; [Romano, Andrea] Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol, Dept Gynecol,GROW, Maastricht, Netherlands; [Post, Mark J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, CARIM, Dept Physiol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Xanthoulea, S (corresponding author), Maastricht Univ, Med Ctr, Sch Nutr Toxicol & Metab, Dept Plast Surg,NUTRIM, Maastricht, Netherlands.	sofia.xanthoulea@maastrichtuniversity.nl	Romano, Andrea/K-1373-2016	Romano, Andrea/0000-0002-5900-6883; xanthoulea, sofia/0000-0003-4700-3404; de Winther, Menno/0000-0002-4038-6636; Roumans, Nadia/0000-0003-4789-1050	internal funds of the Maastricht University Medical Centre	internal funds of the Maastricht University Medical Centre	This study was supported by internal funds of the Maastricht University Medical Centre. MdW is an Established Investigator of the Netherlands Heart Foundation (2007T067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren MS, 2001, EXP DERMATOL, V10, P337, DOI 10.1034/j.1600-0625.2001.100506.x; Ashcroft GS, 2012, WOUND REPAIR REGEN, V20, P38, DOI 10.1111/j.1524-475X.2011.00748.x; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; Danon D, 1997, EXP GERONTOL, V32, P633, DOI 10.1016/S0531-5565(97)00094-6; DIPIETRO LA, 1995, AM J PATHOL, V146, P868; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Dreymueller D, 2013, WOUND REPAIR REGEN, V21, P44, DOI 10.1111/j.1524-475X.2012.00858.x; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Falanga V, 2004, WOUND REPAIR REGEN, V12, P320, DOI 10.1111/j.1067-1927.2004.012316.x; Giel-Moloney M, 2007, GENESIS, V45, P83, DOI 10.1002/dvg.20269; Goren I, 2007, J INVEST DERMATOL, V127, P2259, DOI 10.1038/sj.jid.5700842; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Grochot-Przeczek A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005803; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Huang WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042507; Hunter MM, 2010, GASTROENTEROLOGY, V138, P1395, DOI 10.1053/j.gastro.2009.12.041; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Jetten N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068811; Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539; Lai JJ, 2009, J CLIN INVEST, V119, P3739, DOI 10.1172/JCI39335; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mirastschijski U, 2002, J INVEST DERMATOL, V118, P55, DOI 10.1046/j.0022-202x.2001.01652.x; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Parsa R, 2012, DIABETES, V61, P2881, DOI 10.2337/db11-1635; Shinozaki M, 2009, ARCH DERMATOL RES, V301, P531, DOI 10.1007/s00403-009-0969-z; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Wang Y, 2007, KIDNEY INT, V72, P290, DOI 10.1038/sj.ki.5002275; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Wigglesworth KM, 2011, J IMMUNOL, V186, P4422, DOI 10.4049/jimmunol.1002324	40	84	90	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102994	10.1371/journal.pone.0102994	http://dx.doi.org/10.1371/journal.pone.0102994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068282	gold, Green Submitted, Green Published			2022-12-25	WOS:000339993700028
J	Liang, DD; Zhen, LX; Yuan, TY; Huang, J; Deng, FF; Wuyahan; Zhang, H; Pan, L; Liu, Y; The, E; Yu, ZR; Zhu, WD; Zhang, YZ; Li, L; Peng, LY; Li, J; Chen, YH				Liang, Dandan; Zhen, Lixiao; Yuan, Tianyou; Huang, Jian; Deng, Fangfei; Wuyahan; Zhang, Hong; Pan, Lei; Liu, Yi; The, Erlinda; Yu, Zuoren; Zhu, Weidong; Zhang, Yuzhen; Li, Li; Peng, Luying; Li, Jun; Chen, Yi-Han			miR-10a Regulates Proliferation of Human Cardiomyocyte Progenitor Cells by Targeting GATA6	PLOS ONE			English	Article							CARDIOVASCULAR DEVELOPMENT; SIGNALING PATHWAYS; CHAMBER FORMATION; HEART; DIFFERENTIATION; EXPRESSION; GROWTH; CONTRIBUTES	microRNAs (miRNAs) play essential roles in cardiogenesis. The altered expression of miRNAs can result in cardiac malformations by inducing abnormalities in the behavior of cardiac cells. However, the role of miR-10a in the regulation of cardiomyocyte progenitor cells (CMPCs) remains undetermined. In the present study, we found that up- or down-regulation of miR-10a inhibited or promoted the proliferation of human CMPCs, respectively, without affecting their differentiation toward cardiomyocytes. miR-10a bound to GATA6 directly and reduced GATA6 expression. Over-expression of GATA6 greatly attenuated the miR-10a-mediated inhibitory effect on the proliferation of human CMPCs. Thus, our results indicate that miR-10a could effectively modulate the proliferation of human CMPCs by targeting GATA6. The finding provides novel insights into the potency of miR-10a during heart development.	[Liang, Dandan; Zhen, Lixiao; Yuan, Tianyou; Huang, Jian; Deng, Fangfei; Wuyahan; Zhang, Hong; Pan, Lei; Liu, Yi; The, Erlinda; Yu, Zuoren; Zhu, Weidong; Zhang, Yuzhen; Li, Li; Peng, Luying; Li, Jun; Chen, Yi-Han] Tongji Univ, Sch Med, Key Lab Arrhythmia, Minist Educ China,East Hosp, Shanghai 200092, Peoples R China; [Liang, Dandan; Zhen, Lixiao; Yuan, Tianyou; Huang, Jian; Deng, Fangfei; Wuyahan; Zhang, Hong; Pan, Lei; Liu, Yi; The, Erlinda; Yu, Zuoren; Zhu, Weidong; Zhang, Yuzhen; Li, Li; Peng, Luying; Li, Jun; Chen, Yi-Han] Tongji Univ, Inst Med Genet, Shanghai 200092, Peoples R China; [Zhen, Lixiao; Huang, Jian; Deng, Fangfei; Wuyahan; Pan, Lei; The, Erlinda; Chen, Yi-Han] Tongji Univ, East Hosp, Dept Cardiol, Shanghai 200092, Peoples R China; [Zhu, Weidong; Li, Li; Peng, Luying; Chen, Yi-Han] Tongji Univ, Sch Med, Dept Pathol & Pathophysiol, Shanghai 200092, Peoples R China	Ministry of Education, China; Tongji University; Tongji University; Tongji University; Tongji University	Chen, YH (corresponding author), Tongji Univ, Sch Med, Key Lab Arrhythmia, Minist Educ China,East Hosp, Shanghai 200092, Peoples R China.	yihanchen@tongji.edu.cn			National Key Basic Research Program of China [2013CB531100]; Foundation for Innovative Research Groups of China [81221001]; Major International Joint Research Program Fund of China [81120108004]; National Natural Science Foundation of China [81170224, 81270313, 31271214]; Shanghai Natural Science Fund [10JC1414700]	National Key Basic Research Program of China(National Basic Research Program of China); Foundation for Innovative Research Groups of China(National Natural Science Foundation of China (NSFC)); Major International Joint Research Program Fund of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Fund	This work was supported by the National Key Basic Research Program of China (2013CB531100, to Yi-Han Chen), the Foundation for Innovative Research Groups of China (81221001, to Yi-Han Chen), the Major International Joint Research Program Fund of China (81120108004, to Yi-Han Chen), the National Natural Science Foundation of China (81170224 and 81270313, to Jun Li; 31271214, to Yi-Han Chen), and the Shanghai Natural Science Fund (10JC1414700, to Yi-Han Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Davis DL, 2000, DEV BIOL, V217, P310, DOI 10.1006/dbio.1999.9561; Gove C, 1997, EMBO J, V16, P355, DOI 10.1093/emboj/16.2.355; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; Hussein K, 2009, ANN HEMATOL, V88, P325, DOI 10.1007/s00277-008-0602-9; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Liang DD, 2014, J CELL MOL MED, V18, P1830, DOI 10.1111/jcmm.12309; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Long MJ, 2012, CANCER LETT, V324, P186, DOI 10.1016/j.canlet.2012.05.022; Lu TY, 2013, J MOL CELL CARDIOL, V63, P146, DOI 10.1016/j.yjmcc.2013.07.019; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Rochais F, 2009, CIRC RES, V104, P933, DOI 10.1161/CIRCRESAHA.109.194464; Rosenthal N, 2010, HEART DEV REGENERATI; Seeger FH, 2013, ARTERIOSCL THROM VAS, V33, P1739, DOI 10.1161/ATVBAHA.113.300138; Sizarov A, 2011, CIRCULATION, V123, P1125, DOI 10.1161/CIRCULATIONAHA.110.980607; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229; Soufan AT, 2006, CIRC RES, V99, P545, DOI 10.1161/01.RES.0000239407.45137.97; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; van den Berg G, 2009, CIRC RES, V104, P179, DOI 10.1161/CIRCRESAHA.108.185843; Xiao JJ, 2012, J MOL CELL CARDIOL, V53, P751, DOI 10.1016/j.yjmcc.2012.08.024; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Zhao RO, 2005, MOL CELL BIOL, V25, P2622, DOI 10.1128/MCB.25.7.2622-2631.2005; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhu SK, 2013, CIRC RES, V112, P152, DOI 10.1161/CIRCRESAHA.112.280016	28	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103097	10.1371/journal.pone.0103097	http://dx.doi.org/10.1371/journal.pone.0103097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068583	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993700033
J	Torres-Fuentes, C; Theeuwes, WF; McMullen, MK; McMullen, AK; Dinan, TG; Cryan, JF; Schellekens, H				Torres-Fuentes, Cristina; Theeuwes, Wessel F.; McMullen, Michael K.; McMullen, Anna K.; Dinan, Timothy G.; Cryan, John F.; Schellekens, Harriet			Devil's Claw to Suppress Appetite-Ghrelin Receptor Modulation Potential of a Harpagophytum procumbens Root Extract	PLOS ONE			English	Article							DIETARY FIBER; HORMONE; DESENSITIZATION; HARPAGOSIDE; ARRESTINS; PEPTIDES; PROTEINS; STOMACH; AGONIST; OBESITY	Ghrelin is a stomach-derived peptide that has been identified as the only circulating hunger hormone that exerts a potent orexigenic effect via activation of its receptor, the growth hormone secretagogue receptor (GHS-R1a). Hence, the ghrelinergic system represents a promising target to treat obesity and obesity-related diseases. In this study we analysed the GHS-R1a receptor activating potential of Harpagophytum procumbens, popularly known as Devil's Claw, and its effect on food intake in vivo. H. procumbens is an important traditional medicinal plant from Southern Africa with potent anti-inflammatory and analgesic effects. This plant has been also used as an appetite modulator but most evidences are anecdotal and to our knowledge, no clear scientific studies relating to appetite modulation have been done to this date. The ghrelin receptor activation potential of an extract derived from the dried tuberous roots of H. procumbens was analysed by calcium mobilization and receptor internalization assays in human embryonic kidney cells (Hek) stably expressing the GHS-R1a receptor. Food intake was investigated in male C57BL/6 mice following intraperitoneal administration of H. procumbens root extract in ad libitum and food restricted conditions. Exposure to H. procumbens extract demonstrated a significant increased cellular calcium influx but did not induce subsequent GHS-R1a receptor internalization, which is a characteristic for full receptor activation. A significant anorexigenic effect was observed in male C57BL/6 mice following peripheral administration of H. procumbens extract. We conclude that H. procumbens root extract is a potential novel source for potent anti-obesity bioactives. These results reinforce the promising potential of natural bioactives to be developed into functional foods with weight-loss and weight maintenance benefits.	[Torres-Fuentes, Cristina; Dinan, Timothy G.; Cryan, John F.; Schellekens, Harriet] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Theeuwes, Wessel F.; Cryan, John F.; Schellekens, Harriet] Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland; [McMullen, Michael K.; McMullen, Anna K.] Life Force Res, Ljungskile, Sweden; [McMullen, Michael K.] Univ Westminster, Sch Biosci, London W1R 8AL, England; [Dinan, Timothy G.] Natl Univ Ireland Univ Coll Cork, Dept Psychiat, Cork, Ireland	University College Cork; University College Cork; University of Westminster; University College Cork	Schellekens, H (corresponding author), Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland.	h.schellekens@ucc.ie	Torres-Fuentes, Cristina/J-5551-2019; Cryan, John F./A-6950-2013; Dinan, Timothy/ABA-8284-2020	Torres-Fuentes, Cristina/0000-0002-2917-6910; Cryan, John F./0000-0001-5887-2723; Dinan, Timothy/0000-0002-2316-7220; Schellekens, Harriet/0000-0002-6065-3797	Enterprise Ireland [CC20080001]; Science Foundation Ireland (SFI) in the form of a centre grant (Alimentary Pharmabiotic Centre); SFI [02/CE/B124, 07/CE/B1368]	Enterprise Ireland; Science Foundation Ireland (SFI) in the form of a centre grant (Alimentary Pharmabiotic Centre)(Science Foundation Ireland); SFI(Science Foundation Ireland)	This work was supported by Enterprise Ireland under Grant Number CC20080001. JFC and TGD are also supported in part by Science Foundation Ireland (SFI) in the form of a centre grant (Alimentary Pharmabiotic Centre) through the Irish Government's National Development Plan. The authors and their work were supported by SFI (grant nos. 02/CE/B124 and 07/CE/B1368). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, OILS DET OIL CONT RE; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Beck B, 2004, LIFE SCI, V76, P473, DOI 10.1016/j.lfs.2004.09.001; Brendler Thomas, 2006, Journal of Herbal Pharmacotherapy, V6, P89, DOI 10.1300/J157v06n01_09; Camina JP, 2004, ENDOCRINOLOGY, V145, P930, DOI 10.1210/en.2003-0974; Costantino L, 2012, EXPERT OPIN THER PAT, V22, P697, DOI 10.1517/13543776.2012.684946; Depoortere I, 2009, REGUL PEPTIDES, V156, P13, DOI 10.1016/j.regpep.2009.04.002; Derosa G, 2012, EXPERT OPIN DRUG SAF, V11, P459, DOI 10.1517/14740338.2012.675326; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Els S, 2010, METHOD ENZYMOL, V485, P103, DOI [10.1016/S0076-6879(10)85006-2, 10.1016/B978-0-12-381296-4.00006-3]; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Finger BC, 2011, PSYCHOPHARMACOLOGY, V216, P421, DOI 10.1007/s00213-011-2234-3; Georgiev MI, 2013, PHYTOCHEMISTRY, V92, P8, DOI 10.1016/j.phytochem.2013.04.009; Grant L, 2007, PHYTOTHER RES, V21, P199, DOI 10.1002/ptr.2029; Gunther M, 2006, PHYTOCHEM ANALYSIS, V17, P1, DOI 10.1002/pca.822; Helrich K., 1990, ASS OFFICIAL ANAL CH; Hidalgo FJ, 2001, ANAL CHEM, V73, P698, DOI 10.1021/ac000876o; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Howarth NC, 2001, NUTR REV, V59, P129, DOI 10.1111/j.1753-4887.2001.tb07001.x; Kang JG, 2012, DIABETES METAB J, V36, P13, DOI 10.4093/dmj.2012.36.1.13; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; LEE SC, 1992, J AOAC INT, V75, P395; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Liu G, 2007, J PHARMACOL EXP THER, V322, P1036, DOI 10.1124/jpet.107.123141; Mear Y, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00087; Mncwangi N, 2012, J ETHNOPHARMACOL, V143, P755, DOI 10.1016/j.jep.2012.08.013; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Patterson M, 2011, PEPTIDES, V32, P2290, DOI 10.1016/j.peptides.2011.07.021; Petersen PS, 2009, ENDOCRINOLOGY, V150, P4920, DOI 10.1210/en.2008-1638; Qi J, 2006, PHYTOCHEMISTRY, V67, P1372, DOI 10.1016/j.phytochem.2006.05.029; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Rolland Y, 2011, CURR OPIN CLIN NUTR, V14, P15, DOI 10.1097/MCO.0b013e328340c2c2; Schellekens H, 2012, J PHARM PHARM; Schellekens H, 2013, J PHARM PHARMACOL, V65, P528, DOI 10.1111/jphp.12010; Schellekens H, 2013, J BIOL CHEM, V288, P181, DOI 10.1074/jbc.M112.382473; Schellekens H, 2012, PHARMACOL THERAPEUT, V135, P316, DOI 10.1016/j.pharmthera.2012.06.004; Schellekens H, 2010, NEUROPHARMACOLOGY, V58, P2, DOI 10.1016/j.neuropharm.2009.06.024; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Soares JB, 2008, PEPTIDES, V29, P1255, DOI 10.1016/j.peptides.2008.02.018; Stewart KM, 2005, J ETHNOPHARMACOL, V100, P225, DOI 10.1016/j.jep.2005.07.004; Torres-Fuentes C, 2014, NUTR NEUROSCI; Torres-Fuentes C, 2011, FOOD CHEM, V129, P485, DOI 10.1016/j.foodchem.2011.04.103; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Vermaak I, 2011, NAT PROD REP, V28, P1493, DOI 10.1039/c1np00035g; World Health Organization, 2013, OB OV, P311; Yi CX, 2011, MOL CELL ENDOCRINOL, V340, P29, DOI 10.1016/j.mce.2011.03.001; Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011	51	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103118	10.1371/journal.pone.0103118	http://dx.doi.org/10.1371/journal.pone.0103118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068823	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700036
J	Bischel, LL; Sung, KE; Jimenez-Torres, JA; Mader, B; Keely, PJ; Beebe, DJ				Bischel, Lauren L.; Sung, Kyung E.; Jimenez-Torres, Jose A.; Mader, Brianah; Keely, Patricia J.; Beebe, David J.			The importance of being a lumen	FASEB JOURNAL			English	Article						tissue engineering; cell culture; tissue geometry; microtechnology; microfluidics	CELL-CULTURE; MODEL; MATRIX; ANGIOGENESIS; GEOMETRY; MORPHOGENESIS; MECHANICS	Advances in tissue engineering and microtechnology have enabled researchers to more easily generate in vitro tissue models that mimic the tissue geometry and spatial organization found in vivo (e.g., vessel or mammary duct models with tubular structures). However, the widespread adoption of these models for biological studies has been slow, in part due to the lack of direct comparisons between existing 2-dimensional and 3-dimensional cell culture models and new organotypic models that better replicate tissue structure. Using previously developed vessel and mammary duct models with 3-dimensional lumen structures, we have begun to explore this question. In a direct comparison between these next generation organotypic models and more traditional methods, we observed differences in the levels of several secreted growth factors and cytokines. In addition, endothelial vessel geometry profoundly affects the phenotypic behavior of carcinoma cells, suggesting that more traditional in vitro assays may not capture in vivo events. Here, we seek to review and add to the increasing evidence supporting the hypothesis that using cell culture models with more relevant tissue structure influences cell fate and behavior, potentially increasing the relevance of biological findings.Bischel, L. L., Sung, K. E., Jimenez-Torres, J. A., Mader, B., Keely, P. J., Beebe, D. J. The importance of being a lumen.	[Bischel, Lauren L.; Sung, Kyung E.; Jimenez-Torres, Jose A.; Mader, Brianah; Keely, Patricia J.; Beebe, David J.] Univ Wisconsin, Wisconsin Inst Med Res, Dept Biomed Engn, Carbone Comprehens Canc Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Beebe, DJ (corresponding author), Univ Wisconsin, Wisconsin Inst Med Res, Dept Biomed Engn, 1111 Highland Ave, Madison, WI 53706 USA.	djbeebe@wisc.edu		Sung, Kyung/0000-0001-9664-6399	U.S. National Institutes of Health [R01EB10039, NIH T32HL007889]; University of Wisconsin Graduate Engineering Research Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007889, T32HL007899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010039] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Graduate Engineering Research Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank Moon Hee Lee and Jason Able (University of Wisconsin) for providing primary endothelial cells, Victoria Seewaldt (Duke University, Durham, NC, USA) for providing the HMEC15-hTERT and HMEC-SR cell lines, and Caroline Alexander for helpful discussion. This work was supported by U.S. National Institutes of Health grants R01EB10039 and NIH T32HL007889 and the University of Wisconsin Graduate Engineering Research Scholars Program. D.J.B. has an ownership interest in BellBrook Labs, LLC (Madison, WI, USA), which has licensed technology presented in this article.	Barreto-Ortiz SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081061; Bischel LL, 2013, BIOMATERIALS, V34, P1471, DOI 10.1016/j.biomaterials.2012.11.005; Bischel LL, 2012, JALA-J LAB AUTOM, V17, P96, DOI 10.1177/2211068211426694; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Choe MM, 2003, AM J PHYSIOL-LUNG C, V285, pL427, DOI 10.1152/ajplung.00005.2003; Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Gjorevski N, 2012, BIOPHYS J, V103, P152, DOI 10.1016/j.bpj.2012.05.048; Gomez EW, 2010, J CELL BIOCHEM, V110, P44, DOI 10.1002/jcb.22545; Goubko CA, 2009, MAT SCI ENG C-MATER, V29, P1855, DOI 10.1016/j.msec.2009.02.016; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Jeon JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056910; Jo BH, 2000, J MICROELECTROMECH S, V9, P76, DOI 10.1109/84.825780; Katoh M, 2005, DRUG METAB DISPOS, V33, P1333, DOI 10.1124/dmd.105.005157; Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261; Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062; Kim S, 2013, LAB CHIP, V13, P1489, DOI 10.1039/c3lc41320a; Kottakis F, 2011, MOL CELL, V43, P285, DOI 10.1016/j.molcel.2011.06.020; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lee JG, 2006, INVEST OPHTH VIS SCI, V47, P1376, DOI 10.1167/iovs.05-1223; Lee J, 2013, BIOMATERIALS, V34, P8140, DOI 10.1016/j.biomaterials.2013.07.074; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Page H, 2013, CELL TISSUE RES, V352, P123, DOI 10.1007/s00441-012-1441-5; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y; Polnaszek N, 2003, CANCER RES, V63, P5754; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Rodriguez ML, 2013, APPL MECH REV, V65, DOI 10.1115/1.4025355; Sirica AE, 1997, HEPATOLOGY, V26, P537, DOI 10.1053/jhep.1997.v26.pm0009303480; Sung KE, 2011, INTEGR BIOL-UK, V3, P439, DOI 10.1039/c0ib00063a; Sung KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076373; Sung KE, 2009, BIOMATERIALS, V30, P4833, DOI 10.1016/j.biomaterials.2009.05.043; Talbot NC, 2002, CELLS TISSUES ORGANS, V171, P99, DOI 10.1159/000063704; Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108; Verbridge SS, 2013, J BIOMED MATER RES A, V101, P2948, DOI 10.1002/jbm.a.34587; Walker GM, 2002, LAB CHIP, V2, P131, DOI 10.1039/b204381e; Xue NN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093590; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109; Zhang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053359; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109	44	41	41	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4583	4590		10.1096/fj.13-243733	http://dx.doi.org/10.1096/fj.13-243733			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25077562	Green Published			2022-12-25	WOS:000344050900001
J	Moraga, A; Pradillo, JM; Cuartero, MI; Hernandez-Jimenez, M; Oses, M; Moro, MA; Lizasoain, I				Moraga, Ana; Pradillo, Jesus M.; Cuartero, Maria I.; Hernandez-Jimenez, Macarena; Oses, Marta; Moro, Maria A.; Lizasoain, Ignacio			Toll-like receptor 4 modulates cell migration and cortical neurogenesis after focal cerebral ischemia	FASEB JOURNAL			English	Article						innate immunity; neuroblast; proliferation; stroke	SUBVENTRICULAR ZONE; ISCHEMIA/REPERFUSION INJURY; EXPERIMENTAL STROKE; PROGENITOR CELLS; CYCLE LENGTH; ADULT BRAIN; RAT; PROLIFERATION; DAMAGE; TLR4	Toll-like receptor 4 (TLR4) mediates brain damage after stroke. Now our objective is to determine TLR4 involvement in stroke-induced neurogenesis. Stroke was induced by permanent middle cerebral artery occlusion in wild-type and TLR4-deficient mice. Stereological and densitometric analysis of immunofluorescence-labeled brain sections and FACS analysis of cell suspensions were performed. Our results show that subventricular zone (SVZ) cell proliferation after stroke depends on infarct size. Second, when comparing brains with similar lesions, TLR4 attenuated SVZ proliferation, as shown by a decrease in prominin-1(+)/EGFR(+)/nestin(-) cells (type-C cells) at 1-2 d, and in BrdU(+) cells at 7 d, in TLR4(+/+)vs. TLR4(-/-) mice. Interestingly, 7 d after the infarct, neuroblasts in TLR4(+/+) mice migrated farther distances, reaching areas closer to the lesion than those in TLR4-deficient mice. However, at 14 d, TLR4-deficient mice presented a higher number of neuroblasts in all migratory zones than the TLR4(+/+) counterparts, which suggests that TLR4 deficiency delays neuroblast migration. Consistently, TLR4(+/+) mice showed an increased number of interneurons (NeuN(+)/BrdU(+)/GAD67(+) cells) in peri-infarct cortex 14-28 d after stroke. Our data indicate that, despite a negative effect on SVZ cell proliferation, TLR4 plays an important role in stroke-induced neurogenesis by promoting neuroblasts migration and increasing the number of new cortical neurons after stroke.Moraga, A., Pradillo, J. M., Cuartero, M. I., Hernandez-Jimenez, M., Oses, M., Moro, M. A., Lizasoain, I. Toll-like receptor 4 modulates cell migration and cortical neurogenesis after focal cerebral ischemia.	[Moraga, Ana; Pradillo, Jesus M.; Cuartero, Maria I.; Hernandez-Jimenez, Macarena; Oses, Marta; Moro, Maria A.; Lizasoain, Ignacio] Univ Complutense, Fac Med, Dept Farmacol, Unidad Invest Neurovasc, E-28040 Madrid, Spain	Complutense University of Madrid	Lizasoain, I (corresponding author), Univ Complutense, Fac Med, Dept Farmacol, Unidad Invest Neurovasc, Ave Complutense S-N, E-28040 Madrid, Spain.	ignacio.lizasoain@med.ucm.es	Cuartero, Maria Isabel/E-8103-2012; PRADILLO, JESUS M/L-6344-2014; Moraga, Ana/ABD-4248-2020; Moro, María Ángeles/K-6396-2014; Lizasoain, Ignacio/K-9844-2014	Cuartero, Maria Isabel/0000-0003-4728-068X; PRADILLO, JESUS M/0000-0002-8266-7946; Moro, María Ángeles/0000-0003-1010-8237; Lizasoain, Ignacio/0000-0002-6028-7379; Hernandez Jimenez, Macarena/0000-0003-3329-3965; Moraga, Ana/0000-0001-6695-557X	Spanish Ministry of Economy and Innovation [SAF2011-23354, SAF2012-33216, CSD2010-00045]; Spanish Ministry of Health; Fondo Europeo de Desarrollo Regional (FEDER) [RET-ICS RD12/0014/003]; Regional Madrid Government [S2010/BMD-2330, S2010/BMD-2349]	Spanish Ministry of Economy and Innovation(Spanish Government); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Regional Madrid Government	The authors thank Tamara Atones and Roberto Canadas for technical assistance. This work was supported by the Spanish Ministry of Economy and Innovation, grants SAF2011-23354 (I.L.), SAF2012-33216 (M.A.M.), and CSD2010-00045 (M.A.M.); by the Spanish Ministry of Health and Fondo Europeo de Desarrollo Regional (FEDER), RET-ICS RD12/0014/003 (I.L.); and by the Regional Madrid Government, grants S2010/BMD-2330 (M.A.M.) and S2010/BMD-2349 (I.L.). The authors declare no conflicts of interest.	Ao LH, 2009, AM J PHYSIOL-HEART C, V297, pH21, DOI 10.1152/ajpheart.00292.2009; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Cao CX, 2007, BIOCHEM BIOPH RES CO, V353, P509, DOI 10.1016/j.bbrc.2006.12.057; Caso JR, 2008, STROKE, V39, P1314, DOI 10.1161/STROKEAHA.107.498212; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; Chong AJ, 2004, J THORAC CARDIOV SUR, V128, P170, DOI 10.1016/j.jtcvs.2003.11.036; Dvoriantchikova G, 2010, MOL VIS, V16, P1907; Gonzalez FF, 2007, DEV NEUROSCI-BASEL, V29, P321, DOI 10.1159/000105473; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hernandez-Jimenez M, 2013, STROKE, V44, P2333, DOI 10.1161/STROKEAHA.113.001715; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; LaFrance-Corey RG, 2011, JOVE-J VIS EXP, DOI 10.3791/2747; Lee SR, 2006, J NEUROSCI, V26, P3491, DOI 10.1523/JNEUROSCI.4085-05.2006; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; SCHULTZE B, 1981, CELL TISSUE KINET, V14, P309, DOI 10.1111/j.1365-2184.1981.tb00535.x; Sierra A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00006; Smith CM, 1998, DEV DYNAM, V213, P220, DOI 10.1002/(SICI)1097-0177(199810)213:2<220::AID-AJA7>3.0.CO;2-I; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Yan YP, 2007, J CEREBR BLOOD F MET, V27, P1213, DOI 10.1038/sj.jcbfm.9600432; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007; Zhang RL, 2006, J CEREBR BLOOD F MET, V26, P857, DOI 10.1038/sj.jcbfm.9600237	29	45	47	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4710	4718		10.1096/fj.14-252452	http://dx.doi.org/10.1096/fj.14-252452			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25063846				2022-12-25	WOS:000344050900012
J	Vaghi, V; Polacchini, A; Baj, G; Pinheiro, VLM; Vicario, A; Tongiorgi, E				Vaghi, Valentina; Polacchini, Alessio; Baj, Gabriele; Pinheiro, Vera L. M.; Vicario, Annalisa; Tongiorgi, Enrico			Pharmacological Profile of Brain-derived Neurotrophic Factor (BDNF) Splice Variant Translation Using a Novel Drug Screening Assay A "QUANTITATIVE CODE"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain-derived Neurotrophic Factor (BDNF); Drug Screening; Neurotransmitter; Signaling; Translation; In Vitro Assay; Splice Variants	FACTOR MESSENGER-RNA; BAC TRANSGENIC MICE; GENE-EXPRESSION; RAT HIPPOCAMPUS; TOTAL NUMBER; IN-VIVO; PROTEIN; TRANSCRIPTION; NEURONS; CELLS	Background: Brain-derived neurotrophic factor is encoded by multiple transcripts with specific brain localization. Results: BDNF transcripts display a different ability to translate, basally and after stimulation. Conclusion:BDNF mRNA variants represent a quantitative code to regulate expression of the protein. Significance: This cell-based assay allows identification of compounds able to modulate BDNF variants having local effects in specific brain regions. The neurotrophin brain-derived neurotrophic factor (BDNF) is a key regulator of neuronal development and plasticity. BDNF is a major pharmaceutical target in neurodevelopmental and psychiatric disorders. However, pharmacological modulation of this neurotrophin is challenging because BDNF is generated by multiple, alternatively spliced transcripts with different 5- and 3UTRs. Each BDNF mRNA variant is transcribed independently, but translation regulation is unknown. To evaluate the translatability of BDNF transcripts, we developed an in vitro luciferase assay in human neuroblastoma cells. In unstimulated cells, each BDNF 5- and 3UTR determined a different basal translation level of the luciferase reporter gene. However, constructs with either a 5UTR or a 3UTR alone showed poor translation modulation by BDNF, KCl, dihydroxyphenylglycine, AMPA, NMDA, dopamine, acetylcholine, norepinephrine, or serotonin. Constructs consisting of the luciferase reporter gene flanked by the 5UTR of one of the most abundant BDNF transcripts in the brain (exons 1, 2c, 4, and 6) and the long 3UTR responded selectively to stimulation with the different receptor agonists, and only transcripts 2c and 6 were increased by the antidepressants desipramine and mirtazapine. We propose that BDNF mRNA variants represent a quantitative code for regulated expression of the protein. Thus, to discriminate the efficacy of drugs in stimulating BDNF synthesis, it is appropriate to use variant-specific in vitro screening tests.	[Vaghi, Valentina; Polacchini, Alessio; Baj, Gabriele; Pinheiro, Vera L. M.; Vicario, Annalisa; Tongiorgi, Enrico] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy	University of Trieste	Tongiorgi, E (corresponding author), Univ Trieste, Dept Life Sci, Via Giorgieri 5, I-34127 Trieste, Italy.	tongi@units.it	; Baj, Gabriele/H-4228-2012	Tongiorgi, Enrico/0000-0003-0485-0603; POLACCHINI, ALESSIO/0000-0001-7555-1024; Baj, Gabriele/0000-0002-2625-9454	Telethon Grant [GGP08258]; MIUR Grant [2010N8PBAA]; Compagnia San Paolo; Fondazione Kathleen Foreman Casali-Trieste; FRA-UniTS; Beneficentia Stiftung-Vaduz (Lichtenstein)	Telethon Grant(Fondazione Telethon); MIUR Grant(Ministry of Education, Universities and Research (MIUR)); Compagnia San Paolo(Compagnia di San Paolo); Fondazione Kathleen Foreman Casali-Trieste; FRA-UniTS; Beneficentia Stiftung-Vaduz (Lichtenstein)	This work was supported by Telethon Grant GGP08258, MIUR Grant PRIN 2010-11 2010N8PBAA, and Compagnia San Paolo. The assay and the results presented in this paper are related to patent application number PCT/EP2010/067081.; Supported by Fondazione Kathleen Foreman Casali-Trieste, FRA-UniTS 2012, and Beneficentia Stiftung-Vaduz (Lichtenstein).	Abuhatzira L, 2007, EPIGENETICS-US, V2, P214, DOI 10.4161/epi.2.4.5212; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Allen GFG, 2013, NEUROCHEM INT, V62, P684, DOI 10.1016/j.neuint.2012.12.004; Altar CA, 2009, NEUROPSYCHOPHARMACOL, V34, P18, DOI 10.1038/npp.2008.172; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Baj G, 2013, HIPPOCAMPUS, V23, P413, DOI 10.1002/hipo.22100; Baj G, 2011, P NATL ACAD SCI USA, V108, P16813, DOI 10.1073/pnas.1014168108; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Bowling H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004331; Bustos G, 2009, J NEUROSCI RES, V87, P2308, DOI 10.1002/jnr.22063; Calabrese F, 2007, NEUROPSYCHOPHARMACOL, V32, P2351, DOI 10.1038/sj.npp.1301360; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Castren E, 2012, J NEUROSCI, V32, P14074, DOI 10.1523/JNEUROSCI.3287-12.2012; Cattaneo E., 2002, U. S. Patent, Patent No. [20050123922 A1, 20050123922]; Chiaruttini C, 2008, MOL CELL NEUROSCI, V37, P11, DOI 10.1016/j.mcn.2007.08.011; Chiaruttini C, 2009, P NATL ACAD SCI USA, V106, P16481, DOI 10.1073/pnas.0902833106; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Deng WB, 2004, P NATL ACAD SCI USA, V101, P7751, DOI 10.1073/pnas.0307850101; Dias BG, 2003, NEUROPHARMACOLOGY, V45, P553, DOI 10.1016/S0028-3908(03)00198-9; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Donnici L, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-61; Doshi KJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-105; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dunston JA, 2004, GENOMICS, V84, P565, DOI 10.1016/j.ygeno.2004.06.002; Fukuyama K, 2013, PSYCHOPHARMACOLOGY, V229, P617, DOI 10.1007/s00213-013-3122-9; Gangarossa G, 2012, NEUROPHARMACOLOGY, V63, P1107, DOI 10.1016/j.neuropharm.2012.06.062; Garzon D, 2002, J NEUROCHEM, V82, P1058, DOI 10.1046/j.1471-4159.2002.01030.x; Guillemot F, 2007, TRANSGENIC RES, V16, P223, DOI 10.1007/s11248-006-9060-0; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Heinrich G., 2003, U. S. Patent, Patent No. [US 7491910 B2, 7491910]; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jin AH, 2014, BIOCHEMISTRY-US, V53, P1, DOI 10.1021/bi400882s; Koppel I, 2010, GENESIS, V48, P214, DOI 10.1002/dvg.20606; Koppel I, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-68; Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Martin-Montaneza E, 2010, NEUROREPORT, V21, P1034, DOI 10.1097/WNR.0b013e32833f7b7b; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Moussa CEH, 2004, BIOCHEMISTRY-US, V43, P5539, DOI 10.1021/bi036114f; Nakagawa S, 2008, NUCLEIC ACIDS RES, V36, P861, DOI 10.1093/nar/gkm1102; Oury F, 2010, GENE DEV, V24, P2330, DOI 10.1101/gad.1977210; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Rogers DA, 2013, PEDIATR RES, V74, P517, DOI 10.1038/pr.2013.146; Ruiz A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.134; Russo-Neustadt AA, 2004, NEUROPSYCHOPHARMACOL, V29, P2189, DOI 10.1038/sj.npp.1300514; Sakata K, 2009, P NATL ACAD SCI USA, V106, P5942, DOI 10.1073/pnas.0811431106; Tardito D, 2006, PHARMACOL REV, V58, P115, DOI 10.1124/pr.58.1.7; Tongiorgi E, 2004, J NEUROSCI, V24, P6842, DOI 10.1523/JNEUROSCI.5471-03.2004; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Tongiorgi E, 2008, NEUROSCI RES, V61, P335, DOI 10.1016/j.neures.2008.04.013; Tongiorgi Enrico, 2008, Novartis Found Symp, V289, P136; Tropea D, 2001, EUR J NEUROSCI, V13, P709, DOI 10.1046/j.0953-816x.2000.01436.x; Tsukahara T, 1998, NEUROCHEM INT, V33, P201, DOI 10.1016/S0197-0186(97)00112-5; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Yanow SK, 1998, J NEUROCHEM, V70, P572; Yasuda S, 2009, MOL PSYCHIATR, V14, P51, DOI 10.1038/sj.mp.4002099	60	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27702	27713		10.1074/jbc.M114.586719	http://dx.doi.org/10.1074/jbc.M114.586719			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25074925	Green Published, hybrid			2022-12-25	WOS:000342852800029
J	Han, L; Yang, J; Wang, XW; Wu, QS; Yin, SY; Li, ZY; Zhang, J; Xing, Y; Chen, ZJ; Tsun, A; Li, D; Piccioni, M; Zhang, Y; Guo, Q; Jiang, LD; Bao, LM; Lv, L; Li, B				Han, Lei; Yang, Jing; Wang, Xiuwen; Wu, Qingsi; Yin, Shuying; Li, Zhiyuan; Zhang, Jing; Xing, Yue; Chen, Zuojia; Tsun, Andy; Li, Dan; Piccioni, Miranda; Zhang, Yu; Guo, Qiang; Jiang, Lindi; Bao, Liming; Lv, Ling; Li, Bin			The E3 Deubiquitinase USP17 Is a Positive Regulator of Retinoic Acid-related Orphan Nuclear Receptor gamma t (ROR gamma t) in Th17 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TRANSCRIPTION FACTOR FOXP3; GROWTH-FACTOR-BETA; T-H-17 CELLS; T(H)17 CELLS; DIFFERENTIATION; INFLAMMATION; INDUCTION; LINEAGE; PROLIFERATION	Stable retinoic acid-related orphan nuclear receptor gamma t (ROR gamma t) expression is pivotal for the development and function of Th17 cells. Here we demonstrate that expression of the transcription factor ROR gamma t can be regulated through deubiquitination, which prevents proteasome-mediated degradation. We establish that USP17 stabilizes ROR gamma t protein expression by reducing ROR gamma t polyubiquitination at its Lys-360 residue. In contrast, knockdown of endogenous USP17 in Th17 cells resulted in decreased ROR gamma t protein levels and down-regulation of Th17-related genes. Furthermore, USP17 expression was up-regulated in CD4(+) T cells from systemic lupus erythematosus patients. Our data reveal a molecular mechanism in which ROR gamma t expression in Th17 cells can be positively regulated by USP17, thereby modulating Th17 cell functions.	[Han, Lei; Wang, Xiuwen; Tsun, Andy; Li, Dan; Piccioni, Miranda; Lv, Ling] Fudan Univ, Huashan Hosp, Div Rheumatol, Shanghai 200040, Peoples R China; [Yang, Jing; Yin, Shuying; Li, Zhiyuan; Zhang, Jing; Xing, Yue; Chen, Zuojia; Li, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol,Unit Mol Immunol, Shanghai 200032, Peoples R China; [Wu, Qingsi] Anhui Med Univ, Dept Immunol, Hefei 230032, Peoples R China; [Zhang, Yu] Shanghai Jiao Tong Univ, Sch Med, Dept Obstet & Gynecol, Shanghai 200127, Peoples R China; [Guo, Qiang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Rheumatol, Shanghai 200127, Peoples R China; [Jiang, Lindi] Fudan Univ, Zhongshan Hosp, Dept Rheumatol, Shanghai 200032, Peoples R China; [Bao, Liming] Dartmouth Coll, Geisel Sch Med, Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03756 USA	Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Anhui Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University; Dartmouth College	Lv, L (corresponding author), Fudan Univ, Huashan Hosp, Div Rheumatol, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.	huashanlvling@sina.com; binli@sibs.ac.cn	Piccioni, Miranda/X-4530-2018; lI, Bin/AAR-4966-2021; Chen, Zuojia/AAM-9465-2020	Piccioni, Miranda/0000-0002-4434-6770; lI, Bin/0000-0002-7640-8884; xing, yue/0000-0001-5845-2286; Yang, Jing/0000-0001-6441-709X	National Basic Research Program of China (973 Program) [2014CB541803, 2014CB541903, NSFC 81330072, 31370863, 31170825, 31200646, 31200647, 81271835, 81302532, 81270714, 31300711, 31350110505]; National Science and Technology [2012ZX10002007-003, 2013ZX10003009-002, SMCST 11ZR1404900, 14JC1406100]; Knowledge Innovation Program of the Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2012KIP204]; Chinese Academy of Sciences Fellowship for Young International Scientists [2013Y1SB0005]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science and Technology; Knowledge Innovation Program of the Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences Fellowship for Young International Scientists	This work was supported by National Basic Research Program of China (973 Program) Grants 2014CB541803, 2014CB541903, NSFC 81330072, 31370863, 31170825, 31200646, 31200647, 81271835, 81302532, 81270714, 31300711, and 31350110505 and by National Science and Technology Major Project Grants 2012ZX10002007-003, 2013ZX10003009-002, SMCST 11ZR1404900, and 14JC1406100. This work was also supported by the Knowledge Innovation Program of the Shanghai Institutes for Biological Sciences, by Chinese Academy of Sciences Grant 2012KIP204, and by Chinese Academy of Sciences Fellowship for Young International Scientists 2013Y1SB0005.	Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Burrows JF, 2009, J BIOL CHEM, V284, P9587, DOI 10.1074/jbc.M807216200; Burrows JF, 2004, J BIOL CHEM, V279, P13993, DOI 10.1074/jbc.M311291200; Chen DY, 2012, LUPUS, V21, P1385, DOI 10.1177/0961203312457718; Chen R, 2010, CELL RES, V20, P802, DOI 10.1038/cr.2010.41; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; de la Vega M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1243; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Liu XK, 2013, J EXP MED, V210, P1575, DOI 10.1084/jem.20122327; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pernis AB, 2009, J INTERN MED, V265, P644, DOI 10.1111/j.1365-2796.2009.02099.x; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Ratajewski M, 2012, J IMMUNOL, V189, P3034, DOI 10.4049/jimmunol.1200519; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Saito Y, 2014, ARTHRITIS RHEUMATOL, V66, P1185, DOI 10.1002/art.38324; Shin MS, 2011, CURR OPIN RHEUMATOL, V23, P444, DOI 10.1097/BOR.0b013e328349a255; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Tanaka T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001637; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yu YY, 2013, J IMMUNOL, V190, P3054, DOI 10.4049/jimmunol.1203275; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zhang J, 2013, J BIOL CHEM, V288, P9373, DOI 10.1074/jbc.M112.374744; Zhong B, 2012, NAT IMMUNOL, V13, P1110, DOI 10.1038/ni.2427; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	33	46	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25546	25555		10.1074/jbc.M114.565291	http://dx.doi.org/10.1074/jbc.M114.565291			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070893	hybrid, Green Published			2022-12-25	WOS:000342130800016
J	Peffers, MJ; Thorpe, CT; Collins, JA; Eong, R; Wei, TKJ; Screen, HRC; Clegg, PD				Peffers, Mandy J.; Thorpe, Chavaunne T.; Collins, John A.; Eong, Robin; Wei, Timothy K. J.; Screen, Hazel R. C.; Clegg, Peter D.			Proteomic Analysis Reveals Age-related Changes in Tendon Matrix Composition, with Age- and Injury-specific Matrix Fragmentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIGITAL FLEXOR TENDON; ACHILLES-TENDON; MECHANICAL-PROPERTIES; COLLAGEN; PROTEIN; TENDINOPATHY; LIGAMENT; FIBRIL; COMP; GLYCOSAMINOGLYCANS	Energy storing tendons, such as the human Achilles and equine superficial digital flexor tendon (SDFT), are highly prone to injury, the incidence of which increases with aging. The cellular and molecular mechanisms that result in increased injury in aged tendons are not well established but are thought to result in altered matrix turnover. However, little attempt has been made to fully characterize the tendon proteome nor determine how the abundance of specific tendon proteins changes with aging and/or injury. The aim of this study was, therefore, to assess the protein profile of normal SDFTs from young and old horses using label-free relative quantification to identify differentially abundant proteins and peptide fragments between age groups. The protein profile of injured SDFTs from young and old horses was also assessed. The results demonstrate distinct proteomic profiles in young and old tendon, with alterations in the levels of proteins involved in matrix organization and regulation of cell tension. Furthermore, we identified several new peptide fragments (neopeptides) present in aged tendons, suggesting that there are age-specific cleavage patterns within the SDFT. Proteomic profile also differed between young and old injured tendon, with a greater number of neopeptides identified in young injured tendon. This study has increased the knowledge of molecular events associated with tendon aging and injury, suggesting that maintenance and repair of tendon tissue may be reduced in aged individuals and may help to explain why the risk of injury increases with aging.	[Peffers, Mandy J.; Thorpe, Chavaunne T.; Collins, John A.; Eong, Robin; Wei, Timothy K. J.; Clegg, Peter D.] Univ Liverpool, Dept Musculoskeletal Biol, Inst Ageing & Chron Dis, Neston CH64 7TE, Cheshire, England; [Thorpe, Chavaunne T.; Screen, Hazel R. C.] Queen Mary Univ London, Inst Bioengn, London E1 4NS, England; [Eong, Robin; Wei, Timothy K. J.] Ngee Ann Polytech, Sch Life Sci, Singapore 599489, Singapore	University of Liverpool; University of London; Queen Mary University London	Thorpe, CT (corresponding author), Queen Mary Univ London, Inst Bioengn, Sch Engn & Mat Sci, Mile End Rd, London E1 4NS, England.	c.thorpe@qmul.ac.uk	Peffers, Mandy Jayne/AAV-9411-2020; Thorpe, Chavaunne T/T-7289-2018; Screen, Hazel RC/A-2801-2014	Peffers, Mandy Jayne/0000-0001-6979-0440; Thorpe, Chavaunne T/0000-0001-7051-3504; Clegg, Peter/0000-0003-0632-0032	Horserace Betting Levy Board, UK [prj/752]; Biosciences and Biotechnology Research Council, UK [BB/K008412/1]; Wellcome Trust [WT088557MA]; Biotechnology and Biological Sciences Research Council [BB/K00672X/1, BB/K008412/1, BB/K006452/1, BB/K008781/1] Funding Source: researchfish; Medical Research Council [MR/K006312/1] Funding Source: researchfish; BBSRC [BB/K008781/1, BB/K006452/1, BB/K008412/1, BB/K00672X/1] Funding Source: UKRI; MRC [MR/K006312/1] Funding Source: UKRI	Horserace Betting Levy Board, UK; Biosciences and Biotechnology Research Council, UK; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a project grant from the Horserace Betting Levy Board, UK (prj/752) and the Biosciences and Biotechnology Research Council, UK (BB/K008412/1).; Supported by Wellcome Trust Integrated Veterinary Research Training Fellowship WT088557MA.	Avery NC, 2005, SCAND J MED SCI SPOR, V15, P231, DOI 10.1111/j.1600-0838.2005.00464.x; Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200; Biewener AA, 1998, COMP BIOCHEM PHYS B, V120, P73, DOI 10.1016/S0305-0491(98)00024-8; Birch HL, 2008, MATRIX BIOL, V27, P182, DOI 10.1016/j.matbio.2007.10.004; Birch HL, 1999, EQUINE VET J, V31, P391, DOI 10.1111/j.2042-3306.1999.tb03838.x; Birch HL, 1998, EQUINE VET J, V30, P534, DOI 10.1111/j.2042-3306.1998.tb04530.x; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Clayton RAE, 2008, INJURY, V39, P1338, DOI 10.1016/j.injury.2008.06.021; Dakin SG, 2014, VET IMMUNOL IMMUNOP, V158, P121, DOI 10.1016/j.vetimm.2014.01.007; Dakin SG, 2014, J BIOL CHEM, V289, P4919, DOI 10.1074/jbc.M113.511972; Dakin SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048978; Dakin SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032333; de Mos M, 2007, AM J SPORT MED, V35, P1549, DOI 10.1177/0363546507301885; Dwivedi RC, 2010, J PROTEOME RES, V9, P1144, DOI 10.1021/pr900608z; Ely ER, 2009, EQUINE VET J, V41, P372, DOI 10.2746/042516409X371224; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Grant TM, 2013, J ANAT, V222, P573, DOI 10.1111/joa.12048; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; Han GY, 2011, EXP BIOL MED, V236, P783, DOI 10.1258/ebm.2011.010358; Innes JF, 2010, RHEUMATOLOGY, V49, P1030, DOI 10.1093/rheumatology/kep465; Izu Y, 2011, MATRIX BIOL, V30, P53, DOI 10.1016/j.matbio.2010.10.001; Jiang YK, 2011, BIOMATERIALS, V32, P4085, DOI 10.1016/j.biomaterials.2011.02.033; Jielile J, 2012, NEURAL REGEN RES, V7, P2801, DOI 10.3969/j.issn.1673-5374.2012.35.008; Jielile J, 2011, APPL BIOCHEM BIOTECH, V165, P1092, DOI 10.1007/s12010-011-9327-7; Kalamajski S, 2009, BIOCHEM J, V423, P53, DOI 10.1042/BJ20090542; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Kasashima Y, 2004, EQUINE VET J, V36, P346, DOI 10.2746/0425164044890580; KASTELIC J, 1978, CONNECT TISSUE RES, V6, P11, DOI 10.3109/03008207809152283; Kobayashi A, 1999, J COMP PATHOL, V120, P403, DOI 10.1053/jcpa.1998.0288; Kujala UM, 2005, CLIN J SPORT MED, V15, P133, DOI 10.1097/01.jsm.0000165347.55638.23; Legerlotz K, 2010, J BIOMECH, V43, P2274, DOI 10.1016/j.jbiomech.2010.04.040; Lichtwark GA, 2005, J EXP BIOL, V208, P4715, DOI 10.1242/jeb.01950; Lodish H. B., 2000, MOL CELL BIOL, p806 ; Loeser RF, 2010, CLIN GERIATR MED, V26, P371, DOI 10.1016/j.cger.2010.03.002; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; McLean L, 2007, J CHEM ECOL, V33, P1997, DOI 10.1007/s10886-007-9354-6; Millar NL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/436203; Pan TC, 2013, J BIOL CHEM, V288, P14320, DOI 10.1074/jbc.M112.433078; Patterson-Kane JC, 2009, VET J, V181, P79, DOI 10.1016/j.tvjl.2008.02.009; Peffers MJ, 2013, INT J MOL SCI, V14, P20658, DOI 10.3390/ijms141020658; Peffers MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4278; Provenzano PP, 2006, MATRIX BIOL, V25, P71, DOI 10.1016/j.matbio.2005.09.005; Redaelli A, 2003, J BIOMECH, V36, P1555, DOI 10.1016/S0021-9290(03)00133-7; RILEY GP, 1994, ANN RHEUM DIS, V53, P367, DOI 10.1136/ard.53.6.367; Riley G, 2008, NAT CLIN PRACT RHEUM, V4, P82, DOI 10.1038/ncprheum0700; Rousseau JC, 2007, NAT CLIN PRACT RHEUM, V3, P346, DOI 10.1038/ncprheum0508; September AV, 2009, BRIT J SPORT MED, V43, P357, DOI 10.1136/bjsm.2008.048793; Smith RKW, 1997, MATRIX BIOL, V16, P255, DOI 10.1016/S0945-053X(97)90014-7; Smith RKW, 2002, EQUINE VET J, V34, P726, DOI 10.2746/042516402776250423; Smith SM, 2012, CONNECT TISSUE RES, V53, P2, DOI 10.3109/03008207.2011.602766; Sodersten F, 2013, CONNECT TISSUE RES, V54, P62, DOI 10.3109/03008207.2012.734879; Tasheva ES, 2002, MOL VIS, V8, P407; Taylor SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016337; Thorpe CT, 2013, INT J EXP PATHOL, V94, P248, DOI 10.1111/iep.12027; Thorpe CT, 2013, EUR CELLS MATER, V25, P48, DOI 10.22203/eCM.v025a04; Thorpe CT, 2012, J R SOC INTERFACE, V9, P3108, DOI 10.1098/rsif.2012.0362; Thorpe CT, 2010, J BIOL CHEM, V285, P15674, DOI 10.1074/jbc.M109.077503; Tully LJ, 2014, EQUINE VET J, V46, P289, DOI 10.1111/evj.12134; WEBBON PM, 1977, EQUINE VET J, V9, P61, DOI 10.1111/j.2042-3306.1977.tb03981.x; Weist S, 2008, PROTEOMICS, V8, P3389, DOI 10.1002/pmic.200800236; Wilson R, 2010, MOL CELL PROTEOMICS, V9, P1296, DOI 10.1074/mcp.M000014-MCP201; Yoon J. H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P22; Zhang GY, 2003, J ANAT, V202, P411, DOI 10.1046/j.1469-7580.2003.00174.x	63	60	60	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25867	25878		10.1074/jbc.M114.566554	http://dx.doi.org/10.1074/jbc.M114.566554			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25077967	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000342130800043
J	Adkins, I; Kamanova, J; Kocourkova, A; Svedova, M; Tomala, J; Janova, H; Masin, J; Chladkova, B; Bumba, L; Kovar, M; Ross, PJ; Tuckova, L; Spisek, R; Mills, KHG; Sebo, P				Adkins, Irena; Kamanova, Jana; Kocourkova, Aneta; Svedova, Martina; Tomala, Jakub; Janova, Hana; Masin, Jiri; Chladkova, Barbora; Bumba, Ladislav; Kovar, Marek; Ross, Padraig J.; Tuckova, Ludmila; Spisek, Radek; Mills, Kingston H. G.; Sebo, Peter			Bordetella Adenylate Cyclase Toxin Differentially Modulates Toll-Like Receptor-Stimulated Activation, Migration and T Cell Stimulatory Capacity of Dendritic Cells	PLOS ONE			English	Article							RESPIRATORY-INFECTION; INTERLEUKIN-10 PRODUCTION; PROTECTIVE IMMUNITY; IL-12 PRODUCTION; PERTUSSIS TOXIN; 3RD SIGNAL; RESPONSES; INHIBITION; BINDING; MOLECULE	Adenylate cyclase toxin (CyaA) is a key virulence factor of the whooping cough agent Bordetella pertussis. The toxin targets CD11b-expressing phagocytes and delivers into their cytosol an adenylyl cyclase (AC) enzyme that subverts cellular signaling by increasing cAMP levels. In the present study, we analyzed the modulatory effects of CyaA on adhesive, migratory and antigen presenting properties of Toll-like receptor (TLR)-activated murine and human dendritic cells (DCs). cAMP signaling of CyaA enhanced TLR-induced dissolution of cell adhesive contacts and migration of DCs towards the lymph node-homing chemokines CCL19 and CCL21 in vitro. Moreover, we examined in detail the capacity of toxin-treated DCs to induce CD4(+) and CD8(+) T cell responses. Exposure to CyaA decreased the capacity of LPS-stimulated DCs to present soluble protein antigen to CD4(+) T cells independently of modulation of co-stimulatory molecules and cytokine production, and enhanced their capacity to promote CD4(+) CD25(+) Foxp3(+) T regulatory cells in vitro. In addition, CyaA decreased the capacity of LPS-stimulated DCs to induce CD8(+) T cell proliferation and limited the induction of IFN-gamma producing CD8(+) T cells while enhancing IL-10 and IL-17-production. These results indicate that through activation of cAMP signaling, the CyaA may be mobilizing DCs impaired in T cell stimulatory capacity and arrival of such DCs into draining lymph nodes may than contribute to delay and subversion of host immune responses during B. pertussis infection.	[Adkins, Irena; Kamanova, Jana; Svedova, Martina; Janova, Hana; Masin, Jiri; Bumba, Ladislav; Sebo, Peter] Acad Sci Czech Republ, Inst Microbiol, Lab Mol Biol Bacterial Pathogens, Prague, Czech Republic; [Tomala, Jakub; Kovar, Marek] Acad Sci Czech Republ, Inst Microbiol, Lab Tumor Immunol, Prague, Czech Republic; [Chladkova, Barbora; Tuckova, Ludmila] Acad Sci Czech Republ, Inst Microbiol, Lab Specif Cellular Immun, Prague, Czech Republic; [Kocourkova, Aneta; Spisek, Radek] Charles Univ Prague, Fac Med 2, Inst Immunol, Prague, Czech Republic; [Kocourkova, Aneta; Spisek, Radek] Univ Hosp Motol, Prague, Czech Republic; [Mills, Kingston H. G.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Immune Regulat Res Grp, Dublin 2, Ireland	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; Motol University Hospital; Trinity College Dublin	Adkins, I (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Lab Mol Biol Bacterial Pathogens, Prague, Czech Republic.	adkins@sotio.com	Mills, Kingston H/F-5684-2013; Bumba, Ladislav/ABC-9943-2020; Kovar, Marek/H-7793-2014; Bumba, Ladislav/H-2494-2014; Tomala, Jakub/J-6042-2014; SEBO, Peter/N-2043-2019; Kamanova, Jana/Q-4477-2017; Masin, Jiri/H-3125-2014; Chládková, Barbora/J-6882-2014; SEBO, Peter/F-7423-2011	Mills, Kingston H/0000-0003-3646-8222; Bumba, Ladislav/0000-0001-6659-5447; Tomala, Jakub/0000-0002-6315-2832; SEBO, Peter/0000-0002-9755-7715; Kamanova, Jana/0000-0001-6574-4404; SEBO, Peter/0000-0002-9755-7715; Masin, Jiri/0000-0001-6258-4599	National Science Foundation of the Czech Republic [GA310/08/0447, GA310/09/P582, P301/11/0325]; Czech Ministry of Health [IGA NT12402-5]; Science Foundation Ireland [06/IN.1/B87]; Ministry of Education of Czech Republic; Charles University in Prague, Czech Republic [33779266]; FEBS short-term fellowship;  [1M0506]	National Science Foundation of the Czech Republic; Czech Ministry of Health(Ministry of Health, Czech Republic); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Ministry of Education of Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague, Czech Republic(Czech Republic Government); FEBS short-term fellowship; 	This work was supported by the grant No. GA310/08/0447 (to PS), No. GA310/09/P582 (to IA) and No. P301/11/0325 (to MK) of the National Science Foundation of the Czech Republic, the Research center 1M0506, and by research grant IGA NT12402-5 from the Czech Ministry of Health. KM and PR are supported by a principal investigator grant (06/IN.1/B87) from Science Foundation Ireland. MS was a recipient of a stipend from the Ministry of Education of Czech Republic and of the support from the Specific Research Project No. 33779266 of the Charles University in Prague, Czech Republic. The support from a FEBS short-term fellowship granted to IA is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins I, 2008, MICROBES INFECT, V10, P798, DOI 10.1016/j.micinf.2008.04.014; Anderson P, 2010, MOL CELL BIOL, V30, P2537, DOI 10.1128/MCB.01282-09; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Bagley KC, 2002, J LEUKOCYTE BIOL, V72, P962; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bartoszewski R, 2011, J BIOL CHEM, V286, P41862, DOI 10.1074/jbc.M111.304956; Basler M, 2006, INFECT IMMUN, V74, P2207, DOI 10.1128/IAI.74.4.2207-2214.2006; Boschwitz JS, 1997, J INFECT DIS, V176, P678, DOI 10.1086/514090; Boyd AP, 2005, J IMMUNOL, V175, P730, DOI 10.4049/jimmunol.175.2.730; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Challier J, 2013, IMMUNOLOGY, V138, P402, DOI 10.1111/imm.12053; Coleman MM, 2012, FEMS IMMUNOL MED MIC, V64, P413, DOI 10.1111/j.1574-695X.2011.00927.x; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; Day PM, 1997, P NATL ACAD SCI USA, V94, P8064, DOI 10.1073/pnas.94.15.8064; de Gouw D, 2011, FEMS MICROBIOL REV, V35, P441, DOI 10.1111/j.1574-6976.2010.00257.x; Dirix V, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/795958; Dunne A, 2010, J IMMUNOL, V185, P1711, DOI 10.4049/jimmunol.1000105; Dunne PJ, 2009, J IMMUNOL, V183, P400, DOI 10.4049/jimmunol.0900169; Eby JC, 2013, INFECT IMMUN, V81, P1390, DOI 10.1128/IAI.00110-13; Fedele G, 2011, J IMMUNOL, V186, P5388, DOI 10.4049/jimmunol.1003765; Fedele G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008734; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; Granados DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-10; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hickey FB, 2008, J LEUKOCYTE BIOL, V84, P234, DOI 10.1189/jlb.0208113; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Higgs R, 2012, MUCOSAL IMMUNOL, V5, P485, DOI 10.1038/mi.2012.54; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kamanova J, 2008, J IMMUNOL, V181, P5587, DOI 10.4049/jimmunol.181.8.5587; KHELEF N, 1993, INFECT IMMUN, V61, P4064, DOI 10.1128/IAI.61.10.4064-4071.1993; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; Lamberti YA, 2010, INFECT IMMUN, V78, P907, DOI 10.1128/IAI.01031-09; Leef M, 2000, J EXP MED, V191, P1841, DOI 10.1084/jem.191.11.1841; Lutz MB, 1997, J IMMUNOL, V159, P3707; Masin J, 2005, BIOCHEMISTRY-US, V44, P12759, DOI 10.1021/bi050459b; Matousek MP, 1998, INFECT IMMUN, V66, P3480, DOI 10.1128/IAI.66.7.3480-3484.1998; Matousek MP, 1996, J IMMUNOL, V156, P4137; McGuirk P, 2000, EUR J IMMUNOL, V30, P415, DOI 10.1002/1521-4141(200002)30:2<415::AID-IMMU415>3.3.CO;2-O; McGuirk P, 1998, EUR J IMMUNOL, V28, P153, DOI 10.1002/(SICI)1521-4141(199801)28:01<153::AID-IMMU153>3.3.CO;2-R; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; MILLS KHG, 1993, INFECT IMMUN, V61, P399, DOI 10.1128/IAI.61.2.399-410.1993; Paccani SR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000325; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; PEARSON RD, 1987, J IMMUNOL, V139, P2749; Plotkin SA, 2014, CLIN INFECT DIS, V58, P830, DOI 10.1093/cid/cit934; Ricart BG, 2011, J IMMUNOL, V186, P53, DOI 10.4049/jimmunol.1002358; Rieber N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017271; Ross PJ, 2004, INFECT IMMUN, V72, P1568, DOI 10.1128/IAI.72.3.1568-1579.2004; Schmidt CS, 2002, J IMMUNOL, V168, P5521, DOI 10.4049/jimmunol.168.11.5521; Spensieri F, 2006, INFECT IMMUN, V74, P2831, DOI 10.1128/IAI.74.5.2831-2838.2006; Spisek R, 2004, VACCINE, V22, P2761, DOI 10.1016/j.vaccine.2004.01.006; Tanaka Y, 1999, EUR J IMMUNOL, V29, P1561; Tartz S, 2006, INFECT IMMUN, V74, P2277, DOI 10.1128/IAI.74.4.2277-2285.2006; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011	57	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e104064	10.1371/journal.pone.0104064	http://dx.doi.org/10.1371/journal.pone.0104064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084094	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800123
J	Arroteia, KF; Barbieri, MF; Souza, GHMF; Tanaka, H; Eberlin, MN; Hyslop, S; Alvares, LE; Pereira, LAVD				Arroteia, Kelen Fabiola; Barbieri, Mainara Ferreira; Martins Ferreira Souza, Gustavo Henrique; Tanaka, Hiromitsu; Eberlin, Marcos Nogueira; Hyslop, Stephen; Alvares, Lucia Elvira; Violin Dias Pereira, Luis Antonio			Albumin Is Synthesized in Epididymis and Aggregates in a High Molecular Mass Glycoprotein Complex Involved in Sperm-Egg Fertilization	PLOS ONE			English	Article							RAT EPIDIDYMIS; CYSTATIN CRES; PROTEINS; SPERMATOZOA; IDENTIFICATION; EXPRESSION; ANTIGEN; MICE; MATURATION; FERTILITY	The epididymis has an important role in the maturation of sperm for fertilization, but little is known about the epididymal molecules involved in sperm modifications during this process. We have previously described the expression pattern for an antigen in epididymal epithelial cells that reacts with the monoclonal antibody (mAb) TRA 54. Immunohistochemical and immunoblotting analyses suggest that the epitope of the epididymal antigen probably involves a sugar moiety that is released into the epididymal lumen in an androgen-dependent manner and subsequently binds to luminal sperm. Using column chromatography, SDS-PAGE with in situ digestion and mass spectrometry, we have identified the protein recognized by mAb TRA 54 in mouse epididymal epithelial cells. The similar to 65 kDa protein is part of a high molecular mass complex (similar to 260 kDa) that is also present in the sperm acrosomal vesicle and is completely released after the acrosomal reaction. The amino acid sequence of the protein corresponded to that of albumin. Immunoprecipitates with anti-albumin antibody contained the antigen recognized by mAb TRA 54, indicating that the epididymal molecule recognized by mAb TRA 54 is albumin. RT-PCR detected albumin mRNA in the epididymis and fertilization assays in vitro showed that the glycoprotein complex containing albumin was involved in the ability of sperm to recognize and penetrate the egg zona pellucida. Together, these results indicate that epididymal-derived albumin participates in the formation of a high molecular mass glycoprotein complex that has an important role in egg fertilization.	[Arroteia, Kelen Fabiola; Barbieri, Mainara Ferreira; Alvares, Lucia Elvira; Violin Dias Pereira, Luis Antonio] State Univ Campinas UNICAMP, Inst Biol, Dept Histol & Embryol, Campinas, SP, Brazil; [Martins Ferreira Souza, Gustavo Henrique; Hyslop, Stephen] State Univ Campinas UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil; [Martins Ferreira Souza, Gustavo Henrique; Eberlin, Marcos Nogueira] State Univ Campinas UNICAMP, Inst Chem, Dept Organ Chem, ThoMSon Mass Spectrometry Lab, Campinas, SP, Brazil; [Tanaka, Hiromitsu] Nagasaki Int Univ, Fac Pharmaceut Sci, Nagasaki, Japan	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Nagasaki International University	Pereira, LAVD (corresponding author), State Univ Campinas UNICAMP, Inst Biol, Dept Histol & Embryol, Campinas, SP, Brazil.	lviolin@unicamp.br	Alvares, Lúcia Elvira E/O-6557-2014; Pereira, Luis A V D/A-5263-2019; SOUZA, GUSTAVO HENRIQUE MARTINS FERREIRA/B-5101-2017; Pereira, Luís Antônio Violin Dias/C-5570-2014; Hyslop, Stephen/F-2910-2012	Alvares, Lúcia Elvira E/0000-0002-2229-8966; SOUZA, GUSTAVO HENRIQUE MARTINS FERREIRA/0000-0002-9410-8578; Pereira, Luís Antônio Violin Dias/0000-0002-9332-7285; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [130779/2012-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [01/12773-7, 01/00016-7, 05/04007-3]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	KFA and MFB were supported by a PhD and MSc scholarship, from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; http://www.capes.gov.br) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; http://www.cnpq.br, grant number 130779/2012-1), respectively. GHMFS was supported by a PhD scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). MNE and SH were supported by research fellowships from Conselho Nacional de Pesquisa e Desenvolvimento Cientifico (CNPq). This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; http://www.fapesp.br, grant numbers 01/12773-7, 01/00016-7 and 05/04007-3) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002829; Arroteia KF, 2004, J ANDROL, V25, P914; Boue F, 1996, BIOL REPROD, V54, P1018, DOI 10.1095/biolreprod54.5.1018; BROOKS DE, 1980, J REPROD FERTIL, V59, P363, DOI 10.1530/jrf.0.0590363; Brooks DE, 1998, ANN NY ACAD SCI, V513, P179; CARLES C, 1992, REPROD NUTR DEV, V32, P277, DOI 10.1051/rnd:19920307; Castella S, 2004, BIOL REPROD, V70, P319, DOI 10.1095/biolreprod.103.022459; Chau KM, 2011, BIOL REPROD, V84, P140, DOI 10.1095/biolreprod.110.084855; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Dacheux JL, 2009, MOL CELL ENDOCRINOL, V306, P45, DOI 10.1016/j.mce.2009.03.007; Dacheux JL, 2005, THERIOGENOLOGY, V63, P319, DOI 10.1016/j.theriogenology.2004.09.015; DACHEUX JL, 1987, ANN NY ACAD SCI, V513, P560, DOI 10.1111/j.1749-6632.1987.tb25107.x; FOURNIERDELPECH S, 1988, REPROD NUTR DEV, V28, P1283, DOI 10.1051/rnd:19880809; FOURNIERDELPECH S, 1988, CR ACAD SCI III-VIE, V306, P333; FournierDelpech S, 1997, MOL REPROD DEV, V47, P483, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;483::AID-MRD15&gt;3.0.CO;2-X; FOURNIERDELPECH S, 1985, J ANDROL, V6, P246; Hall JC, 1996, BIOL REPROD, V54, P914, DOI 10.1095/biolreprod54.4.914; Hamil KG, 2000, ENDOCRINOLOGY, V141, P1245, DOI 10.1210/en.141.3.1245; Heisig M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-163; Kaunisto K, 1999, BIOL REPROD, V61, P1521, DOI 10.1095/biolreprod61.6.1521; Kirchhoff C, 1998, ANDROLOGIA, V30, P225; Kirchhoff C, 1996, MOL HUM REPROD, V2, P177, DOI 10.1093/molehr/2.3.177; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larson JL, 1999, MOL REPROD DEV, V52, P445, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;445::AID-MRD14&gt;3.0.CO;2-6; LEE SH, 1987, J REPROD FERTIL, V80, P65, DOI 10.1530/jrf.0.0800065; Legare C, 1999, ENDOCRINOLOGY, V140, P3318, DOI 10.1210/en.140.7.3318; Lokhov PG, 2004, PROTEOMICS, V4, P633, DOI 10.1002/pmic.200300580; MAHADEVAN MM, 1985, FERTIL STERIL, V43, P263; Manandhar G, 2001, BIOL REPROD, V65, P1425, DOI 10.1095/biolreprod65.5.1425; Mathur PP, 2000, ASIAN J ANDROL, V2, P57; NAHON JL, 1988, J BIOL CHEM, V263, P11436; Nishio H, 1996, P NATL ACAD SCI USA, V93, P7557, DOI 10.1073/pnas.93.15.7557; Pereira LAVD, 1998, INT J ANDROL, V21, P34; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PRIMAKOFF P, 1994, AM J REPROD IMMUNOL, V31, P208, DOI 10.1111/j.1600-0897.1994.tb00869.x; Saxena DK, 1999, J REPROD FERTIL, V117, P17, DOI 10.1530/jrf.0.1170017; Shamay A, 2005, J DAIRY SCI, V88, P569, DOI 10.3168/jds.S0022-0302(05)72719-3; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sipila P, 2002, MOL ENDOCRINOL, V16, P2603, DOI 10.1210/me.2002-0100; TANPHAICHITR N, 1994, MOL REPROD DEV, V37, P326, DOI 10.1002/mrd.1080370312; TAO J, 1993, MOL REPROD DEV, V36, P183, DOI 10.1002/mrd.1080360209; TULSIANI DRP, 1993, BIOL REPROD, V48, P417, DOI 10.1095/biolreprod48.2.417; Ventela S, 2003, MOL BIOL CELL, V14, P2768, DOI 10.1091/mbc.E02-10-0647; von Horsten HH, 2007, J BIOL CHEM, V282, P32912, DOI 10.1074/jbc.M703956200; Wassler M, 2002, BIOL REPROD, V67, P795, DOI 10.1095/biolreprod.102.003970; WATANABE D, 1992, MOL REPROD DEV, V33, P307, DOI 10.1002/mrd.1080330312	46	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103566	10.1371/journal.pone.0103566	http://dx.doi.org/10.1371/journal.pone.0103566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084016	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800052
J	Gerzova, L; Videnska, P; Faldynova, M; Sedlar, K; Provaznik, I; Cizek, A; Rychlik, I				Gerzova, Lenka; Videnska, Petra; Faldynova, Marcela; Sedlar, Karel; Provaznik, Ivo; Cizek, Alois; Rychlik, Ivan			Characterization of Microbiota Composition and Presence of Selected Antibiotic Resistance Genes in Carriage Water of Ornamental Fish	PLOS ONE			English	Article							REAL-TIME PCR; ANTIMICROBIAL RESISTANCE; BACTERIAL COMMUNITIES; TREATMENT-PLANT; GUT MICROBIOTA; QUANTIFICATION; PREVALENCE; INTEGRONS; TETRACYCLINE; PLASMID	International trade with ornamental fish is gradually recognized as an important source of a wide range of different antibiotic resistant bacteria. In this study we therefore characterized the prevalence of selected antibiotic resistance genes in the microbiota found in the carriage water of ornamental fish originating from 3 different continents. Real-time PCR quantification showed that the sul1 gene was present in 11 out of 100 bacteria. tet(A) was present in 6 out of 100 bacteria and strA, tet(G), sul2 and aadA were present in 1-2 copies per 100 bacteria. Class I integrons were quite common in carriage water microbiota, however, pyrosequencing showed that only 12 different antibiotic gene cassettes were present in class I integrons. The microbiota characterized by pyrosequencing of the V3/V4 variable region of 16S rRNA genes consisted of Proteobacteria (48%), Bacteroidetes (29.5%), Firmicutes (17.8%), Actinobacteria (2.1%) and Fusobacteria (1.6%). Correlation analysis between antibiotic resistance gene prevalence and microbiota composition verified by bacterial culture showed that major reservoirs of sul1 sul2, tet(A), tet(B) tet(G), cat, cml, bla, strA, aacA, aph and aadA could be found among Alpha-, Beta-and Gammaproteobacteria with representatives of Enterobacteriaceae, Pseudomonadaceae, Rhizobiaceae and Comamonadaceae being those most positively associated with the tested antibiotic resistance genes.	[Gerzova, Lenka; Videnska, Petra; Faldynova, Marcela; Rychlik, Ivan] Vet Res Inst, CS-62132 Brno, Czech Republic; [Sedlar, Karel; Provaznik, Ivo] Brno Univ Technol, Dept Biomed Engn, CS-61090 Brno, Czech Republic; [Cizek, Alois] Univ Vet & Pharmaceut Sci, Brno, Czech Republic	Czech Veterinary Research Institute; Brno University of Technology; University of Veterinary Sciences Brno	Rychlik, I (corresponding author), Vet Res Inst, CS-62132 Brno, Czech Republic.	rychlik@vri.cz	Sedlar, Karel/K-1120-2014; , Ivan/GPS-9674-2022; Cizek, Alois/G-8833-2014; Provaznik, Ivo/F-4121-2012	Sedlar, Karel/0000-0002-8269-4020; , Ivan/0000-0001-7995-6483; Cizek, Alois/0000-0001-5706-4601; Provaznik, Ivo/0000-0002-3422-7938	PROMISE project 7th Framework Programme of Czech Ministry of Agriculture [MZE0002716202]; Czech Ministry of Education [CZ.1.05/2.1.00/01.0006-ED0006/01/01]; CEITEC, project of the European Regional Development Fund [CZ.1.05/1.1.00/02.0068]	PROMISE project 7th Framework Programme of Czech Ministry of Agriculture; Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); CEITEC, project of the European Regional Development Fund	This study was supported by PROMISE project 7th Framework Programme, project MZE0002716202 of the Czech Ministry of Agriculture and AdmireVet project CZ.1.05/2.1.00/01.0006-ED0006/01/01 from the Czech Ministry of Education. A. Cizek was also supported by CEITEC, project of the European Regional Development Fund (CZ.1.05/1.1.00/02.0068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen J, 2007, APPL ENVIRON MICROB, V73, P4407, DOI 10.1128/AEM.02799-06; Cizek A, 2010, VET MICROBIOL, V142, P435, DOI 10.1016/j.vetmic.2009.10.001; Faldynova M, 2013, VET MED-CZECH, V58, P298, DOI 10.17221/6865-VETMED; GALIMAND M, 1993, ANTIMICROB AGENTS CH, V37, P1456, DOI 10.1128/AAC.37.7.1456; Geraylou Z, 2013, FEMS MICROBIOL ECOL, V86, P357, DOI 10.1111/1574-6941.12169; HOPKINS JD, 1991, ANTIMICROB AGENTS CH, V35, P1605, DOI 10.1128/AAC.35.8.1605; Hradecka H, 2008, J ANTIMICROB CHEMOTH, V62, P938, DOI 10.1093/jac/dkn286; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Lim LC, 2003, AQUAC RES, V34, P923, DOI 10.1046/j.1365-2109.2003.00946.x; Lin CH, 2007, FEBS J, V274, P2946, DOI 10.1111/j.1742-4658.2007.05828.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mann E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086950; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Matulova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048101; Moura A, 2007, J ANTIMICROB CHEMOTH, V60, P1243, DOI 10.1093/jac/dkm340; Roe MT, 2003, EMERG INFECT DIS, V9, P822, DOI 10.3201/eid0907.020529; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; Tseng CP, 2003, CLIN CHEM, V49, P306, DOI 10.1373/49.2.306; Vaz-Moreira I, 2011, ANTON LEEUW INT J G, V100, P245, DOI 10.1007/s10482-011-9583-0; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Verner-Jeffreys DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008388; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-30; Ye L, 2013, APPL MICROBIOL BIOT, V97, P2681, DOI 10.1007/s00253-012-4082-4; Yu ZT, 2005, APPL ENVIRON MICROB, V71, P6926, DOI 10.1128/AEM.71.11.6926-6933.2005; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P397, DOI 10.1007/s00253-008-1829-z	30	28	29	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103865	10.1371/journal.pone.0103865	http://dx.doi.org/10.1371/journal.pone.0103865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084116	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800093
J	Ma, LJ; Liu, HM; Xie, ZL; Yang, SA; Xu, W; Hou, JB; Yu, B				Ma, Lijia; Liu, Huimin; Xie, Zulong; Yang, Shuang; Xu, Wei; Hou, Jingbo; Yu, Bo			Ginsenoside Rb3 Protects Cardiomyocytes against Ischemia-Reperfusion Injury via the Inhibition of JNK-Mediated NF-kappa B Pathway: A Mouse Cardiomyocyte Model	PLOS ONE			English	Article							MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; PC12 CELLS; MATRIX METALLOPROTEINASE-2; SIGNALING PATHWAYS; IN-VITRO; ACTIVATION; EXPRESSION; APOPTOSIS; INFLAMMATION; DEATH	Ginsenoside Rb3 is extracted from the plant Panax ginseng and plays important roles in cardiovascular diseases, including myocardial ischemia-reperfusion (I/R) injury. NF-kappa B is an important transcription factor involved in I/R injury. However, the underlying mechanism of ginsenoside Rb3 in myocardial I/R injury remains poorly understood. In the current study, a model of myocardial I/R injury was induced via oxygen and glucose deprivation (OGD) followed by reperfusion (OGD-Rep) in mouse cardiac myoblast H9c2 cells. Our data demonstrate that ginsenoside Rb3 suppresses OGD-Rep-induced cell apoptosis by the suppression of ROS generation. By detecting the NF-kappa B signaling pathway, we discover that the protective effect of ginsenoside Rb3 on the OGD-Rep injury is closely related to the inhibition of NF-kappa B activity. Ginsenoside Rb3 inhibits the upregulation of phospho-I kappa B-alpha and nuclear translocation of NF-kappa B subunit p65 which are induced by ORD-Rep injury. In addition, the extract also inhibits the OGD-Rep-induced increase in the expression of inflammation-related factors, such as IL-6, TNF-alpha, monocyte chemotactic protein-1 (MCP-1), MMP-2 and MMP-9. However, LPS treatment alleviates the protective roles of ginsenoside Rb3 and activates the NF-kappa B pathway. Finally, the upstream factors of NF-kappa B were analyzed, including the Akt/Foxo3a and MAPK signaling pathways. We find that ginsenoside Rb3 pretreatment only decreases the phosphorylation of JNK induced by OGD-Rep injury, an indicator of the MAPK pathway. Importantly, an inhibitor of phospho-JNK, SP600125, protects against OGD-Rep induced apoptosis and inhibited NF-kappa B signaling pathway, similar to the roles of ginsenoside Rb3. Taken together, our results demonstrate that the protective effect of ginsenoside Rb3 on the OGD-Rep injury is attributed to the inhibition of JNK-mediated NF-kappa B activation, suggesting that ginsenoside Rb3 has the potential to serve as a novel therapeutic agent for myocardial I/R injury.	[Ma, Lijia; Liu, Huimin; Xie, Zulong; Yang, Shuang; Xu, Wei; Hou, Jingbo; Yu, Bo] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Key Lab Myocardial Ischemia Mech & Treatment Mini, Harbin 150006, Heilongjiang, Peoples R China	Harbin Medical University	Yu, B (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Key Lab Myocardial Ischemia Mech & Treatment Mini, Harbin 150006, Heilongjiang, Peoples R China.	yubo200012@163.com		Hou, Jingbo/0000-0002-9671-5099; Yu, Bo/0000-0002-2045-8567	State natural key project [81330033/H18]; National Natural Science Foundation of China [81171430/H1816]	State natural key project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the State natural key project (No: 81330033/H18, the effect of NF-kappaB signaling pathway on the interaction between the bracket and vascular wall) and the National Natural Science Foundation of China (No: 81171430/H1816, Studying the effect of stent thrombosis on the intimal healing mode and its regulation mechanism by the application of VIVI-OCT). The URL is http://isisn.nsfc.gov.cn/egrantweb/contract/index. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chauhan D, 1996, BLOOD, V87, P1104, DOI 10.1182/blood.V87.3.1104.bloodjournal8731104; Cheung PY, 2000, CIRCULATION, V101, P1833, DOI 10.1161/01.CIR.101.15.1833; Chung JW, 2012, ARCH PHARM RES, V35, P723, DOI 10.1007/s12272-012-0417-z; Ekshyyan O, 2004, FRONT BIOSCI-LANDMRK, V9, P1567, DOI 10.2741/1357; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Gross GJ, 2007, J MOL CELL CARDIOL, V42, P12, DOI 10.1016/j.yjmcc.2006.09.009; Gu JH, 2012, EUR J PHARM SCI, V47, P652, DOI 10.1016/j.ejps.2012.07.016; Higa JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045082; Himaya SWA, 2012, TOXICOL IN VITRO, V26, P878, DOI 10.1016/j.tiv.2012.04.022; Kang CH, 2013, INT IMMUNOPHARMACOL; Kim MS, 2012, J TOXICOL SCI, V37, P1275, DOI 10.2131/jts.37.1275; Kim SO, 2013, EVID-BASED COMPL ALT, V2013; Kim YS, 2010, INT HEART J, V51, P348, DOI 10.1536/ihj.51.348; Lee CS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/580135; Liu QA, 2011, NEUROCHEM INT, V58, P119, DOI 10.1016/j.neuint.2010.11.004; Lu CY, 2013, ACTA TROP, V127, P14, DOI 10.1016/j.actatropica.2013.03.004; Mestre JR, 2001, J BIOL CHEM, V276, P3977, DOI 10.1074/jbc.M005077200; Mozaffari MS, 2013, AM J CARDIOVASC DIS, V3, P180; Nakamura M, 2000, CARDIOVASC RES, V45, P661, DOI 10.1016/S0008-6363(99)00393-4; Onai Y, 2004, CARDIOVASC RES, V63, P51, DOI 10.1016/j.cardiores.2004.03.002; Palladini G, 2014, SCI WORLD J, DOI 10.1155/2014/867548; Pan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079084; Parks RJ, 2018, METHODS MOL BIOL, V1782, P187, DOI [10.1007/978-1-61779-382-0_15, 10.1007/978-1-4939-7831-1_11]; Poynter JA, 2011, J AM COLL SURGEONS, V213, P253, DOI 10.1016/j.jamcollsurg.2011.04.005; Qi LW, 2011, PHYTOCHEMISTRY, V72, P689, DOI 10.1016/j.phytochem.2011.02.012; Ramachandran S, 2012, TRANSPL IMMUNOL, V26, P201, DOI 10.1016/j.trim.2012.01.001; Stokes SE, 2013, TOXICOL SCI; Tabakman R, 2005, ANN NY ACAD SCI, V1053, P84, DOI 10.1196/annals.1344.008; Thirunavukkarasu M, 2008, J AGR FOOD CHEM, V56, P6733, DOI 10.1021/jf801473v; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang X, 2013, J MOL HISTOL; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070956; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Xiao XH, 2008, EUR J PHARMACOL, V591, P21, DOI 10.1016/j.ejphar.2008.06.045; Zhu JR, 2010, ACTA PHARMACOL SIN, V31, P273, DOI 10.1038/aps.2010.9	35	84	86	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103628	10.1371/journal.pone.0103628	http://dx.doi.org/10.1371/journal.pone.0103628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084093	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800063
J	Kunicka, T; Vaclavikova, R; Hlavac, V; Vrana, D; Pecha, V; Raus, K; Trnkova, M; Kubackova, K; Ambrus, M; Vodickova, L; Vodicka, P; Soucek, P				Kunicka, Tereza; Vaclavikova, Radka; Hlavac, Viktor; Vrana, David; Pecha, Vaclav; Raus, Karel; Trnkova, Marketa; Kubackova, Katerina; Ambrus, Miloslav; Vodickova, Ludmila; Vodicka, Pavel; Soucek, Pavel			Non-Coding Polymorphisms in Nucleotide Binding Domain 1 in ABCC1 Gene Associate with Transcript Level and Survival of Patients with Breast Cancer	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE PROTEIN-1; TRANSPORTER GENES; MRP1 GENE; EXPRESSION; CHEMOTHERAPY; CELLS; MRP1/ABCC1; MUTATIONS; CARCINOMA; SUBTYPES	Objectives: ATP-Binding Cassette (ABC) transporters may cause treatment failure by transporting of anticancer drugs outside of the tumor cells. Multidrug resistance-associated protein 1 coded by the ABCC1 gene has recently been suggested as a potential prognostic marker in breast cancer patients. This study aimed to explore tagged haplotype covering nucleotide binding domain 1 of ABCC1 in relation with corresponding transcript levels in tissues and clinical phenotype of breast cancer patients. Methods: The distribution of twelve ABCC1 polymorphisms was assessed by direct sequencing in peripheral blood DNA (n = 540). Results: Tumors from carriers of the wild type genotype in rs35623 or rs35628 exhibited significantly lower levels of ABCC1 transcript than those from carriers of the minor allele (p = 0.003 and p = 0.004, respectively). The ABCC1 transcript levels significantly increased in the order CT-GT>CC-GT>CC-GG for the predicted rs35626-rs4148351 diplotype. Chemotherapy-treated patients carrying the T allele in rs4148353 had longer disease-free survival than those with the GG genotype (p = 0.043). On the other hand, hormonal therapy-treated patients with the AA genotype in rs35628 had significantly longer disease-free survival than carriers of the G allele (p = 0.012). Conclusions: Taken together, our study shows that genetic variability in the nucleotide binding domain 1 has a significant impact on the ABCC1 transcript level in the target tissue and may modify survival of breast cancer patients.	[Kunicka, Tereza; Vaclavikova, Radka; Hlavac, Viktor; Vrana, David; Vodickova, Ludmila; Soucek, Pavel] Natl Inst Publ Hlth, Dept Toxicogen, Prague, Czech Republic; [Kunicka, Tereza; Hlavac, Viktor] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Vrana, David] Palacky Univ, Dept Oncol, Sch Med, CR-77147 Olomouc, Czech Republic; [Vrana, David] Teaching Hosp, Olomouc, Czech Republic; [Pecha, Vaclav; Raus, Karel] Inst Care Mother & Child, Prague, Czech Republic; [Trnkova, Marketa] Biolab Praha Ks, Prague, Czech Republic; [Kubackova, Katerina] Motol Univ Hosp, Dept Oncol, Prague, Czech Republic; [Ambrus, Miloslav] Fac Hosp Kralovske Vinohrady, Dept Radiotherapy & Oncol, Prague, Czech Republic; [Vodickova, Ludmila; Vodicka, Pavel] Acad Sci Czech Republ, Inst Expt Med, Prague, Czech Republic; [Vodicka, Pavel] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic	National Institute of Public Health (SZU) - Czech Republic; Charles University Prague; Palacky University Olomouc; University Hospital Olomouc; Motol University Hospital; University Hospital Vinohrady; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague	Soucek, P (corresponding author), Natl Inst Publ Hlth, Dept Toxicogen, Prague, Czech Republic.	psoucek@szu.cz	Soucek, Pavel/H-8018-2019	Soucek, Pavel/0000-0002-4294-6799; Hlavac, Viktor/0000-0003-0695-0552; Vodicka, Pavel/0000-0003-2376-1243	Internal Grant Agency of the Czech Ministry of Health [NT13679-4]; Czech Science Foundation [P303/12/G163]; Biolab Praha, k.s	Internal Grant Agency of the Czech Ministry of Health; Czech Science Foundation(Grant Agency of the Czech Republic); Biolab Praha, k.s	This work was supported by grant of the Internal Grant Agency of the Czech Ministry of Health (www.mzcr.cz), no.: NT13679-4 and by the project of the Czech Science Foundation no.: P303/12/G163 (www.gacr.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biolab Praha, k.s provided support in the form of salary for author MT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akan I, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-22; [Anonymous], 2008, IARC CANCERBASE; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIEDLER JL, 1970, CANCER RES, V30, P1174; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brynychova V, 2013, FUTURE ONCOL, V9, P427, DOI [10.2217/fon.12.200, 10.2217/FON.12.200]; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cole SPC, 2014, ANNU REV PHARMACOL, V54, P95, DOI 10.1146/annurev-pharmtox-011613-135959; Conrad S, 2002, PHARMACOGENETICS, V12, P321, DOI 10.1097/00008571-200206000-00008; Conrad S, 2001, J HUM GENET, V46, P656, DOI 10.1007/s100380170017; Ferguson LR, 2005, MUTAT RES-FUND MOL M, V591, P24, DOI 10.1016/j.mrfmmm.2005.02.030; Filipits M, 2005, J CLIN ONCOL, V23, P1161, DOI 10.1200/JCO.2005.03.033; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Grant CE, 1997, GENOMICS, V45, P368, DOI 10.1006/geno.1997.4950; Hipfner DR, 1999, BBA-BIOMEMBRANES, V1461, P359, DOI 10.1016/S0005-2736(99)00168-6; Hlavac V, 2013, PHARMACOGENOMICS, V14, P515, DOI [10.2217/PGS.13.26, 10.2217/pgs.13.26]; Iram SH, 2011, J BIOL CHEM, V286, P7202, DOI 10.1074/jbc.M110.166959; Kim B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062766; Kiyotani K, 2012, DRUG METAB PHARMACOK, V27, P122, DOI 10.2133/dmpk.DMPK-11-RV-084; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Leslie EM, 2003, BIOCHEMISTRY-US, V42, P5214, DOI 10.1021/bi027076n; Letourneau IJ, 2005, PHARMACOGENET GENOM, V15, P647, DOI 10.1097/01.fpc.0000173484.51807.48; Lips EH, 2013, BREAST CANCER RES TR, V140, P63, DOI 10.1007/s10549-013-2620-0; Liscovitch Mordechai, 2002, IDrugs, V5, P349; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McDonagh EM, 2011, BIOMARK MED, V5, P795, DOI [10.2217/BMM.11.94, 10.2217/bmm.11.94]; Oselin K, 2003, EUR J CLIN PHARMACOL, V59, P347, DOI 10.1007/s00228-003-0625-z; Qin L, 2008, BIOCHEMISTRY-US, V47, P13952, DOI 10.1021/bi801532g; Ramaen O, 2006, J MOL BIOL, V359, P940, DOI 10.1016/j.jmb.2006.04.005; Rungsardthong K, 2012, BIOINFORMATION, V8, P907, DOI 10.6026/97320630008907; Soucek P, 2005, STEM CELLS, V23, P1417, DOI 10.1634/stemcells.2005-0066; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Teft WA, 2011, DRUG METAB DISPOS, V39, P558, DOI 10.1124/dmd.110.036160; Thomas Hilary, 2003, Cancer Control, V10, P159; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56; TOPIC E, 1991, EUR J CLIN CHEM CLIN, V29, P327; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vaclavikova R, 2008, PHARMACOGENET GENOM, V18, P263, DOI 10.1097/FPC.0b013e3282f60a91; Vulsteke C, 2013, ANN ONCOL, V24, P1513, DOI 10.1093/annonc/mdt008; Wang ZH, 2005, HUM MOL GENET, V14, P2075, DOI 10.1093/hmg/ddi212; Yamada A, 2013, BREAST CANCER RES TR, V137, P773, DOI 10.1007/s10549-012-2398-5; Yin JY, 2009, PHARMACOGENET GENOM, V19, P206, DOI 10.1097/FPC.0b013e328323f680	49	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e101740	10.1371/journal.pone.0101740	http://dx.doi.org/10.1371/journal.pone.0101740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078270	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800008
J	Lei, BL; Mace, B; Dawson, HN; Warner, DS; Laskowitz, DT; James, ML				Lei, Beilei; Mace, Brian; Dawson, Hana N.; Warner, David S.; Laskowitz, Daniel T.; James, Michael L.			Anti-Inflammatory Effects of Progesterone in Lipopolysaccharide-Stimulated BV-2 Microglia	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; CEREBRAL-ARTERY OCCLUSION; PRIMARY GLIAL CULTURES; INTRACEREBRAL HEMORRHAGE; RATS; EXPRESSION; ISCHEMIA	Female sex is associated with improved outcome in experimental brain injury models, such as traumatic brain injury, ischemic stroke, and intracerebral hemorrhage. This implies female gonadal steroids may be neuroprotective. A mechanism for this may involve modulation of post-injury neuroinflammation. As the resident immunomodulatory cells in central nervous system, microglia are activated during acute brain injury and produce inflammatory mediators which contribute to secondary injury including proinflammatory cytokines, and nitric oxide (NO) and prostaglandin E-2 (PGE(2)), mediated by inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2), respectively. We hypothesized that female gonadal steroids reduce microglia mediated neuroinflammation. In this study, the progesterone's effects on tumor necrosis factor alpha (TNF-alpha), iNOS, and COX-2 expression were investigated in lipopolysaccharide (LPS)-stimulated BV-2 microglia. Further, investigation included nuclear factor kappa B (NF-kappa B) and mitogen activated protein kinase (MAPK) pathways. LPS (30 ng/ml) upregulated TNF-alpha, iNOS, and COX-2 protein expression in BV-2 cells. Progesterone pretreatment attenuated LPS-stimulated TNF-alpha, iNOS, and COX-2 expression in a dose-dependent fashion. Progesterone suppressed LPS-induced NF-kappa B activation by decreasing inhibitory kappa B alpha and NF-kappa B p65 phosphorylation and p65 nuclear translocation. Progesterone decreased LPS-mediated phosphorylation of p38, c-Jun N-terminal kinase and extracellular regulated kinase MAPKs. These progesterone effects were inhibited by its antagonist mifepristone. In conclusion, progesterone exhibits pleiotropic anti-inflammatory effects in LPS-stimulated BV-2 microglia by down-regulating proinflammatory mediators corresponding to suppression of NF-kappa B and MAPK activation. This suggests progesterone may be used as a potential neurotherapeutic to treat inflammatory components of acute brain injury.	[Lei, Beilei; Warner, David S.; Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Med Ctr, Multidisciplinary Neuroprotect Labs, Durham, NC 27708 USA; [Lei, Beilei; Warner, David S.; Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Mace, Brian; Dawson, Hana N.; Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA; [Warner, David S.; Laskowitz, Daniel T.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	James, ML (corresponding author), Duke Univ, Med Ctr, Multidisciplinary Neuroprotect Labs, Durham, NC 27708 USA.	Michael.james@duke.edu	James, Michael L./AAJ-5592-2020	James, Michael L./0000-0002-8715-5210; Mace, Brian/0000-0002-5478-6227	American Heart Association-Scientist Development Grant	American Heart Association-Scientist Development Grant(American Heart Association)	This work was supported by American Heart Association-Scientist Development Grant (MLJ). The funders had no role in study design, data collection and analysis, decision to publish, or prearation of the manuscript.	Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Bhat NR, 2002, J BIOL CHEM, V277, P29584, DOI 10.1074/jbc.M204994200; Bhat NR, 1998, J NEUROSCI, V18, P1633; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; DAcquisto F, 1997, FEBS LETT, V418, P175, DOI 10.1016/S0014-5793(97)01377-X; Dang J, 2011, BRAIN BEHAV IMMUN, V25, P715, DOI 10.1016/j.bbi.2011.01.013; Floden AM, 2006, J NEUROSCI, V26, P4644, DOI 10.1523/JNEUROSCI.4822-05.2006; Gibson CL, 2011, BRAIN, V134, P2125, DOI 10.1093/brain/awr132; Gomes-Leal W, 2012, BRAIN BEHAV, V2, P345, DOI 10.1002/brb3.51; Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009; Hardy DB, 2008, MOL ENDOCRINOL, V22, P1812, DOI 10.1210/me.2007-0443; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Jang BC, 2005, CELL SIGNAL, V17, P625, DOI 10.1016/j.cellsig.2004.10.001; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Lei BL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-103; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mani S, 2008, ENDOCRINOLOGY, V149, P2750, DOI 10.1210/en.2008-0097; Mani SK, 2012, FRONT ENDOCRINOL, V3, P7, DOI DOI 10.3389/FENDO.2012.00007; Marks-Konczalik J, 1998, J BIOL CHEM, V273, P22201, DOI 10.1074/jbc.273.35.22201; Morali G, 2005, NEUROSCI LETT, V382, P286, DOI 10.1016/j.neulet.2005.03.066; NELSON JF, 1992, ENDOCRINOLOGY, V130, P805, DOI 10.1210/en.130.2.805; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Singh M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00159; Singh M, 2013, HORM BEHAV, V63, P284, DOI 10.1016/j.yhbeh.2012.06.003; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vallee M, 1997, P NATL ACAD SCI USA, V94, P14865, DOI 10.1073/pnas.94.26.14865; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Wagner CK, 2006, FRONT NEUROENDOCRIN, V27, P340, DOI 10.1016/j.yfrne.2006.07.003; Wang Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/848309; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yan F, 2013, NEUROSCI LETT, V543, P163, DOI 10.1016/j.neulet.2013.03.005; Zhang P, 1998, NEUROCHEM RES, V23, P219, DOI 10.1023/A:1022489127107; Zhao XR, 2007, J NEUROCHEM, V101, P652, DOI 10.1111/j.1471-4159.2006.04414.x; Zhou ZG, 2010, PAIN, V151, P296, DOI 10.1016/j.pain.2010.06.017; Zhu Y, 2008, COMP BIOCHEM PHYS C, V148, P381, DOI 10.1016/j.cbpc.2008.05.019	52	88	94	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103969	10.1371/journal.pone.0103969	http://dx.doi.org/10.1371/journal.pone.0103969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080336	Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800102
J	Dvorkin-Gheva, A; Hassell, JA				Dvorkin-Gheva, Anna; Hassell, John A.			Identification of a Novel Luminal Molecular Subtype of Breast Cancer	PLOS ONE			English	Article							EXPRESSION; CARCINOMAS; RESISTANCE; PREDICTOR; SIGNATURE; SURVIVAL; RECEPTOR; MARKERS	The molecular classification of human breast tumors has afforded insights into subtype specific biological processes, patient prognosis and response to therapies. However, using current methods roughly one quarter of breast tumors cannot be classified into one or another molecular subtype. To explore the possibility that the unclassifiable samples might comprise one or more novel subtypes we employed a collection of publically available breast tumor datasets with accompanying clinical information to assemble 1,593 transcript profiles: 25% of these samples could not be assigned to one of the current molecular subtypes of breast cancer. All of the unclassifiable samples could be grouped into a new molecular subtype, which we termed ''luminal-like''. We also identified the luminal-like subtype in an independent collection of tumor samples (NKI295). We found that patients harboring tumors of the luminal-like subtype have a better prognosis than those with basal-like breast cancer, a similar prognosis to those with ERBB2+, luminal B or claudin-low tumors, but a worse prognosis than patients with luminal A or normal-like breast tumors. Our findings suggest the occurrence of another molecular subtype of breast cancer that accounts for the vast majority of previously unclassifiable breast tumors.	[Dvorkin-Gheva, Anna; Hassell, John A.] McMaster Univ, Dept Biochem & Biomed Sci, Ctr Funct Genom, Hamilton, ON L8N 3Z5, Canada	McMaster University	Hassell, JA (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Ctr Funct Genom, Hamilton, ON L8N 3Z5, Canada.	hassell@mcmaster.ca		Dvorkin-Gheva, Anna/0000-0001-7295-7440	Canadian Breast Cancer Foundation (CBCF), Ontario	Canadian Breast Cancer Foundation (CBCF), Ontario	The Canadian Breast Cancer Foundation (CBCF), Ontario chapter supported the research described herein. AD-G is supported by a postdoctoral fellowship from the CBCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2011, J PATHOL, V223, P646, DOI 10.1002/path.2833; Aoudjit Fawzi, 2012, Chemother Res Pract, V2012, P283181, DOI 10.1155/2012/283181; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; Benjamini Y, 2001, ANN STAT, V29, P1165; CLAYTON F, 1991, CANCER, V68, P1309, DOI 10.1002/1097-0142(19910915)68:6<1309::AID-CNCR2820680621>3.0.CO;2-I; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Dvorkin-Gheva A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026023; Everitt B. S., 1981, FINITE MIXTURE DISTR; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Gradishar WJ, 2012, NEW ENGL J MED, V366, P176, DOI 10.1056/NEJMe1113641; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Isidoro A, 2005, CARCINOGENESIS, V26, P2095, DOI 10.1093/carcin/bgi188; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kapp AV, 2007, BIOSTATISTICS, V8, P9, DOI 10.1093/biostatistics/kxj029; Lee DD, 2001, ADV NEUR IN, V13, P556; Maffei R, 2012, HAEMATOL-HEMATOL J, V97, P952, DOI 10.3324/haematol.2011.054924; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Menard S, 2000, J CELL PHYSIOL, V182, P150, DOI 10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E; Oh EJ, 2003, LEUKEMIA RES, V27, P903, DOI 10.1016/S0145-2126(03)00026-2; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Poirot M, 2012, CURR OPIN PHARMACOL, V12, P683, DOI 10.1016/j.coph.2012.09.007; Prat A, 2012, BREAST CANCER RES TR, V135, P301, DOI 10.1007/s10549-012-2143-0; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Sanga S, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-59; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105	31	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103514	10.1371/journal.pone.0103514	http://dx.doi.org/10.1371/journal.pone.0103514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076125	Green Published, Green Submitted, gold			2022-12-25	WOS:000340028800058
J	Hui, FL; Ren, YC; Chen, L; Li, Y; Zhang, L; Niu, QH				Hui, Fengli; Ren, Yongcheng; Chen, Liang; Li, Ying; Zhang, Lin; Niu, Qiuhong			Molecular Phylogenetic Analysis Reveals the New Genus Hemisphaericaspora of the Family Debaryomycetaceae	PLOS ONE			English	Article							XYLOSE-FERMENTING YEAST; SP-NOV.; ASCOMYCETOUS YEASTS; WOOD; GENERA; SUBSTITUTIONS; BEETLES; GUT; DNA	Four strains of a novel ascomycetous yeast species were recovered from the frass of wood-boring beetles collected from the Baotianman Nature Reserve and the Laojieling Nature Reserve in Henan Province, China. This species produced unconjugated and deliquescent asci with hemispheroid or helmet-shaped ascospores. Analysis of gene sequences for the D1/D2 domain of the large subunit (LSU) rRNA, as well as analysis of concatenated gene sequences for the nearly complete small subunit (SSU) rRNA and D1/D2 domain of the large subunit (LSU) rRNA placed the novel species in a small clade including only one recognised species, Candida insectamans, in the family Debaryomycetaceae (Saccharomycotina, Ascomycota). DNA sequence analyses demonstrated that the novel species was distinct from all currently recognised teleomorphic yeast genus. The name Hemisphaericaspora nanyangensis gen nov., sp. nov. is proposed to accommodate the novel genus and species. The new genus can be distinguished from closely related teleomorphic genera Lodderomyces and Spathaspora through sequence comparison and ascospore morphology. The ex-type strain of H. nanyangensis is CBS 13020(T) (= CICC 33021 = NYNU 13717). Furthermore, based on phenotypic and genotypic characteristics, C. insectamans is transferred to the newly described genus as Hemisphaericaspora insectamans comb. nov., in accordance with the changes in the International Code of Nomenclature for algae, fungi and plants.	[Hui, Fengli; Ren, Yongcheng; Chen, Liang; Li, Ying; Zhang, Lin; Niu, Qiuhong] Nanyang Normal Univ, Sch Life Sci & Technol, Nanyang, Peoples R China	Nanyang Normal College	Hui, FL (corresponding author), Nanyang Normal Univ, Sch Life Sci & Technol, Nanyang, Peoples R China.	huifl@126.com		liang, CHEN/0000-0001-7429-4505	National Natural Science Foundation of China [31370073]; Research Planning Project of Basic and Advanced Technology of Henan Province, China [122300410032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Planning Project of Basic and Advanced Technology of Henan Province, China	This work was supported by the National Natural Science Foundation of China (31370073) and the Research Planning Project of Basic and Advanced Technology of Henan Province, China (122300410032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbogbo FK, 2008, BIOTECHNOL LETT, V30, P1515, DOI 10.1007/s10529-008-9728-z; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARNETT JA, 2000, YEASTS CHARACTERISTI; Cadete RM, 2013, ANTON LEEUW INT J G, V103, P421, DOI 10.1007/s10482-012-9822-z; Cadete RM, 2009, FEMS YEAST RES, V9, P1338, DOI 10.1111/j.1567-1364.2009.00582.x; Chen L, 2013, INT J SYST EVOL MICR, V63, P3501, DOI 10.1099/ijs.0.053686-0; Dlauchy D, 2011, ANTON LEEUW INT J G, V99, P619, DOI 10.1007/s10482-010-9534-1; Hui FL, 2013, ANTON LEEUW INT J G, V103, P899, DOI 10.1007/s10482-012-9871-3; Hui FL, 2013, INT J SYST EVOL MICR, V63, P1174, DOI 10.1099/ijs.0.048637-0; Hui FL, 2012, INT J SYST EVOL MICR, V62, P2805, DOI 10.1099/ijs.0.044214-0; Jindamorakot S, 2007, FEMS YEAST RES, V7, P1409, DOI 10.1111/j.1567-1364.2007.00305.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kurtzman Cletus P., 2006, Mycoscience, V47, P65, DOI 10.1007/s10267-006-0280-1; Kurtzman CP, 2013, FEMS YEAST RES, V13, P23, DOI 10.1111/1567-1364.12006; Kurtzman CP, 2011, ANTON LEEUW INT J G, V99, P13, DOI 10.1007/s10482-010-9505-6; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P87, DOI 10.1016/B978-0-444-52149-1.00007-0; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P887, DOI 10.1016/B978-0-444-52149-1.00078-1; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P561, DOI 10.1016/B978-0-444-52149-1.00044-6; Kurtzman CP, 2010, MYCOSCIENCE, V51, P2, DOI 10.1007/s10267-009-0011-5; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lachance MA, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P987, DOI 10.1016/B978-0-444-52149-1.00090-2; Nguyen NH, 2006, MYCOL RES, V110, P1232, DOI 10.1016/j.mycres.2006.07.002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith MT, 2012, IMA FUNGUS, V3, P179, DOI 10.5598/imafungus.2012.03.02.10; Sugita T, 1999, SYST APPL MICROBIOL, V22, P79, DOI 10.1016/S0723-2020(99)80030-7; Suh SO, 2003, MOL ECOL, V12, P3137, DOI 10.1046/j.1365-294X.2003.01973.x; Suh SO, 2013, INT J SYST EVOL MICR, V63, P4330, DOI 10.1099/ijs.0.053009-0; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Urbina H, 2013, FUNGAL ECOL, V6, P339, DOI 10.1016/j.funeco.2013.06.005; VANDERWALT JP, 1972, MYCOPATH MYCOL APPL, V47, P221; White T., 1990, PCR PROTOCOLS GUIDE, P315	35	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103737	10.1371/journal.pone.0103737	http://dx.doi.org/10.1371/journal.pone.0103737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075963	Green Submitted, Green Published, gold			2022-12-25	WOS:000340028800076
J	Melville, J; Smith, K; Hobson, R; Hunjan, S; Shoo, L				Melville, Jane; Smith, Katie; Hobson, Rod; Hunjan, Sumitha; Shoo, Luke			The Role of Integrative Taxonomy in the Conservation Management of Cryptic Species: The Taxonomic Status of Endangered Earless Dragons (Agamidae: Tympanocryptis) in the Grasslands of Queensland, Australia	PLOS ONE			English	Article							DARLING DOWNS; EASTERN; INFERENCE; REPTILIA; GENETICS; LIZARDS; DNA	Molecular phylogenetics is increasingly highlighting the prevalence of cryptic species, where morphologically similar organisms have long independent evolutionary histories. When such cryptic species are known to be declining in numbers and are at risk of extinction due to a range of threatening processes, the disjunction between molecular systematics research and conservation policy becomes a significant problem. We investigate the taxonomic status of Tympanocryptis populations in Queensland, which have previously been assigned to T. tetraporophora, using three species delimitation approaches. The taxonomic uncertainties in this species-group are of particular importance in the Darling Downs Earless Dragon (T. cf. tetraporophora), which is ranked as an endangered 'species' of high priority for conservation by the Queensland Department of Environment and Heritage Protection. We undertook a morphological study, integrated with a comprehensive genetic study and species delimitation analyses, to investigate the species status of populations in the region. Phylogenetic analyses of two gene regions (mtDNA: ND2; nuclear: RAG1) revealed high levels of genetic divergence between populations, indicating isolation over long evolutionary time frames, and strongly supporting two independent evolutionary lineages in southeastern Queensland, from the Darling Downs, and a third in the Gulf Region of northern Queensland. Of the three species delimitation protocols used, we found integrative taxonomy the most applicable to this cryptic species complex. Our study demonstrates the utility of integrative taxonomy as a species delimitation approach in cryptic complexes of species with conservation significance, where limited numbers of specimens are available.	[Melville, Jane; Smith, Katie; Hunjan, Sumitha] Museum Victoria, Dept Sci, Melbourne, Vic, Australia; [Hobson, Rod] Queensland Parks & Wildlife Serv, Toowoomba, Qld, Australia; [Shoo, Luke] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	Museum Victoria; University of Queensland	Melville, J (corresponding author), Museum Victoria, Dept Sci, Melbourne, Vic, Australia.	jmelv@museum.vic.gov.au	Smith, Katie Elizabeth/GXH-2114-2022; Shoo, Luke P/A-2715-2009	Melville, Jane/0000-0002-9994-6423	Pittsworth District Landcare Assn Inc; Mt Tyson District Landcare Group; Australian Research Council Discovery [DP0452082]	Pittsworth District Landcare Assn Inc; Mt Tyson District Landcare Group; Australian Research Council Discovery(Australian Research Council)	Funding provided to JM by Pittsworth District Landcare Assn Inc and Mt Tyson District Landcare Group (www.pittsworthlandcare.com) and to JM by an Australian Research Council Discovery grant (DP0452082) www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin JJ, 2006, MOL ECOL NOTES, V6, P1089, DOI 10.1111/j.1471-8286.2006.01443.x; Covacevich J. A., 1998, Memoirs of the Queensland Museum, V42, P475; Greer A.E., 1989, BIOL EVOLUTION AUSTR; Harris P.S., 1999, CENTRAL DARLING DOWN; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Kozak KH, 2006, P ROY SOC B-BIOL SCI, V273, P539, DOI 10.1098/rspb.2005.3326; Melville J, 2011, MOL PHYLOGENET EVOL, V58, P257, DOI 10.1016/j.ympev.2010.11.025; Melville J, 2007, CONSERV GENET, V8, P185, DOI 10.1007/s10592-006-9161-6; Melville J, 2009, MOL PHYLOGENET EVOL, V52, P898, DOI 10.1016/j.ympev.2008.12.027; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; MITCHELL FRANCIS J., 1948, REC S AUSTRAL MUS, V9, P57; Nylander J, 2004, MR MODELTEST V2 PROG; Rambaut A, 2007, TRACER V 1 4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Silcock RG, 2007, TROP GRASSLANDS, V41, P154; Smith WJS, 1999, AUST J ZOOL, V47, P551, DOI 10.1071/ZO99028; Solis R, 2013, Complete Guide to Physical Security, P175; Starr CR, 2006, J WILDLIFE MANAGE, V70, P897, DOI 10.2193/0022-541X(2006)70[897:HUBTDD]2.0.CO;2; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880	22	16	22	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e101847	10.1371/journal.pone.0101847	http://dx.doi.org/10.1371/journal.pone.0101847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076129	Green Submitted, Green Published, gold			2022-12-25	WOS:000340028800008
J	Iga, M; Nakaoka, T; Suzuki, Y; Kataoka, H				Iga, Masatoshi; Nakaoka, Takayoshi; Suzuki, Yutaka; Kataoka, Hiroshi			Pigment Dispersing Factor Regulates Ecdysone Biosynthesis via Bombyx Neuropeptide G Protein Coupled Receptor-B2 in the Prothoracic Glands of Bombyx mori	PLOS ONE			English	Article							IMMUNOREACTIVE NEURONS; DEVELOPMENTAL PROFILE; KINASE ERK; HORMONE; SILKWORM; ECDYSTEROIDOGENESIS; STIMULATION; PEPTIDES; PDF; HEMOLYMPH	Ecdysone is the key hormone regulating insect growth and development. Ecdysone synthesis occurs in the prothoracic glands (PGs) and is regulated by several neuropeptides. Four prothoracicotropic and three prothoracicostatic factors have been identified to date, suggesting that ecdysone biosynthesis is intricately regulated. Here, we demonstrate that the neuropeptide pigment dispersing factor (PDF) stimulates ecdysone biosynthesis and that this novel signaling pathway partially overlaps with the prothoracicotropic hormone (PTTH) signaling pathway. We performed transcriptome analysis and focused on receptors predominantly expressed in the PGs. From this screen, we identified a candidate orphan G protein coupled receptor (GPCR), Bombyx neuropeptide GPCR-B2 (BNGR-B2). BNGR-B2 was predominantly expressed in ecdysteroidogenic tissues, and the expression pattern in the PGs corresponded to the ecdysteroid titer in the hemolymph. Furthermore, we identified PDF as a ligand for BNGR-B2. PDF stimulated ecdysone biosynthesis in the PGs, but the stimulation was only observed in the PGs during a specific larval stage. PDF did not affect the transcript level of known ecdysone biosynthetic enzymes, and inhibiting transcription did not suppress ecdysone biosynthesis, suggesting that the effects of PDF might be mediated by translational regulation and/or post-translational modification. In addition, the participation of protein kinase A (PKA), phosphatidylinositol 3-kinase (PI3K), target of rapamycin (TOR) and eukaryotic translation initiation factor 4E (eIF4E)-binding protein (4E-BP) in the PDF signaling pathway was discovered.	[Iga, Masatoshi; Nakaoka, Takayoshi; Suzuki, Yutaka; Kataoka, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan	University of Tokyo	Iga, M (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	masatoshiiga@ib.k.u-tokyo.ac.jp; kataoka@k.u-tokyo.ac.jp			Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Japan Society for the Promotion of Science [19380034]	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to H. K. (Grant# 19380034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARROW GM, 1981, P NATL ACAD SCI-BIOL, V78, P5866, DOI 10.1073/pnas.78.9.5866; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gilbert Lawrence I., 1997, Invertebrate Neuroscience, V3, P205, DOI 10.1007/BF02480376; Gu SH, 1998, INSECT BIOCHEM MOLEC, V28, P861, DOI 10.1016/S0965-1748(98)00074-5; Gu SH, 2012, INSECT BIOCHEM MOLEC, V42, P296, DOI 10.1016/j.ibmb.2011.12.010; Hamanaka Y, 2005, J COMP NEUROL, V491, P390, DOI 10.1002/cne.20712; HelfrichForster C, 1997, J COMP NEUROL, V380, P335, DOI 10.1002/(SICI)1096-9861(19970414)380:3<335::AID-CNE4>3.0.CO;2-3; Hikiba J, 2013, J CHROMATOGR B, V915, P52, DOI 10.1016/j.jchromb.2012.12.014; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Iga M, 2012, BIOL PHARM BULL, V35, P838, DOI 10.1248/bpb.35.838; Kagawa N, 1999, DRUG METAB REV, V31, P333, DOI 10.1081/DMR-100101921; Kaneko Y, 2006, ZOOL SCI, V23, P533, DOI 10.2108/zsj.23.533; Kanematsu S, 2014, GENE, V533, P520, DOI 10.1016/j.gene.2013.08.005; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; KEIGHTLEY DA, 1990, MOL CELL ENDOCRINOL, V74, P229, DOI 10.1016/0303-7207(90)90228-Z; Koyama T, 2004, J INSECT PHYSIOL, V50, P123, DOI 10.1016/j.jinsphys.2003.09.009; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Lin JL, 2007, J INSECT PHYSIOL, V53, P622, DOI 10.1016/j.jinsphys.2007.03.004; Meelkop E, 2011, PROG NEUROBIOL, V93, P125, DOI 10.1016/j.pneurobio.2010.10.004; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Mizoguchi A, 2001, INSECT BIOCHEM MOLEC, V31, P349, DOI 10.1016/S0965-1748(00)00127-2; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Persson MGS, 2001, J NEUROBIOL, V48, P19, DOI 10.1002/neu.1040; RAO KR, 1993, ANN NY ACAD SCI, V680, P78, DOI 10.1111/j.1749-6632.1993.tb19676.x; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Rewitz KF, 2009, INSECT BIOCHEM MOLEC, V39, P475, DOI 10.1016/j.ibmb.2009.04.005; RYBCZYNSKI R, 1994, INSECT BIOCHEM MOLEC, V24, P175, DOI 10.1016/0965-1748(94)90084-1; Rybczynski R, 2001, MOL CELL ENDOCRINOL, V184, P1, DOI 10.1016/S0303-7207(01)00664-5; Sakurai S, 1998, J INSECT PHYSIOL, V44, P867, DOI 10.1016/S0022-1910(98)00075-4; SMITH WA, 1985, MOL CELL ENDOCRINOL, V39, P71, DOI 10.1016/0303-7207(85)90093-0; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tanaka Yoshiaki, 2011, Front Endocrinol (Lausanne), V2, P107, DOI 10.3389/fendo.2011.00107; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Watanabe K, 2007, MOL CELL ENDOCRINOL, V273, P51, DOI 10.1016/j.mce.2007.05.008; Yamanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P2808, DOI 10.1271/bbb.70420; Yamanaka N, 2011, J COMP NEUROL, V519, P238, DOI 10.1002/cne.22517; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384	42	31	32	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103239	10.1371/journal.pone.0103239	http://dx.doi.org/10.1371/journal.pone.0103239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072638	Green Submitted, Green Published, gold			2022-12-25	WOS:000341307600032
J	Hosseinzadeh, R; Movahedi, AAM; Ghourchian, H				Hosseinzadeh, Reza; Movahedi, Ali Akbar Moosavi; Ghourchian, Hedayatollah			New Insight on Biological Interaction Analysis: New Nanocrystalline Mixed Metal Oxide SPME Fiber for GC-FID Analysis of BTEX and Its Application in Human Hemoglobin-Benzene Interaction Studies	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; MASS-SPECTROMETRY; HS-SPME; DODECYLTRIMETHYLAMMONIUM BROMIDE; MS; CHLORIDE; BINDING; DRUGS; AIR	Nanocrystalline mixed metal oxides (MMO) of various metal cations were synthesized and were used for coating a piece of copper wire as a new high sensitive solid phase micro extraction (SPME) fiber in extraction and determination of BTEX compounds from the headspace of aqueous samples prior to GC-FID analysis. Under optimum extraction conditions, the proposed fiber exhibited low detection limits, and quantification limits, good reproducibility, simple and fast preparation method, high fiber capacity and high thermal and mechanical durability. These are some of the most important advantages of the new fiber. The proposed fiber was used for human hemoglobin upon interaction with benzene. Binding isotherm, Scatchard and Klotz logarithmic plots were constructed using HS-SPME-GC data, accurately. The obtained binding isotherm analyzed using Hill method. The Hill parameters have been obtained by calculating saturation parameter from the ratio of measured chromatographic peak areas in the presence and absence of hemoglobin. In this interaction, Hill coefficient and Hill constant determined as (n(H) = 6.14 and log K-H = 6.47) respectively. These results reveal the cooperativity of hemoglobin upon interaction with benzene.	[Hosseinzadeh, Reza; Movahedi, Ali Akbar Moosavi; Ghourchian, Hedayatollah] Univ Tehran, IBB, Tehran, Iran; [Hosseinzadeh, Reza] Univ Urmia, Urmia Branch, ACECR, Chromatog Res Grp, Orumiyeh, Iran; [Movahedi, Ali Akbar Moosavi] Univ Tehran, Ctr Excellence Biothermodyman, Tehran, Iran	University of Tehran; Academic Center for Education, Culture & Research (ACECR); Urmia University; University of Tehran	Movahedi, AAM (corresponding author), Univ Tehran, IBB, Tehran, Iran.	moosavi@ut.ac.ir	Hosseinzadeh, Reza/N-5330-2017	Hosseinzadeh, Reza/0000-0003-2524-176X; Moosavi-Movahedi, Ali Akbar/0000-0002-1707-8432				Alizadeh R, 2012, J PHARMACEUT BIOMED, V70, P492, DOI 10.1016/j.jpba.2012.07.004; ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Barro R, 2005, J CHROMATOGR A, V1072, P99, DOI 10.1016/j.chroma.2004.12.062; Bordbar AK, 2006, COLLOID SURFACE B, V53, P288, DOI 10.1016/j.colsurfb.2006.09.019; Bordbar AK, 2004, B CHEM SOC JPN, V77, P2027, DOI 10.1246/bcsj.77.2027; Brown SD, 2007, FORENSIC SCI INT, V171, P142, DOI 10.1016/j.forsciint.2006.10.015; Bryant RJ, 2011, FOOD CHEM, V124, P501, DOI 10.1016/j.foodchem.2010.06.061; Chatterjee T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037468; Dacie JV, 1967, HEMOLTYIC ANEMIAS CO, P1024; Ekiert RJ, 2010, TALANTA, V82, P1090, DOI 10.1016/j.talanta.2010.06.056; Harwood AD, 2013, ENVIRON POLLUT, V173, P47, DOI 10.1016/j.envpol.2012.09.012; Hill AV, 1910, PHYSIOL, V40; Hosseinzadeh R, 2007, J BRAZIL CHEM SOC, V18, P359, DOI 10.1590/S0103-50532007000200017; Hosseinzadeh R, 2011, COLLOID SURFACE B, V84, P13, DOI 10.1016/j.colsurfb.2010.11.036; Hu L, 2009, ACTA PHARMACOL SIN, V30, P1573, DOI 10.1038/aps.2009.148; Huber F, 2008, CHEM ENG J, V137, P686, DOI 10.1016/j.cej.2007.07.025; IRWIN RJ, 1997, ENV CONTAMINANTS ENC; Ma QL, 2013, MICROCHEM J, V111, P16, DOI 10.1016/j.microc.2012.10.007; Maggi F, 2010, FOOD CHEM, V123, P983, DOI 10.1016/j.foodchem.2010.05.049; Mastrogianni O, 2012, FORENSIC SCI INT, V215, P105, DOI 10.1016/j.forsciint.2011.05.008; Montes R, 2010, J CHROMATOGR A, V1217, P14, DOI 10.1016/j.chroma.2009.11.029; MOSAVIMOVAHEDI AA, 1989, THERMOCHIM ACTA, V146, P215, DOI 10.1016/0040-6031(89)87090-X; NOVAK RF, 1979, MOL PHARMACOL, V16, P1046; Pellati F, 2013, J PHARMACEUT BIOMED, V84, P103, DOI 10.1016/j.jpba.2013.05.045; Pereira A, 2014, J CHROMATOGR SCI, V52, P423, DOI 10.1093/chromsci/bmt053; Ponder E, 1971, HEMOLYSIS RELATED PH, P331; Reinhard H, 2008, LWT-FOOD SCI TECHNOL, V41, P1906, DOI 10.1016/j.lwt.2007.11.012; ROSSIFANELLI A, 1961, J BIOL CHEM, V236, P397; Tankiewicz M, 2013, TALANTA, V107, P1, DOI 10.1016/j.talanta.2012.12.052; Tassi F, 2013, ENVIRON POLLUT, V180, P111, DOI 10.1016/j.envpol.2013.05.023	30	4	4	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102992	10.1371/journal.pone.0102992	http://dx.doi.org/10.1371/journal.pone.0102992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068260	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700027
J	Moore, CL; Amin, J; Gidding, HF; Law, MG				Moore, Cecilia L.; Amin, Janaki; Gidding, Heather F.; Law, Matthew G.			A New Method for Assessing How Sensitivity and Specificity of Linkage Studies Affects Estimation	PLOS ONE			English	Article							NATIONAL DEATH INDEX; COMMUNITY-BASED LINKAGE; HEPATITIS-C INFECTION; CANCER INCIDENCE; PROSTATE-CANCER; RECORD LINKAGE; COHORT; RISK; MORTALITY; HEALTH	Background: While the importance of record linkage is widely recognised, few studies have attempted to quantify how linkage errors may have impacted on their own finding and outcomes. Even where authors of linkage studies have attempted to estimate sensitivity and specificity based on subjects with known status, the effects of false negatives and positives on event rates and estimates of effect are not often described. Methods: We present quantification of the effect of sensitivty and specificity of the linkage process on event rates and incidence, as well as the resultant effect on relative lative risk. Formulae to estimate the true number of events and estimated relative risk adjusted for given linkage sensitivity and specificity are then derived and applied to data from a prisoner mortality study. The implications of false positive and false negative matches are also discussed. Discussion: Comparisons of the effect of sensitivity and specificity on incidence and relative risks indicate that it is more mportant for linkages to be highly specific than sensitive, particularly if true incidence rates are low. We would recommend that, where possible, some quantitative estimates of the sensitivity and specificity of the linkage process be performed, allowing the effect of these quantities on observed results to be assessed.	[Moore, Cecilia L.; Amin, Janaki; Law, Matthew G.] UNSW Australia, Kirby Inst, Sydney, NSW, Australia; [Gidding, Heather F.] UNSW Australia, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney	Moore, CL (corresponding author), UNSW Australia, Kirby Inst, Sydney, NSW, Australia.	cmoore@kirby.unsw.edu.au		Amin, Janaki/0000-0003-2161-9366; Law, Matthew/0000-0002-3540-8837; Gidding, Heather/0000-0001-7595-9281; Moore, Cecilia/0000-0002-5438-6143	Australian Government Department of Health and Ageing	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	This research was funded by the Australian Government Department of Health and Ageing. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin J, 2006, LANCET, V368, P938, DOI 10.1016/S0140-6736(06)69374-4; Amin J, 2006, J HEPATOL, V45, P197, DOI 10.1016/j.jhep.2006.02.014; Aminisani N, 2012, CANCER EPIDEMIOL, V36, pE394, DOI 10.1016/j.canep.2012.08.009; Bohensky MA, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-346; Breslow NE., 1987, STATISTICAL METHODS, P48; Flick ED, 2007, CANCER EPIDEM BIOMAR, V16, P2218, DOI 10.1158/1055-9965.EPI-07-0197; Freemantle CJ, 2006, LANCET, V367, P1758, DOI 10.1016/S0140-6736(06)68771-0; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Kariminia A, 2005, AUST NZ J PUBL HEAL, V29, P572, DOI 10.1111/j.1467-842X.2005.tb00253.x; Kariminia A, 2007, EUR J EPIDEMIOL, V22, P417, DOI 10.1007/s10654-007-9134-1; Lahiri P, 2005, J AM STAT ASSOC, V100, P222, DOI 10.1198/016214504000001277; Lindstrom LS, 2007, LANCET ONCOL, V8, P1001, DOI 10.1016/S1470-2045(07)70282-6; Magliano D, 2003, AUST NZ J PUBL HEAL, V27, P649, DOI 10.1111/j.1467-842X.2003.tb00615.x; Magnussen EB, 2007, BRIT MED J, V335, P978, DOI 10.1136/bmj.39366.416817.BE; Merry AHH, 2007, GUT, V56, P1503, DOI 10.1136/gut.2006.116665; NETER J, 1965, J AM STAT ASSOC, V60, P1005; Powers J, 2000, AUST NZ J PUBL HEAL, V24, P526, DOI 10.1111/j.1467-842X.2000.tb00504.x; Rainsford C., 2003, RECORD LINKAGE CURRE; Scheuren F., 1997, SURV METHODOL, V23, P157; Scheuren F., 1993, SURV METHODOL, V19, P39; Sorensen HT, 1996, INT J EPIDEMIOL, V25, P435, DOI 10.1093/ije/25.2.435; Tromp M, 2011, J CLIN EPIDEMIOL, V64, P565, DOI 10.1016/j.jclinepi.2010.05.008; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Verhage BAJ, 2012, CANCER CAUSE CONTROL, V23, P2003, DOI 10.1007/s10552-012-0079-7; Xia QA, 2011, HEALTH INFORM J, V17, P41, DOI 10.1177/1460458210380524	25	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103690	10.1371/journal.pone.0103690	http://dx.doi.org/10.1371/journal.pone.0103690			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068293	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993700084
J	Poulsen, K; Cleal, B; Clausen, T; Andersen, LL				Poulsen, Kjeld; Cleal, Bryan; Clausen, Thomas; Andersen, Lars L.			Work, Diabetes and Obesity: A Seven Year Follow-Up Study among Danish Health Care Workers	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SHIFT WORK; STRESS; PREVALENCE; PRODUCTIVITY; OVERWEIGHT; EMPLOYMENT; ABILITY; TRENDS; IMPACT	Objectives: The rise in prevalence of diabetes is alarming and research ascribes most of the increase to lifestyle. However, little knowledge exists about the influence of occupational factors on the risk for developing diabetes. This study estimates the importance of work and lifestyle as risk factors for developing diabetes mellitus among healthcare workers and explores the association of work factors and obesity, which is a risk factor for diabetes. Methods: Questionnaire-based prospective cohort study among 7,305 health care workers followed for seven years in the Danish National Diabetes Register. We used bivariate comparisons to give an unadjusted estimate of associations, followed by adjusted survival analysis and logistic regression models to estimate the influences of potential risk factors related to job, health and lifestyle on diabetes and obesity. Results: During seven years of follow up, 3.5% of participants developed diabetes, associated with obesity (HR = 6.53; 95% CI 4.68-9.10), overweight (HR = 2.89; CI 2.11-3.96) age 50-69 y (HR = 2.27; 95% CI 1.57-3.43) and high quality of leadership (HR = 1.60; CI 1.19-2.16). Obesity at baseline was most common among the youngest employees, and was mainly associated with developing diabetes (OR = 3.84; CI 2.85-5.17), impaired physical capacity and physical inactivity. In the occupational setting, obesity was associated with shift work, severe musculoskeletal pain, low influence, but also by good management, fewer role conflicts and a positive work-life balance. Looking only at non-smokers, removed the influence of age and pain. However, non-smokers also had higher depression scores and more role conflicts. Conclusions: Confirming obesity as the strongest risk factor for developing diabetes, the present study identified few occupational risk factors. However, obesity, the key risk factor for diabetes, had a more variable relation with work than did diabetes.	[Poulsen, Kjeld; Cleal, Bryan] Steno Hlth Promot Ctr, Gentofte, Denmark; [Clausen, Thomas; Andersen, Lars L.] Natl Res Ctr Working Environm, Copenhagen, Denmark	National Research Centre for the Working Environment	Poulsen, K (corresponding author), Steno Hlth Promot Ctr, Gentofte, Denmark.	KjPo@Steno.dk	Andersen, Lars Louis/AAQ-4802-2020; cleal, bryan/AAJ-5464-2021	Andersen, Lars L./0000-0003-2777-8085; Cleal, Bryan/0000-0003-3065-7364	Steno Diabetes Center; National Research Centre; Novo Foundation; Novo Nordisk A/S	Steno Diabetes Center; National Research Centre(National Research Centre (NRC)); Novo Foundation; Novo Nordisk A/S(Novo Nordisk)	This paper is financed by internal funding from Steno Diabetes Center and National Research Centre for the Working Environment. Steno Diabetes Center receives part of its core funding from unrestricted grants from the Novo Foundation and Novo Nordisk A/S. The funder, Steno Diabetes Center, provided support in the form of salaries for authors KP and BC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Agardh EE, 2003, DIABETES CARE, V26, P719, DOI 10.2337/diacare.26.3.719; Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; Andersen LL, 2014, SCAND J WORK ENV HEA, V40, P74, DOI 10.5271/sjweh.3382; Andersen LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041287; Andersen LL, 2012, INT ARCH OCC ENV HEA, V85, P615, DOI 10.1007/s00420-011-0709-5; Anderson LM, 2009, AM J PREV MED, V37, P340, DOI 10.1016/j.amepre.2009.07.003; Breton MC, 2013, DIABETES CARE, V36, P740, DOI 10.2337/dc12-0354; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Carstensen B, 2011, SCAND J PUBLIC HEALT, V39, P58, DOI 10.1177/1403494811404278; Catalina-Romero C, 2013, SCAND J PUBLIC HEALT, V41, P142, DOI 10.1177/1403494812470400; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Clausen T, 2013, OCCUP ENVIRON MED, V70, P538, DOI 10.1136/oemed-2012-101281; Clausen T, 2012, J ADV NURS, V68, P127, DOI 10.1111/j.1365-2648.2011.05724.x; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Grossschadl F, 2012, PUBLIC HEALTH NUTR, V15, P20, DOI 10.1017/S1368980011001911; Hannerz Harald, 2004, Int J Occup Med Environ Health, V17, P465; Hansen MB, 2012, DIABETOLOGIA, V55, P294, DOI 10.1007/s00125-011-2383-2; Harris SB, 2013, PATIENT PREFER ADHER, V7, P925, DOI 10.2147/PPA.S46805; Hempler NF, 2013, SCAND J PUBLIC HEALT, V41, P340, DOI 10.1177/1403494813482535; Heraclides A, 2009, DIABETES CARE, V32, P2230, DOI 10.2337/dc09-0132; Herquelot E, 2011, DIABETES CARE, V34, P1344, DOI 10.2337/dc10-2225; HOSMER DW, 1989, APPL LOGISTIC REGRES; Jakobsen MD, 2014, EUR J APPL PHYSIOL, V114, P425, DOI 10.1007/s00421-013-2782-9; Jensen JN, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-87; Kahn-Marshall JL, 2012, HEALTH EDUC BEHAV, V39, P752, DOI 10.1177/1090198111434153; Karlson B, 2006, SCAND J WORK ENV HEA, P27; Karlsson B, 2005, SCAND J WORK ENV HEA, V31, P30, DOI 10.5271/sjweh.845; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knutsson A, 2013, ARBETE HALSA, V47, P1; Lavigne JE, 2003, PHARMACOECONOMICS, V21, P1123, DOI 10.2165/00019053-200321150-00006; Li CY, 1999, OCCUP MED-OXFORD, V49, P225, DOI 10.1093/occmed/49.4.225; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Marmot M., 2010, FAIR SOC HLTH LIVES, P1; Morikawa Y, 2005, SCAND J WORK ENV HEA, V31, P179, DOI 10.5271/sjweh.867; Norberg M, 2007, DIABETES RES CLIN PR, V76, P368, DOI 10.1016/j.diabres.2006.09.002; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pejtersen JH, 2010, SCAND J PUBLIC HEALT, V38, P8, DOI 10.1177/1403494809349858; Ramsey S, 2002, DIABETES CARE, V25, P23, DOI 10.2337/diacare.25.1.23; Robroek SJW, 2013, SCAND J WORK ENV HEA, V39, P233, DOI 10.5271/sjweh.3354; Rongen A, 2013, AM J PREV MED, V44, P406, DOI 10.1016/j.amepre.2012.12.007; Seeger Rolf, 2011, Ther Umsch, V68, P249, DOI 10.1024/0040-5930/a000159; Sundhedsstyrelsen, 2007, REF UN DEPR HOS VOKS, P1; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P8, DOI 10.1177/1403494811409654; Tobias M, 2011, LANCET, V378, P3, DOI 10.1016/S0140-6736(11)60604-1; Tsutsumi A, 2004, SOC SCI MED, V59, P2335, DOI 10.1016/j.socscimed.2004.03.030; Tunceli K, 2005, DIABETES CARE, V28, P2662, DOI 10.2337/diacare.28.11.2662; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	51	26	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103425	10.1371/journal.pone.0103425	http://dx.doi.org/10.1371/journal.pone.0103425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RZ	25068830	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993700069
J	Aranda, F; Bloy, N; Pesquet, J; Petit, B; Chaba, K; Sauvat, A; Kepp, O; Khadra, N; Enot, D; Pfirschke, C; Pittet, M; Zitvogel, L; Kroemer, G; Senovilla, L				Aranda, F.; Bloy, N.; Pesquet, J.; Petit, B.; Chaba, K.; Sauvat, A.; Kepp, O.; Khadra, N.; Enot, D.; Pfirschke, C.; Pittet, M.; Zitvogel, L.; Kroemer, G.; Senovilla, L.			Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer	ONCOGENE			English	Article							MULTICENTER PHASE-II; CALRETICULIN EXPOSURE; VITAMIN-B6 METABOLISM; DOSE EPIRUBICIN; CHEMOTHERAPY; THERAPY; MECHANISM; DEATH; IMMUNOGENICITY; EFFICACY	cis-Diamminedichloroplatinum(II) (CDDP), which is mostly referred to as cisplatin, is a widely used antineoplastic. The efficacy of cisplatin can be improved by combining it with the vitamin B6 precursor pyridoxine. Here, we evaluated the putative synergistic interaction of CDDP with pyridoxine in the treatment of an orthotopic mouse model of non-small-cell lung cancer (NSCLC). CDDP and pyridoxine exhibited hyperadditive therapeutic effects. However, this synergy was only observed in the context of an intact immune system and disappeared when the otherwise successful drug combination was applied to the same NSCLC cancer implanted in the lungs of athymic mice (which lack T lymphocytes). Immunocompetent mice that had been cured from NSCLC by the combined regimen of CDDP plus pyridoxine became resistant against subcutaneous rechallenge with the same (but not with an unrelated) cancer cell line. In vitro, CDDP and pyridoxine did not only cause synergistic killing of NSCLC cells but also elicited signs of immunogenic cell death including an endoplasmic reticulum stress response and exposure of calreticulin at the surface of the NSCLC cells. NSCLC cells treated with CDDP plus pyridoxine in vitro elicited a protective anticancer immune response upon their injection into immunocompetent mice. Altogether, these results suggest that the combined regimen of cisplatin plus pyridoxine mediates immune-dependent antineoplastic effects against NSCLC.	[Aranda, F.; Bloy, N.; Pesquet, J.; Chaba, K.; Sauvat, A.; Kepp, O.; Khadra, N.; Enot, D.; Kroemer, G.; Senovilla, L.] Ctr Rech Cordeliers, INSERM U1138, Equipe Labellisee Pas Ligue Natl Canc 11, F-75006 Paris, France; [Aranda, F.; Bloy, N.; Pesquet, J.; Chaba, K.; Sauvat, A.; Kepp, O.; Khadra, N.; Enot, D.; Kroemer, G.] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Aranda, F.; Bloy, N.; Pesquet, J.; Sauvat, A.; Kepp, O.; Khadra, N.; Enot, D.; Kroemer, G.; Senovilla, L.] Metab & Cell Biol Platforms, Villejuif, France; [Bloy, N.; Zitvogel, L.] Univ Paris 11, Villejuif, France; [Petit, B.] INSERM, U1030, Villejuif, France; [Pfirschke, C.; Pittet, M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Pittet Lab, Boston, MA USA; [Zitvogel, L.; Senovilla, L.] INSERM, U1015, Villejuif, France; [Zitvogel, L.] Ctr Invest Clin Biotherapie CICBT 507, Villejuif, France; [Kroemer, G.] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Harvard Medical School; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Kroemer, G (corresponding author), Ctr Rech Cordeliers, INSERM U1138, Equipe Labellisee Pas Ligue Natl Canc 11, 15 Rue Ecole Med, F-75006 Paris, France.	kroemer@orange.fr; laurasenovilla@hotmail.com	Aranda, Fernando/N-2112-2014; Aranda, Fernando/N-9649-2019; Kroemer, Guido/AAY-9859-2020; Kepp, Oliver/GPX-8627-2022; KROEMER, Guido/B-4263-2013; Kepp, Oliver/N-2763-2017; Senovilla, Laura/AAX-5599-2021	Aranda, Fernando/0000-0002-9364-474X; Aranda, Fernando/0000-0002-9364-474X; KROEMER, Guido/0000-0002-9334-4405; Kepp, Oliver/0000-0002-6081-9558; Senovilla, Laura/0000-0001-6887-2436; ZITVOGEL, laurence/0000-0003-1596-0998	Deutsche Forschungsgemeinschaft (DFG) [PF809/1-1]; Fondation Tourre; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Ligue contre le Cancer (equipe labelisee); Agence National de la Recherche (ANR); Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer (INCa); Fondation Bettencourt-Schueller; Fondation de France; Fondation pour la Recherche Medicale (FRM); European Commission (ArtForce); European Research Council (ERC); LabEx Immuno-Oncology; Paris Alliance of Cancer Research Institutes (PACRI)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fondation Tourre; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Ligue contre le Cancer (equipe labelisee)(Ligue nationale contre le cancer); Agence National de la Recherche (ANR)(French National Research Agency (ANR)); Association pour la recherche sur le cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Fondation Bettencourt-Schueller; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC)(European Research Council (ERC)); LabEx Immuno-Oncology; Paris Alliance of Cancer Research Institutes (PACRI)	We are indepted to Dr Gonin (Gustave Roussy) for help in mouse experiments. CP is supported by the Deutsche Forschungsgemeinschaft (DFG) PF809/1-1. LS is supported by the Fondation Tourre, the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE) and the SIRIC Cancer Research and Personalized Medicine (CARPEM). GK is supported by the Ligue contre le Cancer (equipe labelisee); Agence National de la Recherche (ANR); Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer (INCa); Fondation Bettencourt-Schueller; Fondation de France; Fondation pour la Recherche Medicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); the LabEx Immuno-Oncology; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); and the Paris Alliance of Cancer Research Institutes (PACRI).	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Atmaca A, 2013, BRIT J CANCER, V108, P265, DOI 10.1038/bjc.2012.555; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Castedo M, 2002, J IMMUNOL METHODS, V265, P39, DOI 10.1016/S0022-1759(02)00069-8; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Feldman DR, 2008, JAMA-J AM MED ASSOC, V299, P672, DOI 10.1001/jama.299.6.672; Finn OJ, 2012, ANN ONCOL, V23, P6, DOI 10.1093/annonc/mds256; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Galanski M, 2006, RECENT PAT ANTI-CANC, V1, P285, DOI 10.2174/157489206777442287; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Galluzzi L, 2013, CELL CYCLE, V12, P417, DOI 10.4161/cc.23275; Galluzzi L, 2012, CELL REP, V2, P257, DOI 10.1016/j.celrep.2012.06.017; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Hsu C, 2008, LUNG CANCER, V62, P334, DOI 10.1016/j.lungcan.2008.03.010; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kelland LR, 2004, EUR J CANCER, V40, P827, DOI 10.1016/j.ejca.2003.11.028; KELMAN AD, 1979, CANCER TREAT REP, V63, P1445; Kepp O, 2011, CANCER METAST REV, V30, P61, DOI 10.1007/s10555-011-9273-4; Kim D, 2007, HUM GENE THER, V18, P575, DOI 10.1089/hum.2007.038; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; Li QQ, 2013, ANTICANCER RES, V33, P1421; Martins I, 2011, ONCOGENE, V30, P1147, DOI 10.1038/onc.2010.500; Martins I, 2009, CELL CYCLE, V8, P3723, DOI 10.4161/cc.8.22.10026; MAYO JG, 1972, CANCER CHEMOTH REP 2, V3, P325; McDonnell AM, 2011, SEMIN IMMUNOPATHOL, V33, P353, DOI 10.1007/s00281-011-0246-z; Menard C, 2008, CANCER IMMUNOL IMMUN, V57, P1579, DOI 10.1007/s00262-008-0505-6; Mordant P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026073; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Otterson GA, 2010, CLIN CANCER RES, V16, P2466, DOI 10.1158/1078-0432.CCR-09-3015; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Phernambucq ECJ, 2006, BRIT J CANCER, V95, P470, DOI 10.1038/sj.bjc.6603289; PRESTAYKO AW, 1979, CANCER TREAT REV, V6, P17, DOI 10.1016/S0305-7372(79)80057-2; Sanderson BJS, 1996, MUTAT RES-FUND MOL M, V355, P59, DOI 10.1016/0027-5107(96)00022-X; Senovilla L, 2012, SCIENCE, V337, P1678, DOI 10.1126/science.1224922; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Talmadge JE, 2007, AM J PATHOL, V170, P793, DOI 10.2353/ajpath.2007.060929; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Winter C, 2011, NAT REV ENDOCRINOL, V7, P43, DOI 10.1038/nrendo.2010.196; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223; Zitvogel L, 2010, CLIN CANCER RES, V16, P3100, DOI 10.1158/1078-0432.CCR-09-2891	46	53	55	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 4	2015	34	23					3053	3062		10.1038/onc.2014.234	http://dx.doi.org/10.1038/onc.2014.234			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK3EX	25065595				2022-12-25	WOS:000356100500010
J	Josson, S; Gururajan, M; Sung, SY; Hu, P; Shao, C; Zhau, HE; Liu, C; Lichterman, J; Duan, P; Li, Q; Rogatko, A; Posadas, EM; Haga, CL; Chung, LWK				Josson, S.; Gururajan, M.; Sung, S. Y.; Hu, P.; Shao, C.; Zhau, H. E.; Liu, C.; Lichterman, J.; Duan, P.; Li, Q.; Rogatko, A.; Posadas, E. M.; Haga, C. L.; Chung, L. W. K.			Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis	ONCOGENE			English	Article							STEM-CELLS; CANCER PROGRESSION; METASTATIC-DISEASE; CHROMOSOME 12QF1; REACTIVE STROMA; BONE METASTASIS; LARGE ONCOSOMES; MICRORNA; GENE; ACTIVATION	Tumor-stromal interaction is a dynamic process that promotes tumor growth and metastasis via cell-cell interaction and extracellular vesicles. Recent studies demonstrate that stromal fibroblast-derived molecular signatures can be used to predict disease progression and drug resistance. To identify the epigenetic role of stromal noncoding RNAs in tumor-stromal interactions in the tumor microenvironment, we performed microRNA profiling of patient cancer-associated prostate stromal fibroblasts isolated by laser capture dissection microscopy and in bone-associated stromal models. We found specific upregulation of miR-409-3p and miR-409-5p located within the embryonically and developmentally regulated DLK1-DIO3 (delta-like 1 homolog-deiodinase, iodothyronine 3) cluster on human chromosome 14. The findings in cell lines were further validated in human prostate cancer tissues. Strikingly, ectopic expression of miR-409 in normal prostate fibroblasts conferred a cancer-associated stroma-like phenotype and led to the release of miR-409 via extracellular vesicles to promote tumor induction and epithelial-to-mesenchymal transition in vitro and in vivo. miR-409 promoted tumorigenesis through repression of tumor suppressor genes such as Ras suppressor 1 and stromal antigen 2. Thus, stromal fibroblasts derived miR-409-induced tumorigenesis, epithelial-to-mesenchymal transition and stemness of the epithelial cancer cells in vivo. Therefore, miR-409 appears to be an attractive therapeutic target to block the vicious cycle of tumor-stromal interactions that plagues prostate cancer patients.	[Josson, S.; Gururajan, M.; Hu, P.; Shao, C.; Zhau, H. E.; Liu, C.; Lichterman, J.; Duan, P.; Posadas, E. M.; Chung, L. W. K.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Med, Urooncol Res Program, Los Angeles, CA 90048 USA; [Sung, S. Y.] Taipei Med Univ, Phd Program Translat Med, Taipei, Taiwan; [Li, Q.; Rogatko, A.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Biostat & Bioinformat, Los Angeles, CA 90048 USA; [Haga, C. L.] Scripps Res Inst, Jupiter, FL USA	Cedars Sinai Medical Center; Taipei Medical University; Cedars Sinai Medical Center; Scripps Research Institute	Josson, S (corresponding author), Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Med, Urooncol Res Program, Los Angeles, CA 90048 USA.	Sajni.Josson@cshs.org; Murali.Gururajan@cshs.org; Leland.Chung@cshs.org	Li, Quanlin/H-2358-2015	Li, Quanlin/0000-0002-3876-0617; Lichterman, Jake/0000-0002-3428-1555	TSRI Stem Cell fellowship;  [P01-CA98912];  [DAMD-17-03-02-0033];  [RO1-CA122602];  [TMU102-AE-B01];  [NSC102-2320-B-039-058];  [MOHW103-TD-B-111-01]; NATIONAL CANCER INSTITUTE [P01CA098912, R01CA122602] Funding Source: NIH RePORTER	TSRI Stem Cell fellowship; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a grant from P01-CA98912, DAMD-17-03-02-0033, RO1-CA122602 (LWKC) and TMU102-AE-B01, NSC102-2320-B-039-058, and MOHW103-TD-B-111-01 (S-YS). Dr Haga is funded by the TSRI Stem Cell fellowship. We thank Dr Ladan Fazli for providing the Gleason score tissue array. We also thank Dror Berel for helping with the statistical analysis.	Aprelikova O, 2010, CELL CYCLE, V9, P4387, DOI 10.4161/cc.9.21.13674; Barron DA, 2012, ENDOCR-RELAT CANCER, V19, pR187, DOI 10.1530/ERC-12-0085; Becker-Santos DD, 2012, CARCINOGENESIS, V33, P2558, DOI 10.1093/carcin/bgs285; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Chung LWK, 2005, J UROLOGY, V173, P10, DOI 10.1097/01.ju.0000141582.15218.10; Dakhova O, 2009, CLIN CANCER RES, V15, P3979, DOI 10.1158/1078-0432.CCR-08-1899; Di Vizio D, 2012, AM J PATHOL, V181, P1573, DOI 10.1016/j.ajpath.2012.07.030; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; Dougherty GW, 2008, EUR J CELL BIOL, V87, P721, DOI 10.1016/j.ejcb.2008.02.011; Formosa A, 2014, ONCOGENE, V33, P5173, DOI 10.1038/onc.2013.451; Freeman MR, 2013, CLIN CANCER RES, V19, P4905, DOI 10.1158/1078-0432.CCR-13-1694; Gonzalez-Nieves R, 2013, J CELL COMMUN SIGNAL, V7, P279, DOI 10.1007/s12079-013-0207-5; Gross M, 2007, CLIN CANCER RES, V13, P1979, DOI 10.1158/1078-0432.CCR-06-1156; Haga CL, 2012, J BIOL CHEM, V287, P42695, DOI 10.1074/jbc.M112.387761; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Hu PZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028670; Josson S, 2008, PROSTATE, V68, P1599, DOI 10.1002/pros.20827; Josson S, 2011, CANCER RES, V71, P2600, DOI 10.1158/0008-5472.CAN-10-3382; Kim MS, 2012, NEOPLASMA, V59, P524, DOI 10.4149/neo_2012_067; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lempiainen H, 2013, TOXICOL SCI, V131, P375, DOI 10.1093/toxsci/kfs303; Lim L, 2014, HEPATOLOGY, V59, P202, DOI 10.1002/hep.26662; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Luk JM, 2011, J BIOL CHEM, V286, P30706, DOI 10.1074/jbc.M111.229831; Morello M, 2013, CELL CYCLE, V12, P3526, DOI 10.4161/cc.26539; Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405; Nguyen HCN, 2013, PROSTATE, V73, P346, DOI 10.1002/pros.22572; Nomura T, 2006, CLIN CANCER RES, V12, P7294, DOI 10.1158/1078-0432.CCR-06-2060; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Sung SY, 2008, CANCER RES, V68, P9996, DOI 10.1158/0008-5472.CAN-08-2492; THALMANN GN, 1994, CANCER RES, V54, P2577; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Zhang Y, 2013, NAT CELL BIOL, V15, P284, DOI 10.1038/ncb2690; Zong Y, 2012, P NATL ACAD SCI USA, V109, pE3395, DOI 10.1073/pnas.1217982109	35	141	144	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2015	34	21					2690	2699		10.1038/onc.2014.212	http://dx.doi.org/10.1038/onc.2014.212			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI7XN	25065597				2022-12-25	WOS:000354979500002
J	Farrokhnia, F; Aplin, JD; Westwood, M; Forbes, K				Farrokhnia, Farkhondeh; Aplin, John D.; Westwood, Melissa; Forbes, Karen			MicroRNA Regulation of Mitogenic Signaling Networks in the Human Placenta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC; CELL-PROLIFERATION; UP-REGULATION; CANCER CELLS; GROWTH; TROPHOBLAST; CYTOTROPHOBLAST; INHIBITION; EXPRESSION; APOPTOSIS	Placental cell growth depends on an adaptable combination of an endogenous developmental program and the exogenous influence of maternal growth factors, both of which may be influenced by microRNA (miR)-dependent effects on gene expression. We have previously shown that global miR suppression in placenta accelerates proliferation and enhances levels of growth factor signaling mediators in cytotrophoblast. This study aimed to identify miRs involved in regulating placental growth. An initial array revealed 58 miR species whose expression differs between first trimester, when cytotrophoblast proliferation is rapid, and term, by which time proliferation has slowed. In silico analysis defined potential growth-regulatory miRs; among these, hsa-miR-145, hsa-miR-377, and hsa-let-7a were predicted to target known placental growth genes and were higher at term than in the first trimester, so they were selected for further analysis. Overexpression of miR-377 and let-7a, but not miR-145, in first trimester placental explants significantly reduced basal cytotrophoblast proliferation and expression of ERK and MYC. PCR arrays, in silico analysis, Western blotting, and 3 '-UTR luciferase reporter assays revealed targets of miR-145 within the insulin-like growth factor axis. Analysis of proliferation in placental explants overexpressing miR-145 demonstrated its role as a mediator of insulin-like growth factor-induced trophoblast proliferation. These findings identify miR-377 and let-7a in regulation of endogenous cell growth and miR-145 in the placental response to maternal stimulation and will aid the development of therapeutic strategies for problem pregnancies.	[Farrokhnia, Farkhondeh; Aplin, John D.; Westwood, Melissa; Forbes, Karen] Univ Manchester, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester M13 9WL, Lancs, England; [Farrokhnia, Farkhondeh; Aplin, John D.; Westwood, Melissa; Forbes, Karen] Cent Manchester Univ Hosp Natl Hlth Serv Fdn Trus, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England	University of Manchester; University of Manchester	Forbes, K (corresponding author), Univ Manchester, Maternal & Fetal Hlth Res Ctr, Manchester Acad Hlth Sci Ctr, St Marys Hosp, Oxford Rd, Manchester M13 9WL, Lancs, England.	karen.forbes@manchester.ac.uk	Westwood, Melissa/G-5954-2015; Aplin, John/AET-4363-2022; Forbes, Karen/V-4794-2017	Westwood, Melissa/0000-0001-9725-7010; Aplin, John/0000-0001-8777-9261; Forbes, Karen/0000-0002-3745-1337	Biochemical Society (United Kingdom) Guildford Bench Methodology Fund; National Institute for Health Research Manchester Biomedical Research Centre; Society for Endocrinology Early Career Grant; Manchester Biomedical Research Centre; Greater Manchester Comprehensive Local Research Network; University of Manchester Stepping Stones Fellowship	Biochemical Society (United Kingdom) Guildford Bench Methodology Fund; National Institute for Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Society for Endocrinology Early Career Grant; Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Greater Manchester Comprehensive Local Research Network; University of Manchester Stepping Stones Fellowship	This work was supported by awards from the Biochemical Society (United Kingdom) Guildford Bench Methodology Fund, the National Institute for Health Research Manchester Biomedical Research Centre, and a Society for Endocrinology Early Career Grant. The Maternal and Fetal Health Research Centre is supported by funding from the Manchester Biomedical Research Centre and the Greater Manchester Comprehensive Local Research Network.; Supported by a University of Manchester Stepping Stones Fellowship.	Akao Y, 2010, CANCER GENE THER, V17, P398, DOI 10.1038/cgt.2009.88; Ambros V, 2011, CURR OPIN GENET DEV, V21, P511, DOI 10.1016/j.gde.2011.04.003; APLIN JD, 1991, J CELL SCI, V99, P681; Aplin JD, 2010, INT J DEV BIOL, V54, P323, DOI 10.1387/ijdb.082759ja; ARNHOLDT H, 1991, VIRCHOWS ARCH B, V60, P365, DOI 10.1007/BF02899568; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; COBB MH, 1994, SEMIN CANCER BIOL, V5, P261; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Dubois NC, 2008, DEVELOPMENT, V135, P2455, DOI 10.1242/dev.022707; Forbes K, 2012, PLACENTA, V33, P581, DOI 10.1016/j.placenta.2012.03.006; Forbes K, 2009, PLACENTA, V30, P124, DOI 10.1016/j.placenta.2008.10.003; Forbes K, 2008, AM J PHYSIOL-CELL PH, V294, pC1313, DOI 10.1152/ajpcell.00035.2008; Forbes K, 2012, CELL MOL LIFE SCI, V69, P4029, DOI 10.1007/s00018-012-1067-5; Forbes K, 2010, ENDOCRINOLOGY, V151, P1723, DOI 10.1210/en.2009-0896; Forbes K, 2009, ENDOCRINOLOGY, V150, P4744, DOI 10.1210/en.2009-0166; Fu YY, 2010, HUM REPROD, V25, P623, DOI 10.1093/humrep/dep457; Goodman RH, 2000, GENE DEV, V14, P1553; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Harris LK, 2006, AM J PATHOL, V169, P1863, DOI 10.2353/ajpath.2006.060265; He XY, 2010, J CANCER RES CLIN, V136, P1023, DOI 10.1007/s00432-009-0747-5; Heazell AEP, 2008, PLACENTA, V29, P175, DOI 10.1016/j.placenta.2007.11.002; Iio A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-136; Ingman K, 2010, PLACENTA, V31, P535, DOI 10.1016/j.placenta.2010.03.003; Jansson T, 2006, PLACENTA, V27, pS91, DOI 10.1016/j.placenta.2005.11.010; Kar M, 2007, HUM REPROD, V22, P2814, DOI 10.1093/humrep/dem284; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; Law PTY, 2012, CARCINOGENESIS, V33, P1134, DOI 10.1093/carcin/bgs130; Liu YC, 2012, BIOCHEM BIOPH RES CO, V417, P371, DOI 10.1016/j.bbrc.2011.11.119; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; Morrish DW, 1997, PLACENTA, V18, P577, DOI 10.1016/0143-4004(77)90013-3; Noguchi S, 2013, CANCER LETT, V328, P353, DOI 10.1016/j.canlet.2012.10.017; Pagliuca A, 2013, ONCOGENE, V32, P4806, DOI 10.1038/onc.2012.495; Pu HH, 2012, PLACENTA, V33, P387, DOI 10.1016/j.placenta.2012.01.015; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Schneider H, 1996, PLACENTA, V17, P15, DOI 10.1016/S0143-4004(05)80639-3; Shin JK, 2009, J OBSTET GYNAECOL RE, V35, P888, DOI 10.1111/j.1447-0756.2009.01053.x; Shu JM, 2012, RNA BIOL, V9, P1275, DOI 10.4161/rna.21998; Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007; Torrisani J, 2009, HUM GENE THER, V20, P831, DOI 10.1089/hum.2008.134; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Zhong M, 2010, CHEM-BIOL INTERACT, V184, P431, DOI 10.1016/j.cbi.2010.01.025; Zhong ZW, 2012, EXP THER MED, V4, P267, DOI 10.3892/etm.2012.580; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	48	33	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30404	30416		10.1074/jbc.M114.587295	http://dx.doi.org/10.1074/jbc.M114.587295			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25077964	Green Published, hybrid			2022-12-25	WOS:000344549700022
J	Shetty, SP; Shah, R; Copeland, PR				Shetty, Sumangala P.; Shah, Ravi; Copeland, Paul R.			Regulation of Selenocysteine Incorporation into the Selenium Transport Protein, Selenoprotein P	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN READING FRAME; AMINOACYL-TRANSFER RNA; RAT PLASMA; GLUTATHIONE-PEROXIDASE; TRANSLATION TERMINATION; ELONGATION-FACTOR; DIETARY SELENIUM; BINDING PROTEIN; MESSENGER-RNAS; UGA CODONS	Selenoproteins are unique as they contain selenium in their active site in the form of the 21st amino acid selenocysteine (Sec), which is encoded by an in-frame UGA stop codon. Sec incorporation requires both cis- and trans-acting factors, which are known to be sufficient for Sec incorporation in vitro, albeit with low efficiency. However, the abundance of the naturally occurring selenoprotein that contains 10 Sec residues (SEPP1) suggests that processive and efficient Sec incorporation occurs in vivo. Here, we set out to study native SEPP1 synthesis in vitro to identify factors that regulate processivity and efficiency. Deletion analysis of the long and conserved 3'-UTR has revealed that the incorporation of multiple Sec residues is inherently processive requiring only the SECIS elements but surprisingly responsive to the selenium concentration. We provide evidence that processive Sec incorporation is linked to selenium utilization and that reconstitution of known Sec incorporation factors in a wheat germ lysate does not permit multiple Sec incorporation events, thus suggesting a role for yet unidentified mammalian-specific processes or factors. The relationship between our findings and the channeling theory of translational efficiency is discussed.	[Shetty, Sumangala P.; Shah, Ravi; Copeland, Paul R.] Rutgers Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Copeland, PR (corresponding author), Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, 675 Hoes Ln, Piscataway, NJ 08854 USA.	paul.copeland@rutgers.edu	Shetty, Sumangala/T-9505-2017	Copeland, Paul/0000-0003-3343-0587	National Institutes of Health [GM077073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM077073 (to P. R. C.)	BARANOV VI, 1993, METHOD ENZYMOL, V217, P123; Bellinger FP, 2008, J ALZHEIMERS DIS, V15, P465; BERRY MJ, 1991, J BIOL CHEM, V266, P14155; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Bubenik JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062102; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; BURK RF, 1991, FASEB J, V5, P2274, DOI 10.1096/fasebj.5.9.1830557; Burk RF, 2003, J NUTR, V133, p1517S, DOI 10.1093/jn/133.5.1517S; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Cheng WH, 1997, J NUTR, V127, P675, DOI 10.1093/jn/127.5.675; Chittum HS, 1996, ARCH BIOCHEM BIOPHYS, V325, P124, DOI 10.1006/abbi.1996.0015; CHRISTENSEN MJ, 1995, J NUTR BIOCHEM, V6, P367, DOI 10.1016/0955-2863(95)80004-V; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; DEAGEN JT, 1993, ANAL BIOCHEM, V208, P176, DOI 10.1006/abio.1993.1025; Dewing AST, 2012, RNA BIOL, V9, P1361, DOI 10.4161/rna.22290; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Fixsen SM, 2010, J MOL BIOL, V399, P385, DOI 10.1016/j.jmb.2010.04.033; Gonzalez-Flores JN, 2012, J BIOL CHEM, V287, P38936, DOI 10.1074/jbc.M112.415463; Gupta M, 2007, J BIOL CHEM, V282, P36797, DOI 10.1074/jbc.M707061200; Gupta N, 2013, J MOL BIOL, V425, P2415, DOI 10.1016/j.jmb.2013.04.016; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; HILL KE, 1991, J BIOL CHEM, V266, P10050; Himeno S, 1996, J BIOL CHEM, V271, P15769, DOI 10.1074/jbc.271.26.15769; Howard MT, 2007, RNA, V13, P912, DOI 10.1261/rna.473907; Kinzy SA, 2005, NUCLEIC ACIDS RES, V33, P5172, DOI 10.1093/nar/gki826; Kurokawa S., 2014, FREE RADIC BIOL MED; LEE BJ, 1990, MOL CELL BIOL, V10, P1940, DOI 10.1128/MCB.10.5.1940; Ma SG, 2002, J BIOL CHEM, V277, P12749, DOI 10.1074/jbc.M111462200; Maiti B, 2009, HUM MUTAT, V30, P411, DOI 10.1002/humu.20879; Martin GW, 1996, RNA, V2, P171; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Meplan C, 2009, ANTIOXID REDOX SIGN, V11, P2631, DOI [10.1089/ars.2009.2533, 10.1089/ARS.2009.2533]; Miniard AC, 2010, NUCLEIC ACIDS RES, V38, P4807, DOI 10.1093/nar/gkq247; Mostert V, 1998, ARCH BIOCHEM BIOPHYS, V357, P326, DOI 10.1006/abbi.1998.0809; MOTCHNIK PA, 1989, BIOCHIM BIOPHYS ACTA, V993, P27, DOI 10.1016/0304-4165(89)90138-4; MOTCHNIK PA, 1990, J INORG BIOCHEM, V40, P265, DOI 10.1016/0162-0134(90)80060-B; MOTSENBOCKER MA, 1984, J NUTR, V114, P279, DOI 10.1093/jn/114.2.279; Nasim MT, 2000, J BIOL CHEM, V275, P14846, DOI 10.1074/jbc.275.20.14846; NEGRUTSKII BS, 1991, P NATL ACAD SCI USA, V88, P4991, DOI 10.1073/pnas.88.11.4991; READ R, 1990, J BIOL CHEM, V265, P17899; Reeves MA, 2009, CELL MOL LIFE SCI, V66, P2457, DOI 10.1007/s00018-009-0032-4; Renko K, 2008, BIOCHEM J, V409, P741, DOI 10.1042/BJ20071172; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; SIVARAM P, 1990, P NATL ACAD SCI USA, V87, P3665, DOI 10.1073/pnas.87.10.3665; STAPULIONIS R, 1995, P NATL ACAD SCI USA, V92, P7158, DOI 10.1073/pnas.92.16.7158; Stoytcheva Z, 2006, MOL CELL BIOL, V26, P9177, DOI 10.1128/MCB.00856-06; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Suppmann S, 1999, EMBO J, V18, P2284, DOI 10.1093/emboj/18.8.2284; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Tujebajeva RM, 2000, J BIOL CHEM, V275, P6288, DOI 10.1074/jbc.275.9.6288; Turanov AA, 2013, NUCLEIC ACIDS RES, V41, P6952, DOI 10.1093/nar/gkt409; Turanov AA, 2011, ADV NUTR, V2, P122, DOI 10.3945/an.110.000265; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; YANG JG, 1987, J BIOL CHEM, V262, P13372; YANG JG, 1989, J NUTR, V119, P1010, DOI 10.1093/jn/119.7.1010	55	35	37	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25317	25326		10.1074/jbc.M114.590430	http://dx.doi.org/10.1074/jbc.M114.590430			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25063811	hybrid, Green Published			2022-12-25	WOS:000341985300050
J	Chettier, R; Ward, K; Albertsen, HM				Chettier, Rakesh; Ward, Kenneth; Albertsen, Hans M.			Endometriosis Is Associated with Rare Copy Number Variants	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DISEASE; POPULATION; SOFTWARE; SAMPLE; LOCUS; RISK	Endometriosis is a complex gynecological condition that affects 6-10% of women in their reproductive years and is defined by the presence of endometrial glands and stroma outside the uterus. Twin, family, and genome-wide association (GWA) studies have confirmed a genetic role, yet only a small part of the genetic risk can be explained by SNP variation. Copy number variants (CNVs) account for a greater portion of human genetic variation than SNPs and include more recent mutations of large effect. CNVs, likely to be prominent in conditions with decreased reproductive fitness, have not previously been examined as a genetic contributor to endometriosis. Here we employ a high-density genotyping microarray in a genome-wide survey of CNVs in a case-control population that includes 2,126 surgically confirmed endometriosis cases and 17,974 population controls of European ancestry. We apply stringent quality filters to reduce the false positive rate common to many CNV-detection algorithms from 77.7% to 7.3% without noticeable reduction in the true positive rate. We detected no differences in the CNV landscape between cases and controls on the global level which showed an average of 1.92 CNVs per individual with an average size of 142.3 kb. On the local level we identify 22 CNV-regions at the nominal significance threshold (P<0.05), which is greater than the 8.15 CNV-regions expected based on permutation analysis (P<0.001). Three CNV's passed a genome-wide P-value threshold of 9.3x10(-4); a deletion at SGCZ on 8p22 (P = 7.3x10(-4), OR = 8.5, Cl = 2.3-31.7), a deletion in MALRD1 on 10p12.31 (P = 5.6x10(-4), OR = 14.1, Cl = 2.7-90.9), and a deletion at 11q14.1 (P = 5.7x10(-4), OR = 33.8, Cl = 3.3-1651). Two SNPs within the 22 CNVRs show significant genotypic association with endometriosis after adjusting for multiple testing; rs758316 in DPP6 on 7q36.2 (P = 0.0045) and rs4837864 in ASTN2 on 9q33.1 (P = 0.0002). Together, the CNV-loci are detected in 6.9% of affected women compared to 2.1% in the general population.	[Chettier, Rakesh; Ward, Kenneth; Albertsen, Hans M.] Juneau Biosci LLC, Salt Lake City, UT 84109 USA		Ward, K (corresponding author), Juneau Biosci LLC, Salt Lake City, UT 84109 USA.	kenw@juneaubiosciences.com; halbertsen@juneaubiosciences.com			Juneau Biosciences, LLC	Juneau Biosciences, LLC	This study was funded by Juneau Biosciences, LLC. The funder provided support in the form of salaries for authors RC, KW and HA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albertsen HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058257; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; de Arellano ML, 2014, J MOL MED; Dyson MT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004158; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Glessner JT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1346; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Iafrate A, 2004, DATABASE GENOMIC VAR; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Medicine ASfR, 1997, FERTIL STERIL, V67, P817; Mhawech-Fauceglia P, 2013, GYNECOL ONCOL, V130, P174, DOI 10.1016/j.ygyno.2013.03.030; Munksgaard PS, 2012, GYNECOL ONCOL, V124, P164, DOI 10.1016/j.ygyno.2011.10.001; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Nyholt DR, 2012, NAT GENET, V44, P1355, DOI 10.1038/ng.2445; Painter JN, 2011, NAT GENET, V43, P51, DOI 10.1038/ng.731; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritchie ME, 2009, BIOINFORMATICS, V25, P2621, DOI 10.1093/bioinformatics/btp470; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Saare M, 2012, HUM REPROD, V27, P1857, DOI 10.1093/humrep/des125; Satten GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086272; Scharpf RB, 2011, J STAT SOFTW, V40, P1; Sebat J, 2007, NAT GENET, V39, pS3, DOI 10.1038/ng2095; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Stefanson H, 2002, HUM REPROD, V17, P555, DOI 10.1093/humrep/17.3.555; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Treloar SA, 1999, FERTIL STERIL, V71, P701, DOI 10.1016/S0015-0282(98)00540-8; Uno S, 2010, NAT GENET, V42, P707, DOI 10.1038/ng.612; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhao W, 2012, OBESITY, V20, P2431, DOI 10.1038/oby.2012.162	33	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103968	10.1371/journal.pone.0103968	http://dx.doi.org/10.1371/journal.pone.0103968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083881	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800111
J	Mola, JM; Varner, JM; Jules, ES; Spector, T				Mola, John M.; Varner, J. Morgan; Jules, Erik S.; Spector, Tova			Altered Community Flammability in Florida's Apalachicola Ravines and Implications for the Persistence of the Endangered Conifer Torreya taxifolia	PLOS ONE			English	Article							BURNING CHARACTERISTICS; LITTER FLAMMABILITY; LEAF TRAITS; FIRE; FOREST; OAKS; MESOPHICATION; DYNAMICS; PLANT	Plant species and communities often reflect historic fire regimes via ecological and evolutionary responses to recurrent fires. Plant communities of the southeastern USA experience a wide array of fire regimes, perhaps nowhere more marked than the juxtaposition of fire-prone uplands and adjacent mesic ravines along Florida's Apalachicola River. The ravines contain many endemic and disjunct species, most notably the endangered endemic conifer Torreya taxifolia. A rapid decline in T. taxifolia over the past 60 years has been associated with widespread replacement by other tree species. To understand the changes accompanying the shift in ravine composition, we compared leaf litter flammability of nine historic and contemporary species. We measured maximum flame height, flame duration, smoldering duration, mass loss, absorptive capacity, and drying rate. Ordination and perMANOVA suggest the nine species segregated into three distinct groups: the fire-impeding T. taxifolia and Taxus floridana; an intermediate group of three deciduous angiosperms; and a mixed cluster of four flammable species. Results suggest T. taxifolia and T. floridana were fire-impeding species in these communities, while contemporary dominants burn similarly to the upslope pyric species. The increasing presence of fire-facilitating species may portend a shifting fire regime that further imperils T. taxifolia and other rare species in the formerly fire-safe ravines.	[Mola, John M.; Jules, Erik S.] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA; [Varner, J. Morgan] Mississippi State Univ, Forest & Wildlife Res Ctr, Dept Forestry, Mississippi State, MS 39762 USA; [Spector, Tova] Environm Protect Dept, Florida Pk Serv, Panama City, FL USA; [Mola, John M.] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA	California State University System; California State Polytechnic University, Humboldt; Mississippi State University; University of California System; University of California Davis	Mola, JM (corresponding author), Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA.	jmmola@ucdavis.edu		Mola, John/0000-0002-5394-9071	National Science Foundation (NSF) Research Experience for Undergraduates Program [REU 0755466]; NSF Graduate Research Fellowship Program [1049702]; Mississippi Forest & Wildlife Research Center	National Science Foundation (NSF) Research Experience for Undergraduates Program(National Science Foundation (NSF)); NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Mississippi Forest & Wildlife Research Center	Funding for this research was provided by the National Science Foundation (NSF) Research Experience for Undergraduates Program (REU 0755466 to S.F. Craig and M.D. Johnson), the NSF Graduate Research Fellowship Program (Grant 1049702 to J.M.M.) and the Mississippi Forest & Wildlife Research Center (http://fwrc.msstate.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson H. E., 1970, Fire Technology, V6, P312, DOI 10.1007/BF02588932; Balch JK, 2008, GLOBAL CHANGE BIOL, V14, P2276, DOI 10.1111/j.1365-2486.2008.01655.x; Beckage B, 2009, AM NAT, V174, P805, DOI 10.1086/648458; Bond W. J., 1996, FIRE PLANTS, DOI DOI 10.2307/2404797; Chen E., 1990, ECOSYSTEMS FLORIDA, P11; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; de Magalhaes RMQ, 2012, J ECOL, V100, P1153, DOI 10.1111/j.1365-2745.2012.01987.x; Ellair DP, 2013, J ECOL, V101, P192, DOI 10.1111/1365-2745.12008; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Engber EA, 2012, CAN J FOREST RES, V42, P1965, DOI 10.1139/x2012-138; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fonda RW, 2001, FOREST SCI, V47, P390; Gagnon PR, 2010, ECOLOGY, V91, P3481, DOI 10.1890/10-0291.1; GLITZENSTEIN JS, 1995, ECOL MONOGR, V65, P441, DOI 10.2307/2963498; Godfrey R K, 1962, Science, V136, P900, DOI 10.1126/science.136.3519.900-a; Harper R.M., 1914, 6TH FLOR STAT GEOL S, P163; Hiers JK, 2014, J WILDLIFE MANAGE, V78, P383, DOI 10.1002/jwmg.676; Hintze JL, 2006, NUMBER CRUNCHING STA; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; Kane JM, 2008, FOREST ECOL MANAG, V256, P2039, DOI 10.1016/j.foreco.2008.07.039; Kreye JK, 2013, ECOL APPL, V23, P1976, DOI 10.1890/13-0503.1; Kwit C, 1998, J TORREY BOT SOC, V125, P309, DOI 10.2307/2997244; Metz MR, 2013, ECOLOGY, V94, P2152, DOI 10.1890/13-0915.1; MUTCH R W, 1970, Ecology (Washington D C), V51, P1046, DOI 10.2307/1933631; Nowacki GJ, 2008, BIOSCIENCE, V58, P123, DOI 10.1641/B580207; Ormeno E, 2009, FOREST ECOL MANAG, V257, P471, DOI 10.1016/j.foreco.2008.09.019; R Core Team, 2021, R LANG ENV STAT COMP; Robbins L. E., 1992, TALL TIMBERS RES STA, V8; Scarff FR, 2006, FUNCT ECOL, V20, P745, DOI 10.1111/j.1365-2435.2006.01174.x; SCHWARTZ MW, 1993, B TORREY BOT CLUB, V120, P275, DOI 10.2307/2996992; SCHWARTZ MW, 1995, ECOL APPL, V5, P501, DOI 10.2307/1942039; Schwartz MW, 2000, CONSERV BIOL, V14, P1023, DOI 10.1046/j.1523-1739.2000.98393.x; Schwartz MW, 1999, J TORREY BOT SOC, V126, P307, DOI 10.2307/2997314; Schwilk DW, 2011, J ECOL, V99, P970, DOI 10.1111/j.1365-2745.2011.01828.x; Smith JA, 2011, PLANT DIS, V95, P633, DOI 10.1094/PDIS-10-10-0703; Spector T, 2009, FLORIDA PARK SERVICE; Stein B., 2000, PRECIOUS HERITAGE ST; US Fish and Wildlife Service (USFWS), 1986, FLOR TORR TORR TAX R	38	14	14	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103933	10.1371/journal.pone.0103933	http://dx.doi.org/10.1371/journal.pone.0103933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084166	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800104
J	Clapauch, R; Mourao, AF; Mecenas, AS; Maranhao, PA; Rossini, A; Bouskela, E				Clapauch, Ruth; Mourao, Andre Felipe; Mecenas, Anete S.; Maranhao, Priscila A.; Rossini, Ana; Bouskela, Eliete			Endothelial Function and Insulin Resistance in Early Postmenopausal Women with Cardiovascular Risk Factors: Importance of ESR1 and NOS3 Polymorphisms	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ESTROGEN-RECEPTOR-ALPHA; CORONARY-ARTERY-DISEASE; GENE POLYMORPHISMS; BREAST-CANCER; HEART-DISEASE; ASSOCIATION; DYSFUNCTION; LOCALIZATION; MECHANISMS	Cardiovascular benefits from estradiol activation of nitric oxide endothelial production may depend on vascular wall and on estrogen receptor alpha (ESR1) and nitric oxide synthase (NOS3) polymorphisms. We have evaluated the microcirculation in vivo through nailfold videocapillaroscopy, before and after acute nasal estradiol administration at baseline and after increased sheer stress (postocclusive reactive hyperemia response) in 100 postmenopausal women, being 70 controls (healthy) and 30 simultaneously hypertensive and diabetic (HD), correlating their responses to PvuII and XbaI ESR1 polymorphisms and to VNTR, T-786C and G894T NOS3 variants. In HD women, C variant allele of ESR1 Pvull was associated to higher vasodilatation after estradiol (1.72 vs 1.64 mm/s, p = 0.01 compared to TT homozygotes) while G894T and T-786C NOS3 polymorphisms were connected to lower increment after shear stress (15% among wild type and 10% among variant alleles, p = 0.02 and 0.04). The G variant allele of ESR1 XbaI polymorphism was associated to higher HOMA-IR (3.54 vs. 1.64, p = 0.01) in HD and higher glucose levels in healthy women (91.8 vs. 87.1 mg/dl, p = 0.01), in which increased waist and HOMA-IR were also related to the G allele in NOS3 G894T (waist 93.5 vs 88.2 cm, p = 0.02; HOMA-IR 2.89 vs 1.48, p = 0.05). ESR1 Pvull, NOS3 G894T and T-786C polymorphism analysis may be considered in HD postmenopausal women for endothelial response prediction following estrogen therapy but were not discriminatory for endothelial response in healthy women. ESR1 XbaI and G894T NOS3 polymorphisms may be useful in accessing insulin resistance and type 2 diabetes risks in all women, even before menopause and occurrence of metabolic disease.	[Clapauch, Ruth; Mecenas, Anete S.; Maranhao, Priscila A.; Bouskela, Eliete] Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol BioVasc, Rio De Janeiro, Brazil; [Clapauch, Ruth] Minist Hlth, Endocrinol Sect, Hosp da Lagoa, Rio De Janeiro, Brazil; [Mourao, Andre Felipe; Rossini, Ana] Univ Estado Rio De Janeiro, IBRAG, Dept Bioquim, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Clapauch, R (corresponding author), Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol BioVasc, Rio De Janeiro, Brazil.	rclapauch@uol.com.br		Maranhao, Priscila/0000-0002-4804-4999	National Research Council of Brazil (CNPq) [474116/2008-5]; State of Rio de Janeiro Research Supporting Agency (FAPERJ) [E-26/110.318/2007]	National Research Council of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Rio de Janeiro Research Supporting Agency (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grant 474116/2008-5 from the National Research Council of Brazil (CNPq- htpp://www.cnpq.br) and grant E-26/110.318/2007 from the State of Rio de Janeiro Research Supporting Agency (FAPERJ - htpp://www.faperj.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevizaki M, 2007, EUR J ENDOCRINOL, V156, P489, DOI 10.1530/EJE-06-0685; Almeida S, 2006, BRAZ J MED BIOL RES, V39, P447, DOI 10.1590/S0100-879X2006000400004; ANDERSEN TI, 1994, HUM GENET, V94, P665; Arnal JF, 2010, ARTERIOSCL THROM VAS, V30, P1506, DOI 10.1161/ATVBAHA.109.191221; Asif AR, 2009, J PROTEOME RES, V8, P3161, DOI 10.1021/pr800998k; Billon-Gales A, 2009, CIRCULATION, V120, P2567, DOI 10.1161/CIRCULATIONAHA.109.898445; Bollig A, 2000, MOL ENDOCRINOL, V14, P634, DOI 10.1210/me.14.5.634; Casazza K, 2010, BIOL RES NURS, V12, P84, DOI 10.1177/1099800410371118; Channon KM, 2002, J PHYSIOL PHARMACOL, V53, P515; Chow RWY, 2010, ENDOCRINOLOGY, V151, P2411, DOI 10.1210/en.2009-1456; Clapauch R, 2012, MENOPAUSE, V19, P672, DOI 10.1097/gme.0b013e31823a8f43; Clapauch R, 2009, MICROVASC RES, V78, P405, DOI 10.1016/j.mvr.2009.08.003; Doshi AA, 2010, J CARD FAIL, V16, P314, DOI 10.1016/j.cardfail.2009.12.013; Gallagher CJ, 2007, DIABETES, V56, P2135, DOI 10.2337/db06-1017; Gavin KM, 2009, J CLIN ENDOCR METAB, V94, P3513, DOI 10.1210/jc.2009-0278; Gilchrist M, 2011, CARDIOVASC RES, V89, P492, DOI 10.1093/cvr/cvq309; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Holm P, 1997, J CLIN INVEST, V100, P821, DOI 10.1172/JCI119597; Ingelsson E, 2008, J HUM HYPERTENS, V22, P569, DOI 10.1038/jhh.2008.37; Joshi MS, 2007, FASEB J, V21, P2655, DOI 10.1096/fj.06-7088com; Kim KH, 2009, MOL CELL ENDOCRINOL, V308, P3, DOI 10.1016/j.mce.2009.03.025; Kjaergaard AD, 2007, CIRCULATION, V115, P861, DOI 10.1161/CIRCULATIONAHA.106.615567; Knowlton AA, 2012, PHARMACOL THERAPEUT, V135, P54, DOI 10.1016/j.pharmthera.2012.03.007; Leeson CPM, 2002, CIRC RES, V90, P1153, DOI 10.1161/01.RES.0000020562.07492.D4; Li RL, 2004, AM J HYPERTENS, V17, P560, DOI 10.1016/j.amjhyper.2004.02.013; Liu SH, 2009, ISLETS, V1, P273, DOI 10.4161/isl.1.3.9781; Lo JC, 2006, AM J MED, V119, P69, DOI 10.1016/j.amjmed.2006.07.009; Lu H, 2002, ARTERIOSCL THROM VAS, V22, P817, DOI 10.1161/01.ATV.0000014424.18209.21; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; Masood DEN, 2010, CURR DRUG METAB, V11, P693, DOI 10.2174/138920010794233477; Matic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057458; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meshkani R, 2012, MOL CELL BIOCHEM, V359, P225, DOI 10.1007/s11010-011-1017-9; Mikkola TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063347; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Nakayama M, 1999, CIRCULATION, V99, P2864, DOI 10.1161/01.CIR.99.22.2864; Neves FJ, 2010, J HYPERTENS, V28, P764, DOI 10.1097/HJH.0b013e328334f55c; Nilsson S, 2011, CLIN PHARMACOL THER, V89, P44, DOI 10.1038/clpt.2010.226; Nofer JR, 2012, J MOL ENDOCRINOL, V48, pR13, DOI 10.1530/JME-11-0145; OSTERGREN J, 1986, INT J MICROCIRC, V5, P37; Rasool AHG, 2009, MICROVASC RES, V78, P230, DOI 10.1016/j.mvr.2009.05.005; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Rodriguez-Manas L, 2009, AGING CELL, V8, P226, DOI 10.1111/j.1474-9726.2009.00466.x; Safarinejad MR, 2013, UROL ONCOL-SEMIN ORI, V31, P1132, DOI 10.1016/j.urolonc.2012.01.002; Safarinejad MR, 2010, J STEROID BIOCHEM, V122, P193, DOI 10.1016/j.jsbmb.2010.06.011; Santen RJ, 2010, J CLIN ENDOCR METAB, V95, pS7, DOI 10.1210/jc.2009-2509; Shearman AM, 2006, CIRC RES, V98, P590, DOI 10.1161/01.RES.0000210578.62102.a6; Shearman AM, 2003, JAMA-J AM MED ASSOC, V290, P2263, DOI 10.1001/jama.290.17.2263; Shen C, 2012, EUR J INTERN MED, V23, P175, DOI 10.1016/j.ejim.2011.05.006; Simoncini T, 2005, MATURITAS, V50, P247, DOI 10.1016/j.maturitas.2004.04.001; Speroff L, 2000, ANN NY ACAD SCI, V900, P26; Tanus-Santos JE, 2002, PHARMACOGENETICS, V12, P407, DOI 10.1097/00008571-200207000-00008; Tesauro M, 2000, P NATL ACAD SCI USA, V97, P2832, DOI 10.1073/pnas.97.6.2832; Vanhoutte PM, 2008, J PHYSIOL-LONDON, V586, P5295, DOI 10.1113/jphysiol.2008.161430; Ward BW, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120203; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; YAICH L, 1992, CANCER RES, V52, P77	57	7	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103444	10.1371/journal.pone.0103444	http://dx.doi.org/10.1371/journal.pone.0103444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077953	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800046
J	Mezzina, MP; Wetzler, DE; Catone, MV; Bucci, H; Di Paola, M; Pettinari, MJ				Mezzina, Mariela P.; Wetzler, Diana E.; Catone, Mariela V.; Bucci, Hernan; Di Paola, Matias; Pettinari, M. Julia			A Phasin with Many Faces: Structural Insights on PhaP from Azotobacter sp FA8	PLOS ONE			English	Article							GRANULE-ASSOCIATED PROTEIN; RALSTONIA-EUTROPHA H16; POLYHYDROXYALKANOIC ACID GRANULES; AEROMONAS-HYDROPHILA; PHB GRANULES; EXPRESSION; POLYHYDROXYBUTYRATE; PURIFICATION; DEGRADATION; PREDICTION	Phasins are a group of proteins associated to granules of polyhydroxyalkanoates (PHAs). Apart from their structural role as part of the PHA granule cover, different structural and regulatory functions have been found associated to many of them, and several biotechnological applications have been developed using phasin protein fusions. Despite their remarkable functional diversity, the structure of these proteins has not been analyzed except in very few studies. PhaP from Azotobacter sp. FA8 (PhaP(Az)) is a representative of the prevailing type in the multifunctional phasin protein family. Previous work performed in our laboratory using this protein have demonstrated that it has some very peculiar characteristics, such as its stress protecting effects in recombinant Escherichia coli, both in the presence and absence of PHA. The aim of the present work was to perform a structural characterization of this protein, to shed light on its properties. Its aminoacid composition revealed that it lacks clear hydrophobic domains, a characteristic that appears to be common to most phasins, despite their lipid granule binding capacity. The secondary structure of this protein, consisting of a-helices and disordered regions, has a remarkable capacity to change according to its environment. Several experimental data support that it is a tetramer, probably due to interactions between coiled-coil regions. These structural features have also been detected in other phasins, and may be related to their functional diversity.	[Mezzina, Mariela P.; Wetzler, Diana E.; Catone, Mariela V.; Bucci, Hernan; Di Paola, Matias; Pettinari, M. Julia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, IQUIBICEN CONICET, Dept Quim Biol, Buenos Aires, DF, Argentina	University of Buenos Aires	Wetzler, DE (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, IQUIBICEN CONICET, Dept Quim Biol, Buenos Aires, DF, Argentina.	diana.wetzler@gmail.com; jul@qb.fcen.uba.ar	Pettinari, M. Julia/B-7404-2011	Pettinari, Julia/0000-0002-6130-4740; Wetzler, Diana Elena/0000-0003-2231-6690; Mezzina, Mariela Paula/0000-0003-0026-173X	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires (UBA); Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT); CONICET	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires (UBA)(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), the University of Buenos Aires (UBA), and Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT). DEW and MJP are career members of CONICET, and MPM, HB and MDP have scholarships from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu MM, 2012, SCIENCE, V337, P1460, DOI 10.1126/science.1228775; Barnard GC, 2005, APPL ENVIRON MICROB, V71, P5735, DOI 10.1128/AEM.71.10.5735-5742.2005; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BUCK M, 1995, BIOCHEMISTRY-US, V34, P4041, DOI 10.1021/bi00012a023; COOPER TM, 1990, BIOPOLYMERS, V30, P657, DOI 10.1002/bip.360300703; de Almeida A, 2007, APPL ENVIRON MICROB, V73, P7912, DOI 10.1128/AEM.01900-07; de Almeida A, 2011, APPL ENVIRON MICROB, V77, P6622, DOI 10.1128/AEM.05469-11; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Galan B, 2011, MOL MICROBIOL, V79, P402, DOI 10.1111/j.1365-2958.2010.07450.x; Handrick R, 2004, J BACTERIOL, V186, P2466, DOI 10.1128/JB.186.8.2466-2475.2004; Hanley SZ, 1999, FEBS LETT, V447, P99, DOI 10.1016/S0014-5793(99)00235-5; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Keshavarz T, 2010, CURR OPIN MICROBIOL, V13, P321, DOI 10.1016/j.mib.2010.02.006; Kuchta K, 2007, BIOMACROMOLECULES, V8, P657, DOI 10.1021/bm060912e; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAU SYM, 1984, J BIOL CHEM, V259, P3253; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Luo YZ, 1998, J MOL BIOL, V279, P49, DOI 10.1006/jmbi.1998.1774; Maestro B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056904; McCool GJ, 1999, J BACTERIOL, V181, P585, DOI 10.1128/JB.181.2.585-592.1999; Moldes C, 2004, APPL ENVIRON MICROB, V70, P3205, DOI 10.1128/AEM.70.6.3205-3212.2004; Neumann L, 2008, J BACTERIOL, V190, P2911, DOI 10.1128/JB.01486-07; Peralta-Gil M, 2002, J BACTERIOL, V184, P5672, DOI 10.1128/JB.184.20.5672-5677.2002; Pfeiffer D, 2012, J BACTERIOL, V194, P5909, DOI 10.1128/JB.00779-12; PIEPERFURST U, 1994, J BACTERIOL, V176, P4328, DOI 10.1128/jb.176.14.4328-4337.1994; Potter M, 2005, BIOMACROMOLECULES, V6, P552, DOI 10.1021/bm049401n; Potter M, 2004, MICROBIOL-SGM, V150, P2301, DOI 10.1099/mic.0.26970-0; Prieto MA, 1999, J BACTERIOL, V181, P858, DOI 10.1128/JB.181.3.858-868.1999; Qi Q, 2000, APPL MICROBIOL BIOT, V54, P37, DOI 10.1007/s002530000357; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Slavik J, 1995, BIOCHIM BIOPHYS ACTA, V694, P1; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; Tian SJ, 2005, FEMS MICROBIOL LETT, V244, P19, DOI 10.1016/j.femsle.2005.01.020; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; WIECZOREK R, 1995, J BACTERIOL, V177, P2425, DOI 10.1128/jb.177.9.2425-2435.1995; Xue B, 2011, BIOCHIM BIOPHYS ACTA, V1804, P996; York GM, 2001, J BACTERIOL, V183, P2394, DOI 10.1128/JB.183.7.2394-2397.2001; Zhao ML, 2006, ACTA CRYSTALLOGR F, V62, P814, DOI 10.1107/S1744309106025000	38	20	20	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103012	10.1371/journal.pone.0103012	http://dx.doi.org/10.1371/journal.pone.0103012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077609	Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800024
J	Raza, H; John, A; Shafarin, J				Raza, Haider; John, Annie; Shafarin, Jasmin			NAC Attenuates LPS-Induced Toxicity in Aspirin-Sensitized Mouse Macrophages via Suppression of Oxidative Stress and Mitochondrial Dysfunction	PLOS ONE			English	Article							ACETYLSALICYLIC-ACID; LIVER-INJURY; APOPTOSIS; ACETAMINOPHEN; MECHANISMS; CYTOKINES; PROTEINS; CELLS	Bacterial endotoxin lipopolysaccharide (LPS) induces the production of inflammatory cytokines and reactive oxygen species (ROS) under in vivo and in vitro conditions. Acetylsalicylic acid (ASA, aspirin) is a commonly used anti-inflammatory drug. Our aim was to study the effects of N-acetyl cysteine (NAC), an antioxidant precursor of GSH synthesis, on aspirin-sensitized macrophages treated with LPS. We investigated the effects of LPS alone and in conjunction with a sub-toxic concentration of ASA, on metabolic and oxidative stress, apoptosis, and mitochondrial function using J774.2 mouse macrophage cell line. Protection from LPS-induced toxicity by NAC was also studied. LPS alone markedly induced ROS production and oxidative stress in macrophage cells. When ASA was added to LPS-treated macrophages, the increase in oxidative stress was significantly higher than that with LPS alone. Similarly, alteration in glutathione-dependent redox metabolism was also observed in macrophages after treatment with LPS and ASA. The combination of LPS and ASA selectively altered the CYP 3A4, CYP 2E1 and CYP 1A1 catalytic activities. Mitochondrial respiratory complexes and ATP production were also inhibited by LPS-ASA treatment. Furthermore a higher apoptotic cell death was also observed in LPS-ASA treated macrophages. NAC pre-treatment showed protection against oxidative stress induced apoptosis and mitochondrial dysfunction. These effects are presumed, at least in part, to be associated with alterations in NF-kappa B/Nrf-2 mediated cell signaling. These results suggest that macrophages are more sensitive to LPS when challenged with ASA and that NAC pre-treatment protects the macrophages from these deleterious effects.	[Raza, Haider; John, Annie; Shafarin, Jasmin] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates	United Arab Emirates University	Raza, H (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates.	h.raza@uaeu.ac.ae		Raza, Haider/0000-0001-9680-5388	Sheikh Hamdan bin Rashid Al Maktoum Award [MRG01/2011-2012]; College of Medicine and Health Sciences; Terry Fox Cancer Research Fund	Sheikh Hamdan bin Rashid Al Maktoum Award; College of Medicine and Health Sciences; Terry Fox Cancer Research Fund	This work was supported by Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, MRG01/2011-2012 (HR), College of Medicine and Health Sciences, and Terry Fox Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Belooshi T, 2010, FOOD CHEM TOXICOL, V48, P2624, DOI 10.1016/j.fct.2010.06.031; Bhagwat SV, 1999, TOXICOL APPL PHARM, V156, P231, DOI 10.1006/taap.1999.8646; Bian K, 2001, FREE RADICAL BIO MED, V31, P421, DOI 10.1016/S0891-5849(01)00600-1; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Brune B, 2013, ANTIOXID REDOX SIGN, V19, P595, DOI 10.1089/ars.2012.4785; Bykov I, 2003, SCAND J GASTROENTERO, V38, P1256, DOI 10.1080/00365520310007116; Cederbaum AI, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/582790; Cosgrove BD, 2009, TOXICOL APPL PHARM, V237, P317, DOI 10.1016/j.taap.2009.04.002; Crowley SD, 2014, ANTIOXID REDOX SIGN, V20, P102, DOI 10.1089/ars.2013.5258; Cuschieri J, 2007, ANTIOXID REDOX SIGN, V9, P1485, DOI 10.1089/ars.2007.1670; Duan YZ, 2014, BMB REP, V47, P45, DOI 10.5483/BMBRep.2014.47.1.089; Endres S, 1996, IMMUNOLOGY, V87, P264, DOI 10.1046/j.1365-2567.1996.472535.x; Hartel C, 2004, SCAND J IMMUNOL, V60, P412, DOI 10.1111/j.0300-9475.2004.01481.x; Ho LJ, 2001, SCAND J RHEUMATOL, V30, P346; Kang PT, 2014, BIOCHEM PHARMACOL, V89, P490, DOI 10.1016/j.bcp.2014.03.012; Kim KM, 2005, J BIOL CHEM, V280, P41047, DOI 10.1074/jbc.M503713200; Lacour S, 2009, J IMMUNOTOXICOL, V6, P84, DOI 10.1080/15476910902938250; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laskin DL, 2001, TOXICOLOGY, V160, P111, DOI 10.1016/S0300-483X(00)00437-6; Lu YK, 2005, AM J PHYSIOL-GASTR L, V289, pG308, DOI 10.1152/ajpgi.00054.2005; Lu YK, 2010, GENES NUTR, V5, P149, DOI 10.1007/s12263-009-0150-5; Nandakishore Ravindran, 2014, Curr Drug Discov Technol, V11, P127; Rao RK, 2004, AM J PHYSIOL-GASTR L, V286, pG881, DOI 10.1152/ajpgi.00006.2004; Raza H, 1996, BIOCHEM PHARMACOL, V52, P1639, DOI 10.1016/S0006-2952(96)00526-6; Raza H, 2014, HAMDAN MED IN PRESS; Raza H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036325; Raza H, 2011, EUR J PHARMACOL, V668, P15, DOI 10.1016/j.ejphar.2011.06.016; Roberts RA, 2009, TOXICOL SCI, V112, P4, DOI 10.1093/toxsci/kfp179; Stark LA, 2007, CARCINOGENESIS, V28, P968, DOI 10.1093/carcin/bgl220; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Xu XM, 1999, P NATL ACAD SCI USA, V96, P5292, DOI 10.1073/pnas.96.9.5292; Zhao GQ, 2013, MOL PHARMACOL, V83, P167, DOI 10.1124/mol.112.080762	33	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103379	10.1371/journal.pone.0103379	http://dx.doi.org/10.1371/journal.pone.0103379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075522	gold, Green Submitted, Green Published			2022-12-25	WOS:000340028800042
J	Awoliyi, S; Ball, D; Parkinson, N; Preedy, VR				Awoliyi, Susanna; Ball, David; Parkinson, Norman; Preedy, Victor R.			Alcohol Misuse among University Staff: A Cross-Sectional Study	PLOS ONE			English	Article							DISORDERS IDENTIFICATION TEST; BINGE DRINKING; TEST AUDIT; WORKPLACE; HEALTH; CONSUMPTION; PREVALENCE; POPULATION; WORKFORCE	Objectives: To examine the prevalence of hazardous drinking among staff in a UK university and its association with key socio-demographic features. Design: A cross-sectional study. Setting: A university in the UK. Participants: All employees on the university employee database were eligible to participate. Those who completed and returned the questionnaire were included in the sample. Respondents were 131 university employees. Primary and Secondary Outcome Measures: An AUDIT cut-off score of >= 8 was used as a measure of hazardous drinking. AUDIT total score as well as a score of >= 1 in each of the three conceptual domains of alcohol consumption (questions 1-3), dependence symptoms (questions 4-6) and alcohol-related problems (questions 7-10) were used as indicators of levels of drinking and alcohol-related consequences. Secondary outcomes were employees' demographics. Results: Over one third (35%) of respondents were classified as hazardous drinkers. Twenty three per cent reported having blackouts after drinking and 14% had injuries or had injured someone. The odds of being a hazardous drinker for an employee in central departments (Human Resources, Registry etc) is only one third of that of an employee in science and health-related departments (OR = 0.35, 95% CI = 0.14 to 0.91). The proportion of hazardous drinkers was higher in males compared to females (43% and 30% respectively), part-time compared to full-time (46% and 34% respectively), and academic compared to non-academic employees (39% and 32% respectively), although these were not statistically significant (p>0.05). Furthermore, age, religion and ethnic origin were not found to be significantly associated with hazardous drinking, although total scores were significantly lower for ethnic minorities compared to white employees (p = 0.019). Conclusions: In this study, hazardous drinking was highly prevalent among university employees. However, overt recruiting of staff to address sensitive issues such as alcohol misuse is problematic.	[Awoliyi, Susanna; Parkinson, Norman] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London, England; [Awoliyi, Susanna] Kings Coll London, Dept Nutr & Dietet, London, England; [Ball, David] Kings Coll London, Inst Psychiat, London, England; [Preedy, Victor R.] Kings Coll London, Diabet & Nutr Sci Div, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London	Preedy, VR (corresponding author), Kings Coll London, Dept Primary Care & Publ Hlth Sci, London, England.	victor.preedy@kcl.ac.uk						Aertgeerts B, 2001, BRIT J GEN PRACT, V51, P206; Alcohol Concern, 2006, ACQ ALC CONC Q INF R; Alcohol Concern, 2011, MAK ALC HLTH PRIOR O; [Anonymous], 2010, ALC US DIS PREV HARM; Babor TF., 2001, ALCOHOL USE DISORDER; Berry JG, 2007, ADDICTION, V102, P1399, DOI 10.1111/j.1360-0443.2007.01893.x; Boniface S, 2013, EUR J PUBLIC HEALTH, V23, P1076, DOI 10.1093/eurpub/ckt016; British Medical Association Board of Science, 2008, ALC MIS TACKL UK EP; Chan-Pensley E, 1999, ALCOHOL ALCOHOLISM, V34, P882, DOI 10.1093/alcalc/34.6.882; CONIGRAVE KM, 1995, ADDICTION, V90, P1349, DOI 10.1046/j.1360-0443.1995.901013496.x; Curry SJ, 2002, ALCOHOL ALCOHOLISM, V37, P289, DOI 10.1093/alcalc/37.3.289; Davey JD, 2000, DRUG ALCOHOL REV, V19, P49; David Annette M, 2010, Hawaii Med J, V69, P45; Department of Health Home Office Department for Education and Skills Department for Culture Media and Sport, 2007, SAF SENS SOC NEXT ST; Foster A I, 1997, J Ky Med Assoc, V95, P105; Frone MR, 2006, J STUD ALCOHOL, V67, P147, DOI 10.15288/jsa.2006.67.147; Gill JS, 2002, ALCOHOL ALCOHOLISM, V37, P109, DOI 10.1093/alcalc/37.2.109; Health Inprovement Analytic Team, 2008, COST ALC HARM NHS EN; Hermansson U, 2000, ALCOHOL CLIN EXP RES, V24, P180, DOI 10.1097/00000374-200002000-00008; Home Office, 2012, GOV ALC STRAT; Home Office Statistics Unit, 2011, CRIM ENGL WAL 2010 1; Institute of Alcohol Studies, 2009, ALC WORKPL IAS FACTS; Mahmoud AO, 2011, MIDDLE EAST AFR J OP, V18, P164, DOI 10.4103/0974-9233.80707; Matano RA, 2003, ADDICT BEHAV, V28, P1299, DOI 10.1016/S0306-4603(02)00248-4; Matano RA, 2002, J BEHAV HEALTH SER R, V29, P30, DOI 10.1007/BF02287830; National Audit Office, 2008, RED ALC HARM HLTH SE; O'Malley PM, 2002, J STUD ALCOHOL, P23, DOI 10.15288/jsas.2002.s14.23; Poikolainen K, 2005, COMPREHENSIVE HDB AL, P49; *PRIM MIN STRAT UN, 2004, ALC HARM RED STRAT E; Roman PM, 2002, ALCOHOL RES HEALTH, V26, P49; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SEPPA K, 1995, ALCOHOL CLIN EXP RES, V19, P999, DOI 10.1111/j.1530-0277.1995.tb00980.x; Taylor C, 2007, BRIT J PSYCHIAT, V190, P268, DOI 10.1192/bjp.bp.106.023234; The NHS Information Centre, 2009, AD PSYCH MORB SURV 2; The NHS Information Centre Lifestyle Statistics, 2011, STAT ALC ENGL 2011; Trades Union Congress, 2003, ALC WORK POT COCKT T; Vasianovich A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-58; WHO, 1994, LEX ALC DRUG TERMS	38	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e98134	10.1371/journal.pone.0098134	http://dx.doi.org/10.1371/journal.pone.0098134			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072628	gold, Green Published, Green Submitted			2022-12-25	WOS:000341307600002
J	Baboota, RK; Singh, DP; Sarma, SM; Kaur, J; Sandhir, R; Boparai, RK; Kondepudi, KK; Bishnoi, M				Baboota, Ritesh K.; Singh, Dhirendra P.; Sarma, Siddhartha M.; Kaur, Jaspreet; Sandhir, Rajat; Boparai, Ravneet K.; Kondepudi, Kanthi K.; Bishnoi, Mahendra			Capsaicin Induces "Brite" Phenotype in Differentiating 3T3-L1 Preadipocytes	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; ADIPOSE-TISSUE; HIGH-FAT; KAPPA-B; ENERGY-METABOLISM; SPICY COMPONENT; GENE-EXPRESSION; ADIPONECTIN; ADIPOGENESIS; TRPV1	Objective: Targeting the energy storing white adipose tissue (WAT) by pharmacological and dietary means in order to promote its conversion to energy expending "brite'' cell type holds promise as an anti-obesity approach. Present study was designed to investigate/revisit the effect of capsaicin on adipogenic differentiation with special reference to induction of "brite'' phenotype during differentiation of 3T3-L1 preadipocytes. Methods: Multiple techniques such as Ca2+ influx assay, Oil Red-O staining, nutrigenomic analysis in preadipocytes and matured adipocytes have been employed to understand the effect of capsaicin at different doses. In addition to in-vitro experiments, in-vivo studies were carried out in high-fat diet (HFD) fed rats treated with resiniferatoxin (RTX) (a TRPV1 agonist) and in mice administered capsaicin. Results: TRPV1 channels are expressed in preadipocytes but not in adipocytes. In preadipocytes, both capsaicin and RTX stimulate Ca2+ influx in dose-dependent manner. This stimulation may be prevented by capsazepine, a TRPV1 antagonist. At lower doses, capsaicin inhibits lipid accumulation and stimulates TRPV1 gene expression, while at higher doses it enhances accumulation of lipids and suppresses expression of its receptor. In doses of 0.1-100 mu M, capsaicin promotes expression of major pro-adipogenic factor PPAR gamma and some of its downstream targets. In concentrations of 1 mu M, capsaicin up-regulates anti-adipogenic genes. Low-dose capsaicin treatment of 3T3-L1 preadipocytes differentiating into adipocytes results in increased expression of brown fat cell marker genes. In white adipose of mice, capsaicin administration leads to increase in browning-specific genes. Global TRPV1 ablation (i.p. by RTX administration) leads to increase in locomotor activity with no change in body weight. Conclusion: Our findings suggest the dual modulatory role of capsaicin in adipogenesis. Capsaicin inhibits adipogenesis in 3T3-L1 via TRPV1 activation and induces brown-like phenotype whereas higher doses.	[Baboota, Ritesh K.; Singh, Dhirendra P.; Sarma, Siddhartha M.; Kondepudi, Kanthi K.; Bishnoi, Mahendra] Natl Agri Food Biotechnol Inst NABI, Sas Nagar, Punjab, India; [Kaur, Jaspreet] Panjab Univ, UIET, Dept Biotechnol, Chandigarh 160014, India; [Sandhir, Rajat; Boparai, Ravneet K.] Panjab Univ, Dept Biochem, Chandigarh 160014, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Panjab University; Panjab University	Bishnoi, M (corresponding author), Natl Agri Food Biotechnol Inst NABI, Sas Nagar, Punjab, India.	mbishnoi@gmail.com	Baboota, Ritesh Kumar/AAQ-2606-2020; Bishnoi, Mahendra/CAG-3229-2022; Kondepudi, Kanthi Kiran/P-8336-2014	Kondepudi, Kanthi Kiran/0000-0001-8036-7555; Singh, Dhirendra Pratap/0000-0002-9454-9752; Bishnoi, Mahendra/0000-0002-7785-1204	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The authors would like to thank Department of Biotechnology, Government of India, for research grants given to National Agri-Food Biotechnology Institute (NABI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuwon KM, 2005, AM J PHYSIOL-REG I, V288, pR1220, DOI 10.1152/ajpregu.00397.2004; Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Bishnoi M, 2011, J PAIN, V12, P991, DOI 10.1016/j.jpain.2011.03.005; Bonet ML, 2013, BBA-MOL CELL BIOL L, V1831, P969, DOI 10.1016/j.bbalip.2012.12.002; Bruun JM, 2002, MOL CELL ENDOCRINOL, V190, P91, DOI 10.1016/S0303-7207(02)00007-2; Chandrasekar B, 2008, J BIOL CHEM, V283, P4200, DOI 10.1074/jbc.M708142200; Chavez M, 1997, AM J PHYSIOL-REG I, V272, pR1657, DOI 10.1152/ajpregu.1997.272.5.R1657; Cheng X, 2012, J BIOL CHEM, V287, P36896, DOI 10.1074/jbc.M112.409516; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Clegg ME, 2013, EUR J NUTR, V52, P1579, DOI 10.1007/s00394-012-0463-9; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gaur V, 2010, BRAIN RES BULL, V82, P57, DOI 10.1016/j.brainresbull.2010.01.010; Gonzalez LE, 1996, BRAIN RES, V732, P145, DOI 10.1016/0006-8993(96)00517-3; Hsu CL, 2007, J AGR FOOD CHEM, V55, P1730, DOI 10.1021/jf062912b; Jeffry JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007021; Kang JH, 2007, FEBS LETT, V581, P4389, DOI 10.1016/j.febslet.2007.07.082; Kang JH, 2010, OBESITY, V18, P780, DOI 10.1038/oby.2009.301; Kawabata F, 2009, BIOSCI BIOTECH BIOCH, V73, P2690, DOI 10.1271/bbb.90555; KAWADA T, 1986, P SOC EXP BIOL MED, V183, P250; Kim CS, 2004, J MED FOOD, V7, P267, DOI 10.1089/jmf.2004.7.267; Kobayashi Y, 2001, PLANTA MED, V67, P628, DOI 10.1055/s-2001-17353; Lappas M, 2005, ENDOCRINOLOGY, V146, P3334, DOI 10.1210/en.2005-0406; Lee MS, 2011, PHYTOTHER RES, V25, P935, DOI 10.1002/ptr.3339; Li HF, 2010, MOL CELL ENDOCRINOL, V323, P201, DOI 10.1016/j.mce.2010.03.021; Lihn AS, 2004, MOL CELL ENDOCRINOL, V219, P9, DOI 10.1016/j.mce.2004.03.002; Lira FS, 2012, CYTOKINE, V57, P98, DOI 10.1016/j.cyto.2011.10.001; Ludy MJ, 2012, CHEM SENSES, V37, P103, DOI 10.1093/chemse/bjr100; Marshall NJ, 2013, HYPERTENSION, V61, P246, DOI 10.1161/HYPERTENSIONAHA.112.201434; Motter AL, 2008, FEBS LETT, V582, P2257, DOI 10.1016/j.febslet.2008.05.021; Park JY, 2004, FEBS LETT, V572, P266, DOI 10.1016/j.febslet.2004.06.084; Premkumar LS, 2010, AAPS J, V12, P361, DOI 10.1208/s12248-010-9196-y; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874; Romanovsky AA, 2009, PHARMACOL REV, V61, P228, DOI 10.1124/pr.109.001263; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; Safieh-Garabedian B, 2013, NEUROSCIENCE, V250, P455, DOI 10.1016/j.neuroscience.2013.07.031; Sanz-Salvador L, 2012, J BIOL CHEM, V287, P19462, DOI 10.1074/jbc.M111.289751; Schwarz NA, 2013, NUTR RES; Sukumar P, 2012, CIRC RES, V111, P191, DOI [10.1161/CIRCRESAHA.112.270751, 10.1161/circresaha.112.270751]; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10; Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yoneshiro T, 2012, AM J CLIN NUTR, V95, P845, DOI 10.3945/ajcn.111.018606; Yoshioka M, 1998, BRIT J NUTR, V80, P503, DOI 10.1017/S0007114598001597; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zhang B, 1996, MOL ENDOCRINOL, V10, P1457, DOI 10.1210/me.10.11.1457; Zhang LL, 2007, CIRC RES, V100, P1063, DOI 10.1161/01.RES.0000262653.84850.8b	51	89	92	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103093	10.1371/journal.pone.0103093	http://dx.doi.org/10.1371/journal.pone.0103093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072597	gold, Green Published, Green Submitted			2022-12-25	WOS:000341307600022
J	Hirako, N; Nakano, H; Takahashi, S				Hirako, Naomi; Nakano, Hiroko; Takahashi, Shinichiro			A PU.1 Suppressive Target Gene, Metallothionein 1G, Inhibits Retinoic Acid-Induced NB4 Cell Differentiation	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTOR; EXPRESSION; INDUCTION; GROWTH; NEUTROPHILS; RESISTANCE; ROLES; LEVEL; FLT3	We recently revealed that myeloid master regulator SPI1/PU. 1 directly represses metallothionein (MT) 1G through its epigenetic activity of PU. 1, but the functions of MT1G in myeloid differentiation remain unknown. To clarify this, we established MT1G-overexpressing acute promyelocytic leukemia NB4 (NB4MTOE) cells, and investigated whether MT1G functionally contributes to all-trans retinoic acid (ATRA)-induced NB4 cell differentiation. Real-time PCR analyses demonstrated that the inductions of CD11b and CD11c and reductions in myeloperoxidase and c-myc by ATRA were significantly attenuated in NB4MTOE cells. Morphological examination revealed that the percentages of differentiated cells induced by ATRA were reduced in NB4MTOE cells. Since G1 arrest is a hallmark of ATRA-induced NB4 cell differentiation, we observed a decrease in G1 accumulation, as well as decreases in p21(WAF1/CIP1) and cyclin D1 inductions, by ATRA in NB4MTOE cells. Nitroblue tetrazolium (NBT) reduction assays revealed that the proportions of NBT-positive cells were decreased in NB4MTOE cells in the presence of ATRA. Microarray analyses showed that the changes in expression of several myeloid differentiation-related genes (GATA2, azurocidin 1, pyrroline-5-carboxylate reductase 1, matrix metallopeptidase -8, S100 calcium-binding protein A12, neutrophil cytosolic factor 2 and oncostatin M) induced by ATRA were disturbed in NB4MTOE cells. Collectively, overexpression of MT1G inhibits the proper differentiation of myeloid cells.	[Hirako, Naomi; Takahashi, Shinichiro] Kitasato Univ, Grad Sch Med Sci, Div Mol Hematol, Minami Ku, Sagamihara, Kanagawa, Japan; [Nakano, Hiroko; Takahashi, Shinichiro] Kitasato Univ, Sch Allied Hlth Sci, Div Hematol, Minami Ku, Sagamihara, Kanagawa 228, Japan	Kitasato University; Kitasato University	Takahashi, S (corresponding author), Kitasato Univ, Grad Sch Med Sci, Div Mol Hematol, Minami Ku, Sagamihara, Kanagawa, Japan.	shin@kitasato-u.ac.jp	Takahashi, Shinichiro/AAX-7125-2020	Takahashi, Shinichiro/0000-0003-0011-6065	Ministry of Education, Culture, Sports, Science and Technology, Japan [23590687, 26460685]; Takeda Science Foundation; Kitasato University School of Allied Health Sciences [2012-1002, 2013-1001]; Grants-in-Aid for Scientific Research [23590687] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kitasato University School of Allied Health Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (No. 23590687 and 26460685) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the Takeda Science Foundation, and a foundation from Kitasato University School of Allied Health Sciences (Grant-in-Aid for Research Project, No. 2012-1002, 2013-1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mageed AB, 2003, EXP BIOL MED, V228, P1033, DOI 10.1177/153537020322800908; Aoyama S, 2012, BIOCHEM BIOPH RES CO, V420, P775, DOI 10.1016/j.bbrc.2012.03.071; Bagheri PM, 2011, MOL BIOL REP, V38, P3017, DOI 10.1007/s11033-010-9967-7; Britschgi C, 2008, BRIT J HAEMATOL, V141, P179, DOI 10.1111/j.1365-2141.2008.06992.x; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013; COLLINS SJ, 1979, J EXP MED, V149, P969, DOI 10.1084/jem.149.4.969; FITTSCHEN C, 1991, J LEUKOCYTE BIOL, V50, P517, DOI 10.1002/jlb.50.5.517; Garwicz D, 2005, HAEMATOLOGICA, V90, P38; Hirosawa M, 2009, LEUKEMIA RES, V33, P693, DOI 10.1016/j.leukres.2008.09.028; Imoto A, 2010, J BIOL CHEM, V285, P10300, DOI 10.1074/jbc.M109.095810; Inomata M, 2006, LEUKEMIA RES, V30, P659, DOI 10.1016/j.leukres.2005.07.015; Kaiser V, 2000, J LEUKOCYTE BIOL, V68, P779; KARIN M, 1982, NATURE, V299, P797, DOI 10.1038/299797a0; Kondo Y, 1997, MOL PHARMACOL, V52, P195, DOI 10.1124/mol.52.2.195; Kuchenbauer F, 2005, HAEMATOLOGICA, V90, P1617; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu J, 1999, TOXICOL APPL PHARM, V159, P98, DOI 10.1006/taap.1999.8718; Lopez-Otin C, 2009, CELL CYCLE, V8, P3657, DOI 10.4161/cc.8.22.9956; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; Meplan C, 2000, ONCOGENE, V19, P5227, DOI 10.1038/sj.onc.1203907; MICHALSKA AE, 1993, P NATL ACAD SCI USA, V90, P8088, DOI 10.1073/pnas.90.17.8088; Miyajima A, 2000, CYTOKINE GROWTH F R, V11, P177, DOI 10.1016/S1359-6101(00)00003-4; Moffatt P, 1997, DRUG METAB REV, V29, P261, DOI 10.3109/03602539709037585; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; ORKIN SH, 1992, BLOOD, V80, P575; Ozeki K, 2004, BLOOD, V103, P1901, DOI 10.1182/blood-2003-06-1845; Phang JM, 2008, J NUTR, V138, p2008S, DOI 10.1093/jn/138.10.2008S; Pietzsch J, 2009, AMINO ACIDS, V36, P381, DOI 10.1007/s00726-008-0097-7; QUAIFE CJ, 1994, BIOCHEMISTRY-US, V33, P7250, DOI 10.1021/bi00189a029; RICHARDS RI, 1984, CELL, V37, P263, DOI 10.1016/0092-8674(84)90322-2; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Sauerbrey A, 1998, ANTICANCER RES, V18, P1231; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SEARLE PF, 1984, MOL CELL BIOL, V4, P1221, DOI 10.1128/MCB.4.7.1221; Sugiura Tsutomu, 2004, Journal of UOEH, V26, P193; Tabe Y, 2006, BLOOD, V107, P1546, DOI 10.1182/blood-2004-10-4126; Takahashi S, 2005, BRIT J HAEMATOL, V130, P428, DOI 10.1111/j.1365-2141.2005.05621.x; Takahashi S, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-41; Tan JQ, 2000, BLOOD, V96, P1230, DOI 10.1182/blood.V96.4.1230.h8001230_1230_1238; Torlakovic EE, 2006, J PATHOL, V209, P352, DOI 10.1002/path.1986; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; UCHIDA Y, 1991, NEURON, V7, P337, DOI 10.1016/0896-6273(91)90272-2	43	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103282	10.1371/journal.pone.0103282	http://dx.doi.org/10.1371/journal.pone.0103282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072246	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600038
J	Andersen, JP; Hughes, TL; Zou, C; Wilsnack, SC				Andersen, Judith P.; Hughes, Tonda L.; Zou, Christopher; Wilsnack, Sharon C.			Lifetime Victimization and Physical Health Outcomes among Lesbian and Heterosexual Women	PLOS ONE			English	Article							CHILDHOOD SEXUAL-ABUSE; MENTAL-HEALTH; SAMPLE; GAY; CONSEQUENCES; DRINKING; STRESS; ASSOCIATION; PREVALENCE; IDENTITY	Background: Lifetime victimization experiences, including child sexual abuse (CSA), child physical abuse (CPA), adult sexual assault (ASA), and adult physical assault (APA), are associated with health problems. Purpose: To examine relationships between cumulative victimization and physical health among heterosexual and lesbian women and determine whether these relationships differ by sexual identity. Methods: Large samples of heterosexual (n = 482) and lesbian women (n = 394) were interviewed. Questions included lifetime victimization experiences and physical health problems. Results: Compared to women who reported no childhood victimization, those who reported experiencing both CSA and CPA were 44% more likely to report health problems and women who experienced all four types of victimization (CSA, CPA, APA, ASA) were nearly 240% as likely to report physical health problems. Interaction analyses revealed the association between victimization and physical health did not differ by sexual identity. Conclusions: Although lesbians were more likely to report all types of victimization, results suggest that victimization conferred increased physical health risks regardless of sexual identity.	[Andersen, Judith P.; Zou, Christopher] Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada; [Hughes, Tonda L.] Univ Illinois, Coll Nursing, Dept Hlth Syst Sci, Chicago, IL USA; [Wilsnack, Sharon C.] Univ N Dakota, Sch Med & Hlth Sci, Dept Clin Neurosci, Grand Forks, ND 58201 USA	University of Toronto; University Toronto Mississauga; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Dakota Grand Forks	Andersen, JP (corresponding author), Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada.	judith.andersen@utoronto.ca		Andersen, Judith/0000-0001-8477-1432; Hughes, Tonda/0000-0003-1326-7655	National Institute on Alcohol Abuse and Alcoholism [R01 AA004610, K01AA00266, R01 AA13328]; Summer Institute in LGBT Population Health; National Institute of Child Health and Human Development (NICHD) [R25HD064426]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD064426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013328, R01AA004610, K01AA000266] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Summer Institute in LGBT Population Health; National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by National Institute on Alcohol Abuse and Alcoholism (http://www.niaaa.nih.gov) grants R01 AA004610 (to Dr. Sharon Wilsnack) and K01AA00266 and R01 AA13328 (to Dr. Tonda Hughes) and the Summer Institute in LGBT Population Health, supported by the National Institute of Child Health and Human Development (NICHD) http://www.nichd.nih.gov/Pages/index.aspx, under Award Number R25HD064426 (to Dr. Judith Andersen). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Alcohol Abuse and Alcoholism or the National Institutes of Health, or the NICHD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron DJ, 2007, OBESITY, V15, P1023, DOI 10.1038/oby.2007.634; Alvy LM, 2013, J INTERPERS VIOLENCE, V28, P2088, DOI 10.1177/0886260512471081; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Andersen JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053327; ANESHENSEL CS, 1984, J HEALTH SOC BEHAV, V25, P350, DOI 10.2307/2136376; Balsam KF, 2005, J CONSULT CLIN PSYCH, V73, P477, DOI 10.1037/0022-006X.73.3.477; Balsam KF, 2011, J INTERPERS VIOLENCE, V26, P1798, DOI 10.1177/0886260510372946; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Black Michele, 2010, NATL INTIMATE PARTNE; Campbell R, 2008, J CONSULT CLIN PSYCH, V76, P194, DOI 10.1037/0022-006X.76.2.194; Cargiulo T, 2007, AM J HEALTH-SYST PH, V64, pS5, DOI 10.2146/ajhp060647; Center on the Developing Child at Harvard University, 2010, FDN LIF HLTH AR BUIL; Cohen J., 2003, APPL MULTIPLE REGRES; Conron KJ, 2010, AM J PUBLIC HEALTH, V100, P1953, DOI 10.2105/AJPH.2009.174169; D'Andrea Wendy, 2011, J Am Psychiatr Nurses Assoc, V17, P378, DOI 10.1177/1078390311425187; Diamond LM, 2003, J CLIN CHILD ADOLESC, V32, P490, DOI 10.1207/S15374424JCCP3204_1; Fagundes CP, 2012, ARCH GEN PSYCHIAT, V69, P618, DOI 10.1001/archgenpsychiatry.2011.1535; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Gulliford MC, 1999, J CLIN EPIDEMIOL, V52, P773, DOI 10.1016/S0895-4356(99)00053-0; Heck JE, 2006, J ASTHMA, V43, P579, DOI 10.1080/02770900600878289; Heim C, 2001, AM J PSYCHIAT, V158, P575, DOI 10.1176/appi.ajp.158.4.575; Hughes T, 2010, ADDICTION, V105, P2130, DOI 10.1111/j.1360-0443.2010.03088.x; Institute of Medicine, 2011, HLTH LESB GAY BIS TR; Irish L, 2010, J PEDIATR PSYCHOL, V35, P450, DOI 10.1093/jpepsy/jsp118; LillieBlanton M, 1996, ANNU REV PUBL HEALTH, V17, P411; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Nemeroff CB, 2004, J CLIN PSYCHIAT, V65, P18; Roberts AL, 2010, AM J PUBLIC HEALTH, V100, P2433, DOI 10.2105/AJPH.2009.168971; Rothman EF, 2011, TRAUMA VIOLENCE ABUS, V12, P55, DOI 10.1177/1524838010390707; Russo M., 2007, HLTH SEXUAL MINORITI, P523; Savin-Williams RC, 2008, DEV PSYCHOL, V44, P135, DOI 10.1037/0012-1649.44.1.135; SIGNORINI DF, 1991, BIOMETRIKA, V78, P446; Springer KW, 2007, CHILD ABUSE NEGLECT, V31, P517, DOI 10.1016/j.chiabu.2007.01.003; Stoddard J, 2009, J HOMOSEXUAL, V56, P407, DOI 10.1080/00918360902821395; US Department of Justice, 2000, RES REPORT; Vogeltanz ND, 1999, CHILD ABUSE NEGLECT, V23, P579, DOI 10.1016/S0145-2134(99)00026-5; Wegman HL, 2009, PSYCHOSOM MED, V71, P805, DOI 10.1097/PSY.0b013e3181bb2b46; Wilsnack RW, 2006, J STUD ALCOHOL, V67, P341, DOI 10.15288/jsa.2006.67.341; WILSNACK RW, 1984, AM J PUBLIC HEALTH, V74, P1231, DOI 10.2105/AJPH.74.11.1231; Wilsnack SC, 2002, CHILD ABUSE NEGLECT, V26, P139, DOI 10.1016/S0145-2134(01)00313-1; Wilsnack SC, 2008, J STUD ALCOHOL DRUGS, V69, P129, DOI 10.15288/jsad.2008.69.129; Wilsnack SC, 2012, CHILD ABUSE NEGLECT, V36, P260, DOI 10.1016/j.chiabu.2011.10.008; WYATT GE, 1985, CHILD ABUSE NEGLECT, V9, P507, DOI 10.1016/0145-2134(85)90060-2; Zou C, 2013, J AM PSYCHIAT NURSES, V19, P356, DOI 10.1177/1078390313510739	45	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e101939	10.1371/journal.pone.0101939	http://dx.doi.org/10.1371/journal.pone.0101939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RZ	25068978	Green Published, gold			2022-12-25	WOS:000339993700003
J	Canoui-Poitrine, F; Veerabudun, K; Larmignat, P; Letournel, M; Bastuji-Garin, S; Richalet, JP				Canoui-Poitrine, Florence; Veerabudun, Kalaivani; Larmignat, Philippe; Letournel, Murielle; Bastuji-Garin, Sylvie; Richalet, Jean-Paul			Risk Prediction Score for Severe High Altitude Illness: A Cohort Study	PLOS ONE			English	Article							ACUTE MOUNTAIN-SICKNESS; VALIDATION; HYPOXIA	Background: Risk prediction of acute mountain sickness, high altitude (HA) pulmonary or cerebral edema is currently based on clinical assessment. Our objective was to develop a risk prediction score of Severe High Altitude Illness (SHAI) combining clinical and physiological factors. Study population was 1017 sea-level subjects who performed a hypoxia exercise test before a stay at HA. The outcome was the occurrence of SHAI during HA exposure. Two scores were built, according to the presence (PRE, n = 537) or absence (ABS, n = 480) of previous experience at HA, using multivariate logistic regression. Calibration was evaluated by Hosmer-Lemeshow chisquare test and discrimination by Area Under ROC Curve (AUC) and Net Reclassification Index (NRI). Results: The score was a linear combination of history of SHAI, ventilatory and cardiac response to hypoxia at exercise, speed of ascent, desaturation during hypoxic exercise, history of migraine, geographical location, female sex, age under 46 and regular physical activity. In the PRE/ABS groups, the score ranged from 0 to 12/10, a cut-off of 5/5.5 gave a sensitivity of 87%/87% and a specificity of 82%/73%. Adding physiological variables via the hypoxic exercise test improved the discrimination ability of the models: AUC increased by 7% to 0.91 (95% CI: 0.87-0.93) and 17% to 0.89 (95% CI: 0.85-0.91), NRI was 30% and 54% in the PRE and ABS groups respectively. A score computed with ten clinical, environmental and physiological factors accurately predicted the risk of SHAI in a large cohort of sea-level residents visiting HA regions.	[Canoui-Poitrine, Florence; Veerabudun, Kalaivani; Bastuji-Garin, Sylvie] Univ Paris Est, Fac Med, Clin Invest Lab, EA 4393, Creteil, France; [Canoui-Poitrine, Florence; Veerabudun, Kalaivani; Bastuji-Garin, Sylvie] Serv Sante Publ, Grp Henri Mondor Albert Chenevier, AP HP, Creteil, France; [Larmignat, Philippe] Hop Avicenne, AP HP, Serv Anesthesie & Reanimat, F-93009 Bobigny, France; [Richalet, Jean-Paul] Univ Paris 13, Sorbonne Paris Cite, UFR SMBH, Reponses Cellulaires & Fonct Hypoxie EA2363, Bobigny, France; [Letournel, Murielle; Richalet, Jean-Paul] Hop Avicenne, AP HP, Serv Physiol Explorat Fonct & Med Sport, F-93009 Bobigny, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Canoui-Poitrine, F (corresponding author), Univ Paris Est, Fac Med, Clin Invest Lab, EA 4393, Creteil, France.	florence.canoui-poitrine@hmn.aphp.fr	Canoui-Poitrine, Florence/R-4474-2018; Bastuji-Garin, Sylvie/R-3479-2018	Canoui-Poitrine, Florence/0000-0001-9970-6051; Bastuji-Garin, Sylvie/0000-0001-9855-5183; Richalet, Jean-Paul/0000-0002-7110-008X	Universities of Paris; Paris Est	Universities of Paris; Paris Est	The Universities of Paris 13 and Paris Est contributed to the financial support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Bartsch P, 2013, NEW ENGL J MED, V369, P1666, DOI 10.1056/NEJMc1309747; Bloch KE, 2009, HIGH ALT MED BIOL, V10, P25, DOI 10.1089/ham.2008.1043; Dehnert C, 2005, EUR RESPIR J, V25, P545, DOI 10.1183/09031936.05.00070404; HACKETT PH, 1976, LANCET, V2, P1149; HACKETT PH, 1988, J APPL PHYSIOL, V64, P1268, DOI 10.1152/jappl.1988.64.3.1268; Hackett PH, 2004, HIGH ALT MED BIOL, V5, P136, DOI 10.1089/1527029041352054; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hippisley-Cox J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4656; HONIGMAN B, 1993, ANN INTERN MED, V118, P587, DOI 10.7326/0003-4819-118-8-199304150-00003; Lhuissier FJ, 2012, J PHYSIOL-LONDON, V590, P5461, DOI 10.1113/jphysiol.2012.238527; Lhuissier FJ, 2012, J APPL PHYSIOL, V112, P566, DOI 10.1152/japplphysiol.00906.2011; Luks AM, 2010, WILD ENVIRON MED, V21, P146, DOI 10.1016/j.wem.2010.03.002; Mairer K, 2009, HIGH ALT MED BIOL, V10, P239, DOI 10.1089/ham.2008.1091; MATSUZAWA Y, 1989, J APPL PHYSIOL, V66, P1152, DOI 10.1152/jappl.1989.66.3.1152; Mollard P, 2007, RESP PHYSIOL NEUROBI, V159, P178, DOI 10.1016/j.resp.2007.06.012; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Richalet JP, 2012, AM J RESP CRIT CARE, V185, P192, DOI 10.1164/rccm.201108-1396OC; Richalet JP, 2009, CLIN AUTON RES, V19, P335, DOI 10.1007/s10286-009-0028-z; SAVOUREY G, 1995, AVIAT SPACE ENVIR MD, V66, P963; Schneider M, 2002, MED SCI SPORT EXER, V34, P1886, DOI 10.1097/00005768-200212000-00005; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; van Patot MCT, 2008, HIGH ALT MED BIOL, V9, P289, DOI 10.1089/ham.2008.1029	24	56	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e100642	10.1371/journal.pone.0100642	http://dx.doi.org/10.1371/journal.pone.0100642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068815	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993700001
J	Xu, WM; Chen, ZX; Liu, H; Huo, LL; Huang, YM; Jin, XY; Deng, J; Zhu, SJ; Jin, W; Zhang, SC; Yu, YX				Xu, Weimin; Chen, Zexin; Liu, Hui; Huo, Liangliang; Huang, Yangmei; Jin, Xingyi; Deng, Jin; Zhu, Sujuan; Jin, Wen; Zhang, Shanchun; Yu, Yunxian			The Association of Thyroid Nodule with Non-Iodized Salt among Chinese Children	PLOS ONE			English	Article							DIFFERENT IODINE STATUS; LACTATING WOMEN; POPULATION; SERUM; ULTRASONOGRAPHY; ABNORMALITIES; NODULARITY; PREVALENCE; IODIZATION; DEFICIENCY	Objective: The controversy that iodized salt may increase the risk of thyroid disorders has been aroused in China during the past decade. Most of studies focused on adult rather than children. We aimed to explore whether iodized salt was associated with an increased risk of thyroid nodule in Chinese children. Methods: The cross-sectional study was conducted in Hangzhou, China, in 2010. Iodized salt intake, urine iodine concentration (UIC) and thyroid nodule (by ultrasonography) were measured in 3026 children. The associations of iodized salt with thyroid nodule were evaluated using multiple logistic regression models. Results: The prevalence of thyroid nodule was 10.59% among Chinese children. Girls (11.89%) had higher prevalence of thyroid nodule than boys (9.26%). No significant association was observed between type of salt and thyroid nodule in pooled samples, boys and girls, respectively. Similar associations were observed between UIC and thyroid nodule. There was no significant association between milk consumption and thyroid nodule as well. Conclusion: The present study indicated that non-iodized salt may not increase the risk of thyroid nodules among Chinese children. Similar associations were observed between milk consumption, UIC and thyroid nodules.	[Xu, Weimin; Huo, Liangliang; Huang, Yangmei; Jin, Xingyi; Deng, Jin; Zhu, Sujuan] Hangzhou Ctr Dis Control & Prevent, Dept Endem Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Chen, Zexin; Liu, Hui; Jin, Wen; Zhang, Shanchun; Yu, Yunxian] Zhejiang Univ, Sch Med, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Zexin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Clin Epidemiol & Biostat Ctr, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yu, YX (corresponding author), Zhejiang Univ, Sch Med, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hangzhou 310003, Zhejiang, Peoples R China.	yunxianyu@zju.edu.cn			Hangzhou Science and Technology Bureau [200908033B27]; National Basic Research Program of China (973 Program) [2011CB503706]; National Key Technology R&D Program of China [2009BAI80B01]	Hangzhou Science and Technology Bureau; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Key Technology R&D Program of China(National Key Technology R&D Program)	The study was funded in part by grants from Hangzhou Science and Technology Bureau (Grant number: 200908033B27), National Basic Research Program of China (973 Program) (Grant number: 2011CB503706), and the National Key Technology R&D Program of China (Grant number: 2009BAI80B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P. D., 2001, MISSING DATA SAGE U; Bastemir M, 2007, SWISS MED WKLY, V137, P431; Bath SC, 2012, BRIT J NUTR, V107, P935, DOI 10.1017/S0007114511003059; Brauer VFH, 2005, THYROID, V15, P364, DOI 10.1089/thy.2005.15.364; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058379; Chen ZX, 2013, AM J CLIN NUTR, V98, P684, DOI 10.3945/ajcn.112.054353; Clar C, 2002, ENDOCRIN METAB CLIN, V31, P681, DOI 10.1016/S0889-8529(02)00011-7; Dahl L, 2004, PUBLIC HEALTH NUTR, V7, P569, DOI 10.1079/PHN2003554; Deng Jing, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P1009; Ding GangQiang, 2014, Acta Nutrimenta Sinica, V36, P58; EZZAT S, 1994, ARCH INTERN MED, V154, P1838; Guruge KS, 2011, J ENVIRON MONITOR, V13, P2312, DOI 10.1039/c1em10327j; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hegedus L, 2004, NEW ENGL J MED, V351, P1764, DOI 10.1056/NEJMcp031436; Huang Q, 2001, Zhonghua Liu Xing Bing Xue Za Zhi, V22, P455; Knudsen N, 2000, CLIN ENDOCRINOL, V53, P479, DOI 10.1046/j.1365-2265.2000.01121.x; Knudsen N, 2000, EUR J ENDOCRINOL, V143, P485, DOI 10.1530/eje.0.1430485; Li S, ASIA PAC J CLIN NUTR, V20, P501; Ma HM, 2009, PEDIATRICS, V124, pE269, DOI 10.1542/peds.2008-2638; Manz F, 2002, ANN NUTR METAB, V46, P128, DOI 10.1159/000063083; Niedziela M, 2006, ENDOCR-RELAT CANCER, V13, P427, DOI 10.1677/erc.1.00882; Pedersen IB, 2005, CLIN ENDOCRINOL, V62, P713, DOI 10.1111/j.1365-2265.2005.02284.x; RALLISON ML, 1975, JAMA-J AM MED ASSOC, V233, P1069, DOI 10.1001/jama.233.10.1069; Rasmussen LB, 2002, AM J CLIN NUTR, V76, P1069, DOI 10.1093/ajcn/76.5.1069; Soldin OP, 2002, CLIN BIOCHEM, V35, P575, DOI 10.1016/S0009-9120(02)00406-X; Soriguer F, 2012, CLIN NUTR; Sun Y, 2012, ANN HUM BIOL, V39, P461, DOI 10.3109/03014460.2012.712156; Teng WP, 2006, NEW ENGL J MED, V354, P2783, DOI 10.1056/NEJMoa054022; Wang JuanJuan, 2013, Chinese Journal of Endemiology, V32, P359; Wang YL, 2009, ASIA PAC J CLIN NUTR, V18, P34; WHO, 2001, ASS IOD DEF DIS MON; WHO/UNICEF/ICCIDD, 2007, ASS IOD DEF DIS MON, P98; Yan YQ, 2005, J ENDOCRINOL INVEST, V28, P547, DOI 10.1007/BF03347244	33	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102726	10.1371/journal.pone.0102726	http://dx.doi.org/10.1371/journal.pone.0102726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068269	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993700017
J	Pennisi, G; Lanza, G; Giuffrida, S; Vinciguerra, L; Puglisi, V; Cantone, M; Pennisi, M; D'Agate, CC; Naso, P; Aprile, G; Malaguarnera, G; Ferri, R; Bella, R				Pennisi, Giovanni; Lanza, Giuseppe; Giuffrida, Salvatore; Vinciguerra, Luisa; Puglisi, Valentina; Cantone, Mariagiovanna; Pennisi, Manuela; D'Agate, Carmela Cinzia; Naso, Pietro; Aprile, Giuseppe; Malaguarnera, Giulia; Ferri, Raffaele; Bella, Rita			Excitability of the Motor Cortex in De Novo Patients with Celiac Disease	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTICAL EXCITABILITY; COGNITIVE IMPAIRMENT; GLUTEN SENSITIVITY; INHIBITION; BRAIN; AUTOANTIBODIES; FACILITATION; MECHANISMS; DIAGNOSIS	Introduction: Celiac disease (CD) may initially present as a neurological disorder or may be complicated by neurological changes. To date, neurophysiological studies aiming to an objective evaluation of the potential central nervous system involvement in CD are lacking. Objective: To assess the profile of cortical excitability to Transcranial Magnetic Stimulation (TMS) in a group of de novo CD patients. Materials and methods: Twenty CD patients underwent a screening for cognitive and neuropsychiatric symptoms by means of the Mini Mental State Examination and the Structured Clinical Interview for DSM-IV Axis I Disorders, respectively. Instrumental exams, including electroencephalography and brain computed tomography, were also performed. Corticospinal excitability was assessed by means of single and paired-pulse TMS using the first dorsal interosseus muscle of the dominant hand. TMS measures consisted of resting motor threshold, motor evoked potentials, cortical silent period (CSP), intracortical inhibition (ICI) and facilitation (ICF). None of the CD was on gluten-free diet. A group of 20 age-matched healthy controls was used for comparisons. Results: CD showed a significantly shorter CSP (78.0 vs 125.0 ms, p<0.025), a reduced ICI (0.3 vs 0.2, p<0.045) and an enhanced ICF (1.1 vs 0.7, p<0.042) compared to controls. A dysthymic disorder was identified in five patients. The effect size between dysthymic and non-dysthymic CD patients indicated a low probability of interference with the CSP (Cohen's d - 0.414), ICI (-0.278) and ICF (-0.292) measurements. Conclusion: A pattern of cortical excitability characterized by "disinhibition" and "hyperfacilitation" was found in CD patients. Immune system dysregulation might play a central role in triggering changes of the motor cortex excitability.	[Pennisi, Giovanni; Giuffrida, Salvatore; Vinciguerra, Luisa; Puglisi, Valentina; Bella, Rita] Univ Catania, Sect Neurosci, Dept GF Ingrassia, Catania, Italy; [Lanza, Giuseppe; Ferri, Raffaele] Oasi Inst Res Mental Retardat & Brain Aging IRCCS, Dept Neurol IC, Troina, Enna, Italy; [Cantone, Mariagiovanna; Pennisi, Manuela] Univ Catania, Dept Chem, Catania, Italy; [D'Agate, Carmela Cinzia; Naso, Pietro; Aprile, Giuseppe] Univ Catania, Gastroenterol & Endoscopy Unit, Catania, Italy; [Malaguarnera, Giulia] Univ Catania, Dept Biomed Sci, Catania, Italy	University of Catania; IRCCS Oasi Maria SS; University of Catania; University of Catania; University of Catania	Pennisi, G (corresponding author), Univ Catania, Sect Neurosci, Dept GF Ingrassia, Catania, Italy.	pennigi@unict.it	Ferri, Raffaele/B-5439-2013; Lanza, Giuseppe/R-3065-2017; Malaguarnera, Giulia/ABD-4968-2020; Cantone, Mariagiovanna/C-9392-2017; Pennisi, Manuela/AAC-2362-2019	Ferri, Raffaele/0000-0001-6937-3065; Lanza, Giuseppe/0000-0002-5659-662X; Malaguarnera, Giulia/0000-0003-3655-4307; Cantone, Mariagiovanna/0000-0002-9072-4971; Pennisi, Manuela/0000-0003-0776-1411				Alaedini A, 2007, J IMMUNOL, V178, P6590, DOI 10.4049/jimmunol.178.10.6590; Andersen H, 2006, J DIABETES COMPLICAT, V20, P51, DOI 10.1016/j.jdiacomp.2005.06.001; Bajbouj M, 2006, BIOL PSYCHIAT, V59, P395, DOI 10.1016/j.biopsych.2005.07.036; Bella R, 2011, INT J PSYCHOPHYSIOL, V82, P248, DOI 10.1016/j.ijpsycho.2011.09.006; Bella R, 2011, NEUROSCI LETT, V503, P171, DOI 10.1016/j.neulet.2011.08.022; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; Briani C, 2008, J NEUROIMMUNOL, V195, P171, DOI 10.1016/j.jneuroim.2008.01.008; Burk K, 2001, BRAIN, V124, P1013, DOI 10.1093/brain/124.5.1013; Chen R, 1999, EXP BRAIN RES, V128, P539, DOI 10.1007/s002210050878; Ciacci C, 1998, SCAND J GASTROENTERO, V33, P247; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Di Lazzaro V, 2000, CLIN NEUROPHYSIOL, V111, P794, DOI 10.1016/S1388-2457(99)00314-4; Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3; Fitzgerald PB, 2004, J AFFECT DISORDERS, V82, P71, DOI 10.1016/j.jad.2003.09.014; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freeman HJ, 2008, CAN J GASTROENTEROL, V22, P273, DOI 10.1155/2008/905325; Giordano D, 2012, COMPUT METH PROG BIO, V107, P4, DOI 10.1016/j.cmpb.2011.10.008; Greco L, 2002, GUT, V50, P624, DOI 10.1136/gut.50.5.624; Hadjivassiliou M, 2006, NEUROLOGY, V66, P373, DOI 10.1212/01.wnl.0000196480.55601.3a; Hadjivassiliou M, 2004, P 11 INT S CEL DIS B; Hadjivassiliou M, 2008, ANN NEUROL, V64, P332, DOI 10.1002/ana.21450; Hadjivassiliou M, 2010, LANCET NEUROL, V9, P318, DOI 10.1016/S1474-4422(09)70290-X; HALLERT C, 1982, SCAND J GASTROENTERO, V17, P17, DOI 10.3109/00365528209181037; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hu WT, 2006, ARCH NEUROL-CHICAGO, V63, P1440, DOI 10.1001/archneur.63.10.1440; Humeau Y, 2001, J NEUROSCI, V21, P4195, DOI 10.1523/JNEUROSCI.21-12-04195.2001; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Jackson JR, 2012, PSYCHIAT QUART, V83, P91, DOI 10.1007/s11126-011-9186-y; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Oberhuber G, 2000, BIOMED PHARMACOTHER, V54, P368, DOI 10.1016/S0753-3322(01)80003-2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliviero A, 2002, J NEUROL NEUROSUR PS, V72, P414, DOI 10.1136/jnnp.72.3.414; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; Pennisi G, 2011, DEMENT GERIATR COGN, V31, P71, DOI 10.1159/000322798; Pennisi G, 2011, J NEURAL TRANSM, V118, P587, DOI 10.1007/s00702-010-0554-9; Radhu N, 2013, CLIN NEUROPHYSIOL, V124, P1309, DOI 10.1016/j.clinph.2013.01.014; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Rossini PM, 2007, PROG NEUROBIOL, V83, P375, DOI 10.1016/j.pneurobio.2007.07.010; Rossini PM, 2007, NEUROLOGY, V68, P484, DOI 10.1212/01.wnl.0000250268.13789.b2; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sollid LM, 2005, CURR OPIN IMMUNOL, V17, P595, DOI 10.1016/j.coi.2005.09.015; Spampinato C, 2013, IEEE T NEUR SYS REH, V21, P391, DOI 10.1109/TNSRE.2013.2256432; Takenoshita H, 2001, J NEUROL NEUROSUR PS, V70, P386, DOI 10.1136/jnnp.70.3.386; Volta U, 2012, NAT REV GASTRO HEPAT, V9, P295, DOI 10.1038/nrgastro.2012.15; Volta U, 2010, LANCET NEUROL, V9, P233, DOI 10.1016/S1474-4422(09)70357-6; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; WILLIAMSON S, 1995, J AUTONOM NERV SYST, V55, P18, DOI 10.1016/0165-1838(95)00028-V; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006	51	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e102790	10.1371/journal.pone.0102790	http://dx.doi.org/10.1371/journal.pone.0102790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	25062250	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992600023
J	Rehm, CD; Drewnowski, A				Rehm, Colin D.; Drewnowski, Adam			A New Method to Monitor the Contribution of Fast Food Restaurants to the Diets of US Children	PLOS ONE			English	Article							CHAIN RESTAURANTS; ENERGY-INTAKE; CONSUMPTION; QUALITY; SODIUM; ADULTS; LOCATION; ENTREES; INDEX; HOME	Background: American adults consume 11.3% of total daily calories from foods and beverages from fast food restaurants. The contribution of different types of fast food restaurants to the diets of US children is unknown. Objective: To estimate the consumption of energy, sodium, added sugars, and solid fats among US children ages 4-19 y by fast food restaurant type. Methods: Analyses used the first 24-h recall for 12,378 children in the 2003-2010 cycles of the nationally representative National Health and Nutrition Examination Survey (NHANES 2003-2010). NHANES data identify foods by location of origin, including stores and fast food restaurants (FFR). A novel custom algorithm divided FFRs into 8 segments and assigned meals and snacks to each. These included burger, pizza, sandwich, Mexican, Asian, fish, and coffee/snack restaurants. The contribution of each restaurant type to intakes of energy and other dietary constituents was then assessed by age group (4 11 y and 12-19 y) and by race/ethnicity. Results: Store-bought foods and beverages provided 64.8% of energy, 61.9% of sodium, 68.9% of added sugars, and 60.1% of solid fats. FFRs provided 14.1% of energy, 15.9% of sodium, 10.4% of added sugars and 17.9% of solid fats. Among FFR segments, burger restaurants provided 6.2% of total energy, 5.8% of sodium, 6.2% of added sugars, and 7.6% of solid fats. Less energy was provided by pizza (3.3%), sandwich (1.4%), Mexican (1.3%), and chicken restaurants (1.2%). Non-Hispanic black children obtained a greater proportion of their total energy (7.4%), sodium (7.1%), and solid fats (9.5%) from burger restaurants as compared to non-Hispanic white children (6.0% of energy, 5.5% of sodium, and 7.3% of solid fat). Conclusions: These novel analyses, based on consumption data by fast food market segment, allow public health stakeholders to better monitor the effectiveness of industry efforts to promote healthier menu options.	[Rehm, Colin D.; Drewnowski, Adam] Univ Washington, Ctr Publ Hlth Nutr, Seattle, WA 98195 USA; [Drewnowski, Adam] Grp Hosp Pitie Salpetriere, Inst Cardiometab & Nutr, F-75634 Paris, France	University of Washington; University of Washington Seattle; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Rehm, CD (corresponding author), Univ Washington, Ctr Publ Hlth Nutr, Seattle, WA 98195 USA.	crehm@uw.edu	REHM, COLIN D./J-1215-2019; Drewnowski, Adam/HCI-4117-2022	REHM, COLIN D./0000-0002-7644-0040; 	McDonald's Corp.	McDonald's Corp.	This study was funded by a research grant from McDonald's Corp. to the University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer KW, 2012, AM J PREV MED, V43, P490, DOI 10.1016/j.amepre.2012.06.033; Bauer KW, 2009, PREV MED, V48, P284, DOI 10.1016/j.ypmed.2008.12.021; Bowman S, 2008, MYPYRAMID EQUIVALENT; Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112; Bruemmer B, 2012, J ACAD NUTR DIET, V112, P1169, DOI 10.1016/j.jand.2012.04.019; Centers for Disease Control and Prevention (CDC), 2014, NAT HLTH NUTR EX SUR; Drewnowski A, 2013, NUTRIENTS, V5, P1840, DOI 10.3390/nu5061840; Drewnowski A, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-59; Guenther PM, 2008, J AM DIET ASSOC, V108, P1896, DOI 10.1016/j.jada.2008.08.016; Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Hearst MO, 2013, AM J PREV MED, V44, P589, DOI 10.1016/j.amepre.2013.01.028; Jeffery RW, 1998, AM J PUBLIC HEALTH, V88, P277, DOI 10.2105/AJPH.88.2.277; Kirkpatrick SI, 2013, PUBLIC HEALTH NUTR, V15, P1, DOI DOI 10.1017/S1368980012005563; KREBSSMITH SM, 1989, J AM DIET ASSOC, V89, P671; Lafay L, 2000, INT J OBESITY, V24, P1500, DOI 10.1038/sj.ijo.0801392; Mancino L, 2009, FOOD POLICY, V34, P557, DOI 10.1016/j.foodpol.2009.09.003; Namba A, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120224; National Health and Nutrition Examination Survey, MEC PERS DIET INT PR; National Health and Nutrition Examination Survey, DIET INT IND FOODS 1; National Health and Nutrition Examination Survey, 2011, AN NOT REG 2007 2010; National Health and Nutrition Examination Survey, NCHS RES ETH REV BOA; Oches S, 2011, TOP 50 BREAKDOWN MAR; Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1; Powell LM, 2013, JAMA PEDIATR, V167, P14, DOI 10.1001/jamapediatrics.2013.417; Rasmussen LB, 2007, PUBLIC HEALTH NUTR, V10, P230, DOI 10.1017/S136898000724666X; Schmidt M, 2005, ARCH PEDIAT ADOL MED, V159, P626, DOI 10.1001/archpedi.159.7.626; Taveras EM, 2005, PEDIATRICS, V116, pE518, DOI 10.1542/peds.2004-2732; Todd J, 2010, IMPACT FOOD AWAY HOM; U.S. Food and Drug Administration, BACKGR KEYST FOR AW; Wu HW, 2014, J ACAD NUTR DIET, V114, P209, DOI 10.1016/j.jand.2013.07.035; Wu HW, 2013, PUBLIC HEALTH NUTR, V16, P87, DOI 10.1017/S136898001200122X	32	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103543	10.1371/journal.pone.0103543	http://dx.doi.org/10.1371/journal.pone.0103543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	25062277	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992600083
J	Effenberger, T; von der Heyde, J; Bartsch, K; Garbers, C; Schulze-Osthoff, K; Chalaris, A; Murphy, G; Rose-John, S; Rabe, B				Effenberger, Timo; von der Heyde, Jan; Bartsch, Kareen; Garbers, Christoph; Schulze-Osthoff, Klaus; Chalaris, Athena; Murphy, Gillian; Rose-John, Stefan; Rabe, Bjoern			Senescence-associated release of transmembrane proteins involves proteolytic processing by ADAM17 and microvesicle shedding	FASEB JOURNAL			English	Article						SASP; p38; exosomes; TNFRI; ICAM-1	NECROSIS-FACTOR-ALPHA; PROSTATE-CANCER CELLS; SECRETORY PHENOTYPE; CELLULAR SENESCENCE; DNA-DAMAGE; CONVERTING ENZYME; HUMAN FIBROBLASTS; FACTOR RECEPTOR; GROWTH-FACTOR; TUMOR	Cellular senescence, a state of persistent cell cycle arrest, has emerged as a potent tumor suppressor mechanism by restricting proliferation of cells at risk for neoplastic transformation. Senescent cells secrete various growth factors, cytokines, and other proteins that can either elicit the clearance of tumor cells or potentially promote tumor progression. In addition, this senescence-associated secretory phenotype (SASP) includes various factors that are synthesized as transmembrane precursors and subsequently converted into their soluble counterparts. Despite the importance of the SASP to tumor biology, it is virtually unknown how transmembrane proteins are released from senescent cancer cells. Here we show in different models of senescence that the metalloprotease A disintegrin and metalloproteinase 17 (ADAM17) is activated and releases the epidermal growth factor receptor ligand amphiregulin and tumor necrosis factor receptor I (TNFRI) from the surface of senescent cells by ectodomain shedding. ADAM17 activation involves phosphorylation of its cytoplasmic tail by mitogen-activated protein kinase (MAPK) p38. Interestingly, unlike amphiregulin and TNFRI, full-length intercellular adhesion molecule 1 (ICAM1) is released from senescent cells by microvesicles independently of ADAM17. Thus, our results suggest that transmembrane proteins can be released by two distinct mechanisms and point to a crucial role for ADAM17 in shaping the secretory profile of senescent cells.Effenberger, T., von der Heyde, J., Bartsch, K., Garbers, C., Schulze-Osthoff, K., Chalaris, A., Murphy, G., Rose-John, S., Rabe, B. Senescence-associated release of transmembrane proteins involves proteolytic processing by ADAM17 and microvesicle shedding.	[Effenberger, Timo; von der Heyde, Jan; Bartsch, Kareen; Garbers, Christoph; Chalaris, Athena; Rose-John, Stefan; Rabe, Bjoern] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany; [Schulze-Osthoff, Klaus] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Schulze-Osthoff, Klaus] German Canc Consortium DKTK, Heidelberg, Germany; [Schulze-Osthoff, Klaus] German Canc Res Ctr, Heidelberg, Germany; [Murphy, Gillian] Univ Cambridge, Canc Res UK Cambridge Inst, Dept Oncol, Cambridge, England	University of Kiel; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Rabe, B (corresponding author), Univ Kiel, Inst Biochem, Rudolf Hober Str 1, D-24118 Kiel, Germany.	brabe@biochem.uni-kiel.de	Garbers, Christoph/D-9932-2015; Rose-John, Stefan/A-7998-2010; Schulze-Osthoff, Klaus/N-9025-2013	Garbers, Christoph/0000-0003-4939-6950; Rose-John, Stefan/0000-0002-7519-3279; Schulze-Osthoff, Klaus/0000-0003-1443-2720	Deutsche Forschungsgemeinschaft (Bonn, Germany) [RA 2401/1-1, SFR 877]; Deutsche Forschungsgemeinschaft (Bonn, Germany, the Cluster of Excellence Inflammation at Interfaces)	Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (Bonn, Germany, the Cluster of Excellence Inflammation at Interfaces)	The authors thank Stefanie Schnell and Annett Lickert for excellent technical assistance. This work was supported by grants from the Deutsche Forschungsgemeinschaft (Bonn, Germany; project grant RA 2401/1-1 to B.R., SFR 877, project A1 to A.C. and S.R.-J.; the Cluster of Excellence Inflammation at Interfaces to S.R.-J. B.R., and A.C.).	Alexander E, 2013, J CELL SCI, V126, P3738, DOI 10.1242/jcs.128835; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Essick E, 2008, MOL CELL BIOCHEM, V314, P151, DOI 10.1007/s11010-008-9776-7; Fiore E, 2002, ONCOGENE, V21, P5213, DOI 10.1038/sj.onc.1205684; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Garbers C, 2013, CELL CYCLE, V12, P3421, DOI 10.4161/cc.26431; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kang MK, 2003, EXP CELL RES, V287, P272, DOI 10.1016/S0014-4827(03)00061-2; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Kharaziha P, 2012, BBA-REV CANCER, V1826, P103, DOI 10.1016/j.bbcan.2012.03.006; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lehmann BD, 2008, CANCER RES, V68, P7864, DOI 10.1158/0008-5472.CAN-07-6538; Madge LA, 1999, J BIOL CHEM, V274, P13643, DOI 10.1074/jbc.274.19.13643; MILLIS AJT, 1992, EXP CELL RES, V201, P373, DOI 10.1016/0014-4827(92)90286-H; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rodland KD, 2008, J BIOL CHEM, V283, P31477, DOI 10.1074/jbc.M800456200; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Trad A, 2011, J IMMUNOL METHODS, V371, P91, DOI 10.1016/j.jim.2011.06.015; Tsakadze NL, 2006, J BIOL CHEM, V281, P3157, DOI 10.1074/jbc.M510797200; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Walcheck B, 2006, EUR J IMMUNOL, V36, P968, DOI 10.1002/eji.200535257; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yamamoto K, 2012, BIOCHEM J, V445, P135, DOI 10.1042/BJ20120433	41	42	43	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4847	4856		10.1096/fj.14-254565	http://dx.doi.org/10.1096/fj.14-254565			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25077560	Bronze			2022-12-25	WOS:000344050900022
J	Curtis, FA; Malay, AD; Trotter, AJ; Wilson, LA; Barradell-Black, MMH; Bowers, LY; Reed, P; Hillyar, CRT; Yeo, RP; Sanderson, JM; Heddle, JG; Sharples, GJ				Curtis, Fiona A.; Malay, Ali D.; Trotter, Alexander J.; Wilson, Lindsay A.; Barradell-Black, Michael M. H.; Bowers, Laura Y.; Reed, Patricia; Hillyar, Christopher R. T.; Yeo, Robert P.; Sanderson, John M.; Heddle, Jonathan G.; Sharples, Gary J.			Phage Orf Family Recombinases: Conservation of Activities and Involvement of the Central Channel in DNA Binding	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; ESCHERICHIA-COLI RECO; CIRCULAR-DICHROISM SPECTRA; LAMBDA ORF; HOMOLOGOUS RECOMBINATION; REPLICATION; REPAIR; RECFOR; DAMAGE; RNA	Genetic and biochemical evidence suggests that lambda Orf is a recombination mediator, promoting nucleation of either bacterial RecA or phage Red beta recombinases onto single-stranded DNA (ssDNA) bound by SSB protein. We have identified a diverse family of Orf proteins that includes representatives implicated in DNA base flipping and those fused to an HNH endonuclease domain. To confirm a functional relationship with the Orf family, a distantly-related homolog, YbcN, from Escherichia coli cryptic prophage DLP12 was purified and characterized. As with its lambda relative, YbcN showed a preference for binding ssDNA over duplex. Neither Orf nor YbcN displayed a significant preference for duplex DNA containing mismatches or 1-3 nucleotide bulges. YbcN also bound E. coli SSB, although unlike Orf, it failed to associate with an SSB mutant lacking the flexible C-terminal tail involved in coordinating heterologous protein-protein interactions. Residues conserved in the Orf family that flank the central cavity in the lambda Orf crystal structure were targeted for mutagenesis to help determine the mode of DNA binding. Several of these mutant proteins showed significant defects in DNA binding consistent with the central aperture being important for substrate recognition. The widespread conservation of Orf-like proteins highlights the importance of targeting SSB coated ssDNA during lambdoid phage recombination.	[Curtis, Fiona A.; Trotter, Alexander J.; Wilson, Lindsay A.; Barradell-Black, Michael M. H.; Bowers, Laura Y.; Reed, Patricia; Hillyar, Christopher R. T.; Yeo, Robert P.; Sharples, Gary J.] Univ Durham, Biophys Sci Inst, Sch Biol & Biomed Sci, Durham, England; [Malay, Ali D.; Heddle, Jonathan G.] RIKEN, Heddle Initiat Res Unit, Wako, Saitama, Japan; [Sanderson, John M.] Univ Durham, Biophys Sci Inst, Dept Chem, Durham, England	Durham University; RIKEN; Durham University	Sharples, GJ (corresponding author), Univ Durham, Biophys Sci Inst, Sch Biol & Biomed Sci, Durham, England.	gary.sharples@durham.ac.uk	Hillyar, Christopher/AAM-5755-2021; Heddle, Jonathan G/H-4586-2014; Heddle, Jonathan/AAP-7167-2020; Sharples, Gary/B-8638-2016; Sanderson, John/E-6562-2012; Malay, Ali/N-9136-2015	Sharples, Gary/0000-0003-2495-0062; Sanderson, John/0000-0001-7023-8442; Malay, Ali/0000-0003-0885-5524; Reed, Patricia/0000-0002-4263-6993; Hillyar, Christopher/0000-0001-8316-5772	Biotechnology and Biological Sciences Research Council [BB/C514523/1, BB/FO20503/1]; RIKEN Initiative; BBSRC [BB/F020503/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F020503/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); RIKEN Initiative; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk/) grants BB/C514523/1 and BB/FO20503/1 to GS. JGH and ADM were funded by RIKEN Initiative Research Funding awarded to JGH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Balaji S, 2007, NUCLEIC ACIDS RES, V35, P5658, DOI 10.1093/nar/gkm558; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bell JC, 2012, NATURE, V491, P274, DOI 10.1038/nature11598; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; CHASE JW, 1984, J BIOL CHEM, V259, P805; Chen CS, 2008, NAT METHODS, V5, P69, DOI 10.1038/NMETH1148; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Courcelle J, 2003, SCIENCE, V299, P1064, DOI 10.1126/science.1081328; Court R, 2007, J MOL BIOL, V371, P25, DOI 10.1016/j.jmb.2007.05.037; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Curtis FA, 2011, J MOL RECOGNIT, V24, P333, DOI 10.1002/jmr.1079; De Paepe M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004181; Donaldson JR, 2004, GENETICS, V166, P1631, DOI 10.1534/genetics.166.4.1631; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Fabrini R, 2009, BIOCHEMISTRY-US, V48, P10473, DOI 10.1021/bi901238t; GOHLKE C, 1994, P NATL ACAD SCI USA, V91, P11660, DOI 10.1073/pnas.91.24.11660; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Li XT, 2013, MOL MICROBIOL, V88, P906, DOI 10.1111/mmi.12231; LILLEY DMJ, 1995, P NATL ACAD SCI USA, V92, P7140, DOI 10.1073/pnas.92.16.7140; Liu J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-357; Mahdi AA, 1996, J MOL BIOL, V257, P561, DOI 10.1006/jmbi.1996.0185; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Maxwell KL, 2005, P NATL ACAD SCI USA, V102, P11260, DOI 10.1073/pnas.0503399102; Moore T, 2003, EMBO J, V22, P735, DOI 10.1093/emboj/cdg048; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Morimatsu K, 2012, J BIOL CHEM, V287, P35621, DOI 10.1074/jbc.M112.397034; Murphy KC, 2007, J MOL BIOL, V371, P19, DOI 10.1016/j.jmb.2007.05.085; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Poteete AR, 2008, MOL MICROBIOL, V68, P66, DOI 10.1111/j.1365-2958.2008.06133.x; Poteete AR, 2004, J BACTERIOL, V186, P2699, DOI 10.1128/JB.186.9.2699-2707.2004; Poteete AR, 2001, FEMS MICROBIOL LETT, V201, P9, DOI 10.1016/S0378-1097(01)00242-7; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; Sakai A, 2009, J BIOL CHEM, V284, P3264, DOI 10.1074/jbc.M807220200; SAWITZKE JA, 1992, GENETICS, V130, P7; Sawitzke JA, 1997, GENETICS, V147, P357; Sharples GJ, 2004, J MOL BIOL, V340, P739, DOI 10.1016/j.jmb.2004.05.030; Sharples GJ, 2002, MOL MICROBIOL, V44, P549, DOI 10.1046/j.1365-2958.2002.02916.x; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; SHUB DA, 1994, TRENDS BIOCHEM SCI, V19, P402, DOI 10.1016/0968-0004(94)90086-8; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stahl MM, 1997, GENETICS, V147, P961; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; UMEZU K, 1994, J BIOL CHEM, V269, P30005; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X	55	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e102454	10.1371/journal.pone.0102454	http://dx.doi.org/10.1371/journal.pone.0102454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083707	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000339819800009
J	Gu, SH; Sun, L; Yang, RN; Wu, KM; Guo, YY; Li, XC; Zhou, JJ; Zhang, YJ				Gu, Shao-Hua; Sun, Liang; Yang, Ruo-Nan; Wu, Kong-Ming; Guo, Yu-Yuan; Li, Xian-Chun; Zhou, Jing-Jiang; Zhang, Yong-Jun			Molecular Characterization and Differential Expression of Olfactory Genes in the Antennae of the Black Cutworm Moth Agrotis ipsilon	PLOS ONE			English	Article							ODORANT-BINDING PROTEINS; SEX-PHEROMONE GLAND; CHEMOSENSORY PROTEINS; IMMUNOCYTOCHEMICAL LOCALIZATION; CHEMORECEPTOR SUPERFAMILY; TRANSCRIPTOME ANALYSIS; REGENERATING LEGS; FEMALE ANTENNAE; RECEPTORS; IDENTIFICATION	Insects use their sensitive and selective olfactory system to detect outside chemical odorants, such as female sex pheromones and host plant volatiles. Several groups of olfactory proteins participate in the odorant detection process, including odorant binding proteins (OBPs), chemosensory proteins (CSPs), odorant receptors (ORs), ionotropic receptors (IRs) and sensory neuron membrane proteins (SNMPs). The identification and functional characterization of these olfactory proteins will enhance our knowledge of the molecular basis of insect chemoreception. In this study, we report the identification and differential expression profiles of these olfactory genes in the black cutworm moth Agrotis ipsilon. In total, 33 OBPs, 12 CSPs, 42 ORs, 24 IRs, 2 SNMPs and 1 gustatory receptor (GR) were annotated from the A. ipsilon antennal transcriptomes, and further RT-PCR and RT-qPCR revealed that 22 OBPs, 3 CSPs, 35 ORs, 14 IRs and the 2 SNMPs are uniquely or primarily expressed in the male and female antennae. Furthermore, one OBP (AipsOBP6) and one CSP (AipsCSP2) were exclusively expressed in the female sex pheromone gland. These antennae-enriched OBPs, CSPs, ORs, IRs and SNMPs were suggested to be responsible for pheromone and general odorant detection and thus could be meaningful target genes for us to study their biological functions in vivo and in vitro.	[Gu, Shao-Hua; Sun, Liang; Yang, Ruo-Nan; Wu, Kong-Ming; Guo, Yu-Yuan; Li, Xian-Chun; Zhang, Yong-Jun] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Zhou, Jing-Jiang] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England; [Sun, Liang] Nanjing Agr Univ, Coll Plant Protect, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Nanjing Agricultural University	Zhang, YJ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yjzhang@ippcaas.cn			China National 973 Basic Research Program [2012CB114104]; National Natural Science Foundation of China [31071694, 31171858, 31272048]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [31321004]; BBSRC [BBS/E/C/00005194] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005194] Funding Source: researchfish	China National 973 Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the China National 973 Basic Research Program (Grant No. 2012CB114104) the National Natural Science Foundation of China (Grant No. 31071694, 31171858 and 31272048) and the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (Grant No. 31321004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson I, 1998, BIOINFORMATICS, V14, P349, DOI 10.1093/bioinformatics/14.4.349; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Carlsson MA, 2002, CHEM SENSES, V27, P231, DOI 10.1093/chemse/27.3.231; Chen YA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-416; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Clement S. L., 1982, California Agriculture, V36, P20; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dani FR, 2011, CHEM SENSES, V36, P335, DOI 10.1093/chemse/bjq137; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; Forstner M, 2008, CHEM SENSES, V33, P291, DOI 10.1093/chemse/bjm087; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gonzalez D, 2009, INSECT MOL BIOL, V18, P395, DOI 10.1111/j.1365-2583.2009.00883.x; Greiner B, 2004, J COMP NEUROL, V475, P202, DOI 10.1002/cne.20173; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-636; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073524; Gu SH, 2013, J INSECT PHYSIOL, V59, P430, DOI 10.1016/j.jinsphys.2013.02.003; Gu SH, 2013, INSECT BIOCHEM MOLEC, V43, P237, DOI 10.1016/j.ibmb.2012.12.009; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jacquin-Joly E, 2012, INT J BIOL SCI, V8, P1036, DOI 10.7150/ijbs.4469; Jin X, 2005, CELL MOL LIFE SCI, V62, P1156, DOI 10.1007/s00018-005-5014-6; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; KAISSLING KE, 1986, ANNU REV NEUROSCI, V9, P121, DOI 10.1146/annurev.ne.09.030186.001005; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; KLEIN U, 1987, INSECT BIOCHEM, V17, P1193, DOI 10.1016/0020-1790(87)90093-X; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Lassmann T, 2009, BIOINFORMATICS, V25, P2839, DOI 10.1093/bioinformatics/btp527; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; Mamidala P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056555; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nishimura O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050664; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 1996, J NEUROBIOL, V30, P3; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Rings R.W., 1974, OHIO AGR RES DEV CEN, V198, P1; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rogers ME, 2001, CELL TISSUE RES, V303, P433, DOI 10.1007/s004410000305; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schneider D, 1998, J COMP PHYSIOL A, V182, P153, DOI 10.1007/s003590050166; Smadja C, 2009, MOL BIOL EVOL, V26, P2073, DOI 10.1093/molbev/msp116; Steinbrecht RA, 1997, INT J INSECT MORPHOL, V26, P229, DOI 10.1016/S0020-7322(97)00024-X; STEINBRECHT RA, 1992, CELL TISSUE RES, V270, P287, DOI 10.1007/BF00328015; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Vosshall LB, 2001, CHEM SENSES, V26, P207, DOI 10.1093/chemse/26.2.207; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou SH, 2008, J APPL ENTOMOL, V132, P439, DOI 10.1111/j.1439-0418.2007.01255.x	94	55	64	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103420	10.1371/journal.pone.0103420	http://dx.doi.org/10.1371/journal.pone.0103420			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083706	gold, Green Submitted, Green Published			2022-12-25	WOS:000339819800039
J	Oh, YT; Cho, HJ; Kim, JK; Lee, JH; Rho, K; Seo, YJ; Choi, YS; Jung, HJ; Song, HS; Kong, DS; Seol, HJ; Lee, JI; Yoon, Y; Kim, SH; Nam, DH; Joo, KM				Oh, Young Taek; Cho, Hee Jin; Kim, Jinkuk; Lee, Ji-Hyun; Rho, Kyoohyoung; Seo, Yun-Jee; Choi, Yeon-Sook; Jung, Hye Jin; Song, Hyeon Suk; Kong, Doo-Sik; Seol, Ho Jun; Lee, Jung-Il; Yoon, Yeup; Kim, Sunghoon; Nam, Do-Hyun; Joo, Kyeung Min			Translational Validation of Personalized Treatment Strategy Based on Genetic Characteristics of Glioblastoma	PLOS ONE			English	Article							RECURSIVE PARTITIONING ANALYSIS; CENTRAL-NERVOUS-SYSTEM; NUDE-MOUSE MODEL; TUMOR MICROENVIRONMENT; PANCREATIC-CANCER; DRUG DEVELOPMENT; MULTIFORME; TEMOZOLOMIDE; XENOGRAFT; BRAIN	Glioblastoma (GBM) heterogeneity in the genomic and phenotypic properties has potentiated personalized approach against specific therapeutic targets of each GBM patient. The Cancer Genome Atlas (TCGA) Research Network has been established the comprehensive genomic abnormalities of GBM, which sub-classified GBMs into 4 different molecular subtypes. The molecular subtypes could be utilized to develop personalized treatment strategy for each subtype. We applied a classifying method, NTP (Nearest Template Prediction) method to determine molecular subtype of each GBM patient and corresponding orthotopic xenograft animal model. The models were derived from GBM cells dissociated from patient's surgical sample. Specific drug candidates for each subtype were selected using an integrated pharmacological network database (PharmDB), which link drugs with subtype specific genes. Treatment effects of the drug candidates were determined by in vitro limiting dilution assay using patient-derived GBM cells primarily cultured from orthotopic xenograft tumors. The consistent identification of molecular subtype by the NTP method was validated using TCGA database. When subtypes were determined by the NTP method, orthotopic xenograft animal models faithfully maintained the molecular subtypes of parental tumors. Subtype specific drugs not only showed significant inhibition effects on the in vitro clonogenicity of patient-derived GBM cells but also synergistically reversed temozolomide resistance of MGMT-unmethylated patient-derived GBM cells. However, inhibitory effects on the clonogenicity were not totally subtype-specific. Personalized treatment approach based on genetic characteristics of each GBM could make better treatment outcomes of GBMs, although more sophisticated classifying techniques and subtype specific drugs need to be further elucidated.	[Oh, Young Taek; Cho, Hee Jin; Kim, Jinkuk; Seo, Yun-Jee; Choi, Yeon-Sook; Jung, Hye Jin; Song, Hyeon Suk; Kong, Doo-Sik; Seol, Ho Jun; Lee, Jung-Il; Yoon, Yeup; Nam, Do-Hyun; Joo, Kyeung Min] Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea; [Oh, Young Taek; Cho, Hee Jin; Kim, Jinkuk; Seo, Yun-Jee; Choi, Yeon-Sook; Jung, Hye Jin; Song, Hyeon Suk; Kong, Doo-Sik; Seol, Ho Jun; Lee, Jung-Il; Yoon, Yeup; Nam, Do-Hyun; Joo, Kyeung Min] Samsung Med Ctr, Inst Refractory Canc Res, Seoul, South Korea; [Oh, Young Taek; Cho, Hee Jin; Yoon, Yeup; Nam, Do-Hyun; Joo, Kyeung Min] Sungkyunkwan Univ, SAIHST, Seoul, South Korea; [Kong, Doo-Sik; Seol, Ho Jun; Lee, Jung-Il; Nam, Do-Hyun] Sungkyunkwan Univ, Sch Med, Dept Neurosurg, Seoul, South Korea; [Joo, Kyeung Min] Sungkyunkwan Univ, Sch Med, Dept Anat & Cell Biol, Seoul, South Korea; [Kim, Jinkuk] Samsung Elect Co Ltd, Samsung Adv Inst Technol, Seoul, South Korea; [Lee, Ji-Hyun; Rho, Kyoohyoung; Kim, Sunghoon] Seoul Natl Univ, Coll Pharm, Med Bioconvergence Res Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung; Seoul National University (SNU)	Kim, SH (corresponding author), Seoul Natl Univ, Coll Pharm, Med Bioconvergence Res Ctr, Seoul, South Korea.	sungkim@snu.ac.kr; nsnam@skku.edu; kmjoo@skku.edu	Kim, Jinkuk/AAJ-1999-2020; Kim, Sunghoon/AAE-8314-2020; Oh, Michael/AAO-8026-2020	Oh, Michael/0000-0001-8356-2428; kim, sunghoon/0000-0002-1570-3230	Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [H109C1552]	Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant of the Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (H109C1552). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Groves MD, 2002, J CLIN ONCOL, V20, P1383, DOI 10.1200/JCO.20.5.1383; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; HORTEN BC, 1981, J NEUROPATH EXP NEUR, V40, P493, DOI 10.1097/00005072-198109000-00002; Hoshida Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015543; Hoshida Y, 2010, SEMIN LIVER DIS, V30, P35, DOI 10.1055/s-0030-1247131; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Joo KM, 2013, CELL REP, V3, P260, DOI 10.1016/j.celrep.2012.12.013; Karam JA, 2011, EUR UROL, V59, P619, DOI 10.1016/j.eururo.2010.11.043; Kreth FW, 1999, CANCER, V86, P2117, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2117::AID-CNCR33>3.3.CO;2-#; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Lathia JD, 2011, CELL STEM CELL, V8, P482, DOI 10.1016/j.stem.2011.04.013; Lee HS, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-80; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Martens T, 2008, CLIN CANCER RES, V14, P5447, DOI 10.1158/1078-0432.CCR-08-0147; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Scott CB, 1998, INT J RADIAT ONCOL, V40, P51, DOI 10.1016/S0360-3016(97)00485-9; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taillandier L, 2003, J NEUROSCI METH, V125, P147, DOI 10.1016/S0165-0270(03)00043-8; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-465; Xie Q, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-77; Zhuo Ying, 2010, Zhongguo Fei Ai Za Zhi, V13, P568, DOI 10.3779/j.issn.1009-3419.2010.06.020	32	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103327	10.1371/journal.pone.0103327	http://dx.doi.org/10.1371/journal.pone.0103327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084005	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800032
J	Ramdasi, AY; Arya, RP; Arankalle, VA				Ramdasi, Ashwini Y.; Arya, Ravi P.; Arankalle, Vidya A.			Effect of Pregnancy on Anti-HEV Antibody Titres, Plasma Cytokines and the Corresponding Gene Expression Levels in the PBMCs of Patients Presenting with Self-Recovering Clinical and Subclinical Hepatitis E	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; E VIRUS-INFECTION; FULMINANT-HEPATITIS; VIRAL LOAD; IMMUNE-RESPONSES; INFLUENZA; SEVERITY; CELLS; SERUM; RISK	High mortality in pregnant women (PR) is a characteristic of hepatitis E in developing countries. To understand the pathogenesis of HEV infection in self-limiting disease during pregnancy, we compared clinical (PR-patients) and subclinical-HEV-infections in pregnant women in the first (SC-PR-1) and later (2nd and 3rd, SC-PR-2+3) trimesters with the respective healthy controls and acute non-PR patients. The SC-PR-2+3 exhibited lower ALT, bilirubin levels, anti-HEV-IgM/IgG titres than the acute-PR/non-PR-patients (p<0.05-0.0001). IFN gamma/IL4ratios indicated Th2/Th1 bias in non-PR and PR-patients respectively. Raised levels of 10/20 plasma cytokines in the non-PR-patients reflect predominant inflammatory response, unaltered-IFN gamma/reduced-IFN alpha responses and a robust chemokine secretion. On contrary, the acute-PR-patients exhibited drastic reduction in majority of the cytokines relative to in the non-PR-patients. Importantly, diminished or unaltered response was noted in the acute-PR-group when compared to the corresponding controls. The only exception was sIL2RA, increasing in both patient categories. Of the 14 genes evaluated, the expression of IFN gamma/IL10/IL1A/IL7/CCL2/CCL3/CXCL8/CXCL10 was higher in the non-PR patients. Of these, the expression of IFN gamma/IL10/IL1A/CCL2/CCL3/CXCL8 and, additionally, IL2/IL6/TNF genes was higher in the clinical-PRs. Almost identical pattern was noted in the control-PR-2+3 category indicating no influence of HEV infection. Comparison of patient-categories identified significant elevation of IFN gamma(P<0.001), CCL2(p<0.01), CXCL8(P<0.05), IL1B(p<0.05) and IL10(P<0.0001) and decrease in CXCL10(<0.05) in the PR-patients. The results suggest antibody-dependent disease severity and impaired immune response in the PR patients. Higher expression of cytokine-genes in the PBMCs did not correlate with the plasma-cytokine levels in the PR-patients.	[Ramdasi, Ashwini Y.; Arya, Ravi P.; Arankalle, Vidya A.] Natl Inst Virol, Hepatitis Div, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Arankalle, VA (corresponding author), Natl Inst Virol, Hepatitis Div, Pune, Maharashtra, India.	varankalle@yahoo.com	ARYA, RAVI/AAF-4108-2020; ARYA, RAVI/F-7684-2015	ARYA, RAVI/0000-0001-9255-610X; ARYA, RAVI/0000-0001-9255-610X; Arankalle, Vidya/0000-0002-9940-3437	Indian Council of Medical Research (ICMR), Ministry of health and family welfare, Government of India	Indian Council of Medical Research (ICMR), Ministry of health and family welfare, Government of India(Indian Council of Medical Research (ICMR))	Financial support for this study was provided by the Indian Council of Medical Research (ICMR), Ministry of health and family welfare, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SK, 1996, HEPATOLOGY, V23, P1448, DOI 10.1053/jhep.1996.v23.pm0008675163; Arankalle VA, 2007, J VIRAL HEPATITIS, V14, P435, DOI 10.1111/j.1365-2893.2006.00801.x; Arankalle VA, 1998, J VIRAL HEPATITIS, V5, P199, DOI 10.1046/j.1365-2893.1998.00096.x; ARANKALLE VA, 1995, J VIRAL HEPATITIS, V2, P189, DOI 10.1111/j.1365-2893.1995.tb00028.x; ARANKALLE VA, 1993, INDIAN J MED RES-A, V97, P4; Arankalle VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013099; Borkakoti J, 2013, J MED VIROL, V85, P620, DOI 10.1002/jmv.23508; Bose PD, 2011, J HEPATOL, V54, P1107, DOI 10.1016/j.jhep.2010.08.037; Cabrera R, 2010, SCAND J IMMUNOL, V72, P293, DOI 10.1111/j.1365-3083.2010.02427.x; Chadha M.S., 1991, IND J COMM MED, V16, P153; Fossum C, 1998, DOMEST ANIM ENDOCRIN, V15, P439, DOI 10.1016/S0739-7240(98)80001-5; Gu X, 2011, EXP LUNG RES, V37, P445, DOI 10.3109/01902148.2011.587136; Harger JH, 2002, J INFECT DIS, V185, P422, DOI 10.1086/338832; Jilani N, 2007, J GASTROEN HEPATOL, V22, P676, DOI 10.1111/j.1440-1746.2007.04913.x; Kar P, 2008, AM J GASTROENTEROL, V103, P2495, DOI 10.1111/j.1572-0241.2008.02032.x; Keay SD, 2004, BJOG-INT J OBSTET GY, V111, P1218, DOI 10.1111/j.1471-0528.2004.00412.x; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; KHUROO MS, 1981, AM J MED, V70, P252, DOI 10.1016/0002-9343(81)90758-0; Kraus TA, 2012, J CLIN IMMUNOL, V32, P300, DOI 10.1007/s10875-011-9627-2; Kraus TA, 2010, AM J REPROD IMMUNOL, V64, P411, DOI 10.1111/j.1600-0897.2010.00889.x; Lederman M M, 1984, Chest, V86, p6S, DOI 10.1378/chest.86.3_Supplement.6S; Lygnos MC, 2006, IN VIVO, V20, P157; Madan K, 1998, J GASTROEN HEPATOL, V13, P125, DOI 10.1111/j.1440-1746.1998.tb00626.x; Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667; Rathod SB, 2014, J VIRAL HEPATITIS, V21, P141, DOI 10.1111/jvh.12125; Saravanabalaji S, 2009, INTERVIROLOGY, V52, P78, DOI 10.1159/000214862; Srivastava R, 2011, J GASTROEN HEPATOL, V26, P306, DOI 10.1111/j.1440-1746.2010.06356.x; Stockman LJ, 2004, EMERG INFECT DIS, V10, P1689, DOI 10.3201/eid1009.040244; Tripathy AS, 2012, EUR J CLIN MICROBIOL, V31, P179, DOI 10.1007/s10096-011-1291-1; TSAREV SA, 1995, J INFECT DIS, V172, P31, DOI 10.1093/infdis/172.1.31; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Yajnik CS, 2008, DIABETOLOGIA, V51, P39, DOI 10.1007/s00125-007-0847-1	32	15	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103257	10.1371/journal.pone.0103257	http://dx.doi.org/10.1371/journal.pone.0103257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084004	gold, Green Submitted, Green Published			2022-12-25	WOS:000339819800022
J	Chen, XN; Wang, XD; Liebman, M; Cavigelli, M; Wander, M				Chen, Xianni; Wang, Xudong; Liebman, Matt; Cavigelli, Michel; Wander, Michelle			Influence of Residue and Nitrogen Fertilizer Additions on Carbon Mineralization in Soils with Different Texture and Cropping Histories	PLOS ONE			English	Article							ORGANIC-MATTER FRACTIONS; CONVENTIONAL FARMING SYSTEMS; MICROBIAL BIOMASS; POULTRY MANURE; DECOMPOSITION; TEMPERATURE; TILLAGE; AVAILABILITY; PARTICULATE; MOISTURE	To improve our ability to predict SOC mineralization response to residue and N additions in soils with different inherent and dynamic organic matter properties, a 330-day incubation was conducted using samples from two long-term experiments (clay loam Mollisols in Iowa [IAsoil] and silt loam Ultisols in Maryland [MDsoil]) comparing conventional grain systems (Conv) amended with inorganic fertilizers with 3 yr (Med) and longer (Long), more diverse cropping systems amended with manure. A double exponential model was used to estimate the size (C-a, C-s) and decay rates (k(a), k(s)) of active and slow C pools which we compared with total particulate organic matter (POM) and occluded-POM (OPOM). The high-SOC IAsoil containing highly active smectite clays maintained smaller labile pools and higher decay rates than the low-SOC MDsoil containing semi-active kaolinitic clays. Net SOC loss was greater (2.6 g kg(-1); 8.6%) from the IAsoil than the MDsoil (0.9 g kg(-1), 6.3%); fractions and coefficients suggest losses were principally from IAsoil's resistant pool. Cropping history did not alter SOC pool size or decay rates in IAsoil where rotation-based differences in OPOM-C were small. In MDsoil, use of diversified rotations and manure increased k(a) by 32% and k(s) by 46% compared to Conv; differences mirrored in POM- and OPOM-C contents. Residue addition prompted greater increases in C-a (340% vs 230%) and C-s (38% vs 21%) and decreases in k(a) (58% vs 9%) in IAsoil than MDsoil. Reduced losses of SOC from residue-amended MDsoil were associated with increased OPOM-C. Nitrogen addition dampened CO2-C release. Clay type and C saturation dominated the IAsoil's response to external inputs and made labile and stable fractions more vulnerable to decay. Trends in OPOM suggest aggregate protection influences C turnover in the low active MDsoil. Clay charge and OPOM-C contents were better predictors of soil C dynamics than clay or POM-C contents.	[Chen, Xianni; Wang, Xudong] Northwest A&F Univ, Coll Resources & Environm, Yangling, Shaanxi, Peoples R China; [Liebman, Matt] Iowa State Univ, Dept Agron, Ames, IA USA; [Cavigelli, Michel] Agr Res Ctr, Sustainable Agr Syst Lab, Beltsville, MD USA; [Wander, Michelle] Univ Illinois, Dept NRES, Urbana, IL 61801 USA	Northwest A&F University - China; Iowa State University; University of Illinois System; University of Illinois Urbana-Champaign	Wang, XD (corresponding author), Northwest A&F Univ, Coll Resources & Environm, Yangling, Shaanxi, Peoples R China.	wangxudong01@126.com; mwander@illinois.edu		Liebman, Matt/0000-0001-6193-3849	NIFA (Hatch) [LLU-875-320]; Leopold Center for Sustainable Agriculture [2010-E02]; Iowa Soybean Association; Ministry of Science and Technology-Technology Integration and Demonstration of Agriculture-Fruit-Livestock Industry Recycling in Loss Plantae, China [2012BAD14B11]; ARS [ARS-0424914] Funding Source: Federal RePORTER	NIFA (Hatch); Leopold Center for Sustainable Agriculture; Iowa Soybean Association; Ministry of Science and Technology-Technology Integration and Demonstration of Agriculture-Fruit-Livestock Industry Recycling in Loss Plantae, China; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Financial support was given by NIFA (Hatch) LLU-875-320, and grants from the Leopold Center for Sustainable Agriculture (Project 2010-E02) and the Iowa Soybean Association. This project was also partially funded by the National 15th Key Technology R&D Program of the Ministry of Science and Technology-Technology Integration and Demonstration of Agriculture-Fruit-Livestock Industry Recycling in Loss Plantae, China (2012BAD14B11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiku SGK, 2008, PLANT SOIL, V311, P29, DOI 10.1007/s11104-008-9652-y; Arrouays D, 2006, SOIL USE MANAGE, V22, P48, DOI 10.1111/j.1475-2743.2006.00020.x; Bailey VL, 2002, SOIL BIOL BIOCHEM, V34, P997, DOI 10.1016/S0038-0717(02)00033-0; Bauer J, 2008, GEODERMA, V145, P17, DOI 10.1016/j.geoderma.2008.01.026; Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; BONDE TA, 1987, SOIL SCI SOC AM J, V51, P1508, DOI 10.2136/sssaj1987.03615995005100060019x; Borchardt G, 1989, SSSA BOOK SERIES; Brady NC, 2004, ELEMENTS NATURE PROP, P386; Bukowski R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033047, 10.1371/journal.pone.0047149]; Chivenge P, 2011, AGR ECOSYST ENVIRON, V140, P361, DOI 10.1016/j.agee.2010.12.004; Cochran RL, 2007, BIOL FERT SOILS, V43, P479, DOI 10.1007/s00374-006-0126-1; Ding WX, 2010, GEODERMA, V155, P381, DOI 10.1016/j.geoderma.2009.12.023; Dixon J.B., 1989, SSSA BOOK SERIES; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Franzluebbers AJ, 1997, SOIL SCI SOC AM J, V61, P1382, DOI 10.2136/sssaj1997.03615995006100050014x; Franzluebbers AJ, 1996, SOIL BIOL BIOCHEM, V28, P1367, DOI 10.1016/S0038-0717(96)00143-5; Gee G.W., 1986, METHODS SOIL ANAL PA, P383, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C15; Govaerts B, 2009, CRIT REV PLANT SCI, V28, P97, DOI 10.1080/07352680902776358; GREEN CJ, 1995, SOIL SCI SOC AM J, V59, P453, DOI 10.2136/sssaj1995.03615995005900020026x; Gulde S, 2008, SOIL SCI SOC AM J, V72, P605, DOI 10.2136/sssaj2007.0251; Hassink J, 1997, SOIL SCI SOC AM J, V61, P131, DOI 10.2136/sssaj1997.03615995006100010020x; Hobbie SE, 2000, ECOSYSTEMS, V3, P484, DOI 10.1007/s100210000042; Jindaluang W, 2013, GEODERMA, V195, P207, DOI 10.1016/j.geoderma.2012.12.003; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Kleber M, 2007, BIOGEOCHEMISTRY, V85, P9, DOI 10.1007/s10533-007-9103-5; Kremen C, 2012, ECOL SOC, V17, DOI 10.5751/ES-05035-170440; LADD JN, 1981, SOIL BIOL BIOCHEM, V13, P119, DOI 10.1016/0038-0717(81)90007-9; Lazicki PA, 2011, THESIS U ILLINOIS CH; Li LJ, 2013, EUR J SOIL BIOL, V54, P1, DOI 10.1016/j.ejsobi.2012.11.002; Liebman M, 2008, AGRON J, V100, P600, DOI 10.2134/agronj2007.0222; Lipson DA, 2000, SOIL BIOL BIOCHEM, V32, P441, DOI 10.1016/S0038-0717(99)00068-1; Marriott EE, 2006, SOIL SCI SOC AM J, V70, P950, DOI 10.2136/sssaj2005.0241; Marriott EE, 2006, SOIL BIOL BIOCHEM, V38, P1527, DOI 10.1016/j.soilbio.2005.11.009; Martin JV, 2012, SOIL RES, V50, P222, DOI 10.1071/SR11170; MCGILL WB, 1996, NATO ASI SERIES I, V38, P111, DOI DOI 10.1007/978-3-642-61094-3_9; Miyittah M, 2003, SOIL SCI PLANT NUTR, V49, P61, DOI 10.1080/00380768.2003.10409980; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; PARTON WJ, 1988, BIOGEOCHEMISTRY, V5, P109, DOI 10.1007/BF02180320; Paustian K, 1995, AUST J EXP AGR, V35, P929, DOI 10.1071/EA9950929; Peterson GA, 1998, SOIL TILL RES, V47, P207, DOI 10.1016/S0167-1987(98)00107-X; Qi Y, 2001, PLANT SOIL, V237, P15, DOI 10.1023/A:1013368800287; Rodrigo A, 1997, ECOL MODEL, V102, P325, DOI 10.1016/S0304-3800(97)00067-7; Saby NPA, 2008, SOIL USE MANAGE, V24, P254, DOI 10.1111/j.1475-2743.2008.00159.x; Sakala WD, 2000, SOIL BIOL BIOCHEM, V32, P679, DOI 10.1016/S0038-0717(99)00204-7; Saviozzi A, 1997, BIOL FERT SOILS, V25, P401, DOI 10.1007/s003740050332; Scott NA, 1996, SOIL SCI SOC AM J, V60, P1102, DOI 10.2136/sssaj1996.03615995006000040020x; Setia R, 2011, SOIL BIOL BIOCHEM, V43, P667, DOI 10.1016/j.soilbio.2010.12.004; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Spargo JT, 2011, NUTR CYCL AGROECOSYS, V90, P253, DOI 10.1007/s10705-011-9426-4; Stewart CE, 2008, SOIL BIOL BIOCHEM, V40, P1741, DOI 10.1016/j.soilbio.2008.02.014; Townsend AR, 1997, BIOGEOCHEMISTRY, V38, P1, DOI 10.1023/A:1017942918708; VANVEEN JA, 1985, SOIL BIOL BIOCHEM, V17, P747, DOI 10.1016/0038-0717(85)90128-2; Waldrop MP, 2004, OECOLOGIA, V138, P275, DOI 10.1007/s00442-003-1419-9; Wander M, 2004, ADV AGROECOL, P67; Wander MM, 2007, PLANT SOIL, V291, P311, DOI 10.1007/s11104-007-9198-4; WANDER MM, 1994, SOIL SCI SOC AM J, V58, P1130, DOI 10.2136/sssaj1994.03615995005800040018x; Wang WJ, 2003, SOIL BIOL BIOCHEM, V35, P273, DOI 10.1016/S0038-0717(02)00274-2; Wang WJ, 2004, SOIL BIOL BIOCHEM, V36, P2045, DOI 10.1016/j.soilbio.2004.05.023; Yang XM, 2001, SOIL TILL RES, V59, P107, DOI 10.1016/S0167-1987(01)00162-3; Yoo G, 2008, SOIL SCI SOC AM J, V72, P670, DOI 10.2136/sssaj2007.0110; Zentner RP, 2002, AGRON J, V94, P216, DOI 10.2134/agronj2002.0216; Zhang WW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052849, 10.1371/journal.pone.0054779]; Zhang XH, 2007, J ENVIRON SCI, V19, P319, DOI 10.1016/S1001-0742(07)60052-7	63	5	6	6	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103720	10.1371/journal.pone.0103720	http://dx.doi.org/10.1371/journal.pone.0103720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078458	gold, Green Published, Green Submitted			2022-12-25	WOS:000339954800070
J	Fonin, AV; Sulatskaya, AI; Kuznetsova, IM; Turoverov, KK				Fonin, Alexander V.; Sulatskaya, Anna I.; Kuznetsova, Irina M.; Turoverov, Konstantin K.			Fluorescence of Dyes in Solutions with High Absorbance. Inner Filter Effect Correction	PLOS ONE			English	Article							THIOFLAVIN T; AMYLOID FIBRILS; QUANTUM YIELD; RIGHT-ANGLE; LUMINESCENCE; ABSORPTION; SPECTRA; PHOTOLUMINESCENCE; EMISSION; BINDING	Fluorescence is a proven tool in all fields of knowledge, including biology and medicine. A significant obstacle in its use is the nonlinearity of the dependence of the fluorescence intensity on fluorophore concentration that is caused by the so-called primary inner filter effect. The existing methods for correcting the fluorescence intensity are hard to implement in practice; thus, it is generally considered best to use dilute solutions. We showed that correction must be performed always. Furthermore, high-concentration solutions (high absorbance) are inherent condition in studying of the photophysical properties of fluorescent dyes and the functionally significant interactions of biological macromolecules. We proposed an easy to use method to correct the experimentally recorded total fluorescence intensity and showed that informative component of fluorescence intensity numerically equals to the product of the absorbance and the fluorescence quantum yield of the object. It is shown that if dye molecules do not interact with each other and there is no reabsorption (as for NATA) and spectrofluorimeter provides the proportionality of the detected fluorescence intensity to the part of the absorbed light (that is possible for spectrofluorimeter with horizontal slits) then the dependence of experimentally detected total fluorescence intensity of the dye on its absorbance coincides with the calculated dependence and the correction factor for eliminating the primary inner filter effect can be calculated on the basis of solution absorbance. It was experimentally shown for NATA fluorescence in the wide range of absorbance (at least up to 60). For ATTO-425, which fluorescence and absorption spectra overlap, the elimination of the primary and secondary filter effects and additional spectral analysis allow to conclude that the most probable reason of the deviation of experimentally detected fluorescence intensity dependence on solution absorbance from the calculated dependence is the dye molecules self-quenching, which accompanies resonance radiationless excitation energy transfer.	[Fonin, Alexander V.; Sulatskaya, Anna I.; Kuznetsova, Irina M.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Prot Folding, St Petersburg 194064, Russia; [Turoverov, Konstantin K.] St Petersburg State Polytech Univ, Dept Biophys, St Petersburg 194064, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Peter the Great St. Petersburg Polytechnic University	Turoverov, KK (corresponding author), Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Prot Folding, St Petersburg 194064, Russia.	kkt@incras.ru	Sulatskaya, Anna/I-6042-2014; Fonin, Alexander/F-4361-2017; Kuznetsova, Irina M./R-9844-2017; Turoverov, Konstantin/S-2079-2016	Sulatskaya, Anna/0000-0002-1207-3384; Fonin, Alexander/0000-0003-4469-2531; Kuznetsova, Irina M./0000-0002-3336-4834; Turoverov, Konstantin/0000-0002-6977-1896	Program "Molecular and Cell Biology'' of the Russian Academy of Sciences, Russian Foundation of Basic Research [14-04-90024_Bel, 12-04-01651, 12-04-31708, 13-04-01842, 13-04-02068]; Ministry of Education and Science of the Russian Federation [14.132.21.1311, 8830]; RF President fellowships [SP-2390.2012.4, SP-776.2012.4]	Program "Molecular and Cell Biology'' of the Russian Academy of Sciences, Russian Foundation of Basic Research; Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); RF President fellowships	This work was supported by the Program "Molecular and Cell Biology'' of the Russian Academy of Sciences, Russian Foundation of Basic Research, grant 14-04-90024_Bel (K. K. T.), 12-04-01651 (K. K. T.), 12-04-31708 (A. V. F.), 13-04-01842 (I. M. K.), 13-04-02068 (A. I. S.) by Ministry of Education and Science of the Russian Federation, Agreements 14.132.21.1311 (A. I. S.) and 8830 (K. K. T.) and by RF President fellowships SP-2390.2012.4 (A. V. F.) and SP-776.2012.4 (A. I. S.). Fluorescence measurements by Fluorolog-3 (Horiba, Japan) were carried out in the Resource Center for Optical and Laser Materials Research of St. Petersburg State University, Russia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRDSALL B, 1983, ANAL BIOCHEM, V132, P353, DOI 10.1016/0003-2697(83)90020-9; BRITTEN A, 1978, ANALYST, V103, P928, DOI 10.1039/an9780300928; Brouwer AM, 2011, PURE APPL CHEM, V83, P2213, DOI 10.1351/PAC-REP-10-09-31; Credi A, 1998, SPECTROCHIM ACTA A, V54, P159, DOI 10.1016/S1386-1425(97)00224-2; EFTINK MR, 1995, J PHYS CHEM-US, V99, P5713, DOI 10.1021/j100015a064; Fanget B, 2003, ANAL CHEM, V75, P2790, DOI 10.1021/ac0262255; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GALANIN MD, 1955, SOV PHYS JETP-USSR, V1, P317; GAUTHIER TD, 1986, ENVIRON SCI TECHNOL, V20, P1162, DOI 10.1021/es00153a012; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Hamann S, 2002, J FLUORESC, V12, P139, DOI 10.1023/A:1016832027325; HOLLAND JF, 1977, ANAL CHEM, V49, P706, DOI 10.1021/ac50014a011; Jameson DM, 2003, METHOD ENZYMOL, V360, P1; KUBISTA M, 1994, ANALYST, V119, P417, DOI 10.1039/an9941900417; Kuznetsova IM, 2012, MOL NEUROBIOL, V45, P488, DOI 10.1007/s12035-012-8272-y; Kuznetsova IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030724; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; LEESE RA, 1978, ANAL CHEM, V50, P1193, DOI 10.1021/ac50030a047; MATSUI T, 1991, APPL SPECTROSC, V45, P32, DOI 10.1366/0003702914337795; MODE VA, 1974, ANAL CHEM, V46, P200, DOI 10.1021/ac60338a013; Morimoto K, 2009, J BIOCHEM, V145, P677, DOI 10.1093/jb/mvp025; PARKER CA, 1957, ANALYST, V82, P606, DOI 10.1039/an9578200606; PARKER CA, 1960, ANALYST, V85, P587, DOI 10.1039/an9608500587; Perrin J, 1929, CR HEBD ACAD SCI, V189, P1213; RATZLAFF EH, 1983, ANAL CHEM, V55, P348, DOI 10.1021/ac00253a036; Riesz J, 2005, SPECTROCHIM ACTA A, V61, P2153, DOI 10.1016/j.saa.2004.08.014; Steensrud J, 2012, SELECTING CORRECT SP, P25; STREET KW, 1985, ANALYST, V110, P1169, DOI 10.1039/an9851001169; Sulatskaya AI, 2012, J PHYS CHEM B, V116, P2538, DOI 10.1021/jp2083055; TANKE HJ, 1982, CYTOMETRY, V2, P359; Territo PR, 2007, APPL SPECTROSC, V61, P138, DOI 10.1366/000370207779947530; Turoverov K K, 1998, Tsitologiia, V40, P806; Vavilov S. I., 1949, DOKL AKAD NAUK SSSR, V67, P811; YAPPERT MC, 1989, APPL SPECTROSC, V43, P759, DOI 10.1366/0003702894202120; Zhadin NN, 1998, J BIOMED OPT, V3, P171, DOI 10.1117/1.429874	36	148	152	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103878	10.1371/journal.pone.0103878	http://dx.doi.org/10.1371/journal.pone.0103878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072376	Green Submitted, gold, Green Published			2022-12-25	WOS:000341307600090
J	Giatsis, C; Sipkema, D; Smidt, H; Verreth, J; Verdegem, M				Giatsis, Christos; Sipkema, Detmer; Smidt, Hauke; Verreth, Johan; Verdegem, Marc			The Colonization Dynamics of the Gut Microbiota in Tilapia Larvae	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; 16S RIBOSOMAL-RNA; EARLY-LIFE STAGES; GADUS-MORHUA; FISH; POPULATIONS; GENES; DETERMINANT; COMMUNITIES; AQUACULTURE	The gut microbiota of fish larvae evolves fast towards a complex community. Both host and environment affect the development of the gut microbiota; however, the relative importance of both is poorly understood. Determining specific changes in gut microbial populations in response to a change in an environmental factor is very complicated. Interactions between factors are difficult to separate and any response could be masked due to high inter-individual variation even for individuals that share a common environment. In this study we characterized and quantified the spatio-temporal variation in the gut microbiota of tilapia larvae, reared in recirculating aquaculture systems (RAS) or active suspension tanks (AS). Our results showed that variation in gut microbiota between replicate tanks was not significantly higher than within tank variation, suggesting that there is no tank effect on water and gut microbiota. However, when individuals were reared in replicate RAS, gut microbiota differed significantly. The highest variation was observed between individuals reared in different types of system (RAS vs. AS). Our data suggest that under experimental conditions in which the roles of deterministic and stochastic factors have not been precisely determined, compositional replication of the microbial communities of an ecosystem is not predictable.	[Giatsis, Christos; Verreth, Johan; Verdegem, Marc] Wageningen Univ, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands; [Sipkema, Detmer; Smidt, Hauke] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Giatsis, C (corresponding author), Wageningen Univ, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands.	christos.giatsis@wur.nl	Verreth, Johan/ABD-7198-2020; Smidt, Hauke/D-7054-2014; Verdegem, Marc/C-6659-2014	Verreth, Johan/0000-0001-7277-5129; Smidt, Hauke/0000-0002-6138-5026; Verdegem, Marc/0000-0002-2058-3894	European Community [227197]	European Community(European Commission)	This work was funded by The European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement no. 227197 Promicrobe "Microbes as positive actors for more sustainable aquaculture''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2008, PRIM PLYMOUTH, V214; Avnimelech Y, 2007, AQUACULTURE, V264, P140, DOI 10.1016/j.aquaculture.2006.11.025; Bakke I, 2013, ENV MICROBIOL REP, V5, P537, DOI 10.1111/1758-2229.12042; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Burford MA, 2003, AQUACULTURE, V219, P393, DOI 10.1016/S0044-8486(02)00575-6; CAHILL MM, 1990, MICROB ECOL, V19, P21, DOI 10.1007/BF02015051; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chapman MG, 1999, MAR ECOL PROG SER, V180, P257, DOI 10.3354/meps180257; Clarke K.R., 1993, AUST J ECOL; Crab R, 2012, AQUACULTURE, V356, P351, DOI 10.1016/j.aquaculture.2012.04.046; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Ercolini D, 2004, J MICROBIOL METH, V56, P297, DOI 10.1016/j.mimet.2003.11.006; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340, DOI 10.1128/AEM.62.2.340-346.1996; Fjellheim A. J., 2011, AQUAC RES, P1; Fjellheim AJ, 2007, AQUACULTURE, V269, P98, DOI 10.1016/j.aquaculture.2007.04.021; Gatesoupe F, 2012, AQUAC RES, P1; Gatesoupe FJ, 1999, AQUACULTURE, V180, P147, DOI 10.1016/S0044-8486(99)00187-8; Gomez GD, 2008, FEMS IMMUNOL MED MIC, V52, P145, DOI 10.1111/j.1574-695X.2007.00343.x; Goodhead AK, 2013, ENV SCI POL IN PRESS; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hansen GH, 1999, MICROB ECOL, V38, P1, DOI 10.1007/s002489900158; Joossens M, 2011, FEMS MICROBIOL ECOL, V75, P343, DOI 10.1111/j.1574-6941.2010.01008.x; Kowalchuk GA, 2006, SOIL BIOL BIOCHEM, V38, P2852, DOI 10.1016/j.soilbio.2006.04.043; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Li W, 2014, MICROBIOL R IN PRESS; Li XM, 2012, J MICROBIOL, V50, P29, DOI 10.1007/s12275-012-1340-1; Machiels K, 2013, GUT IN PRESS; Mouchet MA, 2012, FEMS MICROBIOL ECOL, V79, P568, DOI 10.1111/j.1574-6941.2011.01241.x; Muyzer G, 1999, CURR OPIN MICROBIOL, V2, P317, DOI 10.1016/S1369-5274(99)80055-1; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Navarrete P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031335; Nayak SK, 2010, AQUAC RES, V41, P1553, DOI 10.1111/j.1365-2109.2010.02546.x; Nubel U, 1996, J BACTERIOL, V178, P5636; Ringo E, 2008, AQUAC RES, V39, P1087, DOI 10.1111/j.1365-2109.2008.01972.x; Romero J, 2006, MICROB ECOL, V51, P422, DOI 10.1007/s00248-006-9037-9; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; Temmerman R, 2003, APPL ENVIRON MICROB, V69, P220, DOI 10.1128/AEM.69.1.220-226.2003; Thompson CL, 2014, ANAL COMMUNITY DYNAM; Tourlomousis P, 2010, MICROB ECOL, V59, P776, DOI 10.1007/s00248-009-9613-x; van den Bogert B, 2013, FEMS MICROBIOL ECOL, V85, P376, DOI 10.1111/1574-6941.12127; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Verschuere L, 1997, J APPL MICROBIOL, V83, P603, DOI 10.1046/j.1365-2672.1997.00270.x; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wilson JM, 2011, FISH PHYSIOL, V30, P1, DOI 10.1016/S1546-5098(10)03001-3	52	56	57	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103641	10.1371/journal.pone.0103641	http://dx.doi.org/10.1371/journal.pone.0103641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072852	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600075
J	Halbroth, BR; Heil, A; Distler, E; Dass, M; Wagner, EM; Plachter, B; Probst, HC; Strand, D; Hartwig, UF; Karner, A; Aichinger, G; Kistner, O; Landfester, K; Herr, W				Halbroth, Benedict R.; Heil, Alexander; Distler, Eva; Dass, Martin; Wagner, Eva M.; Plachter, Bodo; Probst, Hans Christian; Strand, Dennis; Hartwig, Udo F.; Karner, Anita; Aichinger, Gerald; Kistner, Otfried; Landfester, Katharina; Herr, Wolfgang			Superior In Vitro Stimulation of Human CD8(+) T-Cells by Whole Virus versus Split Virus Influenza Vaccines	PLOS ONE			English	Article							DENDRITIC CELLS; VACCINATION STRATEGIES; AVIAN INFLUENZA; H5N1 INFLUENZA; A VIRUSES; RESPONSES; IMMUNITY; CULTURE; LYMPHOCYTES; EPITOPES	Pandemic and seasonal influenza viruses cause considerable morbidity and mortality in the general human population. Protection from severe disease may result from vaccines that activate antigen-presenting DC for effective stimulation of influenza-specific memory T cells. Special attention is paid to vaccine-induced CD8(+) T-cell responses, because they are mainly directed against conserved internal influenza proteins thereby presumably mediating cross-protection against circulating seasonal as well as emerging pandemic virus strains. Our study showed that influenza whole virus vaccines of major seasonal A and B strains activated DC more efficiently than those of pandemic swine-origin H1N1 and pandemic-like avian H5N1 strains. In contrast, influenza split virus vaccines had a low ability to activate DC, regardless which strain was investigated. We also observed that whole virus vaccines stimulated virus-specific CD8(+) memory T cells much stronger compared to split virus counterparts, whereas both vaccine formats activated CD4(+) Th cell responses similarly. Moreover, our data showed that whole virus vaccine material is delivered into the cytosolic pathway of DC for effective activation of virus-specific CD8(+) T cells. We conclude that vaccines against seasonal and pandemic (-like) influenza strains that aim to stimulate cross-reacting CD8(+) T cells should include whole virus rather than split virus formulations.	[Halbroth, Benedict R.; Heil, Alexander; Distler, Eva; Wagner, Eva M.; Hartwig, Udo F.; Herr, Wolfgang] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 3, D-55122 Mainz, Germany; [Dass, Martin; Landfester, Katharina] Max Planck Inst Polymer Res, D-55128 Mainz, Germany; [Plachter, Bodo] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Virol, D-55122 Mainz, Germany; [Probst, Hans Christian] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Immunol, D-55122 Mainz, Germany; [Strand, Dennis] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 1, D-55122 Mainz, Germany; [Karner, Anita; Aichinger, Gerald; Kistner, Otfried] Baxter, Vienna, Austria; [Herr, Wolfgang] Univ Med Ctr Regensburg, Dept Med 3, Regensburg, Germany	Johannes Gutenberg University of Mainz; Max Planck Society; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Regensburg	Herr, W (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 3, D-55122 Mainz, Germany.	wolfgang.herr@ukr.de	Landfester, Katharina/F-9449-2011; Hartwig, Udo/L-1308-2013	Landfester, Katharina/0000-0001-9591-4638; Hartwig, Udo/0000-0002-6714-6923; Juerchott, Alexander/0000-0003-0556-908X; PROBST, Hans Christian/0000-0002-7926-0651; Halbroth, Benedict/0000-0002-1253-2843	Deutsche Forschungsgemeinschaft [KFO183-TP5, KFO183-TP8a]; Baxter	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baxter	This work was supported in part by grant no. KFO183-TP5 from the 'Deutsche Forschungsgemeinschaft' (http://www.dfg.de/en/index.jsp) to E.D. and W.H., and by grant no. KFO183-TP8a from the 'Deutsche Forschungsgemeinschaft' (http://www.dfg.de/en/index.jsp) to B.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Unrestricted supply of influenza vaccine preparations was provided by G.A., A.K. and O.K. (Baxter, Vienna, Austria) to W.H.G.A., A.K. and O.K. are employed by Baxter. Baxter provided support in the form of salaries for authors G.A., A.K. and O.K., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI [10.1586/erv.09.19, 10.1586/ERV.09.19]; BENDER A, 1995, J EXP MED, V182, P1663, DOI 10.1084/jem.182.6.1663; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Boon ACM, 2004, J IMMUNOL, V172, P2453, DOI 10.4049/jimmunol.172.4.2453; Brown LE, 2009, IMMUNOL CELL BIOL, V87, P300, DOI 10.1038/icb.2009.16; Budimir N, 2010, VACCINE, V28, P8280, DOI 10.1016/j.vaccine.2010.10.007; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Cerundolo V, 1997, EUR J IMMUNOL, V27, P336, DOI 10.1002/eji.1830270148; Chomczynski P, 1993, BIOTECHNIQUES, V15, P536; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doherty PC, 2008, J CLIN INVEST, V118, P3273, DOI 10.1172/JCI37232; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; European Medicines Agency (EMA), 2012, VEP INFL VACC WHOL V; Furuya Y, 2010, J VIROL, V84, P4212, DOI 10.1128/JVI.02508-09; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Goy K, 2008, INFLUENZA OTHER RESP, V2, P115, DOI 10.1111/j.1750-2659.2008.00046.x; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Howard MK, 2008, BIOL CHEM, V389, P569, DOI 10.1515/BC.2008.060; Jameson J, 1999, J IMMUNOL, V162, P7578; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kistner O, 1998, VACCINE, V16, P960, DOI 10.1016/S0264-410X(97)00301-0; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kleemann P, 2012, HAEMATOL-HEMATOL J, V97, P874, DOI 10.3324/haematol.2011.052597; Koyama S, 2009, EXPERT REV VACCINES, V8, P1099, DOI 10.1586/ERV.09.57; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Kreijtz JHCM, 2009, HUM VACCINES, V5, P126, DOI 10.4161/hv.5.3.6986; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Neumann G, 2011, INFLUENZA OTHER RESP, V5, P157, DOI 10.1111/j.1750-2659.2011.00231.x; NICHOLSON KG, 1979, J BIOL STAND, V7, P123, DOI 10.1016/S0092-1157(79)80044-X; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rimmelzwaan GF, 2009, VACCINE, V27, P6363, DOI 10.1016/j.vaccine.2009.01.016; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tambyah PA, 2012, VACCINE, V30, P329, DOI 10.1016/j.vaccine.2011.10.088; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Walther P, 2002, J MICROSC-OXFORD, V208, P3, DOI 10.1046/j.1365-2818.2002.01064.x; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; YAP KL, 1978, NATURE, V273, P238, DOI 10.1038/273238a0	44	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103392	10.1371/journal.pone.0103392	http://dx.doi.org/10.1371/journal.pone.0103392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072749	Green Submitted, Green Published, gold			2022-12-25	WOS:000341307600044
J	Yao, CF; Wang, C; Li, YR; Ding, Y; Rath, U; Sengupta, S; Girton, J; Johansen, KM; Johansen, J				Yao, Changfu; Wang, Chao; Li, Yeran; Ding, Yun; Rath, Uttama; Sengupta, Saheli; Girton, Jack; Johansen, Kristen M.; Johansen, Jorgen			The Spindle Matrix Protein, Chromator, Is a Novel Tubulin Binding Protein That Can Interact with Both Microtubules and Free Tubulin	PLOS ONE			English	Article							CHROMODOMAIN PROTEIN; MITOSIS; LOCALIZES; MEGATOR; CELL	The chromodomain protein, Chromator, is localized to chromosomes during interphase; however, during cell division together with other nuclear proteins Chromator redistributes to form a macro molecular spindle matrix complex that embeds the microtubule spindle apparatus. It has been demonstrated that the CTD of Chromator is sufficient for localization to the spindle matrix and that expression of this domain alone could partially rescue Chro mutant microtubule spindle defects. Furthermore, the presence of frayed and unstable microtubule spindles during mitosis after Chromator RNAi depletion in S2 cells indicated that Chromator may interact with microtubules. In this study using a variety of biochemical assays we have tested this hypothesis and show that Chromator not only has binding activity to microtubules with a Kd of 0.23 mu M but also to free tubulin. Furthermore, we have mapped the interaction with microtubules to a relatively small stretch of 139 amino acids in the carboxy-terminal region of Chromator. This sequence is likely to contain a novel microtubule binding interface since database searches did not find any sequence matches with known microtubule binding motifs.	[Yao, Changfu; Wang, Chao; Li, Yeran; Ding, Yun; Rath, Uttama; Sengupta, Saheli; Girton, Jack; Johansen, Kristen M.; Johansen, Jorgen] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Johansen, KM (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	kristen@iastate.edu; jorgen@iastate.edu		Sengupta, Saheli/0000-0002-1192-8467	National Science Foundation [MCB0817107]	National Science Foundation(National Science Foundation (NSF))	Work in the Johansen laboratory is supported by a grant from the National Science Foundation [MCB0817107]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brangwynne CP, 2013, J CELL BIOL, V203, P875, DOI 10.1083/jcb.201308087; De Souza CP, 2009, TRENDS GENET, V25, P545, DOI 10.1016/j.tig.2009.10.005; De Souza CP, 2009, MOL BIOL CELL, V20, P2146, DOI 10.1091/mbc.E08-08-0878; Ding Y, 2009, DEV BIOL, V334, P253, DOI 10.1016/j.ydbio.2009.07.027; Hayashi H, 2012, MOL BIOL CELL, V23, P1688, DOI 10.1091/mbc.E11-09-0815; Johansen J, 2009, FLY, V3, P213; Johansen KM, 2007, INT REV CYTOL, V263, P155, DOI 10.1016/S0074-7696(07)63004-6; Johansen KM, 2002, CELL CYCLE, V1, P312, DOI 10.4161/cc.1.5.144; Johansen KM, 2011, CHROMOSOME RES, V19, P345, DOI 10.1007/s10577-011-9187-6; Lee SH, 2008, GENE DEV, V22, P2926, DOI 10.1101/gad.1677208; Lince-Faria M, 2009, J CELL BIOL, V184, P647, DOI 10.1083/jcb.200811012; Pickett-Heaps J, 2009, PROTOPLASMA, V235, P91, DOI 10.1007/s00709-009-0030-2; PICKETTHEAPS JD, 1982, CELL, V29, P729, DOI 10.1016/0092-8674(82)90435-4; Qi HY, 2005, J CELL BIOCHEM, V95, P1284, DOI 10.1002/jcb.20495; Qi HY, 2004, MOL BIOL CELL, V15, P4854, DOI 10.1091/mbc.E04-07-0579; Rath U, 2004, J CELL BIOCHEM, V93, P1033, DOI 10.1002/jcb.20243; Rath U, 2006, J CELL SCI, V119, P2332, DOI 10.1242/jcs.02960; Roberts DB, 1988, DROSOPHILA PRACTICAL; Sambrook J, 2001, MOL CLONING LAB MANU; Schweizer N, 2014, CURR OPIN CELL BIOL, V28, P1, DOI 10.1016/j.ceb.2014.01.002; Walker DL, 2000, J CELL BIOL, V151, P1401, DOI 10.1083/jcb.151.7.1401; Wozniak R, 2010, CELL MOL LIFE SCI, V67, P2215, DOI 10.1007/s00018-010-0325-7; Yao CF, 2012, MOL BIOL CELL, V23, P3532, DOI 10.1091/mbc.E12-06-0429; Yao CF, 2012, CHROMOSOMA, V121, P209, DOI 10.1007/s00412-011-0355-4; Zhang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060596; Zheng YX, 2010, NAT REV MOL CELL BIO, V11, P529, DOI 10.1038/nrm2919	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103855	10.1371/journal.pone.0103855	http://dx.doi.org/10.1371/journal.pone.0103855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072297	Green Submitted, Green Published, gold			2022-12-25	WOS:000341307600089
J	Dille, S; Herbst, K; Volceanov, L; Nolke, T; Kretz, O; Hacker, G				Dille, Stephanie; Herbst, Katharina; Volceanov, Larisa; Noelke, Thilo; Kretz, Oliver; Haecker, Georg			Golgi Fragmentation and Sphingomyelin Transport to Chlamydia trachomatis during Penicillin-Induced Persistence Do Not Depend on the Cytosolic Presence of the Chlamydial Protease CPAF	PLOS ONE			English	Article							SPHINGOLIPIDS; APPARATUS; CELLS; CHOLESTEROL; SECRETION; INFECTION	Chlamydia grows inside a cytosolic vacuole (the inclusion) that is supplied with nutrients by the host through vesicular and non-vesicular transport. It is unclear in many respects how Chlamydia organizes this transport. One model posits that the Chlamydia-induced fragmentation of the Golgi-apparatus is required for normal transport processes to the inclusion and for chlamydial development, and the chlamydial protease CPAF has been controversially implicated in Golgi-fragmentation. We here use a model of penicillin-induced persistence of infection with Chlamydia trachomatis to test this link. Under penicillin-treatment the inclusion grew in size for the first 24 h but after that growth was severely reduced. Penicillin did not reduce the number of infected cells with fragmented Golgi-apparatus, and normal Golgi-fragmentation was found in a CPAF-deficient mutant. Surprisingly, sphingomyelin transport into the inclusion and into the bacteria, as measured by fluorescence accumulation upon addition of labelled ceramide, was not reduced during penicillin-treatment. Thus, both Golgi-fragmentation and transport of sphingomyelin to C. trachomatis still occurred in this model of persistence. The portion of cells in which CPAF was detected in the cytosol, either by immunofluorescence or by immune-electron microscopy, was drastically reduced in cells cultured in the presence of penicillin. These data argue against an essential role of cytosolic CPAF for Golgi-fragmentation or for sphingomyelin transport in chlamydial infection.	[Dille, Stephanie; Herbst, Katharina; Volceanov, Larisa; Haecker, Georg] Univ Med Ctr Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany; [Noelke, Thilo] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79106 Freiburg, Germany; [Kretz, Oliver] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Hacker, G (corresponding author), Univ Med Ctr Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany.	georg.haecker@uniklinik-freiburg.de		Dille, Stephanie/0000-0002-7712-6002; Dille, Stephanie/0000-0001-9465-8345; Kretz, Oliver/0000-0003-1152-5956	German Research Foundation [SPP1580]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation (SPP1580 grant to G. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya U, 1998, CELL, V92, P183, DOI 10.1016/S0092-8674(00)80913-7; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Belland R, 2004, NAT REV MICROBIOL, V2, P530, DOI 10.1038/nrmicro931; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Chen AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002842; Chen D, 2010, MICROBIOL-SGM, V156, P3031, DOI 10.1099/mic.0.040527-0; Christian J, 2010, J BIOL CHEM, V285, P41320, DOI 10.1074/jbc.M110.152280; Christian JG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002283; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Dumoux M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083511; Echeverry N, 2013, CELL DEATH DIFFER, V20, P785, DOI 10.1038/cdd.2013.10; Elwell CA, 2012, CELL MICROBIOL, V14, P1010, DOI 10.1111/j.1462-5822.2012.01794.x; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Gerbase AC, 1998, LANCET, V351, P2, DOI 10.1016/S0140-6736(98)90001-0; Gonatas NK, 2006, J NEUROL SCI, V246, P21, DOI 10.1016/j.jns.2006.01.019; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Haider S, 2010, MOL MICROBIOL, V77, P687, DOI 10.1111/j.1365-2958.2010.07241.x; Hatch GM, 1998, INFECT IMMUN, V66, P3727, DOI 10.1128/IAI.66.8.3727-3735.1998; Heuer D, 2003, CELL MICROBIOL, V5, P315, DOI 10.1046/j.1462-5822.2003.00278.x; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Johnson RM, 2004, INFECT IMMUN, V72, P3951, DOI 10.1128/IAI.72.7.3951-3960.2004; Lee JE, 2011, AM J PHYSIOL-HEART C, V300, pH1141, DOI 10.1152/ajpheart.00767.2010; Lisauskas T, 2012, TRAFFIC, V13, P416, DOI 10.1111/j.1600-0854.2011.01318.x; LUCOCQ JM, 1987, EMBO J, V6, P3239, DOI 10.1002/j.1460-2075.1987.tb02641.x; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Mounier J, 2012, CELL HOST MICROBE, V12, P381, DOI 10.1016/j.chom.2012.07.010; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Romano JD, 2013, MOL BIOL CELL, V24, P1974, DOI 10.1091/mbc.E12-11-0827; Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363; Skilton RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007723; Snavely EA, 2014, PATHOG DIS; van Ooij C, 2000, CELL MICROBIOL, V2, P627, DOI 10.1046/j.1462-5822.2000.00077.x; Wang J, 2011, MICROBIOL-SGM, V157, P2759, DOI 10.1099/mic.0.044917-0; WATZELE G, 1990, NUCLEIC ACIDS RES, V18, P7174, DOI 10.1093/nar/18.23.7174; Weber A, 2009, TRANSL ONCOL, V2, P73, DOI 10.1593/tlo.08223; WELCH WJ, 1985, J CELL BIOL, V101, P1198, DOI 10.1083/jcb.101.4.1198; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394; Zhong GM, 2009, TRENDS MICROBIOL, V17, P467, DOI 10.1016/j.tim.2009.07.007; Zhou ZG, 2013, J VIROL, V87, P11721, DOI 10.1128/JVI.01355-13	42	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103220	10.1371/journal.pone.0103220	http://dx.doi.org/10.1371/journal.pone.0103220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068694	gold, Green Published, Green Submitted			2022-12-25	WOS:000339993700046
J	Ozanne, CMP; Cabral, C; Shaw, PJ				Ozanne, Claire M. P.; Cabral, Christie; Shaw, Peter J.			Variation in Indigenous Forest Resource Use in Central Guyana	PLOS ONE			English	Article							LOW-DIVERSITY FORESTS; FLORISTIC COMPOSITION; TREE POPULATION; LAND-USE; CONSERVATION; DEFORESTATION; BIODIVERSITY; AMAZONIA; DYNAMICS	Sustainable forest conservation strategies should be based on local as well as landscape-scale forest resource use data. Using ecological and sociological techniques, we test the hypotheses that (1) forest resource use differs between ethnic and socioeconomic indigenous groups and (2) that this difference results in differing spatial patterns of resource use, with implications for forest diversity and for conservation planning. In the North Rupununi Guyana, three adjacent indigenous communities (differing in their indigenous/immigrant balance) were recorded using 73 animal and 164 plant species (plus several unidentified ethno-species). Farm sites formed important foci for most forest based activities and ex-farm sites supported similar floristic diversity to surrounding forest. Resource usage differences between communities could be attributed to socio-cultural drivers, e.g. mammal meat consumption and the use of the fruits from the palm tree A. maripa were higher in more traditional households. When extracting household construction timber, lower income groups created small scattered felling sites akin to tree fall gaps whereas higher income groups created larger gaps. Lower income (indigenous) households tended to clear larger but more contained sites for farming while mixed or non-Amerindian household tended to clear smaller but more widely dispersed farm sites. These variations resulted in different patterns of forest disturbance originating from agriculture and timber extraction.	[Ozanne, Claire M. P.; Shaw, Peter J.] Univ Roehampton, Dept Life Sci, Ctr Res Ecol, London, England; [Cabral, Christie] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	Roehampton University; University of Bristol	Ozanne, CMP (corresponding author), Univ Roehampton, Dept Life Sci, Ctr Res Ecol, London, England.	c.ozanne@roehampton.ac.uk		shaw, peter/0000-0002-6621-2204; Cabral, Christie/0000-0002-9884-0555	University of Roehampton PhD Bursary Botanical Research Fund	University of Roehampton PhD Bursary Botanical Research Fund	This work was supported by the University of Roehampton PhD Bursary Botanical Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Armenteras D, 2009, BIOL CONSERV, V142, P1411, DOI 10.1016/j.biocon.2009.02.002; Balee W., 1989, Advances in Economic Botany, V7, P1; Beckerman S, 1993, TROPICAL FORESTS PEO, P52; Brooks JS, 2012, P NATL ACAD SCI USA, V109, P21265, DOI 10.1073/pnas.1207141110; Brunner M, 1994, MAJOR TIMBER TREES G; Cannon CH, 1998, SCIENCE, V281, P1366, DOI 10.1126/science.281.5381.1366; Castellan, 1988, NONPARAMETRIC STAT B; CHAMBERS R, 1994, WORLD DEV, V22, P953, DOI 10.1016/0305-750X(94)90141-4; Chambers R, 1992, 311 IDS IIED; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Conservation International Climate Focus Terracarbon LLC SarVision. Development and Policy Management Consultants, 2009, ATNNP10749GYATNSF107; De Souza-Mazurek RR, 2000, BIODIVERS CONSERV, V9, P579, DOI 10.1023/A:1008999201747; Department of Lands and Surveys, 1973, GUYAN SUR SHEET 55 S; Dickson B, 2012, CURR OPIN ENV SUST, V4, P717, DOI 10.1016/j.cosust.2012.09.017; Ecosecurities, 2002, BASELINE ANAL GUIANA; Eigenmann C.H., 1912, INDIANA U STUD, V16, P1; Ellen RF, 1984, RES METHODS SOCIAL A, V1; Ellenbroek A, 1996, BOS NIEUWSLETTER, V15, P7; FAO, 2001, GLOBAL FOREST RESOUR; Forte J, 1996, GUYANESE AMERINDIANS; Gerard J, 1996, MAJOR TIMBER TREES G; Government of Guyana, 1974, GAS GUYAN; Guyana Forestry Commission, 2009, QUICK ASS PAP DEF FO; Haden P, 1999, 3 OV DEV I EUR UN; Hammond DS, 2005, TROPICAL FORESTS OF THE GUIANA SHIELD: ANCIENT FORESTS IN A MODERN WORLD, P1, DOI 10.1079/9780851995366.0000; Hawkes M. D., 1993, COMMONWEALTH GOVT GU; HENDERSON A, 1995, FIELD GUIDE PALMS AM; Hills TL, 1968, AMERINDIAN AGR; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Holstein J. A., 1997, QUALITATIVE RES THEO; JOHNSTON M, 1995, BIODIVERS CONSERV, V4, P339, DOI 10.1007/BF00058421; Johnston M, 1998, BIODIVERS CONSERV, V7, P73, DOI 10.1023/A:1008859713118; Kayhko N, 2011, LAND USE POLICY, V28, P26, DOI 10.1016/j.landusepol.2010.04.006; Lambin EF, 2003, ANNU REV ENV RESOUR, V28, P205, DOI 10.1146/annurev.energy.28.050302.105459; Lu F, 2010, CONSERV BIOL, V24, P881, DOI 10.1111/j.1523-1739.2010.01463.x; Maguire B, 1981, MEMOIRS NEW YORK BOT, V32; Meggers B. J., 1996, AMAZONIA MAN CULTURE; Mennega E.A., 1988, CHECK LIST WOODY PLA; Messerschmidt DA, 1995, RAPID APPRAISAL COMM; Milliken W., 1992, ETHNOBOTANY WAIMIRI, P4; Moran E. F., 1989, Advances in Economic Botany, V7, P22; Mwampamba TH, 2011, FOREST ECOL MANAG, V261, P1042, DOI 10.1016/j.foreco.2010.12.026; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; PENACLAROS M, 2001, PROMAB SCI SERIES, V3; Peres CA, 2006, BIODIVERS CONSERV, V15, P2627, DOI 10.1007/s10531-005-5406-9; Polak A.M., 1992, MAJOR TIMBER TREES G; Porter-Bolland L, 2012, FOREST ECOL MANAG, V268, P6, DOI 10.1016/j.foreco.2011.05.034; Posey D. A., 1985, Agroforestry Systems, V3, P139, DOI 10.1007/BF00122640; RISSER PG, 1995, CONSERV BIOL, V9, P742, DOI 10.1046/j.1523-1739.1995.09040742.x; ROSE SA, 2000, TROPENBOS GUYANA SER, V9; Salisbury RF, 1968, ETHNOGRAPHIC NOTES A; Shaw P.J.A., 2003, MULTIVARIATE STAT EN; Silverman D., 2015, INTERPRETING QUALITA; Smith DA, 2008, BIOL CONSERV, V141, P925, DOI 10.1016/j.biocon.2007.12.021; Sokal R.R., 2012, BIOMETRY PRINCIPLES; STRICKLAND SS, 1997, FORM FUNCTION STUDY; TERSTEEGE H, 2001, NATL VEGETATION MAP; Toledo VM, 2003, CONSERV ECOL, V7; van Andel T, 2001, BIODIVERS CONSERV, V10, P1645, DOI 10.1023/A:1012069717077; van Andel TR, 2000, THESIS; Van Gemerden BS, 2003, BIODIVERS CONSERV, V12, P1553, DOI 10.1023/A:1023603813163; Van Roosmalen M.G.M., 1985, FRUITS GUIANAN FLORA; Walker R, 2009, P NATL ACAD SCI USA, V106, P10582, DOI 10.1073/pnas.0806059106; Wangpakapattanawong P, 2010, FOREST ECOL MANAG, V260, P1399, DOI 10.1016/j.foreco.2010.07.042; Wolcott H., 1990, WRITING QUALITATIVE; Yeo-Chang Y, 2009, FOREST ECOL MANAG, V257, P2027, DOI 10.1016/j.foreco.2009.01.054	68	1	1	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102952	10.1371/journal.pone.0102952	http://dx.doi.org/10.1371/journal.pone.0102952			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068801	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993700025
J	Suico, MA; Fukuda, R; Miyakita, R; Koyama, K; Taura, M; Shuto, T; Kai, H				Suico, Mary Ann; Fukuda, Ryosuke; Miyakita, Rui; Koyama, Kosuke; Taura, Manabu; Shuto, Tsuyoshi; Kai, Hirofumi			The Transcription Factor MEF/Elf4 Is Dually Modulated by p53-MDM2 Axis and MEF-MDM2 Autoregulatory Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELOID ELF-1-LIKE FACTOR; REGULATES LYSOZYME TRANSCRIPTION; PROMYELOCYTIC LEUKEMIA PROTEIN; TUMOR-SUPPRESSOR P53; EPITHELIAL-CELLS; FACTOR MEF; HUMAN BETA-DEFENSIN-2; HEMATOPOIETIC-CELLS; CARCINOMA CELLS; ENDOGENOUS P53	Myeloid Elf-1-like factor (MEF) or Elf4 is an ETS transcription factor that activates innate immunity-associated genes such as lysozyme (LYZ), human beta-defensin 2 (H beta D2), and interleukin-8 (IL-8) in epithelial cells and is also known to influence cell cycle progression. MEF is transcriptionally activated by E2F1, but the E2F1-mediated transcriptional activation is inhibited by p53 through E2F1-p53 protein interaction. Although the transcriptional activation of MEF has been investigated in depth, its post-translational regulation is not well explored. By overexpressing MEF cDNA in human cell lines, here we show that MEF protein expression is suppressed by p53. By screening a number of E3 ligases regulated by p53, we found that MDM2 is involved in the effect of p53 on MEF. MDM2 is transcriptionally activated by p53 and interacts with MEF protein to enhance MEF degradation. MDM2 reduces MEF protein expression, as well as stability and function of MEF as transcriptional activator. Furthermore, MDM2 was able to down-regulate MEF in the absence of p53, indicating a p53-independent effect on MEF. Notably, MEF transcriptionally activates MDM2, which was previously demonstrated to be the mechanism by which MEF suppresses the p53 protein. These results reveal that in addition to the potential of MEF to down-regulate p53 by transcriptionally activating E3 ligase MDM2, MEF participates with MDM2 in a novel autoregulatory feedback loop to regulate itself. Taken together with the findings on the effect of p53 on MEF, these data provide evidence that the p53-MDM2-MEF axis is a feedback mechanism that exquisitely controls the balance of these transcriptional regulators.	[Suico, Mary Ann; Fukuda, Ryosuke; Miyakita, Rui; Koyama, Kosuke; Taura, Manabu; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto 8620973, Japan	Kumamoto University	Suico, MA (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	mann@gpo.kumamoto-u.ac.jp; hirokai@gpo.kumamoto-u.ac.jp	Taura, Manabu/Y-6844-2019	Taura, Manabu/0000-0001-9577-8007; Shuto, Tsuyoshi/0000-0003-1275-4988; Suico, Mary Ann/0000-0002-6751-8352	Ministry of Education, Science, Sports, and Culture of Japan (MEXT) [22390015, 23590082]; Program for Leading Graduate Schools "HIGO" (Health life science: Interdisciplinary and Glocal Oriented), MEXT, Japan	Ministry of Education, Science, Sports, and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Leading Graduate Schools "HIGO" (Health life science: Interdisciplinary and Glocal Oriented), MEXT, Japan	This work was supported by Grants-in-Aid for Science Research from the Ministry of Education, Science, Sports, and Culture of Japan (MEXT) 22390015 (to H. K.) and 23590082 (to M. S.) and the Program for Leading Graduate Schools "HIGO" (Health life science: Interdisciplinary and Glocal Oriented), MEXT, Japan.	Barre B, 2010, MOL CELL, V38, P524, DOI 10.1016/j.molcel.2010.03.018; Bazzoli E, 2012, CELL STEM CELL, V11, P836, DOI 10.1016/j.stem.2012.09.012; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Carter S, 2009, CURR OPIN GENET DEV, V19, P18, DOI 10.1016/j.gde.2008.11.010; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Fujita K, 2010, NAT CELL BIOL, V12, P1205, DOI 10.1038/ncb2123; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hedvat CV, 2004, J BIOL CHEM, V279, P6395, DOI 10.1074/jbc.M307524200; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; HOPPESEYLER F, 1993, J VIROL, V67, P3111, DOI 10.1128/JVI.67.6.3111-3117.1993; Jung YS, 2010, MOL CELL BIOL, V30, P1041, DOI 10.1128/MCB.01198-09; Kai H, 1999, J BIOL CHEM, V274, P20098, DOI 10.1074/jbc.274.29.20098; Koga T, 2005, FEBS LETT, V579, P2811, DOI 10.1016/j.febslet.2005.04.015; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lacorazza HD, 2006, CANCER CELL, V9, P175, DOI 10.1016/j.ccr.2006.02.017; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Lehmann J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-20; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Liu Y, 2006, MOL CELL BIOL, V26, P3114, DOI 10.1128/MCB.26.8.3114-3123.2006; Lu Z, 2004, FEBS LETT, V561, P117, DOI 10.1016/S0014-5793(04)00138-3; Miyazaki Y, 2001, J BIOL CHEM, V276, P40528, DOI 10.1074/jbc.M103051200; Miyazaki Y, 1996, ONCOGENE, V13, P1721; Morissette MC, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-62; O'Keefe K, 2003, MOL CELL BIOL, V23, P6396, DOI 10.1128/MCB.23.18.6396-6405.2003; Ohki R, 2007, CANCER SCI, V98, P189, DOI 10.1111/j.1349-7006.2006.00375.x; Riley Maurisa F, 2012, Genes Cancer, V3, P226, DOI 10.1177/1947601912455322; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sashida G, 2010, CELL CYCLE, V9, P3457, DOI 10.4161/cc.9.17.13000; Sashida G, 2009, MOL CELL BIOL, V29, P3687, DOI 10.1128/MCB.01551-08; Seki Y, 2002, CANCER RES, V62, P6579; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Suico MA, 2004, J PHARMACOL SCI, V95, P466, DOI 10.1254/jphs.SC0040077; Suico MA, 2004, J BIOL CHEM, V279, P19091, DOI 10.1074/jbc.M312439200; Suico MA, 2002, BBA-GENE STRUCT EXPR, V1577, P113, DOI 10.1016/S0167-4781(02)00370-6; Suico MA, 2006, BIOCHEM BIOPH RES CO, V348, P880, DOI 10.1016/j.bbrc.2006.07.151; TAMURA T, 1995, ONCOGENE, V11, P1939; Taura M, 2008, MOL CELL BIOL, V28, P6557, DOI 10.1128/MCB.01202-08; Taura M, 2011, NUCLEIC ACIDS RES, V39, P76, DOI 10.1093/nar/gkq762; Turner DP, 2008, EXPERT REV ANTICANC, V8, P33, DOI 10.1586/14737140.8.1.33; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wu H, 2011, NAT MED, V17, P347, DOI 10.1038/nm.2283; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	47	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26143	26154		10.1074/jbc.M114.580209	http://dx.doi.org/10.1074/jbc.M114.580209			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25081543	Green Published, hybrid			2022-12-25	WOS:000342128800011
J	Obata, J; Takeshita, T; Shibata, Y; Yamanaka, W; Unemori, M; Akamine, A; Yamashita, Y				Obata, Junko; Takeshita, Toru; Shibata, Yukie; Yamanaka, Wataru; Unemori, Masako; Akamine, Akifumi; Yamashita, Yoshihisa			Identification of the Microbiota in Carious Dentin Lesions Using 165 rRNA Gene Sequencing	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; MOLECULAR ANALYSIS; CARIES; MUTANS; PROFILES; DATABASE; UNIFRAC; TEETH	While mutans streptococci have long been assumed to be the specific pathogen responsible for human dental caries, the concept of a complex dental caries-associated microbiota has received significant attention in recent years. Molecular analyses revealed the complexity of the microbiota with the predominance of Lactobacillus and Prevotella in carious dentine lesions. However, characterization of the dentin caries-associated microbiota has not been extensively explored in different ethnicities and races. In the present study, the bacterial communities in the carious dentin of Japanese subjects were analyzed comprehensively with molecular approaches using the16S rRNA gene. Carious dentin lesion samples were collected from 32 subjects aged 4-76 years, and the 16S rRNA genes, amplified from the extracted DNA with universal primers, were sequenced with a pyrosequencer. The bacterial composition was classified into clusters I, II, and III according to the relative abundance (high, middle, low) of Lactobacillus. The bacterial composition in cluster II was composed of relatively high proportions of Olsenella and Propionibacterium or subdominated by heterogeneous genera. The bacterial communities in cluster III were characterized by the predominance of Atopobium, Prevotella, or Propionibacterium with Streptococcus or Actinomyces. Some samples in clusters II and III, mainly related to Atopobium and Propionibacterium, were novel combinations of microbiota in carious dentin lesions and may be characteristic of the Japanese population. Clone library analysis revealed that Atopobium sp. HOT-416 and P. acidifaciens were specific species associated with dentinal caries among these genera in a Japanese population. We summarized the bacterial composition of dentinal carious lesions in a Japanese population using next-generation sequencing and found typical Japanese types with Atopobium or Propionibacterium predominating.	[Obata, Junko; Takeshita, Toru; Shibata, Yukie; Yamanaka, Wataru; Yamashita, Yoshihisa] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Prevent & Publ Hlth Dent, Fukuoka 812, Japan; [Obata, Junko; Unemori, Masako; Akamine, Akifumi] Kyushu Univ, Fac Dent Sci, Dept Endodontol & Operat Dent, Div Oral Rehabil, Fukuoka 812, Japan	Kyushu University; Kyushu University	Yamashita, Y (corresponding author), Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Prevent & Publ Hlth Dent, Fukuoka 812, Japan.	yoshi@dent.kyushu-u.ac.jp	Takeshita, Toru/AAT-2321-2021		Ministry of Education, Culture, Sports, Science and Technology of Japan [25463249, 25463251, 25293428]; Grants-in-Aid for Scientific Research [25463249] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in Aid for Scientific Research 25463249 (T. T.), 25463251 (Y. S.) and 25293428 (Y. Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Bagramian RA, 2009, AM J DENT, V22, P3; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CARLSSON P, 1989, SCAND J DENT RES, V97, P120; Chaussain-Miller C, 2006, J DENT RES, V85, P22, DOI 10.1177/154405910608500104; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Chhour KL, 2005, J CLIN MICROBIOL, V43, P843, DOI 10.1128/JCM.43.2.843-849.2005; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLLINS MD, 1992, FEMS MICROBIOL LETT, V95, P235, DOI 10.1111/j.1574-6968.1992.tb05372.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edwardsson S, 1974, Odontol Revy Suppl, V32, P1; Gross EL, 2010, J CLIN MICROBIOL, V48, P4121, DOI 10.1128/JCM.01232-10; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HAHN CL, 1991, ARCH ORAL BIOL, V36, P147, DOI 10.1016/0003-9969(91)90077-8; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Helderman WHV, 1996, J DENT RES, V75, P535, DOI 10.1177/00220345960750010501; HOSHINO E, 1985, J DENT RES, V64, P1195, DOI 10.1177/00220345850640100301; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Kraatz M, 2011, INT J SYST EVOL MICR, V61, P795, DOI 10.1099/ijs.0.022954-0; Lima KC, 2011, CARIES RES, V45, P21, DOI 10.1159/000322299; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mason MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077287; Munson MA, 2004, J CLIN MICROBIOL, V42, P3023, DOI 10.1128/JCM.42.7.3023-3029.2004; Nadkarni MA, 2004, J CLIN MICROBIOL, V42, P5238, DOI 10.1128/JCM.42.11.5238-5244.2004; Nasidze I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023352; Preza D, 2008, J CLIN MICROBIOL, V46, P2015, DOI 10.1128/JCM.02411-07; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; R Development Core Team, 2012, R LANG ENV STAT COMP; Reich E, 1999, INT DENT J, V49, P15, DOI 10.1111/j.1875-595X.1999.tb00503.x; Takeshita T, 2007, ORAL MICROBIOL IMMUN, V22, P419, DOI 10.1111/j.1399-302X.2007.00384.x; Tjaderhane L, 1998, J DENT RES, V77, P1622, DOI 10.1177/00220345980770081001; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wei GX, 1999, ORAL MICROBIOL IMMUN, V14, P348, DOI 10.1034/j.1399-302X.1999.140603.x	35	50	51	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103712	10.1371/journal.pone.0103712	http://dx.doi.org/10.1371/journal.pone.0103712			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083880	gold, Green Submitted, Green Published			2022-12-25	WOS:000339819800071
J	Selvamani, SP; Mishra, R; Singh, SK				Selvamani, Sakthi Priya; Mishra, Ritu; Singh, Sunit K.			Chikungunya Virus Exploits miR-146a to Regulate NF-kappa B Pathway in Human Synovial Fibroblasts	PLOS ONE			English	Article							MICRORNA-146A EXPRESSION; TARGETING TRAF6; MOUSE MODEL; ARTHRITIS; MECHANISM; DISEASE; PATHOGENESIS; BIOGENESIS; INDUCTION; FEATURES	Objectives: Chikungunya virus causes chronic infection with manifestations of joint pain. Human synovial fibroblasts get infected with CHIKV and could lead to pro-inflammatory responses. MicroRNAs have potentials to regulate the gene expression of various anti-viral and pro-inflammatory genes. The study aims to investigate the role of miR-146a in modulation of inflammatory responses of human synovial fibroblasts by Chikungunya virus. Methods: To study the role of miR-146a in CHIKV pathogenesis in human synovial cells and underlying inflammatory manifestations, we performed CHIKV infection in primary human synovial fibroblasts. Western blotting, real-time PCR, luciferase reporter assay, overexpression and knockdown of cellular miR-146a strategies have been employed to validate the role of miR-146a in regulation of pro-inflammatory NF-kappa B pathway. Results: CHIKV infection induced the expression of cellular miR-146a, which resulted into down-regulation of TRAF6, IRAK1, IRAK2 and increased replication of CHIKV in human synovial fibroblasts. Exogenous expression of miR-146a in human synovial fibroblasts led to decreased expression of TRAF6, IRAK1, IRAK2 and decreased replication of CHIKV. Inhibition of cellular miR-146a by anti-miR-146a restored the expression levels of TRAF6, IRAK1 and IRAK2. Downregulation of TRAF6, IRAK1 and IRAK2 led to downstream decreased NF-kappa B activation through negative feedback loop. Conclusion: This study demonstrated the mechanism of exploitation of cellular miR-146a by CHIKV in modulating the host antiviral immune response in primary human synovial fibroblasts.	[Selvamani, Sakthi Priya; Mishra, Ritu; Singh, Sunit K.] Ctr Cellular & Mol Biol, CSIR, Lab Neurovirol & Inflammat Biol, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Singh, SK (corresponding author), Ctr Cellular & Mol Biol, CSIR, Lab Neurovirol & Inflammat Biol, Hyderabad 500007, Andhra Pradesh, India.	sunitsingh2000@gmail.com	Singh, Sunit K/AAO-4760-2021	Singh, Sunit K/0000-0002-8802-1169; Mishra, Ritu/0000-0002-4090-0893	Indo-Korean Grant - Department of Science and Technology, Govt. of India, New Delhi [INT/Korea/P-08]	Indo-Korean Grant - Department of Science and Technology, Govt. of India, New Delhi	Authors acknowledge the financial support through Indo-Korean Grant (INT/Korea/P-08) funded by Department of Science and Technology, Govt. of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075854; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; CALISHER CH, 1980, INTERVIROLOGY, V14, P229, DOI 10.1159/000149190; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789; Jensen LE, 2000, J IMMUNOL, V164, P5277, DOI 10.4049/jimmunol.164.10.5277; Kam YW, 2009, MICROBES INFECT, V11, P1186, DOI 10.1016/j.micinf.2009.09.003; Kandasamy S, 2014, VACCINE, V32, P816, DOI 10.1016/j.vaccine.2013.12.039; Kovalchuk L. V., 2009, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P100; Krejbich-Trotot P, 2011, FASEB J, V25, P314, DOI 10.1096/fj.10-164178; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; Labbaye C, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-13; Lakshmi V, 2008, CLIN INFECT DIS, V46, P1436, DOI 10.1086/529444; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Nakasa T, 2011, ARTHRITIS RHEUM-US, V63, P1582, DOI 10.1002/art.30321; Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631; Paik JH, 2011, CLIN CANCER RES, V17, P4761, DOI 10.1158/1078-0432.CCR-11-0494; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Rusca Nicole, 2011, Mol Biol Int, V2011, P437301, DOI 10.4061/2011/437301; Sarma NJ, 2014, J VIROL, V88, P3733, DOI 10.1128/JVI.03060-13; Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Sehnert B, 2013, P NATL ACAD SCI USA, V110, P16556, DOI 10.1073/pnas.1218219110; Shi XL, 2013, CRIT CARE, V17, DOI 10.1186/cc13171; Singh SK, 2008, FEBS J, V275, P4929, DOI 10.1111/j.1742-4658.2008.06624.x; Singh SK, 2011, REV MED VIROL, V21, P78, DOI 10.1002/rmv.681; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Teo TH, 2012, IMMUNOL RES, V53, P136, DOI 10.1007/s12026-012-8266-x; TESH RB, 1982, ANNU REV MED, V33, P31, DOI 10.1146/annurev.me.33.020182.000335; Thon-Hon VG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-213; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Wu SY, 2013, J INFECTION, V67, P329, DOI 10.1016/j.jinf.2013.05.003; Xu WD, 2012, INFLAMMATION, V35, P1525, DOI 10.1007/s10753-012-9467-0; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zhuo Y, 2013, CELL PHYSIOL BIOCHEM, V32, P499, DOI 10.1159/000354455	52	43	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103624	10.1371/journal.pone.0103624	http://dx.doi.org/10.1371/journal.pone.0103624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083878	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800061
J	Wypych, M; Nagy, A; Mochol, G; Foik, A; Benedek, G; Waleszczyk, WJ				Wypych, Marek; Nagy, Attila; Mochol, Gabriela; Foik, Andrzej; Benedek, Gyoergy; Waleszczyk, Wioletta J.			Spectral Characteristics of Phase Sensitivity and Discharge Rate of Neurons in the Ascending Tectofugal Visual System	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; LATERAL SUPRASYLVIAN CORTEX; POSTERIOR-PULVINAR COMPLEX; RECEPTIVE-FIELD PROPERTIES; STRIATE-RECIPIENT ZONE; RESPONSE PROPERTIES; SUPERIOR COLLICULUS; SINGLE NEURONS; FUNCTIONAL ARCHITECTURE; SUPRAGENICULATE NUCLEUS	Drifting gratings can modulate the activity of visual neurons at the temporal frequency of the stimulus. In order to characterize the temporal frequency modulation in the cat's ascending tectofugal visual system, we recorded the activity of single neurons in the superior colliculus, the suprageniculate nucleus, and the anterior ectosylvian cortex during visual stimulation with drifting sine-wave gratings. In response to such stimuli, neurons in each structure showed an increase in firing rate and/or oscillatory modulated firing at the temporal frequency of the stimulus (phase sensitivity). To obtain a more complete characterization of the neural responses in spatiotemporal frequency domain, we analyzed the mean firing rate and the strength of the oscillatory modulations measured by the standardized Fourier component of the response at the temporal frequency of the stimulus. We show that the spatiotemporal stimulus parameters that elicit maximal oscillations often differ from those that elicit a maximal discharge rate. Furthermore, the temporal modulation and discharge-rate spectral receptive fields often do not overlap, suggesting that the detection range for visual stimuli provided jointly by modulated and unmodulated response components is larger than the range provided by a one response component.	[Wypych, Marek; Mochol, Gabriela; Foik, Andrzej; Waleszczyk, Wioletta J.] Nencki Inst Expt Biol, Warsaw, Poland; [Nagy, Attila; Benedek, Gyoergy] Univ Szeged, Szeged, Hungary	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Szeged University	Waleszczyk, WJ (corresponding author), Nencki Inst Expt Biol, Warsaw, Poland.	w.waleszczyk@nencki.gov.pl	Waleszczyk, Wioletta/F-6027-2010; Foik, Andrzej/F-6014-2010; Wypych, Marek/C-1371-2019; Foik, Andrzej/AAB-8105-2019	Foik, Andrzej/0000-0003-1110-9223; Wypych, Marek/0000-0002-8710-0244; Foik, Andrzej/0000-0003-1110-9223; Waleszczyk, Wioletta/0000-0002-7300-6193	Hungarian Brain Research Program KTIA [13 NAP-A-I/15]; OTKA Hungary [K83810]; Polish National Science Centre [N N303 820640]; Polish-Hungarian bilateral academic grants; EU [264173]	Hungarian Brain Research Program KTIA; OTKA Hungary(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Polish National Science Centre; Polish-Hungarian bilateral academic grants; EU(European Commission)	This work was supported by Hungarian Brain Research Program KTIA 13 NAP-A-I/15 grant, OTKA Hungary Grant K83810, Polish National Science Centre Grant N N303 820640, Polish-Hungarian bilateral academic grants for years (2011-2016) and EU FP7 Project, GA No 264173 (Bio-Imagine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON BP, 1988, J COMP NEUROL, V271, P397, DOI 10.1002/cne.902710308; Benedek G, 1996, PROG BRAIN RES, V112, P325; Berman RA, 2011, J NEUROSCI, V31, P373, DOI 10.1523/JNEUROSCI.4738-10.2011; Berman RA, 2010, J NEUROSCI, V30, P6342, DOI 10.1523/JNEUROSCI.6176-09.2010; Brosseau-Lachaine O, 2001, CEREB CORTEX, V11, P989, DOI 10.1093/cercor/11.10.989; Burke W, 1998, EUR J NEUROSCI, V10, P8; CASANOVA C, 1989, J NEUROPHYSIOL, V62, P544, DOI 10.1152/jn.1989.62.2.544; CASANOVA C, 1993, EXP BRAIN RES, V96, P247; CRONER LJ, 1993, P NATL ACAD SCI USA, V90, P8128, DOI 10.1073/pnas.90.17.8128; Crowder NA, 2003, J NEUROPHYSIOL, V90, P1829, DOI 10.1152/jn.00654.2002; Crowder NA, 2002, J COMP PHYSIOL A, V188, P109, DOI 10.1007/s00359-002-0280-3; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Eordegh G, 2005, BRAIN RES BULL, V67, P281, DOI 10.1016/j.brainresbull.2005.06.036; Guirado S, 2005, BRAIN RES BULL, V66, P290, DOI 10.1016/j.brainresbull.2005.02.015; HICKS TP, 1988, J NEUROPHYSIOL, V60, P397, DOI 10.1152/jn.1988.60.2.397; Hietanen MA, 2013, NEUROSCIENCE, V237, P19, DOI 10.1016/j.neuroscience.2013.01.030; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P265, DOI 10.1113/jphysiol.1976.sp011595; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; IBBOTSON MR, 1994, J NEUROPHYSIOL, V72, P2927, DOI 10.1152/jn.1994.72.6.2927; Kara P, 2003, J NEUROSCI, V23, P8547; LEHMKUHLE S, 1980, J NEUROPHYSIOL, V43, P520, DOI 10.1152/jn.1980.43.2.520; Lui LL, 2007, EUR J NEUROSCI, V25, P1780, DOI 10.1111/j.1460-9568.2007.05453.x; Lyon DC, 2010, NEURON, V65, P270, DOI 10.1016/j.neuron.2010.01.003; Markus Z, 2009, NEUROSCI LETT, V454, P76, DOI 10.1016/j.neulet.2009.02.063; Mechler F, 2002, J NEUROSCI, V22, P6129; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; Merabet L, 2000, NEUROSCIENCE, V97, P611, DOI 10.1016/S0306-4522(00)00056-7; MORRONE MC, 1986, J NEUROPHYSIOL, V56, P969, DOI 10.1152/jn.1986.56.4.969; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; MUCKE L, 1982, EXP BRAIN RES, V46, P1; Nagy A, 2003, EXP BRAIN RES, V151, P108, DOI 10.1007/s00221-003-1488-3; Nagy AJ, 2011, NEUROSCI LETT, V503, P52, DOI 10.1016/j.neulet.2011.08.007; Nagy A, 2008, EUR J NEUROSCI, V27, P1801, DOI 10.1111/j.1460-9568.2008.06137.x; Nolt MJ, 2004, J NEUROPHYSIOL, V92, P1708, DOI 10.1152/jn.00176.2004; NORITA M, 1986, EXP BRAIN RES, V62, P225; OCarroll DC, 1996, NATURE, V382, P63, DOI 10.1038/382063a0; Ouellette BG, 2004, NEUROSCIENCE, V123, P231, DOI 10.1016/j.neuroscience.2003.09.002; Paroczy Z, 2006, NEUROSCIENCE, V137, P1397, DOI 10.1016/j.neuroscience.2005.10.068; Passaglia CL, 2001, J NEUROSCI, V21, P5794, DOI 10.1523/JNEUROSCI.21-15-05794.2001; Perrone JA, 2001, NAT NEUROSCI, V4, P526, DOI 10.1038/87480; PINTER RB, 1981, BRAIN RES, V207, P73, DOI 10.1016/0006-8993(81)90680-6; Priebe NJ, 2006, J NEUROSCI, V26, P2941, DOI 10.1523/JNEUROSCI.3936-05.2006; RACZKOWSKI D, 1983, J NEUROSCI, V3, P1912; Rathbun DL, 2010, J NEUROSCI, V30, P13558, DOI 10.1523/JNEUROSCI.0909-10.2010; ROWE MH, 1993, VISUAL NEUROSCI, V10, P765, DOI 10.1017/S0952523800005459; SCHNEIDER GE, 1969, SCIENCE, V163, P895, DOI 10.1126/science.163.3870.895; SIEGEL S., 1956, NONPARAMETRIC STAT B; SIRETEANU R, 1979, EXP BRAIN RES, V34, P591; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SNIDER RS, 1964, STEREOTAXIC ATLAS CA; Sommer MA, 2008, PERCEPTION, V37, P408, DOI 10.1068/p5873; Sprague JM, 1996, PROG BRAIN RES, V112, P1; SUR M, 1982, J NEUROPHYSIOL, V47, P869, DOI 10.1152/jn.1982.47.5.869; Tardif E, 2000, NEUROSCIENCE, V97, P625, DOI 10.1016/S0306-4522(00)00061-0; TOLHURST DJ, 1981, PROC R SOC SER B-BIO, V213, P183, DOI 10.1098/rspb.1981.0061; TROY JB, 1989, VISUAL NEUROSCI, V3, P213, DOI 10.1017/S0952523800009974; TROY JB, 1995, VISUAL NEUROSCI, V12, P285, DOI 10.1017/S0952523800007975; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; van Kleef JP, 2010, J PHYSIOL-LONDON, V588, P3457, DOI 10.1113/jphysiol.2010.191452; Victor JD, 2007, J PHYSIOL-LONDON, V579, P29, DOI 10.1113/jphysiol.2006.122283; VICTOR JD, 1988, J PHYSIOL-LONDON, V405, P289, DOI 10.1113/jphysiol.1988.sp017334; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; VICTOR JD, 1977, P NATL ACAD SCI USA, V74, P3068, DOI 10.1073/pnas.74.7.3068; Villeneuve MY, 2003, J NEUROSCI METH, V129, P19, DOI 10.1016/S0165-0270(03)00198-5; Waleszczyk WJ, 2007, EXP BRAIN RES, V181, P87, DOI 10.1007/s00221-007-0908-1; Waleszczyk WJ, 2004, ACTA NEUROBIOL EXP, V64, P209; Waleszczyk WJ, 1999, NEUROSCIENCE, V93, P1063, DOI 10.1016/S0306-4522(99)00190-6; Wylie DRW, 2000, J NEUROPHYSIOL, V84, P2529, DOI 10.1152/jn.2000.84.5.2529; Wypych M, 2012, VISION RES, V72, P14, DOI 10.1016/j.visres.2012.09.004; Wypych M, 2009, 41 EBBS C 13 18 09 2, V09, P13; ZUMBROICH TJ, 1987, J NEUROSCI, V7, P482	76	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103557	10.1371/journal.pone.0103557	http://dx.doi.org/10.1371/journal.pone.0103557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083715	Green Published, gold			2022-12-25	WOS:000339819800049
J	Dabire, RK; Namountougou, M; Diabate, A; Soma, DD; Bado, J; Toe, HK; Bass, C; Combary, P				Dabire, Roch K.; Namountougou, Moussa; Diabate, Abdoulaye; Soma, Dieudonne D.; Bado, Joseph; Toe, Hyacinthe K.; Bass, Chris; Combary, Patrice			Distribution and Frequency of kdr Mutations within Anopheles gambiae s.I. Populations and First Report of the Ace. 1G119S Mutation in Anopheles arabiensis from Burkina Faso (West Africa)	PLOS ONE			English	Article							GATED SODIUM-CHANNEL; INSECTICIDE RESISTANCE; PYRETHROID RESISTANCE; MOLECULAR-FORMS; ACE-1(R) MUTATION; S.L. POPULATIONS; MALARIA VECTORS; TREATED NETS; EFFICACY; BENIN	An entomological survey was carried out at 15 sites dispersed throughout the three eco-climatic regions of Burkina Faso (West Africa) in order to assess the current distribution and frequency of mutations that confer resistance to insecticides in An. gambiae s.I. populations in the country. Both knockdown (kdr) resistance mutation variants (L1014F and L1014S), that confer resistance to pyrethroid insecticides, were identified concomitant with the ace-1 G119S mutation confirming the presence of multiple resistance mechanisms in the An. gambiae complex in Burkina Faso. Compared to the last survey, the frequency of the L1014F kdr mutation appears to have remained largely stable and relatively high in all species. In contrast, the distribution and frequency of the L1014S mutation has increased significantly in An. gambiae s.I. across much of the country. Furthermore we report, for the first time, the identification of the ace.1 G116S mutation in An. arabiensis populations collected at 8 sites. This mutation, which confers resistance to organophosphate and carbamate insecticides, has been reported previously only in the An. gambiae S and M molecular forms. This finding is significant as organophosphates and carbamates are used in indoor residual sprays (IRS) to control malaria vectors as complementary strategies to the use of pyrethroid impregnated bednets. The occurrence of the three target-site resistance mutations in both An. gambiae molecular forms and now An. arabiensis has significant implications for the control of malaria vector populations in Burkina Faso and for resistance management strategies based on the rotation of insecticides with different modes of action.	[Dabire, Roch K.; Namountougou, Moussa; Diabate, Abdoulaye; Soma, Dieudonne D.; Bado, Joseph; Toe, Hyacinthe K.] Ctr Muraz, Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Toe, Hyacinthe K.] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Bass, Chris] Biol Chem & Crop Protect Rothamsted Res, Harpenden, Herts, England; [Combary, Patrice] Minist Hlth, Natl Malaria Control Programme, Ouagadougou, Burkina Faso	Centre Muraz; Liverpool School of Tropical Medicine; University of Liverpool	Dabire, RK (corresponding author), Ctr Muraz, Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso.	dabire_roch@hotmail.com	Dabire, Roch Kounbobr/ABF-3525-2020	DIABATE, Abdoulaye/0000-0002-9666-9395; Bass, Chris/0000-0002-2590-1492	National Malaria Control Program (NMCP) of Burkina Faso; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005193] Funding Source: researchfish; BBSRC [BBS/E/C/00005193] Funding Source: UKRI	National Malaria Control Program (NMCP) of Burkina Faso; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the National Malaria Control Program (NMCP) of Burkina Faso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoulaye D, 2003, J MED ENTOMOL, V40, P195, DOI 10.1603/0022-2585-40.2.195; Aikpon R, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-192; Awolola TS, 2005, ACTA TROP, V95, P204, DOI 10.1016/j.actatropica.2005.06.002; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-232; Binka FN, 1996, TROP MED INT HEALTH, V1, P147; Carnevale P, 1998, B SOC PATHOL EXOT, V81, P832; Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230; Chandre F, 1997, J MED ENTOMOL, V34, P664, DOI 10.1093/jmedent/34.6.664; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Dabire KR, 2012, INSECTICIDES - PEST ENGINEERING, P479; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; Dabire KR, 2009, TROP MED INT HEALTH, V14, P396, DOI 10.1111/j.1365-3156.2009.02243.x; Dabire RK, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-127; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; Diabate A, 2004, TROP MED INT HEALTH, V9, P1267, DOI 10.1111/j.1365-3156.2004.01336.x; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Djegbe I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-261; Djogbenou L, 2008, AM J TROP MED HYG, V78, P298, DOI 10.4269/ajtmh.2008.78.298; Djogbenou L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002172; ELISSA N, 1993, ANN SOC BELG MED TR, V73, P291; Fanello C, 2000, T R SOC TROP MED HYG, V94, P132; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Gillies M, 1987, PUBL S AFRI CAN I ME, V55, P1; Guillet P, 2001, MED VET ENTOMOL, V15, P105, DOI 10.1046/j.1365-2915.2001.00288.x; Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x; Henry MC, 2005, AM J TROP MED HYG, V73, P859, DOI 10.4269/ajtmh.2005.73.859; Jones CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045995; Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; N'Guessan R, 2003, MED VET ENTOMOL, V17, P19, DOI 10.1046/j.1365-2915.2003.00406.x; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Namountougou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048412; Namountougou M, 2013, ACTA TROP, V125, P123, DOI 10.1016/j.actatropica.2012.10.012; Osse R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-163; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; Scott JG, 1996, J PESTIC SCI, V21, P241; Verhaeghen K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-16; Weill M, 2000, INSECT MOL BIOL, V9, P451, DOI 10.1046/j.1365-2583.2000.00206.x; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b	42	50	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e101484	10.1371/journal.pone.0101484	http://dx.doi.org/10.1371/journal.pone.0101484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077792	Green Published, Green Accepted, gold			2022-12-25	WOS:000339954800005
J	Machado, FB; Machado, FB; Faria, MA; Lovatel, VL; da Silva, AFA; Radic, CP; De Brasi, CD; Rios, AFL; Lopes, SMCD; da Silveira, LS; Ruiz-Miranda, CR; Ramos, ES; Medina-Acosta, E				Machado, Filipe Brum; Machado, Fabricio Brum; Faria, Milena Amendro; Lovatel, Viviane Lamim; Alves da Silva, Antonio Francisco; Pamela Radic, Claudia; Daniel De Brasi, Carlos; Lopes Rios, Alvaro Fabricio; Lopes, Susana Marina Chuva de Sousa; da Silveira, Leonardo Serafim; Ruiz-Miranda, Carlos Ramon; Ramos, Ester Silveira; Medina-Acosta, Enrique			5(me)CpG Epigenetic Marks Neighboring a Primate-Conserved Core Promoter Short Tandem Repeat Indicate X-Chromosome Inactivation	PLOS ONE			English	Article							ANDROGEN-RECEPTOR GENE; CAG REPEAT; DNA; METHYLATION; ESCAPE; LOCI; IDENTIFICATION; POLYMORPHISM; MUTATIONS; EXPANSION	X-chromosome inactivation (XCI) is the epigenetic transcriptional silencing of an X-chromosome during the early stages of embryonic development in female eutherian mammals. XCI assures monoallelic expression in each cell and compensation for dosage-sensitive X-linked genes between females (XX) and males (XY). DNA methylation at the carbon-5 position of the cytosine pyrimidine ring in the context of a CpG dinucleotide sequence (5(me)CpG) in promoter regions is a key epigenetic marker for transcriptional gene silencing. Using computational analysis, we revealed an extragenic tandem GAAA repeat 230-bp from the landmark CpG island of the human X-linked retinitis pigmentosa 2 RP2 promoter whose 5(me)CpG status correlates with XCI. We used this RP2 onshore tandem GAAA repeat to develop an allele-specific 5(me)CpG-based PCR assay that is highly concordant with the human androgen receptor (AR) exonic tandem CAG repeat-based standard HUMARA assay in discriminating active (Xa) from inactive (Xi) X-chromosomes. The RP2 onshore tandem GAAA repeat contains neutral features that are lacking in the AR disease-linked tandem CAG repeat, is highly polymorphic (heterozygosity rates approximately 0.8) and shows minimal variation in the Xa/Xi ratio. The combined informativeness of RP2/AR is approximately 0.97, and this assay excels at determining the 5(me)CpG status of alleles at the Xp (RP2) and Xq (AR) chromosome arms in a single reaction. These findings are relevant and directly translatable to nonhuman primate models of XCI in which the AR CAG-repeat is monomorphic. We conducted the RP2 onshore tandem GAAA repeat assay in the naturally occurring chimeric New World monkey marmoset (Callitrichidae) and found it to be informative. The RP2 onshore tandem GAAA repeat will facilitate studies on the variable phenotypic expression of dominant and recessive X-linked diseases, epigenetic changes in twins, the physiology of aging hematopoiesis, the pathogenesis of age-related hematopoietic malignancies and the clonality of cancers in human and nonhuman primates.	[Machado, Filipe Brum; Ramos, Ester Silveira] Univ Sao Paulo, Sch Med, Dept Genet, Sao Paulo, Brazil; [Machado, Fabricio Brum; Faria, Milena Amendro; Lovatel, Viviane Lamim; Alves da Silva, Antonio Francisco; Lopes Rios, Alvaro Fabricio; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Biotechnol Lab, Rio De Janeiro, Brazil; [Pamela Radic, Claudia; Daniel De Brasi, Carlos] Natl Acad Med, Inst Expt Med, Lab Mol Genet Hemophilia, Buenos Aires, DF, Argentina; [Lopes, Susana Marina Chuva de Sousa] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, South Holland, Netherlands; [da Silveira, Leonardo Serafim] Univ Estadual Norte Fluminense, Ctr Studies & Res Wildlife, Lab Anim Morphol & Pathol, Rio De Janeiro, Brazil; [Ruiz-Miranda, Carlos Ramon] Univ Estadual Norte Fluminense, Lab Environm Sci, Sect Studies Ethol Reintroduct & Conservat Wild A, Rio De Janeiro, Brazil; [Medina-Acosta, Enrique] Hosp Escola Alvaro Alvim, Mol Identificat & Diagnost Unit, Rio De Janeiro, Brazil	Universidade de Sao Paulo; Universidade Estadual do Norte Fluminense; Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense	Ramos, ES (corresponding author), Univ Sao Paulo, Sch Med, Dept Genet, Sao Paulo, Brazil.	esramos@fmrp.usp.br; quique@uenf.br	Ruiz-Miranda, Carlos R/A-4719-2008; Medina-Acosta, E./AAN-9724-2021; Ramos, Ester Silveira/E-3200-2019; Medina-Acosta, Enrique/G-3041-2010; Ruiz, Carlos R/I-4446-2016; Ruiz-Miranda, Carlos R/H-7308-2015; Rios, Álvaro Fabrício Lopes/AGN-5862-2022	Ruiz-Miranda, Carlos R/0000-0001-9786-5315; Medina-Acosta, E./0000-0002-2529-0548; Ramos, Ester Silveira/0000-0001-7253-2143; Medina-Acosta, Enrique/0000-0002-2529-0548; Ruiz-Miranda, Carlos R/0000-0001-7360-0304; De Brasi, Carlos Daniel/0000-0003-2379-4379; Lamim Lovatel, Viviane/0000-0001-8493-5855	FAPERJ; CNPq; FAPESP; CAPES-NUFFIC [302731/2009-1, E- 26/111.450/2012, E- 111.398/2013, E-26/111.788/2013, E-26/110.035/201]; CAPES	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES-NUFFIC(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The research leading to these results has received funding from FAPERJ (http://www.faperj.br), CNPq (http://www.cnpq.br), FAPESP (http://www.fapesp.br/en/), CAPES-NUFFIC (http://www.capes.gov.br/cooperacao-internacional/holanda/programa-capesnuffic), under grant agreements 302731/2009-1, E- 26/111.450/2012, E- 111.398/2013, E-26/111.788/2013, E-26/110.035/201, and graduate fellowships by FAPESP(FiBM), FAPERJ (FaBM and MAF), CAPES (VLL) and CNPq (AFAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Bacher J, 1998, PROFILES DNA, V2, P3; Batra R, 2010, HUM MOL GENET, V19, pR77, DOI 10.1093/hmg/ddq132; Beever C, 2003, AM J MED GENET A, V120A, P439, DOI 10.1002/ajmg.a.20045; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berletch JB, 2011, HUM GENET, V130, P237, DOI 10.1007/s00439-011-1011-z; Berletch JB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-213; Bertelsen B, 2011, J MOL DIAGN, V13, P537, DOI 10.1016/j.jmoldx.2011.05.003; Bird A, 2011, J MOL BIOL, V409, P47, DOI 10.1016/j.jmb.2011.01.056; Busque L, 1996, BLOOD, V88, P59; Busque L, 2009, BLOOD, V113, P3472, DOI 10.1182/blood-2008-12-195677; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Choong CS, 1998, J MOL EVOL, V47, P334, DOI 10.1007/PL00006391; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Gu ML, 2012, MOL BIOL REP, V39, P2615, DOI 10.1007/s11033-011-1014-9; HENDRIKS RW, 1992, HUM MOL GENET, V1, P187, DOI 10.1093/hmg/1.3.187; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Ji JP, 1996, NUCLEIC ACIDS RES, V24, P2835, DOI 10.1093/nar/24.14.2835; Kar S, 2012, EPIGENETICS-US, V7, P994, DOI 10.4161/epi.21568; Kawaji H, 2011, NUCLEIC ACIDS RES, V39, pD856, DOI 10.1093/nar/gkq1112; Kawaji H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r40; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Machado FB, 2011, HAEMOPHILIA, V17, P257, DOI 10.1111/j.1365-2516.2010.02404.x; Machado FB, 2009, HAEMOPHILIA, V15, P1135, DOI 10.1111/j.1365-2516.2009.02056.x; Machado FB, 2009, HAEMOPHILIA, V15, P297, DOI 10.1111/j.1365-2516.2008.01866.x; Mossner M, 2013, J MED GENET, V50, P108, DOI 10.1136/jmedgenet-2012-101093; Mubiru JN, 2012, J MED PRIMATOL, V41, P67, DOI 10.1111/j.1600-0684.2011.00517.x; Ohadi M, 2012, GENE, V507, P61, DOI 10.1016/j.gene.2012.07.001; Pessia E, 2012, P NATL ACAD SCI USA, V109, P5346, DOI 10.1073/pnas.1116763109; Radic CP, 2009, PRENATAL DIAG, V29, P1183, DOI 10.1002/pd.2393; Ranum LPW, 2002, CURR OPIN GENET DEV, V12, P266, DOI 10.1016/S0959-437X(02)00297-6; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rossetti LC, 2008, J THROMB HAEMOST, V6, P830, DOI 10.1111/j.1538-7836.2008.02926.x; Sales ID, 2010, VET PARASITOL, V171, P123, DOI 10.1016/j.vetpar.2010.02.044; Sambrook J, 2001, MOL CLONING LAB MANU; Santacroce R, 2008, J HUM GENET, V53, P275, DOI 10.1007/s10038-007-0238-y; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Sharp AJ, 2011, GENOME RES, V21, P1592, DOI 10.1101/gr.112680.110; Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178; Sin HS, 2013, EPIGENETICS-US, V8, P887, DOI 10.4161/epi.25672; Sweeney CG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-98; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	51	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103714	10.1371/journal.pone.0103714	http://dx.doi.org/10.1371/journal.pone.0103714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078280	Green Published, gold, Green Submitted			2022-12-25	WOS:000339954800068
J	Bartels, T; Kim, NC; Luth, ES; Selkoe, DJ				Bartels, Tim; Kim, Nora C.; Luth, Eric S.; Selkoe, Dennis J.			N-Alpha-Acetylation of alpha-Synuclein Increases Its Helical Folding Propensity, GM1 Binding Specificity and Resistance to Aggregation	PLOS ONE			English	Article							LIPID-PEPTIDE INTERACTIONS; PARKINSONS-DISEASE; MEMBRANE INTERACTIONS; TERMINAL ACETYLATION; FIBRIL FORMATION; PACKING DEFECTS; IN-VITRO; GANGLIOSIDE; THERMODYNAMICS; TETRAMER	A switch in the conformational properties of alpha-synuclein (alpha S) is hypothesized to be a key step in the pathogenic mechanism of Parkinson's disease (PD). Whereas the beta-sheet-rich state of alpha S has long been associated with its pathological aggregation in PD, a partially alpha-helical state was found to be related to physiological lipid binding; this suggests a potential role of the alpha-helical state in controlling synaptic vesicle cycling and resistance to beta-sheet rich aggregation. N-terminal acetylation is the predominant post-translational modification of mammalian alpha S. Using circular dichroism, isothermal titration calorimetry, and fluorescence spectroscopy, we have analyzed the effects of N-terminal acetylation on the propensity of recombinant human alpha S to form the two conformational states in interaction with lipid membranes. Small unilamellar vesicles of negatively charged lipids served as model membranes. Consistent with previous NMR studies using phosphatidylserine, we found that membrane-induced alpha-helical folding was enhanced by N-terminal acetylation and that greater exothermic heat could be measured upon vesicle binding of the modified protein. Interestingly, the folding and lipid binding enhancements with phosphatidylserine in vitro were weak when compared to that of alpha S with GM1, a lipid enriched in presynaptic membranes. The resultant increase in helical folding propensity of N-acetylated alpha S enhanced its resistance to aggregation. Our findings demonstrate the significance of the extreme N-terminus for folding nucleation, for relative GM1 specificity of alpha S-membrane interaction, and for a protective function of N-terminal-acetylation against alpha S aggregation mediated by GM1.	[Bartels, Tim] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bartels, T (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	tbartels@partners.org	Bartels, Tim/AAD-6128-2021	Bartels, Tim/0000-0002-4071-5612	Harvard NeuroDiscovery Center (HNDC Pilot Award); Parkinson's Disease Foundation [PDF-IRG-1204]; Fidelity Biosciences Research Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083845] Funding Source: NIH RePORTER	Harvard NeuroDiscovery Center (HNDC Pilot Award); Parkinson's Disease Foundation; Fidelity Biosciences Research Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Harvard NeuroDiscovery Center (HNDC 2012 Pilot Award) and the Parkinson's Disease Foundation (PDF-IRG-1204) to TB and the Fidelity Biosciences Research Initiative to DJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Bevington P. R., 1969, DATA REDUCTION ERROR; Bodner CR, 2009, J MOL BIOL; Burre J, 2013, NATURE, V498, pE4, DOI 10.1038/nature12125; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; DeWitt DC, 2013, BIOCHEMISTRY-US, V52, P2385, DOI 10.1021/bi4002369; Dikiy I, 2014, J BIOL CHEM, V289, P3652, DOI 10.1074/jbc.M113.512459; Fauvet B, 2012, J BIOL CHEM, V287, P28243, DOI 10.1074/jbc.M112.383711; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Johnson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015801; Kamp F, 2006, J BIOL CHEM, V281, P9251, DOI 10.1074/jbc.M512292200; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Leftin A, 2013, J MOL BIOL, V425, P2973, DOI 10.1016/j.jmb.2013.04.002; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P5004, DOI 10.1021/bi300642h; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Moriarty GM, 2013, FEBS LETT, V587, P1128, DOI 10.1016/j.febslet.2013.02.049; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Ohrfelt A, 2011, NEUROCHEM RES, V36, P2029, DOI 10.1007/s11064-011-0527-x; Ouberai MM, 2013, J BIOL CHEM, V288, P20883, DOI 10.1074/jbc.M113.478297; Perlmutter JD, 2009, J BIOL CHEM, V284, P7177, DOI 10.1074/jbc.M808895200; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Roze E, 2005, MOVEMENT DISORD, V20, P1366, DOI 10.1002/mds.20593; Schneider JS, 2013, J NEUROL SCI, V324, P140, DOI 10.1016/j.jns.2012.10.024; Schneider JS, 2010, J NEUROL SCI, V292, P45, DOI 10.1016/j.jns.2010.02.009; SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; Vamvaca K., 2009, J MOL BIOL; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Westphal CH, 2013, J BIOL CHEM, V288, P1829, DOI 10.1074/jbc.M112.418871; Wu GS, 2012, J NEUROSCI RES, V90, P1997, DOI 10.1002/jnr.23090; Wu GS, 2011, NEUROCHEM RES, V36, P1706, DOI 10.1007/s11064-011-0437-y; Zhu M, 2003, J BIOL CHEM, V278, P16873, DOI 10.1074/jbc.M210136200	48	102	105	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103727	10.1371/journal.pone.0103727	http://dx.doi.org/10.1371/journal.pone.0103727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075858	Green Submitted, Green Published, gold			2022-12-25	WOS:000340028800075
J	Calabro, SR; Maczurek, AE; Morgan, AJ; Tu, T; Wen, VW; Yee, C; Mridha, A; Lee, M; d'Avigdor, W; Locarnini, SA; McCaughan, GW; Warner, FJ; McLennan, SV; Shackel, NA				Calabro, Sarah R.; Maczurek, Annette E.; Morgan, Alison J.; Tu, Thomas; Wen, Victoria W.; Yee, Christine; Mridha, Auvro; Lee, Maggie; d'Avigdor, William; Locarnini, Stephen A.; McCaughan, Geoffrey W.; Warner, Fiona J.; McLennan, Susan V.; Shackel, Nicholas A.			Hepatocyte Produced Matrix Metalloproteinases Are Regulated by CD147 in Liver Fibrogenesis	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; HEPATITIS-C VIRUS; CELLS IN-VITRO; HEPATOCELLULAR-CARCINOMA; RHEUMATOID-ARTHRITIS; TISSUE INHIBITOR; INDUCER EMMPRIN; 4-AMINOPHENYLMERCURIC ACETATE; IMMUNOGLOBULIN SUPERFAMILY; MONOCLONAL-ANTIBODIES	Background: The classical paradigm of liver injury asserts that hepatic stellate cells (HSC) produce, remodel and turnover the abnormal extracellular matrix (ECM) of fibrosis via matrix metalloproteinases (MMPs). In extrahepatic tissues MMP production is regulated by a number of mechanisms including expression of the glycoprotein CD147. Previously, we have shown that CD147 is expressed on hepatocytes but not within the fibrotic septa in cirrhosis [1]. Therefore, we investigated if hepatocytes produce MMPs, regulated by CD147, which are capable of remodelling fibrotic ECM independent of the HSC. Methods: Non-diseased, fibrotic and cirrhotic livers were examined for MMP activity and markers of fibrosis in humans and mice. CD147 expression and MMP activity were co-localised by in-situ zymography. The role of CD147 was studied in-vitro with siRNA to CD147 in hepatocytes and in-vivo in mice with CCl4 induced liver injury using a CD147 antibody intervention. Results: In liver fibrosis in both human and mouse tissue MMP expression and activity (MMP-2, -9, -13 and -14) increased with progressive injury and localised to hepatocytes. Additionally, as expected, MMPs were abundantly expressed by activated HSC. Further, with progressive fibrosis there was expression of CD147, which localised to hepatocytes but not to HSC. Functionally significant in-vitro regulation of hepatocyte MMP production by CD147 was demonstrated using siRNA to CD147 that decreased hepatocyte MMP-2 and -9 expression/activity. Further, in-vivo alpha-CD147 antibody intervention decreased liver MMP-2, -9, -13, -14, TGF-beta and alpha-SMA expression in CCl4 treated mice compared to controls. Conclusion: We have shown that hepatocytes produce active MMPs and that the glycoprotein CD147 regulates hepatocyte MMP expression. Targeting CD147 regulates hepatocyte MMP production both in-vitro and in-vivo, with the net result being reduced fibrotic matrix turnover in-vivo. Therefore, CD147 regulation of hepatocyte MMP is a novel pathway that could be targeted by future anti-fibrogenic agents.	[Calabro, Sarah R.; Maczurek, Annette E.; Morgan, Alison J.; Tu, Thomas; Wen, Victoria W.; Yee, Christine; Lee, Maggie; d'Avigdor, William; Warner, Fiona J.; Shackel, Nicholas A.] Centenary Inst, Sydney, NSW, Australia; [Calabro, Sarah R.; Maczurek, Annette E.; Morgan, Alison J.; Tu, Thomas; Wen, Victoria W.; Yee, Christine; Mridha, Auvro; Lee, Maggie; d'Avigdor, William; McCaughan, Geoffrey W.; Warner, Fiona J.; McLennan, Susan V.; Shackel, Nicholas A.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Locarnini, Stephen A.] Victorian Infect Dis Lab, Melbourne, Vic, Australia; [McLennan, Susan V.] Royal Prince Alfred Hosp, Dept Endocrinol, Sydney, NSW, Australia; [McCaughan, Geoffrey W.; Shackel, Nicholas A.] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia	University of Sydney; Centenary Institute; University of Sydney; Victorian Infectious Diseases Reference Laboratory; University of Sydney; University of Sydney	Shackel, NA (corresponding author), Centenary Inst, Sydney, NSW, Australia.	n.shackel@centenary.usyd.edu.au	Tu, Thomas/H-2894-2019	Tu, Thomas/0000-0002-0482-4387; Mridha, Auvro/0000-0001-5045-6899; MCCAUGHAN, GEOFFREY/0000-0002-1483-1636; Yee, Christine/0000-0001-7243-5634	NHMRC [571408, 512283, 1063515, 1009815]; University of Sydney Australian Postgraduate Awards; Rebecca L Cooper Medical Foundation	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney Australian Postgraduate Awards; Rebecca L Cooper Medical Foundation	This research was funded by NHMRC grants 571408, 512283, 1063515 and 1009815. SC and AM were supported by University of Sydney Australian Postgraduate Awards and W. d'A by a scholarship from the Rebecca L Cooper Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SM, 2011, BBA-MOL BASIS DIS, V1812, P213, DOI 10.1016/j.bbadis.2010.07.018; Arthur MJP, 1998, DIGESTION, V59, P376, DOI 10.1159/000007492; ARTHUR MJP, 1994, PATHOL RES PRACT, V190, P825; ARTHUR MJP, 1990, SEMIN LIVER DIS, V10, P47, DOI 10.1055/s-2008-1040456; Arthur MJP, 1997, HEPATOLOGY, V26, P1069, DOI 10.1002/hep.510260440; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2005, HEPATOLOGY, V41, P1046, DOI 10.1002/hep.20665; Bertolino P, 1998, EUR J IMMUNOL, V28, P221, DOI 10.1002/(SICI)1521-4141(199801)28:01<221::AID-IMMU221>3.3.CO;2-6; Betsuyaku T, 2003, AM J RESP CELL MOL, V28, P600, DOI 10.1165/rcmb.2002-0059OC; Cho JY, 2001, BLOOD, V98, P374, DOI 10.1182/blood.V98.2.374; Egawa N, 2006, J BIOL CHEM, V281, P37576, DOI 10.1074/jbc.M606993200; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Garcia-Irigoyen O, 2013, LIVER INT; Guillot S, 2006, EXP LUNG RES, V32, P81, DOI 10.1080/01902140600710512; Hamzavi J, 2008, J CELL MOL MED, V12, P2130, DOI 10.1111/j.1582-4934.2008.00262.x; Han YP, 2006, J GASTROEN HEPATOL, V21, pS88, DOI 10.1111/j.1440-1746.2006.04586.x; Haruyama T, 2000, BIOCHEM BIOPH RES CO, V272, P681, DOI 10.1006/bbrc.2000.2837; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Henkel C, 2005, Z GASTROENTEROL, V43, P23, DOI 10.1055/s-2004-813911; Hou Q, 2011, CANCER SCI, V102, P1287, DOI 10.1111/j.1349-7006.2011.01933.x; HOWE RC, 1988, J IMMUNOL, V140, P1047; Igakura T, 1998, DEV BIOL, V194, P152, DOI 10.1006/dbio.1997.8819; Ikeda M, 1998, VIRUS RES, V56, P157, DOI 10.1016/S0168-1702(98)00063-X; Iredale JP, 2013, BBA-MOL BASIS DIS, V1832, P876, DOI 10.1016/j.bbadis.2012.11.002; Iredale JP, 1997, INT J BIOCHEM CELL B, V29, P43, DOI 10.1016/S1357-2725(96)00118-5; ITOH Y, 1995, BIOCHEM J, V308, P645, DOI 10.1042/bj3080645; Jia L, 2008, CANCER INVEST, V26, P977, DOI 10.1080/07357900802072723; JOSEPH J, 1993, ADV EXP MED BIOL, V342, P389; Kasinrerk W, 1999, IMMUNOLOGY, V96, P184; Knittel T, 1999, J HEPATOL, V30, P48, DOI 10.1016/S0168-8278(99)80007-5; Kuno N, 1998, FEBS LETT, V425, P191, DOI 10.1016/S0014-5793(98)00213-0; Leon MDG, 2006, EXP MOL PATHOL, V80, P97, DOI 10.1016/j.yexmp.2005.03.008; MACDONALD HR, 1985, J IMMUNOL, V135, P3944; Matsumoto G, 2002, J IMMUNOL, V169, P7087, DOI 10.4049/jimmunol.169.12.7087; McLennan SV, 2012, J HEPATOL; Min DQ, 2006, ELECTROPHORESIS, V27, P357, DOI 10.1002/elps.200500484; Noguchi M, 1996, IN VITRO CELL DEV-AN, V32, P135; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; Ohteki T, 1999, J IMMUNOL, V162, P3753; Paizis G, 2005, GUT, V54, P1790, DOI 10.1136/gut.2004.062398; Pinzani M, 2004, DIGEST LIVER DIS, V36, P231, DOI 10.1016/j.dld.2004.01.003; Pushkarsky T, 2001, P NATL ACAD SCI USA, V98, P6360, DOI 10.1073/pnas.111583198; Roeb E, 2005, WORLD J GASTROENTERO, V11, P1096, DOI 10.3748/wjg.v11.i8.1096; Sawanyawisuth K, 2012, ASIAN PAC J CANCER P, V13, P89, DOI 10.7314/APJCP.2012.13.KKSuppl.89; Serandour AL, 2005, HEPATOLOGY, V41, P478, DOI 10.1002/hep.20602; Shackel NA, 2001, GUT, V49, P565, DOI 10.1136/gut.49.4.565; Shackel NA, 2002, AM J PATHOL, V160, P641, DOI 10.1016/S0002-9440(10)64884-5; Shi ZD, 1997, P NATL ACAD SCI USA, V94, P10663, DOI 10.1073/pnas.94.20.10663; Tang J, 2012, CELL DEATH DIFFER, V19, P1779, DOI 10.1038/cdd.2012.60; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; Tang Y, 2004, MOL CANCER RES, V2, P73; Thomas JA, 2011, HEPATOLOGY; Tomita T, 2002, ARTHRITIS RHEUM, V46, P373, DOI 10.1002/art.10050; Toole BP, 2003, CURR TOP DEV BIOL, V54, P371, DOI 10.1016/S0070-2153(03)54015-7; Treese C, 2008, CYTOM PART A, V73A, P351, DOI 10.1002/cyto.a.20532; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Veidal SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024753; Wang CH, 2011, J CELL MOL MED, V15, P850, DOI 10.1111/j.1582-4934.2010.01084.x; Watanabe T, 2001, J HEPATOL, V35, P465, DOI 10.1016/S0168-8278(01)00177-5; Xu Q, 2002, INFLAMM RES, V51, P44, DOI 10.1007/PL00000281; Yan L, 2005, THROMB HAEMOSTASIS, V93, P199, DOI 10.1160/TH04-08-0536; Yoshiji H, 2002, HEPATOLOGY, V36, P850, DOI 10.1053/jhep.2002.35625; Zhanet DW, 2012, J HEPATOL, V57, P1283, DOI 10.1016/j.jhep.2012.07.042; Zhang DW, 2012, J HEPATOL; Zhao P, 2010, CANCER SCI, V101, P387, DOI 10.1111/j.1349-7006.2009.01420.x; Zhu P, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1899	66	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e90571	10.1371/journal.pone.0090571	http://dx.doi.org/10.1371/journal.pone.0090571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076423	Green Published, Green Submitted, gold			2022-12-25	WOS:000340028800001
J	Ferrara, MA; Dardano, P; De Stefano, L; Rea, I; Coppola, G; Rendina, I; Congestri, R; Antonucci, A; De Stefano, M; De Tommasi, E				Ferrara, Maria Antonietta; Dardano, Principia; De Stefano, Luca; Rea, Ilaria; Coppola, Giuseppe; Rendina, Ivo; Congestri, Roberta; Antonucci, Alessandra; De Stefano, Mario; De Tommasi, Edoardo			Optical Properties of Diatom Nanostructured Biosilica in Arachnoidiscus sp: Micro-Optics from Mother Nature	PLOS ONE			English	Article							SILICA	Some natural structures show three-dimensional morphologies on the micro-and nano-scale, characterized by levels of symmetry and complexity well far beyond those fabricated by best technologies available. This is the case of diatoms, unicellular microalgae, whose protoplasm is enclosed in a nanoporous microshell, made of hydrogenated amorphous silica, called frustule. We have studied the optical properties of Arachnoidiscus sp. single valves both in visible and ultraviolet range. We found photonic effects due to diffraction by ordered pattern of pores and slits, accordingly to an elaborated theoretical model. For the first time, we experimentally revealed spatial separation of focused light in different spots, which could be the basis of a micro-bio-spectrometer. Characterization of such intricate structures can be of great inspiration for photonic devices of next generation.	[Ferrara, Maria Antonietta; Dardano, Principia; De Stefano, Luca; Rea, Ilaria; Coppola, Giuseppe; Rendina, Ivo; De Tommasi, Edoardo] CNR, Dept Naples, Inst Microelect & Microsyst, I-80125 Naples, Italy; [Congestri, Roberta] Univ Roma Tor Vergata, Dept Biol, Lab Biol Algae, I-00173 Rome, Italy; [Antonucci, Alessandra; De Stefano, Mario] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per la Microelettronica e Microsistemi (IMM-CNR); University of Rome Tor Vergata; Universita della Campania Vanvitelli	Ferrara, MA (corresponding author), CNR, Dept Naples, Inst Microelect & Microsyst, I-80125 Naples, Italy.	antonella.ferrara@na.imm.cnr.it	Coppola, Giuseppe/B-3991-2012; Rea, Ilaria/ABC-4892-2020; Antonucci, Alessandra/AAC-2135-2020; De Stefano, Luca/H-7103-2019; Ferrara, Maria Antonietta/E-5111-2016; Dardano, Principia/AFK-5115-2022; De Tommasi, Edoardo/B-7365-2015; Dardano, Principia/AAG-3720-2022; Rendina, Ivo/F-8266-2013	Coppola, Giuseppe/0000-0001-7139-3719; Rea, Ilaria/0000-0003-0568-9911; Antonucci, Alessandra/0000-0002-5456-5336; De Stefano, Luca/0000-0002-9442-4175; Ferrara, Maria Antonietta/0000-0001-5291-1373; De Tommasi, Edoardo/0000-0003-2030-4557; Rendina, Ivo/0000-0002-3861-373X; Dardano, Principia/0000-0002-0616-3914	Ministero Istruzione Universita e Ricerca (MIUR) Programma "Futuro in Ricerca'' FIRB [RBFR08QXL2/2008]	Ministero Istruzione Universita e Ricerca (MIUR) Programma "Futuro in Ricerca'' FIRB(Ministry of Education, Universities and Research (MIUR))	Funding provided by Ministero Istruzione Universita e Ricerca (MIUR) Programma "Futuro in Ricerca'' FIRB project RBFR08QXL2/2008 http://futuroinricerca.miur.it EDT MDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biro LP, 2011, LASER PHOTONICS REV, V5, P27, DOI 10.1002/lpor.200900018; Brown NE, 1993, ARACHNOIDISCUS ACCOU; De Stefano L, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2140087; De Stefano L, 2009, SUPERLATTICE MICROST, V46, P84, DOI 10.1016/j.spmi.2008.10.031; De Stefano L, 2007, OPT EXPRESS, V15, P18082, DOI 10.1364/OE.15.018082; De Tommasi E, 2010, OPT EXPRESS, V18, P12203, DOI 10.1364/OE.18.012203; De Tommasi E, 2008, P SPIE MICROOPTICS, V6992, P69920; Di Caprio G, 2012, J BIOPH, V5, P1, DOI DOI 10.1002/JBIO.201200198; Ehrlich PR, 1981, J RES LEPIDOPTERA, V20, P199; Gale DK, 2009, ADV FUNCT MATER, V19, P926, DOI 10.1002/adfm.200801137; Goodman J. W., 1996, INTRO FOURIER OPTICS; HADLEY GR, 1992, OPT LETT, V17, P1426, DOI 10.1364/OL.17.001426; Kammer M, 2010, ANAL BIOANAL CHEM, V398, P509, DOI 10.1007/s00216-010-3924-0; Kirk J.T.O., 2011, LIGHT PHOTOSYNTHESIS; Lettieri S, 2008, ADV FUNCT MATER, V18, P1257, DOI 10.1002/adfm.200701124; Mann D.G., 1990, DIATOMS BIOL MORPHOL, DOI 10.1017/S0025315400059245; Marmur A, 2004, LANGMUIR, V20, P3517, DOI 10.1021/la036369u; Milligan AJ, 2002, SCIENCE, V297, P1848, DOI 10.1126/science.1074958; NAZARATHY M, 1980, J OPT SOC AM, V70, P150, DOI 10.1364/JOSA.70.000150; Palik E.D, 1991, HDB OPTICAL CONSTANT, V2; Polini A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00607; Potyrailo RA, 2007, NAT PHOTONICS, V1, P123, DOI 10.1038/nphoton.2007.2; Pris AD, 2012, NAT PHOTONICS, V6, P195, DOI [10.1038/nphoton.2011.355, 10.1038/NPHOTON.2011.355]; Qin T, 2008, J NANOSCI NANOTECHNO, V8, P2392, DOI 10.1166/jnn.2008.241; Schmid A.M., 1976, NOVA HEDWIGIA, V28, P309; SCHMID AMM, 1979, PROTOPLASMA, V100, P267, DOI 10.1007/BF01279316; Setaro A, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768027; Wang C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01025; Yu LF, 2001, J OPT SOC AM A, V18, P1033, DOI 10.1364/JOSAA.18.001033	29	65	66	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103750	10.1371/journal.pone.0103750	http://dx.doi.org/10.1371/journal.pone.0103750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076045	gold, Green Submitted, Green Published			2022-12-25	WOS:000340028800077
J	Liu, YW; Huang, YT				Liu, Ya-Wei; Huang, Yi-Tsau			Inhibitory Effect of Tanshinone IIA on Rat Hepatic Stellate Cells	PLOS ONE			English	Article							SALVIANOLIC-ACID-B; TNF-ALPHA; LIVER; FIBROSIS; MILTIORRHIZA; ACTIVATION; EXPRESSION; RECEPTOR; MIGRATION; LIPOPOLYSACCHARIDE	Background: Anti-inflammation via inhibition of NF-kappa B pathways in hepatic stellate cells (HSCs) is one therapeutic approach to hepatic fibrosis. Tanshinone IIA (C19H18O3, Tan IIA) is a lipophilic diterpene isolated from Salvia miltiorrhiza Bunge, with reported anti-inflammatory activity. We tested whether Tan IIA could inhibit HSC activation. Materials and Methods: The cell line of rat hepatic stellate cells (HSC-T6) was stimulated with lipopolysaccharide (LPS) (100 ng/ml). Cytotoxicity was assessed by MTT assay. HSC-T6 cells were pretreated with Tan IIA (1, 3 and 10 mu M), then induced by LPS (100 ng/ml). NF-kappa B activity was evaluated by the luciferase reporter gene assay. Western blotting analysis was performed to measure NF-kappa B-p65, and phosphorylations of MAPKs (ERK, JNK, p38). Cell chemotaxis was assessed by both wound-healing assay and trans-well invasion assay. Quantitative real-time PCR was used to detect gene expression in HSC-T6 cells. Results: All concentrations of drugs showed no cytotoxicity against HSC-T6 cells. LPS stimulated NF-kappa B luciferase activities, nuclear translocation of NF-kappa B-p65, and phosphorylations of ERK, JNK and p38, all of which were suppressed by Tan IIA. In addition, Tan IIA significantly inhibited LPS-induced HSCs chemotaxis, in both wound-healing and trans-well invasion assays. Moreover, Tan IIA attenuated LPS-induced mRNA expressions of CCL2, CCL3, CCL5, IL-1 beta, TNF-alpha, IL-6, ICAM-1, iNOS, and alpha-SMA in HSC-T6 cells. Conclusion: Our results demonstrated that Tan IIA decreased LPS-induced HSC activation.	[Liu, Ya-Wei; Huang, Yi-Tsau] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan; [Huang, Yi-Tsau] Minist Hlth & Welf, Natl Res Inst Chinese Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Research Institute of Chinese Medicine	Huang, YT (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan.	huangyt@nricm.edu.tw			National Science Council [NSC99-2628-B-077-001-MY3, NSC-102-2320-B-077-001]; National Research Institute of Chinese Medicine in Taiwan [NRICM99-DBCM-05]	National Science Council(Ministry of Science and Technology, Taiwan); National Research Institute of Chinese Medicine in Taiwan	This work was supported by the National Science Council (NSC99-2628-B-077-001-MY3, NSC-102-2320-B-077-001) and the National Research Institute of Chinese Medicine (NRICM99-DBCM-05) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonacchi A, 2003, GASTROENTEROLOGY, V125, P1060, DOI 10.1016/S0016-5085(03)01194-6; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chen HJ, 2013, J ETHNOPHARMACOL, V150, P835, DOI 10.1016/j.jep.2013.08.049; Chen YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040165; Chen YH, 2001, J CELL BIOCHEM, V82, P512, DOI 10.1002/jcb.1176; Choi HS, 2004, ARCH PHARM RES, V27, P1233, DOI 10.1007/BF02975887; Fan GW, 2009, J STEROID BIOCHEM, V113, P275, DOI 10.1016/j.jsbmb.2009.01.011; Feng Yibin, 2009, Chin Med, V4, P16, DOI 10.1186/1749-8546-4-16; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Friedman SL, 2012, P NATL ACAD SCI USA, V109, P9230, DOI 10.1073/pnas.1206645109; Gao B, 2011, AM J PHYSIOL-GASTR L, V300, pG516, DOI 10.1152/ajpgi.00537.2010; Han JY, 2008, PHARMACOL THERAPEUT, V117, P280, DOI 10.1016/j.pharmthera.2007.09.008; Hsu CJ, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-68; Hsu YC, 2005, J BIOMED SCI, V12, P185, DOI 10.1007/s11373-004-8167-7; Hsu YC, 2007, J GASTROEN HEPATOL, V22, P99, DOI 10.1111/j.1440-1746.2006.04361.x; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Huang XY, 2009, J CANCER RES CLIN, V135, P1245, DOI 10.1007/s00432-009-0566-8; Inokuchi S, 2011, ALCOHOL CLIN EXP RES, V35, P1509, DOI 10.1111/j.1530-0277.2011.01487.x; Jang SI, 2003, PLANTA MED, V69, P1057, DOI 10.1055/s-2003-45157; Joe Y, 2012, J PHARMACOL EXP THER, V341, P850, DOI 10.1124/jpet.111.190736; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kong XN, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00069; Kuo YF, 2006, J PHARM PHARMACOL, V58, P521, DOI 10.1211/jpp.58.4.0012; Lee TF, 2011, LIVER INT, V31, P618, DOI 10.1111/j.1478-3231.2011.02485.x; Lee TY, 2003, J PHARMACOL SCI, V91, P202, DOI 10.1254/jphs.91.202; Lee Y, 2010, PROG MOL BIOL TRANSL, V97, P151, DOI 10.1016/B978-0-12-385233-5.00006-4; Lin YL, 2006, J ETHNOPHARMACOL, V105, P215, DOI 10.1016/j.jep.2005.10.021; Lin YL, 2009, J GASTROEN HEPATOL, V24, P453, DOI 10.1111/j.1440-1746.2008.05573.x; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Marra F, 2004, AM J PHYSIOL-GASTR L, V287, pG18, DOI 10.1152/ajpgi.00336.2003; Novo E, 2007, AM J PATHOL, V170, P1942, DOI 10.2353/ajpath.2007.060887; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Parajuli DR, 2013, MOLECULES, V18, P2122, DOI 10.3390/molecules18022122; Pradere JP, 2013, HEPATOLOGY; Schrimpf C, 2011, CURR OPIN NEPHROL HY, V20, P297, DOI 10.1097/MNH.0b013e328344c3d4; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Ueng YF, 2004, LIFE SCI, V74, P885, DOI 10.1016/j.lfs.2003.07.035; Vogel S, 2000, J LIPID RES, V41, P882; Wang B, 2009, J HEPATOL, V51, P1037, DOI 10.1016/j.jhep.2009.06.020; Weng TC, 2012, PHYTOTHER RES, V26, P344, DOI 10.1002/ptr.3539; Xu Y, 2008, J CLIN IMMUNOL, V28, P512, DOI 10.1007/s10875-008-9206-3; Yamamoto M, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/240365; Yeligar SM, 2009, J IMMUNOL, V183, P5964, DOI 10.4049/jimmunol.0901564; Yin HQ, 2008, ARCH PHARM RES, V31, P659, DOI 10.1007/s12272-001-1209-2; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zimmermann Henning W., 2011, Inflammation & Allergy Drug Targets, V10, P509	56	23	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103229	10.1371/journal.pone.0103229	http://dx.doi.org/10.1371/journal.pone.0103229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076488	Green Published, Green Submitted, gold			2022-12-25	WOS:000340028800031
J	Yasuda, K; Watkins, AA; Kochar, GS; Wilson, GE; Laskow, B; Richez, C; Bonegio, RG; Rifkin, IR				Yasuda, Kei; Watkins, Amanda A.; Kochar, Guneet S.; Wilson, Gabriella E.; Laskow, Bari; Richez, Christophe; Bonegio, Ramon G.; Rifkin, Ian R.			Interferon Regulatory Factor-5 Deficiency Ameliorates Disease Severity in the MRL/lpr Mouse Model of Lupus in the Absence of a Mutation in DOCK2	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; RAC ACTIVATOR DOCK2; B-CELLS; GENETIC-VARIANTS; I INTERFERON; IRF5; ERYTHEMATOSUS; MICE; RISK; ASSOCIATION	Interferon regulatory factor 5 (IRF5) polymorphisms are strongly associated with an increased risk of developing the autoimmune disease systemic lupus erythematosus. In mouse lupus models, IRF5-deficiency was shown to reduce disease severity consistent with an important role for IRF5 in disease pathogenesis. However these mouse studies were confounded by the recent demonstration that the IRF5 knockout mouse line contained a loss-of-function mutation in the dedicator of cytokinesis 2 (DOCK2) gene. As DOCK2 regulates lymphocyte trafficking and Toll-like receptor signaling, this raised the possibility that some of the protective effects attributed to IRF5 deficiency in the mouse lupus models may instead have been due to DOCK2 deficiency. We have therefore here evaluated the effect of IRF5-deficiency in the MRL/lpr mouse lupus model in the absence of the DOCK2 mutation. We find that IRF5-deficient (IRF5(-/-)) MRL/lpr mice develop much less severe disease than their IRF5-sufficient (IRF5(+/+)) littermates. Despite markedly lower serum levels of anti-nuclear autoantibodies and reduced total splenocyte and CD4(+) T cell numbers, IRF5(-/-) MRL/lpr mice have similar numbers of all splenic B cell subsets compared to IRF5(+/+) MRL/lpr mice, suggesting that IRF5 is not involved in B cell development up to the mature B cell stage. However, IRF5(-/-) MRL/lpr mice have greatly reduced numbers of spleen plasmablasts and bone marrow plasma cells. Serum levels of B lymphocyte stimulator (BLyS) were markedly elevated in the MRL/lpr mice but no effect of IRF5 on serum BLyS levels was seen. Overall our data demonstrate that IRF5 contributes to disease pathogenesis in the MRL/lpr lupus model and that this is due, at least in part, to the role of IRF5 in plasma cell formation. Our data also suggest that combined therapy targeting both IRF5 and BLyS might be a particularly effective therapeutic approach in lupus.	[Yasuda, Kei; Watkins, Amanda A.; Kochar, Guneet S.; Wilson, Gabriella E.; Laskow, Bari; Richez, Christophe; Bonegio, Ramon G.; Rifkin, Ian R.] Boston Univ, Sch Med, Dept Med, Renal Sect, Boston, MA 02118 USA	Boston University	Yasuda, K (corresponding author), Boston Univ, Sch Med, Dept Med, Renal Sect, Boston, MA 02118 USA.	kyasuda@bu.edu; irifkin@bu.edu		Yasuda, Kei/0000-0002-6791-4531	National Institutes of Health [P01 AR050256, 1K01AR060857-01, R01 DK090558, T32DK007053, AI007309-23]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR060857, P01AR050256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007053, R01DK095058, R01DK090558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health (http://www.nih.gov/) (P01 AR050256 to I. R. R., 1K01AR060857-01 to K. Y., R01 DK090558 to R. G. B., T32DK007053 to K. Y. and AI007309-23 to A. A. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Baudino L, 2006, SPRINGER SEMIN IMMUN, V28, P175, DOI 10.1007/s00281-006-0037-0; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Borchers AT, 2012, AUTOIMMUN REV, V12, P174, DOI 10.1016/j.autrev.2012.08.018; Brink R, 2014, CURR OPIN IMMUNOL, V28, P97, DOI 10.1016/j.coi.2014.03.001; Bronson PG, 2012, CURR OPIN IMMUNOL, V24, P530, DOI 10.1016/j.coi.2012.07.008; Cash H, 2010, J RHEUMATOL, V37, P60, DOI 10.3899/jrheum.090194; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Couzinet A, 2008, P NATL ACAD SCI USA, V105, P2556, DOI 10.1073/pnas.0712295105; Douagi I, 2009, J IMMUNOL, V182, P1991, DOI 10.4049/jimmunol.0802257; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Feng D, 2012, EUR J IMMUNOL, V42, P1477, DOI 10.1002/eji.201141642; Feng D, 2010, ARTHRITIS RHEUM-US, V62, P562, DOI 10.1002/art.27223; Ferreiro-Neira I, 2007, GENES IMMUN, V8, P429, DOI 10.1038/sj.gene.6364407; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gotoh K, 2010, J EXP MED, V207, P721, DOI 10.1084/jem.20091776; Graham DSC, 2007, HUM MOL GENET, V16, P579, DOI 10.1093/hmg/ddl469; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Greenspan NS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-3; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Harley ITW, 2009, NAT REV GENET, V10, P285, DOI 10.1038/nrg2571; Hedl M, 2012, J IMMUNOL, V188, P5348, DOI 10.4049/jimmunol.1103319; Hu GD, 2009, J BIOL CHEM, V284, P2767, DOI 10.1074/jbc.M804744200; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lien CY, 2010, P NATL ACAD SCI USA, V107, P4664, DOI 10.1073/pnas.0911193107; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Panchanathan R, 2011, J IMMUNOL; Panchanathan R, 2013, MOL IMMUNOL, V53, P15, DOI 10.1016/j.molimm.2012.06.013; Paun A, 2008, J BIOL CHEM, V283, P14295, DOI 10.1074/jbc.M800501200; Purtha WE, 2012, P NATL ACAD SCI USA, V109, pE898, DOI 10.1073/pnas.1118155109; Richez C, 2010, J IMMUNOL, V184, P796, DOI 10.4049/jimmunol.0901748; Savitsky DA, 2010, P NATL ACAD SCI USA, V107, P10154, DOI 10.1073/pnas.1005599107; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Sigurdsson S, 2008, HUM MOL GENET, V17, P872, DOI 10.1093/hmg/ddm359; Steinhagen F, 2013, EUR J IMMUNOL, V43, P1896, DOI 10.1002/eji.201242792; Stohl W, 2012, NAT BIOTECHNOL, V30, P69, DOI 10.1038/nbt.2076; Tada Y, 2011, ARTHRITIS RHEUM-US, V63, P738, DOI 10.1002/art.30183; TAKAHASHI S, 1991, J IMMUNOL, V147, P515; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tanaka Y, 2007, NAT IMMUNOL, V8, P1067, DOI 10.1038/ni1506; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Xu Y, 2012, J IMMUNOL, V188, P4113, DOI 10.4049/jimmunol.1103113; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Yasuda K, 2007, J IMMUNOL, V178, P6876, DOI 10.4049/jimmunol.178.11.6876; Yasuda K, 2013, INT IMMUNOL, V25, P295, DOI 10.1093/intimm/dxs114	53	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103478	10.1371/journal.pone.0103478	http://dx.doi.org/10.1371/journal.pone.0103478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076492	gold, Green Published, Green Submitted			2022-12-25	WOS:000340028800051
J	Kawano, R; Tsuji, Y; Kamiya, K; Kodama, T; Osaki, T; Miki, N; Takeuchi, S				Kawano, Ryuji; Tsuji, Yutaro; Kamiya, Koki; Kodama, Taiga; Osaki, Toshihisa; Miki, Norihisa; Takeuchi, Shoji			A Portable Lipid Bilayer System for Environmental Sensing with a Transmembrane Protein	PLOS ONE			English	Article							MICROFLUIDIC DEVICE; CHIP	This paper describes a portable measurement system for current signals of an ion channel that is composed of a planar lipid bilayer. A stable and reproducible lipid bilayer is formed in outdoor environments by using a droplet contact method with a micropipette. Using this system, we demonstrated that the single-channel recording of a transmembrane protein (alpha-hemolysin) was achieved in the field at a high-altitude (similar to 3623 m). This system would be broadly applicable for obtaining environmental measurements using membrane proteins as a highly sensitive sensor.	[Kawano, Ryuji; Tsuji, Yutaro; Kamiya, Koki; Kodama, Taiga; Osaki, Toshihisa; Miki, Norihisa; Takeuchi, Shoji] KAST, Artificial Cell Membrane Syst Grp, Takatsu Ku, Kawasaki, Kanagawa, Japan; [Tsuji, Yutaro; Kodama, Taiga; Miki, Norihisa] Keio Univ, Dept Mech Engn, Kohoku Ku, Yokohama, Kanagawa 223, Japan; [Osaki, Toshihisa; Takeuchi, Shoji] Univ Tokyo, CIRMM IIS, Meguro Ku, Tokyo, Japan	Kanagawa Academy Science & Technology; Keio University; University of Tokyo	Takeuchi, S (corresponding author), KAST, Artificial Cell Membrane Syst Grp, Takatsu Ku, Kawasaki, Kanagawa, Japan.	takeuchi@iis.u-tokyo.ac.jp	Takeuchi, Shoji/J-5349-2019; Kawano, Ryuji/A-3177-2011; Kamiya, Koki/F-9889-2018; OSAKI, Toshihisa/F-3815-2012; Miki, Norihisa/F-7659-2014; Kamiya, Koki/AAL-6950-2020	Kawano, Ryuji/0000-0001-6523-0649; OSAKI, Toshihisa/0000-0003-1659-2541; Kamiya, Koki/0000-0001-9143-9841; Takeuchi, Shoji/0000-0001-6946-0409	MEXT (KAKENHI) in Japan [23107534, 24655072, 25708024, 25246071]	MEXT (KAKENHI) in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 23107534), Challenging Exploratory Research (No. 24655072), Young Scientists (A) (No. 25708024), and Scientific Research (A) (No. 25246071) from MEXT (KAKENHI) in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JN, 1997, ION CHANNELS, V207; Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Du LP, 2013, BIOSENS BIOELECTRON, V42, P570, DOI 10.1016/j.bios.2012.09.001; Funakoshi K, 2006, ANAL CHEM, V78, P8169, DOI 10.1021/ac0613479; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; Jeon TJ, 2008, LAB CHIP, V8, P1742, DOI 10.1039/b807932c; Kang XF, 2007, J AM CHEM SOC, V129, P4701, DOI 10.1021/ja068654g; Kawano R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01995; Kawano R, 2011, J AM CHEM SOC, V133, P8474, DOI 10.1021/ja2026085; Kawano R, 2010, SMALL, V6, P2100, DOI 10.1002/smll.201000997; Nielsen CH, 2009, ANAL BIOANAL CHEM, V395, P697, DOI 10.1007/s00216-009-2960-0; Sarles SA, 2010, LAB CHIP, V10, P710, DOI 10.1039/b916736f; Shim JW, 2007, ANAL CHEM, V79, P2207, DOI 10.1021/ac0614285; Tsuji Y, 2013, ANAL CHEM, V85, P10913, DOI 10.1021/ac402299z; Tsuji Y, 2013, LAB CHIP, V13, P1476, DOI 10.1039/c3lc41359d; WONDERLIN WF, 1990, BIOPHYS J, V58, P289, DOI 10.1016/S0006-3495(90)82376-6; Wu HC, 2008, J AM CHEM SOC, V130, P6813, DOI 10.1021/ja8004607	18	41	41	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e102427	10.1371/journal.pone.0102427	http://dx.doi.org/10.1371/journal.pone.0102427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072468	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600011
J	Moll, K; Kunze, S; Neuhoff, N; Bruder, J; Schulte-Koerne, G				Moll, Kristina; Kunze, Sarah; Neuhoff, Nina; Bruder, Jennifer; Schulte-Koerne, Gerd			Specific Learning Disorder: Prevalence and Gender Differences	PLOS ONE			English	Article							DEVELOPMENTAL DYSCALCULIA; READING-DISABILITY; COMORBIDITY; DIFFICULTIES; MATHEMATICS; DEFICITS; CHILDREN; PSYCHOPATHOLOGY; IMPAIRMENT; PRECURSORS	Comprehensive models of learning disorders have to consider both isolated learning disorders that affect one learning domain only, as well as comorbidity between learning disorders. However, empirical evidence on comorbidity rates including all three learning disorders as defined by DSM-5 (deficits in reading, writing, and mathematics) is scarce. The current study assessed prevalence rates and gender ratios for isolated as well as comorbid learning disorders in a representative sample of 1633 German speaking children in 3rd and 4th Grade. Prevalence rates were analysed for isolated as well as combined learning disorders and for different deficit criteria, including a criterion for normal performance. Comorbid learning disorders occurred as frequently as isolated learning disorders, even when stricter cutoff criteria were applied. The relative proportion of isolated and combined disorders did not change when including a criterion for normal performance. Reading and spelling deficits differed with respect to their association with arithmetic problems: Deficits in arithmetic co-occurred more often with deficits in spelling than with deficits in reading. In addition, comorbidity rates for arithmetic and reading decreased when applying stricter deficit criteria, but stayed high for arithmetic and spelling irrespective of the chosen deficit criterion. These findings suggest that the processes underlying the relationship between arithmetic and reading might differ from those underlying the relationship between arithmetic and spelling. With respect to gender ratios, more boys than girls showed spelling deficits, while more girls were impaired in arithmetic. No gender differences were observed for isolated reading problems and for the combination of all three learning disorders. Implications of these findings for assessment and intervention of learning disorders are discussed.	[Moll, Kristina; Kunze, Sarah; Neuhoff, Nina; Bruder, Jennifer; Schulte-Koerne, Gerd] Univ Munich, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany	University of Munich	Moll, K (corresponding author), Univ Munich, Dept Child & Adolescent Psychiat Psychosomat & Ps, Marchioninistr 15, Munich, Germany.	kristina.moll@gmail.com	Schulte-Körne, Gerd/AAI-4828-2021; Moll, Kristina/AAZ-1087-2021; Bruder, Jennifer/GLN-6445-2022	Schulte-Körne, Gerd/0000-0002-9960-1572; Bruder, Jennifer/0000-0002-3815-6313	European Community's EU [018696]	European Community's EU	The research leading to these results has received funding from the European Community's EU, within the context of the Sixth Framework Program LifeScienceHealth project "Dyslexia genes and neurobiological pathways'' (Neurodys, 018696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DSM 4; American Psychiatric Association, 2013, DSM 5; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1111/1469-7610.00424; Badian N. A., 1983, PROGR LEARNING DISAB, V5, P235; Badian NA, 1999, ANN DYSLEXIA, V49, P45; Barbaresi WJ, 2005, AMBUL PEDIATR, V5, P281, DOI 10.1367/A04-209R.1; Bishop DVM, 2008, J PAEDIATR CHILD H, V44, P520, DOI 10.1111/j.1440-1754.2008.01358.x; Bishop DVM, 2001, J CHILD PSYCHOL PSYC, V42, P189, DOI 10.1111/1469-7610.00710; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Bull R, 1997, J EXP CHILD PSYCHOL, V65, P1, DOI 10.1006/jecp.1996.2358; Cain K., 2010, READING DEV DIFFICUL; CARON C, 1991, J CHILD PSYCHOL PSYC, V32, P1063, DOI 10.1111/j.1469-7610.1991.tb00350.x; Dirks E, 2008, J LEARN DISABIL-US, V41, P460, DOI 10.1177/0022219408321128; Ehri L. C., 1992, RECONCEPTUALIZING DE; Ehri L. C., 1997, LEARNING SPELL RES T, P237; Fischbach A., 2013, LERNEN LERNSTORUNGEN, P65, DOI DOI 10.1024/2235-0977/A000035; Frith U., 1985, SURFACE DYSLEXIA, V32; Geary DC, 2001, APHASIOLOGY, V15, P635, DOI 10.1080/02687040143000113; GrossTsur V, 1996, DEV MED CHILD NEUROL, V38, P25, DOI 10.1111/j.1469-8749.1996.tb15029.x; Grund M, 2003, DRT 4 DIAGNOSTISCHER; Haffner J., 2005, HEIDELBERGER RECHENT; Helzer J.E., 2008, DIMENSIONAL APPROACH; HULME C, 1992, COGNITIVE NEUROPSYCH, V9, P47, DOI 10.1080/02643299208252052; Hulme C., 2013, DEV DISORDERS LANGUA; KLAUER KJ, 1992, Z ENTWICKL PADAGOGIS, V24, P48; Knopik VS, 1997, BEHAV GENET, V27, P447, DOI 10.1023/A:1025622400239; Kovas Y, 2007, J CHILD PSYCHOL PSYC, V48, P914, DOI 10.1111/j.1469-7610.2007.01748..x; LABERGE D, 1974, COGNITIVE PSYCHOL, V6, P293, DOI 10.1016/0010-0285(74)90015-2; Landerl K, 2013, TRENDS NEUROSCI EDUC, V2, P38, DOI 10.1016/j.tine.2013.06.002; Landerl K, 2010, J CHILD PSYCHOL PSYC, V51, P287, DOI 10.1111/j.1469-7610.2009.02164.x; LEWIS C, 1994, J CHILD PSYCHOL PSYC, V35, P283, DOI 10.1111/j.1469-7610.1994.tb01162.x; Mayringer H, 2003, SALZBURGER LESE SCRE; Moll K, 2014, LEARN INSTR, V29, P65, DOI 10.1016/j.learninstruc.2013.09.003; Moll K, 2009, SCI STUD READ, V13, P359, DOI 10.1080/10888430903162878; Muller R., 2004, DRT 3 DIAGNOSTISCHER; Murphy MM, 2007, J LEARN DISABIL-US, V40, P458, DOI 10.1177/00222194070400050901; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Perfetti C. A., 1997, PSYCHOLINGUISTICS SP; Perfetti C.A., 1985, READING ABILITY; Ramus F, 2008, Q J EXP PSYCHOL, V61, P129, DOI 10.1080/17470210701508822; Rutter M, 2004, JAMA-J AM MED ASSOC, V291, P2007, DOI 10.1001/jama.291.16.2007; Rutter M., 2006, GENES BEHAV; SIEGEL LS, 1989, J LEARN DISABIL-US, V22, P469, DOI 10.1177/002221948902200803; Siegel LS, 2003, IQ DISCREPANCY DEFIN; Snowling MJ, 2012, J CHILD PSYCHOL PSYC, V53, P593, DOI 10.1111/j.1469-7610.2011.02495.x; Snowling MJ, 2003, CHILD DEV, V74, P358, DOI 10.1111/1467-8624.7402003; von Aster M, 2007, Z ENTWICKL PADAGOGIS, V39, P85, DOI 10.1026/0049-8637.39.2.85; Willcutt EG, 2013, J LEARN DISABIL-US, V46, P500, DOI 10.1177/0022219413477476; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wimmer H, 2002, J EDUC PSYCHOL, V94, P272, DOI 10.1037//0022-0663.94.2.272; World Health Organisation, 1993, ICD 10 CLASS MENT BE	51	137	141	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103537	10.1371/journal.pone.0103537	http://dx.doi.org/10.1371/journal.pone.0103537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KU	25072465	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000341307600060
J	Polley, S; Jana, B; Chakrabarti, G; Sau, S				Polley, Soumitra; Jana, Biswanath; Chakrabarti, Gopal; Sau, Subrata			Inhibitor-Induced Conformational Stabilization and Structural Alteration of a Mip-Like Peptidyl Prolyl cis-trans Isomerase and Its C-Terminal Domain	PLOS ONE			English	Article							SINGLE TRYPTOPHAN MUTANTS; ESCHERICHIA-COLI; LEGIONELLA-PNEUMOPHILA; LIGAND-BINDING; CIS/TRANS-ISOMERASE; CHAPERONE ACTIVITY; GLOBULAR-PROTEINS; STABILITY; DENATURATION; RAPAMYCIN	FKBP22, an Escherichia coli-encoded PPIase (peptidyl-prolyl cis-trans isomerase) enzyme, shares substantial identity with the Mip-like pathogenic factors, caries two domains, exists as a dimer in solution and binds some immunosuppressive drugs (such as FK506 and rapamycin) using its C-terminal domain (CTD). To understand the effects of these drugs on the structure and stability of the Mip-like proteins, rFKBP22 (a chimeric FKBP22) and CTD+ (a CTD variant) have been studied in the presence and absence of rapamycin using different probes. We demonstrated that rapamycin binding causes minor structural alterations of rFKBP22 and CTD+. Both the proteins (equilibrated with rapamycin) were unfolded via the formation of intermediates in the presence of urea. Further study revealed that thermal unfolding of both rFKBP22 and rapamycin-saturated rFKBP22 occurred by a three-state mechanism with the synthesis of intermediates. Intermediate from the rapamycin-equilibrated rFKBP22 was formed at a comparatively higher temperature. All intermediates carried substantial extents of secondary and tertiary structures. Intermediate resulted from the thermal unfolding of rFKBP22 existed as the dimers in solution, carried an increased extent of hydrophobic surface and possessed relatively higher rapamycin binding activity. Despite the formation of intermediates, both the thermal and urea-induced unfolding reactions were reversible in nature. Unfolding studies also indicated the considerable stabilization of both proteins by rapamycin binding. The data suggest that rFKBP22 or CTD+ could be exploited to screen the rapamycin-like inhibitors in the future.	[Polley, Soumitra; Jana, Biswanath; Sau, Subrata] Bose Inst, Dept Biochem, Kolkata, India; [Chakrabarti, Gopal] Univ Calcutta, Dr BC Guha Ctr Genet Engn & Biotechnol, Kolkata, India	Department of Science & Technology (India); Bose Institute; University of Calcutta	Sau, S (corresponding author), Bose Inst, Dept Biochem, Kolkata, India.	subratasau@gmail.com	jana, biswanath/AAC-7540-2022	Jana, Biswanath/0000-0002-6464-7570; Polley, Soumitra/0000-0002-6337-7935	Bose Institute	Bose Institute(Department of Science & Technology (India))	The work was supported by the financial assistance from Bose Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M, 2000, ADV PROTEIN CHEM, V53, P209; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bowler BE, 2007, MOL BIOSYST, V3, P88, DOI 10.1039/b611895j; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Budiman C, 2009, FEBS J, V276, P4091, DOI 10.1111/j.1742-4658.2009.07116.x; Cashikar AG, 1996, J BIOL CHEM, V271, P4741, DOI 10.1074/jbc.271.9.4741; Celej MS, 2003, PROTEIN SCI, V12, P1496, DOI 10.1110/ps.0240003; Cellini B, 2006, BIOCHEMISTRY-US, V45, P14140, DOI 10.1021/bi061496l; Ceymann A, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-17; Chatterjee T, 2013, BIOCHIMIE, V95, P912, DOI 10.1016/j.biochi.2012.12.013; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; CONNELLY PR, 1992, P NATL ACAD SCI USA, V89, P4781, DOI 10.1073/pnas.89.11.4781; Creighton T.E., 1997, PROTEIN STRUCTURE PR; EGAN DA, 1993, BIOCHEMISTRY-US, V32, P1920, DOI 10.1021/bi00059a006; ENGLEBERG NC, 1989, INFECT IMMUN, V57, P1263, DOI 10.1128/IAI.57.4.1263-1270.1989; Gaudet M, 2010, PROTEIN SCI, V19, P1544, DOI 10.1002/pro.433; GOLDENBERG DP, 1984, ANAL BIOCHEM, V138, P1, DOI 10.1016/0003-2697(84)90761-9; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Horne SM, 1997, INFECT IMMUN, V65, P806, DOI 10.1128/IAI.65.2.806-810.1997; HORNE SM, 1995, ARCH MICROBIOL, V163, P357, DOI 10.1007/s002030050215; Jaenicke R, 2000, J BIOTECHNOL, V79, P193, DOI 10.1016/S0168-1656(00)00236-4; Jana B, 2012, BIOCHEMISTRY-US, V51, P7930, DOI 10.1021/bi300720g; Jana B, 2012, BIOCHEMISTRY-US, V51, P1223, DOI 10.1021/bi2015037; Kuntal Bhusan K, 2010, BMC Res Notes, V3, P226, DOI 10.1186/1756-0500-3-226; Kuznetsova IM, 2004, J PROTEOME RES, V3, P485, DOI 10.1021/pr034094y; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Leuzzi R, 2005, MOL MICROBIOL, V58, P669, DOI 10.1111/j.1365-2958.2005.04859.x; Liu CP, 2005, BIOCHIMIE, V87, P1023, DOI 10.1016/j.biochi.2005.03.017; Ludwig HC, 2007, FEBS J, V274, P5337, DOI 10.1111/j.1742-4658.2007.06059.x; LUNDEMOSE AG, 1993, MOL MICROBIOL, V7, P777, DOI 10.1111/j.1365-2958.1993.tb01168.x; Main ERG, 1999, J MOL BIOL, V291, P429, DOI 10.1006/jmbi.1999.2941; MATTHEWS BW, 1995, ADV PROTEIN CHEM, V46, P249, DOI 10.1016/S0065-3233(08)60337-X; MICHNICK SW, 1991, SCIENCE, V252, P836, DOI 10.1126/science.1709301; Mitra D, 2006, FEBS LETT, V580, P6846, DOI 10.1016/j.febslet.2006.11.042; MORO A, 1995, EMBO J, V14, P2483, DOI 10.1002/j.1460-2075.1995.tb07245.x; Naganathan AN, 2007, J AM CHEM SOC, V129, P5673, DOI 10.1021/ja0689740; Natalello A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042511; OLIVEBERG M, 1995, P NATL ACAD SCI USA, V92, P8926, DOI 10.1073/pnas.92.19.8926; Pace CN, 2000, PROTEINS, P1; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; Pal C, 2012, ANTIOXID REDOX SIGN, V17, P555, DOI 10.1089/ars.2011.4436; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; Rahfeld JU, 1996, J BIOL CHEM, V271, P22130, DOI 10.1074/jbc.271.36.22130; Ramm K, 2000, J BIOL CHEM, V275, P17106, DOI 10.1074/jbc.M910234199; Riboldi-Tunnicliffe A, 2001, NAT STRUCT BIOL, V8, P779, DOI 10.1038/nsb0901-779; ROYER CA, 1993, PROTEIN SCI, V2, P1844, DOI 10.1002/pro.5560021106; Sambrook J, 2001, MOL CLONING LAB MANU; Sancho J, 2013, ARCH BIOCHEM BIOPHYS, V531, P4, DOI 10.1016/j.abb.2012.10.014; Sandoz KM, 2012, ANTIMICROB AGENTS CH, V56, P4296, DOI 10.1128/AAC.00356-12; Saul FA, 2004, J MOL BIOL, V335, P595, DOI 10.1016/j.jmb.2003.10.056; Suzuki Y, 2005, FEBS J, V272, P632, DOI 10.1111/j.1742-4658.2004.04468.x; Suzuki Y, 2004, EUR J BIOCHEM, V271, P1372, DOI 10.1111/j.1432-1033.2004.04049.x; Thiem U, 2011, DRUG AGING, V28, P519, DOI 10.2165/11591980-000000000-00000; Unemo M, 2012, FUTURE MICROBIOL, V7, P1401, DOI [10.2217/fmb.12.117, 10.2217/FMB.12.117]; VANDUYNE GD, 1991, SCIENCE, V252, P839, DOI 10.1126/science.1709302; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Waldron TT, 2003, BIOCHEMISTRY-US, V42, P5058, DOI 10.1021/bi034212v; Zang N, 2007, MOL PLANT MICROBE IN, V20, P21, DOI 10.1094/MPMI-20-0021	59	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e102891	10.1371/journal.pone.0102891	http://dx.doi.org/10.1371/journal.pone.0102891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072141	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600017
J	Tsai, MJ; Fu, YS; Lin, YH; Huang, YB; Wu, PC				Tsai, Ming-Jun; Fu, Yaw-Syan; Lin, Yu-Hsuan; Huang, Yaw-Bin; Wu, Pao-Chu			The Effect of Nanoemulsion as a Carrier of Hydrophilic Compound for Transdermal Delivery	PLOS ONE			English	Article							DRUG-DELIVERY; PARKINSONS-DISEASE; SUBMICRON EMULSIONS; TOPICAL DELIVERY; SKIN PERMEATION; MICROEMULSIONS; DESIGN; FORMULATION; ROPINIROLE; LIPOSOMES	The purpose of the present study was to investigate the effect of nanoemulsions as a carrier vehicle of hydrophilic drug for transdermal delivery. The response surface methodology with a mixture design was used to evaluate the effect of ingredient levels of nanoemulsion formulations including cosurfactant (isopropyl alcohol, 20 similar to 30%), surfactant (mixed of Brij 30 and Brij 35, 20 similar to 30%), and distilled-water (34.5 similar to 50.0%) on properties of the drug-loaded nanoemulsions including physicochemical characters and drug permeability through rat skin. The result showed that the hydrophilic drug in aqueous solution with or without penetration enhancer could not transport across rat skin after 12 h of application. Used nanoemulsions as carrier vehicle, the permeation rate of drug was significantly increased from 0 to 63.23 mu g/cm(2)/h and the lag time was shortened from more than 12 h to about 2.7 similar to 4.0 h. Moreover, the drug-loaded nanoemulsion formulation also showed physicochemical stability after 3 month storage at 25 degrees C and 40 degrees C.	[Tsai, Ming-Jun] China Med Univ, Coll Med, Sch Med, Dept Neurol,China Med Univ Hosp, Taichung, Taiwan; [Tsai, Ming-Jun] Tainan Municipal An Nan Hosp, Dept Neurol, Tainan, Taiwan; [Fu, Yaw-Syan] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Lin, Yu-Hsuan; Huang, Yaw-Bin; Wu, Pao-Chu] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University	Wu, PC (corresponding author), Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan.	pachwu@kmu.edu.tw		Fu, Yaw-Syan/0000-0001-8715-9644; Huang, Yaw-Bin/0000-0002-6024-0108	National Science Council of Taiwan [NSC 102-2320-B-037-006-MY2, NSC101-2320-B-037-33]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a Grant from the National Science Council of Taiwan (NSC 102-2320-B-037-006-MY2 and NSC101-2320-B-037-33). The funders had no role in study design, data collection and analysis to publish, or preparation of the manuscript.	Alonso Canovas A, 2011, NEUROLOGIA; Aydogmus Z, 2008, SPECTROCHIM ACTA A, V70, P69, DOI 10.1016/j.saa.2007.07.012; Azeem A, 2009, AAPS PHARMSCITECH, V10, P1093, DOI 10.1208/s12249-009-9306-2; Azeem A, 2009, DRUG DEV IND PHARM, V35, P525, DOI 10.1080/03639040802448646; Azeem A, 2009, AAPS PHARMSCITECH, V10, P69, DOI 10.1208/s12249-008-9178-x; Brown MB, 2006, DRUG DELIV, V13, P175, DOI 10.1080/10717540500455975; Cevc G, 2004, ADV DRUG DELIVER REV, V56, P675, DOI 10.1016/j.addr.2003.10.028; Chen Y, 2012, MOLECULES, V17, P5972, DOI 10.3390/molecules17055972; El Maghraby GM, 2008, INT J PHARMACEUT, V355, P285, DOI 10.1016/j.ijpharm.2007.12.022; El Maghraby GM, 2013, DRUG DEV IND PHARM; Fang YP, 2009, EUR J PHARM BIOPHARM, V73, P391, DOI 10.1016/j.ejpb.2009.07.011; Fouad SA, 2013, INT J PHARMACEUT, V453, P569, DOI 10.1016/j.ijpharm.2013.06.009; Fuh JL, 1997, CLIN NEUROL NEUROSUR, V99, P106, DOI 10.1016/S0303-8467(97)00606-9; Heuschkel S, 2008, J PHARM SCI-US, V97, P603, DOI 10.1002/jps.20995; Kaye CM, 2000, CLIN PHARMACOKINET, V39, P243, DOI 10.2165/00003088-200039040-00001; Kim HM, 2012, INT J DERMATOL, V51, P859, DOI 10.1111/j.1365-4632.2011.05343.x; Kimura C, 2007, EUR J PHARM BIOPHARM, V67, P420, DOI 10.1016/j.ejpb.2007.02.022; Kogan A, 2006, ADV COLLOID INTERFAC, V123, P369, DOI 10.1016/j.cis.2006.05.014; Makraduli L, 2013, J MICROENCAPSUL, V30, P81, DOI 10.3109/02652048.2012.700957; Matheson AJ, 2000, DRUGS, V60, P115, DOI 10.2165/00003495-200060010-00007; Mostafa DM, 2014, DRUG DELIV, V21, P130, DOI 10.3109/10717544.2013.834419; Nair A, 2011, DRUG DELIV, V18, P19, DOI 10.3109/10717544.2010.509361; OSBORNE DW, 1991, J PHARM PHARMACOL, V43, P451, DOI 10.1111/j.2042-7158.1991.tb03511.x; Pabari RM, 2012, INT J PHARMACEUT, V430, P18, DOI 10.1016/j.ijpharm.2012.03.021; Peltola S, 2003, INT J PHARMACEUT, V254, P99, DOI 10.1016/S0378-5173(02)00632-4; Piemi MPY, 1999, J CONTROL RELEASE, V58, P177, DOI 10.1016/S0168-3659(98)00156-4; Raza K, 2011, J MICROENCAPSUL, V28, P190, DOI 10.3109/02652048.2010.546435; Ryan E, 2012, EUR J PHARM SCI, V47, P297, DOI 10.1016/j.ejps.2012.06.012; SCHREIER H, 1994, J CONTROL RELEASE, V30, P1, DOI 10.1016/0168-3659(94)90039-6; Shi J, 2012, J LIPOSOME RES, V22, P270, DOI 10.3109/08982104.2012.690159; Teichmann A, 2007, EUR J PHARM BIOPHARM, V67, P699, DOI 10.1016/j.ejpb.2007.04.006; Tompson DJ, 2007, CLIN THER, V29, P2654, DOI 10.1016/j.clinthera.2007.12.010; Tsai PJ, 2013, THESCIENTIFICWORLDJO, V2013, DOI [10.1155/2013/856967, DOI 10.1155/2013/856967]; Tsai YH, 2012, J FOOD DRUG ANAL, V20, P22; Wang LJ, 2009, J COLLOID INTERF SCI, V330, P443, DOI 10.1016/j.jcis.2008.10.077; Wu HL, 2001, INT J PHARM, V220, P63, DOI 10.1016/S0378-5173(01)00671-8; Zidan AS, 2007, J PHARM SCI-US, V96, P2409, DOI 10.1002/jps.20824	37	26	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102850	10.1371/journal.pone.0102850	http://dx.doi.org/10.1371/journal.pone.0102850			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068531	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700022
J	Chanmee, T; Ontong, P; Mochizuki, N; Kongtawelert, P; Konno, K; Itano, N				Chanmee, Theerawut; Ontong, Pawared; Mochizuki, Nobutoshi; Kongtawelert, Prachya; Konno, Kenjiro; Itano, Naoki			Excessive Hyaluronan Production Promotes Acquisition of Cancer Stem Cell Signatures through the Coordinated Regulation of Twist and the Transforming Growth Factor beta (TGF-beta)-Snail Signaling Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; STROMAL HYALURONAN; SIDE POPULATION; SYNTHASE HAS2; CARCINOMA; INVASION; SUBPOPULATION; METASTASIS; PHENOTYPE	The cancer stem cell (CSC) model suggests that a small subpopulation of cancer cells possesses the ability to self-renew and give rise to malignant progeny that drive cancer progression. Recent reports have also proposed the existence of certain extra- or intracellular signals that allow cancer progenitors to dynamically revert to a stem cell state. However, the mechanisms underlying cancer cell plasticity and CSC expansion are not entirely clear. Our previous studies using a hyaluronan synthase 2 (Has2) transgenic mouse model demonstrated that hyaluronan overproduction caused rapid development of aggressive breast carcinoma at a high incidence. Thus, we hypothesize that hyaluronan overproduction may accelerate cancer progression by expanding CSC subpopulations during cancer development. Primary cancer cells were established from mammary tumors developed in the transgenic mice and subjected to the Hoechst 33342 dye exclusion assay to sort side population (SP) from nonside population (non-SP) cells. Flow cytometric analysis demonstrated the enrichment of CD44(high)/CD24(low) CSC-like cells in the SP fraction of hyaluronan-overproducing cancer cells. This subpopulation exhibited several characteristics that were similar to CSCs, including cancer-initiating and mammosphere-forming abilities. Excess hyaluronan production drove the epithelial-to-mesenchymal transition process defined as the loss of epithelial phenotypes, up-regulation of transforming growth factor beta (TGF-beta), and induction of the epithelial-to-mesenchymal transition-related transcriptional factors Snail and Twist. Inhibition of TGF-beta-Snail signaling or silencing of Twist expression abrogated the entrance into a stem cell state. Taken together, our findings suggest that hyaluronan overproduction allows plastic cancer cell populations to revert to stem cell states via Twist and the TGF-beta-Snail signaling axis.	[Chanmee, Theerawut; Itano, Naoki] Kyoto Sangyo Univ, Inst Adv Technol, Kita Ku, Kyoto 6038555, Japan; [Ontong, Pawared; Itano, Naoki] Kyoto Sangyo Univ, Div Engn Biotechnol, Grad Sch Engn, Kita Ku, Kyoto 6038555, Japan; [Mochizuki, Nobutoshi; Itano, Naoki] Kyoto Sangyo Univ, Dept Mol Biosci, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Kongtawelert, Prachya] Chiang Mai Univ, Fac Med, Dept Biochem, Thailand Excellence Ctr Tissue Engn & Stem Cells, Chiang Mai 50200, Thailand; [Konno, Kenjiro] Kyoto Sangyo Univ, Dept Anim Med Sci, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan	Kyoto Sangyo University; Kyoto Sangyo University; Kyoto Sangyo University; Chiang Mai University; Kyoto Sangyo University	Konno, K (corresponding author), Kyoto Sangyo Univ, Dept Anim Med Sci, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan.	kkonno@cc.kyoto-su.ac.jp; itanon@cc.kyoto-su.ac.jp	Xia, Bo/P-9380-2016	kongtawelert, prachya/0000-0002-5963-2796; Chanmee, Theerawut/0000-0001-6577-4216	Japan Society for the Promotion of Science KAKENHI [23590478, 26430125]; Kyoto Sangyo University Research Grant [C1301]; Royal Golden Jubilee Ph.D. Program Grant [PHD/0258/2549]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kyoto Sangyo University Research Grant; Royal Golden Jubilee Ph.D. Program Grant	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 23590478 and 26430125 (to N. I.), Kyoto Sangyo University Research Grant C1301 (to N. I.), and The Royal Golden Jubilee Ph.D. Program Grant PHD/0258/2549 (to T. C.).	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alison MR, 2012, CANCER TREAT REV, V38, P589, DOI 10.1016/j.ctrv.2012.03.003; Anttila MA, 2000, CANCER RES, V60, P150; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Auvinen P, 2014, BREAST CANCER RES TR, V143, P277, DOI 10.1007/s10549-013-2804-7; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Bernert B, 2011, J BIOL CHEM, V286, P42349, DOI 10.1074/jbc.M111.278598; Biddle A, 2011, CANCER RES, V71, P5317, DOI 10.1158/0008-5472.CAN-11-1059; Bomken S, 2010, BRIT J CANCER, V103, P439, DOI 10.1038/sj.bjc.6605821; Chen F, 2007, DEVELOPMENT, V134, P2969, DOI 10.1242/dev.006221; Cheng JC, 2013, J BIOL CHEM, V288, P33181, DOI 10.1074/jbc.M113.488866; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 1999, CANCER RES, V59, P2499; Ju SY, 2014, STEM CELL RES, V12, P86, DOI 10.1016/j.scr.2013.09.011; Kabashima A, 2009, INT J CANCER, V124, P2771, DOI 10.1002/ijc.24349; Klopp AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012180; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Koyama H, 2008, AM J PATHOL, V172, P179, DOI 10.2353/ajpath.2008.070360; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066558; Lipponen P, 2001, EUR J CANCER, V37, P849, DOI 10.1016/S0959-8049(00)00448-2; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mima K, 2012, CANCER RES, V72, P3414, DOI 10.1158/0008-5472.CAN-12-0299; Okuda H, 2012, CANCER RES, V72, P537, DOI 10.1158/0008-5472.CAN-11-1678; Porsch H, 2013, ONCOGENE, V32, P4355, DOI 10.1038/onc.2012.475; Qu CJ, 2014, INT J BIOCHEM CELL B, V48, P45, DOI 10.1016/j.biocel.2013.12.016; Saito A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056587; Scheel C, 2011, INT J CANCER, V129, P2310, DOI 10.1002/ijc.26311; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Tan EJ, 2012, J BIOL CHEM, V287, P7134, DOI 10.1074/jbc.M111.291385; Tanaka H, 2009, ANTICANCER RES, V29, P2147; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Yang G, 2012, BRIT J CANCER, V106, P1512, DOI 10.1038/bjc.2012.126; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	43	62	63	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26038	26056		10.1074/jbc.M114.564120	http://dx.doi.org/10.1074/jbc.M114.564120			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25077968	Green Published, hybrid			2022-12-25	WOS:000342128800004
J	Mukherjee, M; Jing-Song, F; Ramachandran, S; Guy, GR; Sivaraman, J				Mukherjee, Manjeet; Jing-Song, Fan; Ramachandran, Sarath; Guy, Graeme R.; Sivaraman, J.			Dimeric Switch of Hakai-truncated Monomers during Substrate Recognition INSIGHTS FROM SOLUTION STUDIES AND NMR STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; SRC HOMOLOGY-2 DOMAIN; E-CADHERIN; SIGNAL-TRANSDUCTION; SH2 DOMAIN; TYROSINE KINASES; PROTEIN; DIMERIZATION; CELL; INHIBITORS	Hakai, an E3 ubiquitin ligase, disrupts cell-cell contacts in epithelial cells and is up-regulated in human colon and gastric adenocarcinomas. Hakai acts through its phosphotyrosine-binding (HYB) domain, which bears a dimeric fold that recognizes the phosphotyrosine motifs of E-cadherin, cortactin, DOK1, and other Src substrates. Unlike the monomeric nature of the SH2 and phosphotyrosine-binding domains, the architecture of the HYB domain consists of an atypical, zinc-coordinated tight homodimer. Here, we report a C-terminal truncation mutant of the HYB domain (HYB Delta C), comprising amino acids 106-194, which exists as a monomer in solution. The NMR structure revealed that this deletion mutant undergoes a dramatic structural change caused by a rearrangement of the atypical zinc-coordinated unit in the C terminus of the HYB domain to a C2H2-like zinc finger in HYB Delta C. Moreover, using isothermal titration calorimetry, we show that dimerization of HYB Delta C can be induced using a phosphotyrosine substrate peptide. This ligand-induced dimerization of HYB Delta C is further validated using analytical ultracentrifugation, size-exclusion chromatography, NMR relaxation studies, dynamic light scattering, and circular dichroism experiments. Overall, these observations suggest that the dimeric architecture of the HYB domain is essential for the phosphotyrosine-binding property of Hakai.	[Mukherjee, Manjeet; Jing-Song, Fan; Ramachandran, Sarath; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Guy, Graeme R.] Inst Mol & Cell Biol, Singapore 138673, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Sivaraman, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsjayar@nus.edu.sg		Mukherjee, Manjeet/0000-0002-3615-7574; J, Sivaraman/0000-0001-9781-5326	MOE (Tier 2) [R154000625112]	MOE (Tier 2)	This work was supported by MOE (Tier 2) Grant R154000625112.	Abella V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052568; Akke M, 1996, J AM CHEM SOC, V118, P911, DOI 10.1021/ja953503r; Andreola ML, 2009, CURR PHARM DESIGN, V15, P2508, DOI 10.2174/138161209788682244; Austin D J, 1994, Chem Biol, V1, P131, DOI 10.1016/1074-5521(94)90002-7; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Burke TR, 2001, BIOPOLYMERS, V60, P32, DOI 10.1002/1097-0282(2001)60:1<32::AID-BIP1002>3.0.CO;2-I; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DECLUE JE, 1987, P NATL ACAD SCI USA, V84, P9064, DOI 10.1073/pnas.84.24.9064; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Depetris RS, 2005, MOL CELL, V20, P325, DOI 10.1016/j.molcel.2005.09.001; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Evans JV, 2012, J CELL SCI, V125, P6185, DOI 10.1242/jcs.121046; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FESIK SW, 1990, J AM CHEM SOC, V112, P886, DOI 10.1021/ja00158a069; Figueroa A, 2009, MOL BIOL CELL, V20, P3533, DOI 10.1091/mbc.E08-08-0845; Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001; Flint J, 2004, J MOL BIOL, V337, P417, DOI 10.1016/j.jmb.2003.12.081; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Goddard T.D., 2004, SPARKY 3; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hu JJ, 2005, J BIOL CHEM, V280, P18943, DOI 10.1074/jbc.M414157200; Huber KL, 2012, BIOPOLYMERS, V98, P451, DOI 10.1002/bip.22080; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Ishiyama Noboru, 2012, Subcell Biochem, V60, P39, DOI 10.1007/978-94-007-4186-7_3; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Kang X, 2012, P NATL ACAD SCI USA, V109, P14900, DOI 10.1073/pnas.1205241109; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lebon F, 2000, CURR MED CHEM, V7, P455, DOI 10.2174/0929867003375146; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Machida K, 2005, BBA-PROTEINS PROTEOM, V1747, P1, DOI 10.1016/j.bbapap.2004.10.005; Manelyte L, 2006, NUCLEIC ACIDS RES, V34, P5270, DOI 10.1093/nar/gkl489; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; McMillan K, 2000, P NATL ACAD SCI USA, V97, P1506, DOI 10.1073/pnas.97.4.1506; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Mishra A, 2010, P NATL ACAD SCI USA, V107, P10866, DOI 10.1073/pnas.1000843107; Mukherjee M, 2012, EMBO J, V31, P1308, DOI 10.1038/emboj.2011.496; Nakatani Y, 2013, BIOCHEM J, V450, P629, DOI 10.1042/BJ20121702; Noh SJ, 2013, PATHOL RES PRACT, V209, P365, DOI 10.1016/j.prp.2013.03.011; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pawson T, 2002, EUR J CANCER, V38, pS3, DOI 10.1016/S0959-8049(02)80597-4; Pece S, 2002, NAT CELL BIOL, V4, pE72, DOI 10.1038/ncb0402-e72; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; Sanchez-Vallet A, 2013, ELIFE, V2, DOI 10.7554/eLife.00790; Sawyer TK, 2002, MINI-REV MED CHEM, V2, P475, DOI 10.2174/1389557023405765; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Siouda M, 2012, MOL CELL BIOL, V32, P4877, DOI 10.1128/MCB.01050-12; Soler-Lopez M, 2004, MOL CELL, V13, P791, DOI 10.1016/S1097-2765(04)00130-3; Stein EG, 2003, J BIOL CHEM, V278, P13257, DOI 10.1074/jbc.M212026200; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	67	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25611	25623		10.1074/jbc.M114.592840	http://dx.doi.org/10.1074/jbc.M114.592840			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074933	Green Published, hybrid			2022-12-25	WOS:000342130800022
J	Clague, J; Reynolds, P; Henderson, KD; Sullivan-Halley, J; Ma, HY; Lacey, JV; Chang, SN; Delclos, GL; Du, XLL; Forman, MR; Bernstein, L				Clague, Jessica; Reynolds, Peggy; Henderson, Katherine D.; Sullivan-Halley, Jane; Ma, Huiyan; Lacey, James V., Jr.; Chang, Shine; Delclos, George L.; Du, Xianglin L.; Forman, Michele R.; Bernstein, Leslie			Menopausal Hormone Therapy and Lung Cancer-Specific Mortality Following Diagnosis: The California Teachers Study	PLOS ONE			English	Article							REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; NEVER SMOKERS; ESTROGEN; SURVIVAL; INFLAMMATION; OUTCOMES; RISK; BETA	Previous results from research on menopausal hormone therapy (MHT) and lung cancer survival have been mixed and most have not studied women who used estrogen therapy (ET) exclusively. We examined the associations between MHT use reported at baseline and lung cancer-specific mortality in the prospective California Teachers Study cohort. Among 727 postmenopausal women diagnosed with lung cancer from 1995 through 2007, 441 women died before January 1, 2008. Hazard Ratios (HR) and 95% Confidence Intervals (CI) for lung-cancer-specific mortality were obtained by fitting multivariable Cox proportional hazards regression models using age in days as the timescale. Among women who used ET exclusively, decreases in lung cancer mortality were observed (HR, 0.69; 95% CI, 0.52-0.93). No association was observed for estrogen plus progestin therapy use. Among former users, shorter duration (<5 years) of exclusive ET use was associated with a decreased risk of lung cancer mortality (HR, 0.56; 95% CI, 0.35-0.89), whereas among recent users, longer duration (>15 years) was associated with a decreased risk (HR, 0.60; 95% CI, 0.38-0.95). Smoking status modified the associations with deceases in lung cancer mortality observed only among current smokers. Exclusive ET use was associated with decreased lung cancer mortality.	[Clague, Jessica; Henderson, Katherine D.; Sullivan-Halley, Jane; Ma, Huiyan; Lacey, James V., Jr.; Bernstein, Leslie] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Div Canc Etiol, Duarte, CA 91010 USA; [Reynolds, Peggy] Canc Prevent Inst Calif, Fremont, CA USA; [Chang, Shine] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Delclos, George L.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Houston, TX 77030 USA; [Du, Xianglin L.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Epidemiol, Houston, TX 77030 USA; [Forman, Michele R.] Coll Nat Sci, Dell Pediat Res Inst, Dept Nutr Sci, Austin, TX USA	City of Hope; Beckman Research Institute of City of Hope; Cancer Prevention Institute of California; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Bernstein, L (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Div Canc Etiol, Duarte, CA 91010 USA.	lbernstein@coh.org		Chang, Shine/0000-0003-3804-9697	National Cancer Institute [R01 CA77398, K05 CA 136967, R25T CA57730]; National Cancer Institute's Surveillance, Epidemiology and End Results Program [N01-PC-35136]; Northern California Cancer Center [N01-PC-35139]; University of Southern California [N01-PC-35139]; Public Health Institute [N02-PC-15105]; Centers for Disease Control and Prevention's National Program of Cancer Registries [U55/CCR921930-02]; NATIONAL CANCER INSTITUTE [R01CA077398, K05CA136967, R25CA057730] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute's Surveillance, Epidemiology and End Results Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Northern California Cancer Center; University of Southern California; Public Health Institute; Centers for Disease Control and Prevention's National Program of Cancer Registries(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work reported here was supported by National Cancer Institute grants R01 CA77398, K05 CA 136967 and R25T CA57730. The collection of cancer incidence data used in this study was supported by the California Department of Health Services as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract N01-PC-35136 awarded to the Northern California Cancer Center (now known as the Cancer Prevention Institute of California), contract N01-PC-35139 awarded to the University of Southern California, and contract N02-PC-15105 awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries, under agreement #U55/CCR921930-02 awarded to the Public Health Institute. The ideas and opinions expressed herein are those of the authors. Endorsement by the State of California, Department of Health Services, the National Cancer Institute, and the Centers for Disease Control and Prevention or their contractors and subcontractors is not intended nor should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayeni O, 2009, CURR ONCOL, V16, P162; Bernstein L, 2002, CANCER CAUSE CONTROL, V13, P625, DOI 10.1023/A:1019552126105; Chlebowski RT, 2010, JNCI-J NATL CANCER I, V102, P1413, DOI 10.1093/jnci/djq285; Chlebowski RT, 2009, LANCET, V374, P1243, DOI 10.1016/S0140-6736(09)61526-9; Ettinger B, 1996, OBSTET GYNECOL, V87, P6, DOI 10.1016/0029-7844(95)00358-4; Flototto T, 2001, HORM METAB RES, V33, P451, DOI 10.1055/s-2001-16936; Ganti AK, 2006, J CLIN ONCOL, V24, P59, DOI 10.1200/JCO.2005.02.9827; Henschke CI, 2006, JAMA-J AM MED ASSOC, V296, P180; Horn-Ross PL, 2004, CANCER EPIDEM BIOMAR, V13, P405; Huang B, 2009, CANCER, V115, P4167, DOI 10.1002/cncr.24475; Hulley S, 2002, JAMA-J AM MED ASSOC, V288, P58, DOI 10.1001/jama.288.1.58; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kovacs EJ, 2005, EXP GERONTOL, V40, P549, DOI 10.1016/j.exger.2005.04.009; Meireles SI, 2010, CANCER PREV RES, V3, P707, DOI 10.1158/1940-6207.CAPR-09-0162; Niikawa H, 2008, CLIN CANCER RES, V14, P4417, DOI 10.1158/1078-0432.CCR-07-1950; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Schabath MB, 2004, CLIN CANCER RES, V10, P113, DOI 10.1158/1078-0432.CCR-0911-3; Sekine I, 2009, JPN J CLIN ONCOL, V39, P707, DOI 10.1093/jjco/hyp095; Siegfried JM, 2001, LANCET ONCOL, V2, P506, DOI 10.1016/S1470-2045(01)00457-0; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Thomas L, 2005, CHEST, V128, P370, DOI 10.1378/chest.128.1.370; Wakelee HA, 2007, J CLIN ONCOL, V25, P472, DOI 10.1200/JCO.2006.07.2983	24	23	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103735	10.1371/journal.pone.0103735	http://dx.doi.org/10.1371/journal.pone.0103735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079077	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800074
J	Deshmukh, R; Trivedi, V				Deshmukh, Rohitas; Trivedi, Vishal			Phagocytic Uptake of Oxidized Heme Polymer Is Highly Cytotoxic to Macrophages	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; MALARIA PIGMENT HEMOZOIN; NF-KAPPA-B; IN-VITRO; CEREBRAL MALARIA; MONONUCLEAR-CELLS; OXIDATIVE STRESS; DENDRITIC CELLS; HUMAN MONOCYTE; METHEMOGLOBIN	Apoptosis in macrophages is responsible for immune-depression and pathological effects during malaria. Phagocytosis of PRBC causes induction of apoptosis in macrophages through release of cytosolic factors from infected cells. Heme polymer or beta-hematin causes dose-dependent death of macrophages with LC50 of 132 mu g/ml and 182 mu g/ml respectively. The toxicity of hemin or heme polymer was amplified several folds in the presence of non-toxic concentration of methemoglobin. beta-hematin uptake in macrophage through phagocytosis is crucial for enhanced toxicological effects in the presence of methemoglobin. Higher accumulation of beta-hematin is observed in macrophages treated with beta-hematin along with methemoglobin. Light and scanning electron microscopic observations further confirm accumulation of beta-hematin with cellular toxicity. Toxicological potentiation of pro-oxidant molecules toward macrophages depends on generation of H2O2 and independent to release of free iron from pro-oxidant molecules. Methemoglobin oxidizes beta-hematin to form oxidized beta-hematin (beta H*) through single electron transfer mechanism. Pre-treatment of reaction mixture with spin-trap Phenyl-N-t-butyl-nitrone dose-dependently reverses the beta-hematin toxicity, indicates crucial role of beta H* generation with the toxicological potentiation. Acridine orange/ethidium bromide staining and DNA fragmentation analysis indicate that macrophage follows an oxidative stress dependent apoptotic pathway to cause death. In summary, current work highlights mutual co-operation between methemoglobin and different pro-oxidant molecules to enhance toxicity towards macrophages. Hence, methemoglobin peroxidase activity can be probed for subduing cellular toxicity of pro-oxidant molecules and it may in-turn make up for host immune response against the malaria parasite.	[Deshmukh, Rohitas; Trivedi, Vishal] Indian Inst Technol Guwahati, Dept Biotechnol, Malaria Res Grp, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Trivedi, V (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Malaria Res Grp, Gauhati, Assam, India.	vtrivedi@iitg.ernet.in	Deshmukh, Rohitas/AAU-3455-2021	Deshmukh, Rohitas/0000-0002-8962-6821				Anstey NM, 1996, T ROY SOC TROP MED H, V90, P147, DOI 10.1016/S0035-9203(96)90118-2; Arkusz J, 2006, TOXICOL IN VITRO, V20, P109, DOI 10.1016/j.tiv.2005.06.044; Ashikawa K, 2002, J IMMUNOL, V169, P6490, DOI 10.4049/jimmunol.169.11.6490; Balaji S. N., 2013, Journal of Basic and Clinical Physiology and Pharmacology, V24, P105, DOI 10.1515/jbcpp-2012-0058; Balaji SN, 2013, FEBS LETT, V587, P350, DOI 10.1016/j.febslet.2012.12.015; Balde AT, 2000, PARASITE IMMUNOL, V22, P307, DOI 10.1046/j.1365-3024.2000.00307.x; BALDE AT, 1995, IMMUNOL LETT, V46, P59, DOI 10.1016/0165-2478(95)00017-Y; Barrera V, 2011, BLOOD, V117, P5674, DOI 10.1182/blood-2010-10-312413; Buehler PW, 2010, ANTIOXID REDOX SIGN, V12, P275, DOI 10.1089/ars.2009.2799; Burhop K, 2004, ARTIF CELL BLOOD SUB, V32, P353, DOI 10.1081/LABB-200027429; Cai H, 2011, CURR GENOMICS, V12, P417, DOI 10.2174/138920211797248565; Cambos M, 2011, J LEUKOCYTE BIOL, V89, P159, DOI 10.1189/jlb.0510249; Carmona-Fonseca J, 2009, AM J TROP MED HYG, V80, P188, DOI 10.4269/ajtmh.2009.80.188; Carney CK, 2006, J BIOL INORG CHEM, V11, P917, DOI 10.1007/s00775-006-0147-0; Chua CLL, 2013, TRENDS PARASITOL, V29, P26, DOI 10.1016/j.pt.2012.10.002; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Deshmukh Rohitas, 2013, Inflammation & Allergy Drug Targets, V12, P68; Deshmukh R, 2013, TOXICOL IN VITRO, V27, P16, DOI 10.1016/j.tiv.2012.09.016; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Eberson L, 1998, J CHEM SOC PERK T 2, P41, DOI 10.1039/a704637e; Eda S, 2002, CELL PHYSIOL BIOCHEM, V12, P373, DOI 10.1159/000067908; Fortes GB, 2012, BLOOD, V119, P2368, DOI 10.1182/blood-2011-08-375303; FRANCIS SE, 1994, EMBO J, V13, P306, DOI 10.1002/j.1460-2075.1994.tb06263.x; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Huy NT, 2006, PARASITOL INT, V55, P75, DOI 10.1016/j.parint.2005.10.003; Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475; Kamchonwongpaisan S, 1997, MOL BIOCHEM PARASIT, V86, P179, DOI 10.1016/S0166-6851(97)02855-7; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Lee HJ, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-176; Leitner WW, 1997, PARASITE IMMUNOL, V19, P103, DOI 10.1046/j.1365-3024.1997.d01-188.x; LIEGLER TJ, 1995, CLIN DIAGN LAB IMMUN, V2, P369, DOI 10.1128/CDLI.2.3.369-376.1995; Lucchi NW, 2011, PLACENTA, V32, P579, DOI 10.1016/j.placenta.2011.05.003; Newton CRJC, 1998, AM J TROP MED HYG, V58, P673, DOI 10.4269/ajtmh.1998.58.673; Nuchsongsin F, 2007, AM J TROP MED HYG, V77, P617, DOI 10.4269/ajtmh.2007.77.617; OO MM, 1987, J NEUROPATH EXP NEUR, V46, P223, DOI 10.1097/00005072-198703000-00009; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Pamplona A, 2009, INT J BIOCHEM CELL B, V41, P711, DOI 10.1016/j.biocel.2008.09.020; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; PICHYANGKUL S, 1994, AM J TROP MED HYG, V51, P430, DOI 10.4269/ajtmh.1994.51.430; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Reeder BJ, 2010, ANTIOXID REDOX SIGN, V13, P1087, DOI 10.1089/ars.2009.2974; Regan RF, 1996, J NEUROTRAUM, V13, P223, DOI 10.1089/neu.1996.13.223; Reimer T, 2010, EUR J IMMUNOL, V40, P764, DOI 10.1002/eji.200939996; RODKEY FL, 1979, CLIN CHEM, V25, P1388; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sakamoto M, 2002, NEUROL RES, V24, P301, DOI 10.1179/016164102101199783; Salman H, 2000, CRYOBIOLOGY, V41, P66, DOI 10.1006/cryo.2000.2267; Schwarzer E., 2008, Parassitologia (Rome), V50, P143; Schwarzer E, 1996, BBA-MOL BASIS DIS, V1316, P169, DOI 10.1016/0925-4439(96)00021-X; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; Scorza T, 1999, PARASITE IMMUNOL, V21, P545, DOI 10.1046/j.1365-3024.1999.00254.x; SHERRY BA, 1995, J INFLAMM, V45, P85; Srivastava K, 2007, EXP PARASITOL, V116, P171, DOI 10.1016/j.exppara.2006.12.003; ToureBalde A, 1996, INFECT IMMUN, V64, P744, DOI 10.1128/IAI.64.3.744-750.1996; Trivedi V, 2005, J BIOL CHEM, V280, P41129, DOI 10.1074/jbc.M501563200; Urban BC, 2002, CURR OPIN IMMUNOL, V14, P458, DOI 10.1016/S0952-7915(02)00368-0; WINTERBOURN CC, 1990, METHOD ENZYMOL, V186, P265	60	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103706	10.1371/journal.pone.0103706	http://dx.doi.org/10.1371/journal.pone.0103706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078090	Green Submitted, gold, Green Published			2022-12-25	WOS:000339954800067
J	Hassanzadeh, R; Eslahchi, C; Sung, WK				Hassanzadeh, Reza; Eslahchi, Changiz; Sung, Wing-Kin			Do Triplets Have Enough Information to Construct the Multi-Labeled Phylogenetic Tree?	PLOS ONE			English	Article							ROOTED TRIPLETS; GENE TREES; MULTILABELED TREES; POLYNOMIAL-TIME; NETWORKS; EVOLUTION; SET	The evolutionary history of certain species such as polyploids are modeled by a generalization of phylogenetic trees called multi-labeled phylogenetic trees, or MUL trees for short. One problem that relates to inferring a MUL tree is how to construct the smallest possible MUL tree that is consistent with a given set of rooted triplets, or SMRT problem for short. This problem is NP-hard. There is one algorithm for the SMRT problem which is exact and runs in O(7(n)) time, where n is the number of taxa. In this paper, we show that the SMRT does not seem to be an appropriate solution from the biological point of view. Indeed, we present a heuristic algorithm named MTRT for this problem and execute it on some real and simulated datasets. The results of MTRT show that triplets alone cannot provide enough information to infer the true MUL tree. So, it is inappropriate to infer a MUL tree using triplet information alone and considering the minimum number of duplications. Finally, we introduce some new problems which are more suitable from the biological point of view.	[Hassanzadeh, Reza] Shahid Beheshti Univ, Dept Math, GC, Tehran, Iran; [Eslahchi, Changiz] Shahid Beheshti Univ, Dept Comp Sci, GC, Tehran, Iran; [Sung, Wing-Kin] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore; [Sung, Wing-Kin] Genome Inst Singapore, Singapore, Singapore	Shahid Beheshti University; Shahid Beheshti University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Eslahchi, C (corresponding author), Shahid Beheshti Univ, Dept Comp Sci, GC, Tehran, Iran.	ch-eslahchi@sbu.ac.ir		Sung, Wing-Kin/0000-0001-7806-7086; Hassanzadeh, Reza/0000-0001-8819-8864				AHO AV, 1981, SIAM J COMPUT, V10, P405, DOI 10.1137/0210030; Berry A., 2000, International Journal of Foundations of Computer Science, V11, P397, DOI 10.1142/S0129054100000211; BUI TN, 1992, INFORM PROCESS LETT, V42, P153, DOI 10.1016/0020-0190(92)90140-Q; Byrka J, 2010, DISCRETE APPL MATH, V158, P1136, DOI 10.1016/j.dam.2010.03.004; Critchlow DE, 1996, SYST BIOL, V45, P323, DOI 10.2307/2413567; Cui Y, 2012, J COMPUT BIOL, V19, P1073, DOI 10.1089/cmb.2012.0008; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ganapathy G, 2006, IEEE ACM T COMPUT BI, V3, P334, DOI 10.1109/TCBB.2006.57; Guillemot S, 2011, IEEE ACM T COMPUT BI, V8, P1141, DOI 10.1109/TCBB.2010.77; Huber KT, 2006, MOL BIOL EVOL, V23, P1784, DOI 10.1093/molbev/msl045; Huber KT, 2011, IEEE ACM T COMPUT BI, V8, P1029, DOI 10.1109/TCBB.2010.122; Jansson J, 2006, BIOINFORMATICS, V18, P337; Lott M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-216; Lott M, 2009, BIOINFORMATICS, V25, P1199, DOI 10.1093/bioinformatics/btp133; Maddison WP, 2011, MESQUITE MODULAR SYS; Marcussen T, 2012, SYST BIOL, V61, P107, DOI 10.1093/sysbio/syr096; Nelson G., 1981, SYSTEMATICS BIOGEORA; PAGE RDM, 1994, SYST BIOL, V43, P58, DOI 10.2307/2413581; PAGE RDM, 1993, INT J PARASITOL, V23, P499, DOI 10.1016/0020-7519(93)90039-2; Popp M, 2005, SYST BOT, V30, P302, DOI 10.1600/0363644054223648; Scornavacca C, 2011, INFORM COMPUT, V209, P590, DOI 10.1016/j.ic.2010.11.022; Scornavacca C, 2009, LECT NOTES COMPUT SC, V5457, P702, DOI 10.1007/978-3-642-00982-2_60; To TH, 2009, LECT NOTES COMPUT SC, V5577, P275, DOI 10.1007/978-3-642-02441-2_25; van Iersel L, 2011, ALGORITHMICA, V60, P207, DOI 10.1007/s00453-009-9333-0; van Iersel L, 2009, IEEE ACM T COMPUT BI, V6, P667, DOI 10.1109/TCBB.2009.22	26	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103622	10.1371/journal.pone.0103622	http://dx.doi.org/10.1371/journal.pone.0103622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080217	Green Published, gold, Green Submitted			2022-12-25	WOS:000339954800061
J	Kittelmann, S; Pinares-Patino, CS; Seedorf, H; Kirk, MR; Ganesh, S; McEwan, JC; Janssen, PH				Kittelmann, Sandra; Pinares-Patino, Cesar S.; Seedorf, Henning; Kirk, Michelle R.; Ganesh, Siva; McEwan, John C.; Janssen, Peter H.			Two Different Bacterial Community Types Are Linked with the Low-Methane Emission Trait in Sheep	PLOS ONE			English	Article							IN-VITRO; SP-NOV; GEN. NOV.; RUMEN; FERMENTATION; ENTEROTYPES; METABOLISM; MICROBIOTA; STARCH; GROWTH	The potent greenhouse gas methane (CH4) is produced in the rumens of ruminant animals from hydrogen produced during microbial degradation of ingested feed. The natural animal-to-animal variation in the amount of CH4 emitted and the heritability of this trait offer a means for reducing CH4 emissions by selecting low-CH4 emitting animals for breeding. We demonstrate that differences in rumen microbial community structure are linked to high and low CH4 emissions in sheep. Bacterial community structures in 236 rumen samples from 118 high-and low-CH4 emitting sheep formed gradual transitions between three ruminotypes. Two of these (Q and S) were linked to significantly lower CH4 yields (14.4 and 13.6 g CH4/kg dry matter intake [DMI], respectively) than the third type (H; 15.9 g CH4/kg DMI; p<0.001). Low-CH4 ruminotype Q was associated with a significantly lower ruminal acetate to propionate ratio (3.7 +/- 0.4) than S (4.4 +/- 0.7; p<0.001) and H (4.3 +/- 0.5; p<0.001), and harbored high relative abundances of the propionate-producing Quinella ovalis. Low-CH4 ruminotype S was characterized by lactate-and succinate-producing Fibrobacter spp., Kandleria vitulina, Olsenella spp., Prevotella bryantii, and Sharpea azabuensis. High-CH4 ruminotype H had higher relative abundances of species belonging to Ruminococcus, other Ruminococcaceae, Lachnospiraceae, Catabacteriaceae, Coprococcus, other Clostridiales, Prevotella, other Bacteroidales, and Alphaproteobacteria, many of which are known to form significant amounts of hydrogen. We hypothesize that lower CH4 yields are the result of bacterial communities that ferment ingested feed to relatively less hydrogen, which results in less CH4 being formed.	[Kittelmann, Sandra; Pinares-Patino, Cesar S.; Seedorf, Henning; Kirk, Michelle R.; Ganesh, Siva; Janssen, Peter H.] AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand; [McEwan, John C.] AgResearch Ltd, Invermay Agr Ctr, Mosgiel, New Zealand	AgResearch - New Zealand; AgResearch - New Zealand	Janssen, PH (corresponding author), AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand.	peter.janssen@agresearch.co.nz	McEwan, John/A-1143-2008; Seedorf, Henning/AAW-6023-2020	McEwan, John/0000-0003-4801-6207; Seedorf, Henning/0000-0002-5763-0236; Kittelmann, Sandra/0000-0002-6019-9854; Ganesh, Siva/0000-0001-8148-1704; Pinares Patino, Cesar Silvino/0000-0001-9195-8844; Janssen, Peter/0000-0002-1022-3502	Pastoral Greenhouse Gas Research Consortium; Beef+ Lamb New Zealand	Pastoral Greenhouse Gas Research Consortium; Beef+ Lamb New Zealand	This research was funded by the Pastoral Greenhouse Gas Research Consortium (www.pggrc.co.nz). All the authors are employees of AgResearch Ltd., which is a Crown Research Institute. The animals were part of the Ovita partnership and the related Central Progeny Test, both supported by funding from Beef+ Lamb New Zealand (www.beeflambnz.com). The funders did play a role in the decision to publish, but did not play a role in study design, data collection and analysis, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Blaxter KL, 1967, ENERGY METABOLISM RU; BRYANT MP, 1954, J DAIRY SCI, V37, P1176, DOI 10.3168/jds.S0022-0302(54)91387-9; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dewhirst FE, 2001, INT J SYST EVOL MICR, V51, P1797, DOI 10.1099/00207713-51-5-1797; Fievez V, 2003, ANIM FEED SCI TECH, V104, P41, DOI 10.1016/S0377-8401(02)00330-9; Fricke WF, 2006, J BACTERIOL, V188, P642, DOI 10.1128/JB.188.2.642-658.2006; Goopy JP, 2014, BRIT J NUTR, V111, P578, DOI 10.1017/S0007114513002936; Haisan J, 2014, J DAIRY SCI, V97, P3110, DOI 10.3168/jds.2013-7834; Hegarty RS, 1999, AUST J AGR RES, V50, P1321, DOI 10.1071/AR99008; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; HOLDEMAN LV, 1974, INT J SYST BACTERIOL, V24, P260, DOI 10.1099/00207713-24-2-260; HOWLETT MR, 1976, APPL ENVIRON MICROB, V32, P274, DOI 10.1128/AEM.32.2.274-283.1976; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Janssen PH, 2010, ANIM FEED SCI TECH, V160, P1, DOI 10.1016/j.anifeedsci.2010.07.002; Jeyanathan J, 2011, FEMS MICROBIOL ECOL, V76, P311, DOI 10.1111/j.1574-6941.2011.01056.x; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; KRUMHOLZ LR, 1993, INT J SYST BACTERIOL, V43, P293, DOI 10.1099/00207713-43-2-293; MILLER TL, 1985, ARCH MICROBIOL, V141, P116, DOI 10.1007/BF00423270; Miller TL, 2001, J DAIRY SCI, V84, P1445, DOI 10.3168/jds.S0022-0302(01)70177-4; Moeller AH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2159; Morita H, 2008, INT J SYST EVOL MICR, V58, P2682, DOI 10.1099/ijs.0.65543-0; NEWBOLD CJ, 1995, LETT APPL MICROBIOL, V21, P230, DOI 10.1111/j.1472-765X.1995.tb01048.x; Nkrumah JD, 2006, J ANIM SCI, V84, P145; Pinares-Patino CS, 2013, ANIMAL, V7, P316, DOI 10.1017/S1751731113000864; Pinares-Patino CS, 2003, J AGR SCI-CAMBRIDGE, V140, P205, DOI 10.1017/S0021859603003046; Pinares-Patino CS, 2003, J AGR SCI-CAMBRIDGE, V140, P227, DOI 10.1017/S0021859603003071; Popova M, 2013, APPL ENVIRON MICROB, V79, P1777, DOI 10.1128/AEM.03115-12; Popova M, 2011, ANIM FEED SCI TECH, V166-67, P113, DOI 10.1016/j.anifeedsci.2011.04.060; Poulsen M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2432; Quin J. I., 1943, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V18, P91; Rius AG, 2012, J DAIRY SCI, V95, P5024, DOI 10.3168/jds.2012-5392; Ross EM, 2013, J DAIRY SCI, V96, P6030, DOI 10.3168/jds.2013-6766; Salvetti E, 2011, INT J SYST EVOL MICR, V61, P2520, DOI 10.1099/ijs.0.029231-0; SHARPE ME, 1973, J GEN MICROBIOL, V77, P37, DOI 10.1099/00221287-77-1-37; Shi WB, 2014, GENOME RES, V24, P1517, DOI 10.1101/gr.168245.113; Stewart CS., 1997, RUMEN MICROBIAL ECOS, P10, DOI [10.1007/978-94-009-1453-7_2, DOI 10.1007/978-94-009-1453-7_2]; Sun XZ, 2011, ANIM FEED SCI TECH, V166-67, P391, DOI 10.1016/j.anifeedsci.2011.04.027; VICINI JL, 1987, APPL ENVIRON MICROB, V53, P1273, DOI 10.1128/AEM.53.6.1273-1276.1987; Wedlock DN, 2013, ANIMAL, V7, P244, DOI 10.1017/S1751731113000682; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zeitz JO, 2013, EUR J PROTISTOL, V49, P389, DOI 10.1016/j.ejop.2013.02.003; Zened A, 2013, FEMS MICROBIOL ECOL, V83, P504, DOI 10.1111/1574-6941.12011; Zhou M, 2009, APPL ENVIRON MICROB, V75, P6524, DOI 10.1128/AEM.02815-08	46	155	166	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103171	10.1371/journal.pone.0103171	http://dx.doi.org/10.1371/journal.pone.0103171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078564	Green Published, gold, Green Submitted			2022-12-25	WOS:000339954800031
J	Koelzer, S; Kolsch, Y; Panfilio, KA				Koelzer, Stefan; Koelsch, Yvonne; Panfilio, Kristen A.			Visualizing Late Insect Embryogenesis: Extraembryonic and Mesodermal Enhancer Trap Expression in the Beetle Tribolium castaneum	PLOS ONE			English	Article							EMBRYONIC LETHAL MUTATIONS; CHITIN-SYNTHASE GENES; RED FLOUR BEETLE; TBX20-RELATED GENES; SEGMENTATION CLOCK; SEROSA; CELL; MORPHOGENESIS; ANTERIOR; MARKER	The beetle Tribolium castaneum has increasingly become a powerful model for comparative research on insect development. One recent resource is a collection of piggyBac transposon-based enhancer trap lines. Here, we provide a detailed analysis of three selected lines and demonstrate their value for investigations in the second half of embryogenesis, which has thus far lagged behind research on early stages. Two lines, G12424 and KT650, show enhanced green fluorescent protein (EGFP) expression throughout the extraembryonic serosal tissue and in a few discrete embryonic domains. Intriguingly, both lines show for the first time a degree of regionalization within the mature serosa. However, their expression profiles illuminate distinct aspects of serosal biology: G12424 tracks the tissue's rapid maturation while KT650 expression likely reflects ongoing physiological processes. The third line, G04609, is stably expressed in mesodermal domains, including segmental muscles and the heart. Genomic mapping followed by in situ hybridization for genes near to the G04609 insertion site suggests that the transposon has trapped enhancer information for the Tribolium orthologue of midline (Tc-mid). Altogether, our analyses provide the first live imaging, long-term characterizations of enhancer traps from this collection. We show that EGFP expression is readily detected, including in heterozygote crosses that permit the simultaneous visualization of multiple tissue types. The tissue specificity provides live, endogenous marker gene expression at key developmental stages that are inaccessible for whole mount staining. Furthermore, the nonlocalized EGFP in these lines illuminates both the nucleus and cytoplasm, providing cellular resolution for morphogenesis research on processes such as dorsal closure and heart formation. In future work, identification of regulatory regions driving these enhancer traps will deepen our understanding of late developmental control, including in the extraembryonic domain, which is a hallmark of insect development but which is not yet well understood.	[Koelzer, Stefan; Koelsch, Yvonne; Panfilio, Kristen A.] Univ Cologne, Inst Dev Biol, D-50931 Cologne, Germany	University of Cologne	Panfilio, KA (corresponding author), Univ Cologne, Inst Dev Biol, D-50931 Cologne, Germany.	Kristen.Panfilio@alum.swarthmore.edu	Panfilio, Kristen/S-3179-2019	Panfilio, Kristen/0000-0002-6417-251X	Deutsche Forschungsgemeinschaft (German Research Foundation) [PA 2044/1-1]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This work was supported by Emmy Noether grant PA 2044/1-1 from the Deutsche Forschungsgemeinschaft (German Research Foundation) to K.A.P. The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akay T, 2001, J NEUROPHYSIOL, V85, P594, DOI 10.1152/jn.2001.85.2.594; Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; Arakane Y, 2004, INSECT BIOCHEM MOLEC, V34, P291, DOI 10.1016/j.ibmb.2003.11.004; Beermann A, 2011, DEVELOPMENT, V138, P2793, DOI 10.1242/dev.063644; Benton MA, 2013, DEVELOPMENT, V140, P3210, DOI 10.1242/dev.096271; Berghammer A, 1999, DEV GENES EVOL, V209, P382, DOI 10.1007/s004270050268; Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463; Blanchard GB, 2009, NAT METHODS, V6, P458, DOI [10.1038/nmeth.1327, 10.1038/NMETH.1327]; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; Brown S. J., 2009, COLD SPRING HARB PRO, V2009; Chen G, 2000, DEVELOPMENT, V127, P5145; da Fonseca RN, 2008, DEV CELL, V14, P605, DOI 10.1016/j.devcel.2008.02.011; DORN A, 1976, ZOOMORPHOLOGIE, V85, P111, DOI 10.1007/BF00995407; El-Sherif E, 2012, DEVELOPMENT, V139, P4341, DOI 10.1242/dev.085126; ENSLEE EC, 1981, J EMBRYOL EXP MORPH, V61, P35; Evdokimov AG, 2006, EMBO REP, V7, P1006, DOI 10.1038/sj.embor.7400787; Grossmann D, 2012, DEV BIOL, V370, P264, DOI 10.1016/j.ydbio.2012.08.005; Grossmann D, 2009, DEV GENES EVOL, V219, P469, DOI 10.1007/s00427-009-0310-z; Hammonds AS, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r140; Handel K, 2005, DEV GENES EVOL, V215, P13, DOI 10.1007/s00427-004-0446-9; Handel K, 2000, DEV GENES EVOL, V210, P167, DOI 10.1007/s004270050301; Horn C, 2000, DEV GENES EVOL, V210, P623, DOI 10.1007/s004270000111; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Jacobs CGC, 2013, DEV COMP IMMUNOL, V41, P263, DOI 10.1016/j.dci.2013.05.017; Jacobs CGC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1082; Janssen R, 2008, EVOL DEV, V10, P155, DOI 10.1111/j.1525-142X.2008.00223.x; Jin H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003195; Kittelmann S, 2013, DEV BIOL, V374, P174, DOI 10.1016/j.ydbio.2012.11.026; Lamer A, 2001, TISSUE CELL, V33, P580, DOI 10.1054/tice.2001.0213; Lorenzen MD, 2003, INSECT MOL BIOL, V12, P433, DOI 10.1046/j.1365-2583.2003.00427.x; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Miskolczi-McCallum CM, 2005, DEV BIOL, V278, P459, DOI 10.1016/j.ydbio.2004.11.026; MORI H, 1972, J INSECT PHYSIOL, V18, P675, DOI 10.1016/0022-1910(72)90193-X; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Panfilio KA, 2008, DEV BIOL, V313, P471, DOI 10.1016/j.ydbio.2007.11.004; Panfilio KA, 2013, BIOL OPEN, V2, P1108, DOI 10.1242/bio.20136072; Panfilio KA, 2010, DEV BIOL, V340, P100, DOI 10.1016/j.ydbio.2009.12.034; Panfilio KA, 2009, DEV BIOL, V333, P297, DOI 10.1016/j.ydbio.2009.06.036; Peel AD, 2010, DEV DYNAM, V239, P2875, DOI 10.1002/dvdy.22423; Qian L, 2005, DEV BIOL, V279, P509, DOI 10.1016/j.ydbio.2005.01.013; Reim I, 2005, MECH DEVELOP, V122, P1056, DOI 10.1016/j.mod.2005.04.006; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sarrazin AF, 2012, SCIENCE, V336, P338, DOI 10.1126/science.1218256; Schinko JB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-53; Schinko JB, 2012, DEV GENES EVOL, V222, P287, DOI 10.1007/s00427-012-0412-x; Schmitt-Engel C, 2012, DEV BIOL, V364, P224, DOI 10.1016/j.ydbio.2012.01.024; Sharma R, 2013, GENE EXPR PATTERNS, V13, P362, DOI 10.1016/j.gep.2013.07.002; Sharma R, 2013, DEV BIOL, V381, P121, DOI 10.1016/j.ydbio.2013.05.031; STANLEY MSM, 1970, ANN ENTOMOL SOC AM, V63, P1248, DOI 10.1093/aesa/63.5.1248; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Trauner J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-73; TRUCKENBRODT W, 1973, Z MORPHOL TIERE, V76, P193, DOI 10.1007/BF00280672; van der Zee M, 2005, CURR BIOL, V15, P624, DOI 10.1016/j.cub.2005.02.057; Yoshihara M, 2004, NEUROSCIENTIST, V10, P566, DOI 10.1177/1073858404268770; ZILL SN, 1985, J EXP BIOL, V116, P435	56	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103967	10.1371/journal.pone.0103967	http://dx.doi.org/10.1371/journal.pone.0103967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080214	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800101
J	Olivares, S; Green, RM; Henkel, AS				Olivares, Shantel; Green, Richard M.; Henkel, Anne S.			Endoplasmic Reticulum Stress Activates the Hepatic Activator Protein 1 Complex via Mitogen Activated Protein Kinase-Dependent Signaling Pathways	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; FATTY LIVER-DISEASE; CELL-DEATH; DOWN-REGULATION; AP-1; TRANSCRIPTION; APOPTOSIS; CANCER; GRP78; DYSREGULATION	Background and Aims: Endoplasmic reticulum (ER) stress is induced in many forms of chronic liver disease and may promote the development of hepatocellular carcinoma. The activator protein 1 (AP-1) complex is a transcription factor that promotes hepatic carcinogenesis in response to cellular stress. The aim of this study was to determine the role of ER stress in the regulation of the hepatic AP-1 complex. Methods: Human hepatocellular carcinoma (HepG2) cells and C57BL/6J mice were subjected to pharmacologic ER stress and the expression of AP-1-associated genes and proteins was assessed. To determine the role of MAPK signaling in ER stress-induced AP-1 activation, ER stress was induced in JNK-and ERK-inhibited HepG2 cells. Results: Induction of ER stress promoted the activation of both Jun- and Fos-related genes and proteins of the AP-1 complex in HepG2 cells and murine liver. Inhibition of ERK phosphorylation in HepG2 cells completely prevented ER stress-induced activation of the fos-related components of AP-1 whereas activation of Jun-related components was only partially attenuated. Conversely, inhibition of JNK phosphorylation in HepG2 cells reduced ER stress-induced activation of Jun-related components but did not prevent activation of fos-related components. Conclusions: ER stress activates the hepatic AP-1 complex via MAPK-dependent signaling pathways. ER stress-induced activation of Fos-related components is dependent primarily on ERK activation whereas ER stress-induced activation of Jun-related components is dependent primarily on JNK activation, although there is interplay between these regulatory pathways. These data implicate a novel signaling pathway by which sustained ER stress, as observed in many chronic liver diseases, may promote hepatic carcinogenesis.	[Olivares, Shantel; Green, Richard M.; Henkel, Anne S.] Northwestern Univ, Feinberg Sch Med, Div Gastroenterol & Hepatol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Henkel, AS (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Gastroenterol & Hepatol, Chicago, IL 60611 USA.	a-henkel2@northwestern.edu			NIH/NIDDK [R01DK080810, K08DK095992]; AGA Research Scholar Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093807, R01DK080810, K08DK095992] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AGA Research Scholar Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH/NIDDK grants R01DK080810 and K08DK095992 and an AGA Research Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Belfi CA, 1999, BIOCHEM BIOPH RES CO, V257, P361, DOI 10.1006/bbrc.1999.0472; Chang QS, 2009, J HEPATOL, V50, P323, DOI 10.1016/j.jhep.2008.07.037; Chen R, 2011, FOLIA BIOL-PRAGUE, V57, P87; Dai RY, 2009, INT J ONCOL, V34, P1749, DOI 10.3892/ijo_00000306; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Ertle J, 2011, INT J CANCER, V128, P2436, DOI 10.1002/ijc.25797; Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Han Hui, 2013, Frontiers in Genetics, V4, P224, DOI 10.3389/fgene.2013.00224; Henkel AS, 2011, J LIPID RES, V52, P289, DOI 10.1194/jlr.M012781; Henkel AS, 2009, J BIOL CHEM, V284, P31807, DOI 10.1074/jbc.M109.017970; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Honma Y, 2013, EXP CELL RES; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Ji C, 2003, GASTROENTEROLOGY, V124, P1488, DOI 10.1016/S0016-5085(03)00276-2; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kawada N, 2009, J GASTROENTEROL, V44, P1190, DOI 10.1007/s00535-009-0112-0; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; Liu P, 2002, J HEPATOL, V37, P63, DOI 10.1016/S0168-8278(02)00064-8; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Nguyen DT, 2004, MOL BIOL CELL, V15, P4248, DOI 10.1091/mbc.E03-11-0851; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Tang J, 2012, CELL DEATH DIFFER, V19, P1779, DOI 10.1038/cdd.2012.60; Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu M, 2012, HEPATOL RES; Yang F, 2011, NEOPLASIA, V13, P590, DOI 10.1593/neo.11422; Yi P, 2012, MOL CANCER THER, V11, P2610, DOI 10.1158/1535-7163.MCT-12-0516; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	46	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103828	10.1371/journal.pone.0103828	http://dx.doi.org/10.1371/journal.pone.0103828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077945	Green Published, gold, Green Submitted			2022-12-25	WOS:000339954800086
J	Xu, P; Mohorianu, I; Yang, L; Zhao, HS; Gao, ZM; Dalmay, T				Xu, Ping; Mohorianu, Irina; Yang, Li; Zhao, Hansheng; Gao, Zhimin; Dalmay, Tamas			Small RNA Profile in Moso Bamboo Root and Leaf Obtained by High Definition Adapters	PLOS ONE			English	Article							MESSENGER-RNA; CELL-DEATH; MICRORNAS; ARABIDOPSIS; IDENTIFICATION; EXPRESSION; GENES; TARGETS; TRANSCRIPTS; SEQUENCES	Moso bamboo (Phyllostachy heterocycla cv. pubescens L.) is an economically important fast-growing tree. In order to gain better understanding of gene expression regulation in this important species we used next generation sequencing to profile small RNAs in leaf and roots of young seedlings. Since standard kits to produce cDNA of small RNAs are biased for certain small RNAs, we used High Definition adapters that reduce ligation bias. We identified and experimentally validated five new microRNAs and a few other small non-coding RNAs that were not microRNAs. The biological implication of microRNA expression levels and targets of microRNAs are discussed.	[Xu, Ping; Mohorianu, Irina; Dalmay, Tamas] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Yang, Li; Zhao, Hansheng; Gao, Zhimin] Int Ctr Bamboo, State Forestry Adm, Key Open Lab Sci & Technol Bamboo & Rattan, Beijing, Peoples R China	University of East Anglia; International Centre for Bamboo & Rattan	Dalmay, T (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	t.dalmay@uea.ac.uk	zhao, hansheng/GRS-2764-2022; Mohorianu, Irina/J-2549-2019; Dalmay, Tamas/E-1377-2011	Dalmay, Tamas/0000-0003-1492-5429; Mohorianu, Irina/0000-0003-4863-761X	State Forestry Administration of China [2011-4-55]; Biotechnology and Biological Sciences Research Council [BB/J021601/1]; BBSRC [BB/J021601/1] Funding Source: UKRI	State Forestry Administration of China; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The project received financial support from the State Forestry Administration of China (http://english.forestry.gov.cn) to ZG (grant 2011-4-55) and the Biotechnology and Biological Sciences Research Council (http://bbsrc.ac.uk) to TD (grant BB/J021601/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Alonso-Peral MM, 2010, PLANT PHYSIOL, V154, P757, DOI 10.1104/pp.110.160630; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Goyal AK, 2010, BIOINFORMATION, V5, P184, DOI 10.6026/97320630005184; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Gustafson AM, 2005, NUCLEIC ACIDS RES, V33, pD637, DOI 10.1093/nar/gki127; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; He CY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-119; Javelle M, 2012, NAT PROTOC, V7, P533, DOI 10.1038/nprot.2012.006; Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693; Kang MM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-360; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kruszka K, 2012, J PLANT PHYSIOL, V169, P1664, DOI 10.1016/j.jplph.2012.03.009; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Liu B, 2005, PLANT PHYSIOL, V139, P296, DOI 10.1104/pp.105.063420; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Lu SF, 2013, P NATL ACAD SCI USA, V110, P10848, DOI 10.1073/pnas.1308936110; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Meng YJ, 2009, PLANTA, V230, P883, DOI 10.1007/s00425-009-0994-3; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.0960-7412.2010.04208.x, 10.1111/j.1365-313X.2010.04208.x]; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sorefan Karim, 2012, Silence, V3, P4, DOI 10.1186/1758-907X-3-4; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Szittya G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000838; Wang B, 2012, GENE, V498, P36, DOI 10.1016/j.gene.2012.01.075; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Xu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028009; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zhang XH, 2011, FEBS LETT, V585, P435, DOI 10.1016/j.febslet.2010.12.036; Zhang Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhao HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078755; Zhelyazkova P, 2012, NUCLEIC ACIDS RES, V40, P3092, DOI 10.1093/nar/gkr1137	51	13	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103590	10.1371/journal.pone.0103590	http://dx.doi.org/10.1371/journal.pone.0103590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079776	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000339954800058
J	Choi, K; Ghaddar, B; Moya, C; Shi, H; Sridharan, GV; Lee, K; Jayaraman, A				Choi, KyungOh; Ghaddar, Bassel; Moya, Colby; Shi, Hai; Sridharan, Gautham V.; Lee, Kyongbum; Jayaraman, Arul			Analysis of Transcription Factor Network Underlying 3T3-L1 Adipocyte Differentiation	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; ELEMENT-BINDING PROTEIN-1; PPAR-GAMMA; FATTY-ACIDS; C/EBP-ALPHA; EXPRESSION; ADIPOGENESIS; BETA; GENE; LIGANDS	Lipid accumulation in adipocytes reflects a balance between enzymatic pathways leading to the formation and breakdown of esterified lipids, primarily triglycerides. This balance is extremely important, as both high and low lipid levels in adipocytes can have deleterious consequences. The enzymes responsible for lipid synthesis and breakdown (lipogenesis and lipolysis, respectively) are regulated through the coordinated actions of several transcription factors (TFs). In this study, we examined the dynamics of several key transcription factors (TFs) - PPAR gamma, C/EBP beta, CREB, NFAT, FoxO1, and SREBP-1c-during adipogenic differentiation (week 1) and ensuing lipid accumulation. The activation profiles of these TFs at different times following induction of adipogenic differentiation were quantified using 3T3-L1 reporter cell lines constructed to secrete the Gaussia luciferase enzyme upon binding of a TF to its DNA binding element. The dynamics of the TFs was also modeled using a combination of logical gates and ordinary differential equations, where the logical gates were used to explore different combinations of activating inputs for PPAR gamma, C/EBP beta, and SREBP-1c. Comparisons of the experimental profiles and model simulations suggest that SREBP-1c could be independently activated by either insulin or PPAR gamma, whereas PPAR gamma activation required both C/EBP beta as well as a putative ligand. Parameter estimation and sensitivity analysis indicate that feedback activation of SREBP-1c by PPAR gamma is negligible in comparison to activation of SREBP-1c by insulin. On the other hand, the production of an activating ligand could quantitatively contribute to a sustained elevation in PPAR gamma activity.	[Choi, KyungOh; Moya, Colby; Jayaraman, Arul] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA; [Ghaddar, Bassel; Shi, Hai; Sridharan, Gautham V.; Lee, Kyongbum] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA	Texas A&M University System; Texas A&M University College Station; Tufts University	Lee, K (corresponding author), Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.	kyongbum.lee@tufts.edu; arulj@tamu.edu		Lee, Kyongbum/0000-0002-0699-8057; Choi, Kyungoh/0000-0001-8585-1266	National Science Foundation (CBET) [0846453]; National Institutes of Health [1R56DK081768]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK081768] Funding Source: NIH RePORTER	National Science Foundation (CBET)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the National Science Foundation (CBET 0846453) to AJ and the National Institutes of Health (1R56DK081768) to AJ and KL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000340; Arner P, 2011, NATURE, V478, P110, DOI 10.1038/nature10426; Bergalet J, 2011, MOL CANCER RES, V9, P485, DOI 10.1158/1541-7786.MCR-10-0351; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Chan CP, 2010, J CELL SCI, V123, P1438, DOI 10.1242/jcs.067819; Chehab FF, 2008, ENDOCRINOLOGY, V149, P925, DOI 10.1210/en.2007-1355; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Fu MG, 2001, CIRC RES, V89, P1058, DOI 10.1161/hh2301.099642; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Joshi M, 2006, METAB ENG, V8, P447, DOI 10.1016/j.ymben.2006.04.003; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Kraeutler MJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-157; Krell T, 2007, J MOL BIOL, V369, P1188, DOI 10.1016/j.jmb.2007.04.025; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Limor R, 2008, AM J HYPERTENS, V21, P219, DOI 10.1038/ajh.2007.39; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Morris MK, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001099; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; OLEFSKY JM, 1977, ENDOCRINOLOGY, V100, P1169; Penumetcha M, 2012, PPAR RES, V2012, DOI 10.1155/2012/858352; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; RON D, 1992, J CLIN INVEST, V89, P223, DOI 10.1172/JCI115566; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Savage David B., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405008793; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; SHOBACK DM, 1984, METABOLISM, V33, P509, DOI 10.1016/0026-0495(84)90004-0; Si YG, 2007, AM J PHYSIOL-ENDOC M, V292, pE1637, DOI 10.1152/ajpendo.00670.2006; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Simicevic J, 2013, NAT METHODS, V10, P570, DOI [10.1038/NMETH.2441, 10.1038/nmeth.2441]; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tian J, 2009, GENE THER, V16, P874, DOI 10.1038/gt.2009.46; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tzameli I, 2004, J BIOL CHEM, V279, P36093, DOI 10.1074/jbc.M405346200; Waite KJ, 2001, J BIOL CHEM, V276, P7062, DOI 10.1074/jbc.M007894200; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Wickelgren I, 1998, SCIENCE, V280, P1364, DOI 10.1126/science.280.5368.1364; Wittmann DM, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-98; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Yang TTC, 2003, J BIOL CHEM, V278, P15874, DOI 10.1074/jbc.M211560200; Yang XY, 2000, J BIOL CHEM, V275, P4541, DOI 10.1074/jbc.275.7.4541; Yellaturu CR, 2009, J BIOL CHEM, V284, P31726, DOI 10.1074/jbc.M109.050914; Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	61	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e100177	10.1371/journal.pone.0100177	http://dx.doi.org/10.1371/journal.pone.0100177			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075860	gold, Green Published, Green Submitted			2022-12-25	WOS:000340028800005
J	Dijoux, L; Viard, F; Payri, C				Dijoux, Laury; Viard, Frederique; Payri, Claude			The More We Search, the More We Find: Discovery of a New Lineage and a New Species Complex in the Genus Asparagopsis	PLOS ONE			English	Article							MARINE ALGAL FLORA; TAXIFORMIS BONNEMAISONIALES; SARGASSUM-MANGAREVENSE; CRYPTIC INTRODUCTIONS; MOLECULAR EVIDENCE; TURBINARIA-ORNATA; INVASION PATTERNS; GENETIC DIVERSITY; RHODOPHYTA; PHYLOGEOGRAPHY	In the past few decades, in the marine realm in particular, the use of molecular tools has led to the discovery of hidden taxonomic diversity, revealing complexes of sister species. A good example is the red algal genus Asparagopsis. The two species (A. armata and A. taxiformis) recognized in this genus have been introduced in many places around the world. Within the nominal species A. taxiformis, previous molecular analyses have uncovered several lineages, suggesting the existence of sister species or subspecies. Although the genus has been well studied in some regions (e.g., the Mediterranean Sea and Hawaii), it remains poorly investigated in others (e.g., South Pacific). Our study mainly focused on these latter areas to clarify lineages and better determine lineage status (i.e., native vs. introduced). A total of 188 specimens were collected from 61 sites, 58 of which had never been sampled before. We sequenced the DNA from samples for three markers and obtained 112 sequences for the chloroplastic RuBisCo spacer, 118 sequences for the nuclear LSU rRNA gene, and 174 for the mitochondrial spacer cox2-3. Phylogenetic analyses using all three markers suggested the existence of two cryptic sister species with the discovery of a new clade within A. armata. This clade was found only in Western Australia, Tasmania and New Zealand, and is thus restricted to a subregional biogeographic unit. We also discovered a new, fifth lineage for A. taxiformis restricted to the South Pacific and Western Australia. Except for this newly described lineage, all other lineages showed a global distribution influenced by introduction events. These results illustrate the difficulty in accurately defining cosmopolitan species. Our findings also highlight the need for targeted (i.e., in poorly studied areas) and geographically extensive sampling efforts when studying taxa that have been introduced globally and that are likely to hide species complexes.	[Dijoux, Laury; Payri, Claude] Inst Rech Dev, CoReUs LabEx CORAIL UR227, Noumea, New Caledonia; [Dijoux, Laury; Viard, Frederique] Univ Paris 06, Sorbonne Univ, UMR 7144, Stn Biol Roscoff, Roscoff, France; [Dijoux, Laury; Viard, Frederique] CNRS, UMR 7144, Divco Team, Stn Biol Roscoff, Roscoff, France	Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Dijoux, L (corresponding author), Inst Rech Dev, CoReUs LabEx CORAIL UR227, Noumea, New Caledonia.	laury.dijoux@ird.fr; claude.payri@ird.fr	Payri, Claude/K-5646-2016; Viard, Frédérique/O-4360-2018	Payri, Claude/0000-0002-0393-6811; Viard, Frédérique/0000-0001-5603-9527	ERA-net NETBIOME; ANR [PCS-10-NET-BIOME00]; Province Sud (New Caledonia)	ERA-net NETBIOME; ANR(French National Research Agency (ANR)); Province Sud (New Caledonia)	This work was supported by ERA-net NETBIOME and ANR grants, project SEAPROLIF (PCS-10-NET-BIOME00). L.D. also wishes to acknowledge support provided through a PhD grant by the Province Sud (New Caledonia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott IA, 1984, LIMU ETHNOBOTANY HAW; Adams NM, 1994, COMMON SEAWEEDS NZ; Altamirano Maria, 2008, Acta Botanica Malacitana, V33, P5; Andreakis N, 2004, EUR J PHYCOL, V39, P273, DOI 10.1080/0967026042000236436; Andreakis N, 2009, MOL ECOL, V18, P212, DOI 10.1111/j.1365-294X.2008.04022.x; Andreakis N, 2007, MOL ECOL, V16, P2285, DOI 10.1111/j.1365-294X.2007.03306.x; Appeltans W, 2011, WORLD REGISTER MARIN; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barber PH, 2006, EVOLUTION, V60, P1825; Blomster J, 2002, AM J BOT, V89, P1756, DOI 10.3732/ajb.89.11.1756; Bolton JJ, 2011, AFR J MAR SCI, V33, P263, DOI 10.2989/1814232X.2011.600339; BONIN DR, 1987, NEW ZEAL J BOT, V25, P577, DOI 10.1080/0028825X.1987.10410088; Boudouresque CF, 2002, MAR POLLUT BULL, V44, P32, DOI 10.1016/S0025-326X(01)00150-3; Carlton James T., 2009, V204, P13; Carlton JT, 1996, ECOLOGY, V77, P1653, DOI 10.2307/2265767; Chualain FN, 2004, J PHYCOL, V40, P1112, DOI 10.1111/j.1529-8817.2004.03135.x; Colwell RK., 2013, STAT ESTIMATION SPEC; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Coyer JA, 2011, MOL PHYLOGENET EVOL, V58, P283, DOI 10.1016/j.ympev.2010.11.015; Crandall ED, 2008, MOL ECOL, V17, P611, DOI 10.1111/j.1365-294X.2007.03600.x; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Delile AR, 1813, HIST NATURELLE, V2, P145; Farnham W.F., 1980, SYSTEMATICS ASS SPEC, V17B, P875; Feldmann J, 1939, CR HEBD ACAD SCI, V208, P1420; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flagella MM, 2007, MAR POLLUT BULL, V54, P1395, DOI 10.1016/j.marpolbul.2007.05.015; Freshwater DW, 2010, CRYPTOGAMIE ALGOL, V31, P435; Freshwater D. Wilson, 1999, Phycological Research, V47, P33, DOI 10.1111/j.1440-1835.1999.tb00281.x; Gaither MR, 2013, J BIOGEOGR, V40, P1638, DOI 10.1111/jbi.12126; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Gonzalez A, 2012, J PHYCOL, V48, P1153, DOI 10.1111/j.1529-8817.2012.01200.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guerra-Garcia JM, 2012, J EXP MAR BIOL ECOL, V416, P121, DOI 10.1016/j.jembe.2012.02.018; Guiry MD, 2014, ALGAEBASE; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harvey W.H., 1855, T R IRISH ACAD, V22, P525, DOI DOI 10.5962/BHL.TITLE.112433; Haydar D, 2011, DIVERS DISTRIB, V17, P68, DOI 10.1111/j.1472-4642.2010.00718.x; Haydar D, 2012, DIVERS DISTRIB, V18, P101, DOI 10.1111/j.1472-4642.2011.00863.x; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Jousson O, 2000, NATURE, V408, P157, DOI 10.1038/35041623; Kato A, 2009, PHYCOL RES, V57, P74, DOI 10.1111/j.1440-1835.2008.00523.x; Klautau M, 1999, EVOLUTION, V53, P1414, DOI 10.1111/j.1558-5646.1999.tb05406.x; Klein J, 2008, MAR POLLUT BULL, V56, P205, DOI 10.1016/j.marpolbul.2007.09.043; Kraan S, 2005, J APPL PHYCOL, V17, P103, DOI 10.1007/s10811-005-2799-5; Layeghifard M, 2012, MOL PHYLOGENET EVOL, V64, P190, DOI 10.1016/j.ympev.2012.03.016; Lee KM, 2014, J APPL PHYCOL, V26, P491, DOI 10.1007/s10811-013-0052-1; LENAERS G, 1989, J MOL EVOL, V29, P40, DOI 10.1007/BF02106180; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mackie JA, 2006, MAR BIOL, V149, P285, DOI 10.1007/s00227-005-0196-x; MAGGS CA, 1992, J PHYCOL, V28, P214, DOI 10.1111/j.0022-3646.1992.00214.x; Mattio L, 2010, CRYPTOGAMIE ALGOL, V31, P467; May V, 1953, NATL HERBARIUM, V2, P38; McIvor L, 2001, MOL ECOL, V10, P911, DOI 10.1046/j.1365-294X.2001.01240.x; Meinesz Alexandre, 2001, Biological Invasions, V3, P201, DOI 10.1023/A:1014549500678; Mineur F, 2007, MAR BIOL, V151, P1299, DOI 10.1007/s00227-006-0567-y; Mineur F, 2010, P ROY SOC B-BIOL SCI, V277, P2693, DOI 10.1098/rspb.2010.0494; Muirhead JR, 2008, MOL ECOL, V17, P1020, DOI 10.1111/j.1365-294X.2008.03669.x; Muirhead JR, 2006, FRESHWATER BIOL, V51, P1696, DOI 10.1111/j.1365-2427.2006.01614.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; N'Yeurt ADR, 2006, CRYPTOGAMIE ALGOL, V27, P111; N'Yeurt ADR, 2010, CRYPTOGAMIE ALGOL, V31, P3; Posada D, 2006, MOL ECOL NOTES, V6, P590, DOI 10.1111/j.1471-8286.2006.01368.x; Price J. H., 1986, B BRIT MUS NAT HIST, V15, P1; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Sala E, 1997, J EXP MAR BIOL ECOL, V212, P25, DOI 10.1016/S0022-0981(96)02745-1; Sauvageau C, 1925, CR HEBD ACAD SCI, V180, P1887; Schaffelke B, 2002, MAR POLLUT BULL, V44, P204, DOI 10.1016/S0025-326X(01)00202-8; Schmidt H, 2000, ZOOL SCR, V29, P17, DOI 10.1046/j.1463-6409.2000.00026.x; Sherwood AR, 2008, PHYCOLOGIA, V47, P79, DOI 10.2216/07-39.1; SILVA P.C., 1996, U CALIFORNIA PUBLICA, V79, P1, DOI DOI 10.2216/i0031-8884-38-4-342b.1; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stiger V, 1999, BOT MAR, V42, P295, DOI 10.1515/BOT.1999.033; Stiger V, 1999, MAR ECOL PROG SER, V191, P91, DOI 10.3354/meps191091; Streftaris N, 2006, MEDITERR MAR SCI, V7, P87, DOI 10.12681/mms.180; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor R., 1999, Botanical Journal of Scotland, V51, P195; Tellier F, 2009, MOL PHYLOGENET EVOL, V53, P679, DOI 10.1016/j.ympev.2009.07.030; Todaro MA, 1996, MAR BIOL, V125, P735, DOI 10.1007/BF00349256; Trevisan VBA, 1845, SEMINARIE PADOUE, P1; Verlaque M, 2004, BIOL INVASIONS, V6, P269, DOI 10.1023/B:BINV.0000034589.18347.d3; Voisin M, 2005, P NATL ACAD SCI USA, V102, P5432, DOI 10.1073/pnas.0501754102; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Womerseley HBS, 1996, FLORA AUSTR 5 S, V5, P325; Zanolla M, 2014, PHYCOLOGIA, V53, P233, DOI 10.2216/13-247.1; Zhan AB, 2010, MOL ECOL, V19, P4678, DOI 10.1111/j.1365-294X.2010.04837.x; Zuccarello GC, 1999, MOL ECOL, V8, P1443, DOI 10.1046/j.1365-294x.1999.00710.x; Zuccarello GC, 2002, PHYCOLOGIA, V41, P49, DOI 10.2216/i0031-8884-41-1-49.1	90	48	48	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103826	10.1371/journal.pone.0103826	http://dx.doi.org/10.1371/journal.pone.0103826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076489	Green Published, Green Submitted, gold			2022-12-25	WOS:000340028800081
J	Ma, HR; Yang, X; Lu, Z; Liu, N; Chen, YJ				Ma, Hairong; Yang, Xin; Lu, Zhuo; Liu, Nan; Chen, Yijun			The "Gate Keeper'' Role of Trp222 Determines the Enantiopreference of Diketoreductase toward 2-Chloro-1-Phenylethanone	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; ACINETOBACTER-BAYLYI; DIRECTED MUTAGENESIS; DICARBONYL REDUCTION; ESCHERICHIA-COLI; GENETIC-CODE; SPECIFICITY; DEHYDROGENASE; EVOLUTION; CATALYSIS	Trp222 of diketoreductase (DKR), an enzyme responsible for reducing a variety of ketones to chiral alcohols, is located at the hydrophobic dimeric interface of the C-terminus. Single substitutions at DKR Trp222 with either canonical (Val, Leu, Met, Phe and Tyr) or unnatural amino acids (UAAs) (4-cyano-L-phenylalanine, 4-methoxy-L-phenylalanine, 4-phenyl-L-phenyalanine, O-tert- butyl-L-tyrosine) inverts the enantiotope preference of the enzyme toward 2-chloro-1-phenylethanone with close side chain correlation. Analyses of enzyme activity, substrate affinity and ternary structure of the mutants revealed that substitution at Trp222 causes a notable change in the overall enzyme structure, and specifically in the entrance tunnel to the active center. The size of residue 222 in DKR is vital to its enantiotope preference. Trp222 serves as a "gate keeper'' to control the direction of substrate entry into the active center. Consequently, opposite substrate-binding orientations produce respective alcohol enantiomers.	[Ma, Hairong; Yang, Xin; Lu, Zhuo; Liu, Nan; Chen, Yijun] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Ma, Hairong; Yang, Xin; Lu, Zhuo; Liu, Nan; Chen, Yijun] China Pharmaceut Univ, Biol Chem Lab, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University	Chen, YJ (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	yjchen@cpu.edu	Chen, Yijun/H-3209-2019	Chen, Yijun/0000-0002-4920-152X	"111 Project" - Ministry of Education of China; State Administration of Foreign Experts Affairs of China [111-2-07]; Research Project of State Key Laboratory of Natural Medicines, China Pharmaceutical University [SKLNMZZCX201301]; PAPD of Jiangsu Province, China	"111 Project" - Ministry of Education of China; State Administration of Foreign Experts Affairs of China; Research Project of State Key Laboratory of Natural Medicines, China Pharmaceutical University; PAPD of Jiangsu Province, China	This work was supported by the "111 Project'' funded by the Ministry of Education of China and the State Administration of Foreign Experts Affairs of China (No. 111-2-07), the Research Project of State Key Laboratory of Natural Medicines, China Pharmaceutical University (No. SKLNMZZCX201301) and the PAPD of Jiangsu Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baerga-Ortiz A, 2006, CHEM BIOL, V13, P277, DOI 10.1016/j.chembiol.2006.01.004; Bottcher D, 2010, CURR OPIN MICROBIOL, V13, P274, DOI 10.1016/j.mib.2010.01.010; Cassimjee KE, 2012, ORG BIOMOL CHEM, V10, P5466, DOI 10.1039/c2ob25893e; Chen YJ, 2012, CHEM SOC REV, V41, P1742, DOI 10.1039/c1cs15230k; Copeland R. A., 2000, ENZYMES PRACTICAL IN, P76; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Hoesl MG, 2012, CURR OPIN BIOTECH, V23, P751, DOI 10.1016/j.copbio.2011.12.027; Huang WC, 2011, METALLOMICS, V3, P410, DOI 10.1039/c0mt00082e; Huang Y, 2012, BMB REP, V45, P452, DOI 10.5483/BMBRep.2012.45.8.064; Huang Y, 2012, BIOCHIMIE, V94, P471, DOI 10.1016/j.biochi.2011.08.015; Huang Y, 2010, CURR ORG CHEM, V14, P1447, DOI 10.2174/138527210791616795; Humble MS, 2012, CHEMCATCHEM, V4, P1167, DOI 10.1002/cctc.201100487; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Liu J, 2010, BIOORG MED CHEM LETT, V20, P5613, DOI 10.1016/j.bmcl.2010.08.049; Liu ZZ, 2012, AMINO ACIDS, V43, P2553, DOI 10.1007/s00726-012-1311-1; Lu ML, 2012, CHEM COMMUN, V48, P11352, DOI 10.1039/c2cc36334h; Musa MM, 2009, CHEMCATCHEM, V1, P89, DOI 10.1002/cctc.200900033; Otten LG, 2010, TRENDS BIOTECHNOL, V28, P46, DOI 10.1016/j.tibtech.2009.10.001; Reetz MT, 2011, ANGEW CHEM INT EDIT, V50, P138, DOI 10.1002/anie.201000826; Reetz MT, 2001, ANGEW CHEM INT EDIT, V40, P3589, DOI 10.1002/1521-3773(20011001)40:19<3589::AID-ANIE3589>3.0.CO;2-X; Santoro SW, 2002, NAT BIOTECHNOL, V20, P1044, DOI 10.1038/nbt742; Shehzad A, 2013, CHEM COMMUN, V49, P4694, DOI 10.1039/c3cc39076d; Tang WL, 2010, CHEM COMMUN, V46, P5461, DOI 10.1039/c0cc00735h; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; WU XG, 2011, CHINESE SOCIOL REV, V44, P3; Wu XR, 2011, ACS CATAL, V1, P1661, DOI 10.1021/cs200408y; Wu XR, 2010, AMINO ACIDS, V39, P305, DOI 10.1007/s00726-009-0390-0; Wu XR, 2009, TETRAHEDRON-ASYMMETR, V20, P2504, DOI 10.1016/j.tetasy.2009.10.036; Wu XR, 2009, ACTA BIOCH BIOPH SIN, V41, P163, DOI 10.1093/abbs/gmn019; Young DD, 2011, BIOORG MED CHEM LETT, V21, P7502, DOI 10.1016/j.bmcl.2011.09.108; Young DD, 2011, BIOCHEMISTRY-US, V50, P1894, DOI 10.1021/bi101929e	32	18	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103792	10.1371/journal.pone.0103792	http://dx.doi.org/10.1371/journal.pone.0103792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072248	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600088
J	Martinez-Gonzalez, MA; Garcia-Arellano, A; Toledo, E; Bes-Rastrollo, M; Bullo, M; Corella, D; Fito, M; Ros, E; Lamuela-Raventos, RM; Rekondo, J; Gomez-Gracia, E; Fiol, M; Santos-Lozano, JM; Serra-Majem, L; Martinez, JA; Eguaras, S; Saez-Tormo, G; Pinto, X; Estruch, R				Martinez-Gonzalez, Miguel A.; Garcia-Arellano, Ana; Toledo, Estefania; Bes-Rastrollo, Maira; Bullo, Monica; Corella, Dolores; Fito, Montserrat; Ros, Emilio; Maria Lamuela-Raventos, Rosa; Rekondo, Javier; Gomez-Gracia, Enrique; Fiol, Miquel; Manuel Santos-Lozano, Jose; Serra-Majem, Lluis; Alfredo Martinez, J.; Eguaras, Sonia; Saez-Tormo, Guillermo; Pinto, Xavier; Estruch, Ramon			Obesity Indexes and Total Mortality among Elderly Subjects at High Cardiovascular Risk: The PREDIMED Study	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY QUESTIONNAIRE; ALL-CAUSE MORTALITY; TO-HEIGHT RATIO; WAIST CIRCUMFERENCE; ASSOCIATION; DISEASE; OVERWEIGHT; ADIPOSITY; ADULTS	Background: Different indexes of regional adiposity have been proposed for identifying persons at higher risk of death. Studies specifically assessing these indexes in large cohorts are scarce. It would also be interesting to know whether a dietary intervention may counterbalance the adverse effects of adiposity on mortality. Methods: We assessed the association of four different anthropometric indexes (waist-to-height ratio (WHtR), waist circumference (WC), body mass index (BMI) and height) with all-cause mortality in 7447 participants at high cardiovascular risk from the PREDIMED trial. Forty three percent of them were men (55 to 80 years) and 57% were women (60 to 80 years). All of them were initially free of cardiovascular disease. The recruitment took place in 11 recruiting centers between 2003 and 2009. Results: After adjusting for age, sex, smoking, diabetes, hypertension, intervention group, family history of coronary heart disease, and leisure-time physical activity, WC and WHtR were found to be directly associated with a higher mortality after 4.8 years median follow-up. The multivariable-adjusted HRs for mortality of WHtR (cut-off points: 0.60, 0.65, 0.70) were 1.02 (0.78-1.34), 1.30 (0.97-1.75) and 1.55 (1.06-2.26). When we used WC (cut-off points: 100, 105 and 110 cm), the multivariable adjusted Hazard Ratios (HRs) for mortality were 1.18 (0.88-1.59), 1.02 (0.74-1.41) and 1.57 (1.19-2.08). In all analyses, BMI exhibited weaker associations with mortality than WC or WHtR. The direct association between WHtR and overall mortality was consistent within each of the three intervention arms of the trial. Conclusions: Our study adds further support to a stronger association of abdominal obesity than BMI with total mortality among elderly subjects at high risk of cardiovascular disease. We did not find evidence to support that the PREDIMED intervention was able to counterbalance the harmful effects of increased adiposity on total mortality.	[Martinez-Gonzalez, Miguel A.; Garcia-Arellano, Ana; Toledo, Estefania; Bes-Rastrollo, Maira; Bullo, Monica; Corella, Dolores; Fito, Montserrat; Ros, Emilio; Maria Lamuela-Raventos, Rosa; Rekondo, Javier; Gomez-Gracia, Enrique; Fiol, Miquel; Manuel Santos-Lozano, Jose; Serra-Majem, Lluis; Alfredo Martinez, J.; Eguaras, Sonia; Saez-Tormo, Guillermo; Pinto, Xavier; Estruch, Ramon] Inst Salud Carlos II, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Martinez-Gonzalez, Miguel A.; Garcia-Arellano, Ana; Toledo, Estefania; Bes-Rastrollo, Maira; Bullo, Monica; Maria Lamuela-Raventos, Rosa; Rekondo, Javier; Gomez-Gracia, Enrique; Serra-Majem, Lluis; Alfredo Martinez, J.; Saez-Tormo, Guillermo; Pinto, Xavier; Estruch, Ramon] Inst Salud Carlos III, PREDIMED Prevenc Con Dieta Mediterranea Network, Madrid, Spain; [Martinez-Gonzalez, Miguel A.; Garcia-Arellano, Ana; Toledo, Estefania; Bes-Rastrollo, Maira; Eguaras, Sonia] Univ Navarra Osasunbidea, Dept Prevent Med & Publ Hlth, Serv Navarro Salud, Pamplona, Spain; [Bullo, Monica] Univ Rovira & Virgili, Hosp Univ Sant Joan, Inst Invest Sanitaria Pere Virgili, Dept Human Nutr, E-43201 Reus, Spain; [Corella, Dolores] Univ Valencia, Dept Prevent Med, Valencia, Spain; [Fito, Montserrat] Hosp Mar, Inst Recerca, Cardiovasc & Nutr Res Grp, Barcelona, Spain; [Ros, Emilio] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Dept Endocrinol & Nutr,Lipid Clin, Barcelona, Spain; [Maria Lamuela-Raventos, Rosa] Univ Barcelona, Inst Invest Nutr & Seguridad Alimentaria, Sch Pharm Xarxa Referencia Tecnol Dels Aliments, Dept Nutr & Food Sci, Barcelona, Spain; [Rekondo, Javier] Univ Hosp Alava, Dept Cardiol, Vitoria, Spain; [Gomez-Gracia, Enrique] Univ Malaga, Dept Prevent Med, E-29071 Malaga, Spain; [Fiol, Miquel] Univ Balear Islands, Inst Hlth Sci, Palma de Mallorca, Spain; [Fiol, Miquel] Hosp Son Espases, Palma de Mallorca, Spain; [Manuel Santos-Lozano, Jose] San Pablo Hlth Ctr, Dept Family Med, Primary Care Div Seville, Seville, Spain; [Serra-Majem, Lluis] Univ Los Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Alfredo Martinez, J.] Univ Navarra, Dept Nutr & Food Sci Physiol & Toxicol, E-31080 Pamplona, Spain; [Saez-Tormo, Guillermo] Univ Valencia, Dept Biochem & Mol Biol, Serv Clin Anal, Valencia, Spain; [Pinto, Xavier] Hosp Univ Bellvitge, Hosp Llobregat, Lipids & Vasc Risk Unit, Barcelona, Spain; [Estruch, Ramon] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Dept Internal Med, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Servicio Navarro de Salud - Osasunbidea; University of Navarra; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Valencia; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Universidad de Malaga; Hospital Universitari Son Espases; University of Navarra; University of Valencia; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Martinez-Gonzalez, MA (corresponding author), Inst Salud Carlos II, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain.	mamartinez@unav.es	Estruch, Ramon/AAZ-3723-2020; Bulló, Mònica/F-2925-2016; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Pintó, Xavier/AGI-4297-2022; IBIS, ATENCION PRIMARIA/I-3524-2016; Serra-Majem, Lluis/I-6708-2019; Toledo, Estefania/H-6211-2014; Fiol, Miguel/F-6793-2016; Fito, Montserrat/C-1822-2012; Bes-Rastrollo, Maira/A-1329-2009; Santos-Lozano, JM/J-9312-2018; Lamuela-Raventos, Rosa M/F-3986-2016; Martinez Hernandez, J Alfredo/K-8709-2014	Bulló, Mònica/0000-0002-0218-7046; Pintó, Xavier/0000-0002-2216-2444; Serra-Majem, Lluis/0000-0002-9658-9061; Toledo, Estefania/0000-0002-6263-4434; Fiol, Miguel/0000-0002-5370-1391; Fito, Montserrat/0000-0002-1817-483X; Bes-Rastrollo, Maira/0000-0002-9139-4206; Santos-Lozano, JM/0000-0001-7097-5653; GARCIA ARELLANO, ANA/0000-0003-1491-9627; Saez, Guillermo/0000-0002-8164-4048; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808; Lamuela-Raventos, Rosa M/0000-0002-1287-4560; Ros, Emilio/0000-0002-2573-1294; Martinez Hernandez, J Alfredo/0000-0001-5218-6941	Spanish government, Instituto de Salud Carlos III (ISCIII) [RTIC G03/140, RTIC RD 06/0045]; Spanish government, Instituto de Salud Carlos III (ISCIII) through Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion [CIBERobn]; Centro Nacional de Investigaciones Cardiovasculares [CNIC 06/2007]; Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional [PI04-2239, PI 05/2584, CP06/00100, PI07/0240, PI07/1138, PI07/0954, PI07/0473, PI10/01407, PI10/02658, PI11/01647, P11/02505]; Ministerio de Ciencia e Innovacion [AGL-2009-13906-C02, AGL2010-22319-C03]; Fundacion Mapfre; Consejeria de Salud de la Junta de Andalucia [PI0105/2007]; Public Health Division of the Department of Health of the Autonomous Government of Catalonia, Generalitat Valenciana [ACOMP06109, GVACOMP2010-181, GVACOMP2011-151, CS2010-AP-111, CS2011-AP-042]; Regional Government of Navarra [P27/2011]	Spanish government, Instituto de Salud Carlos III (ISCIII); Spanish government, Instituto de Salud Carlos III (ISCIII) through Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion [CIBERobn]; Centro Nacional de Investigaciones Cardiovasculares; Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Mapfre; Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); Public Health Division of the Department of Health of the Autonomous Government of Catalonia, Generalitat Valenciana; Regional Government of Navarra	Supported by the official funding agency for biomedical research of the Spanish government, Instituto de Salud Carlos III (ISCIII), through grants provided to research networks specifically developed for the trial (RTIC G03/140, to Dr. Estruch; RTIC RD 06/0045, to Dr. Martinez-Gonzalez and through Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion [CIBERobn]), and by grants from Centro Nacional de Investigaciones Cardiovasculares (CNIC 06/2007), Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (PI04-2239, PI 05/2584, CP06/00100, PI07/0240, PI07/1138, PI07/0954, PI07/0473, PI10/01407, PI10/02658, PI11/01647, and P11/02505), Ministerio de Ciencia e Innovacion (AGL-2009-13906-C02 and AGL2010-22319-C03), Fundacion Mapfre 2010, Consejeria de Salud de la Junta de Andalucia (PI0105/2007), Public Health Division of the Department of Health of the Autonomous Government of Catalonia, Generalitat Valenciana (ACOMP06109, GVACOMP2010-181, GVACOMP2011-151, CS2010-AP-111, and CS2011-AP-042), and Regional Government of Navarra (P27/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martinez-Gonzalez MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250; Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Canning KL, 2013, J GERONTOL A-BIOL, V22; Cox BD, 1998, INT J OBESITY, V22, P966, DOI 10.1038/sj.ijo.0800705; de Hollander EL, 2012, INT J EPIDEMIOL, V41, P805, DOI 10.1093/ije/dys008; De Larochelliere E, 2014, ATHEROSCLEROSIS, V234, P23, DOI 10.1016/j.atherosclerosis.2014.01.053; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Elosua R, 2000, MED SCI SPORT EXER, V32, P1431, DOI 10.1097/00005768-200008000-00011; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Flanders WD, 2008, INT J OBESITY, V32, pS42, DOI 10.1038/ijo.2008.84; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gelber RP, 2008, J AM COLL CARDIOL, V52, P605, DOI 10.1016/j.jacc.2008.03.066; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x; Kahn HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050428; Katzmarzyk PT, 2013, OBESITY, V21, P1070, DOI 10.1002/oby.20151; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Kuk JL, 2009, J AM GERIATR SOC, V57, P2077, DOI 10.1111/j.1532-5415.2009.02486.x; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Masters RK, 2013, AM J EPIDEMIOL, V177, P431, DOI 10.1093/aje/kws325; Mauriege P, 2013, J PHYSIOL BIOCHEM, V69, P497, DOI 10.1007/s13105-013-0237-8; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Mombelli G, 2009, METAB SYNDR RELAT D, V7, P477, DOI 10.1089/met.2008.0101; Petursson H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026621; Reis JP, 2009, OBESITY, V17, P1232, DOI 10.1038/oby.2008.664; Reis JP, 2009, ANN EPIDEMIOL, V19, P134, DOI 10.1016/j.annepidem.2008.10.008; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; Sairenchi T, 2008, DIABETES CARE, V31, P583, DOI 10.2337/dc07-1390; Schneider Harald J, 2011, Diabetes Care, V34, pe7, DOI 10.2337/dc10-1794; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Taylor AE, 2010, AM J CLIN NUTR, V91, P547, DOI 10.3945/ajcn.2009.28757; Tobias DK, 2013, OBESITY, V21, P1746, DOI 10.1002/oby.20602; Zazpe I, 2008, J AM DIET ASSOC, V108, P1134, DOI 10.1016/j.jada.2008.04.011	38	21	23	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103246	10.1371/journal.pone.0103246	http://dx.doi.org/10.1371/journal.pone.0103246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072784	Green Published, gold			2022-12-25	WOS:000341307600034
J	Chu, M; Wang, LB; Wang, H; Shen, T; Yang, YQ; Sun, Y; Tang, NN; Ni, T; Zhu, J; Mailman, RB; Wang, Y				Chu, Min; Wang, Libo; Wang, Huan; Shen, Ting; Yang, Yanqin; Sun, Yun; Tang, Nannan; Ni, Ting; Zhu, Jun; Mailman, Richard B.; Wang, Yuan			A Novel Role of CDX1 in Embryonic Epicardial Development	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELLS; SMOOTH-MUSCLE; HOX GENES; HEART; MOUSE; DIFFERENTIATION; HEMATOPOIESIS; TRANSCRIPTION; PROGENITORS	The molecular mechanism that regulates epicardial development has yet to be understood. In this study, we explored the function of CDX1, a Caudal-related family member, in epicardial epithelial-to-mesenchymal transition (EMT) and in the migration and the differentiation of epicardium-derived progenitors into vascular smooth muscle cells. We detected a transient expression of CDX1 in murine embryonic hearts at 11.5 days post coitum (dpc). Using a doxycycline-inducible CDX1 mouse model, primary epicardium, and ex vivo heart culture, we further demonstrated that ectopic expression of CDX1 promoted epicardial EMT. In addition, a low-dose CDX1 induction led to enhanced migration and differentiation of epicardium-derived cells into alpha-SMA+ vascular smooth muscles. In contrast, either continued high-level induction of CDX1 or CDX1 deficiency attenuated the ability of epicardium-derived cells to migrate and to mature into smooth muscles induced by TGF-beta 1. Further RNA-seq analyses showed that CDX1 induction altered the transcript levels of genes involved in neuronal development, angiogenesis, and cell adhesions required for EMT. Our data have revealed a previously undefined role of CDX1 during epicardial development, and suggest that transient expression of CDX1 promotes epicardial EMT, whereas subsequent down-regulation of CDX1 after 11.5 dpc in mice is necessary for further subepicardial invasion of EPDCs and contribution to coronary vascular endothelium or smooth muscle cells.	[Chu, Min; Wang, Libo; Wang, Huan; Sun, Yun; Tang, Nannan; Wang, Yuan] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China; [Chu, Min; Wang, Libo; Wang, Huan; Sun, Yun; Tang, Nannan; Wang, Yuan] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Shen, Ting; Ni, Ting] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Shen, Ting; Ni, Ting] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Yang, Yanqin; Zhu, Jun] NHLBI, Syst Biol Ctr, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Mailman, Richard B.] Penn State Coll Med, Dept Pharmacol, Hershey, PA USA	East China Normal University; East China Normal University; Fudan University; Fudan University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Wang, Y (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China.	ywang@bio.ecnu.edu.cn		Mailman, Richard/0000-0003-1353-2738; wang, Yuan/0000-0002-0939-1269	Ministry of Science and Technology of China [2010CB945403, 2014CB964800]; National Science Foundation of China [31271589, 30971522]; Science and Technology Commission of Shanghai Municipality [11DZ2260300, 13JC1406402]; intramural research program at the National Heart Lung and Blood Institute (USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); intramural research program at the National Heart Lung and Blood Institute (USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Ministry of Science and Technology of China (2010CB945403 and 2014CB964800), the National Science Foundation of China (31271589 and 30971522), the Science and Technology Commission of Shanghai Municipality (11DZ2260300 and 13JC1406402), and the intramural research program at the National Heart Lung and Blood Institute (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avantaggiato V, 1998, MECH DEVELOP, V73, P221, DOI 10.1016/S0925-4773(98)00049-5; Bai YQ, 2003, ONCOGENE, V22, P7942, DOI 10.1038/sj.onc.1206634; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bhat AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037174; Braitsch CM, 2012, DEV BIOL, V368, P345, DOI 10.1016/j.ydbio.2012.06.002; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Compton LA, 2006, DEV DYNAM, V235, P82, DOI 10.1002/dvdy.20629; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Deb K, 2006, SCIENCE, V311, P992, DOI 10.1126/science.1120925; Funakoshi S, 2008, MOL CANCER RES, V6, P1478, DOI 10.1158/1541-7786.MCR-07-2161; Gittenberger-de Groot AC, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.05.002; Keller MS, 2004, AM J PHYSIOL-GASTR L, V287, pG104, DOI 10.1152/ajpgi.00484.2003; Lengerke C, 2011, DEV BIOL, V354, P134, DOI 10.1016/j.ydbio.2011.03.027; Lie-Venema H, 2007, THESCIENTIFICWORLDJO, V7, P1777, DOI 10.1100/tsw.2007.294; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Nordstrom U, 2006, PLOS BIOL, V4, P1438, DOI 10.1371/journal.pbio.0040252; Paik EJ, 2013, STEM CELL REP, V1, P425, DOI 10.1016/j.stemcr.2013.10.001; Savory JGA, 2011, DEVELOPMENT, V138, P1361, DOI 10.1242/dev.056622; Savory JGA, 2009, DEVELOPMENT, V136, P4099, DOI 10.1242/dev.041582; Savory JGA, 2009, DEV BIOL, V330, P114, DOI 10.1016/j.ydbio.2009.03.016; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Sturgeon K, 2011, DEVELOPMENT, V138, P65, DOI 10.1242/dev.058727; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; van den Akker E, 2002, DEVELOPMENT, V129, P2181; van Nes J, 2006, DEVELOPMENT, V133, P419, DOI 10.1242/dev.02216; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; Wang Q, 2013, STEM CELL RES, V11, P845, DOI 10.1016/j.scr.2013.05.012; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Wang Y, 2008, P NATL ACAD SCI USA, V105, P7756, DOI 10.1073/pnas.0708951105; Watanabe Y, 2010, CIRC RES, V106, P495, DOI 10.1161/CIRCRESAHA.109.201665; Young T, 2009, CURR TOP DEV BIOL, V88, P235, DOI 10.1016/S0070-2153(09)88008-3; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652	33	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103271	10.1371/journal.pone.0103271	http://dx.doi.org/10.1371/journal.pone.0103271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068460	gold, Green Submitted, Green Published			2022-12-25	WOS:000339993700053
J	Tremblay, RL; McCarthy, MA				Tremblay, Raymond L.; McCarthy, Michael A.			Bayesian Estimates of Transition Probabilities in Seven Small Lithophytic Orchid Populations: Maximizing Data Availability from Many Small Samples	PLOS ONE			English	Article							EPIPHYTIC ORCHID; LEPANTHES ORCHIDACEAE; DYNAMICS; REPRODUCTION; DISTURBANCE	Predicting population dynamics for rare species is of paramount importance in order to evaluate the likelihood of extinction and planning conservation strategies. However, evaluating and predicting population viability can be hindered from a lack of data. Rare species frequently have small populations, so estimates of vital rates are often very uncertain due to lack of data. We evaluated the vital rates of seven small populations from two watersheds with varying light environment of a common epiphytic orchid using Bayesian methods of parameter estimation. From the Lefkovitch matrices we predicted the deterministic population growth rates, elasticities, stable stage distributions and the credible intervals of the statistics. Populations were surveyed on a monthly basis between 18-34 months. In some of the populations few or no transitions in some of the vital rates were observed throughout the sampling period, however, we were able to predict the most likely vital rates using a Bayesian model that incorporated the transitions rates from the other populations. Asymptotic population growth rate varied among the seven orchid populations. There was little difference in population growth rate among watersheds even though it was expected because of physical differences as a result of differing canopy cover and watershed width. Elasticity analyses of Lepanthes rupestris suggest that growth rate is more sensitive to survival followed by growth, shrinking and the reproductive rates. The Bayesian approach helped to estimate transition probabilities that were uncommon or variable in some populations. Moreover, it increased the precision of the parameter estimates as compared to traditional approaches.	[Tremblay, Raymond L.] Univ Puerto Rico, Dept Biol, Humacao, PR 00792 USA; [Tremblay, Raymond L.] Univ Puerto Rico, Catec Ctr Appl Trop Ecol & Conservat, Rio Piedras, PR 00931 USA; [McCarthy, Michael A.] Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia	University of Puerto Rico; University of Puerto Rico Humacao; University of Puerto Rico; University of Puerto Rico Rio Piedras; University of Melbourne	Tremblay, RL (corresponding author), Univ Puerto Rico, Dept Biol, Humacao Campus, Humacao, PR 00792 USA.	raymond@hpcf.upr.edu	Tremblay, Raymond L/Q-3763-2019; McCarthy, Michael A/O-5655-2014	Tremblay, Raymond L/0000-0002-8588-4372; McCarthy, Michael A/0000-0003-1039-7980	FoPI grant from the University of Puerto Rico - Humacao campus; National Science Foundation, HRD [026200]; Australian Research Centre for Urban Ecology; Australian Research Council [DP0346165]; Applied Environmental Decision Analysis hub	FoPI grant from the University of Puerto Rico - Humacao campus; National Science Foundation, HRD(National Science Foundation (NSF)); Australian Research Centre for Urban Ecology; Australian Research Council(Australian Research Council); Applied Environmental Decision Analysis hub	This research was partly funded by a FoPI grant from the University of Puerto Rico - Humacao campus, and by the National Science Foundation, HRD #026200, the Australian Research Centre for Urban Ecology, the Australian Research Council (DP0346165), and the Applied Environmental Decision Analysis hub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JD, 1995, MEMOIRS NEW YORK BOT, P203; Agosto-Pedroza MM, 2003, LANKESTERIANA, V7, P65; Akcakaya H. Resit, 2000, Ecological Bulletins, V48, P23; [Anonymous], 2005, WINBUGS USER MANUAL; BERGER JO, 1988, AM SCI, V76, P159; Bernardo JM, 1994, BAYESIAN THEORY, P610; Blanco MA, 2005, ANN BOT-LONDON, V95, P763, DOI 10.1093/aob/mci090; Bolstad WM, 2007, INTRO BAYESIAN STAT, P437; BROWN S, 1983, SO44 USDA FOR SERV, P128; Campbell C, 2004, THESIS U MELBOURNE V; Carey PD, 2002, TRENDS AND FLUCTUATIONS AND UNDERLYING MECHANISMS IN TERRESTRIAL ORCHID POPULATIONS, P187; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed., P722; Cintron-Berdecia ST, 2006, FOLIA GEOBOT, V41, P33, DOI 10.1007/BF02805260; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Coates F, 2006, BIOL CONSERV, V129, P59, DOI 10.1016/j.biocon.2005.06.037; Dorland E, 2002, TRENDS AND FLUCTUATIONS AND UNDERLYING MECHANISMS IN TERRESTRIAL ORCHID POPULATIONS, P225; Ebert T.A, 1999, PLANT ANIMAL POPULAT, P312; FERNANDEZ DS, 2003, LANKERSTERIANA, V7, P73; Halpern BS, 2006, ECOL LETT, V9, P2, DOI 10.1111/j.1461-0248.2005.00827.x; Hernandez-Apolinar M., 1992, THESIS U NACL AUTONO; Jersakova J, 2002, TRENDS AND FLUCTUATIONS AND UNDERLYING MECHANISMS IN TERRESTRIAL ORCHID POPULATIONS, P209; Johnson SL, 1998, INT VER THEOR ANGEW, V26, P2076; Kaitala V, 2002, TRENDS AND FLUCTUATIONS AND UNDERLYING MECHANISMS IN TERRESTRIAL ORCHID POPULATIONS, P43; Kery M, 2004, J ECOL, V92, P686, DOI 10.1111/j.0022-0477.2004.00885.x; Kruschke J.K, 2011, DOING BAYESIAN DATA, P653; Kull T, 2002, ORCHID BIOLOGY: REVIEWS AND PERSPECTIVES, VIII, P139; Light MHS, 2006, FOLIA GEOBOT, V41, P77, DOI 10.1007/BF02805263; Lunn D., 2012, BUGS BOOK PRACTICAL, P399; McCarthy MA, 2005, J APPL ECOL, V42, P1012, DOI 10.1111/j.1365-2664.2005.01101.x; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P30; Oien DI, 2002, TRENDS AND FLUCTUATIONS AND UNDERLYING MECHANISMS IN TERRESTRIAL ORCHID POPULATIONS, P3; Primack RB, 2002, TRENDS AND FLUCTUATIONS AND UNDERLYING MECHANISMS IN TERRESTRIAL ORCHID POPULATIONS, P239; Rosa-Fuentes EA., 2007, LANKESTERIANA, V7, P204; Shefferson RP, 2006, FOLIA GEOBOT, V41, P95, DOI 10.1007/BF02805264; Shefferson RP, 2002, TRENDS AND FLUCTUATIONS AND UNDERLYING MECHANISMS IN TERRESTRIAL ORCHID POPULATIONS, P53; Silvertown Jonathan, 1993, Plant Species Biology, V8, P67, DOI 10.1111/j.1442-1984.1993.tb00058.x; Stott I, 2011, ECOL LETT, V14, P959, DOI 10.1111/j.1461-0248.2011.01659.x; Stott I, 2010, METHODS ECOL EVOL, V1, P242, DOI 10.1111/j.2041-210X.2010.00032.x; Stott I, 2010, J ECOL, V98, P302, DOI 10.1111/j.1365-2745.2009.01632.x; Tali K, 2002, TRENDS AND FLUCTUATIONS AND UNDERLYING MECHANISMS IN TERRESTRIAL ORCHID POPULATIONS, P33; Tremblay RL, 2006, CARIBB J SCI, V42, P75; Tremblay Raymond L., 2000, Lindleyana, V15, P257; Tremblay Raymond L., 1997, Selbyana, V18, P160; Tremblay RL, 2005, BIOL J LINN SOC, V84, P1, DOI 10.1111/j.1095-8312.2004.00400.x; Tremblay RL, 2006, BIOL CONSERV, V129, P70, DOI 10.1016/j.biocon.2005.11.017; Tremblay RL, 1997, BIOTROPICA, V29, P38, DOI 10.1111/j.1744-7429.1997.tb00004.x; Tremblay RL, 2001, BIOL J LINN SOC, V72, P47, DOI [10.1111/j.1095-8312.2001.tb01300.x, 10.1006/bijl.2000.0485]; Wade PR, 2000, CONSERV BIOL, V14, P1308, DOI 10.1046/j.1523-1739.2000.99415.x; Wade PR, 2002, POPULATION VIABILITY ANALYSIS, P213; Waide Robert B., 1996, P1; WAITE S, 1991, POPULATION ECOLOGY OF TERRESTRIAL ORCHIDS, P161; Willems JH, 2002, TRENDS AND FLUCTUATIONS AND UNDERLYING MECHANISMS IN TERRESTRIAL ORCHID POPULATIONS, P23; Zotz G, 1996, OECOLOGIA, V107, P151, DOI 10.1007/BF00327898; Zotz G, 1999, ANN BOT-LONDON, V84, P791, DOI 10.1006/anbo.1999.0983; Zotz G, 1998, J TROP ECOL, V14, P725, DOI 10.1017/S0266467498000534; Zotz Gerhard, 2000, Ecotropica (Bonn), V6, P95	56	9	9	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102859	10.1371/journal.pone.0102859	http://dx.doi.org/10.1371/journal.pone.0102859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068598	Green Published, gold			2022-12-25	WOS:000339993700023
J	Habel, N; Vilalta, M; Bawa, O; Opolon, P; Blanco, J; Fromigue, O				Habel, N.; Vilalta, M.; Bawa, O.; Opolon, P.; Blanco, J.; Fromigue, O.			Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors	ONCOGENE			English	Article							PRO-ANGIOGENIC ACTIVITIES; IMMEDIATE-EARLY GENE; GROWTH-FACTOR VEGF; ENDOTHELIAL-CELLS; POOR-PROGNOSIS; BREAST-CANCER; UP-REGULATION; CCN1 CYR61; EXPRESSION; INTEGRIN	Osteosarcoma is the most prevalent primary pediatric cancer-related bone disease. These tumors frequently develop resistance to chemotherapy and are highly metastatic, leading to poor outcome. Thus, there is a need for new therapeutic strategies that can prevent cell dissemination. We previously showed that CYR61/CCN1 expression in osteosarcoma cells is correlated to aggressiveness both in vitro and in vivo in mouse models, as well as in patients. In this study, we found that CYR61 is a critical contributor to the vascularization of primary tumor. We demonstrate that silencing CYR61, using lentiviral transduction, leads to a significant reduction in expression level of pro-angiogenic markers such as VEGF, FGF2, PECAM and angiopoietins concomitantly to an increased expression of major anti-angiogenic markers such as thrombospondin-1 and SPARC. Matrix metalloproteinase-2 family member expression, a key pathway in osteosarcoma metastatic capacity was also downregulated when CYR61 was downregulated in osteosarcoma cells. Using a metastatic murine model, we show that CYR61 silencing in osteosarcoma cells results in reduced tumor vasculature and slows tumor growth compared with control. We also find that microvessel density correlates with lung metastasis occurrence and that CYR61 silencing in osteosarcoma cells limits the number of metastases. Taken together, our data indicate that CYR61 silencing can blunt the malignant behavior of osteosarcoma tumor cells by limiting primary tumor growth and dissemination process.	[Habel, N.; Fromigue, O.] Inst Cancerol Gustave Roussy, INSERM, U981, F-94805 Villejuif, France; [Habel, N.; Bawa, O.; Opolon, P.; Fromigue, O.] Gustave Roussy, Villejuif, France; [Habel, N.; Bawa, O.; Opolon, P.; Fromigue, O.] Univ Paris 11, Orsay, France; [Habel, N.] Univ Paris Diderot, Paris, France; [Vilalta, M.; Blanco, J.] CSIC, Inst Adv Chem Catalonia, Cell Therapy Grp, Barcelona, Spain; [Bawa, O.; Opolon, P.] Gustave Roussy, IRCIV, Lab Pathol Expt, Villejuif, France; [Blanco, J.] Networking Biomed Res Ctr Bioengn Biomat & Nanome, Barcelona, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); UNICANCER; Gustave Roussy; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Fromigue, O (corresponding author), Inst Cancerol Gustave Roussy, INSERM, U981, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	olivia.fromigue@inserm.fr	Blanco, Jeronimo/H-2764-2015; Fromigue, Olivia/B-8225-2013	Blanco, Jeronimo/0000-0003-3765-0640; Fromigue, Olivia/0000-0002-3050-6155; habel, nadia/0000-0002-4083-8495	Ministere de la Recherche (Paris, France); Inserm (France); Fondation de l'Avenir pour la Recherche Medicale Appliquee (Paris, France); Red Tematica de Investigacion Cooperativa (TERCEL, Spain); MINECO (Spain) [SAF2012-33404]	Ministere de la Recherche (Paris, France)(Ministry of Research, France); Inserm (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation de l'Avenir pour la Recherche Medicale Appliquee (Paris, France); Red Tematica de Investigacion Cooperativa (TERCEL, Spain); MINECO (Spain)	NH is a recipient of a PhD award from the Ministere de la Recherche (Paris, France). This work was supported in part by Inserm (France), by Fondation de l'Avenir pour la Recherche Medicale Appliquee (Paris, France), by Red Tematica de Investigacion Cooperativa (TERCEL, Spain) and SAF2012-33404 from MINECO (Spain). We thank the Department of Medical Biology and Pathology of Gustave Roussy Institute (Dr Adam; Villejuif, France) for their contribution.	Athanasopoulos AN, 2007, J BIOL CHEM, V282, P26746, DOI 10.1074/jbc.M705200200; Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Babkina IV, 2009, B EXP BIOL MED+, V148, P246, DOI 10.1007/s10517-009-0710-0; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Chen D, 2013, TUMOR BIOL, V34, P1895, DOI 10.1007/s13277-013-0733-z; Chen NY, 2004, J BIOL CHEM, V279, P44166, DOI 10.1074/jbc.M406813200; Cheng YY, 2004, PEDIATR BLOOD CANCER, V42, P410, DOI 10.1002/pbc.20019; DuBois S, 2007, CANCER-AM CANCER SOC, V109, P813, DOI 10.1002/cncr.22455; Estrada R, 2009, J CELL PHYSIOL, V219, P563, DOI 10.1002/jcp.21701; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Foukas AF, 2002, J BONE JOINT SURG BR, V84B, P706, DOI 10.1302/0301-620X.84B5.12512; Fromigue O, 2008, J BIOL CHEM, V283, P30549, DOI 10.1074/jbc.M801436200; Fromigue O, 2011, J BONE MINER RES, V26, P1533, DOI 10.1002/jbmr.343; Gomes N, 2005, CLIN EXP METASTAS, V22, P215, DOI 10.1007/s10585-005-7359-5; Grignani G, 2012, ANN ONCOL, V23, P508, DOI 10.1093/annonc/mdr151; Hara H, 2006, ANTICANCER RES, V26, P4307; Huang YP, 2008, ONKOLOGIE, V31, P535, DOI 10.1159/000151685; Jiang WG, 2004, ENDOCR-RELAT CANCER, V11, P781, DOI 10.1677/erc.1.00825; Kaya M, 2000, CLIN CANCER RES, V6, P572; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; Kreuter M, 2004, CLIN CANCER RES, V10, P8531, DOI 10.1158/1078-0432.CCR-04-0969; Lammli J, 2012, INT ORTHOP, V36, P2307, DOI 10.1007/s00264-012-1629-z; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Lee YH, 1999, EUR J CANCER, V35, P1089, DOI 10.1016/S0959-8049(99)00073-8; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; Li C, 2013, EUR REV MED PHARMACO, V17, P2804; Maris JM, 2008, PEDIATR BLOOD CANCER, V50, P581, DOI 10.1002/pbc.21232; Menendez JA, 2005, ONCOGENE, V24, P761, DOI 10.1038/sj.onc.1208238; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Meyuhas R, 2008, MOL CANCER RES, V6, P1397, DOI 10.1158/1541-7786.MCR-07-2086; Mintz MB, 2005, CANCER RES, V65, P1748, DOI 10.1158/0008-5472.CAN-04-2463; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; North S, 2005, CANCER LETT, V218, P1, DOI 10.1016/j.canlet.2004.08.007; Oda Y, 2006, MODERN PATHOL, V19, P738, DOI 10.1038/modpathol.3800587; Odagiri H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004612; Pignochino Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-118; Rastogi S, 2012, INT ORTHOP, V36, P2315, DOI 10.1007/s00264-012-1663-x; Ren T, 2014, CANCER SCI, V105, P186, DOI 10.1111/cas.12334; Roman I, 2007, BIOMATERIALS, V28, P2718, DOI 10.1016/j.biomaterials.2007.02.011; Sabile AA, 2012, J BONE MINER RES, V27, P58, DOI 10.1002/jbmr.535; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sun ZJ, 2008, BRIT J CANCER, V99, P1656, DOI 10.1038/sj.bjc.6604712; Tsou R, 2001, MOL CELL BIOCHEM, V224, P81, DOI 10.1023/A:1011947301849; Vilalta M, 2008, STEM CELLS DEV, V17, P993, DOI 10.1089/scd.2007.0201; Wagner L, 2013, PEDIATR BLOOD CANCER, V60, P1447, DOI 10.1002/pbc.24547; Wang CT, 2013, J ORTHOP RES, V31, P335, DOI 10.1002/jor.22218; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070689; Wen XY, 2014, TUMOR BIOL, V35, P845, DOI 10.1007/s13277-013-1116-1; Wilkinson-Berka JL, 2006, INVEST OPHTH VIS SCI, V47, P1600, DOI 10.1167/iovs.05-1314; Xin ZF, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-105; Yang JL, 2011, CANCER-AM CANCER SOC, V117, P4925, DOI 10.1002/cncr.26116; Zhou QA, 2011, SURG ONCOL, V20, P13, DOI 10.1016/j.suronc.2009.09.002	52	18	21	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 11	2015	34	24					3207	3213		10.1038/onc.2014.232	http://dx.doi.org/10.1038/onc.2014.232			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK3FD	25065593				2022-12-25	WOS:000356101100012
J	Dominguez, N; Estevez-Herrera, J; Borges, R; Machado, JD				Dominguez, Natalia; Estevez-Herrera, Judith; Borges, Ricardo; Machado, Jose D.			The interaction between chromogranin A and catecholamines governs exocytosis	FASEB JOURNAL			English	Article						amperometry; chromaffin; LDCV; PC12; secretion; TIRFM	SINGLE SECRETORY GRANULES; CHROMAFFIN CELLS; QUANTAL SIZE; OSMOTIC-PRESSURE; ON/OFF SWITCH; PC12 CELL; RELEASE; VESICLES; CALCIUM; PH	Chromogranins (Cgs) are acidic proteins that have been described in the large, dense core vesicles (LDCVs) of adrenal chromaffin cells and that have been shown to promote LDCV formation, even in nonsecretory cells. Catecholamines (CAs) are adsorbed by Cgs in vitro, and the absence of Cgs modifies the storage and exocytosis of CAs in chromaffin cells. In this study, we set out to assess the role of CgA in the accumulation and exocytosis of CAs in cells when the levels of CgA and CA are manipulated. We overexpressed CgA in nonsecretory HEK293 cells and in secretory PC12 cells, to study the formation, movement, and exocytosis of newly formed granules by evanescent wave microscopy. We analyzed the association of Cgs/CA by HPLC and amperometry and their role in the accumulation and exocytosis of amines, both under resting conditions and after l-DOPA overloading. To our knowledge, this is the first demonstration that CgA expression in a nonsecretory cell line facilitates the storage and exocytosis of CA. In addition, CgA overexpression causes a doubling of the accumulation of CA, although it slows down exocytosis in PC12 cells. We propose a model to explain how the CgA/CA complex governs the accumulation and exocytosis of secreted amines.Dominguez, N., Estevez-Herrera, J., Borges, R., Machado, J. D. The interaction between chromogranin A and catecholamines governs exocytosis.	[Dominguez, Natalia; Estevez-Herrera, Judith; Borges, Ricardo; Machado, Jose D.] Univ La Laguna, Fac Med, Unidad Farmacol, E-38071 Tenerife, Spain	Universidad de la Laguna	Borges, R (corresponding author), Univ La Laguna, Fac Med, Unidad Farmacol, E-38071 Tenerife, Spain.	rborges@ull.es	Dominguez, Natalia/ABG-7769-2020; Borges, Ricardo/N-3250-2014; Machado, José David/N-5210-2014; Estevez Herrera, Judith/R-5333-2018	Borges, Ricardo/0000-0003-3413-4392; Machado, José David/0000-0003-3531-7051; Dominguez, Natalia/0000-0002-2615-3414; Estevez Herrera, Judith/0000-0001-8130-2294	Spanish Ministry of Economia y Competitividad (MINECO) [BFU2010-15822, CSD2008-00005]; Formacion del Profesorado Universitario (FPU) fellowship from the Spanish Ministry of Education; Formacion del Personal Investigador (FPI) fellowship from the MINECO; CajaCanarias Foundation scholarship; Ramon y Cajal contract (MINECO) [RC-2010-06256]	Spanish Ministry of Economia y Competitividad (MINECO); Formacion del Profesorado Universitario (FPU) fellowship from the Spanish Ministry of Education(German Research Foundation (DFG)); Formacion del Personal Investigador (FPI) fellowship from the MINECO; CajaCanarias Foundation scholarship; Ramon y Cajal contract (MINECO)	The authors thank Mr. Ayoze Santana for Valuable technical assistance, Dr. Agustin Valenzuela-Fenrandez (University of La Laguna, Santa Cruz de Tenerife, Spain) for providing the HEK293 cells and anti-EGFP antibody, and Dr. Jacqueline Keighron for help in revising the manuscript. This work was supported by grants from the Spanish Ministry of Economia y Competitividad (MINECO) BFU2010-15822 and CONSOLIDER (CSD2008-00005). N.D. was the recipient of a Formacion del Profesorado Universitario (FPU) fellowship from the Spanish Ministry of Education, J.E.H. holds a Formacion del Personal Investigador (FPI) fellowship from the MINECO, A.C.S. is recipient of a CajaCanarias Foundation scholarship, and "D.M. holds a Ramon y Cajal contract (R&C-2010-06256, MINECO). The authors declare no conflicts of interests.	Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Allersma MW, 2004, MOL BIOL CELL, V15, P4658, DOI 10.1091/mbc.E04-02-0149; Barroso-Gonzalez J, 2009, J BIOL CHEM, V284, P2419, DOI 10.1074/jbc.M805311200; BORGES R, 1986, J NEUROSCI METH, V16, P289, DOI 10.1016/0165-0270(86)90054-3; Borges R, 1997, J BIOL CHEM, V272, P8325, DOI 10.1074/jbc.272.13.8325; Camacho M, 2008, J BIOL CHEM, V283, P22383, DOI 10.1074/jbc.M800552200; Colliver TL, 2001, J NEUROSCI METH, V105, P95, DOI 10.1016/S0165-0270(00)00359-9; Colliver TL, 2000, J NEUROSCI, V20, P5276, DOI 10.1523/JNEUROSCI.20-14-05276.2000; Day R, 2003, TRENDS ENDOCRIN MET, V14, P10, DOI 10.1016/S1043-2760(02)00011-5; Diaz-Vera J, 2012, FASEB J, V26, P430, DOI 10.1096/fj.11-181941; Diaz-Vera J, 2010, J NEUROSCI, V30, P950, DOI 10.1523/JNEUROSCI.2894-09.2010; Elhamdani A, 2006, J NEUROSCI, V26, P3030, DOI 10.1523/JNEUROSCI.5275-05.2006; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Gong LW, 2003, J NEUROSCI, V23, P7917; HELLE KB, 1985, ACTA PHYSIOL SCAND, V123, P21, DOI 10.1111/j.1748-1716.1985.tb07556.x; KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123; Kim T, 2005, J NEUROSCI, V25, P6958, DOI 10.1523/JNEUROSCI.1058-05.2005; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Machado David J., 2008, V440, P297, DOI 10.1007/978-1-59745-178-9_23; Machado JD, 2000, J BIOL CHEM, V275, P20274, DOI 10.1074/jbc.M000930200; Machado JD, 2010, CELL MOL NEUROBIOL, V30, P1181, DOI 10.1007/s10571-010-9584-y; Malosio ML, 2004, J CELL SCI, V117, P743, DOI 10.1242/jcs.00934; Mica OI, 2004, BIOCHEM J, V381, P13, DOI 10.1042/BJ20040434; Montero-Hadjadje M, 2009, J BIOL CHEM, V284, P12420, DOI 10.1074/jbc.M805607200; Montesinos MS, 2008, J NEUROSCI, V28, P3350, DOI 10.1523/JNEUROSCI.5292-07.2008; Montesinos MS, 2010, BRIT J PHARMACOL, V159, P1548, DOI 10.1111/j.1476-5381.2010.00650.x; Mosharov EV, 2003, J NEUROSCI, V23, P5835; NANAVATI C, 1993, SCIENCE, V259, P963, DOI 10.1126/science.8438154; Omiatek DM, 2010, ACS CHEM NEUROSCI, V1, P234, DOI 10.1021/cn900040e; Pihel K, 1996, BIOPHYS J, V71, P1633, DOI 10.1016/S0006-3495(96)79368-2; Poea-Guyon S, 2013, ANAL BIOANAL CHEM, V405, P3983, DOI 10.1007/s00216-013-6860-y; Pothos E, 1996, J NEUROCHEM, V66, P629; Pothos EN, 2002, J PHYSIOL-LONDON, V542, P453, DOI 10.1113/jphysiol.2002.018630; Segura F, 2000, J NEUROSCI METH, V103, P151, DOI 10.1016/S0165-0270(00)00309-5; Sombers LA, 2004, J NEUROSCI, V24, P303, DOI 10.1523/JNEUROSCI.1119-03.2004; Sombers LA, 2005, J NEUROCHEM, V93, P1122, DOI 10.1111/j.1471-4159.2005.03087.x; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Sulzer D, 2000, NEURON, V28, P5; VERDUGO P, 1991, AM REV RESPIR DIS, V144, pS33, DOI 10.1164/ajrccm/144.3_pt_2.S33; VIDEEN JS, 1992, J BIOL CHEM, V267, P3066; Westerink RHS, 2008, ACTA PHYSIOL, V192, P273, DOI 10.1111/j.1748-1716.2007.01805.x; Westerink RHS, 2000, BIOCHEM BIOPH RES CO, V270, P625, DOI 10.1006/bbrc.2000.2470; Yoo SH, 2010, FASEB J, V24, P653, DOI 10.1096/fj.09-132456; YOO SH, 1991, J BIOL CHEM, V266, P7740	45	14	14	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4657	4667		10.1096/fj.14-249607	http://dx.doi.org/10.1096/fj.14-249607			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25077558				2022-12-25	WOS:000344050900007
J	Kim, J; Ko, J				Kim, Jeonghan; Ko, Jesang			Human sLZIP promotes atherosclerosis via MMP-9 transcription and vascular smooth muscle cell migration	FASEB JOURNAL			English	Article						sLZIP; matrix metalloproteinase; vascular smooth muscle cell; macrophage; atherosclerosis	NECROSIS-FACTOR-ALPHA; LEUCINE-ZIPPER PROTEIN; E-DEFICIENT MICE; MATRIX METALLOPROTEINASES; DIFFERENTIALLY AFFECTS; MACROPHAGES; EXPRESSION; MATRIX-METALLOPROTEINASE-9; DISEASE; CYTOKINES	Atherosclerosis is a chronic inflammatory response of the vascular wall, and immune responses are involved in every phase of atherosclerosis, from initiation, to progression, and finally to plaque rupture. Cytokines are the major atherogenic mediators that promote plaque formation and progression by activation of inflammatory cells. They induce expressions of matrix metalloproteinases (MMPs), leading to vascular smooth muscle cell (VSMC) migration in atherosclerotic lesions. Although chronic inflammatory mediators, including tumor necrosis factor (TNF-) and MMPs, exacerbate atherosclerosis, the molecular mechanism of atherogenesis remains unclear. In this study we investigated the role of a novel transcription factor the human small leucine zipper protein (sLZIP) in TNF--induced MMP expression, VSMC migration, and atherosclerosis progression. The proinflammatory cytokine TNF- enhanced sLZIP expression by 3-fold via activation of NF-B signaling. sLZIP induced MMP-9 transcription and the proteolytic activity of MMP-9 by 2.8- and 3.2-fold (P< 0.05), respectively, in macrophages, leading to enhancement of VSMC migration by 2.7-fold (P<0.005). sLZIP(OE/+) (sLZIP transgenic); LDLR-/- mice fed a high-cholesterol diet exhibited enhanced arterial plaque formation and increased VSMC migration from the media into the intima by 2.8- and 2.6-fold (P<0.01), respectively, compared with atherosclerosis-prone LDLR-/- mice. These results indicate that human sLZIP plays a critical role in development of atherosclerosis and can be used as a therapeutic target molecule for treatment of atherosclerosis.Kim, J., Ko, J. Human sLZIP promotes atherosclerosis via MMP-9 transcription and vascular smooth muscle cell migration.	[Kim, Jeonghan; Ko, Jesang] Korea Univ, Div Life Sci, Seoul 136701, South Korea	Korea University	Ko, J (corresponding author), Korea Univ, Div Life Sci, 5-1 Anam Dong, Seoul 136701, South Korea.	jesangko@korea.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2014R1A2A2A01002826]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT and Future Planning (2014R1A2A2A01002826)	Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Chen L, 2009, AM J PHYSIOL-HEART C, V296, pH987, DOI 10.1152/ajpheart.01158.2008; Choi ET, 2005, ARTERIOSCL THROM VAS, V25, P1020, DOI 10.1161/01.ATV.0000161275.82687.f6; Danenberg HD, 2003, J CARDIOVASC PHARM, V42, P671, DOI 10.1097/00005344-200311000-00014; George J, 2008, NAT CLIN PRACT CARD, V5, P531, DOI 10.1038/ncpcardio1279; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Jang SY, 2012, CANCER LETT, V314, P185, DOI 10.1016/j.canlet.2011.09.028; Jang SW, 2007, J BIOL CHEM, V282, P11092, DOI 10.1074/jbc.M607962200; Johnson C, 2004, ARTERIOSCL THROM VAS, V24, P54, DOI 10.1161/01.ATV.0000100402.69997.C3; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, pE35, DOI 10.1161/ATVBAHA.111.225623; Kang H, 2011, J BIOL CHEM, V286, P42072, DOI 10.1074/jbc.M111.272302; Kang H, 2009, MOL ENDOCRINOL, V23, P1746, DOI 10.1210/me.2009-0009; Kim HC, 2010, CELL MOL LIFE SCI, V67, P3499, DOI 10.1007/s00018-010-0388-5; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Ko J, 2004, FASEB J, V18, P890, DOI 10.1096/fj.03-0867fje; Koga J, 2012, VASC PHARMACOL, V57, P24, DOI 10.1016/j.vph.2012.02.011; Kwon Sang-Hee, 2008, Nutr Res Pract, V2, P134, DOI 10.4162/nrp.2008.2.2.134; Li H, 2007, MOL CELL BIOL, V27, P2676, DOI 10.1128/MCB.01748-06; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Ohta H, 2005, ATHEROSCLEROSIS, V180, P11, DOI 10.1016/j.atherosclerosis.2004.11.016; Ono H, 2004, ARTERIOSCL THROM VAS, V24, P1634, DOI 10.1161/01.ATV.0000138052.86051.0d; Poon M, 2001, ATHEROSCLEROSIS, V155, P371, DOI 10.1016/S0021-9150(00)00605-5; Rickard AJ, 2009, J MOL ENDOCRINOL, V42, P449, DOI 10.1677/JME-08-0144; Siefert SA, 2012, VASCULAR, V20, P210, DOI 10.1258/vasc.2011.201202; Skoog T, 2002, EUR HEART J, V23, P376, DOI 10.1053/euhj.2001.2805; Sung HJ, 2008, EXP MOL MED, V40, P332, DOI 10.3858/emm.2008.40.3.332; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Xiong WF, 2009, J IMMUNOL, V183, P2741, DOI 10.4049/jimmunol.0803164	34	19	21	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					5010	5021		10.1096/fj.14-259218	http://dx.doi.org/10.1096/fj.14-259218			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25077563				2022-12-25	WOS:000344050900036
J	Chen, XY; Wilson, JB; McChesney, P; Williams, SA; Kwon, Y; Longerich, S; Marriott, AS; Sung, P; Jones, NJ; Kupfer, GM				Chen, Xiaoyong; Wilson, James B.; McChesney, Patricia; Williams, Stacy A.; Kwon, Youngho; Longerich, Simonne; Marriott, Andrew S.; Sung, Patrick; Jones, Nigel J.; Kupfer, Gary M.			The Fanconi Anemia Proteins FANCD2 and FANCJ Interact and Regulate Each Other's Chromatin Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; HELICASE BRIP1; CORE COMPLEX; PATHWAY; BRCA1; BACH1; CANCER; PHOSPHORYLATION; BRCA2/FANCD1; FANCG/XRCC9	Fanconi anemia is a genetic disease resulting in bone marrow failure, birth defects, and cancer that is thought to encompass a defect in maintenance of genomic stability. Mutations in 16 genes (FANCA, B, C, D1, D2, E, F, G, I, J, L, M, N, O, P, and Q) have been identified in patients, with the Fanconi anemia subtype J (FA-J) resulting from homozygous mutations in the FANCJ gene. Here, we describe the direct interaction of FANCD2 with FANCJ. We demonstrate the interaction of FANCD2 and FANCJ in vivo and in vitro by immunoprecipitation in crude cell lysates and from fractions after gel filtration and with baculovirally expressed proteins. Mutation of the monoubiquitination site of FANCD2 (K561R) preserves interaction with FANCJ constitutively in a manner that impedes proper chromatin localization of FANCJ. FANCJ is necessary for FANCD2 chromatin loading and focus formation in response to mitomycin C treatment. Our results suggest not only that FANCD2 regulates FANCJ chromatin localization but also that FANCJ is necessary for efficient loading of FANCD2 onto chromatin following DNA damage caused by mitomycin C treatment.	[Chen, Xiaoyong; McChesney, Patricia; Williams, Stacy A.; Kupfer, Gary M.] Yale Univ, Sch Med, Sect Hematol Oncol, Dept Pediat, New Haven, CT 06520 USA; [Kupfer, Gary M.] Yale Univ, Sch Med, Sect Hematol Oncol, Dept Pathol, New Haven, CT 06520 USA; [Kwon, Youngho; Longerich, Simonne; Sung, Patrick] Yale Univ, Sch Med, Sect Hematol Oncol, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Marriott, Andrew S.; Jones, Nigel J.] Univ Liverpool, Dept Biochem, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England; [Wilson, James B.] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Canc Med, Liverpool L3 9TA, Merseyside, England	Yale University; Yale University; Yale University; University of Liverpool; University of Liverpool	Kupfer, GM (corresponding author), Yale Univ, Box 208604, New Haven, CT 06520 USA.	gary.kupfer@yale.edu	Jones, Nigel J/D-1997-2010		National Institutes of Health [R01-HL063776, R01-ES015252]; North West Cancer Research Fund [NWCRF-CR863, NWCRF-CR968]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North West Cancer Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL063776 (to G. M. K.) and R01-ES015252 (to P. S.). This work was also supported by North West Cancer Research Fund Grants NWCRF-CR863 and NWCRF-CR968 (to N. J. J.).	Alter BP, 2003, CANCER-AM CANCER SOC, V97, P425, DOI 10.1002/cncr.11046; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Collins N, 2005, INT J HEMATOL, V82, P176, DOI 10.1532/IJH97.05108; Collins NB, 2009, BLOOD, V113, P2181, DOI 10.1182/blood-2008-05-154294; Constantinou A, 2012, CHROMOSOMA, V121, P21, DOI 10.1007/s00412-011-0349-2; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; Garaycoechea JI, 2014, BLOOD, V123, P26, DOI 10.1182/blood-2013-09-427740; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gong ZH, 2010, MOL CELL, V37, P438, DOI 10.1016/j.molcel.2010.01.002; Green AM, 2009, HEMATOL ONCOL CLIN N, V23, P193, DOI 10.1016/j.hoc.2009.01.008; Gupta R, 2007, BLOOD, V110, P2390, DOI 10.1182/blood-2006-11-057273; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Hussain S, 2004, HUM MOL GENET, V13, P1241, DOI 10.1093/hmg/ddh135; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kitao H, 2006, J BIOL CHEM, V281, P21312, DOI 10.1074/jbc.M603290200; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Meetei AR, 2004, CELL CYCLE, V3, P179; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Park WH, 2005, J BIOL CHEM, V280, P23593, DOI 10.1074/jbc.M503730200; Peng M, 2006, ONCOGENE, V25, P2245, DOI 10.1038/sj.onc.1209257; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sommers JA, 2009, J BIOL CHEM, V284, P7505, DOI 10.1074/jbc.M809019200; Thomashevski A, 2004, J BIOL CHEM, V279, P26201, DOI 10.1074/jbc.M400091200; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Vandenberg CJ, 2003, MOL CELL, V12, P247, DOI 10.1016/S1097-2765(03)00281-8; Waisfisz Q, 1999, P NATL ACAD SCI USA, V96, P10320, DOI 10.1073/pnas.96.18.10320; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang XZ, 2004, DNA REPAIR, V3, P1063, DOI 10.1016/j.dnarep.2004.04.005; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Wilson JB, 2008, ONCOGENE, V27, P3641, DOI 10.1038/sj.onc.1211034; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2009, CURR MOL MED, V9, P470, DOI 10.2174/156652409788167159; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xie J, 2010, CANCER PREV RES, V3, P1409, DOI 10.1158/1940-6207.CAPR-10-0118; Yamashita T, 1998, P NATL ACAD SCI USA, V95, P13085, DOI 10.1073/pnas.95.22.13085; Zhang F, 2010, CHROMOSOMA, V119, P637, DOI 10.1007/s00412-010-0285-6	50	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25774	25782		10.1074/jbc.M114.552570	http://dx.doi.org/10.1074/jbc.M114.552570			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070891	Green Published, hybrid			2022-12-25	WOS:000342130800035
J	Ho, MH; Ho, CW; Cheung, E; Chan, PH; Hai, JJ; Chan, KH; Chan, EW; Leung, GKK; Tse, HF; Siu, CW				Ho, Mei Han; Ho, Chi Wai; Cheung, Emmanuel; Chan, Pak Hei; Hai, Jo Jo; Chan, Koon Ho; Chan, Esther W.; Leung, Gilberto Ka Kit; Tse, Hung Fat; Siu, Chung Wah			Continuation of Dabigatran Therapy in "Real-World" Practice in Hong Kong	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; STROKE PREVENTION; ISCHEMIC-STROKE; HEART-FAILURE; WARFARIN; EXPERIENCE; COMMUNITY; REGISTRY; CHINESE; DISEASE	Background: Dabigatran, an oral direct thrombin inhibitor, possesses several advantages over warfarin that can in principle simplify the management of stroke prevention in atrial fibrillation (AF). Nonetheless it remains unclear whether these advantages can translate to clinical practice and encourage long-term therapy. The objective was to describe long-term dabigatran therapy for stroke prevention in AF and to identify risk factors for discontinuation of therapy. Methods and Results: We studied 467 consecutive Chinese patients (72 +/- 11 years, male: 53.8%) with a mean CHA(2)DS(2)-VASc score of 3.6 prescribed dabigatran for stroke prevention in AF from March 2010 to September 2013. Over a mean follow-up of 16 months, 101 patients (21.6%) permanently discontinued dabigatran. The mean time-to-discontinuation was 8 months. The most common reason for discontinuation was dyspepsia (30.7%), followed by other adverse events (17.8%) such as minor bleeding (8.9%), major gastrointestinal bleeding (7.9%), and intracranial hemorrhage (1%). Other reasons included dosing frequency (5.9%), fear of side effects (4.0%), lack of laboratory monitoring (1.0%), and cost (1.0%). Multivariable analysis revealed that low baseline estimated glomerular filtration rate (p = 0.02), absence of hypertension (p = 0.01), and prior use of a proton-pump inhibitor (p = 0.02) and H-2-receptor blocker (p = 0.01) were independent predictors of drug discontinuation. In addition, there were altogether 9 ischemic strokes (1.5%/years), 3 intracranial hemorrhages (0.5%/year), and 24 major gastrointestinal bleedings (4.1%/year). Conclusion: Dabigatran discontinuation is very common amongst Chinese AF patients. This reveals a management gap in the prevention of stroke in AF.	[Ho, Mei Han; Ho, Chi Wai; Cheung, Emmanuel; Chan, Pak Hei; Hai, Jo Jo; Tse, Hung Fat; Siu, Chung Wah] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China; [Chan, Koon Ho] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Div Neurol, Hong Kong, Hong Kong, Peoples R China; [Chan, Esther W.] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Leung, Gilberto Ka Kit] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Div Neurosurg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Siu, CW (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China.	cwdsiu@hku.hk	Siu, Chung Wah/C-6947-2011; Tse, Hung-Fat/C-4426-2009; Ho, Chi Wai/AAH-2387-2021; Leung, Gilberto Ka Kit/C-4337-2009; /M-6666-2014; Chan, Esther Wai Yin/B-3522-2012	Tse, Hung-Fat/0000-0002-9578-7808; Ho, Chi Wai/0000-0001-8008-5646; Tse, Hung Fat/0000-0003-4665-7887; Leung, Gilberto Ka Kit/0000-0003-3147-3057; /0000-0003-1256-982X; Chan, Esther Wai Yin/0000-0002-7602-9470				Bin Yap L, 2014, J THROMB THROMBOLYS, V38, P39, DOI 10.1007/s11239-013-1020-y; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chan HT, 2011, J CARDIOVASC PHARM, V58, P87, DOI 10.1097/FJC.0b013e31821cd888; Chien KL, 2010, INT J CARDIOL, V139, P173, DOI 10.1016/j.ijcard.2008.10.045; Connolly SJ, 2013, CIRCULATION, V128, P237, DOI 10.1161/CIRCULATIONAHA.112.001139; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Ho JCS, 2012, CLIN CARDIOL, V35, pE40, DOI 10.1002/clc.22069; Ho LY, 2011, J HUM HYPERTENS, V25, P304, DOI 10.1038/jhh.2010.57; Hori M, 2014, STROKE, V45, pE43, DOI 10.1161/STROKEAHA.113.002854; HUANG CY, 1990, STROKE, V21, P230, DOI 10.1161/01.STR.21.2.230; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Li SY, 2012, CNS NEUROSCI THER, V18, P988, DOI 10.1111/cns.12021; Lin LY, 2011, ATHEROSCLEROSIS, V217, P292, DOI 10.1016/j.atherosclerosis.2011.03.033; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Michel J, 2013, HEART LUNG CIRC, V22, P50, DOI 10.1016/j.hlc.2012.09.002; Miyamoto K, 2014, J ARRYTHM, V30, P58, DOI 10.1016/j.joa.2013.04.010; Nieuwlaat W, 2014, EUROPEAN HEART J S1, V34, DOI [10.1093/eurheartj/eht307.P549, DOI 10.1093/EURHEARTJ/EHT307.P549]; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Siu CW, 2007, HEART, V93, P483, DOI 10.1136/hrt.2006.100628; Tse HF, 2013, HEART RHYTHM, V10, P1082, DOI 10.1016/j.hrthm.2013.03.017; Tsivgoulis G, 2014, THER ADV NEUROL DISO, V7, P155, DOI 10.1177/1756285614528064; Yang QD, 2004, CEREBROVASC DIS, V17, P303, DOI 10.1159/000077341; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C	23	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e101245	10.1371/journal.pone.0101245	http://dx.doi.org/10.1371/journal.pone.0101245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084117	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800004
J	Kim, H; Jones, KE; Heckman, CJ				Kim, Hojeong; Jones, Kelvin E.; Heckman, C. J.			Asymmetry in Signal Propagation between the Soma and Dendrites Plays a Key Role in Determining Dendritic Excitability in Motoneurons	PLOS ONE			English	Article							PERSISTENT INWARD CURRENTS; CHRONIC SPINAL RATS; IN-VIVO; ELECTRICAL-PROPERTIES; ALPHA-MOTONEURONS; PYRAMIDAL NEURONS; LUMBAR MOTONEURONS; PLATEAU POTENTIALS; CALCIUM-CHANNELS; FIRING PATTERN	It is widely recognized that propagation of electrophysiological signals between the soma and dendrites of neurons differs depending on direction, i.e. it is asymmetric. How this asymmetry influences the activation of voltage-gated dendritic channels, and consequent neuronal behavior, remains unclear. Based on the analysis of asymmetry in several types of motoneurons, we extended our previous methodology for reducing a fully reconstructed motoneuron model to a two-compartment representation that preserved asymmetric signal propagation. The reduced models accurately replicated the dendritic excitability and the dynamics of the anatomical model involving a persistent inward current (PIC) dispersed over the dendrites. The relationship between asymmetric signal propagation and dendritic excitability was investigated using the reduced models while varying the asymmetry in signal propagation between the soma and the dendrite with PIC density constant. We found that increases in signal attenuation from soma to dendrites increased the activation threshold of a PIC (hypo-excitability), whereas increases in signal attenuation from dendrites to soma decreased the activation threshold of a PIC (hyper-excitability). These effects were so strong that reversing the asymmetry in the soma-to-dendrite vs. dendrite-to-soma attenuation, reversed the correlation between PIC threshold and distance of this current source from the soma. We propose the tight relation of the asymmetric signal propagation to the input resistance in the dendrites as a mechanism underlying the influence of the asymmetric signal propagation on the dendritic excitability. All these results emphasize the importance of maintaining the physiological asymmetry in dendritic signaling not only for normal function of the cells but also for biophysically realistic simulations of dendritic excitability.	[Kim, Hojeong] Daegu Gyeongbuk Inst Sci & Technol, Div Robot Res, Taegu, South Korea; [Jones, Kelvin E.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Jones, Kelvin E.] Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB, Canada; [Kim, Hojeong; Heckman, C. J.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Heckman, C. J.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Heckman, C. J.] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA	Daegu Gyeongbuk Institute of Science & Technology (DGIST); University of Alberta; University of Alberta; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Kim, H (corresponding author), Daegu Gyeongbuk Inst Sci & Technol, Div Robot Res, Taegu, South Korea.	hojeong.kim03@gmail.com	Jones, Kelvin/M-6487-2019; Jones, Kelvin/AAJ-6112-2021; Jones, Kelvin/AFW-5002-2022	Jones, Kelvin/0000-0003-4764-7031; Heckman, CJ/0000-0002-1324-7278	National Institutes of Health [RO1 N5071951, N562200]; Natural Sciences and Engineering Research Council of Canada; DGIST R&D Program of the Ministry of Science, ICT and Future Planning of Korea [13-01-HRSS-03, 14-RS-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071951, R01NS062200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); DGIST R&D Program of the Ministry of Science, ICT and Future Planning of Korea; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant RO1 N5071951, N562200, the Natural Sciences and Engineering Research Council of Canada, and the DGIST R&D Program of the Ministry of Science, ICT and Future Planning of Korea (13-01-HRSS-03 and 14-RS-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Ballou EW, 2006, J NEUROSCI METH, V156, P257, DOI 10.1016/j.jneumeth.2006.03.014; Bar-Yehuda D, 2008, J NEUROPHYSIOL, V99, P1127, DOI 10.1152/jn.01232.2007; Bennett DJ, 2001, J NEUROPHYSIOL, V86, P1955, DOI 10.1152/jn.2001.86.4.1955; Bennett DJ, 1998, J NEUROPHYSIOL, V80, P2023, DOI 10.1152/jn.1998.80.4.2023; Booth V, 1995, J COMPUT NEUROSCI, V2, P299, DOI 10.1007/BF00961442; Bui TV, 2006, J NEUROPHYSIOL, V95, P225, DOI 10.1152/jn.00646.2005; BUSH PC, 1993, J NEUROSCI METH, V46, P159, DOI 10.1016/0165-0270(93)90151-G; Carlin KP, 2009, J NEUROSCI, V29, P5343, DOI 10.1523/JNEUROSCI.5458-08.2009; Carlin KP, 2000, EUR J NEUROSCI, V12, P1635, DOI 10.1046/j.1460-9568.2000.00055.x; CARNEVALE NT, 1982, J NEUROPHYSIOL, V47, P606, DOI 10.1152/jn.1982.47.4.606; CLEMENTS JD, 1989, J PHYSIOL-LONDON, V409, P63, DOI 10.1113/jphysiol.1989.sp017485; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P291, DOI 10.1113/jphysiol.1955.sp005411; CULLHEIM S, 1987, J COMP NEUROL, V255, P68, DOI 10.1002/cne.902550106; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; ElBasiouny SM, 2006, J PHYSIOL-LONDON, V570, P355, DOI 10.1113/jphysiol.2005.099119; ElBasiouny SM, 2005, J NEUROPHYSIOL, V94, P3961, DOI 10.1152/jn.00391.2005; FLESHMAN JW, 1988, J NEUROPHYSIOL, V60, P60, DOI 10.1152/jn.1988.60.1.60; Gidon A, 2012, NEURON, V75, P330, DOI 10.1016/j.neuron.2012.05.015; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Heckman CJ, 2003, TRENDS NEUROSCI, V26, P688, DOI 10.1016/j.tins.2003.10.002; Hendrickson EB, 2011, J COMPUT NEUROSCI, V30, P301, DOI 10.1007/s10827-010-0258-z; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HOCHMAN S, 1994, J NEUROPHYSIOL, V71, P1468, DOI 10.1152/jn.1994.71.4.1468; HOLMES WR, 1992, J NEUROPHYSIOL, V68, P1421, DOI 10.1152/jn.1992.68.4.1421; HOUNSGAARD J, 1989, J PHYSIOL-LONDON, V414, P265, DOI 10.1113/jphysiol.1989.sp017687; Kim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043654; Kim H, 2011, J COMPUT NEUROSCI, V30, P659, DOI 10.1007/s10827-010-0284-x; Kim H, 2009, J COMPUT NEUROSCI, V27, P321, DOI 10.1007/s10827-009-0145-7; Krenz NR, 1998, NEUROSCI LETT, V243, P61, DOI 10.1016/S0304-3940(98)00101-3; Krichmar JL, 2002, BRAIN RES, V941, P11, DOI 10.1016/S0006-8993(02)02488-5; Lee RH, 2003, J NEUROPHYSIOL, V89, P27, DOI 10.1152/jn.00137.2002; Lee RH, 1998, J NEUROPHYSIOL, V80, P583, DOI 10.1152/jn.1998.80.2.583; Lee RH, 1999, J NEUROPHYSIOL, V82, P2518, DOI 10.1152/jn.1999.82.5.2518; Li YR, 2003, J NEUROPHYSIOL, V90, P857, DOI 10.1152/jn.00236.2003; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; MAJOR G, 1993, BIOPHYS J, V65, P423, DOI 10.1016/S0006-3495(93)81037-3; Meehan CF, 2010, J NEUROPHYSIOL, V103, P2599, DOI 10.1152/jn.00668.2009; Moritz AT, 2007, J NEUROPHYSIOL, V98, P1042, DOI 10.1152/jn.01294.2006; MULLER W, 1993, J NEUROPHYSIOL, V69, P241, DOI 10.1152/jn.1993.69.1.241; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; Oviedo H, 2005, J NEUROSCI, V25, P4985, DOI 10.1523/JNEUROSCI.0562-05.2005; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; SEGEV I, 1990, J NEUROPHYSIOL, V64, P648, DOI 10.1152/jn.1990.64.2.648; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Teskey GC, 2006, SYNAPSE, V59, P1, DOI 10.1002/syn.20215; Thurbon D, 1998, J NEUROPHYSIOL, V79, P2485, DOI 10.1152/jn.1998.79.5.2485; van Elburg RAJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000781; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; YAMADA M, 1988, J NEUROL NEUROSUR PS, V51, P1088, DOI 10.1136/jnnp.51.8.1088; ZADOR AM, 1995, J NEUROSCI, V15, P1669, DOI 10.1523/JNEUROSCI.15-03-01669.1995; ZENGEL JE, 1985, J NEUROPHYSIOL, V53, P1323, DOI 10.1152/jn.1985.53.5.1323; Zomorrodi R, 2008, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.005.2008	58	23	24	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e95454	10.1371/journal.pone.0095454	http://dx.doi.org/10.1371/journal.pone.0095454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083794	Green Submitted, Green Published, gold			2022-12-25	WOS:000339819800001
J	Li, NJ; Nattie, E; Li, AH				Li, Ningjing; Nattie, Eugene; Li, Aihua			The Role of Melanin Concentrating Hormone (MCH) in the Central Chemoreflex: A Knockdown Study by siRNA in the Lateral Hypothalamus in Rats	PLOS ONE			English	Article							NUCLEUS-TRACTUS-SOLITARIUS; OREXIN NEURONS; CENTRAL CHEMORECEPTION; FEEDING-BEHAVIOR; BODY-WEIGHT; SLEEP; MICE; EXPRESSION; GENE; MICROINJECTIONS	Melanin concentrating hormone (MCH), a neuropeptide produced mainly in neurons localized to the lateral hypothalamic area (LHA), has been implicated in the regulation of food intake, energy balance, sleep state, and the cardiovascular system. Hypothalamic MCH neurons also have multisynaptic connections with diaphragmatic motoneurons and project to many central chemoreceptor sites. However, there are few studies of MCH involvement in central respiratory control. To test the hypothesis that MCH plays a role in the central chemoreflex, we induced a down regulation of MCH in the central nervous system by knocking down the MCH precursor (pMCH) mRNA in the LHA using a pool of small interfering RNA (siRNA), and measured the resultant changes in breathing, metabolic rate, body weight, and blood glucose levels in conscious rats. The injections of pMCH-siRNA into the LHA successfully produced a similar to 62% reduction of pMCH mRNA expression in the LHA and a similar to 43% decrease of MCH levels in the cerebrospinal fluid relative to scrambled-siRNA treatment (P = 0.006 and P = 0.02 respectively). Compared to the pretreatment baseline and the scrambled-siRNA treated control rats, knockdown of MCH resulted in: 1) an enhanced hypercapnic chemoreflex (similar to 42 & 47% respectively; P < 0.05) only in wakefulness; 2) a decrease in body weight and basal glucose levels; and 3) an unchanged metabolic rate. Our results indicate that MCH participates not only in the regulation of glucose and sleep-wake homeostasis but also the vigilance-state dependent regulation of the central hypercapnic chemoreflex and respiratory control.	[Li, Ningjing; Nattie, Eugene; Li, Aihua] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH 03755 USA	Dartmouth College	Li, AH (corresponding author), Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH 03755 USA.	Aihua.Li@Dartmouth.edu		Li, Ningjing/0000-0002-1170-7971	National Heart, Lung, and Blood Institute [HL 28066]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028066, R37HL028066] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work and the authors were supported by HL 28066 from The National Heart, Lung, and Blood Institute (https://www.nhIbi.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon T, 2006, J NEUROSCI, V26, P389, DOI 10.1523/JNEUROSCI.1203-05.2006; Badami VM, 2010, BRAIN RES, V1323, P119, DOI 10.1016/j.brainres.2010.02.002; BARTLETT D, 1970, RESP PHYSIOL, V10, P384, DOI 10.1016/0034-5687(70)90056-3; Biancardi V, 2008, PFLUG ARCH EUR J PHY, V455, P1119, DOI 10.1007/s00424-007-0338-8; Bittencourt JC, 2011, GEN COMP ENDOCR, V172, P185, DOI 10.1016/j.ygcen.2011.03.028; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Borsu L, 2000, J BIOL CHEM, V275, P40576, DOI 10.1074/jbc.M006524200; Brown SN, 2007, NEUROSCIENCE, V150, P796, DOI 10.1016/j.neuroscience.2007.10.002; Burdakov D, 2005, PHILOS T R SOC B, V360, P2227, DOI 10.1098/rstb.2005.1763; Burdakov D, 2013, PHYSIOL BEHAV, V121, P117, DOI 10.1016/j.physbeh.2013.03.023; Chen LC, 2006, EUR J NEUROSCI, V24, P2039, DOI 10.1111/j.1460-9568.2006.05058.x; Clegg DJ, 2003, AM J PHYSIOL-REG I, V284, pR494, DOI 10.1152/ajpregu.00399.2002; Della-Zuana O, 2002, INT J OBESITY, V26, P1289, DOI 10.1038/sj.ijo.0802079; Egwuenu EJ, 2012, AM J PHYSIOL-REG I, V303, pR624, DOI 10.1152/ajpregu.00215.2012; Elias CF, 2008, J CHEM NEUROANAT, V35, P188, DOI 10.1016/j.jchemneu.2007.10.002; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Guan JL, 2002, INT J OBESITY, V26, P1523, DOI 10.1038/sj.ijo.0802155; Hahn JD, 2010, NEUROSCI LETT, V468, P12, DOI 10.1016/j.neulet.2009.10.047; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kerman IA, 2007, J COMP NEUROL, V505, P586, DOI 10.1002/cne.21511; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Kong D, 2010, CELL METAB, V12, P545, DOI 10.1016/j.cmet.2010.09.013; Lagos P, 2011, BEHAV BRAIN RES, V218, P259, DOI 10.1016/j.bbr.2010.10.035; Lagos P, 2009, BRAIN RES, V1265, P103, DOI 10.1016/j.brainres.2009.02.010; Leinninger GM, 2011, PHYSIOL BEHAV, V104, P572, DOI 10.1016/j.physbeh.2011.04.060; Li AH, 2006, J PHYSIOL-LONDON, V570, P385, DOI 10.1113/jphysiol.2005.099325; Li AH, 2006, J PHYSIOL-LONDON, V577, P307, DOI 10.1113/jphysiol.2006.114504; Li AH, 2010, J PHYSIOL-LONDON, V588, P2935, DOI 10.1113/jphysiol.2010.191288; Li N, 2012, RESP PHYSL NEUROBIOL; Li Y, 2006, J NEUROSCI, V26, P13037, DOI 10.1523/JNEUROSCI.3380-06.2006; Louis GW, 2010, J NEUROSCI, V30, P11278, DOI 10.1523/JNEUROSCI.1340-10.2010; Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660; Marsh DJ, 2002, P NATL ACAD SCI USA, V99, P3240, DOI 10.1073/pnas.052706899; Meister B, 2007, PHYSIOL BEHAV, V92, P263, DOI 10.1016/j.physbeh.2007.05.021; Messina MM, 2007, REGUL PEPTIDES, V139, P23, DOI 10.1016/j.regpep.2006.08.013; Nahon JL, 2006, CR BIOL, V329, P623, DOI 10.1016/j.crvi.2006.03.021; NAHON JL, 1989, ENDOCRINOLOGY, V125, P2056, DOI 10.1210/endo-125-4-2056; Nattie EE, 2002, J APPL PHYSIOL, V92, P2119, DOI 10.1152/japplphysiol.01128.2001; Nattie E, 2012, PROG BRAIN RES, V198, P25, DOI 10.1016/B978-0-444-59489-1.00004-5; Pereira-Da-Silva M, 2005, J ENDOCRINOL, V186, P193, DOI 10.1677/joe.1.06111; Rao Y, 2008, J NEUROSCI, V28, P9101, DOI 10.1523/JNEUROSCI.1766-08.2008; Saito Y, 2001, J COMP NEUROL, V435, P26, DOI 10.1002/cne.1191; Saito Yumiko, 2008, V46, P159, DOI 10.1007/400_2007_052; Sanchez MS, 1999, PEPTIDES, V20, P611, DOI 10.1016/S0196-9781(99)00014-5; Severson CA, 2003, NAT NEUROSCI, V6, P1139, DOI 10.1038/nn1130; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Shirasaka T, 2002, REGUL PEPTIDES, V104, P91, DOI 10.1016/S0167-0115(01)00352-4; SKOFITSCH G, 1985, BRAIN RES BULL, V15, P635, DOI 10.1016/0361-9230(85)90213-8; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; Wang Y, 2010, GUT, V59, P1625, DOI 10.1136/gut.2010.210526; Watson PG, 1998, RAT BRAIN STEREOTAXI; Whiddon BB, 2013, J NEUROSCI, V33, P2009, DOI 10.1523/JNEUROSCI.3921-12.2013; Williams RH, 2007, P NATL ACAD SCI USA, V104, P10685, DOI 10.1073/pnas.0702676104; Wu M, 2009, P NATL ACAD SCI USA, V106, P17217, DOI 10.1073/pnas.0908200106	56	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103585	10.1371/journal.pone.0103585	http://dx.doi.org/10.1371/journal.pone.0103585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084113	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800053
J	Biesenbach, P; Kain, R; Derfler, K; Perkmann, T; Soleiman, A; Benharkou, A; Druml, W; Rees, A; Saemann, MD				Biesenbach, Peter; Kain, Renate; Derfler, Kurt; Perkmann, Thomas; Soleiman, Afschin; Benharkou, Alexandra; Druml, Wilfred; Rees, Andrew; Saeemann, Marcus D.			Long-Term Outcome of Anti-Glomerular Basement Membrane Antibody Disease Treated with Immunoadsorption	PLOS ONE			English	Article							RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; PROTEIN-A-IMMUNOADSORPTION; PLASMA-EXCHANGE; PLASMAPHERESIS; PROGNOSIS; THERAPY; SLE; IAS	Background: Anti-glomerular basement membrane (GBM) antibody disease may lead to acute crescentic glomerulonephritis with poor renal prognosis. Current therapy favours plasma exchange (PE) for removal of pathogenic antibodies. Immunoadsorption (IAS) is superior to PE regarding efficiency of antibody-removal and safety. Apart from anecdotal data, there is no systemic analysis of the long-term effects of IAS on anti-GBM-disease and antibody kinetics. Objective: To examine the long-term effect of high-frequency IAS combined with standard immunosuppression on patient and renal survival in patients with anti-GBM-disease and to quantify antibody removal and kinetics through IAS. Design: Retrospective review of patients treated with IAS for anti-GBM-antibody disease confirmed by biopsy and/or anti-GBM-antibodies. Setting: University Hospital of Vienna, Austria. Participants: 10 patients with anti-GBM-disease treated with IAS. Measurements: Patient and renal survival, renal histology, anti-GBM-antibodies. Results: Anti-GBM-antibodies were reduced by the first 9 IAS treatments (mean number of 23) to negative levels in all patients. Renal survival was 40% at diagnosis, 70% after the end of IAS, 63% after one year and 50% at the end of observation (mean 84 months, range 9 to 186). Dialysis dependency was successfully reversed in three of six patients. Patient survival was 90% at the end of observation. Conclusion: IAS efficiently eliminates anti-GBM-antibodies suggesting non-inferiority to PE with regard to renal and patient survival. Hence IAS should be considered as a valuable treatment option for anti-GBM-disease, especially in patients presenting with a high percentage of crescents and dialysis dependency due to an unusual high proportion of responders.	[Biesenbach, Peter; Derfler, Kurt; Druml, Wilfred; Saeemann, Marcus D.] Med Univ Vienna, Internal Med Clin Div Nephrol & Dialysis 3, Vienna, Austria; [Kain, Renate; Soleiman, Afschin; Benharkou, Alexandra; Rees, Andrew] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Perkmann, Thomas] Med Univ Vienna, Dept Lab Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Biesenbach, P (corresponding author), Med Univ Vienna, Internal Med Clin Div Nephrol & Dialysis 3, Vienna, Austria.	Peter.biesenbach@meduniwien.ac.at	Perkmann, Thomas/F-3074-2012; Kain, Renate/ACR-4709-2022	Kain, Renate/0000-0002-2428-543X; Perkmann, Thomas/0000-0002-7976-0285; Derfler, Kurt/0000-0003-2062-7620				ANDRASSY K, 1991, NEPHRON, V59, P206, DOI 10.1159/000186552; Aringer M, 1998, ARTHRITIS RHEUM, V41, P414, DOI 10.1002/1529-0131(199803)41:3<414::AID-ART6>3.0.CO;2-N; Biesenbach P, 2009, ATHEROSCLEROSIS SUPP, V10, P114, DOI 10.1016/S1567-5688(09)71824-0; Bolton WK, 1996, KIDNEY INT, V50, P1753, DOI 10.1038/ki.1996.495; COUSER WG, 1988, AM J KIDNEY DIS, V11, P449, DOI 10.1016/S0272-6386(88)80079-9; Cui Z, 2011, MEDICINE, V90, P303, DOI 10.1097/MD.0b013e31822f6f68; Dantal J, 1998, J AM SOC NEPHROL, V9, P1709; Heaf J, 1999, NEPHROL DIAL TRANSPL, V14, P1889, DOI 10.1093/ndt/14.8.1889; Hu WX, 2006, J NEPHROL, V19, P312; Jindal KK, 1999, KIDNEY INT, V55, pS33, DOI 10.1046/j.1523-1755.1999.07005.x; Kaplan AA, 2003, THER APHER DIAL, V7, P165, DOI 10.1046/j.1526-0968.2003.00030.x; Kasperkiewicz M, 2012, CLIN DERMATOL, V30, P84, DOI 10.1016/j.clindermatol.2011.03.014; KNOBL P, 1995, THROMB HAEMOSTASIS, V74, P1035; Laczika K, 2000, AM J KIDNEY DIS, V36, P392, DOI 10.1053/ajkd.2000.8993; Levy JB, 2001, ANN INTERN MED, V134, P1033, DOI 10.7326/0003-4819-134-11-200106050-00009; Madore F, 1996, J AM SOC NEPHROL, V7, P367; MORESO F, 1995, MED CLIN-BARCELONA, V105, P59; PETERS DK, 1982, TRANSPLANT P, V14, P513; Pusey CD, 2003, KIDNEY INT, V64, P1535, DOI 10.1046/j.1523-1755.2003.00241.x; Pusey CD, 2012, BLOOD PURIFICAT, V33, P190, DOI 10.1159/000334155; SAVAGE COS, 1986, BRIT MED J, V292, P301, DOI 10.1136/bmj.292.6516.301; Schmaldienst S, 2002, AM J KIDNEY DIS, V39, P415, DOI 10.1053/ajkd.2002.30564; Schmaldienst S, 2001, RHEUMATOLOGY, V40, P513, DOI 10.1093/rheumatology/40.5.513; Schmaldienst S, 2000, AM J KIDNEY DIS, V36, P490, DOI 10.1053/ajkd.2000.9789; SNYDER HW, 1992, BLOOD, V79, P2237; Stegmayr BG, 1999, INT J ARTIF ORGANS, V22, P81, DOI 10.1177/039139889902200205; Stummvoll GH, 2012, NEPHROL DIAL TRANSPL, V27, P618, DOI 10.1093/ndt/gfr239; Stummvoll GH, 2004, WIEN KLIN WOCHENSCHR, V116, P716, DOI 10.1007/s00508-004-0232-8; TURNER N, 1992, J CLIN INVEST, V89, P592, DOI 10.1172/JCI115625	29	33	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103568	10.1371/journal.pone.0103568	http://dx.doi.org/10.1371/journal.pone.0103568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079220	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800055
J	Elisabetta, V; Ferrero, V; Pedotti, M; Chiado, A; Simonelli, L; Calzolai, L; Varani, L; Lettieri, T				Elisabetta, Valentina; Ferrero, Viviana; Pedotti, Mattia; Chiado, Alessandro; Simonelli, Luca; Calzolai, Luigi; Varani, Luca; Lettieri, Teresa			Rational Modification of Estrogen Receptor by Combination of Computational and Experimental Analysis	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; LIGAND-BINDING DOMAIN; WASTE-WATER; ALPHA; BETA; HOMEOSTASIS; RIVER; BIOACCUMULATION; IDENTIFICATION; TRANSCRIPTION	In this manuscript, we modulate the binding properties of estrogen receptor protein by rationally modifying the amino acid composition of its ligand binding domain. By combining sequence alignment and structural analysis of known estrogen receptor-ligand complexes with computational analysis, we were able to predict estrogen receptor mutants with altered binding properties. These predictions were experimentally confirmed by producing single point variants with up to an order of magnitude increased binding affinity towards some estrogen disrupting chemicals and reaching an half maximal inhibitory concentration (IC50) value of 2 nM for the 17 alpha-ethinylestradiol ligand. Due to increased affinity and stability, utilizing such mutated estrogen receptor instead of the wild type as bio-recognition element would be beneficial in an assay or biosensor.	[Elisabetta, Valentina; Lettieri, Teresa] European Commiss, Directorate Gen, Joint Res Ctr, Inst Environm & Sustainabil, Ispra, Varese, Italy; [Ferrero, Viviana; Pedotti, Mattia; Chiado, Alessandro; Calzolai, Luigi] Biomed Res Inst, Bellinzona, Switzerland; [Calzolai, Luigi] European Commiss, Directorate Gen, Joint Res Ctr, Inst Hlth & Consumer Protect, Ispra, Varese, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site; Universita della Svizzera Italiana; European Commission Joint Research Centre; EC JRC ISPRA Site	Varani, L (corresponding author), European Commiss, Directorate Gen, Joint Res Ctr, Inst Environm & Sustainabil, Ispra, Varese, Italy.	luca.varani@irb.usi.ch; teresa.lettieri@jrc.ec.europa.eu	Chiadò, Alessandro/I-1501-2019	Chiadò, Alessandro/0000-0002-3230-8427; Lettieri, Teresa/0000-0002-3363-9666; Simonelli, Luca/0000-0001-6331-7716; Varani, Luca/0000-0002-0963-0987	FP7-KBBE/Programme 'Cooperation' - Research Theme: 'Food, agriculture and fisheries, and biotechnology' [265721]; Erasmus program; SVRI; BSJRP; SNF	FP7-KBBE/Programme 'Cooperation' - Research Theme: 'Food, agriculture and fisheries, and biotechnology'; Erasmus program; SVRI; BSJRP; SNF	The whole project achievements were possible thanks to the RADAR FP7 project funds FP7-KBBE/Programme 'Cooperation' - Research Theme: 'Food, agriculture and fisheries, and biotechnology', project number 265721). AC was supported in part by the Erasmus program. LV acknowledges financial support from SVRI, BSJRP and SNF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS H, 1992, RECEPTOR, V2, P77; Allen Y, 1999, SCI TOTAL ENVIRON, V233, P5, DOI 10.1016/S0048-9697(99)00175-8; Aqai P, 2013, ANAL BIOANAL CHEM, V405, P9427, DOI 10.1007/s00216-013-7384-1; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chung AC, 2003, NUCL RECEPTOR SIGNAL, V1, P1; Colasanti T, 2012, ARTHRITIS RHEUM-US, V64, P778, DOI 10.1002/art.33400; Colborn T, 2002, ENVIRON HEALTH PERSP, V110, P363, DOI 10.1289/ehp.02110s3363; Damstra T, 2002, J TOXICOL-CLIN TOXIC, V40, P457, DOI 10.1081/CLT-120006748; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Fu XD, 2008, IUBMB LIFE, V60, P502, DOI 10.1002/iub.80; Gong J, 2012, ENVIRON TOXICOL CHEM, V31, P2456, DOI 10.1002/etc.1961; Greenfield N, 2001, BIOCHEMISTRY-US, V40, P6646, DOI 10.1021/bi002846l; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Haberthur U, 2008, J COMPUT CHEM, V29, P701, DOI 10.1002/jcc.20832; Harries JE, 1997, ENVIRON TOXICOL CHEM, V16, P534, DOI [10.1897/1551-5028(1997)016&lt;0534:EAIFUK&gt;2.3.CO;2, 10.1002/etc.5620160320]; Katzenellenbogen BS, 2000, BREAST CANCER RES, V2, P335, DOI 10.1186/bcr78; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kim S, 2004, J MED CHEM, V47, P2171, DOI 10.1021/jm034243o; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; Lai KM, 2002, SCI TOTAL ENVIRON, V289, P159, DOI 10.1016/S0048-9697(01)01036-1; Laws SC, 2000, TOXICOL SCI, V54, P154, DOI 10.1093/toxsci/54.1.154; LEDREAN Y, 1995, MOL CELL ENDOCRINOL, V109, P27, DOI 10.1016/0303-7207(95)03482-M; Liu JL, 2012, ENVIRON POLLUT, V162, P325, DOI 10.1016/j.envpol.2011.11.036; Mater N, 2014, ENVIRON INT, V63, P191, DOI 10.1016/j.envint.2013.11.011; Matthews J, 2000, TOXICOL SCI, V53, P326, DOI 10.1093/toxsci/53.2.326; Matthews J, 2000, J STEROID BIOCHEM, V74, P223, DOI 10.1016/S0960-0760(00)00126-6; Morris GM, 2009, AUTODOCK4 AUTODOCKTO, V16; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Nair SK, 2005, J MOL ENDOCRINOL, V35, P211, DOI 10.1677/jme.1.01830; Noaksson E, 2001, TOXICOL APPL PHARM, V174, P160, DOI 10.1006/taap.2001.9194; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersson K, 2001, ANNU REV PHYSIOL, V63, P165, DOI 10.1146/annurev.physiol.63.1.165; Pietras RJ, 2007, CLIN CANCER RES, V13, P4672, DOI 10.1158/1078-0432.CCR-07-1373; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Ribas V, 2011, P NATL ACAD SCI USA, V108, P16457, DOI 10.1073/pnas.1104533108; Ricciardi C, 2013, BIOSENS BIOELECTRON, V40, P407, DOI 10.1016/j.bios.2012.08.043; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruff M, 2000, BREAST CANCER RES, V2, P353, DOI 10.1186/bcr80; SEIELSTAD DA, 1995, BIOCHEMISTRY-US, V34, P12605, DOI 10.1021/bi00039a016; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Snyder SA, 2008, REMOVAL ENDOCRINE DI; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Strauss L, 2009, ENDOCRINOLOGY, V150, P2865, DOI 10.1210/en.2008-1311; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; Sumpter JP, 1998, TOXICOL LETT, V103, P337, DOI 10.1016/S0378-4274(98)00328-2; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Torres NH., 2012, IOSR J ENG, V2, P984, DOI [10.9790/3021-0205984989, DOI 10.9790/3021-0205984989]; Tyler CR, 1998, CRIT REV TOXICOL, V28, P319, DOI 10.1080/10408449891344236; Vigano L, 2010, ENVIRON POLLUT, V158, P3675, DOI 10.1016/j.envpol.2010.07.033; Watanabe H, 2003, J MOL ENDOCRINOL, V31, P487, DOI 10.1677/jme.0.0310487; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	59	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102658	10.1371/journal.pone.0102658	http://dx.doi.org/10.1371/journal.pone.0102658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075862	gold, Green Published, Green Submitted			2022-12-25	WOS:000340028800015
J	Ning, SW; Zhao, ZXL; Ye, JR; Wang, P; Zhi, H; Li, RH; Wang, TT; Wang, JJ; Wang, LH; Li, X				Ning, Shangwei; Zhao, Zuxianglan; Ye, Jingrun; Wang, Peng; Zhi, Hui; Li, Ronghong; Wang, Tingting; Wang, Jianjian; Wang, Lihua; Li, Xia			SNP@lincTFBS: An Integrated Database of Polymorphisms in Human LincRNA Transcription Factor Binding Sites	PLOS ONE			English	Article							LONG NONCODING RNA; CANCER; GENE; PROMOTER; SUSCEPTIBILITY; IDENTIFICATION; ASSOCIATION; METASTASIS; ANNOTATION; EXPRESSION	Large intergenic non-coding RNAs (lincRNAs) are a new class of functional transcripts, and aberrant expression of lincRNAs was associated with several human diseases. The genetic variants in lincRNA transcription factor binding sites (TFBSs) can change lincRNA expression, thereby affecting the susceptibility to human diseases. To identify and annotate these functional candidates, we have developed a database SNP@lincTFBS, which is devoted to the exploration and annotation of single nucleotide polymorphisms (SNPs) in potential TFBSs of human lincRNAs. We identified 6,665 SNPs in 6,614 conserved TFBSs of 2,423 human lincRNAs. In addition, with ChIPSeq dataset, we identified 139,576 SNPs in 304,517 transcription factor peaks of 4,813 lincRNAs. We also performed comprehensive annotation for these SNPs using 1000 Genomes Project datasets across 11 populations. Moreover, one of the distinctive features of SNP@lincTFBS is the collection of disease-associated SNPs in the lincRNA TFBSs and SNPs in the TFBSs of disease-associated lincRNAs. The web interface enables both flexible data searches and downloads. Quick search can be query of lincRNA name, SNP identifier, or transcription factor name. SNP@lincTFBS provides significant advances in identification of disease-associated lincRNA variants and improved convenience to interpret the discrepant expression of lincRNAs.	[Ning, Shangwei; Zhao, Zuxianglan; Ye, Jingrun; Wang, Peng; Zhi, Hui; Li, Ronghong; Wang, Tingting; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Wang, Jianjian; Wang, Lihua] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Wang, LH (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China.	wanglh211@163.com; lixia@hrbmu.edu.cn	wang, tingting/AAK-2640-2020; li, xia/HHZ-7468-2022; Ye, jingrun/GSJ-2822-2022		National High Technology Research and Development Program of China [863 Program] [2014AA021102]; National Natural Science Foundation of China [91129710, 61073136, 61170154]; Undergraduate Innovation Funds of Harbin Medical University [YJSCX2012-226HLJ]	National High Technology Research and Development Program of China [863 Program](National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Undergraduate Innovation Funds of Harbin Medical University	This work was supported by the National High Technology Research and Development Program of China [863 Program, Grant Nos. 2014AA021102], the National Natural Science Foundation of China [Grant Nos. 91129710, 61073136 and 61170154], and the Undergraduate Innovation Funds of Harbin Medical University [Grant Nos. YJSCX2012-226HLJ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airavaara M, 2011, J BIOL CHEM, V286, P45093, DOI 10.1074/jbc.M111.310250; Astuti D, 2005, BRIT J CANCER, V92, P1574, DOI 10.1038/sj.bjc.6602478; Badano I, 2012, J CLIN VIROL, V53, P54, DOI 10.1016/j.jcv.2011.09.030; Baldinu P, 2004, HUM MUTAT, V23, P318, DOI 10.1002/humu.20015; Barber MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009763; Bialkowska-Hobrzanska Hanna, 2006, Can J Urol, V13, P2967; Blanton SH, 2010, CLEFT PALATE-CRAN J, V47, P574, DOI 10.1597/09-153; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2013, J MOL MED, V91, P791, DOI 10.1007/s00109-013-1028-y; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hata J, 2007, HUM MOL GENET, V16, P630, DOI 10.1093/hmg/ddm005; Hollingworth P, 2012, MOL PSYCHIATR, V17, P1316, DOI 10.1038/mp.2011.125; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Jendrzejewski J, 2012, P NATL ACAD SCI USA, V109, P8646, DOI 10.1073/pnas.1205654109; Jung M, 2012, YONSEI MED J, V53, P1128, DOI 10.3349/ymj.2012.53.6.1128; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kohanbash G, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19964; Kumar V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003201; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Maruyama R, 2012, BMB REP, V45, P604, DOI 10.5483/BMBRep.2012.45.11.227; Matouk IJ, 2009, EUR J GASTROEN HEPAT, V21, P688, DOI 10.1097/MEG.0b013e328306a3a2; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Nie Y, 2013, CANCER SCI, V104, P458, DOI 10.1111/cas.12092; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Pujana MA, 2007, GENE CHROMOSOME CANC, V46, P155, DOI 10.1002/gcc.20396; Qureshi IA, 2010, BRAIN RES, V1338, P20, DOI 10.1016/j.brainres.2010.03.110; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Tan Chen, 2002, Ai Zheng, V21, P449; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wang PJ, 2012, J CELL BIOCHEM, V113, P1868, DOI 10.1002/jcb.24055; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Ying L, 2013, MOL BIOSYST, V9, P407, DOI 10.1039/c2mb25386k; Zhang WL, 2013, J MOL HISTOL, V44, P545, DOI 10.1007/s10735-013-9503-x	46	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103851	10.1371/journal.pone.0103851	http://dx.doi.org/10.1371/journal.pone.0103851			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075616	Green Published, gold, Green Submitted			2022-12-25	WOS:000340028800083
J	Pelletier, CC; Koppe, L; Alix, PM; Kalbacher, E; Croze, ML; Hadj-Aissa, A; Fouque, D; Guebre-Egziabher, F; Soulage, CO				Pelletier, Caroline C.; Koppe, Laetitia; Alix, Pascaline M.; Kalbacher, Emilie; Croze, Marine L.; Hadj-Aissa, Aoumeur; Fouque, Denis; Guebre-Egziabher, Fitsum; Soulage, Christophe O.			The Relationship between Renal Function and Plasma Concentration of the Cachectic Factor Zinc-Alpha2-Glycoprotein (ZAG) in Adult Patients with Chronic Kidney Disease	PLOS ONE			English	Article							LIPID-MOBILIZING FACTOR; GLOMERULAR-FILTRATION-RATE; BODY-MASS INDEX; ADIPOSE-TISSUE; SERUM-LEVELS; ZINC ALPHA-2-GLYCOPROTEIN; CARDIOVASCULAR EVENTS; ZINC-ALPHA-2-GLYCOPROTEIN; ADIPOKINE; EXPRESSION	Zinc-alpha 2-glycoprotein (ZAG), a potent cachectic factor, is increased in patients undergoing maintenance dialysis. However, there is no data for patients before initiation of renal replacement therapy. The purpose of the present study was to assess the relationship between plasma ZAG concentration and renal function in patients with a large range of glomerular filtration rate (GFR). Plasma ZAG concentration and its relationship to GFR were investigated in 71 patients with a chronic kidney disease (CKD) stage 1 to 5, 17 chronic hemodialysis (HD), 8 peritoneal dialysis (PD) and 18 non-CKD patients. Plasma ZAG concentration was 2.3-fold higher in CKD stage 5 patients and 3-fold higher in HD and PD patients compared to non-CKD controls (P < 0.01). The hemodialysis session further increased plasma ZAG concentration (+39%, P < 0.01). An inverse relationship was found between ZAG levels and plasma protein (r(s) = -0.284; P < 0.01), albumin (rs = -0.282, P < 0.05), hemoglobin (r(s) = 20.267, P < 0.05) and HDL-cholesterol (r(s) = -0.264, P < 0.05) and a positive correlation were seen with plasma urea (r(s) = 0.283; P < 0.01). In multiple regression analyses, plasma urea and HDL-cholesterol were the only variables associated with plasma ZAG (r(2) = 0.406, P < 0.001). In CKD-5 patients, plasma accumulation of ZAG was not correlated with protein energy wasting. Further prospective studies are however needed to better elucidate the potential role of ZAG in end-stage renal disease.	[Pelletier, Caroline C.; Koppe, Laetitia; Alix, Pascaline M.; Kalbacher, Emilie; Croze, Marine L.; Hadj-Aissa, Aoumeur; Fouque, Denis; Guebre-Egziabher, Fitsum; Soulage, Christophe O.] Univ Lyon, F-69600 Oullins, France; [Pelletier, Caroline C.; Koppe, Laetitia; Alix, Pascaline M.; Kalbacher, Emilie; Croze, Marine L.; Fouque, Denis; Guebre-Egziabher, Fitsum; Soulage, Christophe O.] Univ Lyon 1, INSERM, U1060, INSA Lyon,CarMeN, F-69622 Villeurbanne, France; [Pelletier, Caroline C.; Koppe, Laetitia; Alix, Pascaline M.; Kalbacher, Emilie; Guebre-Egziabher, Fitsum] Hop Edouard Herriot, Serv Nephrol, Hosp Civils Lyon, Lyon, France; [Hadj-Aissa, Aoumeur] Hop Edouard Herriot, Hosp Civils Lyon, Lyon, France; [Fouque, Denis] Ctr Hosp Lyon SUD, Serv Nephrol, Hosp Civils Lyon, Pierre Benite, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; CHU Lyon	Soulage, CO (corresponding author), Univ Lyon, F-69600 Oullins, France.	Christophe.Soulage@insa-lyon.fr	KOPPE, Laetitia/I-5978-2015; Carmen, Team1/Y-7382-2019; SOULAGE, Christophe O/J-2759-2014; Carmen, Team3/Y-7384-2019	KOPPE, Laetitia/0000-0002-5076-2420; Carmen, Team1/0000-0003-4234-1746; SOULAGE, Christophe O/0000-0002-8800-2144; Carmen, Team3/0000-0002-3614-0924; Lab, Carmen/0000-0002-5935-3236	governmental institution from France, INSERM; governmental institution from INSA-Lyon; Federation Nationale d'Aide aux Insuffisants Renaux (FNAIR); Societe Francaise de Nephrologie; Academie de Medecine; Fondation pour la Recherche Medicale; French "Ministere de l'Enseignement Superieur et de la Recherche"	governmental institution from France, INSERM; governmental institution from INSA-Lyon; Federation Nationale d'Aide aux Insuffisants Renaux (FNAIR); Societe Francaise de Nephrologie; Academie de Medecine; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French "Ministere de l'Enseignement Superieur et de la Recherche"	This study was supported by two governmental institutions from France, INSERM and INSA-Lyon, and by the Federation Nationale d'Aide aux Insuffisants Renaux (FNAIR). CC.PELLETIER and PM. ALIX held grants from "Societe Francaise de Nephrologie," E KALBACHER was the recipient of a grant from "Academie de Medecine" and L. KOPPE held a fellowship from "Fondation pour la Recherche Medicale". ML CROZE held a grant from the French "Ministere de l'Enseignement Superieur et de la Recherche." The authors have no competing financial interests to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson J, 2011, NEPHROL DIAL TRANSPL, V26, P2485, DOI 10.1093/ndt/gfq755; Bao Y, 2005, FEBS LETT, V579, P41, DOI 10.1016/j.febslet.2004.11.042; Bing Chen, 2011, Curr Opin Support Palliat Care, V5, P356, DOI 10.1097/SPC.0b013e32834bde0e; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUERGI W, 1961, J BIOL CHEM, V236, P1066; Buron F, 2011, TRANSPLANTATION, V92, P1005, DOI 10.1097/TP.0b013e3182301602; Cirillo M, 2005, NEPHROL DIAL TRANSPL, V20, P1791, DOI 10.1093/ndt/gfh962; Cumin F, 1997, INT J OBESITY, V21, P495, DOI 10.1038/sj.ijo.0800428; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Dubourg L, 2010, ANAL BIOCHEM, V405, P266, DOI 10.1016/j.ab.2010.06.016; EKMAN R, 1976, J CLIN INVEST, V57, P945, DOI 10.1172/JCI108371; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Gao D, 2010, MOL CELL ENDOCRINOL, V325, P135, DOI 10.1016/j.mce.2010.05.020; Gong FY, 2009, INT J OBESITY, V33, P1023, DOI 10.1038/ijo.2009.141; Guebre-Egziabher F, 2005, J RENAL NUTR, V15, P116, DOI 10.1053/j.jrn.2004.09.015; Guebre-Egziabher F, 2005, NEPHROL DIAL TRANSPL, V20, P129, DOI 10.1093/ndt/gfh568; Hassan MI, 2008, MOL CANCER RES, V6, P892, DOI 10.1158/1541-7786.MCR-07-2195; Hirai K, 1998, CANCER RES, V58, P2359; Leal VO, 2012, RENAL FAILURE, V34, P1062, DOI 10.3109/0886022X.2012.712859; Leal VO, 2012, CLIN CHIM ACTA, V413, P616, DOI 10.1016/j.cca.2011.12.002; Letizia C, 1996, SCAND J UROL NEPHROL, V30, P399, DOI 10.3109/00365599609181317; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Merabet E, 1997, J CLIN ENDOCR METAB, V82, P847, DOI 10.1210/jc.82.3.847; Mracek T, 2010, J ENDOCRINOL, V204, P165, DOI 10.1677/JOE-09-0299; Mracek T, 2011, BRIT J CANCER, V104, P441, DOI 10.1038/sj.bjc.6606083; Olofsson LE, 2010, METABOLISM, V59, P1316, DOI 10.1016/j.metabol.2009.12.006; Pelletier CC, 2013, KIDNEY INT, V83, P878, DOI 10.1038/ki.2013.9; Pfau D, 2010, DIABETES CARE, V33, P171, DOI 10.2337/dc09-1351; Philipp A, 2011, METABOLISM, V60, P669, DOI 10.1016/j.metabol.2010.06.019; Rubinger D, 2013, SEMIN DIALYSIS, V26, P333, DOI 10.1111/sdi.12093; Russell ST, 2005, BRIT J CANCER, V92, P876, DOI 10.1038/sj.bjc.6602404; Russell ST, 2004, BBA-MOL CELL BIOL L, V1636, P59, DOI 10.1016/j.bbalip.2003.12.004; Russell ST, 2002, BRIT J CANCER, V86, P424, DOI 10.1038/sj.bjc.6600086; Russell ST, 2012, BBA-MOL CELL BIOL L, V1821, P590, DOI 10.1016/j.bbalip.2011.12.003; Ryden M, 2012, J INTERN MED, V271, P414, DOI 10.1111/j.1365-2796.2011.02441.x; Sanchez LM, 1999, SCIENCE, V283, P1914, DOI 10.1126/science.283.5409.1914; Sanders PM, 2004, CANCER LETT, V212, P71, DOI 10.1016/j.canlet.2004.03.021; Schmitt R, 2008, J AM SOC NEPHROL, V19, P2375, DOI 10.1681/ASN.2008010035; Stein S, 2009, DIABETES CARE, V32, P126, DOI 10.2337/dc08-1054; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; TADA T, 1991, J HISTOCHEM CYTOCHEM, V39, P1221, DOI 10.1177/39.9.1918940; Tedeschi S, 2012, METABOLISM, V61, P37, DOI 10.1016/j.metabol.2011.05.011; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Ziegelmeier M, 2007, DIABETES CARE, V30, P2588, DOI 10.2337/dc07-0275; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134; Zoccali C, 2002, CIRCULATION, V105, P1354, DOI 10.1161/hc1102.105261	46	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103475	10.1371/journal.pone.0103475	http://dx.doi.org/10.1371/journal.pone.0103475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076420	Green Published, gold, Green Submitted			2022-12-25	WOS:000340028800050
J	Regan, FH; Hockenhull, J; Pritchard, JC; Waterman-Pearson, AE; Whay, HR				Regan, Fran H.; Hockenhull, Jo; Pritchard, Joy C.; Waterman-Pearson, Avril E.; Whay, Helen R.			Behavioural Repertoire of Working Donkeys and Consistency of Behaviour over Time, as a Preliminary Step towards Identifying Pain-Related Behaviours	PLOS ONE			English	Article							ASSES EQUUS AFRICANUS; SOCIAL-ORGANIZATION; INTEROBSERVER RELIABILITY; TEST PERSON; TEST-RETEST; RESPONSES; WELFARE; HUMANS; ASINUS; FAMILIARITY	Background: The donkey has a reputation for stoicism and its behavioural repertoire in clinical contexts is under-reported. Lack of understanding of the norms of donkey behaviour and how it may vary over time can compromise use of behavioural measures as indicators of pain or emotional state. The objective of this study was to find out whether the behaviour of working donkeys was influenced by gender, the time of day or differed between days with a view to assessing how robust these measures are for inclusion in a working donkey ethogram. Methodology/Principal Findings: Frequency and consistency of postural and event behaviours were measured in 21 adult working donkeys (12 females; 9 males). Instantaneous (scan) and focal sampling were used to measure maintenance, lying, ingestive and investigative behaviours at hourly intervals for ten sessions on each of two consecutive days. High head carriage and biting were seen more frequently in male donkeys than females (P<0.001). Level head carriage, licking/chewing and head-shaking were observed more frequently in female donkeys (P<0.001). Tail position, ear orientation, foot stamping, rolling/lying and head-shaking behaviours were affected by time of day (P<0.001). However, only two variations in ear orientation were found to be significantly different over the two days of observations (P<0.001). Tail swishing, head shaking, foot stamping, and ears held sideways and downwards were significantly correlated (P<0.001) and are assumed to be behaviours to discourage flies. Conclusions/Significance: All donkeys expressed an extensive behavioural repertoire, although some differences in behaviour were evident between genders. While most behaviours were consistent over time, some behaviours were influenced by time of day. Few behaviours differed between the two test days. The findings can be used to inform the development of a robust, evidence-based ethogram for working donkeys.	[Regan, Fran H.; Hockenhull, Jo; Waterman-Pearson, Avril E.; Whay, Helen R.] Univ Bristol, Sch Vet Sci, Langford, North Somerset, England; [Pritchard, Joy C.] Animals Int Dev, Banwell, North Somerset, England; [Pritchard, Joy C.] Brooke, London, England	University of Bristol	Whay, HR (corresponding author), Univ Bristol, Sch Vet Sci, Langford, North Somerset, England.	bec.whay@bristol.ac.uk		Hockenhull, Jo/0000-0002-9224-7304	The Brooke	The Brooke	The authors received funding from a UK based working equine charity called "The Brooke." One author (JCP) who contributed to preparation of the manuscript is employed part-time for The Brooke, independently of the current work which was carried out under her second affiliation. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersen IL, 2000, APPL ANIM BEHAV SCI, V69, P227, DOI 10.1016/S0168-1591(00)00133-7; Ashley FH., 2006, P 5 INT C WORK EQ AD, P15; Ayo JO, 2008, J EQUINE VET SCI, V28, P281, DOI 10.1016/j.jevs.2008.03.003; Berger A, 1999, APPL ANIM BEHAV SCI, V64, P1, DOI 10.1016/S0168-1591(99)00026-X; Burn CC, 2010, APPL ANIM BEHAV SCI, V126, P109, DOI 10.1016/j.applanim.2010.06.007; Canacoo EA, 1998, APPL ANIM BEHAV SCI, V60, P229, DOI 10.1016/S0168-1591(98)00167-1; Chaya W, 2006, APPL ANIM BEHAV SCI, V101, P177, DOI 10.1016/j.applanim.2005.11.009; Gilkeson J, 2009, J EQUINE VET SCI, V29, P491; GONYOU HW, 1994, J ANIM SCI, V72, P2171, DOI 10.2527/1994.7282171x; Gregory NG, 2004, PHYSIOLOGY AND BEHAVIOUR OF ANIMAL SUFFERING, P1, DOI 10.1002/9780470752494; Hay M, 2003, APPL ANIM BEHAV SCI, V82, P201, DOI 10.1016/S0168-1591(03)00059-5; Hemsworth PH, 1996, APPL ANIM BEHAV SCI, V50, P43, DOI 10.1016/0168-1591(96)01067-2; Henry M, 1998, APPL ANIM BEHAV SCI, V60, P263, DOI 10.1016/S0168-1591(98)00175-0; HOLM S, 1979, SCAND J STAT, V6, P65; Klingel H, 1998, APPL ANIM BEHAV SCI, V60, P103, DOI 10.1016/S0168-1591(98)00160-9; Lamoot I, 2005, APPL ANIM BEHAV SCI, V92, P93, DOI 10.1016/j.applanim.2004.10.017; Mcdonnell SM, 2003, EQUID ETHOGRAM; McGreevy P., 2004, EQUINE BEHAV GUIDE V, DOI 10.1016/B978-0-7020-2634-8.50006-X; Moehlman PD, 1998, APPL ANIM BEHAV SCI, V60, P125, DOI 10.1016/S0168-1591(98)00162-2; Moehlman PD, 1998, APPL ANIM BEHAV SCI, V60, P171, DOI 10.1016/S0168-1591(98)00163-4; Molony V, 1997, J ANIM SCI, V75, P266; Murray LMA, 2013, APPL ANIM BEHAV SCI, V143, P67, DOI 10.1016/j.applanim.2012.11.005; Pritchard JC, 2005, PREV VET MED, V69, P265, DOI 10.1016/j.prevetmed.2005.02.002; Rousing T, 2005, APPL ANIM BEHAV SCI, V94, P237, DOI 10.1016/j.applanim.2005.02.011; Rousing T, 2004, APPL ANIM BEHAV SCI, V85, P215, DOI 10.1016/j.applanim.2003.09.014; Rudman R, 1998, APPL ANIM BEHAV SCI, V60, P211, DOI 10.1016/S0168-1591(98)00165-8; Rushen J, 1999, APPL ANIM BEHAV SCI, V65, P285, DOI 10.1016/S0168-1591(99)00089-1; Schrader L, 2002, APPL ANIM BEHAV SCI, V77, P255, DOI 10.1016/S0168-1591(02)00075-8; Smith D, 2008, DONKEY NUTR PROFESSI; Thornton PD, 1999, RES VET SCI, V66, P107, DOI 10.1053/rvsc.1998.0252; Tyler S.J., 1972, Animal Behav Monogr, V5, P85; Visser EK, 2001, APPL ANIM BEHAV SCI, V74, P241, DOI 10.1016/S0168-1591(01)00177-0	32	27	27	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e101877	10.1371/journal.pone.0101877	http://dx.doi.org/10.1371/journal.pone.0101877			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076209	Green Published, Green Submitted, gold			2022-12-25	WOS:000340028800009
J	Vangone, A; Abdel-Azeim, S; Caputo, I; Sblattero, D; Di Niro, R; Cavallo, L; Oliva, R				Vangone, Anna; Abdel-Azeim, Safwat; Caputo, Ivana; Sblattero, Daniele; Di Niro, Roberto; Cavallo, Luigi; Oliva, Romina			Structural Basis for the Recognition in an Idiotype-Anti-Idiotype Antibody Complex Related to Celiac Disease	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; INTER-RESIDUE CONTACTS; ANTIIDIOTYPIC ANTIBODIES; TISSUE TRANSGLUTAMINASE; CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; AUTOIMMUNE-DISEASES; ANGSTROM RESOLUTION; PROTEIN COMPLEXES; IDIOTOPE COMPLEX	Anti-idiotype antibodies have potential therapeutic applications in many fields, including autoimmune diseases. Herein we report the isolation and characterization of AIM2, an anti-idiotype antibody elicited in a mouse model upon expression of the celiac disease-specific autoantibody MB2.8 (directed against the main disease autoantigen type 2 transglutaminase, TG2). To characterize the interaction between the two antibodies, a 3D model of the MB2.8-AIM2 complex has been obtained by molecular docking. Analysis and selection of the different obtained docking solutions was based on the conservation within them of the inter-residue contacts. The selected model is very well representative of the different solutions found and its stability is confirmed by molecular dynamics simulations. Furthermore, the binding mode it adopts is very similar to that observed in most of the experimental structures available for idiotype-anti-idiotype antibody complexes. In the obtained model, AIM2 is directed against the MB2.8 CDR region, especially on its variable light chain. This makes the concurrent formation of the MB2.8-AIM2 complex and of the MB2.8-TG2 complex incompatible, thus explaining the experimentally observed inhibitory effect on the MB2.8 binding to TG2.	[Vangone, Anna; Caputo, Ivana; Cavallo, Luigi] Univ Salerno, Dept Biol & Chem, I-84100 Salerno, Italy; [Abdel-Azeim, Safwat; Cavallo, Luigi] King Abdullah Univ Sci & Technol, Kaust Catalysis Ctr, Thuwal, Saudi Arabia; [Caputo, Ivana] Univ Naples Federico II, European Lab Invest Food Induced Dis ELFID, Naples, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, Interdisciplinary Res Ctr Autoimmune Dis, Novara, Italy; [Di Niro, Roberto] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA; [Oliva, Romina] Univ Parthenope Naples, Dept Sci & Technol, Naples, Italy	University of Salerno; King Abdullah University of Science & Technology; University of Naples Federico II; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Parthenope University Naples	Oliva, R (corresponding author), Univ Parthenope Naples, Dept Sci & Technol, Naples, Italy.	romina.oliva@uniparthenope.it	Oliva, Romina/ABA-6313-2021; Cavallo, Luigi/D-5215-2019; Abdel-azeim, Safwat/R-8096-2019; Vangone, Anna/K-4756-2014; cavallo, luigi/C-7272-2015	Oliva, Romina/0000-0002-6156-6249; Cavallo, Luigi/0000-0002-1398-338X; Vangone, Anna/0000-0003-2485-7378; Caputo, Ivana/0000-0003-2825-9711; abdel-Azeim, Safwat sayed/0000-0001-8611-1251; Sblattero, Daniele/0000-0003-4309-242X	Italian MIUR (Ministero dell'Istruzione, dell' Universita della Ricerca) [PRIN2008]; Regione Campania [LR5-2002-AF2008]; EC Marie Curie Research Training Network [MRTN-CT-20010-289964]; King Abdullah University of Science and Technology	Italian MIUR (Ministero dell'Istruzione, dell' Universita della Ricerca); Regione Campania(Regione Campania); EC Marie Curie Research Training Network(European Commission); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	IC and RO were supported by the Italian MIUR (Ministero dell'Istruzione, dell' Universita della Ricerca; Grant PRIN2008). RO was also supported by Regione Campania (LR5-2002-AF2008). DS was supported by EC Marie Curie Research Training Network (contract n. MRTN-CT-20010-289964). LC was supported by the King Abdullah University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Azeim S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S5-S1; Abu-Shakra M, 2007, AUTOANTIBODIES, 2ND EDITION, P69, DOI 10.1016/B978-044452763-9/50014-7; Amadei A, 1999, PROTEINS, V36, P419, DOI 10.1002/(SICI)1097-0134(19990901)36:4<419::AID-PROT5>3.3.CO;2-L; BAN N, 1994, P NATL ACAD SCI USA, V91, P1604, DOI 10.1073/pnas.91.5.1604; BENTLEY GA, 1990, NATURE, V348, P254, DOI 10.1038/348254a0; Bhattacharya-Chatterjee M, 2000, IMMUNOL LETT, V74, P51, DOI 10.1016/S0165-2478(00)00249-2; Boscolo S, 2012, NEW BIOTECHNOL, V29, P477, DOI 10.1016/j.nbt.2011.12.005; Braden BC, 1996, J MOL BIOL, V264, P137, DOI 10.1006/jmbi.1996.0629; Brenke R, 2012, BIOINFORMATICS, V28, P2608, DOI 10.1093/bioinformatics/bts493; Bryson S, 2008, J MOL BIOL, V382, P910, DOI 10.1016/j.jmb.2008.07.057; Burioni R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003423; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Caputo I, 2013, AMINO ACIDS, V44, P251, DOI 10.1007/s00726-011-1120-y; Chailyan A, 2012, NUCLEIC ACIDS RES, V40, pD1230, DOI 10.1093/nar/gkr806; Chong G, 2006, ANN ONCOL, V17, P437, DOI 10.1093/annonc/mdj090; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; DALGLEISH AG, 1988, VACCINE, V6, P215, DOI 10.1016/0264-410X(88)90213-7; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Debret G, 2009, NUCLEIC ACIDS RES, V37, pW459, DOI 10.1093/nar/gkp304; deGroot BL, 1996, BIOPHYS J, V71, P1707, DOI 10.1016/S0006-3495(96)79372-4; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Di Niro R, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-46; Di Niro R, 2008, MOL IMMUNOL, V45, P1782, DOI 10.1016/j.molimm.2007.09.025; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; DIETRICH G, 1993, EUR J IMMUNOL, V23, P2945, DOI 10.1002/eji.1830231133; Eigenbrot C, 2003, J MOL BIOL, V331, P433, DOI 10.1016/S0022-2836(03)00735-6; EVANS SV, 1994, J MOL BIOL, V241, P691, DOI 10.1006/jmbi.1994.1544; Hess B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031910; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2000, PHYS REV E, V62, P8438, DOI 10.1103/PhysRevE.62.8438; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; JAYNE DRW, 1993, J AUTOIMMUN, V6, P221, DOI 10.1006/jaut.1993.1019; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JOST CR, 1994, J BIOL CHEM, V269, P26267; Konc J, 2012, NUCLEIC ACIDS RES, V40, pW214, DOI 10.1093/nar/gks435; Kuroda D, 2009, PROTEINS, V75, P139, DOI 10.1002/prot.22230; Ladjemi MZ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2826; Lensink MF, 2007, PROTEINS, V69, P704, DOI 10.1002/prot.21804; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; LUNDKVIST I, 1993, CLIN IMMUNOL IMMUNOP, V67, P192, DOI 10.1006/clin.1993.1064; LUNDKVIST I, 1989, IMMUNOL REV, V110, P105, DOI 10.1111/j.1600-065X.1989.tb00029.x; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Maki M, 1998, DIGEST DIS, V16, P330, DOI 10.1159/000016885; Marzari R, 2001, J IMMUNOL, V166, P4170, DOI 10.4049/jimmunol.166.6.4170; Mendez R, 2005, PROTEINS, V60, P150, DOI 10.1002/prot.20551; Mohanty K, 2007, BREAST CANCER RES TR, V104, P1, DOI 10.1007/s10549-006-9391-9; Oliva R, 2013, PROTEINS, V81, P1571, DOI 10.1002/prot.24314; PAN Y, 1995, FASEB J, V9, P43, DOI 10.1096/fasebj.9.1.7821758; Paolella G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084403; Park HJ, 2008, BRIT J HAEMATOL, V142, P179, DOI 10.1111/j.1365-2141.2008.07143.x; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Sblattero D, 2000, NAT BIOTECHNOL, V18, P75, DOI 10.1038/71958; Shoenfeld Y, 1996, J AUTOIMMUN, V9, P235, DOI 10.1006/jaut.1996.0029; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Sircar A, 2009, NUCLEIC ACIDS RES, V37, pW474, DOI 10.1093/nar/gkp387; Sivasubramanian A, 2009, PROTEINS, V74, P497, DOI 10.1002/prot.22309; Tzioufas AG, 2010, AUTOIMMUN REV, V9, P631, DOI 10.1016/j.autrev.2010.05.013; Vangone A, 2013, PROTEINS, V81, P2210, DOI 10.1002/prot.24423; Vangone A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S19; Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484; Warncke M, 2011, CANCER IMMUNOL IMMUN, V60, P49, DOI 10.1007/s00262-010-0918-x; Weiner LM, 2009, LANCET, V373, P1033, DOI 10.1016/S0140-6736(09)60251-8; Wilks D, 1992, Mol Cell Biol Hum Dis Ser, V1, P283; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; ZANETTI M, 1986, CRC CR REV IMMUNOL, V6, P151; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571	70	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102839	10.1371/journal.pone.0102839	http://dx.doi.org/10.1371/journal.pone.0102839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076134	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000340028800018
J	Lozano, J; Belles, X				Lozano, Jesus; Belles, Xavier			Role of Methoprene-Tolerant (Met) in Adult Morphogenesis and in Adult Ecdysis of Blattella germanica	PLOS ONE			English	Article							BEETLE TRIBOLIUM-CASTANEUM; KRUPPEL HOMOLOG 1; RED FLOUR BEETLE; BHLH-PAS FAMILY; JUVENILE-HORMONE; TRANSCRIPTIONAL REGULATORS; DROSOPHILA-MELANOGASTER; INSECT METAMORPHOSIS; SIGNALING PATHWAY; SYSTEMIC RNAI	Juvenile Hormone (JH) represses metamorphosis of young instars in insects. One of the main players in hormonal signalling is Methoprene-tolerant (Met), which plays the role of JH receptor. Using the Polyneopteran insect Blattella germanica as the model and RNAi for transcript depletion, we have confirmed that Met transduces the antimetamorphic signal of JH in young nymphs and plays a role in the last nymphal instar moult in this species. Previously, the function of Met as the JH receptor had been demonstrated in the Eumetabola clade, with experiments in Holometabola (in the beetle Tribolium castaneum) and in their sister group Paraneoptera (in the bug Pyrrhocoris apterus). Our result shows that the function of Met as JH receptor is also conserved in the more basal Polyneoptera. The function of Met as JH transducer might thus predate the evolutionary innovation of metamorphosis. Moreover, expression of Met was also found in last nymphal instar of B. germanica, when JH is absent. Depletion of Met in this stage provoked deficiencies in wing growth and ecdysis problems in the imaginal moult. Down-regulation of the ecdysone-inducible gene E75A and Insulin-Like-Peptide 1 in these Met-depleted specimens suggest that Met is involved in the ecdysone and insulin signalling pathways in last nymphal instar, when JH is virtually absent.	[Lozano, Jesus; Belles, Xavier] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Belles, X (corresponding author), Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Catalonia, Spain.	xavier.belles@ibe.upf-csic.es	Belles, Xavier/G-2354-2015; Lozano-Fernandez, Jesus/H-3704-2016	Belles, Xavier/0000-0002-1566-303X; Lozano-Fernandez, Jesus/0000-0003-3597-1221	Spanish MICINN [CGL2008-03517/BOS]; MINECO [CGL2012-36251]; Catalan Government [2009 SGR 1498]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MINECO(Spanish Government); Catalan Government	Financial support for this research was provided by the Spanish MICINN (grant CGL2008-03517/BOS to XB and predoctoral fellowship to JL) and MINECO (grant CGL2012-36251 to XB), and from the Catalan Government (2009 SGR 1498). The research has also benefited from FEDER funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Bitra K, 2009, ARCH INSECT BIOCHEM, V70, P90, DOI 10.1002/arch.20281; Bitra K, 2009, GENE, V448, P74, DOI 10.1016/j.gene.2009.08.003; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Ciudad L, 2006, FEBS J, V273, P325, DOI 10.1111/j.1742-4658.2005.05066.x; Cruz J, 2006, DEV BIOL, V297, P158, DOI 10.1016/j.ydbio.2006.06.048; Gomez-Orte E, 2009, P NATL ACAD SCI USA, V106, P21678, DOI 10.1073/pnas.0907391106; Grimaldi David, 2005, pi; Guo EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053256; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kayukawa T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01570; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Konopova B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028728; Lozano J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00163; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Nijhout H.F., 1994, INSECT HORMONES; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Sheng ZT, 2011, J BIOL CHEM, V286, P41924, DOI 10.1074/jbc.M111.269845; Smykal V, 2014, DEV BIOL, V390, P221, DOI 10.1016/j.ydbio.2014.03.006; Smykal V, 2014, INSECT BIOCHEM MOLEC, V45, P69, DOI 10.1016/j.ibmb.2013.12.003; Treiblmayr K, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.4301; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1006/clad.2000.0147, 10.1111/j.1096-0031.2001.tb00115.x]; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Xu JJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003535	29	45	47	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103614	10.1371/journal.pone.0103614	http://dx.doi.org/10.1371/journal.pone.0103614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072526	gold, Green Submitted, Green Published			2022-12-25	WOS:000341307600071
J	Vilela, FMP; Syed, DN; Chamcheu, JC; Calvo-Castro, LA; Fortes, VS; Fonseca, MJV; Mukhtar, H				Pinto Vilela, Fernanda Maria; Syed, Deeba N.; Chamcheu, Jean Christopher; Calvo-Castro, Laura A.; Fortes, Vanessa Silveira; Vieira Fonseca, Maria Jose; Mukhtar, Hasan			Biotransformed Soybean Extract (BSE) Inhibits Melanoma Cell Growth and Viability In Vitro: Involvement of Nuclear Factor-Kappa B Signaling	PLOS ONE			English	Article							CANCER CHEMOPREVENTION; BETA-GLUCOSIDASE; INDUCED APOPTOSIS; SKIN-CANCER; ISOFLAVONES; ACTIVATION; PATHWAY; KERATINOCYTES; FISETIN; TRAIL	Melanoma is recognized as one of the most aggressive cancers with a relatively high propensity for metastasis. The prognosis of melanoma remains poor in spite of treatment advances, emphasizing the importance of additional preventive measures. Isoflavonoids have become not only potential chemopreventive, but also important therapeutic natural agents. We evaluated the antiproliferative and proapoptotic properties of biotransformed soybean extract (BSE) in A375 melanoma cells. Previous analyses demonstrated that the concentration of daidzein, genistein and aminoacids/peptides present in BSE, fermented by Aspergillus awamori is much higher than in the non biotransformed extract (NBSE). Experiments comparing the efficacy of the extracts in preventing cancer cell growth showed that treatment (24 h) of aggressive melanoma cells (A375 and 451Lu) with BSE resulted in a dose-dependent inhibition of growth and viability. In contrast, treatment with similar doses of NBSE failed to inhibit melanoma cell viability. Further studies in A375 cells showed that decrease in cell viability with BSE treatment (1.5-1.9 mg/ml; 24 h) was associated with induction of apoptosis. Immunoblot analysis revealed that BSE treatment resulted in induction of PARP cleavage, activation of caspase-3, -7, and -8 and increased expression of TRAIL and its receptor DR4. BSE did not activate the intrinsic apoptotic pathway in A375 cells, as no change was observed in caspase-9 expression. The expression of Bcl-2 apoptotic proteins such as Bid and Bax remained unaffected with BSE treated cells. Interestingly, we also showed that BSE treatment increased the phosphorylation and activation of IKK, I kappa B alpha degradation and p65/NF-kappa B translocation to the nucleus, and that stimulation of the NF-??? B pathway was required for BSE-induced apoptosis of A375 cells. Our findings indicate that the biotransformation of soybean plays a crucial role in the extract anti-cancer effect observed in melanoma cells. However, further studies are warranted to define the active anticancer agent(s) present in BSE.	[Pinto Vilela, Fernanda Maria; Fortes, Vanessa Silveira; Vieira Fonseca, Maria Jose] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Pinto Vilela, Fernanda Maria; Syed, Deeba N.; Chamcheu, Jean Christopher; Mukhtar, Hasan] Univ Wisconsin, Dept Dermatol, Madison, WI USA; [Calvo-Castro, Laura A.] Inst Tecnol Costa Rica, Ctr Invest Biotecnol, Cartago, Costa Rica	Universidade de Sao Paulo; University of Wisconsin System; University of Wisconsin Madison; Instituto Tecnologico de Costa Rica	Mukhtar, H (corresponding author), Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil.	hmukhtar@wisc.edu	Vilela, Fernanda/P-3538-2015; Chamcheu, Jean Christopher/J-5451-2018	Chamcheu, Jean Christopher/0000-0002-3927-5664; Calvo-Castro, Laura A./0000-0001-5101-9105	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil); CNPQ [200450/2012-3]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are grateful to Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil) for the research fellowship. F. M. P. Vilela was the recipient of a CNPQ fellowship (process # 200450/2012-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFAQ F, 2005, MUTAT RES, V57, P1153; Afaq F, 2007, J INVEST DERMATOL, V127, P222, DOI 10.1038/sj.jid.5700510; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Calvo-Castro L, 2013, PHOTOCHEM PHOTOBIOL, V89, P1199, DOI 10.1111/php.12104; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Chen F, 2003, J CELL BIOCHEM, V90, P732, DOI 10.1002/jcb.10668; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Einspahr JG, 2003, RECENT RESULTS CANC, V163, P151; F'guyer S, 2003, PHOTODERMATOL PHOTO, V19, P56, DOI 10.1034/j.1600-0781.2003.00019.x; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Georgetti SR, 2009, J APPL MICROBIOL, V106, P459, DOI 10.1111/j.1365-2672.2008.03978.x; Hsieh MC, 2001, PHYTOCHEMISTRY, V58, P995, DOI 10.1016/S0031-9422(01)00380-6; Huang Y, 2000, CANCER RES, V60, P4426; Khan N, 2008, CARCINOGENESIS, V29, P1049, DOI 10.1093/carcin/bgn078; Kim SB, 2006, FEBS LETT, V580, P311, DOI 10.1016/j.febslet.2005.12.012; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Kurbanov BM, 2007, ONCOGENE, V26, P3364, DOI 10.1038/sj.onc.1210134; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Lin JK, 2002, ARCH PHARM RES, V25, P561, DOI 10.1007/BF02976924; McCue P., 2004, Innovative Food Science & Emerging Technologies, V5, P385, DOI 10.1016/j.ifset.2004.05.003; Otieno DO, 2006, FOOD RES INT, V39, P394, DOI 10.1016/j.foodres.2005.08.010; Sarkar FH, 2004, FRONT BIOSCI-LANDMRK, V9, P2714, DOI 10.2741/1430; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Stark LA, 2001, FASEB J, V15, P1273, DOI 10.1096/fj.00-0529fje; Stark LA, 2007, CARCINOGENESIS, V28, P968, DOI 10.1093/carcin/bgl220; Syed DN, 2007, ONCOGENE, V26, P673, DOI 10.1038/sj.onc.1209829; Syed DN, 2011, J INVEST DERMATOL, V131, P1291, DOI 10.1038/jid.2011.6; Szliszka E, 2011, ONCOL REP, V26, P533, DOI 10.3892/or.2011.1332; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Wang HZ, 2002, J NUTR BIOCHEM, V13, P421, DOI 10.1016/S0955-2863(02)00184-5; Waters JP, 2013, J PATHOL, V230, P241, DOI 10.1002/path.4188; Yin LJ, 2005, BIOSCI BIOTECH BIOCH, V69, P267, DOI 10.1271/bbb.69.267	32	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103248	10.1371/journal.pone.0103248	http://dx.doi.org/10.1371/journal.pone.0103248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072850	gold, Green Published, Green Submitted			2022-12-25	WOS:000341307600035
J	Xu, M; Xiao, YY; Yin, J; Hou, WL; Yu, XY; Shen, L; Liu, F; Wei, L; Jia, WP				Xu, Miao; Xiao, Yuanyuan; Yin, Jun; Hou, Wolin; Yu, Xueying; Shen, Li; Liu, Fang; Wei, Li; Jia, Weiping			Berberine Promotes Glucose Consumption Independently of AMP-Activated Protein Kinase Activation	PLOS ONE			English	Article							FATTY LIVER-DISEASE; 3T3-L1 ADIPOCYTE; ALDOSE REDUCTASE; MESSENGER-RNA; METABOLISM; MECHANISM; METFORMIN; RATS; EXPRESSION; PATHWAY	Berberine is a plant alkaloid with anti-diabetic action. Activation of AMP-activated protein kinase (AMPK) pathway has been proposed as mechanism for berberine's action. This study aimed to examine whether AMPK activation was necessary for berberine's glucose-lowering effect. We found that in HepG2 hepatocytes and C2C12 myotubes, berberine significantly increased glucose consumption and lactate release in a dose-dependent manner. AMPK and acetyl coenzyme A synthetase (ACC) phosphorylation were stimulated by 20 mu mol/L berberine. Nevertheless, berberine was still effective on stimulating glucose utilization and lactate production, when the AMPK activation was blocked by (1) inhibition of AMPK activity by Compound C, (2) suppression of AMPK alpha expression by siRNA, and (3) blockade of AMPK pathway by adenoviruses containing dominant-negative forms of AMPK alpha 1/alpha 2. To test the effect of berberine on oxygen consumption, extracellular flux analysis was performed in Seahorse XF24 analyzer. The activity of respiratory chain complex I was almost fully blocked in C2C12 myotubes by berberine. Metformin, as a positive control, showed similar effects as berberine. These results suggest that berberine and metformin promote glucose metabolism by stimulating glycolysis, which probably results from inhibition of mitochondrial respiratory chain complex I, independent of AMPK activation.	[Xu, Miao; Xiao, Yuanyuan; Yin, Jun; Hou, Wolin; Yu, Xueying; Liu, Fang; Wei, Li; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6,Shanghai Key Lab Diabet, Shanghai Clin Ctr Diabet,Dept Endocrinol & Metab, Shanghai Clin Ctr Metab Dis,Shanghai Diabet Inst, Shanghai 200030, Peoples R China; [Shen, Li] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Clin Nutr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yin, J (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6,Shanghai Key Lab Diabet, Shanghai Clin Ctr Diabet,Dept Endocrinol & Metab, Shanghai Clin Ctr Metab Dis,Shanghai Diabet Inst, Shanghai 200030, Peoples R China.	yinjun@sjtu.edu.cn; weili63@hotmail.com			NSFC fund [31171128, 81200655]; Shanghai Pujiang Project [11PJ1407700]	NSFC fund(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Project(Shanghai Pujiang Program)	This work was supported by NSFC fund (31171128) and Shanghai Pujiang Project (11PJ1407700) to Jun Yin, and NSFC fund (81200655) to Li Shen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2010, AM J PHYSIOL-CELL PH, V299, pC464, DOI 10.1152/ajpcell.00563.2009; Affuso F, 2010, WORLD J CARDIOL, V2, P71, DOI [10.4330/wjc.v2.i3.68, 10.4330/wjc.v2.i4.71]; Bao JJ, 2010, FREE RADICAL BIO MED, V49, P1230, DOI 10.1016/j.freeradbiomed.2010.07.009; Brusq JM, 2006, J LIPID RES, V47, P1281, DOI 10.1194/jlr.M600020-JLR200; Choi BH, 2006, EXP MOL MED, V38, P599, DOI 10.1038/emm.2006.71; Clerc P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034465; Cui GL, 2009, J BIOL CHEM, V284, P28420, DOI 10.1074/jbc.M109.012674; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Hu YS, 2012, PHYTOMEDICINE, V19, P861, DOI 10.1016/j.phymed.2012.05.009; Huang C, 2006, BIOCHEM BIOPH RES CO, V348, P571, DOI 10.1016/j.bbrc.2006.07.095; Hwang JM, 2002, ARCH TOXICOL, V76, P664, DOI 10.1007/s00204-002-0351-9; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Jung HA, 2008, ARCH PHARM RES, V31, P1405, DOI 10.1007/s12272-001-2124-z; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Li YY, 2013, TOXICOL APPL PHARM, V273, P325, DOI 10.1016/j.taap.2013.09.006; Liu WH, 2008, ARCH BIOCHEM BIOPHYS, V475, P128, DOI 10.1016/j.abb.2008.04.022; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Nicholls DG, 2010, J VIS EXP, P2511; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Singh AB, 2013, ARTERIOSCLER THROMB; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Wang LH, 2012, PHYTOMEDICINE, V19, P206, DOI 10.1016/j.phymed.2011.11.002; Xing LJ, 2011, EUR J PHARMACOL, V668, P467, DOI 10.1016/j.ejphar.2011.07.036; Yang QH, 2011, CHIN J INTEGR MED, V17, P205, DOI 10.1007/s11655-011-0668-4; Yin J, 2002, METABOLISM, V51, P1439, DOI 10.1053/meta.2002.34715; Yin J., 2001, ACTA U MED SECONDAE, V21, P425; Yin Jun, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P99, DOI 10.2174/187153008784534330; Yin J, 2008, METABOLISM, V57, P712, DOI 10.1016/j.metabol.2008.01.013; Yin J, 2008, AM J PHYSIOL-ENDOC M, V294, pE148, DOI 10.1152/ajpendo.00211.2007; [殷峻 Yin Jun], 2003, [北京中医药大学学报, Journal of Beijing University of Traditional Chinese Medicine], V26, P36; Yin J, 2012, ACTA PHARM SIN B, V2, P327, DOI 10.1016/j.apsb.2012.06.003; Yin J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1275, DOI 10.1152/ajpendo.00092.2009; [殷峻 Yin Jun], 2002, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V18, P488; Zhang LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072092; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	40	63	69	6	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103702	10.1371/journal.pone.0103702	http://dx.doi.org/10.1371/journal.pone.0103702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072399	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600080
J	Land, AD; Luo, QW; Levin, PA				Land, Adrian D.; Luo, Qingwei; Levin, Petra Anne			Functional Domain Analysis of the Cell Division Inhibitor EzrA	PLOS ONE			English	Article							FTSZ-INTERACTING PROTEIN; BACILLUS-SUBTILIS; RING; LOCALIZATION; DYNAMICS	The precise spatial and temporal control of bacterial cell division is achieved through the balanced actions of factors that inhibit assembly of the tubulin-like protein FtsZ at aberrant subcellular locations or promote its assembly at the future sites of division. In Bacillus subtilis, the membrane anchored cell division protein EzrA, interacts directly with FtsZ to prevent aberrant FtsZ assembly at cell poles and contributes to the inherently dynamic nature of the cytokinetic ring. Recent work suggests EzrA also serves as a scaffolding protein to coordinate lateral growth with cell wall biosynthesis through interactions with a host of proteins, a finding consistent with EzrA's four extensive coiled-coil domains. In a previous study we identified a conserved patch of residues near EzrA's C-terminus (the QNR motif) that are critical for maintenance of a dynamic cytokinetic ring, but dispensable for EzrA-mediated inhibition of FtsZ assembly at cell poles. In an extension of this work, here we report that EzrA's two C-terminal coiled-coils function in concert with the QNR motif to mediate interactions with FtsZ and maintain the dynamic nature of the cytokinetic ring. In contrast, EzrA's two N-terminal coiled-coils are dispensable for interaction between EzrA and FtsZ in vitro and in vivo, but required for EzrA mediated inhibition of FtsZ assembly at cell poles. Finally, chimeric analysis indicates that EzrA's transmembrane anchor plays a generic role: concentrating EzrA at the plasma membrane where presumably it can most effectively modulate FtsZ assembly.	[Land, Adrian D.; Luo, Qingwei; Levin, Petra Anne] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Levin, PA (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	plevin@wustl.edu		Levin, Petra/0000-0003-2071-0547	NIH [GM64671]; National Science Foundation CAREER [MCB-0448186]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064671] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CAREER(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Public Health Service grant GM64671 from the NIH and by a National Science Foundation CAREER award MCB-0448186 to PAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Chivers PT, 1999, PROTEIN SCI, V8, P2494, DOI 10.1110/ps.8.11.2494; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; Considine KM, 2011, J APPL MICROBIOL, V110, P618, DOI 10.1111/j.1365-2672.2010.04924.x; Gamba P, 2009, J BACTERIOL, V191, P4186, DOI 10.1128/JB.01758-08; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Haeusser DP, 2007, J BACTERIOL, V189, P9001, DOI 10.1128/JB.01172-07; Haeusser DP, 2009, J BACTERIOL, V191, P1986, DOI 10.1128/JB.01606-07; Haeusser DP, 2004, MOL MICROBIOL, V52, P801, DOI 10.1111/j.1365-2958.2004.04016.x; Hamoen LW, 2006, MOL MICROBIOL, V59, P989, DOI 10.1111/j.1365-2958.2005.04987.x; Harry E, 2006, INT REV CYTOL, V253, P27, DOI [DOI 10.1016/S0074-7696(06)53002-5, 10.1016/S0074-7696(06)53002-5.]; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; Ishikawa S, 2006, MOL MICROBIOL, V60, P1364, DOI 10.1111/j.1365-2958.2006.05184.x; Jorge AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027542; Kawai Y, 2006, MICROBIOL-SGM, V152, P1129, DOI 10.1099/mic.0.28497-0; LEDEAUX JR, 1995, J BACTERIOL, V177, P166, DOI 10.1128/jb.177.1.166-175.1995; Levin PA, 1999, P NATL ACAD SCI USA, V96, P9642, DOI 10.1073/pnas.96.17.9642; Levin PA, 2001, J BACTERIOL, V183, P5449, DOI 10.1128/JB.183.18.5449-5452.2001; Levin PA, 2002, METHOD MICROBIOL, V31, P115, DOI 10.1016/S0580-9517(02)31007-9; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Mo AH, 2010, J BACTERIOL, V192, P3159, DOI 10.1128/JB.00027-10; Son SH, 2013, BIOCHEM BIOPH RES CO, V433, P108, DOI 10.1016/j.bbrc.2013.02.055; Steele VR, 2011, MOL MICROBIOL, V80, P542, DOI 10.1111/j.1365-2958.2011.07591.x; Weart RB, 2005, MOL MICROBIOL, V57, P238, DOI 10.1111/j.1365-2958.2005.04673.x; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999	27	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102616	10.1371/journal.pone.0102616	http://dx.doi.org/10.1371/journal.pone.0102616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068683	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993700012
J	Sawant, PB; Bera, A; Dasgupta, S; Sawant, BT; Chadha, NK; Pal, AK				Sawant, Paramita Banerjee; Bera, Aritra; Dasgupta, Subrata; Sawant, Bhawesh T.; Chadha, Narinder K.; Pal, Asim K.			p53 Dependent Apoptotic Cell Death Induces Embryonic Malformation in Carassius auratus under Chronic	PLOS ONE			English	Article							ENDOCRINE DISRUPTING CHEMICALS; GENE-EXPRESSION; AQUATIC HYPOXIA; ZEBRAFISH; FISH; SURVIVAL	Hypoxia is a global phenomenon affecting recruitment as well as the embryonic development of aquatic fauna. The present study depicts hypoxia induced disruption of the intrinsic pathway of programmed cell death (PCD), leading to embryonic malformation in the goldfish, Carrasius auratus. Constant hypoxia induced the early expression of pro-apoptotic/tumor suppressor p53 and concomitant expression of the cell death molecule, caspase-3, leading to high level of DNA damage and cell death in hypoxic embryos, as compared to normoxic ones. As a result, the former showed delayed 4 and 64 celled stages and a delay in appearance of epiboly stage. Expression of p53 efficiently switched off expression of the antiapoptotic Bcl-2 during the initial 12 hours post fertilization (hpf) and caused embryonic cell death. However, after 12 hours, simultaneous downregulation of p53 and Caspase-3 and exponential increase of Bcl-2, caused uncontrolled cell proliferation and prevented essential programmed cell death (PCD), ultimately resulting in significant (p<0.05) embryonic malformation up to 144 hpf. Evidences suggest that uncontrolled cell proliferation after 12 hpf may have been due to downregulation of p53 abundance, which in turn has an influence on upregulation of anti-apoptotic Bcl-2. Therefore, we have been able to show for the first time and propose that hypoxia induced downregulation of p53 beyond 12 hpf, disrupts PCD and leads to failure in normal differentiation, causing malformation in gold fish embryos.	[Sawant, Paramita Banerjee; Bera, Aritra; Dasgupta, Subrata; Chadha, Narinder K.; Pal, Asim K.] Cent Inst Fisheries Educ ICAR, Bombay, Maharashtra, India; [Sawant, Bhawesh T.] Konkan Krishi Vidyapeeth, Taraporewala Marine Biol Res Stn, Bombay, Maharashtra, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Fisheries Education	Bera, A (corresponding author), Cent Inst Brackishwater Aquaculture ICAR, Madras, Tamil Nadu, India.	bera.aritra@gmail.com	Dasgupta, Subrata/AAF-9395-2020; Sawant, Paramita Banerjee/AAR-2139-2020		CIFE's	CIFE's	The study was carried out with the help of CIFE's institutional project funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTLE HELEN I., 1940, OHIO JOUR SCI, V40, P82; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Sanchez RC, 2011, AQUACULTURE, V316, P13, DOI 10.1016/j.aquaculture.2011.03.012; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gracey AY, 2001, P NATL ACAD SCI USA, V98, P1993, DOI 10.1073/pnas.98.4.1993; Hassell KL, 2008, MAR POLLUT BULL, V57, P302, DOI 10.1016/j.marpolbul.2008.02.045; Hong HN, 2007, CHEMOSPHERE, V67, P2115, DOI 10.1016/j.chemosphere.2006.12.090; Ikegami R, 1999, DEV BIOL, V209, P409, DOI 10.1006/dbio.1999.9243; Jungblut M, 2009, JOVE-J VIS EXP, DOI [10.3791/1266, DOI 10.3791/1266]; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lee YM, 2008, COMP BIOCHEM PHYS C, V147, P150, DOI 10.1016/j.cbpc.2007.09.005; Malikova MA, 2007, DEV BIOL, V311, P434, DOI 10.1016/j.ydbio.2007.08.047; Mei J, 2008, DEV BIOL, V319, P273, DOI 10.1016/j.ydbio.2008.04.022; Min JH, 2003, J BIOCHEM MOL TOXIC, V17, P272, DOI 10.1002/jbt.10089; Nadzialek S, 2010, AQUAT TOXICOL, V98, P304, DOI 10.1016/j.aquatox.2010.02.016; Nikinmaa M, 2002, COMP BIOCHEM PHYS A, V133, P1, DOI 10.1016/S1095-6433(02)00132-0; Nilsson GE, 2004, P ROY SOC B-BIOL SCI, V271, pS30, DOI 10.1098/rsbl.2003.0087; Porreca I, 2012, DEV BIOL, V366, P142, DOI 10.1016/j.ydbio.2012.04.013; Pyati UJ, 2007, SEMIN CANCER BIOL, V17, P154, DOI 10.1016/j.semcancer.2006.11.007; Shang EHH, 2006, ENVIRON SCI TECHNOL, V40, P3118, DOI 10.1021/es0522579; Shang EHH, 2004, ENVIRON SCI TECHNOL, V38, P4763, DOI 10.1021/es0496423; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; Silvan U, 2009, DIFFERENTIATION, V78, P159, DOI 10.1016/j.diff.2009.06.002; Sollid J, 2005, AM J PHYSIOL-REG I, V289, pR1196, DOI 10.1152/ajpregu.00267.2005; Sollid J, 2003, J EXP BIOL, V206, P3667, DOI 10.1242/jeb.00594; Sun CF, 2011, GEN COMP ENDOCR, V172, P409, DOI 10.1016/j.ygcen.2011.04.005; Ton C, 2003, PHYSIOL GENOMICS, V13, P97, DOI 10.1152/physiolgenomics.00128.2002; Vacotto M, 2008, NEUROCHEM INT, V52, P857, DOI 10.1016/j.neuint.2007.10.006; van der Meer DLM, 2005, AM J PHYSIOL-REG I, V289, pR1512, DOI 10.1152/ajpregu.00089.2005; Vuori KAM, 2004, AQUAT TOXICOL, V68, P301, DOI 10.1016/j.aquatox.2004.03.019; Wallingford JB, 1997, CURR BIOL, V7, P747, DOI 10.1016/S0960-9822(06)00333-2; Wu RSS, 2003, ENVIRON SCI TECHNOL, V37, P1137, DOI 10.1021/es0258327; Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9; Yu RMK, 2012, ENVIRON SCI TECHNOL, V46, P9112, DOI 10.1021/es301758c; Zhong XP, 2009, COMP BIOCHEM PHYS B, V152, P161, DOI 10.1016/j.cbpb.2008.10.013	35	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102650	10.1371/journal.pone.0102650	http://dx.doi.org/10.1371/journal.pone.0102650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068954	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700015
J	Zhang, C; He, XL; Gu, YP; Zhou, HY; Cao, J; Gao, Q				Zhang, Chao; He, Xinlong; Gu, Yaping; Zhou, Huayun; Cao, Jun; Gao, Qi			Recombinant Scorpine Produced Using SUMO Fusion Partner in Escherichia coli Has the Activities against Clinically Isolated Bacteria and Inhibits the Plasmodium falciparum Parasitemia In Vitro	PLOS ONE			English	Article							HUMAN MALARIA PARASITES; ANTIMICROBIAL PEPTIDE; BIOFILM FORMATION; STAPHYLOCOCCUS-AUREUS; UBIQUITIN; RESISTANT; PROTEINS; VENOM; ANTIBACTERIAL; EXPRESSION	Scorpine, a small cationic peptide from the venom of Pandinus imperator, which has been shown to have anti-bacterial and anti-plasmodial activities, has potential important applications in the pharmaceutical industries. However, the isolation of scorpine from natural sources is inefficient and time-consuming. Here, we first report the expression and purification of recombinant scorpine in Escherichia coli, using small ubiquitin-related modifier (SUMO) fusion partner. The fusion protein was expressed in soluble form in E. coli, and expression was verified by SDS-PAGE and western blotting analysis. The fusion protein was purified to 90% purity by nickel-nitrilotriacetic acid (Ni2+-NTA) resin chromatography. After the SUMO-scorpine fusion protein was cleaved by the SUMO protease, the cleaved sample was reapplied to a Ni2+-NTA column. Tricine/SDS-PAGE gel results indicated that Scorpine had been purified successfully to more than 95% purity. The recombinantly expressed Scorpine showed anti-bacterial activity against two standard bacteria including Staphylococcus aureus ATCC 29213 and Acinetobacter baumannii ATCC 19606, and clinically isolated bacteria including S. aureus S, S. aureus R, A. baumannii S, and A. baumannii R. It also produced 100% reduction in Plasmodium falciparum parasitemia in vitro. Thus, the expression strategy presented in this study allowed convenient high yield and easy purification of recombinant Scorpine for pharmaceutical applications in the future.	[Zhang, Chao; Gao, Qi] Soochow Univ, Coll Med, Sch Basic Med & Biol Sci, Suzhou, Jiangsu, Peoples R China; [Zhang, Chao; Gu, Yaping; Zhou, Huayun; Cao, Jun; Gao, Qi] Jiangsu Inst Parasit Dis, Jiangsu Prov Key Lab Parasite Mol Biol, Key Lab Parasit Dis Control & Prevent, Minist Hlth, Wuxi, Jiangsu, Peoples R China; [He, Xinlong] Third Peoples Hosp Wuxi, Wuxi, Jiangsu, Peoples R China	Soochow University - China; Jiangnan University	Cao, J (corresponding author), Jiangsu Inst Parasit Dis, Jiangsu Prov Key Lab Parasite Mol Biol, Key Lab Parasit Dis Control & Prevent, Minist Hlth, Wuxi, Jiangsu, Peoples R China.	caojuncn@hotmail.com; gaoqi54@hotmail.com	Cao, Jun/AAR-7268-2020	Cao, Jun/0000-0001-5298-9234	National Nature Science Foundation of China [81101276, 81271870]; Nature Science Foundation of Jiangsu Province [BK2011163]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from National Nature Science Foundation of China (Nos. 81101276 and 81271870), and Nature Science Foundation of Jiangsu Province (No. BK2011163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mauricio M. Rodrigues	ALI SA, 1995, COMP BIOCHEM PHYS A, V112, P225, DOI 10.1016/0300-9629(95)00058-F; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Carballar-Lejarazu R, 2008, CELL MOL LIFE SCI, V65, P3081, DOI 10.1007/s00018-008-8250-8; Chiang MC, 2011, J MICROBIOL IMMUNOL, V44, P106, DOI 10.1016/j.jmii.2010.04.003; Chmielewski R A N, 2003, Compr Rev Food Sci Food Saf, V2, P22, DOI 10.1111/j.1541-4337.2003.tb00012.x; CLSI, 2018, METHODS DILUTION ANT; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Ding J, 2014, EXP BIOL MED MAYWOOD; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; EhretSabatier L, 1996, J BIOL CHEM, V271, P29537, DOI 10.1074/jbc.271.47.29537; Fang WG, 2011, SCIENCE, V331, P1074, DOI 10.1126/science.1199115; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; HamiltonMiller JMT, 1996, J ANTIMICROB CHEMOTH, V37, P1171, DOI 10.1093/jac/37.6.1171; Hetru C, 2000, BIOCHEM J, V345, P653, DOI 10.1042/0264-6021:3450653; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Kim SH, 2007, J FOOD PROTECT, V70, P22, DOI 10.4315/0362-028X-70.1.22; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Langsrud S, 2004, J APPL MICROBIOL, V96, P201, DOI 10.1046/j.1365-2672.2003.02140.x; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Moerman L, 2002, EUR J BIOCHEM, V269, P4799, DOI 10.1046/j.1432-1033.2002.03177.x; Ngwai Yakubu B., 2006, Journal of Microbiology Immunology and Infection, V39, P278; Niu C, 2004, APPL ENVIRON MICROB, V70, P6951, DOI 10.1128/AEM.70.12.6951-6956.2004; Pan WQ, 2004, J IMMUNOL, V172, P6167, DOI 10.4049/jimmunol.172.10.6167; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; SAMBROOK J, 1989, LAB MANUAL, P880; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sun ZY, 2008, APPL MICROBIOL BIOT, V78, P495, DOI 10.1007/s00253-007-1330-0; Torres-Larios A, 2000, EUR J BIOCHEM, V267, P5023, DOI 10.1046/j.1432-1327.2000.01556.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x; Wang Q, 2011, CURR MICROBIOL, V62, P1535, DOI 10.1007/s00284-011-9891-7; WilmesRiesenberg MR, 1996, INFECT IMMUN, V64, P1085, DOI 10.1128/IAI.64.4.1085-1092.1996; Wu Y, 2006, ONCOGENE, V25, P5787, DOI 10.1038/sj.onc.1209576; Xun Z, 2005, PROTEIN EXPRES PURIF, V42, P100; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Zhou LF, 2009, PROTEIN EXPRES PURIF, V64, P225, DOI 10.1016/j.pep.2008.11.006	41	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103456	10.1371/journal.pone.0103456	http://dx.doi.org/10.1371/journal.pone.0103456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068263	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700071
J	Pathiraja, TN; Thakkar, KN; Jiang, S; Stratton, S; Liu, Z; Gagea, M; Shi, X; Shah, PK; Phan, L; Lee, MH; Andersen, J; Stampfer, M; Barton, MC				Pathiraja, T. N.; Thakkar, K. N.; Jiang, S.; Stratton, S.; Liu, Z.; Gagea, M.; Shi, X.; Shah, P. K.; Phan, L.; Lee, M-H; Andersen, J.; Stampfer, M.; Barton, M. C.			TRIM24 links glucose metabolism with transformation of human mammary epithelial cells	ONCOGENE			English	Article							BREAST-CANCER; GENE-EXPRESSION; TUMOR SUPPRESSORS; P53 FUNCTION; PROLIFERATION; GROWTH; WARBURG; LINES; IMMORTALIZATION; INACTIVATION	Tripartite motif 24 protein (TRIM24) is a plant homeodomain/bromodomain histone reader, recently associated with poor overall survival of breast-cancer patients. At a molecular level, TRIM24 is a negative regulator of p53 levels and a co-activator of estrogen receptor. However, the role of TRIM24 in breast tumorigenesis remains largely unknown. We used an isogenic human mammary epithelial cell (HMEC) culture model, derived from reduction mammoplasty tissue, and found that ectopic expression of TRIM24 in immortalized HMECs (TRIM24 iHMECs) greatly increased cellular proliferation and induced malignant transformation. Subcutaneous injection of TRIM24 iHMECs in nude mice led to growth of intermediate to high-grade tumors in 60-70% of mice. Molecular analysis of TRIM24 iHMECs revealed a glycolytic and tricarboxylic acid cycle gene signature, alongside increased glucose uptake and activated aerobic glycolysis. Collectively, these results identify a role for TRIM24 in breast tumorigenesis through reprogramming of glucose metabolism in HMECs, further supporting TRIM24 as a viable therapeutic target in breast cancer.	[Pathiraja, T. N.; Thakkar, K. N.; Jiang, S.; Stratton, S.; Liu, Z.; Barton, M. C.] Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Ctr Canc Epigenet, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Gagea, M.] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA; [Shi, X.; Shah, P. K.; Andersen, J.] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Phan, L.; Lee, M-H] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Stampfer, M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Barton, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Ctr Canc Epigenet, Dept Biochem & Mol Biol, 1515 Holcombe Blvd,Houston 207, Houston, TX 77030 USA.	mbarton@mdanderson.org	Liu, Zhiming/GXG-6785-2022	Shi, Xiaobing/0000-0001-5242-8189; THAKKAR, KAUSHIK/0000-0002-4900-3371; Lee, Mong-Hong/0000-0001-8675-8215; Barton, Michelle/0000-0002-4042-1374	Cancer Prevention and Research Initiative of Texas [RP100602]; Center for Cancer Epigenetics scholarship; MD Anderson Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	Cancer Prevention and Research Initiative of Texas; Center for Cancer Epigenetics scholarship; MD Anderson Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Abhinav Jain and Srikanth Appikonda for helpful discussions. Zeynep Coban and Kadir Akdemir for help with Bioinformatic analyses. Lindsey Minter and Joseph Taube for help with Xenograft experiments. This research is supported by grant RP100602 from the Cancer Prevention and Research Initiative of Texas to MCB, the Center for Cancer Epigenetics scholarship to KNT and in part by the MD Anderson Cancer Center Support Grant CA016672.	Allred DC, 1998, MODERN PATHOL, V11, P155; Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chambon M, 2011, AM J PATHOL, V178, P1461, DOI 10.1016/j.ajpath.2010.12.026; Chen JQ, 2012, BBA-REV CANCER, V1826, P370, DOI 10.1016/j.bbcan.2012.06.004; Chen MQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025564; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diers AR, 2012, BIOCHEM J, V444, P561, DOI 10.1042/BJ20120294; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Garbe JC, 2007, CELL CYCLE, V6, P1927, DOI 10.4161/cc.6.15.4519; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Goel A, 2003, J BIOL CHEM, V278, P15333, DOI 10.1074/jbc.M300608200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lee E, 2013, NEOPLASIA, V15, P112, DOI 10.1593/neo.121638; Lim HY, 2011, MITOCHONDRION, V11, P437, DOI 10.1016/j.mito.2010.12.015; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Milke L, 2013, CARCINOGENESIS, V34, P850, DOI 10.1093/carcin/bgs387; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; PIERCE JH, 1991, ONCOGENE, V6, P1189; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046; Smolkova K, 2011, INT J BIOCHEM CELL B, V43, P950, DOI 10.1016/j.biocel.2010.05.003; Stampfer MR, 2003, ONCOGENE, V22, P5238, DOI 10.1038/sj.onc.1206667; Stampfer MR, 2003, CANCER LETT, V194, P199, DOI 10.1016/S0304-3835(02)00707-3; Stampfer MR, 2000, J MAMMARY GLAND BIOL, V5, P365, DOI 10.1023/A:1009525827514; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Stampfer MR, 2013, CELL MOL BIOL BREAST, P323, DOI [10.1007/978-1-62703-634-4_15, DOI 10.1007/978-1-62703-634-4_15]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Werner H, 2012, LANCET ONCOL, V13, pE537, DOI 10.1016/S1470-2045(12)70362-5; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928; Zhu CW, 2011, CLIN DEV IMMUNOL, P1, DOI 10.1155/2011/920146	54	31	33	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 28	2015	34	22					2836	2845		10.1038/onc.2014.220	http://dx.doi.org/10.1038/onc.2014.220			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CJ2OM	25065590	Green Accepted, Green Published			2022-12-25	WOS:000355324300003
J	Nyarko, A; Singarapu, KK; Figueroa, M; Manning, VA; Pandelova, I; Wolpert, TJ; Ciuffetti, LM; Barbar, E				Nyarko, Afua; Singarapu, Kiran K.; Figueroa, Melania; Manning, Viola A.; Pandelova, Iovanna; Wolpert, Thomas J.; Ciuffetti, Lynda M.; Barbar, Elisar			Solution NMR Structures of Pyrenophora tritici-repentis ToxB and Its Inactive Homolog Reveal Potential Determinants of Toxin Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-SELECTIVE TOXIN; PTR TOXA; TAN SPOT; PROTEIN FUNCTION; GENE; PROGRAM; RESISTANCE; EFFECTORS; MUTANT; SERVER	Pyrenophora tritici-repentis Ptr ToxB (ToxB) is a proteinaceous host-selective toxin produced by Pyrenophora tritici-repentis (P. tritici-repentis), a plant pathogenic fungus that causes the disease tan spot of wheat. One feature that distinguishes ToxB from other host-selective toxins is that it has naturally occurring homologs in non-pathogenic P. tritici-repentis isolates that lack toxic activity. There are no high-resolution structures for any of the ToxB homologs, or for any protein with >30% sequence identity, and therefore what underlies activity remains an open question. Here, we present the NMR structures of ToxB and its inactive homolog Ptr toxb. Both proteins adopt a beta-sandwich fold comprising three strands in each half that are bridged together by two disulfide bonds. The inactive toxb, however, shows higher flexibility localized to the sequence-divergent beta-sandwich half. The absence of toxicactivity is attributed to a more open structure in the vicinity of one disulfide bond, higher flexibility, and residue differences in an exposed loop that likely impacts interaction with putative targets. We propose that activity is regulated by perturbations in a putative active site loop and changes in dynamics distant from the site of activity. Interestingly, the new structures identify AvrPiz-t, a secreted avirulence protein produced by the rice blast fungus, as a structural homolog to ToxB. This homology suggests that fungal proteins involved in either disease susceptibility such as ToxB or resistance such as AvrPiz-t may have a common evolutionary origin.	[Nyarko, Afua; Barbar, Elisar] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Singarapu, Kiran K.] Indian Inst Chem Technol, Ctr NMR & Struct Chem, Hyderabad 500007, Andhra Pradesh, India; [Figueroa, Melania; Manning, Viola A.; Pandelova, Iovanna; Wolpert, Thomas J.; Ciuffetti, Lynda M.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Figueroa, Melania; Manning, Viola A.; Pandelova, Iovanna; Wolpert, Thomas J.; Ciuffetti, Lynda M.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Oregon State University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Oregon State University; Oregon State University	Ciuffetti, LM (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	ciuffetL@science.oregonstate.edu; barbare@science.oregonstate.edu	Nyarko, Afua/R-9872-2019; Singarapu, Kiran/AAU-3435-2020; Figueroa, Melania/R-7696-2017; Figueroa, Melania/AAI-8692-2021	Figueroa, Melania/0000-0003-2636-661X; Figueroa, Melania/0000-0003-2636-661X; Barbar, Elisar/0000-0003-4892-5259	Agriculture and Food Research Initiative Competitive Grant [2010-65108-20548]; National Science Foundation [MCB 0818896]; Medical Research Foundation of Oregon grant; National Science Foundation Minority Postdoctoral Fellowship Award [0706881]; Department of Science and Technology (India) for the Ramanujan Fellowship	Agriculture and Food Research Initiative Competitive Grant; National Science Foundation(National Science Foundation (NSF)); Medical Research Foundation of Oregon grant; National Science Foundation Minority Postdoctoral Fellowship Award; Department of Science and Technology (India) for the Ramanujan Fellowship(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines)	This work was supported by Agriculture and Food Research Initiative Competitive Grant 2010-65108-20548 (to L. M. C.), by the National Science Foundation Grant MCB 0818896 (to E. B.), a Medical Research Foundation of Oregon grant (to A. N.), and in part by a National Science Foundation Minority Postdoctoral Fellowship Award 0706881 (to M. F.).; Supported by the Department of Science and Technology (India) for the Ramanujan Fellowship.	Andrie RM, 2008, FUNGAL GENET BIOL, V45, P363, DOI 10.1016/j.fgb.2007.10.014; Andrie RM, 2011, MOL PLANT MICROBE IN, V24, P359, DOI 10.1094/MPMI-06-10-0142; Ballance GM, 1998, DEV PLANT PATHOL, V13, P177; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Betts MF, 2011, PHYSIOL MOL PLANT P, V75, P138, DOI 10.1016/j.pmpp.2011.03.002; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Ciuffetti LM, 1997, PLANT CELL, V9, P135, DOI 10.1105/tpc.9.2.135; Ciuffetti LM, 2010, NEW PHYTOL, V187, P911, DOI 10.1111/j.1469-8137.2010.03362.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Faris JD, 2013, THEOR APPL GENET, V126, P2197, DOI 10.1007/s00122-013-2157-y; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Goddard T. D., 2008, SPARKY 3; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ji FL, 2013, J BIOL CHEM, V288, P99, DOI 10.1074/jbc.M112.416354; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnston CA, 2011, P NATL ACAD SCI USA, V108, pE973, DOI 10.1073/pnas.1104365108; Jung J, 2009, BIOCHEMISTRY-US, V48, P2597, DOI 10.1021/bi802292q; Kalodimos CG, 2012, ANN NY ACAD SCI, V1260, P81, DOI 10.1111/j.1749-6632.2011.06319.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lamari L, 2010, CAN J PLANT PATHOL, V32, P4, DOI 10.1080/07060661003594117; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Liu Y, 2012, MOL BIOL EVOL, V29, P2253, DOI 10.1093/molbev/mss097; Lorang J, 2012, SCIENCE, V338, P659, DOI 10.1126/science.1226743; Manning VA, 2005, PLANT CELL, V17, P3203, DOI 10.1105/tpc.105.035063; Manning VA, 2004, MOL PLANT MICROBE IN, V17, P491, DOI 10.1094/MPMI.2004.17.5.491; Manning VA, 2008, MOL PLANT MICROBE IN, V21, P315, DOI 10.1094/MPMI-21-3-0315; Martinez JP, 2004, MOL PLANT MICROBE IN, V17, P467, DOI 10.1094/MPMI.2004.17.5.467; Martinez JP, 2001, MOL PLANT MICROBE IN, V14, P675, DOI 10.1094/MPMI.2001.14.5.675; Meinhardt SW, 2002, PLANT PHYSIOL, V130, P1545, DOI 10.1104/pp.006684; Moreno MV, 2010, MANAGEMENT OF FUNGAL PLANT PATHOGENS, P275, DOI 10.1079/9781845936037.0275; Nagy ED, 2008, GENOME RES, V18, P1918, DOI 10.1101/gr.078766.108; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Sarma GN, 2005, PLANT CELL, V17, P3190, DOI 10.1105/tpc.105.034918; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Strelkov SE, 2005, PHYSIOL MOL PLANT P, V67, P164, DOI 10.1016/j.pmpp.2005.12.004; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; Zhang ZM, 2013, J BIOMOL NMR, V55, P219, DOI 10.1007/s10858-012-9695-5	41	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25946	25956		10.1074/jbc.M114.569103	http://dx.doi.org/10.1074/jbc.M114.569103			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25063993	Green Published, hybrid			2022-12-25	WOS:000342130800049
J	Pan, CC; Kumar, S; Shah, N; Hoyt, DG; Hawinkels, LJAC; Mythreye, K; Lee, NY				Pan, Christopher C.; Kumar, Sanjay; Shah, Nirav; Hoyt, Dale G.; Hawinkels, Lukas J. A. C.; Mythreye, Karthikeyan; Lee, Nam Y.			Src-mediated Post-translational Regulation of Endoglin Stability and Function Is Critical for Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL MIGRATION; TGF-BETA RECEPTOR; TUMOR ANGIOGENESIS; BMP RECEPTORS; ANTIBODY; CANCER; PATHWAYS; KINASE; CD105; PHOSPHORYLATION	Endoglin is a transforming growth factor beta (TGF-beta) co-receptor essential for angiogenesis and tumor vascularization. Endoglin modulates the crucial balance between pro-and anti-angiogenic signaling by activin receptor-like kinase (ALK) 1, 5, and TGF-beta type II (T beta RII) receptors. Despite its established role in physiology and disease, the mechanism of endoglin down-regulation remains unknown. Here we report that the conserved juxtamembrane cytoplasmic tyrosine motif ((YIY614)-Y-612) is a critical determinant of angiogenesis. Src directly phosphorylates this motif to induce endoglin internalization and degradation via the lysosome. We identified epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF) as Src-activators that induce endoglin turnover following (YIY614)-Y-612 phosphorylation. Interestingly, Src phosphorylation of endoglin-(YIY614)-Y-612 was also an important process for receptor down-regulation by TRACON105 (TRC105), an endoglin-targeting antibody currently in clinical trials. The regulation of (YIY614)-Y-612 phosphorylation was critical for angiogenesis, as both the phosphomimetic and unphosphorylatable mutants impaired endothelial functions including proliferation, migration, and capillary tube formation. Collectively, these findings establish Src and pro-angiogenic mitogens as critical mediators of endoglin stability and function.	[Pan, Christopher C.; Kumar, Sanjay; Shah, Nirav; Hoyt, Dale G.; Lee, Nam Y.] Ohio State Univ, Coll Pharm, Div Pharmacol, Columbus, OH 43210 USA; [Lee, Nam Y.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Mythreye, Karthikeyan] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Hawinkels, Lukas J. A. C.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2333 Leiden, Netherlands	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Lee, NY (corresponding author), Ohio State Univ, Coll Pharm, Div Pharmacol, 500 West 12th Ave, Columbus, OH 43210 USA.	lee.5064@osu.edu	Karthikeyan, Mythreye/ABC-7345-2020; Lee, Nam/H-3073-2016; Hawinkels, Lukas/Q-5098-2019	Karthikeyan, Mythreye/0000-0001-5478-0098; Hawinkels, Lukas/0000-0002-2274-9325	National Institutes of Health [CA178443]; Patil Fellowship; Dutch Cancer Society/Alp d'huZes-Bas Mulder Award [UL2011-5051]; NATIONAL CANCER INSTITUTE [R01CA178443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patil Fellowship; Dutch Cancer Society/Alp d'huZes-Bas Mulder Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA178443 (to N. Y. L.), the Patil Fellowship (to C. C. P.), and the Dutch Cancer Society/Alp d'huZes-Bas Mulder Award (UL2011-5051) (to L. H.).	Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Bernabeu C, 2007, J CELL BIOCHEM, V102, P1375, DOI 10.1002/jcb.21594; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ehrlich M, 2012, FEBS LETT, V586, P1885, DOI 10.1016/j.febslet.2012.01.040; Ehrlich M, 2011, CELL SIGNAL, V23, P1424, DOI 10.1016/j.cellsig.2011.04.004; Fonsatti E, 2010, CARDIOVASC RES, V86, P12, DOI 10.1093/cvr/cvp332; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Huang F, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-9; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Koleva RI, 2006, J BIOL CHEM, V281, P25110, DOI 10.1074/jbc.M601288200; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; LAM KS, 1995, INT J PEPT PROT RES, V45, P587; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Lee NY, 2012, MOL BIOL CELL, V23, P2412, DOI 10.1091/mbc.E11-12-0993; Li CG, 2003, ANTICANCER RES, V23, P1189; Lonn P, 2012, J BIOL CHEM, V287, P12867, DOI 10.1074/jbc.M111.307249; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, GENE DEV, V14, P627; Meng QJ, 2006, J BIOL CHEM, V281, P37069, DOI 10.1074/jbc.M608614200; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; Park SS, 2004, ONCOGENE, V23, P6272, DOI 10.1038/sj.onc.1207856; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Perez-Gomez E, 2010, THESCIENTIFICWORLDJO, V10, P2367, DOI 10.1100/tsw.2010.230; Ray BN, 2010, CARCINOGENESIS, V31, P435, DOI 10.1093/carcin/bgp327; Rosen LS, 2012, CLIN CANCER RES, V18, P4820, DOI 10.1158/1078-0432.CCR-12-0098; Schliess F, 2004, J BIOL CHEM, V279, P21294, DOI 10.1074/jbc.M313901200; Takahashi T, 2003, MOL CELL BIOL, V23, P1817, DOI 10.1128/MCB.23.5.1817-1831.2003; Tang H, 2005, BLOOD, V105, P1977, DOI 10.1182/blood-2004-08-3308; Tsujie M, 2008, INT J CANCER, V122, P2266, DOI 10.1002/ijc.23314; Tsujie M, 2006, INT J ONCOL, V29, P1087; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537	40	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25486	25496		10.1074/jbc.M114.578609	http://dx.doi.org/10.1074/jbc.M114.578609			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070888	hybrid, Green Published			2022-12-25	WOS:000342130800011
J	Kruh-Garcia, NA; Wolfe, LM; Chaisson, LH; Worodria, WO; Nahid, P; Schorey, JS; Davis, JL; Dobos, KM				Kruh-Garcia, Nicole A.; Wolfe, Lisa M.; Chaisson, Lelia H.; Worodria, William O.; Nahid, Payam; Schorey, Jeff S.; Davis, J. Lucian; Dobos, Karen M.			Detection of Mycobacterium tuberculosis Peptides in the Exosomes of Patients with Active and Latent M. tuberculosis Infection Using MRM-MS	PLOS ONE			English	Article							NEGATIVE PULMONARY TUBERCULOSIS; MASS-SPECTROMETRY; STATISTICAL-MODEL; PROTEINS; VERIFICATION; MACROPHAGES; BIOMARKERS; IDENTIFICATION; DISCOVERY; APOPTOSIS	The identification of easily measured, accurate diagnostic biomarkers for active tuberculosis (TB) will have a significant impact on global TB control efforts. Because of the host and pathogen complexities involved in TB pathogenesis, identifying a single biomarker that is adequately sensitive and specific continues to be a major hurdle. Our previous studies in models of TB demonstrated that exosomes, such as those released from infected macrophages, contain mycobacterial products, including many Mtb proteins. In this report, we describe the development of targeted proteomics assays employing multiplexed multiple reaction monitoring mass spectrometry (MRM-MS) in order to allow us to follow those proteins previously identified by western blot or shotgun mass spectrometry, and enhance biomarker discovery to include detection of Mtb proteins in human serum exosomes. Targeted MRM-MS assays were applied to exosomes isolated from human serum samples obtained from culture-confirmed active TB patients to detect 76 peptides representing 33 unique Mtb proteins. Our studies revealed the first identification of bacteria-derived biomarker candidates of active TB in exosomes from human serum. Twenty of the 33 proteins targeted for detection were found in the exosomes of TB patients, and included multiple peptides from 8 proteins (Antigen 85B, Antigen 85C, Apa, BfrB, GlcB, HspX, KatG, and Mpt64). Interestingly, all of these proteins are known mycobacterial adhesins and/or proteins that contribute to the intracellular survival of Mtb. These proteins will be included as target analytes in future validation studies as they may serve as markers for persistent active and latent Mtb infection. In summary, this work is the first step in identifying a unique and specific panel of Mtb peptide biomarkers encapsulated in exosomes and reveals complex biomarker patterns across a spectrum of TB disease states.	[Kruh-Garcia, Nicole A.; Wolfe, Lisa M.; Dobos, Karen M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Wolfe, Lisa M.] Colorado State Univ, Prote & Metabol Facil, Ft Collins, CO 80523 USA; [Chaisson, Lelia H.; Nahid, Payam; Davis, J. Lucian] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA USA; [Worodria, William O.] Makerere Univ, Mulago Hosp, Dept Med, Kampala, Uganda; [Nahid, Payam; Davis, J. Lucian] Univ Calif San Francisco, San Francisco Gen Hosp, Curry Int TB Ctr, San Francisco, CA USA; [Schorey, Jeff S.] Univ Notre Dame, Eck Inst Global Hlth, Dept Biol Sci, Notre Dame, IN 46556 USA	Colorado State University; Colorado State University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University; Mulago National Referral Hospital; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Notre Dame	Dobos, KM (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	kdobos@colostate.edu	Kruh-Garcia, Nicole/D-5853-2017; Dobos, Karen/D-1170-2017; Davis, J. Lucian/AAC-8376-2019	Kruh-Garcia, Nicole/0000-0002-9896-8380; Dobos, Karen/0000-0001-7115-8524; Davis, J. Lucian/0000-0002-8629-9992; Nahid, Payam/0000-0003-2811-1311	Bill and Melinda Gates Foundation [OPP1039688]; National Institutes of Health [1 R21 Al101714-01]; Colorado State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101714, R01AI052439] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by the Bill and Melinda Gates Foundation (to KMD; OPP1039688), the National Institutes of Health (to JLD; 1 R21 Al101714-01), and internal funds from Colorado State University to KMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addona TA, 2011, NAT BIOTECHNOL, V29, P635, DOI 10.1038/nbt.1899; [Anonymous], 2011, COMM SER TESTS DIAGN; Bartlett JW, 2012, BIOMARK MED, V6, P391, DOI [10.2217/BMM.12.49, 10.2217/bmm.12.49]; Beatty WL, 2000, INFECT IMMUN, V68, P6997, DOI 10.1128/IAI.68.12.6997-7002.2000; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Giri PK, 2010, PROTEOMICS, V10, P3190, DOI 10.1002/pmic.200900840; Grover A, 2008, CELL MICROBIOL, V10, P1390, DOI 10.1111/j.1462-5822.2008.01135.x; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Izzo A, 2005, TUBERCULOSIS, V85, P25, DOI 10.1016/j.tube.2004.09.008; Jaffe JD, 2008, MOL CELL PROTEOMICS, V7, P1952, DOI 10.1074/mcp.M800218-MCP200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; Kruh-Garcia NA, 2013, J PROTEOMICS; Kruh-Garcia NA, 2012, UNDERSTANDING TUBERCULOSIS - GLOBAL EXPERIENCES AND INNOVATIVE APPROACHES TO THE DIAGNOSIS, P395; Kumar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069790; Kyeyune R, 2010, JAIDS-J ACQ IMM DEF, V55, P446, DOI 10.1097/QAI.0b013e3181eb611a; MacLean B, 2010, ANAL CHEM, V82, P10116, DOI 10.1021/ac102179j; Mahanty S, 2001, J INFECT DIS, V183, P1713, DOI 10.1086/320722; Mehaffy C, 2010, PROTEOMICS, V10, P1966, DOI 10.1002/pmic.200900836; Mustafa T, 2007, CLIN EXP IMMUNOL, V150, P105, DOI 10.1111/j.1365-2249.2007.03476.x; Mustafa T, 2008, VIRCHOWS ARCH, V452, P449, DOI 10.1007/s00428-008-0575-z; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pandey R, 2012, INFECT IMMUN, V80, P3650, DOI 10.1128/IAI.00229-12; Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]; Pieper R, 2003, PROTEOMICS, V3, P1345, DOI 10.1002/pmic.200300449; Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Searle BCaT Mark, 2007, IMPR SENS COMB RES M; Shingadia D, 2003, LANCET INFECT DIS, V3, P624, DOI 10.1016/S1473-3099(03)00771-0; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Sjogren M, 2001, CLIN CHEM, V47, P1776; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Whiteaker JR, 2011, NAT BIOTECHNOL, V29, P625, DOI 10.1038/nbt.1900; Worodria W, 2010, EUR RESPIR J, V36, P446, DOI 10.1183/09031936.00010210	37	102	115	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103811	10.1371/journal.pone.0103811	http://dx.doi.org/10.1371/journal.pone.0103811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080351	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800082
J	Kwizera, R; Nguna, J; Kiragga, A; Nakavuma, J; Rajasingham, R; Boulware, DR; Meya, DB				Kwizera, Richard; Nguna, Joyce; Kiragga, Agnes; Nakavuma, Jesca; Rajasingham, Radha; Boulware, David R.; Meya, David B.			Performance of Cryptococcal Antigen Lateral Flow Assay Using Saliva in Ugandans with CD4 < 100	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; ANTIRETROVIRAL THERAPY; MENINGITIS; HIV; SERUM; DIAGNOSIS; CARE	Background: Cryptococcal meningitis can best be diagnosed by cerebrospinal fluid India ink microscopy, cryptococcal antigen detection, or culture. These require invasive lumbar punctures. The utility of cryptococcal antigen detection in saliva is unknown. We evaluated the diagnostic performance of the point-of-care cryptococcal antigen lateral flow assay (CrAg LFA) in saliva. Methods: We screened HIV-infected, antiretroviral therapy naive persons with symptomatic meningitis (n = 130) and asymptomatic persons with CD4+<100 cells/mu L entering into HIV care (n = 399) in Kampala, Uganda. The diagnostic performance of testing saliva was compared to serum/plasma cryptococcal antigen as the reference standard. Results: The saliva lateral flow assay performance was overall more sensitive in symptomatic patients (88%) than in asymptomatic patients (27%). The specificity of saliva lateral flow assay was excellent at 97.8% in the symptomatic patients and 100% in asymptomatic patients. The degree of accuracy of saliva in diagnosing cryptococcosis and the level of agreement between the two sample types was better in symptomatic patients (C-statistic 92.9, kappa-0.82) than in asymptomatic patients (C-statistic 63.5, kappa-0.41). Persons with false negative salvia CrAg tests had lower levels of peripheral blood CrAg titers (P<0.001). Conclusion: There was poor diagnostic performance in testing saliva for cryptococcal antigen, particularly among asymptomatic persons screened for preemptive treatment of cryptococcosis.	[Kwizera, Richard; Nguna, Joyce; Kiragga, Agnes; Rajasingham, Radha; Meya, David B.] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Nakavuma, Jesca] Makerere Univ, Coll Vet Med Anim Resource & Biosecur, Kampala, Uganda; [Rajasingham, Radha; Boulware, David R.; Meya, David B.] Univ Minnesota, Dept Med, Div Infect Dis & Int Med, Minneapolis, MN 55455 USA; [Meya, David B.] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Med, Kampala, Uganda	Makerere University; Makerere University; University of Minnesota System; University of Minnesota Twin Cities; Makerere University	Kwizera, R (corresponding author), Makerere Univ, Infect Dis Inst, Kampala, Uganda.	kwizerarichard@ymail.com	Boulware, David R/GRS-0999-2022; Boulware, David R/AAF-7124-2021; Meya, David/AAO-2796-2020; hlupeni, admire/M-1539-2018; Kwizera, Richard/I-5247-2019	Boulware, David R/0000-0002-4715-0060; Kwizera, Richard/0000-0002-5270-3539; Nguna, Joyce/0000-0002-6708-2069; , David/0000-0002-8854-0321	National Institute of Allergy and Infectious Diseases [U01 AI089244]; Centers for Disease Control and Prevention [U01GH11005]; Welcome Trust [087540]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI089244] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Welcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this research was provided by the National Institute of Allergy and Infectious Diseases (U01 AI089244), Centers for Disease Control and Prevention (U01GH11005) and Welcome Trust funding (THRiVE, 087540) to Dr. Meya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058377; Boulware DR, 2014, NEW ENGL J MED, V370, P2487, DOI 10.1056/NEJMoa1312884; Boulware DR, 2014, EMERG INFECT DIS, V20, P45, DOI 10.3201/eid2001.130906; Butler EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051291; Durski KN, 2013, JAIDS-J ACQ IMM DEF, V63, pE101, DOI 10.1097/QAI.0b013e31828e1e56; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Jarvis JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069288; Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613; Jarvis JN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-67; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Lindsley MD, 2011, CLIN INFECT DIS, V53, P321, DOI 10.1093/cid/cir379; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Rajasingham R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001316; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M	16	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103156	10.1371/journal.pone.0103156	http://dx.doi.org/10.1371/journal.pone.0103156			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078453	Green Published, gold			2022-12-25	WOS:000339954800030
J	Tsuruyama, T				Tsuruyama, Tatsuaki			A Model of Cell Biological Signaling Predicts a Phase Transition of Signaling and Provides Mathematical Formulae	PLOS ONE			English	Article							CONCENTRATION-DEPENDENCE; ACTIN POLYMERIZATION; ATP HYDROLYSIS; PROTEIN; DIFFUSION; OSCILLATION; CASCADE	A biological signal is transmitted by interactions between signaling molecules in the cell. To date, there have been extensive studies regarding signaling pathways using numerical simulation of kinetic equations that are based on equations of continuity and Fick's law. To obtain a mathematical formulation of cell signaling, we propose a stability kinetic model of cell biological signaling of a simple two-parameter model based on the kinetics of the diffusion-limiting step. In the present model, the signaling is regulated by the binding of a cofactor, such as ATP. Non-linearity of the kinetics is given by the diffusion fluctuation in the interaction between signaling molecules, which is different from previous works that hypothesized autocatalytic reactions. Numerical simulations showed the presence of a critical concentration of the cofactor beyond which the cell signaling molecule concentration is altered in a chaos-like oscillation with frequency, which is similar to a discontinuous phase transition in physics. Notably, we found that the frequency is given by the logarithm function of the difference of the outside cofactor concentration from the critical concentration. This implies that the outside alteration of the cofactor concentration is transformed into the oscillatory alteration of cell inner signaling. Further, mathematical stability kinetic analysis predicted a discontinuous dynamic phase transition in the critical state at which the cofactor concentration is equivalent to the critical concentration. In conclusion, the present model illustrates a unique feature of cell signaling, and the stability analysis may provide an analytical framework of the cell signaling system and a novel formulation of biological signaling.	Kyoto Univ, Grad Sch Med, Dept Mol Pathol, Kyoto, Japan	Kyoto University	Tsuruyama, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Pathol, Kyoto, Japan.	tsuruyam@kuhp.kyoto-u.ac.jp			MEXT, Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, MEXT, Japan. Project name is "Synergy of fluctuation and Structure". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal I, 2000, J CELL BIOL, V149, P767, DOI 10.1083/jcb.149.4.767; Carles H, 1981, POLYMER, V22, P1165; Carlier M F, 1990, Adv Biophys, V26, P51, DOI 10.1016/0065-227X(90)90007-G; Carlsson AE, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036002; Dorsaz N, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/10/104116; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GALLAGHER WH, 1989, BIOPOLYMERS, V28, P2001, DOI 10.1002/bip.360281115; Godbout C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064560; Hazra P, 2006, BIOPHYS J, V91, P654, DOI 10.1529/biophysj.106.083915; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Ikeda Y, 2013, CELL, V155, P1323, DOI 10.1016/j.cell.2013.10.052; Kasche V, 2003, J CHROMATOGR B, V790, P115, DOI 10.1016/S0021-9673(02)02001-0; Katanaev VL, 2007, BIOCHEM J, V401, P485, DOI 10.1042/BJ20060517; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; Nesmelova IV, 2002, BIOPOLYMERS, V63, P132, DOI 10.1002/bip.10023; OLEARY TJ, 1987, BIOPHYS J, V52, P137, DOI 10.1016/S0006-3495(87)83199-5; PANTALONI D, 1985, P NATL ACAD SCI USA, V82, P7207, DOI 10.1073/pnas.82.21.7207; Poincare H, 1892, COURBES DEFINIES EQU; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; TILTON RD, 1990, BIOPHYS J, V58, P1321, DOI 10.1016/S0006-3495(90)82473-5; Woolley DM, 2010, BIOL REV, V85, P453, DOI 10.1111/j.1469-185X.2009.00110.x; Wustner D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-296; Yamahawa H, 1971, MODERN THEORY POLYM, P266; Zilberman M, 2007, J BIOMED MATER RES A, V80A, P679, DOI 10.1002/jbm.a.30985; Zumsande M, 2010, J THEOR BIOL, V265, P481, DOI 10.1016/j.jtbi.2010.04.025	25	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102911	10.1371/journal.pone.0102911	http://dx.doi.org/10.1371/journal.pone.0102911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079957	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800019
J	Escalera-Zamudio, M; Nelson, MI; Guemes, AGC; Lopez-Martinez, I; Cruz-Ortiz, N; Iguala-Vidales, M; Garcia, ER; Barrera-Badillo, G; Diaz-Quinonez, JA; Lopez, S; Arias, CF; Isa, P				Escalera-Zamudio, Marina; Nelson, Martha I.; Cobian Gueemes, Ana Georgina; Lopez-Martinez, Irma; Cruz-Ortiz, Natividad; Iguala-Vidales, Miguel; Rodriguez Garcia, Elvia; Barrera-Badillo, Gisela; Alberto Diaz-Quinonez, Jose; Lopez, Susana; Arias, Carlos F.; Isa, Pavel		Colegio Pediat Estado Veracruz	Molecular Epidemiology of Influenza A/H3N2 Viruses Circulating in Mexico from 2003 to 2012	PLOS ONE			English	Article							A H3N2 VIRUS; SEQUENCE ALIGNMENT; GENETIC EVOLUTION; REASSORTMENT; HEMAGGLUTININ; ORIGIN; PERSISTENCE; RESISTANT; DYNAMICS; REVEALS	In this work, nineteen influenza A/H3N2 viruses isolated in Mexico between 2003 and 2012 were studied. Our findings show that different human A/H3N2 viral lineages co-circulate within a same season and can also persist locally in between different influenza seasons, increasing the chance for genetic reassortment events. A novel minor cluster was also identified, named here as Korea, that circulated worldwide during 2003. Frequently, phylogenetic characterization did not correlate with the determined antigenic identity, supporting the need for the use of molecular evolutionary tools additionally to antigenic data for the surveillance and characterization of viral diversity during each flu season. This work represents the first long-term molecular epidemiology study of influenza A/H3N2 viruses in Mexico based on the complete genomic sequences and contributes to the monitoring of evolutionary trends of A/H3N2 influenza viruses within North and Central America.	[Escalera-Zamudio, Marina; Cobian Gueemes, Ana Georgina; Lopez, Susana; Arias, Carlos F.; Isa, Pavel] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico; [Nelson, Martha I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Lopez-Martinez, Irma; Cruz-Ortiz, Natividad; Iguala-Vidales, Miguel; Rodriguez Garcia, Elvia; Barrera-Badillo, Gisela; Alberto Diaz-Quinonez, Jose] Inst Diagnost & Referencia Epidemiol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Isa, P (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico.	pavel@ibt.unam.mx	Lopez, Susana/H-6661-2017; Lopez, Susana/O-1986-2019; Arias, Carlos/O-4036-2019; Isa, Pavel/GVU-8303-2022; Díaz-Quiñonez, José Alberto/GOV-5928-2022	Lopez, Susana/0000-0001-6336-9209; Lopez, Susana/0000-0001-6336-9209; Arias, Carlos/0000-0003-3130-4501; Díaz-Quiñonez, José Alberto/0000-0002-3503-7079; Escalera-Zamudio, Marina/0000-0002-4773-2773	Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico [PICOSI09-209]; Consejo Nacional de Ciencia y Tecnologia CONACyT-Mexico [S0008-126823]; CONACyT-Mexico	Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico; Consejo Nacional de Ciencia y Tecnologia CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partially supported by grant PICOSI09-209 from the Instituto de Ciencia y Tecnologia del Distrito Federal to PI, Mexico and S0008-126823 from Consejo Nacional de Ciencia y Tecnologia CONACyT-Mexico to CFA. Marina Escalera-Zamudio y Ana Georgina Cobian Guemes were supported by a scholarship from CONACyT-Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl J, 2011, P NATL ACAD SCI USA, V108, P19359, DOI 10.1073/pnas.1109314108; Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918; Blanton L., 2007, Morbidity and Mortality Weekly Report, V56, P789; Blanton L., 2006, Morbidity and Mortality Weekly Report, V55, P648; Bokhari SH, 2010, IEEE ACM T COMPUT BI, V7, P288, DOI 10.1109/TCBB.2008.73; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Brammer L, 2013, MMWR-MORBID MORTAL W, V62, P473; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P466; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P631; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P375; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P503; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P516; Dao C., 2008, Morbidity and Mortality Weekly Report, V57, P404; Daum LT, 2005, EMERG INFECT DIS, V11, P1186, DOI 10.3201/eid1108.050302; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fourment M, 2010, J CLIN MICROBIOL, V48, P295, DOI 10.1128/JCM.01687-09; Furuse Y, 2009, J CLIN MICROBIOL, V47, P841, DOI 10.1128/JCM.01622-08; Ganatra Rahul, 2012, Morbidity and Mortality Weekly Report, V61, P414; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Jhung M., 2010, Morbidity and Mortality Weekly Report, V59, P423; Jin H, 2005, VIROLOGY, V336, P113, DOI 10.1016/j.virol.2005.03.010; Kang S, 2010, J CLIN MICROBIOL, V48, P2177, DOI 10.1128/JCM.00209-10; Kniss Krista, 2011, Morbidity and Mortality Weekly Report, V60, P705; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Nelson MI, 2009, VIROLOGY, V388, P270, DOI 10.1016/j.virol.2009.03.026; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000133; Peebles P., 2009, Morbidity and Mortality Weekly Report, V58, P369; Ponstigl H, 2010, SMALT; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Sarkar M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-3; Schweiger B, 2006, VACCINE, V24, P6683, DOI 10.1016/j.vaccine.2006.05.105; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Thompson WW, 2009, AM J PUBLIC HEALTH, V99, pS225, DOI 10.2105/AJPH.2008.151944; Viboud C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0199; Wang Zhao-guo, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P35; Westgeest KB, 2012, J GEN VIROL, V93, P1996, DOI 10.1099/vir.0.043059-0; WHO webside, 2014, FLUNET; WHO webside, 2014, WHO REC COMP INFL VI; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09	47	2	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102453	10.1371/journal.pone.0102453	http://dx.doi.org/10.1371/journal.pone.0102453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075517	gold, Green Published, Green Submitted			2022-12-25	WOS:000340028800012
J	Hu, XW; Yi, ES; Ryu, JH				Hu, Xiaowen; Yi, Eunhee S.; Ryu, Jay H.			Aspiration-Related Deaths in 57 Consecutive Patients: Autopsy Study	PLOS ONE			English	Article							NURSING-HOME RESIDENTS; RISK-FACTORS; PNEUMONIA; DISEASE; MANAGEMENT; MORTALITY; FOOD	Background: Aspiration can cause a diverse spectrum of pulmonary disorders some of which can lead to death but can be difficult to diagnose. Patients and Methods: The medical records and autopsy findings of 57 consecutive patients in whom aspiration was the immediate cause of death at Mayo Clinic (Rochester, MN, USA) over a 9-yr period, from January 1 2004 to December 31 2012 were analyzed. Results: The median age at death was 72 years (range, 13-95 years) and included 39 (68%) males. The most common symptom before death was dyspnea (63%) and chest radiography revealed bilateral infiltrates in the majority (81%). Most common precipitating factors for aspiration were depressed consciousness (46%) and dysphagia (44%). Aspiration-related syndromes leading to death were aspiration pneumonia in 26 (46%), aspiration pneumonitis in 25 (44%), and large airway obstruction in 6 patients (11%). Aspiration was clinically unsuspected in 19 (33%) patients. Antimicrobial therapy had been empirically administered to most patients (90%) with aspiration pneumonia and aspiration pneumonitis. Conclusion: We conclude aspiration-related deaths occur most commonly in the elderly with identifiable risks and presenting bilateral pulmonary infiltrates. One-third of these aspiration-related pulmonary syndromes were clinically unsuspected at the time of death.	[Hu, Xiaowen] Anhui Med Univ, Anhui Prov Hosp, Dept Resp Med, Hefei, Peoples R China; [Yi, Eunhee S.] Mayo Clin, Div Anat Pathol, Rochester, MN USA; [Ryu, Jay H.] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN 55905 USA	Anhui Medical University; Mayo Clinic; Mayo Clinic	Ryu, JH (corresponding author), Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN 55905 USA.	ryu.jay@mayo.edu		Ryu, Jay/0000-0002-9576-2272; Hu, Xiaowen/0000-0002-3727-6049				Auroy Y, 2009, ANAESTHESIA, V64, P366, DOI 10.1111/j.1365-2044.2008.05792.x; Barnes TW, 2006, MAYO CLIN PROC, V81, P172, DOI 10.4065/81.2.172; Beck-Schimmer B, 2011, EUR J ANAESTH, V28, P78, DOI 10.1097/EJA.0b013e32834205a8; Berzlanovich AM, 2005, AM J PREV MED, V28, P65, DOI 10.1016/j.amepre.2004.04.002; Chang CY, 2013, STROKE, V44, P1182, DOI 10.1161/STROKEAHA.111.000663; Christ A, 2006, INTENS CARE MED, V32, P1423, DOI 10.1007/s00134-006-0277-4; Chung CH, 2013, ACCIDENT ANAL PREV, V50, P523, DOI 10.1016/j.aap.2012.05.033; IRWIN RS, 1977, JAMA-J AM MED ASSOC, V237, P2744, DOI 10.1001/jama.237.25.2744; Komiya K, 2013, GERIATR GERONTOL INT, V13, P580, DOI 10.1111/j.1447-0594.2012.00940.x; Lanspa MJ, 2013, J HOSP MED, V8, P83, DOI 10.1002/jhm.1996; Marik PE, 2011, CURR OPIN PULM MED, V17, P148, DOI 10.1097/MCP.0b013e32834397d6; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Marik PE, 1999, CHEST, V115, P178, DOI 10.1378/chest.115.1.178; Marik PE, 2003, CHEST, V124, P328, DOI 10.1378/chest.124.1.328; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Mukhopadhyay S, 2007, AM J SURG PATHOL, V31, P752, DOI 10.1097/01.pas.0000213418.08009.f9; Mylotte JM, 2005, J AM GERIATR SOC, V53, P755, DOI 10.1111/j.1532-5415.2005.53258.x; Mylotte JM, 2003, J AM GERIATR SOC, V51, P17, DOI 10.1034/j.1601-5215.2002.51004.x; Raghavendran K, 2011, CRIT CARE MED, V39, P818, DOI 10.1097/CCM.0b013e31820a856b; Taylor JK, 2013, AM J MED, V126, P995, DOI 10.1016/j.amjmed.2013.07.012; Ventura F, 2012, AM J FOREN MED PATH, V33, P259, DOI 10.1097/PAF.0b013e31824e5be0; Wada H, 2001, GERONTOLOGY, V47, P271, DOI 10.1159/000052811; Yang I, 2013, FEMS MICROBIOL REV, V37, P736, DOI 10.1111/1574-6976.12027	23	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103795	10.1371/journal.pone.0103795	http://dx.doi.org/10.1371/journal.pone.0103795			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076409	Green Submitted, Green Published, gold			2022-12-25	WOS:000340028800080
J	Lu, WD; Zhang, L; Wu, CL; Liu, ZG; Lei, GY; Liu, J; Gao, W; Hu, YR				Lu, Wei-Dong; Zhang, Lei; Wu, Chun-Lin; Liu, Zhi-Gang; Lei, Guang-Yan; Liu, Jia; Gao, Wei; Hu, Ye-Rong			Development of an Acellular Tumor Extracellular Matrix as a Three-Dimensional Scaffold for Tumor Engineering	PLOS ONE			English	Article							JUGULAR-VEIN CONDUITS; MECHANICAL-PROPERTIES; IN-VITRO; CANCER CELLS; 3D SCAFFOLDS; TISSUE; HYDROGELS; DECELLULARIZATION; VASCULARIZATION; MORPHOGENESIS	Tumor engineering is defined as the construction of three-dimensional (3D) tumors in vitro with tissue engineering approaches. The present 3D scaffolds for tumor engineering have several limitations in terms of structure and function. To get an ideal 3D scaffold for tumor culture, A549 human pulmonary adenocarcinoma cells were implanted into immunodeficient mice to establish xenotransplatation models. Tumors were retrieved at 30-day implantation and sliced into sheets. They were subsequently decellularized by four procedures. Two decellularization methods, Tris-Trypsin-Triton multi-step treatment and sodium dodecyl sulfate (SDS) treatment, achieved complete cellular removal and thus were chosen for evaluation of histological and biochemical properties. Native tumor tissues were used as controls. Human breast cancer MCF-7 cells were cultured onto the two 3D scaffolds for further cell growth and growth factor secretion investigations, with the two-dimensional (2D) culture and cells cultured onto the Matrigel scaffolds used as controls. Results showed that Tris-Trypsin-Triton multi-step treated tumor sheets had well-preserved extracellular matrix structures and components. Their porosity was increased but elastic modulus was decreased compared with the native tumor samples. They supported MCF-7 cell repopulation and proliferation, as well as expression of growth factors. When cultured within the Tris-Trypsin-Triton treated scaffold, A549 cells and human colorectal adenocarcinoma cells (SW-480) had similar behaviors to MCF-7 cells, but human esophageal squamous cell carcinoma cells (KYSE-510) had a relatively slow cell repopulation rate. This study provides evidence that Tris-Trypsin-Triton treated acellular tumor extracellular matrices are promising 3D scaffolds with ideal spatial arrangement, biomechanical properties and biocompatibility for improved modeling of 3D tumor microenvironments.	[Lu, Wei-Dong; Liu, Zhi-Gang; Lei, Guang-Yan; Liu, Jia; Gao, Wei] Xi An Jiao Tong Univ, Tumor Hosp Shaanxi Prov, Coll Med, Dept Thorac Surg, Xian 710049, Shaanxi, Peoples R China; [Zhang, Lei] Tianjin Med Univ, Canc Inst & Hosp, Tianjin Lung Canc Ctr, Dept Thorac Surg,Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Wu, Chun-Lin; Hu, Ye-Rong] Cent S Univ, Xiangya Hosp 2, Dept Thorac & Cardiovasc Surg, Changsha, Hunan, Peoples R China	Xi'an Jiaotong University; Tianjin Medical University; Central South University	Lu, WD (corresponding author), Xi An Jiao Tong Univ, Tumor Hosp Shaanxi Prov, Coll Med, Dept Thorac Surg, Xian 710049, Shaanxi, Peoples R China.	wdlu76@aliyun.com		Lu, Wei-Dong/0000-0003-2685-4218	National Natural Science Foundation of China [31100686]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (No. 31100686). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005; Caicedo-Carvajal C. E., 2011, J TISSUE ENG, V2011; Cartmell JS, 2000, J BIOMED MATER RES, V49, P134, DOI 10.1002/(SICI)1097-4636(200001)49:1<134::AID-JBM17>3.0.CO;2-D; Chiu YC, 2011, BIOMATERIALS, V32, P6045, DOI 10.1016/j.biomaterials.2011.04.066; Choi YC, 2012, TISSUE ENG PART C-ME, V18, P866, DOI [10.1089/ten.tec.2012.0009, 10.1089/ten.TEC.2012.0009]; De S, 2005, P NATL ACAD SCI USA, V102, P7589, DOI 10.1073/pnas.0502935102; Deeken CR, 2011, J BIOMED MATER RES B, V96B, P199, DOI 10.1002/jbm.b.31753; Feldman JP, 2009, J APPL QUANT METHODS, V4, P455, DOI DOI 10.1111/J.2042-3306.2010.TB05629.X; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Fong ELS, 2013, P NATL ACAD SCI USA, V110, P6500, DOI 10.1073/pnas.1221403110; Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015; Ghajar CM, 2010, TISSUE ENG PT A, V16, P2153, DOI 10.1089/ten.TEA.2010.0135; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gill BJ, 2012, CANCER RES, V72, P6013, DOI 10.1158/0008-5472.CAN-12-0895; Godugu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053708; Gratzer PF, 2006, TISSUE ENG, V12, P2975, DOI 10.1089/ten.2006.12.2975; Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Hoshiba T, 2010, EXPERT OPIN BIOL TH, V10, P1717, DOI 10.1517/14712598.2010.534079; Hutmacher DW, 2010, TRENDS BIOTECHNOL, V28, P125, DOI 10.1016/j.tibtech.2009.12.001; Kagadis GC, 2010, MED PHYS, V37, P6421, DOI 10.1118/1.3515456; Leung M, 2010, PHARM RES-DORDR, V27, P1939, DOI 10.1007/s11095-010-0198-3; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liao J, 2008, BIOMATERIALS, V29, P1065, DOI 10.1016/j.biomaterials.2007.11.007; Lu WD, 2012, J BIOMED MATER RES A, V100A, P2644, DOI 10.1002/jbm.a.34203; Lu Wei-Dong, 2009, Interact Cardiovasc Thorac Surg, V8, P301, DOI 10.1510/icvts.2008.194076; Lu WD, 2010, BIOMATERIALS, V31, P2934, DOI 10.1016/j.biomaterials.2009.12.046; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Mishra DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045308; Mishra DK, 2012, ANN THORAC SURG, V93, P1075, DOI 10.1016/j.athoracsur.2012.01.011; Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023; Nyga A, 2013, ACTA BIOMATER, V9, P7917, DOI 10.1016/j.actbio.2013.04.028; Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4; Pagoulatou E, 2012, J MATER SCI-MATER M, V23, P1387, DOI 10.1007/s10856-012-4620-8; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Petersen TH, 2012, CELLS TISSUES ORGANS, V195, P222, DOI 10.1159/000324896; Sahoo SK, 2005, BIOMACROMOLECULES, V6, P1132, DOI 10.1021/bm0492632; Szot CS, 2011, BIOMATERIALS, V32, P7905, DOI 10.1016/j.biomaterials.2011.07.001; Tilghman RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037231; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]; Tudorache I, 2007, J HEART VALVE DIS, V16, P567; Verbridge SS, 2010, TISSUE ENG PT A, V16, P2133, DOI 10.1089/ten.TEA.2009.0670; Williams C, 2009, ACTA BIOMATER, V5, P993, DOI 10.1016/j.actbio.2008.11.028; Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066; Wu SF, 2011, BIOMATERIALS, V32, P1317, DOI 10.1016/j.biomaterials.2010.10.006; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yang B, 2010, TISSUE ENG PART C-ME, V16, P1201, DOI [10.1089/ten.tec.2009.0311, 10.1089/ten.TEC.2009.0311]; Zhang RY, 1999, J BIOMED MATER RES, V44, P446	53	76	78	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103672	10.1371/journal.pone.0103672	http://dx.doi.org/10.1371/journal.pone.0103672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072252	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600078
J	Gutierrez, AG; Armesto, JJ; Diaz, MF; Huth, A				Gutierrez, Alvaro G.; Armesto, Juan J.; Diaz, M. Francisca; Huth, Andreas			Increased Drought Impacts on Temperate Rainforests from Southern South America: Results of a Process-Based, Dynamic Forest Model	PLOS ONE			English	Article							NORTHERN CHILOE ISLAND; INDUCED TREE MORTALITY; WATER-USE EFFICIENCY; CLIMATE-CHANGE; GAP MODELS; SOIL PROPERTIES; VEGETATION; CONSERVATION; PHYSIOLOGY; NOTHOFAGUS	Increased droughts due to regional shifts in temperature and rainfall regimes are likely to affect forests in temperate regions in the coming decades. To assess their consequences for forest dynamics, we need predictive tools that couple hydrologic processes, soil moisture dynamics and plant productivity. Here, we developed and tested a dynamic forest model that predicts the hydrologic balance of North Patagonian rainforests on Chiloe Island, in temperate South America (42 degrees S). The model incorporates the dynamic linkages between changing rainfall regimes, soil moisture and individual tree growth. Declining rainfall, as predicted for the study area, should mean up to 50% less summer rain by year 2100. We analysed forest responses to increased drought using the model proposed focusing on changes in evapotranspiration, soil moisture and forest structure (above-ground biomass and basal area). We compared the responses of a young stand (YS, ca. 60 years-old) and an old-growth forest (OG, >500 years-old) in the same area. Based on detailed field measurements of water fluxes, the model provides a reliable account of the hydrologic balance of these evergreen, broad-leaved rainforests. We found higher evapotranspiration in OG than YS under current climate. Increasing drought predicted for this century can reduce evapotranspiration by 15% in the OG compared to current values. Drier climate will alter forest structure, leading to decreases in above ground biomass by 27% of the current value in OG. The model presented here can be used to assess the potential impacts of climate change on forest hydrology and other threats of global change on future forests such as fragmentation, introduction of exotic tree species, and changes in fire regimes. Our study expands the applicability of forest dynamics models in remote and hitherto overlooked regions of the world, such as southern temperate rainforests.	[Gutierrez, Alvaro G.; Huth, Andreas] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modeling, Leipzig, Germany; [Gutierrez, Alvaro G.] ETH, Swiss Fed Inst Technol, Dept Environm Sci, Inst Terr Ecosyst,Forest Ecol Grp, Zurich, Switzerland; [Armesto, Juan J.] IEB, Santiago, Chile; [Armesto, Juan J.] Univ Catolica Chile, Dept Ecol, Fac Ciencias Biol, Santiago, Chile; [Diaz, M. Francisca] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Swiss Federal Institutes of Technology Domain; ETH Zurich; Pontificia Universidad Catolica de Chile; Universidad Catolica del Norte; Universidad Andres Bello	Gutierrez, AG (corresponding author), Univ Austral Chile, Fac Ciencias Forest & Recursos Nat, Inst Conservac Biodiversidad & Territorio, Valdivia, Chile.	bosqueciencia@gmail.com	Gutierrez, Alvaro G./AAC-9385-2019; Gutierrez, Alvaro G/C-1979-2009; Armesto, Juan J/G-6467-2016	Gutierrez, Alvaro G./0000-0001-8928-3198; Gutierrez, Alvaro G/0000-0001-8928-3198; Diaz, Maria F/0000-0002-1350-4879	Millennium Scientific Initiative [P05-002]; CONICYT [PFB-23]; DAAD; Marie Curie Intra European Fellowship [PIEF-GA-2010-274798]; CONICYT-PAI [82130046]; ERC [233066]	Millennium Scientific Initiative; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Marie Curie Intra European Fellowship(European Commission); CONICYT-PAI; ERC(European Research Council (ERC)European Commission)	This study was supported by grants from Millennium Scientific Initiative (P05-002) and CONICYT PFB-23 to the Institute of Ecology and Biodiversity. AGG was funded by a DAAD doctoral fellowship, by a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme (PIEF-GA-2010-274798) and CONICYT-PAI grant (82130046). Additional funding was provided by the ERC advanced grant 233066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; ALABACK PB, 1991, REV CHIL HIST NAT, V64, P399; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Aravena JC, 2002, REV CHIL HIST NAT, V75, P339; Armesto JJ, 1998, SCIENCE, V282, P1271, DOI 10.1126/science.282.5392.1271; Armesto JJ, 2009, ECOL STUD-ANAL SYNTH, V207, P367, DOI 10.1007/978-3-540-92706-8_16; Asbjornsen H, 2011, J PLANT ECOL, V4, P3, DOI 10.1093/jpe/rtr005; Barbour MM, 2005, NEW PHYTOL, V165, P549, DOI 10.1111/j.1469-8137.2004.01257.x; BAZZAZ FA, 1979, ANNU REV ECOL SYST, V10, P351, DOI 10.1146/annurev.es.10.110179.002031; BOTKIN DB, 1972, J ECOL, V60, P849, DOI 10.2307/2258570; Breda NJJ, 2003, J EXP BOT, V54, P2403, DOI 10.1093/jxb/erg263; Brodribb T, 1998, FUNCT ECOL, V12, P465, DOI 10.1046/j.1365-2435.1998.00213.x; Bugmann H, 1998, FOREST ECOL MANAG, V103, P247, DOI 10.1016/S0378-1127(97)00217-X; Bugmann H, 2001, CLIMATIC CHANGE, V51, P259, DOI 10.1023/A:1012525626267; Bugmann HKM, 2001, CLIMATIC CHANGE, V51, P349, DOI 10.1023/A:1012537914881; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; CIREN, 1994, DEL DESCR MICR TRANS; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Cunningham SC, 2005, OECOLOGIA, V142, P521, DOI 10.1007/s00442-004-1766-1; DGF CONAMA, 2006, EST VAR CLIM CHIL SI; Di Castri F, 1976, BIOCLIMATOLOGIA CHIL; Diaz MF, 2007, FOREST ECOL MANAG, V244, P32, DOI 10.1016/j.foreco.2007.03.030; Diaz MF, 2007, REV CHIL HIST NAT, V80, P13; Dingman S., 2002, PHYS HYDROLOGY; Donoso PJ, 2007, FOREST ECOL MANAG, V239, P120, DOI 10.1016/j.foreco.2006.11.015; Echeverria C, 2007, GLOBAL ECOL BIOGEOGR, V16, P426, DOI 10.1111/j.1466-8238.2007.00311.x; Figueroa JA, 2010, TREE PHYSIOL, V30, P574, DOI 10.1093/treephys/tpq016; Gerten D, 2004, J HYDROL, V286, P249, DOI 10.1016/j.jhydrol.2003.09.029; Groeneveld J, 2009, ECOL MODEL, V220, P2450, DOI 10.1016/j.ecolmodel.2009.06.015; Gutierrez AG, 2004, J ECOL, V92, P598, DOI 10.1111/j.0022-0477.2004.00891.x; Gutierrez AG, 2010, THESIS TU MUNCHEN FR; Gutierrez AG, 2012, PERSPECT PLANT ECOL, V14, P243, DOI 10.1016/j.ppees.2012.01.004; Gutierrez AG, 2009, FOREST ECOL MANAG, V258, P376, DOI 10.1016/j.foreco.2009.03.011; Hall GMJ, 2000, ECOL APPL, V10, P115, DOI 10.1890/1051-0761(2000)010[0115:SNZFDW]2.0.CO;2; Haxeltine A, 1996, GLOBAL BIOGEOCHEM CY, V10, P693, DOI 10.1029/96GB02344; Hobbie SE, 1998, J ECOL, V86, P449, DOI 10.1046/j.1365-2745.1998.00278.x; HOLDGATE MW, 1961, J ECOL, V49, P559, DOI 10.2307/2257223; Huber A, 2001, J HYDROL, V248, P78, DOI 10.1016/S0022-1694(01)00394-8; Janssen I., 2004, Revista de la Ciencia del Suelo y Nutricion Vegetal, V4, P14; Keenan TF, 2013, NATURE, V499, P324, DOI 10.1038/nature12291; Kohler P, 2003, ECOSYSTEMS, V6, P114, DOI 10.1007/s10021-002-0121-9; Kohler P, 1998, ECOL MODEL, V109, P301, DOI 10.1016/S0304-3800(98)00066-0; KOHLER P, 2000, THESIS U KASSEL OSNA; Kumagai T, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002226; Laio F, 2001, ADV WATER RESOUR, V24, P707, DOI 10.1016/S0309-1708(01)00005-7; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Lara A, 2009, FOREST ECOL MANAG, V258, P415, DOI 10.1016/j.foreco.2009.01.004; Larcher W., 2001, OKOPHYSIOLOGIE PFLAN, V6; Lenth R., 2019, Journal of Statistical Software, V60, P1; Levesque M, 2013, GLOBAL CHANGE BIOL, V19, P3184, DOI 10.1111/gcb.12268; Little C, 2009, J HYDROL, V374, P162, DOI 10.1016/j.jhydrol.2009.06.011; Lusk CH, 2001, REV CHIL HIST NAT, V74, P711, DOI 10.4067/S0716-078X2001000300017; Lusk CH, 2001, GAYANA BOT, V58, P25, DOI DOI 10.4067/S0717-66432001000100003; Maidment D.R., 1993, HDB HYDROLOGY; Naulin P, 2002, ESTIMACION BIOMASA R; Navarro C, 1999, SILVICULTURA BOSQUES; NEILSON RP, 1995, ECOL APPL, V5, P362, DOI 10.2307/1942028; Oyarzun CE, 2011, HYDROL PROCESS, V25, P623, DOI 10.1002/hyp.7850; Penuelas J, 2008, GLOBAL CHANGE BIOL, V14, P1076, DOI 10.1111/j.1365-2486.2008.01563.x; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; Phillips OL, 2010, NEW PHYTOL, V187, P631, DOI 10.1111/j.1469-8137.2010.03359.x; Piper FI, 2007, ANN FOREST SCI, V64, P447, DOI 10.1051/forest:2007022; Porporato A, 2004, AM NAT, V164, P625, DOI 10.1086/424970; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; PRENTICE IC, 1993, ECOL MODEL, V65, P51, DOI 10.1016/0304-3800(93)90126-D; R Development Core Team, 2012, R LANG ENV STAT COMP; Rey JM, 1999, ECOL MODEL, V123, P141, DOI 10.1016/S0304-3800(99)00129-5; Reynolds JF, 2001, CLIMATIC CHANGE, V51, P541, DOI 10.1023/A:1012551728510; Rodriguez-Iturbe I, 1999, P ROY SOC A-MATH PHY, V455, P3789, DOI 10.1098/rspa.1999.0477; Ruger N, 2007, FOREST ECOL MANAG, V252, P52, DOI 10.1016/j.foreco.2007.06.020; RUTTER AJ, 1977, J APPL ECOL, V14, P567, DOI 10.2307/2402568; Ryan MG, 2005, BIOGEOCHEMISTRY, V73, P3, DOI 10.1007/s10533-004-5167-7; Seki K., 2007, HYDROL EARTH SYST SC, V2007, P407, DOI [DOI 10.5194/HESSD-4-407-2007, 10.5194/hessd-4-407-2007]; Silva LCR, 2013, GLOBAL ECOL BIOGEOGR, V22, P83, DOI 10.1111/j.1466-8238.2012.00783.x; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Suarez ML, 2004, J ECOL, V92, P954, DOI 10.1111/j.1365-2745.2004.00941.x; Thornley HMJ, 1990, PLANT CROP MODELLING; Trenberth KE, 2007, CLIMATE CHANGE 2007, P336; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Veblen TT, 1983, TEMPERATE BROAD LEAV, P5; Venevsky S, 2007, ENVIRON MODELL SOFTW, V22, P104, DOI 10.1016/j.envsoft.2006.02.002; Vose JM, 2011, ECOHYDROLOGY, V4, P146, DOI 10.1002/eco.193; Wattenbach M, 2005, ECOL MODEL, V187, P40, DOI 10.1016/j.ecolmodel.2005.01.026; Willson MF, 1996, REV CHIL HIST NAT, V69, P149; Zuniga R, 2006, REV CHIL HIST NAT, V79, P489	86	14	14	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103226	10.1371/journal.pone.0103226	http://dx.doi.org/10.1371/journal.pone.0103226			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068869	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993700048
J	Ali, S; Shourideh, M; Koochekpour, S				Ali, Shafat; Shourideh, Mojgan; Koochekpour, Shahriar			Identification of Novel GRM1 Mutations and Single Nucleotide Polymorphisms in Prostate Cancer Cell Lines and Tissues	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; SIGNALING PATHWAYS; SOMATIC MUTATIONS; MELANOMA; PROLIFERATION; LANDSCAPE; BLOCKADE; PROTEINS	Metabotropic glutamate receptor 1 (GRM1) signaling has been implicated in benign and malignant disorders including prostate cancer (PCa). To further explore the role of genetic alterations of GRM1 in PCa, we screened the entire human GRM1 gene including coding sequence, exon-intron junctions, and flanking untranslated regions (UTRs) for the presence of mutations and single nucleotide polymorphisms (SNPs) in several PCa cell lines and matched tumor-normal tissues from Caucasian Americans (CAs) and African Americans (AAs). We used bidirectional sequencing, allele-specific PCR, and bioinformatics to identify the genetic changes in GRM1 and to predict their functional role. A novel missense mutation identified at C1744T (582 Pro > Ser) position of GRM1 gene in a primary AA-PCa cell line (E006AA) was predicted to affect the protein stability and functions. Another novel mutation identified at exon-intron junction of exon-8 in C4-2B cell line resulted in alteration of the GRM1 splicing donor site. In addition, we found missense SNP at T2977C (993 Ser > Pro) position and multiple non-coding mutations and SNPs in 3'-UTR of GRM1 gene in PCa cell lines and tissues. These novel mutations may contribute to the disease by alterations in GRM1 gene splicing, receptor activation, and post-receptor downstream signaling.	[Ali, Shafat; Shourideh, Mojgan; Koochekpour, Shahriar] Roswell Pk Canc Inst, Ctr Genet & Pharmacol, Dept Canc Genet, Buffalo, NY 14263 USA; [Koochekpour, Shahriar] Roswell Pk Canc Inst, Ctr Genet & Pharmacol, Dept Urol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Koochekpour, S (corresponding author), Roswell Pk Canc Inst, Ctr Genet & Pharmacol, Dept Canc Genet, Buffalo, NY 14263 USA.	Shahriar.Koochekpour@roswellpark.org			Roswell Park Cancer Institute and National Cancer Institute [P30 CA016056];  [R01MD005824];  [R21CA183892];  [R21CA181152]; NATIONAL CANCER INSTITUTE [R21CA181152, R21CA183892, P30CA016056] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD005824] Funding Source: NIH RePORTER	Roswell Park Cancer Institute and National Cancer Institute; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by R01MD005824, R21CA183892, and R21CA181152 grants to Dr. Shahriar Koochekpour. Additional support was provided by Roswell Park Cancer Institute and National Cancer Institute grant # P30 CA016056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Choi KY, 2011, P NATL ACAD SCI USA, V108, P15219, DOI 10.1073/pnas.1107304108; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; D'Onofrio M, 2003, J NEUROCHEM, V84, P1288, DOI 10.1046/j.1471-4159.2003.01633.x; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; DiRaddo JO, 2013, GENE, V519, P367, DOI 10.1016/j.gene.2013.02.009; Elia J, 2012, NAT GENET, V44, P78, DOI 10.1038/ng.1013; Esseltine JL, 2013, MOL PHARMACOL, V83, P770, DOI 10.1124/mol.112.081695; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Koochekpour S, 2005, GENE CHROMOSOME CANC, V44, P351, DOI 10.1002/gcc.20249; Koochekpour S, 2004, PROSTATE, V60, P141, DOI 10.1002/pros.20053; Koochekpour S, 2012, CLIN CANCER RES, V18, P5888, DOI 10.1158/1078-0432.CCR-12-1308; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Martino JJ, 2013, ONCOGENE, V32, P4366, DOI 10.1038/onc.2012.471; Mehta MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069851; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Ortiz P, 2007, EUR J HUM GENET, V15, P1176, DOI 10.1038/sj.ejhg.5201887; Platz EA, 2000, JNCI-J NATL CANCER I, V92, P2009, DOI 10.1093/jnci/92.24.2009; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Prickett TD, 2012, CLIN CANCER RES, V18, P4240, DOI 10.1158/1078-0432.CCR-11-1217; Rzeski W, 2001, P NATL ACAD SCI USA, V98, P6372, DOI 10.1073/pnas.091113598; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; Speyer CL, 2012, BREAST CANCER RES TR, V132, P565, DOI 10.1007/s10549-011-1624-x; Teh JLF, 2012, PIGM CELL MELANOMA R, V25, P331, DOI 10.1111/j.1755-148X.2012.00983.x; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; WAINSTEIN MA, 1994, CANCER RES, V54, P6049; Willard MD, 2012, MOL CANCER RES, V10, P739, DOI 10.1158/1541-7786.MCR-11-0483; Willard SS, 2013, INT J BIOL SCI, V9, P948, DOI 10.7150/ijbs.6426; Willard SS, 2013, INT J BIOL SCI, V9, P728, DOI 10.7150/ijbs.6475	33	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103204	10.1371/journal.pone.0103204	http://dx.doi.org/10.1371/journal.pone.0103204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	25062106	Green Submitted, gold, Green Published			2022-12-25	WOS:000339992600043
J	Hattula, K; Hirschberg, D; Kalkkinen, N; Butcher, SJ; Ora, A				Hattula, Katarina; Hirschberg, Daniel; Kalkkinen, Nisse; Butcher, Sarah J.; Ora, Ari			Association between the Intrinsically Disordered Protein PEX19 and PEX3	PLOS ONE			English	Article							PEROXISOMAL MEMBRANE-PROTEINS; ENDOPLASMIC-RETICULUM; HYDROGEN-EXCHANGE; BIOGENESIS DISORDERS; MASS-SPECTROMETRY; ZELLWEGER-SYNDROME; TARGETING SIGNALS; STRUCTURAL BASIS; POTENTIAL ROLE; RECEPTOR	In perxisomes, peroxins (PEXs) 3 and 19 are the principal protein components of the machinery required for early peroxisomal biogenesis. For further insight into the interaction of PEX3 and PEX19, we used hydrogen exhange mass spectrometry to monitor conformational changes during complex between PEX3 and PEX19 in vitrto. Our data showed that PEX19 remained highly flexible during interaction with PEX3. However, we could detect three changes, one each in the N-and C-terminus along with a small stretch in the middle of PEX19 (E64-L74) which became shielded from hydrogen exhange when interacting with PEX3. PEX3 became more protected from hydrogen exchange in the binding groove for PEX19 with only small changes elsewhere. Most likely the N-terminus of PEX19 initiates the binding to PEX3, and then subtle conformational changes in PEX3 affect the surface of the PEX3 molecule. PEX19 in turn, is stabilized by folding of a short helix and its C-terminal folding core permitting PEX19 to bling to PEX3 with higher affinity than just the N-terminal interaction allows. Thus within the cell, PEX3 is stabilized by PEX19 preventing PEX3 aggregation.	[Hattula, Katarina; Hirschberg, Daniel; Kalkkinen, Nisse; Butcher, Sarah J.; Ora, Ari] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	University of Helsinki	Ora, A (corresponding author), Aalto Univ, Dept Appl Phys, Aalto, Finland.	ari.ora@aalto.fi	ora, ari/P-5180-2015; Hirschberg, Daniel/J-3133-2014	Hirschberg, Daniel/0000-0002-1136-9802; Butcher, Sarah/0000-0001-7060-5871	Academy of Finland Centre of Excellence Programme in Virus Research [129684]; Sigrid Juselius Foundation (SJB); Biocenter Finland	Academy of Finland Centre of Excellence Programme in Virus Research(Academy of Finland); Sigrid Juselius Foundation (SJB); Biocenter Finland	This work was supported by the Academy of Finland Centre of Excellence Programme in Virus Research (2006-2011; 129684 to SJB), the Sigrid Juselius Foundation (SJB) and Biocenter Finland (N.K and D.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of	Abrescia NGA, 2004, NATURE, V432, P68, DOI 10.1038/nature03056; Agrawal G, 2011, P NATL ACAD SCI USA, V108, P9113, DOI 10.1073/pnas.1018749108; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; DEDUVE C, 1966, PHYSIOL REV, V46, P323, DOI 10.1152/physrev.1966.46.2.323; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X; Fagarasanu A, 2007, ANNU REV CELL DEV BI, V23, P321, DOI 10.1146/annurev.cellbio.23.090506.123456; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Fransen M, 2005, J MOL BIOL, V346, P1275, DOI 10.1016/j.jmb.2005.01.013; Fransen M, 2004, J BIOL CHEM, V279, P12615, DOI 10.1074/jbc.M304941200; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; Funato M, 2006, BRAIN DEV-JPN, V28, P287, DOI 10.1016/j.braindev.2005.10.010; Geraghty MT, 1999, P NATL ACAD SCI USA, V96, P2937, DOI 10.1073/pnas.96.6.2937; Ghaedi K, 2000, MOL BIOL CELL, V11, P2085, DOI 10.1091/mbc.11.6.2085; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gould SJ, 2000, TRENDS GENET, V16, P340, DOI 10.1016/S0168-9525(00)02056-4; Gsponer J, 2009, PROG BIOPHYS MOL BIO, V99, P94, DOI 10.1016/j.pbiomolbio.2009.03.001; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Hazy E, 2009, CHEMPHYSCHEM, V10, P1415, DOI 10.1002/cphc.200900205; Heiland I, 2005, FEBS J, V272, P2362, DOI 10.1111/j.1742-4658.2005.04690.x; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; JAMES GL, 1994, J BIOL CHEM, V269, P14182; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Jones JM, 2001, J CELL BIOL, V153, P1141, DOI 10.1083/jcb.153.6.1141; Jorgensen TJD, 2004, BIOCHEMISTRY-US, V43, P15044, DOI 10.1021/bi048706j; Kammerer S, 1997, GENOMICS, V45, P200, DOI 10.1006/geno.1997.4914; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Matsuzono Y, 2006, J CELL SCI, V119, P3539, DOI 10.1242/jcs.03100; Muntau AC, 2003, EUR J CELL BIOL, V82, P333, DOI 10.1078/0171-9335-00325; Neufeld C, 2009, EMBO J, V28, P745, DOI 10.1038/emboj.2009.7; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Rucktaschel R, 2010, BIOCHIM BIOPHYS ACTA, V1808, P892; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; SANTOS MJ, 1988, J BIOL CHEM, V263, P10502; Sato Y, 2008, J BIOL CHEM, V283, P6136, DOI 10.1074/jbc.M706139200; Sato Y, 2010, EMBO J, V29, P4083, DOI 10.1038/emboj.2010.293; Schmidt F, 2010, J BIOL CHEM, V285, P25410, DOI 10.1074/jbc.M110.138503; Schrader M, 2008, HISTOCHEM CELL BIOL, V129, P421, DOI 10.1007/s00418-008-0396-9; Schueller N, 2010, EMBO J, V29, P2491, DOI 10.1038/emboj.2010.115; Shibata H, 2004, J BIOL CHEM, V279, P38486, DOI 10.1074/jbc.M402204200; Shimozawa N, 2000, HUM MOL GENET, V9, P1995, DOI 10.1093/hmg/9.13.1995; Snyder WB, 2000, J CELL BIOL, V149, P1171, DOI 10.1083/jcb.149.6.1171; Soukupova M, 1999, EUR J CELL BIOL, V78, P357, DOI 10.1016/S0171-9335(99)80078-8; Steinberg S.J., 1993, GENEREVIEWS; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; Suzuki Y, 2001, J INHERIT METAB DIS, V24, P151, DOI 10.1023/A:1010310816743; Thoms S, 2012, TRAFFIC, V13, P599, DOI 10.1111/j.1600-0854.2011.01324.x; Titorenko VI, 2011, TRAFFIC, V12, P252, DOI 10.1111/j.1600-0854.2010.01144.x; van der Zand A, 2012, CELL, V149, P397, DOI 10.1016/j.cell.2012.01.054; Wanders RJA, 1998, MOL ASPECTS MED, V19, P71, DOI 10.1016/S0098-2997(98)00003-X; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025	56	6	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103101	10.1371/journal.pone.0103101	http://dx.doi.org/10.1371/journal.pone.0103101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	25062251	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992600032
J	Poulsen, JB; Sanderson, LE; Agerschou, ED; Dedic, E; Boesen, T; Brodersen, DE				Poulsen, Jesper Buchhave; Sanderson, Lee Edward; Agerschou, Emil Dandanell; Dedic, Emil; Boesen, Thomas; Brodersen, Ditlev E.			Structural Characterization of the Saccharomyces cerevisiae THO Complex by Small-Angle X-Ray Scattering	PLOS ONE			English	Article							MESSENGER-RNA; TRANSCRIPTION ELONGATION; PROTEIN; RECRUITMENT; EXPORT; GENE; TREX; HPR1; DNA; RECOMBINATION	The THO complex participates during eukaryotic mRNA biogenesis in coupling transcription to formation and nuclear export of translation-competent messenger ribonucleoprotein particles. In Saccharomyces cerevisiae, THO has been defined as a heteropentamer composed of the Tho2p, Hpr1p, Tex1p, Mft1p, and Thp2p subunits and the overall three-dimensional shape of the complex has been established by negative stain electron microscopy. Here, we use small-angle X-ray scattering measured for isolated THO components (Mft1p and Thp2p) as well as THO subcomplexes (Mft1p-Thp2p and Mft1p-Thp2p Tho2p) to construct structural building blocks that allow positioning of each subunit within the complex. To accomplish this, the individual envelopes determined for Mft1p and Thp2p are first fitted inside those of the Mft1p-Thp2p and Mft1p-Thp2p-Tho2p complexes. Next, the ternary complex structure is placed in the context of the five-component electron microscopy structure. Our model reveals not only the position of each protein in the THO complex relative to each other, but also shows that the pentamer is likely somewhat larger than what was observed by electron microscopy.	[Poulsen, Jesper Buchhave; Sanderson, Lee Edward; Agerschou, Emil Dandanell; Dedic, Emil; Brodersen, Ditlev E.] Aarhus Univ, Ctr mRNP Biogenesis & Metab, Aarhus, Denmark; [Boesen, Thomas] Aarhus Univ, Dept Mol Biol & Genet, Pumpkin Ctr Membrane Pumps Cells & Dis, Aarhus, Denmark	Aarhus University; Aarhus University	Brodersen, DE (corresponding author), Aarhus Univ, Ctr mRNP Biogenesis & Metab, Aarhus, Denmark.	deb@mb.au.dk	Brodersen, Ditlev E./AAQ-5241-2020	Boesen, Thomas/0000-0002-5633-6844; Brodersen, Ditlev/0000-0002-5413-4667	Danish National Research Foundation's Centre; Lundbeck Foundation	Danish National Research Foundation's Centre; Lundbeck Foundation(Lundbeckfonden)	This work has been funded by the Danish National Research Foundation's Centre for mRNP Biogenesis and Metabolism and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2005, CURR OPIN CELL BIOL, V17, P242, DOI 10.1016/j.ceb.2005.03.001; AGUILERA A, 1990, MOL CELL BIOL, V10, P1439, DOI 10.1128/MCB.10.4.1439; Chanarat S, 2011, GENE DEV, V25, P1147, DOI 10.1101/gad.623411; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Chavez S, 2001, MOL CELL BIOL, V21, P7054, DOI 10.1128/MCB.21.20.7054-7064.2001; Flemming D, 2010, NAT STRUCT MOL BIOL, V17, P775, DOI 10.1038/nsmb.1811; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gwizdek C, 2006, P NATL ACAD SCI USA, V103, P16376, DOI 10.1073/pnas.0607941103; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Homma K, 2012, MOL BIOSYST, V8, P247, DOI 10.1039/c1mb05208j; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Hurt E, 2004, P NATL ACAD SCI USA, V101, P1858, DOI 10.1073/pnas.0308663100; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Meinel DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003914; Pena A, 2012, EMBO J, V31, P1605, DOI 10.1038/emboj.2012.10; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rougemaille M, 2008, CELL, V135, P308, DOI 10.1016/j.cell.2008.08.005; Schneiter R, 1999, MOL CELL BIOL, V19, P3415; Singh GP, 2007, PROTEINS, V66, P761, DOI 10.1002/prot.21281; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002	32	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103470	10.1371/journal.pone.0103470	http://dx.doi.org/10.1371/journal.pone.0103470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	25062267	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992600073
J	Lee, KW; Bogenhagen, DF				Lee, Ken-Wing; Bogenhagen, Daniel F.			Assignment of 2 '-O-Methyltransferases to Modification Sites on the Mammalian Mitochondrial Large Subunit 16 S Ribosomal RNA (rRNA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEATH-ASSOCIATED PROTEIN-3; MODIFIED NUCLEOTIDES; DETECTING SITES; FUNCTIONAL-ROLE; IDENTIFICATION; MUTATION; GENE; METHYLATION; DEMETHYLASE; COMPONENTS	Advances in proteomics and large scale studies of potential mitochondrial proteins have led to the identification of many novel mitochondrial proteins in need of further characterization. Among these novel proteins are three mammalian rRNA methyltransferase family members RNMTL1, MRM1, and MRM2. MRM1 and MRM2 have bacterial and yeast homologs, whereas RNMTL1 appears to have evolved later in higher eukaryotes. We recently confirmed the localization of the three proteins to mitochondria, specifically in the vicinity of mtDNA nucleoids. In this study, we took advantage of the ability of 2'-O-ribose modification to block site-specific cleavage of RNA by DNAzymes to show that MRM1, MRM2, and RNMTL1 are responsible for modification of human large subunit rRNA at residues G(1145), U-1369, and G(1370), respectively.	[Lee, Ken-Wing; Bogenhagen, Daniel F.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bogenhagen, DF (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	daniel.bogenhagen@stonybrook.edu			Ellison Medical Foundation	Ellison Medical Foundation(Lawrence Ellison Foundation)	This research was supported by a Senior Scholar Award from the Ellison Medical Foundation (to D. F. B.).	Agrawal RK, 2012, CURR OPIN STRUC BIOL, V22, P797, DOI 10.1016/j.sbi.2012.08.003; Almajan ER, 2012, J CLIN INVEST, V122, P4048, DOI 10.1172/JCI64604; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; BAER RJ, 1981, NUCLEIC ACIDS RES, V9, P323, DOI 10.1093/nar/9.2.323; Behm-Ansmant I, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/408053; Blanchard SC, 2001, P NATL ACAD SCI USA, V98, P3720, DOI 10.1073/pnas.051608498; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bogenhagen DF, 2014, CELL METAB, V19, P618, DOI 10.1016/j.cmet.2014.03.013; Britton RA, 2009, ANNU REV MICROBIOL, V63, P155, DOI 10.1146/annurev.micro.091208.073225; Buchhaupt M, 2007, ANAL BIOCHEM, V361, P102, DOI 10.1016/j.ab.2006.11.001; Caldas T, 2000, J BIOL CHEM, V275, P16414, DOI 10.1074/jbc.M001854200; Chen BE, 2012, J AM CHEM SOC, V134, P17963, DOI 10.1021/ja3064149; Coulbault L, 2007, BIOCHEM BIOPH RES CO, V362, P601, DOI 10.1016/j.bbrc.2007.08.040; Cruz RPG, 2004, CHEM BIOL, V11, P57, DOI 10.1016/j.chembiol.2003.12.012; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Dennerlein S, 2010, BIOCHEM J, V430, P551, DOI 10.1042/BJ20100757; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dong ZW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks698; DUBIN DT, 1978, NUCLEIC ACIDS RES, V5, P4385, DOI 10.1093/nar/5.11.4385; Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562; Goldschmidt-Reisin S, 1998, J BIOL CHEM, V273, P34828, DOI 10.1074/jbc.273.52.34828; Graack HR, 1999, BIOCHEMISTRY-US, V38, P16569, DOI 10.1021/bi991543s; Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890; Haque ME, 2010, J BIOL CHEM, V285, P28353, DOI 10.1074/jbc.M110.148262; He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257; Hengesbach M, 2014, ANGEW CHEM INT EDIT, V53, P1742, DOI 10.1002/anie.201309604; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Kaushal PS, 2014, P NATL ACAD SCI USA, V111, P7284, DOI 10.1073/pnas.1401657111; Kenmochi N, 2001, GENOMICS, V77, P65, DOI 10.1006/geno.2001.6622; KING MP, 1993, J BIOL CHEM, V268, P10228; Koc EC, 2001, FEBS LETT, V492, P166, DOI 10.1016/S0014-5793(01)02250-5; Koc EC, 2001, PROTEIN SCI, V10, P471, DOI 10.1110/ps.35301; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Koc EC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00183; Kolanczyk M, 2011, MOL BIOL CELL, V22, P1, DOI 10.1091/mbc.E10-07-0643; Lapinaite A, 2013, NATURE, V502, P519, DOI 10.1038/nature12581; Lee KW, 2013, J BIOL CHEM, V288, P31386, DOI 10.1074/jbc.M113.515692; Liu Z, 2014, J MED GENET, V51, P176, DOI 10.1136/jmedgenet-2013-101818; Lovgren JM, 2001, J BACTERIOL, V183, P6957, DOI 10.1128/JB.183.23.6957-6960.2001; Maden BEH, 1997, CHROMOSOMA, V105, P391, DOI 10.1007/s004120050200; MADEN BEH, 1995, BIOCHIMIE, V77, P22, DOI 10.1016/0300-9084(96)88100-4; Mears JA, 2006, J MOL BIOL, V358, P193, DOI 10.1016/j.jmb.2006.01.094; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Metodiev MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004110; Miyazaki T, 2004, J BIOL CHEM, V279, P44667, DOI 10.1074/jbc.M408101200; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; O'Brien TW, 2005, GENE, V354, P147, DOI 10.1016/j.gene.2005.03.026; O'Brien TW, 1999, J BIOL CHEM, V274, P36043, DOI 10.1074/jbc.274.51.36043; O'Brien TW, 2000, J BIOL CHEM, V275, P18153, DOI 10.1074/jbc.M909762199; Ofengand J, 1997, J MOL BIOL, V266, P246, DOI 10.1006/jmbi.1996.0737; Paul MF, 2012, J BIOL CHEM, V287, P24346, DOI 10.1074/jbc.M112.363309; Pintard L, 2002, EMBO J, V21, P1139, DOI 10.1093/emboj/21.5.1139; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Purta E, 2009, MOL MICROBIOL, V72, P1147, DOI 10.1111/j.1365-2958.2009.06709.x; Rorbach J, 2014, MOL BIOL CELL, V25, P2542, DOI 10.1091/mbc.E14-01-0014; Rorbach J, 2012, BIOCHEM J, V444, P357, DOI 10.1042/BJ20112208; Saikia M, 2006, RNA, V12, P2025, DOI 10.1261/rna.208906; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; SIRUMCONNOLLY K, 1995, BIOCHIMIE, V77, P30, DOI 10.1016/0300-9084(96)88101-6; Suzuki T, 2001, J BIOL CHEM, V276, P33181, DOI 10.1074/jbc.M103236200; Suzuki T, 2001, J BIOL CHEM, V276, P21724, DOI 10.1074/jbc.M100432200; Uchiumi T, 2010, NUCLEIC ACIDS RES, V38, P5554, DOI 10.1093/nar/gkq305; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Vincze E, 2005, ANAL BIOCHEM, V342, P356, DOI 10.1016/j.ab.2005.02.026; Yu YT, 1997, RNA, V3, P324; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	67	53	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24936	24942		10.1074/jbc.C114.581868	http://dx.doi.org/10.1074/jbc.C114.581868			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25074936	Green Published, hybrid			2022-12-25	WOS:000341985300018
J	Brunye, TT; Carney, PA; Allison, KH; Shapiro, LG; Weaver, DL; Elmore, JG				Brunye, Tad T.; Carney, Patricia A.; Allison, Kimberly H.; Shapiro, Linda G.; Weaver, Donald L.; Elmore, Joann G.			Eye Movements as an Index of Pathologist Visual Expertise: A Pilot Study	PLOS ONE			English	Article							VIRTUAL SLIDES; IMAGE PERCEPTION; GAZE-TRACKING; PERFORMANCE; EXPERIENCE; ATTENTION	A pilot study examined the extent to which eye movements occurring during interpretation of digitized breast biopsy whole slide images (WSI) can distinguish novice interpreters from experts, informing assessments of competency progression during training and across the physician-learning continuum. A pathologist with fellowship training in breast pathology interpreted digital WSI of breast tissue and marked the region of highest diagnostic relevance (dROI). These same images were then evaluated using computer vision techniques to identify visually salient regions of interest (vROI) without diagnostic relevance. A non-invasive eye tracking system recorded pathologists' (N = 7) visual behavior during image interpretation, and we measured differential viewing of vROIs versus dROIs according to their level of expertise. Pathologists with relatively low expertise in interpreting breast pathology were more likely to fixate on, and subsequently return to, diagnostically irrelevant vROIs relative to experts. Repeatedly fixating on the distracting vROI showed limited value in predicting diagnostic failure. These preliminary results suggest that eye movements occurring during digital slide interpretation can characterize expertise development by demonstrating differential attraction to diagnostically relevant versus visually distracting image regions. These results carry both theoretical implications and potential for monitoring and evaluating student progress and providing automated feedback and scanning guidance in educational settings.	[Brunye, Tad T.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA; [Carney, Patricia A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Allison, Kimberly H.] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA; [Shapiro, Linda G.] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Weaver, Donald L.] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Weaver, Donald L.] Vermont Canc Ctr, Burlington, VT USA; [Elmore, Joann G.] Univ Washington, Dept Med, Seattle, WA USA	Tufts University; Oregon Health & Science University; Stanford University; University of Washington; University of Washington Seattle; University of Vermont; University of Washington; University of Washington Seattle	Brunye, TT (corresponding author), Tufts Univ, Dept Psychol, Medford, MA 02155 USA.	tbruny01@tufts.edu		Brunye, Tad/0000-0002-8788-8764	National Cancer Institute of the National Institutes of Health [R01 CA172343, KO5 CA104699]; National Cancer Institute [U01CA86082, U01CA70013, U01CA69976, HHSN261201100031C]; NATIONAL CANCER INSTITUTE [R01CA172343, U01CA069976, K05CA104699, U01CA070013, U01CA086082] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers R01 CA172343 and KO5 CA104699 and by the National Cancer Institute-funded Breast Cancer Surveillance Consortium (U01CA86082, U01CA70013, U01CA69976, HHSN261201100031C). The content is solely the responsibility of the authors and does not necessarily represent the views of the National Cancer Institute or the National Institutes of Health. The collection of cancer and vital status data used in this study was supported in part by several state public health departments and cancer registries throughout the U.S. For a full description of these sources, please see: http://www.breastscreening.cancer.gov/work/acknowledgement.html. The authors wish to thank Ventana Medical Systems, Inc., a member of the Roche Group, for use of iScan Coreo Au whole slide imaging system, and HD View SL for the source code used to build our digital viewer. For a full description of HD View SL please see http://hdviewsl.codeplex.com/. No funding was received from these commercial entities, and they have no vested interest in the outcomes of this study. The authors would also like to thank the participating pathologists who kindly donated their time to this study, Tom Morgan and Vignesh Raghunath at University of Washington for their assistance with data collection, and Sarah Tower-Richardi at Tufts University for her assistance with scoring of eye tracking videos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACGME, 2011, ACGME PROGR REQ GRAN, P1; Bombari D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038023; Carney PA, 1996, AM J ROENTGENOL, V167, P367, DOI 10.2214/ajr.167.2.8686606; Carney PA, 2000, AM J EPIDEMIOL, V152, P371, DOI 10.1093/aje/152.4.371; Crowley RS, 2003, J AM MED INFORM ASSN, V10, P39, DOI 10.1197/jamia.M1123; Dalkey NC, 1969, DELPHI METHOD 3 USE; Derry SJ, 1996, EDUC PSYCHOL, V31, P163, DOI 10.1207/s15326985ep3103&4_2; Dreyfus HL, 1986, PLOS ONE, V7; Duchowski A., 2007, EYE TRACKING METHODO; Elstein AS, 1978, MED PROBLEM SOLVING; Everling S., 2011, OXFORD HDB EYE MOVEM, P523; Farr M.J., 1988, NATURE EXPERTISE, P311; Folberg R, 2002, HUM PATHOL, V33, P3, DOI 10.1053/hupa.2002.30226; Greenwood P. E., 1996, GUIDE CHI SQUARED TE, V280; Harel A, 2011, J VISION, V11, DOI 10.1167/11.8.18; Harel A, 2010, CEREB CORTEX, V20, P2304, DOI 10.1093/cercor/bhp316; Harel J, 2006, SALIENCY IMPLEMENTAT; Helle L, 2010, MED EDUC, V44, P621, DOI 10.1111/j.1365-2923.2010.03625.x; Hung AJ, 2011, J UROLOGY, V186, P1019, DOI 10.1016/j.juro.2011.04.064; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Krupinski EA, 2006, HUM PATHOL, V37, P1543, DOI 10.1016/j.humpath.2006.08.024; Kulatunga-Moruzi C, 2004, J EXP PSYCHOL LEARN, V30, P563, DOI 10.1037/0278-7393.30.3.563; Kundel HL, 2008, ACAD RADIOL, V15, P881, DOI 10.1016/j.acra.2008.01.023; Kundel HL, 2007, RADIOLOGY, V242, P396, DOI 10.1148/radiol.2422051997; KUNDEL HL, 1983, RADIOLOGY, V146, P363, DOI 10.1148/radiology.146.2.6849084; KUNDEL HL, 1972, RADIOLOGY, V103, P523, DOI 10.1148/103.3.523; Mello-Thoms C, 2012, ARCH PATHOL LAB MED, V136, P551, DOI 10.5858/arpa.2010-0697-OA; Nodine C, 2010, ROLE EXPERTISE RADIO, P139; Oster NV, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-3; Raghunath Vignesh, 2012, J Pathol Inform, V3, P43, DOI 10.4103/2153-3539.104905; SCHMIDT HG, 1990, ACAD MED, V65, P611, DOI 10.1097/00001888-199010000-00001; SIMON HA, 1973, AM SCI, V61, P394; Treanor D, 2009, HISTOPATHOLOGY, V55, P37, DOI 10.1111/j.1365-2559.2009.03325.x; TREISMAN A, 1985, J EXP PSYCHOL GEN, V114, P285, DOI 10.1037/0096-3445.114.3.285	35	43	43	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103447	10.1371/journal.pone.0103447	http://dx.doi.org/10.1371/journal.pone.0103447			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084012	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800042
J	Guan, NN; Thor, A; Hallen, K; Wiklund, NP; Gustafsson, LE				Guan, Na N.; Thor, Anna; Hallen, Katarina; Wiklund, N. Peter; Gustafsson, Lars E.			Cascade Bioassay Evidence for the Existence of Urothelium-Derived Inhibitory Factor in Guinea Pig Urinary Bladder	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE; RAT; ATP; RELEASE; TRACT; CONTRACTION; RELAXATION; PROSTAGLANDINS; MODULATION	Our aim was to investigate whether guinea pig urothelium-derived bioactivities compatible with the existence of urothelium-derived inhibitory factor could be demonstrated by in vitro serial bioassay and whether purinergic P1 receptor agonists, nitric oxide, nitrite or prostaglandins might explain observed activities. In a cascade superfusion system, urothelium-denuded guinea pig ureters were used as bioassay tissues, recording their spontaneous rhythmic contractions in presence of scopolamine. Urothelium-intact or -denuded guinea pig urinary bladders were used as donor tissues, stimulated by intermittent application of carbachol before or during the nitric oxide synthase inhibitor N-G-nitro-L-arginine methyl ester (L-NAME), the adenosine/P1 nucleoside receptor antagonist 8-(p-sulfophenyl) theophylline (8-PST) or the cyclooxygenase inhibitor diclofenac infused to bath donor and bioassay tissues. The spontaneous contractions of bioassay ureters were unaltered by application of carbachol 1-5 mu M in the presence of scopolamine 5-30 mu M. When carbachol was applied over the urothelium-denuded bladder, the assay ureter contraction rate was unaltered. Introducing carbachol over the everted urothelium-intact bladder significantly inhibited the contraction frequency of the assay ureter, suggesting the transfer of an inhibitory activity from the bladder to the assay ureter. The transmissible inhibitory activity was not markedly antagonized by L-NAME, 8-PST or diclofenac, while L-NAME nearly abolished nitrite release from the urothelium-intact bladder preparations. We suggest that urothelium-derived inhibitory factor is a transmissible entity over a significant distance as demonstrated in this novel cascade superfusion assay and seems less likely to be nitric oxide, nitrite, an adenosine receptor agonist or subject to inhibition by administration of a cyclo-oxygenase inhibitor.	[Guan, Na N.; Gustafsson, Lars E.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Thor, Anna; Hallen, Katarina; Wiklund, N. Peter] Karolinska Inst, Dept Mol Med & Surg, Urol Sect, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Gustafsson, LE (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	lars.gustafsson@ki.se	Gustafsson, Lars E/E-6950-2013	Wiklund, Peter/0000-0001-6497-4697	Swedish Science Council; Swedish National Space Board; EU FP7 INComb; Karolinska Institutet	Swedish Science Council; Swedish National Space Board; EU FP7 INComb; Karolinska Institutet(Karolinska Institutet)	Supported by the Swedish Science Council, the Swedish National Space Board, the EU FP7 INComb and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; ABRAMS PH, 1979, INVEST UROL, V16, P346; Andersson KE, 2013, J UROLOGY, V190, P1173, DOI 10.1016/j.juro.2013.02.104; BOLAND B, 1993, BRIT J PHARMACOL, V108, P749, DOI 10.1111/j.1476-5381.1993.tb12872.x; Braverman AS, 2007, NEUROUROL URODYNAM, V26, P63, DOI 10.1002/nau.20378; Burnstock G, 2014, PURINERG SIGNAL, V10, P103, DOI 10.1007/s11302-013-9395-y; Canda AE, 2007, UROL INT, V78, P289, DOI 10.1159/000100830; Chaiyaprasithi B, 2003, J UROLOGY, V170, P1897, DOI 10.1097/01.ju.0000091870.51841.ae; DAHLEN SE, 1980, ACTA PHYSIOL SCAND, V109, P137, DOI 10.1111/j.1748-1716.1980.tb06578.x; Davidson ME, 2000, BRIT J PHARMACOL, V129, P661, DOI 10.1038/sj.bjp.0703104; Fathian-Sabet B, 2001, J UROLOGY, V165, P1724, DOI 10.1016/S0022-5347(05)66402-6; Fovaeus M, 1999, J UROLOGY, V161, P649, DOI 10.1016/S0022-5347(01)61988-8; Fovaeus M, 1998, ACTA PHYSIOL SCAND, V162, P115; Fry CH, 2004, SCAND J UROL NEPHROL, V38, P20, DOI 10.1080/03008880410015138; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gopalakrishnan SM, 2002, J PHARMACOL EXP THER, V300, P910, DOI 10.1124/jpet.300.3.910; GRYGLEWSKI RJ, 1986, BRIT J PHARMACOL, V87, P685, DOI 10.1111/j.1476-5381.1986.tb14586.x; GUSTAFSSON LE, 1989, ANN NY ACAD SCI, V559, P178; Hallen K, 2007, BRIT J PHARMACOL, V150, P353, DOI 10.1038/sj.bjp.0706991; Hawthorn MH, 2000, BRIT J PHARMACOL, V129, P416, DOI 10.1038/sj.bjp.0703068; Iselin CE, 1996, J UROLOGY, V155, P763, DOI 10.1016/S0022-5347(01)66517-0; Iversen HH, 1995, UROL RES, V23, P391, DOI 10.1007/BF00698741; IVERSEN HH, 1994, BRIT J PHARMACOL, V113, P1088, DOI 10.1111/j.1476-5381.1994.tb17107.x; Jansson OT, 1998, BRIT J CANCER, V78, P588, DOI 10.1038/bjc.1998.545; Lang RJ, 2002, EXP PHYSIOL, V87, P129, DOI 10.1113/eph8702290; MAGGI CA, 1987, J PHARM PHARMACOL, V39, P653, DOI 10.1111/j.2042-7158.1987.tb03447.x; Mamas MA, 2003, UROLOGY, V61, P1079, DOI 10.1016/S0090-4295(03)00131-6; Mastrangelo D, 2007, J UROLOGY, V178, P702, DOI 10.1016/j.juro.2007.03.099; Mastrangelo D, 2003, J UROLOGY, V170, P1409, DOI 10.1097/01.ju.0000083492.80217.20; McMurray G, 1998, BRIT J PHARMACOL, V123, P1579, DOI 10.1038/sj.bjp.0701774; Munoz A, 2010, BMC UROL, V10, DOI 10.1186/1471-2490-10-10; Murakami S, 2007, BJU INT, V99, P669, DOI 10.1111/j.1464-410X.2006.06679.x; MUTOH S, 1983, UROL INT, V38, P219, DOI 10.1159/000280895; Persson K, 1999, J HISTOCHEM CYTOCHEM, V47, P739, DOI 10.1177/002215549904700603; Santoso AGH, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.06.040; Sui GP, 2014, AM J PHYSIOL-RENAL, V306, pF286, DOI 10.1152/ajprenal.00291.2013; Templeman L, 2002, J UROLOGY, V167, P742, DOI 10.1016/S0022-5347(01)69137-7; Yoshimura N, 2012, BJU INT	38	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103932	10.1371/journal.pone.0103932	http://dx.doi.org/10.1371/journal.pone.0103932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084114	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800103
J	Zhang, YC; Hu, TY; Hua, CL; Gu, J; Zhang, LY; Hao, S; Liang, HY; Wang, XM; Wang, WL; Xu, J; Liu, HZ; Liu, B; Cheng, T; Yuan, WP				Zhang, Yingchi; Hu, Tianyuan; Hua, Chunlan; Gu, Jie; Zhang, Liyan; Hao, Sha; Liang, Haoyue; Wang, Xiaomin; Wang, Weili; Xu, Jing; Liu, Hanzhi; Liu, Bin; Cheng, Tao; Yuan, Weiping			Rictor Is Required for Early B Cell Development in Bone Marrow	PLOS ONE			English	Article							MTOR COMPLEX 2; PHOSPHOINOSITIDE 3-KINASE; SELF-RENEWAL; RAPAMYCIN; GENE; DIFFERENTIATION; RECEPTOR; HEMATOPOIESIS; TRANSCRIPTION; MECHANISMS	The development of early B cells, which are generated from hematopoietic stem cells (HSCs) in a series of well-characterized stages in bone marrow (BM), represents a paradigm for terminal differentiation processes. Akt is primarily regulated by phosphorylation at Thr308 by PDK1 and at Ser473 by mTORC2, and Akt signaling plays a key role in hematopoiesis. However, the role of mTORC2 in the development of early B cells remains poorly understood. In this study, we investigated the functional role of mTORC2 by specifically deleting an integral component, Rictor, in a hematopoietic system. We demonstrated that the deletion of Rictor induced an aberrant increase in the FoxO1 and Rag-1 proteins in BM B cells and that this increase was accompanied by a significant decrease in the abundance of B cells in the peripheral blood (PB) and the spleen, suggesting impaired development of early B cells in adult mouse BM. A BM transplantation assay revealed that the B cell differentiation defect induced by Rictor deletion was not affected by the BM microenvironment, thus indicating a cell-intrinsic mechanism. Furthermore, the knockdown of FoxO1 in Rictor-deleted HSCs and hematopoietic progenitor cells (HPCs) promoted the maturation of B cells in the BM of recipient mice. In addition, we revealed that treatment with rapamycin (an mTORC1 inhibitor) aggravated the deficiency in B cell development in the PB and BM. Taken together, our results provide further evidence that Rictor regulates the development of early B cells in a cell-intrinsic manner by modifying the expression of FoxO1 and Rag-1.	[Zhang, Yingchi; Hu, Tianyuan; Hua, Chunlan; Gu, Jie; Zhang, Liyan; Hao, Sha; Liang, Haoyue; Wang, Xiaomin; Wang, Weili; Xu, Jing; Liu, Hanzhi; Liu, Bin; Cheng, Tao; Yuan, Weiping] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Zhang, Yingchi; Hu, Tianyuan; Hua, Chunlan; Gu, Jie; Zhang, Liyan; Hao, Sha; Liang, Haoyue; Wang, Xiaomin; Wang, Weili; Xu, Jing; Liu, Hanzhi; Liu, Bin; Cheng, Tao; Yuan, Weiping] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Zhang, Yingchi; Hu, Tianyuan; Hua, Chunlan; Gu, Jie; Zhang, Liyan; Hao, Sha; Liang, Haoyue; Wang, Xiaomin; Wang, Weili; Xu, Jing; Liu, Hanzhi; Liu, Bin; Cheng, Tao; Yuan, Weiping] Peking Union Med Coll, Tianjin, Peoples R China; [Zhang, Yingchi; Hu, Tianyuan; Hua, Chunlan; Gu, Jie; Zhang, Liyan; Hao, Sha; Liang, Haoyue; Wang, Xiaomin; Wang, Weili; Xu, Jing; Liu, Hanzhi; Cheng, Tao; Yuan, Weiping] Chinese Acad Med Sci, Ctr Stem Cell Med, Beijing 100730, Peoples R China; [Liu, Bin] Acad Mil Med Sci, Affiliated Hosp, Ivy Translat Med Ctr 307, Lab Oncol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Academy of Military Medical Sciences - China	Cheng, T (corresponding author), Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China.	chengt@pumc.edu.cn; wpyuan@ihcams.ac.cn	Zhang, Li/GWM-7501-2022; Liang, Haoyue/ABI-1811-2020; Liang, Haoyue/D-7940-2017	Liang, Haoyue/0000-0002-3766-7605; Liang, Haoyue/0000-0002-3766-7605; Cheng, Tao/0000-0002-5925-2769	Ministry of Science and Technology of China [2012CB966604, 2013CB966902, 2011CB964801, 2013BA101B09]; National Natural Science Foundation [81090410, 81130074, 81330015, 81070390, 81300374, 81300436]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	Funds from the Ministry of Science and Technology of China (2012CB966604, 2013CB966902, 2011CB964801, 2013BA101B09) supported this study in study design and data collection. WPY and TC received these funds. Funds from National Natural Science Foundation (81090410, 81130074, 81330015, 81070390, 81300374, 81300436) supported this study in analysis, decision to publish and preparation of this manuscript. WPY and TC received these funds.	AAGAARDTILLERY KM, 1994, CELL IMMUNOL, V156, P493, DOI 10.1006/cimm.1994.1193; Aiba Y, 2008, BLOOD, V111, P1497, DOI 10.1182/blood-2007-08-109769; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Benhamron S, 2011, EUR J IMMUNOL, V41, P2390, DOI 10.1002/eji.201041336; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Calamito M, 2010, BLOOD, V115, P4043, DOI 10.1182/blood-2009-09-241638; Conley ME, 2012, J EXP MED, V209, P463, DOI 10.1084/jem.20112533; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Donahue AC, 2007, EUR J IMMUNOL, V37, P2923, DOI 10.1002/eji.200737281; Edry E, 2004, J IMMUNOL, V173, P4265, DOI 10.4049/jimmunol.173.7.4265; Fruman DA, 2004, CURR OPIN IMMUNOL, V16, P314, DOI 10.1016/j.coi.2004.03.014; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Hinman RM, 2007, J IMMUNOL, V178, P740, DOI 10.4049/jimmunol.178.2.740; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; KAY JE, 1991, IMMUNOLOGY, V72, P544; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lazorchak AS, 2010, MOL CELL, V39, P433, DOI 10.1016/j.molcel.2010.07.031; Lee K, 2013, BLOOD, V122, P2369, DOI 10.1182/blood-2013-01-477505; Lee K, 2012, J EXP MED, V209, P713, DOI 10.1084/jem.20111470; Limon JJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00228; Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Polak R, 2012, BLOOD, V119, P911, DOI 10.1182/blood-2011-07-366203; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ramadani F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001104; Rolink A, 1996, Int Rev Immunol, V13, P341, DOI 10.3109/08830189609061757; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Tang F, 2012, J IMMUNOL, V189, P1850, DOI 10.4049/jimmunol.1201057; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Warr MR, 2011, WIRES SYST BIOL MED, V3, P681, DOI 10.1002/wsbm.145; WICKER LS, 1990, EUR J IMMUNOL, V20, P2277, DOI 10.1002/eji.1830201017; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	40	23	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103970	10.1371/journal.pone.0103970	http://dx.doi.org/10.1371/journal.pone.0103970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084011	Green Submitted, gold, Green Published			2022-12-25	WOS:000339819800112
J	Donlin, MJ; Lomonosova, E; Kiss, A; Cheng, XH; Cao, F; Curto, TM; Di Bisceglie, A; Tavis, JE				Donlin, Maureen J.; Lomonosova, Elena; Kiss, Alexi; Cheng, Xiaohong; Cao, Feng; Curto, Teresa M.; Di Bisceglie, Adrian; Tavis, John E.			HCV Genome-Wide Genetic Analyses in Context of Disease Progression and Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; AMINO-ACID SUBSTITUTIONS; COMPARATIVE SEQUENCE-ANALYSIS; INTERFERON PLUS RIBAVIRIN; OPEN-READING FRAME; CORE PROTEIN; LIVER-DISEASE; ANTIVIRAL THERAPY; F-PROTEIN; GENOTYPES	Hepatitis C virus (HCV) is a major cause of hepatitis and hepatocellular carcinoma (HCC) world-wide. Most HCV patients have relatively stable disease, but approximately 25% have progressive disease that often terminates in liver failure or HCC. HCV is highly variable genetically, with seven genotypes and multiple subtypes per genotype. This variation affects HCV's sensitivity to antiviral therapy and has been implicated to contribute to differences in disease. We sequenced the complete viral coding capacity for 107 HCV genotype 1 isolates to determine whether genetic variation between independent HCV isolates is associated with the rate of disease progression or development of HCC. Consensus sequences were determined by sequencing RT-PCR products from serum or plasma. Positions of amino acid conservation, amino acid diversity patterns, selection pressures, and genome-wide patterns of amino acid covariance were assessed in context of the clinical phenotypes. A few positions were found where the amino acid distributions or degree of positive selection differed between in the HCC and cirrhotic sequences. All other assessments of viral genetic variation and HCC failed to yield significant associations. Sequences from patients with slow disease progression were under a greater degree of positive selection than sequences from rapid progressors, but all other analyses comparing HCV from rapid and slow disease progressors were statistically insignificant. The failure to observe distinct sequence differences associated with disease progression or HCC employing methods that previously revealed strong associations with the outcome of interferon abased therapy implies that variable ability of HCV to modulate interferon responses is not a dominant cause for differential pathology among HCV patients. This lack of significant associations also implies that host and/or environmental factors are the major causes of differential disease presentation in HCV patients.	[Donlin, Maureen J.; Lomonosova, Elena; Kiss, Alexi; Cheng, Xiaohong; Cao, Feng; Di Bisceglie, Adrian; Tavis, John E.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA; [Donlin, Maureen J.; Cao, Feng] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Tavis, John E.] St Louis Univ, Sch Med, St Louis Liver Ctr, St Louis, MO USA; [Di Bisceglie, Adrian] St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO USA; [Curto, Teresa M.] New England Res Inst Inc, Watertown, MA USA	Saint Louis University; Saint Louis University; Saint Louis University; Saint Louis University; HealthCore, Inc	Tavis, JE (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA.	tavisje@slu.edu	Kiss, Alexi/AAH-6830-2021; Donlin, Maureen J./M-4709-2019	Donlin, Maureen/0000-0001-7312-079X; Kiss, Alexi/0000-0003-2330-6929	National Institute of Allergy and Infectious Disease [DK045715]; National Cancer Institute [CA126807]; National Institute of Diabetes & Digestive & Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Center for Minority Health and Health Disparities; General Clinical Research Center and Clinical and Translational Science Center grants from the National Center for Research Resources, National Institutes of Health; Hoffmann-La Roche, Ltd; National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA126807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R43DK045715] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes & Digestive & Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); General Clinical Research Center and Clinical and Translational Science Center grants from the National Center for Research Resources, National Institutes of Health; Hoffmann-La Roche, Ltd(Hoffmann-La Roche); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institute of Allergy and Infectious Disease grant number DK045715 to JT and National Cancer Institute grant number CA126807 to JT. The authors acknowledge the HALT-C Trial group for providing samples and data for this publication. The HALT-C Trial was funded through contracts from the National Institute of Diabetes & Digestive & Kidney Diseases. Additional support was provided by the National Institute of Allergy and Infectious Diseases, the National Cancer Institute, the National Center for Minority Health and Health Disparities and by General Clinical Research Center and Clinical and Translational Science Center grants from the National Center for Research Resources, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. Additional funding to conduct this study was supplied by Hoffmann-La Roche, Ltd., through a Cooperative Research and Development Agreement with the National Institutes of Health. The HALT-C Trial was registered with clinicaltrials.gov (#NCT00006164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Akuta N, 2007, HEPATOLOGY, V46, P1357, DOI 10.1002/hep.21836; Akuta N, 2011, J MED VIROL, V83, P1016, DOI 10.1002/jmv.22094; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Benvegnu LB, 1997, HEPATOLOGY, V25, P211, DOI 10.1002/hep.510250138; Bostan N, 2010, CRIT REV MICROBIOL, V36, P91, DOI 10.3109/10408410903357455; Bruno S, 1997, HEPATOLOGY, V25, P754, DOI 10.1002/hep.510250344; Caldwell S, 2009, J GASTROENTEROL, V44, P96, DOI 10.1007/s00535-008-2258-6; Campo DS, 2008, P NATL ACAD SCI USA, V105, P9685, DOI 10.1073/pnas.0801774105; Cannon NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002123; De Mitri MS, 2002, J HEPATOL, V36, P116, DOI 10.1016/S0168-8278(01)00235-5; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Donlin MJ, 2007, J VIROL, V81, P8211, DOI 10.1128/JVI.00487-07; Donlin MJ, 2012, J VIROL, V86, P3050, DOI 10.1128/JVI.06857-11; Donlin MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009032; DUSHEIKO G, 1994, HEPATOLOGY, V19, P13, DOI 10.1016/0270-9139(94)90046-9; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Farci P, 2000, SEMIN LIVER DIS, V20, P103; Fishman SL, 2009, CLIN CANCER RES, V15, P3205, DOI 10.1158/1078-0432.CCR-08-2418; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gale M, 1999, J VIROL, V73, P6506, DOI 10.1128/JVI.73.8.6506-6516.1999; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Gimenez-Barcons M, 2005, J INTERF CYTOK RES, V25, P152, DOI 10.1089/jir.2005.25.152; Gimenez-Barcons M, 2001, HEPATOLOGY, V34, P158, DOI 10.1053/jhep.2001.25512; Gremion C, 2005, REV MED VIROL, V15, P235, DOI 10.1002/rmv.466; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hngtyszyn HJ, 2005, ANTIVIR THER, V10, P1; Hoshida Y, 2005, J INFECT DIS, V192, P266, DOI 10.1086/430924; ICHIMURA H, 1994, J MED VIROL, V43, P212, DOI 10.1002/jmv.1890430303; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jarvis LM, 1996, BLOOD, V87, P3007, DOI 10.1182/blood.V87.7.3007.bloodjournal8773007; Kadokura M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024514; Kadoya H, 2005, MICROBIOL IMMUNOL, V49, P265, DOI 10.1111/j.1348-0421.2005.tb03728.x; Kanwal F, 2012, ALIMENT PHARM THER, V36, P257, DOI 10.1111/j.1365-2036.2012.05174.x; Kato N, 2000, HEPATOLOGY, V32, P405, DOI 10.1053/jhep.2000.9198; Kobayashi M, 2010, J MED VIROL, V82, P41, DOI 10.1002/jmv.21629; Kowdley KV, 2013, LANCET, V381, P2100, DOI 10.1016/S0140-6736(13)60247-0; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Lara James, 2011, In Silico Biology, V11, P213, DOI 10.3233/ISB-2012-0456; Lara J, 2011, J VIROL, V85, P3649, DOI 10.1128/JVI.02197-10; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lee Chuan-Mo, 2006, Intervirology, V49, P76, DOI 10.1159/000087267; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Manns MP, 2011, J HEPATOL, V54, P1114, DOI 10.1016/j.jhep.2010.08.040; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2007, AM J MANAG CARE, V13, pS327; Miura M, 2011, HEPATOL INT; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Naas T, 2005, J GEN VIROL, V86, P2185, DOI 10.1099/vir.0.80969-0; Nagayama K, 2000, HEPATOLOGY, V31, P745, DOI 10.1002/hep.510310327; Nelson D R, 1997, Clin Liver Dis, V1, P515, DOI 10.1016/S1089-3261(05)70318-4; Neumann-Haefelin C, 2005, J CLIN VIROL, V32, P75, DOI 10.1016/j.jcv.2004.05.008; Ogata S, 2002, J CLIN MICROBIOL, V40, P3625, DOI 10.1128/JCM.40.10.3625-3630.2002; Pawlotsky JM, 2003, ANTIVIR RES, V59, P1, DOI 10.1016/S0166-3542(03)00088-3; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Polyak SJ, 2001, J VIROL, V75, P6095, DOI 10.1128/JVI.75.13.6095-6106.2001; Polyak SJ, 2001, J VIROL, V75, P6209, DOI 10.1128/JVI.75.13.6209-6211.2001; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; POZZATO G, 1994, J MED VIROL, V43, P291, DOI 10.1002/jmv.1890430318; POZZATO G, 1991, LANCET, V338, P509, DOI 10.1016/0140-6736(91)90578-D; Ray SC., 2013, FIELDS VIROL, P795; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romeo R, 1996, J VIRAL HEPATITIS, V3, P183, DOI 10.1111/j.1365-2893.1996.tb00093.x; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; Ruster B, 2001, J MED VIROL, V63, P128, DOI 10.1002/1096-9071(20000201)63:2&lt;128::AID-JMV1007&gt;3.0.CO;2-S; Seko Y, 2013, INTERVIROLOGY, V56, P13, DOI 10.1159/000339993; Serfaty L, 1998, HEPATOLOGY, V27, P1435, DOI 10.1002/hep.510270535; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silini E, 1996, GASTROENTEROLOGY, V111, P199, DOI 10.1053/gast.1996.v111.pm8698200; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Sobesky R, 2007, HEPATOLOGY, V46, P1704, DOI 10.1002/hep.21898; Takahashi K, 2001, HEPATOL RES, V20, P161, DOI 10.1016/S1386-6346(00)00141-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavis JE, 2011, GENOME MED, V3, DOI 10.1186/gm222; Thimme R, 2006, ANTIVIR RES, V69, P129, DOI 10.1016/j.antiviral.2005.12.001; Thimme R, 2012, FEMS MICROBIOL REV, V36, P663, DOI 10.1111/j.1574-6976.2011.00319.x; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; Tsai WL, 2010, ONCOGENE, V29, P2309, DOI 10.1038/onc.2010.36; Vaidya A, 2013, DRUGS, V73, P2093, DOI 10.1007/s40265-013-0153-9; Washenberger CL, 2007, VIRUS RES, V130, P85, DOI 10.1016/j.virusres.2007.05.020; Yao E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-88; Zein NN, 1996, AM J GASTROENTEROL, V91, P2560; Zeuzem S, 2012, HEPATOLOGY, V55, P749, DOI 10.1002/hep.24744	88	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103748	10.1371/journal.pone.0103748	http://dx.doi.org/10.1371/journal.pone.0103748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079603	Green Published, gold			2022-12-25	WOS:000339954800077
J	Rother, M; Brauner, JM; Ebert, K; Welzel, O; Jung, J; Bauereiss, A; Kornhuber, J; Groemer, TW				Roether, Mareike; Brauner, Jan M.; Ebert, Katrin; Welzel, Oliver; Jung, Jasmin; Bauereiss, Anna; Kornhuber, Johannes; Groemer, Teja W.			Dynamic Properties of the Alkaline Vesicle Population at Hippocampal Synapses	PLOS ONE			English	Article							ENDOCYTOSIS; MEMBRANE; KINETICS; RELEASE; POOL; PROTEINS	In compensatory endocytosis, scission of vesicles from the plasma membrane to the cytoplasm is a prerequisite for intravesicular reacidification and accumulation of neurotransmitter molecules. Here, we provide time-resolved measurements of the dynamics of the alkaline vesicle population which appears upon endocytic retrieval. Using fast perfusion pH-cycling in live-cell microscopy, synapto-pHluorin expressing rat hippocampal neurons were electrically stimulated. We found that the relative size of the alkaline vesicle population depended significantly on the electrical stimulus size: With increasing number of action potentials the relative size of the alkaline vesicle population expanded. In contrast to that, increasing the stimulus frequency reduced the relative size of the population of alkaline vesicles. Measurement of the time constant for reacification and calculation of the time constant for endocytosis revealed that both time constants were variable with regard to the stimulus condition. Furthermore, we show that the dynamics of the alkaline vesicle population can be predicted by a simple mathematical model. In conclusion, here a novel methodical approach to analyze dynamic properties of alkaline vesicles is presented and validated as a convenient method for the detection of intracellular events. Using this method we show that the population of alkaline vesicles is highly dynamic and depends both on stimulus strength and frequency. Our results implicate that determination of the alkaline vesicle population size may provide new insights into the kinetics of endocytic retrieval.	[Roether, Mareike; Brauner, Jan M.; Ebert, Katrin; Welzel, Oliver; Jung, Jasmin; Bauereiss, Anna; Kornhuber, Johannes; Groemer, Teja W.] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Groemer, TW (corresponding author), Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany.	teja.groemer@uk-erlangen.de	Kornhuber, Johannes/B-9613-2014	Kornhuber, Johannes/0000-0002-8096-3987; Brauner, Jan/0000-0002-1588-5724	Interdisciplinary Center of Clinical Research (IZKF) in Erlangen [J5]	Interdisciplinary Center of Clinical Research (IZKF) in Erlangen	This work was supported by the Interdisciplinary Center of Clinical Research (IZKF) in Erlangen (to Teja W. Gromer, Project J5 and Mareike Rather, Thesis-Stipend). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie EJ, 2002, BIOTECHNIQUES, V33, P1152, DOI 10.2144/02335dd10; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Briggs MS, 2000, CHEM COMMUN, P2323, DOI 10.1039/b007108k; Budzinski KL, 2011, BIOPHYS J, V101, P1580, DOI 10.1016/j.bpj.2011.08.032; Denker Annette, 2010, Front Synaptic Neurosci, V2, P135, DOI 10.3389/fnsyn.2010.00135; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Granseth B, 2008, J PHYSIOL-LONDON, V586, P5969, DOI 10.1113/jphysiol.2008.159715; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hua YF, 2013, NEURON, V80, P343, DOI 10.1016/j.neuron.2013.08.010; Hua YF, 2011, NAT NEUROSCI, V14, P833, DOI 10.1038/nn.2838; Lindgren CA, 1997, J NEUROSCI, V17, P3074; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Royle Stephen J., 2008, V457, P293, DOI 10.1007/978-1-59745-261-8_22; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Welzel O, 2013, J FLUORESC, V23, P487, DOI 10.1007/s10895-013-1164-3; Welzel O, 2011, BIOPHYS J, V100, P593, DOI 10.1016/j.bpj.2010.12.3706; Welzel O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013514; Wenzel EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038188; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739	32	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102723	10.1371/journal.pone.0102723	http://dx.doi.org/10.1371/journal.pone.0102723			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079223	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800015
J	Kleemann, B; Loos, B; Scriba, TJ; Lang, D; Davids, LM				Kleemann, Britta; Loos, Benjamin; Scriba, Thomas J.; Lang, Dirk; Davids, Lester M.			St John's Wort (Hypericum perforatum L.) Photomedicine: Hypericin-Photodynamic Therapy Induces Metastatic Melanoma Cell Death	PLOS ONE			English	Article							SUBCELLULAR-DISTRIBUTION; ENDOPLASMIC-RETICULUM; MOLECULAR EFFECTORS; INDUCED APOPTOSIS; CYTOCHROME-C; HELA-CELLS; IN-VITRO; CANCER; MELANOGENESIS; ACTIVATION	Hypericin, an extract from St John's Wort (Hypericum perforatum L.), is a promising photosensitizer in the context of clinical photodynamic therapy due to its excellent photosensitizing properties and tumoritropic characteristics. Hypericin-PDT induced cytotoxicity elicits tumor cell death by various mechanisms including apoptosis, necrosis and autophagy-related cell death. However, limited reports on the efficacy of this photomedicine for the treatment of melanoma have been published. Melanoma is a highly aggressive tumor due to its metastasizing potential and resistance to conventional cancer therapies. The aim of this study was to investigate the response mechanisms of melanoma cells to hypericin-PDT in an in vitro tissue culture model. Hypericin was taken up by all melanoma cells and partially co-localized to the endoplasmic reticulum, mitochondria, lysosomes and melanosomes, but not the nucleus. Light activation of hypericin induced a rapid, extensive modification of the tubular mitochondrial network into a beaded appearance, loss of structural details of the endoplasmic reticulum and concomitant loss of hypericin co-localization. Surprisingly the opposite was found for lysosomal-related organelles, suggesting that the melanoma cells may be using these intracellular organelles for hypericin-PDT resistance. In line with this speculation we found an increase in cellular granularity, suggesting an increase in pigmentation levels in response to hypericin-PDT. Pigmentation in melanoma is related to a melanocyte-specific organelle, the melanosome, which has recently been implicated in drug trapping, chemotherapy and hypericin-PDT resistance. However, hypericin-PDT was effective in killing both unpigmented (A375 and 501mel) and pigmented (UCT Mel-1) melanoma cells by specific mechanisms involving the externalization of phosphatidylserines, cell shrinkage and loss of cell membrane integrity. In addition, this treatment resulted in extrinsic (A375) and intrinsic (UCT Mel-1) caspase-dependent apoptotic modes of cell death, as well as a caspase-independent apoptotic mode that did not involve apoptosis-inducing factor (501 mel). Further research is needed to shed more light on these mechanisms.	[Kleemann, Britta; Lang, Dirk; Davids, Lester M.] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Redox Lab & Confocal & Light Microscope Imaging F, ZA-7925 Cape Town, South Africa; [Loos, Benjamin] Univ Stellenbosch, Dept Physiol Sci, ZA-7600 Stellenbosch, South Africa; [Scriba, Thomas J.] Univ Cape Town, South African TB Vaccine Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Scriba, Thomas J.] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa	University of Cape Town; Stellenbosch University; University of Cape Town; University of Cape Town	Davids, LM (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Redox Lab & Confocal & Light Microscope Imaging F, ZA-7925 Cape Town, South Africa.	lester.davids@uct.ac.za	Scriba, Thomas/GPX-2573-2022; Scriba, Thomas/AAH-9413-2020; Lang, Dirk/I-2554-2015	Scriba, Thomas/0000-0002-0641-1359; Lang, Dirk/0000-0003-3901-2079; Loos, Ben/0000-0002-5517-373X	National Research Foundation of South Africa (LMD), NRF Thuthuka [TTK2008051600001]	National Research Foundation of South Africa (LMD), NRF Thuthuka	Funding for this study was obtained from the National Research Foundation of South Africa (LMD), NRF Thuthuka Grant ID TTK2008051600001, www.nrf.ac.za. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.30; Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Ali SM, 2002, INT J ONCOL, V21, P531; Ali SM, 2002, INT J MOL MED, V9, P461; Ali SM, 2002, INT J MOL MED, V9, P601; Ali SM, 2001, INT J MOL MED, V8, P521; Assefa Z, 1999, J BIOL CHEM, V274, P8788, DOI 10.1074/jbc.274.13.8788; Bahadoran P, 2003, J BIOL CHEM, V278, P11386, DOI 10.1074/jbc.M211996200; Baldea I, 2012, J PHYSIOL PHARMACOL, V63, P109; Ballios BG, 2012, BIOL OPEN, V1, P237, DOI 10.1242/bio.2012027; Baritaud M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.120; Baritaud M, 2010, CELL CYCLE, V9, P3166, DOI 10.4161/cc.9.16.12552; Barliya T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022849; Beattie PE, 2005, BRIT J DERMATOL, V153, P1187, DOI 10.1111/j.1365-2133.2005.06946.x; Berlanda J, 2006, J ENVIRON PATHOL TOX, V25, P173, DOI 10.1615/JEnvironPatholToxicolOncol.v25.i1-2.100; Berlanda J, 2010, J PHOTOCH PHOTOBIO B, V100, P173, DOI 10.1016/j.jphotobiol.2010.06.004; Bernd A, 1999, PHOTOCHEM PHOTOBIOL, V69, P218, DOI 10.1111/j.1751-1097.1999.tb03276.x; Blank M, 2004, INT J CANCER, V111, P596, DOI 10.1002/ijc.20285; Blank M, 2003, CANCER RES, V63, P8241; BOISSY RE, 1989, CYTOMETRY, V10, P779, DOI 10.1002/cyto.990100616; Boujrad H, 2007, CELL CYCLE, V6, P2612, DOI 10.4161/cc.6.21.4842; Brouckaert G, 2004, MOL BIOL CELL, V15, P1089, DOI 10.1091/mbc.E03-09-0668; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Buytaert E, 2008, ONCOGENE, V27, P1916, DOI 10.1038/sj.onc.1210825; Buytaert E, 2006, AUTOPHAGY, V2, P238, DOI 10.4161/auto.2730; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Carlson JA, 2005, J AM ACAD DERMATOL, V52, P743, DOI 10.1016/j.jaad.2004.08.034; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Chaloupka R, 1999, FEBS LETT, V462, P295, DOI 10.1016/S0014-5793(99)01538-0; Chen KG, 2006, P NATL ACAD SCI USA, V103, P9903, DOI 10.1073/pnas.0600213103; Chen KG, 2009, PIGM CELL MELANOMA R, V22, P740, DOI 10.1111/j.1755-148X.2009.00630.x; Chen KG, 2009, JNCI-J NATL CANCER I, V101, P1259, DOI 10.1093/jnci/djp259; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Clarke L, 2012, EUR J NEUROSCI, V36, P1951, DOI 10.1111/j.1460-9568.2012.08123.x; Colella AD, 2012, ANAL BIOCHEM, V430, P108, DOI 10.1016/j.ab.2012.08.015; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; Davids LM, 2011, CANCER TREAT REV, V37, P465, DOI 10.1016/j.ctrv.2010.11.007; Davids LM, 2008, J PHOTOCH PHOTOBIO B, V91, P67, DOI 10.1016/j.jphotobiol.2008.01.011; Davids LM, 2006, CELL BIOL INT, V30, P416, DOI 10.1016/j.cellbi.2006.02.001; Davids LM, 2009, CELL BIOL INT, V33, P1065, DOI 10.1016/j.cellbi.2009.06.026; Davids LM, 2013, MELANOMA EARLY DETEC, P583; Dewaele M, 2011, J CELL MOL MED, V15, P1402, DOI 10.1111/j.1582-4934.2010.01118.x; Dewaele M, 2010, AUTOPHAGY, V6, P838, DOI 10.4161/auto.6.7.12113; Falk H, 1999, ANGEW CHEM INT EDIT, V38, P3117; Galanou MC, 2008, PHOTOCHEM PHOTOBIOL, V84, P1073, DOI 10.1111/j.1751-1097.2008.00392.x; Garg AD, 2013, AUTOPHAGY, V9, P1292, DOI 10.4161/auto.25399; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Green DR, 2007, APOPTOSIS CELLS, P533; Hadjur C, 1996, PHOTOCHEM PHOTOBIOL, V64, P375, DOI 10.1111/j.1751-1097.1996.tb02474.x; Halaban R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004563; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Handerson T, 2003, CANCER RES, V63, P5363; Handerson T, 2007, J CUTAN PATHOL, V34, P679, DOI 10.1111/j.1600-0560.2006.00681.x; HEARING VJ, 1976, BIOCHEM J, V157, P549, DOI 10.1042/bj1570549; Heintzmann R, 1999, P SOC PHOTO-OPT INS, V3568, P185, DOI 10.1117/12.336833; Hendrickx N, 2003, J BIOL CHEM, V278, P52231, DOI 10.1074/jbc.M307591200; Hersey P, 2008, PIGM CELL MELANOMA R, V21, P358, DOI 10.1111/j.1755-148X.2008.00467.x; Huntosova V, 2012, PHOTOCH PHOTOBIO SCI, V11, P1428, DOI 10.1039/c2pp05409d; Jakubowska M, 2013, NITRIC OXIDE-BIOL CH, V35, P79, DOI 10.1016/j.niox.2013.08.004; Jendzelovsky R, 2009, PHOTOCH PHOTOBIO SCI, V8, P1716, DOI 10.1039/b9pp00086k; Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014; Karioti A, 2010, INT J MOL SCI, V11, P562, DOI 10.3390/ijms11020562; Kascakova S, 2008, PHOTOCHEM PHOTOBIOL, V84, P120, DOI 10.1111/j.1751-1097.2007.00207.x; Kessel David, 2010, Methods Mol Biol, V635, P35, DOI 10.1007/978-1-60761-697-9_3; Kleban J, 2008, J PHOTOCH PHOTOBIO B, V93, P108, DOI 10.1016/j.jphotobiol.2008.07.007; Krammer B, 2012, CURR MED CHEM, V19, P793, DOI 10.2174/092986712799034842; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Land EJ, 2004, METHOD ENZYMOL, V378, P88; Lavie Gad, 2005, Angiogenesis, V8, P35, DOI 10.1007/s10456-005-3828-3; Lazova R, 2010, J CUTAN PATHOL, V37, P256, DOI 10.1111/j.1600-0560.2009.01359.x; Lazova R, 2009, EXP DERMATOL, V18, P934, DOI 10.1111/j.1600-0625.2009.00933.x; Lee SH, 2013, CELL DEATH DIFFER, V20, P64, DOI 10.1038/cdd.2012.93; Lui P, 2007, CANCER TREAT REV, V33, P665, DOI 10.1016/j.ctrv.2007.06.004; Mikes J, 2009, PHOTOCH PHOTOBIO SCI, V8, P1558, DOI 10.1039/b9pp00021f; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Nikolaou VA, 2012, J INVEST DERMATOL, V132, P854, DOI 10.1038/jid.2011.421; OIKAWA A, 1972, ARCH BIOCHEM BIOPHYS, V148, P548, DOI 10.1016/0003-9861(72)90173-7; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Plonka PM, 2003, EXP DERMATOL, V12, P356, DOI 10.1034/j.1600-0625.2002.120401.x; Rebecca VW, 2012, MELANOMA RES, V22, P114, DOI 10.1097/CMR.0b013e328351fa4d; Ritz R, 2008, ANTICANCER RES, V28, P2033; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Sackova V, 2011, INT J MOL SCI, V12, P8388, DOI 10.3390/ijms12128388; Sambrook J, 1989, MOL CLONING LABORATO, p1 25; Sanovic R, 2009, INT J ONCOL, V35, P921, DOI 10.3892/ijo_00000407; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; Schempp CM, 2001, FEBS LETT, V493, P26, DOI 10.1016/S0014-5793(01)02268-2; Sevrioukova IF, 2011, APOPTOSIS INDUCING F, P14; Sharma KV, 2012, PHOTODIAGN PHOTODYN, V9, P156, DOI 10.1016/j.pdpdt.2011.09.003; Sharma KV, 2011, CELL BIOL INT, V35, P939, DOI 10.1042/CBI20110103; Siboni G, 2002, PHOTOCH PHOTOBIO SCI, V1, P483, DOI 10.1039/b202884k; Slominski A, 1998, ANTICANCER RES, V18, P3709; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2001, ARCH PATHOL LAB MED, V125, P1295; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Sodhi RK, 2010, VASC PHARMACOL, V53, P77, DOI 10.1016/j.vph.2010.06.003; Theodossiou TA, 2010, PHOTOCHEM PHOTOBIOL, V86, P18, DOI 10.1111/j.1751-1097.2009.00668.x; Theodossiou TA, 2009, MOL PHARMACEUT, V6, P1775, DOI 10.1021/mp900166q; Uzdensky AB, 2001, LASER MED SCI, V16, P276, DOI 10.1007/PL00011364; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Vanden Berghe T, 2013, METHODS, V61, P117, DOI 10.1016/j.ymeth.2013.02.011; VanderWerf QM, 1996, LARYNGOSCOPE, V106, P479, DOI 10.1097/00005537-199604000-00016; Vantieghem A, 2001, PHOTOCHEM PHOTOBIOL, V74, P133, DOI 10.1562/0031-8655(2001)074&lt;0133:DPMCCR&gt;2.0.CO;2; Vantieghem A, 1998, FEBS LETT, V440, P19, DOI 10.1016/S0014-5793(98)01416-1; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Volkovova K, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-S1-S12; Wang NS, 2001, J BIOL CHEM, V276, P44117, DOI 10.1074/jbc.M101958200; Wang XL, 2010, J PHARMACOL EXP THER, V334, P847, DOI 10.1124/jpet.110.168856; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Westbroek W, 2003, J INVEST DERMATOL, V120, P465, DOI 10.1046/j.1523-1747.2003.12068.x; WHO, 2014, SKIN CANC; Wiegell SR, 2013, BRIT J DERMATOL, V168, P186, DOI 10.1111/j.1365-2133.2012.11200.x; Wiegell SR, 2012, J EUR ACAD DERMATOL, V26, P673, DOI 10.1111/j.1468-3083.2011.04386.x; Wiegell SR, 2012, BRIT J DERMATOL, V166, P1327, DOI 10.1111/j.1365-2133.2012.10833.x; Wiegell SR, 2011, BRIT J DERMATOL, V164, P1083, DOI 10.1111/j.1365-2133.2011.10209.x; WILSON EL, 1980, CANCER RES, V40, P933; Wood JM, 1999, EXP DERMATOL, V8, P153, DOI 10.1111/j.1600-0625.1999.tb00365.x	121	69	70	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103762	10.1371/journal.pone.0103762	http://dx.doi.org/10.1371/journal.pone.0103762			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076130	Green Submitted, Green Published, gold			2022-12-25	WOS:000340028800078
J	Thevenard, J; Verzeaux, L; Devy, J; Etique, N; Jeanne, A; Schneider, C; Hachet, C; Ferracci, G; David, M; Martiny, L; Charpentier, E; Khrestchatisky, M; Rivera, S; Dedieu, S; Emonard, H				Thevenard, Jessica; Verzeaux, Laurie; Devy, Jerome; Etique, Nicolas; Jeanne, Albin; Schneider, Christophe; Hachet, Cathy; Ferracci, Geraldine; David, Marion; Martiny, Laurent; Charpentier, Emmanuelle; Khrestchatisky, Michel; Rivera, Santiago; Dedieu, Stephane; Emonard, Herve			Low-Density Lipoprotein Receptor-Related Protein-1 Mediates Endocytic Clearance of Tissue Inhibitor of Metalloproteinases-1 and Promotes Its Cytokine-Like Activities	PLOS ONE			English	Article							ERYTHROID CELL-SURVIVAL; NEURITE OUTGROWTH; TIMP-1; BINDING; NEURONS; COMPLEX; DOMAIN; ALPHA(2)-MACROGLOBULIN; DISSECTION; REQUIRES	Tissue inhibitor of metalloproteinases-1 (TIMP-1) regulates the extracellular matrix turnover by inhibiting the proteolytic activity of matrix metalloproteinases (MMPs). TIMP-1 also displays MMP-independent activities that influence the behavior of various cell types including neuronal plasticity, but the underlying molecular mechanisms remain mostly unknown. The trans-membrane receptor low-density lipoprotein receptor-related protein-1 (LRP-1) consists of a large extracellular chain with distinct ligand-binding domains that interact with numerous ligands including TIMP-2 and TIMP-3 and a short transmembrane chain with intracellular motifs that allow endocytosis and confer signaling properties to LRP-1. We addressed TIMP-1 interaction with recombinant ligand-binding domains of LRP-1 expressed by CHO cells for endocytosis study, or linked onto sensor chips for surface plasmon resonance analysis. Primary cortical neurons bound and internalized endogenous TIMP-1 through a mechanism mediated by LRP-1. This resulted in inhibition of neurite outgrowth and increased growth cone volume. Using a mutated inactive TIMP-1 variant we showed that TIMP-1 effect on neurone morphology was independent of its MMP inhibitory activity. We conclude that TIMP-1 is a new ligand of LRP-1 and we highlight a new example of its MMP-independent, cytokine-like functions.	[Thevenard, Jessica; Verzeaux, Laurie; Devy, Jerome; Etique, Nicolas; Jeanne, Albin; Schneider, Christophe; Hachet, Cathy; Martiny, Laurent; Charpentier, Emmanuelle; Dedieu, Stephane; Emonard, Herve] Univ Reims, CNRS, Unite Mixte Rech UMR Matrice Extracellulaire & Dy, Unite Format & Rech UFR Sci Exactes & Nat, Reims, France; [Ferracci, Geraldine] Aix Marseille Univ, CNRS, Ctr Rech Neurobiol & Neurophysiol Marseille CRN2M, Plate Forme Rech Neurosci,UMR 7286, Marseille, France; [David, Marion] VECT HORUS SAS, Fac Med Sect Nord, Marseille, France; [Khrestchatisky, Michel; Rivera, Santiago] Aix Marseille Univ, UMR 7259, Marseille, France; [Khrestchatisky, Michel; Rivera, Santiago] CNRS, UMR 7259, NICN, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Emonard, H (corresponding author), Univ Reims, CNRS, Unite Mixte Rech UMR Matrice Extracellulaire & Dy, Unite Format & Rech UFR Sci Exactes & Nat, Reims, France.	herve.emonard@univ-reims.fr	Emonard, Hervé/AAD-5432-2019; MARTINY, Laurent/ABI-5531-2020; etique, nicolas/J-4159-2017; Emonard, Herve/R-9718-2019	etique, nicolas/0000-0001-6613-9257; Dedieu, Stephane/0000-0003-1447-5640; SCHNEIDER, Christophe/0000-0002-7867-0579; VERZEAUX, Laurie/0000-0001-8644-892X	National Centre for Scientific Research (CNRS); French National Research Agency (ANR) [ANR-08-MNPS-042-04 TIMPAD]; French Ministry of Research; Region Champagne-Ardenne; ANR [ANR-09-BIOT-015-01 VECtoBrain, ANR-2011-MALZ-007-01 PREVENTAD]; Ligue Europeenne Contre la Maladie d'Alzheimer (LECMA)	National Centre for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French National Research Agency (ANR)(French National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Region Champagne-Ardenne(Region Grand-Est); ANR(French National Research Agency (ANR)); Ligue Europeenne Contre la Maladie d'Alzheimer (LECMA)	This work was supported by The National Centre for Scientific Research (CNRS) and a grant from The French National Research Agency (ANR) grant number [ANR-08-MNPS-042-04 TIMPAD to S.R. and H.E.]. A.J. is recipient of a doctoral fellowship from the French Ministry of Research; L.V. and S.D. are recipients of grants from Region Champagne-Ardenne; M.K. acknowledges support from the ANR [ANR-09-BIOT-015-01 VECtoBrain and ANR-2011-MALZ-007-01 PREVENTAD]; and S.R. acknowledges support from the Ligue Europeenne Contre la Maladie d'Alzheimer (LECMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barmina OY, 1999, J BIOL CHEM, V274, P30087, DOI 10.1074/jbc.274.42.30087; Beaujouin M, 2010, J CELL SCI, V123, P3336, DOI 10.1242/jcs.070938; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Bridoux L, 2013, FEBS LETT, V587, P1524, DOI 10.1016/j.febslet.2013.03.032; BU GJ, 1994, J BIOL CHEM, V269, P18521; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Dedieu S, 2008, MOL CELL BIOL, V28, P2980, DOI 10.1128/MCB.02238-07; Egea V, 2012, P NATL ACAD SCI USA, V109, pE309, DOI 10.1073/pnas.1115083109; Emonard H, 2004, J BIOL CHEM, V279, P54944, DOI 10.1074/jbc.M406792200; Etique N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/152163; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Lambert E, 2009, INT J BIOCHEM CELL B, V41, P1102, DOI 10.1016/j.biocel.2008.10.017; Langlois B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011584; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Ould-yahoui A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008289; Perez-Martinez L, 2005, J NEUROSCI, V25, P4917, DOI 10.1523/JNEUROSCI.5066-04.2005; Perrot G, 2012, MOL CELL BIOL, V32, P3293, DOI 10.1128/MCB.00228-12; Qiu ZH, 2004, J BIOL CHEM, V279, P34948, DOI 10.1074/jbc.M401055200; Ranganathan S, 2011, J NEUROSCI, V31, P10836, DOI 10.1523/JNEUROSCI.5065-10.2011; Ries C, 2014, CELL MOL LIFE SCI, V71, P659, DOI 10.1007/s00018-013-1457-3; Rivera S, 1997, J NEUROSCI, V17, P4223; Rivera S, 2002, EUR J NEUROSCI, V15, P19, DOI 10.1046/j.0953-816x.2001.01838.x; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Scilabra SD, 2013, J BIOL CHEM, V288, P332, DOI 10.1074/jbc.M112.393322; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Stiles TL, 2013, J CELL SCI, V126, P209, DOI 10.1242/jcs.113191; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; Troeberg L, 2008, FASEB J, V22, P3515, DOI 10.1096/fj.08-112680; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200	40	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103839	10.1371/journal.pone.0103839	http://dx.doi.org/10.1371/journal.pone.0103839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075518	gold, Green Published, Green Submitted			2022-12-25	WOS:000340028800082
J	Kong, YJ; Chen, JC; Zhou, ZM; Xia, HJ; Qiu, MH; Chen, CS				Kong, Yanjie; Chen, Jianchao; Zhou, Zhongmei; Xia, Houjun; Qiu, Ming-Hua; Chen, Ceshi			Cucurbitacin E Induces Cell Cycle G2/M Phase Arrest and Apoptosis in Triple Negative Breast Cancer	PLOS ONE			English	Article							INHIBITORY-ACTIVITY; SIGNALING PATHWAY; CARCINOMA; GROWTH; ACTIVATION	Triple negative breast cancer (TNBC) is a highly aggressive form of breast cancer resistant to many common treatments. In this study, we compared the effects of 12 phytochemical drugs on four cancer cell lines, and noticed that Cucurbitacin E (CuE) significantly inhibited TNBC cell growth by inducing cell cycle G2/M phase arrest and apoptosis. CuE reduced expression of Cyclin D1, Survivin, XIAP, Bcl2, and Mcl-1 in MDA-MB-468 and SW527, and within MDA-MB-468, CuE significantly increased activation of JNK and inhibited activation of AKT and ERK. Collectively, these results suggest that CuE may be a viable compound for developing novel TNBC therapeutics.	[Kong, Yanjie; Zhou, Zhongmei; Xia, Houjun; Chen, Ceshi] Chinese Acad Sci, Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Chen, Jianchao; Qiu, Ming-Hua] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China; [Kong, Yanjie] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Qiu, MH (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China.	qiuminghua@mail.kib.ac.cn; chenc@mail.kiz.ac.cn		Xia, Houjun/0000-0003-1045-1465	National Natural Science Foundation of China [81120108019, U1132605, 81325016, U1192604, 39970086]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81120108019, U1132605, and 81325016 to Chen, C; U1192604 and 39970086 to Qiu, M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghasham AA, 2013, INT J HEALTH SCI-IJH, V7, P77, DOI 10.12816/0006025; Chacon RD, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2574; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Chen JC, 2005, PLANTA MED, V71, P983, DOI 10.1055/s-2005-873110; Chen JC, 2008, J NAT PROD, V71, P153, DOI 10.1021/np0704396; Chen XP, 2012, ANTI-CANCER DRUG, V23, P777, DOI 10.1097/CAD.0b013e3283541384; Dong YM, 2010, CARCINOGENESIS, V31, P2097, DOI 10.1093/carcin/bgq167; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Huang WW, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/952762; Hung CM, 2013, INT J MOL SCI, V14, P17147, DOI 10.3390/ijms140817147; Ishdorj G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-268; Jayaprakasam B, 2003, CANCER LETT, V189, P11, DOI 10.1016/S0304-3835(02)00497-4; Kongtun S, 2009, PLANTA MED, V75, P839, DOI 10.1055/s-0029-1185455; Lan T, 2013, INT J CLIN EXP PATHO, V6, P1799; Li YC, 2010, ANTI-CANCER DRUG, V21, P389, DOI 10.1097/CAD.0b013e328336b383; Liu TY, 2008, EUR ARCH OTO-RHINO-L, V265, P1225, DOI 10.1007/s00405-008-0625-9; Promkan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055732; Shan Xiao-Lei, 2010, Chin J Cancer, V29, P20; Tannin-Spitz T, 2007, BIOCHEM PHARMACOL, V73, P56, DOI 10.1016/j.bcp.2006.09.012; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; Wakimoto N, 2008, CANCER SCI, V99, P1793, DOI 10.1111/j.1349-7006.2008.00899.x; Yasuda S, 2010, MOL NUTR FOOD RES, V54, P559, DOI 10.1002/mnfr.200900165; Yin D, 2008, INT J CANCER, V123, P1364, DOI 10.1002/ijc.23648; Zhang MX, 2009, CANCER CHEMOTH PHARM, V63, P635, DOI 10.1007/s00280-008-0780-0; Zhang T, 2012, BREAST CANCER RES TR, V135, P445, DOI 10.1007/s10549-012-2175-5; Zhou XY, 2012, HEPATOL RES, V42, P401, DOI 10.1111/j.1872-034X.2011.00933.x; Zhu JS, 2012, PHARMACOLOGY, V89, P348, DOI 10.1159/000338757	27	47	51	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103760	10.1371/journal.pone.0103760	http://dx.doi.org/10.1371/journal.pone.0103760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072848	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600085
J	Najjar, RP; Wolf, L; Taillard, J; Schlangen, LJM; Salam, A; Cajochen, C; Gronfier, C				Najjar, Raymond P.; Wolf, Luzian; Taillard, Jacques; Schlangen, Luc J. M.; Salam, Alex; Cajochen, Christian; Gronfier, Claude			Chronic Artificial Blue-Enriched White Light Is an Effective Countermeasure to Delayed Circadian Phase and Neurobehavioral Decrements	PLOS ONE			English	Article							SEASONAL AFFECTIVE-DISORDER; INTERMITTENT BRIGHT LIGHT; ANTARCTIC WINTER; MELATONIN SUPPRESSION; POLYCHROMATIC-LIGHT; BODY-TEMPERATURE; ACTION SPECTRUM; GANGLION-CELLS; SLEEP QUALITY; NIGHT WORKERS	Studies in Polar Base stations, where personnel have no access to sunlight during winter, have reported circadian misalignment, free-running of the sleep-wake rhythm, and sleep problems. Here we tested light as a countermeasure to circadian misalignment in personnel of the Concordia Polar Base station during the polar winter. We hypothesized that entrainment of the circadian pacemaker to a 24-h light-dark schedule would not occur in all crew members (n = 10) exposed to 100-300 lux of standard fluorescent white (SW) light during the daytime, and that chronic non-time restricted daytime exposure to melanopsin-optimized blue-enriched white (BE) light would establish an a stable circadian phase, in participants, together with increased cognitive performance and mood levels. The lighting schedule consisted of an alternation between SW lighting (2 weeks), followed by a BE lighting (2 weeks) for a total of 9 weeks. Rest-activity cycles assessed by actigraphy showed a stable rest-activity pattern under both SW and BE light. No difference was found between light conditions on the intra-daily stability, variability and amplitude of activity, as assessed by non-parametric circadian analysis. As hypothesized, a significant delay of about 30 minutes in the onset of melatonin secretion occurred with SW, but not with BE light. BE light significantly enhanced well being and alertness compared to SW light. We propose that the superior efficacy of blue-enriched white light versus standard white light involves melanopsin-based mechanisms in the activation of the non-visual functions studied, and that their responses do not dampen with time (over 9-weeks). This work could lead to practical applications of light exposure in working environment where background light intensity is chronically low to moderate (polar base stations, power plants, space missions, etc.), and may help design lighting strategies to maintain health, productivity, and personnel safety.	[Najjar, Raymond P.; Gronfier, Claude] Inserm U846, Stem Cell & Brain Res Inst, Bron, France; [Najjar, Raymond P.; Gronfier, Claude] Univ Lyon, Claude Bernard Lyon 1, Villeurbanne, France; [Wolf, Luzian] Wolf Technolberatung Object Tracker, Perchtoldsdorf, Austria; [Taillard, Jacques] Univ Bordeaux, Sommeil Attent & Neuropsychiat, USR 3413, Bordeaux, France; [Taillard, Jacques] CNRS, Sommeil Attent & Neuropsychiat, USR 3413, Bordeaux, France; [Schlangen, Luc J. M.] Philips Res, NL-5656 AE Eindhoven, Netherlands; [Salam, Alex] Inst Polaire Francais Paul Emile Victor IPEV, Plouzane, France; [Cajochen, Christian] Univ Basel, Ctr Chronobiol Psychiat Univ Clin, Basel, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Philips; Philips Research; University of Basel	Cajochen, C (corresponding author), Univ Basel, Ctr Chronobiol Psychiat Univ Clin, Basel, Switzerland.	christian.cajochen@upkbs.ch; claude.gronfier@inserm.fr	Gronfier, Claude/C-1243-2008; Najjar, Raymond P./J-4979-2019; Cajochen, Christian/N-6748-2014; Taillard, Jacques/H-5063-2018	Gronfier, Claude/0000-0002-6549-799X; Najjar, Raymond P./0000-0002-3770-2300; Taillard, Jacques/0000-0001-9067-8189; Schlangen, Luc/0000-0002-8424-7240	European Space Agency (ESA); Centre National d'Etudes Spatiales (CNES, France); Ministere de l'Enseignement Superieur et de la Recherche Francais; Federation des Aveugles et Handicapes Visuels de France; Wolf Technologieberatung - Object-Tracker	European Space Agency (ESA)(European Space Agency); Centre National d'Etudes Spatiales (CNES, France)(Centre National D'etudes Spatiales); Ministere de l'Enseignement Superieur et de la Recherche Francais; Federation des Aveugles et Handicapes Visuels de France; Wolf Technologieberatung - Object-Tracker	This work was supported by the European Space Agency (ESA), and a grant from the Centre National d'Etudes Spatiales (CNES, France) to CG. RPN was funded by "Ministere de l'Enseignement Superieur et de la Recherche Francais'' and "Federation des Aveugles et Handicapes Visuels de France.'' Light bulbs were provided by Philips Lighting B. V., Eindhoven, The Netherlands. LightWatcher data loggers and the Neurobehavioral Test Battery were provided by Object-Tracker, Austria. The funder, Wolf Technologieberatung - Object-Tracker, provided support in the form of salaries for authors [LW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDT J, 1987, CHRONOBIOL INT, V4, P273, DOI 10.3109/07420528709078534; Arendt J, 2012, CHRONOBIOL INT, V29, P379, DOI 10.3109/07420528.2012.668997; Bailes HJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2987; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bhattacharyya M, 2008, INT J BIOMETEOROL, V52, P869, DOI 10.1007/s00484-008-0183-2; Brainard GC, 2001, J NEUROSCI, V21, P6405; BROADWAY J, 1987, NEUROSCI LETT, V79, P185, DOI 10.1016/0304-3940(87)90694-X; BUYSSE DJ, 1991, SLEEP, V14, P331; Chang A-M, 2012, J PHYSL; Chellappa SL, 2012, J CLIN ENDOCR METAB, V97, pE433, DOI 10.1210/jc.2011-2391; Corbett RW, 2012, NEUROSCI LETT, V525, P146, DOI 10.1016/j.neulet.2012.06.046; CZEISLER CA, 1989, SCIENCE, V244, P1328, DOI 10.1126/science.2734611; Deguchi Takatsugu, 1992, Annals of Physiological Anthropology, V11, P37; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Francis G, 2008, J SLEEP RES, V17, P354, DOI 10.1111/j.1365-2869.2008.00664.x; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Gordijn MCM, 2012, J AFFECT DISORDERS, V136, P72, DOI 10.1016/j.jad.2011.08.016; Gronfier C, 2004, AM J PHYSIOL-ENDOC M, V287, pE174, DOI 10.1152/ajpendo.00385.2003; Gronfier C, 2007, P NATL ACAD SCI USA, V104, P9081, DOI 10.1073/pnas.0702835104; HANSEN T, 1987, ACTA PSYCHIAT SCAND, V75, P428, DOI 10.1111/j.1600-0447.1987.tb02811.x; Harris A, 2010, RURAL REMOTE HEALTH, V10; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; KENNAWAY DJ, 1991, AM J PHYSIOL, V260, pR1137, DOI 10.1152/ajpregu.1991.260.6.R1137; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; LEWIS HE, 1957, LANCET, V1, P1262, DOI 10.1016/S0140-6736(57)92298-5; LINGJAERDE O, 1985, ACTA PSYCHIAT SCAND, V71, P506, DOI 10.1111/j.1600-0447.1985.tb05064.x; Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570; Mottram V, 2011, J SLEEP RES, V20, P154, DOI 10.1111/j.1365-2869.2010.00875.x; Najjar RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085837; Noguchi Hiroki, 1999, Applied Human Science, V18, P117, DOI 10.2114/jpa.18.117; OWEN J, 1992, NEUROSCI LETT, V137, P181, DOI 10.1016/0304-3940(92)90399-R; PALINKAS LA, 1995, ACTA PSYCHIAT SCAND, V91, P423, DOI 10.1111/j.1600-0447.1995.tb09803.x; Palinkas LA, 1996, J NERV MENT DIS, V184, P530, DOI 10.1097/00005053-199609000-00003; Palinkas Lawrence A, 2004, Int J Circumpolar Health, V63, P157; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Rimmer DW, 2000, AM J PHYSIOL-REG I, V279, pR1574, DOI 10.1152/ajpregu.2000.279.5.R1574; Smith MR, 2009, SLEEP MED, V10, P287, DOI 10.1016/j.sleep.2008.05.005; Smith MR, 2009, CHRONOBIOL INT, V26, P709, DOI 10.1080/07420520902927742; Spiegel K, 2002, JAMA-J AM MED ASSOC, V288, P1471, DOI 10.1001/jama.288.12.1471-a; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Usui A, 2000, PSYCHIAT CLIN NEUROS, V54, P361, DOI 10.1046/j.1440-1819.2000.00715.x; Van Cauter E, 2000, JAMA-J AM MED ASSOC, V284, P861, DOI 10.1001/jama.284.7.861; Van Someren E J, 1997, IEEE Trans Rehabil Eng, V5, P394, DOI 10.1109/86.650297; Vandewalle G, 2011, J BIOL RHYTHM, V26, P249, DOI 10.1177/0748730411401736; Viola AU, 2008, SCAND J WORK ENV HEA, V34, P297, DOI 10.5271/sjweh.1268; Weibel L, 1998, J BIOL RHYTHM, V13, P202, DOI 10.1177/074873098129000048; Weibel L, 1997, AM J PHYSIOL-REG I, V272, pR948, DOI 10.1152/ajpregu.1997.272.3.R948; Wright KP, 2006, J COGNITIVE NEUROSCI, V18, P508, DOI 10.1162/jocn.2006.18.4.508; Wright KP, 2002, AM J PHYSIOL-REG I, V283, pR1370, DOI 10.1152/ajpregu.00205.2002; Wright KP, 2001, P NATL ACAD SCI USA, V98, P14027, DOI 10.1073/pnas.201530198; Yoneyama S, 1999, AM J PHYSIOL-REG I, V277, pR1091, DOI 10.1152/ajpregu.1999.277.4.R1091; Zeitzer JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022078; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x; Zeitzer JM, 2005, AM J PHYSIOL-REG I, V289, pR839, DOI 10.1152/ajpregu.00232.2005	59	38	41	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e102827	10.1371/journal.pone.0102827	http://dx.doi.org/10.1371/journal.pone.0102827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072880	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600016
J	Repetto-Llamazares, AHV; Larsen, RH; Giusti, AM; Riccardi, E; Bruland, OS; Selbo, PK; Dahle, J				Repetto-Llamazares, Ada H. V.; Larsen, Roy H.; Giusti, Anna Maria; Riccardi, Elena; Bruland, Oyvind S.; Selbo, Pal Kristian; Dahle, Jostein			Lu-177-DOTA-HH1, a Novel Anti-CD37 Radio-Immunoconjugate: A Study of Toxicity in Nude Mice	PLOS ONE			English	Article							B-CELL LYMPHOMA; MONOCLONAL-ANTIBODIES; THERAPY; DOSIMETRY; ANTIGEN; RADIOIMMUNOCONJUGATE; RADIOIMMUNOTHERAPY; BIODISTRIBUTION; YIELD; MB-1	Background: CD37 is an internalizing B-cell antigen expressed on Non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia cells (CLL). The anti-CD37 monoclonal antibody HH1 was conjugated to the bifunctional chelator p-SCN-Bn-DOTA and labelled with the beta-particle emitting radionuclide Lu-177 creating the radio-immunoconjugate (RIC) Lu-177-DOTA- HH1 (Lu-177-HH1, trade name Betalutin). The present toxicity study was performed prior to initiation of clinical studieswith Lu-177-HH1. Methodology/Principal Findings: Nude mice with or without tumor xenografts were treated with 50 to 1000 MBq/kg Lu-177- HH1 and followed for clinical signs of toxicity up to ten months. Acute, life threatening bone marrow toxicity was observed in animals receiving 800 and 1000 MBq/kg Lu-177-HH1. Significant changes in serum concentrations of liver enzymes were evident for treatment with 1000 MBq/kg Lu-177-HH1. Lymphoid depletion, liver necrosis and atrophy, and interstitial cell hyperplasia of the ovaries were also observed for mice in this dose group. Conclusions/Significance: Lu-177-DOTA-HH1 was well tolerated at dosages about 10 times above those considered relevant for radioimmunotherapy in patients with B-cell derived malignancies. The toxicity profile was as expected for RICs. Our experimental results have paved the way for clinical evaluation of Lu-177-HH1 in NHL patients.	[Repetto-Llamazares, Ada H. V.; Dahle, Jostein] Nord Nanovector AS, Oslo, Norway; [Repetto-Llamazares, Ada H. V.; Selbo, Pal Kristian] Oslo Univ Hosp, Dept Radiat Biol, Inst Canc Res, Oslo, Norway; [Larsen, Roy H.] Sciencons Ltd, Oslo, Norway; [Giusti, Anna Maria; Riccardi, Elena] Accelera Srl, Milan, Italy; [Bruland, Oyvind S.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway; [Bruland, Oyvind S.] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Dahle, J (corresponding author), Nord Nanovector AS, Oslo, Norway.	jd@nordicnanovector.no	Dahle, Jostein/AAE-7776-2020; Selbo, Pål Kristian/B-4638-2009; Riccardi, Elena/AAE-4666-2019	Dahle, Jostein/0000-0002-1447-6005; Selbo, Pål Kristian/0000-0002-5310-057X; Bruland, Oyvind Sverre/0000-0003-1631-3733	Norwegian Research Council [213633]; company Nordic Nanovector AS	Norwegian Research Council(Research Council of NorwayEuropean Commission); company Nordic Nanovector AS	The work was supported by the Norwegian Research Council grant No 213633 through the Industrial PhD program and by the company Nordic Nanovector AS, which owns the commercial rights for <SUP>177</SUP>Lu-HH1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bander NH, 2005, J CLIN ONCOL, V23, P4591, DOI 10.1200/JCO.2005.05.160; Brown RS, 1997, NUCL MED BIOL, V24, P657, DOI 10.1016/S0969-8051(97)00099-1; BUCHSBAUM DJ, 1992, CANCER RES, V52, P6476; Capen C. C., 1996, PATHOBIOLOGY AGING M, P453; Claringbold PG, 2011, EUR J NUCL MED MOL I, V38, P302, DOI 10.1007/s00259-010-1631-x; Dahle J, 2013, ANTICANCER RES, V33, P85; Dvorakova Z, 2008, APPL RADIAT ISOTOPES, V66, P147, DOI 10.1016/j.apradiso.2007.08.013; EARY JF, 1990, J NUCL MED, V31, P1257; Forrer F, 2013, J NUCL MED, V54, P1045, DOI 10.2967/jnumed.112.115170; Forrer F, 2009, EUR J NUCL MED MOL I, V36, P1138, DOI 10.1007/s00259-009-1072-6; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; KAMINSKI MS, 1992, J CLIN ONCOL, V10, P1696, DOI 10.1200/JCO.1992.10.11.1696; Kunikowska J, 2011, EUR J NUCL MED MOL I, V38, P1788, DOI 10.1007/s00259-011-1833-x; Leblond V, 1997, HEMATOL CELL THER, V39, P213, DOI 10.1007/s00282-997-0213-2; LINDMO T, 1986, METHOD ENZYMOL, V121, P678; Lohri A., 2010, 50 ASH ANN M EXP; Michel RB, 2005, NUCL MED BIOL, V32, P269, DOI 10.1016/j.nucmedbio.2005.01.003; Moldenhauer G, 2000, J BIOL REG HOMEOS AG, V14, P281; MURPHY ED, 1972, J NATL CANCER I, V48, P1283; PRESS OW, 1989, J CLIN ONCOL, V7, P1027, DOI 10.1200/JCO.1989.7.8.1027; PRESS OW, 1993, NEW ENGL J MED, V329, P1219, DOI 10.1056/NEJM199310213291702; PRESS OW, 1989, CANCER RES, V49, P4906; PRESS OW, 1994, BLOOD, V83, P1390; Repetto-Llamazares AHV, 2013, CURR RADIOPHARM, V6, P20, DOI 10.2174/1874471011306010004; SCHLOM J, 1991, CANCER RES, V51, P2889; Schmitt A, 2003, CANCER BIOTHER RADIO, V18, P593, DOI 10.1089/108497803322287682; SHARKEY RM, 1990, CANCER RES, V50, pS964; Sharkey RM, 1997, CANCER IMMUNOL IMMUN, V44, P179, DOI 10.1007/s002620050371; Sierra ML, 2009, CANCER BIOTHER RADIO, V24, P659, DOI 10.1089/cbr.2009.0641; SMELAND E, 1985, SCAND J IMMUNOL, V21, P205, DOI 10.1111/j.1365-3083.1985.tb01422.x	30	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103070	10.1371/journal.pone.0103070	http://dx.doi.org/10.1371/journal.pone.0103070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068508	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993700032
J	Ilyas, S; Rehman, A; Varela, AC; Sheehan, D				Ilyas, Sidra; Rehman, Abdul; Varela, Ana Coelho; Sheehan, David			Redox Proteomics Changes in the Fungal Pathogen Trichosporon asahii on Arsenic Exposure: Identification of Protein Responses to Metal-Induced Oxidative Stress in an Environmentally-Sampled Isolate	PLOS ONE			English	Article							REVERSIBLE CYSTEINE OXIDATION; SACCHAROMYCES-CEREVISIAE; GENOME SEQUENCE; IN-VIVO; CADMIUM; YEAST; NANOPARTICLES; TRANSFERASES; BIOSORPTION; RESISTANCE	Trichosporon asahii is a yeast pathogen implicated in opportunistic infections. Cultures of an isolate collected from industrial wastewater were exposed for 2 days to 100 mg/L sodium arsenite (NaAsO2) and cadmium (CdCl2). Both metals reduced glutathione transferase (GST) activity but had no effect on superoxide dismutase or catalase. NaAsO2 exposure increased glutathione reductase activity while CdCl2 had no effect. Protein thiols were labeled with 5-iodoacetamido fluorescein followed by one dimensional electrophoresis which revealed extensive protein thiol oxidation in response to CdCl2 treatment but thiol reduction in response to NaAsO2. Two dimensional electrophoresis analyses showed that the intensity of some protein spots was enhanced on treatment as judged by SameSpots image analysis software. In addition, some spots showed decreased IAF fluorescence suggesting thiol oxidation. Selected spots were excised and tryptic digested for identification by MALDI-TOF/TOF MS. Twenty unique T. asahii proteins were identified of which the following proteins were up-regulated in response to NaAsO2: 3-isopropylmalate dehydrogenase, phospholipase B, alanine-glyoxylate aminotransferase, ATP synthase alpha chain, 20S proteasome beta-type subunit Pre3p and the hypothetical proteins A1Q1_08001, A1Q2_03020, A1Q1_06950, A1Q1_06913. In addition, the following showed decreased thiol-associated fluorescence consistent with thiol oxidation; aconitase; aldehyde reductase I; phosphoglycerate kinase; translation elongation factor 2; heat shock protein 70 and hypothetical protein A1Q2_04745. Some proteins showed both increase in abundance coupled with decrease in IAF fluorescence; 3-hydroxyisobutyryl-CoA hydrolase; homoserine dehydrogenase Hom6 and hypothetical proteins A1Q2_03020 and A1Q1_00754. Targets implicated in redox response included 10 unique metabolic enzymes, heat shock proteins, a component of the 20S proteasome and translation elongation factor 2. These data suggest extensive proteomic alterations in response to metal-induced oxidative stress in T. asahii. Amino acid metabolism, protein folding and degradation are principally affected.	[Ilyas, Sidra; Rehman, Abdul] Univ Punjab, Dept Microbiol & Mol Genet, Lahore, Pakistan; [Varela, Ana Coelho] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Sheehan, David] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland; [Sheehan, David] Natl Univ Ireland Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland	University of Punjab; Universidade Nova de Lisboa; University College Cork; University College Cork	Sheehan, D (corresponding author), Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland.	d.sheehan@ucc.ie	Rehman, Abdul/AAE-3884-2020; Sheehan, David/ABB-5315-2020	ilyas, sidra/0000-0001-5339-6561	Programme for Research in Third Level Institutions of the Higher Education Authority of Ireland; International research Initiative Programme of the Higher Education Commission of Pakistan	Programme for Research in Third Level Institutions of the Higher Education Authority of Ireland; International research Initiative Programme of the Higher Education Commission of Pakistan	Prof Sheehan's lab is supported by the Programme for Research in Third Level Institutions of the Higher Education Authority of Ireland. Ms. Ilyas was supported to make a research visit by the International research Initiative Programme of the Higher Education Commission of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis PDB, 2007, TOXICOL LETT, V173, P1, DOI 10.1016/j.toxlet.2007.06.002; Aposhian HV, 2006, CHEM RES TOXICOL, V19, P1, DOI 10.1021/tx050106d; Ayer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044278; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Baty JW, 2002, PROTEOMICS, V2, P1261, DOI 10.1002/1615-9861(200209)2:9<1261::AID-PROT1261>3.0.CO;2-Q; BEERS RF, 1952, J BIOL CHEM, V195, P133; BLACKWELL KJ, 1995, APPL MICROBIOL BIOT, V43, P579, DOI 10.1007/BF00164757; Braconi D, 2011, J PROTEOMICS, V74, P2324, DOI 10.1016/j.jprot.2011.06.029; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Cho DH, 2003, BIOPROC BIOSYST ENG, V25, P271, DOI 10.1007/s00449-002-0315-8; Choi HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066605; Corbi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014481; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Daware V, 2012, J BIOTECHNOL, V158, P8, DOI 10.1016/j.jbiotec.2011.12.013; Du L, 2007, FEMS YEAST RES, V7, P860, DOI 10.1111/j.1567-1364.2007.00274.x; Dyballa Nadine, 2009, J Vis Exp, DOI 10.3791/1431; Ewing JF, 1995, ANAL BIOCHEM, V232, P243, DOI 10.1006/abio.1995.0014; Garcia-Santamarina S, 2014, BIOCHEMISTRY-US, V53, P2560, DOI 10.1021/bi401700f; Garcia-Santamarina S, 2014, NAT PROTOC, V9, P1131, DOI 10.1038/nprot.2014.065; Ghezzi P, 2003, PROTEOMICS, V3, P1145, DOI 10.1002/pmic.200300435; Gomes DS, 2008, BBA-GEN SUBJECTS, V1780, P160, DOI 10.1016/j.bbagen.2007.09.014; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; He Y, 2009, PLANT J, V60, P679, DOI 10.1111/j.1365-313X.2009.03990.x; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; Hofgen R, 2001, AMINO ACIDS, V20, P291, DOI 10.1007/s007260170045; Irazusta V, 2010, FREE RADICAL BIO MED, V48, P411, DOI 10.1016/j.freeradbiomed.2009.11.010; Jacobson T, 2012, J CELL SCI, V125, P5073, DOI 10.1242/jcs.107029; Kitchin KT, 2008, J INORG BIOCHEM, V102, P532, DOI 10.1016/j.jinorgbio.2007.10.021; Klomsiri C, 2011, ANTIOXID REDOX SIGN, V14, P1065, DOI 10.1089/ars.2010.3376; Knott TG, 2000, BIOCHEM J, V352, P409, DOI 10.1042/0264-6021:3520409; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Li Z, 2008, BIORESOURCE TECHNOL, V99, P1339, DOI 10.1016/j.biortech.2007.02.004; Li ZJ, 2006, APPL MICROBIOL BIOT, V73, P458, DOI 10.1007/s00253-006-0473-8; Liang QL, 2007, MOL BIOL CELL, V18, P4741, DOI 10.1091/mbc.E07-05-0431; Liu SX, 2001, P NATL ACAD SCI USA, V98, P1643, DOI 10.1073/pnas.031482998; Maisonneuve E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007269; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Marino SM, 2011, ANTIOXID REDOX SIGN, V15, P135, DOI 10.1089/ars.2010.3561; Marino SM, 2010, BIOCHEMISTRY-US, V49, P7709, DOI 10.1021/bi100677a; Martyniuk CJ, 2012, ECOTOX ENVIRON SAFE, V76, P3, DOI 10.1016/j.ecoenv.2011.09.020; McDonagh B, 2009, J PROTEOMICS, V72, P677, DOI 10.1016/j.jprot.2009.01.023; Mejare M, 2001, TRENDS BIOTECHNOL, V19, P67, DOI 10.1016/S0167-7799(00)01534-1; Menezes RA, 2008, BIOCHEM J, V414, P301, DOI 10.1042/BJ20071537; Munoz AJ, 2012, CHEM ENG J, V210, P325, DOI 10.1016/j.cej.2012.09.007; Muzio G, 2012, FREE RADICAL BIO MED, V52, P735, DOI 10.1016/j.freeradbiomed.2011.11.033; Nimrod G, 2008, STRUCTURE, V16, P1755, DOI 10.1016/j.str.2008.10.017; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Pal SK, 2005, J BIOSCIENCES, V30, P639, DOI 10.1007/BF02703564; Pandey S, 2012, J PROTEOMICS, V75, P921, DOI 10.1016/j.jprot.2011.10.011; Pedriali A, DRUG TESTING ANAL, V5, P646; Pfaller MA, 2004, J CLIN MICROBIOL, V42, P4419, DOI 10.1128/JCM.42.10.4419-4431.2004; Qiao JJ, 2013, GENE, V512, P6, DOI 10.1016/j.gene.2012.10.004; Rabek JP, 2003, BIOCHEM BIOPH RES CO, V305, P566, DOI 10.1016/S0006-291X(03)00826-X; Rebelato E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024507; Regoli F, 2014, MAR ENVIRON RES, V93, P106, DOI 10.1016/j.marenvres.2013.07.006; Rehman A, 2011, ENVIRON MONIT ASSESS, V174, P585, DOI 10.1007/s10661-010-1480-x; Rodriguez-Tudela JL, 2005, ANTIMICROB AGENTS CH, V49, P4026, DOI 10.1128/AAC.49.10.4026-4034.2005; Salinas E, 2000, BIORESOURCE TECHNOL, V72, P107, DOI 10.1016/S0960-8524(99)00111-X; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sheehan D, 2006, BIOCHEM BIOPH RES CO, V349, P455, DOI 10.1016/j.bbrc.2006.08.124; Sugita T, 2001, J CLIN MICROBIOL, V39, P2405, DOI 10.1128/JCM.39.7.2405-2411.2001; Sugita T, 2000, MED MYCOL, V38, P27, DOI 10.1080/714030894; Sun MA, 2012, BIOINFORMATICS, V28, P2551, DOI 10.1093/bioinformatics/bts468; Sun W, 2012, J MED MICROBIOL, V61, P1750, DOI 10.1099/jmm.0.049817-0; Tedesco S, 2008, MAR ENVIRON RES, V66, P131, DOI 10.1016/j.marenvres.2008.02.044; Thorsen M, 2007, PHYSIOL GENOMICS, V30, P35, DOI 10.1152/physiolgenomics.00236.2006; van der Vlies D, 2002, BIOCHEM J, V366, P825, DOI 10.1042/BJ20020618; Vanderklish PW, 2000, INT J EXP PATHOL, V81, P323, DOI 10.1046/j.1365-2613.2000.00169.x; VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001; von Moos N, 2014, NANOTOXICOLOGY, V8, P605, DOI 10.3109/17435390.2013.809810; Whittaker MM, 1999, J BIOL CHEM, V274, P36226, DOI 10.1074/jbc.274.51.36226; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wu SJ, 2013, CHEMOSPHERE, V93, P963, DOI 10.1016/j.chemosphere.2013.05.062; Yang RY, 2012, EUKARYOT CELL, V11, P1586, DOI 10.1128/EC.00264-12; Yang RY, 2012, EUKARYOT CELL, V11, P1415, DOI 10.1128/EC.00237-12; Zhang E, 2011, MICROBIOL IMMUNOL, V55, P483, DOI 10.1111/j.1348-0421.2011.00341.x	82	18	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e102340	10.1371/journal.pone.0102340	http://dx.doi.org/10.1371/journal.pone.0102340			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	25062082	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992600012
J	Verkade, E; Kluytmans-van den Bergh, M; van Benthem, B; van Cleef, B; van Rijen, M; Bosch, T; Schouls, L; Kluytmans, J				Verkade, Erwin; Kluytmans-van den Bergh, Marjolein; van Benthem, Birgit; van Cleef, Brigitte; van Rijen, Miranda; Bosch, Thijs; Schouls, Leo; Kluytmans, Jan			Transmission of Methicillin-Resistant Staphylococcus aureus CC398 from Livestock Veterinarians to Their Household Members	PLOS ONE			English	Article							NASAL COLONIZATION; SKIN INFECTIONS; HIGH PREVALENCE; RISK-FACTORS; MRSA; CONTACTS; NETHERLANDS; EMERGENCE; HUMANS; ORIGIN	There are indications that livestock-associated MRSA CC398 has a reduced human-to-human transmissibility, limiting its impact on public health and justifying modified control measures. This study determined the transmissibility of MRSA CC398 from livestock veterinarians to their household members in the community as compared to MRSA non-CC398 strains. A one-year prospective cohort study was performed to determine the presence of MRSA CC398 in four-monthly nasal and oropharyngeal samples of livestock veterinarians (n = 137) and their household members (n = 389). In addition, a cross-sectional survey was performed to detect the presence of MRSA non-CC398 in hospital derived control patients (n = 20) and their household members (n = 41). Staphylococcus aureus isolates were genotyped by staphylococcal protein A (spa) typing and multiple-locus variable-number tandem repeat analysis (MLVA). Mean MRSA CC398 prevalence over the study period was 44% (range 41.6-46.0%) in veterinarians and 4.0% (range 2.8-4.7%) in their household members. The MRSA CC398 prevalence in household members of veterinarians was significantly lower than the MRSA non-CC398 prevalence in household members of control patients (PRR 6.0; 95% CI 2.4-15.5), indicating the reduced transmissibility of MRSA CC398. The impact of MRSA CC398 appears to be low at the moment. However, careful monitoring of the human-to-human transmissibility of MRSA CC398 remains important.	[Verkade, Erwin; van Cleef, Brigitte; van Rijen, Miranda; Kluytmans, Jan] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Verkade, Erwin; van Cleef, Brigitte; Kluytmans, Jan] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Kluytmans-van den Bergh, Marjolein] Amphia Acad Infect Dis Fdn, Amphia Hosp, Breda, Netherlands; [van Benthem, Birgit; van Cleef, Brigitte; Bosch, Thijs; Schouls, Leo] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, NL-3720 BA Bilthoven, Netherlands; [Schouls, Leo; Kluytmans, Jan] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands	Amphia Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Amphia Hospital; Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Verkade, E (corresponding author), Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands.	erwinverkade@gmail.com	van den Bergh, Marjolein Kluytmans -/A-7267-2016	van den Bergh, Marjolein Kluytmans -/0000-0002-6576-6408	Netherlands Organization for Health Research and Development (ZonMw) [125010003]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by The Netherlands Organization for Health Research and Development (ZonMw) [grant number 125010003]. The funding authority did not interfere with data collection, data analysis, or writing the manuscript, nor did it have the right to approve or disapprove the manuscript.	Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Bode LGM, 2011, J HOSP INFECT, V79, P198, DOI 10.1016/j.jhin.2011.05.009; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Calfee DP, 2003, INFECT CONT HOSP EP, V24, P422, DOI 10.1086/502225; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Davis MF, 2012, LANCET INFECT DIS, V12, P703, DOI 10.1016/S1473-3099(12)70156-1; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Feingold BJ, 2012, EMERG INFECT DIS, V18, P1841, DOI 10.3201/eid1811.111850; Fritz SA, 2012, ARCH PEDIAT ADOL MED, V166, P551, DOI 10.1001/archpediatrics.2011.900; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Haenen APJ, 2011, INFECTIEZIEKTEN B, V22, P250; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Johansson PJH, 2007, SCAND J INFECT DIS, V39, P764, DOI 10.1080/00365540701302501; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans J, 2002, J CLIN MICROBIOL, V40, P2480, DOI 10.1128/JCM.40.7.2480-2482.2002; Kluytmans-Vandenbergh MF, 2006, CLIN MICROBIOL INFEC, P9; Knol MJ, 2012, CAN MED ASSOC J, V184, P895, DOI 10.1503/cmaj.101715; Lekkerkerk WSN, 2012, CLIN MICROBIOL INFEC, V18, P656, DOI 10.1111/j.1469-0691.2011.03662.x; Lucet JC, 2009, ARCH INTERN MED, V169, P1372, DOI 10.1001/archinternmed.2009.217; Miller LG, 2012, CLIN INFECT DIS, V54, P1523, DOI 10.1093/cid/cis213; Mollema FPN, 2010, J CLIN MICROBIOL, V48, P202, DOI 10.1128/JCM.01499-09; Nerby JM, 2011, PEDIATR INFECT DIS J, V30, P927, DOI 10.1097/INF.0b013e31822256c3; Noskin GA, 2007, CLIN INFECT DIS, V45, P1132, DOI 10.1086/522186; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van Griethuysen AJ, 1997, J CLIN MICROBIOL, V37, P2789; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; van Rijen MML, 2009, EUR J CLIN MICROBIOL, V28, P1245, DOI 10.1007/s10096-009-0775-8; van Rijen MML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065594; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; Verkade E, 2011, J MED MICROBIOL, V60, P905, DOI 10.1099/jmm.0.021964-0; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x; Zafar U, 2007, INFECT CONT HOSP EP, V28, P966, DOI 10.1086/518965	37	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e100823	10.1371/journal.pone.0100823	http://dx.doi.org/10.1371/journal.pone.0100823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	25062364	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992600002
J	Bhattacharya, A; Parillon, X; Zeng, SY; Han, SH; Eissa, NT				Bhattacharya, Abhisek; Parillon, Xyanthine; Zeng, Shenyan; Han, Shuhua; Eissa, N. Tony			Deficiency of Autophagy in Dendritic Cells Protects against Experimental Autoimmune Encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; ANTIGEN; EXPRESSION; CNS; HOMEOSTASIS; IMMUNITY; COMPLEX	Dendritic cells (DCs) are the most potent antigen-presenting cells (APCs) in the immune system. DCs present antigens to CD8 and CD4 T cells in the context of class I or II MHC. Recent evidence suggests that autophagy, a conserved intracellular degradation pathway, regulates class II antigen presentation. In vitro studies have shown that deletion of autophagy-related genes reduced antigen presentation by APCs to CD4 T cells. In vivo studies confirmed these findings in the context of infectious diseases. However, the relevance of autophagy-mediated antigen presentation in autoimmunity remains to be elucidated. Here, we report that loss of autophagy-related gene 7 (Atg7) in DCs ameliorated experimental autoimmune encephalomyelitis (EAE), a CD4 T cell-mediated mouse model of multiple sclerosis, by reducing in vivo priming of T cells. In contrast, severity of hapten-induced contact hypersensitivity, in which CD8 T cells and NK cells play major roles, was unaffected. Administration of the autophagy-lysosomal inhibitor chloroquine, before EAE onset, delayed disease progression and, when administered after the onset, reduced disease severity. Our data show that autophagy is required in DCs for induction of EAE and suggest that autophagy might be a potential target for treating CD4 T cell-mediated autoimmune conditions.	[Bhattacharya, Abhisek; Zeng, Shenyan; Eissa, N. Tony] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Bhattacharya, Abhisek; Parillon, Xyanthine; Han, Shuhua; Eissa, N. Tony] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Eissa, NT (corresponding author), Baylor Coll Med, One Baylor Plaza,BCM 285 Ste,535E, Houston, TX 77030 USA.	teissa@bcm.edu	Bhattacharya, Abhisek/AAN-6511-2020	Bhattacharya, Abhisek/0000-0002-1667-7169; Parillon, Xyanthine/0000-0002-4780-508X	National Institutes of Health from NHLBI [R01 HL69033]; Cytometry and Cell Sorting Core at Baylor College of Medicine (National Institutes of Health) [AI036211, CA125123, RR024574]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cytometry and Cell Sorting Core at Baylor College of Medicine (National Institutes of Health); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL69033 from NHLBI. This work was also supported by the Cytometry and Cell Sorting Core at Baylor College of Medicine (supported by National Institutes of Health Grants AI036211, CA125123, and RR024574.	Aichinger M, 2013, J EXP MED, V210, P287, DOI 10.1084/jem.20122149; Alirezaei M, 2009, AUTOPHAGY, V5, P152, DOI 10.4161/auto.5.2.7348; Bhattacharya A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00088; Bonilla DL, 2013, IMMUNITY, V39, P537, DOI 10.1016/j.immuni.2013.08.026; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Harno E, 2013, CELL METAB, V18, P21, DOI 10.1016/j.cmet.2013.05.019; Ireland JM, 2011, J EXP MED, V208, P2625, DOI 10.1084/jem.20110640; Isaksson M, 2009, EUR J IMMUNOL, V39, P2925, DOI 10.1002/eji.200839179; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Ji QY, 2013, NAT IMMUNOL, V14, P254, DOI 10.1038/ni.2513; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; MILLER HG, 1963, BMJ-BRIT MED J, P1436, DOI 10.1136/bmj.2.5370.1436; Muenz C, 2009, ANNU REV IMMUNOL, V27, P423, DOI 10.1146/annurev.immunol.021908.132537; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Pierdominici M, 2012, FASEB J, V26, P1400, DOI 10.1096/fj.11-194175; Reed M, 2013, J IMMUNOL, V191, P2526, DOI 10.4049/jimmunol.1300477; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schulz TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001013; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Shin JN, 2013, J BIOL CHEM, V288, P35886, DOI 10.1074/jbc.M113.514919; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Thome R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065913; Vocanson M, 2009, ALLERGY, V64, P1699, DOI 10.1111/j.1398-9995.2009.02082.x; Wang YY, 2012, P NATL ACAD SCI USA, V109, pE343, DOI 10.1073/pnas.1115635109; Yogev N, 2012, IMMUNITY, V37, P264, DOI 10.1016/j.immuni.2012.05.025; Zhang ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036589; Zhou XJ, 2011, ANN RHEUM DIS, V70, P1330, DOI 10.1136/ard.2010.140111	32	59	64	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26525	26532		10.1074/jbc.M114.575860	http://dx.doi.org/10.1074/jbc.M114.575860			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25077962	Green Published, hybrid			2022-12-25	WOS:000342128800043
J	Chen, XM; Wang, X; Feng, J; Chen, YH; Fang, Y; Zhao, S; Zhao, AG; Zhang, M; Liu, L				Chen, Xuemin; Wang, Xiao; Feng, Juan; Chen, Yuhong; Fang, Ying; Zhao, Shun; Zhao, Aiguo; Zhang, Min; Liu, Lin			Structural Insights into the Catalytic Mechanism of Synechocystis Magnesium Protoporphyrin IX O-Methyltransferase (ChlM)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTINUOUS SPECTROPHOTOMETRIC ASSAY; CHELATASE H SUBUNIT; CRYSTAL-STRUCTURE; TETRAPYRROLE BIOSYNTHESIS; ENZYMES; PROTEIN; SAM; PURIFICATION; EXPRESSION; PORPHYRIN	Magnesium protoporphyrin IX O-methyltransferase (ChlM) catalyzes transfer of the methyl group from S-adenosylmethionine to the carboxyl group of the C13 propionate side chain of magnesium protoporphyrin IX. This reaction is the second committed step in chlorophyll biosynthesis from protoporphyrin IX. Here we report the crystal structures of ChlM from the cyanobacterium Synechocystis sp. PCC 6803 in complex with S-adenosylmethionine and S-adenosylhomocysteine at resolutions of 1.6 and 1.7 angstrom, respectively. The structures illustrate the molecular basis for cofactor and substrate binding and suggest that conformational changes of the two "arm" regions may modulate binding and release of substrates/products to and from the active site. Tyr-28 and His139 were identified to play essential roles for methyl transfer reaction but are not indispensable for cofactor/substrate binding. Based on these structural and functional findings, a catalytic model is proposed.	[Chen, Xuemin; Wang, Xiao; Feng, Juan; Chen, Yuhong; Fang, Ying; Zhao, Shun; Zhao, Aiguo; Liu, Lin] Chinese Acad Sci, Photosynthesis Res Ctr, Key Lab Photobiol, Inst Bot, Beijing 100093, Peoples R China; [Zhang, Min] Anhui Univ, Sch Life Sci, Engn Res Ctr Biomed Mat, Hefei 230601, Anhui, Peoples R China; [Chen, Xuemin; Wang, Xiao; Feng, Juan; Fang, Ying; Zhao, Shun; Zhao, Aiguo] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Anhui University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, L (corresponding author), Chinese Acad Sci, Photosynthesis Res Ctr, Key Lab Photobiol, Inst Bot, Beijing 100093, Peoples R China.	liulin@ibcas.ac.cn	Chen, Xuemin/AAW-6728-2020	Chen, Xuemin/0000-0002-1818-9206	National Natural Science Foundation of China [31340044]; National Basic Research Program of China [2011CBA00901]; Hundred Talents Program of Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Hundred Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grant 31340044, National Basic Research Program of China Grant 2011CBA00901, and the Hundred Talents Program of Chinese Academy of Sciences.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alawady A, 2005, PLANT MOL BIOL, V57, P679, DOI 10.1007/s11103-005-1427-8; Alawady AE, 2005, PLANT J, V41, P282, DOI 10.1111/j.1365-313X.2004.02291.x; Ariyawutthiphan O, 2012, ACTA CRYSTALLOGR D, V68, P1558, DOI 10.1107/S0907444912038486; Byrne RT, 2013, ACTA CRYSTALLOGR D, V69, P1090, DOI 10.1107/S0907444913004939; Cakici O, 2010, J MOL BIOL, V404, P874, DOI 10.1016/j.jmb.2010.10.016; Chi W, 2013, ANNU REV PLANT BIOL, V64, P559, DOI 10.1146/annurev-arplant-050312-120147; Davison PA, 2005, BIOCHEMISTRY-US, V44, P7603, DOI 10.1021/bi050240x; Dorgan KM, 2006, ANAL BIOCHEM, V350, P249, DOI 10.1016/j.ab.2006.01.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Gao YG, 2005, PROTEINS, V61, P1141, DOI 10.1002/prot.20678; Hinchigeri SB, 1997, FEBS LETT, V407, P337, DOI 10.1016/S0014-5793(97)00371-2; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; Hollingshead S, 2012, J BIOL CHEM, V287, P27823, DOI 10.1074/jbc.M112.352526; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Jansson A, 2003, J MOL BIOL, V334, P269, DOI 10.1016/j.jmb.2003.09.061; Johnson ET, 2008, J BIOL CHEM, V283, P27776, DOI 10.1074/jbc.M804486200; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; Kim J, 2013, NATURE, V498, P123, DOI 10.1038/nature12180; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JE, 2001, ACTA CRYSTALLOGR D, V57, P150, DOI 10.1107/S0907444900014669; Lee JH, 2010, P NATL ACAD SCI USA, V107, P17557, DOI 10.1073/pnas.1006848107; Lee SG, 2012, J BIOL CHEM, V287, P1426, DOI 10.1074/jbc.M111.315267; Lim K, 2001, PROTEINS, V45, P397, DOI 10.1002/prot.10004; Lundqvist J, 2010, STRUCTURE, V18, P354, DOI 10.1016/j.str.2010.01.001; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; McLean S, 2009, ANAL BIOCHEM, V394, P223, DOI 10.1016/j.ab.2009.07.036; Minamizaki K, 2008, J BIOL CHEM, V283, P2684, DOI 10.1074/jbc.M708954200; Miyazaki G, 1999, J MOL BIOL, V292, P1121, DOI 10.1006/jmbi.1999.3124; Mochizuki N, 2010, TRENDS PLANT SCI, V15, P488, DOI 10.1016/j.tplants.2010.05.012; Montange RK, 2010, J MOL BIOL, V396, P761, DOI 10.1016/j.jmb.2009.12.007; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng Y, 2011, BIOCHEMISTRY-US, V50, P7800, DOI 10.1021/bi2007614; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pontier D, 2007, J BIOL CHEM, V282, P2297, DOI 10.1074/jbc.M610286200; Qian P, 2012, J BIOL CHEM, V287, P4946, DOI 10.1074/jbc.M111.308239; Richter AS, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00371; Richter AS, 2013, PLANT PHYSIOL, V162, P63, DOI 10.1104/pp.113.217141; Sawicki A, 2010, FEBS J, V277, P4709, DOI 10.1111/j.1742-4658.2010.07877.x; Schlicke H, 2014, MOL PLANT, V7, P1211, DOI 10.1093/mp/ssu034; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shepherd M, 2005, FEBS J, V272, P4532, DOI 10.1111/j.1742-4658.2005.04873.x; Shepherd M, 2004, BIOCHEM J, V382, P1009, DOI 10.1042/BJ20040661; Shepherd M, 2003, BIOCHEM J, V371, P351, DOI 10.1042/BJ20021394; Sirijovski N, 2008, J BIOL CHEM, V283, P11652, DOI 10.1074/jbc.M709172200; Takata Y, 2003, BIOCHEMISTRY-US, V42, P8394, DOI 10.1021/bi034245a; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Verdecia MA, 2005, PLOS BIOL, V3, P777, DOI 10.1371/journal.pbio.0030151; VON WETTSTEIN D, 1995, PLANT CELL, V7, P1039, DOI 10.1105/tpc.7.7.1039	56	14	16	4	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25690	25698		10.1074/jbc.M114.584920	http://dx.doi.org/10.1074/jbc.M114.584920			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25077963	hybrid, Green Published			2022-12-25	WOS:000342130800028
J	Jockel-Schneider, Y; Harks, I; Haubitz, I; Fickl, S; Eigenthaler, M; Schlagenhauf, U; Baulmann, J				Jockel-Schneider, Yvonne; Harks, Inga; Haubitz, Imme; Fickl, Stefan; Eigenthaler, Martin; Schlagenhauf, Ulrich; Baulmann, Johannes			Arterial Stiffness and Pulse Wave Reflection Are Increased in Patients Suffering from Severe Periodontitis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR EVENTS; CLINICAL-APPLICATIONS; AORTIC STIFFNESS; RISK; VELOCITY; METAANALYSIS; ASSOCIATION; MORTALITY	Aim: This single blind cross-sectional study compared the vascular health of subjects suffering from severe chronic periodontitis, severe aggressive periodontitis and periodontal healthy controls by evaluating pulse wave velocity (PWV), augmentation index (AIx) and pulse pressure amplification (PPA). Material and Methods: In a total of 158 subjects, 92 suffering from severe periodontitis and 66 matched periodontal healthy controls, PWV, AIx, central and peripheral blood pressure were recorded using an oscillometric device (Arteriograph). Results: Subjects suffering from severe chronic or aggressive periodontitis exhibited significantly higher PWV (p = 0.00004), higher AIx (p = 0.0049) and lower PPA (p = 0.028) than matched periodontal healthy controls. Conclusions: The results of this study confirm the association between periodontal inflammation and increased cardiovascular risk shown by impaired vascular health in case of severe periodontitis. As impaired vascular health is a common finding in patients suffering from severe periodontal disease a concomitant routine cardiovascular evaluation may be advised.	[Jockel-Schneider, Yvonne; Haubitz, Imme; Fickl, Stefan; Eigenthaler, Martin; Schlagenhauf, Ulrich] Univ Hosp Wuerzburg, Dept Periodontol, Wurzburg, Germany; [Harks, Inga] Univ Hosp Muenster, Dept Periodontol, Munster, Germany; [Baulmann, Johannes] Univ Hosp Schleswig Holstein, Clin Internal Med 2, Lubeck, Germany	University of Wurzburg; University of Munster; University of Kiel; Schleswig Holstein University Hospital	Jockel-Schneider, Y (corresponding author), Univ Hosp Wuerzburg, Dept Periodontol, Wurzburg, Germany.	jockel_y@klinik.uni-wuerzburg.de	Stefanadis, Christodoulos/ABH-2232-2020; Jockel-Schneider, Yvonne/GQA-6206-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; Jockel-Schneider, Yvonne/0000-0002-5646-3691	German Research Foundation [EH 365/1-1]; IZKF Wuerzburg [Z-2/34]	German Research Foundation(German Research Foundation (DFG)); IZKF Wuerzburg	This study was funded externally by a grant of the German Research Foundation (EH 365/1-1) and by the IZKF Wuerzburg (Z-2/34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINAMO J, 1982, INT DENT J, V32, P281; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Baulmann J, 2010, DEUT MED WOCHENSCHR, V135, pS4, DOI 10.1055/s-0030-1249183; Baulmann J, 2008, J HYPERTENS, V26, P523, DOI 10.1097/HJH.0b013e3282f314f7; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; Briggs JE, 2006, J PERIODONTOL, V77, P95, DOI 10.1902/jop.2006.77.1.95; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Dietrich T, 2008, CIRCULATION, V117, P1668, DOI 10.1161/CIRCULATIONAHA.107.711507; Elter JR, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.10.002; Ferrari AU, 2003, J APPL PHYSIOL, V95, P2591, DOI 10.1152/japplphysiol.00601.2003; Franek E, 2009, AM J HYPERTENS, V22, P203, DOI 10.1038/ajh.2008.330; Grossi SG, 1996, J PERIODONTAL RES, V31, P330, DOI 10.1111/j.1600-0765.1996.tb00500.x; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Hujoel PP, 2000, JAMA-J AM MED ASSOC, V284, P1406, DOI 10.1001/jama.284.11.1406; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Janket SJ, 2003, ORAL SURG ORAL MED O, V95, P559, DOI 10.1067/moe.2003.107; Jimenez M, 2009, ANN NEUROL, V66, P505, DOI 10.1002/ana.21742; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; London GM, 2001, HYPERTENSION, V38, P434, DOI 10.1161/01.HYP.38.3.434; MARCHAIS SJ, 1993, HYPERTENSION, V22, P876, DOI 10.1161/01.HYP.22.6.876; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Meaume S, 2001, ARTERIOSCL THROM VAS, V21, P2046, DOI 10.1161/hq1201.100226; Mercanoglu F, 2004, J PERIODONTOL, V75, P1694, DOI 10.1902/jop.2004.75.12.1694; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Morrison HI, 1999, J CARDIOVASC RISK, V6, P7; O'Rourke MF, 1999, J HYPERTENS, V17, pS45; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Roman MJ, 2009, J AM COLL CARDIOL, V54, P1730, DOI 10.1016/j.jacc.2009.05.070; Safar H, 2002, ARCH MAL COEUR VAISS, V95, P1215; Seinost G, 2005, AM HEART J, V149, P1050, DOI 10.1016/j.ahj.2004.09.059; Sigurdsson E, 1996, J AM COLL CARDIOL, V27, P1140, DOI 10.1016/0735-1097(95)00614-1; SYRJANEN J, 1989, J INTERN MED, V225, P179, DOI 10.1111/j.1365-2796.1989.tb00060.x; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Tonetti MS, 2009, J CLIN PERIODONTOL, V36, P15, DOI 10.1111/j.1600-051X.2009.01417.x; Van Bortel LM, 2002, AM J HYPERTENS, V15, P445, DOI 10.1016/S0895-7061(01)02326-3; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Weber T, 2004, CIRCULATION, V109, P184, DOI 10.1161/01.CIR.0000105767.94169.E3	39	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103449	10.1371/journal.pone.0103449	http://dx.doi.org/10.1371/journal.pone.0103449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084111	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800043
J	Harastani, HH; Tokajian, ST				Harastani, Houda H.; Tokajian, Sima T.			Community-Associated Methicillin-Resistant Staphylococcus aureus Clonal Complex 80 Type IV (CC80-MRSA-IV) Isolated from the Middle East: A Heterogeneous Expanding Clonal Lineage	PLOS ONE			English	Article							VALENTINE LEUKOCIDIN GENES; TOXIC-SHOCK-SYNDROME; MULTIPLEX PCR ASSAY; MOLECULAR CHARACTERISTICS; LEUCOCIDIN GENES; ST80-IV CLONE; STRAINS; EPIDEMIOLOGY; MRSA; CHROMOSOME	Background: The emergence of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA) has caused a change in MRSA epidemiology worldwide. In the Middle East, the persistent spread of CA-MRSA isolates that were associated with multilocus sequence type (MLST) clonal complex 80 and with staphylococcal cassette chromosome mec (SCCmec) type IV (CC80-MRSA-IV), calls for novel approaches for infection control that would limit its spread. Methodology/Principal Findings: In this study, the epidemiology of CC80-MRSA-IV was investigated in Jordan and Lebanon retrospectively covering the period from 2000 to 2011. Ninety-four S. aureus isolates, 63 (67%) collected from Lebanon and 31 (33%) collected from Jordan were included in this study. More than half of the isolates (56%) were associated with skin and soft tissue infections (SSTIs), and 73 (78%) were Panton-Valentine Leukocidin (PVL) positive. Majority of the isolates (84%) carried the gene for exofoliative toxin d (etd), 19% had the Toxic Shock Syndrome Toxin-1 gene (tst), and seven isolates from Jordan had a rare combination being positive for both tst and PVL genes. spa typing showed the prevalence of type t044 (85%) and pulsed-field gel electrophoresis (PFGE) recognized 21 different patterns. Antimicrobial susceptibility testing showed the prevalence (36%) of a unique resistant profile, which included resistance to streptomycin, kanamycin, and fusidic acid (SKF profile). Conclusions: The genetic diversity among the CC80 isolates observed in this study poses an additional challenge to infection control of CA-MRSA epidemics. CA-MRSA related to ST80 in the Middle East was distinguished in this study from the ones described in other countries. Genetic diversity observed, which may be due to mutations and differences in the antibiotic regimens between countries may have led to the development of heterogeneous strains. Hence, it is difficult to maintain "the European CA-MRSA clone" as a uniform clone and it is better to designate as CC80-MRSA-IV isolates.	[Harastani, Houda H.; Tokajian, Sima T.] Lebanese Amer Univ, Sch Arts & Sci, Dept Nat Sci, Byblos, Lebanon	Lebanese American University	Tokajian, ST (corresponding author), Lebanese Amer Univ, Sch Arts & Sci, Dept Nat Sci, Byblos, Lebanon.	stokjian@lau.edu.lb	Tokajian, Sima T/G-9644-2018	Tokajian, Sima T/0000-0002-3653-8940; Harastani, Houda/0000-0002-1234-6194	Lebanese American University Research Council	Lebanese American University Research Council	This work was supported by the Lebanese American University Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2010, J CLIN MICROBIOL, V48, P531, DOI 10.1128/JCM.02290-08; Ahmad N, 2009, J MED MICROBIOL, V58, P1213, DOI 10.1099/jmm.0.011353-0; Al-Bakri AG, 2013, EPIDEMIOL INFECT, V141, P2384, DOI 10.1017/S0950268813000010; Antri K, 2011, CLIN MICROBIOL INFEC, V17, P526, DOI 10.1111/j.1469-0691.2010.03273.x; Bekkhoucha SN, 2009, EUR J CLIN MICROBIOL, V28, P553, DOI 10.1007/s10096-008-0660-x; Ben Nejma M, 2013, DIAGN MICR INFEC DIS, V77, P20, DOI 10.1016/j.diagmicrobio.2008.02.010; Boakes E, 2011, J CLIN MICROBIOL, V49, P684, DOI 10.1128/JCM.01917-10; Borg MA, 2007, J ANTIMICROB CHEMOTH, V60, P1310, DOI 10.1093/jac/dkm365; Brady JM, 2007, J CLIN MICROBIOL, V45, P2654, DOI 10.1128/JCM.02579-06; Budimir A, 2010, CLIN MICROBIOL INFEC, V16, P1077, DOI 10.1111/j.1469-0691.2009.03042.x; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; CLSI, 2010, M100S20 CLSI; Cucarella C, 2004, INFECT IMMUN, V72, P2177, DOI 10.1128/IAI.72.4.2177-2185.2004; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P3806, DOI 10.1128/JCM.41.8.3806-3815.2003; DeLeo FR, 2011, P NATL ACAD SCI USA, V108, P18091, DOI 10.1073/pnas.1111084108; Denis O, 2005, J ANTIMICROB CHEMOTH, V56, P1103, DOI 10.1093/jac/dki379; Denis O, 2004, EUROSURVEILLANCE, V8, P2483; Deresinski S, 2005, CLIN INFECT DIS, V40, P562, DOI 10.1086/427701; Djoudi F, 2013, NEW MICROBIOL, V36, P49; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; El-Mahdy TS, 2014, CLIN MICROBIOL INFEC, V20, P169, DOI 10.1111/1469-0691.12240; Enany S, 2010, MICROBIOL RES, V165, P152, DOI 10.1016/j.micres.2009.03.005; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Goering RV, 2009, CLIN MICROBIOL INFEC, V15, P748, DOI 10.1111/j.1469-0691.2009.02850.x; GOERING RV, 1992, J CLIN MICROBIOL, V30, P577, DOI 10.1128/JCM.30.3.577-580.1992; Hadjihannas L, 2012, DIAGN MICR INFEC DIS, V74, P420, DOI 10.1016/j.diagmicrobio.2012.08.012; Hanssen AM, 2005, J CLIN MICROBIOL, V43, P2118, DOI 10.1128/JCM.43.5.2118-2124.2005; Harastani HH, 2014, INT J INFECT DIS, V19, P33, DOI 10.1016/j.ijid.2013.10.007; Harbarth S, 2005, EMERG INFECT DIS, V11, P962, DOI 10.3201/eid1106.041308; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Hsu LY, 2005, EMERG INFECT DIS, V11, P341, DOI 10.3201/eid1102.040782; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Jekle A, 2013, ANTIMICROB AGENTS CH, V57, P924, DOI 10.1128/AAC.01945-12; JOHNSON WM, 1991, J CLIN MICROBIOL, V29, P426, DOI 10.1128/JCM.29.3.426-430.1991; Khalil W, 2012, DIAGN MICR INFEC DIS, V73, P228, DOI 10.1016/j.diagmicrobio.2012.03.012; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Larsen AR, 2008, J ANTIMICROB CHEMOTH, V61, P589, DOI 10.1093/jac/dkm532; Larsen AR, 2008, J CLIN MICROBIOL, V46, P62, DOI 10.1128/JCM.01381-07; Larsen AR, 2009, J CLIN MICROBIOL, V47, P73, DOI 10.1128/JCM.01557-08; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Maier J, 2005, EUR J CLIN MICROBIOL, V24, P637, DOI 10.1007/s10096-005-0008-8; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; McClure JA, 2006, J CLIN MICROBIOL, V44, P1141, DOI 10.1128/JCM.44.3.1141-1144.2006; Monday SR, 1999, J CLIN MICROBIOL, V37, P3411, DOI 10.1128/JCM.37.10.3411-3414.1999; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; Ramdani-Bouguessa N, 2006, ANTIMICROB AGENTS CH, V50, P1083, DOI 10.1128/AAC.50.3.1083-1085.2006; Scicluna EA, 2010, EUR J CLIN MICROBIOL, V29, P163, DOI 10.1007/s10096-009-0834-1; SHANDS KN, 1980, NEW ENGL J MED, V303, P1436, DOI 10.1056/NEJM198012183032502; Shorr AF, 2007, CLIN INFECT DIS, V45, pS171, DOI 10.1086/519473; Song JH, 2011, J ANTIMICROB CHEMOTH, V66, P1061, DOI 10.1093/jac/dkr024; Sonnevend A, 2012, J CLIN PATHOL, V65, P178, DOI 10.1136/jclinpath-2011-200436; Stam-Bolink EM, 2007, EUR J CLIN MICROBIOL, V26, P723, DOI 10.1007/s10096-007-0352-y; Strommenger B, 2008, J CLIN MICROBIOL, V46, P582, DOI 10.1128/JCM.01600-07; STRUELENS MJ, 1992, J CLIN MICROBIOL, V30, P2599, DOI 10.1128/JCM.30.10.2599-2605.1992; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tokajian ST, 2010, EPIDEMIOL INFECT, V138, P707, DOI 10.1017/S0950268810000440; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316; Udo EE, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-31; Urth T, 2005, INFECT CONT HOSP EP, V26, P144, DOI 10.1086/502518; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Witte W, 2004, EUROSURVEILLANCE, V9, P440, DOI DOI 10.2807/ESM.09.01.00440-EN; Yamaguchi T, 2002, INFECT IMMUN, V70, P5835, DOI 10.1128/IAI.70.10.5835-5845.2002; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005; Zhi L, 2010, PLOS ONE, V6	66	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103715	10.1371/journal.pone.0103715	http://dx.doi.org/10.1371/journal.pone.0103715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078407	Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800069
J	Shi, XY; Wu, YY; Ai, ZY; Du, J; Cao, LX; Guo, ZK; Zhang, Y				Shi, Xiaoyan; YongyanWu; Ai, Zhiying; Du, Juan; Cao, Lixia; Guo, Zekun; Zhang, Yong			MicroRNA Modulation Induced by AICA Ribonucleotide in J1 Mouse ES Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; TRANSCRIPTION FACTOR; SMALL-MOLECULE; DIFFERENTIATION; PLURIPOTENCY; EXPRESSION; NANOG; OCT4; GENE	ES cells can propagate indefinitely, maintain self-renewal, and differentiate into almost any cell type of the body. These properties make them valuable in the research of embryonic development, regenerative medicine, and organ transplantation. MicroRNAs (miRNAs) are considered to have essential functions in the maintenance and differentiation of embryonic stem cells (ES cells). It was reported that, strong external stimuli, such as a transient low-pH and hypoxia stress, were conducive to the formation of induced pluripotent stem cells (iPS cells). AICA ribonucleotide (AICAR) is an AMP-activated protein kinase activator, which can let cells in the state of energy stress. We have demonstrated that AICAR can maintain the pluripotency of J1 mouse ES cells through modulating protein expression in our previous research, but its effects on ES cell miRNA expression remain unknown. In this study, we conducted small RNA high-throughput sequencing to investigate AICAR influence on J1 mouse ES cells by comparing the miRNA expression patterns of the AICAR-treated cells and those without treatment. The result showed that AICAR can significantly modulate the expression of multiple miRNAs, including those have crucial functions in ES cell development. Some differentially expressed miRNAs were selected and confirmed by real-time PCR. For the differently expressed miRNAs identified, further study was conducted regarding the pluripotency and differentiation associated miRNAs with their targets. Moreover, miR-134 was significantly down-regulated after AICAR treatment, and this was suggested to be directly associated with the up-regulated pluripotency markers, Nanog and Sox2. Lastly, Myc was significantly down-regulated after AICAR treatment; therefore, we predicted miRNAs that may target Myc and identified that AICAR induced up-regulation of miR-34a, 34b, and 34c can repress Myc expression in J1 mouse ES cells. Taken together, our study provide a new mechanism for AICAR in ES cells pluripotency maintenance and give insight for its usage in iPS cells generation.	[Shi, Xiaoyan; Ai, Zhiying; Du, Juan; Cao, Lixia] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [YongyanWu; Guo, Zekun; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Shi, Xiaoyan; YongyanWu; Ai, Zhiying; Du, Juan; Cao, Lixia; Guo, Zekun; Zhang, Yong] Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Guo, ZK (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	gzk@nwsuaf.edu.cn; zhylab@hotmail.com		Wu, Yongyan/0000-0003-1669-3860	National Natural Science Foundation of China [31172279]; National Major Project for Production of Transgenic Breeding [2013ZX08007-004]; National High Technology Research and Development Program of China (863 Program) [2011AA100303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Project for Production of Transgenic Breeding; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by a grant from the National Natural Science Foundation of China (No. 31172279), the National Major Project for Production of Transgenic Breeding (No. 2013ZX08007-004), and the National High Technology Research and Development Program of China (863 Program) (No. 2011AA100303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Christophersen NS, 2010, J EXP MED, V207, P2287, DOI 10.1084/jem.20101438; Gardner RL, 1998, PATHOL BIOL, V46, P676; Guo Z, 2013, J DERMATOL SCI, V69, P68, DOI 10.1016/j.jdermsci.2012.10.014; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Kang PJ, 2014, BIOMATERIALS, DOI [10.1016/j.biomaterials, DOI 10.1016/J.BIOMATERIALS]; Kim MO, 2012, NAT STRUCT MOL BIOL, V19, P283, DOI 10.1038/nsmb.2217; Koller K, 2013, GENE CHROMOSOME CANC, V52, P709, DOI 10.1002/gcc.22066; Li XN, 2013, J BIOL CHEM, V288, P18121, DOI 10.1074/jbc.M113.478560; Liu XF, 2013, UNIVERSITAS-TAIWAN, V40, P1; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mahmood A, 2010, J BONE MINER RES, V25, P1216, DOI 10.1002/jbmr.34; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Merrill BJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007971; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Obokata H, 2014, NATURE; Ou X, 2014, STEM CELLS, V32, P1183, DOI 10.1002/stem.1641; Puceat M, 2007, CARDIOVASC RES, V74, P256, DOI 10.1016/j.cardiores.2006.12.012; Rothschild SI, 2012, J THORAC ONCOL, V7, P1069, DOI 10.1097/JTO.0b013e31824fe976; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shi XY, 2013, CELL PHYSIOL BIOCHEM, V32, P459, DOI 10.1159/000354451; Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan XC, 2012, P NATL ACAD SCI USA, V109, P15805, DOI 10.1073/pnas.1207787109; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wang YL, 2009, J CELL PHYSIOL, V218, P251, DOI 10.1002/jcp.21607; Wu YY, 2013, EXP CELL RES, V319, P2684, DOI 10.1016/j.yexcr.2013.08.027; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yamamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029722; Ye D, 2012, STEM CELLS, V30, P1645, DOI 10.1002/stem.1149; Zhang XY, 2012, IN VITRO CELL DEV-AN, V48, P131, DOI 10.1007/s11626-012-9482-3; Zovoilis A, 2009, DIFFERENTIATION, V78, P69, DOI 10.1016/j.diff.2009.06.003	42	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103724	10.1371/journal.pone.0103724	http://dx.doi.org/10.1371/journal.pone.0103724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078608	Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800071
J	Hart, KM; Lamont, MM; Sartain, AR; Fujisaki, I				Hart, Kristen M.; Lamont, Margaret M.; Sartain, Autumn R.; Fujisaki, Ikuko			Migration, Foraging, and Residency Patterns for Northern Gulf Loggerheads: Implications of Local Threats and International Movements	PLOS ONE			English	Article							TURTLES CARETTA-CARETTA; STATE-SPACE MODELS; SEA-TURTLES; OF-MEXICO; SATELLITE-TRACKING; HOME-RANGE; POPULATION-MODEL; GREEN TURTLES; FIDELITY; BEHAVIOR	Northern Gulf of Mexico (NGoM) loggerheads (Caretta caretta) make up one of the smallest subpopulations of this threatened species and have declining nest numbers. We used satellite telemetry and a switching state-space model to identify distinct foraging areas used by 59 NGoM loggerheads tagged during 2010-2013. We tagged turtles after nesting at three sites, 1 in Alabama (Gulf Shores; n = 37) and 2 in Florida (St. Joseph Peninsula; n = 20 and Eglin Air Force Base; n = 2). Peak migration time was 22 July to 9 August during which >40% of turtles were in migration mode; the mean post-nesting migration period was 23.0 d (+/- 13.8 d SD). After displacement from nesting beaches, 44 turtles traveled to foraging sites where they remained resident throughout tracking durations. Selected foraging locations were variable distances from tagging sites, and in 5 geographic regions; no turtles selected foraging sites outside the Gulf of Mexico (GoM). Foraging sites delineated using 50% kernel density estimation were located a mean distance of 47.6 km from land and in water with mean depth of -32.5 m; other foraging sites, delineated using minimum convex polygons, were located a mean distance of 43.0 km from land and in water with a mean depth of -24.9 m. Foraging sites overlapped with known trawling activities, oil and gas extraction activities, and the footprint of surface oiling during the 2010 Deepwater Horizon oil spill (n = 10). Our results highlight the year-round use of habitats in the GoM by loggerheads that nest in the NGoM. Our findings indicate that protection of females in this subpopulation requires both international collaborations and management of threats that spatially overlap with distinct foraging habitats.	[Hart, Kristen M.] US Geol Survey, Southeast Ecol Sci Ctr, Ft Lauderdale, FL 33314 USA; [Lamont, Margaret M.] US Geol Survey, Southeast Ecol Sci Ctr, Gainesville, FL USA; [Sartain, Autumn R.] Cherokee Nat Technol Solut LLC, Sci R&D, US Geol Survey, Southeast Ecol Sci Ctr, Davie, FL USA; [Fujisaki, Ikuko] Univ Florida, Ft Lauderdale Res & Educ Ctr, Davie, FL USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Florida	Hart, KM (corresponding author), US Geol Survey, Southeast Ecol Sci Ctr, Ft Lauderdale, FL 33314 USA.	kristen_hart@usgs.gov			KMH by the Natural Resource Damage Assessment (NRDA); U.S. Geological Survey Priority Ecosystem Science (PES) Program	KMH by the Natural Resource Damage Assessment (NRDA); U.S. Geological Survey Priority Ecosystem Science (PES) Program	Funding was provided to KMH by the Natural Resource Damage Assessment (NRDA) and the U.S. Geological Survey Priority Ecosystem Science (PES) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine JW, 1972, TEXAS A M U OCEANOGR, V3; Arendt MD, 2012, MAR BIOL, V159, P113, DOI 10.1007/s00227-011-1826-0; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Benson SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00053.1; Bjorndal KA, 2011, SCIENCE, V331, P537, DOI 10.1126/science.1199935; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bogdanova MI, 2014, BIOL CONSERV, V170, P292, DOI 10.1016/j.biocon.2013.12.025; Bograd Steven J., 2010, Endangered Species Research, V10, P1, DOI 10.3354/esr00269; Bolten A.B., 2003, LOGGERHEAD SEA TURTL, P63; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Campagna C, 2011, BIOSCIENCE, V61, P393, DOI 10.1525/bio.2011.61.5.8; CLS, 2011, ARG US MAN WORLDW TR; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; Dagg MJ, 2003, J MARINE SYST, V43, P133, DOI 10.1016/j.jmarsys.2003.09.002; Dodd C. Kenneth Jr, 2003, Chelonian Conservation and Biology, V4, P530; Eckert SA, 2008, ECOL APPL, V18, P290, DOI 10.1890/06-2107.1; ESRI, 2007, ARCGIS 9 3 GIS; Fertl D., 2005, Gulf and Caribbean Research, V17, P69; Finkbeiner EM, 2011, BIOL CONSERV, V144, P2719, DOI 10.1016/j.biocon.2011.07.033; Foley AM, 2014, MAR BIOL, V161, P1251, DOI 10.1007/s00227-014-2415-9; Foley AM, 2013, ENDANGER SPECIES RES, V21, P129, DOI 10.3354/esr00512; Fossette S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3065; Girard C, 2009, MAR BIOL, V156, P1827, DOI 10.1007/s00227-009-1216-z; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Griffin DB, 2013, MAR BIOL, V160, P3071, DOI 10.1007/s00227-013-2296-3; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hamann M, 2002, J COMP PHYSIOL B, V172, P485, DOI [10.1002/s00360-002-0271-2, 10.1007/s00360-002-0271-2]; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hansson M, 2000, MAR ECOL PROG SER, V198, P191, DOI 10.3354/meps198191; Hart KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066921; Hart KM, 2012, MAR ECOL PROG SER, V457, P193, DOI 10.3354/meps09744; Hart KM, 2012, BIOL CONSERV, V145, P185, DOI 10.1016/j.biocon.2011.10.030; Hatase H, 2004, MAR BIOL, V144, P807, DOI 10.1007/s00227-003-1232-3; Hatase H, 2013, ECOLOGY, V94, P2583, DOI 10.1890/12-1588.1; Hawkes LA, 2007, DIVERS DISTRIB, V13, P447, DOI 10.1111/j.1472-4642.2007.00354.x; Hawkes LA, 2011, DIVERS DISTRIB, V17, P624, DOI 10.1111/j.1472-4642.2011.00768.x; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Hays GC, 2013, FUNCT ECOL, V27, P748, DOI 10.1111/1365-2435.12073; Hays GC, 2010, CONSERV BIOL, V24, P1636, DOI 10.1111/j.1523-1739.2010.01531.x; Hazel Julia, 2007, Endangered Species Research, V3, P105, DOI 10.3354/esr003105; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Hooge P.H. W., 2001, ANIMAL MOVEMENT 2 5; International Maritime Organization (IMO), 2008, COLREG2CIRC60 IMO; International Whaling Commission (IWC), 2008, J CETACEAN RES MAN S, V10, P233; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jones TT, 2013, METHODS ECOL EVOL, V4, P1178, DOI 10.1111/2041-210X.12109; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2006, J ANIM ECOL, V75, P1046, DOI 10.1111/j.1365-2656.2006.01129.x; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Kalman R. E, 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Lagueux Kerry M., 2011, Endangered Species Research, V14, P69, DOI 10.3354/esr00335; Lamont MM, 2014, J HERPETOL, V48, P98, DOI 10.1670/12-217; Lamont MM, 2012, CHELONIAN CONSERV BI, V11, P190, DOI 10.2744/CCB-1006.1; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; LEATHERWOOD S, 1975, MAR FISH REV, V37, P10; Lewison RL, 2007, CONSERV BIOL, V21, P79, DOI 10.1111/j.1523-1739.2006.00592.x; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Malarde J, 2011, IMPROVING ARGOS DOPP; Marcovaldi Maria Angela, 2010, Endangered Species Research, V12, P263, DOI 10.3354/esr00308; Maxwell SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3688; Maxwell SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019905; McDaniel CJ, 2000, CONSERV ECOL, V4; MEYLAN AB, 1983, BIOL CONSERV, V26, P79, DOI 10.1016/0006-3207(83)90050-2; Mitsch WJ, 2001, BIOSCIENCE, V51, P373, DOI 10.1641/0006-3568(2001)051[0373:RNLTTG]2.0.CO;2; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; National Marine Fisheries Service, 2002, ESA BIOL OP SHRIMP T; National Marine Fisheries Service Southeast Fisheries Science Center (NMFS SEFSC), 2008, NOAA TECHNICAL MEMOR; National Marine Fisheries Service U.S. Fish Wildlife Service, 2008, REC PLAN NW ATL POP; Pajuelo M, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00220.1; Pajuelo M, 2012, MAR BIOL, V159, P1255, DOI 10.1007/s00227-012-1906-9; Parauka FM, 2011, J APPL ICHTHYOL, V27, P343, DOI 10.1111/j.1439-0426.2011.01671.x; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Peterson CH, 2012, BIOSCIENCE, V62, P461, DOI 10.1525/bio.2012.62.5.7; Phillips KF, 2014, MAR BIOL, V161, P863, DOI 10.1007/s00227-013-2386-2; Rabalais NN, 2001, COAST EST S, V58, P1; Rees AF, 2010, MAR ECOL PROG SER, V418, P201, DOI 10.3354/meps08767; RENAUD ML, 1994, B MAR SCI, V55, P1; Richards Paul M., 2011, Endangered Species Research, V15, P151, DOI 10.3354/esr00379; Riley GA, 1938, J MAR RES, V1, P60; Rodgers A. R., 2005, HRT HOME RANGE TOOLS; Sammarco PW, 2004, MAR ECOL PROG SER, V280, P129, DOI 10.3354/meps280129; Schofield G, 2013, DIVERS DISTRIB, V19, P834, DOI 10.1111/ddi.12077; Schofield G, 2013, BIOL CONSERV, V161, P101, DOI 10.1016/j.biocon.2013.03.004; Schofield G, 2010, DIVERS DISTRIB, V16, P840, DOI 10.1111/j.1472-4642.2010.00694.x; Schofield G, 2010, BIOL CONSERV, V143, P722, DOI 10.1016/j.biocon.2009.12.011; Schwinghamer P, 1998, CONSERV BIOL, V12, P1215, DOI 10.1046/j.1523-1739.1998.0120061215.x; Scott R, 2012, GLOBAL ECOL BIOGEOGR, V21, P1053, DOI 10.1111/j.1466-8238.2011.00757.x; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Shamblin BM, 2012, MAR ECOL PROG SER, V469, P145, DOI 10.3354/meps09980; Shamblin BM, 2011, MAR BIOL, V158, P571, DOI 10.1007/s00227-010-1582-6; Shaver DJ, 2005, CHELONIAN CONSERV BI, V4, P817; Shaver DJ, 2013, ECOL EVOL, V3, P2002, DOI 10.1002/ece3.594; Shillinger George L., 2010, Endangered Species Research, V10, P215, DOI 10.3354/esr00251; SONNIER F, 1976, COPEIA, P105; Stewart KR, 2013, J ANIM ECOL, V82, P791, DOI 10.1111/1365-2656.12056; Thomson JA, 2012, MAR ECOL PROG SER, V453, P213, DOI 10.3354/meps09637; Troeng S, 2005, MAR BIOL, V148, P435, DOI 10.1007/s00227-005-0076-4; Tucker AD, 2014, MAR ECOL PROG SER, V502, P267, DOI 10.3354/meps10655; Turtle Expert Working Group, 2009, NMFSSEFSC575 NOAA TU, DOI [10.1007/s00227-005-0076-4, DOI 10.1007/S00227-005-0076-4]; U.S. Coast Guard (USCG), 2010, FED REGISTER, V75, P17562; USFWS NMFS, 2013, FED REGISTER, V78, P18000; Weishampel JF, 2004, GLOBAL CHANGE BIOL, V10, P1424, DOI 10.1111/j.1529-8817.2003.00817.x; White G. C., 1990, ANAL WILDLIFE RADIOT; Witherington B, 2009, ECOL APPL, V19, P30, DOI 10.1890/08-0434.1; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022; Work PA, 2010, J EXP MAR BIOL ECOL, V393, P168, DOI 10.1016/j.jembe.2010.07.019; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3; Zanden HBV, 2014, MAR BIOL, V161, P585, DOI 10.1007/s00227-013-2361-y; Zbinden JA, 2008, MAR BIOL, V153, P899, DOI 10.1007/s00227-007-0862-2; Zbinden JA, 2011, MAR ECOL PROG SER, V421, P291, DOI 10.3354/meps08871	116	41	42	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103453	10.1371/journal.pone.0103453	http://dx.doi.org/10.1371/journal.pone.0103453			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076053	Green Submitted, Green Published, gold			2022-12-25	WOS:000340028800047
J	Lu, N; Karlsen, TV; Reed, RK; Kusche-Gullberg, M; Gullberg, D				Lu, Ning; Karlsen, Tine V.; Reed, Rolf K.; Kusche-Gullberg, Marion; Gullberg, Donald			Fibroblast alpha 11 beta 1 Integrin Regulates Tensional Homeostasis in Fibroblast/A549 Carcinoma Heterospheroids	PLOS ONE			English	Article							INTERSTITIAL FLUID PRESSURE; CELL LUNG-CANCER; IN-VITRO; TUMOR SPHEROIDS; MYOFIBROBLAST DIFFERENTIATION; CXCR2 EXPRESSION; GENE-EXPRESSION; TGF-BETA; MIGRATION; GROWTH	We have previously shown that fibroblast expression of alpha 11 beta 1 integrin stimulates A549 carcinoma cell growth in a xenograft tumor model. To understand the molecular mechanisms whereby a collagen receptor on fibroblast can regulate tumor growth we have used a 3D heterospheroid system composed of A549 tumor cells and fibroblasts without (alpha 11(+/+)) or with a deletion (alpha 11(-/-)) in integrin alpha 11 gene. Our data show that alpha 11(-/-)/A549 spheroids are larger than alpha 11(+/+)/A549 spheroids, and that A549 cell number, cell migration and cell invasion in a collagen I gel are decreased in alpha 11(-/-)/A549 spheroids. Gene expression profiling of differentially expressed genes in fibroblast/A549 spheroids identified CXCL5 as one molecule down-regulated in A549 cells in the absence of alpha 11 on the fibroblasts. Blocking CXCL5 function with the CXCR2 inhibitor SB225002 reduced cell proliferation and cell migration of A549 cells within spheroids, demonstrating that the fibroblast integrin alpha 11 beta 1 in a 3D heterospheroid context affects carcinoma cell growth and invasion by stimulating autocrine secretion of CXCL5. We furthermore suggest that fibroblast alpha 11 beta 1 in fibroblast/A549 spheroids regulates interstitial fluid pressure by compacting the collagen matrix, in turn implying a role for stromal collagen receptors in regulating tensional hemostasis in tumors. In summary, blocking stromal alpha 11 beta 1 integrin function might thus be a stroma-targeted therapeutic strategy to increase the efficacy of chemotherapy.	[Lu, Ning; Karlsen, Tine V.; Reed, Rolf K.; Kusche-Gullberg, Marion; Gullberg, Donald] Univ Bergen, Dept Biomed, Bergen, Norway; [Lu, Ning; Reed, Rolf K.; Kusche-Gullberg, Marion; Gullberg, Donald] Univ Bergen, Norwegian Ctr Excellence, Ctr Canc Biomarkers, Bergen, Norway	University of Bergen; University of Bergen	Gullberg, D (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	donald.gullberg@biomed.uib.no	Reed, Rolf K./B-9422-2017; Gullberg, Donald/H-2495-2016; Kusche-Gullberg, Marion/P-4466-2016	Reed, Rolf K./0000-0002-2633-6595; Gullberg, Donald/0000-0002-7245-4437; Kusche-Gullberg, Marion/0000-0002-5636-1695; Karlsen, Tine Veronica/0000-0002-1512-2479	Research council of Norway [183258, 197066]; Norwegian Centre of Excellence grant [223250]; Norwegian cancer society [536711, 3292722]	Research council of Norway(Research Council of Norway); Norwegian Centre of Excellence grant; Norwegian cancer society(Norwegian Cancer Society)	This research was supported by grants from Research council of Norway (http://www.forskningsradet.no/, grants 183258; 197066 to DG) and Norwegian Centre of Excellence grant (http://www.forskningsradet.no/, grants 223250), and the Norwegian cancer society (https://kreftforeningen.no, id 536711to DG; id 3292722 to MKG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenberg DA, 1998, J CLIN INVEST, V102, P465, DOI 10.1172/JCI3145; Carracedo S, 2010, J BIOL CHEM, V285, P10434, DOI 10.1074/jbc.M109.078766; Eberlein C, 2014, ONCOGENE; Enzerink A, 2009, MOL IMMUNOL, V46, P1787, DOI 10.1016/j.molimm.2009.01.018; Francia G, 2004, MOL CELL BIOL, V24, P6837, DOI 10.1128/mcb.24.15.6837-6849.2004; Green SK, 2004, MOL CANCER THER, V3, P149; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Ivascu A, 2007, INT J ONCOL, V31, P1403; JAIN RK, 1987, CANCER RES, V47, P3039; Kankuri E, 2005, CANCER RES, V65, P9914, DOI 10.1158/0008-5472.CAN-05-1559; Kilarski WW, 2005, LAB INVEST, V85, P643, DOI 10.1038/labinvest.3700255; Kim BJ, 2007, BIOTECHNOL BIOENG, V96, P1167, DOI 10.1002/bit.21205; Kim JB, 2004, BREAST CANCER RES TR, V85, P281, DOI 10.1023/B:BREA.0000025418.88785.2b; Kunz-Schughart LA, 1998, INT J EXP PATHOL, V79, P1, DOI 10.1046/j.1365-2613.1998.00051.x; Kunz-Schughart LA, 2003, AM J PHYSIOL-CELL PH, V284, pC209, DOI 10.1152/ajpcell.00557.2001; Kunz-Schughart LA, 2001, EXP CELL RES, V266, P74, DOI 10.1006/excr.2001.5210; Kunz-Schughart LA, 2006, AM J PHYSIOL-CELL PH, V290, pC1385, DOI 10.1152/ajpcell.00248.2005; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Lu N, 2010, MATRIX BIOL, V29, P166, DOI 10.1016/j.matbio.2009.11.003; Luppi F, 2007, LUNG CANCER, V56, P25, DOI 10.1016/j.lungcan.2006.11.014; Marsh T., 2012, BIOCH BIOPHYS ACTA; Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536; MUELLERKLIESER W, 1983, ADV EXP MED BIOL, V159, P497; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Okabe H, 2012, INT J CANCER, V131, P2234, DOI 10.1002/ijc.27496; Osterholm C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041334; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pettet GJ, 2001, B MATH BIOL, V63, P231, DOI 10.1006/bulm.2000.0217; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Popova SN, 2004, DEV BIOL, V270, P427, DOI 10.1016/j.ydbio.2004.03.006; Popova SN, 2007, MOL CELL BIOL, V27, P4306, DOI 10.1128/MCB.00041-07; Rangarajan R, 2008, CELL ADHES MIGR, V2, P106, DOI 10.4161/cam.2.2.6211; REED RK, 1992, CIRC RES, V71, P978, DOI 10.1161/01.RES.71.4.978; Robinson EE, 2003, J CELL SCI, V116, P377, DOI 10.1242/jcs.00231; Saintigny P, 2013, CANCER RES, V73, P571, DOI 10.1158/0008-5472.CAN-12-0263; Salmenpera P, 2008, EXP CELL RES, V314, P3444, DOI 10.1016/j.yexcr.2008.09.004; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Seidl P, 2002, INT J CANCER, V102, P129, DOI 10.1002/ijc.10675; Silzle T, 2003, EUR J IMMUNOL, V33, P1311, DOI 10.1002/eji.200323057; Stein AM, 2007, BIOPHYS J, V92, P356, DOI 10.1529/biophysj.106.093468; Stuhr LEB, 2003, AM J PHYSIOL-CELL PH, V285, pC1101, DOI 10.1152/ajpcell.00050.2003; Svendsen OS, 2009, ARTERIOSCL THROM VAS, V29, P1864, DOI 10.1161/ATVBAHA.109.194308; Takacova M, 2007, INT J ONCOL, V31, P1103; Talior-Volodarsky I, 2012, CARDIOVASC RES, V96, P265, DOI 10.1093/cvr/cvs259; Tazzyman S, 2011, INT J CANCER, V129, P847, DOI 10.1002/ijc.25987; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; Velling T, 1999, J BIOL CHEM, V274, P25735, DOI 10.1074/jbc.274.36.25735; WIIG H, 1981, MICROVASC RES, V21, P308, DOI 10.1016/0026-2862(81)90014-5; Xu ZG, 2012, ANAT REC, V295, P1446, DOI 10.1002/ar.22521; Yanagawa J, 2009, CLIN CANCER RES, V15, P6820, DOI 10.1158/1078-0432.CCR-09-1558; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yip D, 2013, BIOCHEM BIOPH RES CO, V433, P327, DOI 10.1016/j.bbrc.2013.03.008; Zhou SL, 2012, HEPATOLOGY, V56, P2242, DOI 10.1002/hep.25907; Zhu CQ, 2007, P NATL ACAD SCI USA, V104, P11754, DOI 10.1073/pnas.0703040104	56	20	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103173	10.1371/journal.pone.0103173	http://dx.doi.org/10.1371/journal.pone.0103173			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076207	gold, Green Submitted, Green Published			2022-12-25	WOS:000340028800029
J	Nagy, A; Cernikova, L; Jirincova, H; Havlickova, M; Hornickova, J				Nagy, Alexander; Cernikova, Lenka; Jirincova, Helena; Havlickova, Martina; Hornickova, Jitka			Local-Scale Diversity and Between-Year "Frozen Evolution" of Avian Influenza A Viruses in Nature	PLOS ONE			English	Article							RT-PCR; HEMAGGLUTININ; REASSORTMENT; PERSISTENCE; PATTERNS; WATER; NEURAMINIDASE; SURVEILLANCE; ACCUMULATION; INFECTIONS	Influenza A virus (IAV) in wild bird reservoir hosts is characterized by the perpetuation in a plethora of subtype and genotype constellations. Multiyear monitoring studies carried out during the last two decades worldwide have provided a large body of knowledge regarding the ecology of IAV in wild birds. Nevertheless, other issues of avian IAV evolution have not been fully elucidated, such as the complexity and dynamics of genetic interactions between the co-circulating IAV genomes taking place at a local-scale level or the phenomenon of frozen evolution. We investigated the IAV diversity in a mallard population residing in a single pond in the Czech Republic. Despite the relative small number of samples collected, remarkable heterogeneity was revealed with four different IAV subtype combinations, H6N2, H6N9, H11N2, and H11N9, and six genomic constellations in co-circulation. Moreover, the H6, H11, and N2 segments belonged to two distinguishable sub-lineages. A reconstruction of the pattern of genetic reassortment revealed direct parent-progeny relationships between the H6N2, H11N9 and H6N9 viruses. Interestingly the IAV, with the H6N9 subtype, was re-detected a year later in a genetically unchanged form in the close proximity of the original sampling locality. The almost absolute nucleotide sequence identity of all the respective genomic segments between the two H6N9 viruses indicates frozen evolution as a result of prolonged conservation in the environment. The persistence of the H6N9 IAV in various abiotic and biotic environmental components was also discussed.	[Nagy, Alexander; Cernikova, Lenka; Hornickova, Jitka] State Vet Inst Prague, Natl Reference Lab Avian Influenza & Newcastle Di, Lab Mol Methods, Prague, Czech Republic; [Nagy, Alexander; Jirincova, Helena; Havlickova, Martina] Natl Inst Publ Hlth, Ctr Epidemiol & Microbiol, Natl Reference Lab Influenza, Prague, Czech Republic	National Institute of Public Health (SZU) - Czech Republic	Nagy, A (corresponding author), State Vet Inst Prague, Natl Reference Lab Avian Influenza & Newcastle Di, Lab Mol Methods, Prague, Czech Republic.	alexander.nagy@svupraha.cz	Jirincova, Helena/GRJ-0968-2022		Ministry of Health of the Czech Republic [IGA NT 12493-3/2011]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	The work was supported in part by research grant IGA NT 12493-3/2011, Ministry of Health of the Czech Republic. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bountouri M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-350; Chambers TM, 2013, TEXTBOOK OF INFLUENZA, 2ND EDITION, P203; Chen RB, 2006, MOL BIOL EVOL, V23, P2336, DOI 10.1093/molbev/msl102; Delogu M, 2012, EPIDEMIOL BIOSTAT PU, V9, P29; Delogu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011315; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; ENDO A, 1992, ARCH VIROL, V123, P73, DOI 10.1007/BF01317139; Faust C, 2009, P ROY SOC B-BIOL SCI, V276, P3727, DOI 10.1098/rspb.2009.0572; Fereidouni SR, 2009, VET MICROBIOL, V135, P253, DOI 10.1016/j.vetmic.2008.09.077; Globig A, 2013, TRANSBOUND EMERG DIS, V60, P395, DOI 10.1111/j.1865-1682.2012.01357.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hatchette TF, 2004, J GEN VIROL, V85, P2327, DOI 10.1099/vir.0.79878-0; HAYASHIDA H, 1985, MOL BIOL EVOL, V2, P289; Henaux V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031471; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Horm VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034160; Huyvaert KP, 2012, VECTOR-BORNE ZOONOT, V12, P904, DOI 10.1089/vbz.2012.0993; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keeler SP, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-13; Krasnitz M, 2008, J VIROL, V82, P8947, DOI 10.1128/JVI.00101-08; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; Lebarbenchon C, 2012, P ROY SOC B-BIOL SCI, V279, P3967, DOI 10.1098/rspb.2012.1271; Li OTW, 2007, J VIROL METHODS, V142, P218, DOI 10.1016/j.jviromet.2007.01.015; Lindsay LL, 2013, VIRUSES-BASEL, V5, P1964, DOI 10.3390/v5081964; Meixell BW, 2013, APPL ENVIRON MICROB, V79, P7249, DOI 10.1128/AEM.02439-13; Monne I, 2008, J CLIN MICROBIOL, V46, P1769, DOI 10.1128/JCM.02204-07; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Nagy A, 2012, VIRUS RES, V165, P126, DOI 10.1016/j.virusres.2012.02.005; Nagy A, 2010, ARCH VIROL, V155, P665, DOI 10.1007/s00705-010-0636-x; Nazir J, 2011, APPL ENVIRON MICROB, V77, P4981, DOI 10.1128/AEM.00415-11; Oesterle PT, 2011, THESIS COLORADO STAT; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Phipps LP, 2004, J VIROL METHODS, V122, P119, DOI 10.1016/j.jviromet.2004.08.008; Qiu BF, 2009, J VIROL METHODS, V155, P193, DOI 10.1016/j.jviromet.2008.10.001; Sharp GB, 1997, J VIROL, V71, P6128, DOI 10.1128/JVI.71.8.6128-6135.1997; Shoham Dany, 2012, Influenza Res Treat, V2012, P912326, DOI 10.1155/2012/912326; Stumpf P, 2010, AVIAN DIS, V54, P1183, DOI 10.1637/9162-111709-Reg.1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tolf C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061201; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Wang RX, 2008, VIROLOGY, V375, P182, DOI 10.1016/j.virol.2008.01.041; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Webster RG, 1998, EMERG INFECT DIS, V4, P436, DOI 10.3201/eid0403.980325; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010; Wille M, 2013, VIROLOGY, V443, P150, DOI 10.1016/j.virol.2013.05.004; Worobey M, 2008, J VIROL, V82, P3769, DOI 10.1128/JVI.02207-07	48	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103053	10.1371/journal.pone.0103053	http://dx.doi.org/10.1371/journal.pone.0103053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075739	Green Published, gold			2022-12-25	WOS:000340028800024
J	Yoo, JS; Das, RK; Jow, ZY; Chang, YT				Yoo, Jung Sun; Das, Raj Kumar; Jow, Zhi Yen; Chang, Young-Tae			In Vivo Detection of Macrophage Recruitment in Hind-Limb Ischemia Using a Targeted Near-Infrared Fluorophore	PLOS ONE			English	Article							ATHEROSCLEROTIC PLAQUES; MAGNETIC-RESONANCE; FLUORESCENCE; DISEASE; LIMB; ANGIOGENESIS; INFLAMMATION; HOMEOSTASIS; MONOCYTES; CANCER	Macrophages are an essential component of the immune system and have protective and pathogenic functions in various diseases. Imaging of macrophages in vivo could furnish new tools to advance evaluation of disease and therapies. Critical limb ischemia is a disease in which macrophages have considerable pathogenic roles, and are potential targets for cell-based immunotherapy. We sought to develop a new near-infrared fluorescence (NIRF) imaging probe to target macrophages specifically in vivo in various pathological states, including hind-limb ischemia. We rapidly screened the photostable cyanine-based NIRF library against different blood cell lines. The identified monocyte/macrophage-selective hit was tested in vitro in live-cell labeling assay. Non-invasive NIRF imaging was performed with murine models of paw inflammation by lipopolysaccharide challenge and hind-limb ischemia with femoral artery ligation. in vivo macrophage targeting was further evaluated using intravital microscopy with Csf1r-EGFP transgenic mice and immunofluorescent staining with macrophage-specific markers. We discovered MF800, a Macrophage-specific near-infrared Fluorophore, which showed selective live-cell imaging performance in a panel of cell lines and primary human blood samples. MF800 outperforms the clinically-available NIRF contrast agent ICG for in vivo specificity in paw inflammation and hind-limb ischemia models. We observed a marked overlap of MF800-labeled cells and EGFP-expressing macrophages in intravital imaging of Csf1r-EGFP transgenic mice. In the histologic analysis, MF800-positive cells also expressed the macrophage markers CD68 and CD169. NIRF imaging showcased the potential of using MF800 to understand macrophage behavior in vivo, characterize macrophage-associated diseases, and may help in assessing therapeutic responses in the clinic.	[Yoo, Jung Sun] Seoul Natl Univ, Smart Human Convergence Ctr, Grad Sch Convergence Sci & Technol, Dept Transdisciplinary Studies, Suwon, South Korea; [Yoo, Jung Sun; Das, Raj Kumar; Chang, Young-Tae] Natl Univ Singapore, Dept Chem, Singapore 117548, Singapore; [Jow, Zhi Yen; Chang, Young-Tae] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Bioimaging Probe Dev, Singapore, Singapore	Seoul National University (SNU); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC)	Chang, YT (corresponding author), Natl Univ Singapore, Dept Chem, Singapore 117548, Singapore.	chmcyt@nus.edu.sg	Chang, Young-Tae/B-2780-2010; Yoo, Jung Sun/I-8760-2017	Chang, Young-Tae/0000-0002-1927-3688; Yoo, Jung Sun/0000-0002-8865-0424	A*STAR (Agency for Science, Technology and Research, Singapore) Biomedical Research Council; Singapore Ministry of Education Academic Research Fund Tier 2 [MOE2010-T2-2-030]	A*STAR (Agency for Science, Technology and Research, Singapore) Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Education Academic Research Fund Tier 2(Ministry of Education, Singapore)	This study was supported by intramural funding from A*STAR (Agency for Science, Technology and Research, Singapore) Biomedical Research Council, and by the Singapore Ministry of Education Academic Research Fund Tier 2 (MOE2010-T2-2-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger JS, 2012, CIRCULATION, V126, P491, DOI 10.1161/CIRCULATIONAHA.111.033886; CAMPBELL WB, 1994, ANN ROY COLL SURG, V76, P205; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Das RK, 2011, RSC ADV, V1, P573, DOI 10.1039/c1ra00498k; Deguchi J, 2006, CIRCULATION, V114, P55, DOI 10.1161/CIRCULATIONAHA.106.619056; FDA, 2013, PROD INS IND GREEN I; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Garcia-Allende PB, 2013, J NUCL MED, V54, P664, DOI 10.2967/jnumed.111.099796; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Hirose N, 2008, CELL TRANSPLANT, V17, P211, DOI 10.3727/000000008783906919; Jaffer FA, 2008, CIRCULATION, V118, P1802, DOI 10.1161/CIRCULATIONAHA.108.785881; Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141; Kooi ME, 2003, CIRCULATION, V107, P2453, DOI 10.1161/01.CIR.0000068315.98705.CC; Lee SC, 2013, MATERIALS, V6, P1779, DOI 10.3390/ma6051779; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Moazzami K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008347.pub2; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nahrendorf M, 2010, P NATL ACAD SCI USA, V107, P7910, DOI 10.1073/pnas.0915163107; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Pande AN, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2186337; Patel AS, 2013, EMBO MOL MED, V5, P858, DOI 10.1002/emmm.201302752; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Samanta A, 2010, CHEM COMMUN, V46, P7406, DOI 10.1039/c0cc02366c; Sanberg PR, 2010, J CELL MOL MED, V14, P553, DOI 10.1111/j.1582-4934.2009.00903.x; Saxena A, 2013, MOL IMAGING BIOL, V15, P282, DOI 10.1007/s11307-012-0599-2; Severino DN, 2009, INFLAMMATION, V32, P57, DOI 10.1007/s10753-008-9102-2; Sevick-Muraca EM, 2012, ANNU REV MED, V63, P217, DOI 10.1146/annurev-med-070910-083323; Tu CQ, 2010, J AM CHEM SOC, V132, P2016, DOI 10.1021/ja909303g; Vahrmeijer AL, 2013, NAT REV CLIN ONCOL, V10, P507, DOI 10.1038/nrclinonc.2013.123; Waldeck J, 2008, J NUCL MED, V49, P1845, DOI 10.2967/jnumed.108.052514; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	33	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103721	10.1371/journal.pone.0103721	http://dx.doi.org/10.1371/journal.pone.0103721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072508	Green Submitted, gold, Green Published			2022-12-25	WOS:000341307600081
J	de Castro, MV; Bissaco, MAS; Panccioni, BM; Rodrigues, SCM; Domingues, AM				de Castro, Marcus Vasconcelos; Silva Bissaco, Marcia Aparecida; Panccioni, Bruno Marques; Martini Rodrigues, Silvia Cristina; Domingues, Andreia Miranda			Effect of a Virtual Environment on the Development of Mathematical Skills in Children with Dyscalculia	PLOS ONE			English	Article							COMPUTER GAMES; EDUCATION; STUDENTS	In this study, we show the effectiveness of a virtual environment comprising 18 computer games that cover mathematics topics in a playful setting and that can be executed on the Internet with the possibility of player interaction through chat. An arithmetic pre-test contained in the Scholastic Performance Test was administered to 300 children between 7 and 10 years old, including 162 males and 138 females, in the second grade of primary school. Twenty-six children whose scores showed a low level of mathematical knowledge were chosen and randomly divided into the control (CG) and experimental (EG) groups. The EG participated to the virtual environment and the CG participated in reinforcement using traditional teaching methods. Both groups took a post-test in which the Scholastic Performance Test (SPT) was given again. A statistical analysis of the results using the Student's t-test showed a significant learning improvement for the EG and no improvement for the CG (p <= 0.05). The virtual environment allows the students to integrate thought, feeling and action, thus motivating the children to learn and contributing to their intellectual development	[de Castro, Marcus Vasconcelos; Martini Rodrigues, Silvia Cristina; Domingues, Andreia Miranda] Nove de Julho Univ UNINOVE, Sao Paulo, Brazil; [de Castro, Marcus Vasconcelos; Silva Bissaco, Marcia Aparecida; Panccioni, Bruno Marques; Domingues, Andreia Miranda] UMC, Technol Res Ctr, Sao Paulo, Brazil; [Panccioni, Bruno Marques] Technol Coll Mogi Cruzes FATEC, Sao Paulo, Brazil	Universidade Nove de Julho; Universidade de Mogi das Cruzes	Bissaco, MAS (corresponding author), UMC, Technol Res Ctr, Sao Paulo, Brazil.	mbissaco@gmail.com	Bissaco, Marcia Aparecida S/I-4904-2013; Domingues, Andreia Miranda/AAZ-5947-2021		FAEP - Foundation for Support to Education and Research; FAPESP - Sao Paulo Research Foundation; CAPES - Coordination for the Improvement of Higher Education Personnel	FAEP - Foundation for Support to Education and Research; FAPESP - Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES - Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	MASB and SCMR gratefully acknowledge financial support from the FAEP - Foundation for Support to Education and Research and FAPESP - Sao Paulo Research Foundation. AMD and BMP acknowledge research grant support from CAPES - Coordination for the Improvement of Higher Education Personnel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M.D., 2003, ACM COMPUTERS ENTERT, V1, P10; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Andersson U, 2007, J EXP CHILD PSYCHOL, V96, P197, DOI 10.1016/j.jecp.2006.10.001; [Anonymous], REV ZETETIKE; Ansari D, 2006, TRENDS COGN SCI, V10, P146, DOI 10.1016/j.tics.2006.02.007; Archibald LMD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077463; Ardito C, 2013, EDUC TECHNOL SOC, V16, P44; Arnab S, 2013, COMPUT EDUC, V69, P15, DOI 10.1016/j.compedu.2013.06.013; Bertolo M, 2013, INTED PROC, P698; Biembengut MS, 2000, MATH MODELLING TEACH, P9; Bottino RM, 2007, COMPUT EDUC, V49, P1272, DOI 10.1016/j.compedu.2006.02.003; Brooks AL, 2010, STUD COMPUT INTELL, V326, P143; Brunda A, 2010, P 1 AMR ACM W CEL WO, P16; Butterworth B., 2005, HDB MATH COGNITION, V1st, P455; Butterworth B, 2003, MIN DES REH SOFT DYS; Castelhano N, 2013, OCCUP THER INT, V20, P134, DOI 10.1002/oti.1347; Castro-Canizares D, 2009, REV NEUROLOGIA, V49, P143, DOI 10.33588/rn.4903.2008488; Chuang TY, 2009, EDUC TECHNOL SOC, V12, P1; Coelho JP, 2008, PSYCHOLOGY, V26, P663; Csikszentmihalyi M., 1991, FLOW PSYCHOL OPTIMAL; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P186, DOI 10.1016/j.jecp.2009.01.004; Dehaene S, 2004, CURR OPIN NEUROBIOL, V14, P218, DOI 10.1016/j.conb.2004.03.008; Dehaene Stanislas, 2011, NUMBER SENSE MIND CR, DOI 10.1016/C2010-0-66570-9; Dellatolas G, 2007, EUROPEAN CHILD ADOLE, V9, P102; Department for Education and Skills-DFES, 2001, 05212001 DFES; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Ecalle J, 2009, COMPUT EDUC, V52, P554, DOI 10.1016/j.compedu.2008.10.010; Echeverria A, 2011, COMPUT EDUC, V57, P1127, DOI 10.1016/j.compedu.2010.12.010; Ferrer G., 2006, ED ASSESSMENT SYSTEM; Figueiredo CZ, 2005, PORTO ALEGRE, V3, P1; Geary D, 2010, ENCY EARLY CHILDHOOD, P1; Geary DC, 2011, J DEV BEHAV PEDIATR, V32, P250, DOI 10.1097/DBP.0b013e318209edef; Geary DC, 2000, J EXP CHILD PSYCHOL, V77, P236, DOI 10.1006/jecp.2000.2561; Gee JP, 2003, COMPUTERS ENTERTAINM, V1, P20, DOI DOI 10.1145/950566.950595; Ginsburg H. P., 1998, HDB CHILD PSYCHOL CH, V4, P401; GrossTsur V, 1996, DEV MED CHILD NEUROL, V38, P25, DOI 10.1111/j.1469-8749.1996.tb15029.x; Hughes S, 1994, J INSTRUCTIONAL PSYC, V21, P64; Kadosh RC, 2008, PROG NEUROBIOL, V84, P132, DOI 10.1016/j.pneurobio.2007.11.001; Ke FF, 2008, ETR&D-EDUC TECH RES, V56, P539, DOI 10.1007/s11423-008-9086-5; Krajewski K, 2009, J EXP CHILD PSYCHOL, V103, P516, DOI 10.1016/j.jecp.2009.03.009; Landerl K, 2009, J EXP CHILD PSYCHOL, V103, P309, DOI 10.1016/j.jecp.2009.03.006; Li YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070160; MacArthur CA, 2001, ELEM SCHOOL J, V101, P273, DOI 10.1086/499669; Macaruso P, 2006, J RES READ, V29, P162, DOI 10.1111/j.1467-9817.2006.00282.x; Magnan A, 2006, COMPUT EDUC, V46, P407, DOI 10.1016/j.compedu.2004.08.008; MCCLOSKEY M, 1985, BRAIN COGNITION, V4, P171, DOI 10.1016/0278-2626(85)90069-7; Moita F, 2007, GAMEON JOGOS ELETRON; Nicolson R., 2000, J RES READ, V23, P194, DOI [10.1111/1467-9817.00114, DOI 10.1111/1467-9817.00114]; OECD, 2006, DIR ED SKILLS CHILDH; Papastergiou M, 2009, COMPUT EDUC, V52, P1, DOI 10.1016/j.compedu.2008.06.004; Ponte JP, 1998, I ED INNOVATION, P21; Rasanen P, 2009, COGNITIVE DEV, V24, P450, DOI 10.1016/j.cogdev.2009.09.003; Rethey-Prikkel B, 2007, EURO LOGO CONFERENCE; Rethey-Prikkel B, 2007, P EUROLOGO 2007; Rizzo G, 2001, JOGOS INTELIGENTS CO, P442; Rotzer S, 2009, NEUROPSYCHOLOGIA, V47, P2859, DOI 10.1016/j.neuropsychologia.2009.06.009; Santos VM, 2009, REVISTA ZETETIKE, V32; SARESP, 2013, ASS SYST SCH ACH SAO; Seo YJ, 2009, COMPUT EDUC, V53, P913, DOI 10.1016/j.compedu.2009.05.002; Shalev RS, 2004, J CHILD NEUROL, V19, P765, DOI 10.1177/08830738040190100601; Shalev RS, 2005, DEV MED CHILD NEUROL, V47, P121, DOI 10.1017/S0012162205000216; Shalev RS, 2001, J LEARN DISABIL-US, V34, P59, DOI 10.1177/002221940103400105; Shin N, 2006, P 7 INT C LEARN SCI, P702; Siegel LS, 1999, J LEARN DISABIL-US, V32, P304, DOI 10.1177/002221949903200405; Soltesz F, 2007, NEUROSCI LETT, V417, P181, DOI 10.1016/j.neulet.2007.02.067; Srinivasan V, 2008, P 2008 C FUT PLAY RE, V2008, P196; Stein L. M., 1994, TDE TESTE DESEMPENHO; Stieler-Hunt C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00073; Strauss V, 2003, WASHINGTON POST 1202; Valentini M, 2012, EDUCATION, V2, P123; von Aster MG, 2007, DEV MED CHILD NEUROL, V49, P868, DOI 10.1111/j.1469-8749.2007.00868.x; Voss U, 2012, J SLEEP RES, V21, P634, DOI 10.1111/j.1365-2869.2012.01022.x; Vygotsky LS, 1980, ROLE PALY DEV MIND S, P90; Wang Q, 2011, VISUAL COMPUT, V27, P299, DOI 10.1007/s00371-011-0551-5; Wang SK, 2006, ETR&D-EDUC TECH RES, V54, P597, DOI 10.1007/s11423-006-0638-2; Wilson AJ, 2007, HUM BEH LEARN DEV BR; Wilson Anna J, 2006, Behav Brain Funct, V2, P19, DOI 10.1186/1744-9081-2-19; Wilson Anna J, 2006, Behav Brain Funct, V2, P20, DOI 10.1186/1744-9081-2-20; Zamarian L, 2009, NEUROSCI BIOBEHAV R, V33, P909, DOI 10.1016/j.neubiorev.2009.03.005	79	20	21	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103354	10.1371/journal.pone.0103354	http://dx.doi.org/10.1371/journal.pone.0103354			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RZ	25068511	gold, Green Submitted, Green Published			2022-12-25	WOS:000339993700065
J	Jansen, C; Eischeid, H; Goertzen, J; Schierwagen, R; Anadol, E; Strassburg, CP; Sauerbruch, T; Odenthal, M; Trebicka, J				Jansen, Christian; Eischeid, Hannah; Goertzen, Jan; Schierwagen, Robert; Anadol, Evrim; Strassburg, Christian P.; Sauerbruch, Tilman; Odenthal, Margarete; Trebicka, Jonel			The Role of miRNA-34a as a Prognostic Biomarker for Cirrhotic Patients with Portal Hypertension Receiving TIPS	PLOS ONE			English	Article							INTRAHEPATIC PORTOSYSTEMIC SHUNT; NONALCOHOLIC FATTY LIVER; ALCOHOLIC HEPATITIS; NATURAL-HISTORY; HEPATOCELLULAR-CARCINOMA; CIRCULATING MICRORNAS; MIR-34A; STEATOHEPATITIS; VEIN; PATHOPHYSIOLOGY	Background-Circulating miRNA-34a is increased in blood of patients with different liver diseases when compared to healthy controls. However, the origin of miRNA-34a and its possible relationship with hemodynamics and outcome in cirrhotic patients with portal hypertension is unknown. We analyzed the levels of miRNA-34a in cirrhotic patients with severe portal hypertension. Methods: We included 60 cirrhotic patients receiving TIPS for prevention of rebleeding and/or therapy-refractory ascites. miRNA-34a levels were measured using qPCR and normalized by SV-40 in the portal and hepatic venous blood of these patients taken at TIPS procedure. Hemodynamic and clinical parameters were assessed before TIPS and during follow-up. Results: Levels of miRNA-34a were higher in the hepatic vein than in the portal vein. Circulating miRNA-34a in the hepatic vein correlated with ALT, CHE and sodium excretion after TIPS. miRNA-34a showed no correlation with portal pressure, but its levels in the portal vein correlated inversely with the congestion index. Interestingly, the levels of miRNA-34a in the portal and hepatic vein showed inverse correlation with arterial pressure. Furthermore, levels of miRNA-34a in the hepatic vein had a predictive value for survival, but MELD, creatinine at short-time follow-up 14 days after TIPS-insertion and portal pressure after TIPS performed better. Conclusion: This study demonstrates for the first time, that miRNA-34a may originate to a large extent from the liver. Even though higher levels of miRNA-34a are possibly associated with better survival at long-term follow-up in cirrhotic patients with severe portal hypertension receiving TIPS, classical prognostic parameters predict the survival better.	[Jansen, Christian; Goertzen, Jan; Schierwagen, Robert; Anadol, Evrim; Strassburg, Christian P.; Sauerbruch, Tilman; Trebicka, Jonel] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Eischeid, Hannah; Odenthal, Margarete] Univ Cologne, Dept Pathol, Cologne, Germany	University of Bonn; University of Cologne	Trebicka, J (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.	jonel.trebicka@ukb.uni-bonn.de	Schierwagen, Robert/AAE-6305-2019	Schierwagen, Robert/0000-0002-2195-3666; Gortzen-Patin, Jan/0000-0003-2008-4865; Trebicka, Jonel/0000-0002-7028-3881	Deutsche Forschungsgemeinschaft [SFB TRR57 P18]; J. & W. Hector-Foundation; Research and Education program of the Medical Faculty of the University of Cologne; German Ministry of Education and Research (BMBF) [01KI0601]; German Liver Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); J. & W. Hector-Foundation; Research and Education program of the Medical Faculty of the University of Cologne; German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Liver Foundation	The study was supported by grants from Deutsche Forschungsgemeinschaft (SFB TRR57 P18 to J.T./T.S.) and from J. & W. Hector-Foundation (to J.T.). This study was further supported by the Research and Education program of the Medical Faculty of the University of Cologne and funded by the German Ministry of Education and Research (BMBF), Grant No. 01KI0601 (to MD.) and the German Liver Foundation (to MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JF, 1971, AM J GASTROENTEROL, V56, P515; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benvegnu L, 2004, GUT, V53, P744, DOI 10.1136/gut.2003.020263; Bosch J, 2000, J HEPATOL, V32, P141, DOI 10.1016/S0168-8278(00)80422-5; BOYER TD, 1977, GASTROENTEROLOGY, V72, P584; Brensing KA, 2000, GUT, V47, P288, DOI 10.1136/gut.47.2.288; Bureau C, 2011, J HEPATOL, V54, P901, DOI 10.1016/j.jhep.2010.08.025; Garcia-Pagan JC, 2013, J HEPATOL, V58, P45, DOI 10.1016/j.jhep.2012.08.020; Garcia-Pagan JC, 2010, NEW ENGL J MED, V362, P2370, DOI 10.1056/NEJMoa0910102; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; CHEDID A, 1991, AM J GASTROENTEROL, V86, P210; de Franchis R, 2010, J HEPATOL, V53, P762, DOI 10.1016/j.jhep.2010.06.004; Di Marco V, 1999, HEPATOLOGY, V30, P257, DOI 10.1002/hep.510300109; Dunn W, 2005, HEPATOLOGY, V41, P353, DOI 10.1002/hep.20503; Ekataksin W, 1999, SEMIN LIVER DIS, V19, P359, DOI 10.1055/s-2007-1007126; Forrest EH, 2005, GUT, V54, P1174, DOI 10.1136/gut.2004.050781; Groszmann RJ, 2005, NEW ENGL J MED, V353, P2254, DOI 10.1056/NEJMoa044456; Lee YM, 2005, SEMIN LIVER DIS, V25, P321, DOI 10.1055/s-2005-916323; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Locke JM, 2014, ACTA DIABETOL, V51, P325, DOI 10.1007/s00592-013-0499-1; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; McCullough AJ, 2006, J CLIN GASTROENTEROL, V40, pS17; MORIYASU F, 1986, AM J ROENTGENOL, V146, P735, DOI 10.2214/ajr.146.4.735; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; Pogribny IP, 2010, LAB INVEST, V90, P1437, DOI 10.1038/labinvest.2010.113; REYNOLDS TB, 1960, NEW ENGL J MED, V263, P734, DOI 10.1056/NEJM196010132631505; Salerno F, 2007, GASTROENTEROLOGY, V133, P825, DOI 10.1053/j.gastro.2007.06.020; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Trebicka J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083341; Trebicka J, 2013, J HEPATOL, V58, P234, DOI 10.1016/j.jhep.2012.10.015; Trebicka J, 2011, EUR J GASTROEN HEPAT, V23, P1218, DOI 10.1097/MEG.0b013e32834a75dc; Wang YT, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-72; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Yamada H, 2013, CLIN CHIM ACTA, V424, P99, DOI 10.1016/j.cca.2013.05.021; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023	36	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103779	10.1371/journal.pone.0103779	http://dx.doi.org/10.1371/journal.pone.0103779			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068403	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993700086
J	Tomao, L; Sbardella, D; Gioia, M; Di Masi, A; Marini, S; Ascenzi, P; Coletta, M				Tomao, Luigi; Sbardella, Diego; Gioia, Magda; Di Masi, Alessandra; Marini, Stefano; Ascenzi, Paolo; Coletta, Massimo			Characterization of the Prostate-Specific Antigen (PSA) Catalytic Mechanism: A Pre-Steady-State and Steady-State Study	PLOS ONE			English	Article							CANCER CELL INVASION; SUBSTRATE-SPECIFICITY; SERINE-PROTEASE; CRYSTAL-STRUCTURE; SEMINAL PLASMA; PH-DEPENDENCE; KALLIKREIN; FLUID; INHIBITOR; INSIGHTS	Prostate-specific antigen (PSA), an enzyme of 30 kDa grouped in the kallikrein family is synthesized to high levels by normal and malignant prostate epithelial cells. Therefore, it is the main biomarker currently used for early diagnosis of prostate cancer. Here, presteady-state and steady-state kinetics of the PSA-catalyzed hydrolysis of the fluorogenic substrate Mu-His-Ser-Ser-Lys-Leu-GIn-AMC (spanning from pH 6.5 to pH 9.0, at 37.0 degrees C) are reported. Steady-state kinetics display at every pH value a peculiar feature, represented by an initial "burst" phase of the fluorescence signal before steady-state conditions are taking place. This behavior, which has been already observed in other members of the kallikrein family, suggests the occurrence of a proteolytic mechanism wherefore the acylation step is faster than the deacylation process. This feature allows to detect the acyl intermediate, where the newly formed C-terminal carboxylic acid of the cleaved substrate forms an ester bond with the -OH group of the Ser195 catalytic residue, whereas the AMC product has been already released. Therefore, the pH-dependence of the two enzymatic steps (i.e., acylation and deacylation) has been separately characterized, allowing the determination of pK(a) values. On this basis, possible residues are tentatively identified in PSA, which might regulate these two steps by interacting with the two portions of the substrate.	[Tomao, Luigi; Di Masi, Alessandra; Ascenzi, Paolo] Univ Roma Tre, Dept Sci, Rome, Italy; [Sbardella, Diego; Gioia, Magda; Marini, Stefano; Coletta, Massimo] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy; [Sbardella, Diego; Gioia, Magda; Marini, Stefano; Coletta, Massimo] Interuniv Consortium Res Chem Met Biol Syst, Bari, Italy; [Di Masi, Alessandra; Ascenzi, Paolo] Univ Roma Tre, Interdept Lab Electron Microscopy, Rome, Italy	Italfarmaco; Roma Tre University; University of Rome Tor Vergata; Roma Tre University	Coletta, M (corresponding author), Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy.	coletta@seneca.uniroma2.it	Sbardella, Diego/N-9187-2015; Coletta, Massimiliano/GSN-5927-2022; Marini, Stefano/B-1161-2012; Sbardella, Diego/K-7519-2016; Tomao, Luigi/AAH-9980-2019; Coletta, Massimo/N-9049-2015; Gioia, Magda/AAD-4781-2022; di Masi, Alessandra/K-2300-2018; Gioia, Magda/ABF-8909-2020	Marini, Stefano/0000-0003-1299-6696; Sbardella, Diego/0000-0002-9924-7761; Tomao, Luigi/0000-0002-4774-3042; Gioia, Magda/0000-0003-0352-3547; COLETTA, Massimiliano/0000-0002-5489-9467	Italian Ministery of University and Research [MiUR 265 PRIN 200993WWF_003]	Italian Ministery of University and Research	This work was financially supported by the Italian Ministery of University and Research (MiUR 265 PRIN 200993WWF_003 to M.C. and CLA 2014 to P.A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONINI E, 1981, J BIOL CHEM, V256, P2449; ASCENZI P, 1989, BIOCHIM BIOPHYS ACTA, V998, P210, DOI 10.1016/0167-4838(89)90275-6; ASCENZI P, 1984, BIOCHIM BIOPHYS ACTA, V785, P75, DOI 10.1016/0167-4838(84)90236-X; COHEN P, 1992, J CLIN ENDOCR METAB, V75, P1046, DOI 10.1210/jc.75.4.1046; Dallas SL, 2005, J CELL PHYSIOL, V202, P361, DOI 10.1002/jcp.20147; Denmeade SR, 1997, CANCER RES, V57, P4924; Denmeade SR, 2001, PROSTATE, V48, P1; Edstrom AML, 2008, J IMMUNOL, V181, P3413, DOI 10.4049/jimmunol.181.5.3413; Fernandez IS, 2008, J MOL BIOL, V377, P1488, DOI 10.1016/j.jmb.2008.01.089; Gioia M, 2010, J BIOL INORG CHEM, V15, P1219, DOI 10.1007/s00775-010-0680-8; Ilic D, 2011, BJU INT, V107, P882, DOI 10.1111/j.1464-410X.2010.10032.x; Ishii K, 2004, CANCER LETT, V207, P79, DOI 10.1016/j.canlet.2003.09.029; Iwamura M, 1996, UROLOGY, V48, P317, DOI 10.1016/S0090-4295(96)00182-3; LeBeau AM, 2009, BIOCHEMISTRY-US, V48, P3490, DOI 10.1021/bi9001858; LILJA H, 1985, J CLIN INVEST, V76, P1899, DOI 10.1172/JCI112185; Lilja H., 2000, COMPREHENSIVE TXB GE, P638; Malm J, 2000, PROSTATE, V45, P132, DOI 10.1002/1097-0045(20001001)45:2<132::AID-PROS7>3.0.CO;2-3; Mattsson JM, 2008, PROSTATE, V68, P945, DOI 10.1002/pros.20751; Menez R, 2008, J MOL BIOL, V376, P1021, DOI 10.1016/j.jmb.2007.11.052; Peter A, 1998, EUR J BIOCHEM, V252, P216, DOI 10.1046/j.1432-1327.1998.2520216.x; Petrera A, 2012, BIOL CHEM, V393, P631, DOI 10.1515/hsz-2012-0106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Singh P, 2009, PROTEINS, V77, P984, DOI 10.1002/prot.22524; Suzuki K, 2007, SEMIN THROMB HEMOST, V33, P46, DOI 10.1055/s-2006-958461; Tang J, 2005, J BIOL CHEM, V280, P41077, DOI 10.1074/jbc.M506766200; WATT KWK, 1986, P NATL ACAD SCI USA, V83, P3166, DOI 10.1073/pnas.83.10.3166; Webber MM, 1995, CLIN CANCER RES, V1, P1089; Williams SA, 2007, PROSTATE, V67, P312, DOI 10.1002/pros.20531	28	7	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102470	10.1371/journal.pone.0102470	http://dx.doi.org/10.1371/journal.pone.0102470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068395	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700008
J	Zhang, QP; Pell, J; Canino-Koning, R; Howe, AC; Brown, CT				Zhang, Qingpeng; Pell, Jason; Canino-Koning, Rosangela; Howe, Adina Chuang; Brown, C. Titus			These Are Not the K-mers You Are Looking For: Efficient Online K-mer Counting Using a Probabilistic Data Structure	PLOS ONE			English	Article							GENERATION; SIZE	K-mer abundance analysis is widely used for many purposes in nucleotide sequence analysis, including data preprocessing for de novo assembly, repeat detection, and sequencing coverage estimation. We present the khmer software package for fast and memory efficient online counting of k-mers in sequencing data sets. Unlike previous methods based on data structures such as hash tables, suffix arrays, and trie structures, khmer relies entirely on a simple probabilistic data structure, a Count-Min Sketch. The Count-Min Sketch permits online updating and retrieval of k-mer counts in memory which is necessary to support online k-mer analysis algorithms. On sparse data sets this data structure is considerably more memory efficient than any exact data structure. In exchange, the use of a Count-Min Sketch introduces a systematic overcount for k-mers; moreover, only the counts, and not the k-mers, are stored. Here we analyze the speed, the memory usage, and the miscount rate of khmer for generating k-mer frequency distributions and retrieving k-mer counts for individual k-mers. We also compare the performance of khmer to several other k-mer counting packages, including Tallymer, Jellyfish, BFCounter, DSK, KMC, Turtle and KAnalyze. Finally, we examine the effectiveness of profiling sequencing error, k-mer abundance trimming, and digital normalization of reads in the context of high khmer false positive rates. khmer is implemented in C++ wrapped in a Python interface, offers a tested and robust API, and is freely available under the BSD license at github.com/ged-lab/khmer.	[Zhang, Qingpeng; Pell, Jason; Canino-Koning, Rosangela; Brown, C. Titus] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Howe, Adina Chuang; Brown, C. Titus] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Howe, Adina Chuang] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Brown, CT (corresponding author), Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA.	ctb@msu.edu	Zhang, Qingpeng/D-4682-2011	Zhang, Qingpeng/0000-0002-6819-0686; Brown, C. Titus/0000-0001-6001-2677; Howe, Adina/0000-0002-7705-343X	United States Department of Agriculture from the National Institute of Food and Agriculture [2009-03296]; National Science Foundation [09-23812]; National Institutes of Health [1R01HG007513-01]; NSF Postdoctoral Fellowship [0905961]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007513] Funding Source: NIH RePORTER	United States Department of Agriculture from the National Institute of Food and Agriculture; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Postdoctoral Fellowship(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by the United States Department of Agriculture under grant 2009-03296 from the National Institute of Food and Agriculture, to CTB (www.usda.gov); National Science Foundation grant 09-23812 to CTB (www.nsf.gov); and the National Institutes of Health grant 1R01HG007513-01 to CTB. AH was supported by NSF Postdoctoral Fellowship Award #0905961. (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audano P, 2014, BIOINFORMATICS, V30, P2070, DOI 10.1093/bioinformatics/btu152; BLOOM BH, 1970, COMMUN ACM, V13, P422, DOI 10.1145/362686.362692; Broder A., 2004, INTERNET MATH, V1, P485, DOI [DOI 10.1080/15427951.2004.10129096, 10.1080/15427951.2004.10129096]; Brown C.T., 2012, ARXIV12034802; Brown CT, 2012, WHAT DOES TRINITYS S; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Cohen S., 2003, P 2003 ACM SIGMOD IN, P241, DOI [10.1145/872757.872787, DOI 10.1145/872757.872787]; Conway TC, 2011, BIOINFORMATICS, V27, P479, DOI 10.1093/bioinformatics/btq697; Cormode G, 2005, J ALGORITHMS, V55, P58, DOI 10.1016/j.jalgor.2003.12.001; Cormode G, 2005, SIAM PROC S, P44; Crusoe M, 2014, KHMER SOFTWARE PACKA; Deorowicz S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-160; Estan C, 2002, ACM SIGCOMM COMP COM, V32, P323, DOI 10.1145/964725.633056; Fan L, 2000, IEEE ACM T NETWORK, V8, P281, DOI 10.1109/90.851975; Flajolet P., 2015, DISCRETE MATH THEOR; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Howe AC, 2012, ARXIV12120159; Howe AC, 2014, P NATL ACAD SCI USA, V111, P4904, DOI 10.1073/pnas.1402564111; Jones DC, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks754; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Kurtz S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-517; Li XM, 2003, GENOME RES, V13, P1916, DOI 10.1101/gr.1251803; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Malde K, 2009, LECT NOTES COMPUT SC, V5418, P183, DOI 10.1007/978-3-540-92995-6_13; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; McDonald E, 2013, PERFORMANCE OPEN SOU, P151; Medvedev P, 2011, BIOINFORMATICS, V27, pI137, DOI 10.1093/bioinformatics/btr208; Melsted P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-333; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Pell J, 2012, P NATL ACAD SCI USA, V109, P13272, DOI 10.1073/pnas.1121464109; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rizk G, 2013, BIOINFORMATICS, V29, P652, DOI 10.1093/bioinformatics/btt020; Roy RS, 2014, BIOINFORMATICS, DOI [10.1093/bioinformat-ics/btu132, DOI 10.1093/BIOINFORMAT-ICS/BTU132]; Rusu F, 2008, ACM T DATABASE SYST, V33, DOI 10.1145/1386118.1386121; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	39	33	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e101271	10.1371/journal.pone.0101271	http://dx.doi.org/10.1371/journal.pone.0101271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	25062443	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992600003
J	Yeom, E; Hong, ST; Choi, KW				Yeom, E.; Hong, S-T; Choi, K-W			Crumbs interacts with Xpd for nuclear division control in Drosophila	ONCOGENE			English	Article							TRANSMEMBRANE PROTEIN CRUMBS; EPITHELIAL-CELLS; DNA METABOLISM; MUTATIONS; POLARITY; MELANOGASTER; COMPLEX; MORPHOGENESIS; ORGANIZATION; EXPRESSION	Crumbs (Crb) family proteins are crucial for cell polarity. Recent studies indicate that they are also involved in growth regulation and cancer. However, it is not well-understood how Crb participates in mitotic processes. Here, we report that Drosophila Crb is critically involved in nuclear division by interacting with Xeroderma pigmentosum D (XPD). A novel gene named galla-1 was identified from a genetic screen for crb modifiers. Galla-1 protein shows homology to MIP18, a subunit of the mitotic spindle-associated MMS19-XPD complex. Loss-of-function galla-1 mutants show abnormal chromosome segregation, defective centrosome positions and branched spindles during nuclear division in early embryos. Embryos with loss-of-function or overexpression of crb show similar mitotic defects and genetic interaction with galla-1. Both Galla-1 and Crb proteins show overlapping localization with spindle microtubules during nuclear division. Galla-1 physically interacts with the intracellular domain of Crb. Interestingly, Galla-1 shows little binding to the Drosophila homolog of XPD, but a related protein Galla-2 binds both Crb and Xpd. Loss-of-function galla-2 mutants show similar mitotic defects as galla-1 and strong genetic interaction with crb. Xpd can form a physical complex with Crb. In imaginal disc, Crb overexpression causes tissue overgrowth as well as DNA damages marked by H2Av phosphorylation. These phenotypes are suppressed by reduction of Xpd. Taken together, this study identifies a novel Crb-Galla-Xpd complex and its function for proper chromosome segregation during nuclear division, implicating a potential link between Crb and Xpd-related genome instability.	[Yeom, E.; Hong, S-T; Choi, K-W] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Choi, K-W] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Choi, KW (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Taejon 305701, South Korea.	kchoi100@kaist.ac.kr	Choi, Kwang-Wook/C-1707-2011	Choi, Kwang-Wook/0000-0002-8997-3065; Hong, Sung-Tae/0000-0001-5981-4859	World Class University Program [R31-2008-000-10071-0]; National President Fellowship [35B-2011-1-C00033]; National Research Laboratory grant through the National Research Foundation of Korea - Ministry of Education, Science Technology [NRF-2011-0028326]	World Class University Program; National President Fellowship; National Research Laboratory grant through the National Research Foundation of Korea - Ministry of Education, Science Technology	We are grateful to Kyung-Ok Cho, Sang-Chul Nam and Walton Jones for critical comments on the manuscript. We thank Beat Suter and Tom Kaufmann for xpd mutant and anti-centrosomin antibody, respectively. We also thank Yang Hong for Crb::GFP and crb mutant alleles. We acknowledge the Bloomington Drosophila Stock Center, the National Institute of Genetics stock center and the Developmental Studies Hybridoma Bank for fly stocks and antibodies. This research was supported by grants from the World Class University Program (R31-2008-000-10071-0), the National President Fellowship (35B-2011-1-C00033) and the National Research Laboratory grant (NRF-2011-0028326) through the National Research Foundation of Korea funded by the Ministry of Education, Science & Technology.	Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brust-Mascher I, 2007, INT REV CYTOL, V259, P139, DOI 10.1016/S0074-7696(06)59004-7; Cameroni E, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-24; Capalbo L, 2011, P NATL ACAD SCI USA, V108, P17343, DOI 10.1073/pnas.1103720108; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Chen J, 2003, NATURE, V424, P228, DOI 10.1038/nature01746; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2001, HUM MOL GENET, V10, P2767, DOI 10.1093/hmg/10.24.2767; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Gao GJ, 2009, P NATL ACAD SCI USA, V106, P10728, DOI 10.1073/pnas.0902707106; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Hehnly H, 2014, DEV CELL, V28, P497, DOI 10.1016/j.devcel.2014.01.014; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Ito S, 2010, MOL CELL, V39, P632, DOI 10.1016/j.molcel.2010.07.029; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; KNUST E, 1987, EMBO J, V6, P761, DOI 10.1002/j.1460-2075.1987.tb04818.x; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Li XM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000876; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Madigan JP, 2002, NUCLEIC ACIDS RES, V30, P3698, DOI 10.1093/nar/gkf496; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; Parsons LM, 2010, FLY, V4, P288, DOI 10.4161/fly.4.4.13116; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; PERRIMON N, 1984, GENETICS, V108, P927; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Su TT, 2001, CURR BIOL, V11, P8, DOI 10.1016/S0960-9822(00)00042-7; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; TEPASS U, 1990, ROUX ARCH DEV BIOL, V199, P189, DOI 10.1007/BF01682078; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WODARZ A, 1993, MECH DEVELOP, V44, P175, DOI 10.1016/0925-4773(93)90066-7; WOLFF T, 1993, DEV DROSOPHILA MELAN, V2, P1277; Zurita M, 2003, TRENDS GENET, V19, P578, DOI 10.1016/j.tig.2003.08.005	42	14	17	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2015	34	21					2777	2789		10.1038/onc.2014.202	http://dx.doi.org/10.1038/onc.2014.202			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI7XN	25065591	Bronze			2022-12-25	WOS:000354979500010
J	Kim, JY; Hwang, JY; Lee, DY; Song, EH; Park, KJ; Kim, GH; Jeong, EA; Lee, YJ; Go, MJ; Kim, DJ; Lee, SS; Kim, BJ; Song, J; Roh, GS; Gao, B; Kim, WH				Kim, Ji Yeon; Hwang, Joo-Yeon; Lee, Dae Yeon; Song, Eun Hyun; Park, Keon Jae; Kim, Gyu Hee; Jeong, Eun Ae; Lee, Yoo Jeong; Go, Min Jin; Kim, Dae Jin; Lee, Seong Su; Kim, Bong-Jo; Song, Jihyun; Roh, Gu Seob; Gao, Bin; Kim, Won-Ho			Chronic Ethanol Consumption Inhibits Glucokinase Transcriptional Activity by Atf3 and Triggers Metabolic Syndrome in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALCOHOL-CONSUMPTION; INSULIN-RESISTANCE; GENE-EXPRESSION; GLUCOSE; CELLS; PDX-1; DYSFUNCTION; PROGRESSION; ASSOCIATION	Chronic ethanol consumption induces pancreatic beta-cell dysfunction through glucokinase (Gck) nitration and down-regulation, leading to impaired glucose tolerance and insulin resistance, but the underlying mechanism remains largely unknown. Here, we demonstrate that Gck gene expression and promoter activity in pancreatic beta-cells were suppressed by chronic ethanol exposure in vivo and in vitro, whereas expression of activating transcription factor 3 (Atf3) and its binding to the putative Atf/Creb site (from -287 to -158 bp) on the Gck promoter were up-regulated. Furthermore, in vitro ethanol-induced Atf3 inhibited the positive effect of Pdx-1 on Gck transcriptional regulation, enhanced recruitment of Hdac1/2 and histone H3 deacetylation, and subsequently augmented the interaction of Hdac1/Pdx-1 on the Gck promoter, which were diminished by Atf3 siRNA. In vivo Atf3-silencing reversed ethanol-mediated Gck down-regulation and beta-cell dysfunction, followed by the amelioration of impaired glucose tolerance and insulin resistance. Together, we identified that ethanol-induced Atf3 fosters beta-cell dysfunction via Gck down-regulation and that its loss ameliorates metabolic syndrome and could be a potential therapeutic target in treating type 2 diabetes. The Atf3 gene is associated with the induction of type 2 diabetes and alcohol consumption-induced metabolic impairment and thus may be the major negative regulator for glucose homeostasis.	[Kim, Ji Yeon; Lee, Dae Yeon; Song, Eun Hyun; Park, Keon Jae; Kim, Gyu Hee; Jeong, Eun Ae; Lee, Yoo Jeong; Song, Jihyun; Kim, Won-Ho] Natl Inst Hlth, Ctr Biomed Sci, Div Metab Dis, Cheongwon Gun 363951, Chungbuk, South Korea; [Hwang, Joo-Yeon; Go, Min Jin; Kim, Bong-Jo] Natl Inst Hlth, Div Struct & Funct Genom, Ctr Genom Sci, Cheongwon Gun 363951, Chungbuk, South Korea; [Kim, Dae Jin] Catholic Univ, Coll Med, Dept Psychiat, Puchon 420743, South Korea; [Lee, Seong Su] Catholic Univ, Coll Med, Dept Endocrinol, Puchon 420743, South Korea; [Roh, Gu Seob] Gyeongsang Natl Univ, Inst Hlth Sci, Dept Anat & Neurobiol, Jinju 660751, Gyeongnam, South Korea; [Lee, Dae Yeon] Korea Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 136701, South Korea; [Park, Keon Jae] Chungbuk Natl Univ, Div Cardiol, Dept Internal Med, Sch Med, Cheongju 361763, South Korea; [Gao, Bin] NIAAA, Lab Liver Dis, Bethesda, MD 20892 USA	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Catholic University of Korea; Catholic University of Korea; Gyeongsang National University; Korea University; Chungbuk National University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Kim, WH (corresponding author), Natl Inst Hlth, Ctr Biomed Sci, Div Metab Dis, 187 Osong Saengmyeong2 Ro, Cheongwon Gun 363951, Chungbuk, South Korea.	jhkwh@nih.go.kr		Song, Eun Hyeon/0000-0001-9524-2595; song, jihyun/0000-0003-0420-2374; Kim, Won-Ho/0000-0002-4849-472X	Korean National Institutes of Health [4845-302-210-13]	Korean National Institutes of Health	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by Research Grant 4845-302-210-13 from the Korean National Institutes of Health.	Adaramoye OA, 2012, W INDIAN MED J, V61, P3, DOI 10.7727/wimj.2011.111; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bolcato-Bellemin AL, 2007, P NATL ACAD SCI USA, V104, P16050, DOI 10.1073/pnas.0707831104; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Chakrabarti SK, 2003, TRENDS ENDOCRIN MET, V14, P78, DOI 10.1016/S1043-2760(02)00039-5; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Conigrave KM, 2001, DIABETES, V50, P2390, DOI 10.2337/diabetes.50.10.2390; Dam-Larsen S, 2004, GUT, V53, P750, DOI 10.1136/gut.2003.019984; Dolganiuc A, 2006, ALCOHOL CLIN EXP RES, V30, P76, DOI 10.1111/j.1530-0277.2006.00003.x; Dolganiuc A, 2009, WORLD J GASTROENTERO, V15, P1168, DOI 10.3748/wjg.15.1168; Fueki Y, 2007, CLIN CHIM ACTA, V382, P71, DOI 10.1016/j.cca.2007.03.027; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kaneto H, 2008, ENDOCR J, V55, P235, DOI 10.1507/endocrj.K07E-041; Kim JY, 2013, CELL SIGNAL, V25, P2348, DOI 10.1016/j.cellsig.2013.07.028; Kim JY, 2010, J BIOL CHEM, V285, P37251, DOI 10.1074/jbc.M110.142315; Kim JY, 2010, J MOL BIOL, V397, P917, DOI 10.1016/j.jmb.2010.02.016; Kim JW, 2012, J BIOL CHEM, V287, P7780, DOI 10.1074/jbc.M111.278465; Kim SY, 2004, J BIOL CHEM, V279, P30823, DOI 10.1074/jbc.M313223200; Kim WH, 2001, FASEB J, V15, P2551, DOI 10.1096/fj.01-0217; Kim WH, 2011, BIOCHEM BIOPH RES CO, V414, P681, DOI 10.1016/j.bbrc.2011.09.132; Lee JW, 2009, CELL SIGNAL, V21, P69, DOI 10.1016/j.cellsig.2008.09.015; Matschinsky FM, 2006, DIABETES, V55, P1; Mosley AL, 2004, J BIOL CHEM, V279, P54241, DOI 10.1074/jbc.M410379200; Mosley AL, 2003, J BIOL CHEM, V278, P19660, DOI 10.1074/jbc.M212375200; Mosley AL, 2004, MOL ENDOCRINOL, V18, P2279, DOI 10.1210/me.2003-0463; Onishi Y, 2003, BIOCHEM BIOPH RES CO, V303, P788, DOI 10.1016/S0006-291X(03)00407-8; Pochareddy S, 2012, ALCOHOL CLIN EXP RES, V36, P1021, DOI 10.1111/j.1530-0277.2011.01677.x; Roh WG, 2009, ALCOHOL, V43, P643, DOI 10.1016/j.alcohol.2009.10.005; Sioud M, 2005, METH MOL B, V309, P237; Struhl K, 2001, SCIENCE, V293, P1054, DOI 10.1126/science.1064050; Szabo Gyongyi, 2008, V447, P113, DOI 10.1007/978-1-59745-242-7_9; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; TELI MR, 1995, LANCET, V346, P987, DOI 10.1016/S0140-6736(95)91685-7; Watada H, 1996, DIABETES, V45, P1478, DOI 10.2337/diabetes.45.11.1478; Zhao LN, 2009, BRIT J NUTR, V101, P1467, DOI 10.1017/S0007114508094646	39	36	37	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27065	27079		10.1074/jbc.M114.585653	http://dx.doi.org/10.1074/jbc.M114.585653			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25074928	hybrid, Green Published			2022-12-25	WOS:000342853900034
J	Kendall, RT; Lee, MH; Pleasant, DL; Robinson, K; Kuppuswamy, D; McDermott, PJ; Luttrell, LM				Kendall, Ryan T.; Lee, Mi-Hye; Pleasant, Dorea L.; Robinson, Katherine; Kuppuswamy, Dhandapani; McDermott, Paul J.; Luttrell, Louis M.			Arrestin-dependent Angiotensin AT(1) Receptor Signaling Regulates Akt and mTor-mediated Protein Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN; PHOSPHORYLATION; ACTIVATION; KINASE; PATHWAYS; ERK; COMPLEX; BETA-ARRESTIN-2; MECHANISMS; CONVERGE	Control of protein synthesis is critical to both cell growth and proliferation. The mammalian target of rapamycin (mTOR) integrates upstream growth, proliferation, and survival signals, including those transmitted via ERK1/2 and Akt, to regulate the rate of protein translation. The angiotensin AT(1) receptor has been shown to activate both ERK1/2 and Akt in arrestin-based signalsomes. Here, we examine the role of arrestin-dependent regulation of ERK1/2 and Akt in the stimulation of mTOR-dependent protein translation by the AT(1) receptor using HEK293 and primary vascular smooth muscle cell models. Nascent protein synthesis stimulated by both the canonical AT(1) receptor agonist angiotensin II (AngII), and the arrestin pathway-selective agonist [Sar(1)-Ile(4)-Ile(8)] AngII (SII), is blocked by shRNA silencing of beta arrestin1/2 or pharmacological inhibition of Akt, ERK1/2, or mTORC1. In HEK293 cells, SII activates a discrete arrestin-bound pool of Akt and promotes Akt-dependent phosphorylation of mTOR and its downstream effector p70/p85 ribosomal S6 kinase (p70/85S6K). In parallel, SII-activated ERK1/2 helps promote mTOR and p70/85S6K phosphorylation, and is required for phosphorylation of the known ERK1/2 substrate p90 ribosomal S6 kinase (p90RSK). Thus, arrestins coordinate AT(1) receptor regulation of ERK1/2 and Akt activity and stimulate protein translation via both Akt-mTOR-p70/85S6K and ERK1/2-p90RSK pathways. These results suggest that in vivo, arrestin pathway-selective AT(1) receptor agonists may promote cell growth or hypertrophy through arrestin-mediated mechanisms despite their antagonism of G protein signaling.	[Kendall, Ryan T.; Lee, Mi-Hye; Pleasant, Dorea L.; Robinson, Katherine; Kuppuswamy, Dhandapani; McDermott, Paul J.; Luttrell, Louis M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Kuppuswamy, Dhandapani; McDermott, Paul J.; Luttrell, Louis M.] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29401 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Luttrell, LM (corresponding author), Med Univ S Carolina, Div Endocrinol Diabet & Med Genet, Dept Med, 96 Jonathan Lucas St, Charleston, SC 29425 USA.	luttrell@musc.edu		Luttrell, Louis/0000-0003-2805-6949; Jenkins, Dorea/0000-0001-9510-8601	National Institutes of Health [5K12GM081265, 5R01DK055524]; Research Service of the Ralph H. Johnson Veterans Affairs Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM072643, K12GM081265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service of the Ralph H. Johnson Veterans Affairs Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants 5K12GM081265 (to R. T. K.) and 5R01DK055524 (to L. M. L.), and the Research Service of the Ralph H. Johnson Veterans Affairs Medical Center.	Ahn S, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M808463200; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Alvarez CJP, 2009, ENDOCR-RELAT CANCER, V16, P599, DOI 10.1677/ERC-08-0192; Aplin M, 2007, BASIC CLIN PHARMACOL, V100, P296, DOI 10.1111/j.1742-7843.2007.00064.x; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Coffa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028723; Dewire SM, 2008, J BIOL CHEM, V283, P10611, DOI 10.1074/jbc.M710515200; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; Kendall RT, 2011, J BIOL CHEM, V286, P19880, DOI 10.1074/jbc.M111.233080; Kendall RT, 2009, CELL MOL LIFE SCI, V66, P2953, DOI 10.1007/s00018-009-0088-1; Kim J, 2008, CIRC RES, V103, P70, DOI 10.1161/CIRCRESAHA.108.172338; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Lee MH, 2008, J BIOL CHEM, V283, P2088, DOI 10.1074/jbc.M706892200; Lenormand P, 1996, J BIOL CHEM, V271, P15762, DOI 10.1074/jbc.271.26.15762; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 2013, PROG MOL BIOL TRANSL, V118, P115, DOI 10.1016/B978-0-12-394440-5.00005-X; Lymperopoulos A, 2013, PROG MOL BIOL TRANSL, V118, P297, DOI 10.1016/B978-0-12-394440-5.00012-7; Lymperopoulos A, 2011, J AM COLL CARDIOL, V57, P356, DOI [10.1016/j.jacc.2010.08.635, 10.1016/j.yjmcc.2010.08.014]; Lymperopoulos A, 2009, P NATL ACAD SCI USA, V106, P5825, DOI 10.1073/pnas.0811706106; Monasky MM, 2013, AM J PHYSIOL-HEART C, V305, pH856, DOI 10.1152/ajpheart.00327.2013; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Rolfe M, 2005, BIOCHEM J, V388, P973, DOI 10.1042/BJ20041888; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Tan Y, 2004, AM J PHYSIOL-HEART C, V286, pH926, DOI 10.1152/ajpheart.00757.2003; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wilson PC, 2013, J BIOL CHEM, V288, P18872, DOI 10.1074/jbc.M113.472381; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522; Zimmerman B, 2009, CELL SIGNAL, V21, P103, DOI 10.1016/j.cellsig.2008.09.013	44	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26155	26166		10.1074/jbc.M114.595728	http://dx.doi.org/10.1074/jbc.M114.595728			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25081544	Green Published, hybrid			2022-12-25	WOS:000342128800012
J	Acharya, S; Kaul, Z; Gocha, AS; Martinez, AR; Harris, J; Parvin, JD; Groden, J				Acharya, Samir; Kaul, Zeenia; Gocha, April Sandy; Martinez, Alaina R.; Harris, Julia; Parvin, Jeffrey D.; Groden, Joanna			Association of BLM and BRCA1 during Telomere Maintenance in ALT Cells	PLOS ONE			English	Article							SYNDROME HELICASE; PROTEIN COMPLEXES; RECQ HELICASES; DNA; RECOMBINATION; SENESCENCE; REPAIR; END; WRN; RECOGNITION	Fifteen percent of tumors utilize recombination-based alternative lengthening of telomeres (ALT) to maintain telomeres. The mechanisms underlying ALT are unclear but involve several proteins involved in homologous recombination including the BLM helicase, mutated in Bloom's syndrome, and the BRCA1 tumor suppressor. Cells deficient in either BLM or BRCA1 have phenotypes consistent with telomere dysfunction. Although BLM associates with numerous DNA damage repair proteins including BRCA1 during DNA repair, the functional consequences of BLM-BRCA1 association in telomere maintenance are not completely understood. Our earlier work showed the involvement of BRCA1 in different mechanisms of ALT, and telomere shortening upon loss of BLM in ALT cells. In order to delineate their roles in telomere maintenance, we studied their association in telomere metabolism in cells using ALT. This work shows that BLM and BRCA1 co-localize with RAD50 at telomeres during S-and G2-phases of the cell cycle in immortalized human cells using ALT but not in cells using telomerase to maintain telomeres. Co-immunoprecipitation of BRCA1 and BLM is enhanced in ALT cells at G2. Furthermore, BRCA1 and BLM interact with RAD50 predominantly in S-and G2-phases, respectively. Biochemical assays demonstrate that full-length BRCA1 increases the unwinding rate of BLM three-fold in assays using a DNA substrate that models a forked structure composed of telomeric repeats. Our results suggest that BRCA1 participates in ALT through its interactions with RAD50 and BLM.	[Acharya, Samir; Kaul, Zeenia; Gocha, April Sandy; Martinez, Alaina R.; Harris, Julia; Parvin, Jeffrey D.; Groden, Joanna] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	Ohio State University	Groden, J (corresponding author), Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	joanna.groden@osumc.edu	Parvin, Jeffrey D/C-8955-2009		National Institutes of Health [CA117898]; National Cancer Institute-T32; National Science Foundation Award [GRFP DGE-0822215]; Ohio State University Pelotonia Fellowship Program; National Center For Advancing Translational Sciences [8UL1TR000090-05, 8KL2TR000112-05, 8TL1TR000091-05]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070, TL1TR000091, KL2TR000112, UL1TR000090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute-T32; National Science Foundation Award(National Science Foundation (NSF)); Ohio State University Pelotonia Fellowship Program; National Center For Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by funding from the National Institutes of Health [CA117898 to J.G.]; National Cancer Institute-T32 [Z.K.]; National Science Foundation Award GRFP DGE-0822215 [J.L.H.]; The Ohio State University Pelotonia Fellowship Program (A.S.G; Z.K.]; The project described was supported by Award Number 8UL1TR000090-05, 8KL2TR000112-05, and 8TL1TR000091-05 from the National Center For Advancing Translational Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Ballal RD, 2009, J BIOL CHEM, V284, P36083, DOI 10.1074/jbc.M109.025825; Barefield C, 2012, NUCLEIC ACIDS RES, V40, P7358, DOI 10.1093/nar/gks407; Bhattacharyya S, 2010, J CELL BIOCHEM, V109, P7, DOI 10.1002/jcb.22388; Bhattacharyya S, 2009, J BIOL CHEM, V284, P14966, DOI 10.1074/jbc.M900195200; Bryan TM, 1997, EUR J CANCER, V33, P767, DOI 10.1016/S0959-8049(97)00065-8; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cabuy E, 2008, CYTOGENET GENOME RES, V122, P336, DOI 10.1159/000167820; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Chaudhury I, 2013, NUCLEIC ACIDS RES, V41, P6444, DOI 10.1093/nar/gkt348; Cheng WH, 2006, NUCLEIC ACIDS RES, V34, P2751, DOI 10.1093/nar/gkl362; Chiba N, 2001, J BIOL CHEM, V276, P38549, DOI 10.1074/jbc.M105227200; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Davalos AR, 2003, J CELL BIOL, V162, P1197, DOI 10.1083/jcb.200304016; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Dutertre S, 2000, ONCOGENE, V19, P2731, DOI 10.1038/sj.onc.1203595; French JD, 2006, GENE CHROMOSOME CANC, V45, P277, DOI 10.1002/gcc.20290; Gocha ARS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093991; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Grierson PM, 2013, MUTAT RES-FUND MOL M, V743, P89, DOI 10.1016/j.mrfmmm.2012.12.002; Grierson PM, 2012, HUM MOL GENET, V21, P1172, DOI 10.1093/hmg/ddr545; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Grobelny JV, 2000, J CELL SCI, V113, P4577; Hagelstrom RT, 2010, P NATL ACAD SCI USA, V107, P15768, DOI 10.1073/pnas.1006338107; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hartman AR, 2002, NAT GENET, V32, P180, DOI 10.1038/ng953; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Lillard-Wetherell K, 2004, HUM MOL GENET, V13, P1919, DOI 10.1093/hmg/ddh193; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Lowndes NF, 2010, DNA REPAIR, V9, P1112, DOI 10.1016/j.dnarep.2010.07.012; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Mak TW, 2000, NAT IMMUNOL, V1, P77, DOI 10.1038/76950; Martinez-Delgado B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002182; McPherson JP, 2006, HUM MOL GENET, V15, P831, DOI 10.1093/hmg/ddl002; Mendez-Bermudez A, 2012, NUCLEIC ACIDS RES, V40, P10809, DOI 10.1093/nar/gks862; Montgomery E, 2004, AM J PATHOL, V164, P1523, DOI 10.1016/S0002-9440(10)63710-8; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nabetani A, 2011, J BIOCHEM, V149, P5, DOI 10.1093/jb/mvq119; Niida H, 2000, MOL CELL BIOL, V20, P4115, DOI 10.1128/MCB.20.11.4115-4127.2000; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; O'Sullivan RJ, 2014, NAT STRUCT MOL BIOL, V21, P167, DOI 10.1038/nsmb.2754; Ohta T, 2011, FEBS LETT, V585, P2836, DOI 10.1016/j.febslet.2011.05.005; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Reddel RR, 2003, CANCER LETT, V194, P155, DOI 10.1016/S0304-3835(02)00702-4; Schawalder J, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-15; Schulz VP, 1996, HUM GENET, V97, P750; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Simons AM, 2006, CANCER RES, V66, P2012, DOI 10.1158/0008-5472.CAN-05-3296; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Tahara H, 1997, ONCOGENE, V15, P1911, DOI 10.1038/sj.onc.1201377; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Wang Y, 2000, GENE DEV, V14, P927; Wu GK, 2003, CANCER RES, V63, P2589; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Xiong JB, 2003, MOL CELL BIOL, V23, P8668, DOI 10.1128/MCB.23.23.8668-8690.2003; Yeager TR, 1999, CANCER RES, V59, P4175; Zhang JR, 2005, MOL CANCER RES, V3, P531, DOI 10.1158/1541-7786.MCR-05-0192; Zhong Q, 2002, J BIOL CHEM, V277, P28641, DOI 10.1074/jbc.M200748200; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	69	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103819	10.1371/journal.pone.0103819	http://dx.doi.org/10.1371/journal.pone.0103819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084169	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800084
J	Piryankova, IV; Wong, HY; Linkenauger, SA; Stinson, C; Longo, MR; Bulthoff, HH; Mohler, BJ				Piryankova, Ivelina V.; Wong, Hong Yu; Linkenauger, Sally A.; Stinson, Catherine; Longo, Matthew R.; Buelthoff, Heinrich H.; Mohler, Betty J.			Owning an Overweight or Underweight Body: Distinguishing the Physical, Experienced and Virtual Body	PLOS ONE			English	Article							RUBBER HAND; OWNERSHIP; ILLUSION; AGENCY; TOUCH; DISTANCE; REALITY; IMAGE	Our bodies are the most intimately familiar objects we encounter in our perceptual environment. Virtual reality provides a unique method to allow us to experience having a very different body from our own, thereby providing a valuable method to explore the plasticity of body representation. In this paper, we show that women can experience ownership over a whole virtual body that is considerably smaller or larger than their physical body. In order to gain a better understanding of the mechanisms underlying body ownership, we use an embodiment questionnaire, and introduce two new behavioral response measures: an affordance estimation task (indirect measure of body size) and a body size estimation task (direct measure of body size). Interestingly, after viewing the virtual body from first person perspective, both the affordance and the body size estimation tasks indicate a change in the perception of the size of the participant's experienced body. The change is biased by the size of the virtual body (overweight or underweight). Another novel aspect of our study is that we distinguish between the physical, experienced and virtual bodies, by asking participants to provide affordance and body size estimations for each of the three bodies separately. This methodological point is important for virtual reality experiments investigating body ownership of a virtual body, because it offers a better understanding of which cues (e. g. visual, proprioceptive, memory, or a combination thereof) influence body perception, and whether the impact of these cues can vary between different setups.	[Piryankova, Ivelina V.; Stinson, Catherine; Buelthoff, Heinrich H.; Mohler, Betty J.] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, D-72076 Tubingen, Germany; [Piryankova, Ivelina V.; Wong, Hong Yu; Stinson, Catherine] Werner Reichardt Ctr Integrat Neurosci, Dept Philosophy Neurosci, Tubingen, Germany; [Linkenauger, Sally A.] Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England; [Longo, Matthew R.] Univ London, Dept Psychol Sci, London, England; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; Eberhard Karls University of Tubingen; Lancaster University; University of London; Korea University	Piryankova, IV (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Spemannstr 38, D-72076 Tubingen, Germany.	ivelina.piryankova@tuebingen.mpg.de; heinrich.buelthoff@tuebingen.mpg.de; betty.mohler@tuebingen.mpg.de	Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019; Longo, Matthew R/I-4090-2018	Bülthoff, Heinrich H/0000-0003-2568-0607; Longo, Matthew R/0000-0002-2450-4903; Linkenauger, Sally/0000-0002-6056-0187	Werner Reichardt Centre for Integrative Neuroscience, Tuebingen [CIN2011-16]; EC FP7 project VR-HYPERSPACE [AAT-2011-RTD-1-285681]; Brain Korea 21 PLUS Program through the National Research Foundation of Korea - Ministry of Education	Werner Reichardt Centre for Integrative Neuroscience, Tuebingen; EC FP7 project VR-HYPERSPACE; Brain Korea 21 PLUS Program through the National Research Foundation of Korea - Ministry of Education	The research leading to these results was funded by the Werner Reichardt Centre for Integrative Neuroscience, Tuebingen (CIN2011-16), and the EC FP7 project VR-HYPERSPACE (AAT-2011-RTD-1-285681). Part of Heinrich H. Bulthoff's research was supported by the Brain Korea 21 PLUS Program through the National Research Foundation of Korea funded by the Ministry of Education (correspondence should be directed to Heinrich H. Bulthoff). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASKEVOLD F, 1975, PSYCHOTHER PSYCHOSOM, V26, P71, DOI 10.1159/000286913; Bos JE, 2008, DISPLAYS, V29, P47, DOI 10.1016/j.displa.2007.09.002; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; BRODIE DA, 1989, PERCEPT MOTOR SKILL, V69, P723, DOI 10.2466/pms.1989.69.3.723; Croll J, 2002, J ADOLESCENT HEALTH, V31, P166, DOI 10.1016/S1054-139X(02)00368-3; de Vignemont F, 2011, CONSCIOUS COGN, V20, P82, DOI 10.1016/j.concog.2010.09.004; Di Luca M, 2010, PRESENCE-TELEOP VIRT, V19, P569, DOI 10.1162/pres_a_00023; Dobricki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083840; FALLON AE, 1985, J ABNORM PSYCHOL, V94, P102, DOI 10.1037/0021-843X.94.1.102; Farrell C, 2005, EUR EAT DISORD REV, V13, P75, DOI 10.1002/erv.622; Forrest LN, 2012, ROLE PERCEPTION EATI; FREEMAN RJ, 1984, PSYCHOL MED, V14, P411, DOI 10.1017/S0033291700003652; Geuss M., 2010, PROCE 7 S APPL PERCE, P61; Gibson JJ, 1979, ECOLOGICAL APPROACH; Grogan S., 2007, BODY IMAGE UNDERSTAN; Hashimoto T, 2013, EUR J NEUROSCI, V37, P1747, DOI 10.1111/ejn.12187; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2012, CURR DIR PSYCHOL SCI, V21, P140, DOI 10.1177/0963721411434982; Longo MR, 2009, PERCEPTION, V38, P69, DOI 10.1068/p6045; Longo MR, 2008, CONSCIOUS COGN, V17, P1181, DOI 10.1016/j.concog.2008.01.001; Michaels CF, 2003, ECOL PSYCHOL, V15, P135, DOI 10.1207/S15326969ECO1502_3; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; Normand JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016128; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Perez-Marcos D, 2009, NEUROREPORT, V20, P589, DOI 10.1097/WNR.0b013e32832a0a2a; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Petkova VI, 2011, FRONT PSYCHOL, V2; Preston C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085773; Riva G, 2005, CYBERPSYCHOL BEHAV, V8, P220, DOI 10.1089/cpb.2005.8.220; Riva G, 2008, J CYBERTHERAPY REHAB, V1, P7; Riva G, 2000, NATURE PRECEDINGS, P2; Riva Giuseppe, 2011, J Diabetes Sci Technol, V5, P283; Rizzo AA, 2006, CNS SPECTRUMS, V11, P35, DOI 10.1017/S1092852900024196; Schilder P., 1936, J NERV MENT DIS, V83, P227, DOI [10.1097/00005053-193602000-00051, DOI 10.1097/00005053-193602000-00051]; SLADE PD, 1973, PSYCHOL MED, V3, P188, DOI 10.1017/S0033291700048510; Slater M, 2009, FRONT NEUROSCI-SWITZ, V3, P214, DOI 10.3389/neuro.01.029.2009; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Stefanucci JK, 2009, PERCEPTION, V38, P1782, DOI 10.1068/p6437; Stunckard Albert J., 1983, GENETICS NEUROLOGICA; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P2740, DOI 10.1016/j.neuropsychologia.2010.05.021; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; WARREN WH, 1987, J EXP PSYCHOL HUMAN, V13, P371, DOI 10.1037/0096-1523.13.3.371; Willemsen P, 2008, PRESENCE-TELEOP VIRT, V17, P91, DOI 10.1162/pres.17.1.91; Willemsen P, 2009, ACM T APPL PERCEPT, V6, DOI 10.1145/1498700.1498702; Witt JK, 2005, J EXP PSYCHOL HUMAN, V31, P880, DOI 10.1037/0096-1523.31.5.880	51	89	89	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103428	10.1371/journal.pone.0103428	http://dx.doi.org/10.1371/journal.pone.0103428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4JL	25083784	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000339819800040
J	Berdal, JE; Haagensen, R; Ranheim, T; Bjornholt, JV				Berdal, Jan-Erik; Haagensen, Rolf; Ranheim, Trond; Bjornholt, Jorgen V.			Nosocomial Candidemia; Risk Factors and Prognosis Revisited; 11 Years Experience from a Norwegian Secondary Hospital	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES SOCIETY; BLOOD-STREAM INFECTIONS; ATTRIBUTABLE MORTALITY; 2009 UPDATE; MANAGEMENT	The aim of the study was to review the epidemiology and prognosis of candidemia in a secondary hospital, and to examine the intra-hospital distribution of candidemia patients. Study design is a retrospective cohort study. Trough 2002-2012, 110 cases of candidemia were diagnosed, giving an incidence of 2, 6/100000 citizens/year. Overall prognosis of candidemia was dismal, with a 30 days case fatality rate of 49% and one year case fatality rate of 64%. Candidemia was a terminal event in 55% of 30 days non-survivors, defined as Candida blood cultures reported positive on the day of death or thereafter (39%), or treatment refrained due to hopeless short-term prognosis (16%). In terminal event candidemias, advanced or incurable cancer was present in 29%. Non-survivors at 30 days were 9 years (median) older than survivors. In 30 days survivors, candidemia was not recognised before discharge in 13% of cases. No treatment were given and no deaths or complications were observed in this group. Candidemia patients were grouped into 8 patient categories: Abdominal surgery (35%), urology (13%), other surgery (11%), pneumonia (13%), haematological malignancy (7%), intravenous drug abuse (4%), other medical (15%), and new-borns (3%). Candidemia was diagnosed while admitted in the ICU in 46% of patients. Urology related cases were all diagnosed in the general ward. Multiple surgical procedures were done in 60% of abdominal surgery patients. Antibiotics were administered prior to candidemia in 87% of patients, with median duration 17 (1-108) days. Neutropenia was less common than expected in patients with candidemia (8/105) and closely associated to haematological malignancy (6/8). Compared with previous national figures the epidemiology of invasive candidiasis seems not to have changed over the last decade.	[Berdal, Jan-Erik] Akershus Univ Hosp, Dept Infect Dis, Nordbyhagen, Norway; [Haagensen, Rolf] Akershus Univ Hosp, Dept Anaesthesiol, Nordbyhagen, Norway; [Ranheim, Trond] Akershus Univ Hosp, Dept Microbiol, Nordbyhagen, Norway; [Bjornholt, Jorgen V.] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH)	Berdal, JE (corresponding author), Akershus Univ Hosp, Dept Infect Dis, Nordbyhagen, Norway.	jan.erik.berdal@ahus.no		Bjornholt, Jorgen Vildershoj/0000-0002-0079-8062				Achkar JM, 2010, CLIN MICROBIOL REV, V23, P253, DOI 10.1128/CMR.00076-09; Arendrup MC, 2011, J CLIN MICROBIOL, V49, P325, DOI 10.1128/JCM.01811-10; DiNubile MJ, 2007, J CRIT CARE, V22, P237, DOI 10.1016/j.jcrc.2006.11.004; Ericsson J, 2013, CLIN MICROBIOLOGY IN; Falagas ME, 2006, EUR J CLIN MICROBIOL, V25, P419, DOI 10.1007/s10096-006-0159-2; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Lundstrom T, 2001, CLIN INFECT DIS, V32, P1602, DOI 10.1086/320531; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Morgan Juliette, 2005, Curr Infect Dis Rep, V7, P429, DOI 10.1007/s11908-005-0044-7; Odds FC, 2007, J MED MICROBIOL, V56, P1066, DOI 10.1099/jmm.0.47239-0; Pappas PG, 2008, CURR FUNGAL INFECT R, V2, P112, DOI 10.1007/s12281-008-0017-z; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Poikonen E, 2003, EMERG INFECT DIS, V9, P985; Rothman KJ, 1979, EPIDEMIOLOGIC ANAL P; Sandven Per, 2000, Revista Iberoamericana de Micologia, V17, P73; Shorr AF, 2009, CRIT CARE, V13, DOI 10.1186/cc8110; Tortorano A, 2013, INFECTION, P1; Trick WE, 2002, CLIN INFECT DIS, V35, P627, DOI 10.1086/342300; Wenzel RP, 2005, CLIN INFECT DIS, V41, pS389, DOI 10.1086/430923; WENZEL RP, 1995, CLIN INFECT DIS, V20, P1531, DOI 10.1093/clinids/20.6.1531	21	28	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103916	10.1371/journal.pone.0103916	http://dx.doi.org/10.1371/journal.pone.0103916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079361	Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800096
J	Cook, GS; Parnell, PE; Levin, LA				Cook, Geoffrey S.; Parnell, P. Ed; Levin, Lisa A.			Population Connectivity Shifts at High Frequency within an Open-Coast Marine Protected Area Network	PLOS ONE			English	Article							CORAL-REEF FISH; LARVAL CONNECTIVITY; SWIMMING ABILITIES; DISPERSAL; PATTERNS; RECRUITMENT; RESERVES; METAPOPULATIONS; REPLENISHMENT; PERSISTENCE	A complete understanding of population connectivity via larval dispersal is of great value to the effective design and management of marine protected areas (MPA). However empirical estimates of larval dispersal distance, self-recruitment, and within season variability of population connectivity patterns and their influence on metapopulation structure remain rare. We used high-resolution otolith microchemistry data from the temperate reef fish Hypsypops rubicundus to explore biweekly, seasonal, and annual connectivity patterns in an open-coast MPA network. The three MPAs, spanning 46 km along the southern California coastline were connected by larval dispersal, but the magnitude and direction of connections reversed between 2008 and 2009. Self-recruitment, i.e. spawning, dispersal, and settlement to the same location, was observed at two locations, one of which is a MPA. Self-recruitment to this MPA ranged from 50-84%; within the entire 60 km study region, self-recruitment accounted for 45% of all individuals settling to study reefs. On biweekly time scales we observed directional variability in alongshore current data and larval dispersal trajectories; if viewed in isolation these data suggest the system behaves as a source-sink metapopulation. However aggregate biweekly data over two years reveal a reef network in which H. rubicundus behaves more like a well-mixed metapopulation. As one of the few empirical studies of population connectivity within a temperate open coast reef network, this work can inform the MPA design process, implementation of ecosystem based management plans, and facilitate conservation decisions.	[Cook, Geoffrey S.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Cooperat Inst Marine & Atmospher Studies, Miami, FL 33149 USA; [Cook, Geoffrey S.] NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA; [Parnell, P. Ed; Levin, Lisa A.] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA	University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); University of California System; University of California San Diego; Scripps Institution of Oceanography	Cook, GS (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Cooperat Inst Marine & Atmospher Studies, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	gcook@rsmas.miami.edu		Levin, Lisa/0000-0002-2858-8622	United States Environmental Protection Agency Science; NSF- Marine Biodiversity and Conservation IGERT Fellowship (NSF) [0333444]; University of California Coastal Environmental Quality Initiative Graduate Fellowship; Moore Family Foundation - Center for Marine Biodiversity and Conservation at SIO; PADI Foundation; Mia J. Tegner coastal ecology grant; California Seagrant Traineeship [52-ANS-N]; NSF [OCE 0648656]	United States Environmental Protection Agency Science(United States Environmental Protection Agency); NSF- Marine Biodiversity and Conservation IGERT Fellowship (NSF); University of California Coastal Environmental Quality Initiative Graduate Fellowship; Moore Family Foundation - Center for Marine Biodiversity and Conservation at SIO; PADI Foundation; Mia J. Tegner coastal ecology grant; California Seagrant Traineeship; NSF(National Science Foundation (NSF))	This study was supported in part by the United States Environmental Protection Agency Science to Achieve Results (STAR) Graduate Fellowship Program, an NSF- Marine Biodiversity and Conservation IGERT Fellowship (NSF Award No. 0333444), a University of California Coastal Environmental Quality Initiative Graduate Fellowship, a Moore Family Foundation grant awarded by the Center for Marine Biodiversity and Conservation at SIO, a PADI Foundation grant, a Mia J. Tegner coastal ecology grant, and a California Seagrant Traineeship (52-ANS-N) to GSC. LAL was supported by NSF award OCE 0648656. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Becker BJ, 2007, P NATL ACAD SCI USA, V104, P3267, DOI 10.1073/pnas.0611651104; Ben-Tzvi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042672; Bernardi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044953; Berumen ML, 2012, ECOL EVOL, V2, P444, DOI 10.1002/ece3.208; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; CADFG, 2012, CAL DEP FISH GAM PUB; Carson HS, 2013, MAR ECOL PROG SER, V473, P133, DOI 10.3354/meps10078; Carson HS, 2010, CURR BIOL, V20, P1926, DOI 10.1016/j.cub.2010.09.057; Chittaro PM, 2013, CORAL REEFS, V32, P341, DOI 10.1007/s00338-012-0990-0; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; CLARKE TA, 1970, ECOL MONOGR, V40, P189, DOI 10.2307/1942295; Cook GS, 2011, MAR ECOL PROG SER, V423, P197, DOI 10.3354/meps08942; Cook GS, 2005, NAT AREA J, V25, P390; Cook GS, 2011, THESIS U CALIFORNIA; Corell H, 2012, MAR ECOL PROG SER, V467, P29, DOI 10.3354/meps09963; Correia AT, 2014, FISH RES, V149, P76, DOI 10.1016/j.fishres.2013.09.016; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Crook DA, 2013, CAN J FISH AQUAT SCI, V70, P953, DOI 10.1139/cjfas-2012-0504; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052108; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031681; Dixon PA, 1999, SCIENCE, V283, P1528, DOI 10.1126/science.283.5407.1528; Fisher R, 2000, MAR ECOL PROG SER, V202, P163, DOI 10.3354/meps202163; Hamer PA, 2011, J FISH BIOL, V78, P1090, DOI 10.1111/j.1095-8649.2011.02921.x; Hastings A, 2006, P NATL ACAD SCI USA, V103, P6067, DOI 10.1073/pnas.0506651103; Howe EA, 2013, J GREAT LAKES RES, V39, P239, DOI 10.1016/j.jglr.2013.02.006; Kool JT, 2013, LANDSCAPE ECOL, V28, P165, DOI 10.1007/s10980-012-9819-z; Leis JM, 2007, MAR BIOL, V153, P103, DOI 10.1007/s00227-007-0794-x; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; LIMBAUGH CONRAD, 1964, PAC SCI, V18, P41; Lipcius RN, 2008, REV FISH SCI, V16, P101, DOI 10.1080/10641260701812574; Lopez-Duarte PC, 2012, INTEGR COMP BIOL, V52, P511, DOI 10.1093/icb/ics104; Lubchenco J, 2003, ECOL APPL, V13, pS3; MILLAR RB, 1990, CAN J FISH AQUAT SCI, V47, P2235, DOI 10.1139/f90-248; MILLAR RB, 1987, CAN J FISH AQUAT SCI, V44, P583, DOI 10.1139/f87-071; Mitarai S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005166; MOSER HG, 1996, CALCOFI ATLAS, V33; PALUMBI S, 2002, MARINE RESERVES TOOL; PANNELLA G, 1971, SCIENCE, V173, P1124, DOI 10.1126/science.173.4002.1124; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Quinn GP, 2003, EXPT DESIGN DATA ANA; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; SIKKEL PC, 1988, COPEIA, P710; Silva A, 2009, ICES J MAR SCI, V66, P495, DOI 10.1093/icesjms/fsn225; Stobutzki IC, 1997, MAR ECOL PROG SER, V149, P35, DOI 10.3354/meps149035; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Watson JR, 2011, ECOLOGY, V92, P1193, DOI 10.1890/10-1436.1; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376; White JW, 2007, MAR ECOL PROG SER, V329, P301, DOI 10.3354/meps329301; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zar JH, 1999, BIOSTATISTICAL ANAL	55	13	13	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103654	10.1371/journal.pone.0103654	http://dx.doi.org/10.1371/journal.pone.0103654			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077486	Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800063
J	Yang, X; Richardson, PA; Hong, CX				Yang, Xiao; Richardson, Patricia A.; Hong, Chuanxue			Phytophthora xstagnum nothosp nov., a New Hybrid from Irrigation Reservoirs at Ornamental Plant Nurseries in Virginia	PLOS ONE			English	Article							HIGH-TEMPERATURE TOLERANT; CYTOCHROME-OXIDASE-II; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR CHARACTERIZATION; INTERSPECIFIC HYBRIDS; RIPARIAN ECOSYSTEMS; MITOCHONDRIAL-DNA; NATURAL HYBRIDS; SPECIES HYBRIDS; X PELGRANDIS	A novel Phytophthora species was frequently recovered from irrigation reservoirs at several ornamental plant production facilities in eastern Virginia. Initial sequencing of the internal transcribed spacer (ITS) region of this species generated unreadable sequences due to continual polymorphic positions. Cloning and sequencing the ITS region as well as sequencing the mitochondrially encoded cytochrome c oxidase 1 and beta-tubulin genes revealed that it is a hybrid between P. taxon PgChlamydo as its paternal parent and an unknown species genetically close to P. mississippiae as its maternal parent. This hybrid has some diagnostic morphological features of P. taxon PgChlamydo and P. mississippiae. It produces catenulate hyphal swellings, characteristic of P. mississippiae, and chlamydospores, typical of P. taxon PgChlamydo. It also produces both ornamented and relatively smooth-walled oogonia. Ornamented oogonia are another important diagnostic character of P. mississippiae. The relatively smooth-walled oogonia may be indicative of oogonial character of P. taxon PgChlamydo. The new hybrid is described here as Phytophthora xstagnum.	[Yang, Xiao; Richardson, Patricia A.; Hong, Chuanxue] Virginia Tech, Hampton Roads Agr Res & Extens Ctr, Virginia Beach, VA 23455 USA	Virginia Polytechnic Institute & State University	Yang, X (corresponding author), Virginia Tech, Hampton Roads Agr Res & Extens Ctr, Virginia Beach, VA 23455 USA.	yxiao9@vt.edu			USDA/NIFA [2010-51181-21140]; Virginia Agricultural Experiment Station	USDA/NIFA(United States Department of Agriculture (USDA)); Virginia Agricultural Experiment Station	This research was supported by grants from USDA/NIFA (2010-51181-21140) and the Virginia Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertier L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085385; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Blomquist CL, 2012, PLANT DIS, V96, P1691, DOI 10.1094/PDIS-02-12-0221-PDN; Bonants PJM, 2000, PHYTOPATHOLOGY, V90, P867, DOI 10.1094/PHYTO.2000.90.8.867; Brasier C, 2000, NATURE, V405, P134, DOI 10.1038/35012193; Brasier CM, 2004, MYCOL RES, V108, P1172, DOI 10.1017/S0953756204001005; Brasier CM, 1999, P NATL ACAD SCI USA, V96, P5878, DOI 10.1073/pnas.96.10.5878; Brasier CM, 2003, MYCOL RES, V107, P277, DOI 10.1017/S095375620300738X; Brasier CM, 2001, BIOSCIENCE, V51, P123, DOI 10.1641/0006-3568(2001)051[0123:REOIPP]2.0.CO;2; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Crous PW, 2012, PERSOONIA, V28, P138, DOI 10.3767/003158512X652633; de Cock AWAM, 2004, STUD MYCOL, P481; Donahoo RS, 2008, MYCOLOGIA, V100, P911, DOI 10.3852/08-028; DRECHSLER CHARLES, 1931, JOUR WASHINGTON ACAD SCI, V21, P513; English JT, 1999, MYCOL RES, V103, P1003, DOI 10.1017/S0953756298008028; ERSEK T, 1995, PHYTOPATHOLOGY, V85, P1343, DOI 10.1094/Phyto-85-1343; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Faedda R, 2013, PLANT DIS, V97, P1091, DOI 10.1094/PDIS-11-12-1035-RE; GALLEGLY ME, 2008, PHYTOPHTHORA IDENTIF; Gomez-Alpizar L, 2008, MYCOLOGIA, V100, P590, DOI 10.3852/07-074R1; GOODWIN SB, 1994, EXP MYCOL, V18, P20, DOI 10.1006/emyc.1994.1003; Goss EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024543; Gu YH, 2001, CAN J MICROBIOL, V47, P662; Hong CX, 2010, PLANT PATHOL, V59, P913, DOI 10.1111/j.1365-3059.2010.02323.x; Hong CX, 2008, FEMS MICROBIOL LETT, V285, P203, DOI 10.1111/j.1574-6968.2008.01226.x; Hong CX, 2012, MYCOLOGIA, V104, P1097, DOI 10.3852/11-055; Hurtado-Gonzales OP, 2009, MYCOLOGIA, V101, P496, DOI 10.3852/08-079; 't Veld WAMI, 2007, EUR J PLANT PATHOL, V117, P25, DOI 10.1007/s10658-006-9065-9; in 't Veld WAM, 2012, MYCOLOGIA, V104, P1390, DOI 10.3852/11-272; Ioos R, 2006, FUNGAL GENET BIOL, V43, P511, DOI 10.1016/j.fgb.2006.02.006; Jung T, 2011, PERSOONIA, V26, P13, DOI 10.3767/003158511X557577; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KO WH, 1978, J GEN MICROBIOL, V107, P15, DOI 10.1099/00221287-107-1-15; Kroon LPNM, 2004, FUNGAL GENET BIOL, V41, P766, DOI 10.1016/j.fgb.2004.03.007; Martin FN, 2003, MYCOLOGIA, V95, P269, DOI 10.2307/3762038; Martin FN, 2012, PLANT DIS, V96, P1080, DOI 10.1094/PDIS-12-11-1036-FE; May KJ, 2003, AUSTRALAS PLANT PATH, V32, P353, DOI 10.1071/AP03037; Nagel JH, 2013, FUNGAL BIOL-UK, V117, P329, DOI 10.1016/j.funbio.2013.03.004; Nirenberg HI, 2009, MYCOLOGIA, V101, P220, DOI 10.3852/06-157; Oliva RF, 2010, PLANT PATHOL, V59, P613, DOI 10.1111/j.1365-3059.2010.02287.x; R Core Team, 2012, R LANG ENV STAT COMP; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3966, 10.1101/pdb.prot4044, 10.1101/pdb.prot4085, 10.1101/pdb.prot4056, 10.1101/pdb.prot4027, 10.1101/pdb.prot4453, 10.1101/pdb.prot3825, 10.1101/pdb.prot4050, 10.1101/pdb.prot4022, 10.1101/pdb.prot3871, 10.1101/pdb.prot4455, 10.1101/pdb.prot3972, 10.1101/pdb.prot3723]; SANSOME E, 1991, MYCOL RES, V95, P273, DOI 10.1016/S0953-7562(09)81232-X; t Veld VAMI, 1998, PHYTOPATHOLOGY, V88, P922, DOI 10.1094/PHYTO.1998.88.9.922; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Villa NO, 2006, MYCOLOGIA, V98, P410, DOI 10.3852/mycologia.98.3.410; Warnes GR, 2012, GPLOTS VARIOUS R PRO; Waterhouse, 1963, MYCOLOGICAL PAPERS, V92; Yang X., 2013, Journal of Plant Pathology and Microbiology, V4, P180; Yang X, 2013, MYCOTAXON, V126, P167, DOI 10.5248/126.167; Yang X, 2014, MYCOLOGIA, V106, P57, DOI 10.3852/13-043; Yang X, 2014, FUNGAL BIOL-UK, V118, P72, DOI 10.1016/j.funbio.2013.11.003	55	23	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103450	10.1371/journal.pone.0103450	http://dx.doi.org/10.1371/journal.pone.0103450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072374	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600050
J	Yang, XH; Yang, JG; Li, L; Sun, LY; Yi, X; Han, X; Si, WZ; Yan, RR; Chen, Z; Xie, GJ; Li, WJ; Shang, YF; Liang, J				Yang, Xiaohan; Yang, Jianguo; Li, Lei; Sun, Luyang; Yi, Xia; Han, Xiao; Si, Wenzhe; Yan, Ruorong; Chen, Zhe; Xie, Guojia; Li, Wanjin; Shang, Yongfeng; Liang, Jing			PAAT, a novel ATPase and trans-regulator of mitochondrial ABC transporters, is critically involved in the maintenance of mitochondrial homeostasis	FASEB JOURNAL			English	Article						oxidative stress; NBD domain; cell death; iron metabolism	LINKED SIDEROBLASTIC ANEMIA; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; SIGNATURE SEQUENCE; DNA-DAMAGE; GENE; IDENTIFICATION; MEMBRANE; HOMOLOGY; MUTATION	ATP-binding cassette (ABC) transporters are implicated in a diverse range of physiological and pathophysiological processes, such as cholesterol and lipid transportation and multidrug resistance. Despite the considerable efforts made in understanding of the cellular function of ABC proteins, the regulation mechanism of this type of protein is still poorly defined. Here we report the identification and functional characterization of a novel ATPase protein, protein associated with ABC transporters (PAAT), in humans. PAAT contains a nucleotide-binding domain (NBD)-like domain and a signal for intramitochondrial sorting. We showed that PAAT is localized in both the cytoplasm and the mitochondria and has an intrinsic ATPase activity. PAAT physically interacts with the 3 known mitochondrial inner membrane ABC proteins, ABCB7, ABCB8, and ABCB10, but not ABCB1, ABCB6, or ABCG2, and functionally regulates the transport of ferric nutrients and heme biosynthesis. Significantly, PAAT deficiency promotes cell death, reduces mitochondrial potential, and sensitizes mitochondria to oxidative stress-induced DNA damages. Our experiments revealed that PAAT is a novel ATPase and a trans-regulator of mitochondrial ABC transporters that plays an important role in the maintenance of mitochondrial homeostasis and cell survival.Yang, X., Yang, J., Li, L., Sun, L., Yi, X., Han, X., Si, W., Yan, R., Chen, Z., Xie, G., Li, W., Shang, Y., Liang, J. PAAT, a novel ATPase and trans-regulator of mitochondrial ABC transporters, is critically involved in the maintenance of mitochondrial homeostasis.	[Yang, Xiaohan; Yang, Jianguo; Li, Lei; Sun, Luyang; Yi, Xia; Han, Xiao; Si, Wenzhe; Yan, Ruorong; Chen, Zhe; Xie, Guojia; Li, Wanjin; Shang, Yongfeng; Liang, Jing] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China; [Si, Wenzhe; Shang, Yongfeng] Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin Key Lab Med Epigenet, Tianjin, Peoples R China	Peking University; Tianjin Medical University	Liang, J (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	liang_jing@hsc.pku.edu.cn	Han, Xiao/A-1109-2017; Chen, Zhe/AAA-3235-2020	Han, Xiao/0000-0002-5395-4022; Chen, Zhe/0000-0002-5303-9879; Xie, Guojia/0000-0002-8250-6157; Han, Xiao/0000-0002-6024-6286	National Natural Science Foundation of China [81130048, 30921062, 31371372, 31371301]; Ministry of Science and Technology of China 973 Program [2011CB504204, 2014CB542004]; Beijing Municipal Natural Science Foundation [7132128]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China 973 Program(Ministry of Science and Technology, ChinaNational Basic Research Program of China); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China grants 81130048 and 30921062 to Y.S.), 31371372 (to X.Y.), and 31371301 (to J.L.); Ministry of Science and Technology of China 973 Program grants 2011CB504204 (to Y.S.) and 2014CB542004 (to J.L.); and Beijing Municipal Natural Science Foundation grant 7132128 (to X.Y.).	ALLIGNET J, 1992, GENE, V117, P45, DOI 10.1016/0378-1119(92)90488-B; Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; AMES GF, 1992, ADV ENZYMOL RAMB, V65, P1; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Ardehali H, 2005, CIRC RES, V97, P740, DOI 10.1161/01.RES.0000186277.12336.11; Bekri S, 2000, BLOOD, V96, P3256; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Burke MA, 2007, TRANSL RES, V150, P73, DOI 10.1016/j.trsl.2007.03.002; Cavadini P, 2007, BLOOD, V109, P3552, DOI 10.1182/blood-2006-08-041632; Chavan H, 2013, J BIOL CHEM, V288, P22658, DOI 10.1074/jbc.M113.485284; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Chou KC, 2001, PROTEIN ENG, V14, P75, DOI 10.1093/protein/14.2.75; Chou KC, 2007, BIOCHEM BIOPH RES CO, V357, P633, DOI 10.1016/j.bbrc.2007.03.162; Csere P, 1998, FEBS LETT, V441, P266, DOI 10.1016/S0014-5793(98)01560-9; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Dean M, 2001, J LIPID RES, V42, P1007; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; GERLACH JH, 1986, NATURE, V324, P485, DOI 10.1038/324485a0; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Graf SA, 2004, J BIOL CHEM, V279, P42954, DOI 10.1074/jbc.M405040200; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; Helias V, 2012, NAT GENET, V44, P170, DOI 10.1038/ng.1069; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Hogue DL, 1999, J MOL BIOL, V285, P379, DOI 10.1006/jmbi.1998.2259; Ichikawa Y, 2012, P NATL ACAD SCI USA, V109, P4152, DOI 10.1073/pnas.1119338109; Jacquet E, 2008, J BIOL CHEM, V283, P25332, DOI 10.1074/jbc.M800418200; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; Lill R, 2001, RES MICROBIOL, V152, P331, DOI 10.1016/S0923-2508(01)01204-9; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Melin P, 2004, BIOCHEM PHARMACOL, V67, P2187, DOI 10.1016/j.bcp.2004.02.022; Mitsuhashi N, 2000, J BIOL CHEM, V275, P17536, DOI 10.1074/jbc.275.23.17536; Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; Paytubi S, 2009, J BIOL CHEM, V284, P24061, DOI 10.1074/jbc.M109.031625; Puntarulo Susana, 2005, Molecular Aspects of Medicine, V26, P299, DOI 10.1016/j.mam.2005.07.001; Ramaen O, 2005, BIOCHEM J, V391, P481, DOI 10.1042/BJ20050897; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; ROSS JI, 1990, MOL MICROBIOL, V4, P1207, DOI 10.1111/j.1365-2958.1990.tb00696.x; Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082; Schmees G, 1999, EUR J BIOCHEM, V266, P420, DOI 10.1046/j.1432-1327.1999.00871.x; Shani N, 1997, HUM MOL GENET, V6, P1925, DOI 10.1093/hmg/6.11.1925; Shirihai OS, 2000, EMBO J, V19, P2492, DOI 10.1093/emboj/19.11.2492; Sinclair PR, 2001, CURR PROTOC TOXICOL, V8; SMITH FE, 1984, CLIN BIOCHEM, V17, P306, DOI 10.1016/S0009-9120(84)90613-1; Szentpetery Z, 2004, J BIOL CHEM, V279, P41670, DOI 10.1074/jbc.M406484200; Taketani S, 2003, BLOOD, V101, P3274, DOI 10.1182/blood-2002-04-1212; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514	55	12	12	0	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4821	4834		10.1096/fj.14-254045	http://dx.doi.org/10.1096/fj.14-254045			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25063848				2022-12-25	WOS:000344050900020
J	Coiro, P; Stoenica, L; Strauss, U; Brauer, AU				Coiro, Pierluca; Stoenica, Luminita; Strauss, Ulf; Braeuer, Anja Ursula			Plasticity-related Gene 5 Promotes Spine Formation in Murine Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC SPINES; ACTIN CYTOSKELETON; PHOSPHATIDIC-ACID; RHO GTPASES; DYNAMICS; MEMBRANE; FILOPODIA; IRSP53; BRAIN; PROTRUSION	The transmembrane protein plasticity-related genes 3 and 5 (PRG3 and PRG5) increase filopodial formation in various cell lines, independently of Cdc42. However, information on the effects of PRG5 during neuronal development is sparse. Here, we present several lines of evidence for the involvement of PRG5 in the genesis and stabilization of dendritic spines. First, PRG5 was strongly expressed during mouse brain development from embryonic day 14 (E14), peaked around the time of birth, and remained stable at least until early adult stages (i.e. P30). Second, on a subcellular level, PRG5 expression shifted from an equal distribution along all neurites toward accumulation only along dendrites during hippocampal development in vitro. Third, overexpression of PRG5 in immature hippocampal neurons induced formation of spine-like structures ahead of time. Proper amino acid sequences in the extracellular domains (D1 to D3) of PRG5 were a prerequisite for trafficking and induction of spine-like structures, as shown by mutation analysis. Fourth, at stages when spines are present, knockdown of PRG5 reduced the number but not the length of protrusions. This was accompanied by a decrease in the number of excitatory synapses and, consequently, by a reduction of miniature excitatory postsynaptic current frequencies, although miniature excitatory postsynaptic current amplitudes remained similar. In turn, overexpressing PRG5 in mature neurons not only increased Homer-positive spine numbers but also augmented spine head diameters. Mechanistically, PRG5 interacts with phosphorylated phosphatidylinositols, phospholipids involved in dendritic spine formation by different lipid-protein assays. Taken together, our data propose that PRG5 promotes spine formation.	[Coiro, Pierluca; Stoenica, Luminita; Strauss, Ulf; Braeuer, Anja Ursula] Charite, Ctr Anat, Inst Cell Biol & Neurobiol, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Brauer, AU (corresponding author), Charite, Ctr Anat, Inst Cell Biol & Neurobiol, Charitepl 1, D-10117 Berlin, Germany.	anja.braeuer@charite.de	Bräuer, Anja/N-3692-2019; Braeuer, Anja/K-8339-2013; Strauss, Ulf/I-4146-2012	Strauss, Ulf/0000-0002-1534-6624	Deutsche Forschungsgemeinschaft [BR 2345/1-1]; Sonnenfeld-Stiftung; NaFoG	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonnenfeld-Stiftung; NaFoG	This work was supported by Deutsche Forschungsgemeinschaft Grant BR 2345/1-1 (to A. U. B.) and the Sonnenfeld-Stiftung for sponsoring technical equipment for A. U. B. and U. S. and the NaFoG sponsored P. C.	Abe R, 2004, AM J PATHOL, V164, P1225, DOI 10.1016/S0002-9440(10)63210-5; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Arstikaitis P, 2008, MOL BIOL CELL, V19, P2026, DOI 10.1091/mbc.E07-08-0802; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Brauer AU, 2008, BBA-MOL CELL BIOL L, V1781, P595, DOI 10.1016/j.bbalip.2008.04.004; Brauer AU, 2003, NAT NEUROSCI, V6, P572, DOI 10.1038/nn1052; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Broggini T, 2010, MOL BIOL CELL, V21, P521, DOI 10.1091/mbc.E09-06-0506; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Haeckel A, 2008, J NEUROSCI, V28, P10031, DOI 10.1523/JNEUROSCI.0336-08.2008; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Horne EA, 2007, J NEUROSCI, V27, P3523, DOI 10.1523/JNEUROSCI.4340-06.2007; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Irie F, 2004, FRONT BIOSCI-LANDMRK, V9, P1365, DOI 10.2741/1325; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kim K, 2010, J NEUROCHEM, V112, P577, DOI 10.1111/j.1471-4159.2009.06499.x; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Savaskan NE, 2007, CELL MOL LIFE SCI, V64, P230, DOI 10.1007/s00018-006-6412-0; Savaskan NE, 2004, EUR J NEUROSCI, V19, P212, DOI 10.1046/j.1460-9568.2003.03078.x; Schwamborn JC, 2006, METHOD ENZYMOL, V406, P715, DOI 10.1016/S0076-6879(06)06056-3; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Shirao T, 2013, J NEUROCHEM, V126, P155, DOI 10.1111/jnc.12313; Sigal YJ, 2007, J CELL SCI, V120, P340, DOI 10.1242/jcs.03335; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Strauss U, 2013, BBA-MOL CELL BIOL L, V1831, P133, DOI 10.1016/j.bbalip.2012.08.010; Sun LY, 2005, MOL CELL BIOCHEM, V272, P91, DOI 10.1007/s11010-005-7640-6; Trimbuch T, 2009, CELL, V138, P1222, DOI 10.1016/j.cell.2009.06.050; Velmans T, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-36; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Zhang QX, 2000, BIOCHEM J, V345, P181, DOI 10.1042/0264-6021:3450181	48	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24956	24970		10.1074/jbc.M114.597880	http://dx.doi.org/10.1074/jbc.M114.597880			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25074937	Green Published, hybrid			2022-12-25	WOS:000341985300021
J	Agmon, M; Armon, G				Agmon, Maayan; Armon, Galit			Increased Insomnia Symptoms Predict the Onset of Back Pain among Employed Adults	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NOXIOUS INHIBITORY CONTROLS; SLEEP LOSS; MUSCULOSKELETAL PAIN; PREVALENCE; SENSITIVITY; DISTURBANCES; EPIDEMIOLOGY; MODULATION; DISORDERS	Background: Back pain is among the most prevalent pain disorders causing chronic disability among adults, and insomnia is a common co-morbidity. However, whether insomnia precedes back pain or vice versa remains unclear. The current study tested the temporal association between insomnia and back pain. Methods: A longitudinal design was used to investigate whether changes in insomnia over time predict the onset of back pain and vice versa. The study was conducted on a cohort of active healthy working adults (N = 2,131, 34% women) at three time points (T1, T2, and T3) over a period of 3.7 years (range = 2.2-5.12) years. Logistic regression analysis was used to test whether increased insomnia symptoms from T1 to T2 predicted the onset of new back pain. Ordinary least squares regression was used to test whether the existence of back pain at T2 predicted an increase in insomnia from T2 to T3. Results: The results indicated that after controlling for socioeconomic variables, self-reported health, lifestyle behaviors, and anthropometrics, a T1-T2 increase in insomnia symptoms was associated with a 1.40-fold increased risk of back pain at T3 (OR = 1.40; 95% CI = 1.10-1.71). No support was found for reverse causation; i.e., that back pain predicts subsequent increase in insomnia. Conclusions: Insomnia appears to be a risk factor in the development of back pain in healthy individuals. However, no evidence of reverse causation was found.	[Agmon, Maayan] Univ Haifa, Sch Nursing, IL-31999 Haifa, Israel; [Armon, Galit] Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel	University of Haifa; University of Haifa	Agmon, M (corresponding author), Univ Haifa, Sch Nursing, IL-31999 Haifa, Israel.	Agmon.mn@gmail.com		Agmon, Maayan/0000-0002-1855-1199				Ahn SH, 2002, SPINE, V27, P911, DOI 10.1097/00007632-200205010-00005; Alsaadi SM, 2011, EUR SPINE J, V20, P737, DOI 10.1007/s00586-010-1661-x; Bahouq H, 2013, RHEUMATOL INT, V33, P1277, DOI 10.1007/s00296-012-2550-x; Bergmann MM, 2004, EUR J EPIDEMIOL, V19, P411, DOI 10.1023/B:EJEP.0000027350.85974.47; Bevan S, 2009, FIT WORK MUSCULOSKEL; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; Bongers PM, 2006, J OCCUP REHABIL, V16, P279, DOI 10.1007/s10926-006-9044-1; Burke JG, 2002, J BONE JOINT SURG BR, V84B, P196, DOI 10.1302/0301-620X.84B2.12511; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Dormann C, 2001, STRUCT EQU MODELING, V8, P575, DOI 10.1207/S15328007SEM0804_04; Elfering A, 2008, SCAND J WORK ENV HEA, V34, P337, DOI 10.5271/sjweh.1280; Finan PH, 2012, SLEEP MED REV; Froom P, 1999, J CLIN EPIDEMIOL, V52, P731, DOI 10.1016/S0895-4356(99)00070-0; Griffith LE, 2007, J CLIN EPIDEMIOL, V60, P625, DOI 10.1016/j.jclinepi.2006.09.005; Haack M, 2012, EUR J PAIN, V16, P522, DOI 10.1016/j.ejpain.2011.07.007; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Irwin M, 2002, BRAIN BEHAV IMMUN, V16, P503, DOI 10.1016/S0889-1591(02)00003-X; Kaila-Kangas L, 2006, SPINE, V31, P51, DOI 10.1097/01.brs.0000193902.45315.e5; Kelly GA, 2011, CLIN J PAIN, V27, P169, DOI 10.1097/AJP.0b013e3181f3bdd5; Lautenbacher S, 2006, SLEEP MED REV, V10, P357, DOI 10.1016/j.smrv.2005.08.001; Lavigne GJ, 2011, CURR RHEUMATOL REP, V13, P535, DOI 10.1007/s11926-011-0209-3; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Leger D, 2000, J SLEEP RES, V9, P35, DOI 10.1046/j.1365-2869.2000.00178.x; Louie GH, 2011, ARTHRIT CARE RES, V63, P247, DOI 10.1002/acr.20362; Manek NJ, 2005, CURR OPIN RHEUMATOL, V17, P134; Marty M, 2008, EUR SPINE J, V17, P839, DOI 10.1007/s00586-008-0660-7; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Pielsticker A, 2005, PAIN, V118, P215, DOI 10.1016/j.pain.2005.08.019; Purushothaman B, 2013, J ORTHOP SURG-HONG K, V21, P68, DOI 10.1177/230949901302100118; Rannou F, 2007, ARTHRIT RHEUM-ARTHR, V57, P1311, DOI 10.1002/art.22985; Richardson CR, 2004, MED SCI SPORT EXER, V36, P1923, DOI 10.1249/01.MSS.0000145443.02568.7A; Rifai N, 1999, CLIN CHEM, V45, P2136; Roehrs T, 2006, SLEEP, V29, P145, DOI 10.1093/sleep/29.2.145; Roizenblatt S, 2011, CURR PAIN HEADACHE R, V15, P347, DOI 10.1007/s11916-011-0213-3; Roth T, 2007, SLEEP MED REV, V11, P71, DOI 10.1016/j.smrv.2006.06.002; Roth T, 2011, BIOL PSYCHIAT, V69, P592, DOI 10.1016/j.biopsych.2010.10.023; Sandrini G, 2006, CEPHALALGIA, V26, P782, DOI 10.1111/j.1468-2982.2006.01130.x; Schneider S, 2006, CLIN J PAIN, V22, P738, DOI 10.1097/01.ajp.0000210920.03289.93; Siivola SM, 2004, SPINE, V29, P1662, DOI 10.1097/01.BRS.0000133644.29390.43; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Soldatos CR, 2003, J PSYCHOSOM RES, V55, P263, DOI 10.1016/S0022-3999(02)00604-9; Sturmer T, 2005, ANN RHEUM DIS, V64, P921, DOI 10.1136/ard.2004.027045; TEPAS DI, 1989, WORK STRESS, V3, P93, DOI 10.1080/02678378908256883; Treister R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063808; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Twisk JW, 2013, APPL LONGITUDINAL DA; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Wood PB, 2007, EUR J NEUROSCI, V25, P3576, DOI 10.1111/j.1460-9568.2007.05623.x; Yarnitsky D, 2010, CURR OPIN ANESTHESIO, V23, P611, DOI 10.1097/ACO.0b013e32833c348b; Zapf D, 1996, J Occup Health Psychol, V1, P145, DOI 10.1037/1076-8998.1.2.145; Zhang JH, 2013, SLEEP, V36, P671, DOI 10.5665/sleep.2624	51	44	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103591	10.1371/journal.pone.0103591	http://dx.doi.org/10.1371/journal.pone.0103591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084165	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800054
J	Bellmunt, J; Selvarajah, S; Rodig, S; Salido, M; de Muga, S; Costa, I; Bellosillo, B; Werner, L; Mullane, S; Fay, AP; O'Brien, R; Barretina, J; Minoche, AE; Signoretti, S; Montagut, C; Himmelbauer, H; Berman, DM; Kantoff, P; Choueiri, TK; Rosenberg, JE				Bellmunt, Joaquim; Selvarajah, Shamini; Rodig, Scott; Salido, Marta; de Muga, Silvia; Costa, Irmgard; Bellosillo, Beatriz; Werner, Lillian; Mullane, Stephanie; Fay, Andre P.; O'Brien, Robert; Barretina, Jordi; Minoche, Andre E.; Signoretti, Sabina; Montagut, Clara; Himmelbauer, Heinz; Berman, David M.; Kantoff, Philip; Choueiri, Toni K.; Rosenberg, Jonathan E.			Identification of ALK Gene Alterations in Urothelial Carcinoma	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; CELL-LUNG-CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; BLADDER-CANCER; CLINICOPATHOLOGICAL FEATURES; MOLECULAR CHARACTERIZATION; PROGNOSTIC IMPLICATIONS; ACTIVATING MUTATIONS; COPY-NUMBER; RHABDOMYOSARCOMA	Background: Anaplastic lymphoma kinase (ALK) genomic alterations have emerged as a potent predictor of benefit from treatment with ALK inhibitors in several cancers. Currently, there is no information about ALK gene alterations in urothelial carcinoma (UC) and its correlation with clinical or pathologic features and outcome. Methods: Samples from patients with advanced UC and correlative clinical data were collected. Genomic imbalances were investigated by array comparative genomic hybridization (aCGH). ALK gene status was evaluated by fluorescence in situ hybridization (FISH). ALK expression was assessed by immunohistochemistry (IHC) and high-throughput mutation analysis with Oncomap 3 platform. Next generation sequencing was performed using Illumina Genome Analyzer IIx, and Illumina HiSeq 2000 in the FISH positive case. Results: 70 of 96 patients had tissue available for all the tests performed. Arm level copy number gains at chromosome 2 were identified in 17 (24%) patients. Minor copy number alterations (CNAs) in the proximity of ALK locus were found in 3 patients by aCGH. By FISH analysis, one of these samples had a deletion of the 5'ALK. Whole genome next generation sequencing was inconclusive to confirm the deletion at the level of the ALK gene at the coverage level used. We did not observe an association between ALK CNA and overall survival, ECOG PS, or development of visceral disease. Conclusions: ALK genomic alterations are rare and probably without prognostic implications in UC. The potential for testing ALK inhibitors in UC merits further investigation but might be restricted to the identification of an enriched population.	[Bellmunt, Joaquim; Selvarajah, Shamini; Rodig, Scott; Mullane, Stephanie; Fay, Andre P.; O'Brien, Robert; Kantoff, Philip; Choueiri, Toni K.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Bladder Canc Ctr, Boston, MA 02115 USA; [Bellmunt, Joaquim; Montagut, Clara] Hosp Mar Res Inst IMIM, Barcelona, Spain; [Salido, Marta; de Muga, Silvia; Bellosillo, Beatriz] Hosp Mar Res Inst IMIM, Dept Pathol, Barcelona, Spain; [Costa, Irmgard] Hosp Parc Tauli, Sabadell, Spain; [Werner, Lillian] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Barretina, Jordi] Broad Inst, Cambridge, MA USA; [Minoche, Andre E.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Minoche, Andre E.; Himmelbauer, Heinz] CRG, Barcelona, Spain; [Minoche, Andre E.; Himmelbauer, Heinz] Univ Pompeu Fabra, Barcelona, Spain; [Berman, David M.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Rosenberg, Jonathan E.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Max Planck Society; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Johns Hopkins University; Memorial Sloan Kettering Cancer Center	Bellmunt, J (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Bladder Canc Ctr, 44 Binney St, Boston, MA 02115 USA.	joaquim_bellmunt@dfci.harvard.edu	Choueiri, Toni/K-5238-2019; Bellmunt, Joaquim/B-8151-2019; De Muga, Silvia/AAB-9018-2020; Rodig, Scott/Y-3889-2019; Barretina, Jordi/A-7192-2013	Choueiri, Toni/0000-0002-9201-3217; Bellmunt, Joaquim/0000-0003-2328-3421; De Muga, Silvia/0000-0002-8037-8729; berman, david/0000-0001-5985-3698; Rosenberg, Jonathan/0000-0003-2637-4249; Selvarajah, Shamini/0000-0002-9894-4864; Kantoff, Philip/0000-0001-7275-0597; Himmelbauer, Heinz/0000-0001-8897-2928; Barretina, Jordi/0000-0002-3478-4080	Spanish Health Ministry Grant "Fondo de Investigacion Sanitaria" [PI061513]; RTICC [06/0020/19]	Spanish Health Ministry Grant "Fondo de Investigacion Sanitaria"; RTICC(Instituto de Salud Carlos III)	This work has been supported by PI061513 (Spanish Health Ministry Grant "Fondo de Investigacion Sanitaria") and RTICC 06/0020/19 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbas-Martinez C, 2013, NAT GENET, V45, P1464, DOI 10.1038/ng.2799; Barreca A, 2011, J MOL ENDOCRINOL, V47, pR11, DOI 10.1530/JME-11-0004; Bavi P, 2013, BRIT J CANCER, V109, P2735, DOI 10.1038/bjc.2013.641; Bavi P, 2013, BR J CANC; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Bonvini P, 2013, BRIT J CANCER, V109, P3084, DOI 10.1038/bjc.2013.653; Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Camidge DR, 2010, CLIN CANCER RES, V16, P5581, DOI 10.1158/1078-0432.CCR-10-0851; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Dai ZY, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-44; Debelenko LV, 2011, MODERN PATHOL, V24, P430, DOI 10.1038/modpathol.2010.213; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Hernandez L, 1999, BLOOD, V94, P3265; Hoglund M, 2012, UROL ONCOL-SEMIN ORI, V30, P533, DOI 10.1016/j.urolonc.2012.04.001; Hurst CD, 2012, CLIN CANCER RES, V18, P5865, DOI 10.1158/1078-0432.CCR-12-1807; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Iyer G, 2013, J CLIN ONCOL, V31, P3133, DOI 10.1200/JCO.2012.46.5740; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee JS, 2014, J CLIN PATHOL, V67, P33, DOI 10.1136/jclinpath-2013-201655; Lee JO, 2011, J THORAC ONCOL, V6, P1474, DOI 10.1097/JTO.0b013e3182208fc2; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Lopez V, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-182; Mano H, 2012, CANCER DISCOV, V2, P495, DOI 10.1158/2159-8290.CD-12-0009; Montagut C, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.10537; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Panzeri E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024237; Riester M, 2014, CLIN CANCER RES, V20, P1873, DOI 10.1158/1078-0432.CCR-13-0759; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Ross JS, 2014, MODERN PATHOL, V27, P271, DOI 10.1038/modpathol.2013.135; Salido M, 2011, J THORAC ONCOL, V6, P21, DOI 10.1097/JTO.0b013e3181fb7cd6; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shukla N, 2012, CLIN CANCER RES, V18, P748, DOI 10.1158/1078-0432.CCR-11-2056; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sukov WR, 2012, MODERN PATHOL, V25, P1516, DOI 10.1038/modpathol.2012.107; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; van Gaal JC, 2012, J CLIN ONCOL, V30, P308, DOI 10.1200/JCO.2011.37.8588; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Ze TA, 2010, BIOINFORMATICS, V26, P2313, DOI 10.1093/bioinformatics/btq428	47	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103325	10.1371/journal.pone.0103325	http://dx.doi.org/10.1371/journal.pone.0103325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083769	Green Submitted, Green Published, gold			2022-12-25	WOS:000339819800030
J	Ding, XF; Zhu, LM; Ji, T; Zhang, XP; Wang, FM; Gan, SJ; Zhao, M; Yang, HJ				Ding, Xianfeng; Zhu, Limin; Ji, Ting; Zhang, Xiping; Wang, Fengmei; Gan, Shaoju; Zhao, Ming; Yang, Hongjian			Long Intergenic Non-Coding RNAs (LincRNAs) Identified by RNA-Seq in Breast Cancer	PLOS ONE			English	Article							SUSCEPTIBILITY GENE; OVARIAN-CANCER; AMPLIFICATION; 13Q34; CANDIDATE; CARCINOMA; ONCOGENES; SURVIVAL; SEQUENCE; LINKAGE	In an attempt to find the correlation of aberrant expression of long intergenic noncoding RNAs (lincRNAs) with cancer, twenty-five samples of breast cancer tissue and respective adjacent normal tissue were studied for the expression of lincRNAs by RNA-seq. Among the 538 lincRNAs studied, 124 lincRNAs were exclusively expressed in cancer adjacent tissues and 62 lincRNAs were exclusively expressed in the cancer tissues. Furthermore, the expression of 134 lincRNAs was higher while 272 lower in breast cancer tissue compared with adjacent tissue. The expression of four selected lincRNAs (BC2, BC4, BC5, and BC8) was validated by semi-quantitative and real-time PCR. It was revealed that expression of lincRNA-BC5 was positively correlated with patients' age, pathological stage, and progesterone receptor concentration, while lincRNA-BC8 was negatively correlated with progesterone receptor expression. Higher expression of lincRNA-BC4 was seen in advanced breast cancer grade. LincRNA-BC2 showed no specific changes in the pathological features studied. Interactions between selected lincRNAs and breast cancer associated proteins were highly suggested by RPIseq based on the specific secondary structure. The results demonstrated that this group of lincRNAs was aberrantly expressed in breast cancer. They might play important roles in the function of oncogenes or tumor suppressors affecting the development and progression of breast cancer.	[Ding, Xianfeng; Zhu, Limin; Ji, Ting; Gan, Shaoju; Zhao, Ming] Zhejiang Sci Tech Univ, Coll Life Sci, Inst Bioengn, Hangzhou, Zhejiang, Peoples R China; [Zhang, Xiping; Yang, Hongjian] Zhejiang Canc Hosp, Dept Breast Tumor Surg, Zhejiang Canc Res Inst, Hangzhou, Zhejiang, Peoples R China; [Wang, Fengmei] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang Sci-Tech University; Zhejiang Cancer Hospital; Zhejiang University	Ding, XF (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Inst Bioengn, Hangzhou, Zhejiang, Peoples R China.	xfding@zstu.edu.cn; yhjzlyy@163.com			Natural Science Foundation of Zhejiang Province, China [LY12H16030]; Foundation of Science and Technology Department of Zhejiang Province; China [2011C23043]; Foundation of Health Department of Zhejiang Province, China [2011BCA015]	Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Foundation of Science and Technology Department of Zhejiang Province; China; Foundation of Health Department of Zhejiang Province, China	This work was supported by Natural Science Foundation of Zhejiang Province, China (No. LY12H16030); Foundation of Science and Technology Department of Zhejiang Province; China (No. 2011C23043) and also by Foundation of Health Department of Zhejiang Province, China (No. 2011BCA015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Bernhart SH, 2011, METHODS MOL BIOL, V760, P307, DOI 10.1007/978-1-61779-176-5_19; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BOS JL, 1989, CANCER RES, V49, P4682; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cirillo D, 2012, WILEY INTERDISCIPLIN; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; Dhillon VS, 2003, TERATOGEN CARCIN MUT, P35, DOI 10.1002/tcm.10068; Dohna M, 2000, GENE CHROMOSOME CANC, V28, P145, DOI 10.1002/(SICI)1098-2264(200006)28:2<145::AID-GCC3>3.0.CO;2-7; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; He JH, 2014, BIOMED REP, V2, P19, DOI 10.3892/br.2013.191; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu YZ, 2006, HUM GENET, V119, P295, DOI 10.1007/s00439-006-0136-y; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Melchor L, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2456; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Michiels EMC, 2002, J PEDIAT HEMATOL ONC, V24, P205, DOI 10.1097/00043426-200203000-00009; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Muppirala UK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-489; Ohman M, 2000, J CLIN ENDOCR METAB, V85, P3183, DOI 10.1210/jc.85.9.3183; Osborne C, 2004, ONCOLOGIST, V9, P361, DOI 10.1634/theoncologist.9-4-361; Osborne CK, 1998, BREAST CANCER RES TR, V51, P227, DOI 10.1023/A:1006132427948; Pastural E, 2000, GENOMICS, V63, P299, DOI 10.1006/geno.1999.6081; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Richard F, 2000, INT J CANCER, V89, P305; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shinomiya T, 1999, GENE CHROMOSOME CANC, V24, P337, DOI 10.1002/(SICI)1098-2264(199904)24:4<337::AID-GCC7>3.0.CO;2-O; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Washietl S, 2010, METHODS MOL BIOL, V609, P285, DOI 10.1007/978-1-60327-241-4_17; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683; Yoon JH, 2012, MOL CELL	42	30	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103270	10.1371/journal.pone.0103270	http://dx.doi.org/10.1371/journal.pone.0103270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084155	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800024
J	Maguma, HT; De, DD; Bhave, S; Dewey, WL; Akbarali, HI				Maguma, Hercules T.; De, Dipanjana Datta; Bhave, Sukhada; Dewey, William L.; Akbarali, Hamid I.			Specific Localization of beta-Arrestin2 in Myenteric Plexus of Mouse Gastrointestinal Tract	PLOS ONE			English	Article							BETA-ARRESTIN; PHYSICAL-DEPENDENCE; MORPHINE-TOLERANCE; ENTERIC NEURONS; PROTEIN; PROJECTIONS; ACTIVATION; EXPRESSION	beta-arrestin2 is a key molecule involved in signaling and internalization of activated G protein-coupled receptors including mopioid receptors (MOR). Previously we have shown that decreased expression of beta-arrestin2 upon chronic morphine is associated with the development of opioid tolerance in the gastrointestinal tract. However, the localization of beta-arrestin2 within the gastrointestinal wall is not known. In this study we found that beta-arrestin2 is localized in the soma of a select group of neurons in the myenteric ganglia but not in smooth muscle. The density of beta-arestin2 was significantly higher in the ileum than the colon. We identified four variants of beta-arrestin2 in the ileum, with ARRB-005 and ARRB-013 being the most abundant. Further, the current study utilized multiple-labeling immunofluorescence to characterize the chemical coding of neurons expressing beta-arrestin2 in the murine myenteric plexus and the co-localization of MOR1 and beta-arrestin2. beta-arrestin2 co-localized with choline acetyltransferase and calretinin. In contrast, beta-arrestin2 neither co-localized with substance P, nitric oxide synthase nor calbindin. Genetic deletion of beta-arrestin2 did not affect cholinergic neuron activation by nicotine in the isolated ileum (-log M EC50: wild type = 5.8 vs. beta-arrestin2 knockout = 5.9). Our findings suggest specificity in the localization of beta-arrestin2 in the myenteric plexus within MOR1-expressing neurons and provide a relation for direct intracellular crosstalk between MOR1 receptor activation and beta-arrestin2 signaling in the myenteric neurons. beta-arrestin2 deletion does not directly alter basal enteric cholinergic neuronal function.	[Maguma, Hercules T.; De, Dipanjana Datta; Bhave, Sukhada; Dewey, William L.; Akbarali, Hamid I.] Virginia Commonwealth Univ, Program Enter Neuromuscular Sci, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA	Virginia Commonwealth University	Akbarali, HI (corresponding author), Virginia Commonwealth Univ, Program Enter Neuromuscular Sci, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	hiakbarali@vcu.edu	BHAVE, SUKHADA/AAM-3518-2020; Akbarali, Hamid/Q-9344-2019; Bhave, Sukhada/ABC-4954-2020	Akbarali, Hamid/0000-0003-1423-0774	National Institute of Health [NIH DA024009, NIH DK046367]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024009, P30DA033934] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Health grants NIH DA024009 and NIH DK046367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREHMER A, 2006, ADV ANAT EMBRYOL CEL, V186, P1; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Fan XL, 2003, NEUROSCIENCE, V117, P383, DOI 10.1016/S0306-4522(02)00930-2; Furness JB, 2000, CELL TISSUE RES, V300, P383, DOI 10.1007/s004410000210; Furness JB, 2002, CURR OPIN PHARMACOL, V2, P612, DOI 10.1016/S1471-4892(02)00219-9; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Kang MH, 2012, J PHARMACOL EXP THER, V340, P567, DOI 10.1124/jpet.111.186320; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Maguma HT, 2012, EUR J PHARMACOL, V685, P133, DOI 10.1016/j.ejphar.2012.04.001; MESSENGER JP, 1990, ARCH HISTOL CYTOL, V53, P467, DOI 10.1679/aohc.53.467; Nurgali K, 2004, J COMP NEUROL, V468, P112, DOI 10.1002/cne.10948; PATON WDM, 1968, J PHYSIOL-LONDON, V194, P13, DOI 10.1113/jphysiol.1968.sp008392; Qu ZD, 2008, CELL TISSUE RES, V334, P147, DOI 10.1007/s00441-008-0684-7; Raehal KM, 2011, NEUROPHARMACOLOGY, V60, P58, DOI 10.1016/j.neuropharm.2010.08.003; Ross GR, 2008, J PHARMACOL EXP THER, V327, P561, DOI 10.1124/jpet.108.143438; Schulz S, 2004, EMBO J, V23, P3282, DOI 10.1038/sj.emboj.7600334; Smith TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045251; Taylor DA, 2001, J PHARMACOL EXP THER, V297, P11; Van Ginneken C, 1998, ANAT EMBRYOL, V198, P399, DOI 10.1007/s004290050192; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174	22	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103894	10.1371/journal.pone.0103894	http://dx.doi.org/10.1371/journal.pone.0103894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083714	Green Submitted, gold, Green Published			2022-12-25	WOS:000339819800099
J	Korinth, SP; Breznitz, Z				Korinth, Sebastian Peter; Breznitz, Zvia			Fast and Slow Readers of the Hebrew Language Show Divergence in Brain Response similar to 200 ms Post Stimulus: An ERP Study	PLOS ONE			English	Article							WORD RECOGNITION; FACES; IDENTIFICATION	Higher N170 amplitudes to words and to faces were recently reported for faster readers of German. Since the shallow German orthography allows phonological recoding of single letters, the reported speed advantages might have their origin in especially well-developed visual processing skills of faster readers. In contrast to German, adult readers of Hebrew are forced to process letter chunks up to whole words. This dependence on more complex visual processing might have created ceiling effects for this skill. Therefore, the current study examined whether also in the deep Hebrew orthography visual processing skills as reflected by N170 amplitudes explain reading speed differences. Forty university students, native speakers of Hebrew without reading impairments, accomplished a lexical decision task (i.e., deciding whether a visually presented stimulus represents a real or a pseudo word) and a face decision task (i.e., deciding whether a face was presented complete or with missing facial features) while their electroencephalogram was recorded from 64 scalp positions. In both tasks stronger event related potentials (ERPs) were observed for faster readers in time windows at about 200 ms. Unlike in previous studies, ERP waveforms in relevant time windows did not correspond to N170 scalp topographies. The results support the notion of visual processing ability as an orthography independent marker of reading proficiency, which advances our understanding about regular and impaired reading development.	[Korinth, Sebastian Peter] Goethe Univ Frankfurt, Dept Neurocognit Psychol, D-60054 Frankfurt, Germany; [Korinth, Sebastian Peter] Ctr Individual Dev & Adapt Educ Children Risk IDe, Frankfurt, Germany; [Breznitz, Zvia] Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, IL-31999 Haifa, Israel	Goethe University Frankfurt; University of Haifa	Korinth, SP (corresponding author), Goethe Univ Frankfurt, Dept Neurocognit Psychol, D-60054 Frankfurt, Germany.	korinth@korinth.org	Korinth, Sebastian/AAR-6118-2021	Korinth, Sebastian/0000-0002-3657-9857	Edmond J. SAFRA foundation	Edmond J. SAFRA foundation	This study was supported by a grant awarded by the Edmond J. SAFRA foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Brem S, 2009, HUM BRAIN MAPP, V30, P1833, DOI 10.1002/hbm.20751; Busch NA, 2004, CLIN NEUROPHYSIOL, V115, P1810, DOI 10.1016/j.clinph.2004.03.015; Frost R, 1997, J EXP PSYCHOL LEARN, V23, P829, DOI 10.1037/0278-7393.23.4.829; FROST R, 1987, J EXP PSYCHOL HUMAN, V13, P104, DOI 10.1037/0096-1523.13.1.104; Frost R., 2005, WORD FREQUENCY DATAB; Gauthier I, 2003, NAT NEUROSCI, V6, P428, DOI 10.1038/nn1029; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Herzmann G, 2004, PSYCHOPHYSIOLOGY, V41, P688, DOI 10.1111/j.1469-8986.2004.00196.x; Hillyard SA, 1998, CURR OPIN NEUROBIOL, V8, P202, DOI 10.1016/S0959-4388(98)80141-4; Kast M, 2010, INT J PSYCHOPHYSIOL, V77, P59, DOI 10.1016/j.ijpsycho.2010.04.003; Korinth SP, 2012, BRAIN LANG, V120, P15, DOI 10.1016/j.bandl.2011.08.003; Kutas M., 2006, HDB PSYCHOLINGUISTIC, P659, DOI [10.1016/B978-012369374-7/50018-3, DOI 10.1016/B978-012369374-7/50018-3]; Landerl K, 1997, COGNITION, V63, P315, DOI 10.1016/S0010-0277(97)00005-X; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Maurer U, 2005, J COGNITIVE NEUROSCI, V17, P1532, DOI 10.1162/089892905774597218; Maurer U, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.018.2008; Mercure E, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00006, 10.3389/fnhum.2011.00062]; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Schendan HE, 1998, PSYCHOPHYSIOLOGY, V35, P240, DOI 10.1017/S004857729897010X; Shimron J, 1999, READ WRIT, V11, P301, DOI 10.1023/A:1008045316692; Tanaka JW, 2001, PSYCHOL SCI, V12, P43, DOI 10.1111/1467-9280.00308; Wechsler D., 1997, WECHSLER ADULT INTEL; Westbury CF, 2007, MENT LEX, V2, P273; Wydell TN, 2003, J COGNITIVE NEUROSCI, V15, P1052, DOI 10.1162/089892903770007434; Ziegler JC, 2001, PSYCHOL SCI, V12, P379, DOI 10.1111/1467-9280.00370	27	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103139	10.1371/journal.pone.0103139	http://dx.doi.org/10.1371/journal.pone.0103139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6EF	25078405	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800029
J	Mucha, J; Majchrzak, K; Taciak, B; Hellmen, E; Krol, M				Mucha, Joanna; Majchrzak, Kinga; Taciak, Bartlomiej; Hellmen, Eva; Krol, Magdalena			MDSCs Mediate Angiogenesis and Predispose Canine Mammary Tumor Cells for Metastasis via IL-28/IL-28RA (IFN-lambda) Signaling	PLOS ONE			English	Article							SUPPRESSOR-CELLS; ANTITUMOR IMMUNITY; GENE-EXPRESSION; CANCER; MICE; PROGRESSION; INHIBITION; EXPANSION; INVASION; GROWTH	Background: Myeloid-derived suppressor cells (MDSCs) function in immunosuppression and tumor development by induction of angiogenesis in a STAT3-dependent manner. Knowledge of MDSC biology is mainly limited to mice studies, and more clinical investigations using spontaneous tumor models are required. Here we performed in vitro experiments and clinical data analysis obtained from canine patients. Methods: Using microarrays we examined changes in gene expression in canine mammary cancer cells due to their co-culture with MDSCs. Further, using Real-time rt-PCR, Western blot, IHC, siRNA, angiogenesis assay and migration/invasion tests we examined a role of the most important signaling pathway. Results: In dogs with mammary cancer, the number of circulating MDSCs increases with tumor clinical stage. Microarray analysis revealed that MDSCs had significantly altered molecular pathways in tumor cells in vitro. Particularly important was the detected increased activation of IL-28/IL-28RA (IFN-lambda) signaling. The highest expression of IL-28 was observed in stage III/IV mammary tumor-bearing dogs. IL-28 secreted by MDSCs stimulates STAT3 in tumor cells, which results in increased expression of angiogenic factors and subsequent induction of angiogenesis by endothelial cells, epithelial-mesenchymal transition (EMT) and increased migration of tumor cells in vitro. Knockdown of IL-28RA decreased angiogenesis, tumor cell invasion and migration. Conclusions: We showed for the first time that MDSCs secrete IL-28 (IFN-lambda), which promotes angiogenesis, EMT, invasion and migration of tumor cells. Thus, IL-28 may constitute an interesting target for further therapies. Moreover, the similarity in circulating MDSC levels at various tumor clinical stages between canine and human patients indicates canines as a good model for clinical trials of drugs targeting MDSCs.	[Mucha, Joanna; Taciak, Bartlomiej; Krol, Magdalena] Warsaw Univ Life Sci, Fac Vet Med, Dept Physiol Sci, Warsaw, Poland; [Majchrzak, Kinga] Warsaw Univ Life Sci, Fac Anim Sci, Dept Anim Environm Biol, Warsaw, Poland; [Hellmen, Eva] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden	Warsaw University of Life Sciences; Warsaw University of Life Sciences; Swedish University of Agricultural Sciences	Krol, M (corresponding author), Warsaw Univ Life Sci, Fac Vet Med, Dept Physiol Sci, Warsaw, Poland.	magdalena_krol@sggw.pl	Krol, Magdalena/A-5554-2019	Krol, Magdalena/0000-0003-0421-5167; Taciak, Bartlomiej/0000-0003-2623-4860; Mucha, Joanna/0000-0001-8322-8155; Majchrzak-Kuligowska, Kinga/0000-0002-9504-4588	Ministry of Science and Higher Education and COST Action [IP 2011027171, CM1106]; 'Mazovia' fellowship	Ministry of Science and Higher Education and COST Action; 'Mazovia' fellowship	This work was supported by grant no. IP 2011027171 from the Ministry of Science and Higher Education and COST Action CM1106. JM was supported by 'Mazovia' fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abastado JP, 2012, MYELOID DERIVED SUPP; Balwit JM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-18; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Etschmann B, 2006, VET PATHOL, V43, P934, DOI 10.1354/vp.43-6-934; Gordon I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000161; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Krol M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083995; Krol M, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-65; Krol M, 2011, VET RES COMMUN, V35, P409, DOI 10.1007/s11259-011-9489-3; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Kusmartsev S, 2003, CANCER RES, V63, P4441; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Numasaki M, 2007, J IMMUNOL, V178, P5086, DOI 10.4049/jimmunol.178.8.5086; Owen L.N., 1980, TNM CLASSIFICATION T, pp46; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; Petersen OW, 2001, BREAST CANCER RES, V3, P213; Rivat C, 2004, ONCOGENE, V23, P3317, DOI 10.1038/sj.onc.1207437; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serafini P, 2006, J EXP MED, V203, P2691, DOI 10.1084/jem.20061104; Shaw AK, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-LB-495; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Tamburini BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005549; Vasquez-Dunddel D, 2013, J CLIN INVEST, V123, P1580, DOI 10.1172/JCI60083; Vidal-Vanaclocha F, 2006, CANCER METAST REV, V25, P417, DOI 10.1007/s10555-006-9013-3; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; Wang MJ, 2007, J MOL CELL CARDIOL, V42, P1009, DOI 10.1016/j.yjmcc.2007.04.010; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407; Zhang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057114; Zhang YL, 2009, J IMMUNOL, V182, P3801, DOI 10.4049/jimmunol.0801548	38	39	46	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103249	10.1371/journal.pone.0103249	http://dx.doi.org/10.1371/journal.pone.0103249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075523	gold, Green Published, Green Submitted			2022-12-25	WOS:000340028800032
J	Webber, AD; Hill, CM				Webber, Amanda D.; Hill, Catherine M.			Using Participatory Risk Mapping (PRM) to Identify and Understand People's Perceptions of Crop Loss to Animals in Uganda	PLOS ONE			English	Article							HUMAN-WILDLIFE CONFLICT; BUDONGO FOREST RESERVE; KIBALE NATIONAL-PARK; LOCAL PERCEPTIONS; PROTECTED AREAS; RURAL PEOPLE; CONSERVATION; COMMUNITY; ATTITUDES; PATTERNS	Considering how people perceive risks to their livelihoods from local wildlife is central to (i) understanding the impact of crop damage by animals on local people and (ii) recognising how this influences their interactions with, and attitudes towards, wildlife. Participatory risk mapping (PRM) is a simple, analytical tool that can be used to identify and classify risk within communities. Here we use it to explore local people's perceptions of crop damage by wildlife and the animal species involved. Interviews (n = 93, n = 76) and seven focus groups were conducted in four villages around Budongo Forest Reserve, Uganda during 2004 and 2005. Farms (N = 129) were simultaneously monitored for crop loss. Farmers identified damage by wildlife as the most significant risk to their crops; risk maps highlighted its anomalous status compared to other anticipated challenges to agricultural production. PRM was further used to explore farmers' perceptions of animal species causing crop damage and the results of this analysis compared with measured crop losses. Baboons (Papio anubis) were considered the most problematic species locally but measurements of loss indicate this perceived severity was disproportionately high. In contrast goats (Capra hircus) were considered only a moderate risk, yet risk of damage by this species was significant. Surprisingly, for wild pigs (Potamochoerus sp), perceptions of severity were not as high as damage incurred might have predicted, although perceived incidence was greater than recorded frequency of damage events. PRM can assist researchers and practitioners to identify and explore perceptions of the risk of crop damage by wildlife. As this study highlights, simply quantifying crop loss does not determine issues that are important to local people nor the complex relationships between perceived risk factors. Furthermore, as PRM is easily transferable it may contribute to the identification and development of standardised approaches of mitigation across sites of negative human-wildlife interaction.	[Webber, Amanda D.; Hill, Catherine M.] Oxford Brookes Univ, Anthropol Ctr Conservat Environm & Dev ACCEND, Oxford OX3 0BP, England; [Webber, Amanda D.] Bristol Zool Soc, Bristol, Avon, England	Oxford Brookes University	Webber, AD (corresponding author), Oxford Brookes Univ, Anthropol Ctr Conservat Environm & Dev ACCEND, Oxford OX3 0BP, England.	awebber@brookes.ac.uk	Hill, Catherine M/D-3634-2009		Oxford Brookes University Scholarship; Wildlife Conservation Society Research Fellowship; Parkes Foundation; Wenner Gren Foundation; Primate Conservation; British Airways/Royal Geographical Society	Oxford Brookes University Scholarship; Wildlife Conservation Society Research Fellowship; Parkes Foundation; Wenner Gren Foundation; Primate Conservation; British Airways/Royal Geographical Society	Funding was provided by an Oxford Brookes University Scholarship, a Wildlife Conservation Society Research Fellowship, grants from the Parkes Foundation, Wenner Gren Foundation, Primate Conservation, Incorporated and a British Airways/Royal Geographical Society (with IBG) Travel Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SE, 2000, ENVIRON CONSERV, V27, P341, DOI 10.1017/S0376892900000394; ASA, 1999, ETH GUID GOOD RES PR; Baird TD, 2009, HUM ECOL, V37, P463, DOI 10.1007/s10745-009-9264-z; Birbili Maria., 2000, SOCIAL RES UPDATE, V31, P1; Bloor M, 2001, FOCUS GROUPS SOCIAL, DOI DOI 10.4135/9781849209175; Brown M., 1992, DESIGNING INTEGRATED; Bryman A, 2000, SOCIAL RES METHODS, P312; Campbell-Smith G, 2010, AM J PRIMATOL, V7, P1; Chalise M. K, 2000, ASIAN PRIMATES, V7, P4; Conforti VA, 2003, BIOL CONSERV, V111, P215, DOI 10.1016/S0006-3207(02)00277-X; De Boer WF, 1998, ENVIRON CONSERV, V25, P208, DOI 10.1017/S0376892998000265; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Gore M. L., 2009, Human Dimensions of Wildlife, V14, P301, DOI 10.1080/10871200903160944; Hill C. M., 2005, PRIMATE COMMENSALISM, P40; Hill CM, 2012, BIODIVERS CONSERV, V21, P2569, DOI 10.1007/s10531-012-0318-y; Hill CM, 1997, INT J PEST MANAGE, V43, P77, DOI 10.1080/096708797229022; Hill CM, 2000, INT J PRIMATOL, V21, P299, DOI 10.1023/A:1005481605637; Hill CM, 2010, AM J PRIMATOL, V71, P1; Hill CM., 2004, HUMAN DIMENSIONS WIL, V9, P279, DOI [10.1080/10871200490505710, DOI 10.1080/10871200490505710]; Inskip C, 2013, HUM ECOL, V41, P169, DOI 10.1007/s10745-012-9556-6; Jackson Rodney M., 2004, Human Dimensions of Wildlife, V9, P307; Jadhav S, 2012, HEALTH PLACE, V18, P1356, DOI 10.1016/j.healthplace.2012.06.019; JHALA YV, 1993, INT J PEST MANAGE, V39, P23, DOI 10.1080/09670879309371754; Kahler JS, 2013, CONSERV BIOL, V27, P177, DOI 10.1111/j.1523-1739.2012.01960.x; Knight J., 2000, NATURAL ENEMIES PEOP, P1; Kreuger R., 2000, FOCUS GROUPS PRACTIC; Lee P. C., 2005, COMMENSALISM CONFLIC, V4, P1, DOI DOI 10.1002/047001539X.CH1; Linkie M, 2007, ANIM CONSERV, V10, P127, DOI 10.1111/j.1469-1795.2006.00083.x; Mackenzie CA, 2012, ECOL ECON, V75, P72, DOI 10.1016/j.ecolecon.2011.12.018; McLennan MR, 2012, J NAT CONSERV, V20, P219, DOI 10.1016/j.jnc.2012.03.002; MITCHELL J, 1991, DISASTERS, V15, P68, DOI 10.1111/j.1467-7717.1991.tb00429.x; Naughton-Treves L, 1997, GEOGR REV, V87, P27, DOI 10.2307/215656; Naughton-Treves L, 1998, CONSERV BIOL, V12, P156, DOI 10.1046/j.1523-1739.1998.96346.x; Naughton-Treves L, 2005, CONSERV BIOL SER, V9, P252; NEWMARK WD, 1993, BIOL CONSERV, V63, P177, DOI 10.1016/0006-3207(93)90507-W; Ogra MV, 2008, GEOFORUM, V39, P1408, DOI 10.1016/j.geoforum.2007.12.004; Okello Moses Makonjio, 2005, Human Dimensions of Wildlife, V10, P19, DOI 10.1080/10871200590904851; PATERSON J, 2005, COMMENSALISM CONFLIC, P76; Priston NEC., 2005, CROP RAIDING MACACA; Quinn CH, 2003, J ENVIRON MANAGE, V68, P111, DOI 10.1016/S0301-4797(03)00013-6; Reynolds V, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P309; Riley E. P., 2010, AM J PRIMATOL, V71, P1; SALAFSKY N, 1993, CONSERV BIOL, V7, P928, DOI 10.1046/j.1523-1739.1993.740928.x; SHEPARD GH, 2002, PRIMATES FACE FACE C, P101, DOI DOI 10.1017/CBO9780511542404.010; Siex KS, 1999, J APPL ECOL, V36, P1009, DOI 10.1046/j.1365-2664.1999.00455.x; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Smith K, 2000, WORLD DEV, V28, P1945, DOI 10.1016/S0305-750X(00)00053-X; SUKUMAR R, 1990, J TROP ECOL, V6, P33, DOI 10.1017/S0266467400004004; Swetnam RD, 2011, LANDSCAPE URBAN PLAN, V100, P411, DOI 10.1016/j.landurbplan.2011.02.002; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Tweheyo M, 2005, WILDLIFE BIOL, V11, P237, DOI 10.2981/0909-6396(2005)11[237:POCRBP]2.0.CO;2; VanVuren D, 1996, BIOL AGRIC HORTIC, V13, P39, DOI 10.1080/01448765.1996.9754765; Vercammen Paul, 1993, P93; Wallace GE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046636; WARREN Y, 2003, OLIVE BABOONS PAPIO; Warren Y, 2007, INT J PEST MANAGE, V53, P207, DOI 10.1080/09670870701288124; Webber AD, 2007, ORYX, V41, P177, DOI 10.1017/S0030605307001792; Webber AD, 2006, PRIMATE CROP RAIDING; Webber AD, 2010, INT J PEST MANAGE, V56, P9, DOI 10.1080/09670870902980826; Weladji RB, 2003, ORYX, V37, P72, DOI 10.1017/S0030605303000140; Wheaton B., 2002, Power games: a critical sociology of sport, P240	62	24	26	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102912	10.1371/journal.pone.0102912	http://dx.doi.org/10.1371/journal.pone.0102912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM7EZ	25076415	gold, Green Published, Green Submitted			2022-12-25	WOS:000340028800020
J	van Bel, N; van der Velden, Y; Bonnard, D; Le Rouzic, E; Das, AT; Benarous, R; Berkhout, B				van Bel, Nikki; van der Velden, Yme; Bonnard, Damien; Le Rouzic, Erwann; Das, Atze T.; Benarous, Richard; Berkhout, Ben			The Allosteric HIV-1 Integrase Inhibitor BI-D Affects Virion Maturation but Does Not Influence Packaging of a Functional RNA Genome	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SMALL-MOLECULE INHIBITORS; REVERSE TRANSCRIPTION; PRIMER TRNA(LYS3); KISSING COMPLEX; DIMERIZATION; REPLICATION; IDENTIFICATION; LEDGF/P75; DIMER	The viral integrase (IN) is an essential protein for HIV-1 replication. IN inserts the viral dsDNA into the host chromosome, thereby aided by the cellular co-factor LEDGF/p75. Recently a new class of integrase inhibitors was described: allosteric IN inhibitors (ALLINIs). Although designed to interfere with the IN-LEDGF/p75 interaction to block HIV DNA integration during the early phase of HIV-1 replication, the major impact was surprisingly found on the process of virus maturation during the late phase, causing a reverse transcription defect upon infection of target cells. Virus particles produced in the presence of an ALLINI are misformed with the ribonucleoprotein located outside the virus core. Virus assembly and maturation are highly orchestrated and regulated processes in which several viral proteins and RNA molecules closely interact. It is therefore of interest to study whether ALLINIs have unpredicted pleiotropic effects on these RNA-related processes. We confirm that the ALLINI BI-D inhibits virus replication and that the produced virus is non-infectious. Furthermore, we show that the wild-type level of HIV-1 genomic RNA is packaged in virions and these genomes are in a dimeric state. The tRNA(lys3) primer for reverse transcription was properly placed on this genomic RNA and could be extended ex vivo. In addition, the packaged reverse transcriptase enzyme was fully active when extracted from virions. As the RNA and enzyme components for reverse transcription are properly present in virions produced in the presence of BI-D, the inhibition of reverse transcription is likely to reflect the mislocalization of the components in the aberrant virus particle.	[van Bel, Nikki; van der Velden, Yme; Das, Atze T.; Berkhout, Ben] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol,Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Bonnard, Damien; Le Rouzic, Erwann; Benarous, Richard] Biodim Mutabilis, Romainville, France	University of Amsterdam; Academic Medical Center Amsterdam	Berkhout, B (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol,Lab Expt Virol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	b.berkhout@amc.uva.nl		Bonnard, Damien/0000-0001-9529-5785; van Bel, Nikki/0000-0003-0070-4043	Netherlands Organization for Scientific Research (NWO-CW, Chemical Sciences Division) [700.59.301]; European Union [305137]	Netherlands Organization for Scientific Research (NWO-CW, Chemical Sciences Division)(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission)	This work is supported in part by the Netherlands Organization for Scientific Research (NWO-CW, http://www.nwo.nl/en, Chemical Sciences Division, Top grant 700.59.301 to BB). This work is also supported in part by the European Union Framework Program 7 HIVINNOV (http://www.hivinnov.eu/, Grant 305137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN P, 1995, VIROLOGY, V209, P327, DOI 10.1006/viro.1995.1264; Amarasinghe GK, 2000, J MOL BIOL, V301, P491, DOI 10.1006/jmbi.2000.3979; Balakrishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074163; Beerens N, 2002, J VIROL, V76, P2329, DOI 10.1128/JVI.76.5.2329-2339.2002; Beerens N, 2001, J BIOL CHEM, V276, P31247, DOI 10.1074/jbc.M102441200; Berkhout B, 1996, J VIROL, V70, P6723, DOI 10.1128/JVI.70.10.6723-6732.1996; Bukovsky A, 1996, J VIROL, V70, P6820, DOI 10.1128/JVI.70.10.6820-6825.1996; Buxton P, 2005, J VIROL, V79, P6338, DOI 10.1128/JVI.79.10.6338-6348.2005; Cen S, 2001, J VIROL, V75, P5043, DOI 10.1128/JVI.75.11.5043-5048.2001; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Christ F, 2012, ANTIMICROB AGENTS CH, V56, P4365, DOI 10.1128/AAC.00717-12; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; DAS AT, 1995, J VIROL, V69, P3090, DOI 10.1128/JVI.69.5.3090-3097.1995; Das AT, 2007, J VIROL, V81, P11159, DOI 10.1128/JVI.01354-07; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; de Marco A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001215; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Engelman A, 2013, CURR OPIN CHEM BIOL, V17, P339, DOI 10.1016/j.cbpa.2013.04.010; Feng YX, 1999, J VIROL, V73, P4251, DOI 10.1128/JVI.73.5.4251-4256.1999; Fenwick C, 2014, ANTIMICROB AGENTS CH; Hare S, 2011, MOL PHARMACOL, V80, P565, DOI 10.1124/mol.111.073189; HENDERSON LE, 1992, J VIROL, V66, P1856, DOI 10.1128/JVI.66.4.1856-1865.1992; Hoglund S, 1997, VIROLOGY, V233, P271, DOI 10.1006/viro.1997.8585; HUANG Y, 1994, J VIROL, V68, P7676, DOI 10.1128/JVI.68.12.7676-7683.1994; Jeeninga RE, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-64; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; KAPLAN AH, 1993, J VIROL, V67, P4050, DOI 10.1128/JVI.67.7.4050-4055.1993; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Khorchid A, 2000, J MOL BIOL, V299, P17, DOI 10.1006/jmbi.2000.3709; Kleiman L, 2010, FEBS LETT, V584, P359, DOI 10.1016/j.febslet.2009.11.038; Le Rouzic E, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-144; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Lu K, 2011, J MOL BIOL, V410, P609, DOI 10.1016/j.jmb.2011.04.029; MAK J, 1994, J VIROL, V68, P2065, DOI 10.1128/JVI.68.4.2065-2072.1994; Maudru T, 1998, BIOTECHNIQUES, V25, P972, DOI 10.2144/98256bm08; Moore MD, 2008, VIROLOGY, V379, P152, DOI 10.1016/j.virol.2008.06.030; Muriaux D, 1996, J BIOL CHEM, V271, P33686, DOI 10.1074/jbc.271.52.33686; Muriaux D, 1996, BIOCHEMISTRY-US, V35, P5075, DOI 10.1021/bi952822s; Ohishi M, 2011, NUCLEIC ACIDS RES, V39, P3404, DOI 10.1093/nar/gkq1314; Olin JL, 2012, ANN PHARMACOTHER, V46, P1671, DOI 10.1345/aph.1R468; Paillart JC, 1996, P NATL ACAD SCI USA, V93, P5572, DOI 10.1073/pnas.93.11.5572; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Saadatmand J, 2012, VIRUS RES, V169, P340, DOI 10.1016/j.virusres.2012.06.001; Shehu-Xhilaga M, 2002, J VIROL, V76, P4331, DOI 10.1128/JVI.76.9.4331-4340.2002; Shehu-Xhilaga M, 2001, J VIROL, V75, P9156, DOI 10.1128/JVI.75.19.9156-9164.2001; SHIN CG, 1994, J VIROL, V68, P1633, DOI 10.1128/JVI.68.3.1633-1642.1994; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Tsantrizos YS, 2009, PREPARATION 2 TERT B; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Wu XY, 1999, J VIROL, V73, P2126, DOI 10.1128/JVI.73.3.2126-2135.1999	58	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103552	10.1371/journal.pone.0103552	http://dx.doi.org/10.1371/journal.pone.0103552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072705	gold, Green Submitted, Green Published			2022-12-25	WOS:000341307600062
J	Friedman, G; McCarthy, S; Rachinskii, D				Friedman, Gary; McCarthy, Stephen; Rachinskii, Dmitrii			Hysteresis Can Grant Fitness in Stochastically Varying Environment	PLOS ONE			English	Article							GALACTOSIDE-ENZYME SYSTEM; ESCHERICHIA-COLI; GENE-EXPRESSION; FLUCTUATING ENVIRONMENTS; BACILLUS-SUBTILIS; SWITCH; CELL; MEMORY; DIFFERENTIATION; TRANSITIONS	Although the existence of multiple stable phenotypes of living organisms enables random switching between phenotypes as well as non-random history dependent switching called hysteresis, only random switching has been considered in prior experimental and theoretical models of adaptation to variable environments. This work considers the possibility that hysteresis may also evolve together with random phenotype switching to maximize population growth. In addition to allowing the possibility that switching rates between different phenotypes may depend not only on a continuous environmental input variable, but also on the phenotype itself, the present work considers an opportunity cost of the switching events. This opportunity cost arises as a result of a lag phase experimentally observed after phenotype switching and stochastic behavior of the environmental input. It is shown that stochastic environmental variation results in maximal asymptotic growth rate when organisms display hysteresis for sufficiently slowly varying environmental input. At the same time, sinusoidal input does not cause evolution of memory suggesting that the connection between the lag phase, stochastic environmental variation and evolution of hysteresis is a result of a stochastic resonance type phenomenon.	[Friedman, Gary] Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA; [McCarthy, Stephen; Rachinskii, Dmitrii] Natl Univ Ireland Univ Coll Cork, Dept Appl Math, Cork, Ireland; [Rachinskii, Dmitrii] Univ Texas Dallas, Dept Math Sci, Richardson, TX 75083 USA	Drexel University; University College Cork; University of Texas System; University of Texas Dallas	Rachinskii, D (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Appl Math, Cork, Ireland.	dmitry.rachinskiy@utdallas.edu		Rachinskii, Dmitrii/0000-0003-2786-7205	Russian Foundation [10-01-93112]; Alexander von Humboldt Foundation, Germany	Russian Foundation(Russian Foundation for Basic Research (RFBR)); Alexander von Humboldt Foundation, Germany(Alexander von Humboldt Foundation)	DR acknowledges the support of the Russian Foundation for basic Research (http://www.rflar.ru/rffi/eng/about) through grant 10-01-93112 and the Alexander von Humboldt Foundation, Germany (http://www.humboldt-foundation.de/web/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; BENZER S, 1953, BIOCHIM BIOPHYS ACTA, V11, P383, DOI 10.1016/0006-3002(53)90057-2; COHN M, 1959, J BACTERIOL, V78, P601, DOI 10.1128/JB.78.5.601-612.1959; COHN M, 1959, J BACTERIOL, V78, P624, DOI 10.1128/JB.78.5.624-635.1959; COHN M, 1959, J BACTERIOL, V78, P613, DOI 10.1128/JB.78.5.613-623.1959; DELBRUCK M, 1949, UNITES BIOL DOUEES C, P33; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ewing JA, 1891, MAGNETIC INDUCTION I; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Graziani S, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-18; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Igoshin OA, 2006, MOL MICROBIOL, V61, P165, DOI 10.1111/j.1365-2958.2006.05212.x; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaufmann BB, 2007, PLOS BIOL, V5, P1973, DOI 10.1371/journal.pbio.0050239; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; Lim HN, 2007, NAT GENET, V39, P269, DOI 10.1038/ng1956; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; MATHESON I, 1975, J STAT PHYS, V12, P21, DOI 10.1007/BF01024182; Mayergoyz ID, 2005, SCI HYSTERESIS, V3; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; Moller Henrik D, 2013, Commun Integr Biol, V6, pe23933, DOI 10.4161/cib.23933; MONOD J, 1966, SCIENCE, V154, P475, DOI 10.1126/science.154.3748.475; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pannala VR, 2010, WIRES SYST BIOL MED, V2, P98, DOI 10.1002/wsbm.38; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; SPIEGELMAN S, 1952, P NATL ACAD SCI USA, V38, P583, DOI 10.1073/pnas.38.7.583; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Thattai M, 2003, BIOPHYS J, V85, P744, DOI 10.1016/S0006-3495(03)74517-2; Wang L, 2009, P NATL ACAD SCI USA, V106, P6638, DOI 10.1073/pnas.0806137106; WINGE O., 1948, COMPT REND TRAV LAB CARLSBERG [COPENHAGEN SER PHYSIOL], V24, P263; Wolf DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001700	43	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103241	10.1371/journal.pone.0103241	http://dx.doi.org/10.1371/journal.pone.0103241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068284	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700050
J	Lowe, RGT; Cassin, A; Grandaubert, J; Clark, BL; Van de Wouw, AP; Rouxel, T; Howlett, BJ				Lowe, Rohan G. T.; Cassin, Andrew; Grandaubert, Jonathan; Clark, Bethany L.; Van de Wouw, Angela P.; Rouxel, Thierry; Howlett, Barbara J.			Genomes and Transcriptomes of Partners in Plant-Fungal- Interactions between Canola (Brassica napus) and Two Leptosphaeria Species	PLOS ONE			English	Article							AVIRULENCE GENE; STAGONOSPORA-NODORUM; OBLIGATE BIOTROPHY; MACULANS GENOME; RNA-SEQ; IDENTIFICATION; RECOGNITION; EXPANSION; AVRLM1; REVEAL	Leptosphaeria maculans 'brassicae' is a damaging fungal pathogen of canola (Brassica napus), causing lesions on cotyledons and leaves, and cankers on the lower stem. A related species, L. biglobosa 'canadensis', colonises cotyledons but causes few stem cankers. We describe the complement of genes encoding carbohydrate-active enzymes (CAZys) and peptidases of these fungi, as well as of four related plant pathogens. We also report dual-organism RNA-seq transcriptomes of these two Leptosphaeria species and B. napus during disease. During the first seven days of infection L. biglobosa 'canadensis', a necrotroph, expressed more cell wall degrading genes than L. maculans 'brassicae', a hemi-biotroph. L. maculans 'brassicae' expressed many genes in the Carbohydrate Binding Module class of CAZy, particularly CBM50 genes, with potential roles in the evasion of basal innate immunity in the host plant. At this time, three avirulence genes were amongst the top 20 most highly upregulated L. maculans 'brassicae' genes in planta. The two fungi had a similar number of peptidase genes, and trypsin was transcribed at high levels by both fungi early in infection. L. biglobosa 'canadensis' infection activated the jasmonic acid and salicylic acid defence pathways in B. napus, consistent with defence against necrotrophs. L. maculans 'brassicae' triggered a high level of expression of isochorismate synthase 1, a reporter for salicylic acid signalling. L. biglobosa 'canadensis' infection triggered coordinated shutdown of photosynthesis genes, and a concomitant increase in transcription of cell wall remodelling genes of the host plant. Expression of particular classes of CAZy genes and the triggering of host defence and particular metabolic pathways are consistent with the necrotrophic lifestyle of L. biglobosa 'canadensis', and the hemibiotrophic life style of L. maculans 'brassicae'.	[Lowe, Rohan G. T.; Clark, Bethany L.; Van de Wouw, Angela P.; Howlett, Barbara J.] Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia; [Cassin, Andrew] Univ Melbourne, Sch Bot, ARC Ctr Excellence Plant Cell Walls, Parkville, Vic 3052, Australia; [Grandaubert, Jonathan; Rouxel, Thierry] INRA Bioger, UR1290, Thiverval Grignon, France	University of Melbourne; University of Melbourne; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Howlett, BJ (corresponding author), Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia.	bhowlett@unimelb.edu.au	Van de Wouw, Angela/AAY-1163-2021	Van de Wouw, Angela/0000-0001-5147-0393; Lowe, Rohan/0000-0003-0653-9704; Grandaubert, Jonathan/0000-0001-7235-0550	Victoria Life Sciences Computation Initiative (VLSCI) [RAS990]; Grains Research and Development Corporation; Australian Research Council; University of Melbourne; French agency Agence Nationale de la Recherche [ANR-09-GENM-028]	Victoria Life Sciences Computation Initiative (VLSCI); Grains Research and Development Corporation(Grains R&D Corp); Australian Research Council(Australian Research Council); University of Melbourne(University of Melbourne); French agency Agence Nationale de la Recherche(French National Research Agency (ANR))	The following sources of funding supported this work: Grains Research and Development Corporation for funding RL AW BC BH, the Australian Research Council for funding AC, the Victoria Life Sciences Computation Initiative (VLSCI) for computational resources via grant RAS990 for RL, the University of Melbourne for an Early Career Researcher award to RL, and the French agency Agence Nationale de la Recherche, contract ANR-09-GENM-028 ('FungIsochores') for funding JG and TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Balesdent MH, 2013, NEW PHYTOL, V198, P887, DOI 10.1111/nph.12178; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Brunner PC, 2013, MOL BIOL EVOL, V30, P1337, DOI 10.1093/molbev/mst041; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; de Gruyter J, 2013, STUD MYCOL, P1, DOI 10.3114/sim0004; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Eckert M, 2005, FEMS MICROBIOL LETT, V253, P67, DOI 10.1016/j.femsle.2005.09.041; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Epple P, 1997, FEBS LETT, V400, P168, DOI 10.1016/S0014-5793(96)01378-6; Feng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092503; Fudal I, 2007, MOL PLANT MICROBE IN, V20, P459, DOI 10.1094/MPMI-20-4-0459; Gout L, 2006, MOL MICROBIOL, V60, P67, DOI 10.1111/j.1365-2958.2006.05076.x; Grandaubert J, 2014, BIOMED CENT IN PRESS; Howlett BJ, 2004, CAN J PLANT PATHOL, V26, P245; Ipcho SVS, 2012, MOL PLANT PATHOL, V13, P531, DOI 10.1111/j.1364-3703.2011.00770.x; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; Larkan NJ, 2013, NEW PHYTOL, V197, P595, DOI 10.1111/nph.12043; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Liu ZH, 2011, MOL PLANT PATHOL, V12, P1, DOI 10.1111/j.1364-3703.2010.00649.x; Love CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012812; O'Connell RJ, 2012, NAT GENET; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Oliver RP, 2010, CURR OPIN PLANT BIOL, V13, P415, DOI 10.1016/j.pbi.2010.05.003; Palmer CL, 2002, MOL PLANT PATHOL, V3, P63, DOI 10.1046/j.1464-6722.2002.00100.x; Parlange F, 2009, MOL MICROBIOL, V71, P851, DOI 10.1111/j.1365-2958.2008.06547.x; Persson M, 2009, NEW PHYTOL, V182, P470, DOI 10.1111/j.1469-8137.2009.02763.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Purwantara A, 1998, EUR J PLANT PATHOL, V104, P895, DOI 10.1023/A:1008609131695; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rouxel T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1189; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; RYPNIEWSKI WR, 1993, PROTEIN ENG, V6, P341, DOI 10.1093/protein/6.4.341; Sasek V, 2012, MOL PLANT MICROBE IN, V25, P1238, DOI 10.1094/MPMI-02-12-0033-R; Shoemaker RA, 2001, CAN J BOT, V79, P412, DOI 10.1139/cjb-79-4-412; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Solomon PS, 2006, MOL PLANT PATHOL, V7, P147, DOI [10.1111/j.1364-3703.2006.00326.x, 10.1111/J.1364-3703.2006.00326.X]; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van de Wouw AP, 2014, MOL PLANT PATHOL, V15, P523, DOI 10.1111/mpp.12105; Van de Wouw AP, 2008, AUSTRALAS PLANT DIS, V3, P124, DOI 10.1071/DN08049; Vogel JP, 2002, PLANT CELL, V14, P2095, DOI 10.1105/tpc.003509; Voigt K, 2005, MOL PHYLOGENET EVOL, V37, P541, DOI 10.1016/j.ympev.2005.07.006; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Yazawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062460; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; ZABLACKIS E, 1995, PLANT PHYSIOL, V107, P1129, DOI 10.1104/pp.107.4.1129	52	51	56	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103098	10.1371/journal.pone.0103098	http://dx.doi.org/10.1371/journal.pone.0103098			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068644	gold, Green Published, Green Submitted			2022-12-25	WOS:000339993700034
J	Yang, YM; Lee, WH; Lee, CG; An, J; Kim, ES; Kim, SH; Lee, SK; Lee, CH; Dhanasekaran, DN; Moon, A; Hwang, S; Lee, SJ; Park, JW; Kim, KM; Kim, SG				Yang, Y. M.; Lee, W. H.; Lee, C. G.; An, J.; Kim, E-S; Kim, S. H.; Lee, S-K; Lee, C. H.; Dhanasekaran, D. N.; Moon, A.; Hwang, S.; Lee, S. J.; Park, J-W; Kim, K. M.; Kim, S. G.			G alpha(12) gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinoma	ONCOGENE			English	Article							HETEROTRIMERIC G-PROTEINS; SPHINGOSINE 1-PHOSPHATE; P53-INDUCIBLE MICRORNAS; TARGETING ZEB1; MIR-200 FAMILY; TUMOR-GROWTH; G12 FAMILY; P53; INVASION; EXPRESSION	Hepatocellular carcinoma (HCC) has a poor prognosis owing to aggressive phenotype. G alpha(12) gep oncogene product couples to G-protein-coupled receptors, whose ligand levels are frequently increased in tumor microenvironments. Here, we report G alpha(12) overexpression in human HCC and the resultant induction of zinc-finger E-box-binding homeobox 1 (ZEB1) as mediated by microRNA deregulation. G alpha(12) expression was higher in HCC than surrounding non-tumorous tissue. Transfection of Huh7 cell with an activated mutant of G alpha(12) (G alpha(12)QL) deregulated microRNA (miRNA or miR)-200b/a/429, -194-2/192 and -194-1/215 clusters in the miRNome. cDNA microarray analyses disclosed the targets affected by G alpha(12) gene knockout. An integrative network of miRNAs and mRNA changes enabled us to predict ZEB1 as a key molecule governed by G alpha(12). Decreases of miR-200a/b, -192 and -215 by G alpha(12) caused ZEB1 induction. The ability of G alpha(12) to decrease p53 levels, as a result of activating protein-1 (AP-1)/c-Jun-mediated mouse double minute 2 homolog induction, contributed to transcriptional deregulation of the miRNAs. G alpha(12)QL induced ZEB1 and other epithelial-mesenchymal transition markers with fibroblastoid phenotype change. Consistently, transfection with miR-200b, -192 or -215 mimic prevented the ability of G alpha(12)QL to increase tumor cell migration/invasion. In xenograft studies, sustained knockdown of G alpha(12) decreased the overall growth rate and average volume of tumors derived from SK-Hep1 cell (mesenchymal-typed). In HCC patients, miR-192, -215 and/or -200a were deregulated with microvascular invasion or growth advantage. In the HCC samples with higher G alpha(12) level, a correlation existed in the comparison of relative changes of G alpha(12) and ZEB1. In conclusion, G alpha(12) overexpressed in HCC causes ZEB1 induction by deregulating p53-responsive miRNAs, which may facilitate epithelial-mesenchymal transition and growth of liver tumor. These findings highlight the significance of G alpha(12) upregulation in liver tumor progression, implicating G alpha(12) as an attractive therapeutic target.	[Yang, Y. M.; Lee, W. H.; Lee, C. G.; Kim, S. G.] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea; [Yang, Y. M.; Lee, W. H.; Lee, C. G.; Kim, S. G.] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [An, J.; Kim, K. M.] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Liver Ctr,Dept Internal Med, Seoul, South Korea; [Kim, E-S; Moon, A.] Duksung Womens Univ, Coll Pharm, Seoul, South Korea; [Kim, S. H.; Lee, C. H.; Hwang, S.] Hanyang Univ, Coll Med, Seoul 133791, South Korea; [Lee, S-K; Park, J-W] Natl Canc Ctr, Ctr Liver Canc, Goyang, South Korea; [Dhanasekaran, D. N.] Univ Oklahoma, Hlth Sci Ctr, OU Inst Canc, Dept Cell Biol, Oklahoma City, OK USA; [Lee, S. J.] Gachon Univ, Coll Pharm, Inchon, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Ulsan; Asan Medical Center; Duksung Women's University; Hanyang University; National Cancer Center - Korea (NCC); University of Oklahoma System; University of Oklahoma Health Sciences Center; Gachon University	Kim, SG (corresponding author), Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro, Seoul 151742, South Korea.	sgk@snu.ac.kr		Lee, Seung Jin/0000-0003-0625-7774; Yang, Yoon Mee/0000-0003-4281-9906; An, Jihyun/0000-0002-0110-0965	National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2007-0056817]; World Class University project [R322012000100980]; National Cancer Center [1110050]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP); World Class University project; National Cancer Center	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2007-0056817) and in part by the World Class University project (R322012000100980) and National Cancer Center (No. 1110050). We thank Prof Dr Soon-Sun Hong and Hee-Seung Lee for their indispensable support.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen XL, 2011, J HEPATOL, V55, P838, DOI 10.1016/j.jhep.2010.12.043; Dharel N, 2008, HEPATOLOGY, V47, P1136, DOI 10.1002/hep.22176; Di Como CJ, 1998, ONCOGENE, V16, P2527; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Feng B, 2012, BIOMED PHARMACOTHER, V66, P397, DOI 10.1016/j.biopha.2012.06.002; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Grzelinski M, 2010, CLIN CANCER RES, V16, P1402, DOI 10.1158/1078-0432.CCR-09-1873; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; Hsieh JL, 2003, CLIN CANCER RES, V9, P338; Kang KW, 2003, J BIOL CHEM, V278, P17368, DOI 10.1074/jbc.M300471200; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Ki SH, 2007, J BIOL CHEM, V282, P1938, DOI 10.1074/jbc.M606080200; Kim ES, 2011, J CELL SCI, V124, P2220, DOI 10.1242/jcs.076794; Kim MS, 2007, MOL CANCER RES, V5, P473, DOI 10.1158/1541-7786.MCR-06-0395; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Lee JM, 2012, INT J CANCER, V130, P716, DOI 10.1002/ijc.26075; Lee SJ, 2009, ONCOGENE, V28, P1230, DOI 10.1038/onc.2008.488; Lin F, 2009, J CELL BIOL, V184, P909, DOI 10.1083/jcb.200805148; Liu SC, 2009, CANCER RES, V69, P6122, DOI 10.1158/0008-5472.CAN-08-3435; Liu YN, 2013, ONCOGENE, V32, P296, DOI 10.1038/onc.2012.58; Mazzocca A, 2011, HEPATOLOGY, V54, P920, DOI 10.1002/hep.24485; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Sanchez-Tillo E, 2014, CELL DEATH DIFFER, V21, P247, DOI 10.1038/cdd.2013.123; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Sumie S, 2008, ANN SURG ONCOL, V15, P1375, DOI 10.1245/s10434-008-9846-9; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Wang ZF, 2010, PROTEIN CELL, V1, P1063, DOI 10.1007/s13238-010-0140-9; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; Yang YM, 2012, HEPATOLOGY, V56, P2209, DOI 10.1002/hep.25912; Yang YM, 2010, CARCINOGENESIS, V31, P1230, DOI 10.1093/carcin/bgq097; Zhou YM, 2012, ANN SURG ONCOL, V19, P1700, DOI 10.1245/s10434-011-1772-6	46	35	35	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 28	2015	34	22					2910	2921		10.1038/onc.2014.218	http://dx.doi.org/10.1038/onc.2014.218			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CJ2OM	25065598				2022-12-25	WOS:000355324300010
J	Zhu, H; Yoshimoto, T; Yamashima, T				Zhu, Hong; Yoshimoto, Tanihiro; Yamashima, Tetsumori			Heat Shock Protein 70.1 (Hsp70.1) Affects Neuronal Cell Fate by Regulating Lysosomal Acid Sphingomyelinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain; Calpain; Cell Death; Ceramide; Lysosome; Neurodegeneration	SPHINGOLIPID ACTIVATOR PROTEINS; TRANSIENT BRAIN ISCHEMIA; CEREBRAL-ISCHEMIA; CALPAIN; DEATH; LIPIDS; HEAT-SHOCK-PROTEIN-70; STIMULATION; DEGRADATION; METABOLISM	Background: The role of Hsp70.1 in neurodegeneration remains unknown. Results: We demonstrate differential profiles in activation of -calpain, bis(monoacylglycero)phosphate (BMP) levels, Hsp70.1-BMP interaction, and acid sphingomyelinase (ASM) activity between motor cortex and CA1 after ischemia/reperfusion. Conclusion: Hsp70.1-mediated ASM activity affects neuronal cell fate by regulating lysosomal membrane stability. Significance: This finding provides new insights into the mechanism of neuronal death. The inducible expression of heat shock protein 70.1 (Hsp70.1) plays cytoprotective roles in its molecular chaperone function. Binding of Hsp70 to an endolysosomal phospholipid, bis(monoacylglycero)phosphate (BMP), has been recently shown to stabilize lysosomal membranes by enhancing acid sphingomyelinase (ASM) activity in cancer cells. Using the monkey experimental paradigm, we have reported that calpain-mediated cleavage of oxidized Hsp70.1 causes neurodegeneration in the hippocampal cornu ammonis 1 (CA1), whereas expression of Hsp70.1 in the motor cortex without calpain activation contributes to neuroprotection. However, the molecular mechanisms of the lysosomal destabilization/stabilization determining neuronal cell fate have not been elucidated. To elucidate whether regulation of lysosomal ASM could affect the neuronal fate, we analyzed Hsp70.1-BMP binding and ASM activity by comparing the motor cortex and the CA1. We show that Hsp70.1 being localized at the lysosomal membrane, lysosomal lipid BMP levels, and the lipid binding domain of Hsp70.1 are crucial for Hsp70.1-BMP binding. In the postischemic motor cortex, Hsp70.1 being localized at the lysosomal membrane could bind to BMP without calpain activation and decreased BMP levels, resulting in increasing ASM activity and lysosomal stability. However, in the postischemic CA1, calpain activation and a concomitant decrease in the lysosomal membrane localization of Hsp70.1 and BMP levels may diminish Hsp70.1-BMP binding, resulting in decreased ASM activity and lysosomal rupture with leakage of cathepsin B into the cytosol. A TUNEL assay revealed the differential neuronal vulnerability between the CA1 and the motor cortex. These results suggest that regulation of ASM activation in vivo by Hsp70.1-BMP affects lysosomal stability and neuronal survival or death after ischemia/reperfusion.	[Zhu, Hong; Yamashima, Tetsumori] Kanazawa Univ, Grad Sch Med Sci, Dept Restorat Neurosurg, Kanazawa, Ishikawa, Japan; [Zhu, Hong; Yoshimoto, Tanihiro] Kanazawa Univ, Grad Sch Med Sci, Dept Mol Pharmacol, Kanazawa, Ishikawa, Japan; [Yamashima, Tetsumori] Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Kanazawa University	Yamashima, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Restorat Neurosurg, 13-1 Takara Machi, Kanazawa, Ishikawa, Japan.	yamashima215@gmail.com			Japanese Ministry of Education, Culture, Sports, Science, and Technology [18390392, 22390273]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Kiban-Kennkyu (B) Grants 18390392 and 22390273 from the Japanese Ministry of Education, Culture, Sports, Science, and Technology.	Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Adibhatla RM, 2006, FREE RADICAL BIO MED, V40, P376, DOI 10.1016/j.freeradbiomed.2005.08.044; Bartus RT, 1998, BRAIN RES, V790, P1, DOI 10.1016/S0006-8993(97)01414-5; Bouvier J, 2009, J LIPID RES, V50, P243, DOI 10.1194/jlr.M800300-JLR200; Chen ZC, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-111; Ellegaard AM, 2013, MOL CANCER THER, V12, P2018, DOI 10.1158/1535-7163.MCT-13-0084; Hullin-Matsuda F, 2009, PROSTAG LEUKOTR ESS, V81, P313, DOI 10.1016/j.plefa.2009.09.006; Jenkins RW, 2011, J BIOL CHEM, V286, P3777, DOI 10.1074/jbc.M110.155234; KIKUCHI H, 1993, BIOCHIM BIOPHYS ACTA, V1162, P171, DOI 10.1016/0167-4838(93)90144-G; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Linke T, 2001, BIOL CHEM, V382, P283, DOI 10.1515/BC.2001.035; Linke T, 2001, J BIOL CHEM, V276, P5760, DOI 10.1074/jbc.M006846200; Mahalka AK, 2014, BBA-BIOMEMBRANES, V1838, P1344, DOI 10.1016/j.bbamem.2014.01.022; Meikle PJ, 2008, BLOOD CELL MOL DIS, V40, P420, DOI 10.1016/j.bcmd.2007.10.004; Neumar RW, 1996, J NEUROCHEM, V66, P421; Neumar RW, 2001, EXP NEUROL, V170, P27, DOI 10.1006/exnr.2001.7708; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Oikawa S, 2009, FREE RADICAL BIO MED, V46, P1472, DOI 10.1016/j.freeradbiomed.2009.02.029; Petersen NHT, 2013, CANCER CELL, V24, P379, DOI 10.1016/j.ccr.2013.08.003; Petersen NHT, 2010, CELL CYCLE, V9, P2305, DOI 10.4161/cc.9.12.12052; Polla BS, 1996, P NATL ACAD SCI USA, V93, P6458, DOI 10.1073/pnas.93.13.6458; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Saftig P, 2013, NATURE, V502, P312, DOI 10.1038/nature12692; Sahara S, 2010, BIOCHEM BIOPH RES CO, V393, P806, DOI 10.1016/j.bbrc.2010.02.087; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Shanta SR, 2012, J LIPID RES, V53, P1823, DOI 10.1194/jlr.M022558; Stetler RA, 2010, PROG NEUROBIOL, V92, P184, DOI 10.1016/j.pneurobio.2010.05.002; Sultana R, 2010, ANTIOXID REDOX SIGN, V12, P327, DOI 10.1089/ars.2009.2810; Wei JS, 2009, AM J PATHOL, V174, P1891, DOI 10.2353/ajpath.2009.080680; Yabuki Y, 2013, NEUROSCIENCE, V250, P394, DOI 10.1016/j.neuroscience.2013.07.017; Yamashima T, 2004, CELL CALCIUM, V36, P285, DOI 10.1016/j.ceca.2004.03.001; Yamashima T, 1996, EUR J NEUROSCI, V8, P1932, DOI 10.1111/j.1460-9568.1996.tb01337.x; Yamashima T, 1998, EUR J NEUROSCI, V10, P1723, DOI 10.1046/j.1460-9568.1998.00184.x; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Yamashima T., 2014, J ALZHEIMERS DIS PAR, DOI [10.4172/2161-0460.1000139, DOI 10.4172/2161-0460.1000139]; Yamashima T, 2012, J NEUROCHEM, V120, P477, DOI 10.1111/j.1471-4159.2011.07596.x; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003; Zeidan YH, 2010, CURR MOL MED, V10, P454, DOI 10.2174/156652410791608225; Zhu H, 2012, J NEUROCHEM, V120, P574, DOI 10.1111/j.1471-4159.2011.07550.x; Zinchuk Vadim, 2008, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s39	44	31	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27432	27443		10.1074/jbc.M114.560334	http://dx.doi.org/10.1074/jbc.M114.560334			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25074941	Green Published, hybrid			2022-12-25	WOS:000342852800007
J	Zairi, M; Stiege, AC; Nhiri, N; Jacquet, E; Tavares, P				Zairi, Mohamed; Stiege, Asita C.; Nhiri, Naima; Jacquet, Eric; Tavares, Paulo			The Collagen-like Protein gp12 Is a Temperature-dependent Reversible Binder of SPP1 Viral Capsids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBTILIS BACTERIOPHAGE SPP1; BACILLUS-SUBTILIS; STRUCTURAL ORGANIZATION; STRUCTURE PREDICTION; SCAFFOLDING PROTEIN; SECONDARY STRUCTURE; PORTAL PROTEIN; PHAGE DISPLAY; IN-VITRO; VIRUS	Icosahedral capsids of viruses are lattices of defined geometry and homogeneous size. The (quasi-)equivalent organization of their protein building blocks provides, in numerous systems, the binding sites to assemble arrays of viral polypeptides organized with nanometer precision that protrude from the capsid surface. The capsid of bacterial virus (bacteriophage) SPP1 exposes, at its surface, the 6.6-kDa viral polypeptide gp12 that binds to the center of hexamers of the major capsid protein. Gp12 forms an elongated trimer with collagen-like properties. This is consistent with the fold of eight internal GXY repeats of gp12 to build a stable intersubunit triple helix in a prokaryotic setting. The trimer dissociates and unfolds at near physiological temperatures, as reported for eukaryotic collagen. Its structural organization is reacquired within seconds upon cooling. Interaction with the SPP1 capsid hexamers strongly stabilizes gp12, increasing its Tm to 54 degrees C. Above this temperature, gp12 dissociates from its binding sites and unfolds reversibly. Multivalent binding of gp12 trimers to the capsid is highly cooperative. The capsid lattice also provides a platform to assist folding and association of unfolded gp12 polypeptides. The original physicochemical properties of gp12 offer a thermoswitchable system for multivalent binding of the polypeptide to the SPP1 capsid surface.	[Zairi, Mohamed; Tavares, Paulo] CNRS, Ctr Rech Gif, Unite Virol Mol & Struct, UPR 3296, F-91190 Gif Sur Yvette, France; [Stiege, Asita C.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Nhiri, Naima; Jacquet, Eric] CNRS, Ctr Rech Gif, Inst Chim Subst Nat, UPR 2301, F-91190 Gif Sur Yvette, France; [Jacquet, Eric] Ctr Rech Gif, IMAGIF CTPF & qPCR Platform, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Tavares, P (corresponding author), CNRS, Ctr Rech Gif, Unite Virol Mol & Struct, UPR 3296, Batiment 14B,1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	tavares@vms.cnrs-gif.fr		JACQUET, Eric/0000-0001-6366-8436; Tavares, Paulo/0000-0002-2566-4546	CNRS; Max Planck Institute for Molecular Genetics; Ministere de l'Education Nationale, de l'Enseignement superieur et de la Recherche (MNERT)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Max Planck Institute for Molecular Genetics; Ministere de l'Education Nationale, de l'Enseignement superieur et de la Recherche (MNERT)	This work was supported by institutional funding from the CNRS and from the Max Planck Institute for Molecular Genetics.; Supported by a doctoral fellowship from Ministere de l'Education Nationale, de l'Enseignement superieur et de la Recherche (MNERT).	Alonso JC, 1997, GENE, V204, P201, DOI 10.1016/S0378-1119(97)00547-7; Auzat I, 2008, MOL MICROBIOL, V70, P557, DOI 10.1111/j.1365-2958.2008.06435.x; Baker TS, 1999, MICROBIOL MOL BIOL R, V63, P862, DOI 10.1128/MMBR.63.4.862-922.1999; Becker B, 1997, J MOL BIOL, V268, P822, DOI 10.1006/jmbi.1997.0997; BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; CABRE F, 1989, J CHROMATOGR, V472, P347, DOI 10.1016/S0021-9673(00)94133-5; Cao H, 2008, FOOD CHEM, V108, P439, DOI 10.1016/j.foodchem.2007.09.022; CASJENS S, 1975, ANNU REV BIOCHEM, V44, P555, DOI 10.1146/annurev.bi.44.070175.003011; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Clark JR, 2006, TRENDS BIOTECHNOL, V24, P212, DOI 10.1016/j.tibtech.2006.03.003; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Droge A, 2000, J MOL BIOL, V296, P103, DOI 10.1006/jmbi.1999.3449; Droge A, 2000, J MOL BIOL, V296, P117, DOI 10.1006/jmbi.1999.3450; Droge A., 1998, THESIS TU BERLIN BER; Effantin G, 2006, J MOL BIOL, V361, P993, DOI 10.1016/j.jmb.2006.06.081; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Ghosh N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037872; HAIMA P, 1987, MOL GEN GENET, V209, P335, DOI 10.1007/BF00329663; Isidro A, 2004, VIROLOGY, V322, P253, DOI 10.1016/j.virol.2004.02.012; Isidro A, 2004, MOL MICROBIOL, V51, P949, DOI 10.1046/j.1365-2958.2003.03880.x; Jakutyte L, 2011, J BACTERIOL, V193, P4893, DOI 10.1128/JB.05104-11; Kranz JK, 2011, METHOD ENZYMOL, V493, P277, DOI 10.1016/B978-0-12-381274-2.00011-X; Lander GC, 2008, STRUCTURE, V16, P1399, DOI 10.1016/j.str.2008.05.016; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Li Q, 2007, J MOL BIOL, V370, P1006, DOI 10.1016/j.jmb.2007.05.008; Lucon J, 2012, NAT CHEM, V4, P781, DOI [10.1038/NCHEM.1442, 10.1038/nchem.1442]; Lurz R, 2001, J MOL BIOL, V310, P1027, DOI 10.1006/jmbi.2001.4800; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; O'Neil A, 2012, BIOMACROMOLECULES, V13, P3902, DOI 10.1021/bm301347x; Oliveira L, 2013, VIRUS RES, V173, P247, DOI 10.1016/j.virusres.2013.01.021; Orlova EV, 2003, EMBO J, V22, P1255, DOI 10.1093/emboj/cdg123; Parent KN, 2010, STRUCTURE, V18, P390, DOI 10.1016/j.str.2009.12.014; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Philo JS, 1997, BIOPHYS J, V72, P435, DOI 10.1016/S0006-3495(97)78684-3; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Poh SL, 2008, J MOL BIOL, V378, P551, DOI 10.1016/j.jmb.2008.02.028; Prasad BVV, 2012, ADV EXP MED BIOL, V726, P17, DOI 10.1007/978-1-4614-0980-9_3; Prevelige PE, 2012, ADV EXP MED BIOL, V726, P325, DOI 10.1007/978-1-4614-0980-9_14; Qin L, 2010, J MOL BIOL, V395, P728, DOI 10.1016/j.jmb.2009.10.007; Ren ZJ, 1996, PROTEIN SCI, V5, P1833, DOI 10.1002/pro.5560050909; Roos WH, 2009, P NATL ACAD SCI USA, V106, P9673, DOI 10.1073/pnas.0901514106; SEIFTER S, 1962, METHOD ENZYMOL, V5, P659, DOI 10.1016/S0076-6879(62)05292-1; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Steinmetz NF, 2009, CURR TOP MICROBIOL, V327, P23; Strable E, 2009, CURR TOP MICROBIOL, V327, P1; Tao P, 2013, P NATL ACAD SCI USA, V110, P5846, DOI 10.1073/pnas.1300867110; Wallace BA, 2001, CURR OPIN CHEM BIOL, V5, P567, DOI 10.1016/S1367-5931(00)00243-X; White HE, 2012, J VIROL, V86, P6768, DOI 10.1128/JVI.00412-12; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yang F, 2000, NAT STRUCT BIOL, V7, P230; Yang Q, 2008, J MOL BIOL, V383, P1037, DOI 10.1016/j.jmb.2008.08.063	52	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27169	27181		10.1074/jbc.M114.590877	http://dx.doi.org/10.1074/jbc.M114.590877			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25074929	hybrid, Green Published			2022-12-25	WOS:000342853900042
J	Kuroki, H; Hayashi, H; Okabe, H; Hashimoto, D; Takamori, H; Nakahara, O; Nakagawa, S; Fukushima, Y; Chikamoto, A; Beppu, T; Hirota, M; Iyama, K; Baba, H				Kuroki, Hideyuki; Hayashi, Hiromitsu; Okabe, Hirohisa; Hashimoto, Daisuke; Takamori, Hiroshi; Nakahara, Osamu; Nakagawa, Shigeki; Fukushima, Yukiko; Chikamoto, Akira; Beppu, Toru; Hirota, Masahiko; Iyama, Ken-ichi; Baba, Hideo			EZH2 Is Associated with Malignant Behavior in Pancreatic IPMN via p27(Kip1) Downregulation	PLOS ONE			English	Article							PAPILLARY-MUCINOUS TUMORS; K-RAS MUTATION; HISTONE METHYLATION; CARCINOMA-CELLS; CANCER CELLS; NEOPLASMS; 3-DEAZANEPLANOCIN; PROGRESSION; EXPRESSION; INHIBITOR	Background: The epigenetic mechanism of tumorigenesis in pancreatic intraductal papillary mucinous neoplasm (IPMN) remains largely unknown. The aim of this study is to examine the role of enhancer of zeste homologue 2 (EZH2) alteration in pancreatic IPMN progression. Methods: Fifty-four surgically resected pancreatic IPMN specimens, including a total of 181 lesions (normal duct in 48, adenoma in 50, borderline atypia in 53, carcinoma in situ (CIS) in 19, and invasive carcinoma in 11) were analyzed by immunohistochemical staining (EZH2, Ki-67, p27(Kip1)). Using paraffin embedded sections, total RNA was successfully extracted from 20 IPMN lesions (borderline IPMN in 9, CIS in 6, invasive carcinoma in 5) and 7 pancreatic normal ducts, and then levels of EZH2 and p27(Kip1) mRNA were analyzed by real time PCR. Results: In immunohistochemical analysis, cell proliferative activity revealed by Ki-67 positive nuclei was increased during IPMN progression (normal duct<adenoma<borderline atypia<CIS approximate to invasive carcinoma). EZH2 expression displayed a similar pattern (normal duct<adenoma<borderline atypia<CIS approximate to invasive carcinoma) with cell proliferative activity. EZH2 expression in malignant (CIS and invasive carcinoma) IPMNs was significantly higher than that in adenoma and borderline-atypia IPMNs. EZH2 expression level in IPMN lesions was positively correlated with the Ki-67 positive nuclear ratio (p, 0.0001). EZH2-positive cells in malignant IPMN did not express p27(Kip1). EZH2 mRNA expressions in malignant lesions were significantly higher than those in benign lesions (p<0.0001). In contrast, p27(Kip1) mRNA in malignant lesions was significantly decreased compared to those in benign lesion (p<0.05), and there was an inverse correlation between EZH2 and p27(Kip1) mRNA levels (p = 0.0109). Conclusion: EZH2 is associated with the accelerated cell proliferation and malignant step in pancreatic IPMN via the downregulation of p27(Kip1).	[Kuroki, Hideyuki; Hayashi, Hiromitsu; Okabe, Hirohisa; Hashimoto, Daisuke; Takamori, Hiroshi; Nakahara, Osamu; Nakagawa, Shigeki; Fukushima, Yukiko; Chikamoto, Akira; Beppu, Toru; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan; [Hirota, Masahiko] Kumamoto Reg Med Ctr, Dept Surg, Kumamoto, Japan; [Iyama, Ken-ichi] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Pathol, Kumamoto, Japan	Kumamoto University; Kumamoto University	Baba, H (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan.	hdobaba@kumamoto-u.ac.jp	Hashimoto, Daisuke/AAE-7134-2020		Grants-in-Aid for Scientific Research [24592034] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Biankin AV, 2002, GUT, V50, P861, DOI 10.1136/gut.50.6.861; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cheng LL, 2012, CLIN CANCER RES, V18, P4201, DOI 10.1158/1078-0432.CCR-12-0036; Chiba T, 2012, INT J CANCER, V130, P2557, DOI 10.1002/ijc.26264; Fan T, 2011, MOL CANCER RES, V9, P418, DOI 10.1158/1541-7786.MCR-10-0511; Fritz S, 2009, ONCOLOGIST, V14, P125, DOI 10.1634/theoncologist.2008-0200; Izawa T, 2001, CANCER, V92, P1807, DOI 10.1002/1097-0142(20011001)92:7<1807::AID-CNCR1697>3.0.CO;2-0; Kikuchi J, 2012, LUNG CANCER, V78, P138, DOI 10.1016/j.lungcan.2012.08.003; Kimura W, 1995, INT J PANCREATOL, V18, P197; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Lubezky N, 2011, J GASTROINTEST SURG, V15, P503, DOI 10.1007/s11605-010-1411-8; Mallen-St Clair J, 2012, GENE DEV, V26, P439, DOI 10.1101/gad.181800.111; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Miyasaka Y, 2007, CLIN CANCER RES, V13, P4371, DOI 10.1158/1078-0432.CCR-07-0032; Ougolkov AV, 2008, CLIN CANCER RES, V14, P6790, DOI 10.1158/1078-0432.CCR-08-1013; Puppe J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2354; Raimondo M, 2002, AM J GASTROENTEROL, V97, P2553; Salvia R, 2004, ANN SURG, V239, P678, DOI 10.1097/01.sla.0000124386.54496.15; Sasaki S, 2003, ONCOL REP, V10, P21; Satoh K, 1996, PANCREAS, V12, P362, DOI 10.1097/00006676-199605000-00007; Sohn TA, 2004, ANN SURG, V239, P788, DOI 10.1097/01.sla.0000128306.90650.aa; Sohn TA, 2001, ANN SURG, V234, P313, DOI 10.1097/00000658-200109000-00005; Song WJ, 2010, CANCER SCI, V101, P1754, DOI 10.1111/j.1349-7006.2010.01577.x; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wu J, 2011, J CELL BIOCHEM, V112, P1938, DOI 10.1002/jcb.23114; Yamao K, 2000, HEPATO-GASTROENTEROL, V47, P1129; Yoshizawa K, 2002, VIRCHOWS ARCH, V441, P437, DOI 10.1007/s00428-002-0645-6; Zgraggen K, 1997, ANN SURG, V226, P491, DOI 10.1097/00000658-199710000-00010; Zhang XM, 2002, RADIOLOGY, V223, P547, DOI 10.1148/radiol.2232010815	29	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e100904	10.1371/journal.pone.0100904	http://dx.doi.org/10.1371/journal.pone.0100904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084021	Green Submitted, Green Published, gold			2022-12-25	WOS:000339819800003
J	Liu, ZM; Ho, SC; Tang, N; Chan, R; Chen, YM; Woo, J				Liu, Zhao-Min; Ho, Suzanne C.; Tang, Nelson; Chan, Ruth; Chen, Yu-Ming; Woo, Jean			Urinary Sodium Excretion and Dietary Sources of Sodium Intake in Chinese Postmenopausal Women with Prehypertension	PLOS ONE			English	Article							BLOOD-PRESSURE; SALT INTAKE; CARDIOVASCULAR RISK; PUBLIC-HEALTH; POTASSIUM; HYPERTENSION; CALCIUM; QUESTIONNAIRE; METAANALYSIS; POPULATION	Background: Reducing salt intake in communities is one of the most effective and affordable public health strategies to prevent hypertension, stroke and renal disease. The present study aimed to determine the sodium intake in Hong Kong Chinese postmenopausal women and identify the major food sources contributing to sodium intake and urine excretion. Methods: This was a cross-sectional study among 655 Chinese postmenopausal women with prehypertension who were screened for a randomized controlled trial. Data collection included 24 h urine collection for the measurement of sodium, potassium and creatinine, 3-day dietary records, anthropometric measures and questionnaire survey on demographic data and dietary habits. Results: The average salt intake estimated from urinary excretion was 7.8 +/- 3.2 g/d with 82.1% women above WHO recommendation of 5 g/day. Food groups as soup (21.6%), rice and noodles (13.5%), baked cereals (12.3%), salted/preserved foods (10.8%), Chinese dim sum (10.2%) and sea foods (10.1%) were the major contributors of non-discretionary salt. Discretionary salt use in cooking made a modest contribution to overall intake. Vegetable and fruit intake, age, sodium intake from salted foods, sea foods and soup were the independent determinants of urinary sodium excretion. Conclusions: Our data revealed a significant room for reduction of the sodium intake. Efforts to reduce sodium from diets in Hong Kong Chinese postmenopausal women should focus on both processed foods and discretionary salt during cooking. Sodium reduction in soup and increase in fruit intake would be potentially effective strategy for reducing sodium.	[Liu, Zhao-Min; Tang, Nelson; Chan, Ruth; Woo, Jean] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Ho, Suzanne C.] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China; [Chen, Yu-Ming] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Sun Yat Sen University	Liu, ZM (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	liuzhaomin@cuhk.edu.hk; jeanwoowong@cuhk.edu.hk	Woo, Jean/K-2625-2014; Liu, Zhaomin/L-8685-2019; Chen, Yu/Y-3292-2019; Chan, Ruth/K-4995-2014; LIU, Zhao-min/ABA-4413-2021; Tang, Nelson L/P-5018-2017	Woo, Jean/0000-0001-7593-3081; Tang, Nelson L/0000-0002-3607-5819; Chan, Ruth/0000-0002-5725-4066	Chinese University of Hong Kong Research Committee [2041783]	Chinese University of Hong Kong Research Committee(Chinese University of Hong Kong)	The study was funded by the Chinese University of Hong Kong Research Committee Direct Grant No. 2041783. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; [Anonymous], 2011, CHIN NCD REP 2011; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Centre for Food Safety, 2012, STUD SOD CONT LOC FO; Charlton KE, 2008, PUBLIC HEALTH NUTR, V11, P83, DOI 10.1017/S1368980007000146; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Cook NR, 2014, CIRCULATION, V129, P981, DOI 10.1161/CIRCULATIONAHA.113.006032; Du S, 2013, AM J CLIN NUTR; Espeland MA, 2001, AM J EPIDEMIOL, V153, P996, DOI 10.1093/aje/153.10.996; Forman JP, 2012, CIRCULATION, V125, P3108, DOI 10.1161/CIRCULATIONAHA.112.096115; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; Ho S. C., 1988, Journal of Human Nutrition and Dietetics, V1, P205, DOI 10.1111/j.1365-277X.1988.tb00190.x; Ho SC, 2001, OSTEOPOROSIS INT, V12, P723, DOI 10.1007/s001980170047; JAMES WPT, 1987, LANCET, V1, P426; Joosten MM, 2014, CIRCULATION, V129, P1121, DOI 10.1161/CIRCULATIONAHA.113.004290; Koliaki C, 2013, NUTR REV, V71, P402, DOI 10.1111/nure.12036; Kwok TCY, 2003, EUR J CLIN NUTR, V57, P299, DOI 10.1038/sj.ejcn.1601553; Liu Z-m, 2013, J OBESITY, V2013, P9; LUFT FC, 1982, HYPERTENSION, V4, P805, DOI 10.1161/01.HYP.4.6.805; MASSEY LK, 1995, NUTR REV, V53, P131, DOI 10.1111/j.1753-4887.1995.tb01536.x; MATTES RD, 1991, J AM COLL NUTR, V10, P383; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Morris RC, 2006, J AM COLL NUTR, V25, p262S, DOI 10.1080/07315724.2006.10719576; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Ovesen L, 2002, EUR J CLIN NUTR, V56, pS12, DOI 10.1038/sj.ejcn.1601424; Reinivuo H, 2006, EUR J CLIN NUTR, V60, P1160, DOI 10.1038/sj.ejcn.1602431; SANCHEZCASTILLO CP, 1987, CLIN SCI, V72, P95, DOI 10.1042/cs0720095; SIERSBAE.K, 1971, LANCET, V1, P1133; Stamler J, 1997, AM J CLIN NUTR, V65, P626, DOI 10.1093/ajcn/65.2.626S; Weaver CM, 2013, ADV NUTR, V4, p368S, DOI 10.3945/an.112.003533; Webster JL, 2010, AM J CLIN NUTR, V91, P413, DOI 10.3945/ajcn.2009.28688; Woo J., 1998, Hong Kong Medical Journal, V4, P383; Woo J, 1997, NUTR RES, V17, P1633, DOI 10.1016/S0271-5317(97)00170-X; World Health Organization [Internet]. WHO Press, 2010, STRAT MON EV POP SOD; Yuexin Y., 2002, CHINA FOOD COMPOSITI; Zhai FY, 2006, DIET NUTR INTAKE 2; Zhao LC, 2004, HYPERTENSION, V43, P1332, DOI 10.1161/01.HYP.0000128243.06502.bc	41	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e104018	10.1371/journal.pone.0104018	http://dx.doi.org/10.1371/journal.pone.0104018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083775	Green Submitted, Green Published			2022-12-25	WOS:000339819800120
J	Abdelhamid, RF; Plessy, C; Yamauchi, Y; Taoka, M; de Hoon, M; Gingeras, TR; Isobe, T; Carninci, P				Abdelhamid, Rehab F.; Plessy, Charles; Yamauchi, Yoshio; Taoka, Masato; de Hoon, Michiel; Gingeras, Thomas R.; Isobe, Toshiaki; Carninci, Piero			Multiplicity of 5 ' Cap Structures Present on Short RNAs	PLOS ONE			English	Article							MESSENGER-RNA; SMALL NUCLEAR; NONCODING RNAS; IDENTIFICATION; DATABASE; PROTEIN; U1	Most RNA molecules are co- or post-transcriptionally modified to alter their chemical and functional properties to assist in their ultimate biological function. Among these modifications, the addition of 59 cap structure has been found to regulate turnover and localization. Here we report a study of the cap structure of human short (<200 nt) RNAs (sRNAs), using sequencing of cDNA libraries prepared by enzymatic pretreatment of the sRNAs with cap sensitive-specificity, thin layer chromatographic (TLC) analyses of isolated cap structures and mass spectrometric analyses for validation of TLC analyses. Processed versions of snoRNAs and tRNAs sequences of less than 50 nt were observed in capped sRNA libraries, indicating additional processing and recapping of these annotated sRNAs biotypes. We report for the first time 2,7 dimethylguanosine in human sRNAs cap structures and surprisingly we find multiple type 0 cap structures (mGpppC, 7mGpppG, GpppG, GpppA, and 7mGpppA) in RNA length fractions shorter than 50 nt. Finally, we find the presence of additional uncharacterized cap structures that wait determination by the creation of needed reference compounds to be used in TLC analyses. These studies suggest the existence of novel biochemical pathways leading to the processing of primary and sRNAs and the modifications of their RNA 59 ends with a spectrum of chemical modifications.	[Abdelhamid, Rehab F.; Plessy, Charles; de Hoon, Michiel; Carninci, Piero] RIKEN, Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [Abdelhamid, Rehab F.; Plessy, Charles; de Hoon, Michiel; Carninci, Piero] RIKEN, Omics Sci Ctr, Yokohama, Kanagawa, Japan; [Yamauchi, Yoshio; Taoka, Masato; Isobe, Toshiaki] Tokyo Metropolitan Univ, Dept Chem, Grad Sch Sci & Technol, Tokyo 158, Japan; [Yamauchi, Yoshio; Taoka, Masato; Isobe, Toshiaki] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo, Japan; [Gingeras, Thomas R.] Cold Spring Harbor Lab, Funct Genom Lab, Cold Spring Harbor, NY 11724 USA	RIKEN; RIKEN; Tokyo Metropolitan University; Japan Science & Technology Agency (JST); Cold Spring Harbor Laboratory	Carninci, P (corresponding author), RIKEN, Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan.	carninci@riken.jp	Plessy, Charles/N-5054-2015; Isobe, Toshiaki/Q-9279-2017; de Hoon, Michiel/A-6443-2013; Carninci, Piero/K-1568-2014	Plessy, Charles/0000-0001-7410-6295; Carninci, Piero/0000-0001-7202-7243; Taoka, Masato/0000-0001-5554-4951; de Hoon, Michiel/0000-0003-0489-2352	National Institutes of Health [U54HG004557]; MEXT; Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants from the National Institutes of Health (U54HG004557) to PC, a research grant for RIKEN Omics Science Center from MEXT to Yoshihide Hayashizaki, and a research grant from MEXT to the RIKEN Center for Life Science Technologies. This work was supported by Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts GJ, 1998, CURR BIOL, V8, P305, DOI 10.1016/S0960-9822(98)70130-7; BANERJEE AK, 1980, MICROBIOL REV, V44, P175, DOI 10.1128/MMBR.44.2.175-205.1980; Benarroch D, 2010, RNA, V16, P211, DOI 10.1261/rna.1872110; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; CAMPER SA, 1984, MOL CELL BIOL, V4, P538, DOI 10.1128/MCB.4.3.538; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; DIMOCK K, 1979, J BIOL CHEM, V254, P5591; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Girard C, 2008, J BIOL CHEM, V283, P2060, DOI 10.1074/jbc.M704209200; Grosjean H, 2007, METHOD ENZYMOL, V425, P57, DOI 10.1016/S0076-6879(07)25003-7; Hanada T, 2013, NATURE, V495, P474, DOI 10.1038/nature11923; Hartmann RK, 2009, HDB RNA BIOCH STUDEN, P133; Hausmann S, 2005, J BIOL CHEM, V280, P32101, DOI 10.1074/jbc.M506438200; Hausmann S, 2008, J BIOL CHEM, V283, P31706, DOI 10.1074/jbc.M806127200; Helm M, 2006, NUCLEIC ACIDS RES, V34, P721, DOI 10.1093/nar/gkj471; Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756; HSUCHEN CC, 1976, NATURE, V264, P190, DOI 10.1038/264190a0; Huang FQ, 1997, BIOCHEMISTRY-US, V36, P6557, DOI 10.1021/bi970475b; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; IWANAMI Y, 1968, ARCH BIOCHEM BIOPHYS, V126, P8, DOI 10.1016/0003-9861(68)90553-5; Kapranov P, 2010, NATURE, V466, P642, DOI 10.1038/nature09190; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kawano M, 2010, BIOTECHNIQUES, V49, P751, DOI 10.2144/000113516; KEITH G, 1995, BIOCHIMIE, V77, P142, DOI 10.1016/0300-9084(96)88118-1; KRAINER AR, 1988, NUCLEIC ACIDS RES, V16, P9415, DOI 10.1093/nar/16.20.9415; Kuge H, 1998, NUCLEIC ACIDS RES, V26, P3208, DOI 10.1093/nar/26.13.3208; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIMBACH PA, 1995, BIOCHIMIE, V77, P135, DOI 10.1016/0300-9084(96)88116-8; LIPKIN D, 1954, J AM CHEM SOC, V76, P2871, DOI 10.1021/ja01640a004; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Mazieres J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060134; McCue AD, 2012, TRENDS GENET, V28, P616, DOI 10.1016/j.tig.2012.09.001; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; O'Mullane L, 1998, MOL CELL BIOL, V18, P7510, DOI 10.1128/MCB.18.12.7510; Otsuka Y, 2009, MOL CELL BIOL, V29, P2155, DOI 10.1128/MCB.01325-08; PERRY KL, 1987, P NATL ACAD SCI USA, V84, P8190, DOI 10.1073/pnas.84.23.8190; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Ro-Choi TS, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/369058; Ro-Choi TS, 1999, CRIT REV EUKAR GENE, V9, P107, DOI 10.1615/CritRevEukarGeneExpr.v9.i2.20; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Ruan JP, 2007, MOL BIOCHEM PARASIT, V155, P66, DOI 10.1016/j.molbiopara.2007.05.008; SHIMOTOHNO K, 1977, P NATL ACAD SCI USA, V74, P2734, DOI 10.1073/pnas.74.7.2734; Simoes-Barbosa A, 2008, NUCLEIC ACIDS RES, V36, P6848, DOI 10.1093/nar/gkn706; Simos G, 1999, CURR BIOL, V9, pR238, DOI 10.1016/S0960-9822(99)80152-3; SINGH R, 1989, P NATL ACAD SCI USA, V86, P8280, DOI 10.1073/pnas.86.21.8280; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Takahashi H, 2012, METHODS MOL BIOL, V786, P181, DOI 10.1007/978-1-61779-292-2_11; Zaitseva L, 2006, PLOS BIOL, V4, P1689, DOI 10.1371/journal.pbio.0040332; Zuberek J, 2003, RNA, V9, P52, DOI 10.1261/rna.2133403	52	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102895	10.1371/journal.pone.0102895	http://dx.doi.org/10.1371/journal.pone.0102895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079783	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800018
J	Roriz, AKC; Passos, LCS; de Oliveira, CC; Eickemberg, M; Moreira, PD; Sampaio, LR				Carneiro Roriz, Anna Karla; Santana Passos, Luiz Carlos; de Oliveira, Carolina Cunha; Eickemberg, Michaela; Moreira, Pricilla de Almeida; Sampaio, Lilian Ramos			Evaluation of the Accuracy of Anthropometric Clinical Indicators of Visceral Fat in Adults and Elderly	PLOS ONE			English	Article							LIPID-ACCUMULATION PRODUCT; TO-HEIGHT RATIO; CARDIOMETABOLIC RISK-FACTORS; CARDIOVASCULAR-DISEASE; ADIPOSITY INDEX; METABOLIC SYNDROME; SCREENING TOOL; OBESITY; PREDICTION; PATHOPHYSIOLOGY	Background: Visceral obesity is associated with higher occurrence of cardiovascular events. There are few studies about the accuracy of anthropometric clinical indicators, using Computed Tomography (CT) as the gold standard. We aimed to determine the accuracy of anthropometric clinical indicators for discrimination of visceral obesity. Methods: Cross-sectional study with 191 adults and elderly of both sexes. Variables: area of visceral adipose tissue (VAT) identified by CT, Waist-to-Height Ratio (WHtR), Conicity index (C index), Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI). ROC analyzes. Results: There were a strong correlation between adiposity indicators and VAT area. Higher accuracy of C index and WHtR (AUC >= 0.81) than the LAP and the VAI was observed. The higher AUC of LAP and VAI were observed among elderly with areas of 0.88 (CI: 0.766-0.944) and 0.83 (CI: 0.705-0.955) in men and 0.80 (CI: 0.672-0.930) and 0.71 (CI: 0.566-0.856) in women, respectively. The cutoffs of C index were 1.30 in elderly, in both sexes, with sensitivity >= 92%, the LAP ranged from 26.4 to 37.4 in men and from 40.6 to 44.0 in women and the VAI was 1.24 to 1.45 (sens >= 76.9%) in men and 1.46 to 1.84 in women. Conclusion: Both the anthropometric indicators, C Index and WHtR, as well as LAP and VAI had high accuracy in visceral obesity discrimination. So, they are effective in cardiovascular risk assessment and in the follow-up for individual and collective clinical practice.	[Carneiro Roriz, Anna Karla; Santana Passos, Luiz Carlos; de Oliveira, Carolina Cunha] Univ Fed Bahia, Postgrad Program Med & Hlth, Salvador, BA, Brazil; [Carneiro Roriz, Anna Karla; Moreira, Pricilla de Almeida; Sampaio, Lilian Ramos] Univ Fed Bahia, Sch Nutr, Dept Nutr Sci, Salvador, BA, Brazil; [Santana Passos, Luiz Carlos] Univ Fed Bahia, Fac Med, Dept Med, Salvador, BA, Brazil; [de Oliveira, Carolina Cunha] Univ Fed Sergipe, Dept Nutr, Lagarto, Sergipe, Brazil; [Eickemberg, Michaela] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil; [Eickemberg, Michaela] Bahiana Sch Med & Publ Hlth, Salvador, BA, Brazil; [Sampaio, Lilian Ramos] Univ Fed Bahia, Postgrad Program Food & Nutr, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal de Sergipe; Universidade Federal da Bahia; Universidade Federal da Bahia	Roriz, AKC (corresponding author), Univ Fed Bahia, Postgrad Program Med & Hlth, Salvador, BA, Brazil.	karlaroriz@hotmail.com		C. RORIZ, ANNA KARLA/0000-0002-1768-5646; Oliveira, Carolina Cunha de/0000-0003-1196-0683	Brazilian National Council for Scientific and Technological Development; Foundation Coordination of Improvement of Higher Education Personnel by Ministry of Education	Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation Coordination of Improvement of Higher Education Personnel by Ministry of Education	This study was funded by the Brazilian National Council for Scientific and Technological Development and by Foundation Coordination of Improvement of Higher Education Personnel by Ministry of Education through research scholarship to AKCR. The funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-183; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Berber A, 2001, INT J OBESITY, V25, P1794, DOI 10.1038/sj.ijo.0801827; Bouza A, 2008, REV ESP OBES, V6, P153; Bozorgmanesh M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-45; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Roriz AKC, 2010, ARQ BRAS CARDIOL, V95, P698, DOI 10.1590/S0066-782X2010005000159; Chiang JK, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-78; de Almeida RT, 2009, ARQ BRAS CARDIOL, V92, P345; Demura S, 2007, EUR J CLIN NUTR, V61, P727, DOI 10.1038/sj.ejcn.1602576; Elisha B, 2013, APPL PHYSIOL NUTR ME, V38, P892, DOI 10.1139/apnm-2012-0307; Guasch-Ferre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043275; Haun DR, 2009, REV ASSOC MED BRAS, V55, P705, DOI 10.1590/S0104-42302009000600015; Hunter G R, 1994, Obes Res, V2, P563; Kahn Henry S, 2005, BMC Cardiovasc Disord, V5, P26, DOI 10.1186/1471-2261-5-26; Knowles KM, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/931402; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lohman TG, 1988, ANTHROPOMETRIC STAND, P177, DOI DOI 10.1002/AJHB.1310040323; Mohammadreza B, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-20; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Pitanga FJG, 2011, REV BRASILEIRA CINEA, V13, P238; Pitanga Francisco José Gondim, 2005, Arq. Bras. Cardiol., V85, P26, DOI 10.1590/S0066-782X2005001400006; Pitanga Francisco José Gondim, 2006, Rev. Assoc. Med. Bras., V52, P157, DOI 10.1590/S0104-42302006000300016; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Sampaio LR, 2007, ARQ BRAS ENDOCRINOL, V51, P980, DOI 10.1590/S0004-27302007000600013; Silva DAS, 2013, EUR J NUTR, V52, P237, DOI 10.1007/s00394-012-0314-8; Savva SC, 2013, DIABET METAB SYND OB, V6, P403, DOI 10.2147/DMSO.S34220; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; SEIDELL JC, 1987, AM J CLIN NUTR, V45, P7, DOI 10.1093/ajcn/45.1.7; Taverna MJ, 2011, EUR J ENDOCRINOL, V164, P559, DOI 10.1530/EJE-10-1039; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tellechea Mariana L, 2009, Diabetes Care, V32, pe85, DOI 10.2337/dc08-2284; VALDEZ R, 1993, INT J OBESITY, V17, P77; VALDEZ R, 1991, J CLIN EPIDEMIOL, V44, P955, DOI 10.1016/0895-4356(91)90059-I; Vidigal FD, 2013, NUTR HOSP, V28, P1639, DOI 10.3305/nh.2013.28.5.6743	36	70	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103499	10.1371/journal.pone.0103499	http://dx.doi.org/10.1371/journal.pone.0103499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078454	Green Published, gold, Green Submitted			2022-12-25	WOS:000339954800050
J	Diekhof, EK; Wittmer, S; Reimers, L				Diekhof, Esther Kristina; Wittmer, Susanne; Reimers, Luise			Does Competition Really Bring Out the Worst? Testosterone, Social Distance and Inter-Male Competition Shape Parochial Altruism in Human Males	PLOS ONE			English	Article							NEURAL RESPONSES; SEX-DIFFERENCES; ULTIMATUM GAME; UNFAIR OFFERS; AGGRESSION; EVOLUTION; BEHAVIOR; PUNISHMENT; CONFLICT; RESPONSIVENESS	Parochial altruism, defined as increased ingroup favoritism and heightened outgroup hostility, is a widespread feature of human societies that affects altruistic cooperation and punishment behavior, particularly in intergroup conflicts. Humans tend to protect fellow group members and fight against outsiders, even at substantial costs for themselves. Testosterone modulates responses to competition and social threat, but its exact role in the context of parochial altruism remains controversial. Here, we investigated how testosterone influences altruistic punishment tendencies in the presence of an intergroup competition. Fifty male soccer fans played an ultimatum game (UG), in which they faced anonymous proposers that could either be a fan of the same soccer team (ingroup) or were fans of other teams (outgroups) that differed in the degree of social distance and enmity to the ingroup. The UG was played in two contexts with varying degrees of intergroup rivalry. Our data show that unfair offers were rejected more frequently than fair proposals and the frequency of altruistic punishment increased with increasing social distance to the outgroups. Adding an intergroup competition led to a further escalation of outgroup hostility and reduced punishment of unfair ingroup members. High testosterone levels were associated with a relatively increased ingroup favoritism and also a change towards enhanced outgroup hostility in the intergroup competition. High testosterone concentrations further predicted increased proposer generosity in interactions with the ingroup. Altogether, a significant relation between testosterone and parochial altruism could be demonstrated, but only in the presence of an intergroup competition. In human males, testosterone may promote group coherence in the face of external threat, even against the urge to selfishly maximize personal reward. In that way, our observation refutes the view that testosterone generally promotes antisocial behaviors and aggressive responses, but underlines its rather specific role in the fine-tuning of male social cognition.	[Diekhof, Esther Kristina] Univ Hamburg, Bioctr Grindel, Hamburg, Germany; Univ Hamburg, Zool Museum, Inst Human Biol, Neuroendocrinol Unit, Hamburg, Germany	University of Hamburg; University of Hamburg	Diekhof, EK (corresponding author), Univ Hamburg, Bioctr Grindel, Hamburg, Germany.	esther.diekhof@uni-hamburg.de	Diekhof, Esther/AAA-1487-2020	Diekhof, Esther/0000-0003-3826-8494	budget resources of the University of Hamburg	budget resources of the University of Hamburg	This work was supported by budget resources of the University of Hamburg. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; ARCHER J, 1991, BRIT J PSYCHOL, V82, P1, DOI 10.1111/j.2044-8295.1991.tb02379.x; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Bhasin S, 2001, AM J PHYSIOL-ENDOC M, V281, pE1172, DOI 10.1152/ajpendo.2001.281.6.E1172; Book AS, 2001, AGGRESS VIOLENT BEH, V6, P579, DOI 10.1016/S1359-1789(00)00032-X; Bos PA, 2012, NEUROIMAGE, V61, P730, DOI 10.1016/j.neuroimage.2012.04.002; Bos PA, 2010, P NATL ACAD SCI USA, V107, P9991, DOI 10.1073/pnas.0911700107; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Bramen JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033850; Bruneau EG, 2012, PHILOS T R SOC B, V367, P717, DOI 10.1098/rstb.2011.0293; Budickova Marcela, 2007, Biomedical Papers (Olomouc), V151, P69; Burnham TC, 2007, P ROY SOC B-BIOL SCI, V274, P2327, DOI 10.1098/rspb.2007.0546; CAMERER C, 1995, J ECON PERSPECT, V9, P209, DOI 10.1257/jep.9.2.209; Campanha C, 2011, J NEUROSCI, V31, P15569, DOI 10.1523/JNEUROSCI.1253-11.2011; Carre JM, 2009, PSYCHONEUROENDOCRINO, V34, P561, DOI 10.1016/j.psyneuen.2008.10.018; Chapman E, 2006, SOC NEUROSCI-UK, V1, P135, DOI 10.1080/17470910600992239; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; DABBS JM, 1990, PSYCHOL SCI, V1, P209, DOI 10.1111/j.1467-9280.1990.tb00200.x; Derntl B, 2009, PSYCHONEUROENDOCRINO, V34, P687, DOI 10.1016/j.psyneuen.2008.11.007; Eisenegger C, 2010, NATURE, V463, P356, DOI 10.1038/nature08711; Eisenegger C, 2011, TRENDS COGN SCI, V15, P263, DOI 10.1016/j.tics.2011.04.008; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fershtman C, 2001, Q J ECON, V116, P351, DOI 10.1162/003355301556338; Foddy M, 2009, PSYCHOL SCI, V20, P419, DOI 10.1111/j.1467-9280.2009.02312.x; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gneezy A, 2012, P ROY SOC B-BIOL SCI, V279, P219, DOI 10.1098/rspb.2011.0805; Goette L, 2010, 5189 IZA DP; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Hermans EJ, 2008, BIOL PSYCHIAT, V63, P263, DOI 10.1016/j.biopsych.2007.05.013; Hermans EJ, 2006, PSYCHONEUROENDOCRINO, V31, P859, DOI 10.1016/j.psyneuen.2006.04.002; Hickman T, 2007, ADV CONSUM RES, V34, P314; Mathew S, 2011, P NATL ACAD SCI USA, V108, P11375, DOI 10.1073/pnas.1105604108; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; McDonald MM, 2012, PHILOS T R SOC B, V367, P670, DOI 10.1098/rstb.2011.0301; Mehta PH, 2006, HORM BEHAV, V50, P684, DOI 10.1016/j.yhbeh.2006.07.001; Mehta PH, 2010, J COGNITIVE NEUROSCI, V22, P2357, DOI 10.1162/jocn.2009.21389; Mehta PH, 2009, HORM BEHAV, V56, P158, DOI 10.1016/j.yhbeh.2009.04.001; Muller MN, 2004, ANIM BEHAV, V67, P113, DOI 10.1016/j.anbehav.2003.03.013; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Park J. H., 2010, PSYCHOL PROSOCIAL BE, P13; Roselli CE, 1996, NEUROENDOCRINOLOGY, V64, P139, DOI 10.1159/000127111; Saaksvuori L, 2011, P ROY SOC B-BIOL SCI, V278, P3428, DOI 10.1098/rspb.2011.0252; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sellers JG, 2007, J RES PERS, V41, P126, DOI 10.1016/j.jrp.2006.02.004; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; Tomaszycki ML, 2005, DEV PSYCHOBIOL, V47, P318, DOI 10.1002/dev.20102; Vallerand RJ, 2008, J SPORT SCI, V26, P1279, DOI 10.1080/02640410802123185; van Honk J, 2012, NATURE, V485, pE4, DOI 10.1038/nature11136; van Honka J, 2011, P NATL ACAD SCI USA, V108, P3448, DOI 10.1073/pnas.1011891108; Van Vugt M, 2007, PSYCHOL SCI, V18, P19, DOI 10.1111/j.1467-9280.2007.01842.x; Van Vugt M, 2009, SOC PERSONAL PSYCHOL, V3, P927, DOI 10.1111/j.1751-9004.2009.00221.x; WANN DL, 1995, BRIT J SOC PSYCHOL, V34, P223, DOI 10.1111/j.2044-8309.1995.tb01060.x; Wann DL, 2007, AM J PSY, V9, P251; WEST CD, 1973, J CLIN ENDOCR METAB, V36, P1230, DOI 10.1210/jcem-36-6-1230; Wirth MM, 2007, PHYSIOL BEHAV, V90, P496, DOI 10.1016/j.physbeh.2006.10.016; Wright ND, 2012, P ROY SOC B-BIOL SCI, V279, P2275, DOI 10.1098/rspb.2011.2523; Yamagishi T, 2008, RATION SOC, V20, P5, DOI 10.1177/1043463107085442; Yamagishi T, 2012, P NATL ACAD SCI USA, V109, P20364, DOI 10.1073/pnas.1212126109; Zak PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008330; Zizzo DJ, 2011, INT REV EC, V58, P91	63	37	38	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e98977	10.1371/journal.pone.0098977	http://dx.doi.org/10.1371/journal.pone.0098977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM7EZ	25075516	Green Submitted, Green Published, gold			2022-12-25	WOS:000340028800002
J	Saporiti, F; Bearhop, S; Silva, L; Vales, DG; Zenteno, L; Crespo, EA; Aguilar, A; Cardona, L				Saporiti, Fabiana; Bearhop, Stuart; Silva, Laura; Vales, Damian G.; Zenteno, Lisette; Crespo, Enrique A.; Aguilar, Alex; Cardona, Luis			Longer and Less Overlapping Food Webs in Anthropogenically Disturbed Marine Ecosystems: Confirmations from the Past	PLOS ONE			English	Article							AMERICAN SEA LION; STABLE-ISOTOPE RATIOS; OTARIA-FLAVESCENS; DELTA-N-15 VALUES; TERM CHANGES; NORTH COAST; FUR SEALS; PATAGONIA; PATTERNS; DIET	The human exploitation of marine resources is characterised by the preferential removal of the largest species. Although this is expected to modify the structure of food webs, we have a relatively poor understanding of the potential consequences of such alteration. Here, we take advantage of a collection of ancient consumer tissues, using stable isotope analysis and SIBER to assess changes in the structure of coastal marine food webs in the South-western Atlantic through the second half of the Holocene as a result of the sequential exploitation of marine resources by hunter-gatherers, western sealers and modern fishermen. Samples were collected from shell middens and museums. Shells of both modern and archaeological intertidal herbivorous molluscs were used to reconstruct changes in the stable isotopic baseline, while modern and archaeological bones of the South American sea lion Otaria flavescens, South American fur seal Arctocephalus australis and Magellanic penguin Spheniscus magellanicus were used to analyse changes in the structure of the community of top predators. We found that ancient food webs were shorter, more redundant and more overlapping than current ones, both in northern-central Patagonia and southern Patagonia. These surprising results may be best explained by the huge impact of western sealing on pinnipeds during the fur trade period, rather than the impact of fishing on fish populations. As a consequence, the populations of pinnipeds at the end of the sealing period were likely well below the ecosystem's carrying capacity, which resulted in a release of intraspecific competition and a shift towards larger and higher trophic level prey. This in turn led to longer and less overlapping food webs.	[Saporiti, Fabiana; Zenteno, Lisette; Aguilar, Alex; Cardona, Luis] Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain; [Saporiti, Fabiana; Zenteno, Lisette; Aguilar, Alex; Cardona, Luis] Univ Barcelona, Fac Biol, Inst Recerca Biodiversitat IRBio, Barcelona, Spain; [Bearhop, Stuart] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Silva, Laura; Vales, Damian G.; Crespo, Enrique A.] CENPAT CONICET, Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Lab Marine Mammals, Puerto Madryn, Argentina	University of Barcelona; University of Barcelona; University of Exeter; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Saporiti, F (corresponding author), Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain.	fabiana.saporiti@ub.edu	Cardona, Luis/L-1680-2014; Zenteno-Devaud, Lisette/HGB-2633-2022; Aguilar, Alex/L-1283-2014; Bearhop, Stuart/G-3105-2012; Cardona, Luis/AAL-1354-2021	Cardona, Luis/0000-0002-7892-1323; Zenteno-Devaud, Lisette/0000-0002-1619-911X; Aguilar, Alex/0000-0002-5751-2512; Bearhop, Stuart/0000-0002-5864-0129; Cardona, Luis/0000-0002-7892-1323; Vales, Damian G./0000-0002-6252-1616	Fundacion BBVA [BIOCON08-194/092009-2011]; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina); Spanish Ministerio de Educacion, Cultura y Deporte [AP 2009-4573]; University of Barcelona	Fundacion BBVA(BBVA Foundation); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); Spanish Ministerio de Educacion, Cultura y Deporte(Spanish Government); University of Barcelona	Fundacion BBVA funded this research as part of the project "Efectos de la explotacion humana sobre depredadores apicales y la estructura de la red trofica del Mar Argentino durante los utimos 6000 anos'' (BIOCON08-194/092009-2011). Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) provided additional funding through the project "Analisis del uso de los recursos troficos y su relacion con cambios en la abundancia en tres predadores tope del Mar Argentino''. FS has been supported by an FPU Fellowship granted by the Spanish Ministerio de Educacion, Cultura y Deporte (AP 2009-4573). Half of the cost of the publication of this article has been funded by the University of Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Orquera LA, 2011, QUATERN INT, V239, P61, DOI 10.1016/j.quaint.2011.02.032; Alonso MK, 2000, FISH B-NOAA, V98, P250; Anderson A, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P21; Arnould JPY, 2008, ENCY MARINE MAMMALS, P1079; Bailey G, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P215; Balech Enrique, 2009, Revista de Investigacion y Desarrollo Pesquero, V19, P45; Barrett J, 2008, J ARCHAEOL SCI, V35, P850, DOI 10.1016/j.jas.2007.06.004; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Becker BH, 2006, CONSERV BIOL, V20, P470, DOI 10.1111/j.1523-1739.2006.00379.x; Beretta M, 2011, ARQUEOLOGIA, V17, P137; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boersma DP, 1990, PENGUIN BIOL, P15; BUNN SE, 1995, LIMNOL OCEANOGR, V40, P622, DOI 10.4319/lo.1995.40.3.0622; Burton RK, 2001, OECOLOGIA, V128, P107, DOI 10.1007/s004420100631; Caddy J.F., 1998, SCIENCE, V282, p1383a, DOI 10.1126/science.282.5393.1383a; Marina FC, 2011, MAGALLANIA, V39, P207; Casey MM, 2011, EARTH-SCI REV, V106, P131, DOI 10.1016/j.earscirev.2011.02.001; Chamberlain CP, 2005, P NATL ACAD SCI USA, V102, P16707, DOI 10.1073/pnas.0508529102; Christensen JT, 2008, MAR ECOL PROG SER, V368, P1, DOI 10.3354/meps07635; Christensen V, 2003, FISH FISH, V4, P1, DOI 10.1046/j.1467-2979.2003.00103.x; Coll M, 2012, DEEP SEA RES 2, P1; Corbett DG, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P43; Cousseau M. B., 2000, PECES MARINOS ARGENT; Crenshaw M.A., 1980, Topics in Geobiology, V1, P115; CRESPO E. A., 1991, ECOL AUSTRAL, V1, P87; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; Dans Silvana L., 2003, P100; Dans SL, 2004, CAN J FISH AQUAT SCI, V61, P1681, DOI 10.1139/F04-105; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Devine JA, 2006, NATURE, V439, P29, DOI 10.1038/439029a; Drago M, 2009, J ZOOL, V279, P251, DOI 10.1111/j.1469-7998.2009.00613.x; Drago M, 2009, MAR ECOL PROG SER, V384, P273, DOI 10.3354/meps08017; Dulvy Nicholas K., 2009, P129; Emslie SD, 2007, P NATL ACAD SCI USA, V104, P11666, DOI 10.1073/pnas.0608477104; Favier Dubois C.M., 2009, ARQUEOLOGIA PATAGONI, P985; Dubois CMF, 2009, MAGALLANIA, V37, P139; Garcia-Rubies A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073922; GODOY JC, 1963, FAUNA SILVESTRE; Gomez Otero J, 2007, ARQUEOLOGIA FUEGO PA, P151; Gomez Otero J, 1999, 13 C NAC ARQ ARG, P396; Gomez Otero J., 2006, THESIS U BUENOS AIRE; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hanson NN, 2009, MAR ECOL PROG SER, V388, P263, DOI 10.3354/meps08158; Herling C, 2005, MAR BIOL, V147, P13, DOI 10.1007/s00227-004-1547-8; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jaureguizar AJ, 2008, SCI MAR, V72, P25; Jennings S, 2003, P ROY SOC B-BIOL SCI, V270, P1413, DOI 10.1098/rspb.2003.2392; Jones DS, 1996, PALAIOS, V11, P340, DOI 10.2307/3515244; Koen-Alonso M, 2005, CAN J FISH AQUAT SCI, V62, P1490, DOI 10.1139/F05-087; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; L'Heureux G, 2002, ANALES I PATAGONI CH, V30; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Libralato S, 2010, BIOL CONSERV, V143, P2182, DOI 10.1016/j.biocon.2010.06.002; Lorrain A, 2003, ANAL CHIM ACTA, V491, P125, DOI 10.1016/S0003-2670(03)00815-8; Lotze HK, 2011, ECOSYSTEMS, V14, P198, DOI 10.1007/s10021-010-9404-8; MANGERUD J, 1972, Boreas (Oslo), V1, P143; McClenachan L, 2012, CONSERV LETT, V5, P73, DOI 10.1111/j.1755-263X.2011.00206.x; Milessi AC, 2013, FRENTE MARITIMO, V23, P83; Moreno E, 2008, ARQUEOLOGIA ETNOHIST; Moreno E, 2011, MAGALLANIA, V39, P265, DOI 10.4067/S0718-22442011000100017; Muck P, 1987, PERUVIAN ANCHOVETA I, P351; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Newsome SD, 2006, MAR MAMMAL SCI, V22, P556, DOI 10.1111/j.1748-7692.2006.00043.x; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; O'Donnell TH, 2003, ORG GEOCHEM, V34, P165, DOI 10.1016/S0146-6380(02)00160-2; Obelic Bogomil, 1998, Quaternary of South America and Antarctic Peninsula, V11, P47; Orquera L, 1997, RELACIONES SOC ARGEN, V21, P215; Orquera L, 1987, RELAC SOC ARG ANTR, V17, P201; Padovani LN, 2012, J SEA RES, V67, P85, DOI 10.1016/j.seares.2011.10.007; Paez E., 2006, BASES CONSERVACION M, P577; Page B, 2005, MAR ECOL PROG SER, V293, P283, DOI 10.3354/meps293283; Parnell A. C., 2013, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Piana E, 2007, KAIYAWOTEHA INFORME; Piola AR, 2009, MAR PATAGONICO; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; Reyes LM, 1999, MAR MAMMAL SCI, V15, P478, DOI 10.1111/j.1748-7692.1999.tb00814.x; Riet-Sapriza FG, 2013, DEEP-SEA RES PT II, V88-89, P106, DOI 10.1016/j.dsr2.2012.09.005; Rivadeneira MM, 2010, AQUAT CONSERV, V20, P74, DOI 10.1002/aqc.1051; Rivas AL, 2010, CONT SHELF RES, V30, P752, DOI 10.1016/j.csr.2010.01.009; Sala E, 2004, ECOSYSTEMS, V7, P333, DOI 10.1007/s10021-003-0241-x; Saporiti F, 2013, QUATERN INT, V299, P108, DOI 10.1016/j.quaint.2013.03.026; Saporiti F, PALEOINDIAN PI UNPUB; Schiavini A. M., 1993, LAT AM ANTIQ, V4, P346, DOI DOI 10.2307/972072; Schiavini ACM, 2004, MAMM BIOL, V69, P108, DOI 10.1078/1616-5047-00125; Schiavini Adrián, 2005, Hornero, V20, P5; Schmidt SN, 2007, ECOLOGY, V88, P2793, DOI 10.1890/07-0121.1; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Schweder T, 2006, CONSERV BIOL SER, P310, DOI 10.1017/CBO9780511541964.022; Serran M, 2008, QUATERN INT, V183, P135, DOI 10.1016/j.quaint.2006.12.001; Silva L, 2014, MAR BIOL, V161, P1195, DOI 10.1007/s00227-014-2410-1; Soto KH, 2004, J ZOOL, V264, P419, DOI 10.1017/s0952836904005965; Tivoli AM, 2010, AVES ORG SOCIOECONOM; Tivoli AM, 2011, J ARCHAEOL SCI, V38, P1148, DOI 10.1016/j.jas.2010.12.018; Trites AW, 2006, CONSERV BIOL SER, P11, DOI 10.1017/CBO9780511541964.003; Tunez JI, 2008, HYDROBIOLOGIA, V598, P191, DOI 10.1007/s10750-007-9150-x; Tunez JI, 2008, ICES J MAR SCI, V65, P1733, DOI 10.1093/icesjms/fsn168; Vales DG, 2013, AQUATIC CONSERVATION; Vander Zanden MJ, 2007, OIKOS, V116, P1378, DOI 10.1111/j.2007.0030-1299.16036.x; Vasconcellos M, 2011, 569 FAO, P93; Vaz Ferreira R., 1982, FAO MAMMAL SEAS, VIV, P477; Vaz-Ferreira, 1982, FAO FISHERIES SERIES, V4, P497; Versteegh EAA, 2011, RAPID COMMUN MASS SP, V25, P675, DOI 10.1002/rcm.4905; WAINRIGHT SC, 1993, MAR BIOL, V115, P481, DOI 10.1007/BF00349847; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zangrando AF, 2014, INT J OSTEOARCHAEOL, V24, P231, DOI 10.1002/oa.2352	113	26	27	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103132	10.1371/journal.pone.0103132	http://dx.doi.org/10.1371/journal.pone.0103132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076042	Green Published, Green Submitted, gold			2022-12-25	WOS:000340028800027
J	Ku, SY; Lasorsa, E; Adelaiye, R; Ramakrishnan, S; Ellis, L; Pili, R				Ku, ShengYu; Lasorsa, Elena; Adelaiye, Remi; Ramakrishnan, Swathi; Ellis, Leigh; Pili, Roberto			Inhibition of Hsp90 Augments Docetaxel Therapy in Castrate Resistant Prostate Cancer	PLOS ONE			English	Article							SHOCK-PROTEIN 90; PHASE-I TRIAL; ANDROGEN RECEPTOR; SOLID TUMORS; INCREASED SURVIVAL; ADULT PATIENTS; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN; NVP-AUY922; GROWTH; CHEMOTHERAPY	First line treatment of patients with castrate resistant prostate cancer (CRPC) primarily involves administration of docetaxel chemotherapy. Unfortunately, resistance to docetaxel therapy is an ultimate occurrence. Alterations in androgen receptor (AR) expression and signaling are associated mechanisms underlying resistance to docetaxel treatment in CRPC. Heat shock protein 90 (Hsp90) is a molecular chaperone, which regulates the activation, maturation and stability of critical signaling proteins involved in prostate cancer, including the AR. This knowledge and recent advances in compound design and development have highlighted Hsp90 as an attractive therapeutic target for the treatment of CRPC. We recently reported the development of a MYC-CaP castrate resistant (MYC-CaP/CR) transplant tumor model, which expresses amplified wild type AR. Within, we report that a second generation Hsp90 inhibitor, NVP-AUY922, inhibits cell growth and significantly induces cell death in MYC-CaP/CR and Pten-CaP/cE2 cell lines. NVP-AUY922 induced proteasome degradation of AR, though interestingly does not require loss of AR protein to inhibit AR transcriptional activity. Further, NVP-AUY922 increased docetaxel toxicity in MYC-CaP/CR and Pten-CaP/cE2 cell lines in vitro. Finally, NVP-AUY922/docetaxel combination therapy in mice bearing MYC-CaP/CR tumors resulted in greater anti-tumor activity compared to single treatment. This study demonstrates that NVP-AUY922 elicits potent activity towards AR signaling and augments chemotherapy response in a mouse model of CRPC, providing rationale for the continued clinical development of Hsp90 inhibitors in clinical trials for treatment of CRPC patients.	[Ku, ShengYu; Lasorsa, Elena; Adelaiye, Remi; Ramakrishnan, Swathi; Ellis, Leigh; Pili, Roberto] Roswell Pk Canc Inst, Genitourinary Program, Buffalo, NY 14263 USA; [Lasorsa, Elena; Ellis, Leigh] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Ku, ShengYu; Adelaiye, Remi; Ramakrishnan, Swathi] Roswell Pk Canc Inst, Dept Canc Prevent & Pathol, Buffalo, NY 14263 USA; [Pili, Roberto] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Ellis, L (corresponding author), Roswell Pk Canc Inst, Genitourinary Program, Buffalo, NY 14263 USA.	Leigh.Ellis@roswellpark.org; Roberto.Pili@roswellpark.org	Ramakrishnan, Swathi/O-5054-2019	Adelaiye-Ogala, Remi/0000-0002-6581-7359	Department of Defense [PC094159]; National Cancer Institute [P50 CA58236]; NATIONAL CANCER INSTITUTE [P50CA058236, P30CA016056] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was in part supported by the Department of Defense - PC094159 (L. E.) and the National Cancer Institute - P50 CA58236 (R. P.). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Berrieman HK, 2004, LANCET ONCOL, V5, P158, DOI 10.1016/S1470-2045(04)01411-1; Brubaker KD, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-15; Centenera MM, 2012, CLIN CANCER RES, V18, P3562, DOI 10.1158/1078-0432.CCR-12-0782; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Ellis L, 2012, PROSTATE, V72, P587, DOI 10.1002/pros.21465; Ellis WJ, 1996, CLIN CANCER RES, V2, P1039; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Galsky MD, 2010, ANN ONCOL, V21, P2135, DOI 10.1093/annonc/mdq050; Gandhi N, 2013, CANCER BIOL THER, V14, P347, DOI 10.4161/cbt.23626; Georget V, 2002, BIOCHEMISTRY-US, V41, P11824, DOI 10.1021/bi0259150; Goetz MP, 2005, J CLIN ONCOL, V23, P1078, DOI 10.1200/JCO.2005.09.119; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Grem JL, 2005, J CLIN ONCOL, V23, P1885, DOI 10.1200/JCO.2005.12.085; Heath Elisabeth I, 2005, Clin Prostate Cancer, V4, P138, DOI 10.3816/CGC.2005.n.024; Heath EI, 2008, CLIN CANCER RES, V14, P7940, DOI 10.1158/1078-0432.CCR-08-0221; Iyer G, 2012, CANCER CHEMOTH PHARM, V69, P1089, DOI 10.1007/s00280-011-1789-3; Jensen MR, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1996; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kelland LR, 1999, J NATL CANCER I, V91, P1940, DOI 10.1093/jnci/91.22.1940; Lamoureux F, 2011, CANCER RES, V71, P5838, DOI 10.1158/0008-5472.CAN-11-0994; Liao Chun-Peng, 2010, Hormones & Cancer, V1, P44, DOI 10.1007/s12672-009-0005-y; Morikawa Y, 2012, BIOCHEM BIOPH RES CO, V419, P584, DOI 10.1016/j.bbrc.2012.02.089; Nilsson S, 2013, CLIN GENITOURIN CANC, V11, P20, DOI 10.1016/j.clgc.2012.07.002; O'Malley KJ, 2012, PROSTATE, V72, P1117, DOI 10.1002/pros.22458; Ramanathan RK, 2010, J CLIN ONCOL, V28, P1520, DOI 10.1200/JCO.2009.25.0415; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Solit DB, 2002, CLIN CANCER RES, V8, P986; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Vanaja DK, 2002, CELL STRESS CHAPERON, V7, P55, DOI 10.1379/1466-1268(2002)007<0055:EOGOAR>2.0.CO;2; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441	35	9	10	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103680	10.1371/journal.pone.0103680	http://dx.doi.org/10.1371/journal.pone.0103680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072314	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600079
J	Ren, SL; Kim, JK; Kakiyama, G; Rodriguez-Agudo, D; Pandak, WM; Min, HK; Ning, YX				Ren, Shunlin; Kim, Jin Koung; Kakiyama, Genta; Rodriguez-Agudo, Daniel; Pandak, William M.; Min, Hae-Ki; Ning, Yanxia			Identification of Novel Regulatory Cholesterol Metabolite, 5-Cholesten, 3 beta,25-Diol, Disulfate	PLOS ONE			English	Article							FATTY LIVER-DISEASE; LIPID-METABOLISM; SIGNALING PATHWAY; X-RECEPTOR; INFLAMMATORY RESPONSE; ACID SYNTHESIS; IN-VIVO; OXYSTEROL; PROTEIN; OVEREXPRESSION	Oxysterol sulfation plays an important role in regulation of lipid metabolism and inflammatory responses. In the present study, we report the discovery of a novel regulatory sulfated oxysterol in nuclei of primary rat hepatocytes after overexpression of the gene encoding mitochondrial cholesterol delivery protein (StarD1). Forty-eight hours after infection of the hepatocytes with recombinant StarD1 adenovirus, a water-soluble oxysterol product was isolated and purified by chemical extraction and reverse-phase HPLC. Tandem mass spectrometry analysis identified the oxysterol as 5-cholesten-3 beta, 25-diol, disulfate (25HCDS), and confirmed the structure by comparing with a chemically synthesized compound. Administration of 25HCDS to human THP-1-derived macrophages or HepG2 cells significantly inhibited cholesterol synthesis and markedly decreased lipid levels in vivo in NAFLD mouse models. RT-PCR showed that 25HCDS significantly decreased SREBP-1/2 activities by suppressing expression of their responding genes, including ACC, FAS, and HMG-CoA reductase. Analysis of lipid profiles in the liver tissues showed that administration of 25HCDS significantly decreased cholesterol, free fatty acids, and triglycerides by 30, 25, and 20%, respectively. The results suggest that 25HCDS inhibits lipid biosynthesis via blocking SREBP signaling. We conclude that 25HCDS is a potent regulator of lipid metabolism and propose its biosynthetic pathway.	[Ren, Shunlin] Vet Affairs McGuire Med Center, Dept Med, Richmond, VA 23224 USA; Virginia Commonwealth Univ, Dept Med, Richmond, VA 23298 USA	Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University	Ren, SL (corresponding author), Vet Affairs McGuire Med Center, Dept Med, Richmond, VA 23224 USA.	sren@vcu.edu			Durect Corporation, Cupertino, CA; Department of Veterans Affairs Merit Review Grant; VA Research Career Scientist Award; Veterans Affairs [I01BX000197, I01BX001874] Funding Source: NIH RePORTER	Durect Corporation, Cupertino, CA; Department of Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); VA Research Career Scientist Award; Veterans Affairs(US Department of Veterans Affairs)	The research has been funded by Durect Corporation, Cupertino, CA; Department of Veterans Affairs Merit Review Grant; and VA Research Career Scientist Award; and licensed by Durect Corporation, Cupertino, CA. The funders had no role in study design, data collection and analysis, decision to publish.	Accad M, 1998, CURR BIOL, V8, pR601, DOI 10.1016/S0960-9822(98)70386-0; Bai QM, 2012, METABOLISM, V61, P836, DOI 10.1016/j.metabol.2011.11.014; Bai QM, 2011, ATHEROSCLEROSIS, V214, P350, DOI 10.1016/j.atherosclerosis.2010.11.021; Bai QM, 2010, LIPIDS, V45, P29, DOI 10.1007/s11745-009-3375-6; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Cook IT, 2009, DRUG METAB DISPOS, V37, P2069, DOI 10.1124/dmd.108.025759; Ferber D, 2000, SCIENCE, V289, P1446, DOI 10.1126/science.289.5484.1446; Gill S, 2008, PROG LIPID RES, V47, P391, DOI 10.1016/j.plipres.2008.04.002; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Ip BC, 2013, NUTRIENTS, V6, P124; James OFW, 1998, J HEPATOL, V29, P495, DOI 10.1016/S0168-8278(98)80073-1; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li XB, 2007, J LIPID RES, V48, P2587, DOI 10.1194/jlr.M700301-JLR200; Li XB, 2006, J LIPID RES, V47, P1507, DOI 10.1194/jlr.M600117-JLR200; Ma Y, 2007, INFLAMM RES, V56, P495, DOI 10.1007/s00011-007-6133-3; Ma YJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1369, DOI 10.1152/ajpendo.90555.2008; Ning YX, 2010, J ZHEJIANG UNIV-SC B, V11, P350, DOI 10.1631/jzus.B0900369; Ning YX, 2009, ATHEROSCLEROSIS, V204, P114, DOI 10.1016/j.atherosclerosis.2008.09.006; Ning YX, 2009, LIPIDS, V44, P511, DOI 10.1007/s11745-009-3299-1; Ning YX, 2006, BIOCHEM BIOPH RES CO, V342, P1249, DOI 10.1016/j.bbrc.2006.02.093; Pandak WM, 2001, AM J PHYSIOL-GASTR L, V281, pG878, DOI 10.1152/ajpgi.2001.281.4.G878; Ren SL, 2007, BIOCHEM BIOPH RES CO, V360, P802, DOI 10.1016/j.bbrc.2007.06.143; Ren SL, 2006, J LIPID RES, V47, P1081, DOI 10.1194/jlr.M600019-JLR200; Ren SL, 2014, AM J PHYSIOL-ENDOC M, V306, pE123, DOI 10.1152/ajpendo.00552.2013; Ren SL, 2004, HEPATOLOGY, V40, P910, DOI 10.1002/hep.20382; Shi XJ, 2014, MOL CELL BIOL, V34, P485, DOI 10.1128/MCB.01094-13; Song C, 2001, STEROIDS, V66, P473, DOI 10.1016/S0039-128X(00)00239-7; Tian D, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-144; van Reyk DM, 2006, REDOX REP, V11, P255, DOI 10.1179/135100006X155003; Willson TM, 1996, ANN NY ACAD SCI, V804, P276, DOI 10.1111/j.1749-6632.1996.tb18622.x; Xu LY, 2013, MOL PHARMACOL, V83, P648, DOI 10.1124/mol.112.081505; Xu LY, 2012, AM J PHYSIOL-ENDOC M, V302, pE788, DOI 10.1152/ajpendo.00337.2011; Xu LY, 2010, LIPIDS, V45, P821, DOI 10.1007/s11745-010-3451-y; Zhang X, 2012, J STEROID BIOCHEM, V132, P262, DOI 10.1016/j.jsbmb.2012.06.001; Zhang X, 2012, AM J PHYSIOL-GASTR L, V303, pG344, DOI 10.1152/ajpgi.00403.2011	40	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103621	10.1371/journal.pone.0103621	http://dx.doi.org/10.1371/journal.pone.0103621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072708	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600073
J	Xu, XF; Su, B; Xie, CG; Wei, SM; Zhou, YQ; Liu, H; Dai, WQ; Cheng, P; Wang, F; Xu, XR; Guo, CY				Xu, Xuanfu; Su, Bin; Xie, Chuangao; Wei, Shumei; Zhou, Yingqun; Liu, Hua; Dai, Weiqi; Cheng, Ping; Wang, Fan; Xu, Xiaorong; Guo, Chuanyong			Sonic Hedgehog-Gli1 Signaling Pathway Regulates the Epithelial Mesenchymal Transition (EMT) by Mediating a New Target Gene, S100A4, in Pancreatic Cancer Cells	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; IN-VITRO; METASTASIS; EXPRESSION; OVEREXPRESSION; GROWTH; ACTIVATION; SURVIVAL; DISEASE; LINES	Aims: The hedgehog signaling pathway plays an important role in EMT of pancreatic cancer cells, but the precise mechanisms remain elusive. Because S100A4 as a key EMT moleculer marker was found to be upregulated upon Gli1 in pancreatic cancer cells, we focused on the relationship between Shh-Gli1 signals and S100 genes family. Methods: On the base of cDNA microarray data, we investigated regulating mechanism of Gli1 to some members of S100A genes family in pancreatic cancer cell lines firstly. Then, the regulation of Gli1 to S100A4 gene was studied by molecular biology assays and the pro-metastasis effection of Gli1-dependent S100A4 was investigated in vitro. Finally, the expressions of Shh, Gli1, S100A4 and E-cadherin in pancreatic cancer tissues were studied by using immunohistochemistry assays. Results: Five members of the S100 genes family, S100A2, S100A4, S100A6, S100A11, and S100A14 were found to be downregulated significantly upon Gli1 knockdown. Gli1 enhancer prediction combining with in vitro data demonstrated that Gli1 primarily regulates S100A family members via cis-acting elements. Indeed, the data indicate S100A4 and vimentin genes were upregulated significantly by Shh/Gli1-expression increasing and E-cadherin was significantly reduced at the same time. Migration of PC cells was increased significantly in a dose-dependent manner of Gli1 expression (P<0.05) and siS100A4 significantly reversed the response of PC cells induced by L-Shh transduction (P<0.01). Conclusion: Our data establish a novel connection between Shh-Gli1 signaling and S100A4 regulation, which imply that S100A4 might be one of the key factors in EMT mediated by Shh-Gli1 signaling in pancreatic cancer.	[Xu, Xuanfu; Zhou, Yingqun; Liu, Hua; Dai, Weiqi; Cheng, Ping; Wang, Fan; Xu, Xiaorong; Guo, Chuanyong] Tongji Univ, Peoples Hosp Shanghai 10, Dept Gastroenterol, Shanghai 200092, Peoples R China; [Su, Bin] Tongji Univ, Peoples Hosp Shanghai 10, Dept Endocrinol, Shanghai 200092, Peoples R China; [Xie, Chuangao; Wei, Shumei] Zhejiang Univ, Hosp 2, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China	Tongji University; Tongji University; Zhejiang University	Xu, XF (corresponding author), Tongji Univ, Peoples Hosp Shanghai 10, Dept Gastroenterol, Shanghai 200092, Peoples R China.	shuanfusky@aliyun.com; xuxr2000@gmail.com		Guo, Chuanyong/0000-0002-6527-4673	National Natural Science Foundation of China [81072005, 81172312, 81101839]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by grants from the National Natural Science Foundation of China (81072005, 81172312 and 81101839). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai KX, 2008, WORLD J GASTROENTERO, V14, P1931, DOI 10.3748/wjg.14.1931; Ansari D, 2011, BRIT J SURG, V98, P1041, DOI 10.1002/bjs.7574; Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Bosetti C, 2012, MOL CARCINOGEN, V51, P3, DOI 10.1002/mc.20785; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Carpenter RL, 2012, DISCOV MED, V13, P105; Danilov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026815; Feldmann G, 2008, MOL CANCER THER, V7, P2725, DOI 10.1158/1535-7163.MCT-08-0573; Hejna M, 2001, ANTICANCER RES, V21, P1183; Henry J, 2012, FRONT BIOSCI-LANDMRK, V17, P1517, DOI 10.2741/4001; Ikenaga N, 2009, J GASTROINTEST SURG, V13, P1852, DOI 10.1007/s11605-009-0978-4; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Lees C, 2005, GASTROENTEROLOGY, V129, P1696, DOI 10.1053/j.gastro.2005.05.010; Li DH, 2003, CLIN CANCER RES, V9, P991; Li XQ, 2012, CANCER LETT, V322, P169, DOI 10.1016/j.canlet.2012.02.035; Li ZK, 2004, CANCER-AM CANCER SOC, V101, P58, DOI 10.1002/cncr.20321; Loos M, 2008, ANN NY ACAD SCI, V1138, P169, DOI 10.1196/annals.1414.024; Loos M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-463; Lukanidin E, 2012, SEMIN CANCER BIOL, V22, P216, DOI 10.1016/j.semcancer.2012.02.006; Matthaios D, 2011, ONCOLOGY-BASEL, V81, P259, DOI 10.1159/000334449; Mencia N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-250; Mishra SK, 2012, CANCER METAST REV, V31, P163, DOI 10.1007/s10555-011-9338-4; Neupane D, 2008, CLIN CANCER RES, V14, P7614, DOI 10.1158/1078-0432.CCR-08-1366; Nipp M, 2012, J MOL MED, V90, P163, DOI 10.1007/s00109-011-0815-6; Oida Y, 2006, ONCOL REP, V16, P457; Onishi H, 2011, CANCER SCI, V102, P1144, DOI 10.1111/j.1349-7006.2011.01912.x; Parkin CA, 2008, AM J PHYSIOL-GASTR L, V294, pG363, DOI 10.1152/ajpgi.00457.2007; Quint K, 2009, PANCREATOLOGY, V9, P116, DOI 10.1159/000178882; Seidel K, 2010, DEVELOPMENT, V137, P3753, DOI 10.1242/dev.056358; Shang X, 2008, GENET SEL EVOL, V40, P449, DOI 10.1051/gse:2008013; Singh BN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027306; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Suemizu H, 2007, INT J ONCOL, V31, P741; Tang SN, 2012, INT J CANCER, V131, P30, DOI 10.1002/ijc.26323; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Xu Xuan-Fu, 2009, J Carcinog, V8, P13, DOI 10.4103/1477-3163.55429; Xu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043119; Yu M, 2009, J BIOL CHEM, V284, P5620, DOI 10.1074/jbc.M809172200; Zhang HY, 2012, MOL BIOL REP, V39, P199, DOI 10.1007/s11033-011-0726-1	42	64	73	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e96441	10.1371/journal.pone.0096441	http://dx.doi.org/10.1371/journal.pone.0096441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072505	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600001
J	Platholi, J; Herold, KF; Hemmings, HC; Halpain, S				Platholi, Jimcy; Herold, Karl F.; Hemmings, Hugh C., Jr.; Halpain, Shelley			Isoflurane Reversibly Destabilizes Hippocampal Dendritic Spines by an Actin-Dependent Mechanism	PLOS ONE			English	Article							LONG-TERM POTENTIATION; GLUTAMATE RECEPTORS; INHALED ANESTHETICS; CA1 REGION; DYNAMICS; PLASTICITY; PERSISTENT; PROPOFOL; LTP; MODULATION	General anesthetics produce a reversible coma-like state through modulation of excitatory and inhibitory synaptic transmission. Recent evidence suggests that anesthetic exposure can also lead to sustained cognitive dysfunction. However, the subcellular effects of anesthetics on the structure of established synapses are not known. We investigated effects of the widely used volatile anesthetic isoflurane on the structural stability of hippocampal dendritic spines, a postsynaptic structure critical to excitatory synaptic transmission in learning and memory. Exposure to clinical concentrations of isoflurane induced rapid and non-uniform shrinkage and loss of dendritic spines in mature cultured rat hippocampal neurons. Spine shrinkage was associated with a reduction in spine F-actin concentration. Spine loss was prevented by either jasplakinolide or cytochalasin D, drugs that prevent F-actin disassembly. Isoflurane-induced spine shrinkage and loss were reversible upon isoflurane elimination. Thus, isoflurane destabilizes spine F-actin, resulting in changes to dendritic spine morphology and number. These findings support an actin-based mechanism for isoflurane-induced alterations of synaptic structure in the hippocampus. These reversible alterations in dendritic spine structure have important implications for acute anesthetic effects on excitatory synaptic transmission and synaptic stability in the hippocampus, a locus for anesthetic-induced amnesia, and have important implications for anesthetic effects on synaptic plasticity.	[Platholi, Jimcy; Halpain, Shelley] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA; [Platholi, Jimcy; Halpain, Shelley] Univ Calif San Diego, Sanford Consortium Regenerat Med, San Diego, CA 92103 USA; [Platholi, Jimcy; Herold, Karl F.; Hemmings, Hugh C., Jr.] Weill Cornell Med Coll, Dept Anesthesiol, New York, NY 10065 USA; [Platholi, Jimcy; Herold, Karl F.; Hemmings, Hugh C., Jr.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Cornell University; Cornell University	Hemmings, HC (corresponding author), Weill Cornell Med Coll, Dept Anesthesiol, New York, NY 10065 USA.	hchemmi@med.cornell.edu; shalpain@ucsd.edu			National Institutes of Health (NIH) [MH087823, GM58055]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087823] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (NIH) grants MH087823 to SH and GM58055 to HCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DW, 1998, J NEUROSCI, V18, P2423; Baudry M, 2013, NEUROBIOL LEARN MEM, V104, P64, DOI 10.1016/j.nlm.2013.04.012; Blanpied TA, 2004, BIOL PSYCHIAT, V55, P1121, DOI 10.1016/j.biopsych.2003.10.006; Briner A, 2011, ANESTHESIOLOGY, V115, P282, DOI 10.1097/ALN.0b013e318221fbbd; Briner A, 2010, ANESTHESIOLOGY, V112, P546, DOI 10.1097/ALN.0b013e3181cd7942; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; COOPER JA, 1984, J CELL BIOL, V99, P217, DOI 10.1083/jcb.99.1.217; De Roo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007043; de Sousa SLM, 2000, ANESTHESIOLOGY, V92, P1055, DOI 10.1097/00000542-200004000-00024; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Eger EI, 2008, ANESTH ANALG, V107, P832, DOI 10.1213/ane.0b013e318182aedb; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Halpain S, 2005, PROG BRAIN RES, V147, P29, DOI 10.1016/S0079-6123(04)47003-4; Halpain S, 1998, J NEUROSCI, V18, P9835; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; Hemmings HC, 2005, MOL PHARMACOL, V67, P1591, DOI 10.1124/mol.104.003210; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Jevtovic-Todorovic V, 2013, BRIT J ANAESTH, V111, P143, DOI 10.1093/bja/aet177; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kaech S, 1999, P NATL ACAD SCI USA, V96, P10433, DOI 10.1073/pnas.96.18.10433; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kato R, 2013, ANESTH ANALG, V117, P1429, DOI 10.1213/ANE.0b013e3182a8c709; Koehrmann Martin, 1999, Journal of Neuroscience Research, V58, P831; Koleske AJ, 2013, NAT REV NEUROSCI, V14, P536, DOI 10.1038/nrn3486; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lamprecht R, 2014, PROG NEUROBIOL, V117, P1, DOI 10.1016/j.pneurobio.2014.02.001; Lee SH, 2010, MOL CELLS, V29, P311, DOI 10.1007/s10059-010-0053-8; Lemkuil BP, 2011, ANESTHESIOLOGY, V114, P49, DOI 10.1097/ALN.0b013e318201dcb3; Lin DW, 2011, NEUROPHARMACOLOGY, V61, P1354, DOI 10.1016/j.neuropharm.2011.08.011; LIN DC, 1980, J CELL BIOL, V84, P455, DOI 10.1083/jcb.84.2.455; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Lynch G, 2007, NEUROPHARMACOLOGY, V52, P12, DOI 10.1016/j.neuropharm.2006.07.027; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; MAZZE RI, 1985, ANESTHESIOLOGY, V62, P339, DOI 10.1097/00000542-198503000-00021; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Mintz CD, 2013, ANESTHESIOLOGY, V118, P825, DOI 10.1097/ALN.0b013e318287b850; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; Peng S, 2012, MOL CELL BIOCHEM, V361, P229, DOI 10.1007/s11010-011-1107-8; Peng S, 2011, MOL BIOL REP, V38, P1195, DOI 10.1007/s11033-010-0217-9; Perouansky M, 2011, CAN J ANESTH, V58, P157, DOI 10.1007/s12630-010-9417-y; Perouansky M, 2010, ANESTHESIOLOGY, V113, P1299, DOI 10.1097/ALN.0b013e3181f90ccc; Rochefort NL, 2012, EMBO REP, V13, P699, DOI 10.1038/embor.2012.102; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Sanders RD, 2013, BRIT J ANAESTH, V110, P53, DOI 10.1093/bja/aet054; Scherlach K, 2010, NAT PROD REP, V27, P869, DOI 10.1039/b903913a; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; TAHERI S, 1991, ANESTH ANALG, V72, P627; Tan H, 2009, CHINESE MED J-PEKING, V122, P455, DOI 10.3760/cma.j.issn.0366-6999.2009.04.0018; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; van Rossum D, 1999, TRENDS NEUROSCI, V22, P290, DOI 10.1016/S0166-2236(99)01404-6; Visegrady B, 2005, FEBS LETT, V579, P6, DOI 10.1016/j.febslet.2004.11.023; Wei HM, 2002, NEUROSCI LETT, V324, P181, DOI 10.1016/S0304-3940(02)00183-0; Westphalen RI, 2003, ANESTHESIOLOGY, V98, P364, DOI 10.1097/00000542-200302000-00016; Yang G, 2011, ANESTHESIOLOGY, V115, P718, DOI 10.1097/ALN.0b013e318229a660; Yu DS, 2013, NEUROSCI LETT, V534, P41, DOI 10.1016/j.neulet.2012.12.033; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274	65	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102978	10.1371/journal.pone.0102978	http://dx.doi.org/10.1371/journal.pone.0102978			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068870	Green Submitted, gold, Green Published			2022-12-25	WOS:000339993700026
J	Wan, C; Hao, ZX; Wen, SZ; Leng, HJ				Wan, Chao; Hao, Zhixiu; Wen, Shizhu; Leng, Huijie			A Quantitative Study of the Relationship between the Distribution of Different Types of Collagen and the Mechanical Behavior of Rabbit Medial Collateral Ligaments	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; PATELLAR TENDON; PICROSIRIUS-POLARIZATION; BIOMECHANICAL PROPERTIES; CONNECTIVE-TISSUE; MODEL; STRESS; MICROSCOPY; DIAMETER; REPAIR	The mechanical properties of ligaments are key contributors to the stability and function of musculoskeletal joints. Ligaments are generally composed of ground substance, collagen (mainly type I and III collagen), and minimal elastin fibers. However, no consensus has been reached about whether the distribution of different types of collagen correlates with the mechanical behaviors of ligaments. The main objective of this study was to determine whether the collagen type distribution is correlated with the mechanical properties of ligaments. Using axial tensile tests and picrosirius red staining-polarization observations, the mechanical behaviors and the ratios of the various types of collagen were investigated for twenty-four rabbit medial collateral ligaments from twenty-four rabbits of different ages, respectively. One-way analysis of variance was used in the comparison of the Young's modulus in the linear region of the stress-strain curves and the ratios of type I and III collagen for the specimens (the mid-substance specimens of the ligaments) with different ages. A multiple linear regression was performed using the collagen contents (the ratios of type I and III collagen) and the Young's modulus of the specimens. During the maturation of the ligaments, the type I collagen content increased, and the type III collagen content decreased. A significant and strong correlation (R-2 = 0: 839, P < 0.05) was identified by multiple linear regression between the collagen contents (i. e., the ratios of type I and type III collagen) and the mechanical properties of the specimens. The collagen content of ligaments might provide a new perspective for evaluating the linear modulus of global stress-strain curves for ligaments and open a new door for studying the mechanical behaviors and functions of connective tissues.	[Wan, Chao; Hao, Zhixiu; Wen, Shizhu] Tsinghua Univ, State Key Lab Tribol, Beijing 100084, Peoples R China; [Leng, Huijie] Peking Univ, Dept Orthoped, Hosp 3, Beijing 100871, Peoples R China	Tsinghua University; Peking University	Hao, ZX (corresponding author), Tsinghua Univ, State Key Lab Tribol, Beijing 100084, Peoples R China.	haozx@tsinghua.edu.cn; lenghj@bjmu.edu.cn	Leng, Huijie/AGQ-9574-2022	Leng, Huijie/0000-0002-4436-061X	Science Foundation of China [51275267, 11002004]	Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support from the projects of the Nature Science Foundation of China (51275267, 11002004) is gratefully acknowledged. The URL of the funder's website is: http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AS, 2012, J APPL PHYSIOL, V113, P1784, DOI 10.1152/japplphysiol.00767.2012; AMIEL D, 1987, CONNECT TISSUE RES, V16, P357, DOI 10.3109/03008208709005620; AMIEL D, 1984, Journal of Orthopaedic Research, V1, P257; An KN, 2004, BIORHEOLOGY, V41, P239; Brenda E, 1999, EUR J PLAST SURG, V22, P28, DOI 10.1007/s002380050140; Chandrashekar N, 2008, CLIN BIOMECH, V23, P918, DOI 10.1016/j.clinbiomech.2008.03.070; Chandrashekar N, 2006, J BIOMECH, V39, P2943, DOI 10.1016/j.jbiomech.2005.10.031; CHOWDHURY P, 1991, CONNECT TISSUE RES, V27, P33; Couppe C, 2009, J APPL PHYSIOL, V107, P880, DOI 10.1152/japplphysiol.00291.2009; Cuttle L, 2005, WOUND REPAIR REGEN, V13, P198, DOI 10.1111/j.1067-1927.2005.130211.x; DAYAN D, 1989, HISTOCHEMISTRY, V93, P27, DOI 10.1007/BF00266843; Derwin KA, 1999, J BIOMECH ENG-T ASME, V121, P598, DOI 10.1115/1.2800859; Eberl C., 2010, MATLAB CENTRAL; Foster BL, 2012, INT J ORAL SCI, V4, P119, DOI 10.1038/ijos.2012.57; FRANK C, 1983, AM J SPORT MED, V11, P379, DOI 10.1177/036354658301100602; Frank CB, 1999, OSTEOARTHR CARTILAGE, V7, P130, DOI 10.1053/joca.1998.0168; Goncalves RV, 2013, LASER MED SCI, V28, P383, DOI 10.1007/s10103-012-1066-7; Grytz R, 2009, J MECH BEHAV BIOMED, V2, P522, DOI 10.1016/j.jmbbm.2008.12.009; Hansen KA, 2002, J BIOMECH ENG-T ASME, V124, P72, DOI 10.1115/1.1427698; Hashemi J, 2008, J ORTHOP RES, V26, P945, DOI 10.1002/jor.20621; Hashemi J, 2011, J ORTHOP RES, V29, P993, DOI 10.1002/jor.21245; Hirokawa S, 2000, J BIOMECH, V33, P1069, DOI 10.1016/S0021-9290(00)00073-7; Hurschler C, 2003, J BIOMECH ENG-T ASME, V125, P415, DOI 10.1115/1.1579046; Jung HJ, 2009, BMC SPORTS SCI MED R, V1, DOI 10.1186/1758-2555-1-9; JUNQUEIRA LCU, 1978, ARCH HISTOL JAPON, V41, P267, DOI 10.1679/aohc1950.41.267; JUNQUEIRA LCU, 1982, HISTOCHEMISTRY, V74, P153, DOI 10.1007/BF00495061; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kostrominova TY, 2013, AGE, V35, P2203, DOI 10.1007/s11357-013-9514-2; Lake SP, 2009, J ORTHOP RES, V27, P1596, DOI 10.1002/jor.20938; Lam TC, 1995, J BIOMECH ENG-T ASME, V117, P455, DOI 10.1115/1.2794207; Lavagnino M, 2005, J BIOMECH, V38, P69, DOI 10.1016/j.jbiomech.2004.03.035; LIU SH, 1995, CLIN ORTHOP RELAT R, P265; Lo IKY, 2004, CONNECT TISSUE RES, V45, P11, DOI 10.1080/03008200490278070; Majewski M, 2012, EUR CELLS MATER, V23, P94, DOI 10.22203/eCM.v023a07; Maldonado DC, 2013, J ANAT, V222, P518, DOI 10.1111/joa.12036; MOORE MJ, 1987, J ANAT, V153, P163; MOREIN G, 1978, ANAT EMBRYOL, V154, P121, DOI 10.1007/BF00317959; Ng GYF, 1996, J ORTHOPAED RES, V14, P851, DOI 10.1002/jor.1100140602; Nita LM, 2009, J ANAT, V215, P692, DOI 10.1111/j.1469-7580.2009.01146.x; Nordin M., 2001, BASIC BIOMECHANICS M; Reese SP, 2010, J BIOMECH, V43, P1394, DOI 10.1016/j.jbiomech.2010.01.004; Rigozzi S, 2010, J ANAT, V216, P724, DOI 10.1111/j.1469-7580.2010.01225.x; Saez P, 2011, IEEE T BIO-MED ENG, V58, P3500, DOI 10.1109/TBME.2011.2166154; Shen ZL, 2008, BIOPHYS J, V95, P3956, DOI 10.1529/biophysj.107.124602; Shen ZLL, 2010, BIOPHYS J, V99, P1986, DOI 10.1016/j.bpj.2010.07.021; Shvedova AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030923; Silver FH, 2002, J THEOR BIOL, V216, P243, DOI 10.1006/jtbi.2002.2542; STOUFFER DC, 1985, J BIOMECH ENG-T ASME, V107, P158, DOI 10.1115/1.3138536; Thornton GM, 2001, J ORTHOPAED RES, V19, P845, DOI 10.1016/S0736-0266(01)00005-5; Wan C, 2013, ANN ANAT, V195, P562, DOI 10.1016/j.aanat.2013.09.003; Weiss JA, 2005, MED ENG PHYS, V27, P845, DOI 10.1016/j.medengphy.2005.05.006; Weiss JA, 2002, J BIOMECH, V35, P943, DOI 10.1016/S0021-9290(02)00041-6; WOO SLY, 1986, J ORTHOPAED RES, V4, P133, DOI 10.1002/jor.1100040201; WOO SLY, 1992, J BIOMECH, V25, P377, DOI 10.1016/0021-9290(92)90257-2; Woo SLY, 2006, J BIOMECH, V39, P1, DOI 10.1016/j.jbiomech.2004.10.025; WOO SLY, 1990, MECH AGEING DEV, V56, P129, DOI 10.1016/0047-6374(90)90004-Y	56	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103363	10.1371/journal.pone.0103363	http://dx.doi.org/10.1371/journal.pone.0103363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	25062068	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992600062
J	Reger, AS; Yang, MP; Koide-Yoshida, S; Guo, E; Mehta, S; Yuasa, K; Liu, A; Casteel, DE; Kim, C				Reger, Albert S.; Yang, Matthew P.; Koide-Yoshida, Shizuyo; Guo, Elaine; Mehta, Shrenik; Yuasa, Keizo; Liu, Alan; Casteel, Darren E.; Kim, Choel			Crystal Structure of the cGMP-dependent Protein Kinase II Leucine Zipper and Rab11b Protein Complex Reveals Molecular Details of G-kinase-specific Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; BETA; INTERFACE; RECEPTOR; FAMILY; IDENTIFICATION; TRAFFICKING; RECRUITMENT; CHANNELS; CLONING	cGMP-dependent protein kinase (PKG)-interacting proteins (GKIPs) mediate cellular targeting of PKG isoforms by interacting with their leucine zipper (LZ) domains. These interactions prevent aberrant signaling cross-talk between different PKG isotypes. To gain detailed insight into isotype-specific GKIP recognition by PKG, we analyzed the type II PKG leucine zipper domain and found that residues 40-83 dimerized and specifically interacted with Rab11b. Next, we determined a crystal structure of the PKG II LZ-Rab11b complex. The PKG II LZ domain presents a mostly nonpolar surface onto which Rab11b docks, through van der Waals interactions. Contact surfaces in Rab11b are found in switch I and II, interswitch, and the beta 1/N-terminal regions. This binding surface dramatically differs from that seen in the Rab11 family of interacting protein complex structures. Structural comparison with PKGI alpha and I beta LZs combined with mutagenic analysis reveals that GKIP recognition is mediated through surface charge interactions.	[Reger, Albert S.; Mehta, Shrenik; Kim, Choel] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Yang, Matthew P.] Rice Univ, Dept Biochem, Houston, TX 77005 USA; [Guo, Elaine] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Koide-Yoshida, Shizuyo; Yuasa, Keizo] Univ Tokushima, Grad Sch, Dept Biol Sci & Technol, Tokushima 7708506, Japan; [Liu, Alan; Casteel, Darren E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kim, Choel] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Rice University; Rice University; Tokushima University; University of California System; University of California San Diego; Baylor College of Medicine	Kim, C (corresponding author), Baylor Coll Med, MS 330 Alkek 520,One Baylor Plaza, Houston, TX 77030 USA.	ckim@bcm.edu			United States Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090161] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Goud, C. Peters, G. Y. Huang, T. Palzkill, and J. J. Kim for critical reading of the manuscript. We appreciate the technical support, advice, and assistance of D. C. Chow and K. Klerec in the Center for Drug Discovery at Baylor College of Medicine. We also thank S. R. Wasserman (Eli Lilly Beamline, Advanced Photon Source) for assistance with data collection. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Co., which operates the facility.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Bussow K, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-21; Casteel DE, 2010, J BIOL CHEM, V285, P32684, DOI 10.1074/jbc.C110.161430; Casteel DE, 2005, J BIOL CHEM, V280, P38211, DOI 10.1074/jbc.M507021200; DEJONGE HR, 1981, ADV CYCLIC NUCL PROT, V14, P315; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; FRENCH PJ, 1995, J BIOL CHEM, V270, P26626, DOI 10.1074/jbc.270.44.26626; GOLDENRING JR, 1993, J BIOL CHEM, V268, P18419; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; Huang SH, 2013, J NEUROSCI, V33, P9214, DOI 10.1523/JNEUROSCI.3256-12.2013; Jagoe WN, 2006, STRUCTURE, V14, P1273, DOI 10.1016/j.str.2006.06.010; Junutula JR, 2004, J BIOL CHEM, V279, P33430, DOI 10.1074/jbc.M404633200; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; Kelly EE, 2012, BIOCHEM SOC T, V40, P1360, DOI 10.1042/BST20120157; LAI F, 1994, GENOMICS, V22, P610, DOI 10.1006/geno.1994.1434; Lee E, 2007, J MOL BIOL, V373, P1198, DOI 10.1016/j.jmb.2007.08.049; Orstavik S, 1997, GENOMICS, V42, P311, DOI 10.1006/geno.1997.4743; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Pasqualato S, 2004, J BIOL CHEM, V279, P11480, DOI 10.1074/jbc.M310558200; Pfeffer SR, 2005, J BIOL CHEM, V280, P15485, DOI 10.1074/jbc.R500003200; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; SAKURADA K, 1991, BIOCHEM BIOPH RES CO, V177, P1224, DOI 10.1016/0006-291X(91)90672-T; SANDBERG M, 1989, FEBS LETT, V255, P321, DOI 10.1016/0014-5793(89)81114-7; Scapin SMN, 2006, J STRUCT BIOL, V154, P260, DOI 10.1016/j.jsb.2006.01.007; Schlierf B, 2000, EXP CELL RES, V259, P257, DOI 10.1006/excr.2000.4947; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Schnell JR, 2005, PROTEIN SCI, V14, P2421, DOI 10.1110/ps.051528905; Schwappacher R, 2013, J CELL SCI, V126, P1626, DOI 10.1242/jcs.118190; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Vaandrager AB, 1998, P NATL ACAD SCI USA, V95, P1466, DOI 10.1073/pnas.95.4.1466; van de Graaf SFJ, 2006, MOL CELL BIOL, V26, P303, DOI 10.1128/MCB.26.1.303-312.2006; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yuasa K, 2008, BIOCHEM BIOPH RES CO, V374, P522, DOI 10.1016/j.bbrc.2008.07.071	44	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25393	25403		10.1074/jbc.M114.575894	http://dx.doi.org/10.1074/jbc.M114.575894			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070890	Green Published, hybrid			2022-12-25	WOS:000342130800001
J	Forg, T; Hafner, M; Lux, A				Foerg, Tassilo; Hafner, Mathias; Lux, Andreas			Investigation of Endoglin Wild-Type and Missense Mutant Protein Heterodimerisation Using Fluorescence Microscopy Based IF, BiFC and FRET Analyses	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HEREDITARY HEMORRHAGIC TELANGIECTASIA; TRANSFORMING GROWTH-FACTOR-BETA-1; EXPRESSION ANALYSIS; ENDOTHELIAL-CELLS; CELLULAR-RESPONSES; MUTATION ANALYSIS; RECEPTOR; GENE; IDENTIFICATION	The homodimeric transmembrane receptor endoglin (CD105) plays an important role in angiogenesis. This is highlighted by mutations in its gene, causing the vascular disorder HHT1. The main role of endoglin function has been assigned to the modulation of transforming growth factor beta and bone morphogenetic protein signalling in endothelial cells. Nevertheless, other functions of endoglin have been revealed to be involved in different cellular functions and in other cell types than endothelial cells. Compared to the exploration of its natural function, little experimental data have been gathered about the mode of action of endoglin HHT mutations at the cellular level, especially missense mutations, and to what degree these might interfere with normal endoglin function. In this paper, we have used fluorescence-based microscopic techniques, such as bimolecular fluorescence complementation (BiFC), immunofluorescence staining with the endoglin specific monoclonal antibody SN6, and protein interaction studies by Forster Resonance Energy Transfer (FRET) to investigate the formation and cellular localisation of possible homo-and heterodimers composed of endoglin wild-type and endoglin missense mutant proteins. The results show that all of the investigated missense mutants dimerise with themselves, as well as with wild-type endoglin, and localise, depending on the position of the affected amino acid, either in the rough endoplasmic reticulum (rER) or in the plasma membrane of the cells. We show that the rER retained mutants reduce the amount of endogenous wild-type endoglin on the plasma membrane through interception in the rER when transiently or stably expressed in HMEC-1 endothelial cells. As a result of this, endoglin modulated TGF-beta 1 signal transduction is also abrogated, which is not due to TGF-beta receptor ER trafficking interference. Protein interaction analyses by FRET show that rER located endoglin missense mutants do not perturb protein processing of other membrane receptors, such as T beta RII, ALK5 or ALK1.	[Foerg, Tassilo; Hafner, Mathias] Univ Appl Sci, Inst Mol & Cell Biol, Mannheim, Germany; [Hafner, Mathias; Lux, Andreas] Heidelberg Univ, Med Fac Mannheim, Heidelberg, Germany; [Hafner, Mathias] Heidelberg Univ, Inst Med Technol, Mannheim, Germany; [Hafner, Mathias] Univ Appl Sci, Mannheim, Germany; [Lux, Andreas] Q Bios GmbH Biotechnol, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Lux, A (corresponding author), Heidelberg Univ, Med Fac Mannheim, Heidelberg, Germany.	a.lux@hs-mannheim.de			Ministerium fur Wissenschaft, Forschung und Kunst (Baden-Wurttemberg); Karl-Volker-Stiftung; Fritz-Thyssen Stiftung [10.04.2.171]	Ministerium fur Wissenschaft, Forschung und Kunst (Baden-Wurttemberg); Karl-Volker-Stiftung; Fritz-Thyssen Stiftung	Financial support by Ministerium fur Wissenschaft, Forschung und Kunst (Baden-Wurttemberg), Karl-Volker-Stiftung, and Fritz-Thyssen Stiftung (Grant 10.04.2.171) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Ali BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026206; Anderie I, 2007, CELL SIGNAL, V19, P582, DOI 10.1016/j.cellsig.2006.08.007; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Bourdeau A, 2001, AM J PATHOL, V158, P2011, DOI 10.1016/S0002-9440(10)64673-1; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200; Cymerman U, 2000, PEDIATR RES, V47, P24, DOI 10.1203/00006450-200001000-00008; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; DEAGOSTINI AI, 1990, J CELL BIOL, V111, P1293, DOI 10.1083/jcb.111.3.1293; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fernandez-L A, 2005, CARDIOVASC RES, V68, P235, DOI 10.1016/j.cardiores.2005.06.009; Fernandez-L Africa, 2006, Hum Mutat, V27, P295; Forg LP T., 2010, MICROSCOPY SCI TECHN, V4, P747; Gallione CJ, 1998, HUM MUTAT, V11, P286, DOI 10.1002/(SICI)1098-1004(1998)11:4<286::AID-HUMU6>3.0.CO;2-B; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; Guo BQ, 2004, ANTICANCER RES, V24, P1337; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hume AN, 2013, MOL CELL BIOCHEM, V373, P247, DOI 10.1007/s11010-012-1496-3; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Koleva RI, 2006, J BIOL CHEM, V281, P25110, DOI 10.1074/jbc.M601288200; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Letamendia A, 1998, J BIOL CHEM, V273, P33011, DOI 10.1074/jbc.273.49.33011; Li CG, 2000, FASEB J, V14, P55, DOI 10.1096/fasebj.14.1.55; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Lux A, 2005, J BIOL CHEM, V280, P8482, DOI 10.1074/jbc.M409197200; Lux A, 1999, J BIOL CHEM, V274, P9984, DOI 10.1074/jbc.274.15.9984; Lux A, 2000, HUM MOL GENET, V9, P745, DOI 10.1093/hmg/9.5.745; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; MARCUM JA, 1985, BIOCHEM BIOPH RES CO, V126, P365, DOI 10.1016/0006-291X(85)90615-1; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; MCALLISTER KA, 1995, HUM MOL GENET, V4, P1983, DOI 10.1093/hmg/4.10.1983; Meng QJ, 2006, J BIOL CHEM, V281, P37069, DOI 10.1074/jbc.M608614200; Nolan-Stevaux O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050920; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Pan CC, 2012, BIOCHEM BIOPH RES CO, V424, P620, DOI 10.1016/j.bbrc.2012.06.163; Paquet ME, 2001, HUM MOL GENET, V10, P1347, DOI 10.1093/hmg/10.13.1347; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Pece N, 1997, J CLIN INVEST, V100, P2568, DOI 10.1172/JCI119800; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Pece-Barbara N, 1999, HUM MOL GENET, V8, P2171, DOI 10.1093/hmg/8.12.2171; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Pichuantes S, 1997, TISSUE ANTIGENS, V50, P265, DOI 10.1111/j.1399-0039.1997.tb02870.x; Pyne-Geithman GJ, 2009, NEUROCRIT CARE, V10, P225, DOI 10.1007/s12028-008-9143-2; Raab U, 1999, BIOCHEM J, V339, P579, DOI 10.1042/0264-6021:3390579; Ray BN, 2010, CARCINOGENESIS, V31, P435, DOI 10.1093/carcin/bgp327; Sanz-Rodriguez F, 2004, CLIN CHEM, V50, P2003, DOI 10.1373/clinchem.2004.035287; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Shovlin CL, 1997, AM J HUM GENET, V61, P68, DOI 10.1086/513906; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; YAMASHITA H, 1994, J BIOL CHEM, V269, P1995; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	71	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102998	10.1371/journal.pone.0102998	http://dx.doi.org/10.1371/journal.pone.0102998			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080347	Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800022
J	Jiao, GZ; Lian, HY; Gao, Y; Sun, MJ; Gong, S; Zheng, LL; Zhang, CX; Tan, JH				Jiao, Guang-Zhong; Lian, Hua-Yu; Gao, Yan; Sun, Ming-Ju; Gong, Shuai; Zheng, Liang-Liang; Zhang, Chuan-Xin; Tan, Jing-He			Carrying-Over Effects of GVBD Blocking on Post-Blocking Meiotic Progression of Oocytes: Species Difference and the Signaling Pathway Leading to MPF Activation	PLOS ONE			English	Article							BOVINE FOLLICULAR OOCYTES; IN-VITRO; BUTYROLACTONE-I; CYTOPLASMIC MATURATION; NUCLEAR MATURATION; EMBRYO DEVELOPMENT; GROWTH; INHIBITION; RESUMPTION; ROSCOVITINE	Efforts to improve the quality of in vitro matured oocytes by blocking germinal vesicle breakdown (GVBD) and allowing more time for ooplasmic maturation have achieved little due to a lack of knowledge on the molecular events during GVBD blocking. Such knowledge is also important for studies aimed at regulating gene expression in maturing oocytes prior to GVBD. We studied species difference and signaling pathways leading to the carrying-over effect of GVBD blocking on post-blocking meiotic progression (PBMP). Overall, GVBD-blocking with roscovitine decelerated PBMP of mouse oocytes but accelerated that of pig oocytes. During blocking culture, whereas cyclin B of pig oocytes increased continuously, that of mouse oocytes declined first and then increased slowly. In both species, (a) whereas active CDC2A showed a dynamics similar to cyclin B, inactive CDC2A decreased continuously; (b) when oocytes were blocked in blocking medium containing cycloheximide, PBMP was decelerated significantly while cyclin B and active CDC2A decreasing to the lowest level; (c) whereas sodium vanadate in blocking medium reduced PBMP, epidermal growth factor (EGF) in blocking medium accelerated PBMP significantly with no effect on cyclin B levels. In conclusion, the EGF signaling cascade accelerated PBMP by promoting the pre-MPF (M-phase-promoting factor) to MPF conversion during GVBD blocking with roscovitine. The significant difference in PBMP observed between mouse and pig oocytes was caused by species difference in cyclin B dynamics during blocking culture as no species difference was observed in either pre-MPF to MPF conversion or the EGF signaling activity.	[Jiao, Guang-Zhong; Lian, Hua-Yu; Gao, Yan; Sun, Ming-Ju; Gong, Shuai; Zheng, Liang-Liang; Zhang, Chuan-Xin; Tan, Jing-He] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Tan, JH (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China.	tanjh@sdau.edu.cn			National Basic Research Program of China [2012CB944403, 2014CB138503]; China National Natural Science Foundation [31272444, 30972096]	National Basic Research Program of China(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of China (Nos. 2012CB944403 and 2014CB138503) and the China National Natural Science Foundation (Nos. 31272444 and 30972096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adona PR, 2008, ANIM REPROD SCI, V104, P389, DOI 10.1016/j.anireprosci.2007.06.013; CARPENTER G, 1985, J CELL SCI, P1; Chen XF, 2008, J ENDOCRINOL, V197, P409, DOI 10.1677/JOE-07-0592; COHEN S, 1983, PROG NUCLEIC ACID RE, V29, P245, DOI 10.1016/S0079-6603(08)60452-3; COLEMAN TR, 1994, CURR OPIN CELL BIOL, V6, P877, DOI 10.1016/0955-0674(94)90060-4; Consiglio AL, 2010, REPROD DOMEST ANIM, V45, pe313, DOI 10.1111/j.1439-0531.2009.01565.x; De Avezedo WF, 1997, EUR J BIOCHEM, V243, P518; De Smedt V, 2002, J BIOL CHEM, V277, P28592, DOI 10.1074/jbc.M202742200; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; DING JC, 1994, MOL REPROD DEV, V39, P30, DOI 10.1002/mrd.1080390106; Fujii W, 2011, BIOL REPROD, V85, P1124, DOI 10.1095/biolreprod.111.091801; Gosden R, 1997, BIOESSAYS, V19, P875, DOI 10.1002/bies.950191007; Han D, 2012, THERIOGENOLOGY, V77, P1900, DOI 10.1016/j.theriogenology.2012.01.008; Hyttel P, 1997, THERIOGENOLOGY, V47, P23, DOI 10.1016/S0093-691X(96)00336-6; Jimenez-Macedo AR, 2006, THERIOGENOLOGY, V65, P1769, DOI 10.1016/j.theriogenology.2005.10.012; Kaldis P, 1998, MOL BIOL CELL, V9, P2545, DOI 10.1091/mbc.9.9.2545; Kikuchi K, 2000, BIOL REPROD, V63, P715, DOI 10.1095/biolreprod63.3.715; Le Beux G, 2003, THERIOGENOLOGY, V60, P1049, DOI 10.1016/S0093-691X(03)00124-9; LEVESQUE JT, 1995, MOL REPROD DEV, V42, P114, DOI 10.1002/mrd.1080420115; Lonergan P, 1997, J REPROD FERTIL, V109, P355, DOI 10.1530/jrf.0.1090355; Marchal R, 2001, MOL REPROD DEV, V60, P65, DOI 10.1002/mrd.1062; Nagahara H, 1999, P NATL ACAD SCI USA, V96, P14961, DOI 10.1073/pnas.96.26.14961; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Oh JS, 2010, J CELL BIOL, V188, P199, DOI 10.1083/jcb.200907161; Ponderato N, 2001, MOL REPROD DEV, V60, P579, DOI 10.1002/mrd.1123; Sakaguchi M, 2002, REPRODUCTION, V123, P135, DOI 10.1530/rep.0.1230135; Sakaguchi M, 2000, THERIOGENOLOGY, V54, P1327, DOI 10.1016/S0093-691X(00)00439-8; Sirard MA, 2007, THERIOGENOLOGY, V68, pS71, DOI 10.1016/j.theriogenology.2007.05.053; Sirard MA, 1996, ANIM REPROD SCI, V42, P417, DOI 10.1016/0378-4320(96)01518-7; Sirard MA, 1998, THERIOGENOLOGY, V49, P483, DOI 10.1016/S0093-691X(97)00420-2; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; Stricker SA, 2010, MAR DRUGS, V8, P2417, DOI 10.3390/md8082417; Trounson A, 1998, HUM REPROD, V13, P52, DOI 10.1093/humrep/13.suppl_3.52; Tsuji T, 2012, MOL REPROD DEV, V79, P795, DOI 10.1002/mrd.22114; Vigneron C, 2004, MOL REPROD DEV, V69, P457, DOI 10.1002/mrd.20172; Wang YK, 2013, ENDOCRINOLOGY, V154, P3401, DOI 10.1210/en.2013-1133; Witters LA, 1990, CURR OPIN CELL BIOL, V2, P212, DOI 10.1016/0955-0674(90)90009-4; Zhang DX, 2011, J REPROD DEVELOP, V57, P49, DOI 10.1262/jrd.10-087H	39	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103838	10.1371/journal.pone.0103838	http://dx.doi.org/10.1371/journal.pone.0103838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078078	gold, Green Published, Green Submitted			2022-12-25	WOS:000339954800087
J	Normark, J; Nelson, M; Engstrom, P; Andersson, M; Bjork, R; Moritz, T; Fahlgren, A; Bergstrom, S				Normark, Johan; Nelson, Maria; Engstrom, Patrik; Andersson, Marie; Bjork, Rafael; Moritz, Thomas; Fahlgren, Anna; Bergstrom, Sven			Maladjusted Host Immune Responses Induce Experimental Cerebral Malaria-Like Pathology in a Murine Borrelia and Plasmodium Co-Infection Model	PLOS ONE			English	Article							REGULATORY T-CELLS; BORNE RELAPSING FEVER; ANTIGEN PRESENTATION; DENDRITIC CELLS; NITRIC-OXIDE; BLOOD-STAGE; CONCOMITANT INFECTION; UP-REGULATION; IFN-GAMMA; IN-VIVO	In the Plasmodium infected host, a balance between pro- and anti-inflammatory responses is required to clear the parasites without inducing major host pathology. Clinical reports suggest that bacterial infection in conjunction with malaria aggravates disease and raises both mortality and morbidity in these patients. In this study, we investigated the immune responses in BALB/c mice, co-infected with Plasmodium berghei NK65 parasites and the relapsing fever bacterium Borrelia duttonii. In contrast to single infections, we identified in the co-infected mice a reduction of L-Arginine levels in the serum. It indicated diminished bioavailability of NO, which argued for a dysfunctional endothelium. Consistent with this, we observed increased sequestration of CD8+ cells in the brain as well over expression of ICAM-1 and VCAM by brain endothelial cells. Co-infected mice further showed an increased inflammatory response through IL-1 beta and TNF-alpha, as well as inability to down regulate the same through IL-10. In addition we found loss of synchronicity of pro- and anti-inflammatory signals seen in dendritic cells and macrophages, as well as increased numbers of regulatory T-cells. Our study shows that a situation mimicking experimental cerebral malaria (ECM) is induced in co-infected mice due to loss of timing and control over regulatory mechanisms in antigen presenting cells.	[Normark, Johan; Nelson, Maria; Engstrom, Patrik; Andersson, Marie; Fahlgren, Anna; Bergstrom, Sven] Umea Univ, Dept Mol Biol, Umea, Sweden; [Normark, Johan; Engstrom, Patrik; Bergstrom, Sven] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Normark, Johan; Nelson, Maria; Engstrom, Patrik; Fahlgren, Anna; Bergstrom, Sven] Umea Univ, Umea Ctr Microbial Res, Umea, Sweden; [Normark, Johan] Umea Univ, Dept Clin Microbiol, Div Infect Dis, Umea, Sweden; [Engstrom, Patrik] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bjork, Rafael] Umea Univ, Dept Math & Math Stat, Umea, Sweden; [Moritz, Thomas] Swedish Univ Agr Sci SLU, Umea Plant Sci Ctr, Umea, Sweden	Umea University; Umea University; Umea University; Umea University; University of California System; University of California Berkeley; Umea University; Swedish University of Agricultural Sciences; Umea University	Normark, J (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	johan.normark@molbiol.umu.se		Moritz, Thomas/0000-0002-4258-3190	Swedish Research Council [07922]; Jeansson foundations	Swedish Research Council(Swedish Research CouncilEuropean Commission); Jeansson foundations	This work was supported by Swedish Research Council grants to SB and JN, grant number 07922. JN was also supported by the Jeansson foundations (http://www.jeanssonsstiftelser.se). The authors have no conflicting financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alugupalli KR, 2003, J IMMUNOL, V170, P3819, DOI 10.4049/jimmunol.170.7.3819; Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Barbour AG, 2001, INFECT IMMUN, V69, P1009, DOI 10.1128/IAI.69.2.1009-1015.2001; Barbour AG, 2006, P NATL ACAD SCI USA, V103, P18290, DOI 10.1073/pnas.0605302103; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Belnoue E, 2008, PARASITE IMMUNOL, V30, P544, DOI 10.1111/j.1365-3024.2008.01053.x; Berger SA, 2005, AM J TROP MED HYG, V73, P207, DOI 10.4269/ajtmh.2005.73.207; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Carroll RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013124; Coban C, 2007, TRENDS MICROBIOL, V15, P271, DOI 10.1016/j.tim.2007.04.003; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Dai QY, 2006, MOL MICROBIOL, V60, P1329, DOI 10.1111/j.1365-2958.2006.05177.x; Dickinson GS, 2010, INFECT IMMUN, V78, P4579, DOI 10.1128/IAI.00438-10; Egima CM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-90; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; Goncalves RM, 2010, INFECT IMMUN, V78, P4763, DOI 10.1128/IAI.00578-10; Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Jankovic D, 2001, CURR OPIN IMMUNOL, V13, P403, DOI 10.1016/S0952-7915(00)00234-X; Knowles SCL, 2011, INT J PARASITOL, V41, P1041, DOI 10.1016/j.ijpara.2011.05.009; Koram KA, 2007, AM J TROP MED HYG, V77, P1; Larsson C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000522; Lundie RJ, 2010, EUR J IMMUNOL, V40, P1674, DOI 10.1002/eji.200939265; Lundqvist J, 2010, INFECT IMMUN, V78, P1924, DOI 10.1128/IAI.01082-09; Ma NL, 1996, AM J PATHOL, V149, P1745; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; McCarty MF, 2004, MED HYPOTHESES, V63, P699, DOI 10.1016/j.mehy.2002.11.008; McConnell J, 2003, LANCET INFECT DIS, V3, P604, DOI 10.1016/S1473-3099(03)00787-4; Millington Owain R, 2006, J Biol, V5, P5, DOI 10.1186/jbiol34; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nacher M, 2001, AM J TROP MED HYG, V65, P834, DOI 10.4269/ajtmh.2001.65.834; NEWMAN K, 1984, INFECT IMMUN, V45, P572, DOI 10.1128/IAI.45.3.572-576.1984; Niikura M, 2008, J IMMUNOL, V180, P6877, DOI 10.4049/jimmunol.180.10.6877; Niikura M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/383962; Nordstrand A, 2007, EMERG INFECT DIS, V13, P117, DOI 10.3201/eid1301.060670; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Pino PA, 2011, JOVE-J VIS EXP, DOI 10.3791/2348; Ramos TN, 2013, J BIOL CHEM, V288, P10962, DOI 10.1074/jbc.C113.457028; Serirom S, 2003, AM J PATHOL, V162, P1651, DOI 10.1016/S0002-9440(10)64299-X; Singh RP, 2002, J IMMUNOL, V168, P4674, DOI 10.4049/jimmunol.168.9.4674; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; Spence PJ, 2012, CURR OPIN IMMUNOL, V24, P444, DOI 10.1016/j.coi.2012.05.003; Spiegel A, 2003, T ROY SOC TROP MED H, V97, P198, DOI 10.1016/S0035-9203(03)90117-9; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; TRAPE JF, 1991, LANCET, V337, P473, DOI 10.1016/0140-6736(91)93404-W; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; Vial L, 2006, LANCET, V368, P37, DOI 10.1016/S0140-6736(06)68968-X; Villegas-Mendez A, 2012, J IMMUNOL, V189, P968, DOI 10.4049/jimmunol.1200688; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; Wammes LJ, 2010, EUR J IMMUNOL, V40, P437, DOI 10.1002/eji.200939699; WHITE NJ, 1992, ADV PARASIT, V31, P83, DOI 10.1016/S0065-308X(08)60021-4; WHO, 2010, GUID TREATM MAL, V2nd; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729	58	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103295	10.1371/journal.pone.0103295	http://dx.doi.org/10.1371/journal.pone.0103295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075973	Green Submitted, Green Published, gold			2022-12-25	WOS:000340028800036
J	Ullal-Gupta, S; Hannon, EE; Snyder, JS				Ullal-Gupta, Sangeeta; Hannon, Erin E.; Snyder, Joel S.			Tapping to a Slow Tempo in the Presence of Simple and Complex Meters Reveals Experience-Specific Biases for Processing Music	PLOS ONE			English	Article							OTHER-RACE FACES; SENSORIMOTOR SYNCHRONIZATION; OWN-RACE; RHYTHM PERCEPTION; ADULTS; SEQUENCES; PATTERNS; INFANTS; DISCRIMINATION; ENCULTURATION	Musical meters vary considerably across cultures, yet relatively little is known about how culture-specific experience influences metrical processing. In Experiment 1, we compared American and Indian listeners' synchronous tapping to slow sequences. Inter-tone intervals contained silence or to-be-ignored rhythms that were designed to induce a simple meter (familiar to Americans and Indians) or a complex meter (familiar only to Indians). A subset of trials contained an abrupt switch from one rhythm to another to assess the disruptive effects of contradicting the initially implied meter. In the unfilled condition, both groups tapped earlier than the target and showed large tap-tone asynchronies (measured in relative phase). When inter-tone intervals were filled with simple-meter rhythms, American listeners tapped later than targets, but their asynchronies were smaller and declined more rapidly. Likewise, asynchronies rose sharply following a switch away from simple-meter but not from complex-meter rhythm. By contrast, Indian listeners performed similarly across all rhythm types, with asynchronies rapidly declining over the course of complex-and simple-meter trials. For these listeners, a switch from either simple or complex meter increased asynchronies. Experiment 2 tested American listeners but doubled the duration of the synchronization phase prior to (and after) the switch. Here, compared with simple meters, complex-meter rhythms elicited larger asynchronies that declined at a slower rate, however, asynchronies increased after the switch for all conditions. Our results provide evidence that ease of meter processing depends to a great extent on the amount of experience with specific meters.	[Ullal-Gupta, Sangeeta; Hannon, Erin E.; Snyder, Joel S.] Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Hannon, EE (corresponding author), Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA.	erin.hannon@unlv.edu	Snyder, Joel S/B-4675-2008	Snyder, Joel S/0000-0002-5565-3063	International Programs Office, University of Nevada, Las Vegas; College of Liberal Arts at the University of Nevada Las Vegas	International Programs Office, University of Nevada, Las Vegas; College of Liberal Arts at the University of Nevada Las Vegas	The research was supported in part by a travel grant from the International Programs Office, University of Nevada, Las Vegas awarded to S.U. and summer research stipends from the College of Liberal Arts at the University of Nevada Las Vegas awarded to E.E.H. and J.S.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Batschelet E, 1981, CIRCULAR STAT BIOL; Bird J, 2012, NEWNES ENG SCI POCKE; Clayton M., 2000, TIME INDIAN MUSIC RH; COLLIER GL, 1995, J EXP PSYCHOL HUMAN, V21, P602, DOI 10.1037/0096-1523.21.3.602; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; ESSENS PJ, 1986, PERCEPT PSYCHOPHYS, V40, P69, DOI 10.3758/BF03208185; ESSENS PJ, 1985, PERCEPT PSYCHOPHYS, V37, P1, DOI 10.3758/BF03207132; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fitch WT, 2007, MUSIC PERCEPT, V25, P43, DOI 10.1525/mp.2007.25.1.43; Flege JE, 1997, J PHONETICS, V25, P437, DOI 10.1006/jpho.1997.0052; Fraisse P., 1982, PSYCHOL MUSIC, V1, P149, DOI [DOI 10.1016/B978-0-12-213562-0.50010-3, 10.1016/B978-0-12-213562-0.50010-3]; GETTY DJ, 1976, PERCEPT PSYCHOPHYS, V20, P191, DOI 10.3758/BF03198600; Grondin S, 2004, CAN J EXP PSYCHOL, V58, P1, DOI 10.1037/h0087436; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Grondin S, 1999, J EXP PSYCHOL HUMAN, V25, P993, DOI 10.1037/0096-1523.25.4.993; Hannon EE, 2005, P NATL ACAD SCI USA, V102, P12639, DOI 10.1073/pnas.0504254102; Hannon EE, 2005, PSYCHOL SCI, V16, P48, DOI 10.1111/j.0956-7976.2005.00779.x; Hannon EE, 2007, TRENDS COGN SCI, V11, P466, DOI 10.1016/j.tics.2007.08.008; Hannon EE, 2012, J EXP PSYCHOL HUMAN, V38, P543, DOI 10.1037/a0027225; Hannon EE, 2012, ANN NY ACAD SCI, V1252, P92, DOI 10.1111/j.1749-6632.2012.06466.x; Hannon EE, 2011, DEVELOPMENTAL SCI, V14, P865, DOI 10.1111/j.1467-7687.2011.01036.x; Johnson JJ, 1989, COGNITIVE PSYCHOL, V1, P60, DOI DOI 10.1016/0010-0285(89)90003-0; Kirschner S, 2009, J EXP CHILD PSYCHOL, V102, P299, DOI 10.1016/j.jecp.2008.07.005; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Large EW, 2008, PSYCHOLOGY OF TIME, P189, DOI 10.1016/B978-0-08046-977-5.00006-5; Large EW, 2002, COGNITIVE SCI, V26, P1, DOI 10.1207/s15516709cog2601_1; Large EW, 2002, PSYCHOL RES-PSYCH FO, V66, P3, DOI 10.1007/s004260100069; Lerdahl F., 1983, GENERATIVE THEORY TO; LONDON J, 1995, MUSIC PERCEPT, V13, P59; LONGUETHIGGINS HC, 1984, MUSIC PERCEPT, V1, P424; LYNCH MP, 1995, DEV PSYCHOBIOL, V28, P377, DOI 10.1002/dev.420280704; MATES J, 1994, J COGNITIVE NEUROSCI, V6, P332, DOI 10.1162/jocn.1994.6.4.332; McClelland JL, 2002, PHYSIOL BEHAV, V77, P657, DOI 10.1016/S0031-9384(02)00916-2; McNeill W. H., 1995, KEEPING TOGETHER TIM; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Naimpalli S, 2005, THEORY PRACTICE TABL; Nettl B, 2000, ORIGINS OF MUSIC, P463; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Poppel E, 1971, Stud Gen (Berl), V24, P85; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; Repp BH, 2005, MUSIC PERCEPT, V23, P61, DOI 10.1525/mp.2005.23.1.61; Repp BH, 2003, J MOTOR BEHAV, V35, P355, DOI 10.1080/00222890309603156; Repp Bruno H, 2010, Adv Cogn Psychol, V5, P114, DOI 10.2478/v10053-008-0071-7; Rhodes G, 2006, PSYCHON B REV, V13, P499, DOI 10.3758/BF03193876; Semjen A, 2001, J EXP PSYCHOL HUMAN, V27, P251, DOI 10.1037//0096-1523.27.2.251; Snyder J, 2001, MUSIC PERCEPT, V18, P455, DOI 10.1525/mp.2001.18.4.455; Snyder JS, 2006, MUSIC PERCEPT, V24, P135, DOI 10.1525/mp.2006.24.2.135; TRAINOR LJ, 1992, J EXP PSYCHOL HUMAN, V18, P394, DOI 10.1037/0096-1523.18.2.394; Walker PM, 2003, PERCEPTION, V32, P1117, DOI 10.1068/p5098	51	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102962	10.1371/journal.pone.0102962	http://dx.doi.org/10.1371/journal.pone.0102962			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM7EZ	25075514	Green Published, Green Submitted, gold			2022-12-25	WOS:000340028800022
J	Lima, WF; Vickers, TA; Nichols, J; Li, C; Crooke, ST				Lima, Walt F.; Vickers, Timothy A.; Nichols, Josh; Li, Cheryl; Crooke, Stanley T.			Defining the Factors That Contribute to On-Target Specificity of Antisense Oligonucleotides	PLOS ONE			English	Article							EXON JUNCTION COMPLEX; MESSENGER-RNA; GENE-EXPRESSION; RIBONUCLEASE-H; MOLECULAR-MECHANISMS; SPLICING ENHANCER; PROTEIN; INHIBITION; HYBRIDIZATION; PURIFICATION	To better understand the factors that influence the activity and specificity of antisense oligonucleotides (ASOs), we designed a minigene encoding superoxide dismutase 1 (SOD-1) and cloned the minigene into vectors for T7 transcription of pre-mRNA and splicing in a nuclear extract or for stable integration in cells. We designed a series of ASOs that covered the entire mRNA and determined the binding affinities and activities of the ASOs in a cell-free system and in cells. The mRNA bound known RNA-binding proteins on predicted binding sites in the mRNA. The higher order structure of the mRNA had a significantly greater effect than the RNA-binding proteins on ASO binding affinities as the ASO activities in cells and in the cell-free systems were consistent. We identified several ASOs that exhibited off-target hybridization to the SOD-1 minigene mRNA in the cell-free system. Off-target hybridization occurred only at highly accessible unstructured sites in the mRNA and these interactions were inhibited by both the higher order structure of the mRNA and by RNA-binding proteins. The same off-target hybridization interactions were identified in cells that overexpress E. coli RNase H1. No off-target activity was observed for cells expressing only endogenous human RNase H1. Neither were these off-target heteroduplexes substrates for recombinant human RNase H1 under multiple-turnover kinetics suggesting that the endogenous enzyme functions under similar kinetic parameters in cells and in the cell-free system. These results provide a blueprint for design of more potent and more specific ASOs.	[Lima, Walt F.; Vickers, Timothy A.; Nichols, Josh; Li, Cheryl; Crooke, Stanley T.] Isis Pharmaceut Inc, Carlsbad, CA 92010 USA	Isis Pharmaceuticals Inc	Lima, WF (corresponding author), Isis Pharmaceut Inc, Carlsbad, CA 92010 USA.	wlima@isisph.com			Isis Pharmaceuticals Inc.	Isis Pharmaceuticals Inc.	There are no current funding sources for this study. Isis Pharmaceuticals Inc. provided support in the form of salary for authors Walt F. Lima, Timothy A. Vickers, Josh Nichols, Cheryl Li and Stanley T. Crooke, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdelhaleem M, 2003, GENOMICS, V81, P618, DOI 10.1016/S0888-7543(03)00049-1; Arhin GK, 2002, NUCLEIC ACIDS RES, V30, P1842, DOI 10.1093/nar/30.8.1842; Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; Baughan TD, 2009, HUM MOL GENET, V18, P1600, DOI 10.1093/hmg/ddp076; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; BUSEN W, 1980, J BIOL CHEM, V255, P9434; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Cartegni L, 2003, NAT STRUCT BIOL, V10, P120, DOI 10.1038/nsb887; Chou MY, 1999, MOL CELL BIOL, V19, P69; Crooke ST, 1999, BBA-GENE STRUCT EXPR, V1489, P31, DOI 10.1016/S0167-4781(99)00148-7; Crooke ST, 2001, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, P1; Crooke ST, 2003, BURGERS MED CHEM, V5, P115; EDER PS, 1993, BIOCHIMIE, V75, P123, DOI 10.1016/0300-9084(93)90033-O; Freier S, 2007, ANTISENSE DRUG TECHN, P118; Freier SM, 1997, NUCLEIC ACIDS RES, V25, P4429, DOI 10.1093/nar/25.22.4429; GhisolfiNieto L, 1996, J MOL BIOL, V260, P34, DOI 10.1006/jmbi.1996.0380; Goraczniak R, 2009, NAT BIOTECHNOL, V27, P257, DOI 10.1038/nbt.1525; Hashimoto JG, 2004, BIOTECHNIQUES, V36, P54, DOI 10.2144/04361BM06; ITAYA M, 1991, NUCLEIC ACIDS RES, V19, P4443, DOI 10.1093/nar/19.16.4443; ITAYA M, 1991, MOL GEN GENET, V227, P438, DOI 10.1007/BF00273935; JAMISON SF, 1992, MOL CELL BIOL, V12, P4279, DOI 10.1128/MCB.12.10.4279; KANAYA S, 1992, J BIOL CHEM, V267, P10184; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; Lima WF, 2003, J BIOL CHEM, V278, P14906, DOI 10.1074/jbc.M211279200; Lima WF, 1997, J BIOL CHEM, V272, P626; LIMA WF, 1992, BIOCHEMISTRY-US, V31, P12055, DOI 10.1021/bi00163a013; Mathews DH, 1999, RNA, V5, P1458, DOI 10.1017/S1355838299991148; McKay RA, 1999, J BIOL CHEM, V274, P1715, DOI 10.1074/jbc.274.3.1715; MONIA BP, 1992, J BIOL CHEM, V267, P19954; Monia BP, 1996, P NATL ACAD SCI USA, V93, P15481, DOI 10.1073/pnas.93.26.15481; MONIA BP, 1993, J BIOL CHEM, V268, P14514; Reichert VL, 2002, GENE DEV, V16, P2778, DOI 10.1101/gad.1030602; Rigo F, 2012, NAT CHEM BIOL, V8, P555, DOI [10.1038/nchembio.939, 10.1038/NCHEMBIO.939]; RONG YW, 1990, BIOCHEMISTRY-US, V29, P383, DOI 10.1021/bi00454a012; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; Seth PP, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.34; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Skordis LA, 2003, P NATL ACAD SCI USA, V100, P4114, DOI 10.1073/pnas.0633863100; Swayze E.E., 2007, ANTISENSE DRUG TECHN, P143; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Vickers TA, 2007, NUCLEIC ACIDS RES, V35, P6598, DOI 10.1093/nar/gkm663; Vickers TA, 2006, J IMMUNOL, V176, P3652, DOI 10.4049/jimmunol.176.6.3652; Villemaire J, 2003, J BIOL CHEM, V278, P50031, DOI 10.1074/jbc.M308897200; WAGNER RW, 1993, SCIENCE, V260, P1510, DOI 10.1126/science.7684856; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wu HJ, 2004, J BIOL CHEM, V279, P17181, DOI 10.1074/jbc.M311683200; YANG XM, 1994, P NATL ACAD SCI USA, V91, P6924, DOI 10.1073/pnas.91.15.6924; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939	52	37	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e101752	10.1371/journal.pone.0101752	http://dx.doi.org/10.1371/journal.pone.0101752			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072142	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600007
J	Mills, KL; Kemkemer, R; Rudraraju, S; Garikipati, K				Mills, K. L.; Kemkemer, Ralf; Rudraraju, Shiva; Garikipati, Krishna			Elastic Free Energy Drives the Shape of Prevascular Solid Tumors	PLOS ONE			English	Article							ELLIPSOIDAL INCLUSION; CANCER-CELLS; GROWTH; SPHEROIDS; BREAST; SIZE; STABILITY; PHENOTYPE; TISSUE; FIELD	It is well established that the mechanical environment influences cell functions in health and disease. Here, we address how the mechanical environment influences tumor growth, in particular, the shape of solid tumors. In an in vitro tumor model, which isolates mechanical interactions between cancer tumor cells and a hydrogel, we find that tumors grow as ellipsoids, resembling the same, oft-reported observation of in vivo tumors. Specifically, an oblate ellipsoidal tumor shape robustly occurs when the tumors grow in hydrogels that are stiffer than the tumors, but when they grow in more compliant hydrogels they remain closer to spherical in shape. Using large scale, nonlinear elasticity computations we show that the oblate ellipsoidal shape minimizes the elastic free energy of the tumor-hydrogel system. Having eliminated a number of other candidate explanations, we hypothesize that minimization of the elastic free energy is the reason for predominance of the experimentally observed ellipsoidal shape. This result may hold significance for explaining the shape progression of early solid tumors in vivo and is an important step in understanding the processes underlying solid tumor growth.	[Mills, K. L.; Kemkemer, Ralf] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Kemkemer, Ralf] Reutlingen Univ, Reutlingen, Germany; [Rudraraju, Shiva; Garikipati, Krishna] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Garikipati, Krishna] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA	Max Planck Society; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Mills, KL (corresponding author), Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany.	mills@is.mpg.de; krishna@umich.edu	Mills, Kristen L/D-8864-2011	Mills, Kristen L/0000-0003-0104-4200; Rudraraju, Shiva/0000-0002-8313-0198	Alexander von Humboldt Postdoctoral Research Fellowship; Max Planck Society Postdoctoral Research Fellowship	Alexander von Humboldt Postdoctoral Research Fellowship(Alexander von Humboldt Foundation); Max Planck Society Postdoctoral Research Fellowship	This work was supported by an Alexander von Humboldt Postdoctoral Research Fellowship (KLM) and a Max Planck Society Postdoctoral Research Fellowship (KLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi D, 2011, J MECH PHYS SOLIDS, V59, P863, DOI 10.1016/j.jmps.2010.12.011; Bangerth W, 2007, ACM T MATH SOFTWARE, V33, DOI 10.1145/1268776.1268779; BRENNER MW, 1967, BRIT J CANCER, V21, P1, DOI 10.1038/bjc.1967.1; Bruns T, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.101518; CARLSSON G, 1983, J CANCER RES CLIN, V105, P20, DOI 10.1007/BF00391826; CASCIARI JJ, 1992, J CELL PHYSIOL, V151, P386, DOI 10.1002/jcp.1041510220; CHAPLAIN MAJ, 1993, J MATH BIOL, V31, P431, DOI 10.1007/BF00173886; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Costantini M, 2006, J ULTRAS MED, V25, P649, DOI 10.7863/jum.2006.25.5.649; Dachman AH, 2001, CANCER, V91, P555, DOI 10.1002/1097-0142(20010201)91:3<555::AID-CNCR1034>3.3.CO;2-6; Dassios G, 2012, Q APPL MATH, V70, P1; Demou ZN, 2010, ANN BIOMED ENG, V38, P3509, DOI 10.1007/s10439-010-0097-0; DeWall RJ, 2012, PHYS MED BIOL, V57, P2273, DOI 10.1088/0031-9155/57/8/2273; ESHELBY JD, 1959, PROC R SOC LON SER-A, V252, P561, DOI 10.1098/rspa.1959.0173; ESHELBY JD, 1957, PROC R SOC LON SER-A, V241, P376, DOI 10.1098/rspa.1957.0133; FLORY PJ, 1961, T FARADAY SOC, V57, P829, DOI 10.1039/tf9615700829; FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745; FORNAGE BD, 1989, RADIOLOGY, V172, P671, DOI 10.1148/radiology.172.3.2549564; Garikipati K, 2004, J MECH PHYS SOLIDS, V52, P1595, DOI 10.1016/j.jmps.2004.01.004; Garikipati K, 2001, J COMPUT PHYS, V174, P138, DOI 10.1006/jcph.2001.6884; GREENSPAN HP, 1976, J THEOR BIOL, V56, P229, DOI 10.1016/S0022-5193(76)80054-9; Guth U, 2009, BREAST CANCER RES TR, V116, P257, DOI 10.1007/s10549-008-0115-1; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Koike C, 2002, BRIT J CANCER, V86, P947, DOI 10.1038/sj.bjc.6600158; Landman KA, 2001, IMA J MATH APPL MED, V18, P131; Mills KL, 2011, INT J MATER RES, V102, P889, DOI 10.3139/146.110532; MUELLERKLIESER W, 1987, J CANCER RES CLIN, V113, P101, DOI 10.1007/BF00391431; Mura T, 1987, MICROMECHANICS DEFEC, DOI [10.1007/978-94-009-3489-4, DOI 10.1007/978-94-009-3489-4]; Narayanan H, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194122; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Rudraraju S., 2013, COMPUTER MODELS BIOM, P293, DOI DOI 10.1007/978-94-007-5464-5_21; Samani A, 2003, PHYS MED BIOL, V48, P2183, DOI 10.1088/0031-9155/48/14/310; Shieh AC, 2011, ANN BIOMED ENG, V39, P1379, DOI 10.1007/s10439-011-0252-2; Tse JM, 2012, P NATL ACAD SCI USA, V109, P911, DOI 10.1073/pnas.1118910109; Wapnir IL, 1996, BREAST CANCER RES TR, V41, P15, DOI 10.1007/BF01807032; Weinberg RA, 2007, BIOL CANC; Wilhelm Flugge, 1960, STRESSES SHELLS; Yu HM, 2011, TRENDS CELL BIOL, V21, P47, DOI 10.1016/j.tcb.2010.08.015	40	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103245	10.1371/journal.pone.0103245	http://dx.doi.org/10.1371/journal.pone.0103245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072702	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600033
J	Wranke, A; Heidrich, B; Ernst, S; Serrano, BC; Caruntu, FA; Curescu, MG; Yalcin, K; Gurel, S; Zeuzem, S; Erhardt, A; Luth, S; Papatheodoridis, GV; Bremer, B; Stift, J; Grabowski, J; Kirschner, J; Port, K; Cornberg, M; Falk, CS; Dienes, HP; Hardtke, S; Manns, MP; Yurdaydin, C; Wedemeyer, H				Wranke, Anika; Heidrich, Benjamin; Ernst, Stefanie; Serrano, Beatriz Calle; Caruntu, Florin Alexandru; Curescu, Manuela Gabriela; Yalcin, Kendal; Gurel, Selim; Zeuzem, Stefan; Erhardt, Andreas; Lueth, Stefan; Papatheodoridis, George V.; Bremer, Birgit; Stift, Judith; Grabowski, Jan; Kirschner, Janina; Port, Kerstin; Cornberg, Markus; Falk, Christine S.; Dienes, Hans-Peter; Hardtke, Svenja; Manns, Michael P.; Yurdaydin, Cihan; Wedemeyer, Heiner		HIDIT-2 Study Grp	Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta	PLOS ONE			English	Article							B-VIRUS; LIVER-TRANSPLANTATION; INTERFERON; INFECTION; CHALLENGES; ANTIBODIES; PROFILES; THERAPY; CELLS	Background: Hepatitis delta frequently leads to liver cirrhosis and hepatic decompensation. As treatment options are limited, there is a need for biomarkers to determine disease activity and to predict the risk of disease progression. We hypothesized that anti-HDV IgM could represent such a marker. Methods: Samples of 120 HDV-infected patients recruited in an international multicenter treatment trial (HIDIT-2) were studied. Anti-HDV IgM testing was performed using ETI-DELTA-IGMK-2-assay (DiaSorin). In addition, fifty cytokines, chemokines and angiogenetic factors were measured using multiplex technology (Bio-Plex System). A second independent cohort of 78 patients was studied for the development of liver-related clinical endpoints (decompensation, HCC, liver transplantation or death; median follow up of 3.0 years, range 0.6-12). Results: Anti-HDV IgM serum levels were negative in 18 (15%), low (OD<0.5) in 76 (63%), and high in 26 (22%) patients of the HIDIT-2 cohort. Anti-HDV IgM were significantly associated with histological inflammatory (p<0.01) and biochemical disease activity (ALT, AST p<0.01). HDV replication was independent from anti-HDV IgM, however, low HBV-DNA levels were observed in groups with higher anti-HDV IgM levels (p<0.01). While high IP-10 (CXCL10) levels were seen in greater groups of anti-HDV IgM levels, various other antiviral cytokines were negatively associated with anti-HDV IgM. Associations between anti-HDV IgM and ALT, AST, HBV-DNA were confirmed in the independent cohort. Clinical endpoints occurred in 26 anti-HDV IgM positive patients (39%) but in only one anti-HDV IgM negative individual (9%; p = 0.05). Conclusions: Serum anti-HDV IgM is a robust, easy-to-apply and relatively cheap marker to determine disease activity in hepatitis delta which has prognostic implications. High anti-HDV IgM levels may indicate an activated interferon system but exhausted antiviral immunity.	[Wranke, Anika; Serrano, Beatriz Calle; Bremer, Birgit; Grabowski, Jan; Kirschner, Janina; Port, Kerstin; Cornberg, Markus; Manns, Michael P.; Wedemeyer, Heiner] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Ernst, Stefanie] Hannover Med Sch, Inst Biometry, Hannover, Germany; [Yurdaydin, Cihan] Ankara Univ, Fac Med, TR-06100 Ankara, Turkey; [Caruntu, Florin Alexandru] Inst Boli Infect, Bucharest, Romania; [Curescu, Manuela Gabriela] Spitalul Clin Boli Infect, Timisoara, Romania; [Yalcin, Kendal] Dicle Univ, Fac Med, Diyarbakir, Turkey; [Gurel, Selim] Uludag Univ, Fac Med, Bursa, Turkey; [Zeuzem, Stefan] Goethe Univ Frankfurt, Med Ctr, D-60054 Frankfurt, Germany; [Erhardt, Andreas] Univ Dusseldorf, Dusseldorf, Germany; [Lueth, Stefan] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Papatheodoridis, George V.] Univ Athens, Sch Med, GR-11527 Athens, Greece; [Stift, Judith] Med Univ Vienna, Vienna, Austria; [Falk, Christine S.] Hannover Med Sch, IFB Tx, Inst Transplant Immunol, Hannover, Germany; [Dienes, Hans-Peter; Hardtke, Svenja; Manns, Michael P.; Wedemeyer, Heiner; HIDIT-2 Study Grp] HepNet Study House, Hannover, Germany; [Heidrich, Benjamin; Manns, Michael P.; Wedemeyer, Heiner] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat, Hannover, Germany; [Wedemeyer, Heiner] German Ctr Infect Res DZIF, Partner Side HepNet Study House, Hannover, Germany	Hannover Medical School; Hannover Medical School; Ankara University; Dicle University; Uludag University; Goethe University Frankfurt; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Athens Medical School; National & Kapodistrian University of Athens; Medical University of Vienna; Hannover Medical School; Hannover Medical School; German Center for Infection Research	Wranke, A (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	awranke@freenet.de; Wedemeyer.Heiner@mh-hannover.de	Cornberg, Markus/AAN-6939-2021; Papatheodoridis, George/A-4603-2008; Falk, Christine/Q-4143-2016; Zeuzem, Stefan/AAE-7435-2019	Cornberg, Markus/0000-0002-9141-8001; Papatheodoridis, George/0000-0002-3518-4060; Falk, Christine/0000-0003-1376-7318; Stift, Judith/0000-0001-5334-9343; Caruntu, Florin Alexandru/0000-0001-6103-5336; Luth, Stefan/0000-0001-9946-0960	BMBF; Hannover Medical School, Germany (IFB-Tx) [01E00802]; Roche; Gilead	BMBF(Federal Ministry of Education & Research (BMBF)); Hannover Medical School, Germany (IFB-Tx); Roche(Roche Holding); Gilead(Gilead Sciences)	The study was funded by the BMBF-funded Integrated Research and Treatment Center Transplantation, Hannover Medical School, Germany (IFB-Tx funding number 01E00802, Project 37 (H. Wedemeyer and B. Heidrich)). Roche and Gilead funded the HIDIT-2 study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borghesio E, 1998, HEPATOLOGY, V27, P873, DOI 10.1002/hep.510270334; Colloredo G, 1996, J HEPATOL, V25, P644, DOI 10.1016/S0168-8278(96)80233-9; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; FARCI P, 1986, JAMA-J AM MED ASSOC, V255, P1443, DOI 10.1001/jama.255.11.1443; Grabowski J, 2011, LIVER INT, V31, P1395, DOI 10.1111/j.1478-3231.2011.02593.x; Grabowski J, 2010, DIGEST DIS, V28, P133, DOI 10.1159/000282076; Heidrich B, 2013, CURR INFECT DIS REP, V15, P31, DOI 10.1007/s11908-012-0307-z; Heidrich B, 2012, LIVER INT, V32, P1415, DOI 10.1111/j.1478-3231.2012.02831.x; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jaroszewicz J, 2011, ANTIVIR THER, V16, P915, DOI 10.3851/IMP1866; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Mederacke I, 2012, ANTIVIR THER, V17, P305, DOI 10.3851/IMP1926; Mederacke I, 2010, J CLIN MICROBIOL, V48, P2022, DOI 10.1128/JCM.00084-10; Negro F, 1998, J MED VIROL, V56, P224, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;224::AID-JMV8&gt;3.0.CO;2-9; Nisini R, 1997, J VIROL, V71, P2241, DOI 10.1128/JVI.71.3.2241-2251.1997; Pollicino T, 2011, J VIROL, V85, P432, DOI 10.1128/JVI.01609-10; Raimondo G, 2006, HEPATOLOGY, V43, P100, DOI 10.1002/hep.20944; RIZZETTO M, 1979, LANCET, V2, P986; Rizzetto M, 2010, DIGEST DIS, V28, P139, DOI 10.1159/000282077; Sonneveld MJ, 2013, J HEPATOL, V58, P898, DOI 10.1016/j.jhep.2013.01.029; Wedemeyer H, 2011, NEW ENGL J MED, V364, P322, DOI 10.1056/NEJMoa0912696; Wedemeyer H, 2010, NAT REV GASTRO HEPAT, V7, P31, DOI 10.1038/nrgastro.2009.205; Zachou K, 2010, LIVER INT, V30, P430, DOI 10.1111/j.1478-3231.2009.02140.x	26	32	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e101002	10.1371/journal.pone.0101002	http://dx.doi.org/10.1371/journal.pone.0101002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072849	Green Published, gold			2022-12-25	WOS:000341307600005
J	Chentouf, M; Guzman, C; Hamze, M; Gross, R; Lajoix, AD; Peraldi-Roux, S				Chentouf, Myriam; Guzman, Caroline; Hamze, Moustafa; Gross, Rene; Lajoix, Anne Dominique; Peraldi-Roux, Sylvie			Possible Protective Effect of Membrane Lipid Rafts against Interleukin-1 beta-Mediated Anti-Proliferative Effect in INS-1 Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELL; ENDOPLASMIC-RETICULUM STRESS; NITRIC-OXIDE; ISLET INFLAMMATION; INSULIN-SECRETION; ACTIVATION; APOPTOSIS; ANTIBODY; PATHWAY; KINASE	We recently reported that pancreatic islets from pre-diabetic rats undergo an inflammatory process in which IL-1 beta takes part and controls beta-cell function. In the present study, using the INS-1 rat pancreatic beta-cell line, we investigated the potential involvement of membrane-associated cholesterol-enriched lipid rafts in IL-1 beta signaling and biological effects on insulin secretion, beta-cell proliferation and apoptosis. We show that, INS-1 cells exposure to increasing concentrations of IL-1 beta leads to a progressive inhibition of insulin release, an increase in the number of apoptotic cells and a dose-dependent decrease in pancreatic beta-cell proliferation. Disruption of membrane lipid rafts markedly reduced glucose-stimulated insulin secretion but did not affect either cell apoptosis or proliferation rate, demonstrating that membrane lipid raft integrity is essential for beta-cell secretory function. In the same conditions, IL-1 beta treatment of INS-1 cells led to a slight further decrease in insulin secretion for low concentrations of the cytokine, and a more marked one, similar to that observed in normal cells for higher concentrations. These effects occurred together with an increase in iNOS expression and surprisingly with an upregulation of tryptophane hydroxylase and protein Kinase C in membrane lipid rafts suggesting that compensatory mechanisms develop to counteract IL-1 beta inhibitory effects. We also demonstrate that disruption of membrane lipid rafts did not prevent cytokine-induced cell death recorded after exposure to high IL-1 beta concentrations. Finally, concerning cell proliferation, we bring strong evidence that membrane lipid rafts exert a protective effect against IL-1 beta anti-proliferative effect, possibly mediated at least partly by modifications in ERK and PKB expression/activities. Our results 1) demonstrate that IL-1 beta deleterious effects do not require a cholesterol-dependent plasma membrane compartmentalization of IL-1R1 signaling and 2) confer to membrane lipid rafts integrity a possible protective function that deserves to be considered in the context of inflammation and especially T2D pathogenesis.	[Chentouf, Myriam; Guzman, Caroline; Hamze, Moustafa; Gross, Rene; Lajoix, Anne Dominique; Peraldi-Roux, Sylvie] Univ Montpellier UM1 1, CPID, Fac Pharm, EA 7288, Montpellier, France; [Gross, Rene; Peraldi-Roux, Sylvie] Univ Montpellier UM1 1, CNRS, CPID, Fac Pharm,EA 7288, Montpellier, France	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Peraldi-Roux, S (corresponding author), Univ Montpellier UM1 1, CPID, Fac Pharm, EA 7288, Montpellier, France.	sylvie.roux@univ-montp1.fr			University of Montpellier 1	University of Montpellier 1	The authors received no specific funding for this work. The submitted work was funded by base allocation from the University of Montpellier 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbi S, 2002, HISTOL HISTOPATHOL, V17, P1163, DOI 10.14670/HH-17.1163; AMMALA C, 1994, P NATL ACAD SCI USA, V91, P4343, DOI 10.1073/pnas.91.10.4343; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cai EP, 2012, DIABETES, V61, P1708, DOI 10.2337/db11-1344; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Chauhan D, 1999, ONCOGENE, V18, P6733, DOI 10.1038/sj.onc.1203082; Chentouf M, 2007, J IMMUNOL, V179, P409, DOI 10.4049/jimmunol.179.1.409; Chentouf M, 2010, IMMUNOL LETT, V133, P62, DOI 10.1016/j.imlet.2010.07.003; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Dinarello CA, 2009, BIOL BLOOD MARROW TR, V15, P134, DOI 10.1016/j.bbmt.2008.11.006; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Eizirik DL, 1997, DIABETES METAB REV, V13, P293, DOI 10.1002/(SICI)1099-0895(199712)13:4<293::AID-DMR195>3.0.CO;2-4; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Jiang XC, 2011, MOL CELL BIOL, V31, P4205; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Maedler K, 2006, DIABETES, V55, P2713, DOI 10.2337/db05-1430; Mandrup-Poulsen T, 1998, BMJ-BRIT MED J, V316, P1221, DOI 10.1136/bmj.316.7139.1221; McDaniel ML, 1996, P SOC EXP BIOL MED, V211, P24; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Miani M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.236; Mosen H, 2008, REGUL PEPTIDES, V151, P139, DOI 10.1016/j.regpep.2008.07.002; Muhammed SJ, 2012, DIABETES OBES METAB, V14, P1010, DOI 10.1111/j.1463-1326.2012.01632.x; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Oakley FD, 2009, J BIOL CHEM, V284, P33255, DOI 10.1074/jbc.M109.042127; Ohara-Imaizumi M, 2004, J BIOL CHEM, V279, P8403, DOI 10.1074/jbc.M308954200; Osborn O, 2008, CYTOKINE, V44, P141, DOI 10.1016/j.cyto.2008.07.004; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Rondas D, 2011, DIABETES, V60, P1146, DOI 10.2337/db10-0946; Schumann DM, 2007, P NATL ACAD SCI USA, V104, P2861, DOI 10.1073/pnas.0611487104; Sehgal PB, 2002, J BIOL CHEM, V277, P12067, DOI 10.1074/jbc.M200018200; Somanath S, 2009, BIOCHEM BIOPH RES CO, V389, P241, DOI 10.1016/j.bbrc.2009.08.126; SPINAS GA, 1988, ACTA ENDOCRINOL-COP, V119, P307, DOI 10.1530/acta.0.1190307; Summers SA, 2005, DIABETES, V54, P591, DOI 10.2337/diabetes.54.3.591; Veluthakal R, 2005, DIABETES, V54, P2576, DOI 10.2337/diabetes.54.9.2576; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Vikman J, 2009, FASEB J, V23, P58, DOI 10.1096/fj.08-105734; Wan QF, 2004, J GEN PHYSIOL, V124, P653, DOI 10.1085/jgp.200409082; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200; Xiong WC, 1997, J CELL BIOL, V139, P529, DOI 10.1083/jcb.139.2.529; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066; Zhao J, 2000, J CELL SCI, V113, P4363; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997	51	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102889	10.1371/journal.pone.0102889	http://dx.doi.org/10.1371/journal.pone.0102889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068701	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993700024
J	Verweij, KJH; Abdellaoui, A; Veijola, J; Sebert, S; Koiranen, M; Keller, MC; Jarvelin, MR; Zietsch, BP				Verweij, Karin J. H.; Abdellaoui, Abdel; Veijola, Juha; Sebert, Sylvain; Koiranen, Markku; Keller, Matthew C.; Jarvelin, Marjo-Riitta; Zietsch, Brendan P.			The Association of Genotype-Based Inbreeding Coefficient with a Range of Physical and Psychological Human Traits	PLOS ONE			English	Article							INCREASED RISK; CONSANGUINITY; SCHIZOPHRENIA; POPULATION; HETEROZYGOSITY; HOMOZYGOSITY; DEPRESSION; DISORDER; EGYPT; BODY	Across animal species, offspring of closely related mates exhibit lower fitness, a phenomenon called inbreeding depression. Inbreeding depression in humans is less well understood because mating between close relatives is generally rare and stigmatised, confounding investigation of its effect on fitness-relevant traits. Recently, the availability of high-density genotype data has enabled quantification of variation in distant inbreeding in 'outbred' human populations, but the low variance of inbreeding detected from genetic data in most outbred populations means large samples are required to test effects, and only a few traits have yet been studied. However, it is likely that isolated populations, or those with a small effective population size, have higher variation in inbreeding and therefore require smaller sample sizes to detect inbreeding effects. With a small effective population size and low immigration, Northern Finland is such a population. We make use of a sample of similar to 5,500 'unrelated individuals in the Northern Finnish Birth Cohort 1966 with known genotypes and measured phenotypes across a range of fitness-relevant physical and psychological traits, including birth length and adult height, body mass index (BMI), waist-to-hip ratio, blood pressure, heart rate, grip strength, educational attainment, income, marital status, handedness, health, and schizotypal features. We find significant associations in the predicted direction between individuals' inbreeding coefficient (measured by proportion of the genome in runs of homozygosity) and eight of the 18 traits investigated, significantly more than the one or two expected by chance. These results are consistent with inbreeding depression effects on a range of human traits, but further research is needed to replicate and test alternative explanations for these effects.	[Verweij, Karin J. H.; Zietsch, Brendan P.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Verweij, Karin J. H.; Abdellaoui, Abdel] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Veijola, Juha] Univ Oulu, Dept Psychiat, Oulu, Finland; [Veijola, Juha] Oulu Univ Hosp, Oulu, Finland; [Sebert, Sylvain; Koiranen, Markku; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, SF-90100 Oulu, Finland; [Keller, Matthew C.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Keller, Matthew C.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Ctr Environm & Hlth, MRC Hlth Protect Agcy HPA,Dept Epidemiol & Biosta, London SW7 2AZ, England; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Children & Young People & Families, Oulu, Finland; [Zietsch, Brendan P.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia	University of Queensland; Vrije Universiteit Amsterdam; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Imperial College London; University of Oulu; Finland National Institute for Health & Welfare; QIMR Berghofer Medical Research Institute	Zietsch, BP (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	zietsch@psy.uq.edu.au	Zietsch, Brendan/F-7497-2016	Zietsch, Brendan/0000-0003-0274-6140; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Sebert, Sylvain/0000-0001-6681-6983	Academy of Finland [104781, 120315, 129269, 1114194]; University Hospital Oulu, Biocenter, University of Oulu, Finland [75617]; European Commission [QLG1-CT-2000-01643]; National Heart, Lung, and Blood Institute [5R01HL087679-02, 1RL1MH083268-01]; National Institutes of Health/National Institute of Mental Health [5R01MH6370602]; Medical Research Council, UK [G0500539, G0600705]; Wellcome Trust [GR069224]; UK, ENGAGE project [HEALTH-F4-2007201413]; Biocentrum Helsinki; Australian Research Council [DE120100562]; Neuroscience Campus Amsterdam; Centre for Medical Systems Biology; Biobanking and Biomolecular Resources Research Infrastructure NL; NIMH [K01 MH085812, NIMH R01 MH100141]; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706, RL1MH083268, K01MH085812, R01MH100141] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); University Hospital Oulu, Biocenter, University of Oulu, Finland; European Commission(European CommissionEuropean Commission Joint Research Centre); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health/National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UK, ENGAGE project; Biocentrum Helsinki; Australian Research Council(Australian Research Council); Neuroscience Campus Amsterdam; Centre for Medical Systems Biology; Biobanking and Biomolecular Resources Research Infrastructure NL; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Financial support for the Northern Finland Birth Cohort 1966 (NFBC1966) was received from the Academy of Finland (project grants 104781, 120315, 129269, 1114194, Center of Excellence in Complex Disease Genetics and SALVE); University Hospital Oulu, Biocenter, University of Oulu, Finland (75617); the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643); National Heart, Lung, and Blood Institute grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01); National Institutes of Health/National Institute of Mental Health (5R01MH6370602); the Medical Research Council, UK (G0500539, G0600705, PrevMetSyn/SALVE); and the Wellcome Trust (project grant GR069224), UK, ENGAGE project and grant agreement HEALTH-F4-2007201413. The DNA extractions, sample quality controls, biobank upkeep and aliquotting was performed in the National Public Health Institute, Biomedicum Helsinki, Finland and supported financially by the Academy of Finland and Biocentrum Helsinki. KJHV and BPZ are supported by a Discovery Early Career Research Award (DE120100562) from the Australian Research Council (to BPZ). AA is supported by Neuroscience Campus Amsterdam, Centre for Medical Systems Biology, and Biobanking and Biomolecular Resources Research Infrastructure NL. MCK is supported by NIMH grants K01 MH085812 & NIMH R01 MH100141. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellaoui A, ED ATTAINMENT UNPUB; AFZAL M, 1988, BEHAV GENET, V18, P583, DOI 10.1007/BF01082310; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037/0021-843X.85.4.374; CHAPMAN LJ, 1978, J ABNORM PSYCHOL, V87, P399, DOI 10.1037/0021-843X.87.4.399; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; DeRose MA, 1999, EVOLUTION, V53, P1288, DOI 10.2307/2640831; Hovatta I, 1997, AM J MED GENET, V74, P353, DOI 10.1002/(SICI)1096-8628(19970725)74:4<353::AID-AJMG3>3.3.CO;2-I; Howrigan DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-460; Keller MC, 2012, PLOS GENET, V8, P425, DOI 10.1371/journal.pgen.1002656; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; KENDLER KS, 1995, AM J PSYCHIAT, V152, P749; LEBEL RR, 1989, AM J MED GENET, V33, P1, DOI 10.1002/ajmg.1320330102; Mansour H, 2010, SCHIZOPHR RES, V120, P108, DOI 10.1016/j.schres.2010.03.026; Mansour H, 2009, AM J MED GENET B, V150B, P879, DOI 10.1002/ajmg.b.30913; McQuillan R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002655; MORTON NE, 1978, P NATL ACAD SCI USA, V75, P3906, DOI 10.1073/pnas.75.8.3906; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Power RA, 2014, AM J MED GENET B, V165, P157, DOI 10.1002/ajmg.b.32217; Power RA, 2014, EUR J HUM GENET, V22, P386, DOI 10.1038/ejhg.2013.155; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rantakallio P, 1969, PAEDIAT SCAND S, V193, P43; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Rudan I, 2003, GENETICS, V163, P1011; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; SHAMI SA, 1991, LANCET, V338, P954, DOI 10.1016/0140-6736(91)91828-I; Singh D, 2010, EVOL HUM BEHAV, V31, P176, DOI 10.1016/j.evolhumbehav.2009.09.001; Stulp G, 2013, PERS INDIV DIFFER, V54, P877, DOI 10.1016/j.paid.2012.12.019; Verweij KJH, 2012, EVOLUTION, V66, P3238, DOI 10.1111/j.1558-5646.2012.01679.x; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; YEO RA, 1993, PSYCHOBIOLOGY, V21, P161	33	16	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103102	10.1371/journal.pone.0103102	http://dx.doi.org/10.1371/journal.pone.0103102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	25062308	Green Published, gold			2022-12-25	WOS:000339992600033
J	Higashi, K; Asano, K; Yagi, M; Yamada, K; Arakawa, T; Ehashi, T; Mori, T; Sumida, K; Kushida, M; Ando, S; Kinoshita, M; Kakehi, K; Tachibana, T; Saito, K				Higashi, Kiyoshi; Asano, Kouji; Yagi, Masaki; Yamada, Keita; Arakawa, Tatsuhiko; Ehashi, Tomo; Mori, Takashi; Sumida, Kayo; Kushida, Masahiko; Ando, Satoshi; Kinoshita, Mitsuhiro; Kakehi, Kazuaki; Tachibana, Taro; Saito, Koichi			Expression of the Clustered NeuAc alpha 2-3Gal beta O-Glycan Determines the Cell Differentiation State of the Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; COLON-CANCER CELLS; GENE-EXPRESSION; PLURIPOTENCY; INHIBITOR; TRA-1-60; SURFACE; IDENTIFICATION; PODOCALYXIN; ANTIBODIES	Human embryonic stem cells (hESCs) are pluripotent stem cells from early embryos, and their self-renewal capacity depends on the sustained expression of hESC-specific molecules and the suppressed expression of differentiation-associated genes. To discover novel molecules expressed on hESCs, we generated a panel of monoclonal antibodies against undifferentiated hESCs and evaluated their ability to mark cancer cells, as well as hESCs. MAb7 recognized undifferentiated hESCs and showed a diffuse band with molecular mass of > 239 kDa in the lysates of hESCs. Although some amniotic epithelial cells expressed MAb7 antigen, its expression was barely detected in normal human keratinocytes, fibroblasts, or endothelial cells. The expression of MAb7 antigen was observed only in pancreatic and gastric cancer cells, and its levels were elevated in metastatic and poorly differentiated cancer cell lines. Analyses of MAb7 antigen suggested that the clustered NeuAc alpha 2-3Gal beta O-linked oligosaccharides on DMBT1 (deleted in malignant brain tumors 1) were critical for MAb7 binding in cancer cells. Although features of MAb7 epitope were similar with those of TRA-1-60, distribution of MAb7 antigen in cancer cells was different from that of TRA-1-60 antigen. Exposure of a histone deacetylase inhibitor to differentiated gastric cancer MKN74 cells evoked the expression of MAb7 antigen, whereas DMBT1 expression remained unchanged. Cell sorting followed by DNA microarray analyses identified the down-regulated genes responsible for the biosynthesis of MAb7 antigen in MKN74 cells. In addition, treatment of metastatic pancreatic cancer cells with MAb7 significantly abrogated the adhesion to endothelial cells. These results raised the possibility that MAb7 epitope is a novel marker for undifferentiated cells such as hESCs and cancer stem-like cells and plays a possible role in the undifferentiated cells.	[Higashi, Kiyoshi; Asano, Kouji; Ehashi, Tomo; Mori, Takashi; Sumida, Kayo; Kushida, Masahiko; Ando, Satoshi; Saito, Koichi] Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Osaka 5548558, Japan; [Yagi, Masaki; Arakawa, Tatsuhiko; Tachibana, Taro] Osaka City Univ, Grad Sch Engn, Dept Bioengn, Osaka 5588585, Japan; [Yamada, Keita] Osaka Ohtani Univ, Toxicol Lab, Fac Pharm, Tondabaya, Osaka 5848540, Japan; [Kinoshita, Mitsuhiro; Kakehi, Kazuaki] Kinki Univ, Sch Pharm, Higashiosaka, Osaka 5778502, Japan	Sumitomo Chem Co Ltd; Osaka Metropolitan University; Kindai University (Kinki University)	Higashi, K (corresponding author), Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Konohana Ku, 1-98,Kasugadenaka 3 Chome, Osaka 5548558, Japan.	higashik2@sc.sumitomo-chem.co.jp	EHASHI, Tomo/H-4817-2016	Saito, Koichi/0000-0001-6497-5286; Asano, Koji/0000-0001-5873-8161; HIGASHI, KIYOSHI/0000-0003-3577-0526				Alisson-Silva F, 2014, GLYCOBIOLOGY, V24, P458, DOI 10.1093/glycob/cwu012; Dimitroff CJ, 1999, BIOCHEM BIOPH RES CO, V256, P631, DOI 10.1006/bbrc.1999.0388; Evron Ayelet, 2011, Int J Stem Cells, V4, P123; Fong CY, 2009, STEM CELL REV REP, V5, P72, DOI 10.1007/s12015-009-9054-4; Foster MM, 2003, CANCER RES, V63, P2775; Grewal PK, 2005, GLYCOBIOLOGY, V15, P912, DOI 10.1093/glycob/cwi094; Gu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015795; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; HARVEY BE, 1992, CANCER RES, V52, P1775; Hasegawa M, 2009, ARTHRITIS RHEUM-US, V60, P3465, DOI 10.1002/art.24934; Higashi K, 2012, FEBS LETT, V586, P2300, DOI 10.1016/j.febslet.2012.06.022; Higashi K, 2011, J BIOL CHEM, V286, P4485, DOI 10.1074/jbc.M110.151936; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hombach-Klonisch S, 2008, J MOL MED, V86, P1301, DOI 10.1007/s00109-008-0383-6; HOYER LL, 1991, J BIOCHEM-TOKYO, V110, P462, DOI 10.1093/oxfordjournals.jbchem.a123603; Hustinx SR, 2004, CANCER BIOL THER, V3, P1254, DOI 10.4161/cbt.3.12.1238; IKEDA Y, 1990, JPN J CANCER RES, V81, P987, DOI 10.1111/j.1349-7006.1990.tb03336.x; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Lee EJ, 2008, INT J ONCOL, V33, P767, DOI 10.3892/ijo_00000063; Leppanen A, 2002, J BIOL CHEM, V277, P39749, DOI 10.1074/jbc.M206281200; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Natunen S, 2011, GLYCOBIOLOGY, V21, P1125, DOI 10.1093/glycob/cwq209; Ogawa S, 2013, DEVELOPMENT, V140, P3285, DOI 10.1242/dev.090266; Sassetti C, 1998, J EXP MED, V187, P1965, DOI 10.1084/jem.187.12.1965; Schopperle WM, 2007, STEM CELLS, V25, P723, DOI 10.1634/stemcells.2005-0597; Schulz BL, 2002, BIOCHEM J, V366, P511, DOI 10.1042/BJ20011876; Serrano L, 2013, EXP BIOL MED, V238, P259, DOI 10.1177/1535370213480718; Suzuki N, 2011, J TOXICOL SCI, V36, P569; Tomao F, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-48; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Wang SK, 2008, P NATL ACAD SCI USA, V105, P3690, DOI 10.1073/pnas.0712326105; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yamada K, 2013, ANAL CHEM, V85, P3325, DOI 10.1021/ac303771q; Yamada K, 2010, ANAL BIOCHEM, V396, P161, DOI 10.1016/j.ab.2009.08.021; Yamada K, 2009, J PROTEOME RES, V8, P521, DOI 10.1021/pr800710f; Yokoyama C, 2010, HYBRIDOMA, V29, P53, DOI 10.1089/hyb.2009.0101; Zhao WX, 2012, MOLECULES, V17, P6196, DOI 10.3390/molecules17066196	40	8	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25833	25843		10.1074/jbc.M114.550848	http://dx.doi.org/10.1074/jbc.M114.550848			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074924	Green Published, hybrid			2022-12-25	WOS:000342130800040
J	De Houwer, S; Demeulemeester, J; Thys, W; Rocha, S; Dirix, L; Gijsbers, R; Christ, F; Debyser, Z				De Houwer, Stephanie; Demeulemeester, Jonas; Thys, Wannes; Rocha, Susana; Dirix, Lieve; Gijsbers, Rik; Christ, Frauke; Debyser, Zeger			The HIV-1 Integrase Mutant R263A/K264A Is 2-fold Defective for TRN-SR2 Binding and Viral Nuclear Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TERMINAL DOMAIN; TRANSPORTIN 3; INFECTION; REPLICATION; DNA; TNPO3; IDENTIFICATION; COMPLEX; PROTEIN	Transportin-SR2 (Tnpo3, TRN-SR2), a human karyopherin encoded by the TNPO3 gene, has been identified as a cellular cofactor of HIV-1 replication, specifically interacting with HIV-1 integrase (IN). Whether this interaction mediates the nuclear import of HIV remains controversial. We previously characterized the TRN-SR2 binding interface in IN and introduced mutations at these positions to corroborate the biological relevance of the interaction. The pleiotropic nature of IN mutations complicated the interpretation. Indeed, all previously tested IN interaction mutants also affected RT. Here we report on a virus with a pair of IN mutations, INR263A/K264A, that significantly reduce interaction with TRN-SR2. The virus retains wild-type reverse transcription activity but displays a block in nuclear import and integration, as measured by quantitative PCR. The defect in integration of this mutant resulted in a smaller increase in the number of two-long terminal repeat circles than for virus specifically blocked at integration by raltegravir or catalytic site mutations (IND64N/D116N/E152Q). Finally, using an eGFP-IN-labeled HIV fluorescence-based import assay, the defect in nuclear import was corroborated. These data altogether underscore the importance of the HIV-IN TRN-SR2 protein-protein interaction for HIV nuclear import and validate the IN/TRN-SR2 interaction interface as a promising target for future antiviral therapy.	[De Houwer, Stephanie; Demeulemeester, Jonas; Thys, Wannes; Rocha, Susana; Dirix, Lieve; Gijsbers, Rik; Christ, Frauke; Debyser, Zeger] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Virol & Gene Therapy, B-3000 Leuven, Belgium	KU Leuven	Debyser, Z (corresponding author), Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Virol & Gene Therapy, B-3000 Leuven, Belgium.	zeger.debyser@med.kuleuven.be	Christ, Frauke/H-7513-2018; Rocha, Susana/O-7622-2016; Demeulemeester, Jonas/J-6130-2014; Rocha, Susana/AAH-8343-2020; debyser, zeger/H-1310-2013	Rocha, Susana/0000-0003-1258-9396; Demeulemeester, Jonas/0000-0002-2660-2478; Rocha, Susana/0000-0003-1258-9396; Christ, Frauke/0000-0001-9580-3874; debyser, zeger/0000-0002-3982-1565	Research Foundation Flanders [G.0487.10N]; IAP BelVir; FP7 CHAARM; KU Leuven BOF	Research Foundation Flanders(FWO); IAP BelVir; FP7 CHAARM; KU Leuven BOF	This work was supported by Grant G.0487.10N from the Research Foundation Flanders and grants from the IAP BelVir, FP7 CHAARM, and the KU Leuven BOF.	Albanese A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002413; Ambrose Z, 2012, J VIROL, V86, P4708, DOI 10.1128/JVI.05887-11; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Ao ZJ, 2010, J VIROL, V84, P8650, DOI 10.1128/JVI.00508-10; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; BROWN PO, 1987, CELL, V49, P347, DOI 10.1016/0092-8674(87)90287-X; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cereseto A, 2005, EMBO J, V24, P3070, DOI 10.1038/sj.emboj.7600770; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Cribier A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-104; De Houwer S, 2012, J BIOL CHEM, V287, P34059, DOI 10.1074/jbc.M112.387944; De Iaco A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-20; De Iaco A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-98; De Rijck J, 2007, BIOESSAYS, V29, P441, DOI 10.1002/bies.20561; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; Debyser Z, 2000, METH MOL B, V160, P139; DRELICH M, 1992, VIROLOGY, V188, P459, DOI 10.1016/0042-6822(92)90499-F; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Fricke T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-46; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Hearps AC, 2006, BIOCHEM J, V398, P475, DOI 10.1042/BJ20060466; Jayappa KD, 2011, J MOL BIOL, V410, P847, DOI 10.1016/j.jmb.2011.04.011; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Larue R, 2012, J BIOL CHEM, V287, P34044, DOI 10.1074/jbc.M112.384669; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; Li X, 2012, J VIROL, V86, P3861, DOI 10.1128/JVI.06386-11; Logue EC, 2011, J VIROL, V85, P12950, DOI 10.1128/JVI.05384-11; Lu R, 2005, J VIROL, V79, P10356, DOI 10.1128/JVI.79.16.10356-10368.2005; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maertens GN, 2014, P NATL ACAD SCI USA, V111, P2728, DOI 10.1073/pnas.1320755111; Mohammed KD, 2011, J VIROL, V85, P4654, DOI 10.1128/JVI.02374-10; Nakajima N, 2001, J VIROL, V75, P7944, DOI 10.1128/JVI.75.17.7944-7955.2001; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Piller SC, 2003, CURR DRUG TARGETS, V4, P409, DOI 10.2174/1389450033490984; Price AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002896; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Shah VB, 2013, J VIROL, V87, P422, DOI 10.1128/JVI.07177-11; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Taltynov O, 2013, J BIOL CHEM, V288, P25603, DOI 10.1074/jbc.M113.484345; Thys W, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-7; Tsirkone VG, 2014, ACTA CRYSTALLOGR F, V70, P723, DOI 10.1107/S2053230X14009492; Valle-Casuso JC, 2012, J VIROL, V86, P5931, DOI 10.1128/JVI.00451-12; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; WEINBERG JB, 1991, J EXP MED, V174, P1477, DOI 10.1084/jem.174.6.1477; Yamashita M, 2005, PLOS PATHOG, V1, P170, DOI 10.1371/journal.ppat.0010018; Zaitseva L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-11; Zhou LH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002194; Zielske SP, 2005, J VIROL, V79, P11541, DOI 10.1128/JVI.79.17.11541-11546.2005	61	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25351	25361		10.1074/jbc.M113.533281	http://dx.doi.org/10.1074/jbc.M113.533281			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25063804	Green Published, hybrid			2022-12-25	WOS:000341985300053
J	Barez-Lopez, S; Bosch-Garcia, D; Gomez-Andres, D; Pulido-Valdeolivas, I; Montero-Pedrazuela, A; Obregon, MJ; Guadano-Ferraz, A				Barez-Lopez, Soledad; Bosch-Garcia, Daniel; Gomez-Andres, David; Pulido-Valdeolivas, Irene; Montero-Pedrazuela, Ana; Obregon, Maria Jesus; Guadano-Ferraz, Ana			Abnormal Motor Phenotype at Adult Stages in Mice Lacking Type 2 Deiodinase	PLOS ONE			English	Article							II IODOTHYRONINE DEIODINASE; BROWN ADIPOSE-TISSUE; THYROID-HORMONE; RAT-BRAIN; TARGETED DISRUPTION; INSULIN-RESISTANCE; MENTAL-RETARDATION; MOUSE; GENE; ASSOCIATION	Background: Thyroid hormones have a key role in both the developing and adult central nervous system and skeletal muscle. The thyroid gland produces mainly thyroxine (T4) but the intracellular concentrations of 3,5,3'-triiodothyronine (T3; the transcriptionally active hormone) in the central nervous system and skeletal muscle are modulated by the activity of type 2 deiodinase (D2). To date no neurological syndrome has been associated with mutations in the DIO2 gene and previous studies in young and juvenile D2-knockout mice (D2KO) did not find gross neurological alterations, possibly due to compensatory mechanisms. Aim: This study aims to analyze the motor phenotype of 3-and-6-month-old D2KO mice to evaluate the role of D2 on the motor system at adult stages in which compensatory mechanisms could have failed. Results: Motor abilities were explored by validated tests. In the footprint test, D2KO showed an altered global gait pattern (mice walked slower, with shorter strides and with a hindlimb wider base of support than wild-type mice). No differences were detected in the balance beam test. However, a reduced latency to fall was found in the rotarod, coat-hanger and four limb hanging wire tests indicating impairment on coordination and prehensile reflex and a reduction of muscle strength. In histological analyses of cerebellum and skeletal muscle, D2KO mice did not present gross structural abnormalities. Thyroid hormones levels and deiodinases activities were also determined. In D2KO mice, despite euthyroid T3 and high T4 plasma levels, T3 levels were significantly reduced in cerebral cortex (48% reduction) and skeletal muscle (33% reduction), but not in the cerebellum where other deiodinase (type 1) is expressed. Conclusions: The motor alterations observed in D2KO mice indicate an important role for D2 in T3 availability to maintain motor function and muscle strength. Our results suggest a possible implication of D2 in motor disorders.	[Barez-Lopez, Soledad; Bosch-Garcia, Daniel; Montero-Pedrazuela, Ana; Obregon, Maria Jesus; Guadano-Ferraz, Ana] UAM, CSIC, Inst Invest Biomed Alberto Sols, Dept Endocrine & Nervous Syst Pathophysiol, Madrid, Spain; [Gomez-Andres, David; Pulido-Valdeolivas, Irene] Hosp Univ La Paz, IdiPAZ, Madrid, Spain; [Gomez-Andres, David; Pulido-Valdeolivas, Irene] UAM, Dept Anatomia Histol & Neurociencia, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Universitario La Paz; Autonomous University of Madrid	Guadano-Ferraz, A (corresponding author), UAM, CSIC, Inst Invest Biomed Alberto Sols, Dept Endocrine & Nervous Syst Pathophysiol, Madrid, Spain.	aguadano@iib.uam.es	Gómez-Andrés, David/AAO-1847-2020; Montero-Pedrazuela, Ana/J-7723-2013; Barez-Lopez, Soledad/L-3356-2017; Montero García, María Pilar/L-2872-2014; Guadaño-Ferraz, Ana/J-7870-2013	Gómez-Andrés, David/0000-0001-5654-7791; Montero-Pedrazuela, Ana/0000-0003-2308-0894; Montero García, María Pilar/0000-0003-3142-4538; Guadaño-Ferraz, Ana/0000-0002-0666-935X; Barez-Lopez, Soledad/0000-0002-2552-0366; PULIDO-VALDEOLIVAS, IRENE/0000-0003-0188-2458	Plan Nacional de I+D: [BFU2007-62979, BFU 2010-16498, SAF2011-25608, SAF2012-32491]; Community of Madrid [S2010-BMD-2423]; FPI program	Plan Nacional de I+D:; Community of Madrid(Comunidad de Madrid); FPI program	This work was supported by grants from Plan Nacional de I+D: BFU2007-62979 and BFU 2010-16498 and SAF2011-25608 (AGF); SAF2012-32491 (MJO), Community of Madrid: S2010-BMD-2423 (MJO). SBL and DBG were recipients of a fellowship from the FPI program and AMP of a contract all from the Ministry of Science and Innovation and Economy and Competitiveness, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola E, 2005, ENDOCRINOLOGY, V146, P5038, DOI 10.1210/en.2005-0882; Arque G, 2009, NEUROBIOL DIS, V36, P312, DOI 10.1016/j.nbd.2009.07.027; Drigo RAE, 2013, BBA-GEN SUBJECTS, V1830, P3956, DOI 10.1016/j.bbagen.2012.08.019; Bassett JHD, 2010, P NATL ACAD SCI USA, V107, P7604, DOI 10.1073/pnas.0911346107; Bates JM, 1999, ENDOCRINOLOGY, V140, P844, DOI 10.1210/en.140.2.844; Bernal J, 2003, THYROID, V13, P1005, DOI 10.1089/105072503770867174; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Canani LH, 2005, J CLIN ENDOCR METAB, V90, P3472, DOI 10.1210/jc.2004-1977; Castillo M, 2011, DIABETES, V60, P1082, DOI 10.2337/db10-0758; Christoffolete MA, 2004, DIABETES, V53, P577, DOI 10.2337/diabetes.53.3.577; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Croteau W, 1996, J CLIN INVEST, V98, P405, DOI 10.1172/JCI118806; de Escobar GM, 2004, EUR J ENDOCRINOL, V151, pU25, DOI 10.1530/eje.0.151u025; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; DEESCOBAR GM, 1985, ENDOCRINOLOGY, V117, P1890, DOI 10.1210/endo-117-5-1890; Dentice M, 2010, J CLIN INVEST, V120, P4021, DOI 10.1172/JCI43670; DEONA CR, 1988, PEDIATR RES, V24, P588, DOI 10.1203/00006450-198811000-00010; DEONA CR, 1991, ENDOCRINOLOGY, V128, P422, DOI 10.1210/endo-128-1-422; Dumitrescu AM, 2011, ANN ENDOCRINOL-PARIS, V72, P95, DOI 10.1016/j.ando.2011.03.011; Galton VA, 2007, ENDOCRINOLOGY, V148, P3080, DOI 10.1210/en.2006-1727; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Grozovsky R, 2009, ENDOCRINOLOGY, V150, P1976, DOI 10.1210/en.2008-0938; Guadano-Ferraz A, 1999, J NEUROSCI, V19, P3430; GuadanoFerraz A, 1997, P NATL ACAD SCI USA, V94, P10391, DOI 10.1073/pnas.94.19.10391; Guo TW, 2004, J MED GENET, V41, P585, DOI 10.1136/jmg.2004.019190; He B, 2009, PROG NEURO-PSYCHOPH, V33, P986, DOI 10.1016/j.pnpbp.2009.05.003; Klapdor K, 1997, J NEUROSCI METH, V75, P49, DOI 10.1016/S0165-0270(97)00042-3; Koibuchi N, 2003, CEREBELLUM, V2, P279, DOI 10.1080/14734220310011920; LEONARD JL, 1981, SCIENCE, V214, P571, DOI 10.1126/science.7291997; Maia AL, 2005, J CLIN INVEST, V115, P2524, DOI 10.1172/JCI25083; Marsili A, 2011, AM J PHYSIOL-ENDOC M, V301, pE818, DOI 10.1152/ajpendo.00292.2011; Marsili A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020832; Marsili A, 2010, ENDOCRINOLOGY, V151, P5952, DOI 10.1210/en.2010-0631; Mentuccia D, 2002, DIABETES, V51, P880, DOI 10.2337/diabetes.51.3.880; Ng L, 2004, P NATL ACAD SCI USA, V101, P3474, DOI 10.1073/pnas.0307402101; OBREGON MJ, 1989, AM J PHYSIOL, V257, pE625, DOI 10.1152/ajpendo.1989.257.5.E625; Salvatore D, 1996, ENDOCRINOLOGY, V137, P3308, DOI 10.1210/en.137.8.3308; Schneider MJ, 2001, MOL ENDOCRINOL, V15, P2137, DOI 10.1210/me.15.12.2137; SILVA JE, 1984, J CLIN INVEST, V73, P898, DOI 10.1172/JCI111313; StGermain DL, 1997, THYROID, V7, P655; Tu HM, 1997, ENDOCRINOLOGY, V138, P3359, DOI 10.1210/en.138.8.3359; Venero C, 2005, GENE DEV, V19, P2152, DOI 10.1101/gad.346105; Wakeling EN, 2011, J HERED, V102, pS32, DOI 10.1093/jhered/esr031; Wei P, 2011, MOL CELL BIOL, V31, P2838, DOI 10.1128/MCB.05208-11; Zhang KJ, 2012, J HUM GENET, V57, P14, DOI 10.1038/jhg.2011.121	45	34	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103857	10.1371/journal.pone.0103857	http://dx.doi.org/10.1371/journal.pone.0103857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083788	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800090
J	Carracedo, S; Sacher, F; Brandes, G; Braun, U; Leitges, M				Carracedo, Sergio; Sacher, Frank; Brandes, Gudrun; Braun, Ursula; Leitges, Michael			Redundant Role of Protein Kinase C Delta and Epsilon during Mouse Embryonic Development	PLOS ONE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; PKC-DELTA; N-CADHERIN; VASCULAR MORPHOGENESIS; EXPRESSION PATTERN; MURINE ALLANTOIS; VESSEL FORMATION; VE-CADHERIN; IN-VIVO; VASCULOGENESIS	Protein Kinase C delta and epsilon are mediators of important cellular events, such as cell proliferation, migration or apoptosis. The formation of blood vessels, i.e., vasculo- and angiogenesis, is a process where these isoforms have also been shown to participate. However, mice deficient in either Protein Kinase C delta or epsilon are viable and therefore their individual contribution to the formation of the vasculature appeared so far dispensable. In this study, we show that double null mutation of Protein Kinase C delta and epsilon causes embryonic lethality at approximately E9.5. At this stage, whole mount staining of the endothelial marker CD31 in double null embryos revealed defective blood vessel formation. Moreover, culture of double deficient mouse allantois showed impaired endothelial cell organization, and analyses of double deficient embryo sections showed dilated vessels, decreased endothelial-specific adherent junctions, and decreased contact of endothelial cells with mural cells. Protein kinase C delta and epsilon also appeared essential for vascular smooth muscle cell differentiation, since alpha-smooth muscle actin, a classical marker for vascular smooth muscle cells, was almost undetectable in double deficient embryonic aorta at E9.5. Subsequent qPCR analyses showed decreased VE-cadherin, Vegfr2, Cd31, Cdh2, Ets1, and Fli-1, among other angiogenesis related transcripts in double deficient embryos. Taken together, these data suggest for the first time an in vivo redundant role between members of the novel Protein Kinase C subfamily that allows for mutual compensation during mouse embryonic development, with vasculogenesis/angiogenesis as an obvious common function of these two Protein Kinase Cs. Protein Kinase C delta and epsilon might therefore be useful targets for inhibiting vasculo- and/or angiogenesis.	[Carracedo, Sergio; Braun, Ursula; Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, N-0514 Oslo, Norway; [Sacher, Frank; Braun, Ursula] Max Planck Inst Expt Endocrinol, Hannover, Germany; [Sacher, Frank; Braun, Ursula; Leitges, Michael] Zellbiol Zentrum Anat Gebaude I4, Raum, Germany	University of Oslo; Max Planck Society	Carracedo, S (corresponding author), Univ Oslo, Biotechnol Ctr Oslo, N-0514 Oslo, Norway.	s.c.huroz@biotek.uio.no	Leitges, Michael/AAN-1953-2021	Leitges, Michael/0000-0003-4203-6995	Norwegian Research Council [197261]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was funded by The Norwegian Research Council (http://www.forskningsradet.no; project number:197261). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2010, FASEB J, V24, P5033, DOI 10.1096/fj.10-166934; Arora R, 2012, BLOOD, V120, P2562, DOI 10.1182/blood-2012-03-390070; Asano Y, 2010, AM J PATHOL, V176, P1983, DOI 10.2353/ajpath.2010.090593; Bai X, 2010, ARTERIOSCL THROM VAS, V30, P2467, DOI 10.1161/ATVBAHA.110.215723; Bekhite MM, 2011, J CELL SCI, V124, P1819, DOI 10.1242/jcs.077594; Caprioli A, 2001, DEV BIOL, V238, P64, DOI 10.1006/dbio.2001.0362; Carracedo S, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-16; Carracedo S, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-2; De Val S, 2004, DEV BIOL, V275, P424, DOI 10.1016/j.ydbio.2004.08.016; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; Deuse T, 2010, CIRCULATION, V122, pS170, DOI 10.1161/CIRCULATIONAHA.109.927640; Ding RB, 2004, STEM CELLS DEV, V13, P509, DOI 10.1089/1547328042417336; Downs KM, 1998, DEVELOPMENT, V125, P4507; Duncan GS, 1999, J IMMUNOL, V162, P3022; Duquesnes N, 2011, J MOL CELL CARDIOL, V51, P665, DOI 10.1016/j.yjmcc.2011.07.013; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gambardella L., 2012, TXB ANGIOGENESIS LYM, P189; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Harrington EO, 2005, EXP CELL RES, V308, P407, DOI 10.1016/j.yexcr.2005.05.005; Hashiya N, 2004, CIRCULATION, V109, P3035, DOI 10.1161/01.CIR.0000130643.41587.DB; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Kuriyama M, 2004, BIOCHEM BIOPH RES CO, V325, P843, DOI 10.1016/j.bbrc.2004.10.102; Leitges M, 2001, J CLIN INVEST, V108, P1505; Lessmann E, 2006, INT IMMUNOL, V18, P767, DOI 10.1093/intimm/dxl012; Lizotte F, 2013, DIABETES, V62, P2948, DOI 10.2337/db12-1432; Luo Y, 2005, DEV DYNAM, V232, P336, DOI 10.1002/dvdy.20241; Luo Y, 2005, J CELL BIOL, V169, P29, DOI 10.1083/jcb.200411127; Meier M, 2007, J AM SOC NEPHROL, V18, P1190, DOI 10.1681/ASN.2005070694; Monti M, 2013, J MOL CELL CARDIOL, V63, P107, DOI 10.1016/j.yjmcc.2013.07.006; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Patel-Hett S, 2011, INT J DEV BIOL, V55, P353, DOI 10.1387/ijdb.103213sp; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Rask-Madsen C, 2008, ARTERIOSCL THROM VAS, V28, P919, DOI 10.1161/ATVBAHA.108.162842; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SKALLI O, 1989, J HISTOCHEM CYTOCHEM, V37, P315, DOI 10.1177/37.3.2918221; Srinivasan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008283; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	39	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103686	10.1371/journal.pone.0103686	http://dx.doi.org/10.1371/journal.pone.0103686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084151	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800064
J	Taber, DR; Chriqui, JF; Vuillaume, R; Chaloupka, FJ				Taber, Daniel R.; Chriqui, Jamie F.; Vuillaume, Renee; Chaloupka, Frank J.			How State Taxes and Policies Targeting Soda Consumption Modify the Association between School Vending Machines and Student Dietary Behaviors: A Cross-Sectional Analysis	PLOS ONE			English	Article							SUGAR-SWEETENED BEVERAGES; US SECONDARY-SCHOOLS; OBESITY PREVENTION; UNITED-STATES; SOFT DRINKS; COMPETITIVE FOOD; PUBLIC-HEALTH; BODY-WEIGHT; CHILDREN; ADOLESCENTS	Background: Sodas are widely sold in vending machines and other school venues in the United States, particularly in high school. Research suggests that policy changes have reduced soda access, but the impact of reduced access on consumption is unclear. This study was designed to identify student, environmental, or policy characteristics that modify the associations between school vending machines and student dietary behaviors. Methods: Data on school vending machine access and student diet were obtained as part of the National Youth Physical Activity and Nutrition Study (NYPANS) and linked to state-level data on soda taxes, restaurant taxes, and state laws governing the sale of soda in schools. Regression models were used to: 1) estimate associations between vending machine access and soda consumption, fast food consumption, and lunch source, and 2) determine if associations were modified by state soda taxes, restaurant taxes, laws banning in-school soda sales, or student characteristics (race/ethnicity, sex, home food access, weight loss behaviors.) Results: Contrary to the hypothesis, students tended to consume 0.53 fewer servings of soda/week (95% CI: -1.17, 0.11) and consume fast food on 0.24 fewer days/week (95% CI: -0.44, -0.05) if they had in-school access to vending machines. They were also less likely to consume soda daily (23.9% vs. 27.9%, average difference = -4.02, 95% CI: -7.28, -0.76). However, these inverse associations were observed primarily among states with lower soda and restaurant tax rates (relative to general food tax rates) and states that did not ban in-school soda sales. Associations did not vary by any student characteristics except for weight loss behaviors. Conclusion: Isolated changes to the school food environment may have unintended consequences unless policymakers incorporate other initiatives designed to discourage overall soda consumption.	[Taber, Daniel R.; Chriqui, Jamie F.; Chaloupka, Frank J.] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL 60607 USA; [Vuillaume, Renee] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; [Chaloupka, Frank J.] Univ Illinois, Dept Econ, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Taber, DR (corresponding author), Univ Illinois, Inst Hlth Res & Policy, Chicago, IL 60607 USA.	Daniel.Taber@uth.tmc.edu			Robert Wood Johnson Foundation; National Institute of Child Health and Human Development [4R00HD073271-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD073271] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Support for this research was provided by the Robert Wood Johnson Foundation to the Bridging the Gap program located within the Health Policy Center at the University of Illinois at Chicago (PI: Frank Chaloupka), and by grant number 4R00HD073271-02 from the National Institute of Child Health and Human Development (PI: Daniel Taber). The views expressed herein are solely those of the authors and do not reflect the official views or positions of the Robert Wood Johnson Foundation, the National Institute of Child Health and Human Development, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Centers for Disease Control and Prevention, NAT YOUTH PHYS ACT N; Chriqui JF, 2008, J PUBLIC HEALTH POL, V29, P226, DOI 10.1057/jphp.2008.9; Chriqui JF, 2013, JAMA PEDIATR, V167, P714, DOI 10.1001/jamapediatrics.2013.32; Chriqui JF, 2013, J PUBLIC HEALTH POL, V34, P403, DOI 10.1057/jphp.2013.17; Cohen M.L., 1996, LEGAL RES NUTSHELL, V6th ed.; Cradock AL, 2011, PREV CHRONIC DIS, V8; Cullen KW, 2008, AM J PUBLIC HEALTH, V98, P111, DOI 10.2105/AJPH.2007.111765; Cullen KW, 2006, PUBLIC HEALTH NUTR, V9, P814, DOI 10.1079/PHN2005878; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Ellison B, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-21; Finkelstein E, 2004, AM J PREV MED, V27, P163, DOI 10.1016/j.amepre.2004.06.017; Fletcher JM, 2010, HEALTH AFFAIR, V29, P1059, DOI 10.1377/hlthaff.2009.0725; Ghaffarzadegan N, 2011, SYST DYNAM REV, V27, P22, DOI 10.1002/sdr.442; Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016; Hilmers A, 2012, AM J PUBLIC HEALTH, V102, P1644, DOI 10.2105/AJPH.2012.300865; Institute of Medicine, 2007, NUTR STAND FOODS SCH; Levy DT, 2011, ADV NUTR, V2, p182S, DOI 10.3945/an.111.000356; Livingstone MBE, 2000, P NUTR SOC, V59, P279, DOI 10.1017/S0029665100000318; Lovasi GS, 2009, EPIDEMIOL REV, V31, P7, DOI 10.1093/epirev/mxp005; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Mersky Roy M., 2002, FUNDAMENTALS LEGAL R; Pomeranz JL, 2012, J PUBLIC HEALTH POL, V33, P75, DOI 10.1057/jphp.2011.46; Reedy J, 2010, J AM DIET ASSOC, V110, P1477, DOI 10.1016/j.jada.2010.07.010; Story M, 2009, MILBANK Q, V87, P71, DOI 10.1111/j.1468-0009.2009.00548.x; Sturm R, 2008, PUBLIC HEALTH, V122, P681, DOI 10.1016/j.puhe.2007.09.004; Swinburn B, 2009, CHILD ADOL PSYCH CL, V18, P209, DOI 10.1016/j.chc.2008.07.015; Taber DR, 2012, PEDIATRICS, V130, P437, DOI 10.1542/peds.2011-3353; Taber DR, 2012, ARCH PEDIAT ADOL MED, V166, P452, DOI 10.1001/archpediatrics.2011.1839; Taber DR, 2012, ARCH PEDIAT ADOL MED, V166, P256, DOI 10.1001/archpediatrics.2011.200; Taber DR, 2011, AM J PUBLIC HEALTH, V101, P1769, DOI 10.2105/AJPH.2011.300221; Taras HL, 2004, PEDIATRICS, V113, P152; Terry-McElrath YM, 2013, AM J PREV MED, V44, P573, DOI 10.1016/j.amepre.2013.01.026; Terry-McElrath YM, 2012, ARCH PEDIAT ADOL MED, V166, P776, DOI 10.1001/archpediatrics.2012.716; Terry-McElrath YM, 2012, J SCHOOL HEALTH, V82, P44, DOI 10.1111/j.1746-1561.2011.00666.x; Trust for America's Health The Robert Wood Johnson Foundation, 2010, F FAT OB THREAT AM F; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Woodward-Lopez G, 2010, AM J PUBLIC HEALTH, V100, P2137, DOI 10.2105/AJPH.2010.193490	41	19	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e98249	10.1371/journal.pone.0098249	http://dx.doi.org/10.1371/journal.pone.0098249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4JL	25083906	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800002
J	Xu, SH; Yang, Z; Zhang, E; Jiang, Y; Pan, LA; Chen, Q; Xie, ZW; Xu, CW				Xu, Shuhui; Yang, Zefeng; Zhang, Enying; Jiang, Ying; Pan, Liang; Chen, Qing; Xie, Zhengwen; Xu, Chenwu			Nucleotide Diversity of Maize ZmBT1 Gene and Association with Starch Physicochemical Properties	PLOS ONE			English	Article							DNA-SEQUENCE POLYMORPHISM; ADP-GLUCOSE; RICE; GELATINIZATION; CASSAVA; BIOSYNTHESIS; MEMBRANE; SOFTWARE; SAMPLE; WAXY	Cereal Brittle1 protein has been demonstrated to be involved in the ADP-Glc transport into endosperm plastids, and plays vital roles in the biosynthesis of starch. In this study, the genomic sequences of the ZmBT1 gene in 80 elite maize inbred lines were obtained, and the nucleotide polymorphisms and haplotype diversity were detected. A total of 30 variants, including 22 SNPs and 8 indels, were detected from the full sequences of this gene. Among these polymorphic sites, 9 SNPs and 2 indels were found to be located in the coding region. The polymorphisms of CDS sequences classified the maize ZmBT1 gene into 6 haplotypes, which encode 6 different ZmBT1 proteins. Neutrality tests revealed a decrease in population size and/or balancing selection on the maize ZmBT1 locus. To detect the association between sequence variations of this gene and the starch physicochemical properties, 7 pasting and 4 gelatinization traits of starch were measured for the tested inbred lines using rapid visco analyzer (RVA) and differential scanning calorimeter (DSC), respectively. The result of association analysis revealed that an indel in the coding region was significantly associated with the phenotypic variation of starch gelatinization enthalpy.	[Xu, Shuhui; Yang, Zefeng; Zhang, Enying; Jiang, Ying; Pan, Liang; Chen, Qing; Xie, Zhengwen; Xu, Chenwu] Yangzhou Univ, Co Innovat Ctr Modern Prod Technol Grain Crops, Key Lab Plant Funct Gen Minist Educ, Jiangsu Key Lab Crop Genet & Physiology, Yangzhou, Peoples R China; [Zhang, Enying] Qingdao Agr Univ, Coll Agron & Plant Protect, Qingdao, Shandong, Peoples R China	Yangzhou University; Qingdao Agricultural University	Yang, Z (corresponding author), Yangzhou Univ, Co Innovat Ctr Modern Prod Technol Grain Crops, Key Lab Plant Funct Gen Minist Educ, Jiangsu Key Lab Crop Genet & Physiology, Yangzhou, Peoples R China.	zfyang@yzu.edu.cn		Yang, Zefeng/0000-0002-3465-8594	National Training Programs of Innovation and Entrepreneurship for Undergraduates [201311117035Z]	National Training Programs of Innovation and Entrepreneurship for Undergraduates	This work was supported by grants from the National Training Programs of Innovation and Entrepreneurship for Undergraduates (201311117035Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asan, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r95; Bahaji A, 2011, PLANT CELL PHYSIOL, V52, P597, DOI 10.1093/pcp/pcr019; Bowsher CG, 2007, J EXP BOT, V58, P1321, DOI 10.1093/jxb/erl297; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; FU YX, 1993, GENETICS, V133, P693; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Hasjim J, 2013, CARBOHYD POLYM, V92, P682, DOI 10.1016/j.carbpol.2012.09.023; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; HUDSON RR, 1985, GENETICS, V111, P147; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Kirchberger S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702484200; Laloi M, 1999, CELL MOL LIFE SCI, V56, P918, DOI 10.1007/s000180050484; Leroch M, 2005, J BIOL CHEM, V280, P17992, DOI 10.1074/jbc.M412462200; LI HM, 1992, J BIOL CHEM, V267, P18999; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Patron NJ, 2004, PLANT PHYSIOL, V135, P2088, DOI 10.1104/pp.104.045203; Ratnayake WS, 2006, J AGR FOOD CHEM, V54, P3712, DOI 10.1021/jf0529114; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Saithong T, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-75; Sanchez T, 2010, J AGR FOOD CHEM, V58, P5093, DOI 10.1021/jf1001606; Shannon JC, 1998, PLANT PHYSIOL, V117, P1235, DOI 10.1104/pp.117.4.1235; SULLIVAN TD, 1995, PLANTA, V196, P477, DOI 10.1007/BF00203647; TAJIMA F, 1989, GENETICS, V123, P585; Tan YF, 2001, CEREAL CHEM, V78, P666, DOI 10.1094/CCHEM.2001.78.6.666; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Wang GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055469; Xu FF, 2013, J AGR FOOD CHEM, V61, P10110, DOI 10.1021/jf4029688; Yan CJ, 2011, THEOR APPL GENET, V122, P63, DOI 10.1007/s00122-010-1423-5; Yang ZF, 2014, MOL BIOL REP, V41, P1117, DOI 10.1007/s11033-013-2958-8; Yang ZF, 2013, EVOL BIOINFORM, V9, P239, DOI 10.4137/EBO.S11991; Zhang EY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056495	35	8	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103627	10.1371/journal.pone.0103627	http://dx.doi.org/10.1371/journal.pone.0103627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084007	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800062
J	Alonso-Sarduy, L; De Los Rios, P; Benedetti, F; Vobornik, D; Dietler, G; Kasas, S; Longo, G				Alonso-Sarduy, Livan; De Los Rios, Paolo; Benedetti, Fabrizio; Vobornik, Dusan; Dietler, Giovanni; Kasas, Sandor; Longo, Giovanni			Real-Time Monitoring of Protein Conformational Changes Using a Nano-Mechanical Sensor	PLOS ONE			English	Article							LOCAL NANOMECHANICAL MOTION; TOPOISOMERASE-II; REVERSIBLE BINDING; DNA TRANSPORT; DEPENDENCE; CELLS; MICA; ATP	Proteins can switch between different conformations in response to stimuli, such as pH or temperature variations, or to the binding of ligands. Such plasticity and its kinetics can have a crucial functional role, and their characterization has taken center stage in protein research. As an example, Topoisomerases are particularly interesting enzymes capable of managing tangled and supercoiled double-stranded DNA, thus facilitating many physiological processes. In this work, we describe the use of a cantilever-based nanomotion sensor to characterize the dynamics of human topoisomerase II (Topo II) enzymes and their response to different kinds of ligands, such as ATP, which enhance the conformational dynamics. The sensitivity and time resolution of this sensor allow determining quantitatively the correlation between the ATP concentration and the rate of Topo II conformational changes. Furthermore, we show how to rationalize the experimental results in a comprehensive model that takes into account both the physics of the cantilever and the dynamics of the ATPase cycle of the enzyme, shedding light on the kinetics of the process. Finally, we study the effect of aclarubicin, an anticancer drug, demonstrating that it affects directly the Topo II molecule inhibiting its conformational changes. These results pave the way to a new way of studying the intrinsic dynamics of proteins and of protein complexes allowing new applications ranging from fundamental proteomics to drug discovery and development and possibly to clinical practice.	[Alonso-Sarduy, Livan; Benedetti, Fabrizio; Vobornik, Dusan; Dietler, Giovanni; Kasas, Sandor; Longo, Giovanni] Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Phys Biol Syst, Lab Phys Living Matter, Lausanne, Switzerland; [De Los Rios, Paolo] Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Theoret Phys, Lab Stat Biophys, Lausanne, Switzerland; [Kasas, Sandor] Univ Lausanne, Dept Fundamental Neurosci, Fac Biol & Med, Lausanne, Switzerland; [Longo, Giovanni] Ist Super Sanita, I-00161 Rome, Italy	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Istituto Superiore di Sanita (ISS)	Longo, G (corresponding author), Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Phys Biol Syst, Lab Phys Living Matter, Lausanne, Switzerland.	giovanni.longo@epfl.ch	Longo, G./K-8923-2016; De Los Rios, Paolo/B-2456-2010	Longo, G./0000-0003-2434-2155; De Los Rios, Paolo/0000-0002-5394-5062; Benedetti, Fabrizio/0000-0002-9959-9142	Swiss National Science Foundation [32I3-130676]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation (no.: 32I3-130676). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Sarduy L, 2011, FEBS LETT, V585, P3139, DOI 10.1016/j.febslet.2011.08.051; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; BARNES JR, 1994, NATURE, V372, P79, DOI 10.1038/372079a0; Berger R, 1997, SCIENCE, V276, P2021, DOI 10.1126/science.276.5321.2021; Boisen A, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/3/036101; Charbonnier S, 2008, BIOTECHNOL ANN REV, V14, P1, DOI 10.1016/S1387-2656(08)00001-X; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Evans MJ, 2006, CHEM REV, V106, P3279, DOI 10.1021/cr050288g; Fulle S, 2009, METHODS, V49, P181, DOI 10.1016/j.ymeth.2009.04.004; Gakamsky DM, 2007, P NATL ACAD SCI USA, V104, P16639, DOI 10.1073/pnas.0707061104; Godin M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/7/075501; Hammonds TR, 1997, J BIOL CHEM, V272, P32696, DOI 10.1074/jbc.272.51.32696; Ho BK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000343; JENSEN PB, 1993, BIOCHEM PHARMACOL, V45, P2025, DOI 10.1016/0006-2952(93)90013-M; JENSEN PB, 1991, CANCER RES, V51, P5093; Jung S-H, 2012, MOL CELLULAR PROTEOM; Kasas S, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3285262; Kasas S, 2011, NANOSCALE MOTION DET; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Lee HJ, 2005, J PHYSIOL-LONDON, V563, P61, DOI 10.1113/jphysiol.2004.081117; Lindsley JE, 2003, ENZYMES, P371; Longo G, 2013, NAT NANOTECHNOL, V8, P522, DOI [10.1038/nnano.2013.120, 10.1038/NNANO.2013.120]; Longo G, 2014, WIRES NANOMED NANOBI, V6, P230, DOI 10.1002/wnan.1258; MacBeath G, 1999, J AM CHEM SOC, V121, P7967, DOI 10.1021/ja991083q; Mertens J, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/1/015501; Murade CU, 2009, BIOPHYS J, V97, P835, DOI 10.1016/j.bpj.2009.05.024; Nettikadan SR, 1998, J ELECTRON MICROSC, V47, P671, DOI 10.1093/oxfordjournals.jmicro.a023641; OSHEROFF N, 1986, J BIOL CHEM, V261, P9944; Pelling AE, 2004, SCIENCE, V305, P1147, DOI 10.1126/science.1097640; Pelling AE, 2005, NANOMED-NANOTECHNOL, V1, P178, DOI 10.1016/j.nano.2005.04.002; Pietrement O, 2003, LANGMUIR, V19, P2536, DOI 10.1021/la026942u; RADMACHER M, 1994, SCIENCE, V265, P1577, DOI 10.1126/science.8079171; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; Rudin M, 2003, NAT REV DRUG DISCOV, V2, P123, DOI 10.1038/nrd1007; Schmidt BH, 2012, NAT STRUCT MOL BIOL, V19, P1147, DOI 10.1038/nsmb.2388; Schneider SW, 1999, P NATL ACAD SCI USA, V96, P12180, DOI 10.1073/pnas.96.21.12180; Thomson NH, 1996, LANGMUIR, V12, P5905, DOI 10.1021/la960497j; Waggoner PS, 2007, LAB CHIP, V7, P1238, DOI 10.1039/b707401h; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Xie P, 2010, EUR BIOPHYS J BIOPHY, V39, P1251, DOI 10.1007/s00249-010-0578-y; Yan YL, 2003, CURR OPIN CHEM BIOL, V7, P635, DOI 10.1016/j.cbpa.2003.08.017; Zhou Shumin, 2012, [Frontiers in Biology, 生物学前沿], V7, P336	42	20	22	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103674	10.1371/journal.pone.0103674	http://dx.doi.org/10.1371/journal.pone.0103674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077809	Green Submitted, gold, Green Published			2022-12-25	WOS:000339954800065
J	Filtness, AJ; MacKenzie, J; Armstrong, K				Filtness, Ashleigh J.; MacKenzie, Janelle; Armstrong, Kerry			Longitudinal Change in Sleep and Daytime Sleepiness in Postpartum Women	PLOS ONE			English	Article							INFANT; PERFORMANCE; QUALITY; NIGHT; MOOD	Sleep disruption strongly influences daytime functioning; resultant sleepiness is recognised as a contributing risk-factor for individuals performing critical and dangerous tasks. While the relationship between sleep and sleepiness has been heavily investigated in the vulnerable sub-populations of shift workers and patients with sleep disorders, postpartum women have been comparatively overlooked. Thirty-three healthy, postpartum women recorded every episode of sleep and wake each day during postpartum weeks 6, 12 and 18. Although repeated measures analysis revealed there was no significant difference in the amount of nocturnal sleep and frequency of night-time wakings, there was a significant reduction in sleep disruption, due to fewer minutes of wake after sleep onset. Subjective sleepiness was measured each day using the Karolinska Sleepiness Scale; at the two earlier time points this was significantly correlated with sleep quality but not to sleep quantity. Epworth Sleepiness Scores significantly reduced over time; however, during week 18 over 50% of participants were still experiencing excessive daytime sleepiness (Epworth Sleepiness Score >= 12). Results have implications for health care providers and policy makers. Health care providers designing interventions to address sleepiness in new mothers should take into account the dynamic changes to sleep and sleepiness during this initial postpartum period. Policy makers developing regulations for parental leave entitlements should take into consideration the high prevalence of excessive daytime sleepiness experienced by new mothers, ensuring enough opportunity for daytime sleepiness to diminish to a manageable level prior to reengagement in the workforce.	[Filtness, Ashleigh J.; MacKenzie, Janelle; Armstrong, Kerry] Queensland Univ Technol, Ctr Accid Res & Rd Safety Queensland, Kelvin Grove, Qld, Australia	Queensland University of Technology (QUT)	Filtness, AJ (corresponding author), Queensland Univ Technol, Ctr Accid Res & Rd Safety Queensland, Kelvin Grove, Qld, Australia.	Ashleigh.filtness@qut.edu.au	Armstrong, Kerry A/I-9861-2012; Filtness, Ashleigh/AAY-7239-2020	Armstrong, Kerry A/0000-0002-3871-7862; Filtness, Ashleigh/0000-0001-7357-0344; MacKenzie, Janelle/0000-0002-6320-9739	Centre for Accident Research and Road Safety - Queensland	Centre for Accident Research and Road Safety - Queensland	This study was funded by the Centre for Accident Research and Road Safety - Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Akerstedt T, 2003, OCCUP MED-OXFORD, V53, P89, DOI 10.1093/occmed/kqg046; Australian Bureau of Statistcs, 2011, BIRTHS SUMM STAT AUS; Australian Government, 2013, PAR LEAV PAY; Austroads, 2013, ASS FITN DRIV COMM P; Bei B, 2010, SLEEP, V33, P531, DOI 10.1093/sleep/33.4.531; Dennis CL, 2005, BIRTH-ISS PERINAT C, V32, P187, DOI 10.1111/j.0730-7659.2005.00368.x; Doering J, 2011, MCN-AM J MATERN-CHIL, V36, P258, DOI 10.1097/NMC.0b013e31821826e7; Dorheim SK, 2009, SLEEP, V32, P847, DOI 10.1093/sleep/32.7.847; Eurostat, 2011, NUMB LIV BIRTHS; Filtness AJ, 2012, SLEEP BREATH, V16, P865, DOI 10.1007/s11325-011-0588-8; Fitness AJ, 2011, SLEEP MED, V12, P838, DOI 10.1016/j.sleep.2011.07.002; Gay Caryl L, 2004, Biol Res Nurs, V5, P311, DOI 10.1177/1099800403262142; Goyal D, 2009, ARCH WOMEN MENT HLTH, V12, P229, DOI 10.1007/s00737-009-0070-9; Henderson JMT, 2010, PEDIATRICS, V126, pE1081, DOI 10.1542/peds.2010-0976; Horne J, 2012, NEUROSCI BIOBEHAV R, V36, P2226, DOI 10.1016/j.neubiorev.2012.08.005; Insana SP, 2013, DEV PSYCHOBIOL, V55, P361, DOI 10.1002/dev.21040; Insana SP, 2013, SLEEP, V36, P73, DOI 10.5665/sleep.2304; Insana SP, 2011, PHYSIOL BEHAV, V102, P234, DOI 10.1016/j.physbeh.2010.11.017; Insana SP, 2010, J PSYCHOSOM RES, V69, P467, DOI 10.1016/j.jpsychores.2010.07.004; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Kennedy HP, 2007, J PERINAT NEONAT NUR, V21, P114, DOI 10.1097/01.JPN.0000270628.51122.1d; MITLER MM, 1988, SLEEP, V11, P100, DOI 10.1093/sleep/11.1.100; Montgomery-Downs HE, 2010, PEDIATRICS, V126, pE1562, DOI 10.1542/peds.2010-1269; Montgomery-Downs HE, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.057; National Sleep Foundation, 2012, SLEEP AM POLL PLAN T; Nishihara K, 2012, CHRONOBIOL INT, V29, P363, DOI 10.3109/07420528.2012.657762; Philip P, 2005, IND HEALTH, V43, P30, DOI 10.2486/indhealth.43.30; Posmontier B, 2008, JOGNN-J OBST GYN NEO, V37, P722, DOI 10.1111/j.1552-6909.2008.00298.x; Swain AM, 1997, OBSTET GYNECOL, V90, P381, DOI 10.1016/S0029-7844(97)89252-6	31	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103513	10.1371/journal.pone.0103513	http://dx.doi.org/10.1371/journal.pone.0103513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078950	gold, Green Published, Green Submitted			2022-12-25	WOS:000339954800053
J	Khabirova, E; Moloney, A; Marciniak, SJ; Williams, J; Lomas, DA; Oliver, SG; Favrin, G; Sattelle, DB; Crowther, DC				Khabirova, Eleonora; Moloney, Aileen; Marciniak, Stefan J.; Williams, Julie; Lomas, David A.; Oliver, Stephen G.; Favrin, Giorgio; Sattelle, David B.; Crowther, Damian C.			The TRiC/CCT Chaperone Is Implicated in Alzheimer's Disease Based on Patient GWAS and an RNAi Screen in A beta-Expressing Caenorhabditis elegans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; STE20-LIKE KINASE; STRESS RESISTANCE; AMYLOID PEPTIDE; PROTEINS; GENES; PROTEOSTASIS; AUTOPHAGY; DEMENTIA	The human Ab peptide causes progressive paralysis when expressed in the muscles of the nematode worm, C. elegans. We have exploited this model of Ab toxicity by carrying out an RNAi screen to identify genes whose reduced expression modifies the severity of this locomotor phenotype. Our initial finding was that none of the human orthologues of these worm genes is identical with the genome-wide significant GWAS genes reported to date (the "white zone''); moreover there was no identity between worm screen hits and the longer list of GWAS genes which included those with borderline levels of significance (the "grey zone''). This indicates that Ab toxicity should not be considered as equivalent to sporadic AD. To increase the sensitivity of our analysis, we then considered the physical interactors (+1 interactome) of the products of the genes in both the worm and the white+grey zone lists. When we consider these worm and GWAS gene lists we find that 4 of the 60 worm genes have a + 1 interactome overlap that is larger than expected by chance. Two of these genes form a chaperonin complex, the third is closely associated with this complex and the fourth gene codes for actin, the major substrate of the same chaperonin.	[Khabirova, Eleonora; Moloney, Aileen; Crowther, Damian C.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Khabirova, Eleonora] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Moloney, Aileen; Marciniak, Stefan J.; Crowther, Damian C.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Moloney, Aileen; Sattelle, David B.] Univ Oxford, MRC, Funct Genom Unit, Dept Physiol Anat & Genet, Oxford, England; [Moloney, Aileen] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Oliver, Stephen G.; Favrin, Giorgio] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Marciniak, Stefan J.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Williams, Julie] Cardiff Univ, Sch Med, Dept Psychiat & Neurol, MRC,Ctr Neuropsychiat Genet, Cardiff CF10 3AX, S Glam, Wales; [Sattelle, David B.] UCL, Wolfson Inst Biomed Res, London, England; [Lomas, David A.] UCL, Dept Med, London, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Oxford; University of Oxford; University of Cambridge; University of Cambridge; Cardiff University; University of London; University College London; University of London; University College London	Oliver, SG (corresponding author), Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England.	steve.oliver@bioc.cam.ac.uk; dcc26@cam.ac.uk	Oliver, Stephen/AAQ-5992-2021	Oliver, Stephen/0000-0003-3410-6439; Marciniak, Stefan/0000-0001-8472-7183; Favrin, Giorgio/0000-0002-1884-7352; Khabirova, Eleonora/0000-0002-5891-6789; Williams, Julie/0000-0002-4069-0259	Alzheimer's Research UK [ART-SRF2010-2]; MRC; EPSRC, UK [G0700990]; MRC, UK [G0601840, G0300429, G0902227, G0901786]; Wellcome Trust [082604/2/07/Z]; NIHR UCLH BRC; Wellcome Trust/MRC Neurodegenerative Diseases Research Initiative [WT089703AIA]; MRC [MR/K013041/1, G0902227, MC_G1000734, G0601840, G0901786, G0700990, G0300429, G1002610] Funding Source: UKRI; Alzheimers Research UK [ART-SRF2010-2, ARUK-PG2014-1] Funding Source: researchfish; Medical Research Council [G0700990, MR/K013041/1, G0902227, MR/L501517/1, MC_G1000734, G1002610, MR/L010305/1, G0300429, G0901786, G0601840] Funding Source: researchfish	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC, UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR UCLH BRC; Wellcome Trust/MRC Neurodegenerative Diseases Research Initiative(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AM & JW were supported by Alzheimer's Research UK (http://www.alzheimersresearchuk.org). DCC was supported by an Alzheimer's Research UK Senior Research Fellowship (http://www.alzheimersresearchuk.org, grant code: ART-SRF2010-2) and the MRC (http://www.mrc.ac.uk) and EPSRC (http://www.epsrc.ac.uk/), UK (grant code: G0700990). SJM is supported by the MRC, UK (http://www.mrc.ac.uk, grant code: G0601840). JW was supported by the MRC, UK (http://www.mrc.ac.uk, grant codes: G0300429 and G0902227) and the Wellcome Trust (http://www.wellcome.ac.uk, grant code: 082604/2/07/Z). DAL was supported by the MRC, UK (http://www.mrc.ac.uk, grant code: G0901786) and the NIHR UCLH BRC (http://www.uclhospitals.brc.nihr.ac.uk). DCC, DAL, GF, and SGO are all co-investigators on the Wellcome Trust/MRC Neurodegenerative Diseases Research Initiative (http://www.wellcome.ac.uk, grant code: WT089703AIA).	Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; BESAG J, 1991, BIOMETRIKA, V78, P301; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BRENNER S, 1974, GENETICS, V77, P71; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Cong Y, 2010, P NATL ACAD SCI USA, V107, P4967, DOI 10.1073/pnas.0913774107; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Fisher R., 1970, STAT METHODS RES WOR; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Gatz M, 1997, J GERONTOL A-BIOL, V52, pM117, DOI 10.1093/gerona/52A.2.M117; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Gerrish A, 2012, J ALZHEIMERS DIS, V28, P377, DOI 10.3233/JAD-2011-110824; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Guisbert E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003466; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hillier LW, 2005, GENOME RES, V15, P1651, DOI 10.1101/gr.3729105; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Jensen M, 1999, ANN NEUROL, V45, P504, DOI 10.1002/1531-8249(199904)45:4<504::AID-ANA12>3.0.CO;2-9; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kirstein-Miles J, 2013, CELL CYCLE, V12, P2335, DOI 10.4161/cc.25703; Kraemer BC, 2006, HUM MOL GENET, V15, P1483, DOI 10.1093/hmg/ddl067; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lambourne SL, 2005, MOL CELL BIOL, V25, P278, DOI 10.1128/MCB.25.1.278-293.2005; Lapierre LR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3267; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Lorber B, 2009, NAT NEUROSCI, V12, P1407, DOI 10.1038/nn.2414; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Pryszcz LP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq953; Riedel CG, 2013, NAT CELL BIOL, V15, P491, DOI 10.1038/ncb2720; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Schupf N, 2007, ARCH NEUROL-CHICAGO, V64, P1007, DOI 10.1001/archneur.64.7.1007; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Strange K, 2007, NAT PROTOC, V2, P1003, DOI 10.1038/nprot.2007.143; Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; van Oosten-Hawle P, 2013, CELL, V153, P1366, DOI 10.1016/j.cell.2013.05.015; Yoo BC, 2001, J NEURAL TRANSM-SUPP, P321; Zhou TH, 2000, J BIOL CHEM, V275, P2513, DOI 10.1074/jbc.275.4.2513	49	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102985	10.1371/journal.pone.0102985	http://dx.doi.org/10.1371/journal.pone.0102985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080104	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000339954800020
J	Loh, SW; Ng, WL; Yeo, KS; Lim, YY; Ea, CK				Loh, Sheng Wei; Ng, Wei Lun; Yeo, Kok Siong; Lim, Yat-Yuen; Ea, Chee-Kwee			Inhibition of Euchromatic Histone Methyltransferase 1 and 2 Sensitizes Chronic Myeloid Leukemia Cells to Interferon Treatment	PLOS ONE			English	Article							G9A; METHYLATION; EXPRESSION; ALPHA; RESISTANCE; THERAPY; FUTURE; GENE	Background: H3K9 methylation is one of the essential histone post-translational modifications for heterochromatin formation and transcriptional repression. Recently, several studies have demonstrated that H3K9 methylation negatively regulates the type I interferon response. Results: We report the application of EHMT1 and EHMT2 specific chemical inhibitors to sensitize CML cell lines to interferon and imatinib treatments. Inhibition of EHMT1 and EHMT2 with BIX01294 enhances the cytotoxicity of IFN alpha 2a in four CML cell lines, K562, KCL22, BV173 and KT1 cells. Chromatin immunoprecipitation assay shows that BIX01294 treatment enhances type I interferon response by reducing H3K9me2 at the promoters of interferon-stimulated genes. Additionally, BIX01294 treatment augments IFN alpha 2a- and imatinib-mediated apoptosis in CML cell lines. Moreover, our data suggest that the expression level of EHMT1 and EHMT2 inversely correlates with the type I interferon responsiveness in CML cell lines. Conclusions: Our study sheds light on the role of EHMT1 and EHMT2 as potential targets in improving the efficacy of standard treatments of CML.	[Loh, Sheng Wei; Ng, Wei Lun; Yeo, Kok Siong; Lim, Yat-Yuen; Ea, Chee-Kwee] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia	Universiti Malaya	Ea, CK (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	eacheekwee@um.edu.my	Ng, Wei Lun/X-3337-2019; YEO, KOK SIONG/D-9910-2010; Yeo, Kok Siong/AAA-8345-2019; Lim, Yat Yuen/I-6495-2013	Yeo, Kok Siong/0000-0003-2430-2487; Lim, Yat Yuen/0000-0001-8617-6063	University of Malaya, HIR [UM.C1625/1/HIR/MOHE/CHAN-02, H-50001-A000022]; UMRG [RG533-13HTM]	University of Malaya, HIR; UMRG	This work was supported by the University of Malaya, HIR Grant (UM.C1625/1/HIR/MOHE/CHAN-02; H-50001-A000022) and UMRG (RG533-13HTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attema JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075517; BORDEN EC, 1981, PROG HEMATOL, V12, P299; COLAMONICI OR, 1992, BLOOD, V80, P744; Ea CK, 2012, J BIOL CHEM, V287, P31207, DOI 10.1074/jbc.M112.365601; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Fausel C, 2007, AM J HEALTH-SYST PH, V64, pS9, DOI 10.2146/ajhp070482; Guilhot F, 2009, BEST PRACT RES CL HA, V22, P315, DOI 10.1016/j.beha.2009.10.005; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; KUBONISHI I, 1983, International Journal of Cell Cloning, V1, P105; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Pavlovsky C, 2009, AM J HEMATOL, V84, P287, DOI 10.1002/ajh.21380; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Sakai I, 2002, BLOOD, V100, P2926, DOI 10.1182/blood-2002-01-0073; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Talpaz M, 2013, LEUKEMIA, V27, P803, DOI 10.1038/leu.2012.313; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Vial T, 2000, TOXICOLOGY, V142, P161, DOI 10.1016/S0300-483X(99)00141-9; Yanagisawa K, 1998, BLOOD, V91, P641, DOI 10.1182/blood.V91.2.641.641_641_648	22	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103915	10.1371/journal.pone.0103915	http://dx.doi.org/10.1371/journal.pone.0103915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079219	gold, Green Published			2022-12-25	WOS:000339954800095
J	Maximino, C; da Silva, AWB; Araujo, J; Lima, MG; Miranda, V; Puty, B; Benzecry, R; Picanco-Diniz, DLW; Gouveia, A; Oliveira, KRM; Herculano, AM				Maximino, Caio; Batista da Silva, Annanda Waneza; Araujo, Juliana; Lima, Monica Gomes; Miranda, Vanessa; Puty, Bruna; Benzecry, Rances; Wanderley Picanco-Diniz, Domingos Luiz; Gouveia, Amauri, Jr.; Matos Oliveira, Karen Renata; Herculano, Anderson Manoel			Fingerprinting of Psychoactive Drugs in Zebrafish Anxiety-Like Behaviors	PLOS ONE			English	Article							DANIO-RERIO; ANIMAL-MODELS; ADULT ZEBRAFISH; DISCOVERY; SCOTOTAXIS; IDENTIFICATION; MODULATION; LIGHT/DARK; VERTEBRATE; PREFERENCE	A major hindrance for the development of psychiatric drugs is the prediction of how treatments can alter complex behaviors in assays which have good throughput and physiological complexity. Here we report the development of a medium-throughput screen for drugs which alter anxiety-like behavior in adult zebrafish. The observed phenotypes were clustered according to shared behavioral effects. This barcoding procedure revealed conserved functions of anxiolytic, anxiogenic and psychomotor stimulating drugs and predicted effects of poorly characterized compounds on anxiety. Moreover, anxiolytic drugs all decreased, while anxiogenic drugs increased, serotonin turnover. These results underscore the power of behavioral profiling in adult zebrafish as an approach which combines throughput and physiological complexity in the pharmacological dissection of complex behaviors.	[Maximino, Caio; Lima, Monica Gomes] Univ Estado Para, Ctr Ciencias Biol & Saude, Dept Morfol & Ciencias Fisiol, Lab Neurociencias & Comportamento Frederico Graef, Maraba, Para, Brazil; [Batista da Silva, Annanda Waneza; Araujo, Juliana; Miranda, Vanessa; Benzecry, Rances] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Puty, Bruna; Matos Oliveira, Karen Renata; Herculano, Anderson Manoel] Fed Univ Para, Inst Ciencias Biol, Lab Neuroendocrinol, BR-66059 Belem, Para, Brazil; [Wanderley Picanco-Diniz, Domingos Luiz] Univ Fed Oeste Para, Oriximina, Para, Brazil; [Gouveia, Amauri, Jr.] Fed Univ Para, Lab Neurociencias & Comportamento, Nucleo Pesquisa & Teoria Comportamento, BR-66059 Belem, Para, Brazil	Universidade do Estado do Para (UEPA); Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Oeste do Para; Universidade Federal do Para	Maximino, C (corresponding author), Univ Estado Para, Ctr Ciencias Biol & Saude, Dept Morfol & Ciencias Fisiol, Lab Neurociencias & Comportamento Frederico Graef, Maraba, Para, Brazil.	caio.maximino@gmail.com	Maximino, Caio/G-5726-2013; Herculano, Anderson M/M-9016-2017; Puty, Bruna/L-4670-2016; Gouveia, Amauri/AAI-3542-2021; Gouveia, Amauri/D-9296-2012	Maximino, Caio/0000-0002-3261-9196; Puty, Bruna/0000-0001-5570-8530; Gouveia, Amauri/0000-0003-1710-9662; Gouveia, Amauri/0000-0003-1710-9662; Gomes Lima-Maximino, Monica/0000-0002-9816-3443	Conselho Nacional de Pesquisa (CNPq/Brazil) [483336/2009-2, 400039/2009-5]	Conselho Nacional de Pesquisa (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was financed by Conselho Nacional de Pesquisa (CNPq/Brazil, grants 483336/2009-2 and 400039/2009-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2012, BEHAVIOUR, V149, P1241, DOI 10.1163/1568539X-00003020; Araujo J, 2012, ZEBRAFISH PROTOCOLS, DOI [10.1007/978-1-61779-597-8 14, DOI 10.1007/978-1-61779-597-814]; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Baldwin DS, 2011, INT J NEUROPSYCHOPH, V14, P697, DOI 10.1017/S1461145710001434; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Blaser RE, 2012, ANIM BEHAV, V83, P953, DOI 10.1016/j.anbehav.2012.01.014; Brennand KJ, 2012, MOL PSYCHIATR, V17, P1239, DOI 10.1038/mp.2012.20; Cachat J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017597; Cachat J, 2010, BEHAV BRAIN RES, V208, P371, DOI 10.1016/j.bbr.2009.12.004; Cofiel LPV, 2009, BRAZ J MED BIOL RES, V42, P128, DOI 10.1590/S0100-879X2009000100018; Connors KA, 2013, AQUAT TOXICOL; Crabbe JC, 2004, NAT NEUROSCI, V7, P1175, DOI 10.1038/nn1343; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Gerlai R, 2010, MOLECULES, V15, P2609, DOI 10.3390/molecules15042609; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186.x; Griebel G, 2013, NAT REV DRUG DISCOV, V12, P667, DOI 10.1038/nrd4075; Herculano AM, 2014, PROG NEURO-PSYCHOPH, V55, P50, DOI 10.1016/j.pnpbp.2014.03.008; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Kalueff AV, 2008, BEHAV BRAIN RES, V188, P243, DOI 10.1016/j.bbr.2007.11.011; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; Key Brian, 2003, Methods in Cell Science, V25, P1; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Kokel David, 2008, Briefings in Functional Genomics & Proteomics, V7, P483, DOI 10.1093/bfgp/eln040; Lau BYB, 2011, P NATL ACAD SCI USA, V108, P2581, DOI 10.1073/pnas.1018275108; Lawrence C, 2007, AQUACULTURE, V269, P1, DOI 10.1016/j.aquaculture.2007.04.077; Levin ED, 2007, PHYSIOL BEHAV, V90, P54, DOI 10.1016/j.physbeh.2006.08.026; Linker A, 2011, NEUROMETHODS, V51, P181, DOI 10.1007/978-1-60761-953-6_15; Maximino C, 2011, PARAMETROS ESCOTOTAX, DOI [10.6084/m9.figshare.928644, DOI 10.6084/M9.FIGSHARE.928644]; Maximino C, 2013, NEUROPHARMACOLOGY, V71, P83, DOI 10.1016/j.neuropharm.2013.03.006; Maximino C, 2012, BEHAVIOUR, V149, P1099, DOI 10.1163/1568539X-00003029; Maximino C, 2011, BASIC CLIN PHARMACOL, V109, P203, DOI 10.1111/j.1742-7843.2011.00710.x; Maximino C, 2011, PROG NEURO-PSYCHOPH, V35, P624, DOI 10.1016/j.pnpbp.2011.01.006; Maximino C, 2010, ZEBRAFISH, V7, P359, DOI 10.1089/zeb.2010.0669; Maximino C, 2010, BEHAV BRAIN RES, V210, P1, DOI 10.1016/j.bbr.2010.01.031; Maximino C, 2010, NAT PROTOC, V5, P209, DOI 10.1038/nprot.2009.225; Nguyen M, 2013, BRAIN RES BULL, V98, P145, DOI 10.1016/j.brainresbull.2013.08.004; Norton W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-90; Norton WHJ, 2011, J NEUROSCI, V31, P13796, DOI 10.1523/JNEUROSCI.2892-11.2011; Papke RL, 2012, BIOCHEM PHARMACOL, V84, P352, DOI 10.1016/j.bcp.2012.04.022; Peitsaro N, 2003, J NEUROCHEM, V86, P432, DOI 10.1046/j.1471-4159.2003.01850.x; Redfern William S., 2008, Journal of Pharmacological and Toxicological Methods, V58, P110, DOI 10.1016/j.vascn.2008.05.006; Richendrfer H, 2012, BEHAV BRAIN RES, V228, P99, DOI 10.1016/j.bbr.2011.11.041; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Ruhl T, 2014, PSYCHOPHARMACOLOGY, V231, P3829, DOI 10.1007/s00213-014-3522-5; Sackerman James, 2010, Int J Comp Psychol, V23, P43; Schilling Thomas F., 2002, P59; Serra EL, 1999, BRAZ J MED BIOL RES, V32, P1551, DOI 10.1590/S0100-879X1999001200016; Shimada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052549; Steenbergen PJ, 2011, BEHAV BRAIN RES, V222, P15, DOI 10.1016/j.bbr.2011.03.025; Stewart A, 2011, PROG NEURO-PSYCHOPH, V35, P1421, DOI 10.1016/j.pnpbp.2010.11.035; Stewart A, 2011, NEUROMETHODS, V51, P157, DOI 10.1007/978-1-60761-953-6_13; Stewart AM, 2014, BRAIN RES, V1543, P109, DOI 10.1016/j.brainres.2013.11.002; Stewart AM, 2013, NEUROCHEM INT, V62, P893, DOI 10.1016/j.neuint.2013.02.018; Stewart AM, 2013, BEHAV BRAIN RES, V236, P110, DOI 10.1016/j.bbr.2012.08.026; Stewart AM, 2014, BEHAV BRAIN IN PRESS; Stewart AM, 2012, CURR NEUROP IN PRESS; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; van der Staay FJ, 2006, BRAIN RES REV, V52, P131, DOI 10.1016/j.brainresrev.2006.01.006; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	63	68	70	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103943	10.1371/journal.pone.0103943	http://dx.doi.org/10.1371/journal.pone.0103943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079766	Green Published, gold, Green Submitted			2022-12-25	WOS:000339954800098
J	Tirodkar, TS; Budiu, RA; Elishaev, E; Zhang, LX; Mony, JT; Brozick, J; Edwards, RP; Vlad, AM				Tirodkar, Tejas S.; Budiu, Raluca A.; Elishaev, Esther; Zhang, Lixin; Mony, Jyothi T.; Brozick, Joan; Edwards, Robert P.; Vlad, Anda M.			MUC1 Positive, Kras and Pten Driven Mouse Gynecologic Tumors Replicate Human Tumors and Vary in Survival and Nuclear Grade Based on Anatomical Location	PLOS ONE			English	Article							SEROUS OVARIAN-CANCER; ENDOMETRIAL CANCER; FALLOPIAN-TUBE; K-RAS; CELL; CARCINOMAS; MUTATIONS; MODEL; EXPRESSION; METAPLASIA	Activating mutations of Kras oncogene and deletions of Pten tumor suppressor gene play important roles in cancers of the female genital tract. We developed here new preclinical models for gynecologic cancers, using conditional (Cre-loxP) mice with floxed genetic alterations in Kras and Pten. The triple transgenic mice, briefly called MUC1KrasPten, express human MUC1 antigen as self and carry a silent oncogenic Kras(G12D) and Pten deletion mutation. Injection of Cre-encoding adenovirus (AdCre) in the ovarian bursa, oviduct or uterus activates the floxed mutations and initiates ovarian, oviductal, and endometrial cancer, respectively. Anatomical site-specific Cre-loxP recombination throughout the genital tract of MUC1KrasPten mice leads to MUC1 positive genital tract tumors, and the development of these tumors is influenced by the anatomical environment. Endometrioid histology was consistently displayed in all tumors of the murine genital tract (ovaries, oviducts, and uterus). Tumors showed increased expression of MUC1 glycoprotein and triggered de novo antibodies in tumor bearing hosts, mimicking the immunobiology seen in patients. In contrast to the ovarian and endometrial tumors, oviductal tumors showed higher nuclear grade. Survival for oviduct tumors was significantly lower than for endometrial tumors (p = 0.0015), yet similar to survival for ovarian cancer. Oviducts seem to favor the development of high grade tumors, providing preclinical evidence in support of the postulated role of fallopian tubes as the originating site for high grade human ovarian tumors.	[Tirodkar, Tejas S.; Budiu, Raluca A.; Elishaev, Esther; Zhang, Lixin; Mony, Jyothi T.; Edwards, Robert P.; Vlad, Anda M.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA; [Tirodkar, Tejas S.; Budiu, Raluca A.; Zhang, Lixin; Mony, Jyothi T.; Brozick, Joan; Edwards, Robert P.; Vlad, Anda M.] Magee Womens Res Inst, Pittsburgh, PA USA; [Elishaev, Esther] Univ Pittsburgh, Magee Womens Hosp, Dept Pathol, Med Ctr, Pittsburgh, PA 15213 USA; [Edwards, Robert P.] Univ Pittsburgh, Magee Womens Hosp, Med Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vlad, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA.	vladam@upmc.edu	/AAC-3404-2019; Brozick, Joan/AAA-5785-2019; Zhang, Li/GWM-7501-2022	/0000-0002-4587-1868; 	Department of Defense Ovarian Cancer Academy Award [W81XWH-10-1-052]; Pennsylvania Department of Health; Scaife Foundation; NIH/NCI [R01 CA163462]; NATIONAL CANCER INSTITUTE [R01CA163462] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	Department of Defense Ovarian Cancer Academy Award; Pennsylvania Department of Health; Scaife Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the Department of Defense Ovarian Cancer Academy Award W81XWH-10-1-052, Pennsylvania Department of Health, Scaife Foundation and NIH/NCI R01 CA163462. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIG 2013, P1, DOI DOI 10.1017/CB09781107415324.004; Arango NA, 2008, MOL REPROD DEV, V75, P1154, DOI 10.1002/mrd.20858; Awaya H, 2004, AM J CLIN PATHOL, V121, P644, DOI 10.1039/U4WGE9EBFJN6CM8R; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Bansal N, 2009, CANCER CONTROL, V16, P8, DOI 10.1177/107327480901600102; Barrow E, 2009, CLIN GENET, V75, P141, DOI 10.1111/j.1399-0004.2008.01125.x; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Budiu RA, 2012, ONCOGENE, V10, P397; Cabrera S, 2012, CLIN EXP METASTAS, V29, P217, DOI 10.1007/s10585-011-9444-2; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Deng JL, 2013, CANCER METAST REV, V32, P535, DOI 10.1007/s10555-013-9423-y; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Fan HY, 2009, CANCER RES, V69, P6463, DOI 10.1158/0008-5472.CAN-08-3363; Friel Anne M, 2010, Front Biosci (Elite Ed), V2, P882; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Jones S, 2012, J PATHOL, V226, P413, DOI 10.1002/path.3967; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Joshi A, 2011, EXP CELL RES, V317, P1580, DOI 10.1016/j.yexcr.2011.03.006; Kaira K, 2012, INT J SURG PATHOL, V20, P223, DOI 10.1177/1066896911429296; Katz SC, 2013, ANN SURG ONCOL, V20, P946, DOI 10.1245/s10434-012-2668-9; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Kim R, 1997, CANCER EPIDEM BIOMAR, V6, P369; Kimura T, 2013, EXPERT OPIN BIOL TH, V13, P35, DOI 10.1517/14712598.2012.725719; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; LEUBE RE, 1991, VIRCHOWS ARCH B, V61, P227; MIZUUCHI H, 1995, CANCER, V76, P86, DOI 10.1002/1097-0142(19950701)76:1<86::AID-CNCR2820760112>3.0.CO;2-L; Mullany LK, 2011, ONCOGENE, V30, P3522, DOI 10.1038/onc.2011.70; Musrap N, 2012, MOL CANCER RES, V10, P1254, DOI 10.1158/1541-7786.MCR-12-0353; Pearce CL, 2012, LANCET ONCOL, V13, P385, DOI 10.1016/S1470-2045(11)70404-1; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Przybycin CG, 2010, AM J SURG PATHOL, V34, P1407, DOI 10.1097/PAS.0b013e3181ef7b16; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Roh MH, 2010, MODERN PATHOL, V23, P1316, DOI 10.1038/modpathol.2010.119; RUGHETTI A, 1993, CANCER RES, V53, P2457; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Shen ZB, 2010, J CANCER RES CLIN, V136, P1585, DOI 10.1007/s00432-010-0816-9; *US CANC STAT WORK, 2006, US CANC STAT 2003 IN; van der Zee M, 2013, J PATHOL, V230, P48, DOI 10.1002/path.4160; von Mensdorff-Pouilly S, 1998, TUMOR BIOL, V19, P186, DOI 10.1159/000030006; Von Mensdorff-Pouilly Silvia, 2011, Cancers (Basel), V3, P3073, DOI 10.3390/cancers3033073; Watanabe Y, 2010, ORAL SURG ORAL MED O, V109, P744, DOI 10.1016/j.tripleo.2009.12.015; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433	45	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102409	10.1371/journal.pone.0102409	http://dx.doi.org/10.1371/journal.pone.0102409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078979	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000339954800013
J	Blaho, M; Herczeg, T; Kriska, G; Egri, A; Szaz, D; Farkas, A; Tarjanyi, N; Czinke, L; Barta, A; Horvath, G				Blaho, Miklos; Herczeg, Tamas; Kriska, Gyorgy; Egri, Adam; Szaz, Denes; Farkas, Alexandra; Tarjanyi, Nikolett; Czinke, Laszlo; Barta, Andras; Horvath, Gabor			Unexpected Attraction of Polarotactic Water-Leaving Insects to Matt Black Car Surfaces: Mattness of Paintwork Cannot Eliminate the Polarized Light Pollution of Black Cars	PLOS ONE			English	Article							AQUATIC INSECTS; DIPTERA TABANIDAE; OVIPOSITION SITES; SOLAR PANELS; HORSE FLIES; VISION; EPHEMEROPTERA; ADVANTAGE; TRAPS; RED	The horizontally polarizing surface parts of shiny black cars (the reflection-polarization characteristics of which are similar to those of water surfaces) attract water-leaving polarotactic insects. Thus, shiny black cars are typical sources of polarized light pollution endangering water-leaving insects. A new fashion fad is to make car-bodies matt black or grey. Since rough (matt) surfaces depolarize the reflected light, one of the ways of reducing polarized light pollution is to make matt the concerned surface. Consequently, matt black/grey cars may not induce polarized light pollution, which would be an advantageous feature for environmental protection. To test this idea, we performed field experiments with horizontal shiny and matt black car-body surfaces laid on the ground. Using imaging polarimetry, in multiple-choice field experiments we investigated the attractiveness of these test surfaces to various water-leaving polarotactic insects and obtained the following results: (i) The attractiveness of black car-bodies to polarotactic insects depends in complex manner on the surface roughness (shiny, matt) and species (mayflies, dolichopodids, tabanids). (ii) Non-expectedly, the matt dark grey car finish is much more attractive to mayflies (being endangered and protected in many countries) than matt black finish. (iii) The polarized light pollution of shiny black cars usually cannot be reduced with the use of matt painting. On the basis of these, our two novel findings are that (a) matt car-paints are highly polarization reflecting, and (b) these matt paints are not suitable to repel polarotactic insects. Hence, the recent technology used to make matt the car-bodies cannot eliminate or even can enhance the attractiveness of black/grey cars to water-leaving insects. Thus, changing shiny black car painting to matt one is a disadvantageous fashion fad concerning the reduction of polarized light pollution of black vehicles.	[Blaho, Miklos; Herczeg, Tamas; Egri, Adam; Szaz, Denes; Farkas, Alexandra; Czinke, Laszlo; Barta, Andras; Horvath, Gabor] Eotvos Lorand Univ, Inst Phys, Dept Biol Phys, Environm Opt Lab, Budapest, Hungary; [Kriska, Gyorgy; Czinke, Laszlo] Eotvos Lorand Univ, Inst Biol, Grp Methodol Biol Teaching, Budapest, Hungary; [Kriska, Gyorgy; Tarjanyi, Nikolett] Hungarian Acad Sci, Ctr Ecol Res, Danube Res Inst, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research	Horvath, G (corresponding author), Eotvos Lorand Univ, Inst Phys, Dept Biol Phys, Environm Opt Lab, Budapest, Hungary.	gh@arago.elte.hu	Kriska, György/B-5723-2019	Kriska, Gyorgy/0000-0003-4271-3167	European Commission [TabaNOid 232366]; German Alexander von Humboldt Foundation in Regensburg [3.3-UNG/1073032 STP]	European Commission(European CommissionEuropean Commission Joint Research Centre); German Alexander von Humboldt Foundation in Regensburg	This work was supported by the grant TabaNOid 232366 (Trap for the Novel Control of Horse-flies on Open-air Fields) funded by the European Commission under the 7th Framework Programme received by G. Horvath and G. Kriska. Gabor Horvath thanks the German Alexander von Humboldt Foundation for an equipment donation and a three-month research fellowship (3.3-UNG/1073032 STP, between 1 June and 31 August 2013) in Regensburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernath B, 2004, J EXP BIOL, V207, P755, DOI 10.1242/jeb.00810; Bernath B, 2002, FRESHWATER BIOL, V47, P1707, DOI 10.1046/j.1365-2427.2002.00931.x; Blaho M, 2012, VET PARASITOL, V189, P353, DOI 10.1016/j.vetpar.2012.04.016; Blaho M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041138; Boda P, 2013, HYDROBIOLOGIA, V703, P133, DOI 10.1007/s10750-012-1350-3; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Csabai Z, 2006, FRESHWATER BIOL, V51, P1341, DOI 10.1111/j.1365-2427.2006.01576.x; Csabai Z, 2012, NATURWISSENSCHAFTEN, V99, P751, DOI 10.1007/s00114-012-0957-6; Egri A, 2013, INT J PARASITOL, V43, P555, DOI 10.1016/j.ijpara.2013.02.002; Egri A, 2012, NATURWISSENSCHAFTEN, V99, P407, DOI 10.1007/s00114-012-0916-2; Egri A, 2012, J EXP BIOL, V215, P736, DOI 10.1242/jeb.065540; Encalada AC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1437, DOI 10.1007/s00265-007-0376-4; Henze MJ, 2007, J EXP BIOL, V210, P3266, DOI 10.1242/jeb.007831; Horvath G., 2008, Aquatic insects: challenges to populations, P204, DOI 10.1079/9781845933968.0204; Horvath G, 1997, J EXP BIOL, V200, P1155; Horvath G., 2004, POLARIZED LIGHT ANIM; Horvath G, 2010, SERIES ENV REMEDIATI, P47; Horvath G, 2008, NATURWISSENSCHAFTEN, V95, P1093, DOI 10.1007/s00114-008-0425-5; Horvath G, 2011, PHYSIOL BEHAV, V104, P1010, DOI 10.1016/j.physbeh.2011.06.022; Horvath G, 2010, CONSERV BIOL, V24, P1644, DOI 10.1111/j.1523-1739.2010.01518.x; Horvath G, 2010, P ROY SOC B-BIOL SCI, V277, P1643, DOI 10.1098/rspb.2009.2202; Horvath G, 2009, FRONT ECOL ENVIRON, V7, P317, DOI 10.1890/080129; Jach M.A., 1997, Latissimus, V9, P10; Krcmar S, 2013, ENTOMOL GEN, V34, P261; Krcmar S, 2011, ENTOMOL GEN, V33, P245; Kriska G, 1998, J EXP BIOL, V201, P2273; Kriska G, 2009, J INSECT PHYSIOL, V55, P1167, DOI 10.1016/j.jinsphys.2009.08.013; Kriska G, 2007, NATURWISSENSCHAFTEN, V94, P148, DOI 10.1007/s00114-006-0180-4; Kriska G, 2006, P ROY SOC B-BIOL SCI, V273, P1667, DOI 10.1098/rspb.2006.3500; Lerner A, 2008, J EXP BIOL, V211, P3536, DOI 10.1242/jeb.022277; Lerner A, 2012, J OPT SOC AM A, V29, P2394, DOI 10.1364/JOSAA.29.002394; Nilsson Anders N., 1997, Latissimus, V9, P12; Russev Boris K., 1992, Lauterbornia, V9, P13; SCHWIND R, 1995, J COMP PHYSIOL A, V177, P439; SCHWIND R, 1991, J COMP PHYSIOL A, V169, P531; Umow N, 1905, PHYS Z, V6, P674; van Vondel Bernhard, 1998, Latissimus, V10, P29; Wildermuth H, 1998, NATURWISSENSCHAFTEN, V85, P297, DOI 10.1007/s001140050504; Wildermuth Hansruedi, 2007, Libellula, V26, P143; Wildermuth Hansruedi, 2005, International Journal of Odonatology, V8, P97; Zar JH., 2010, BIOSTAT ANAL	41	9	9	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103339	10.1371/journal.pone.0103339	http://dx.doi.org/10.1371/journal.pone.0103339			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076137	Green Published, gold, Green Submitted			2022-12-25	WOS:000340028800038
J	Eduardo, E; Lamb, MR; Kandula, S; Howard, A; Mugisha, V; Kimanga, D; Kilama, B; El-Sadr, W; Elul, B				Eduardo, Eduard; Lamb, Matthew R.; Kandula, Sasi; Howard, Andrea; Mugisha, Veronicah; Kimanga, Davies; Kilama, Bonita; El-Sadr, Wafaa; Elul, Batya			Characteristics and Outcomes among Older HIV-Positive Adults Enrolled in HIV Programs in Four Sub-Saharan African Countries	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; FOLLOW-UP; AGE; INFECTION; RESPONSES; SURVIVAL; HIV/AIDS; PEOPLE; LOST	Background: Limited information exists on adults >= 50 years receiving HIV care in sub-Saharan Africa. Methodology: Using routinely-collected longitudinal patient-level data among 391,111 adults >= 15 years enrolling in HIV care from January 2005-December 2010 and 184,689 initiating ART, we compared characteristics and outcomes between older (>= 50 years) and younger adults at 199 clinics in Kenya, Mozambique, Rwanda, and Tanzania. We calculated proportions over time of newly enrolled and active adults receiving HIV care and initiating ART who were >= 50 years; cumulative incidence of loss to follow-up (LTF) and recorded death one year after enrollment and ART initiation, and CD4+ response following ART initiation. Findings: From 2005-2010, the percentage of adults >= 50 years newly enrolled in HIV care remained stable at 10%, while the percentage of adults >= 50 years newly initiating ART (10% [2005]-12% [2010]), active in follow-up (10% [2005]-14% (2010]), and active on ART (10% [2005]-16% [2010]) significantly increased. One year after enrollment, older patients had significantly lower incidence of LTF (33.1% vs. 32.6%[40-49 years], 40.5%[25-39 years], and 56.3%[15-24 years]; p-value<0.0001), but significantly higher incidence of recorded death (6.0% vs. 5.0% [40-49 years], 4.1% [25-39 years], and 2.8% [1524 years]; p-valve<0.0001). LTF was lower after vs. before ART initiation for all ages, with older adults experiencing less LTF than younger adults. Among 85,763 ART patients with baseline and follow-up CD4+ counts, adjusted average 12-month CD4+ response for older adults was 20.6 cells/mm(3) lower than for adults 25-39 years of age (95% CI: 17.1-24.1). Conclusions: The proportion of patients who are >= 50 years has increased over time and been driven by aging of the existing patient population. Older patients experienced less LTF, higher recorded mortality and less robust CD4+ response after ART initiation. Increased programmatic attention on older adults receiving HIV care in sub-Saharan Africa is warranted.	[Eduardo, Eduard; Lamb, Matthew R.; Howard, Andrea; El-Sadr, Wafaa; Elul, Batya] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Lamb, Matthew R.; Kandula, Sasi; Howard, Andrea; Mugisha, Veronicah; El-Sadr, Wafaa; Elul, Batya] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA; [Kimanga, Davies] Minist Hlth, Natl AIDS & STI Control Programme, Nairobi, Kenya; [Kilama, Bonita] Minist Hlth & Social Welf, Natl AIDS Control Program, Dar Es Salaam, Tanzania	Columbia University; Columbia University	Lamb, MR (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	mrl2013@columbia.edu			U.S. Centers for Disease Control and Prevention, Identifying Optimal Models of HIV Care and Treatment [5U2GPS001537-03]	U.S. Centers for Disease Control and Prevention, Identifying Optimal Models of HIV Care and Treatment(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	U.S. Centers for Disease Control and Prevention, Identifying Optimal Models of HIV Care and Treatment, Grant Number 5U2GPS001537-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Centers for Disease Control and Prevention, 2008, HIV AIDS PERS AG 50; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Dorrington R. E., 2006, DEMOGRAPHIC IMPACT H; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; ELSADR W, 1995, ARCH INTERN MED, V155, P184, DOI 10.1001/archinte.155.2.184; Fang CT, 2007, QJM-INT J MED, V100, P97, DOI 10.1093/qjmed/hcl141; Goodkin K, 2003, JAIDS-J ACQ IMM DEF, V33, pS171, DOI 10.1097/00126334-200306012-00015; Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007; Greig Jane, 2012, AIDS, V26 Suppl 1, pS31; Hontelez Jan A C, 2012, AIDS, V26 Suppl 1, pS19; Kautz T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2841; Manfredi R, 2002, DRUG AGING, V19, P647, DOI 10.2165/00002512-200219090-00003; Manrique L, 2010, JAIDS-J ACQ IMM DEF, V54, P332, DOI 10.1097/QAI.0b013e3181d2eef1; Mayhew S, 1996, HEALTH POLICY PLANN, V11, P339, DOI 10.1093/heapol/11.4.339; Muga GO, 2009, J CROSS-CULT GERONTO, V24, P259, DOI 10.1007/s10823-008-9090-6; Nakagawa F, 2013, CURR OPIN INFECT DIS, V26, P17, DOI 10.1097/QCO.0b013e32835ba6b1; Navarro G, 2008, J INFECTION, V57, P64, DOI 10.1016/j.jinf.2008.05.003; Negin J, 2010, B WHO; Negin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026546; Nguyen N, 2008, CLIN INTERV AGING, V3, P453; Nogueras M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-159; Orlando G, 2006, HIV MED, V7, P549, DOI 10.1111/j.1468-1293.2006.00420.x; Parikh SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076158; Perez JL, 2003, CLIN INFECT DIS, V36, P212, DOI 10.1086/345669; Pontali E, 2003, J HLTH MANAGEMENT, V2003, P315; Remien RH, 2008, AIDS, V22, pS57, DOI 10.1097/01.aids.0000327437.13291.86; Stoff DM, 2004, AIDS, V18, pS3, DOI 10.1097/00002030-200401001-00002; Stoff DM, 2004, AIDS, V18, pS1, DOI 10.1097/00002030-200401001-00001; Tuboi SH, 2010, JAIDS-J ACQ IMM DEF, V53, P70, DOI 10.1097/QAI.0b013e3181c22d19; UNAIDS, 2007, AIDS EP UPD DEC 2007, P1; Valcour V, 2006, CLIN INFECT DIS, V42, P1449, DOI 10.1086/503565; WHO, 2013, GLOB UPD HIV TREATM; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zaba B, 2008, 17 INT AIDS C MEX CI	36	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103864	10.1371/journal.pone.0103864	http://dx.doi.org/10.1371/journal.pone.0103864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075743	Green Published, Green Submitted, gold			2022-12-25	WOS:000340028800084
J	Roozendaal, R; Tolboom, J; Roos, A; Riahi, S; Theeuwsen, J; Bujny, MV; Klaren, V; Korse, HJWM; Dekking, L; Grootenhuis, A; Weverling, GJ; Koudstaal, W; Goudsmit, J; Radosevic, K				Roozendaal, Ramon; Tolboom, Jeroen; Roos, Anna; Riahi, Sarra; Theeuwsen, Jessica; Bujny, Miriam V.; Klaren, Vincent; Korse, Hans J. W. M.; Dekking, Liesbeth; Grootenhuis, Arijan; Weverling, Gerrit Jan; Koudstaal, Wouter; Goudsmit, Jaap; Radosevic, Katarina			Transient Humoral Protection against H5N1 Challenge after Seasonal Influenza Vaccination of Humans	PLOS ONE			English	Article							NEUTRALIZING MONOCLONAL-ANTIBODIES; HEMAGGLUTININ STALK ANTIBODIES; VIRUS; EPITOPE; RECOGNITION; INFECTION; CELLS; BINDS	Current influenza vaccines are believed to confer protection against a narrow range of virus strains. The identification of broadly influenza neutralizing antibodies (bnAbs) has triggered efforts to develop vaccines providing 'universal' protection against influenza. Several bnAbs were isolated from humans recently vaccinated with conventional influenza vaccines, suggesting that such vaccines could, in principle, be broadly protective. Assessing the breadth-of-protection conferred to humans by influenza vaccines is hampered by the lack of in vitro correlates for broad protection. We designed and employed a novel human-to-mouse serum transfer and challenge model to analyze protective responses in serum samples from clinical trial subjects. One dose of seasonal vaccine induces humoral protection not only against vaccine-homologous H1N1 challenge, but also against H5N1 challenge. This heterosubtypic protection is neither detected, nor accurately predicted by in vitro immunogenicity assays. Moreover, heterosubtypic protection is transient and not boosted by repeated inoculations. Strategies to increase the breadth and duration of the protective response against influenza are required to obtain 'universal' protection against influenza by vaccination. In the absence of known correlates of protection for broadly protective vaccines, the human-to-mouse serum transfer and challenge model described here may aid the development of such vaccines.	[Roozendaal, Ramon; Tolboom, Jeroen; Roos, Anna; Riahi, Sarra; Theeuwsen, Jessica; Bujny, Miriam V.; Klaren, Vincent; Korse, Hans J. W. M.; Dekking, Liesbeth; Weverling, Gerrit Jan; Koudstaal, Wouter; Goudsmit, Jaap; Radosevic, Katarina] Crucell Holland BV, Janssen Ctr Excellence Immunoprophylaxis, Crucell Vaccine Inst, Leiden, Netherlands; [Grootenhuis, Arijan] Crucell Holland BV, Clin Immunol, Leiden, Netherlands	Johnson & Johnson; Johnson & Johnson	Radosevic, K (corresponding author), Crucell Holland BV, Janssen Ctr Excellence Immunoprophylaxis, Crucell Vaccine Inst, Leiden, Netherlands.	KRadosev@its.jnj.com						Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Cox RJ, 2011, VACCINE, V29, P8049, DOI 10.1016/j.vaccine.2011.08.042; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Fleury D, 2000, PROTEINS, V40, P572; Howard MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023791; Hu WB, 2013, VIROLOGY, V435, P320, DOI 10.1016/j.virol.2012.09.034; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Khurana S, 2013, J INFECT DIS, V208, P413, DOI 10.1093/infdis/jit178; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.03183-13, 10.1128/JVI.00641-13]; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Medina RA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1026; Miller MS, 2013, J INFECT DIS, V207, P98, DOI 10.1093/infdis/jis652; Ohmit SE, 2011, J INFECT DIS, V204, P1879, DOI 10.1093/infdis/jir661; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Sangster MY, 2013, CLIN VACCINE IMMUNOL, V20, P867, DOI 10.1128/CVI.00735-12; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui J, 2011, CLIN INFECT DIS, V52, P1003, DOI 10.1093/cid/cir121; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thomson CA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00087; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xie H, 2011, CLIN INFECT DIS, V53, P1179, DOI 10.1093/cid/cir693; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	37	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103550	10.1371/journal.pone.0103550	http://dx.doi.org/10.1371/journal.pone.0103550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075622	gold, Green Published, Green Submitted			2022-12-25	WOS:000340028800063
J	Song, YJ; Giske, CG; Gille-Johnson, P; Emanuelsson, O; Lundeberg, J; Gyarmati, P				Song, Yajing; Giske, Christian G.; Gille-Johnson, Patrik; Emanuelsson, Olof; Lundeberg, Joakim; Gyarmati, Peter			Nuclease-Assisted Suppression of Human DNA Background in Sepsis	PLOS ONE			English	Article							CULTURE-BASED METHODS; PCR; BLOOD; DIAGNOSIS; GENE; REHYBRIDIZATION; EPIDEMIOLOGY	Sepsis is a severe medical condition characterized by a systemic inflammatory response of the body caused by pathogenic microorganisms in the bloodstream. Blood or plasma is typically used for diagnosis, both containing large amount of human DNA, greatly exceeding the DNA of microbial origin. In order to enrich bacterial DNA, we applied the C(0)t effect to reduce human DNA background: a model system was set up with human and Escherichia coli (E. coli) DNA to mimic the conditions of bloodstream infections; and this system was adapted to plasma and blood samples from septic patients. As a consequence of the C(0)t effect, abundant DNA hybridizes faster than rare DNA. Following denaturation and re-hybridization, the amount of abundant DNA can be decreased with the application of double strand specific nucleases, leaving the non-hybridized rare DNA intact. Our experiments show that human DNA concentration can be reduced approximately 100,000-fold without affecting the E. coli DNA concentration in a model system with similarly sized amplicons. With clinical samples, the human DNA background was decreased 100-fold, as bacterial genomes are approximately 1,000-fold smaller compared to the human genome. According to our results, background suppression can be a valuable tool to enrich rare DNA in clinical samples where a high amount of background DNA can be found.	[Song, Yajing; Emanuelsson, Olof; Lundeberg, Joakim; Gyarmati, Peter] Royal Inst Technol, Sci Life Lab, Stockholm, Sweden; [Giske, Christian G.; Gyarmati, Peter] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Giske, Christian G.; Gyarmati, Peter] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Gille-Johnson, Patrik] Karolinska Inst, Div Infect Dis, Dept Med, Stockholm, Sweden	Royal Institute of Technology; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Gyarmati, P (corresponding author), Royal Inst Technol, Sci Life Lab, Stockholm, Sweden.	peter.gyarmati@ki.se	Gyarmati, Peter/F-4887-2013	Gyarmati, Peter/0000-0001-7362-316X	Swedish Research Council [2012-3291]; China Scholarship Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); China Scholarship Council(China Scholarship Council)	This work was supported by the Swedish Research Council (Vetenskapsra det, to PG): 2012-3291, and China Scholarship Council, to YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chang SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054564; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Gijavanekar C, 2012, ANAL BIOCHEM, V421, P81, DOI 10.1016/j.ab.2011.11.010; Gyarmati P, 2013, J BIOTECHNOL, V168, P95, DOI 10.1016/j.jbiotec.2013.08.020; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Horz HP, 2010, ANAEROBE, V16, P47, DOI 10.1016/j.anaerobe.2009.04.009; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Jordan JA, 2005, J MOL DIAGN, V7, P575, DOI 10.1016/S1525-1578(10)60590-9; Jordana-Lluch E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062108; Klouche M, 2008, CLIN CHEM LAB MED, V46, P888, DOI 10.1515/CCLM.2008.157; KREGER BE, 1980, AM J MED, V68, P332, DOI 10.1016/0002-9343(80)90101-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; Loonen AJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072349; Mancini N, 2010, CLIN MICROBIOL REV, V23, P235, DOI 10.1128/CMR.00043-09; MathieuDaude F, 1996, NUCLEIC ACIDS RES, V24, P2080, DOI 10.1093/nar/24.11.2080; Matvienko M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055913; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Schreiber J, 2013, MED KLIN-INTENSIVMED, V108, P311, DOI 10.1007/s00063-013-0227-1; Shen W, 2013, CHEM COMMUN, V49, P4959, DOI 10.1039/c3cc41565a; Skvarc M, 2013, EUR J MICROBIOL IMMU, V3, P97, DOI 10.1556/EuJMI.3.2013.2.2; Wu YD, 2008, J CLIN MICROBIOL, V46, P2613, DOI 10.1128/JCM.02237-07; Yi H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr617; Zhou LQ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-164	29	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103610	10.1371/journal.pone.0103610	http://dx.doi.org/10.1371/journal.pone.0103610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076135	Green Published, gold, Green Submitted			2022-12-25	WOS:000340028800068
J	Ascensao, F; Grilo, C; LaPoint, S; Tracey, J; Clevenger, AP; Santos-Reis, M				Ascensao, Fernando; Grilo, Clara; LaPoint, Scott; Tracey, Jeff; Clevenger, Anthony P.; Santos-Reis, Margarida			Inter-Individual Variability of Stone Marten Behavioral Responses to a Highway	PLOS ONE			English	Article							MOVEMENT BEHAVIOR; ANIMAL MOVEMENT; ROAD MORTALITY; LUTRA-LUTRA; HABITAT USE; MITIGATION; CARNIVORES; POPULATIONS; LANDSCAPE; PATTERNS	Efforts to reduce the negative impacts of roads on wildlife may be hindered if individuals within the population vary widely in their responses to roads and mitigation strategies ignore this variability. This knowledge is particularly important for medium-sized carnivores as they are vulnerable to road mortality, while also known to use available road passages (e. g., drainage culverts) for safely crossing highways. Our goal in this study was to assess whether this apparently contradictory pattern of high road-kill numbers associated with a regular use of road passages is attributable to the variation in behavioral responses toward the highway between individuals. We investigated the responses of seven radio-tracked stone martens (Martes foina) to a highway by measuring their utilization distribution, response turning angles and highway crossing patterns. We compared the observed responses to simulated movement parameterized by the observed space use and movement characteristics of each individual, but naive to the presence of the highway. Our results suggested that martens demonstrate a diversity of responses to the highway, including attraction, indifference, or avoidance. Martens also varied in their highway crossing patterns, with some crossing repeatedly at the same location (often coincident with highway passages). We suspect that the response variability derives from the individual's familiarity of the landscape, including their awareness of highway passage locations. Because of these variable yet potentially attributable responses, we support the use of exclusionary fencing to guide transient (e.g., dispersers) individuals to existing passages to reduce the road-kill risk.	[Ascensao, Fernando; Santos-Reis, Margarida] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal; [Ascensao, Fernando; Clevenger, Anthony P.] Montana State Univ, Western Transportat Inst, Bozeman, MT 59717 USA; [Grilo, Clara] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Grilo, Clara] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [LaPoint, Scott] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany; [LaPoint, Scott] Univ Konstanz, Dept Biol, Constance, Germany; [Tracey, Jeff] US Geol Survey, Western Ecol Res Ctr, San Diego, CA USA	Universidade de Lisboa; Montana State University System; Montana State University Bozeman; Universidade de Aveiro; Universidade de Aveiro; Max Planck Society; University of Konstanz; United States Department of the Interior; United States Geological Survey	Ascensao, F (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal.	fernandoascensao@gmail.com	Santos-Reis, Margarida/H-4064-2011; Ascensão, Fernando/G-1513-2014; Grilo, Clara/H-2002-2012; Ascensão, Fernando/ABF-9787-2021	Ascensão, Fernando/0000-0003-1704-0212; Grilo, Clara/0000-0001-9870-3115; Ascensão, Fernando/0000-0003-1704-0212; LaPoint, Scott/0000-0002-5499-6777; Clevenger, Anthony P/0000-0003-0380-6272; Santos-Reis, Margarida/0000-0002-0337-963X	Fundacaopara a Ciencia e Tecnologia [SFRH/BD/38053/2007, SFRH/BPD/64205/2009]	Fundacaopara a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	FA and CG were funded by Fundacaopara a Ciencia e Tecnologia, respectively with the grants SFRH/BD/38053/2007 and SFRH/BPD/64205/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascensao F, 2007, ECOL RES, V22, P57, DOI 10.1007/s11284-006-0004-1; Ascensao F, 2013, ECOL MODEL, V257, P36, DOI 10.1016/j.ecolmodel.2013.02.026; Ascensao F, 2012, BIODIVERS CONSERV, V21, P3681, DOI 10.1007/s10531-012-0390-3; Beckmann J.P., 2010, SAFE PASSAGES HIGHWA; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Benhamou S, 2010, J WILDLIFE MANAGE, V74, P1353, DOI 10.2193/2009-441; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Beyer HL, 2013, J APPL ECOL, V50, P286, DOI 10.1111/1365-2664.12042; Bissonette JA, 2008, BIOL CONSERV, V141, P482, DOI 10.1016/j.biocon.2007.10.019; Blanco JC, 1992, LIVRO ROJO VERTEBRAD; Calenge C., 2011, HOME RANGE ESTIMATIO; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Clarke GP, 1998, BIOL CONSERV, V86, P117, DOI 10.1016/S0006-3207(98)00018-4; Clevenger A.P., 2009, BANFF WILDLIFE CROSS, P165; Clevenger AP, 2005, BIOL CONSERV, V121, P453, DOI 10.1016/j.biocon.2004.04.025; Clevenger AP, 2001, J APPL ECOL, V38, P1340, DOI 10.1046/j.0021-8901.2001.00678.x; Corlatti L, 2009, CONSERV BIOL, V23, P548, DOI 10.1111/j.1523-1739.2008.01162.x; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Dodd NL, 2007, J WILDLIFE MANAGE, V71, P637, DOI 10.2193/2006-340; Eigenbrod F, 2008, LANDSCAPE ECOL, V23, P159, DOI 10.1007/s10980-007-9174-7; Fahrig L, 2009, ECOL SOC, V14; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Gagnon JW, 2011, J WILDLIFE MANAGE, V75, P1477, DOI 10.1002/jwmg.160; Glista DJ, 2009, LANDSCAPE URBAN PLAN, V91, P1, DOI 10.1016/j.landurbplan.2008.11.001; Gotelli N.J., 1996, NULL MODELS ECOLOGY, DOI DOI 10.1098/rspb.2014.0675; Gotelli NJ, 2001, GLOBAL ECOL BIOGEOGR, V10, P337, DOI 10.1046/j.1466-822X.2001.00249.x; Grilo C, 2009, BIOL CONSERV, V142, P301, DOI 10.1016/j.biocon.2008.10.026; Grilo C, 2008, BIODIVERS CONSERV, V17, P1685, DOI 10.1007/s10531-008-9374-8; Grilo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043811; Grilo C, 2011, EUR J WILDLIFE RES, V57, P707, DOI 10.1007/s10344-010-0478-6; Hauer S, 2002, J ZOOL, V256, P361, DOI 10.1017/S0952836902000390; Herr J, 2009, J ZOOL, V277, P54, DOI 10.1111/j.1469-7998.2008.00510.x; Herr J, 2009, EUR J WILDLIFE RES, V55, P471, DOI 10.1007/s10344-009-0263-6; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; Holderegger R, 2010, BASIC APPL ECOL, V11, P522, DOI 10.1016/j.baae.2010.06.006; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Iuell B, 2003, COST 341 WILDLIFE TR; Jackson ND, 2011, BIOL CONSERV, V144, P3143, DOI 10.1016/j.biocon.2011.09.010; Klar N, 2008, BIOL CONSERV, V141, P308, DOI 10.1016/j.biocon.2007.10.004; Klar N, 2009, J WILDLIFE MANAGE, V73, P631, DOI 10.2193/2007-574; LaPoint S, 2013, LANDSCAPE ECOL, V28, P1615, DOI 10.1007/s10980-013-9910-0; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; Lesbarreres D, 2012, TRENDS ECOL EVOL, V27, P374, DOI 10.1016/j.tree.2012.01.015; Lewis JS, 2011, LANDSCAPE URBAN PLAN, V101, P99, DOI 10.1016/j.landurbplan.2011.01.008; Mangas J, 2009, ENCICLOPEDIA VIRTUAL; Martin J, 2008, ECOL MODEL, V213, P257, DOI 10.1016/j.ecolmodel.2007.12.002; Mateus ARA, 2011, ENVIRON MONIT ASSESS, V181, P101, DOI 10.1007/s10661-010-1816-6; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; MORELLE K, 2013, NAT CONSERV CRACOW, V5, P53, DOI DOI 10.3897/NATUREC0NSERVATI0N.5.4634; Mortelliti A, 2008, LANDSCAPE ECOL, V23, P285, DOI 10.1007/s10980-007-9182-7; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Philcox CK, 1999, J APPL ECOL, V36, P748, DOI 10.1046/j.1365-2664.1999.00441.x; Proulx G, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P21; Quantum GIS Development Team, 2011, QUANT GIS GEOGR INF; R Core Team, 2014, R LANG ENV STAT COMP; Richard E, 2013, ECOGRAPHY, V36, P157, DOI 10.1111/j.1600-0587.2012.07604.x; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Rodriguez A, 1996, J APPL ECOL, V33, P1527, DOI 10.2307/2404791; Roedenbeck IA, 2007, ECOL SOC, V12; Rondinini C, 2002, ECOGRAPHY, V25, P257, DOI 10.1034/j.1600-0587.2002.250301.x; Rytwinski T, 2013, OECOLOGIA, V173, P1143, DOI 10.1007/s00442-013-2684-x; Rytwinski T, 2012, BIOL CONSERV, V147, P87, DOI 10.1016/j.biocon.2011.11.023; Santos MJ, 2010, EUR J WILDLIFE RES, V56, P275, DOI 10.1007/s10344-009-0317-9; Santos-Reis M, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P147; Sawaya MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034777; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Serronha AM, 2012, ENV MONITORING ASSES; Shepard DB, 2008, ANIM CONSERV, V11, P288, DOI 10.1111/j.1469-1795.2008.00183.x; Simmons JM, 2010, ECOL SOC, V15; Soanes K, 2013, BIOL CONSERV, V159, P434, DOI 10.1016/j.biocon.2012.10.016; Steiner W, 2014, ACCIDENT ANAL PREV, V66, P168, DOI 10.1016/j.aap.2014.01.020; Stoner D, 1925, Science, V61, P56, DOI 10.1126/science.61.1568.56; SWIHART RK, 1985, J WILDLIFE MANAGE, V49, P1019, DOI 10.2307/3801388; Tracey JA, 2005, J AGR BIOL ENVIR ST, V10, P1, DOI 10.1198/108571105X29056; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; van der Grift EA, 2013, BIODIVERS CONSERV, V22, P425, DOI 10.1007/s10531-012-0421-0; van der Ree R, 2010, ECOLOGY SOC, V15; van der Ree R, 2011, ECOL SOC, V16; Virgos E, 2002, BIODIVERS CONSERV, V11, P1063, DOI 10.1023/A:1015856703786; Whittington J, 2004, ECOL SOC, V9; Wilensky U., 1999, NETLOGO CTR CONNECTE; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; [No title captured], DOI DOI 10.1016/j.jenvman.2010.11.027	86	22	23	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103544	10.1371/journal.pone.0103544	http://dx.doi.org/10.1371/journal.pone.0103544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072639	gold, Green Submitted, Green Published			2022-12-25	WOS:000341307600061
J	Cheung, VWN; Xue, B; Hernandez-Valladares, M; Go, MK; Tung, A; Aguda, AH; Robinson, RC; Yew, WS				Cheung, Vivian Wing Ngar; Xue, Bo; Hernandez-Valladares, Maria; Go, Maybelle Kho; Tung, Alvin; Aguda, Adeleke H.; Robinson, Robert C.; Yew, Wen Shan			Identification of Polyketide Inhibitors Targeting 3-Dehydroquinate Dehydratase in the Shikimate Pathway of Enterococcus faecalis	PLOS ONE			English	Article							ANTIMICROBIAL PROPERTIES; FLAVONOIDS; CHALCONES; MODEL; GLYPHOSATE; PRODUCTS; EXTRACTS	Due to the emergence of resistance toward current antibiotics, there is a pressing need to develop the next generation of antibiotics as therapeutics against infectious and opportunistic diseases of microbial origins. The shikimate pathway is exclusive to microbes, plants and fungi, and hence is an attractive and logical target for development of antimicrobial therapeutics. The Gram-positive commensal microbe, Enterococcus faecalis, is a major human pathogen associated with nosocomial infections and resistance to vancomycin, the "drug of last resort''. Here, we report the identification of several polyketide-based inhibitors against the E. faecalis shikimate pathway enzyme, 3-dehydroquinate dehydratase (DHQase). In particular, marein, a flavonoid polyketide, both inhibited DHQase and retarded the growth of Enterococcus faecalis. The purification, crystallization and structural resolution of recombinant DHQase from E. faecalis (at 2.2 angstrom resolution) are also reported. This study provides a route in the development of polyketide-based antimicrobial inhibitors targeting the shikimate pathway of the human pathogen E. faecalis.	[Cheung, Vivian Wing Ngar; Go, Maybelle Kho; Robinson, Robert C.; Yew, Wen Shan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore; [Xue, Bo; Hernandez-Valladares, Maria; Tung, Alvin; Aguda, Adeleke H.; Robinson, Robert C.] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Yew, Wen Shan] Natl Univ Singapore, Synthet Biol Res Consortium, Singapore 117548, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore	Robinson, RC (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore.	rrobinson@imcb.a-star.edu.sg; bchyws@nus.edu.sg	Robinson, Robert/G-9702-2011; Go, Maybelle Darlene/R-1064-2019; Hernandez-Valladares, Maria del Carmen/GXF-7320-2022	Robinson, Robert/0000-0001-6367-6903; Hernandez-Valladares, Maria del Carmen/0000-0001-9347-7841; Aguda, Adeleke/0000-0001-5187-3264; Xue, Bo/0000-0002-5172-2519	Ministry of Education; National Medical Research Council; National Research Foundation of Singapore; Biomedical Research Council of A*STAR	Ministry of Education; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation of Singapore(National Research Foundation, Singapore); Biomedical Research Council of A*STAR(Agency for Science Technology & Research (A*STAR))	This research was supported by grants from the Ministry of Education, the National Medical Research Council and the National Research Foundation of Singapore to W. S. Y, and grants from the Biomedical Research Council of A*STAR to R. C. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agrawal A.D, 2011, INT J PHARM SCI NANO, V4, P1394, DOI DOI 10.1056/NEJM197302222880814; Bruker AXS, 2010, PROTEUM2; CHAUDHURI S, 1991, BIOCHEM J, V275, P1; CHAUDHURI S, 1986, BIOCHEM J, V239, P699, DOI 10.1042/bj2390699; Coggins JR, 2003, BIOCHEM SOC T, V31, P548, DOI 10.1042/BST0310548; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; Dias T, 2012, J ETHNOPHARMACOL, V139, P485, DOI 10.1016/j.jep.2011.11.038; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eumkeb G, 2012, J APPL MICROBIOL, V112, P55, DOI 10.1111/j.1365-2672.2011.05190.x; Funayama Shinji, 1995, Natural Medicines, V49, P322; Gourley DG, 1999, NAT STRUCT BIOL, V6, P521; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Hodak K, 1967, Cesk Farm, V16, P86; HOLLANDER H, 1980, PLANT PHYSIOL, V66, P823, DOI 10.1104/pp.66.5.823; JAWORSKI EG, 1972, J AGR FOOD CHEM, V20, P1195, DOI 10.1021/jf60184a057; JURD L, 1971, PHYTOCHEMISTRY, V10, P2965, DOI 10.1016/S0031-9422(00)97333-3; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; KOSTOVA IN, 1993, J ETHNOPHARMACOL, V39, P205, DOI 10.1016/0378-8741(93)90037-6; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kubacey TM, 2012, BIOL ACTIVITY FLAVON; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Light SH, 2014, BIOCHEMISTRY-US, V53, P872, DOI 10.1021/bi4015506; Light SH, 2011, BIOCHEMISTRY-US, V50, P2357, DOI 10.1021/bi102020s; Light SH, 2011, J BIOL CHEM, V286, P3531, DOI 10.1074/jbc.M110.192831; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOORE JD, 1993, BIOCHEM J, V295, P277, DOI 10.1042/bj2950277; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Noble M, 2006, BIOTECHNOL BIOENG, V95, P560, DOI 10.1002/bit.20772; Orlikova B, 2012, ONCOL REP, V28, P797, DOI 10.3892/or.2012.1870; Osorio TM, 2012, BIOORG MED CHEM LETT, V22, P225, DOI 10.1016/j.bmcl.2011.11.059; Pereira AP, 2007, MOLECULES, V12, P1153, DOI 10.3390/12051153; Rauha JP, 2000, INT J FOOD MICROBIOL, V56, P3, DOI 10.1016/S0168-1605(00)00218-X; Segel IH, 1975, ENZYME KINETICS BEHA; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; Tran TD, 2012, BIOORG MED CHEM LETT, V22, P4555, DOI 10.1016/j.bmcl.2012.05.112; Tomas-Barberan FA, 2001, PHYTOCHEM ANALYSIS, V12, P214; Ueberschaar N, 2013, J AM CHEM SOC, V135, P17408, DOI 10.1021/ja4080024; Venugopala KN, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/963248; Walker JC, 1997, MICROBIOL IMMUNOL, V41, P809, DOI 10.1111/j.1348-0421.1997.tb01932.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu HX, 2001, PHYTOTHER RES, V15, P39, DOI 10.1002/1099-1573(200102)15:1&lt;39::AID-PTR684&gt;3.0.CO;2-R; Yew WS, 2002, J BACTERIOL, V184, P302, DOI 10.1128/JB.184.1.302-306.2002	46	4	6	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103598	10.1371/journal.pone.0103598	http://dx.doi.org/10.1371/journal.pone.0103598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072253	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600068
J	Lo Sasso, G; Menzies, KJ; Mottis, A; Piersigilli, A; Perino, A; Yamamoto, H; Schoonjans, K; Auwerx, J				Lo Sasso, Giuseppe; Menzies, Keir Joe; Mottis, Adrienne; Piersigilli, Alessandra; Perino, Alessia; Yamamoto, Hiroyasu; Schoonjans, Kristina; Auwerx, Johan			SIRT2 Deficiency Modulates Macrophage Polarization and Susceptibility to Experimental Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL INFLAMMATION; ULCERATIVE-COLITIS; CROHNS-DISEASE; EXPRESSION; DEACETYLASE; ACTIVATION; PERMEABILITY; MONOCYTES; CELLS	Background: SIRT2 belongs to a highly conserved family of NAD(+)-dependent deacylases, consisting of seven members (SIRT1-SIRT7), which vary in subcellular localizations and have substrates ranging from histones to transcription factors and enzymes. Recently SIRT2 was revealed to play an important role in inflammation, directly binding, deacetylating, and inhibiting the p65 subunit of NF-kB. Methods: A Sirt2 deficient mouse line (Sirt2(-/-)) was generated by deleting exons 5-7, encoding part of the SIRT2 deacetylase domain, by homologous recombination. Age-and sex-matched Sirt2(-/-) and Sirt2(+/+) littermate mice were subjected to dextran sulfate sodium (DSS)-induced colitis and analyzed for colitis susceptibility. Results: Sirt2(-/-) mice displayed more severe clinical and histological manifestations after DSS colitis compared to wild type littermates. Notably, under basal condition, Sirt2 deficiency does not affect the basal phenotype and intestinal morphology Sirt2 deficiency, however, affects macrophage polarization, creating a pro-inflammatory milieu in the immune cells compartment. Conclusion: These data confirm a protective role for SIRT2 against the development of inflammatory processes, pointing out a potential role for this sirtuin as a suppressor of colitis. In fact, SIRT2 deletion promotes inflammatory responses by increasing NF-kappa B acetylation and by reducing the M2-associated anti-inflammatory pathway. Finally, we speculate that the activation of SIRT2 may be a potential approach for the treatment of inflammatory bowel disease.	[Lo Sasso, Giuseppe; Menzies, Keir Joe; Mottis, Adrienne; Perino, Alessia; Yamamoto, Hiroyasu; Schoonjans, Kristina; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland; [Piersigilli, Alessandra] Univ Bern, Inst Anim Pathol, Bern, Switzerland; [Piersigilli, Alessandra] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Yamamoto, Hiroyasu] Osaka Univ, Grad Sch Med, Dept Biomed Informat, Div Hlth Sci, Suita, Osaka, Japan	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Bern; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Osaka University	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland.	admin.auwerx@epfl.ch	Auwerx, Johan/ABE-9307-2021	Auwerx, Johan/0000-0002-5065-5393; Menzies, Keir J/0000-0002-1873-8500; Schoonjans, Kristina/0000-0003-1247-4265	Outgoing AIRC/Marie Curie Fellowship; Heart and Stroke Foundation of Canada; EMBO fellowship; Ecole Polytechnique Federale de Lausanne; EU Ideas program [AdG-231138]; Swiss National Science Foundation [31003A-140780, 310030-143748, CSRII3-136201]; NIH [R01AG043930]; NATIONAL INSTITUTE ON AGING [R01AG043930] Funding Source: NIH RePORTER	Outgoing AIRC/Marie Curie Fellowship(Fondazione AIRC per la ricerca sul cancro); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); EMBO fellowship(European Molecular Biology Organization (EMBO)); Ecole Polytechnique Federale de Lausanne; EU Ideas program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	GLS is supported by an Outgoing AIRC/Marie Curie Fellowship. KJM is the recipient of a Heart and Stroke Foundation of Canada research fellowship award. AP is supported by EMBO fellowship. JA is the Nestle Chair in Energy Metabolism and the JA/KS laboratory is supported by grants from the Ecole Polytechnique Federale de Lausanne, the EU Ideas program (AdG-231138), the Swiss National Science Foundation (31003A-140780, 310030-143748, and CSRII3-136201), and NIH (R01AG043930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beirowski B, 2011, P NATL ACAD SCI USA, V108, pE952, DOI 10.1073/pnas.1104969108; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Cader MZ, 2013, GUT, V62, P1653, DOI 10.1136/gutjnl-2012-303955; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; COOPER HS, 1993, LAB INVEST, V69, P238; DONNELLY RP, 1993, J IMMUNOL, V151, P5603; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Imai S., 2014, TRENDS CELL BIOL; Kim MJ, 2013, FREE RADICAL BIO MED, V63, P432, DOI 10.1016/j.freeradbiomed.2013.06.005; Ko Y, 2014, WORLD J GASTROENTERO, V20, P1238, DOI 10.3748/wjg.v20.i5.1238; Kucharzik T, 2001, AM J PATHOL, V159, P2001, DOI 10.1016/S0002-9440(10)63051-9; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lin JT, 2013, BIOCHEM BIOPH RES CO, V441, P897, DOI 10.1016/j.bbrc.2013.10.153; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; MALEFYT RD, 1991, J EXP MED, V174, P1209; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Melgar S, 2008, INT IMMUNOPHARMACOL, V8, P836, DOI 10.1016/j.intimp.2008.01.036; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pais TF, 2013, EMBO J, V32, P2603, DOI 10.1038/emboj.2013.200; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; WEISS L, 1989, EUR J IMMUNOL, V19, P1347, DOI 10.1002/eji.1830190731; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Zigmond E, 2013, TRENDS IMMUNOL, V34, P162, DOI 10.1016/j.it.2013.02.001	31	71	71	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103573	10.1371/journal.pone.0103573	http://dx.doi.org/10.1371/journal.pone.0103573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072851	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600064
J	Choi, SH; Chung, AR; Kang, W; Park, JY; Lee, MS; Hwang, SW; Kim, DY; Kim, SU; Ahn, SH; Kim, S; Han, KH				Choi, Sung Hoon; Chung, Ae Ri; Kang, Wonseok; Park, Jun Yong; Lee, Mi Sol; Hwang, Shin Won; Kim, Do Young; Kim, Seung Up; Ahn, Sang Hoon; Kim, Seungtaek; Han, Kwang-Hyub			Silencing of Hypoxia-Inducible Factor-1 beta Induces Anti-Tumor Effects in Hepatoma Cell Lines under Tumor Hypoxia	PLOS ONE			English	Article							RECEPTOR NUCLEAR TRANSLOCATOR; ARYL-HYDROCARBON RECEPTOR; FACTOR-I; GENE-EXPRESSION; GROWTH-FACTOR; ARNT; ANGIOGENESIS; INDUCTION	Dimerization of hypoxia-inducible factor-1 beta (HIF-1 beta) [aryl hydrocarbon receptor nuclear translocator (ARNT)] with HIF-1 alpha is involved in various aspects of cancer biology, including proliferation and survival under hypoxic conditions. We investigated the in vitro mechanism by which silencing of HIF-1 beta leads to the suppression of tumor cell growth and cellular functions. Various hepatocellular carcinoma (HCC) cell lines (Huh-7, Hep3B, and HepG2) were transfected with small interfering RNA (siRNA) against HIF-1 beta (siHIF-1 beta) and cultured under hypoxic conditions (1% O-2 for 24 h). The expression levels of HIF-1 beta, HIF-1 alpha, and growth factors were examined by immunoblotting. Tumor growth was measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide assay, and tumor activity was measured by terminal deoxynucleotidyl transferase dUTP nick end labeling, tumor cell invasion, and migration assays. Under hypoxic conditions, silencing of HIF-1 beta expression suppressed tumor cell growth and regulated the expression of tumor growth-related factors, such as vascular endothelial growth factor, epidermal growth factor, and hepatocyte growth factor. Suppression of tumor cell invasion and migration was also demonstrated in HIF-1 beta-silenced HCC cell lines. Silencing of HIF-1 beta expression may induce anti-tumor effects under hypoxic conditions in HCC cell lines.	[Choi, Sung Hoon; Chung, Ae Ri; Ahn, Sang Hoon; Kim, Seungtaek; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Brain Korea Plus Project Med Sci 21, Seoul, South Korea; [Lee, Mi Sol; Hwang, Shin Won] Yonsei Univ, Coll Med, Dept Premed, Seoul, South Korea; [Kang, Wonseok; Park, Jun Yong; Kim, Do Young; Kim, Seung Up; Ahn, Sang Hoon; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Wonseok; Park, Jun Yong; Kim, Do Young; Kim, Seung Up; Ahn, Sang Hoon; Han, Kwang-Hyub] Yonsei Univ Hlth Syst, Yonsei Liver Canc Special Clin, Seoul, South Korea; [Kang, Wonseok; Park, Jun Yong; Kim, Do Young; Kim, Seung Up; Ahn, Sang Hoon; Kim, Seungtaek; Han, Kwang-Hyub] Yonsei Univ Hlth Syst, Liver Cirrhosis Clin Res Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Han, KH (corresponding author), Yonsei Univ, Coll Med, Brain Korea Plus Project Med Sci 21, Seoul, South Korea.	gihankhys@yuhs.ac	Park, Jun Yong/H-7127-2019	Kim, Seung Up/0000-0002-9658-8050; Ahn, Sang Hoon/0000-0002-3629-4624; Han, Kwang-Hyub/0000-0003-3960-6539; Park, Jun Yong/0000-0001-6324-2224	Yonsei University College of Medicine; Yonsei University College of Medicine [6-2012-0008]	Yonsei University College of Medicine(General Electric); Yonsei University College of Medicine(General Electric)	This research was supported by student research project funded by Yonsei University College of Medicine (2010-2011). This study was also supported by a faculty research grant of Yonsei University College of Medicine for 2012 (6-2012-0008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chilov D, 1999, J CELL SCI, V112, P1203; Dougherty EJ, 2008, TOXICOL SCI, V103, P191, DOI 10.1093/toxsci/kfm300; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Liang Y, 2012, INT J CANCER, V130, P1745, DOI 10.1002/ijc.26166; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Nukaya M, 2010, TOXICOL SCI, V118, P554, DOI 10.1093/toxsci/kfq305; Pillai R, 2011, J BIOL CHEM, V286, P1014, DOI 10.1074/jbc.M110.149062; POLLENZ RS, 1994, MOL PHARMACOL, V45, P428; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; REISZPORSZASZ S, 1994, MOL CELL BIOL, V14, P6075, DOI 10.1128/MCB.14.9.6075; Roessler Stephanie, 2007, Future Oncol, V3, P429, DOI 10.2217/14796694.3.4.429; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Shi S, 2010, MOL CARCINOGEN, V49, P157, DOI 10.1002/mc.20585; SOGAWA K, 1995, P NATL ACAD SCI USA, V92, P1936, DOI 10.1073/pnas.92.6.1936; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang LH, 2012, MOL CANCER THER, V11, P864, DOI 10.1158/1535-7163.MCT-11-0813; Wang Y, 2012, CANCER LETT, V320, P111, DOI 10.1016/j.canlet.2012.01.037; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Yamaguchi R, 1998, HEPATOLOGY, V28, P68, DOI 10.1002/hep.510280111; Yun CO, 2005, CANCER GENE THER, V12, P61, DOI 10.1038/sj.cgt.7700769; Zhong H, 2000, CANCER RES, V60, P1541	23	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103304	10.1371/journal.pone.0103304	http://dx.doi.org/10.1371/journal.pone.0103304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068796	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993700057
J	Kaushik, NK; Kaushik, N; Park, D; Choi, EH				Kaushik, Nagendra K.; Kaushik, Neha; Park, Daehoon; Choi, Eun H.			Altered Antioxidant System Stimulates Dielectric Barrier Discharge Plasma-Induced Cell Death for Solid Tumor Cell Treatment	PLOS ONE			English	Article							CANCER; APOPTOSIS; GLUTATHIONE; GENERATION; PATHWAYS; STRATEGY; ASSAY	This study reports the experimental findings and plasma delivery approach developed at the Plasma Bioscience Research Center, Korea for the assessment of antitumor activity of dielectric barrier discharge (DBD) for cancer treatment. Detailed investigation of biological effects occurring after atmospheric pressure non-thermal (APNT) plasma application during in vitro experiments revealed the role of reactive oxygen species (ROS) in modulation of the antioxidant defense system, cellular metabolic activity, and apoptosis induction in cancer cells. To understand basic cellular mechanisms, we investigated the effects of APNT DBD plasma on antioxidant defense against oxidative stress in various malignant cells as well as normal cells. T98G glioblastoma, SNU80 thyroid carcinoma, KB oral carcinoma and a non-malignant HEK293 embryonic human cell lines were treated with APNT DBD plasma and cellular effects due to reactive oxygen species were observed. Plasma significantly decreased the metabolic viability and clonogenicity of T98G, SNU80, KB and HEK293 cell lines. Enhanced ROS in the cells led to death via alteration of total antioxidant activity, and NADP(+)/NADPH and GSH/GSSG ratios 24 hours (h) post plasma treatment. This effect was confirmed by annexin V-FITC and propidium iodide staining. These consequences suggested that the failure of antioxidant defense machinery, with compromised redox status, might have led to sensitization of the malignant cells. These findings suggest a promising approach for solid tumor therapy by delivering a lethal dose of APNT plasma to tumor cells while sparing normal healthy tissues.	[Kaushik, Nagendra K.; Kaushik, Neha; Park, Daehoon; Choi, Eun H.] Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul, South Korea	Kwangwoon University	Kaushik, NK (corresponding author), Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul, South Korea.	kaushik.nagendra@kw.ac.kr; ehchoi@kw.ac.kr	Kaushik, Neha/AAL-8177-2020; Kaushik, Neha/AAY-5982-2020; Choi, Eun Ha/AFN-9488-2022	Kaushik, Neha/0000-0001-8671-6779; Choi, Eun Ha/0000-0001-5385-1878; Kaushik, Nagendra Kumar/0000-0002-4965-5046	National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [NRF-2010-0027963]; Kwangwoon University	National Research Foundation of Korea (NRF) grant - Korea government (MSIP); Kwangwoon University	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2010-0027963) and Kwangwoon University in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JS, 2002, CELL DEATH DIFFER, V9, P252, DOI 10.1038/sj.cdd.4400959; Arndt S, 2013, EXP DERMATOL, V22, P284, DOI 10.1111/exd.12127; Baskar R, 2012, INT J MED SCI, V9, P193, DOI 10.7150/ijms.3635; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Bundscherer L, 2013, IMMUNOBIOLOGY, V218, P1248, DOI 10.1016/j.imbio.2013.04.015; Chang JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092198; Chiaviello Angela, 2011, Cancers (Basel), V3, P1014, DOI 10.3390/cancers3011014; Depan D, 2011, MAT SCI ENG C-MATER, V31, P1305, DOI 10.1016/j.msec.2011.04.010; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Fuchs-Tarlovsky V, 2013, NUTRITION, V29, P15, DOI 10.1016/j.nut.2012.02.014; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HALLIWELL B, 1995, FREE RADICAL BIO MED, V18, P125, DOI 10.1016/0891-5849(95)91457-3; Kang SU, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.33; Kaushik NK, 2013, CURR APPL PHYS, V13, P176, DOI 10.1016/j.cap.2012.07.002; Kaushik NK, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3687172; Kaushik NK, 2013, MOLECULES, V18, P4917, DOI 10.3390/molecules18054917; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Liu CB, 2014, TUMOR BIOL, V35, P1791, DOI 10.1007/s13277-013-1238-5; Ma RN, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3693165; Ma YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091947; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ninomiya K, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/42/425401; Panngom K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.168; Passey S, 2007, CURRENT PROTOCOLS CE, V37; Scarlett JL, 2000, FEBS LETT, V475, P267, DOI 10.1016/S0014-5793(00)01681-1; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Utsumi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081576; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vickers CJ, 2013, ACS CHEM BIOL, V8, P1558, DOI 10.1021/cb400209w; Volotskova O, 2012, SCI REP-UK, V2, DOI 10.1038/srep00636; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; Wong HL, 2007, ADV DRUG DELIVER REV, V59, P491, DOI 10.1016/j.addr.2007.04.008; World Health Organization, 2008, GLOB BURD DIS 2004 U; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367	42	68	69	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103349	10.1371/journal.pone.0103349	http://dx.doi.org/10.1371/journal.pone.0103349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068311	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700062
J	Sglunda, O; Mann, H; Hulejova, H; Kuklova, M; Pecha, O; Plestilova, L; Filkova, M; Pavelka, K; Vencovsky, J; Senolt, L				Sglunda, Ondrej; Mann, Herman; Hulejova, Hana; Kuklova, Marketa; Pecha, Ondrej; Plestilova, Lenka; Filkova, Maria; Pavelka, Karel; Vencovsky, Jiri; Senolt, Ladislav			Decreased Circulating Visfatin Is Associated with Improved Disease Activity in Early Rheumatoid Arthritis: Data from the PERAC Cohort	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; TNF-ALPHA THERAPY; METABOLIC SYNDROME; INFLAMMATION; ADIPONECTIN; ADIPOCYTOKINES; PATHOGENESIS; RESISTIN; MARKERS; CELLS	Objective: To evaluate circulating visfatin and its relationship with disease activity and serum lipids in patients with early, treatment-naive rheumatoid arthritis (RA). Methods: Serum visfatin was measured in 40 patients with early RA before and after three months of treatment and in 30 age-and sex-matched healthy individuals. Disease activity was assessed using the Disease Activity Score for 28 joints (DAS28) at baseline and at three and 12 months. Multivariate linear regression analysis was performed to evaluate whether improved disease activity is related to serum visfatin or a change in visfatin level. Results: Serum visfatin was significantly elevated in early RA patients compared to healthy controls (1.92 +/- 1.17 vs. 1.36 +/- 0.93 ng/ml; p = 0.034) and significantly decreased after three months of treatment (to 0.99 +/- 0.67 ng/ml; p<0.001). Circulating visfatin and a change in visfatin level correlated with disease activity and improved disease activity over time, respectively. A decrease in visfatin after three months predicted a DAS28 improvement after 12 months. In addition, decreased serum visfatin was not associated with an improved atherogenic index but was associated with an increase in total cholesterol level. Conclusion: A short-term decrease in circulating visfatin may represent an independent predictor of long-term disease activity improvement in patients with early RA.	[Sglunda, Ondrej; Mann, Herman; Hulejova, Hana; Kuklova, Marketa; Plestilova, Lenka; Filkova, Maria; Pavelka, Karel; Vencovsky, Jiri; Senolt, Ladislav] Inst Rheumatol, Prague, Czech Republic; [Mann, Herman; Pavelka, Karel; Vencovsky, Jiri; Senolt, Ladislav] Charles Univ Prague, Fac Med 1, Dept Rheumatol, Prague, Czech Republic; [Pecha, Ondrej] ASCR, Ctr Technol, Prague, Czech Republic	Institute of Rheumatology; Charles University Prague; Czech Academy of Sciences	Senolt, L (corresponding author), Inst Rheumatol, Prague, Czech Republic.	senolt@revma.cz	Mann, Herman Felix/G-5871-2014; Filkova, Maria/M-9307-2017; Šenolt, Ladislav/O-6097-2017; Hulejová, Hana/H-1909-2019; Vencovsky, Jiri/G-6094-2017; Pavelka, Karel/E-6578-2017; Pecha, Ondrej/M-2568-2016	Mann, Herman Felix/0000-0002-4243-235X; Filkova, Maria/0000-0002-8488-9227; Šenolt, Ladislav/0000-0001-5500-7312; Hulejová, Hana/0000-0002-2335-6996; Vencovsky, Jiri/0000-0002-0851-0713; Pavelka, Karel/0000-0003-1952-8422; Pecha, Ondrej/0000-0002-9096-1432	Ministry of Health of the Czech Republic (MHCR) [NT-13696-4]; SVV project [264 511]; project of MHCR [023728]	Ministry of Health of the Czech Republic (MHCR); SVV project; project of MHCR	This work was supported by a Ministry of Health of the Czech Republic (MHCR) grant (NT-13696-4), SVV project (264 511) and project of MHCR for conceptual development of a research organization (023728). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Boers M, 2003, ANN RHEUM DIS, V62, P842, DOI 10.1136/ard.62.9.842; Brentano F, 2007, ARTHRITIS RHEUM, V56, P2829, DOI 10.1002/art.22833; Chang YH, 2011, DIABETES-METAB RES, V27, P515, DOI 10.1002/dmrr.1201; El-Hini SH, 2013, RHEUMATOL INT, V33, P2283, DOI 10.1007/s00296-013-2714-3; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Gonzalez-Gay MA, 2008, CLIN EXP RHEUMATOL, V26, P596; Gonzalez-Gay MA, 2008, CLIN EXP RHEUMATOL, V26, P311; Gonzalez-Gay MA, 2010, CLIN EXP RHEUMATOL, V28, P56; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Klaasen R, 2012, ANN RHEUM DIS, V71, P1510, DOI 10.1136/annrheumdis-2011-200646; Klein-Wieringa IR, 2011, ARTHRITIS RHEUM-US, V63, P2567, DOI 10.1002/art.30449; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Nowell MA, 2006, ARTHRITIS RHEUM-US, V54, P2084, DOI 10.1002/art.21942; Ospelt C, 2008, BEST PRACT RES CL RH, V22, P239, DOI 10.1016/j.berh.2008.01.004; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; Presumey J, 2013, ANN RHEUM DIS, V72, P1717, DOI 10.1136/annrheumdis-2012-202403; Rho YH, 2009, ARTHRITIS RHEUM-US, V60, P1906, DOI 10.1002/art.24626; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Senolt L, 2011, CYTOKINE, V55, P116, DOI 10.1016/j.cyto.2011.04.004; Smolen JS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2418	21	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103495	10.1371/journal.pone.0103495	http://dx.doi.org/10.1371/journal.pone.0103495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068448	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993700075
J	Gelb, T; Pshenichkin, S; Rodriguez, OC; Hathaway, HA; Grajkowska, E; DiRaddo, JO; Wroblewska, B; Yasuda, RP; Albanese, C; Wolfe, BB; Wroblewski, JT				Gelb, T.; Pshenichkin, S.; Rodriguez, O. C.; Hathaway, H. A.; Grajkowska, E.; DiRaddo, J. O.; Wroblewska, B.; Yasuda, R. P.; Albanese, C.; Wolfe, B. B.; Wroblewski, J. T.			Metabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas	ONCOGENE			English	Article							HUMAN MELANOCYTES; EXPRESSION; GRM1; GLUTAMATE-RECEPTOR-1; BLOCKADE; NETRIN-1; EXCITOTOXICITY; PROLIFERATION; SUPPRESSION; INHIBITION	Metabotropic glutamate 1 (mGlu) receptor has been proposed as a target for the treatment of metastatic melanoma. Studies have demonstrated that inhibiting the release of glutamate (the natural ligand of mGlu1 receptors), results in a decrease of melanoma tumor growth in mGlu1 receptor-expressing melanomas. Here we demonstrate that mGlu1 receptors, which have been previously characterized as oncogenes, also behave like dependence receptors by creating a dependence on glutamate for sustained cell viability. In the mGlu1 receptor-expressing melanoma cell lines SK-MEL-2 (SK2) and SK-MEL-5 (SK5), we show that glutamate is both necessary and sufficient to maintain cell viability, regardless of underlying genetic mutations. Addition of glutamate increased DNA synthesis, whereas removal of glutamate not only suppressed DNA synthesis but also promoted cell death in SK2 and SK5 melanoma cells. Using genetic and pharmacological inhibitors, we established that this effect of glutamate is mediated by the activation of mGlu1 receptors. The stimulatory potential of mGlu1 receptors was further confirmed in vivo in a melanoma cell xenograft model. In this model, subcutaneous injection of SK5 cells with short hairpin RNA-targeted downregulation of mGlu1 receptors resulted in a decrease in the rate of tumor growth relative to control. We also demonstrate for the first time that a selective mGlu1 receptor antagonist JNJ16259685 ((3,4-Dihydro-2H-pyrano[2,3-b]quinolin-7-yl)-(cis-4-methoxycyclohexyl)-methanone) slows SK2 and SK5 melanoma tumor growth in vivo. Taken together, these data suggest that pharmacological inhibition of mGlu1 receptors may be a novel approach for the treatment of metastatic melanoma.	[Gelb, T.; Pshenichkin, S.; Hathaway, H. A.; Grajkowska, E.; DiRaddo, J. O.; Wroblewska, B.; Yasuda, R. P.; Wolfe, B. B.; Wroblewski, J. T.] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20057 USA; [Rodriguez, O. C.; Albanese, C.] Georgetown Univ, Dept Lombardi Comprehens Canc Ctr, Washington, DC USA	Georgetown University; Georgetown University	Wroblewski, JT (corresponding author), Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, 3900 Reservoir Rd,NW, Washington, DC 20057 USA.	wroblewj@georgetown.edu		Hathaway, Hannah/0000-0003-0906-1726	NIH/NCI grant [P30-CA051008]; Pharmaceutical Research and Manufacturers of America Foundation Pre Doctoral Fellowship in Pharmacology/Toxicology; National Institutes of Health grant [NS37436, CA129003]; NATIONAL CANCER INSTITUTE [R01CA129003, P30CA051008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037436] Funding Source: NIH RePORTER	NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmaceutical Research and Manufacturers of America Foundation Pre Doctoral Fellowship in Pharmacology/Toxicology; National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Flow Cytometry and Cell Sorting Shared Resource (partially supported by the NIH/NCI grant P30-CA051008), particularly Karen Creswell, and the Histopathology and Tissue Shared Resource (partially supported by the NIH/NCI grant P30-CA051008) at The Georgetown-Lombardi Comprehensive Cancer Center (Georgetown University, Washington, DC, USA) for their expertise. Also, we thank Dr Suzie Chen from Rutgers University for her guidance and generosity and Maria Salinas (Georgetown) for her technical expertise. This work was partially supported by the Pharmaceutical Research and Manufacturers of America Foundation Pre Doctoral Fellowship in Pharmacology/Toxicology to TG, The National Institutes of Health grant NS37436 to JTW and CA129003 to CA.	American Cancer Society, 2013, CANC FACTS FIG 2013; Banda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081126; Blaabjerg M, 2003, EXP NEUROL, V183, P573, DOI 10.1016/S0014-4886(03)00204-8; Brocke KS, 2010, CANCER BIOL THER, V9; Chang HJ, 2005, CLIN CANCER RES, V11, P3288, DOI 10.1158/1078-0432.CCR-04-1912; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; de Groot J, 2011, GLIA, V59, P1181, DOI 10.1002/glia.21113; Delloye-Bourgeois C, 2009, J EXP MED, V206, P833, DOI 10.1084/jem.20082299; Delloye-Bourgeois C, 2009, JNCI-J NATL CANCER I, V101, P237, DOI 10.1093/jnci/djn491; Deng WB, 2006, J NEUROCHEM, V98, P213, DOI 10.1111/j.1471-4159.2006.03861.x; DiRaddo JO, 2013, GENE, V519, P367, DOI 10.1016/j.gene.2013.02.009; Emery AC, 2010, J BIOL CHEM, V285, P26041, DOI 10.1074/jbc.M110.139899; Fitamant J, 2008, P NATL ACAD SCI USA, V105, P4850, DOI 10.1073/pnas.0709810105; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Frati C, 2000, J CELL PHYSIOL, V183, P364, DOI 10.1002/(SICI)1097-4652(200006)183:3<364::AID-JCP9>3.3.CO;2-O; Goldschneider D, 2010, ONCOGENE, V29, P1865, DOI 10.1038/onc.2010.13; Hartsough EJ, 2014, MOL CANCER RES, V12, P795, DOI 10.1158/1541-7786.MCR-13-0581; Hoogduijn MJ, 2006, PIGM CELL RES, V19, P58, DOI 10.1111/j.1600-0749.2005.00284.x; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Khan AJ, 2011, CLIN CANCER RES, V17, P1807, DOI 10.1158/1078-0432.CCR-10-1276; Koochekpour S, 2012, CLIN CANCER RES, V18, P5888, DOI 10.1158/1078-0432.CCR-12-1308; Lavreysen H, 2004, NEUROPHARMACOLOGY, V47, P961, DOI 10.1016/j.neuropharm.2004.08.007; Le MN, 2010, J INVEST DERMATOL, V130, P2240, DOI 10.1038/jid.2010.126; Lee HJ, 2012, BBA-GENE REGUL MECH, V1819, P1123, DOI 10.1016/j.bbagrm.2012.06.005; Lee HJ, 2011, CLIN CANCER RES, V17, P7080, DOI 10.1158/1078-0432.CCR-11-0098; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Maira F, 2012, CURR DRUG DELIV, V9, P17, DOI 10.2174/156720112798376032; Martino JJ, 2013, ONCOGENE, V32, P4366, DOI 10.1038/onc.2012.471; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Ohtani Y, 2008, ONCOGENE, V27, P7162, DOI 10.1038/onc.2008.329; Ortiz P, 2007, EUR J HUM GENET, V15, P1176, DOI 10.1038/sj.ejhg.5201887; Park SY, 2007, ONCOL REP, V17, P81; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Prickett TD, 2012, CLIN CANCER RES, V18, P4240, DOI 10.1158/1078-0432.CCR-11-1217; Pshenichkin S, 2008, NEUROPHARMACOLOGY, V55, P500, DOI 10.1016/j.neuropharm.2008.06.039; Ringer L, 2011, CANCER BIOL THER, V12, P818, DOI 10.4161/cbt.12.9.17682; Rzeski W, 2002, BIOCHEM PHARMACOL, V64, P1195, DOI 10.1016/S0006-2952(02)01218-2; Seidlitz EP, 2009, CLIN EXP METASTAS, V26, P781, DOI 10.1007/s10585-009-9277-4; Shin SS, 2008, NEUROPHARMACOLOGY, V55, P396, DOI 10.1016/j.neuropharm.2008.04.021; Shin SS, 2008, PIGM CELL MELANOMA R, V21, P368, DOI 10.1111/j.1755-148X.2008.00452.x; Speyer CL, 2012, BREAST CANCER RES TR, V132, P565, DOI 10.1007/s10549-011-1624-x; Steckler T, 2005, BEHAV BRAIN RES, V164, P52, DOI 10.1016/j.bbr.2005.05.010; Steckler T, 2005, PSYCHOPHARMACOLOGY, V179, P198, DOI 10.1007/s00213-004-2056-7; Teh Jessica, 2012, Wiley Interdiscip Rev Membr Transp Signal, V1, P211; Wangari-Talbot J, 2012, MOL CANCER RES, V10, P1440, DOI 10.1158/1541-7786.MCR-12-0158; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wen Y, 2014, CANCER RES, V74, P2499, DOI 10.1158/0008-5472.CAN-13-1531; Willard SS, 2013, INT J BIOL SCI, V9, P948, DOI 10.7150/ijbs.6426; Yajima I, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/354191; Ye ZC, 1999, CANCER RES, V59, P4383	52	17	17	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2015	34	21					2711	2720		10.1038/onc.2014.231	http://dx.doi.org/10.1038/onc.2014.231			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI7XN	25065592	Green Accepted			2022-12-25	WOS:000354979500004
J	Eller, CH; Lomax, JE; Raines, RT				Eller, Chelcie H.; Lomax, Jo E.; Raines, Ronald T.			Bovine Brain Ribonuclease Is the Functional Homolog of Human Ribonuclease 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PANCREATIC RIBONUCLEASE; DOUBLE-STRANDED-RNA; DIFFERENTIAL SCANNING FLUOROMETRY; SEMINAL RIBONUCLEASE; ENDOTHELIAL-CELLS; EXTRACELLULAR RNA; ANTITUMOR-ACTIVITY; HIGH-THROUGHPUT; EXPRESSION; PROTEIN	Mounting evidence suggests that human pancreatic ribonuclease (RNase 1) plays important roles in vivo, ranging from regulating blood clotting and inflammation to directly counteracting tumorigenic cells. Understanding these putative roles has been pursued with continual comparisons of human RNase 1 to bovine RNase A, an enzyme that appears to function primarily in the ruminant gut. Our results imply a different physiology for human RNase 1. We demonstrate distinct functional differences between human RNase 1 and bovine RNase A. Moreover, we characterize another RNase 1 homolog, bovine brain ribonuclease, and find pronounced similarities between that enzyme and human RNase 1. We report that human RNase 1 and bovine brain ribonuclease share high catalytic activity against double-stranded RNA substrates, a rare quality among ribonucleases. Both human RNase 1 and bovine brain RNase are readily endocytosed by mammalian cells, aided by tight interactions with cell surface glycans. Finally, we show that both human RNase 1 and bovine brain RNase are secreted from endothelial cells in a regulated manner, implying a potential role in vascular homeostasis. Our results suggest that brain ribonuclease, not RNase A, is the true bovine homolog of human RNase 1, and provide fundamental insight into the ancestral roles and functional adaptations of RNase 1 in mammals.	[Eller, Chelcie H.; Raines, Ronald T.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Raines, Ronald T.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Lomax, Jo E.] Univ Wisconsin, Grad Program Cellular & Mol Biol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Raines, RT (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	rtraines@wisc.edu	Raines, Ronald T./A-5009-2013	Raines, Ronald T./0000-0001-7164-1719	National Institutes of Health [R01 CA073808]; National Science Foundation Graduate Research Fellowship; NATIONAL CANCER INSTITUTE [R01CA073808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA073808.; Supported by an National Science Foundation Graduate Research Fellowship.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; AlZahal O, 2008, J DAIRY SCI, V91, P202, DOI 10.3168/jds.2007-0535; Antignani A, 2001, BIOCHEMISTRY-US, V40, P3492, DOI 10.1021/bi002781m; BARNARD EA, 1969, NATURE, V221, P340, DOI 10.1038/221340a0; Barrabes S, 2007, GLYCOBIOLOGY, V17, P388, DOI 10.1093/glycob/cwm002; Beintema JJ, 2002, SCIENCE, V297, P1121; Benner SA, 2002, SCIENCE, V296, P864, DOI 10.1126/science.1069863; BRAVO J, 1994, ANAL BIOCHEM, V219, P82, DOI 10.1006/abio.1994.1234; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chao TY, 2011, BIOCHEMISTRY-US, V50, P8374, DOI 10.1021/bi2009079; Chao TY, 2010, BIOCHEMISTRY-US, V49, P10666, DOI 10.1021/bi1013485; Chen C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000683; Confalone E, 1995, J MOL EVOL, V41, P850, DOI 10.1007/BF00173164; Cuchillo CM, 2011, BIOCHEMISTRY-US, V50, P7835, DOI 10.1021/bi201075b; D'Avino C, 2014, PROTEIN ENG DES SEL, V27, P83, DOI 10.1093/protein/gzt065; D'Errico G, 2011, BBA-BIOMEMBRANES, V1808, P3007, DOI 10.1016/j.bbamem.2011.08.009; DALESSIO G, 1991, TRENDS BIOCHEM SCI, V16, P104, DOI 10.1016/0968-0004(91)90042-T; Danese S, 2007, J IMMUNOL, V178, P6017, DOI 10.4049/jimmunol.178.10.6017; DELROSAR.EJ, 1969, BIOCHEMISTRY-US, V8, P1884, DOI 10.1021/bi00833a017; Dey P, 2007, BIOCHEM BIOPH RES CO, V360, P809, DOI 10.1016/j.bbrc.2007.06.141; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELSON M, 1975, BIOCHEMISTRY-US, V14, P1471, DOI 10.1021/bi00678a019; Esbjorner EK, 2007, BIOCHEMISTRY-US, V46, P13490, DOI 10.1021/bi701075y; Fischer S, 2013, CANCER RES, V73, P5080, DOI 10.1158/0008-5472.CAN-12-4657; Fischer S, 2011, THROMB HAEMOSTASIS, V105, P345, DOI 10.1160/TH10-06-0345; Haigis MC, 2003, J CELL SCI, V116, P313, DOI 10.1242/jcs.00214; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; JERMANN TM, 1995, NATURE, V374, P57, DOI 10.1038/374057a0; Johnson RJ, 2007, BIOCHEMISTRY-US, V46, P13131, DOI 10.1021/bi701521q; Johnson RJ, 2007, J MOL BIOL, V368, P434, DOI 10.1016/j.jmb.2007.02.005; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; KATOH H, 1990, CARBOHYD RES, V195, P273, DOI 10.1016/0008-6215(90)84171-P; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kelemen BR, 1999, NUCLEIC ACIDS RES, V27, P3696, DOI 10.1093/nar/27.18.3696; Kleineidam RG, 1999, J MOL EVOL, V48, P360, DOI 10.1007/PL00006480; Ladokhin AS, 1997, METHOD ENZYMOL, V278, P474; Landre JBP, 2002, J CELL BIOCHEM, V86, P540, DOI 10.1002/jcb.10234; Lavis LD, 2007, ANAL CHEM, V79, P6775, DOI 10.1021/ac070907g; Lee JE, 2005, BIOCHEMISTRY-US, V44, P15760, DOI 10.1021/bi051668z; Libonati M, 2001, METHOD ENZYMOL, V341, P234, DOI 10.1016/S0076-6879(01)41155-4; Lomax J. E., 2014, THESIS U TISONSIN MA; Lomax JE, 2014, J MOL BIOL, V426, P3041, DOI 10.1016/j.jmb.2014.06.007; Lomax JE, 2012, METHOD ENZYMOL, V502, P273, DOI 10.1016/B978-0-12-416039-2.00014-8; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marshall GR, 2008, BIOPOLYMERS, V90, P259, DOI 10.1002/bip.20845; Matousek J, 2001, COMP BIOCHEM PHYS C, V129, P175, DOI 10.1016/S1532-0456(01)90202-9; MAZZARELLA L, 1987, GAZZ CHIM ITAL, V117, P91; Menzen T, 2013, J PHARM SCI-US, V102, P415, DOI 10.1002/jps.23405; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; PETERSON LM, 1979, P NATL ACAD SCI USA, V76, P2630, DOI 10.1073/pnas.76.6.2630; PICCOLI R, 1992, P NATL ACAD SCI USA, V89, P1870, DOI 10.1073/pnas.89.5.1870; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; RAPS G, 1947, J DAIRY SCI, V30, P933, DOI 10.3168/jds.S0022-0302(47)92421-1; RIBO M, 1994, BIOL CHEM H-S, V375, P357; Rutkoski TJ, 2008, CURR PHARM BIOTECHNO, V9, P185, DOI 10.2174/138920108784567344; Rutkoski TJ, 2013, TRANSL ONCOL, V6, P392, DOI 10.1593/tlo.13253; SASSO MP, 1991, NUCLEIC ACIDS RES, V19, P6469, DOI 10.1093/nar/19.23.6469; Satkunanathan S, 2014, J VIROL, V88, P2366, DOI 10.1128/JVI.02789-13; Simsekyilmaz S, 2014, CIRCULATION, V129, P598, DOI 10.1161/CIRCULATIONAHA.113.002562; SNOOK JT, 1965, J NUTR, V87, P297, DOI 10.1093/jn/87.3.297; Sorrentino S, 2003, BIOCHEMISTRY-US, V42, P10182, DOI 10.1021/bi030040q; Strong L. E., 2012, J CLIN ONCOL S, V30, DOI 10.1158/1535-7163.targ-09-c42; Strong LE, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-1838; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun XZ, 2013, J IMMUNOL, V190, P2536, DOI 10.4049/jimmunol.1202689; Sundlass NK, 2013, BIOCHEMISTRY-US, V52, P6304, DOI 10.1021/bi400619m; Vallee BL, 1997, CELL MOL LIFE SCI, V53, P803, DOI 10.1007/s000180050101; Walberer M, 2009, CURR NEUROVASC RES, V6, P12, DOI 10.2174/156720209787466037; WATANABE H, 1988, J BIOCHEM-TOKYO, V104, P939, DOI 10.1093/oxfordjournals.jbchem.a122587; Wheeler TT, 2012, J MOL EVOL, V74, P237, DOI 10.1007/s00239-012-9502-7; Zhang JZ, 2003, MOL BIOL EVOL, V20, P1310, DOI 10.1093/molbev/msg143; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; Zhao W, 2001, BBA-PROTEIN STRUCT M, V1547, P95, DOI 10.1016/S0167-4838(01)00173-X	77	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					25996	26006		10.1074/jbc.M114.566166	http://dx.doi.org/10.1074/jbc.M114.566166			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25078100	Green Published, hybrid			2022-12-25	WOS:000342128800001
J	Bouvet, M; Lugari, A; Posthuma, CC; Zevenhoven, JC; Bernard, S; Betzi, S; Imbert, I; Canard, B; Guillemot, JC; Lecine, P; Pfefferle, S; Drosten, C; Snijder, EJ; Decroly, E; Morelli, X				Bouvet, Mickael; Lugari, Adrien; Posthuma, Clara C.; Zevenhoven, Jessika C.; Bernard, Stephanie; Betzi, Stephane; Imbert, Isabelle; Canard, Bruno; Guillemot, Jean-Claude; Lecine, Patrick; Pfefferle, Susanne; Drosten, Christian; Snijder, Eric J.; Decroly, Etienne; Morelli, Xavier			Coronavirus Nsp10, a Critical Co-factor for Activation of Multiple Replicative Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; NONSTRUCTURAL PROTEIN NSP10; MOUSE HEPATITIS-VIRUS; RNA CAPPING APPARATUS; SARS-CORONAVIRUS; MESSENGER-RNA; MIDDLE-EAST; 2'-O METHYLATION; COV; TRANSCRIPTION	RNA- The RNA-synthesizing machinery of the severe acute respiratory syndrome Coronavirus (SARS-CoV) is composed of 16 nonstructural proteins (nsp1-16) encoded by ORF1a/1b. The 148-amino acid nsp10 subunit contains two zinc fingers and is known to interact with both nsp14 and nsp16, stimulating their respective 3'-5' exoribonuclease and 2'-O-methyltransferase activities. Using alanine-scanning mutagenesis, in cellulo bioluminescence resonance energy transfer experiments, and in vitro pulldown assays, we have now identified the key residues on the nsp10 surface that interact with nsp14. The functional consequences of mutations introduced at these positions were first evaluated biochemically by monitoring nsp14 exoribonuclease activity. Disruption of the nsp10-nsp14 interaction abrogated the nsp10-driven activation of the nsp14 exoribonuclease. We further showed that the nsp10 surface interacting with nsp14 overlaps with the surface involved in the nsp10-mediated activation of nsp16 2'-O-methyltransferase activity, suggesting that nsp10 is a major regulator of SARS-CoV replicase function. In line with this notion, reverse genetics experiments supported an essential role of the nsp10 surface that interacts with nsp14 in SARS-CoV replication, as several mutations that abolished the interaction in vitro yielded a replication-negative viral phenotype. In contrast, mutants in which the nsp10-nsp16 interaction was disturbed proved to be crippled but viable. These experiments imply that the nsp10 surface that interacts with nsp14 and nsp16 and possibly other subunits of the viral replication complex may be a target for the development of antiviral compounds against pathogenic coronaviruses.	[Bouvet, Mickael; Imbert, Isabelle; Canard, Bruno; Guillemot, Jean-Claude; Decroly, Etienne] Aix Marseille Univ, AFMB, UMR 7257, F-13288 Marseille, France; [Bouvet, Mickael; Imbert, Isabelle; Canard, Bruno; Guillemot, Jean-Claude; Decroly, Etienne] CNRS, AFMB, UMR 7257, F-13288 Marseille, France; [Lugari, Adrien; Bernard, Stephanie; Betzi, Stephane; Morelli, Xavier] Aix Marseille Univ, Inst Paoli Calmettes, CRCM, CNRS,UMR7258,INSERM,U1068, F-13009 Marseille, France; [Posthuma, Clara C.; Zevenhoven, Jessika C.; Snijder, Eric J.] Leiden Univ, Med Ctr, Mol Virol Lab, Dept Med Microbiol, NL-2300 RC Leiden, Netherlands; [Lecine, Patrick] Univ Lyon 1, ENS Lyon, CIRI, CNRS,UMR5308,INSERM,U1111, F-69007 Lyon, France; [Pfefferle, Susanne; Drosten, Christian] Univ Bonn, Med Ctr, Inst Virol, D-53127 Bonn, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Bonn	Decroly, E (corresponding author), Aix Marseille Univ, AFMB, UMR 7257, F-13288 Marseille, France.	decroly@afmb.univ-mrs.fr; xavier.morelli@inserm.fr	Betzi, Stephane/AAC-6103-2022; Lecine, Patrick/H-9338-2016; morelli, xavier/A-9218-2016; Snijder, Eric J./E-6073-2018; IMBERT, Isabelle/B-1247-2018	Betzi, Stephane/0000-0001-5935-5058; morelli, xavier/0000-0001-8101-7901; Snijder, Eric J./0000-0003-3297-2309; IMBERT, Isabelle/0000-0001-5630-9945; Lecine, Patrick/0000-0002-8091-7286; DECROLY, Etienne/0000-0002-6046-024X; Lugari, Adrien/0000-0001-8337-6043; Bouvet-Gueguen, Mickael/0000-0001-6541-689X; Canard, Bruno/0000-0003-4924-1991	French National Research Agency [ANR-08-MIEN-032, ANR 12 BSV3 07-1, ANR 12 BSV3 07-2, ANR 12 BSV3 07-3]; Fondation pour la Recherche Medicale (Programme Equipe FRM); European Union [260644]; Infectiopole Sud; Netherlands Organization for Scientific Research (NWO) [700.10.352]; Direction Generale pour l'Armement; Present address: Helmholtz Zentrum Munchen (GmbH); German Research Center for Environmental Health Haematologikum; Research Unit Gene Vectors, Marchioninistrasse, Munchen, Germany; "Fondation pour la Recherche Medicale" (FRM); Aix-Marseille University	French National Research Agency(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (Programme Equipe FRM)(Fondation pour la Recherche Medicale); European Union(European Commission); Infectiopole Sud; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Direction Generale pour l'Armement; Present address: Helmholtz Zentrum Munchen (GmbH); German Research Center for Environmental Health Haematologikum; Research Unit Gene Vectors, Marchioninistrasse, Munchen, Germany; "Fondation pour la Recherche Medicale" (FRM)(Fondation pour la Recherche Medicale); Aix-Marseille University	This work was supported by French National Research Agency ANR-08-MIEN-032, ANR 12 BSV3 07-1, -2, and -3, Fondation pour la Recherche Medicale (Programme Equipe FRM), by the European Union Seventh Framework Programme FP7/2007-2013 (Project SILVER (small inhibitor leads against emerging RNA viruses) Grant 260644), Infectiopole Sud, and by the Netherlands Organization for Scientific Research (NWO; TOP-GO Grant 700.10.352).; Recipient of a fellowship from the Direction Generale pour l'Armement. Present address: Helmholtz Zentrum Munchen (GmbH), German Research Center for Environmental Health Haematologikum, Research Unit Gene Vectors, Marchioninistrasse 25, 81377 Munchen, Germany.; Recipient if a fellowship from Agence Nationale de Recherche sur le SIDA et les Hepatites virales (ANRS).; Recipient if a fellowship from the "Fondation pour la Recherche Medicale" (FRM).; Recipient of a "Fond Incitatif de la Recherche-Equipe Jeunes Chercheurs" grant from Aix-Marseille University. To whom correspondence may be addressed. E-mail: xavier.morelli@inserm.fr.	Bacart Johan, 2008, Biotechnol J, V3, P311, DOI 10.1002/biot.200700222; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Bouvet M, 2012, P NATL ACAD SCI USA, V109, P9372, DOI 10.1073/pnas.1201130109; Bouvet M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000863; BRIERLEY I, 1987, EMBO J, V6, P3779, DOI 10.1002/j.1460-2075.1987.tb02713.x; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; Chang Guo-hui, 2010, Virologica Sinica, V25, P361, DOI 10.1007/s12250-010-3124-2; Chen Y, 2013, J VIROL, V87, P6296, DOI 10.1128/JVI.00061-13; Chen Y, 2009, P NATL ACAD SCI USA, V106, P3484, DOI 10.1073/pnas.0808790106; Corman VM, 2014, J VIROL, V88, P717, DOI 10.1128/JVI.01600-13; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Debarnot C, 2011, ACTA CRYSTALLOGR F, V67, P404, DOI 10.1107/S1744309111002867; Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675; Decroly E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002059; Denison MR, 2011, RNA BIOL, V8, P270, DOI 10.4161/rna.8.2.15013; Donaldson EF, 2007, J VIROL, V81, P6356, DOI 10.1128/JVI.02805-06; Donaldson EF, 2007, J VIROL, V81, P7086, DOI 10.1128/JVI.00049-07; Eckerle LD, 2007, J VIROL, V81, P12135, DOI 10.1128/JVI.01296-07; Eckerle LD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000896; Fang Y, 2006, ADV EXP MED BIOL, V581, P153; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Graham RL, 2012, NAT MED, V18, P1820, DOI 10.1038/nm.2972; Gu MG, 2005, CURR OPIN STRUC BIOL, V15, P99, DOI 10.1016/j.sbi.2005.01.009; Hussain S, 2005, J VIROL, V79, P5288, DOI 10.1128/JVI.79.9.5288-5295.2005; Imberta I, 2008, VIRUS RES, V133, P136, DOI 10.1016/j.virusres.2007.11.017; Ivanov KA, 2004, J VIROL, V78, P7833, DOI 10.1128/JVI.78.14.7833-7838.2004; Joseph JS, 2006, J VIROL, V80, P7894, DOI 10.1128/JVI.00467-06; Ke M, 2012, VIRUS RES, V167, P322, DOI 10.1016/j.virusres.2012.05.017; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; LAI MMC, 1981, J VIROL, V38, P661, DOI 10.1128/JVI.38.2.661-670.1981; LAI MMC, 1982, J VIROL, V41, P557, DOI 10.1128/JVI.41.2.557-565.1982; Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12; Lugari A, 2010, J BIOL CHEM, V285, P33230, DOI 10.1074/jbc.M110.120014; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; Menachery VD, 2014, J VIROL, V88, P4251, DOI 10.1128/JVI.03571-13; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Pan JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003299; Pasternak AO, 2006, J GEN VIROL, V87, P1403, DOI 10.1099/vir.0.81611-0; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Pfefferle S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-131; Nga PT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002215; Plant EP, 2013, VIRUSES-BASEL, V5, P279, DOI 10.3390/v5010279; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Sawicki SG, 2007, J VIROL, V81, P20, DOI 10.1128/JVI.01358-06; Sawicki SG, 2005, PLOS PATHOG, V1, P310, DOI 10.1371/journal.ppat.0010039; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Shuman S, 2001, COLD SPRING HARB SYM, V66, P301, DOI 10.1101/sqb.2001.66.301; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003565; Smith I, 2013, CURR OPIN VIROL, V3, P84, DOI 10.1016/j.coviro.2012.11.006; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Snijder EJ, 2006, J VIROL, V80, P5927, DOI 10.1128/JVI.02501-05; Stadler K, 2003, NAT REV MICROBIOL, V1, P209, DOI 10.1038/nrmicro775; Su D, 2006, J VIROL, V80, P7902, DOI 10.1128/JVI.00483-06; Subissi L, 2014, ANTIVIR RES, V101, P122, DOI 10.1016/j.antiviral.2013.11.006; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; van der Meer Y, 1999, J VIROL, V73, P7641, DOI 10.1128/JVI.73.9.7641-7657.1999; van Hemert MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000054; van Vliet ALW, 2002, EMBO J, V21, P6571, DOI 10.1093/emboj/cdf635; von Grotthuss M, 2003, CELL, V113, P701, DOI 10.1016/S0092-8674(03)00424-0; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	66	118	123	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25783	25796		10.1074/jbc.M114.577353	http://dx.doi.org/10.1074/jbc.M114.577353			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074927	Green Published, hybrid			2022-12-25	WOS:000342130800036
J	Shulami, S; Shenker, O; Langut, Y; Lavid, N; Gat, O; Zaide, G; Zehavi, A; Sonenshein, AL; Shoham, Y				Shulami, Smadar; Shenker, Ofer; Langut, Yael; Lavid, Noa; Gat, Orit; Zaide, Galia; Zehavi, Arie; Sonenshein, Abraham L.; Shoham, Yuval			Multiple Regulatory Mechanisms Control the Expression of the Geobacillus stearothermophilus Gene for Extracellular Xylanase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; FAMILY-52 GLYCOSIDE HYDROLASE; CELL WALL DECONSTRUCTION; QUORUM-SENSING SYSTEM; CODY-BINDING SITES; HUMAN GUT SYMBIONT; X-RAY ANALYSIS; BACILLUS-SUBTILIS; BETA-XYLOSIDASE; ENTEROCOCCUS-FAECALIS	Geobacillus stearothermophilus T-6 produces a single extracellular xylanase (Xyn10A) capable of producing short, decorated xylo-oligosaccharides from the naturally branched polysaccharide, xylan. Gel retardation assays indicated that the master negative regulator, XylR, binds specifically to xylR operators in the promoters of xylose and xylan-utilization genes. This binding is efficiently prevented in vitro by xylose, the most likely molecular inducer. Expression of the extracellular xylanase is repressed in medium containing either glucose or casamino acids, suggesting that carbon catabolite repression plays a role in regulating xynA. The global transcriptional regulator CodY was shown to bind specifically to the xynA promoter region in vitro, suggesting that CodY is a repressor of xynA. The xynA gene is located next to an uncharacterized gene, xynX, that has similarity to the NIF3 (Ngg1p interacting factor 3)-like protein family. XynX binds specifically to a 72-bp fragment in the promoter region of xynA, and the expression of xynA in a xynX null mutant appeared to be higher, indicating that XynX regulates xynA. The specific activity of the extracellular xylanase increases over 50-fold during early exponential growth, suggesting cell density regulation (quorum sensing). Addition of conditioned medium to fresh and low cell density cultures resulted in high expression of xynA, indicating that a diffusible extracellular xynA density factor is present in the medium. The xynA density factor is heat-stable, sensitive to proteases, and was partially purified using reverse phase liquid chromatography. Taken together, these results suggest that xynA is regulated by quorum-sensing at low cell densities.	[Shulami, Smadar; Shenker, Ofer; Langut, Yael; Lavid, Noa; Gat, Orit; Zaide, Galia; Zehavi, Arie; Shoham, Yuval] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel; [Sonenshein, Abraham L.] Tufts Univ, Dept Mol Biol & Microbiol, Sch Med, Boston, MA 02111 USA	Technion Israel Institute of Technology; Tufts University	Shoham, Y (corresponding author), Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel.	yshoham@tx.technion.ac.il	Shoham, Yuval/M-4409-2013		United States-Israel Binational Science Foundation Jerusalem, Israel [96-178]; Israel Science Foundation [500/10, 152/11]; I-CORE Program of the Planning and Budgeting Committee; Ministry of Environmental Protection; Grand Technion Energy Program; Leona M. and Harry B. Helmsley Charitable Trust reports on Alternative Energy series of the Technion; Israel Institute of Technology; Weizmann Institute of Science; Russell Berrie Nanotechnology Institute; Lorry I. Lokey Interdisciplinary Center for Life Science and Engineering, Technion	United States-Israel Binational Science Foundation Jerusalem, Israel(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); I-CORE Program of the Planning and Budgeting Committee; Ministry of Environmental Protection; Grand Technion Energy Program; Leona M. and Harry B. Helmsley Charitable Trust reports on Alternative Energy series of the Technion; Israel Institute of Technology; Weizmann Institute of Science; Russell Berrie Nanotechnology Institute; Lorry I. Lokey Interdisciplinary Center for Life Science and Engineering, Technion	This work was supported in part by United States-Israel Binational Science Foundation Jerusalem, Israel, Grant 96-178 (to A. L. S. and Y. S.), Israel Science Foundation Grants 500/10 and 152/11, the I-CORE Program of the Planning and Budgeting Committee, the Ministry of Environmental Protection and the Grand Technion Energy Program, and part of The Leona M. and Harry B. Helmsley Charitable Trust reports on Alternative Energy series of the Technion, Israel Institute of Technology, and the Weizmann Institute of Science.; Supported in part by the Russell Berrie Nanotechnology Institute and The Lorry I. Lokey Interdisciplinary Center for Life Science and Engineering, Technion. Holds the Erwin and Rosl Pollak Chair in Biotechnology at the Technion. To whom correspondence should be addressed. Tel.: 972-4-8293072; Fax: 972-4-8293399; E-mail:yshoham@tx.technion.ac.il.	Akiyama H, 2003, J BIOL CHEM, V278, P10752, DOI 10.1074/jbc.M209856200; Alalouf O, 2011, J BIOL CHEM, V286, P41993, DOI 10.1074/jbc.M111.301051; Alhassid A, 2009, BIOCHEM J, V422, P73, DOI 10.1042/BJ20090180; Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; Ansaldi M, 2002, MOL MICROBIOL, V44, P1561, DOI 10.1046/j.1365-2958.2002.02977.x; ASHWELL G, 1957, METHOD ENZYMOL, V3, P73, DOI 10.1016/S0076-6879(57)03350-9; Bayer E., 2000, GLYCOMICROBIOLOGY, P387; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Belitsky BR, 2008, J BACTERIOL, V190, P1224, DOI 10.1128/JB.01780-07; Belitsky BR, 2013, P NATL ACAD SCI USA, V110, P7026, DOI 10.1073/pnas.1300428110; Ben-David A, 2008, CHEM BIOL, V15, P546, DOI 10.1016/j.chembiol.2008.05.005; Bravman T, 2003, BIOCHEMISTRY-US, V42, P10528, DOI 10.1021/bi034505o; Bravman T, 2003, J BIOL CHEM, V278, P26742, DOI 10.1074/jbc.M304144200; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Cook LC, 2014, FEMS MICROBIOL REV, V38, P473, DOI 10.1111/1574-6976.12046; Czjzek M, 2005, J MOL BIOL, V353, P838, DOI 10.1016/j.jmb.2005.09.003; DAHL MK, 1995, J BACTERIOL, V177, P5467, DOI 10.1128/jb.177.19.5467-5472.1995; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Dunny GM, 2007, PHILOS T R SOC B, V362, P1185, DOI 10.1098/rstb.2007.2043; Ferrari Eugenio, 1993, P917; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; GAT O, 1994, APPL ENVIRON MICROB, V60, P1889, DOI 10.1128/AEM.60.6.1889-1896.1994; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Glass NL, 2013, ANNU REV MICROBIOL, V67, P477, DOI 10.1146/annurev-micro-092611-150044; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Golan G, 2004, J BIOL CHEM, V279, P3014, DOI 10.1074/jbc.M310098200; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hovel K, 2003, EMBO J, V22, P4922, DOI 10.1093/emboj/cdg494; HUECK CJ, 1995, MOL MICROBIOL, V15, P395, DOI 10.1111/j.1365-2958.1995.tb02252.x; Ibrahim M, 2007, J BACTERIOL, V189, P8844, DOI 10.1128/JB.01057-07; Johnson JL, 1981, MANUAL METHODS GENER, P450; Kahel-Raifer H, 2010, FEMS MICROBIOL LETT, V308, P84, DOI 10.1111/j.1574-6968.2010.01997.x; Kazanov MD, 2013, NUCLEIC ACIDS RES, V41, P790, DOI 10.1093/nar/gks1184; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; KHASIN A, 1993, APPL ENVIRON MICROB, V59, P1725, DOI 10.1128/AEM.59.6.1725-1730.1993; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; KOIDE A, 1994, MOL MICROBIOL, V13, P417, DOI 10.1111/j.1365-2958.1994.tb00436.x; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Kopetz H, 2013, NATURE, V494, P29, DOI 10.1038/494029a; Kraus A, 1998, MOL MICROBIOL, V30, P955, DOI 10.1046/j.1365-2958.1998.01123.x; Langut Y., 2006, THESIS TECHNION ISRA; Lansky S, 2014, ACTA CRYSTALLOGR D, V70, P261, DOI 10.1107/S139900471302840X; Larsbrink J, 2011, BIOCHEM J, V436, P567, DOI 10.1042/BJ20110299; MAGNUSON R, 1994, CELL, V77, P207, DOI 10.1016/0092-8674(94)90313-1; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Martens EC, 2009, J BIOL CHEM, V284, P18445, DOI 10.1074/jbc.M109.008094; Mechaly A, 1997, CARBOHYD RES, V304, P111, DOI 10.1016/S0008-6215(97)00209-7; Miyazaki K, 2003, J BACTERIOL, V185, P2219, DOI 10.1128/JB.185.7.2219-2226.2003; Molle V, 2003, J BACTERIOL, V185, P1911, DOI 10.1128/JB.185.6.1911-1922.2003; Moran C., 1990, MOL BIOL METHODS BAC, P267; MORAN CP, 1982, MOL GEN GENET, V186, P339, DOI 10.1007/BF00729452; Nakayama J, 2001, MOL MICROBIOL, V41, P145, DOI 10.1046/j.1365-2958.2001.02486.x; Nataf Y, 2010, P NATL ACAD SCI USA, V107, P18646, DOI 10.1073/pnas.1012175107; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Ouyang Jia, 2006, Biotechnol J, V1, P1266, DOI 10.1002/biot.200600103; Perego M, 1996, P NATL ACAD SCI USA, V93, P1549, DOI 10.1073/pnas.93.4.1549; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201; Rodionov DA, 2001, FEMS MICROBIOL LETT, V205, P305, DOI 10.1111/j.1574-6968.2001.tb10965.x; Salama R, 2012, FEBS LETT, V586, P2436, DOI 10.1016/j.febslet.2012.05.062; Sambrook J, 2001, MOL CLONING LAB MANU; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; Shi K, 2005, P NATL ACAD SCI USA, V102, P18596, DOI 10.1073/pnas.0506163102; Shoham Y, 1999, TRENDS MICROBIOL, V7, P275, DOI 10.1016/S0966-842X(99)01533-4; Shoham Yuval, 1992, Biodegradation, V3, P207, DOI 10.1007/BF00129084; Shulami S, 1999, J BACTERIOL, V181, P3695, DOI 10.1128/JB.181.12.3695-3704.1999; Shulami S, 2007, APPL ENVIRON MICROB, V73, P874, DOI 10.1128/AEM.02367-06; Shulami S, 2011, J BACTERIOL, V193, P2838, DOI 10.1128/JB.00222-11; SMITH H, 1987, J BACTERIOL, V169, P3321, DOI 10.1128/jb.169.7.3321-3328.1987; Solomon JM, 1996, GENE DEV, V10, P2014, DOI 10.1101/gad.10.16.2014; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; Sonnenburg ED, 2006, P NATL ACAD SCI USA, V103, P8834, DOI 10.1073/pnas.0603249103; Steiner E, 2012, APPL ENVIRON MICROB, V78, P1113, DOI 10.1128/AEM.06376-11; Stevens AM, 2012, J BACTERIOL, V194, P2131, DOI 10.1128/JB.00143-12; Tabachnikov O, 2013, FEBS J, V280, P950, DOI 10.1111/febs.12089; Tascou S, 2003, BIOCHEM BIOPH RES CO, V309, P440, DOI 10.1016/j.bbrc.2003.07.008; Taylor LE, 2006, J BACTERIOL, V188, P3849, DOI 10.1128/JB.01348-05; Teplitsky A, 2004, ACTA CRYSTALLOGR D, V60, P836, DOI 10.1107/S0907444904004123; Teplitsky A, 1997, ACTA CRYSTALLOGR D, V53, P608, DOI 10.1107/S0907444997002734; Teplitsky A, 2000, ACTA CRYSTALLOGR D, V56, P181, DOI 10.1107/S0907444999013517; Tomoike F, 2009, PROTEINS, V76, P244, DOI 10.1002/prot.22397; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Wilson DB, 2008, ANN NY ACAD SCI, V1125, P289, DOI 10.1196/annals.1419.026; WU LJ, 1989, J GEN MICROBIOL, V135, P1315; Yaniv O, 2014, ACTA CRYSTALLOGR D, V70, P522, DOI 10.1107/S139900471302926X; Yu H, 2007, BIODEGRADATION, V18, P793, DOI 10.1007/s10532-007-9108-8; Zaide G, 2001, EUR J BIOCHEM, V268, P3006, DOI 10.1046/j.1432-1327.2001.02193.x	96	25	25	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25957	25975		10.1074/jbc.M114.592873	http://dx.doi.org/10.1074/jbc.M114.592873			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070894	Green Published, hybrid			2022-12-25	WOS:000342130800050
J	Suo, L; Kang, K; Wang, X; Cao, YG; Zhao, HF; Sun, XY; Tong, LQ; Zhang, F				Suo, Lida; Kang, Kai; Wang, Xun; Cao, Yonggang; Zhao, Haifeng; Sun, Xueying; Tong, Liquan; Zhang, Feng			Carvacrol Alleviates Ischemia Reperfusion Injury by Regulating the PI3K-Akt Pathway in Rats	PLOS ONE			English	Article							ACUTE LIVER-INJURY; HEPATIC ISCHEMIA/REPERFUSION; KINASE-B; APOPTOSIS; ANTIOXIDANT; CELL; PROTECTION; MECHANISMS; SURVIVAL; GROWTH	Background: Liver ischemia reperfusion (I/R) injury is a common pathophysiological process in many clinical settings. Carvacrol, a food additive commonly used in essential oils, has displayed antimicrobials, antitumor and antidepressant-like activities. In the present study, we investigated the protective effects of carvacrol on I/R injury in the Wistar rat livers and an in vitro hypoxia/restoration (H/R) model. Methods: The hepatoportal vein, hepatic arterial and hepatic duct of Wistar rats were isolated and clamped for 30 min, followed by a 2 h reperfusion. Buffalo rat liver (BRL) cells were incubated under hypoxia for 4 h, followed normoxic conditions for 10 h to establish the H/R model in vitro. Liver injury was evaluated by measuring serum levels of alanine aminotransferase (ALT) and aspatate aminotransferase (AST), and hepatic levels of superoxide dismutase (SOD), catalase (CAT), glutathione (GSH) and malondiadehyde (MDA), and hepatic histology and TUNEL staining. MTT assay, flow cytometric analysis and Hoechst 33258 staining were used to evaluate the proliferation and apoptosis of BRL cells in vitro. Protein expression was examined by Western Blot analysis. Results: Carvacrol protected against I/R-induced liver damage, evidenced by significantly reducing the serum levels of ALT and AST, histological alterations and apoptosis of liver cells in I/R rats. Carvacrol exhibited anti-oxidative activity in the I/R rats, reflected by significantly reducing the activity of SOD and the content of MDA, and restoring the activity of CAT and the content of GSH, in I/R rats. In the in vitro assays, carvacrol restored the viability and inhibited the apoptosis of BRL cells, which were subjected to a mimic I/R injury induced by hypoxia. In the investigation on molecular mechanisms, carvacrol downregulated the expression of Bax and upregulated the expression of Bcl-2, thus inhibited the activation of caspase-3. Carvacrol was also shown to enhance the phosphorylation of Akt. Conclusion: The results suggest that carvacrol could alleviate I/R-induced liver injury by its anti-oxidative and anti-apoptotic activities, and warrant a further investigation for using carvacrol to protect I/R injury in clinic.	[Suo, Lida; Kang, Kai; Zhao, Haifeng; Tong, Liquan; Zhang, Feng] Harbin Med Univ, Affiliated Hosp 5, Dept Gen Surg, Daqing, Heilongjiang Pr, Peoples R China; [Wang, Xun] Daqing Oilfield Gen Hosp, Dept Gen Surg, Daqing, Heilongjiang Pr, Peoples R China; [Cao, Yonggang] Harbin Med Univ, Dept Pharmacol, Daqing, Heilongjiang Pr, Peoples R China; [Sun, Xueying] Harbin Med Univ, Affiliated Hosp 1, Hepatosplen Surg Ctr, Dept Gen Surg, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Tong, LQ (corresponding author), Harbin Med Univ, Affiliated Hosp 5, Dept Gen Surg, Daqing, Heilongjiang Pr, Peoples R China.	tlq777666@163.com; zhangfenghyd@gmail.com		Sun, Xueying/0000-0002-8065-8747	Natural Scientific Foundation of Heilongjiang Province in China [D200927]; National Natural Scientific Foundation of China [81172331]	Natural Scientific Foundation of Heilongjiang Province in China; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Scientific Foundation of Heilongjiang Province in China (No.D200927) and the National Natural Scientific Foundation of China (81172331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristatile B, 2009, FUND CLIN PHARMACOL, V23, P757, DOI 10.1111/j.1472-8206.2009.00721.x; Baser KHC, 2008, CURR PHARM DESIGN, V14, P3106, DOI 10.2174/138161208786404227; Borzecka Halina, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P253; Canbek M, 2008, PHYTOMEDICINE, V15, P447, DOI 10.1016/j.phymed.2007.11.022; Melo FHC, 2011, FUND CLIN PHARMACOL, V25, P362, DOI 10.1111/j.1472-8206.2010.00850.x; Daniel PT, 2003, ESSAYS BIOCHEM, V39, P73, DOI 10.1042/bse0390073; Datta G, 2013, WORLD J GASTROENTERO, V19, P1683, DOI 10.3748/wjg.v19.i11.1683; Eguchi M, 2003, MOL CELL BIOCHEM, V252, P17, DOI 10.1023/A:1025567400384; Esposti MD, 2003, BIOCHEM BIOPH RES CO, V304, P455, DOI 10.1016/S0006-291X(03)00617-X; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fukunaga K, 2003, J PHARMACOL SCI, V92, P317; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hattori R, 2001, ANTIOXID REDOX SIGN, V3, P403, DOI 10.1089/15230860152409059; He SQ, 2006, LIVER TRANSPLANT, V12, P1869, DOI 10.1002/lt.21001; JAESCHKE H, 1991, CHEM-BIOL INTERACT, V79, P115, DOI 10.1016/0009-2797(91)90077-K; JAESCHKE H, 1991, FREE RADICAL RES COM, V12-3, P737; Jiang K, 2013, TRANSPL P, V45, P2439, DOI 10.1016/j.transproceed.2013.04.007; Kang KJ, 2002, TRANSPLANT P, V34, P2659, DOI 10.1016/S0041-1345(02)03465-6; Kirimer N., 1995, Chemistry of Natural Compounds, V31, P37, DOI 10.1007/BF01167568; Kohli V, 1999, TRANSPLANTATION, V67, P1099, DOI 10.1097/00007890-199904270-00003; Lehmann TG, 2003, TRANSPLANTATION, V76, P28, DOI 10.1097/01.TP.0000065299.29900.17; Mocanu MM, 2002, J MOL CELL CARDIOL, V34, P661, DOI 10.1006/jmcc.2002.2006; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Naqvi S, 2010, INT J NANOMED, V5, P983, DOI 10.2147/IJN.S13244; Park SE, 2009, J ETHNOPHARMACOL, V121, P304, DOI 10.1016/j.jep.2008.10.038; Qi HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065147; Roberts RA, 2000, HEPATOLOGY, V31, P420, DOI 10.1002/hep.510310223; Camara-Lemarroy CR, 2009, EUR J PHARMACOL, V621, P78, DOI 10.1016/j.ejphar.2009.08.038; Romanque P, 2005, REV MED CHILE, V133, P469; Sasaki H, 1998, TRANSPLANT P, V30, P2958, DOI 10.1016/S0041-1345(98)00887-2; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Sokmen M, 2004, J AGR FOOD CHEM, V52, P3309, DOI 10.1021/jf049859g; Song Xudong, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1624; Tang B, 2007, BRAZ J MED BIOL RES, V40, P1637, DOI [10.1590/S0100-879X2006005000173, 10.1590/S0100-879X2007001200007]; Teoh NC, 2003, J GASTROEN HEPATOL, V18, P891, DOI 10.1046/j.1440-1746.2003.03056.x; TOLEDOPEREYRA LH, 1975, AM J SURG, V129, P513, DOI 10.1016/0002-9610(75)90308-6; Xing WJ, 2011, CLIN EXP PHARMACOL P, V38, P605, DOI 10.1111/j.1440-1681.2011.05559.x; Yin QH, 2012, CYTOTECHNOLOGY, V64, P43, DOI 10.1007/s10616-011-9389-y; Yu HL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033584, 10.1371/journal.pone.0051239]; Zhang F, 2011, SURG TODAY, V41, P1075, DOI 10.1007/s00595-010-4423-9; Zhang F, 2010, AMINO ACIDS, V38, P237, DOI 10.1007/s00726-009-0233-z; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249; Zhao ZQ, 2002, CARDIOVASC RES, V55, P438, DOI 10.1016/S0008-6363(02)00442-X	43	30	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e104043	10.1371/journal.pone.0104043	http://dx.doi.org/10.1371/journal.pone.0104043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083879	Green Submitted, Green Published, gold			2022-12-25	WOS:000339819800121
J	Iwatani, S; Nagashima, H; Reddy, R; Shiota, S; Graham, DY; Yamaoka, Y				Iwatani, Shun; Nagashima, Hiroyuki; Reddy, Rita; Shiota, Seiji; Graham, David Y.; Yamaoka, Yoshio			Identification of the Genes That Contribute to Lactate Utilization in Helicobacter pylori	PLOS ONE			English	Article							SHEWANELLA-ONEIDENSIS MR-1; ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; METABOLISM; GROWTH; CELLS; DEHYDROGENASE; COLONIZATION; PURIFICATION; PYRUVATE	Helicobacter pylori are Gram-negative, spiral-shaped microaerophilic bacteria etiologically related to gastric cancer. Lactate utilization has been implicated although no corresponding genes have been identified in the H. pylori genome. Here, we report that gene products of hp0137-0139 (lldEFG), hp0140-0141 (lctP), and hp1222 (dld) contribute to D-and L-lactate utilization in H. pylori. The three-gene unit hp0137-0139 in H. pylori 26695 encodes L-lactate dehydrogenase (LDH) that catalyzes the conversion of lactate to pyruvate in an NAD-dependent manner. Isogenic mutants of these genes were unable to grow on L-lactate-dependent medium. The hp1222 gene product functions as an NAD-independent D-LDH and also contributes to the oxidation of L-lactate; the isogenic mutant of this gene failed to grow on D-lactate-dependent medium. The parallel genes hp0140-0141 encode two nearly identical lactate permeases (LctP) that promote uptake of both D- and L-lactate. Interestingly an alternate route must also exist for lactate transport as the knockout of genes did not completely prevent growth on D-or L-lactate. Gene expression levels of hp0137-0139 and hp1222 were not enhanced by lactate as the carbon source. Expression of hp0140-0141 was slightly suppressed in the presence of L-lactate but not D-lactate. This study identified the genes contributing to the lactate utilization and demonstrated the ability of H. pylori to utilize both D- and L-lactate.	[Iwatani, Shun; Nagashima, Hiroyuki; Reddy, Rita; Graham, David Y.; Yamaoka, Yoshio] Baylor Coll Med, Dept Med Gastroenterol, Houston, TX 77030 USA; [Iwatani, Shun; Nagashima, Hiroyuki; Reddy, Rita; Graham, David Y.; Yamaoka, Yoshio] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Iwatani, Shun; Nagashima, Hiroyuki; Shiota, Seiji; Yamaoka, Yoshio] Oita Univ, Fac Med, Dept Environm & Prevent Med, Oita 87011, Japan	Baylor College of Medicine; Baylor College of Medicine; Oita University	Yamaoka, Y (corresponding author), Baylor Coll Med, Dept Med Gastroenterol, Houston, TX 77030 USA.	yyamaoka@bcm.edu	Graham, David/AAL-2165-2021	Shiota, Seiji/0000-0001-9811-218X; Yamaoka, Yoshio/0000-0002-1222-5819	National Institute of Health [DK62813]; Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [25860544] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062813, P30DK056338] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This report is based on work supported in part by grants from the National Institute of Health (DK62813) (http://www.nih.gov/), and Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (JST) (http://www.jst.go.jp/EN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera L, 2008, J BACTERIOL, V190, P2997, DOI [10.1128/JB.02013-07, 10.1128/JB.00815-08]; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; BAER W, 1993, ZBL BAKT-INT J MED M, V280, P253; Baldwin DN, 2007, INFECT IMMUN, V75, P1005, DOI 10.1128/IAI.01176-06; Brutinel ED, 2012, APPL ENVIRON MICROB, V78, P8474, DOI 10.1128/AEM.02183-12; Chai YR, 2009, J BACTERIOL, V191, P2423, DOI 10.1128/JB.01464-08; CHALK PA, 1994, MICROBIOL-UK, V140, P2085, DOI 10.1099/13500872-140-8-2085; CHANG HT, 1995, FEMS MICROBIOL LETT, V129, P33, DOI 10.1016/0378-1097(95)00130-W; Clancy CD, 2012, J BACTERIOL, V194, P2402, DOI 10.1128/JB.00230-12; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; DONG JM, 1993, J BACTERIOL, V175, P6671, DOI 10.1128/jb.175.20.6671-6678.1993; DUNCAN JD, 1989, BIOCHEM BIOPH RES CO, V164, P919, DOI 10.1016/0006-291X(89)91546-5; ERWIN AL, 1993, J BACTERIOL, V175, P6382, DOI 10.1128/jb.175.20.6382-6391.1993; Exley RM, 2007, INFECT IMMUN, V75, P1318, DOI 10.1128/IAI.01530-06; Exley RM, 2005, INFECT IMMUN, V73, P5762, DOI 10.1128/IAI.73.9.5762-5766.2005; Exley RM, 2005, J EXP MED, V201, P1637, DOI 10.1084/jem.20041548; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Gill MJ, 1996, INFECT IMMUN, V64, P3374, DOI 10.1128/IAI.64.8.3374-3378.1996; Goffin P, 2004, J BACTERIOL, V186, P6661, DOI 10.1128/JB.186.19.6661-6666.2004; Herbert MA, 2002, MICROB PATHOGENESIS, V33, P211, DOI 10.1006/mpat.2002.0530; Kudo T, 2007, GASTROENTEROLOGY, V132, P1024, DOI 10.1053/j.gastro.2007.01.009; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Marais A, 1999, MICROBIOL MOL BIOL R, V63, P642, DOI 10.1128/MMBR.63.3.642-674.1999; Matsumoto T, 2008, BIOL PHARM BULL, V31, P143, DOI 10.1248/bpb.31.143; MENDZ GL, 1993, J GEN MICROBIOL, V139, P3023, DOI 10.1099/00221287-139-12-3023; MENDZ GL, 1994, ARCH MICROBIOL, V162, P187, DOI 10.1007/s002030050123; Merrell DS, 2003, INFECT IMMUN, V71, P6510, DOI 10.1128/IAI.71.11.6510-6525.2003; Merrell DS, 2003, INFECT IMMUN, V71, P3529, DOI 10.1128/IAI.71.6.3529-3539.2003; Nakajima N, 1998, J CLIN GASTROENTEROL, V27, pS138, DOI 10.1097/00004836-199800001-00021; Nunez MF, 2002, BIOCHEM BIOPH RES CO, V290, P824, DOI 10.1006/bbrc.2001.6255; Nunez MF, 2001, MICROBIOL-UK, V147, P1069, DOI 10.1099/00221287-147-4-1069; Pinchuk GE, 2011, APPL ENVIRON MICROB, V77, P8234, DOI 10.1128/AEM.05382-11; Pinchuk GE, 2009, P NATL ACAD SCI USA, V106, P2874, DOI 10.1073/pnas.0806798106; PRATT EA, 1979, BIOCHEMISTRY-US, V18, P312, DOI 10.1021/bi00569a013; Rimbara E, 2011, NAT REV GASTRO HEPAT, V8, P79, DOI 10.1038/nrgastro.2010.210; Sambrook J, 2001, MOL CLONING LAB MANU; Takahashi T, 2007, HELICOBACTER, V12, P532, DOI 10.1111/j.1523-5378.2007.00524.x; Thomas MT, 2011, ENVIRON MICROBIOL, V13, P48, DOI 10.1111/j.1462-2920.2010.02307.x; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; van Amsterdam K, 2004, HELICOBACTER, V9, P614, DOI 10.1111/j.1083-4389.2004.00272.x; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; Zhao R, 2013, FEBS OPEN BIO, V3, P379, DOI 10.1016/j.fob.2013.08.005	42	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103506	10.1371/journal.pone.0103506	http://dx.doi.org/10.1371/journal.pone.0103506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078575	gold, Green Published, Green Submitted			2022-12-25	WOS:000339954800051
J	Kihara, M; Kiyoshima, T; Nagata, K; Wada, H; Fujiwara, H; Hasegawa, K; Someya, H; Takahashi, I; Sakai, H				Kihara, Makiko; Kiyoshima, Tamotsu; Nagata, Kengo; Wada, Hiroko; Fujiwara, Hiroaki; Hasegawa, Kana; Someya, Hirotaka; Takahashi, Ichiro; Sakai, Hidetaka			Itm2a Expression in the Developing Mouse First Lower Molar, and the Subcellular Localization of Itm2a in Mouse Dental Epithelial Cells	PLOS ONE			English	Article							TOOTH GERM DEVELOPMENT; FUNCTIONAL INVOLVEMENT; LOWER 1ST-MOLAR; GENE; DIFFERENTIATION; PROTEINS; MORPHOGENESIS	Itm2a is a type II transmembrane protein with a BRICHOS domain. We investigated the temporospatial mRNA and protein expression patterns of Itm2a in the developing lower first molar, and examined the subcellular localization of Itm2a in murine dental epithelial (mDE6) cells. From the initiation to the bud stage, the in situ and protein signals of Itm2a were not detected in either the dental epithelial or mesenchymal cells surrounding the tooth bud. However, at the bell stage, these signals of Itm2a were primarily observed in the inner enamel epithelium of the enamel organ. After the initiation of the matrix formation, strong signals were detected in ameloblasts and odontoblasts. Itm2a showed a punctate pattern in the cytoplasm of the mDE6 cells. The perinuclear-localized Itm2a displayed a frequent overlap with the Golgi apparatus marker, GM130. A tiny amount of Itm2a was colocalized with lysosomes and endoplasmic reticulum. Minimal or no overlap between the Itm2a-EGFP signals with the other organelle markers for endoplasmic reticulum, lysosome and mitochondria used in this study noted in the cytoplasm. These findings suggest that Itm2a may play a role in cell differentiation during odontogenesis, rather than during the initiation of tooth germ formation, and may be related to the targeting of proteins associated with enamel and dentin matrices in the secretory pathway.	[Kihara, Makiko; Kiyoshima, Tamotsu; Nagata, Kengo; Wada, Hiroko; Fujiwara, Hiroaki; Hasegawa, Kana; Someya, Hirotaka; Sakai, Hidetaka] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Lab Oral Pathol, Fukuoka 812, Japan; [Kihara, Makiko; Takahashi, Ichiro] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Orthodont & Dentofacial Orthoped, Fukuoka 812, Japan; [Hasegawa, Kana] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Dept Endodontol & Operat Dent, Fukuoka 812, Japan; [Someya, Hirotaka] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Implant & Rehabil Dent, Fukuoka 812, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University	Sakai, H (corresponding author), Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Lab Oral Pathol, Fukuoka 812, Japan.	hsakaiop@dent.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23659859, 25462862, 23792106]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors disclosed receipt of the following financial support for the research described in this article: Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Nos. 23659859 (to T.K.), 25462862 (to K.N.) and 23792106 (to H.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter M, 2005, HISTOCHEM CELL BIOL, V124, P207, DOI 10.1007/s00418-005-0040-x; Akhter M, 2010, J MOL HISTOL, V41, P185, DOI 10.1007/s10735-010-9277-3; Boeuf S, 2009, DIFFERENTIATION, V78, P108, DOI 10.1016/j.diff.2009.05.007; Buckingham M, 2008, CURR OPIN GENET DEV, V18, P330, DOI 10.1016/j.gde.2008.06.005; Chen JQ, 2009, DEV BIOL, V334, P174, DOI 10.1016/j.ydbio.2009.07.015; Cobourne MT, 2003, ARCH ORAL BIOL, V48, P1, DOI 10.1016/S0003-9969(02)00208-X; Davidson B, 2013, GYNECOL ONCOL, V128, P349, DOI 10.1016/j.ygyno.2012.11.021; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; Hedlund Joel, 2009, BMC Res Notes, V2, P180, DOI 10.1186/1756-0500-2-180; Honda JY, 2008, HISTOL HISTOPATHOL, V23, P423, DOI 10.14670/HH-23.423; Honda J, 2011, J MOL HISTOL, V42, P83, DOI 10.1007/s10735-010-9309-z; Kirchner J, 1999, J EXP MED, V190, P217, DOI 10.1084/jem.190.2.217; Kobayashi I, 2006, BONE, V38, P836, DOI 10.1016/j.bone.2005.10.026; Lagha M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063143; Matsuda S, 2011, NEUROBIOL AGING, V32, P1400, DOI 10.1016/j.neurobiolaging.2009.08.005; Ookuma YF, 2013, HISTOCHEM CELL BIOL, V139, P355, DOI 10.1007/s00418-012-1033-1; Pittois K, 1998, GENE, V217, P141, DOI 10.1016/S0378-1119(98)00354-0; Pittois K, 1999, MAMM GENOME, V10, P54, DOI 10.1007/s003359900942; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Shiotsuka M, 2013, INT J DEV BIOL, V57, P873, DOI 10.1387/ijdb.120240hs; Takahashi KF, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-115; Tanikawa Y, 1999, ARCH ORAL BIOL, V44, P771, DOI 10.1016/S0003-9969(99)00070-9; Thesleff I, 1995, Adv Dent Res, V9, P12; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Tuckermann JP, 2000, J BONE MINER RES, V15, P1257, DOI 10.1359/jbmr.2000.15.7.1257; Tuomela S, 2012, BLOOD, V119, pE151, DOI 10.1182/blood-2012-01-407528; Van den Plas D, 2004, BIOL CELL, V96, P463, DOI 10.1016/j.biolcel.2004.04.007; Van den Plas D, 2004, CELL BIOL INT, V28, P199, DOI 10.1016/j.cellbi.2003.11.019; Wada H, 2002, HISTOCHEM J, V34, P105, DOI 10.1023/A:1020930228303; Wang HJ, 2005, J BONE MINER RES, V20, P1032, DOI 10.1359/JBMR.050111; Xie M, 2007, J BIOL CHEM, V282, P23275, DOI 10.1074/jbc.M610779200; Xie M, 2009, J MOL HISTOL, V40, P361, DOI 10.1007/s10735-009-9249-7; Yamaza H, 2001, HISTOCHEM J, V33, P437, DOI 10.1023/A:1014491111628; Yamaza H, 2001, INT J DEV BIOL, V45, P675	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103928	10.1371/journal.pone.0103928	http://dx.doi.org/10.1371/journal.pone.0103928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079563	Green Published, gold, Green Submitted			2022-12-25	WOS:000339954800097
J	Peng, Y; Yu, G; Tian, SX; Li, H				Peng, Yu; Yu, Ge; Tian, Shaoxiong; Li, Hong			Co-Expression and Co-Purification of Archaeal and Eukaryal Box C/D RNPs	PLOS ONE			English	Article							SMALL NUCLEOLAR RNAS; 18S RIBOSOMAL-RNA; ESCHERICHIA-COLI; PROTEIN COMPLEXES; STRUCTURAL BASIS; RECOMBINANT RNA; SNORNP; BIOGENESIS; METHYLATION; EXPRESSION	Box C/D ribonucleoprotein particles (RNPs) are 2'-O-methylation enzymes required for maturation of ribosomal and small nuclear RNA. Previous biochemical and structural studies of the box C/D RNPs were limited by the unavailability of purified intact RNPs. We developed a bacterial co-expression strategy based on the combined use of a multi-gene expression system and a tRNA-scaffold construct that allowed the expression and purification of homogeneous archaeal and human box C/D RNPs. While the co-expressed and co-purified archaeal box C/D RNP was found to be fully active in a 2'-O-methylation assay, the intact human U14 box C/D RNP showed no detectable catalytic activity, consistent with the earlier findings that assembly of eukaryotic box C/D RNPs is nonspontaneous and requires additional protein factors. Our systems provide a means for further biochemical and structural characterization of box C/D RNPs and their assembly factors.	[Peng, Yu; Li, Hong] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Yu, Ge; Tian, Shaoxiong; Li, Hong] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Li, H (corresponding author), Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.	hong.li@fsu.edu		Li, Hong/0000-0003-2046-9861; Peng, Yu/0000-0003-2039-9015	National Institutes of Health [R01 GM66958-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066958, R01GM099604] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health grant (http://grants.nih.gov/grants/oer.htm) R01 GM66958-01 to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittaleb M, 2003, NAT STRUCT BIOL, V10, P256, DOI 10.1038/nsb905; ARIS JP, 1991, P NATL ACAD SCI USA, V88, P931, DOI 10.1073/pnas.88.3.931; Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bleichert F, 2009, SCIENCE, V325, P1384, DOI 10.1126/science.1176099; Boulon S, 2004, MOL CELL, V16, P777, DOI 10.1016/j.molcel.2004.11.013; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Bower-Phipps KR, 2012, RNA, V18, P1527, DOI 10.1261/rna.033134.112; Bratkovic T, 2014, BBA-GENE REGUL MECH, V1839, P438, DOI 10.1016/j.bbagrm.2014.04.009; Cahill NM, 2002, EMBO J, V21, P3816, DOI 10.1093/emboj/cdf376; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Kakihara Y, 2012, BBA-MOL CELL RES, V1823, P101, DOI 10.1016/j.bbamcr.2011.08.016; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Lapinaite A, 2013, NATURE, V502, P519, DOI 10.1038/nature12581; Liang B, 2011, Q REV BIOPHYS, V44, P95, DOI 10.1017/S0033583510000235; LIANG WQ, 1995, GENE DEV, V9, P2433, DOI 10.1101/gad.9.19.2433; Lin JZ, 2011, NATURE, V469, P559, DOI 10.1038/nature09688; McKeegan KS, 2007, MOL CELL BIOL, V27, P6782, DOI 10.1128/MCB.01097-07; McKeegan KS, 2009, MOL CELL BIOL, V29, P4971, DOI 10.1128/MCB.00752-09; Moore T, 2004, STRUCTURE, V12, P807, DOI 10.1016/j.str.2004.02.033; Nano N, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0399; Nelissen FHT, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks292; Omer AD, 2000, SCIENCE, V288, P517, DOI 10.1126/science.288.5465.517; PECULIS BA, 1993, CELL, V73, P1233, DOI 10.1016/0092-8674(93)90651-6; Ponchon L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt576; Ponchon L, 2009, NAT PROTOC, V4, P947, DOI 10.1038/nprot.2009.67; Rashid R, 2003, J MOL BIOL, V333, P295, DOI 10.1016/j.jmb.2003.08.012; Robichon C, 2011, APPL ENVIRON MICROB, V77, P4634, DOI 10.1128/AEM.00119-11; Rothe B, 2014, NUCLEIC ACIDS RES, V42, P2015, DOI 10.1093/nar/gkt1091; Rucker P, 1997, PROTEIN ENG, V10, P967, DOI 10.1093/protein/10.8.967; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Snaar S, 2000, J CELL BIOL, V151, P653, DOI 10.1083/jcb.151.3.653; Suryadi J, 2005, BIOCHEMISTRY-US, V44, P9657, DOI 10.1021/bi050568q; Watkins NJ, 2012, WIRES RNA, V3, P397, DOI 10.1002/wrna.117; Watkins NJ, 2004, MOL CELL, V16, P789, DOI 10.1016/j.molcel.2004.11.012; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Xue S, 2010, MOL CELL, V39, P939, DOI 10.1016/j.molcel.2010.08.022; Ye KQ, 2009, P NATL ACAD SCI USA, V106, P13808, DOI 10.1073/pnas.0905128106; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061	43	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103096	10.1371/journal.pone.0103096	http://dx.doi.org/10.1371/journal.pone.0103096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078083	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800027
J	Weber, FD; Weinhofer, I; Einwich, A; Forss-Petter, S; Muneer, Z; Maier, H; Weber, WHA; Berger, J				Weber, Franziska D.; Weinhofer, Isabelle; Einwich, Angelika; Forss-Petter, Sonja; Muneer, Zahid; Maier, Harald; Weber, Willi H. A.; Berger, Johannes			Evaluation of Retinoids for Induction of the Redundant Gene ABCD2 as an Alternative Treatment Option in X-Linked Adrenoleukodystrophy	PLOS ONE			English	Article							HEMATOPOIETIC-CELL TRANSPLANTATION; UNION-OF-PHARMACOLOGY; EXPRESSION; THERAPY; ACID; RECEPTORS; ALD; FIBROBLASTS; PROTEIN; TARGET	X-linked adrenoleukodystrophy (X-ALD), the most common peroxisomal disorder, is a clinically heterogeneous disease that can manifest as devastating inflammatory cerebral demyelination (CALD) leading to death of affected males. Currently, the only curative treatment is allogeneic hematopoietic stem cell transplantation (HSCT). However, HSCT is only effective when performed at an early stage because the inflammation may progress for eighteen months after HSCT. Thus, alternative treatment options able to immediately halt the progression are urgently needed. X-ALD is caused by mutations in the ABCD1 gene, encoding the peroxisomal membrane protein ABCD1, resulting in impaired very long-chain fatty acid metabolism. The related ABCD2 protein is able to functionally compensate for ABCD1-deficiency both in vitro and in vivo. Recently, we demonstrated that of the cell types derived from CD34(+) stem cells, predominantly monocytes but not lymphocytes are metabolically impaired in X-ALD. As ABCD2 is virtually not expressed in these cells, we hypothesize that a pharmacological up-regulation of ABCD2 should compensate metabolically and halt the inflammation in CALD. Retinoids are anti-inflammatory compounds known to act on ABCD2. Here, we investigated the capacity of selected retinoids for ABCD2 induction in human monocytes/macrophages. In THP-1 cells, 13-cis-retinoic acid reached the highest, fivefold, increase in ABCD2 expression. To test the efficacy of retinoids in vivo, we analyzed ABCD2 mRNA levels in blood cells isolated from acne patients receiving 13-cis-retinoic acid therapy. In treated acne patients, ABCD2 mRNA levels were comparable to pre-treatment levels in monocytes and lymphocytes. Nevertheless, when primary monocytes were in vitro differentiated into macrophages and treated with 13-cis-retinoic acid, we observed a fourfold induction of ABCD2. However, the level of ABCD2 induction obtained by retinoids alone is probably not of therapeutic relevance for X-ALD. In conclusion, our results suggest a change in promoter accessibility during macrophage differentiation allowing induction of ABCD2 by retinoids.	[Weber, Franziska D.; Weinhofer, Isabelle; Einwich, Angelika; Forss-Petter, Sonja; Muneer, Zahid; Weber, Willi H. A.; Berger, Johannes] Med Univ Vienna, Ctr Brain Res, Vienna, Austria; [Maier, Harald] Med Univ Vienna, Dept Dermatol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Berger, J (corresponding author), Med Univ Vienna, Ctr Brain Res, Vienna, Austria.	johannes.berger@meduniwien.ac.at	Einwich, Angelika/S-2518-2018; Berger, Johannes/A-9122-2014	Berger, Johannes/0000-0003-0182-2658; Einwich, Angelika/0000-0001-7020-1340; Weinhofer, Isabelle/0000-0002-8455-2069	EU [241622]; Austrian Science Fund (FWF) [P26112-B19]; Hertha Firnberg FWF-fellowship [T562-B13]; Higher Education Commission of Pakistan; Austrian Science Fund (FWF) [P 26112, T 562] Funding Source: researchfish	EU(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Hertha Firnberg FWF-fellowship; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the EU project "LEUKOTREAT" [241622]; the Austrian Science Fund (FWF) [P26112-B19]; LW. is supported by a Hertha Firnberg FWF-fellowship (T562-B13) and Z.M. by a PhD scholarship from the Higher Education Commission of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asquith DL, 2013, ANN RHEUM DIS, V72, P2024, DOI 10.1136/annrheumdis-2012-202872; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Berger J, 2014, BIOCHIMIE, V98, P135, DOI 10.1016/j.biochi.2013.11.023; Berger J, 2006, BBA-MOL CELL RES, V1763, P1721, DOI 10.1016/j.bbamcr.2006.07.010; Berger J, 2010, BRAIN PATHOL, V20, P845, DOI 10.1111/j.1750-3639.2010.00393.x; Cartier N, 2010, BRAIN PATHOL, V20, P857, DOI 10.1111/j.1750-3639.2010.00394.x; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Fourcade S, 2003, MOL PHARMACOL, V63, P1296, DOI 10.1124/mol.63.6.1296; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Gondcaille C, 2014, BBA-MOL CELL BIOL L, V1841, P259, DOI 10.1016/j.bbalip.2013.11.003; Holzinger A, 1997, BIOCHEM BIOPH RES CO, V239, P261, DOI 10.1006/bbrc.1997.7391; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ito M, 2001, J NEUROPATH EXP NEUR, V60, P1004, DOI 10.1093/jnen/60.10.1004; Kemp S, 1998, NAT MED, V4, P1261, DOI 10.1038/3242; Kemp S, 2012, BBA-MOL BASIS DIS, V1822, P1465, DOI 10.1016/j.bbadis.2012.03.012; Kiss M, 2013, J ALLERGY CLIN IMMUN, V132, P264, DOI 10.1016/j.jaci.2013.05.044; Miller WP, 2011, BLOOD, V118, P1971, DOI 10.1182/blood-2011-01-329235; Montemurro P, 1999, BRIT J HAEMATOL, V107, P294, DOI 10.1046/j.1365-2141.1999.01698.x; Moser H., 2001, METABOLIC MOL BASES, VII, P3257; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Netik A, 1999, HUM MOL GENET, V8, P907, DOI 10.1093/hmg/8.5.907; Park CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056242; Peters C, 2004, BLOOD, V104, P881, DOI 10.1182/blood-2003-10-3402; Pinheiro J, 2016, NLME LINEAR NONLINEA, DOI DOI 10.1016/S0006-3207(01)00201-4; Pinheiro JC, 2009, MIXED EFFECTS MODELS; Pujol A, 2004, HUM MOL GENET, V13, P2997, DOI 10.1093/hmg/ddh323; Pujol A, 2000, GENOMICS, V70, P131, DOI 10.1006/geno.2000.6367; R Core Team, 2021, R LANG ENV STAT COMP; Singh J, 2011, J LIPID RES, V52, P2056, DOI 10.1194/jlr.M017491; Troffer-Charlier N, 1998, EUR J CELL BIOL, V75, P254, DOI 10.1016/S0171-9335(98)80121-0; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Weber FD, 2014, HUM MOL GENET, V23, P2542, DOI 10.1093/hmg/ddt645; Weinhofer I, 2005, J BIOL CHEM, V280, P41243, DOI 10.1074/jbc.M509450200; Weinhofer I, 2005, FEBS LETT, V579, P5512, DOI 10.1016/j.febslet.2005.09.014; Weinhofer I, 2002, HUM MOL GENET, V11, P2701, DOI 10.1093/hmg/11.22.2701; Weinhofer I, 2008, EUR J CELL BIOL, V87, P933, DOI 10.1016/j.ejcb.2008.08.002; Wiesinger C, 2013, J BIOL CHEM, V288, P19269, DOI 10.1074/jbc.M112.445445	38	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103742	10.1371/journal.pone.0103742	http://dx.doi.org/10.1371/journal.pone.0103742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079382	Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800076
J	Chang, YS; Owen, JP; Desai, SS; Hill, SS; Arnett, AB; Harris, J; Marco, EJ; Mukherjee, P				Chang, Yi-Shin; Owen, Julia P.; Desai, Shivani S.; Hill, Susanna S.; Arnett, Anne B.; Harris, Julia; Marco, Elysa J.; Mukherjee, Pratik			Autism and Sensory Processing Disorders: Shared White Matter Disruption in Sensory Pathways but Divergent Connectivity in Social-Emotional Pathways	PLOS ONE			English	Article							INFERIOR LONGITUDINAL FASCICULUS; DIFFUSION TENSOR TRACKING; HIPPOCAMPO-FUSIFORM; AMYGDALO-FUSIFORM; SPECTRUM DISORDER; CORPUS-CALLOSUM; CHILDREN; SYSTEM; FMRI; ABNORMALITIES	Over 90% of children with Autism Spectrum Disorders (ASD) demonstrate atypical sensory behaviors. In fact, hyper- or hyporeactivity to sensory input or unusual interest in sensory aspects of the environment is now included in the DSM-5 diagnostic criteria. However, there are children with sensory processing differences who do not meet an ASD diagnosis but do show atypical sensory behaviors to the same or greater degree as ASD children. We previously demonstrated that children with Sensory Processing Disorders (SPD) have impaired white matter microstructure, and that this white matter microstructural pathology correlates with atypical sensory behavior. In this study, we use diffusion tensor imaging (DTI) fiber tractography to evaluate the structural connectivity of specific white matter tracts in boys with ASD (n = 15) and boys with SPD (n = 16), relative to typically developing children (n = 23). We define white matter tracts using probabilistic streamline tractography and assess the strength of tract connectivity using mean fractional anisotropy. Both the SPD and ASD cohorts demonstrate decreased connectivity relative to controls in parieto-occipital tracts involved in sensory perception and multisensory integration. However, the ASD group alone shows impaired connectivity, relative to controls, in temporal tracts thought to subserve social-emotional processing. In addition to these group difference analyses, we take a dimensional approach to assessing the relationship between white matter connectivity and participant function. These correlational analyses reveal significant associations of white matter connectivity with auditory processing, working memory, social skills, and inattention across our three study groups. These findings help elucidate the roles of specific neural circuits in neurodevelopmental disorders, and begin to explore the dimensional relationship between critical cognitive functions and structural connectivity across affected and unaffected children.	[Chang, Yi-Shin; Owen, Julia P.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Desai, Shivani S.; Hill, Susanna S.; Arnett, Anne B.; Harris, Julia; Marco, Elysa J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marco, EJ (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94115 USA.	marcoe@neuropeds.ucsf.edu		Arnett, Anne/0000-0003-1342-0488; Mukherjee, Pratik/0000-0001-7473-7409; Hill, Susanna/0000-0001-5376-1872	Wallace Research Foundation; Gates Family Foundation; Holcombe Kawaja Family Foundation; Simons Foundation; NIH [R01 NS060776, K23 MH083890, KL2 RR024130]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH083890] Funding Source: NIH RePORTER	Wallace Research Foundation; Gates Family Foundation; Holcombe Kawaja Family Foundation; Simons Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by grants from the Wallace Research Foundation, the Gates Family Foundation and the Holcombe Kawaja Family Foundation. EJM, JPO and PM acknowledge support from the Simons Foundation. PM also acknowledges support from NIH R01 NS060776. EJM has received support from NIH K23 MH083890 and KL2 RR024130. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn RR, 2004, AM J OCCUP THER, V58, P287, DOI 10.5014/ajot.58.3.287; Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; American Psychiatric Association, 1994, DSM 4 DIAGNOSTIC STA; Aoki Y, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-25; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Ben-Sasson A, 2009, J AUTISM DEV DISORD, V39, P1, DOI 10.1007/s10803-008-0593-3; Brett-Green BA, 2008, BRAIN RES, V1242, P283, DOI 10.1016/j.brainres.2008.03.090; Bundy AC, 2007, AM J OCCUP THER, V61, P201, DOI 10.5014/ajot.61.2.201; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Conturo TE, 2008, J INT NEUROPSYCH SOC, V14, P933, DOI 10.1017/S1355617708081381; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Danielian LE, 2010, NEUROIMAGE, V49, P1572, DOI 10.1016/j.neuroimage.2009.08.062; Dunn W, 1997, AM J OCCUP THER, V51, P25, DOI 10.5014/ajot.51.1.25; Dziobek I, 2010, ARCH GEN PSYCHIAT, V67, P397, DOI 10.1001/archgenpsychiatry.2010.31; Eaves LC, 2006, J DEV BEHAV PEDIATR, V27, pS95, DOI 10.1097/00004703-200604002-00007; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Forkel SJ, 2014, CORTEX, V56, P73, DOI 10.1016/j.cortex.2012.09.005; Haas BW, 2012, GENES BRAIN BEHAV, V11, P62, DOI 10.1111/j.1601-183X.2011.00733.x; Jansma H, 2014, NEUROSCIENCE, V256, P230, DOI 10.1016/j.neuroscience.2013.10.047; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; Jou RJ, 2011, AUST NZ J PSYCHIAT, V45, P153, DOI 10.3109/00048674.2010.534069; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kana RK, 2006, BRAIN, V129, P2484, DOI 10.1093/brain/awl164; Kleinhans NM, 2011, NEUROIMAGE, V54, P697, DOI 10.1016/j.neuroimage.2010.07.037; Koldewyn K, 2014, P NATL ACAD SCI USA, V111, P1981, DOI 10.1073/pnas.1324037111; Kumar A, 2010, CEREB CORTEX, V20, P2103, DOI 10.1093/cercor/bhp278; Lo YC, 2011, PSYCHIAT RES-NEUROIM, V192, P60, DOI 10.1016/j.pscychresns.2010.09.008; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Marco EJ, 2011, PEDIATR RES, V69, p48R, DOI 10.1109/SPL.2011.5782616; McGrath J, 2013, AUTISM RES, V6, P307, DOI 10.1002/aur.1290; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ortibus E, 2012, DEV MED CHILD NEUROL, V54, P38, DOI 10.1111/j.1469-8749.2011.04147.x; Owen JP, 2013, NEUROIMAGE-CLIN, V2, P844, DOI 10.1016/j.nicl.2013.06.009; Perou R, 2013, MMWR-MORBID MORTAL W, V62, P1; Philippi CL, 2009, J NEUROSCI, V29, P15089, DOI 10.1523/JNEUROSCI.0796-09.2009; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Shukla DK, 2011, J CHILD PSYCHOL PSYC, V52, P286, DOI 10.1111/j.1469-7610.2010.02342.x; Smith CD, 2009, J MAGN RESON IMAGING, V29, P1248, DOI 10.1002/jmri.21692; Szatmary B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000879; Tang CY, 2010, INTELLIGENCE, V38, P293, DOI 10.1016/j.intell.2010.03.003; Thomas C, 2011, CORTEX, V47, P863, DOI 10.1016/j.cortex.2010.07.006; Travers BG, 2012, AUTISM RES, V5, P289, DOI 10.1002/aur.1243; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wechsler D, 2003, WISC 4 ADM SCORING M	47	116	116	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103038	10.1371/journal.pone.0103038	http://dx.doi.org/10.1371/journal.pone.0103038			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075609	Green Submitted, Green Published, gold			2022-12-25	WOS:000340028800023
J	Davis, MS; Bonen, A; Snook, LA; Jain, SS; Bartels, K; Geor, R; Hueffer, K				Davis, Michael S.; Bonen, Arend; Snook, Laelie A.; Jain, Swati S.; Bartels, Kenneth; Geor, Raymond; Hueffer, Karsten			Conditioning Increases the Gain of Contraction-Induced Sarcolemmal Substrate Transport in Ultra-Endurance Racing Sled Dogs	PLOS ONE			English	Article							FATTY-ACID TRANSPORT; MUSCLE GLUCOSE-UPTAKE; RAT SKELETAL-MUSCLE; INTRINSIC ACTIVITY; EXERCISE; GLUT-4; EXPRESSION; TRANSLOCATION; PROTEINS; CAPACITY	Endurance exercise relies on transsarcolemmal flux of substrates in order to avoid depletion of intramuscular reserves. Previous studies of endurance trained sled dogs have shown a remarkable capacity of these dogs to adapt rapidly to endurance exercise by decreasing the utilization of intramuscular reserves. The current study tested the hypothesis that the dogs' glycogen-sparing phenotype is due to increased sarcolemmal transport of glucose and fatty acids. Basal and exercise-induced transport of glucose and fatty acids into sarcolemmal vesicles was evaluated in racing sled dogs prior to and after 7 months of exercise conditioning. Sarcolemmal substrate transport capacity was measured using sarcolemmal vesicles and radiolabelled substrates, and transporter abundance was measured using Western blot quantification in whole muscle homogenates and the sarcolemmal vesicle preparations. Conditioning resulted in increased basal and exercise-induced transport of both glucose and palmitate. Neither acute exercise nor conditioning resulted in changes in muscle content of GLUT4 or FAT/CD36, but conditioning did result in decreased abundance of both transporters in the sarcolemmal vesicles used for the basal transport assays, and this decrease was further amplified in the vesicles used for the exercise-induced transport assays. These results demonstrate conditioning-induced increases in sarcolemmal transport of oxidizable substrates, as well as increased gain of exercise-induced sarcolemmal transport of these substrates. These results further indicate that increased sarcolemmal transport of oxidizable substrates may be due to either an increased intrinsic capacity of the existing transporters or to a different population of transporters from those investigated.	[Davis, Michael S.] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA; [Bonen, Arend; Snook, Laelie A.; Jain, Swati S.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Bartels, Kenneth] Oklahoma State Univ, Dept Vet Clin Sci, Stillwater, OK 74078 USA; [Geor, Raymond] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [Hueffer, Karsten] Univ Alaska, Dept Vet Med, Fairbanks, AK 99701 USA	Oklahoma State University System; Oklahoma State University - Stillwater; University of Guelph; Oklahoma State University System; Oklahoma State University - Stillwater; Michigan State University; University of Alaska System; University of Alaska Fairbanks	Davis, MS (corresponding author), Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA.	michael.davis@okstate.edu	Geor, Raymond J/P-4631-2017	Geor, Raymond J/0000-0002-6825-6737; Hueffer, Karsten/0000-0001-7154-9066	United States Department of Defense Army Research Office Division of Life Sciences [W911NF-09-1-0549]; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research; Canada Research Chair program; NSERC Canadian Graduate Scholarship	United States Department of Defense Army Research Office Division of Life Sciences; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair program(Canada Research Chairs); NSERC Canadian Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	These studies were supported by grants from United States Department of Defense Army Research Office Division of Life Sciences (W911NF-09-1-0549) and by the Natural Sciences and Engineering Research Council of Canada (AB), The Heart and Stroke Foundation of Ontario (AB), the Canadian Institutes of Health Research (AB), and the Canada Research Chair program. A. Bonen, PhD, FRSC, was the Canada Research Chair in Metabolism and Health. Swati S. Jain was the recipient of an NSERC Canadian Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhateeb H, 2007, AM J PHYSIOL-ENDOC M, V293, pE783, DOI 10.1152/ajpendo.00685.2006; BEGUM N, 1993, J BIOL CHEM, V268, P3352; Bonen A, 2000, J BIOL CHEM, V275, P14501, DOI 10.1074/jbc.275.19.14501; Bonen A, 2004, P NUTR SOC, V63, P245, DOI 10.1079/PNS2004331; Halseth AE, 1998, J APPL PHYSIOL, V85, P2305, DOI 10.1152/jappl.1998.85.6.2305; HARDIN DS, 1995, J CLIN ENDOCR METAB, V80, P2437, DOI 10.1210/jc.80.8.2437; Hinchcliff KW, 1997, AM J VET RES, V58, P1457; Kitaoka Y, 2012, AM J VET RES, V73, P1813, DOI 10.2460/ajvr.73.11.1813; Klip A, 2009, APPL PHYSIOL NUTR ME, V34, P481, DOI 10.1139/H09-047; Koonen DPY, 2005, BBA-MOL CELL BIOL L, V1736, P163, DOI 10.1016/j.bbalip.2005.08.018; Kristiansen S, 1997, AM J PHYSIOL-ENDOC M, V272, pE385, DOI 10.1152/ajpendo.1997.272.3.E385; Luiken JJFP, 1999, J LIPID RES, V40, P1007; McCutcheon LJ, 2002, EQUINE VET J, V34, P199; McKenzie E, 2005, MED SCI SPORT EXER, V37, P1307, DOI 10.1249/01.mss.0000175086.41080.01; McKenzie EC, 2008, AM J VET RE IN PRESS; Mohan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014217; Nickerson JG, 2009, J BIOL CHEM, V284, P16522, DOI 10.1074/jbc.M109.004788; Phillips SM, 1996, AM J PHYSIOL-ENDOC M, V270, pE456, DOI 10.1152/ajpendo.1996.270.3.E456; PLOUG T, 1990, AM J PHYSIOL, V259, pE778, DOI 10.1152/ajpendo.1990.259.6.E778; REN JM, 1994, J BIOL CHEM, V269, P14396; Richter EA, 1998, AM J PHYSIOL-ENDOC M, V274, pE89, DOI 10.1152/ajpendo.1998.274.1.E89; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Talanian JL, 2010, AM J PHYSIOL-ENDOC M, V299, pE180, DOI 10.1152/ajpendo.00073.2010; Tonouchi M, 2002, AM J PHYSIOL-ENDOC M, V282, pE1062, DOI 10.1152/ajpendo.00358.2001; Zaid H, 2009, BIOCHEM J, V419, P475, DOI 10.1042/BJ20081319	26	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103087	10.1371/journal.pone.0103087	http://dx.doi.org/10.1371/journal.pone.0103087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075856	gold, Green Published, Green Submitted			2022-12-25	WOS:000340028800025
J	La Merrill, M; Karey, E; Moshier, E; Lindtner, C; La Frano, MR; Newman, JW; Buettner, C				La Merrill, Michele; Karey, Emma; Moshier, Erin; Lindtner, Claudia; La Frano, Michael R.; Newman, John W.; Buettner, Christoph			Perinatal Exposure of Mice to the Pesticide DDT Impairs Energy Expenditure and Metabolism in Adult Female Offspring	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; BODY-MASS INDEX; LIPID-METABOLISM; INSULIN-RESISTANCE; GENE-EXPRESSION; MALARIA CONTROL; BILE-ACIDS; GLUCOSE; FAT; PREVALENCE	Dichlorodiphenyltrichloroethane (DDT) has been used extensively to control malaria, typhus, body lice and bubonic plague worldwide, until countries began restricting its use in the 1970s. Its use in malaria control continues in some countries according to recommendation by the World Health Organization. Individuals exposed to elevated levels of DDT and its metabolite dichlorodiphenyldichloroethylene (DDE) have an increased prevalence of diabetes and insulin resistance. Here we hypothesize that perinatal exposure to DDT disrupts metabolic programming leading to impaired metabolism in adult offspring. To test this, we administered DDT to C57BL/6J mice from gestational day 11.5 to postnatal day 5 and studied their metabolic phenotype at several ages up to nine months. Perinatal DDT exposure reduced core body temperature, impaired cold tolerance, decreased energy expenditure, and produced a transient early-life increase in body fat in female offspring. When challenged with a high fat diet for 12 weeks in adulthood, female offspring perinatally exposed to DDT developed glucose intolerance, hyperinsulinemia, dyslipidemia, and altered bile acid metabolism. Perinatal DDT exposure combined with high fat feeding in adulthood further impaired thermogenesis as evidenced by reductions in core temperature and in the expression of numerous RNA that promote thermogenesis and substrate utilization in the brown adipose tissue of adult female mice. These observations suggest that perinatal DDT exposure impairs thermogenesis and the metabolism of carbohydrates and lipids which may increase susceptibility to the metabolic syndrome in adult female offspring.	[La Merrill, Michele; Karey, Emma] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [La Merrill, Michele; Moshier, Erin] Mt Sinai Sch Med, Dept Prevent Med, New York, NY USA; [La Merrill, Michele; Lindtner, Claudia; Buettner, Christoph] Mt Sinai Sch Med, Metab Inst, New York, NY USA; [Lindtner, Claudia; Buettner, Christoph] Mt Sinai Sch Med, Div Endocrinol Diabet & Bone Dis, New York, NY USA; [La Frano, Michael R.; Newman, John W.] Univ Calif Davis, West Coast Metabol Ctr, Davis, CA 95616 USA; [La Frano, Michael R.; Newman, John W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Newman, John W.] ARS, Obes & Metab Res Unit, USDA, Western Human Nutr Res Ctr, Davis, CA USA	University of California System; University of California Davis; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA)	La Merrill, M (corresponding author), Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA.	mlamerrill@ucdavis.edu	La Frano, Michael/X-7701-2019; karey, Emma/AAT-2649-2020	karey, Emma/0000-0002-5446-5351; Newman, John/0000-0001-9632-6571; La Frano, Michael/0000-0002-2269-1688	National Institute of Health [R00 ES019919, R03 DK082724, U24 DK092993, U24 DK097154, T32 ES007059, P60 DK020541]; American Diabetes Association; United States Department of Agriculture - Agricultural Research Service Intramural Project [5306-51530-019-00D]; ARS [ARS-0426826] Funding Source: Federal RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK082724, P30DK020541, P60DK020541, U24DK092993, U24DK097154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES019919, R00ES019919, T32ES007059] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); United States Department of Agriculture - Agricultural Research Service Intramural Project; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported through funding by the National Institute of Health (R00 ES019919, R03 DK082724, U24 DK092993, U24 DK097154, T32 ES007059, and P60 DK020541), the American Diabetes Association, and United States Department of Agriculture - Agricultural Research Service Intramural Project 5306-51530-019-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; [Anonymous], 2007, J BIOL CHEM, V283, P4228; Asahina K, 2009, HEPATOLOGY, V49, P998, DOI 10.1002/hep.22721; ATTILI AF, 1986, MED HYPOTHESES, V19, P57, DOI 10.1016/0306-9877(86)90137-4; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Bastin J, 2011, HUM MOL GENET, V20, P2048, DOI 10.1093/hmg/ddr089; Bazaes RA, 2003, PEDIATRICS, V111, P804, DOI 10.1542/peds.111.4.804; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; BOUWMAN H, 1992, B WORLD HEALTH ORGAN, V70, P241; BOUWMAN H, 1991, J TOXICOL ENV HEALTH, V33, P141, DOI 10.1080/15287399109531514; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Clegg DJ, 2012, MOL ENDOCRINOL, V26, P1957, DOI 10.1210/me.2012-1284; Cox S, 2007, ENVIRON HEALTH PERSP, V115, P1747, DOI 10.1289/ehp.10258; DAHRI S, 1991, DIABETES, V40, P115, DOI 10.2337/diab.40.2.S115; ECOBICHON DJ, 1968, CAN J PHYSIOL PHARM, V46, P785, DOI 10.1139/y68-121; Eskenazi B, 2009, ENVIRON HEALTH PERSP, V117, P1359, DOI 10.1289/ehp.11748; Farhang L, 2005, AM J EPIDEMIOL, V162, P717, DOI 10.1093/aje/kwi276; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gallagher EJ, 2010, MT SINAI J MED, V77, P511, DOI 10.1002/msj.20212; Garcia-Canaveras JC, 2012, J LIPID RES, V53, P2231, DOI 10.1194/jlr.D028803; Grapov D, 2012, BIOINFORMATICS, V28, P2288, DOI 10.1093/bioinformatics/bts439; Green HF, 2012, NEUROCHEM INT, V61, P666, DOI 10.1016/j.neuint.2012.07.003; Guarner-Lans V, 2011, EXP GERONTOL, V46, P517, DOI 10.1016/j.exger.2011.02.007; Hall JA, 2010, ENDOCRINOLOGY, V151, P4573, DOI 10.1210/en.2010-0511; Han J, 2011, DEVELOPMENT, V138, P5027, DOI 10.1242/dev.067686; Herrera-Portugal C, 2005, ENVIRON RES, V99, P158, DOI 10.1016/j.envres.2005.03.010; Hinoi E, 2013, DIABETES; Hondares E, 2013, METABOLISM; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Hult M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013582; Jun HJ, 2012, PPAR RES, V2012, DOI 10.1155/2012/320454; KACEW S, 1974, BIOCHEM J, V142, P145, DOI 10.1042/bj1420145; Karmaus W, 2009, OCCUP ENVIRON MED, V66, P143, DOI 10.1136/oem.2008.041921; Kim JY, 2009, J MED FOOD, V12, P629, DOI 10.1089/jmf.2008.1234; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; Koves TR, 2013, J LIPID RES, V54, P522, DOI 10.1194/jlr.P028910; KREISS K, 1981, JAMA-J AM MED ASSOC, V245, P1926, DOI 10.1001/jama.245.19.1926; Langenberg C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001230; Lee DH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015977, 10.1371/journal.pone.0026172]; Lee JS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-33; Lindtner C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005123; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Merrill ML, 2013, ENVIRON HEALTH PERSP, V121, P594, DOI 10.1289/ehp.1205921; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; NAGAOKA S, 1986, J NUTR, V116, P726, DOI 10.1093/jn/116.5.726; NNODIM JO, 1985, ANAT EMBRYOL, V173, P215, DOI 10.1007/BF00316302; Novo CL, 2013, FASEB J, V27, P3632, DOI 10.1096/fj.12-224204; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Qiao AJ, 2011, HEPATOLOGY, V54, P509, DOI 10.1002/hep.24402; Ramachandran A, 2012, WORLD J DIABETES, V3, P110, DOI 10.4239/wjd.v3.i6.110; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Rolo AP, 2002, TOXICOL LETT, V126, P197, DOI 10.1016/S0378-4274(01)00464-7; Rylander C, 2009, J ENVIRON MONITOR, V11, P370, DOI 10.1039/b811868j; Rylander Lars, 2005, Environ Health, V4, P28, DOI 10.1186/1476-069X-4-28; SANYAL S, 1982, INDIAN J BIOCHEM BIO, V19, P111; Scherer T, 2011, CELL METAB, V13, P183, DOI 10.1016/j.cmet.2011.01.008; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sholtz RI, 2011, ENVIRON INT, V37, P709, DOI 10.1016/j.envint.2011.01.013; Skinner MK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-228; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Stefl B, 1998, AM J PHYSIOL-ENDOC M, V274, pE527, DOI 10.1152/ajpendo.1998.274.3.E527; Taylor KW, 2013, ENVIRON HEALTH PERSP, V121, P774, DOI 10.1289/ehp.1205502; TOMATIS L, 1972, INT J CANCER, V10, P489, DOI 10.1002/ijc.2910100308; TRINDER P, 1969, J CLIN PATHOL, V22, P158, DOI 10.1136/jcp.22.2.158; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; YAU ET, 1977, TOXICOL APPL PHARM, V39, P81, DOI 10.1016/0041-008X(77)90179-X; You L, 1999, TOXICOL APPL PHARM, V157, P134, DOI 10.1006/taap.1999.8673; Yu XX, 2002, FASEB J, V16, P155, DOI 10.1096/fj.01-0568com; Zaytseva YY, 2012, CANCER RES, V72, P1504, DOI 10.1158/0008-5472.CAN-11-4057; Zhao Y, 2012, ADV EXP MED BIOL, V728, P214, DOI 10.1007/978-1-4614-0887-1_14	77	87	89	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103337	10.1371/journal.pone.0103337	http://dx.doi.org/10.1371/journal.pone.0103337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076055	Green Published, Green Submitted, gold			2022-12-25	WOS:000340028800037
J	Won, JC; Park, CY; Oh, SW; Lee, ES; Youn, BS; Kim, MS				Won, Jong Chul; Park, Cheol-Young; Oh, Sang Woo; Lee, Eon Sook; Youn, Byung-Soo; Kim, Min-Seon			Plasma Clusterin (ApoJ) Levels Are Associated with Adiposity and Systemic Inflammation	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GENOME-WIDE ASSOCIATION; C-REACTIVE PROTEIN; APOLIPOPROTEIN-J; INSULIN-RESISTANCE; ALZHEIMERS-DISEASE; CLUSTERIN/APOLIPOPROTEIN-J; IDENTIFIES VARIANTS; METABOLIC SYNDROME; OXIDATIVE STRESS	Obesity and insulin resistance are hallmarks of the metabolic syndrome, which is associated with low-grade chronic inflammation. Clusterin/apolipoprotein J is an abundant plasma chaperone protein that has recently been suggested as a potential biomarker that reflects the inflammatory process in Alzheimer's disease. In the present study, we investigated anthropometric and clinical factors affecting the plasma levels of clusterin in healthy Korean subjects. We measured fasting plasma clusterin levels in healthy Korean adults (111 men and 93 women) using ELISA kit. We analyzed the relationship between plasma clusterin concentrations and anthropometric and clinical parameters. Fasting plasma clusterin concentrations were higher in overweight and obese subjects than in lean subjects. Correlation analysis revealed that the plasma clusterin levels were positively associated with indices of obesity such as body mass index (BMI), waist circumference and waist-hip ratio and markers of systemic inflammation such as high sensitivity C-reactive protein (hsCRP), uric acid, ferritin and retinol binding protein-4. Multiple linear regression analysis showed that sex, BMI and hsCRP were independent determinants of plasma clusterin levels. Furthermore, plasma clusterin levels showed an upward trend with increasing numbers of metabolic syndrome components. These findings suggest that fasting plasma clusterin levels correlate with the parameters of adiposity and systemic inflammation in healthy adults. Therefore, the circulating clusterin level may be a surrogate marker for obesity-associated systemic inflammation.	[Won, Jong Chul] Inje Univ, Sanggye Paik Hosp, Coll Med, Dept Internal Med,Cardiovasc & Metab Dis Ctr, Seoul, South Korea; [Park, Cheol-Young] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Internal Med, Seoul, South Korea; [Oh, Sang Woo] Dongguk Univ, Ilsan Hosp, Dept Family Med, Ilsan, South Korea; [Lee, Eon Sook] Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Family Med,Ctr Hlth Promot, Ilsan, South Korea; [Youn, Byung-Soo] Wonkang Univ, Sch Med, Dept Anat, Iksan, Jeonbuk, South Korea; [Kim, Min-Seon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea	Inje University; Sungkyunkwan University (SKKU); Samsung Medical Center; Dongguk University; NHIS Ilsan Hospital; Inje University; Wonkwang University; University of Ulsan; Asan Medical Center	Youn, BS (corresponding author), Wonkang Univ, Sch Med, Dept Anat, Iksan, Jeonbuk, South Korea.	byung4jc@gmail.com; mskim@amc.seoul.kr	; Park, Cheol-Young/C-6690-2018	Oh, Sang Woo/0000-0002-5623-6720; Lee, Eon Sook/0000-0002-6148-2512; Park, Cheol-Young/0000-0002-9415-9965; Won, Jong Chul/0000-0002-2219-4083	National Research Foundation of Korea [2013M3C7A1056024]; Asan Institute for Life Science [11similar to326]; Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0020224]	National Research Foundation of Korea(National Research Foundation of Korea); Asan Institute for Life Science; Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by grants from the National Research Foundation of Korea (2013M3C7A1056024), and the Asan Institute for Life Science (11 similar to 326). This study was also supported by a Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0020224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MA, 2003, CIRCULATION, V108, P161, DOI 10.1161/01.CIR.0000080289.72166.CF; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Arnold T, 2011, PEDIATR RES, V69, P237, DOI 10.1203/PDR.0b013e31820930cb; Bhamra MS, 2012, ELECTROPHORESIS, V33, P3598, DOI 10.1002/elps.201200161; BURKEY BF, 1992, J LIPID RES, V33, P1517; CHOIMIURA NH, 1992, J BIOCHEM, V112, P557, DOI 10.1093/oxfordjournals.jbchem.a123938; Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112; Falgarone G, 2009, ADV CANCER RES, V104, P139, DOI 10.1016/S0065-230X(09)04008-1; Fernandez-Real JM, 1998, DIABETES CARE, V21, P62, DOI 10.2337/diacare.21.1.62; Fukushima M, 1999, DIABETES CARE, V22, P1911, DOI 10.2337/diacare.22.11.1911; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; HARDARDOTTIR I, 1994, J CLIN INVEST, V94, P1304, DOI 10.1172/JCI117449; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; International Obesity Task Force (IOTF), 2000, AS PAC PERSP RED OB; Ishii T, 2001, ATHEROSCLEROSIS, V158, P215, DOI 10.1016/S0021-9150(01)00416-6; JENNE DE, 1991, J BIOL CHEM, V266, P11030; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; KELSO GJ, 1994, BIOCHEMISTRY-US, V33, P832, DOI 10.1021/bi00169a026; Kim HJ, 2009, ARTERIOSCL THROM VAS, V29, P1558, DOI 10.1161/ATVBAHA.109.190058; Kujiraoka T, 2006, J ATHEROSCLER THROMB, V13, P314, DOI 10.5551/jat.13.314; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Meisinger C, 2008, ARTERIOSCL THROM VAS, V28, P1186, DOI 10.1161/ATVBAHA.107.160184; Navab M, 1997, J CLIN INVEST, V99, P2005, DOI 10.1172/JCI119369; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; ROSENBERG ME, 1995, INT J BIOCHEM CELL B, V27, P633, DOI 10.1016/1357-2725(95)00027-M; Shapiro H, 2011, THESCIENTIFICWORLDJO, V11, P2509, DOI 10.1100/2011/397971; Shirasawa T, 2009, J ATHEROSCLER THROMB, V16, P772; Tamakoshi K, 2003, INT J OBESITY, V27, P443, DOI 10.1038/sj.ijo.0802260; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; Trougakos IP, 2002, EXP GERONTOL, V37, P1175, DOI 10.1016/S0531-5565(02)00139-0; Yao-Borengasser A, 2007, J CLIN ENDOCR METAB, V92, P2590, DOI 10.1210/jc.2006-0816; Yu JT, 2013, NEUROBIOL AGING, V34, p[1921, e1917]	37	60	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103351	10.1371/journal.pone.0103351	http://dx.doi.org/10.1371/journal.pone.0103351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076422	Green Published, gold, Green Submitted			2022-12-25	WOS:000340028800040
J	Young, SD; Daniels, J; Chiu, CJ; Bolan, RK; Flynn, RP; Kwok, J; Klausner, JD				Young, Sean D.; Daniels, Joseph; Chiu, ChingChe J.; Bolan, Robert K.; Flynn, Risa P.; Kwok, Justin; Klausner, Jeffrey D.			Acceptability of Using Electronic Vending Machines to Deliver Oral Rapid HIV Self-Testing Kits: A Qualitative Study	PLOS ONE			English	Article							STIGMA; MEN; SEX; PREVENTION; PERCEPTIONS; INFECTION; EPIDEMIC; RISK	Introduction: Rates of unrecognized HIV infection are significantly higher among Latino and Black men who have sex with men (MSM). Policy makers have proposed that HIV self-testing kits and new methods for delivering self-testing could improve testing uptake among minority MSM. This study sought to conduct qualitative assessments with MSM of color to determine the acceptability of using electronic vending machines to dispense HIV self-testing kits. Materials and Methods: African American and Latino MSM were recruited using a participant pool from an existing HIV prevention trial on Facebook. If participants expressed interest in using a vending machine to receive an HIV self-testing kit, they were emailed a 4-digit personal identification number (PIN) code to retrieve the test from the machine. We followed up with those who had tested to assess their willingness to participate in an interview about their experience. Results: Twelve kits were dispensed and 8 interviews were conducted. In general, participants expressed that the vending machine was an acceptable HIV test delivery method due to its novelty and convenience. Discussion: Acceptability of this delivery model for HIV testing kits was closely associated with three main factors: credibility, confidentiality, and convenience. Future research is needed to address issues, such as user-induced errors and costs, before scaling up the dispensing method.	[Young, Sean D.; Chiu, ChingChe J.; Kwok, Justin] Univ Calif Los Angeles, Dept Family Med, Los Angeles, CA 90095 USA; [Daniels, Joseph; Klausner, Jeffrey D.] Univ Calif Los Angeles, Program Global Hlth, Los Angeles, CA USA; [Bolan, Robert K.; Flynn, Risa P.] Los Angeles Gay & Lesbian Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Young, SD (corresponding author), Univ Calif Los Angeles, Dept Family Med, Los Angeles, CA 90095 USA.	sdyoung@mednet.ucla.edu	Bolan, Robert/AAD-4716-2020	Young, Sean D./0000-0001-6052-4875	National Institutes of Mental Health (NIMH) [K01 MH090884-02]; UCLA CHIPTS; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107, K01MH090884] Funding Source: NIH RePORTER	National Institutes of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UCLA CHIPTS; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study received support from the National Institutes of Mental Health (NIMH; K01 MH090884-02) and from UCLA CHIPTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angotti N, 2009, SOC SCI MED, V68, P2263, DOI 10.1016/j.socscimed.2009.02.041; [Anonymous], 2013, HIV INC; [Anonymous], 2008, SUBP EST HIV INC SUR, P985; Brooks RA, 2005, AIDS PATIENT CARE ST, V19, P737, DOI 10.1089/apc.2005.19.737; Carballo-Dieguez A, 2012, AIDS BEHAV, V16, P1753, DOI 10.1007/s10461-012-0274-2; Centers for Disease Control and Prevention, 2013, HIV US GLANC; Charmaz K., 2003, STRATEGIES QUALITATI, P249, DOI 10.1111/1467-9566.00338; Fullilove MT, 1999, AM BEHAV SCI, V42, P1117, DOI 10.1177/00027649921954796; Hall HI, 2007, AM J PUBLIC HEALTH, V97, P1060, DOI 10.2105/AJPH.2006.087551; HIV Epidemiology Program Los Angeles County Department of Health Services, 2002, SPEC DAT RUN; HIV Epidemiology Program Los Angeles County Department of Health Services, 2008, SPEC DAT RUN; Hoffman ND, 2009, J ADOLESCENT HEALTH, V45, P222, DOI 10.1016/j.jadohealth.2009.01.009; Janssen RS, 2001, AM J PUBLIC HEALTH, V91, P1019, DOI 10.2105/AJPH.91.7.1019; Kirby D, 1999, AM J PUBLIC HEALTH, V89, P182, DOI 10.2105/AJPH.89.2.182; Lyu SY, 2011, AIDS CARE, V23, P508, DOI 10.1080/09540121.2010.516331; MacKellar DA, 2005, JAIDS-J ACQ IMM DEF, V38, P603, DOI 10.1097/01.qai.0000141481.48348.7e; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Marin Barbara VanOss, 2003, J Transcult Nurs, V14, P186, DOI 10.1177/1043659603014003005; Miles M. B., 2019, QUALITATIVE DATA ANA, V4th; Millett G, 2005, J NATL MED ASSOC, V97, p52S; Ng OT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045168; Obadia Y, 1999, AM J PUBLIC HEALTH, V89, P1852, DOI 10.2105/AJPH.89.12.1852; Pilcher CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080629; Stekler JD, 2013, J CLIN VIROL, V58, pE119, DOI 10.1016/j.jcv.2013.09.018; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Worthington C, 2003, QUAL HEALTH RES, V13, P636, DOI 10.1177/1049732303013005004; Wright AA, 2006, NEW ENGL J MED, V354, P437, DOI 10.1056/NEJMp058302; Young SD, 2013, AIDS CARE, P1, DOI DOI 10.1208/SL2249-013-9988-3; Young SD, 2007, PERS SOC PSYCHOL B, V33, P789, DOI 10.1177/0146167207301027; Young SD, 2013, ANN INTERN MED, V159, P318, DOI 10.7326/0003-4819-159-5-201309030-00005; Young SD, 2011, AIDS BEHAV, V15, P643, DOI 10.1007/s10461-009-9653-8; Young SD, 2010, AIDS CARE, V22, P373, DOI 10.1080/09540120903193666	32	49	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103790	10.1371/journal.pone.0103790	http://dx.doi.org/10.1371/journal.pone.0103790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM7EZ	25076208	Green Submitted, gold, Green Published			2022-12-25	WOS:000340028800079
J	Rowinska, Z; Gorressen, S; Merx, MW; Koeppel, TA; Liehn, EA; Zernecke, A				Rowinska, Zuzanna; Gorressen, Simone; Merx, Marc W.; Koeppel, Thomas A.; Liehn, Elisa A.; Zernecke, Alma			Establishment of a New Murine Elastase-Induced Aneurysm Model Combined with Transplantation	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSM; MOUSE MODELS; PREDICTION; DILATION; RUPTURE	Introduction: The aim of our study was to develop a reproducible murine model of elastase-induced aneurysm formation combined with aortic transplantation. Methods: Adult male mice (n = 6-9 per group) underwent infrarenal, orthotopic transplantation of the aorta treated with elastase or left untreated. Subsequently, both groups of mice were monitored by ultrasound until 7 weeks after grafting. Results: Mice receiving an elastase-pretreated aorta developed aneurysms and exhibited a significantly increased diastolic vessel diameter compared to control grafted mice at 7 week after surgery (1.11 +/- 0.10 mm vs. 0.75 +/- 0.03 mm; p <= 0.001). Histopathological examination revealed disruption of medial elastin, an increase in collagen content and smooth muscle cells, and neointima formation in aneurysm grafts. Conclusions: We developed a reproducible murine model of elastase-induced aneurysm combined with aortic transplantation. This model may be suitable to investigate aneurysm-specific inflammatory processes and for use in gene-targeted animals.	[Rowinska, Zuzanna] Dusseldorf Univ Hosp, Dept Vasc & Endovasc Surg, Dusseldorf, Germany; [Rowinska, Zuzanna; Liehn, Elisa A.] Rhein Westfal TH Aachen, Univ Hosp, Inst Mol Cardiovasc Res, Dept Med, Aachen, Germany; [Gorressen, Simone; Merx, Marc W.] Dusseldorf Univ Hosp, Div Cardiol Pneumol & Angiol, Dusseldorf, Germany; [Merx, Marc W.] Klinikum Reg Hannover, Robert Koch Krankenhaus, Dept Cardiol Vasc Med & Intens Care Med, Hannover, Germany; [Koeppel, Thomas A.] Univ Munich, Div Vasc & Endovasc Surg, Munich, Germany; [Zernecke, Alma] Univ Hosp Wurzburg, Inst Clin Biochem & Pathobiochem, Wurzburg, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Munich; University of Wurzburg	Rowinska, Z (corresponding author), Dusseldorf Univ Hosp, Dept Vasc & Endovasc Surg, Dusseldorf, Germany.	zuzanna.rowinska@med.uni-duesseldorf.de	Liehn, Elisa Anamaria/D-9623-2011	Liehn, Elisa Anamaria/0000-0002-1253-3272	Interdisciplinary Center for Clinical Research (IZKF) Aachen of the Faculty of Medicine, RWTH Aachen University (EAL)	Interdisciplinary Center for Clinical Research (IZKF) Aachen of the Faculty of Medicine, RWTH Aachen University (EAL)	This study was supported by the Interdisciplinary Center for Clinical Research (IZKF) Aachen of the Faculty of Medicine, RWTH Aachen University (EAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANIDJAR S, 1990, CIRCULATION, V82, P973, DOI 10.1161/01.CIR.82.3.973; Annambhotla S, 2008, WORLD J SURG, V32, P976, DOI 10.1007/s00268-007-9456-x; Azuma J, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/252141; Barisione C, 2006, J VASC SURG, V44, P372, DOI 10.1016/j.jvs.2006.04.047; Bartoli MA, 2012, EUR J VASC ENDOVASC, V44, P475, DOI 10.1016/j.ejvs.2012.08.002; Boon RA, 2011, CIRC RES, V109, P1115, DOI 10.1161/CIRCRESAHA.111.255737; Cao RY, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00009; Dambrin C, 1999, J HEART LUNG TRANSPL, V18, P946, DOI 10.1016/S1053-2498(99)00051-0; Daugherty A, 2004, TRENDS CARDIOVAS MED, V14, P117, DOI 10.1016/j.tcm.2004.01.002; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Daugherty A, 2002, AM J MED SCI, V323, P3, DOI 10.1097/00000441-200201000-00002; Davies RR, 2002, ANN THORAC SURG, V73, P17, DOI 10.1016/S0003-4975(01)03236-2; Goldberg A, 2007, ULTRASOUND MED BIOL, V33, P1552, DOI 10.1016/j.ultrasmedbio.2007.04.003; JOHNSTON KW, 1991, J VASC SURG, V13, P452, DOI 10.1067/mva.1991.26737; Kniemeyer HW, 2000, EUR J VASC ENDOVASC, V19, P190, DOI 10.1053/ejvs.1999.0980; Lehalle B, 1997, J VASC SURG, V25, P751, DOI 10.1016/S0741-5214(97)70305-7; Maegdefessel L, 2012, J CLIN INVEST, V122, P497, DOI 10.1172/JCI61598; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Rowinska Z, 2012, EUR J RADIOL, V81, P244, DOI 10.1016/j.ejrad.2010.12.083; Saatchi S, 2012, J HISTOCHEM CYTOCHEM, V60, P97, DOI 10.1369/0022155411433066; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855	22	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102648	10.1371/journal.pone.0102648	http://dx.doi.org/10.1371/journal.pone.0102648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068788	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700013
J	Tirupula, KC; Desnoyer, R; Speth, RC; Karnik, SS				Tirupula, Kalyan C.; Desnoyer, Russell; Speth, Robert C.; Karnik, Sadashiva S.			Atypical Signaling and Functional Desensitization Response of MAS Receptor to Peptide Ligands	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTOR; ANGIOTENSIN-II; GENETIC DELETION; ENDOTHELIAL DYSFUNCTION; CONSTITUTIVE ACTIVATION; AT(1) RECEPTOR; MODULATION; RHODOPSIN; IDENTIFICATION; ANTAGONISTS	MAS is a G protein-coupled receptor (GPCR) implicated in multiple physiological processes. Several physiological peptide ligands such as angiotensin-(1-7), angiotensin fragments and neuropeptide FF (NPFF) are reported to act on MAS. Studies of conventional G protein signaling and receptor desensitization upon stimulation of MAS with the peptide ligands are limited so far. Therefore, we systematically analyzed G protein signals activated by the peptide ligands. MAS-selective non-peptide ligands that were previously shown to activate G proteins were used as controls for comparison on a common cell based assay platform. Activation of MAS by the non-peptide agonist (1) increased intracellular calcium and D-myo-inositol-1phosphate (IP1) levels which are indicative of the activation of classical G alpha(q)-phospholipase C signaling pathways, (2) decreased G alpha(i) mediated cAMP levels and (3) stimulated G alpha(12)-dependent expression of luciferase reporter. In all these assays, MAS exhibited strong constitutive activity that was inhibited by the non-peptide inverse agonist. Further, in the calcium response assay, MAS was resistant to stimulation by a second dose of the non-peptide agonist after the first activation has waned suggesting functional desensitization. In contrast, activation of MAS by the peptide ligand NPFF initiated a rapid rise in intracellular calcium with very weak IP1 accumulation which is unlike classical G alpha(q)-phospholipase C signaling pathway. NPFF only weakly stimulated MAS-mediated activation of G alpha(12) and G alpha(i) signaling pathways. Furthermore, unlike non-peptide agonist-activated MAS, NPFF-activated MAS could be readily re-stimulated the second time by the agonists. Functional assays with key ligand binding MAS mutants suggest that NPFF and non-peptide ligands bind to overlapping regions. Angiotensin-(1-7) and other angiotensin fragments weakly potentiated an NPFF-like calcium response at non-physiological concentrations (>= 100 mu M). Overall, our data suggest that peptide ligands induce atypical signaling and functional desensitization of MAS.	[Tirupula, Kalyan C.; Desnoyer, Russell; Karnik, Sadashiva S.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Speth, Robert C.] Nova SE Univ, Coll Pharm, Dept Pharmaceut Sci, Ft Lauderdale, FL USA	Cleveland Clinic Foundation; Nova Southeastern University	Karnik, SS (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA.	karniks@ccf.org	Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753	National Institute of Health Heart-Lung-Blood Institute RO1 [HL57470, HL115964]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115964, R01HL057470] Funding Source: NIH RePORTER	National Institute of Health Heart-Lung-Blood Institute RO1; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health Heart-Lung-Blood Institute RO1 grants: #HL57470 and #HL115964. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Ajit SK, 2010, J BIOMED BIOTECHNOL, V2010, P2010; Alenina N, 2008, EXP PHYSIOL, V93, P528, DOI 10.1113/expphysiol.2007.040345; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Ayoub MA, 2009, J BIOL CHEM, V284, P29136, DOI 10.1074/jbc.M109.042333; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, MOL PHARMACOL, V60, P1, DOI 10.1124/mol.60.1.1; Bian WH, 2013, BIOCHEM J, V453, P345, DOI 10.1042/BJ20121885; Bikkavilli RK, 2006, BIOCHEM PHARMACOL, V71, P319, DOI 10.1016/j.bcp.2005.10.050; Botelho-Santos Giancarla Aparecida, 2012, Ther Adv Cardiovasc Dis, V6, P201, DOI 10.1177/1753944712461164; Breit A, 2006, MOL PHARMACOL, V70, P686, DOI 10.1124/mol.106.022897; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; Castro CH, 2006, LIFE SCI, V80, P264, DOI 10.1016/j.lfs.2006.09.007; Chang M, 2009, BRAIN RES, V1271, P36, DOI 10.1016/j.brainres.2009.03.041; Chen HM, 2004, J NEUROSCI, V24, P5044, DOI 10.1523/JNEUROSCI.0990-04.2004; da Costa Goncalves AC, 2007, AM J PHYSIOL-HEART C, V293, pH2588, DOI 10.1152/ajpheart.00173.2007; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Esteban V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005406; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; Fraga-Silva RA, 2008, MOL MED, V14, P28, DOI 10.2119/2007-00073.Fraga-Silva; Gava E, 2012, REGUL PEPTIDES, V175, P30, DOI 10.1016/j.regpep.2012.01.001; Gembardt F, 2008, MOL CELL BIOCHEM, V319, P115, DOI 10.1007/s11010-008-9884-4; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; Santos SHS, 2008, DIABETES, V57, P340, DOI 10.2337/db07-0953; Heringer-Walther S, 2012, EUR J PHARMACOL, V689, P147, DOI 10.1016/j.ejphar.2012.05.025; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Laguzzi R, 1996, BRAIN RES, V711, P193, DOI 10.1016/0006-8993(95)01382-2; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Liu QY, 2001, J BIOL CHEM, V276, P36961, DOI 10.1074/jbc.M105308200; MARIE J, 1994, J BIOL CHEM, V269, P20815; Mario EG, 2012, PEPTIDES, V33, P174, DOI 10.1016/j.peptides.2011.11.014; Milasta S, 2006, MOL PHARMACOL, V69, P479, DOI 10.1124/mol.105.018788; Miura S, 1999, J BIOL CHEM, V274, P7103, DOI 10.1074/jbc.274.11.7103; Moitra S, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-13; Ndong C, 2009, PAIN, V143, P130, DOI 10.1016/j.pain.2009.02.010; Nirula V, 1996, BRIT J PHARMACOL, V119, P1505, DOI 10.1111/j.1476-5381.1996.tb16065.x; NODA K, 1995, J BIOL CHEM, V270, P28511, DOI 10.1074/jbc.270.48.28511; NODA K, 1995, J BIOL CHEM, V270, P2284, DOI 10.1074/jbc.270.5.2284; Ou WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017398; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Patel AB, 2005, J MOL BIOL, V347, P803, DOI 10.1016/j.jmb.2005.01.069; Peiro C, 2007, J HYPERTENS, V25, P2421, DOI 10.1097/HJH.0b013e3282f0143c; Pinheiro SVB, 2009, KIDNEY INT, V75, P1184, DOI 10.1038/ki.2009.61; Prokai L, 2001, J MED CHEM, V44, P1623, DOI 10.1021/jm000512o; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rabelo LA, 2008, J AM SOC HYPERTENS, V2, P418, DOI 10.1016/j.jash.2008.05.003; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2006, HYPERTENSION, V47, P996, DOI 10.1161/01.HYP.0000215289.51180.5c; Shemesh R, 2008, J BIOL CHEM, V283, P34643, DOI 10.1074/jbc.M805181200; Solinski HJ, 2012, J BIOL CHEM, V287, P40956, DOI 10.1074/jbc.M112.408617; Solinski HJ, 2010, MOL PHARMACOL, V78, P249, DOI 10.1124/mol.110.063867; Subramanian H, 2011, J BIOL CHEM, V286, P44739, DOI 10.1074/jbc.M111.277152; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Than JYXL, 2013, J BIOL CHEM, V288, P12818, DOI 10.1074/jbc.M113.450072; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; von Bohlen und Halbach O, 2000, J NEUROPHYSIOL, V83, P2012; Walther T, 1998, J BIOL CHEM, V273, P11867, DOI 10.1074/jbc.273.19.11867; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Xu P, 2008, HYPERTENSION, V51, P574, DOI 10.1161/HYPERTENSIONAHA.107.102764; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3; Zhang T, 2012, AM J PHYSIOL-HEART C, V302, pH299, DOI 10.1152/ajpheart.00723.2011; Zimpelmann J, 2009, AM J PHYSIOL-RENAL, V296, pF337, DOI 10.1152/ajprenal.90437.2008	64	30	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103520	10.1371/journal.pone.0103520	http://dx.doi.org/10.1371/journal.pone.0103520			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068582	gold, Green Published, Green Submitted			2022-12-25	WOS:000339993700077
J	Ng, CA; Phan, K; Hill, AP; Vandenberg, JI; Perry, MD				Ng, Chai Ann; Phan, Kevin; Hill, Adam P.; Vandenberg, Jamie I.; Perry, Matthew D.			Multiple Interactions between Cytoplasmic Domains Regulate Slow Deactivation of Kv11.1 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNEL; AMINO-TERMINAL DOMAIN; SWISS-MODEL; CARDIAC-ARRHYTHMIA; N-TERMINUS; HERG; EAG; REGION; MUTATIONS; ENVIRONMENT	The intracellular domains of many ion channels are important for fine-tuning their gating kinetics. In Kv11.1 channels, the slow kinetics of channel deactivation, which are critical for their function in the heart, are largely regulated by the N-terminal N-Cap and Per-Arnt-Sim (PAS) domains, as well as the C-terminal cyclic nucleotide-binding homology (cNBH) domain. Here, we use mutant cycle analysis to probe for functional interactions between the N-Cap/PAS domains and the cNBH domain. We identified a specific and stable charge-charge interaction between Arg(56) of the PAS domain and Asp(803) of the cNBH domain, as well an additional interaction between the cNBH domain and the N-Cap, both of which are critical for maintaining slow deactivation kinetics. Furthermore, we found that positively charged arginine residues within the disordered region of the N-Cap interact with negatively charged residues of the C-linker domain. Although this interaction is likely more transient than the PAS-cNBD interaction, it is strong enough to stabilize the open conformation of the channel and thus slow deactivation. These findings provide novel insights into the slow deactivation mechanism of Kv11.1 channels.	[Ng, Chai Ann; Phan, Kevin; Hill, Adam P.; Vandenberg, Jamie I.; Perry, Matthew D.] Univ New S Wales, Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia; [Ng, Chai Ann; Phan, Kevin; Hill, Adam P.; Vandenberg, Jamie I.; Perry, Matthew D.] Univ New S Wales, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia	University of New South Wales Sydney; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Vandenberg, JI (corresponding author), Victor Chang Cardiac Res Inst, Mark Cowley Lidwill Res Programme Cardiac Electro, 405 Liverpool St, Darlinghurst, NSW 2010, Australia.	j.vandenberg@victorchang.edu.au	Vandenberg, Jamie I/B-6608-2013	Vandenberg, Jamie I/0000-0002-3859-3716; Phan, Kevin/0000-0002-5940-3555; Ng, Chai Ann/0000-0002-3120-5450	Heart Foundation of Australia [NHFA G11S 5829S]; National Health and Medical Research Council of Australia [635520, 459401, 1019693]	Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Grant-in-Aid NHFA G11S 5829S from the Heart Foundation of Australia and National Health and Medical Research Council of Australia Project Grant 635520) and Fellowship Grants 459401 and 1019693 (to J. I. V.).	Adaixo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059265; Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barros F, 1997, PFLUG ARCH EUR J PHY, V435, P119; Bauer CK, 1998, RECEPTOR CHANNEL, V6, P19; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Case DA, 2012, AMBER 12; Ng CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031640; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Chiesa N, 1997, J PHYSIOL-LONDON, V501, P313, DOI 10.1111/j.1469-7793.1997.313bn.x; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; de la Pena P, 2011, J BIOL CHEM, V286, P19065, DOI 10.1074/jbc.M111.238899; Gianulis EC, 2013, J GEN PHYSIOL, V142, P351, DOI 10.1085/jgp.201310995; Greenwood IA, 2009, J PHYSIOL-LONDON, V587, P2313, DOI 10.1113/jphysiol.2009.171272; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gustina AS, 2012, CELL SIGNAL, V24, P1592, DOI 10.1016/j.cellsig.2012.04.004; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Huang C. C., 1996, PAC S BIOCOMPUT, P724, DOI DOI 10.1142/9789814531399; Lanigan MD, 2002, BIOCHEMISTRY-US, V41, P11963, DOI 10.1021/bi026400b; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Ng CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077032; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Ohya S, 2002, AM J PHYSIOL-CELL PH, V283, pC866, DOI 10.1152/ajpcell.00099.2002; Pardo LA, 2008, EXPERT OPIN THER TAR, V12, P837, DOI [10.1517/14728222.12.7.837, 10.1517/14728222.12.7.837 ]; Piper DR, 2003, P NATL ACAD SCI USA, V100, P10534, DOI 10.1073/pnas.1832721100; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Schafer R, 1999, J PHYSIOL-LONDON, V518, P401, DOI 10.1111/j.1469-7793.1999.0401p.x; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Tan PS, 2012, J GEN PHYSIOL, V140, P293, DOI 10.1085/jgp.201110761; Terlau H, 1997, J PHYSIOL-LONDON, V502, P537, DOI 10.1111/j.1469-7793.1997.537bj.x; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438	41	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25822	25832		10.1074/jbc.M114.558379	http://dx.doi.org/10.1074/jbc.M114.558379			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074935	Green Published, hybrid			2022-12-25	WOS:000342130800039
J	Bai, E; Li, W; Li, SL; Sun, JF; Peng, B; Dai, WW; Jiang, P; Han, SJ				Bai, Edith; Li, Wei; Li, Shanlong; Sun, Jianfei; Peng, Bo; Dai, Weiwei; Jiang, Ping; Han, Shijie			Pulse Increase of Soil N2O Emission in Response to N Addition in a Temperate Forest on Mt Changbai, Northeast China	PLOS ONE			English	Article							NITROUS-OXIDE EMISSIONS; FIELD MEASUREMENT; ACETYLENE INHIBITION; GENERALIZED-MODEL; CONCEPTUAL-MODEL; CORE INCUBATION; FRESH-WATER; GAS FLUXES; DENITRIFICATION; NITRIFICATION	Nitrogen (N) deposition has increased significantly globally since the industrial revolution. Previous studies on the response of gaseous emissions to N deposition have shown controversial results, pointing to the system-specific effect of N addition. Here we conducted an N addition experiment in a temperate natural forest in northeastern China to test how potential changes in N deposition alter soil N2O emission and its sources from nitrification and denitrification. Soil N2O emission was measured using closed chamber method and a separate incubation experiment using acetylene inhibition method was carried out to determine denitrification fluxes and the contribution of nitrification and denitrification to N2O emissions between Jul. and Oct. 2012. An NH4NO3 addition of 50 kg N/ha/yr significantly increased N2O and N-2 emissions, but their "pulse emission'' induced by N addition only lasted for two weeks. Mean nitrification-derived N2O to denitrification-derived N2O ratio was 0.56 in control plots, indicating higher contribution of denitrification to N2O emissions in the study area, and this ratio was not influenced by N addition. The N2O to (N-2+N2O) ratio was 0.41-0.55 in control plots and was reduced by N addition at one sampling time point. Based on this short term experiment, we propose that N2O and denitrification rate might increase with increasing N deposition at least by the same fold in the future, which would deteriorate global warming problems.	[Bai, Edith; Li, Wei; Li, Shanlong; Sun, Jianfei; Peng, Bo; Dai, Weiwei; Jiang, Ping; Han, Shijie] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Li, Wei; Li, Shanlong; Sun, Jianfei; Peng, Bo] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bai, E (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	baie@iae.ac.cn			Major State Basic Research Development Program of China (973 Program) [2014CB954400, 2011CB403202]; National Science Foundation of China [31100326]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major State Basic Research Development Program of China (973 Program) (2014CB954400 and 2011CB403202) and National Science Foundation of China (31100326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves BJR, 2012, SOIL BIOL BIOCHEM, V46, P129, DOI 10.1016/j.soilbio.2011.11.022; Ambus P, 1998, EUR J SOIL SCI, V49, P495, DOI 10.1046/j.1365-2389.1998.4930495.x; Baggs EM, 2010, BIOL FERT SOILS, V46, P793, DOI 10.1007/s00374-010-0484-6; Bai E, 2012, BIOGEOSCIENCES, V9, P3287, DOI 10.5194/bg-9-3287-2012; Bernal S, 2012, P NATL ACAD SCI USA, V109, P3406, DOI 10.1073/pnas.1121448109; Bollmann A, 1998, GLOBAL CHANGE BIOL, V4, P387, DOI 10.1046/j.1365-2486.1998.00161.x; Bouletreau S, 2012, SCI TOTAL ENVIRON, V416, P323, DOI 10.1016/j.scitotenv.2011.11.066; BOWDEN RD, 1991, J GEOPHYS RES-ATMOS, V96, P9321, DOI 10.1029/91JD00151; Burke W, 1986, SOIL STRUCTURE ASSES; Butterbach-Bahl K, 2002, FOREST ECOL MANAG, V167, P123, DOI 10.1016/S0378-1127(01)00725-3; Butterbach-Bahl K, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0122; Cho CM, 1997, CAN J SOIL SCI, V77, P253, DOI 10.4141/S96-056; Ciarlo E, 2007, BIOL FERT SOILS, V43, P675, DOI 10.1007/s00374-006-0147-9; Dannenmann M, 2008, SOIL BIOL BIOCHEM, V40, P2317, DOI 10.1016/j.soilbio.2008.05.009; Davidson EA, 2000, BIOSCIENCE, V50, P667, DOI 10.1641/0006-3568(2000)050[0667:TACMOS]2.0.CO;2; DAVIDSON EA, 1993, ECOLOGY, V74, P130, DOI 10.2307/1939508; DEBOER W, 1992, SOIL BIOL BIOCHEM, V24, P229, DOI 10.1016/0038-0717(92)90223-K; Del Grosso SJ, 2012, NEW PHYTOL, V196, P327, DOI 10.1111/j.1469-8137.2012.04334.x; Ehhalt D, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P239; Felber R, 2012, BIOGEOSCIENCES, V9, P4125, DOI 10.5194/bg-9-4125-2012; Fierer N, 2003, MICROB ECOL, V45, P63, DOI 10.1007/s00248-002-1007-2; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gee G.W., 1986, METHODS SOIL ANAL PA, P383, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C15; Gillam KM, 2008, CAN J SOIL SCI, V88, P133, DOI 10.4141/CJSS06005; Goebel MO, 2005, GEODERMA, V128, P80, DOI 10.1016/j.geoderma.2004.12.016; GOODROAD LL, 1984, J ENVIRON QUAL, V13, P448, DOI 10.2134/jeq1984.00472425001300030024x; Gregorich EG, 2006, SOIL BIOL BIOCHEM, V38, P2614, DOI 10.1016/j.soilbio.2006.03.017; GROFFMAN PM, 1989, SOIL BIOL BIOCHEM, V21, P613, DOI 10.1016/0038-0717(89)90053-9; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hall SJ, 2003, ECOL MONOGR, V73, P107, DOI 10.1890/0012-9615(2003)073[0107:NSOTRF]2.0.CO;2; HATCH DJ, 1990, PLANT SOIL, V124, P97, DOI 10.1007/BF00010937; Heinen M, 2006, GEODERMA, V133, P444, DOI 10.1016/j.geoderma.2005.06.010; Henault C, 2005, GLOBAL CHANGE BIOL, V11, P115, DOI 10.1111/j.1365-2486.2004.00879.x; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Kachenchart B, 2012, AGR ECOSYST ENVIRON, V158, P15, DOI 10.1016/j.agee.2012.05.008; Kiese R, 2002, SOIL BIOL BIOCHEM, V34, P975, DOI 10.1016/S0038-0717(02)00031-7; KLEMEDTSSON L, 1987, PLANT SOIL, V99, P303, DOI 10.1007/BF02370877; Li KH, 2012, GLOBAL CHANGE BIOL, V18, P2546, DOI 10.1111/j.1365-2486.2012.02704.x; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Lovett GM, 2011, ECOSYSTEMS, V14, P615, DOI 10.1007/s10021-011-9432-z; Lu CQ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007990; MARTIKAINEN PJ, 1993, SOIL BIOL BIOCHEM, V25, P343, DOI 10.1016/0038-0717(93)90133-V; Mogge B, 1999, SOIL BIOL BIOCHEM, V31, P1245, DOI 10.1016/S0038-0717(99)00039-5; Morse JL, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001923; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Papen H, 1999, J GEOPHYS RES-ATMOS, V104, P18487, DOI 10.1029/1999JD900293; Parton WJ, 2001, J GEOPHYS RES-ATMOS, V106, P17403, DOI 10.1029/2001JD900101; Parton WJ, 1996, GLOBAL BIOGEOCHEM CY, V10, P401, DOI 10.1029/96GB01455; Petersen SO, 2008, SOIL BIOL BIOCHEM, V40, P967, DOI 10.1016/j.soilbio.2007.11.017; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Ruser R, 2006, SOIL BIOL BIOCHEM, V38, P263, DOI 10.1016/j.soilbio.2005.05.005; RYDEN JC, 1987, SOIL BIOL BIOCHEM, V19, P753, DOI 10.1016/0038-0717(87)90059-9; Scheer C, 2008, SOIL BIOL BIOCHEM, V40, P290, DOI 10.1016/j.soilbio.2007.08.007; Schindlbacher A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004590; Schjonning P, 2003, SOIL SCI SOC AM J, V67, P156, DOI 10.2136/sssaj2003.0156; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; SPSS Inc, SPSS WIND VERS 11 5; Stevens RJ, 1998, SOIL BIOL BIOCHEM, V30, P1119, DOI 10.1016/S0038-0717(97)00227-7; Stief P, 2009, P NATL ACAD SCI USA, V106, P4296, DOI 10.1073/pnas.0808228106; Templer PH, 2012, FRONT ECOL ENVIRON, V10, P547, DOI 10.1890/120055; TIEDJE JM, 1989, PLANT SOIL, V115, P261, DOI 10.1007/BF02202594; Wang CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031042; WEIER KL, 1993, SOIL SCI SOC AM J, V57, P66, DOI 10.2136/sssaj1993.03615995005700010013x; Weslien P, 2009, EUR J SOIL SCI, V60, P311, DOI 10.1111/j.1365-2389.2009.01123.x; Wolf I, 2002, SOIL BIOL BIOCHEM, V34, P741, DOI 10.1016/S0038-0717(02)00001-9; Wolf I, 2003, SOIL SCI SOC AM J, V67, P1862, DOI 10.2136/sssaj2003.1862; Xu Hui, 2000, Journal of Forestry Research, V11, P177, DOI 10.1007/BF02855520; Yamamoto A, 2014, BIOL FERT SOILS, V50, P53, DOI 10.1007/s00374-013-0830-6; Zhang LH, 2007, ATMOS ENVIRON, V41, P1080, DOI 10.1016/j.atmosenv.2006.09.029; Zhong L, 2014, SOIL BIOL BIOCHEM, V69, P1, DOI 10.1016/j.soilbio.2013.10.028	71	31	34	11	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102765	10.1371/journal.pone.0102765	http://dx.doi.org/10.1371/journal.pone.0102765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079363	gold, Green Published, Green Submitted			2022-12-25	WOS:000339954800016
J	Bjorklund, E; Blomqvist, A; Hedlin, J; Persson, E; Fowler, CJ				Bjorklund, Emmelie; Blomqvist, Anders; Hedlin, Joel; Persson, Emma; Fowler, Christopher J.			Involvement of Fatty Acid Amide Hydrolase and Fatty Acid Binding Protein 5 in the Uptake of Anandamide by Cell Lines with Different Levels of Fatty Acid Amide Hydrolase Expression: A Pharmacological Study	PLOS ONE			English	Article							ENDOGENOUS CANNABINOID ANANDAMIDE; TRANSPORT; HYDROLYSIS; INACTIVATION; ACCUMULATION; INHIBITION; MEMBRANES; RECEPTOR; NEURONS; FAAH	Background: The endocannabinoid ligand anandamide (AEA) is removed from the extracellular space by a process of cellular uptake followed by metabolism. In many cells, such as the RBL-2H3 cell line, inhibition of FAAH activity reduces the observed uptake, indicating that the enzyme regulates uptake by controlling the intra-: extracellular AEA concentration gradient. However, in other FAAH-expressing cells, no such effect is seen. It is not clear, however, whether these differences are methodological in nature or due to properties of the cells themselves. In consequence, we have reinvestigated the role of FAAH in gating the uptake of AEA. Methodology/Principal Findings: The effects of FAAH inhibition upon AEA uptake were investigated in four cell lines: AT1 rat prostate cancer, RBL-2H3 rat basophilic leukaemia, rat C6 glioma and mouse P19 embryonic carcinoma cells. Semi-quantitative PCR for the cells and for a rat brain lysate confirmed the expression of FAAH. No obvious expression of a transcript with the expected molecular weight of FLAT was seen. FAAH expression differed between cells, but all four could accumulate AEA in a manner inhibitable by the selective FAAH inhibitor URB597. However, there was a difference in the sensitivities seen in the reduction of uptake for a given degree of FAAH inhibition produced by a reversible FAAH inhibitor, with C6 cells being more sensitive than RBL-2H3 cells, despite rather similar expression levels and activities of FAAH. The four cell lines all expressed FABP5, and AEA uptake was reduced in the presence of the FABP5 inhibitor SB-FI-26, suggesting that the different sensitivities to FAAH inhibition for C6 and RBL2H3 cells is not due to differences at the level of FABP-5. Conclusions/Significance: When assayed using the same methodology, different FAAH-expressing cells display different sensitivities of uptake to FAAH inhibition.	[Bjorklund, Emmelie; Blomqvist, Anders; Hedlin, Joel; Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Persson, Emma] Umea Univ, Dept Radiat Sci, Umea, Sweden	Umea University; Umea University	Fowler, CJ (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	cf@pharm.umu.se	Fowler, Christopher J./M-6313-2019	Fowler, Christopher J./0000-0002-6658-7874	Swedish Science Research Council [12158]; Research Funds of the Medical Faculty	Swedish Science Research Council; Research Funds of the Medical Faculty	This work was supported by the Swedish Science Research Council (Grant no. 12158) and the Research Funds of the Medical Faculty. Umea University is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Berger WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050968; Bjorklund E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087542; Boldrup L, 2004, J BIOCHEM BIOPH METH, V60, P171, DOI 10.1016/j.jbbm.2004.04.020; Chicca A, 2012, J BIOL CHEM, V287, P34660, DOI 10.1074/jbc.M112.373241; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; Di Pasquale E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004989; Fegley D, 2004, P NATL ACAD SCI USA, V101, P8756, DOI 10.1073/pnas.0400997101; Fowler CJ, 2013, FEBS J, V280, P1895, DOI 10.1111/febs.12212; Fu J, 2012, NAT NEUROSCI, V15, P64, DOI 10.1038/nn.2986; Hillard CJ, 2005, NEUROPHARMACOLOGY, V48, P1072, DOI 10.1016/j.neuropharm.2004.12.012; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; Kaczocha M, 2006, J BIOL CHEM, V281, P9066, DOI 10.1074/jbc.M509721200; Kaczocha M, 2012, ACS CHEM NEUROSCI, V3, P364, DOI 10.1021/cn300001w; Kaczocha M, 2010, J BIOL CHEM, V285, P2796, DOI 10.1074/jbc.M109.058461; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Leung K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079355; Ligresti A, 2004, BIOCHEM J, V380, P265, DOI 10.1042/BJ20031812; Muccioli GG, 2010, DRUG DISCOV TODAY, V15, P474, DOI 10.1016/j.drudis.2010.03.007; Oddi S, 2008, CELL MOL LIFE SCI, V65, P840, DOI 10.1007/s00018-008-7494-7; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Onnis V, 2010, J MED CHEM, V53, P2286, DOI 10.1021/jm901891p; Ortega-Gutierrez S, 2004, BIOCHEMISTRY-US, V43, P8184, DOI 10.1021/bi049395f; R Core Team, 2012, R LANG ENV STAT COMP; Rakhshan F, 2000, J PHARMACOL EXP THER, V292, P960; Sandberg A, 2005, CHEM PHYS LIPIDS, V134, P131, DOI 10.1016/j.chemphyslip.2004.12.010; Thors L, 2007, BRIT J PHARMACOL, V152, P744, DOI 10.1038/sj.bjp.0707401	30	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103479	10.1371/journal.pone.0103479	http://dx.doi.org/10.1371/journal.pone.0103479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078278	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800048
J	Kiesewetter, B; Lukas, J; Kuchar, A; Mayerhoefer, ME; Streubel, B; Lagler, H; Mullauer, L; Wohrer, S; Fischbach, J; Raderer, M				Kiesewetter, Barbara; Lukas, Julius; Kuchar, Andreas; Mayerhoefer, Marius E.; Streubel, Berthold; Lagler, Heimo; Muellauer, Leonhard; Woehrer, Stefan; Fischbach, Julia; Raderer, Markus			Clinical Features, Treatment and Outcome of Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of the Ocular Adnexa: Single Center Experience of 60 Patients	PLOS ONE			English	Article							B-CELL LYMPHOMA; PHASE-II TRIAL; MARGINAL ZONE; CHLAMYDIA-PSITTACI; ANTIBIOTIC-THERAPY; 1ST-LINE TREATMENT; FOLLOW-UP; CLASSIFICATION; RADIOTHERAPY; DOXYCYCLINE	Background: Orbital marginal zone B-cell lymphoma (OAML) constitutes for the most frequent diagnosis in orbital lymphoma. Relatively little data, however, have been reported in larger cohorts of patients staged in a uniform way and no therapy standard exists to date. Material and Methods: We have retrospectively analyzed 60 patients diagnosed and treated at our institution 1999-2012. Median age at diagnosis was 64 years (IQR 51-75) and follow-up time 43 months (IQR 16-92). All patients had undergone uniform extensive staging and histological diagnosis was made by a reference pathologist according to the WHO classification. Results: The majority of patients presented with stage IE (n = 40/60, 67%), three had IIE/IIIE and the remaining 17 stage IVE. Seven patients with IVE had bilateral orbital disease whereas the others showed involvement of further organs. Treatment data were available in 58 patients. Local treatment with radiotherapy (14/58, 24%) or surgery (3/58, 5%) resulted in response in 82% of patients. A total of 26 patients (45%) received systemic treatment with a response rate of 85%. Nine patients received antibiotics as initial therapy; response rate was 38%. Watchful-waiting was the initial approach in 6/58 patients. In total 28/58 patients (48%) progressed and were given further therapy. Median time-to-progression in this cohort was 20 months (IQR 9-39). There was no difference in time-to-progression after first-line therapy between the different therapy arms (p = 0.14). Elevated beta-2-microglobulin, plasmacytic differentiation, autoimmune disorder and site of lymphoma were not associated with a higher risk for progress. Conclusion: Our data underscore the excellent prognosis of OAML irrespective of initial therapy, as there was no significant difference in time-to-progression and response between local or systemic therapy. In the absence of randomized trials, the least toxic individual approach should be chosen for OAML.	[Kiesewetter, Barbara; Fischbach, Julia; Raderer, Markus] Med Univ Vienna, Dept Med 1, Div Oncol, Vienna, Austria; [Lukas, Julius; Kuchar, Andreas] Med Univ Vienna, Dept Ophthalmol, Vienna, Austria; [Mayerhoefer, Marius E.] Med Univ Vienna, Dept Radiol, Vienna, Austria; [Streubel, Berthold; Muellauer, Leonhard] Med Univ Vienna, Dept Pathol, Vienna, Austria; [Lagler, Heimo] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria; [Woehrer, Stefan] Med Univ Vienna, Dept Med 1, Div Bone Marrow Transplantat, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Raderer, M (corresponding author), Med Univ Vienna, Dept Med 1, Div Oncol, Vienna, Austria.	markus.raderer@meduniwien.ac.at	Kiesewetter, Barbara/AGX-3260-2022; Müllauer, Leonhard/GSN-9884-2022; Mayerhoefer, Marius/AAD-2156-2021	Müllauer, Leonhard/0000-0002-3399-078X; Mayerhoefer, Marius/0000-0001-8786-8686; Lagler, Heimo/0000-0003-3240-7385; Kiesewetter, Barbara/0000-0002-5490-2371				Ben Simon GJ, 2006, OPHTHALMOLOGY, V113, P1209, DOI 10.1016/j.ophtha.2006.01.057; Chadunet E, 2006, J PATHOL, V209, P344; Conconi A, 2003, BLOOD, V102, P2741, DOI 10.1182/blood-2002-11-3496; Couland SE, 1998, OPHTHALMOLOGY, V105, P1430; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Esmaeli B, 2009, ANN ONCOL, V20, P709, DOI 10.1093/annonc/mdn692; Ferreri AJM, 2008, ANN ONCOL, V19, P194, DOI 10.1093/annonc/mdm561; Ferreri AJM, 2004, J NATL CANCER I, V96, P586, DOI 10.1093/jnci/djh102; Ferreri AJM, 2006, JNCI-J NATL CANCER I, V98, P1375, DOI 10.1093/jnci/djj373; Ferreri AJM, 2012, J CLIN ONCOL, V30, P2988, DOI 10.1200/JCO.2011.41.4466; Ferry JA, 2007, AM J SURG PATHOL, V31, P170, DOI 10.1097/01.pas.0000213350.49767.46; Govi S, 2010, BRIT J HAEMATOL, V150, P226, DOI 10.1111/j.1365-2141.2010.08179.x; Hasegawa M, 2003, INT J RADIAT ONCOL, V57, P172, DOI 10.1016/S0360-3016(03)00506-6; Hashimoto N, 2012, INT J RADIAT ONCOL, V82, P1509, DOI 10.1016/j.ijrobp.2011.04.052; Hoffmann M, 2011, LEUKEMIA LYMPHOMA, V52, P42, DOI 10.3109/10428194.2010.534519; HUSSELL T, 1993, LANCET, V342, P571, DOI 10.1016/0140-6736(93)91408-E; Isaacson P.G., 2008, WHO CLASSIFICATION T, V4th, P214; Jenkins C, 2000, BRIT J OPHTHALMOL, V84, P907, DOI 10.1136/bjo.84.8.907; Kiesewetter B, 2013, BLOOD, V122, P1350, DOI 10.1182/blood-2013-02-486522; Kiesewetter B, 2013, HAEMATOLOGICA, V98, P353, DOI 10.3324/haematol.2012.065995; Kim TM, 2010, CANCER SCI, V101, P1199, DOI 10.1111/j.1349-7006.2010.01502.x; Lim SH, 2011, INDIAN J OPHTHALMOL, V59, P273, DOI 10.4103/0301-4738.81993; McKelvie PA, 2001, CLIN EXP OPHTHALMOL, V29, P387, DOI 10.1046/j.1442-9071.2001.00450.x; Nakata M, 1999, LEUKEMIA LYMPHOMA, V32, P533, DOI 10.3109/10428199909058411; Nutting CM, 2006, EYE, V20, P645, DOI 10.1038/sj.eye.6702027; Paik JS, 2012, ANN HEMATOL, V91, P1393, DOI 10.1007/s00277-012-1469-3; Raderer M, 2000, BRIT J CANCER, V83, P454, DOI 10.1054/bjoc.2000.1308; Raderer M, 2005, CLIN CANCER RES, V11, P3349, DOI 10.1158/1078-0432.CCR-04-2282; Rummel MJ, 2013, LANCET, V381, P1203, DOI 10.1016/S0140-6736(12)61763-2; Ruskone -Fourmestraux A, 2011, GUT, V60, P747, DOI 10.1136/gut.2010.224949; Smedby KE, 2006, JNCI-J NATL CANCER I, V98, P51, DOI 10.1093/jnci/djj004; Son SH, 2010, INT J RADIAT ONCOL, V77, P86, DOI 10.1016/j.ijrobp.2009.04.018; Song EK, 2008, ANN ONCOL, V19, P242, DOI 10.1093/annonc/mdm457; Stefanovic A, 2009, BLOOD, V114, P501, DOI 10.1182/blood-2008-12-195453; Tanimoto K, 2006, ANN ONCOL, V17, P135, DOI 10.1093/annonc/mdj025; Thieblemont C, 2000, BLOOD, V95, P802, DOI 10.1182/blood.V95.3.802.003k19_802_806; Troch M, 2013, HAEMATOLOGICA, V98, P264, DOI 10.3324/haematol.2012.072587; Tsang RW, 2003, J CLIN ONCOL, V21, P4157, DOI 10.1200/JCO.2003.06.085; Uno T, 2003, CANCER-AM CANCER SOC, V98, P865, DOI 10.1002/cncr.11539; Wohrer S, 2007, LEUKEMIA, V21, P1812, DOI 10.1038/sj.leu.2404782	40	26	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e104004	10.1371/journal.pone.0104004	http://dx.doi.org/10.1371/journal.pone.0104004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077481	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800103
J	Kunkler, PE; Ballard, CJ; Pellman, JJ; Zhang, LJ; Oxford, GS; Hurley, JH				Kunkler, Phillip Edward; Ballard, Carrie Jo; Pellman, Jessica Joan; Zhang, LuJuan; Oxford, Gerry Stephen; Hurley, Joyce Harts			Intraganglionic Signaling as a Novel Nasal-Meningeal Pathway for TRPA1-Dependent Trigeminovascular Activation by Inhaled Environmental Irritants	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; DORSAL-ROOT GANGLIA; PRIMARY AFFERENT NEURONS; EMERGENCY-DEPARTMENT VISITS; RECEPTOR POTENTIAL A1; ION-CHANNEL TRPA1; BLOOD-FLOW; TRIGEMINAL GANGLION; AIR-POLLUTION; NERVE-FIBERS	Headache is the most common symptom associated with air pollution, but little is understood about the underlying mechanism. Nasal administration of environmental irritants activates the trigeminovascular system by a TRPA1-dependent process. This report addresses questions about the anatomical pathway involved and the function of TRP channels in this pathway. TRPV1 and TRPA1 are frequently co-localized and interact to modulate function in sensory neurons. We demonstrate here that resiniferatoxin ablation of TRPV1 expressing neurons significantly reduces meningeal blood flow responses to nasal administration of both TRPV1 and TRPA1 agonists. Accordingly resiniferatoxin also significantly reduces TRPV1 and CGRP immunostaining and TRPV1 and TRPA1 message levels in trigeminal ganglia. Sensory neurons of the trigeminal ganglia innervate the nasal epithelium and the meninges, but the mechanism and anatomical route by which nasal administration evokes meningeal vasodilatation is unclear. Double retrograde labeling from the nose and meninges reveals no co-localization of fluorescent label, however nasal and meningeal labeled cells are located in close proximity to each other within the trigeminal ganglion. Our data demonstrate that TRPV1 expressing neurons are important for TRPA1 responses in the nasal-meningeal pathway. Our data also suggest that the nasal-meningeal pathway is not primarily by axon reflex, but may instead result from intraganglionic transmission.	[Kunkler, Phillip Edward; Ballard, Carrie Jo; Zhang, LuJuan; Hurley, Joyce Harts] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Pellman, Jessica Joan; Oxford, Gerry Stephen] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Hurley, JH (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.	johurley@iupui.edu			National Headache Foundation; Showalter Charitable Trust; NIEHS [ES017430]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017430] Funding Source: NIH RePORTER	National Headache Foundation; Showalter Charitable Trust; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the National Headache Foundation, the Showalter Charitable Trust and NIEHS (ES017430) to JHH and GSO. The funders had no role in the study design data collection or decision to publish this manuscript.	Akerman S, 2013, CEPHALALGIA, V33, P577, DOI 10.1177/0333102412472071; Akopian AN, 2011, CURR PHARM BIOTECHNO, V12, P89; Amir R, 1996, J NEUROSCI, V16, P4733; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; ANTON F, 1991, NEUROSCIENCE, V41, P617, DOI 10.1016/0306-4522(91)90354-Q; Bae YC, 2004, J COMP NEUROL, V478, P62, DOI 10.1002/cne.20272; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Benemei S, 2010, CEPHALALGIA, V30, P744, DOI 10.1111/j.1468-2982.2009.01988.x; Bigal ME, 2013, HEADACHE, V53, P1230, DOI 10.1111/head.12179; CELANDER O, 1953, ACTA PHYSIOL SCAND, V29, P359, DOI 10.1111/j.1748-1716.1953.tb01031.x; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; CULLEN MR, 1987, OCCUP MED, V2, P655; DEVOR M, 1990, J NEUROPHYSIOL, V64, P1733, DOI 10.1152/jn.1990.64.6.1733; FINGER TE, 1993, J COMP NEUROL, V334, P117, DOI 10.1002/cne.903340110; Frederick J, 2007, BIOCHEM BIOPH RES CO, V358, P1058, DOI 10.1016/j.bbrc.2007.05.029; Friedman DI, 2009, HEADACHE, V49, P941, DOI 10.1111/j.1526-4610.2009.01443.x; Gottselig R, 2004, CEPHALALGIA, V24, P206, DOI 10.1111/j.1468-2982.2004.00649.x; Hjerling-Leffler J, 2007, J NEUROSCI, V27, P2435, DOI 10.1523/JNEUROSCI.5614-06.2007; Ho TW, 2008, NEUROLOGY, V70, P1304, DOI 10.1212/01.WNL.0000286940.29755.61; Hou MY, 2002, NEUROSCI LETT, V330, P223, DOI 10.1016/S0304-3940(02)00741-3; Hsieh YL, 2012, EXP NEUROL, V235, P316, DOI 10.1016/j.expneurol.2012.02.013; Huang DY, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-66; Huang LYM, 1996, NEURON, V17, P135, DOI 10.1016/S0896-6273(00)80287-1; Hunter DD, 1998, NEUROSCIENCE, V83, P591, DOI 10.1016/S0306-4522(97)00324-2; Iadarola MJ, 2011, CURR TOP MED CHEM, V11, P2171; Jeffry JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007021; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Kissin I, 2011, CURR TOP MED CHEM, V11, P2159, DOI 10.2174/156802611796904924; Klafke JZ, 2012, NEUROSCIENCE, V222, P136, DOI 10.1016/j.neuroscience.2012.07.022; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Kunkler PE, 2011, PAIN, V152, P38, DOI 10.1016/j.pain.2010.08.021; KUROSAWA M, 1995, BRIT J PHARMACOL, V114, P1397, DOI 10.1111/j.1476-5381.1995.tb13361.x; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; MAYBERG M, 1981, SCIENCE, V213, P228, DOI 10.1126/science.6166046; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; MESSLINGER K, 1995, CAN J PHYSIOL PHARM, V73, P1020; Mishra SK, 2010, MOL CELL NEUROSCI, V43, P157, DOI 10.1016/j.mcn.2009.10.006; Nassini R, 2012, BRAIN, V135, P376, DOI 10.1093/brain/awr272; Nattero G, 1996, HEADACHE, V36, P243, DOI 10.1046/j.1526-4610.1996.3604243.x; OCONNOR TP, 1986, J NEUROSCI, V6, P2200; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Oxford GS., 2013, OPEN PAIN J, V6, P37, DOI DOI 10.2174/1876386301306010037; Pan HL, 2003, J NEUROSCI, V23, P2911; Pecze L, 2009, CAN J NEUROL SCI, V36, P234, DOI 10.1017/S0317167100006600; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pietrobon D, 2013, ANNU REV PHYSIOL, V75, P365, DOI 10.1146/annurev-physiol-030212-183717; Plevkova J, 2013, J APPL PHYSIOL, V115, P268, DOI 10.1152/japplphysiol.01144.2012; Price TJ, 2007, J PAIN, V8, P263, DOI 10.1016/j.jpain.2006.09.005; Rozanski GM, 2012, EUR J NEUROSCI, V36, P3314, DOI 10.1111/j.1460-9568.2012.08233.x; Schwenger N, 2007, CEPHALALGIA, V27, P481, DOI 10.1111/j.1468-2982.2007.01321.x; Shimizu T, 2007, BRAIN RES, V1173, P84, DOI 10.1016/j.brainres.2007.07.068; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; SUZUKI N, 1989, NEUROSCIENCE, V30, P595, DOI 10.1016/0306-4522(89)90154-1; SZALLASI A, 1989, NEUROSCIENCE, V30, P515, DOI 10.1016/0306-4522(89)90269-8; SZALLASI A, 1992, NEUROSCI LETT, V140, P51, DOI 10.1016/0304-3940(92)90679-2; SZALLASI A, 1989, BRAIN RES, V503, P68, DOI 10.1016/0006-8993(89)91705-8; SZOLCSANYI J, 1991, ANN NY ACAD SCI, V632, P473, DOI 10.1111/j.1749-6632.1991.tb33161.x; Szyszkowicz M, 2008, HEADACHE, V48, P1076, DOI 10.1111/j.1526-4610.2007.01039.x; Szyszkowicz M, 2008, HEADACHE, V48, P417, DOI 10.1111/j.1526-4610.2007.00808.x; Szyszkowicz M, 2009, AM J EMERG MED, V27, P391, DOI 10.1016/j.ajem.2008.03.013; Taylor-Clark TE, 2008, MOL PHARMACOL, V73, P274, DOI 10.1124/mol.107.040832; Taylor-Clark TE, 2009, AM J RESP CELL MOL, V40, P756, DOI 10.1165/rcmb.2008-0292OC; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Ulrich-Lai YM, 2001, PAIN, V91, P219, DOI 10.1016/S0304-3959(00)00439-5; Vandewauw I, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-21; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104; Zhong J, 2011, PFLUG ARCH EUR J PHY, V462, P861, DOI 10.1007/s00424-011-1043-1; Zhu WG, 2007, J NEUROSCI, V27, P13770, DOI 10.1523/JNEUROSCI.3822-07.2007; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	75	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103086	10.1371/journal.pone.0103086	http://dx.doi.org/10.1371/journal.pone.0103086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077949	gold, Green Submitted, Green Published			2022-12-25	WOS:000339954800026
J	Tax, CMW; Duits, R; Vilanova, A; Romeny, BMT; Hofman, P; Wagner, L; Leemans, A; Ossenblok, P				Tax, Chantal M. W.; Duits, Remco; Vilanova, Anna; Romeny, Bart M. ter Haar; Hofman, Paul; Wagner, Louis; Leemans, Alexander; Ossenblok, Pauly			Evaluating Contextual Processing in Diffusion MRI: Application to Optic Radiation Reconstruction for Epilepsy Surgery	PLOS ONE			English	Article							VISUAL-FIELD DEFECTS; TEMPORAL-LOBE EPILEPSY; TENSOR FIBER TRACTOGRAPHY; ARTERIOVENOUS-MALFORMATIONS; RESECTION; DECONVOLUTION; ARCHITECTURE; ENHANCEMENT; COMPLETION; LOBECTOMY	Diffusion MRI and tractography allow for investigation of the architectural configuration of white matter in vivo, offering new avenues for applications like presurgical planning. Despite the promising outlook, there are many pitfalls that complicate its use for (clinical) application. Amongst these are inaccuracies in the geometry of the diffusion profiles on which tractography is based, and poor alignment with neighboring profiles. Recently developed contextual processing techniques, including enhancement and well-posed geometric sharpening, have shown to result in sharper and better aligned diffusion profiles. However, the research that has been conducted up to now is mainly of theoretical nature, and so far these techniques have only been evaluated by visual inspection of the diffusion profiles. In this work, the method is evaluated in a clinically relevant application: the reconstruction of the optic radiation for epilepsy surgery. For this evaluation we have developed a framework in which we incorporate a novel scoring procedure for individual pathways. We demonstrate that, using enhancement and sharpening, the extraction of an anatomically plausible reconstruction of the optic radiation from a large amount of probabilistic pathways is greatly improved in three healthy controls, where currently used methods fail to do so. Furthermore, challenging reconstructions of the optic radiation in three epilepsy surgery candidates with extensive brain lesions demonstrate that it is beneficial to integrate these methods in surgical planning.	[Tax, Chantal M. W.; Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Tax, Chantal M. W.; Duits, Remco; Vilanova, Anna; Romeny, Bart M. ter Haar; Ossenblok, Pauly] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Duits, Remco] Eindhoven Univ Technol, Dept Math & Comp Sci, NL-5600 MB Eindhoven, Netherlands; [Vilanova, Anna] Delft Univ Technol, Dept Elect Engn, Delft, Netherlands; [Hofman, Paul; Wagner, Louis; Ossenblok, Pauly] Epilepsy Ctr Kempenhaeghe, Dept Funct & Med Technol, Heeze, Netherlands	Utrecht University; Utrecht University Medical Center; Eindhoven University of Technology; Eindhoven University of Technology; Delft University of Technology	Tax, CMW (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands.	chantal@isi.uu.nl	Leemans, Alexander/A-1784-2011; Romenij, Bart M. ter Haar/A-5323-2013	Leemans, Alexander/0000-0002-9306-6126; 	Physical Sciences division of the Netherlands Organisation for Scientific Research (NWO) [612.001.104]; European Research Council under European Community [335555]	Physical Sciences division of the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council under European Community(European Research Council (ERC))	Chantal Tax is supported by a grant (No. 612.001.104) from the Physical Sciences division of the Netherlands Organisation for Scientific Research (NWO). The research leading to the results of this article has received funding from the European Research Council under the European Community's 7th Framework Programme (FP7/2007-2014)/ERC grant agreement No. 335555. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.A., 2006, CALCULUS COMPLETE CO; Barbieri D, 2012, J PHYSIOL-PARIS, V106, P183, DOI 10.1016/j.jphysparis.2012.03.001; Barmpoutis A, 2008, LECT NOTES COMPUT SC, V5241, P9, DOI 10.1007/978-3-540-85988-8_2; Bartels RH, 1987, INTRO SPLINES USE CO; Ben-Yosef G, 2012, NEURAL COMPUT, V24, P3277, DOI 10.1162/NECO_a_00365; Boscain U, 2010, P STEKLOV I MATH+, V270, P43, DOI 10.1134/S0081543810030041; Cauley KA, 2010, J NEUROSURG, V112, P814, DOI 10.3171/2009.8.JNS09586; Chen X, 2009, NEUROIMAGE, V45, P286, DOI 10.1016/j.neuroimage.2008.11.038; Chirikjian G., 2011, STOCHASTIC MODELS IN; Chirikjian GS, 2010, ENG APPL NONCOMMUTAT; Citti G, 2006, J MATH IMAGING VIS, V24, P307, DOI 10.1007/s10851-005-3630-2; Creusen E, 2013, NUMER MATH-THEORY ME, V6, P138, DOI 10.4208/nmtma.2013.mssvm08; Dela Haije TCJ, 2014, VISUALIZATI IN PRESS; Dell'Acqua F, 2007, IEEE T BIO-MED ENG, V54, P462, DOI 10.1109/TBME.2006.888830; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Duits R., 2014, LECT NOTES MORPHOGEN, P173; Duits R, 2013, J MATH IMAGING VIS, V46, P326, DOI 10.1007/s10851-012-0387-2; Duits R, 2011, INT J COMPUT VISION, V92, P231, DOI 10.1007/s11263-010-0332-z; EBELING U, 1988, ACTA NEUROCHIR, V92, P29, DOI 10.1007/BF01401969; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; FALCONER MA, 1963, J NEUROL NEUROSUR PS, V26, P154, DOI 10.1136/jnnp.26.2.154; Felsberg M, 2012, COMPUTATIONAL IMAGIN, V41, P31, DOI DOI 10.1007/978-1-4471-2353-8_; Florack Luc, 2008, 2008 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P1, DOI 10.1109/CVPRW.2008.4562967; Franken E, 2008, THESIS U TECHNOLOGY; Friston KJ., 1994, FUNCTIONAL NEUROIMAG, P79; Froeling M, 2012, J MAGN RESON IMAGING, V36, P237, DOI 10.1002/jmri.23608; Horton J, 2005, ARCH OPHTHALMOL-CHIC, V109, P1; Hughes TS, 1999, NEUROLOGY, V53, P167, DOI 10.1212/WNL.53.1.167; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jones DK, 2008, IEEE T MED IMAGING, V27, P1268, DOI 10.1109/TMI.2008.922191; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Kikuta K, 2006, NEUROSURGERY, V58, P331, DOI 10.1227/01.NEU.0000195017.82776.90; Kim DS, 2005, ANN NY ACAD SCI, V1064, P1, DOI 10.1196/annals.1340.005; Koga T, 2012, INT J RADIAT ONCOL, V82, P799, DOI 10.1016/j.ijrobp.2010.11.046; Krolak-Salmon P, 2000, BRIT J OPHTHALMOL, V84, P884, DOI 10.1136/bjo.84.8.884; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Mashtakov AP, 2013, NUMER MATH-THEORY ME, V6, P95, DOI 10.4208/nmtma.2013.mssvm05; Medioni G., 2000, COMPUTATIONAL FRAMEW; MomayyezSiahkal P, 2013, IEEE T PATTERN ANAL, V35, P983, DOI 10.1109/TPAMI.2012.184; Nilsson D, 2004, ACTA NEUROL SCAND, V110, P301, DOI 10.1111/j.1600-0404.2004.00331.x; Nilsson DT, 2010, EPILEPSIA, V51, P91; Nilsson D, 2007, EPILEPSY RES, V77, P11, DOI 10.1016/j.eplepsyres.2007.07.012; Okada T, 2007, AM J NEURORADIOL, V28, P1107, DOI 10.3174/ajnr.A0493; OSSENBLOK P, 1994, DOC OPHTHALMOL, V88, P77, DOI 10.1007/BF01203704; Pathak-Ray V, 2002, EYE, V16, P744, DOI 10.1038/sj.eye.6700152; Powell HWR, 2005, NEUROLOGY, V65, P596, DOI 10.1212/01.wnl.0000172858.20354.73; Prckovska V, 2010, CDMRI 10 MICCAI 2010, V1, P26; Reisert M, 2012, LEFT INVARIANT DIFFU; Rodrigues P, 2010, EUR WORKSH VIS COMP, P49; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Sachkov Y, 2011, ESAIM CONTORLE OPTIM, V16, P1018; Sachkov YL, 2011, ESAIM CONTR OPTIM CA, V17, P293, DOI 10.1051/cocv/2010005; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.10.12; Staempfli P, 2008, NEUROIMAGE, V39, P119, DOI 10.1016/j.neuroimage.2007.08.025; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Tabelow K, 2011, 17 ANN M ORG HUM BRA, P616; Taoka T, 2008, AM J NEURORADIOL, V29, P1329, DOI 10.3174/ajnr.A1101; Tax C, 2012, PROCEEDING OF THE IEEE INTERNATIONAL CONFERENCE ON INFORMATION AND AUTOMATION, P441, DOI 10.1109/ICInfA.2012.6246846; Tax CMW, 2014, NEUROIMAGE, V86, P67, DOI 10.1016/j.neuroimage.2013.07.067; Tax CMW, 2012, THESIS EINDHOVEN U T; Thudium MO, 2010, NEUROSURGERY, V67, DOI 10.1227/NEU.0b013e3181f7424b; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Uijl SG, 2008, EPILEPSIA, V49, P1317, DOI 10.1111/j.1528-1167.2008.01695.x; van Baarsen KM, 2009, CURR OPIN OPHTHALMOL, V20, P490, DOI 10.1097/ICU.0b013e3283313c02; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Winston GP, 2012, ANN NEUROL, V71, P334, DOI 10.1002/ana.22619; Yamamoto A, 2007, AM J NEURORADIOL, V28, P92; Yamamoto T, 2005, AM J OPHTHALMOL, V140, P781, DOI 10.1016/j.ajo.2005.05.018; Yogarajah M, 2009, BRAIN, V132, P1656, DOI 10.1093/brain/awp114	71	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e101524	10.1371/journal.pone.0101524	http://dx.doi.org/10.1371/journal.pone.0101524			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077946	Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800006
J	Lorenz, A; Dhingra, R; Chang, HH; Bisanzio, D; Liu, Y; Remais, JV				Lorenz, Alyson; Dhingra, Radhika; Chang, Howard H.; Bisanzio, Donal; Liu, Yang; Remais, Justin V.			Inter-Model Comparison of the Landscape Determinants of Vector-Borne Disease: Implications for Epidemiological and Entomological Risk Modeling	PLOS ONE			English	Article							HEALTH IMPACT ASSESSMENT; EASTERN UNITED-STATES; IXODES-SCAPULARIS; CLIMATE-CHANGE; LYME-DISEASE; INFECTIOUS-DISEASES; EXTRAPOLATION; POLICY; ACARI	Extrapolating landscape regression models for use in assessing vector-borne disease risk and other applications requires thoughtful evaluation of fundamental model choice issues. To examine implications of such choices, an analysis was conducted to explore the extent to which disparate landscape models agree in their epidemiological and entomological risk predictions when extrapolated to new regions. Agreement between six literature-drawn landscape models was examined by comparing predicted county-level distributions of either Lyme disease or Ixodes scapularis vector using Spearman ranked correlation. AUC analyses and multinomial logistic regression were used to assess the ability of these extrapolated landscape models to predict observed national data. Three models based on measures of vegetation, habitat patch characteristics, and herbaceous landcover emerged as effective predictors of observed disease and vector distribution. An ensemble model containing these three models improved precision and predictive ability over individual models. A priori assessment of qualitative model characteristics effectively identified models that subsequently emerged as better predictors in quantitative analysis. Both a methodology for quantitative model comparison and a checklist for qualitative assessment of candidate models for extrapolation are provided; both tools aim to improve collaboration between those producing models and those interested in applying them to new areas and research questions.	[Lorenz, Alyson; Dhingra, Radhika; Liu, Yang; Remais, Justin V.] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Chang, Howard H.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Bisanzio, Donal] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA; [Remais, Justin V.] Emory Univ, Grad Div Biol & Biomed Sci, Program Populat Biol Ecol & Evolut, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Emory University; Emory University	Remais, JV (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA.	justin.remais@emory.edu	Liu, Yang/AAA-7224-2019; Remais, Justin/V-3207-2019	Liu, Yang/0000-0001-5477-2186; Remais, Justin/0000-0002-0223-4615; Bisanzio, Donal/0000-0002-7832-2291	CDC Climate and Health Program [5 U01 EH000405]; Ecology of Infectious Disease program of the National Science Foundation [0622743]; National Institute for Allergy and Infectious Disease [K01AI091864]; Global Health Institute at Emory University; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [U01EH000405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI091864] Funding Source: NIH RePORTER	CDC Climate and Health Program; Ecology of Infectious Disease program of the National Science Foundation; National Institute for Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Global Health Institute at Emory University; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the CDC Climate and Health Program (award # 5 U01 EH000405), the Ecology of Infectious Disease program of the National Science Foundation under Grant No. 0622743, the National Institute for Allergy and Infectious Disease (K01AI091864) and the Global Health Institute at Emory University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ENV MONITORING ASSES; Bernard SM, 2001, ENVIRON HEALTH PERSP, V109, P199, DOI 10.2307/3435010; BRAY J, 1995, ECON J, V105, P989, DOI 10.2307/2235165; Brownstein JS, 2005, OECOLOGIA, V146, P469, DOI 10.1007/s00442-005-0251-9; Carroll M, 2004, 250 M MODIS NORMALIZ; CDC, 1999, REP TUB US 1998, P1; Dannenberg AL, 2008, AM J PREV MED, V34, P241, DOI 10.1016/j.amepre.2007.11.015; Dennis DT, 1998, J MED ENTOMOL, V35, P629, DOI 10.1093/jmedent/35.5.629; Dhingra R, 2013, ISPRS INT J GEO-INF, V2, P645, DOI 10.3390/ijgi2030645; Diuk-Wasser MA, 2006, J MED ENTOMOL, V43, P166, DOI 10.1603/0022-2585(2006)043[0166:SPOHIS]2.0.CO;2; Diuk-Wasser MA, 2010, GLOBAL ECOL BIOGEOGR, V19, P504, DOI 10.1111/j.1466-8238.2010.00526.x; Eisen L, 2007, EMERG INFECT DIS, V13, P1816, DOI 10.3201/eid1312.070211; EPA, 2011, RISK ASS BAS INF; Forbes VE, 2002, BIOSCIENCE, V52, P249, DOI 10.1641/0006-3568(2002)052[0249:EIERAB]2.0.CO;2; Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030; Gagnon AS, 2005, CLIMATIC CHANGE, V69, P269, DOI 10.1007/s10584-005-1815-8; GLASS GE, 1995, AM J PUBLIC HEALTH, V85, P944, DOI 10.2105/AJPH.85.7.944; Guerra M, 2002, EMERG INFECT DIS, V8, P289, DOI 10.3201/eid0803.010166; Hollander A, 2008, J ENVIRON MONITOR, V10, P1139, DOI 10.1039/b803760d; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Killilea ME, 2008, ECOHEALTH, V5, P167, DOI 10.1007/s10393-008-0171-3; Kitron U, 1997, AM J EPIDEMIOL, V145, P558, DOI 10.1093/oxfordjournals.aje.a009145; Kuo T, 2009, AM J PUBLIC HEALTH, V99, P1680, DOI 10.2105/AJPH.2008.153023; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; McGarigal K., 2002, FRAGSTATS SPATIAL PA; Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389; MITCHELL B, 2007, FRAGSTATSBATCH ARCGI; Munns WR, 2002, HUM ECOL RISK ASSESS, V8, P19, DOI 10.1080/20028091056692; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Ogden NH, 2006, J MED ENTOMOL, V43, P600, DOI 10.1603/0022-2585(2006)43[600:ISTCBP]2.0.CO;2; Periwal V, 2008, AM J PHYSIOL-REG I, V295, pR1089, DOI 10.1152/ajpregu.90426.2008; Randolph SE, 2009, ECOLOGY, V90, P927, DOI 10.1890/08-0506.1; Rodder D, 2010, NATURWISSENSCHAFTEN, V97, P781, DOI 10.1007/s00114-010-0694-7; Smith KF, 2005, FRONT ECOL ENVIRON, V3, P29, DOI 10.1890/1540-9295(2005)003[0029:ETTEID]2.0.CO;2; Solomon KR, 1996, ENVIRON TOXICOL CHEM, V15, P31, DOI [10.1002/etc.5620150105, 10.1897/1551-5028(1996)015&lt;0031:ERAOAI&gt;2.3.CO;2]; Stromdahl EY, 2012, ZOONOSES PUBLIC HLTH, V59, P48, DOI 10.1111/j.1863-2378.2012.01475.x; U.S. CITIZENSHIP & IMMIGRATION SERVS, 2008, SURV LYM DIS US 1992, P1; United States Department of Agriculture Natural Resource Conservation Service, 2011, SOIL DAT MART; USCB, 2000, AM FACT FIND; USGS, 2001, NLCD 2001 LAND COV V; USGS, 2003, HYDROGP020 US NAT AT; Zhou XN, 2008, AM J TROP MED HYG, V78, P188, DOI 10.4269/ajtmh.2008.78.188	42	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103163	10.1371/journal.pone.0103163	http://dx.doi.org/10.1371/journal.pone.0103163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072884	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600026
J	Luo, J; Walsh, E; Naik, A; Zhuang, WY; Zhang, KQ; Cai, L; Zhang, N				Luo, Jing; Walsh, Emily; Naik, Abhishek; Zhuang, Wenying; Zhang, Keqin; Cai, Lei; Zhang, Ning			Temperate Pine Barrens and Tropical Rain Forests Are Both Rich in Undescribed Fungi	PLOS ONE			English	Article							PHIALOCEPHALA-FORTINII; ENDOPHYTIC MYCOBIOTA; RUST FUNGI; ROOTS; DIVERSITY; MAGNAPORTHACEAE; BIODIVERSITY; MAGNITUDE; COMMUNITIES; EVOLUTION	Most of fungal biodiversity on Earth remains unknown especially in the unexplored habitats. In this study, we compared fungi associated with grass (Poaceae) roots from two ecosystems: the temperate pine barrens in New Jersey, USA and tropical rain forests in Yunnan, China, using the same sampling, isolation and species identification methods. A total of 426 fungal isolates were obtained from 1600 root segments from 80 grass samples. Based on the internal transcribed spacer (ITS) sequences and morphological characteristics, a total of 85 fungal species (OTUs) belonging in 45 genera, 23 families, 16 orders, and 6 classes were identified, among which the pine barrens had 38 and Yunnan had 56 species, with only 9 species in common. The finding that grass roots in the tropical forests harbor higher fungal species diversity supports that tropical forests are fungal biodiversity hotspots. Sordariomycetes was dominant in both places but more Leotiomycetes were found in the pine barrens than Yunnan, which may play a role in the acidic and oligotrophic pine barrens ecosystem. Equal number of undescribed fungal species were discovered from the two sampled ecosystems, although the tropical Yunnan had more known fungal species. Pine barrens is a unique, unexplored ecosystem. Our finding suggests that sampling plants in such unexplored habitats will uncover novel fungi and that grass roots in pine barrens are one of the major reservoirs of novel fungi with about 47% being undescribed species.	[Luo, Jing; Walsh, Emily; Naik, Abhishek; Zhang, Ning] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA; [Zhuang, Wenying; Cai, Lei] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Zhang, Keqin] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Zhang, Keqin] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming, Peoples R China; [Zhang, Ning] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Chinese Academy of Sciences; Institute of Microbiology, CAS; Yunnan University; Yunnan University; Rutgers State University New Brunswick	Zhang, N (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.	zhang@aesop.rutgers.edu	zhang, ke/AAH-8217-2019; Zhang, Ning/K-3046-2012; Cai, Lei/W-4996-2017; CAI, LEI/K-7226-2014	Zhang, Ning/0000-0002-2680-1354; Cai, Lei/0000-0002-8131-7274; CAI, LEI/0000-0002-8131-7274	National Science Foundation [DEB 1145174]	National Science Foundation(National Science Foundation (NSF))	The research was supported by the National Science Foundation (DEB 1145174, http://www.nsf.gov/) to NZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos C. J., 1996; [Anonymous], 2013, PLANT ROOTS HIDD; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Berndt R, 2012, BIODIVERS CONSERV, V21, P2299, DOI 10.1007/s10531-011-0220-z; Blackwell M, 2000, SCIENCE, V289, P1884, DOI 10.1126/science.289.5486.1884; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Eaton CJ, 2011, PLANT SCI, V180, P190, DOI 10.1016/j.plantsci.2010.10.002; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Forman RTT, 1998, PINE BARRENS ECOSYST; Gazis R, 2010, FUNGAL ECOL, V3, P240, DOI 10.1016/j.funeco.2009.12.001; Gensel PG., 2001, PLANTS INVADE LAND E, P83, DOI DOI 10.7312/GENS11160-006; Ghimire SR, 2011, FUNGAL DIVERS, V47, P19, DOI 10.1007/s13225-010-0085-6; Grunig CR, 2008, BOTANY, V86, P1355, DOI 10.1139/B08-108; Grunig CR, 2004, FUNGAL GENET BIOL, V41, P676, DOI 10.1016/j.fgb.2004.03.004; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hawksworth DL, 1997, PHYTOPATHOLOGY, V87, P888, DOI 10.1094/PHYTO.1997.87.9.888; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hibbett DS, 2013, NAT REV MICROBIOL, V11, P129, DOI 10.1038/nrmicro2963; Hoffman MT, 2008, MYCOL RES, V112, P331, DOI 10.1016/j.mycres.2007.10.014; Joffe JS, 1933, SOIL SCI, V35, P313, DOI 10.1097/00010694-193304000-00007; Khidir HH, 2010, J ARID ENVIRON, V74, P35, DOI 10.1016/j.jaridenv.2009.07.014; Knapp DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032570; Li XiaoShuang, 2012, Guangxi Zhiwu / Guihaia, V32, P475; Lopez-Pujol J, 2006, BIODIVERS CONSERV, V15, P3983, DOI 10.1007/s10531-005-3015-2; Luo J, 2014, MYCOLOGIA, V106, P580, DOI 10.3852/13-306; Luo J, 2013, MYCOLOGIA, V105, P1019, DOI 10.3852/12-359; Macia-Vicente JG, 2008, FEMS MICROBIOL ECOL, V64, P90, DOI 10.1111/j.1574-6941.2007.00443.x; Mandyam K, 2005, STUD MYCOL, P173; Marquez SS, 2007, FUNGAL DIVERS, V27, P171; Mora C., 2011, PLOS BIOL, V9, DOI 10.1111/j.1600-0587.2013.00291.x.; Mouhamadou B, 2011, FUNGAL DIVERS, V47, P55, DOI 10.1007/s13225-011-0091-3; NYLANDER J.A.A., 2004, MRMODELTEST 2 2 PROG; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Porras-Alfaro A, 2008, APPL ENVIRON MICROB, V74, P2805, DOI 10.1128/AEM.02769-07; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Roberts CA, 2005, NEOTYPHODIUM IN COOL-SEASON GRASSES, pXVII; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Marquez SS, 2010, FUNGAL DIVERS, V41, P115, DOI 10.1007/s13225-009-0015-7; Marquez SS, 2008, FUNGAL DIVERS, V33, P87; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Scholler Markus, 2006, Mycoscience, V47, P159, DOI 10.1007/s10267-006-0286-8; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; TEDROW J. C. F., 1952, BARTONIA, V26, P28; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tuininga AR, 2004, CAN J FOREST RES, V34, P1755, DOI [10.1139/x04-037, 10.1139/X04-037]; TURNER RS, 1985, J ENVIRON QUAL, V14, P314, DOI 10.2134/jeq1985.00472425001400030003x; Walsh E, 2014, MYCOLOGIA IN PRESS; Wang Juan, 2006, Scientia Silvae Sinicae, V42, P7; White TJ., 1990, PCR PROTOCOLS GUIDE, P315, DOI [10.1016/B978-0-12-372180-8.50042-1, DOI 10.1016/B978-0-12-372180-8.50042-1]; Yuan ZL, 2010, FEMS MICROBIOL LETT, V307, P94, DOI 10.1111/j.1574-6968.2010.01963.x; Zhang N, 2011, MYCOLOGIA, V103, P1267, DOI 10.3852/11-022; Zhu H, 2004, BIODIVERS CONSERV, V13, P1355, DOI 10.1023/B:BIOC.0000019397.98407.c3	54	7	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103753	10.1371/journal.pone.0103753	http://dx.doi.org/10.1371/journal.pone.0103753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072783	gold, Green Published, Green Submitted			2022-12-25	WOS:000341307600084
J	Matysiak, J; Derezinski, P; Klupczynska, A; Matysiak, J; Kaczmarek, E; Kokot, ZJ				Matysiak, Jan; Derezinski, Pawel; Klupczynska, Agnieszka; Matysiak, Joanna; Kaczmarek, Elzbieta; Kokot, Zenon J.			Effects of a Honeybee Sting on the Serum Free Amino Acid Profile in Humans	PLOS ONE			English	Article							GLUTAMATE; URINE; ELECTROPHORESIS; METABOANALYST; METABOLISM; DIAGNOSIS; CANCER; SERVER; LUNG	The aim of this study was to assess the response to a honeybee venom by analyzing serum levels of 34 free amino acids. Another goal of this study was to apply complex analytic-bioinformatic-clinical strategy based on up-to-date achievements of mass spectrometry in metabolomic profiling. The amino acid profiles were determined using hybrid triple quadrupole/linear ion trap mass spectrometer coupled with a liquid chromatography instrument. Serum samples were collected from 27 beekeepers within 3 hours after they were stung and after a minimum of 6 weeks following the last sting. The differences in amino acid profiles were evaluated using MetaboAnalyst and ROCCET web portals. Chemometric tests showed statistically significant differences in the levels of L-glutamine (Gln), L-glutamic acid (Glu), L-methionine (Met) and 3-methyl-L-histidine (3MHis) between the two analyzed groups of serum samples. Gln and Glu appeared to be the most important metabolites for distinguishing the beekeepers tested shortly after a bee sting from those tested at least 6 weeks later. The role of some amino acids in the response of an organism to the honeybee sting was also discussed. This study indicated that proposed methodology may allow to identify the individuals just after the sting and those who were stung at least 6 weeks earlier. The results we obtained will contribute to better understanding of the human body response to the honeybee sting.	[Matysiak, Jan; Derezinski, Pawel; Klupczynska, Agnieszka; Kokot, Zenon J.] Poznan Univ Med Sci, Dept Inorgan & Analyt Chem, Poznan, Poland; [Matysiak, Joanna] L Perzyna Reg Unified Hosp Kalisz, Ward Paediat Dis, Kalisz, Poland; [Kaczmarek, Elzbieta] Poznan Univ Med Sci, Dept Bioinformat & Computat Biol, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences	Matysiak, J (corresponding author), Poznan Univ Med Sci, Dept Inorgan & Analyt Chem, Poznan, Poland.	jmatysiak@ump.edu.pl	Kokot, Zenon/HGE-3387-2022; Matysiak, Jan/R-6498-2016; Matysiak, Jan/ABG-5556-2020; Klupczynska, Agnieszka/AAB-5103-2020; Matysiak, Joanna/GSI-4777-2022	Matysiak, Jan/0000-0002-9993-1504; Matysiak, Jan/0000-0002-9993-1504; Klupczynska, Agnieszka/0000-0002-5028-1408; Matysiak, Joanna/0000-0002-2475-1066; Kokot, Zenon/0000-0003-4950-9759; Kaczmarek, Elzbieta/0000-0001-5773-7167	Polish National Science Centre [2012/05/B/NZ7/02535]	Polish National Science Centre	The project was supported by the Polish National Science Centre (2012/05/B/NZ7/02535). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austdal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091923; Bartolomeo Maria Paola, 2006, J Biomol Tech, V17, P131; Bilo BM, 2005, ALLERGY, V60, P1339, DOI 10.1111/j.1398-9995.2005.00963.x; CAMPOLLO O, 1992, REV INVEST CLIN, V44, P513; Cano NJM, 2006, J NUTR, V136, p299S, DOI 10.1093/jn/136.1.299S; CASCINO A, 1995, ANTICANCER RES, V15, P507; Chung SY, 2013, J ALLERGY CLIN IMMUN, V131, pAB20, DOI 10.1016/j.jaci.2012.12.750; DANDREA G, 1991, CEPHALALGIA, V11, P197, DOI 10.1046/j.1468-2982.1991.1104197.x; Dang NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076263; Dejong CHC, 2007, J NUTR, V137, p1579S, DOI 10.1093/jn/137.6.1579S; Deng K, 2011, ANAL CHIM ACTA, V694, P100, DOI 10.1016/j.aca.2011.03.053; Gallai V, 2003, CEPHALALGIA, V23, P166, DOI 10.1046/j.1468-2982.2003.00552.x; Held PK, 2011, J CHROMATOGR B, V879, P2695, DOI 10.1016/j.jchromb.2011.07.030; Lai HS, 2005, SEMIN CANCER BIOL, V15, P267, DOI 10.1016/j.semcancer.2005.04.003; LeBoucher J, 1997, CLIN CHEM, V43, P1421; Lee WJ, 1998, AM J PHYSIOL-CELL PH, V274, pC1101, DOI 10.1152/ajpcell.1998.274.4.C1101; Leichtle AB, 2012, METABOLOMICS, V8, P643, DOI 10.1007/s11306-011-0357-5; Maeda J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-690; Massey KA, 1998, AMINO ACIDS, V14, P271, DOI 10.1007/BF01318848; Matysiak J, 2013, ANN AGR ENV MED, V20, P875; Mayboroda OA, 2007, J CHROMATOGR A, V1159, P149, DOI 10.1016/j.chroma.2007.04.055; Miyagi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024143; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Ponder EL, 2003, PARASITOL RES, V89, P242, DOI 10.1007/s00436-002-0760-y; Saude EJ, 2011, J ALLERGY CLIN IMMUN, V127, P757, DOI 10.1016/j.jaci.2010.12.1077; Stabler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022486; Varga EM, 2013, J ALLERGY CLIN IMMUN, V131, P1419, DOI 10.1016/j.jaci.2012.08.037; Walford GA, 2013, METABOLISM; Weinberg RJ, 1999, BRAIN RES BULL, V50, P353, DOI 10.1016/S0361-9230(99)00102-1; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zhang JB, 2013, J CHROMATOGR B, V929, P102, DOI 10.1016/j.jchromb.2013.04.016	33	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103533	10.1371/journal.pone.0103533	http://dx.doi.org/10.1371/journal.pone.0103533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072247	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600058
J	Bilbao-Sieyro, C; Santana, G; Moreno, M; Torres, L; Santana-Lopez, G; Rodriguez-Medina, C; Perera, M; Bellosillo, B; de la Iglesia, S; Molero, T; Gomez-Casares, MT				Bilbao-Sieyro, Cristina; Santana, Guillermo; Moreno, Melania; Torres, Laura; Santana-Lopez, Gonzalo; Rodriguez-Medina, Carlos; Perera, Maria; Bellosillo, Beatriz; de la Iglesia, Silvia; Molero, Teresa; Teresa Gomez-Casares, Maria			High Resolution Melting Analysis: A Rapid and Accurate Method to Detect CALR Mutations	PLOS ONE			English	Article							CALRETICULIN	Background: The recent discovery of CALR mutations in essential thrombocythemia (ET) and primary myelofibrosis (PMF) patients without JAK2/MPL mutations has emerged as a relevant finding for the molecular diagnosis of these myeloproliferative neoplasms (MPN). We tested the feasibility of high-resolution melting (HRM) as a screening method for rapid detection of CALR mutations. Methods: CALR was studied in wild-type JAK2/MPL patients including 34 ET, 21 persistent thrombocytosis suggestive of MPN and 98 suspected secondary thrombocytosis. CALR mutation analysis was performed through HRM and Sanger sequencing. We compared clinical features of CALR-mutated versus 45 JAK2/MPL-mutated subjects in ET. Results: Nineteen samples showed distinct HRM patterns from wild-type. Of them, 18 were mutations and one a polymorphism as confirmed by direct sequencing. CALR mutations were present in 44% of ET (15/34), 14% of persistent thrombocytosis suggestive of MPN (3/21) and none of the secondary thrombocytosis (0/98). Of the 18 mutants, 9 were 52 bp deletions, 8 were 5 bp insertions and other was a complex mutation with insertion/deletion. No mutations were found after sequencing analysis of 45 samples displaying wild-type HRM curves. HRM technique was reproducible, no false positive or negative were detected and the limit of detection was of 3%. Conclusions: This study establishes a sensitive, reliable and rapid HRM method to screen for the presence of CALR mutations.	[Bilbao-Sieyro, Cristina; Santana, Guillermo; Moreno, Melania; Torres, Laura; Rodriguez-Medina, Carlos; Perera, Maria; de la Iglesia, Silvia; Molero, Teresa; Teresa Gomez-Casares, Maria] Hosp Univ Gran Canaria Dr Negrin, Dept Hematol, Las Palmas Gran Canaria, Spain; [Bilbao-Sieyro, Cristina] Univ Las Palmas Gran Canaria, Morfol Dept, Las Palmas Gran Canaria, Spain; [Santana-Lopez, Gonzalo] Hosp Univ Gran Canaria Dr Negrin, Dept Prevent Med, Las Palmas Gran Canaria, Spain; [Bellosillo, Beatriz] Hosp Mar, Lab Biol Mol Servei Patol, Barcelona, Spain; [Molero, Teresa] Univ Las Palmas Gran Canaria, Dept Med Sci, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Universidad de Las Palmas de Gran Canaria	Gomez-Casares, MT (corresponding author), Hosp Univ Gran Canaria Dr Negrin, Dept Hematol, Las Palmas Gran Canaria, Spain.	mgomcasf@gobiernodecanarias.org	CASARES, MARIA TERESA GOMEZ/R-6060-2018; De la Iglesia Iñigo, silvia/HCI-7710-2022; SIEYRO, CRISTINA BILBAO/R-6779-2018	CASARES, MARIA TERESA GOMEZ/0000-0003-0505-5126; SIEYRO, CRISTINA BILBAO/0000-0002-4796-1445; De la Iglesia, Silvia/0000-0003-1399-836X				Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Chi J, LEUKEMIA IN PRESS; Fuster O, 2009, J MOL DIAGN, V11, P458, DOI 10.2353/jmoldx.2009.090043; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Monzon FA, 2009, ARCH PATHOL LAB MED, V133, P1600, DOI 10.1043/1543-2165-133.10.1600; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Rotunno G, BLOOD IN PRESS; Rumi E, BLOOD IN PRESS; Swerdlow E., 2008, WHO CLASSIFICATION T; Tefferi A, LEUKEMIA IN PRESS; Vaughn CP, 2004, J MOL DIAGN, V6, P211, DOI 10.1016/S1525-1578(10)60512-0; Wang XM, 2013, MOL CANCER RES, V11, P986, DOI 10.1158/1541-7786.MCR-12-0704	13	28	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103511	10.1371/journal.pone.0103511	http://dx.doi.org/10.1371/journal.pone.0103511			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068507	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993700076
J	Ji, WD; Yang, M; Praggastis, A; Li, YH; Zhou, HJ; He, Y; Ghazvinian, R; Cincotta, DJ; Rice, KP; Min, W				Ji, Weidong; Yang, Mei; Praggastis, Alexandra; Li, Yonghao; Zhou, Huanjiao Jenny; He, Yun; Ghazvinian, Roxanne; Cincotta, Dylan J.; Rice, Kevin P.; Min, Wang			Carbamoylating Activity Associated with the Activation of the Antitumor Agent Laromustine Inhibits Angiogenesis by Inducing ASK1-Dependent Endothelial Cell Death	PLOS ONE			English	Article							SIGNAL-REGULATING KINASE-1; INDUCED ASK1 ACTIVATION; THIOREDOXIN REDUCTASE; ASK1-MEDIATED APOPTOSIS; GLUTATHIONE-REDUCTASE; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; MOLECULAR-MECHANISMS; INDEPENDENT MANNER; ISOCYANATES; TUMOR	The anticancer agent 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (laromustine), upon decomposition in situ, yields methyl isocyanate and the chloroethylating species 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-hydrazine (90CE). 90CE has been shown to kill tumor cells via a proposed mechanism that involves interstrand DNA cross-linking. However, the role of methyl isocyanate in the antineoplastic function of laromustine has not been delineated. Herein, we show that 1,2-bis(methylsulfonyl)-1-[(methylamino)carbonyl]hydrazine(101MDCE), an analog of laromustine that generates only methyl isocyanate, activates ASK1-JNK/p38 signaling in endothelial cells (EC). We have previously shown that ASK1 forms a complex with reduced thioredoxin (Trx1) in resting EC, and that the Cys residues in ASK1 and Trx1 are critical for their interaction. 101MDCE dissociated ASK1 from Trx1, but not from the phosphoserine-binding inhibitor 14-3-3, in whole cells and in cell lysates, consistent with the known ability of methyl isocyanate to carbamoylate free thiol groups of proteins. 101MDCE had no effect on the kinase activity of purified ASK1, JNK, or the catalytic activity of Trx1. However, 101MDCE, but not 90CE, significantly decreased the activity of Trx reductase-1 (TrxR1). We conclude that methyl isocyanate induces dissociation of ASK1 from Trx1 either directly by carbamoylating the critical Cys groups in the ASK1-Trx1 complex or indirectly by inhibiting TrxR1. Furthermore, 101MDCE (but not 90CE) induced EC death through a non-apoptotic (necroptotic) pathway leading to inhibition of angiogenesis in vitro. Our study has identified methyl isocyanates may contribute to the anticancer activity in part by interfering with tumor angiogenesis.	[Ji, Weidong; He, Yun; Min, Wang] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Mei] Guangzhou Med Univ, Guangdong Women & Children Hosp, Breast Dis Ctr, Guangzhou, Guangdong, Peoples R China; [Praggastis, Alexandra; Ghazvinian, Roxanne; Cincotta, Dylan J.; Rice, Kevin P.] Colby Coll, Dept Chem, Waterville, ME 04901 USA; [Li, Yonghao] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Huanjiao Jenny; Min, Wang] Yale Univ, Sch Med, Dept Pathol, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06510 USA	Sun Yat Sen University; Guangzhou Medical University; Colby College; Sun Yat Sen University; Yale University	Rice, KP (corresponding author), Colby Coll, Dept Chem, Waterville, ME 04901 USA.	kevin.rice@colby.edu; wang.min@yale.edu	ji, weidong/AAX-7397-2020	Rice, Kevin/0000-0002-7777-4325	NIH [HL109420, HL115148]; National Natural Science Foundation of China [81272350, 81202076, 81371019, 81273097]; Natural Science Foundation of Guangdong [S2012010008908]; University Talent Program of Guangzhou [12A015G]; National Center for Research Resources [5P20RR016463-12]; National Institute of General Medical Sciences [8 P20 GM103423-12]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016463] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109420, R01HL115148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103423] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); University Talent Program of Guangzhou; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants HL109420 and HL115148 to WM; National Natural Science Foundation of China (No.81272350), Natural Science Foundation of Guangdong (No.S2012010008908); and the University Talent Program of Guangzhou (No.12A015G) to WJ; National Natural Science Foundation of China (No. 81202076) to MY; National Natural Science Foundation of China (No. 81371019) to YL; National Natural Science Foundation of China (No. 81273097) to YH; National Center for Research Resources (5P20RR016463-12) and National Institute of General Medical Sciences (8 P20 GM103423-12) to KR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABSON JR, 1978, BIOCHEM BIOPH RES CO, V83, P754, DOI 10.1016/0006-291X(78)91053-7; BARIL BB, 1975, CANCER RES, V35, P1; Baumann RP, 2005, ONCOL RES, V15, P313, DOI 10.3727/096504005776404553; Baumann RP, 2004, CANCER CHEMOTH PHARM, V53, P288, DOI 10.1007/s00280-003-0739-0; Becker K, 2000, EUR J BIOCHEM, V267, P6118, DOI 10.1046/j.1432-1327.2000.01703.x; BECKER K, 1995, METHOD ENZYMOL, V251, P173, DOI 10.1016/0076-6879(95)51120-2; Bunkoczi G, 2007, STRUCTURE, V15, P1215, DOI 10.1016/j.str.2007.08.011; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Charette SJ, 2001, J BIOL CHEM, V276, P36071, DOI 10.1074/jbc.C100340200; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; EISENBRAND G, 1986, J CANCER RES CLIN, V112, P196, DOI 10.1007/BF00395912; GIBSON NW, 1982, BIOCHEM PHARMACOL, V31, P2795, DOI 10.1016/0006-2952(82)90135-6; GOMBAR CT, 1980, BIOCHEM PHARMACOL, V29, P2639, DOI 10.1016/0006-2952(80)90079-9; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; Hattori K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-9; HILTON J, 1978, BIOCHEM PHARMACOL, V27, P1359, DOI 10.1016/0006-2952(78)90120-X; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; JOHNSTON TP, 1986, CANCER TREAT REP, V70, P13; KANN HE, 1974, CANCER RES, V34, P398; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Lee S, 2013, ANTIOXID REDOX SIGN, V18, P1165, DOI 10.1089/ars.2011.4322; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; Liu YM, 2001, J CLIN INVEST, V107, P917, DOI 10.1172/JCI11947; Lu J, 2012, ANTIOXID REDOX SIGN, V17, P1738, DOI 10.1089/ars.2012.4650; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Min W, 2008, CIRC RES, V102, P840, DOI 10.1161/CIRCRESAHA.107.168153; Moquin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076841; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; NAGHIPUR A, 1990, J AM CHEM SOC, V112, P3178, DOI 10.1021/ja00164a046; Penketh PG, 2004, CANCER CHEMOTH PHARM, V53, P279, DOI 10.1007/s00280-003-0740-7; Penketh PG, 2014, CHEM RES TOXICOL; Petak I, 1998, CANCER RES, V58, P614; Pober JS, 2009, ANNU REV PATHOL-MECH, V4, P71, DOI 10.1146/annurev.pathol.4.110807.092155; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; Rahman ZU, 1999, CANCER, V85, P104, DOI 10.1002/(SICI)1097-0142(19990101)85:1<104::AID-CNCR15>3.0.CO;2-R; Rice KP, 2012, MOL CELL BIOCHEM, V370, P199, DOI 10.1007/s11010-012-1411-y; Rice KP, 2005, BIOCHEM PHARMACOL, V69, P1463, DOI 10.1016/j.bcp.2005.02.016; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SCHALLREUTER KU, 1990, BIOCHIM BIOPHYS ACTA, V1054, P14, DOI 10.1016/0167-4889(90)90199-N; Shyam K, 1996, J MED CHEM, V39, P796, DOI 10.1021/jm9505021; Song JJ, 2005, J CELL BIOL, V170, P61, DOI 10.1083/jcb.200502070; Teicher BA, 1996, CANCER CHEMOTH PHARM, V38, P169, DOI 10.1007/s002800050466; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Wang TH, 1999, J BIOL CHEM, V274, P8208, DOI 10.1074/jbc.274.12.8208; Zhang HF, 2008, J CLIN INVEST, V118, P3904, DOI 10.1172/JCI36168; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7; Zhang R, 2005, ONCOGENE, V24, P3954, DOI 10.1038/sj.onc.1208548; Zhang R, 2003, J CLIN INVEST, V111, P1933, DOI 10.1172/JCI200317790; Zhang R, 2007, J BIOL CHEM, V282, P14788, DOI 10.1074/jbc.M701148200	54	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103224	10.1371/journal.pone.0103224	http://dx.doi.org/10.1371/journal.pone.0103224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068797	gold, Green Published, Green Submitted			2022-12-25	WOS:000339993700047
J	Shi, Q; Yang, ZY; Zhang, YJ; Hu, CS				Shi, Qi; Yang, Zhongyi; Zhang, Yingjian; Hu, Chaosu			Adding Maximum Standard Uptake Value of Primary Lesion and Lymph Nodes in F-18-Fluorodeoxyglucose PET Helps Predict Distant Metastasis in Patients with Nasopharyngeal Carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; INTENSITY-MODULATED RADIOTHERAPY; POSITRON-EMISSION-TOMOGRAPHY; PHASE-II TRIAL; F-18-FDG PET; RADIATION-THERAPY; STAGING SYSTEM; TUMOR VOLUME; FDG-PET; HEAD	Objective: To find out the most valuable parameter of 18 F-Fluorodeoxyglucose positron emission tomography for predicting distant metastasis in nasopharyngeal carcinoma. Methods: From June 2007 through December 2010, 43 non-metastatic NPC patients who underwent 18 F-Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) before radical Intensity-Modulated Radiation Therapy were enrolled and reviewed retrospectively. PET parameters including maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), metabolic tumor volume (MTV), and total lesion glucose (TLG) of both primary tumor and cervical lymph nodes were calculated. Total SUVmax were recorded as the sum of SUVmax of primary tumor and cervical lymph nodes. Total SUVmean, Total MTV and Total TLG were calculated in the same way as Total SUVmax. Results: The median follow-up was 32 months (range, 23-68 months). Distant metastasis was the main pattern of treatment failure. Univariate analysis showed higher SUVmax, SUVmean, MTV, and TLG of primary tumor, Total SUVmax, Total MTV, Total TLG, and stage T3-4 were factors predicting for significantly poorer distant metastasis-free survival (p = 0.042, p = 0.008, p = 0.023, p = 0.023, p = 0.024, p = 0.033, p = 0.016, p = 0.015). In multivariate analysis, Total SUVmax was the independent predictive factor for distant metastasis (p = 0.046). Spearman Rank correlation analysis showed mediate to strong correlationship between Total SUVmax and SUVmax-T, and between Total SUVmax and SUVmax-N(Spearman coefficient: 0.568 and 0.834; p = 0.000 and p = 0.000). Conclusions: Preliminary results indicated that Total SUVmax was an independently predictive factor for distant metastasis in patients of nasopharyngeal carcinoma treated with Intensity-Modulated Radiation Therapy.	[Shi, Qi; Hu, Chaosu] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Canc Ctr,Dept Radiat Oncol, Shanghai 200433, Peoples R China; [Yang, Zhongyi; Zhang, Yingjian] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Canc Ctr,Dept Nucl Med, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Zhang, YJ (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Canc Ctr,Dept Nucl Med, Shanghai 200433, Peoples R China.	profzhangyj@163.com; hucsu62@yahoo.com		Hu, Chaosu/0000-0002-6503-0951				Allal AS, 2004, INT J RADIAT ONCOL, V59, P1295, DOI 10.1016/j.ijrobp.2003.12.039; Allal AS, 2002, J CLIN ONCOL, V20, P1398, DOI 10.1200/JCO.20.5.1398; Chan SC, 2011, NUCL MED COMMUN, V32, P989, DOI 10.1097/MNM.0b013e3283495662; Chan SC, 2009, ORAL ONCOL, V45, P52, DOI 10.1016/j.oraloncology.2008.03.010; Chang KP, 2012, J NUCL MED, V53, P21, DOI 10.2967/jnumed.111.090696; Chung MK, 2009, CLIN CANCER RES, V15, P5861, DOI 10.1158/1078-0432.CCR-08-3290; COX DR, 1972, J R STAT SOC B, V34, P187; Daisne JF, 2004, RADIOLOGY, V233, P93, DOI 10.1148/radiol.2331030660; Dammann F, 2005, AM J ROENTGENOL, V184, P1326, DOI 10.2214/ajr.184.4.01841326; Edge SB, 2009, AJCC CANC STAGING MA, P6; Haerle SK, 2011, ORAL ONCOL, V47, P653, DOI 10.1016/j.oraloncology.2011.05.011; Ho J H, 1978, IARC Sci Publ, P99; Hui EP, 2009, J CLIN ONCOL, V27, P242, DOI 10.1200/JCO.2008.18.1545; Hung TM, 2013, ORAL ONCOL, V49, P169, DOI 10.1016/j.oraloncology.2012.08.011; Jeong HS, 2007, HEAD NECK-J SCI SPEC, V29, P203, DOI 10.1002/hed.20504; Kam MKM, 2004, INT J RADIAT ONCOL, V60, P1440, DOI 10.1016/j.ijrobp.2004.05.022; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kitagawa Y, 2003, J NUCL MED, V44, P198; Kong L, 2012, INT J RADIAT ONCOL, V84, pS487, DOI 10.1016/j.ijrobp.2012.07.1293; Krabbe CA, 2009, ORAL ONCOL, V45, P234, DOI 10.1016/j.oraloncology.2008.05.024; Lee N, 2002, INT J RADIAT ONCOL, V53, P12, DOI 10.1016/S0360-3016(02)02724-4; Lee N, 2009, J CLIN ONCOL, V27, P3684, DOI 10.1200/JCO.2008.19.9109; Lee NY, 2012, LANCET ONCOL, V13, P172, DOI 10.1016/S1470-2045(11)70303-5; Lee SW, 2008, RADIOTHER ONCOL, V87, P211, DOI 10.1016/j.radonc.2008.01.009; Liao CT, 2009, INT J RADIAT ONCOL, V74, P1054, DOI 10.1016/j.ijrobp.2008.09.045; Liu MT, 2003, JPN J CLIN ONCOL, V33, P501, DOI 10.1093/jjco/hyg092; Ma BBY, 2012, ANN ONCOL, V23, P1287, DOI 10.1093/annonc/mdr401; Mao YP, 2008, CLIN CANCER RES, V14, P7497, DOI 10.1158/1078-0432.CCR-08-0271; METZ CE, 1986, INVEST RADIOL, V21, P720, DOI 10.1097/00004424-198609000-00009; MIN HQ, 1994, INT J RADIAT ONCOL, V30, P1037; Ng SH, 2006, J CLIN ONCOL, V24, P4371, DOI 10.1200/JCO.2006.05.7349; Ng SH, 2008, NEURORADIOLOGY, V50, P969, DOI 10.1007/s00234-008-0426-2; Seol YM, 2010, ACTA ONCOL, V49, P201, DOI 10.3109/02841860903440270; Uyl-de Groot CA, 2010, J NUCL MED, V51, P176, DOI 10.2967/jnumed.109.067371; Xie P, 2010, ANN ONCOL, V21, P1078, DOI 10.1093/annonc/mdp430; Xie P, 2010, J CANCER RES CLIN, V136, P883, DOI 10.1007/s00432-009-0729-7; Xu GZ, 2011, ORAL ONCOL, V47, P560, DOI 10.1016/j.oraloncology.2011.04.021; Zhong Y, 2012, INT J RADIAT ONCOL, V84, pS207, DOI 10.1016/j.ijrobp.2012.07.538	38	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103153	10.1371/journal.pone.0103153	http://dx.doi.org/10.1371/journal.pone.0103153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068373	gold, Green Published, Green Submitted			2022-12-25	WOS:000339993700041
J	Butterfield, YS; Kreitzman, M; Thiessen, N; Corbett, RD; Li, YS; Pang, J; Ma, YP; Jones, SJM; Birol, I				Butterfield, Yaron S.; Kreitzman, Maayan; Thiessen, Nina; Corbett, Richard D.; Li, Yisu; Pang, Johnson; Ma, Yussanne P.; Jones, Steven J. M.; Birol, Inanc			JAGuaR: Junction Alignments to Genome for RNA-Seq Reads	PLOS ONE			English	Article							SPLICE JUNCTIONS; ALGORITHM	JAGuaR is an alignment protocol for RNA-seq reads that uses an extended reference to increase alignment sensitivity. It uses BWA to align reads to the genome and reference transcript models (including annotated exon-exon junctions) specifically allowing for the possibility of a single read spanning multiple exons. Reads aligned to the transcript models are then re-mapped on to genomic coordinates, transforming alignments that span multiple exons into large-gapped alignments on the genome. While JAGuaR does not detect novel junctions, we demonstrate how JAGuaR generates fast and accurate transcriptome alignments, which allows for both sensitive and specific SNV calling.	[Butterfield, Yaron S.; Kreitzman, Maayan; Thiessen, Nina; Corbett, Richard D.; Li, Yisu; Pang, Johnson; Ma, Yussanne P.; Jones, Steven J. M.; Birol, Inanc] Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada		Butterfield, YS (corresponding author), Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada.	ybutterf@bcgsc.ca	Jones, Steven J/C-3621-2009; Birol, Inanc/G-5440-2011	Jones, Steven J/0000-0003-3394-2208; Birol, Inanc/0000-0003-0950-7839	Michael Smith Foundation; BC Cancer Foundation; Science and Technology Innovation Centre at the GSC; Medulloblastoma Advanced Genomics International Consortium (MAGIC) [2443]; TCGA; National Cancer Institute [U24CA143866]	Michael Smith Foundation(Michael Smith Foundation for Health Research); BC Cancer Foundation; Science and Technology Innovation Centre at the GSC; Medulloblastoma Advanced Genomics International Consortium (MAGIC); TCGA; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by the Michael Smith Foundation (www.msfhr.org); BC Cancer Foundation (bccancerfoundation.com); Genome Canada in support of the Science and Technology Innovation Centre at the GSC (www.genomecanada.ca); Genome Canada and Genome BC in support of Medulloblastoma Advanced Genomics International Consortium (MAGIC) (Project 2443); TCGA, the project described was supported by Grant Number U24CA143866 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au KF, 2010, NUCL ACIDS RES, V38; Burrows M, 1994, BLOCK SORTING LOSSLE; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Dobin A, 2012, BIOINFORMATICS; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Fujita PA, 2011, NUCL ACIDS RES; Griebel T, 2012, NUCLEIC ACIDS RES, V40, P10073, DOI 10.1093/nar/gks666; Huang Songbo, 2011, Frontiers in Genetics, V2, P46, DOI 10.3389/fgene.2011.00046; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1311; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Tang SJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-116; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang K, 2010, NUCL ACIDS RES, V38; Wu J, 2013, NUCL ACIDS RES, V41; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	20	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e102398	10.1371/journal.pone.0102398	http://dx.doi.org/10.1371/journal.pone.0102398			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	25062255	Green Submitted, gold, Green Published			2022-12-25	WOS:000339992600013
J	Skrapits, K; Borsay, BA; Herczeg, L; Ciofi, P; Bloom, SR; Ghatei, MA; Dhillo, WS; Liposits, Z; Hrabovszky, E				Skrapits, Katalin; Borsay, Beata A.; Herczeg, Laszlo; Ciofi, Philippe; Bloom, Stephen R.; Ghatei, Mohammad A.; Dhillo, Waljit S.; Liposits, Zsolt; Hrabovszky, Erik			Colocalization of Cocaine- and Amphetamine-Regulated Transcript with Kisspeptin and Neurokinin B in the Human Infundibular Region	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; MONKEY MACACA-MULATTA; KISS-1 MESSENGER-RNA; ARCUATE NUCLEUS; HUMAN HYPOTHALAMUS; CART PEPTIDES; MALE-MOUSE; MORPHOLOGIC EVIDENCE; RAT HYPOTHALAMUS; MEDIAN-EMINENCE	Kisspeptin (KP)- and neurokinin B (NKB)- synthesizing neurons of the hypothalamic arcuate nucleus play a pivotal role in the regulation of pulsatile gonadotropin-releasing hormone (GnRH) secretion. Unlike in rodents and sheep, the homologous KP and NKB neurons in the human infundibular region rarely express dynorphin-but often exhibit Substance P (SP) immunoreactivity, indicating remarkable species differences in the neurochemical phenotype of these neurons. In search for additional neuropeptides in human KP and NKB neurons, we carried out immunofluorescent studies on hypothalamic sections obtained from five postmenopausal women. Colocalization experiments provided evidence for the presence of cocaine-and amphetamine-regulated transcript (CART) in 47.9 +/- 6.6% of KP-immunoreactive (IR) and 30.0 +/- 4.9% of NKB-IR perikarya and in 17.0 +/- 2.3% of KP-IR and 6.2 +/- 2.0% of NKB-IR axon varicosities. All three neuropeptides were present in 33.3 +/- 4.9% of KP-IR and 28.2 +/- 4.6% of NKB-IR somata, respectively, whereas triple-labeling showed lower incidences in KP-IR (14.3 +/- 1.8%) and NKB-IR (5.9 +/- 2.0%) axon varicosities. CART-IR KP and NKB neurons established contacts with other peptidergic cells, including GnRH-IR neurons and also sent projections to the infundibular stalk. KP and NKB fibers with CART often contained SP as well, while being distinct from CART fibers co-containing the orexigenic peptide agouti-related protein. Presence of CART in human, but not rodent, KP and NKB neurons represents a new example of species differences in the neuropeptide repertoire of mediobasal hypothalamic KP and NKB neurons. Target cells, receptor sites and physiological significance of CART in the efferent communication of KP and NKB neurons in primates require clarification.	[Skrapits, Katalin; Liposits, Zsolt; Hrabovszky, Erik] Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary; [Borsay, Beata A.; Herczeg, Laszlo] Univ Debrecen, Fac Med, Dept Forens Med, H-4012 Debrecen, Hungary; [Ciofi, Philippe] INSERM, Neuroctr Magendie, U862, Bordeaux, France; [Bloom, Stephen R.; Ghatei, Mohammad A.; Dhillo, Waljit S.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Invest Med, London, England; [Liposits, Zsolt] Pazmany Peter Catholic Univ, Fac Informat Technol, Dept Neurosci, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Debrecen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Imperial College London	Hrabovszky, E (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary.	hrabovszky.erik@koki.hu	Liposits, Zsolt/K-8145-2019; Ciofi, Philippe/N-7009-2017	Ciofi, Philippe/0000-0001-6339-9977; Hrabovszky, Erik/0000-0001-6927-0015; Dhillo, Waljit/0000-0001-5950-4316; Liposits, Zsolt/0000-0002-3508-2750	National Science Foundation of Hungary [OTKA K83710, K100722]; National Development Agency [BONUS HU 08/2-2011-0006]; European Community [245009]; MRC [G1000455] Funding Source: UKRI; Medical Research Council [G1000455] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10080, NF-SI-0507-10337, CDF-2009-02-05] Funding Source: researchfish	National Science Foundation of Hungary; National Development Agency; European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The research leading to these results has received funding from the National Science Foundation of Hungary (OTKA K83710, K100722), the National Development Agency (BONUS HU 08/2-2011-0006) and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 245009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CR, 2001, ENDOCRINOLOGY, V142, P3457, DOI 10.1210/en.142.8.3457; Burke MC, 2006, J COMP NEUROL, V498, P712, DOI 10.1002/cne.21086; CUELLO AC, 1979, P NATL ACAD SCI USA, V76, P3532, DOI 10.1073/pnas.76.7.3532; de Croft S, 2013, ENDOCRINOLOGY, V154, P2750, DOI 10.1210/en.2013-1231; Dhillo WS, 2005, J CLIN ENDOCR METAB, V90, P6609, DOI 10.1210/jc.2005-1468; Donato Jose Jr, 2011, Front Endocrinol (Lausanne), V2, P57, DOI 10.3389/fendo.2011.00057; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Elias CF, 2001, J COMP NEUROL, V432, P1, DOI 10.1002/cne.1085; Goodman RL, 2007, ENDOCRINOLOGY, V148, P5752, DOI 10.1210/en.2007-0961; Grayson BE, 2006, NEUROSCIENCE, V143, P975, DOI 10.1016/j.neuroscience.2006.08.055; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Hrabovszky E, 2010, EUR J NEUROSCI, V31, P1984, DOI 10.1111/j.1460-9568.2010.07239.x; Hrabovszky E, 2013, NEUROENDOCRINOLOGY; Hrabovszky Erik, 2013, Front Endocrinol (Lausanne), V4, P130, DOI 10.3389/fendo.2013.00130; Hrabovszky E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072369; Hrabovszky E, 2012, ENDOCRINOLOGY, V153, P4978, DOI 10.1210/en.2012-1545; Hrabovszky Erik, 2011, Front Endocrinol (Lausanne), V2, P80, DOI 10.3389/fendo.2011.00080; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Keen KL, 2008, ENDOCRINOLOGY, V149, P4151, DOI 10.1210/en.2008-0231; Kong WM, 2003, FASEB J, V17, P1688, DOI 10.1096/fj.02-0805fje; Koylu EO, 1997, J NEUROENDOCRINOL, V9, P823, DOI 10.1046/j.1365-2826.1997.00651.x; Krajewski SJ, 2005, J COMP NEUROL, V489, P372, DOI 10.1002/cne.20626; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Lambert PD, 1998, SYNAPSE, V29, P293, DOI 10.1002/(SICI)1098-2396(199808)29:4<293::AID-SYN1>3.0.CO;2-0; Lehman MN, 2010, ENDOCRINOLOGY, V151, P3479, DOI 10.1210/en.2010-0022; Leslie RA, 2001, NEUROSCI LETT, V314, P111, DOI 10.1016/S0304-3940(01)02291-1; Ludwig DS, 1998, AM J PHYSIOL-ENDOC M, V274, pE627, DOI 10.1152/ajpendo.1998.274.4.E627; Menyhert J, 2007, ENDOCRINOLOGY, V148, P4276, DOI 10.1210/en.2007-0390; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Mittelman-Smith MA, 2012, ENDOCRINOLOGY, V153, P2800, DOI 10.1210/en.2012-1045; Molnar CS, 2012, ENDOCRINOLOGY, V153, P5428, DOI 10.1210/en.2012-1739; Navarro VM, 2011, ENDOCRINOLOGY, V152, P4265, DOI 10.1210/en.2011-1143; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; Ohkura S, 2009, J NEUROENDOCRINOL, V21, P813, DOI 10.1111/j.1365-2826.2009.01909.x; Ramaswamy S, 2008, ENDOCRINOLOGY, V149, P4387, DOI 10.1210/en.2008-0438; Ramaswamy S, 2010, ENDOCRINOLOGY, V151, P4494, DOI 10.1210/en.2010-0223; Roa J, 2012, ENDOCRINOLOGY, V153, P5587, DOI 10.1210/en.2012-1470; Rogge G, 2008, NAT REV NEUROSCI, V9, P747, DOI 10.1038/nrn2493; Rondini TA, 2004, NEUROSCIENCE, V125, P735, DOI 10.1016/j.neuroscience.2003.12.045; Ruka KA, 2013, ENDOCRINOLOGY, V154, P2761, DOI 10.1210/en.2013-1268; Smith JT, 2007, ENDOCRINOLOGY, V148, P1150, DOI 10.1210/en.2006-1435; Smith JT, 2005, ENDOCRINOLOGY, V146, P2976, DOI 10.1210/en.2005-0323; Smith Y, 1997, SYNAPSE, V27, P90, DOI 10.1002/(SICI)1098-2396(199709)27:1<90::AID-SYN10>3.0.CO;2-V; True C, 2013, ENDOCRINOLOGY, V154, P2821, DOI 10.1210/en.2013-1156; True C, 2011, J NEUROENDOCRINOL, V23, P52, DOI 10.1111/j.1365-2826.2010.02076.x; Vrang N, 1999, J Neurosci, V19, pRC5; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010	47	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103977	10.1371/journal.pone.0103977	http://dx.doi.org/10.1371/journal.pone.0103977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084101	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000339819800113
J	Wu, XJ; Wu, W; Wang, ZZ; Shen, DH; Pan, W; Wang, Y; Wu, LM; Wu, XK; Feng, JC; Liu, KD; Zhu, J; Zhang, HL				Wu, Xiujuan; Wu, Wei; Wang, Zhengzheng; Shen, Donghui; Pan, Wei; Wang, Ying; Wu, Limin; Wu, Xiaokun; Feng, Jiachun; Liu, Kangding; Zhu, Jie; Zhang, Hong-Liang			More Severe Manifestations and Poorer Short-Term Prognosis of Ganglioside-Associated Guillain-Barre Syndrome in Northeast China	PLOS ONE			English	Article							MOTOR AXONAL NEUROPATHY; LOCAL HEALTH DISTRICT; TUMOR-NECROSIS-FACTOR; EXOGENOUS GANGLIOSIDES; MURINE MACROPHAGES; FERRARA; ANTIBODIES; POLYNEUROPATHY; THERAPY; RELEASE	Ganglioside as a neurotrophic drug has been hitherto widely used in China, although Guillain-Barre syndrome (GBS) following intravenous ganglioside treatment was reported in Europe several decades ago. We identified 7 patients who developed GBS after intravenous use of gangliosides (ganglioside+ group) and compared their clinical data with those of 77 non-ganglioside-associated GBS patients (ganglioside- group) in 2013, aiming at gaining the distinct features of ganglioside-associated GBS. Although the mean age, protein levels in cerebrospinal fluid (CSF) and frequency of cranial nerve involvement were similar between the two groups, the Hughes Functional Grading Scale (HFGS) score and the Medical Research Council (MRC) sum score at nadir significantly differed (4.9 +/- 0.4 vs 3.6 +/- 1.0; 7.7 +/- 5.5 vs 36.9 +/- 14.5, both p, 0.001), indicating a higher disease severity of ganglioside-associated GBS. A higher ratio of patients with ganglioside-associated GBS required mechanical ventilation (85.7% vs 15.6%, p<0.01). The short-term prognosis of ganglioside-associated GBS, as measured by the HFGS score and the MRC sum score at discharge, was poorer (4.3 +/- 0.5 vs 2.8 +/- 1.1; 17.3 +/- 12.9 vs 46.0 +/- 13.9, both p<0.001). All the patients in the ganglioside+ group presented an axonal form of GBS, namely acute motor axonal neuropathy (AMAN). When compared with the AMAN patients in the ganglioside- group, more severe functional deficits at nadir and poorer recovery after standard treatment were still prominent in ganglioside-associated GBS. Anti-GM1 and anti-GT1a antibodies were detectable in patients with AMAN while not in patients with the demyelinating subtype of GBS. The concentrations of these antibodies in patients with AMAN were insignificantly different between the ganglioside+ and ganglioside- groups. In sum, ganglioside-associated GBS may be a devastating side effect of intravenous use of gangliosides, which usually manifests a more severe clinical course and poorer outcome.	[Wu, Xiujuan; Wang, Zhengzheng; Shen, Donghui; Wang, Ying; Wu, Limin; Wu, Xiaokun; Feng, Jiachun; Liu, Kangding; Zhu, Jie; Zhang, Hong-Liang] Jilin Univ, Hosp 1, Neurosci Ctr, Dept Neurol, Changchun 130023, Peoples R China; [Wu, Wei] Jilin Univ, Hosp 1, Dept Neurosurg, Changchun 130023, Peoples R China; [Pan, Wei] Jilin Univ, Sch Publ Hlth, Changchun 130023, Peoples R China; [Wang, Ying] Jilin Univ, Norman Bethune Hlth Sci Ctr, Changchun 130023, Peoples R China; [Wu, Limin] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neuroprotect Res Lab, Boston, MA USA; [Zhu, Jie; Zhang, Hong-Liang] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden	Jilin University; Jilin University; Jilin University; Jilin University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Karolinska Institutet	Zhang, HL (corresponding author), Jilin Univ, Hosp 1, Neurosci Ctr, Dept Neurol, Changchun 130023, Peoples R China.	drzhl@hotmail.com	Zhang, Hongliang/AAN-3077-2020	Zhang, Hongliang/0000-0001-9205-5559	Young Scholars Program of Norman Bethune Health Science Center of Jilin University [2013205035]; Young Scholars Program of the First Hospital of Jilin University [JDYY42013003]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; National Natural Science Foundation of China [81241147]	Young Scholars Program of Norman Bethune Health Science Center of Jilin University; Young Scholars Program of the First Hospital of Jilin University; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Young Scholars Program of Norman Bethune Health Science Center of Jilin University (No. 2013205035), Young Scholars Program of the First Hospital of Jilin University (No. JDYY42013003), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, and the National Natural Science Foundation of China (No. 81241147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; DIEZTEJEDOR E, 1993, NEUROEPIDEMIOLOGY, V12, P251, DOI 10.1159/000110325; FIGUERAS A, 1992, BRIT MED J, V305, P1330, DOI 10.1136/bmj.305.6865.1330; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; GARATTINI S, 1993, LANCET, V342, P1191, DOI 10.1016/0140-6736(93)92181-R; Govoni V, 1997, BRAIN, V120, P1123, DOI 10.1093/brain/120.7.1123; Govoni V, 2003, J NEUROL SCI, V216, P99, DOI 10.1016/S0022-510X(03)00215-6; Govoni V, 1996, J NEUROL SCI, V137, P62, DOI 10.1016/0022-510X(95)00333-W; GRANIERI E, 1991, NEUROEPIDEMIOLOGY, V10, P161, DOI 10.1159/000110265; Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512; HaferMacko C, 1996, ANN NEUROL, V40, P635, DOI 10.1002/ana.410400414; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; ILLA I, 1995, ANN NEUROL, V38, P218, DOI 10.1002/ana.410380214; Islam Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043976; KLEYWEG RP, 1991, MUSCLE NERVE, V14, P1103, DOI 10.1002/mus.880141111; Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1; LANDI G, 1993, BRIT MED J, V307, P1463, DOI 10.1136/bmj.307.6917.1463; MCKHANN GM, 1993, ANN NEUROL, V33, P333, DOI 10.1002/ana.410330402; NOBILEORAZIO E, 1992, J NEUROL SCI, V109, P200, DOI 10.1016/0022-510X(92)90169-L; Odaka M, 2000, J NEUROL SCI, V175, P96, DOI 10.1016/S0022-510X(00)00287-2; Yuki N, 2005, CURR OPIN NEUROL, V18, P557, DOI 10.1097/01.wco.0000174604.42272.2d; Yuki N, 2001, ANN NEUROL, V49, P712, DOI 10.1002/ana.1012; Zhang HL, 2013, CYTOKINE GROWTH F R, V24, P443, DOI 10.1016/j.cytogfr.2013.05.005; Zhou CK, 2014, NEURAL REGEN RES, V9, P101, DOI 10.4103/1673-5374.125337	25	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e104074	10.1371/journal.pone.0104074	http://dx.doi.org/10.1371/journal.pone.0104074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084153	Green Published, gold			2022-12-25	WOS:000339819800124
J	Owusu, M; Annan, A; Corman, VM; Larbi, R; Anti, P; Drexler, JF; Agbenyega, O; Adu-Sarkodie, Y; Drosten, C				Owusu, Michael; Annan, Augustina; Corman, Victor Max; Larbi, Richard; Anti, Priscilla; Drexler, Jan Felix; Agbenyega, Olivia; Adu-Sarkodie, Yaw; Drosten, Christian			Human Coronaviruses Associated with Upper Respiratory Tract Infections in Three Rural Areas of Ghana	PLOS ONE			English	Article							FREQUENT DETECTION; VIRAL ETIOLOGY; CHILDREN; VIRUSES; INFLUENZA; DISEASE; BATS; RHINOVIRUS; BOCAVIRUS; ILLNESSES	Background: Acute respiratory tract infections (ARI) are the leading cause of morbidity and mortality in developing countries, especially in Africa. This study sought to determine whether human coronaviruses (HCoVs) are associated with upper respiratory tract infections among older children and adults in Ghana. Methods: We conducted a case control study among older children and adults in three rural areas of Ghana using asymptomatic subjects as controls. Nasal/Nasopharyngeal swabs were tested for Middle East respiratory syndrome coronavirus (MERS-CoV), HCoV-22E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1 using Reverse Transcriptase Real-Time Polymerase Chain Reaction. Results: Out of 1,213 subjects recruited, 150 (12.4%) were positive for one or more viruses. Of these, single virus detections occurred in 146 subjects (12.0%) and multiple detections occurred in 4 (0.3%). Compared with control subjects, infections with HCoV-229E (OR = 5.15, 95% CI = 2.24-11.78), HCoV-OC43 (OR = 6.16, 95% CI = 1.77-21.65) and combine HCoVs (OR = 2.36, 95% CI = 1.5 = 3.72) were associated with upper respiratory tract infections. HCoVs were found to be seasonally dependent with significant detections in the harmattan season (mainly HCoV-229E) and wet season (mainly HCoV-NL63). A comparison of the obtained sequences resulted in no differences to sequences already published in GenBank. Conclusion: HCoVs could play significant role in causing upper respiratory tract infections among adults and older children	[Owusu, Michael; Annan, Augustina; Larbi, Richard] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Corman, Victor Max; Drexler, Jan Felix; Drosten, Christian] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Anti, Priscilla; Agbenyega, Olivia] Kwame Nkrumah Univ Sci & Technol, Inst Renewable & Nat Resources, Kumasi, Ghana; [Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Dept Clin Microbiol, Kumasi, Ghana	Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; University of Bonn; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Drosten, C (corresponding author), Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany.	drosten@virology-bonn.de	Drexler, Jan Felix/GMW-5098-2022; Corman, Victor M/K-1319-2019; Sylverken, Augustina Angelina/ABE-4664-2020	Corman, Victor M/0000-0002-3605-0136; SYLVERKEN, AUGUSTINA/0000-0002-7691-914X; Drexler, Jan Felix/0000-0002-3509-0232; Owusu, Michael/0000-0001-5066-150X	Deutsche Forschungsgemeinschaft [DR 772/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft under grant No DR 772/3-1, to YAS and CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2012, ARCH VIROL, V157, P1411, DOI 10.1007/s00705-012-1299-6; ADEFOLALU DO, 1984, ARCH METEOR GEOPHY B, V33, P387, DOI 10.1007/BF02274004; Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; [Anonymous], 2010, ANN REPORT, V2010, P1; Anthony SJ, 2013, J GEN VIROL, V94, P1028, DOI 10.1099/vir.0.049759-0; Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Corman V. M., 2012, EURO SURVEILL, V17; Cui LJ, 2011, ADV VIROL, V2011, DOI 10.1155/2011/129134; Dare RK, 2007, J INFECT DIS, V196, P1321, DOI 10.1086/521308; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; DENNY FW, 1986, AM J TROP MED HYG, V35, P1; Dominguez SR, 2012, J GEN VIROL, V93, P2387, DOI 10.1099/vir.0.044628-0; Drosten C, 2013, LANCET INFECT DIS, V13, P745, DOI 10.1016/S1473-3099(13)70154-3; Falsey AR, 1997, J AM GERIATR SOC, V45, P706, DOI 10.1111/j.1532-5415.1997.tb01474.x; Gessner BD, 2011, EXPERT REV RESP MED, V5, P459, DOI [10.1586/ERS.11.47, 10.1586/ers.11.47]; Ghana Statistical Service, 2000, POP HOUS CENS; Graat JM, 2003, J CLIN EPIDEMIOL, V56, P1218, DOI 10.1016/S0895-4356(03)00171-9; Herberhold S, 2009, J CLIN MICROBIOL, V47, P2682, DOI 10.1128/JCM.00899-09; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Jartti T, 2004, J MED VIROL, V72, P695, DOI 10.1002/jmv.20027; Lau SKP, 2013, J VIROL, V87, P8638, DOI 10.1128/JVI.01055-13; Mackay IM, 2012, VIRUSES-BASEL, V4, P637, DOI 10.3390/v4040637; MCINTOSH K, 1974, J INFECT DIS, V130, P502, DOI 10.1093/infdis/130.5.502; McIntosh K, 2012, PEDIATR INFECT DIS J, V31, P241, DOI 10.1097/INF.0b013e31823e081e; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Niang MN, 2010, J MED VIROL, V82, P866, DOI 10.1002/jmv.21665; Njouom R, 2012, J INFECT DIS, V206, pS29, DOI 10.1093/infdis/jis573; Penttinen P. M, 2013, EURO SURVEILL, V18; Perera RA, 2013, EUROSURVEILLANCE, V18, P8, DOI 10.2807/1560-7917.ES2013.18.36.20574; Pfefferle S, 2009, DISTANT RELATIVES SE; Prill MM, 2012, PEDIATR INFECT DIS J, DOI [10.1097/INF.1090b1013e31823e31807fe, DOI 10.1097/INF.1090B1013E31823E31807FE]; R Development Core Team, 2008, LANG ENV STAT COMP; Ren LL, 2011, J MED VIROL, V83, P291, DOI 10.1002/jmv.21956; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Sato M, 2009, J CLIN MICROBIOL, V47, P771, DOI 10.1128/JCM.02331-08; Sekyere Central District Assembly, 2010, EURO SURVEILL; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Smuts H, 2008, J MED VIROL, V80, P906, DOI 10.1002/jmv.21135; The Vanuatu National Statistics Office, 2009, NAT POP HOUS CENS AN, V2; The WHO MERS-CoV Research Group, 2013, PLOS CURR, V5; Vabret A, 2003, CLIN INFECT DIS, V36, P985, DOI 10.1086/374222; Vabret A, 2008, J PAEDIATR CHILD H, V44, P176, DOI 10.1111/j.1440-1754.2007.01246.x; van Elden LJR, 2004, J INFECT DIS, V189, P652, DOI 10.1086/381207; Venter M, 2011, J MED VIROL, V83, P1458, DOI 10.1002/jmv.22120; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Xiao Ni-Guang, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P28; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	50	48	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e99782	10.1371/journal.pone.0099782	http://dx.doi.org/10.1371/journal.pone.0099782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080241	Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800001
J	Sunny, A; Monroy-Vilchis, O; Reyna-Valencia, C; Zarco-Gonzalez, MM				Sunny, Armando; Monroy-Vilchis, Octavio; Reyna-Valencia, Carlos; Zarco-Gonzalez, Martha M.			Microhabitat Types Promote the Genetic Structure of a Micro-Endemic and Critically Endangered Mole Salamander (Ambystoma leorae) of Central Mexico	PLOS ONE			English	Article							POPULATION-STRUCTURE; HABITAT USE; MIGRATORY ORIENTATION; LIFE-HISTORIES; CLUTCH SIZE; BODY SIZE; EGG SIZE; LANDSCAPE; FOREST; AMPHIBIANS	The reduced immigration and emigration rates resulting from the lack of landscape connectivity of patches and the hospitality of the intervening matrix could favor the loss of alleles through genetic drift and an increased chance of inbreeding. In order for isolated populations to maintain sufficient levels of genetic diversity and adapt to environmental changes, one important conservation goal must be to preserve or reestablish connectivity among patches in a fragmented landscape. We studied the last known population of Ambystoma leorae, an endemic and critically threatened species. The aims of this study were: (1) to assess the demographic parameters of A. leorae and to distinguish and characterize the microhabitats in the river, (2) to determine the number of existing genetic groups or demes of A. leorae and to describe possible relationships between microhabitats types and demes, (3) to determine gene flow between demes, and (4) to search for geographic locations of genetic discontinuities that limit gene flow between demes. We found three types of microhabitats and three genetically differentiated subpopulations with a significant level of genetic structure. In addition, we found slight genetic barriers. Our results suggest that mole salamander's species are very sensitive to microhabitat features and relatively narrow obstacles in their path. The estimates of bidirectional gene flow are consistent with the pattern of a stepping stone model between demes, where migration occurs between adjacent demes, but there is low gene flow between distant demes. We can also conclude that there is a positive correlation between microhabitats and genetic structure in this population.	[Sunny, Armando; Monroy-Vilchis, Octavio; Reyna-Valencia, Carlos; Zarco-Gonzalez, Martha M.] Univ Autonoma Estado Mexico, Fac Ciencias, Estn Biol Sierra Nanchititla, Toluca, Estado De Mexic, Mexico	Universidad Autonoma del Estado de Morelos	Monroy-Vilchis, O (corresponding author), Univ Autonoma Estado Mexico, Fac Ciencias, Estn Biol Sierra Nanchititla, Toluca, Estado De Mexic, Mexico.	omv@uaemex.mx	Sunny, Armando/E-5620-2012; Zarco-González, Martha Mariela/B-3408-2016; Monroy-Vilchis, Octavio/H-8942-2019	Sunny, Armando/0000-0003-4685-5322; Zarco-González, Martha Mariela/0000-0003-4217-8272; Monroy-Vilchis, Octavio/0000-0003-3159-6014	Universidad Autonoma del Estado de Mexico [3527/2013MT]	Universidad Autonoma del Estado de Mexico(Universidad Nacional Autonoma de Mexico)	This work was supported by grant number 3527/2013MT (http://www.uaemex.mx/) from the Universidad Autonoma del Estado de Mexico to OMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR-MIGUEL Xóchitl, 2009, Acta Zool. Mex, V25, P443; ANDERSON JD, 1967, AM MIDL NAT, V77, P323, DOI 10.2307/2423346; [Anonymous], 1997, MOL BIOL BIOTECHNOLO; Arens P, 2007, LANDSCAPE ECOL, V22, P1489, DOI 10.1007/s10980-007-9132-4; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; BRANDON RA, 1970, COPEIA, P385; Casas-Andreu G, 1989, ECOLOGIA URBANA, VEsp, P117; Clobert J, 1998, J EVOLUTION BIOL, V11, P329; CORTWRIGHT SA, 1990, OECOLOGIA, V83, P123, DOI 10.1007/BF00324643; Demaynadier Phillip G., 1995, Environmental Reviews, V3, P230, DOI 10.1139/a95-012; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Dyer RJ, 2009, MOL ECOL RESOUR, V9, P110, DOI 10.1111/j.1755-0998.2008.02384.x; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Egan RS, 2004, WETLANDS, V24, P1, DOI 10.1672/0277-5212(2004)024[0001:WPAOBW]2.0.CO;2; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Falush D, 2003, GENETICS, V164, P1567; FORD NB, 1989, HERPETOLOGICA, V45, P75; FORMANOWICZ DR, 1989, AM MIDL NAT, V121, P379, DOI 10.2307/2426042; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Garcia P, 2003, THESIS UMSNH MORELIA; GATES J E, 1981, Journal of the Elisha Mitchell Scientific Society, V97, P209; Gibbs JP, 1998, LANDSCAPE ECOL, V13, P263, DOI 10.1023/A:1008056424692; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Goldstein DB, 1995, GENETICS, V140, P679; Greenwald KR, 2009, CONSERV BIOL, V23, P1232, DOI 10.1111/j.1523-1739.2009.01204.x; Guerry AD, 2002, CONSERV BIOL, V16, P745, DOI 10.1046/j.1523-1739.2002.00557.x; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Herrmann HL, 2005, BIOL CONSERV, V123, P139, DOI 10.1016/j.biocon.2004.05.025; Huacuz D, 2002, PLAN MANEJO ACHOQUE; Huacuz-Elias DC, 2003, BIOLOGICAS, V5, P51; HUACUZELIAS DC, 2001, ESTADO CONSERVACION; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; IBM Corp, 2010, IBM SPSS STAT WIND; Jehle R, 2005, CONSERV GENET, V6, P227, DOI 10.1007/s10592-004-7832-8; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kinkead KE, 2007, CONSERV GENET, V8, P281, DOI 10.1007/s10592-006-9168-z; KNUDSEN JENS W., 1960, COPEIA, V1960, P44, DOI 10.2307/1439844; Kraaijeveld-Smit FJL, 2007, OIKOS, V116, P1819, DOI 10.1111/j.0030-1299.2007.16087.x; Langella O, 2002, POPULATIONS 1230 COP; Lemos-Espinal J, 1985, CIENCIA FORESTAL, V10, P44; Lemos-Espinal J, 1999, BRIT HERP SOC B, V68, P1; Lindstrom Jan, 2010, BMC Ecology, V10, P4, DOI 10.1186/1472-6785-10-4; Loredo I, 1996, J HERPETOL, V30, P282, DOI 10.2307/1565527; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Marin-Martinez AI, 2007, THESIS UNAM MEXICO; Marsh DM, 2001, CONSERV BIOL, V15, P40, DOI 10.1046/j.1523-1739.2001.00129.x; Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303; McMenamin Sarah K., 2010, BMC Ecology, V10, P10, DOI 10.1186/1472-6785-10-10; Monroy-Vilchis O, 2014, HERPETOZOA IN PRESS; Morrison C, 2003, J ANIM ECOL, V72, P270, DOI 10.1046/j.1365-2656.2003.00696.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Parra-Olea G, 2007, MOL ECOL NOTES, V7, P818, DOI 10.1111/j.1471-8286.2007.01714.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PORTNOY JW, 1990, BIOL CONSERV, V53, P61, DOI 10.1016/0006-3207(90)90063-U; Pritchard JK, 2000, GENETICS, V155, P945; Purrenhage JL, 2009, MOL ECOL, V18, P235, DOI 10.1111/j.1365-294X.2008.04024.x; Rambaut A, 2009, FIGTREE V1 3 1; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reyes G, 2003, THESIS UNAM MEXICO; Rittenhouse TAG, 2006, BIOL CONSERV, V131, P14, DOI 10.1016/j.biocon.2006.01.024; Rodriguez Reyes F.R., 2009, THESIS, P80; Rothermel BB, 2002, CONSERV BIOL, V16, P1324, DOI 10.1046/j.1523-1739.2002.01085.x; Sandoval-Comte A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034023; SEALE DB, 1982, COPEIA, P627, DOI 10.2307/1444663; SEMLITSCH RD, 1983, COPEIA, P608; Shaffer B, 2004, IUCN RED LIST THREAT; Shaffer H. B., 2005, AMPHIBIAN DECLINES C, P605; SHOOP CR, 1968, BIOL BULL, V135, P230, DOI 10.2307/1539630; SHOOP CR, 1972, BEHAV BIOL, V7, P131, DOI 10.1016/S0091-6773(72)80195-0; SHRIVER MD, 1995, MOL BIOL EVOL, V12, P914; Spear SF, 2008, MOL ECOL, V17, P4642, DOI 10.1111/j.1365-294X.2008.03952.x; StatPoint, 2007, STATGRAPHICS CENT 15; StatSoft Inc, 2007, STAT VERS 7 DAT AN S; Stearns S.C., 1992, pi; Stebbins R. C., 2021, NATURAL HIST AMPHIBI; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Sunny A, 2014, CONSERV GENET, V15, P49, DOI 10.1007/s10592-013-0520-9; Taylor Edward H., 1943, UNIV KANSAS SCI BULL, V29, P343; Todd BD, 2009, J APPL ECOL, V46, P554, DOI 10.1111/j.1365-2664.2009.01645.x; Trenham PC, 2005, ECOL APPL, V15, P1158, DOI 10.1890/04-1150; Trenham PC, 2001, J HERPETOL, V35, P343, DOI 10.2307/1566130; Tyler TJ, 1998, J HERPETOL, V32, P345, DOI 10.2307/1565448; Uribe-Pena Z, 1999, I BIOL U NACL AUTONO, V32, P19; Valiere N., 2002, MOL ECOL NOTES, V10, P1046, DOI DOI 10.1046/J.1471-8286.2002.00228.X-I2; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vega LA, 1992, ACTA ZOOL MEX, V15, P1; Vega-Lopez A, 1992, ACTA ZOOL MEX, V51, P20; Wang IJ, 2009, MOL ECOL, V18, P1365, DOI 10.1111/j.1365-294X.2009.04122.x; WIEBE KL, 1995, J ZOOL, V237, P285, DOI 10.1111/j.1469-7998.1995.tb02763.x; Zamudio KR, 2007, MOL ECOL, V16, P257, DOI 10.1111/j.1365-294X.2006.03139.x	97	17	20	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103595	10.1371/journal.pone.0103595	http://dx.doi.org/10.1371/journal.pone.0103595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076052	Green Submitted, Green Published, gold			2022-12-25	WOS:000340028800067
J	Hong, SW; Kim, SC; Kwon, TM; Jeong, IG; Kim, CS; Ahn, HJ; Hong, JH				Hong, Sungwoo; Kim, Seong-Cheol; Kwon, Taekmin; Jeong, In Gab; Kim, Choung-Soo; Ahn, Hanjong; Hong, Jun Hyuk			Is Bladder Tumor Location Associated with Prostate Cancer Detection after Intravesical Bacillus Calmette-Guerin Instillation?	PLOS ONE			English	Article							NEEDLE-ASPIRATION-CYTOLOGY; GRANULOMATOUS PROSTATITIS; IMMUNOTHERAPY; COMPLICATIONS; DIAGNOSIS; THERAPY; TRIAL	Objectives: The aim of this study was to evaluate the effect of bladder tumor (BT) location on prostate cancer (PCa) detection in patients with elevated PSA levels after intravesical BCG instillation. Methods: Between February 2004 and January 2013 prostate biopsies were performed in 59 non-muscle invasive bladder cancer (NMIBC) patients whose PSA level were elevated (>= 3 ng/ml) after a 6 week course of intravesical BCG (Oncotice, 12.5 mg in 50 ml normal saline). Differences in PCa detection according to the BT location [bladder neck and/or trigone (Group 1, n = 22) vs. other locations (Group 2, n = 37)] were evaluated. The Fisher's exact test and the Mann-Whitney U test were used to evaluate the association between categorical and continuous variables, respectively. Results: A total of 14 patients (23.7%) were diagnosed with PCa. The mean +/- standard deviation (SD) PSA before intravesical BCG instillation and prostate biopsy were 1.36 +/- 1.04 ng/ml in Group 1 and 1.09 +/- 1.12 ng/ml in Group 2 (P = 0.633), and 6.05 +/- 3.57 ng/ml in Group 1 and 5.13 +/- 3.88 ng/ml in Group 2 (P = 0.378), respectively. Interestingly, whereas PCa was detected upon biopsy in only one patient in Group 1 (4.5%), 13 cases were detected in Group 2 (35.1%) (P = 0.009). Conclusions: PCa detection after intravesical BCG was highly associated with BT location. Prostate biopsy should therefore be considered when PSA level is elevated after BCG instillation and his BT is located far from the bladder neck.	[Hong, Sungwoo; Kim, Seong-Cheol; Kwon, Taekmin; Jeong, In Gab; Kim, Choung-Soo; Ahn, Hanjong; Hong, Jun Hyuk] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul, South Korea; [Hong, Sungwoo] Dankook Univ, Coll Med, Dept Urol, Cheonan, South Korea; [Kim, Seong-Cheol] Inje Univ, Coll Med, Dept Urol, Pusan, South Korea	University of Ulsan; Asan Medical Center; Dankook University; Inje University	Hong, JH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul, South Korea.	jhhong@amc.seoul.kr		Kim, Seong Cheol/0000-0003-0228-0037				Bardia A, 2009, CURR OPIN PHARMACOL, V9, P419, DOI 10.1016/j.coph.2009.06.002; Beltrami P, 2008, PROSTATE, V68, P1241, DOI 10.1002/pros.20790; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Drake CG, 2010, NAT REV IMMUNOL, V10, P580, DOI 10.1038/nri2817; ESPOSTI PL, 1966, ACTA CYTOL, V10, P182; Holmang S, 2000, SCAND J UROL NEPHROL, V34, P95, DOI 10.1080/003655900750016698; KIEMENEY LALM, 1993, J UROLOGY, V150, P60, DOI 10.1016/S0022-5347(17)35397-1; Kirkali Z, 2005, UROLOGY, V66, P4, DOI 10.1016/j.urology.2005.07.062; Kuroda M, 2004, EUR UROL, V45, P600, DOI 10.1016/j.eururo.2003.12.010; LAMM DL, 1992, J UROLOGY, V147, P596, DOI 10.1016/S0022-5347(17)37316-0; LAMM DL, 1986, J UROLOGY, V135, P272, DOI 10.1016/S0022-5347(17)45606-0; Leibovici D, 2000, J UROLOGY, V164, P1546, DOI 10.1016/S0022-5347(05)67025-5; Lopez Llaurado H, 2003, ARCH ESP UROL, V56, P19; MIRALLES TG, 1990, ACTA CYTOL, V34, P57; MORALES A, 1976, J UROLOGY, V116, P180, DOI 10.1016/S0022-5347(17)58737-6; MUKAMEL E, 1990, J UROLOGY, V144, P1399, DOI 10.1016/S0022-5347(17)39752-5; OATES RD, 1988, J UROLOGY, V140, P751, DOI 10.1016/S0022-5347(17)41803-9; Schned AR, 2008, SCAND J UROL NEPHROL, V42, P237, DOI 10.1080/00365590801948166; Solano JG, 1998, DIAGN CYTOPATHOL, V18, P215; SORENSEN F B, 1989, Ugeskrift for Laeger, V151, P287; STILMANT M, 1985, ACTA CYTOL, V29, P961; Val-Bernal J Fernando, 2004, Ann Diagn Pathol, V8, P242, DOI 10.1053/j.anndiagpath.2004.06.002; Witjes JA, 1998, J UROLOGY, V160, P1668, DOI 10.1016/S0022-5347(01)62377-2	23	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103791	10.1371/journal.pone.0103791	http://dx.doi.org/10.1371/journal.pone.0103791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072158	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600087
J	Kang, TH; Knoff, J; Yeh, WH; Yang, B; Wang, CG; Kim, YS; Kim, TW; Wu, TC; Hung, CF				Kang, Tae Heung; Knoff, Jayne; Yeh, Wei-Hsi; Yang, Benjamin; Wang, Chenguang; Kim, Young Seob; Kim, Tae Woo; Wu, Tzyy-Choou; Hung, Chien-Fu			Treatment of Tumors with Vitamin E Suppresses Myeloid Derived Suppressor Cells and Enhances CD8+T Cell-Mediated Antitumor Effects	PLOS ONE			English	Article							DNA VACCINE; COLON-CANCER; ANTIGEN; IMMUNITY; IMMUNOTHERAPY; RESPONSES; RISK; GENE	Vitamin E has been shown to have strong anticarcinogenic properties, including antioxidant characteristics, making it an ideal candidate for use in combination with immunotherapies that modify the tumor microenvironment. The tumor microenvironment contains immunosuppressive components, which can be diminished, and immunogenic components, which can be augmented by immunotherapies in order to generate a productive immune response. In the current study, we employ the alpha-tocopherol succinate isomer of vitamin E to reduce immunosuppression by myeloid derived suppressor cells (MDSCs) as well as adoptive transfer of antigen-specific CD8+ T cells to generate potent antitumor effects against the HPV16 E7-expressing TC-1 tumor model. We show that vitamin E alone induces necrosis of TC-1 cells and elicits antitumor effects in TC-1 tumor-bearing mice. We further demonstrate that vitamin E reverses the suppression of T cell activation by MDSCs and that this effect is mediated in part by a nitric oxide-dependent mechanism. Additionally, treatment with vitamin E reduces the percentage of MDSCs in tumor loci, and induces a higher percentage of T cells, following T cell adoptive transfer. Finally, we demonstrate that treatment with vitamin E followed by E7-specific T cell adoptive transfer experience elicits potent antitumor effects in tumor-bearing mice. Our data provide additional evidence that vitamin E has anticancer properties and that it has promise for use as an adjuvant in combination with a variety of cancer therapies.	[Kang, Tae Heung; Kim, Young Seob] Konkuk Univ, Coll Med, Seoul Dept Immunol, Chungju, South Korea; [Knoff, Jayne; Yeh, Wei-Hsi; Yang, Benjamin; Wu, Tzyy-Choou; Hung, Chien-Fu] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Wu, Tzyy-Choou] Johns Hopkins Med Inst, Dept Obstet & Gynecol, Baltimore, MD 21205 USA; [Wu, Tzyy-Choou] Johns Hopkins Med Inst, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Wu, Tzyy-Choou; Hung, Chien-Fu] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Wang, Chenguang] Johns Hopkins Med Inst, Sidney Kimmel Canc Comprehens Canc Ctr, Dept Biostat & Bioinformat, Baltimore, MD 21205 USA; [Kim, Tae Woo] Korea Univ, Grad Sch Med, Div Infect & Immunol, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Korea University; Korea University Medicine (KU Medicine)	Kang, TH (corresponding author), Konkuk Univ, Coll Med, Seoul Dept Immunol, Chungju, South Korea.	kangiron@kku.ac.kr; chung2@jhmi.edu		Bissonette, Jayne/0000-0001-8376-9242	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [NRF-2013M3A9D3045881]; National Institutes of Health/National Cancer Institute Cervical Cancer SPORE [P50CA098252, 2R01CA114425-06]; NATIONAL CANCER INSTITUTE [P50CA098252, R01CA114425] Funding Source: NIH RePORTER	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning; National Institutes of Health/National Cancer Institute Cervical Cancer SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2013M3A9D3045881) and by the National Institutes of Health/National Cancer Institute Cervical Cancer SPORE P50CA098252 and 2R01CA114425-06 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOSTICK RM, 1993, CANCER RES, V53, P4230; BURTON GW, 1990, ANNU REV NUTR, V10, P357, DOI [10.1146/annurev.nu.10.070190.002041, 10.1146/annurev.nutr.10.1.357]; Casaburi I, 2013, MOL NUTR FOOD RES, V57, P71, DOI 10.1002/mnfr.201200503; Cheng WF, 2001, J CLIN INVEST, V108, P669, DOI 10.1172/JCI200112346; Constantinou C, 2008, INT J CANCER, V123, P739, DOI 10.1002/ijc.23689; Hahn T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-471; Jin M, 2013, INT J BIOL MACROMOL; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kim D, 2007, HUM GENE THER, V18, P575, DOI 10.1089/hum.2007.038; Kim TW, 2004, J BIOMED SCI, V11, P493, DOI 10.1159/000077899; Kim TW, 2004, CANCER RES, V64, P400, DOI 10.1158/0008-5472.CAN-03-1475; Lesokhin AM, 2012, CANCER RES, V72, P876, DOI 10.1158/0008-5472.CAN-11-1792; Lin KY, 1996, CANCER RES, V56, P21; Malmberg KJ, 2002, CLIN CANCER RES, V8, P1772; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; MENKES MS, 1986, NEW ENGL J MED, V315, P1250, DOI 10.1056/NEJM198611133152003; Omer B, 1997, J NATL CANCER I, V89, P972, DOI 10.1093/jnci/89.13.972; Prasad KN, 2003, J AM COLL NUTR, V22, P108, DOI 10.1080/07315724.2003.10719283; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; Trimble CL, 2009, CLIN CANCER RES, V15, P361, DOI 10.1158/1078-0432.CCR-08-1725; Tseng CW, 2008, CLIN CANCER RES, V14, P3185, DOI 10.1158/1078-0432.CCR-08-0037; Wang TL, 2000, GENE THER, V7, P726, DOI 10.1038/sj.gt.3301160; White E, 1997, CANCER EPIDEM BIOMAR, V6, P769; Yang CS, 2012, CANCER PREV RES, V5, P701, DOI 10.1158/1940-6207.CAPR-12-0045; YASUNAGA T, 1982, J NUTR, V112, P1075, DOI 10.1093/jn/112.6.1075; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	28	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103562	10.1371/journal.pone.0103562	http://dx.doi.org/10.1371/journal.pone.0103562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072795	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600063
J	Adaszewski, S				Adaszewski, Stanislaw			Mynodbcsv: Lightweight Zero-Config Database Solution for Handling Very Large CSV Files	PLOS ONE			English	Article								Volumes of data used in science and industry are growing rapidly. When researchers face the challenge of analyzing them, their format is often the first obstacle. Lack of standardized ways of exploring different data layouts requires an effort each time to solve the problem from scratch. Possibility to access data in a rich, uniform manner, e.g. using Structured Query Language (SQL) would offer expressiveness and user-friendliness. Comma-separated values (CSV) are one of the most common data storage formats. Despite its simplicity, with growing file size handling it becomes non-trivial. Importing CSVs into existing databases is time-consuming and troublesome, or even impossible if its horizontal dimension reaches thousands of columns. Most databases are optimized for handling large number of rows rather than columns, therefore, performance for datasets with non-typical layouts is often unacceptable. Other challenges include schema creation, updates and repeated data imports. To address the above-mentioned problems, I present a system for accessing very large CSV-based datasets by means of SQL. It's characterized by: "no copy" approach - data stay mostly in the CSV files; "zero configuration" - no need to specify database schema; written in C++, with boost [1], SQLite [2] and Qt [3], doesn't require installation and has very small size; query rewriting, dynamic creation of indices for appropriate columns and static data retrieval directly from CSV files ensure efficient plan execution; effortless support for millions of columns; due to per-value typing, using mixed text/numbers data is easy; very simple network protocol provides efficient interface for MATLAB and reduces implementation time for other languages. The software is available as freeware along with educational videos on its website [4]. It doesn't need any prerequisites to run, as all of the libraries are included in the distribution package. I test it against existing database solutions using a battery of benchmarks and discuss the results.	[Adaszewski, Stanislaw] CHU Vaudois, DNC, Lab Rech Neuroimagerie, Lausanne, Switzerland; [Adaszewski, Stanislaw] Ecole Polytech Fed Lausanne, Blue Brain Project, CH-1015 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Adaszewski, S (corresponding author), CHU Vaudois, DNC, Lab Rech Neuroimagerie, Lausanne, Switzerland.	s.adaszewski@gmail.com						Agrawal S., 2005, P 2005 ACM SIGMOD IN, P930, DOI [DOI 10.1145/1066157.1066292, 10.1145/1066157.1066292]; Agrawal S, 2000, AUTOMATED SELECTION; Agrawal S, 2004, P 2004 ACM SIGMOD IN, P359, DOI [DOI 10.1145/1007568.1007609, 10.1145/1007568.1007609]; Ailamaki A, 2010, COMMUN ACM, V53, P68, DOI 10.1145/1743546.1743568; Alagiannis I, 2012, P 2012 ACM SIGMOD IN, P241, DOI [DOI 10.1145/2213836.2213864, 10.1145/2213836.2213864]; Bruno N., 2005, ACM SIGMOD, P227, DOI [10.1145/1066157.1066184, DOI 10.1145/1066157.1066184]; Bruno Nicolas, 2006, P 32 INT C VER LARG, P499; Chaudhuri S, 1997, PROCEEDINGS OF THE TWENTY-THIRD INTERNATIONAL CONFERENCE ON VERY LARGE DATABASES, P146; Cohen J, 2009, PROC VLDB ENDOW, V2, P1481, DOI 10.14778/1687553.1687576; Dageville Benoit, 2004, P 30 INT C VERY LARG, V30, P1098, DOI DOI 10.1016/B978-012088469-8.50096-6; Dash D, 2011, PROC VLDB ENDOW, V4, P362, DOI 10.14778/1978665.1978668; Fan J, 2011, PROC INT CONF DATA, P351, DOI 10.1109/ICDE.2011.5767843; Graefe G., 2010, EDBT, P371, DOI [DOI 10.1145/1739041.1739087, 10.1145/1739041.1739087]; Graefe G, 2011, LECT NOTES COMPUT SC, V6417, P169, DOI 10.1007/978-3-642-18206-8_13; Graefe G, 2010, I C DATA ENGIN WORKS, P69, DOI 10.1109/ICDEW.2010.5452743; Gray J, 2005, ACM SIGMOD REC; Idreos S., 2007, SIGMOD, P413, DOI [10.1145/1247480.1247527, DOI 10.1145/1247480.1247527]; Idreos S, 2011, 5 BIENN C INN DAT SY, P1; Idreos S, 2011, P VLDB; Idreos S, 2009, ACM SIGMOD/PODS 2009 CONFERENCE, P297; Idreos Stratos, 2007, CIDR, V7, P68, DOI [10.1002/per, DOI 10.1002/PER]; Jain A, 2008, PROC INT CONF DATA, P636, DOI 10.1109/ICDE.2008.4497472; Kersten ML, 2011, PROC VLDB ENDOW, V4, P1474; Lorincz K, 2003, GREP VERSUS FLATSQL; Ordonez C, 2012, IEEE T KNOWL DATA EN, V24, P678, DOI 10.1109/TKDE.2011.16; Papadomanolakis S, 2004, 16TH INTERNATIONAL CONFERENCE ON SCIENTIFIC AND STATISTICAL DATABASE MANAGEMENT, PROCEEDINGS, P383; Schnaitter K., 2006, SIGMOD, P793, DOI [10.1145/1142473.1142592, DOI 10.1145/1142473.1142592]; Stonebraker M, 2009, 4 BIENN C INN DAT SY, DOI 10.1.1.145.1567; Stonebraker M, 2010, COMMUN ACM, V53, P10, DOI 10.1145/1721654.1721659; Valens G, 2000, POSITIF, P101, DOI 10.1109/ICDE.2000.839397; Zilio D.C., 2004, VLDB, P1087	31	0	0	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103319	10.1371/journal.pone.0103319	http://dx.doi.org/10.1371/journal.pone.0103319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068261	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993700060
J	Boutin, S; Sauvage, C; Bernatchez, L; Audet, C; Derome, N				Boutin, Sebastien; Sauvage, Christopher; Bernatchez, Louis; Audet, Celine; Derome, Nicolas			Inter Individual Variations of the Fish Skin Microbiota: Host Genetics Basis of Mutualism?	PLOS ONE			English	Article							METHYLOBACTERIUM-RHODESIANUM; FLAVOBACTERIUM-PSYCHROPHILUM; ARTEMIA-FRANCISCANA; BROOK CHARR; BACTERIA; IDENTIFICATION; SELECTION; INNATE; TISSUE	The commensal microbiota of fish skin is suspected to provide a protection against opportunist infections. The skin of fish harbors a complex and diverse microbiota that closely interacts with the surrounding water microbial communities. Up to now there is no clear evidence as to whether the host regulates the recruitment of environmental bacteria to build a specific skin microbiota. To address this question, we detected Quantitative Trait Loci (QTL) associated with the abundance of specific skin microbiota bacterial strains in brook charr (Salvelinus fontinalis), combining 16S RNA tagged- amplicon 454 pyrosequencing with genetic linkage analysis. Skin microbiota analysis revealed high inter-individual variation among 86 F2 fish progeny based upon the relative abundance of bacterial operational taxonomic units (OTUs). Out of those OTUs, the pathogenic strain Flavobacterium psychrophilum and the non-pathogenic strain Methylobacterium rhodesianum explained the majority of inter-individual distances. Furthermore, a strong negative correlation was found between Flavobacterium and Methylobacterium, suggesting a mutually competitive relationship. Finally, after considering a total of 266 markers, genetic linkage analysis highlighted three major QTL associated with the abundance of Lysobacter, Rheinheimera and Methylobacterium. All these three genera are known for their beneficial antibacterial activity. Overall, our results provide evidence that host genotype may regulate the abundance of specific genera among their surface microbiota. They also indicate that Lysobacter, Rheinheimera and Methylobacterium are potentially important genera in providing protection against pathogens.	[Boutin, Sebastien; Sauvage, Christopher; Bernatchez, Louis; Derome, Nicolas] Univ Laval, Dept Biol, IBIS, Quebec City, PQ G1K 7P4, Canada; [Sauvage, Christopher] INRA, UR1052, F-84143 Montfavet, France; [Audet, Celine] UQAR, Inst Sci Mer Rimouski ISMER, Rimouski, PQ, Canada	Laval University; INRAE; University of Quebec; Universite du Quebec a Rimouski	Derome, N (corresponding author), Univ Laval, Dept Biol, IBIS, Quebec City, PQ G1K 7P4, Canada.	nicolas.derome@bio.ulaval.ca	Audet, Celine/F-5192-2011; Boutin, Sébastien/AAX-5334-2021	Boutin, Sébastien/0000-0002-0499-2460; Bernatchez, Louis/0000-0002-8085-9709	Conseil de recherches en sciences naturelles et en genie (CRSNG); "Collaborative Research And Training Experience'' program (CREATE)	Conseil de recherches en sciences naturelles et en genie (CRSNG)(Natural Sciences and Engineering Research Council of Canada (NSERC)); "Collaborative Research And Training Experience'' program (CREATE)	This work was financially supported by a Partnership grant (Strategic program) of the "Conseil de recherches en sciences naturelles et en genie'' (CRSNG) to Louis Bernatchez, Nicolas Derome, and Celine Audet and the "Collaborative Research And Training Experience'' program (CREATE). This is a contribution to the research program of Resources Aquatiques Quebec (RAQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Balachandran C., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P712, DOI 10.1016/S2221-1691(12)60215-9; Balcazar J. L., 2004, Journal of Aquaculture in the Tropics, V19, P239; Bormann EJ, 1999, BIOTECHNOL LETT, V21, P1059, DOI 10.1023/A:1005640712329; Bormann EJ, 1999, BIOTECHNOL TECH, V13, P539, DOI 10.1023/A:1008904814522; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Boutin S, 2013, CANADIAN J IN PRESS; Boutin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084772; Boutin S, 2012, VET MICROBIOL, V155, P355, DOI 10.1016/j.vetmic.2011.09.002; Chen W-M, 2010, RHEINHEIMERA AQUATIC; Chen WM, 2010, ENZYME MICROB TECH, V46, P487, DOI 10.1016/j.enzmictec.2010.01.006; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Defoirdt T, 2007, ENVIRON MICROBIOL, V9, P445, DOI 10.1111/j.1462-2920.2006.01161.x; Dillon R, 2002, RES MICROBIOL, V153, P503, DOI 10.1016/S0923-2508(02)01361-X; Dionne M, 2009, PHILOS T R SOC B, V364, P1555, DOI 10.1098/rstb.2009.0011; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Halet D, 2007, FEMS MICROBIOL ECOL, V60, P363, DOI 10.1111/j.1574-6941.2007.00305.x; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Korotkova N, 2002, J BACTERIOL, V184, P6174, DOI 10.1128/JB.184.22.6174-6181.2002; Krawczyk M, 2006, TISSUE ANTIGENS, V67, P183, DOI 10.1111/j.1399-0039.2006.00557.x; Langevin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039126; Loiseau C, 2009, MOL ECOL, V18, P1331, DOI 10.1111/j.1365-294X.2009.04105.x; Lucentini L, 2006, MOL ECOL NOTES, V6, P257, DOI 10.1111/j.1471-8286.2005.01142.x; Macpherson AJ, 2011, CURR OPIN GASTROEN, V27, P529, DOI 10.1097/MOG.0b013e32834bb805; Madetoja J, 2000, DIS AQUAT ORGAN, V43, P27, DOI 10.3354/dao043027; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; McKnite AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039191; Mothes G, 1998, ARCH MICROBIOL, V169, P360, DOI 10.1007/s002030050583; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Reichenbach H, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P939, DOI 10.1007/0-387-30746-x_37; Sauvage C, 2012, G3-GENES GENOM GENET, V2, P379, DOI 10.1534/g3.111.001867; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siddharth J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083689; Starliper CE, 2011, J ADV RES, V2, P97, DOI 10.1016/j.jare.2010.04.001; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Takeshita T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00215; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2010, ACTA CRYSTALLOGR F, V66, P1261, DOI 10.1107/S1744309110029088; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wiklund T, 2000, J APPL MICROBIOL, V88, P299, DOI 10.1046/j.1365-2672.2000.00959.x; Yellore V, 1998, LETT APPL MICROBIOL, V26, P391, DOI 10.1046/j.1472-765X.1998.00362.x	49	83	83	4	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102649	10.1371/journal.pone.0102649	http://dx.doi.org/10.1371/journal.pone.0102649			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068850	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993700014
J	Haris, M; Singh, A; Cai, K; Nath, K; Verma, G; Nanga, RPR; Hariharan, H; Detre, JA; Epperson, N; Reddy, R				Haris, Mohammad; Singh, Anup; Cai, Kejia; Nath, Kavindra; Verma, Gaurav; Nanga, Ravi Prakash Reddy; Hariharan, Hari; Detre, John A.; Epperson, Neill; Reddy, Ravinder			High Resolution Mapping of Modafinil Induced Changes in Glutamate Level in Rat Brain	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; COCAINE DEPENDENCE; NARCOLEPSY; PSYCHOSTIMULANT; ATTENTION; MARMOSET; EFFICACY; DISORDER	Modafinil is marketed in the United States for the treatment of narcolepsy and daytime somnolence due to shift-work or sleep apnea. Investigations of this drug in the treatment of cocaine and nicotine dependence in addition to disorders of executive function are also underway. Modafinil has been known to increase glutamate levels in rat brain models. Proton magnetic resonance spectroscopy (1 HMRS) has been commonly used to detect the glutamate (Glu) changes in vivo. In this study, we used a recently described glutamate chemical exchange saturation transfer (GluCEST) imaging technique to measure Modafinil induced regional Glu changes in rat brain and compared the results with Glu concentration measured by single voxel 1 HMRS. No increases in either GluCEST maps or 1 HMRS were observed after Modafinil injection over a period of 5 hours. However, a significant increase in GluCEST (19 +/- 4.4%) was observed 24 hours post Modafinil administration, which is consistent with results from previous biochemical studies. This change was not consistently seen with 1 HMRS. GluCEST mapping allows regional cerebral Glu changes to be measured and may provide a useful clinical biomarker of Modafinil effects for the management of patients with sleep disorders and addiction.	[Haris, Mohammad; Singh, Anup; Cai, Kejia; Nanga, Ravi Prakash Reddy; Hariharan, Hari; Detre, John A.; Reddy, Ravinder] Univ Penn, CMROI, Philadelphia, PA 19104 USA; [Haris, Mohammad] Sidra Med & Res Ctr, Res Branch, Doha, Qatar; [Singh, Anup] Indian Inst Technol, Ctr Biomed Engn, Delhi, India; [Cai, Kejia] Univ Illinois, CMRR, Chicago, IL USA; [Nath, Kavindra; Verma, Gaurav; Epperson, Neill] Univ Penn, Philadelphia, PA 19104 USA; [Detre, John A.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; Sidra Medical & Research Center; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Pennsylvania; University of Pennsylvania	Haris, M (corresponding author), Univ Penn, CMROI, Philadelphia, PA 19104 USA.	mharis@sidra.org	Epperson, Cynthia Neill/ABE-9424-2021	Reddy, Ravinder/0000-0003-4580-2392; Haris, Mohammad/0000-0002-4945-2935; Singh, Anup/0000-0001-6744-8326	National Institutes of Health [P41 EB015893, P41 EB015893S1, R21DA032256-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA032256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants P41 EB015893, P41 EB015893S1, and R21DA032256-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold VK, 2014, J ATTEN DISORD, V18, P133, DOI 10.1177/1087054712441969; BASTUJI H, 1988, PROG NEURO-PSYCHOPH, V12, P695, DOI 10.1016/0278-5846(88)90014-0; Bettendorff L, 1996, SLEEP, V19, P65, DOI 10.1093/sleep/19.1.65; BOIVIN DB, 1993, CLIN NEUROPHARMACOL, V16, P46, DOI 10.1097/00002826-199302000-00005; Bond DJ, 2012, ANN CLIN PSYCHIATRY, V24, P23; Cai KJ, 2012, NAT MED, V18, P302, DOI 10.1038/nm.2615; Dackis CA, 2005, NEUROPSYCHOPHARMACOL, V30, P205, DOI 10.1038/sj.npp.1300600; Goez HR, 2012, J CHILD NEUROL, V27, P1547, DOI 10.1177/0883073812439101; Haris M, 2013, NMR BIOMED, V26, P386, DOI 10.1002/nbm.2875; Haris M, 2011, NEUROIMAGE, V54, P2079, DOI 10.1016/j.neuroimage.2010.10.017; Hurd R, 2004, MAGNET RESON MED, V51, P435, DOI 10.1002/mrm.20007; Jenner P, 2000, EXP BRAIN RES, V133, P178, DOI 10.1007/s002210000370; LAGARDE D, 1995, FUNDAM CLIN PHARM, V9, P271, DOI 10.1111/j.1472-8206.1995.tb00295.x; Lagarde D, 1993, MED SCI RES, V21, P4; LYONS TJ, 1991, AVIAT SPACE ENVIR MD, V62, P432; Mariani JJ, 2012, PSYCHIAT CLIN N AM, V35, P425, DOI 10.1016/j.psc.2012.03.012; Mitler MM, 2000, SLEEP MED, V1, P231, DOI 10.1016/S1389-9457(00)00031-9; Petroff O A, 2000, Adv Neurol, V83, P261; PIERARD C, 1995, BRAIN RES, V693, P251, DOI 10.1016/0006-8993(95)00711-X; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Shearer J, 2009, ADDICTION, V104, P224, DOI 10.1111/j.1360-0443.2008.02437.x; UEKI A, 1993, EXP BRAIN RES, V96, P89, DOI 10.1007/BF00230442; Valentino RM, 2007, CLEV CLIN J MED, V74, P561, DOI 10.3949/ccjm.74.8.561; van Vliet SAM, 2006, BEHAV PHARMACOL, V17, P453, DOI 10.1097/00008877-200609000-00011	24	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103154	10.1371/journal.pone.0103154	http://dx.doi.org/10.1371/journal.pone.0103154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068408	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993700042
J	Schmidt, CM; Blount, JD; Bennett, NC				Schmidt, Christina M.; Blount, Jonathan D.; Bennett, Nigel C.			Reproduction Is Associated with a Tissue-Dependent Reduction of Oxidative Stress in Eusocial Female Damara land Mole-Rats (Fukomys damarensis)	PLOS ONE			English	Article							LIPID-PEROXIDATION; HONEY-BEE; LIFE-SPAN; SOCIAL INSECTS; EGG-PRODUCTION; TRADE-OFF; COST; RESISTANCE; SUPPRESSION; LONGEVITY	Oxidative stress has been implicated as both a physiological cost of reproduction and a driving force on an animal's lifespan. Since increased reproductive effort is generally linked with a reduction in survival, it has been proposed that oxidative stress may influence this relationship. Support for this hypothesis is inconsistent, but this may, in part, be due to the type of tissues that have been analyzed. In Damaraland mole-rats the sole reproducing female in the colony is also the longest lived. Therefore, if oxidative stress does impact the trade-off between reproduction and survival in general, this species may possess some form of enhanced defense. We assessed this relationship by comparing markers of oxidative damage (malondialdehyde, MDA; protein carbonyls, PC) and antioxidants (total antioxidant capacity, TAC; superoxide dismutase, SOD) in various tissues including plasma, erythrocytes, heart, liver, kidney and skeletal muscle between wild-caught reproductive and non-reproductive female Damaraland mole-rats. Reproductive females exhibited significantly lower levels of PC across all tissues, and lower levels of MDA in heart, kidney and liver relative to non-reproductive females. Levels of TAC and SOD did not differ significantly according to reproductive state. The reduction in oxidative damage in breeding females may be attributable to the unusual social structure of this species, as similar relationships have been observed between reproductive and non-reproductive eusocial insects.	[Schmidt, Christina M.; Bennett, Nigel C.] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, Gauteng, South Africa; [Blount, Jonathan D.] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, Cornwall, England	University of Pretoria; University of Exeter	Schmidt, CM (corresponding author), Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, Gauteng, South Africa.	ossavolatus@gmail.com	Blount, Jonathan/K-7695-2012; Bennett, Nigel/E-4238-2010	Blount, Jonathan/0000-0002-0016-0130; Bennett, Nigel/0000-0001-9748-2947	DST-NRF SARChI research chair for Behavioural Ecology and Physiology; University of Pretoria	DST-NRF SARChI research chair for Behavioural Ecology and Physiology; University of Pretoria	This research was supported by a DST-NRF SARChI research chair for Behavioural Ecology and Physiology to NCB and a University of Pretoria postdoctoral fellowship to CMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuja PM, 2001, CLIN CHIM ACTA, V306, P1, DOI 10.1016/S0009-8981(01)00393-X; Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Alonso-Alvarez C, 2006, EVOLUTION, V60, P1913, DOI 10.1111/j.0014-3820.2006.tb00534.x; Aurousseau B, 2006, REPROD NUTR DEV, V46, P601, DOI 10.1051/rnd:2006045; Beguel JP, 2013, COMP BIOCHEM PHYS C, V157, P63, DOI 10.1016/j.cbpc.2012.10.004; Bennett N.C., 2000, AFRICAN MOLE RATS EC; BENNETT NC, 1994, J ZOOL, V234, P25, DOI 10.1111/j.1469-7998.1994.tb06054.x; Bennett NC, 1996, P ROY SOC B-BIOL SCI, V263, P1599, DOI 10.1098/rspb.1996.0234; BENNETT NC, 1994, J ZOOL, V233, P617, DOI 10.1111/j.1469-7998.1994.tb05369.x; BENNETT NC, 1990, J ZOOL, V220, P225, DOI 10.1111/j.1469-7998.1990.tb04305.x; BENNETT NC, 1993, J REPROD FERTIL, V99, P81; Berchieri-Ronchi CB, 2011, ANIMAL, V5, P1774, DOI 10.1017/S1751731111000772; Bergeron P, 2011, FUNCT ECOL, V25, P1063, DOI 10.1111/j.1365-2435.2011.01868.x; Bertrand S, 2006, OECOLOGIA, V147, P576, DOI 10.1007/s00442-005-0317-8; Casanueva E, 2003, J NUTR, V133, p1700S, DOI 10.1093/jn/133.5.1700S; Chen JS, 1997, J MOL EVOL, V44, P440, DOI 10.1007/PL00006164; Christe P, 2012, P ROY SOC B-BIOL SCI, V279, P1142, DOI 10.1098/rspb.2011.1546; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2010, ECOL LETT, V13, P1435, DOI 10.1111/j.1461-0248.2010.01531.x; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dammann P, 2006, CURR BIOL, V16, pR117, DOI 10.1016/j.cub.2006.02.012; Dammann P, 2012, J GERONTOL A-BIOL, V67, P573, DOI 10.1093/gerona/glr208; Dammann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018757; Fainaru O, 2002, BJOG-INT J OBSTET GY, V109, P938, DOI 10.1111/j.1471-0528.2002.01494.x; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flores EE, 2013, FUNCT ECOL, V27, P816, DOI 10.1111/1365-2435.12084; Garratt M, 2011, P ROY SOC B-BIOL SCI, V278, P1098, DOI 10.1098/rspb.2010.1818; Garrel C, 2010, J ENDOCRINOL, V205, P107, DOI 10.1677/JOE-09-0362; Greenberg JA, 1999, MED HYPOTHESES, V52, P15, DOI 10.1054/mehy.1997.0619; Gur S, 2011, REPROD DOMEST ANIM, V46, P289, DOI 10.1111/j.1439-0531.2010.01660.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; JARVIS JUM, 1993, BEHAV ECOL SOCIOBIOL, V33, P253, DOI 10.1007/BF02027122; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; Keller L, 1998, INSECT SOC, V45, P235, DOI 10.1007/s000400050084; Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; LOPEZTORRES M, 1993, COMP BIOCHEM PHYS B, V105, P757, DOI 10.1016/0305-0491(93)90117-N; Lovegrove BG, 1987, ENERGETICS SOCIALITY; Makedou K, 2011, GYNECOL ENDOCRINOL, V27, P1070, DOI 10.3109/09513590.2011.569793; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Metcalfe NB, 2013, TRENDS ECOL EVOL, V28, P347, DOI 10.1016/j.tree.2013.01.015; Mohebbi-Fani M, 2012, TROP ANIM HEALTH PRO, V44, P259, DOI 10.1007/s11250-011-0012-1; Molteno AJ, 2000, J REPROD FERTIL, V119, P35, DOI 10.1530/reprod/119.1.35; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Mutinati M, 2013, REPROD DOMESTIC ANIM; Myatt L, 2004, HISTOCHEM CELL BIOL, V122, P369, DOI 10.1007/s00418-004-0677-x; Naito Y., 2010, ANTIAGING MED, V7, P36, DOI [10.3793/jaam.7.36, DOI 10.3793/jaam.7.36]; Nussey DH, 2009, FUNCT ECOL, V23, P809, DOI 10.1111/j.1365-2435.2009.01555.x; Oldakowski L, 2012, J EXP BIOL, V215, P1799, DOI 10.1242/jeb.068452; Olsson M, 2012, OECOLOGIA, V170, P917, DOI 10.1007/s00442-012-2383-z; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Pamplona R, 2011, AM J PHYSIOL-REG I, V301, pR843, DOI 10.1152/ajpregu.00034.2011; Parker JD, 2010, MYRMECOL NEWS, V13, P103; Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131; PEREZCAMPO R, 1993, COMP BIOCHEM PHYS B, V105, P749, DOI 10.1016/0305-0491(93)90116-M; Radak Z, 2008, AGEING RES REV, V7, P34, DOI 10.1016/j.arr.2007.04.004; Radak Z, 2008, FREE RADICAL BIO MED, V44, P153, DOI 10.1016/j.freeradbiomed.2007.01.029; Remolina SC, 2008, AGE, V30, P177, DOI 10.1007/s11357-008-9061-4; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Roff Derek A., 1992; Sainz RM, 2000, J REPROD FERTIL, V119, P143, DOI 10.1530/reprod/119.1.143; Salmon AB, 2001, EVOLUTION, V55, P1600, DOI 10.1111/j.0014-3820.2001.tb00679.x; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; Schmidt CM, 2013, AFR ZOOL, V48, P193; Schrempf A, 2005, CURR BIOL, V15, P267, DOI 10.1016/S0960-9822(05)00071-0; Schrempf A, 2011, J EVOLUTION BIOL, V24, P1455, DOI 10.1111/j.1420-9101.2011.02278.x; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Sies H., 1985, OXIDATIVE STRESS, V1; Smolenaars MMW, 2007, J LIPID RES, V48, P489, DOI 10.1194/jlr.R600028-JLR200; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Speakman JR, 2014, BIOESSAYS, V36, P93, DOI 10.1002/bies.201300108; Speakman JR, 2011, BIOESSAYS, V33, P255, DOI 10.1002/bies.201000132; Stearns S.C., 1992, pi; Stier A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-37; Wang Y, 2001, EXP GERONTOL, V36, P1349, DOI 10.1016/S0531-5565(01)00095-X; Wang ZM, 2001, J NUTR, V131, P2967, DOI 10.1093/jn/131.11.2967; Wiersma P, 2004, P ROY SOC B-BIOL SCI, V271, pS360, DOI 10.1098/rsbl.2004.0171; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Young AJ, 2010, EVOLUTION, V64, P3190, DOI 10.1111/j.1558-5646.2010.01066.x	86	36	36	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103286	10.1371/journal.pone.0103286	http://dx.doi.org/10.1371/journal.pone.0103286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068591	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700055
J	Shin, ES; Huang, Q; Gurel, Z; Sorenson, CM; Sheibani, N				Shin, Eui Seok; Huang, Qiong; Gurel, Zafer; Sorenson, Christine M.; Sheibani, Nader			High Glucose Alters Retinal Astrocytes Phenotype through Increased Production of Inflammatory Cytokines and Oxidative Stress	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; ACTIVATION; PROMOTES; APOPTOSIS; PATHWAY; BARRIER; NRF2; THROMBOSPONDIN-1; EXPRESSION; INDUCTION	Astrocytes are macroglial cells that have a crucial role in development of the retinal vasculature and maintenance of the blood-retina-barrier (BRB). Diabetes affects the physiology and function of retinal vascular cells including astrocytes (AC) leading to breakdown of BRB. However, the detailed cellular mechanisms leading to retinal AC dysfunction under high glucose conditions remain unclear. Here we show that high glucose conditions did not induce the apoptosis of retinal AC, but instead increased their rate of DNA synthesis and adhesion to extracellular matrix proteins. These alterations were associated with changes in intracellular signaling pathways involved in cell survival, migration and proliferation. High glucose conditions also affected the expression of inflammatory cytokines in retinal AC, activated NF-kappa B, and prevented their network formation on Matrigel. In addition, we showed that the attenuation of retinal AC migration under high glucose conditions, and capillary morphogenesis of retinal endothelial cells on Matrigel, was mediated through increased oxidative stress. Antioxidant proteins including heme oxygenase-1 and peroxiredoxin-2 levels were also increased in retinal AC under high glucose conditions through nuclear localization of transcription factor nuclear factor-erythroid 2-related factor-2. Together our results demonstrated that high glucose conditions alter the function of retinal AC by increased production of inflammatory cytokines and oxidative stress with significant impact on their proliferation, adhesion, and migration.	[Shin, Eui Seok; Huang, Qiong; Gurel, Zafer; Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA; [Sorenson, Christine M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI USA; [Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, McPherson Eye Res Inst, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sheibani, N (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA.	nsheibanikar@wisc.edu	Gurel, Zafer/AAF-3072-2021; Sheibani, Nader/AAG-2379-2020	Sheibani, Nader/0000-0003-2723-9217	National Institutes of Health [R01 EY016995, RC4 EY021357, R24 EY022883, R21 EY023024, P30 EY016665, P30 CA014520]; American Diabetes Association [1-10-BS-160]; Retina Research Foundation; American Heart Association [12PRE12030099]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [RC4EY021357, R24EY022883, P30EY016665, R21EY023024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Retina Research Foundation; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants R01 EY016995, RC4 EY021357, R24 EY022883, R21 EY023024, P30 EY016665 and P30 CA014520 UW Paul P. Carbone Cancer Center Support Grant from the National Institutes of Health and an unrestricted departmental award from Research to Prevent Blindness. NS is a recipient of a Research Award from American Diabetes Association, 1-10-BS-160 and Retina Research Foundation. ESS is supported by a UW-Madison UW-Milwaukee Inter Campus grant and predoctoral fellowship from American Heart Association, 12PRE12030099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Asnaghi V, 2003, DIABETES, V52, P506, DOI 10.2337/diabetes.52.2.506; Barca O, 2013, CELL PHYSIOL BIOCHEM, V32, P111, DOI 10.1159/000350129; Behzadian MA, 1995, GLIA, V15, P480, DOI 10.1002/glia.440150411; Choi YK, 2008, BMB REP, V41, P345, DOI 10.5483/BMBRep.2008.41.5.345; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Clemmons DR, 2007, GROWTH HORM IGF RES, V17, P265, DOI 10.1016/j.ghir.2007.01.004; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; Elobeid A, 2000, J NEUROSCI RES, V60, P245, DOI 10.1002/(SICI)1097-4547(20000415)60:2<245::AID-JNR14>3.0.CO;2-1; Fan JW, 2012, INVEST OPHTH VIS SCI, V53, P6541, DOI 10.1167/iovs.11-9241; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Hsieh H-L, 2013, MOL NEUROBIOL, P1; Huang Q, 2008, AM J PHYSIOL-CELL PH, V295, pC1647, DOI 10.1152/ajpcell.00322.2008; JIANG B, 1995, GLIA, V15, P1, DOI 10.1002/glia.440150102; Kang DH, 2011, MOL CELL, V44, P545, DOI 10.1016/j.molcel.2011.08.040; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Kumar S, 2010, EXP EYE RES, V91, P530, DOI 10.1016/j.exer.2010.07.010; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Li W, 2010, J CLIN INVEST, V120, P3996, DOI 10.1172/JCI42823; Ly A, 2011, INVEST OPHTH VIS SCI, V52, P9316, DOI 10.1167/iovs.11-7879; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; MUDHAR HS, 1993, DEVELOPMENT, V118, P539; Nandi J, 2010, MOL CELL BIOCHEM, V336, P17, DOI 10.1007/s11010-009-0259-2; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Otani A, 2012, AM J PATHOL, V180, P328, DOI 10.1016/j.ajpath.2011.09.025; Palenski TL, 2013, MICROVASC RES, V89, P57, DOI 10.1016/j.mvr.2013.06.007; Quaegebeur A, 2011, NEURON, V71, P406, DOI 10.1016/j.neuron.2011.07.013; Scheef E, 2005, MOL VIS, V11, P613; Serini G, 2006, EXP CELL RES, V312, P651, DOI 10.1016/j.yexcr.2005.10.020; Sheibani N, 1999, HISTOL HISTOPATHOL, V14, P285, DOI 10.14670/HH-14.285; Shin ES, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.517; Sorenson CM, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.S12-005; Su XJ, 2003, MOL VIS, V9, P171; Tang YX, 2009, BLOOD, V113, P744, DOI 10.1182/blood-2008-03-145219; van Strien ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025037; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Yang CZ, 2012, P NATL ACAD SCI USA, V109, P6963, DOI 10.1073/pnas.1118754109; Zhang Wenbo, 2011, J Cardiovasc Dis Res, V2, P96, DOI 10.4103/0975-3583.83035; Zhang WB, 2011, IMMUNOTHERAPY-UK, V3, P609, DOI [10.2217/imt.11.24, 10.2217/IMT.11.24]; Zhao CC, 2014, J BIOL CHEM, V289, P17020, DOI 10.1074/jbc.M114.563114; Ziehr J, 2004, AM J PHYSIOL-RENAL, V287, pF1154, DOI 10.1152/ajprenal.00129.2004; Zucker SN, 2014, MOL CELL, V53, P916, DOI 10.1016/j.molcel.2014.01.033	47	45	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103148	10.1371/journal.pone.0103148	http://dx.doi.org/10.1371/journal.pone.0103148			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068294	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700040
J	Galea, GL; Meakin, LB; Williams, CM; Hulin-Curtis, SL; Lanyon, LE; Poole, AW; Price, JS				Galea, Gabriel L.; Meakin, Lee B.; Williams, Christopher M.; Hulin-Curtis, Sarah L.; Lanyon, Lance E.; Poole, Alastair W.; Price, Joanna S.			Protein Kinase C alpha (PKC alpha) Regulates Bone Architecture and Osteoblast Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; SOST DOWN-REGULATION; GROWTH-FACTOR-I; OSTEOGENIC RESPONSE; MECHANICAL STRAIN; ADAPTIVE RESPONSE; GAUCHER-DISEASE; BETA-CATENIN; PROLIFERATIVE RESPONSES; GENE-EXPRESSION	Bones' strength is achieved and maintained through adaptation to load bearing. The role of the protein kinase PKC alpha in this process has not been previously reported. However, we observed a phenotype in the long bones of Prkca(-/-) female but not male mice, in which bone tissue progressively invades the medullary cavity in the mid-diaphysis. This bone deposition progresses with age and is prevented by disuse but unaffected by ovariectomy. Castration of male Prkca(-/-) but not WT mice results in the formation of small amounts of intramedullary bone. Osteoblast differentiation markers and Wnt target gene expression were up-regulated in osteoblast-like cells derived from cortical bone of female Prkca(-/-) mice compared with WT. Additionally, although osteoblastic cells derived from WT proliferate following exposure to estradiol or mechanical strain, those from Prkca(-/-) mice do not. Female Prkca(-/-) mice develop splenomegaly and reduced marrow GBA1 expression reminiscent of Gaucher disease, in which PKC involvement has been suggested previously. From these data, we infer that in female mice, PKC alpha normally serves to prevent endosteal bone formation stimulated by load bearing. This phenotype appears to be suppressed by testicular hormones in male Prkca(-/-) mice. Within osteoblastic cells, PKC alpha enhances proliferation and suppresses differentiation, and this regulation involves the Wnt pathway. These findings implicate PKC alpha as a target gene for therapeutic approaches in low bone mass conditions.	[Galea, Gabriel L.; Meakin, Lee B.; Hulin-Curtis, Sarah L.; Lanyon, Lance E.; Price, Joanna S.] Univ Bristol, Sch Vet Sci, Bristol BS2 8EJ, Avon, England; [Williams, Christopher M.; Poole, Alastair W.] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol	Galea, GL (corresponding author), Univ Bristol, Sch Vet Sci, Southwell St, Bristol BS2 8EJ, Avon, England.	gabriel.galea@bristol.ac.uk	Meakin, Lee/H-7726-2019; Curtis, Sarah/AAM-5290-2020; Galea, Gabriel/I-9374-2019	Meakin, Lee/0000-0002-2161-9414; Galea, Gabriel/0000-0003-2515-1342; Poole, Alastair/0000-0002-0868-297X	Wellcome Trust [092045/Z/10/Z, 088560/Z/09/Z]; British Heart Foundation [RG/10/006/28299]	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	This work was supported by the Wellcome Trust Grants 092045/Z/10/Z and 088560/Z/09/Z (to G. L. G. and L. B. M.) and by British Heart Foundation Grant RG/10/006/28299 (to A. P.).	Aguirre JI, 2007, J BIOL CHEM, V282, P25501, DOI 10.1074/jbc.M702231200; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Callewaert F, 2010, J BONE MINER RES, V25, P124, DOI 10.1359/jbmr.091001; Cao JJ, 2005, J BONE MINER RES, V20, P30, DOI 10.1359/JBMR.041014; Cheng MZ, 2002, J BONE MINER RES, V17, P593, DOI 10.1359/jbmr.2002.17.4.593; Galea Gabriel L, 2013, Bonekey Rep, V2, P413, DOI 10.1038/bonekey.2013.147; Galea GL, 2013, J BIOL CHEM, V288, P9035, DOI 10.1074/jbc.M112.405456; Galea GL, 2011, FEBS LETT, V585, P2450, DOI 10.1016/j.febslet.2011.06.019; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Geng WD, 2001, J CELL PHYSIOL, V189, P216, DOI 10.1002/jcp.10019; Gillis S, 1999, AM J HEMATOL, V61, P103, DOI 10.1002/(SICI)1096-8652(199906)61:2<103::AID-AJH5>3.3.CO;2-M; Gwak J, 2006, J CELL SCI, V119, P4702, DOI 10.1242/jcs.03256; Gwak J, 2009, J CELL MOL MED, V13, P2171, DOI 10.1111/j.1582-4934.2009.00683.x; HANNUN YA, 1987, SCIENCE, V235, P670, DOI 10.1126/science.3101176; Haughian JM, 2009, INT J CANCER, V125, P2556, DOI 10.1002/ijc.24633; Javaheri B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035726; Joeng KS, 2011, DEV BIOL, V359, P222, DOI 10.1016/j.ydbio.2011.08.020; Kassem M, 2011, AGING CELL, V10, P191, DOI 10.1111/j.1474-9726.2011.00669.x; Kido S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013090; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; Lahooti H, 1998, J MOL ENDOCRINOL, V20, P245, DOI 10.1677/jme.0.0200245; Lanyon L, 2001, J BONE MINER RES, V16, P1937, DOI 10.1359/jbmr.2001.16.11.1937; Lee JM, 2010, MOL CELL, V37, P183, DOI 10.1016/j.molcel.2009.12.022; Lee K, 2003, NATURE, V424, P389, DOI 10.1038/424389a; Lee KCL, 2004, J ENDOCRINOL, V182, P193, DOI 10.1677/joe.0.1820193; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Longo M, 2004, BONE, V34, P100, DOI 10.1016/j.bone.2003.09.007; Longo M, 2006, J MOL ENDOCRINOL, V37, P489, DOI 10.1677/jme.1.02055; Marenzana M, 2007, BONE, V41, P206, DOI 10.1016/j.bone.2007.04.184; Meakin LB, 2014, J BONE MINER RES, V29, P1859, DOI 10.1002/jbmr.2222; MIGLIACCIO S, 1993, MOL ENDOCRINOL, V7, P1133, DOI 10.1210/me.7.9.1133; Mistry PK, 2010, P NATL ACAD SCI USA, V107, P19473, DOI 10.1073/pnas.1003308107; Moustafa A, 2012, OSTEOPOROSIS INT, V23, P1225, DOI 10.1007/s00198-011-1656-4; Nakura A, 2011, BONE, V48, P476, DOI 10.1016/j.bone.2010.09.238; Noh T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005438; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; PEAD MJ, 1988, J BONE MINER RES, V3, P647; Piran S, 2009, BLOOD CELL MOL DIS, V43, P289, DOI 10.1016/j.bcmd.2009.08.002; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; RAWLINSON SCF, 1995, J BONE MINER RES, V10, P1225; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Saxon LK, 2012, ENDOCRINOLOGY, V153, P2254, DOI 10.1210/en.2011-1977; Saxon LK, 2011, BONE, V49, P184, DOI 10.1016/j.bone.2011.03.683; Skerry T. M., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P122; Sokolowska B, 2011, FOLIA HISTOCHEM CYTO, V49, P352, DOI 10.5603/FHC.2011.0048; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Sugiyama T, 2012, J BONE MINER RES, V27, P1784, DOI 10.1002/jbmr.1599; Sugiyama T, 2010, ENDOCRINOLOGY, V151, P5582, DOI 10.1210/en.2010-0645; Sunters A, 2010, J BIOL CHEM, V285, P8743, DOI 10.1074/jbc.M109.027086; Swift JM, 2013, MED SCI SPORT EXER, V45, P1665, DOI 10.1249/MSS.0b013e31828d39bc; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; Turner CH, 1998, BONE, V22, P463, DOI 10.1016/S8756-3282(98)00041-6; UHTHOFF HK, 1978, J BONE JOINT SURG BR, V60, P420, DOI 10.1302/0301-620X.60B3.681422; Vanderschueren D, 2004, ENDOCR REV, V25, P389, DOI 10.1210/er.2003-0003; Wang LP, 2009, BONE, V45, P309, DOI 10.1016/j.bone.2009.04.203; Wang Y, 2013, AM J PHYSIOL-RENAL, V304, pF233, DOI 10.1152/ajprenal.00484.2012; Wenstrup RJ, 2002, BRIT J RADIOL, V75, pA2, DOI 10.1259/bjr.75.suppl_1.750002; Williams CM, 2014, PLATELETS, V25, P62, DOI 10.3109/09537104.2012.761686; Windahl SH, 2013, J BONE MINER RES, V28, P291, DOI 10.1002/jbmr.1754; Yang JZ, 2008, STEROIDS, V73, P1110, DOI 10.1016/j.steroids.2008.04.012; Zaman G, 1999, J BONE MINER RES, V14, P1123, DOI 10.1359/jbmr.1999.14.7.1123; Zaman G, 2012, J BIOL CHEM, V287, P3946, DOI 10.1074/jbc.M111.252742; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	70	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25509	25522		10.1074/jbc.M114.580365	http://dx.doi.org/10.1074/jbc.M114.580365			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070889	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000342130800013
J	Kobayashi, Y; Shiga, T; Shibata, T; Sako, M; Maenaka, K; Koshiba, T; Mizumura, H; Oda, T; Kawabata, S				Kobayashi, Yuki; Shiga, Takafumi; Shibata, Toshio; Sako, Miyuki; Maenaka, Katsumi; Koshiba, Takumi; Mizumura, Hikaru; Oda, Toshio; Kawabata, Shun-ichiro			The N-terminal Arg Residue Is Essential for Autocatalytic Activation of a Lipopolysaccharide-responsive Protease Zymogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TACHYPLEUS-TRIDENTATUS HEMOCYTES; SERINE-PROTEASE; FACTOR-C; HORSESHOE-CRAB; CRYSTAL-STRUCTURE; STAPHYLOCOAGULASE; PLASMINOGEN; RECOGNITION; CASPASE-9; MECHANISM	Factor C, a serine protease zymogen involved in innate immune responses in horseshoe crabs, is known to be autocatalytically activated on the surface of bacterial lipopolysaccharides, but the molecular mechanism of this activation remains unknown. In this study, we show that wild-type factor C expressed in HEK293S cells exhibits a lipopolysaccharide-induced activity equivalent to that of native factor C. Analysis of the N-terminal addition, deletion, or substitution mutants shows that the N-terminal Arg residue and the distance between the N terminus and the tripartite of lipopolysaccharide-binding site are essential factors for autocatalytic activation, and that the positive charge of the N terminus may interact with an acidic amino acid(s) of the molecule to convert the zymogen into an active form. Chemical cross-linking experiments indicate that the N terminus is required to form a complex of the factor C molecules in a sufficiently close vicinity to be chemically cross-linked on the surface of lipopolysaccharides. We propose a molecular mechanism of the autocatalytic activation of the protease zymogen on lipopolysaccharides functioning as a platform to induce specific protein-protein interaction between the factor C molecules.	[Kobayashi, Yuki; Shiga, Takafumi; Koshiba, Takumi; Kawabata, Shun-ichiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8128581, Japan; [Shibata, Toshio; Koshiba, Takumi; Kawabata, Shun-ichiro] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8128581, Japan; [Shibata, Toshio] Kyushu Univ, Inst Adv Study, Fukuoka 8128581, Japan; [Sako, Miyuki; Maenaka, Katsumi] Kyushu Univ, Div Struct Biol, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Mizumura, Hikaru; Oda, Toshio] Seikagaku Corp, LAL Res & Dev Grp, Tokyo 2070021, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University; Seikagaku Corporation	Kawabata, S (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	skawascb@kyudai.jp	Shibata, Toshio/AAE-1694-2020; Koshiba, Takumi/A-3996-2013	Shibata, Toshio/0000-0003-0211-5525; Koshiba, Takumi/0000-0001-8535-5043	Seikagaku Corporation	Seikagaku Corporation	This work was supported by the joint research fund from Seikagaku Corporation.	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Ariki S, 2004, P NATL ACAD SCI USA, V101, P953, DOI 10.1073/pnas.0306904101; Ariki S, 2008, J IMMUNOL, V181, P7994, DOI 10.4049/jimmunol.181.11.7994; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; CORNISHBOWDEN A, 1978, BIOCHIM BIOPHYS ACTA, V523, P268, DOI 10.1016/0005-2744(78)90030-X; Davie E W, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P277; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Higashi S, 1997, J BIOL CHEM, V272, P25724, DOI 10.1074/jbc.272.41.25724; Kawabata S, 2009, ISJ-INVERT SURVIV J, V6, P59; KAWABATA S, 1986, J BIOL CHEM, V261, P1427; Kawabata S, 2010, ADV EXP MED BIOL, V708, P122; Koshiba T, 2007, J BIOL CHEM, V282, P3962, DOI 10.1074/jbc.M609198200; MIURA Y, 1992, J BIOCHEM-TOKYO, V112, P476, DOI 10.1093/oxfordjournals.jbchem.a123924; MUTA T, 1991, J BIOL CHEM, V266, P6554; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; NAKAMURA T, 1988, J BIOCHEM, V103, P370, DOI 10.1093/oxfordjournals.jbchem.a122276; NAKAMURA T, 1986, EUR J BIOCHEM, V154, P511, DOI 10.1111/j.1432-1033.1986.tb09427.x; NAKAMURA T, 1988, EUR J BIOCHEM, V176, P89, DOI 10.1111/j.1432-1033.1988.tb14254.x; NAKAMURA T, 1985, J BIOCHEM, V97, P1561, DOI 10.1093/oxfordjournals.jbchem.a135213; Panizzi P, 2004, CELL MOL LIFE SCI, V61, P2793, DOI 10.1007/s00018-004-4285-7; Park HH, 2012, INT J MOL SCI, V13, P4807, DOI 10.3390/ijms13044807; RANBY M, 1982, THROMB RES, V27, P175, DOI 10.1016/0049-3848(82)90197-9; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Renatus M, 1997, EMBO J, V16, P4797, DOI 10.1093/emboj/16.16.4797; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; TOKUNAGA F, 1991, J BIOCHEM, V109, P150, DOI 10.1093/oxfordjournals.jbchem.a123337; Wang J, 2002, J BIOL CHEM, V277, P36363, DOI 10.1074/jbc.M202837200	30	10	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25987	25995		10.1074/jbc.M114.586933	http://dx.doi.org/10.1074/jbc.M114.586933			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25077965	hybrid, Green Published			2022-12-25	WOS:000342130800052
J	Gaviria-Agudelo, C; Carter, K; Tareen, N; Pascual, V; Copley, LA				Gaviria-Agudelo, Claudia; Carter, Kristen; Tareen, Naureen; Pascual, Virginia; Copley, Lawson A.			Gene Expression Analysis of Children with Acute Hematogenous Osteomyelitis Caused by Methicillin-Resistant Staphylococcus aureus: Correlation with Clinical Severity of Illness	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; INFLAMMATION; SORTILIN; DISEASE; IDENTIFICATION; LEUKOCYTES; PATTERNS; PROTEIN; SEPSIS; CANCER	Children with acute hematogenous osteomyelitis (AHO) demonstrate a broad spectrum of clinical manifestations, ranging from mild to severe. Several advances have been achieved in the study of host immune response to acute invasive Staphylococcus aureus infections through gene expression analysis. However, previous research has neither attempted to evaluate the response of children with AHO specific to Methicillin-resistant Staphylococcus aureus (MRSA) nor to correlate gene expression with clinical phenotype. Study objective was to correlate gene expression of children with AHO due to MRSA with clinical severity of illness. Whole blood samples were obtained in Tempus tubes from 12 children with osteomyelitis once cultures obtained directly from the site of infection confirmed to be positive for MRSA. Using an Illumina platform and a systems-wide modular analysis, microarray findings from ten of these children were compared to that of nine healthy (age, ethnicity and gender) matched controls and correlated with clinical severity of illness. Children with AHO from MRSA demonstrated over-expression of innate immunity with respect to neutrophil activity, coagulation, inflammatory response, and erythrocyte development. Concurrently, these children demonstrated under-expression of adaptive immunity with respect to lymphocyte activation and activity of T-cell, cytotoxic or NK cell, and B-cell lines. Three over-expressed genes, P2RX1, SORT1, and RETN, and two under-expressed genes, LOC641788 and STAT 4, were significantly correlated with severity of illness. STAT 4 showed the strongest correlation (R2 = -0.83). STAT4 downregulation could potentially explain under-expression of genes related to adaptive immunity in this cohort of patients with AHO. This study identified specific genes which correspond to disease severity during the early hospitalization of children with AHO from MRSA. Pattern recognition of this combination of genes could help to identify in the future severe clinical phenotypes before the disease is fully manifest and direct appropriate attention and resources to those children.	[Gaviria-Agudelo, Claudia] Univ Texas SW Med Ctr Dallas, Dept Pediat Infect Dis, Dallas, TX 75390 USA; [Carter, Kristen] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Gaviria-Agudelo, Claudia; Tareen, Naureen; Copley, Lawson A.] Childrens Med Ctr, Dallas, TX 75235 USA; [Pascual, Virginia] Baylor Inst Immunol Res, Dallas, TX USA; [Copley, Lawson A.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Pascual, Virginia; Copley, Lawson A.] Texas Scottish Rite Hosp Crippled Children, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor Scott & White Health; University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas Scottish Rite Hospital for Children	Gaviria-Agudelo, C (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat Infect Dis, Dallas, TX 75390 USA.	clg14@alumni.utsw.edu	Pascual, Virginia/ABD-3099-2020		National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000451]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000451, UL1TR001105] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study funded by UT-STAR Grant from the Translational Pilot Program 2012 Service Package supported in part by grant UL1TR000451 from the National Center for Advancing Translational Sciences, National Institutes of Health (January 31, 2013 to January 31, 2014). The authors would like to acknowledge and thank for its support in the study to Children's Medical Center Dallas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardura MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005446; Banchereau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034390; Bao Lei, 2013, JAKSTAT, V2, pe24137, DOI 10.4161/jkst.24137; Bi LP, 2013, J LIPID RES, V54, P2754, DOI 10.1194/jlr.M039347; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bokarewa M, 2005, J IMMUNOL, V174, P5789, DOI 10.4049/jimmunol.174.9.5789; Bokarewa MI, 2003, J RHEUMATOL, V30, P1719; Bostrom EA, 2009, BBA-MOL CELL RES, V1793, P1894, DOI 10.1016/j.bbamcr.2009.09.008; Bostrom EA, 2008, J RHEUMATOL, V35, P2005; Chaussabel D, 2005, ANN NY ACAD SCI, V1062, P146, DOI 10.1196/annals.1358.017; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chumakov AM, 2004, ONCOGENE, V23, P3414, DOI 10.1038/sj.onc.1207126; Cohen G, 2008, J IMMUNOL, V181, P3761, DOI 10.4049/jimmunol.181.6.3761; Copley LAB, 2014, PEDIATR INFECT DIS J, V33, P35, DOI 10.1097/INF.0000000000000002; Creel AM, 2009, PEDIATR CRIT CARE ME, V10, P323, DOI 10.1097/PCC.0b013e3181988798; Dube JB, 2011, BIOESSAYS, V33, P430, DOI 10.1002/bies.201100003; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; Hawkshead JJ, 2009, J PEDIATR ORTHOPED, V29, P85, DOI 10.1097/BPO.0b013e3181901c3a; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Hollmig ST, 2007, J BONE JOINT SURG AM, V89A, P1517, DOI 10.2106/JBJS.F.01102; Johansson L, 2009, J IMMUNOL, V183, P4047, DOI 10.4049/jimmunol.0901541; Ju KL, 2011, J BONE JOINT SURG AM, V93A, P1693, DOI [10.2106/JBJSJ.01154, 10.2106/JBJS.J.01154]; Kwon S, 2011, J BIOL CHEM, V286, P21876, DOI 10.1074/jbc.M111.228262; Lecut C, 2012, J THROMB HAEMOST, V10, P453, DOI 10.1111/j.1538-7836.2011.04606.x; Lecut C, 2009, J IMMUNOL, V183, P2801, DOI 10.4049/jimmunol.0804007; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liang SX, 2001, CYTOGENET CELL GENET, V92, P333, DOI 10.1159/000056923; Nagaev I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000031; Nogueiras R, 2003, FEBS LETT, V548, P21, DOI 10.1016/S0014-5793(03)00708-7; Pellme S, 2007, J IMMUNOL METHODS, V325, P88, DOI 10.1016/j.jim.2007.06.001; Peltola H, 2010, PEDIATR INFECT DIS J, V29, P1123, DOI 10.1097/INF.0b013e3181f55a89; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Saavedra-Lozano J, 2008, J PEDIATR ORTHOPED, V28, P569, DOI 10.1097/BPO.0b013e31817bb816; Senolt L, 2007, ANN RHEUM DIS, V66, P458, DOI 10.1136/ard.2006.054734; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sunden-Cullberg J, 2007, CRIT CARE MED, V35, P1536, DOI 10.1097/01.CCM.0000266536.14736.03; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Walcher D, 2010, CARDIOVASC RES, V85, P167, DOI 10.1093/cvr/cvp278; Wang J, 2009, NAT STRUCT MOL BIOL, V16, P987, DOI 10.1038/nsmb.1645; White CW, 2015, NEUROUROL URODYNAM, V34, P292, DOI 10.1002/nau.22519; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	46	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103523	10.1371/journal.pone.0103523	http://dx.doi.org/10.1371/journal.pone.0103523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076205	Green Published, Green Submitted, gold			2022-12-25	WOS:000340028800059
J	Aghamohammadzadeh, S; Smaczynska-de Rooij, II; Ayscough, KR				Aghamohammadzadeh, Soheil; Smaczynska-de Rooij, Iwona I.; Ayscough, Kathryn R.			An Abp1-Dependent Route of Endocytosis Functions when the Classical Endocytic Pathway in Yeast Is Inhibited	PLOS ONE			English	Article							ACTIN-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MEDIATED ENDOCYTOSIS; CYTOSKELETON; INTERNALIZATION; MECHANISMS; MACHINERY; DYNAMICS; POLARITY	Clathrin-mediated endocytosis (CME) is a well characterized pathway in both yeast and mammalian cells. An increasing number of alternative endocytic pathways have now been described in mammalian cells that can be both clathrin, actin, and Arf6-dependent or independent. In yeast, a single clathrin-mediated pathway has been characterized in detail. However, disruption of this pathway in many mutant strains indicates that other uptake pathways might exist, at least for bulk lipid and fluid internalization. Using a combination of genetics and live cell imaging, here we show evidence for a novel endocytic pathway in S. cerevisiae that does not involve several of the proteins previously shown to be associated with the 'classic' pathway of endocytosis. This alternative pathway functions in the presence of low levels of the actin-disrupting drug latrunculin-A which inhibits movement of the proteins Sla1, Sla2, and Sac6, and is independent of dynamin function. We reveal that in the absence of the 'classic' pathway, the actin binding protein Abp1 is now essential for bulk endocytosis. This novel pathway appears to be distinct from another described alternative endocytic route in S. cerevisiae as it involves at least some proteins known to be associated with cortical actin patches rather than being mediated at formin-dependent endocytic sites. These data indicate that cells have the capacity to use overlapping sets of components to facilitate endocytosis under a range of conditions.	[Aghamohammadzadeh, Soheil; Smaczynska-de Rooij, Iwona I.; Ayscough, Kathryn R.] Univ Sheffield, Dept Biomed Sci, Sheffield, S Yorkshire, England	University of Sheffield	Ayscough, KR (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield, S Yorkshire, England.	k.ayscough@sheffield.ac.uk			Medical Research Council [G060160]; Biotechnology and Biological Sciences Research Council [BB/K002511/1]; Biotechnology and Biological Sciences Research Council; BBSRC [BB/K002511/1] Funding Source: UKRI; MRC [G0601600] Funding Source: UKRI; Medical Research Council [G0601600] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council Senior non-clinical Fellowship G060160 (http://www.mrc.ac.uk/) to KRA, the Biotechnology and Biological Sciences Research Council BB/K002511/1 project grant funding IIS and a Biotechnology and Biological Sciences Research Council studentship to SA (www.bbsrc.ac.uk/). The funders had no role in study, design, data collection and analysis, decision to publish or preparation of the manuscript.	Abrami L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000792; ADAMS AEM, 1989, SCIENCE, V243, P231, DOI 10.1126/science.2643162; ADAMS AEM, 1991, NATURE, V354, P404, DOI 10.1038/354404a0; Aghamohammadzadeh S, 2009, NAT CELL BIOL, V11, P1039, DOI 10.1038/ncb1918; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Burston HE, 2009, J CELL BIOL, V185, P1097, DOI 10.1083/jcb.200811116; Chu DS, 1996, J BIOL CHEM, V271, P33123, DOI 10.1074/jbc.271.51.33123; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; Dewar H, 2002, MOL BIOL CELL, V13, P3646, DOI 10.1091/mbc.E02-05-0262; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; DRUBIN DG, 1990, NATURE, V343, P288, DOI 10.1038/343288a0; DULIC V, 1991, METHOD ENZYMOL, V194, P697; Friesen H, 2006, MOL BIOL CELL, V17, P1306, DOI 10.1091/mbc.e05-06-0476; Gheorghe DM, 2008, J BIOL CHEM, V283, P15037, DOI 10.1074/jbc.M710332200; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Gourlay CW, 2006, MOL CELL BIOL, V26, P6487, DOI 10.1128/MCB.00117-06; Gourlay CW, 2003, J CELL SCI, V116, P2551, DOI 10.1242/jcs.00454; HOLTZMAN DA, 1993, J CELL BIOL, V122, P635, DOI 10.1083/jcb.122.3.635; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Lanzetti L, 2008, TRAFFIC, V9, P2011, DOI 10.1111/j.1600-0854.2008.00816.x; Lila T, 1997, MOL BIOL CELL, V8, P367, DOI 10.1091/mbc.8.2.367; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Michelot A, 2013, DEV CELL, V24, P182, DOI 10.1016/j.devcel.2012.12.008; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; PAYNE GS, 1988, J CELL BIOL, V106, P1453, DOI 10.1083/jcb.106.5.1453; Prosser DC, 2011, J CELL BIOL, V195, P657, DOI 10.1083/jcb.201104045; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Robertson AS, 2009, CELL MOL LIFE SCI, V66, P2049, DOI 10.1007/s00018-009-0001-y; Smaczynska-de Rooij II, 2008, TRAFFIC, V9, P559, DOI 10.1111/j.1600-0854.2008.00708.x; Smaczynska-de Rooij II, 2012, TRAFFIC, V13, P317, DOI 10.1111/j.1600-0854.2011.01311.x; Smaczynska-de Rooij II, 2010, J CELL SCI, V123, P3496, DOI 10.1242/jcs.070508; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Toret CP, 2007, J CELL SCI, V120, P1501, DOI 10.1242/jcs.03446; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wu FB, 2009, AGEING RES REV, V8, P147, DOI 10.1016/j.arr.2009.03.002; Zabel C, 2005, MOL CELL PROTEOMICS, V4, pS196; Zeng GH, 2001, MOL BIOL CELL, V12, P3759, DOI 10.1091/mbc.12.12.3759	41	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103311	10.1371/journal.pone.0103311	http://dx.doi.org/10.1371/journal.pone.0103311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072293	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000341307600039
J	Kwon, O; Kim, KB; Lee, YI; Byun, SS; Kim, JS; Lee, SE; Hong, SK				Kwon, Ohseong; Kim, Ki Bom; Lee, Young Ik; Byun, Seok-Soo; Kim, Jae-Sung; Lee, Sang Eun; Hong, Sung Kyu			Salvage Radiotherapy after Radical Prostatectomy: Prediction of Biochemical Outcomes	PLOS ONE			English	Article							ANDROGEN-DEPRIVATION THERAPY; CANCER-SPECIFIC MORTALITY; RADIATION-THERAPY; PROGNOSTIC-FACTORS; NATURAL-HISTORY; IMPACT; RECURRENCE; MEN; PSA	Introduction: A significant proportion of patients undergoing salvage radiotherapy (RT) for biochemical recurrence (BCR) following radical prostatectomy (RP) may again experience BCR after salvage RT. Thus, we evaluated the clinical significances of different parameters on the biochemical outcome of RT in salvage setting. Methods: We reviewed the records of 212 patients who underwent salvage RT between November 2003 and December 2012 for BCR following primary RP. BCR-free survivals after salvage RT were estimated using the Kaplan-Meier method. Cox proportional hazard regression models were used to evaluate the impacts of clinicopathologic parameters on BCR following salvage RT. Results: The overall median follow-up duration was 63.5 months. The BCR-free survival rate after salvage RT was 58.2% at 5 years. Multivariate analysis showed that a pre-RT prostate-specific antigen (PSA) level of <= 0.5 ng/mL, a pre-RT PSA doubling time (PSADT) of >4.5 months, concomitant androgen deprivation therapy (ADT) with salvage RT, and a positive surgical margin were independent predictors of favorable biochemical outcomes after salvage RT (hazard ratios [HR] = 3.012, 1.132, 2.000, and 1.805, respectively, p = less than 0.001, 0.013, 0.005, and 0.036, respectively). In the early (pre-RT PSA <= 0.5 ng/mL) salvage RT setting, concomitant ADT administration was also shown to be significantly associated with higher risk of BCR-free survival following salvage RT (HR = 2.611, p = 0.038). Conclusion: Lower pre-RT PSA value, longer PSADT before salvage RT, concomitant ADT administration, and a positive surgical margin were significant predictors of favorable biochemical outcomes following salvage RT performed for BCR after primary RP.	[Kwon, Ohseong; Lee, Young Ik; Byun, Seok-Soo; Lee, Sang Eun; Hong, Sung Kyu] Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea; [Kim, Jae-Sung] Seoul Natl Univ, Bundang Hosp, Dept Radiat Oncol, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Hong, SK (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea.	hsk823@chol.com	Kwon, Ohseong/W-8318-2019; Kwon, OhSeong/DBV-0709-2022	Kwon, Ohseong/0000-0002-8933-6656; Kim, Jae-Sung/0000-0001-5348-9178				Blute ML, 1997, UROLOGY, V50, P733, DOI 10.1016/S0090-4295(97)00450-0; Boorjian SA, 2012, J UROLOGY, V188, P1761, DOI 10.1016/j.juro.2012.07.037; Boorjian SA, 2012, EUR UROL, V61, P664, DOI 10.1016/j.eururo.2011.11.053; Briganti A, 2013, EUR UROL IN PRESS; Buskirk SJ, 2006, J UROLOGY, V176, P985, DOI 10.1016/j.juro.2006.04.083; Bylow K, 2007, CANCER-AM CANCER SOC, V110, P2604, DOI 10.1002/cncr.23084; D'Amico AV, 2003, J NATL CANCER I, V95, P1376, DOI 10.1093/jnci/djg043; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Hayashi S, 2012, J RADIAT RES, V53, P727, DOI 10.1093/jrr/rrs034; Hong SK, 2010, UROLOGY, V76, P723, DOI 10.1016/j.urology.2010.03.081; Karlin JD, 2013, J UROLOGY, V190, P1410, DOI 10.1016/j.juro.2013.04.078; Katz MS, 2003, J CLIN ONCOL, V21, P483, DOI 10.1200/JCO.2003.12.043; King CR, 2012, INT J RADIAT ONCOL, V84, P104, DOI 10.1016/j.ijrobp.2011.10.069; Kinoshita H, 2013, INT J UROL, V20, P806, DOI 10.1111/iju.12049; Lohm G, 2014, STRAHLENTHE IN PRESS; Lohm G, 2013, WORLD J UROL, V31, P423, DOI 10.1007/s00345-012-0860-y; Milecki P, 2011, CENT EUR J UROL, V64, P67, DOI 10.5173/ceju.2011.02.art3; Mottet N, 2011, EUR UROL, V59, P572, DOI 10.1016/j.eururo.2011.01.025; Mullins JK, 2012, J UROLOGY, V188, P2219, DOI 10.1016/j.juro.2012.08.028; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Soto DE, 2012, INT J RADIAT ONCOL, V82, P1227, DOI 10.1016/j.ijrobp.2010.08.030; Stephenson AJ, 2004, JAMA-J AM MED ASSOC, V291, P1325, DOI 10.1001/jama.291.11.1325; Stephenson AJ, 2007, J CLIN ONCOL, V25, P2035, DOI 10.1200/JCO.2006.08.9607; Swanson GP, 2007, J CLIN ONCOL, V25, P2225, DOI 10.1200/JCO.2006.09.6495; Taylor LG, 2009, CANCER-AM CANCER SOC, V115, P2388, DOI 10.1002/cncr.24283; Teeter AE, 2008, J UROLOGY, V180, P1980, DOI 10.1016/j.juro.2008.07.031; Trock BJ, 2008, JAMA-J AM MED ASSOC, V299, P2760, DOI 10.1001/jama.299.23.2760; Umezawa R, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-150; van der Poel HG, 2013, UROLOGY, V82, P834, DOI 10.1016/j.urology.2013.04.057; Zhou P, 2005, J CLIN ONCOL, V23, P6992, DOI 10.1200/JCO.2005.01.2906	30	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103574	10.1371/journal.pone.0103574	http://dx.doi.org/10.1371/journal.pone.0103574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072938	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600065
J	Lin, J; Shigdar, S; Fang, DZ; Xiang, DX; Wei, MQ; Danks, A; Kong, LX; Li, LH; Qiao, L; Duan, W				Lin, Jia; Shigdar, Sarah; Fang, Ding Zhi; Xiang, Dognxi; Wei, Ming Q.; Danks, Andrew; Kong, Lingxue; Li, Lianghong; Qiao, Liang; Duan, Wei			Improved Efficacy and Reduced Toxicity of Doxorubicin Encapsulated in Sulfatide-Containing Nanoliposome in a Glioma Model	PLOS ONE			English	Article							STERICALLY STABILIZED LIPOSOMES; TENASCIN-C; IN-VITRO; ANTITUMOR-ACTIVITY; MULTIDRUG-RESISTANCE; EXTRACELLULAR-MATRIX; DRUG-DELIVERY; CELL-ADHESION; INDUCED CARDIOMYOPATHY; THERAPEUTIC ACTIVITY	As a glycosphingolipid that can bind to several extracellular matrix proteins, sulfatide has the potential to become an effective targeting agent for tumors overexpressing tenasin-C in their microenvironment. To overcome the dose-limiting toxicity of doxorubicin (DOX), a sulfatide-containing nanoliposome (SCN) encapsulation approach was employed to improve treatment efficacy and reduce side effects of free DOX. This study analysed in vitro characteristics of sulfatide-containing nanoliposomal DOX (SCN-DOX) and assessed its cytotoxicity in vitro, as well as biodistribution, therapeutic efficacy, and systemic toxicity in a human glioblastoma U-118MG xenograft model. SCN-DOX was shown to achieve highest drug to lipid ratio (0.5:1) and a remarkable in vitro stability. Moreover, DOX encapsulated in SCN was shown to be delivered into the nuclei and displayed prolonged retention over free DOX in U-118MG cells. This simple two-lipid SCN-DOX nanodrug has favourable pharmacokinetic attributes in terms of prolonged circulation time, reduced volume of distribution and enhanced bioavailability in healthy rats. As a result of the improved biodistribution, an enhanced treatment efficacy of SC-NDOX was found in glioma-bearing mice compared to the free drug. Finally, a reduction in the accumulation of DOX in the drug's principal toxicity organs achieved by SCN-DOX led to the diminished systemic toxicity as evident from the plasma biochemical analyses. Thus, SCN has the potential to be an effective and safer nano-carrier for targeted delivery of therapeutic agents to tumors with elevated expression of tenascin-C in their microenvironment.	[Lin, Jia; Shigdar, Sarah; Xiang, Dognxi; Duan, Wei] Deakin Univ, Fac Hlth, Sch Med, Waurn Ponds, Vic, Australia; [Lin, Jia; Fang, Ding Zhi] Sichuan Univ, West China Sch Preclin & Forens Med, Dept Biochem & Mol Biol, Chengdu 610064, Peoples R China; [Wei, Ming Q.] Griffith Univ, Sch Med Sci, Southport, Qld 4215, Australia; [Wei, Ming Q.] Griffith Univ, Griffith Hlth Inst, Southport, Qld 4215, Australia; [Danks, Andrew] Monash Univ, Southern Clin Sch, Dept Surg, Clayton, Vic, Australia; [Kong, Lingxue] Deakin Univ, Inst Frontier Mat, Waurn Ponds, Vic, Australia; [Li, Lianghong] Dalian Med Univ, Liaoning Key Lab Canc Stem Cell Res, Dalian, Peoples R China; [Qiao, Liang] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Storr Liver Unit, Westmead, NSW 2145, Australia	Deakin University; Sichuan University; Griffith University; Griffith University; Menzies Health Institute Queensland; Monash University; Deakin University; Dalian Medical University; University of Sydney; Westmead Institute for Medical Research	Duan, W (corresponding author), Deakin Univ, Fac Hlth, Sch Med, Waurn Ponds, Vic, Australia.	wduan@deakin.edu.au	Shigdar, Sarah/AFR-0438-2022; Duan, Wei/A-5181-2015; Kong, Lingxue/D-8216-2011	Duan, Wei/0000-0001-5782-9184; Kong, Lingxue/0000-0001-6219-3897; Shigdar, Sarah/0000-0001-8084-8447	National Health and Medical Research Council, Australia [479505]; Australia-India Strategic Research Fund Programme-Indo-Australia Science and Technology Fund [ST040007]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australia-India Strategic Research Fund Programme-Indo-Australia Science and Technology Fund(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by a grants from National Health and Medical Research Council, Australia (#479505), www.nhmrc.gov.au and Australia-India Strategic Research Fund Programme-Indo-Australia Science and Technology Fund (#ST040007), http://www.innovation.gov.au/Science/InternationalCollaboration/aisrf/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2002, CANCER RES, V62, P3289; Adamsky K, 2001, ONCOGENE, V20, P609, DOI 10.1038/sj.onc.1204119; Alexis F, 2008, UROL ONCOL-SEMIN ORI, V26, P74, DOI 10.1016/j.urolonc.2007.03.017; Allen Theresa M., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P513, DOI 10.2174/187152006778699121; Alvarez-Cedron L, 1999, J CHROMATOGR B, V721, P271, DOI 10.1016/S0378-4347(98)00475-7; Bagchi DB, 2003, MUTAT RES-FUND MOL M, V523, P87, DOI 10.1016/S0027-5107(02)00324-X; Bawarski WE, 2008, NANOMED-NANOTECHNOL, V4, P273, DOI 10.1016/j.nano.2008.06.002; Cabanes A, 1999, CLIN CANCER RES, V5, P687; Campbell Robert B., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P503, DOI 10.2174/187152006778699077; Charrois GJR, 2003, BBA-BIOMEMBRANES, V1609, P102, DOI 10.1016/S0005-2736(02)00661-2; Chen MH, 2010, ANTICANCER RES, V30, P65; Chen ZY, 2012, INT J NANOMED, V7, P3803, DOI 10.2147/IJN.S33541; Cheng Cai, 2009, Interact Cardiovasc Thorac Surg, V8, P635, DOI 10.1510/icvts.2008.194720; Cosan D, 2008, FOLIA HISTOCHEM CYTO, V46, P367, DOI 10.2478/v10042-008-0048-x; Cui J, 2008, J PHARM PHARMACOL, V60, P1651, DOI 10.1211/jpp/60.12.0011; de Menezes DEL, 2000, CLIN CANCER RES, V6, P2891; Drummond DC, 1999, PHARMACOL REV, V51, P691; El Bayoumil T, 2009, CLIN CANCER RES, V15, P1973, DOI 10.1158/1078-0432.CCR-08-2392; Farr KP, 2011, CASE REP ONCOL, V4, P229, DOI 10.1159/000327767; Fernando NT, 2008, CLIN CANCER RES, V14, P1529, DOI 10.1158/1078-0432.CCR-07-4126; Foti C, 2009, MOL CANCER THER, V8, P3140, DOI 10.1158/1535-7163.MCT-09-0431; Fritze A, 2006, BBA-BIOMEMBRANES, V1758, P1633, DOI 10.1016/j.bbamem.2006.05.028; Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017; Goren D, 1996, BRIT J CANCER, V74, P1749, DOI 10.1038/bjc.1996.625; Hancox RA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2251; Herman EH, 1999, J CLIN ONCOL, V17, P2237, DOI 10.1200/JCO.1999.17.7.2237; HERNANDEZ J, 1991, BIOCONJUGATE CHEM, V2, P398, DOI 10.1021/bc00012a003; Huang Y, 2010, AAPS PHARMSCITECH, V11, P752, DOI 10.1208/s12249-010-9430-z; Hussain S, 2007, MOL CANCER THER, V6, P3019, DOI 10.1158/1535-7163.MCT-07-0615; Ishida T, 2002, INT J PHARMACEUT, V232, P59, DOI 10.1016/S0378-5173(01)00896-1; Jung SH, 2009, INT J PHARMACEUT, V382, P254, DOI 10.1016/j.ijpharm.2009.08.002; Koh E, 2004, CIRC J, V68, P163, DOI 10.1253/circj.68.163; Li B, 2012, INT J NANOMED, V7, P187, DOI 10.2147/IJN.S27864; Li XM, 2009, INT J PHARMACEUT, V373, P116, DOI 10.1016/j.ijpharm.2009.01.023; Lim HJ, 1997, J PHARMACOL EXP THER, V281, P566; Lin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049277; Liu F, 2008, NEOPLASIA, V10, P1275, DOI 10.1593/neo.08810; Mackie EJ, 1999, J CELL SCI, V112, P3847; MAYER LD, 1989, CANCER RES, V49, P5922; Mercuro G, 2007, ONCOLOGIST, V12, P1124, DOI 10.1634/theoncologist.12-9-1124; Orend G, 2006, CANCER LETT, V244, P143, DOI 10.1016/j.canlet.2006.02.017; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Quemener C, 2007, CANCER RES, V67, P9, DOI 10.1158/0008-5472.CAN-06-2448; RAHMAN A, 1986, CANCER RES, V46, P2295; Rai S, 2008, J DRUG TARGET, V16, P455, DOI 10.1080/10611860802088481 ; Reardon DA, 2007, EXPERT REV ANTICANC, V7, P675, DOI 10.1586/14737140.7.5.675; Sadzuka Y, 2003, J CONTROL RELEASE, V91, P271, DOI 10.1016/S0168-3659(03)00248-7; Sapra Puja, 2005, Current Drug Delivery, V2, P369, DOI 10.2174/156720105774370159; Shao K, 2006, J CONTROL RELEASE, V115, P150, DOI 10.1016/j.jconrel.2006.07.024; Shmeeda H, 2010, J CONTROL RELEASE, V146, P76, DOI 10.1016/j.jconrel.2010.04.028; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Song HF, 2006, CANCER CHEMOTH PHARM, V57, P591, DOI 10.1007/s00280-005-0076-6; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Sugiyama Ikumi, 2011, Curr Drug Discov Technol, V8, P357; Tanaka T, 2010, CANCER RES, V70, P3687, DOI 10.1158/0008-5472.CAN-09-3931; Tang N, 2007, JNCI-J NATL CANCER I, V99, P1004, DOI 10.1093/jnci/djm027; Tokarska-Schlattner M, 2005, AM J PHYSIOL-HEART C, V289, pH37, DOI 10.1152/ajpheart.01057.2004; Townson K, 2007, GLYCOBIOLOGY, V17, P1156, DOI 10.1093/glycob/cwm095; UNEZAKI S, 1994, PHARMACEUT RES, V11, P1180, DOI 10.1023/A:1018949218380; Wang JC, 2005, BIOL PHARM BULL, V28, P822, DOI 10.1248/bpb.28.822; Wei GL, 2008, BIOMED CHROMATOGR, V22, P1252, DOI 10.1002/bmc.1054; Wu J, 2007, J PHARM PHARM SCI, V10, P350; Wu XF, 1999, BBA-BIOMEMBRANES, V1416, P285, DOI 10.1016/S0005-2736(98)00229-6; Xiong XB, 2005, J CONTROL RELEASE, V107, P262, DOI 10.1016/j.jconrel.2005.03.030; Xiong XB, 2005, PHARM RES-DORDR, V22, P933, DOI 10.1007/s11095-005-4588-x; Xu L, 2011, J PHARM SCI-US, V100, P38, DOI 10.1002/jps.22243; Yokogwa K, 2006, BIOL PHARM BULL, V29, P141, DOI 10.1248/bpb.29.141; Zhang FY, 2009, PHARM RES-DORDR, V26, P914, DOI 10.1007/s11095-008-9793-y; Zhu QQ, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-65	69	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103736	10.1371/journal.pone.0103736	http://dx.doi.org/10.1371/journal.pone.0103736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072631	Green Submitted, Green Published, gold			2022-12-25	WOS:000341307600082
J	Soltysinska, E; Bentzen, BH; Barthmes, M; Hattel, H; Thrush, AB; Harper, ME; Qvortrup, K; Larsen, FJ; Schiffer, TA; Losa-Reyna, J; Straubinger, J; Kniess, A; Thomsen, MB; Bruggemann, A; Fenske, S; Biel, M; Ruth, P; Wahl-Schott, C; Boushel, RC; Olesen, SP; Lukowski, R				Soltysinska, Ewa; Bentzen, Bo Hjorth; Barthmes, Maria; Hattel, Helle; Thrush, A. Brianne; Harper, Mary-Ellen; Qvortrup, Klaus; Larsen, Filip J.; Schiffer, Tomas A.; Losa-Reyna, Jose; Straubinger, Julia; Kniess, Angelina; Thomsen, Morten Baekgaard; Brueggemann, Andrea; Fenske, Stefanie; Biel, Martin; Ruth, Peter; Wahl-Schott, Christian; Boushel, Robert Christopher; Olesen, Soren-Peter; Lukowski, Robert			KCNMA1 Encoded Cardiac BK Channels Afford Protection against Ischemia-Reperfusion Injury	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; INNER MITOCHONDRIAL-MEMBRANE; PERMEABILITY TRANSITION PORE; RAT VENTRICULAR MYOCYTES; CYTOCHROME-C-OXIDASE; PROTEIN-KINASE-A; POTASSIUM CHANNEL; ATP CHANNELS; CARDIOPROTECTION; HEART	Mitochondrial potassium channels have been implicated in myocardial protection mediated through pre-/postconditioning. Compounds that open the Ca2+-and voltage-activated potassium channel of big-conductance (BK) have a pre-conditioninglike effect on survival of cardiomyocytes after ischemia/reperfusion injury. Recently, mitochondrial BK channels (mitoBKs) in cardiomyocytes were implicated as infarct-limiting factors that derive directly from the KCNMA1 gene encoding for canonical BKs usually present at the plasma membrane of cells. However, some studies challenged these cardio-protective roles of mitoBKs. Herein, we present electrophysiological evidence for paxilline- and NS11021-sensitive BK-mediated currents of 190 pS conductance in mitoplasts from wild-type but not BK-/- cardiomyocytes. Transmission electron microscopy of BK-/- ventricular muscles fibres showed normal ultra-structures and matrix dimension, but oxidative phosphorylation capacities at normoxia and upon re-oxygenation after anoxia were significantly attenuated in BK-/- permeabilized cardiomyocytes. In the absence of BK, post-anoxic reactive oxygen species (ROS) production from cardiomyocyte mitochondria was elevated indicating that mitoBK fine-tune the oxidative state at hypoxia and reoxygenation. Because ROS and the capacity of the myocardium for oxidative metabolism are important determinants of cellular survival, we tested BK-/- hearts for their response in an ex-vivo model of ischemia/reperfusion (I/R) injury. Infarct areas, coronary flow and heart rates were not different between wild-type and BK-/- hearts upon I/R injury in the absence of ischemic pre-conditioning (IP), but differed upon IP. While the area of infarction comprised 28 +/- 3% of the area at risk in wild-type, it was increased to 58 +/- 5% in BK-/- hearts suggesting that BK mediates the beneficial effects of IP. These findings suggest that cardiac BK channels are important for proper oxidative energy supply of cardiomyocytes at normoxia and upon re-oxygenation after prolonged anoxia and that IP might indeed favor survival of the myocardium upon I/R injury in a BK-dependent mode stemming from both mitochondrial post-anoxic ROS modulation and non-mitochondrial localizations.	[Soltysinska, Ewa; Bentzen, Bo Hjorth; Thomsen, Morten Baekgaard; Olesen, Soren-Peter] Univ Copenhagen, Danish Natl Res Fdn, Ctr Cardiac Arrhythmia, Copenhagen, Denmark; [Soltysinska, Ewa; Hattel, Helle; Thomsen, Morten Baekgaard; Boushel, Robert Christopher; Olesen, Soren-Peter] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [Barthmes, Maria; Fenske, Stefanie; Biel, Martin; Wahl-Schott, Christian] Univ Munich, CIPSM, Munich, Germany; [Barthmes, Maria; Fenske, Stefanie; Biel, Martin; Wahl-Schott, Christian] Univ Munich, Ctr Drug Res, Dept Pharm, Munich, Germany; [Barthmes, Maria; Brueggemann, Andrea] Nan Technol GmbH, Munich, Germany; [Thrush, A. Brianne; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Qvortrup, Klaus] Univ Copenhagen, Fac Hlth & Med Sci, Core Facil Integrated Microscopy, Dept Biomed Sci, Copenhagen, Denmark; [Larsen, Filip J.; Schiffer, Tomas A.; Losa-Reyna, Jose] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Straubinger, Julia; Kniess, Angelina; Ruth, Peter; Lukowski, Robert] Univ Tubingen, Inst Pharm, Dept Pharmacol Toxicol & Clin Pharm, Tubingen, Germany	Danmarks Grundforskningsfond; University of Copenhagen; University of Copenhagen; University of Munich; University of Munich; University of Ottawa; University of Copenhagen; Karolinska Institutet; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Olesen, SP (corresponding author), Univ Copenhagen, Danish Natl Res Fdn, Ctr Cardiac Arrhythmia, Copenhagen, Denmark.	spfo@sund.ku.dk; robert.lukowski@uni-tuebingen.de	Biel, Martin/G-1175-2014; Boushel, Robert/ABD-7840-2021; Wahl-Schott, Christian A/J-2623-2015; Losa-Reyna, Jose/L-8341-2014; Schiffer, Tomas/X-1343-2018; Bentzen, Bo/B-9325-2012; Thomsen, Morten B/B-5377-2009; Olesen, Soren-Peter/H-4206-2011	Biel, Martin/0000-0002-9974-3052; Losa-Reyna, Jose/0000-0001-9545-5654; Schiffer, Tomas/0000-0002-9077-2682; Bentzen, Bo/0000-0002-0253-4992; Thomsen, Morten B/0000-0002-2469-6458; Qvortrup, Klaus/0000-0001-8811-0260; Olesen, Soren-Peter/0000-0002-4381-5192; Fenske, Stefanie/0000-0002-6994-8401; Bruggemann, Andrea/0000-0002-7325-6715; Harper, Mary-Ellen/0000-0003-3864-5886	Danish National Research Foundation; Danish Heart Foundation; Danish Agency for Science, Technology and Innovation, Medical Research Council [10-084244]; Aase and Ejnar Danielsens Foundation; Carlsberg Foundation; Bayerische Forschungsstiftung; SME innovation program "ZIM'' of the German Federal Ministry of Economics and Technology (BMWi); Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tuebingen University; Eliteprogramm of the Baden-Wurttemberg Stiftung	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Heart Foundation; Danish Agency for Science, Technology and Innovation, Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Aase and Ejnar Danielsens Foundation; Carlsberg Foundation(Carlsberg Foundation); Bayerische Forschungsstiftung; SME innovation program "ZIM'' of the German Federal Ministry of Economics and Technology (BMWi); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University; Eliteprogramm of the Baden-Wurttemberg Stiftung	This study was supported by the Danish National Research Foundation to ES, BHB and SPO, by the Danish Heart Foundation to BHB, by the Danish Agency for Science, Technology and Innovation, Medical Research Council (grant 10-084244) to MBT, and by Aase and Ejnar Danielsens Foundation and by Carlsberg Foundation to SPO and ES. CWS and MB received funding from the Bayerische Forschungsstiftung and from the SME innovation program "ZIM'' of the German Federal Ministry of Economics and Technology (BMWi). RL and PR received grants from the Deutsche Forschungsgemeinschaft and acknowledge the support by the Open Access Publishing Fund of Tuebingen University. RL is a fellow of the Eliteprogramm of the Baden-Wurttemberg Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldakkak M, 2010, AM J PHYSIOL-CELL PH, V298, pC530, DOI 10.1152/ajpcell.00468.2009; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P71, DOI 10.1016/j.bbabio.2009.08.002; Baines CP, 1997, J MOL CELL CARDIOL, V29, P207, DOI 10.1006/jmcc.1996.0265; BEAVIS AD, 1992, J BIOENERG BIOMEMBR, V24, P77, DOI 10.1007/BF00769534; Bentzen BH, 2007, MOL PHARMACOL, V72, P1033, DOI 10.1124/mol.107.038331; Bentzen BH, 2009, PFLUG ARCH EUR J PHY, V457, P979, DOI 10.1007/s00424-008-0583-5; Cameron-Smith D, 2003, AM J CLIN NUTR, V77, P313, DOI 10.1093/ajcn/77.2.313; Cancherini DV, 2007, CARDIOVASC RES, V73, P720, DOI 10.1016/j.cardiores.2006.11.035; Cao CM, 2005, BRIT J PHARMACOL, V145, P984, DOI 10.1038/sj.bjp.0706268; CHEN W, 1995, CIRC RES, V77, P424, DOI 10.1161/01.RES.77.2.424; Cheng Y, 2011, CELL PHYSIOL BIOCHEM, V27, P191, DOI 10.1159/000327944; Cheng Y, 2010, FEBS LETT, V584, P2005, DOI 10.1016/j.febslet.2009.12.038; Costa ADT, 2008, AM J PHYSIOL-HEART C, V295, pH874, DOI 10.1152/ajpheart.01189.2007; Costa ADT, 2008, CARDIOVASC RES, V77, P344, DOI 10.1093/cvr/cvm050; Douglas RM, 2006, NEUROSCIENCE, V139, P1249, DOI 10.1016/j.neuroscience.2006.01.061; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; Fahanik-Babaei J, 2011, NEUROSCIENCE, V199, P125, DOI 10.1016/j.neuroscience.2011.09.055; Fenske S, 2011, CIRC RES, V109, P1015, DOI 10.1161/CIRCRESAHA.111.246173; Fretwell L, 2011, CAN J PHYSIOL PHARM, V89, P24, DOI [10.1139/Y10-106, 10.1139/y10-106]; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Garlid KD, 2012, J MOL CELL CARDIOL, V52, P578, DOI 10.1016/j.yjmcc.2011.12.011; Gnaiger E, 2000, P NATL ACAD SCI USA, V97, P11080, DOI 10.1073/pnas.97.20.11080; Gnaiger E, 2003, ADV EXP MED BIOL, V543, P39; Gu XQ, 2007, BIOCHEM BIOPH RES CO, V358, P311, DOI 10.1016/j.bbrc.2007.04.110; Guo YR, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0288-y; Heinen A, 2007, AM J PHYSIOL-CELL PH, V292, pC148, DOI 10.1152/ajpcell.00215.2006; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Hickey AJR, 2012, J COMP PHYSIOL B, V182, P91, DOI 10.1007/s00360-011-0599-6; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; Jin CH, 2012, J PHYSIOL SCI, V62, P325, DOI 10.1007/s12576-012-0206-y; Kang SH, 2007, AM J PHYSIOL-HEART C, V293, pH307, DOI 10.1152/ajpheart.00789.2006; Ko JH, 2009, BIOCHEM BIOPH RES CO, V389, P74, DOI 10.1016/j.bbrc.2009.08.087; Lemieux H, 2011, INT J BIOCHEM CELL B, V43, P1729, DOI 10.1016/j.biocel.2011.08.008; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Lukowski R, 2010, P NATL ACAD SCI USA, V107, P5646, DOI 10.1073/pnas.1001360107; Methner C, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0337-1; MUKHERJEE A, 1979, AM J PHYSIOL, V237, pH224, DOI 10.1152/ajpheart.1979.237.2.H224; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Ohya S, 2005, AM J PHYSIOL-HEART C, V289, pH1635, DOI 10.1152/ajpheart.00016.2005; Oldenburg O, 2004, AM J PHYSIOL-HEART C, V286, pH468, DOI 10.1152/ajpheart.00360.2003; Oldenburg O, 2003, J MOL CELL CARDIOL, V35, P569, DOI 10.1016/S0022-2828(03)00115-9; Palacios-Callender M, 2004, P NATL ACAD SCI USA, V101, P7630, DOI 10.1073/pnas.0401723101; Park WS, 2007, BIOCHEM BIOPH RES CO, V362, P31, DOI 10.1016/j.bbrc.2007.07.057; Redel A, 2008, ANESTH ANALG, V106, P384, DOI 10.1213/ane.0b013e318160650f; Rochetaing A, 2003, J THORAC CARDIOV SUR, V125, P1516, DOI 10.1016/S0022-5223(03)00024-2; Sato T, 2005, CIRCULATION, V111, P198, DOI 10.1161/01.CIR.0000151099.15706.B1; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Shi Y, 2007, J CARDIOVASC PHARM, V50, P497, DOI 10.1097/FJC.0b013e318137991d; Siemen D, 1999, BIOCHEM BIOPH RES CO, V257, P549, DOI 10.1006/bbrc.1999.0496; Singh H, 2013, P NATL ACAD SCI US; Singh H, 2012, J PHYSIOL-LONDON, V590, P5937, DOI 10.1113/jphysiol.2011.215533; Skyschally A, 2012, EUR HEART J; Sommer N, 2010, EUR RESPIR J, V36, P1056, DOI 10.1183/09031936.00013809; Sprossmann F, 2009, FEBS J, V276, P1680, DOI 10.1111/j.1742-4658.2009.06900.x; Stowe DF, 2006, AM J PHYSIOL-HEART C, V290, pH434, DOI 10.1152/ajpheart.00763.2005; Stumpner J, 2012, BRIT J ANAESTH, V108, P594, DOI 10.1093/bja/aer496; Wang XY, 2008, J MOL CELL CARDIOL, V44, P105, DOI 10.1016/j.yjmcc.2007.10.006; Wang XY, 2004, AM J PHYSIOL-HEART C, V287, pH2070, DOI 10.1152/ajpheart.00431.2004; Wojtovich AP, 2013, PEERJ, V1, DOI 10.7717/peerj.48; Wojtovich AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028287; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Xu ZL, 2004, AM J PHYSIOL-HEART C, V286, pH1433, DOI 10.1152/ajpheart.00882.2003; Yellon DM, 2003, PHYSIOL REV, V83, P1113, DOI 10.1152/physrev.00009.2003	64	68	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103402	10.1371/journal.pone.0103402	http://dx.doi.org/10.1371/journal.pone.0103402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072914	Green Submitted, Green Published, gold			2022-12-25	WOS:000341307600046
J	Tartu, S; Bustamante, P; Goutte, A; Cherel, Y; Weimerskirch, H; Bustnes, JO; Chastel, O				Tartu, Sabrina; Bustamante, Paco; Goutte, Aurelie; Cherel, Yves; Weimerskirch, Henri; Bustnes, Jan Ove; Chastel, Olivier			Age-Related Mercury Contamination and Relationship with Luteinizing Hormone in a Long-Lived Antarctic Bird	PLOS ONE			English	Article							STABLE-ISOTOPE SIGNATURES; REPRODUCTIVE SUCCESS; HEAVY-METALS; CATHARACTA-SKUA; SURVIVAL RATES; FORAGING AREAS; GIANT PETRELS; ADELIE LAND; BLOOD; SEABIRD	Seabirds, as long-lived top predators, accumulate contaminants such as mercury (Hg), an established endocrine disruptor. In long lived species hormonal secretion varies with age; therefore, Hg-induced endocrine disruption may be exacerbated in some age classes. Here we investigated relationships between blood total Hg and luteinizing hormone (LH, a key pituitary hormone for the onset of breeding), in pre-laying known-age (11-45 years old) snow petrels (Pagodroma nivea) from Adelie Land, Antarctica. We predicted that 1) blood Hg would increase with advancing age as a consequence of bio-accumulation; and that 2) increasing blood Hg would be related to decreased concentrations of LH in the most Hg-contaminated individuals. Hg concentrations were higher in females than in males (p<0.001), and contrary to our prediction, decreased with advancing age in males (p = 0.009) and tended to do so in females (p = 0.06). The analysis of stable isotopes (delta C-13 and delta N-15) suggested that this unexpected pattern could originate from age and sex-related variations in trophic niche, and hence Hg exposure. Regarding LH, our prediction was only supported in young birds (<= 23 years) where baseline LH was inversely correlated with Hg concentrations (p = 0.04). Hg burden did not predict baseline LH or GnRH-induced LH in birds that were more than 23 years old. These results show that age and contaminants may interfere with major endocrine mechanisms and, together with other recent studies, support the view that Hg could be connected to LH secretion and could then impair the fitness of long-lived birds.	[Tartu, Sabrina; Goutte, Aurelie; Cherel, Yves; Weimerskirch, Henri; Chastel, Olivier] Univ La Rochelle, CNRS, CEBC, UMR 7372, Villiers En Bois, France; [Bustamante, Paco] Univ La Rochelle, CNRS, Littoral Environm Soc LIENSs, UMR 7266, La Rochelle, France; [Bustnes, Jan Ove] Norwegian Inst Nat Res, FRAM, High North Res Ctr Climate & Environm, Tromso, Norway	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Norwegian Institute Nature Research	Tartu, S (corresponding author), Univ La Rochelle, CNRS, CEBC, UMR 7372, Villiers En Bois, France.	tartu.sabrina@gmail.com	Goutte, Aurelie/F-7572-2017; Weimerskirch, Henri/K-7306-2019; Bustamante, Paco/G-5833-2011; Tartu, Sabrina/Q-4062-2018; Weimerskirch, Henri/F-5562-2013	Weimerskirch, Henri/0000-0002-0457-586X; Bustamante, Paco/0000-0003-3877-9390; Tartu, Sabrina/0000-0002-4257-7495; Goutte, Aurelie/0000-0001-8322-5843	Agence Nationale de la Recherche (program POLARTOP); Institut Polaire Francais Paul Emile Victor (IPEV) [109]; Terres Australes et Antarctiques Francaises (TAAF)	Agence Nationale de la Recherche (program POLARTOP)(French National Research Agency (ANR)); Institut Polaire Francais Paul Emile Victor (IPEV); Terres Australes et Antarctiques Francaises (TAAF)	Financial support was provided by the Agence Nationale de la Recherche (program POLARTOP, O. Chastel), the Institut Polaire Francais Paul Emile Victor (IPEV, program no. 109, H. Weimerskirch), and the Terres Australes et Antarctiques Francaises (TAAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ORJ, 2009, MAR ECOL PROG SER, V375, P277, DOI 10.3354/meps07784; Angelier F, 2007, J ANIM ECOL, V76, P1181, DOI 10.1111/j.1365-2656.2007.01295.x; Authier M, 2012, METHODS ECOL EVOL, V3, P281, DOI 10.1111/j.2041-210X.2011.00162.x; Bargagli R, 1998, MAR ECOL PROG SER, V169, P65, DOI 10.3354/meps169065; Bearhop S, 2000, ENVIRON TOXICOL CHEM, V19, P1638, DOI [10.1002/etc.5620190622, 10.1897/1551-5028(2000)019&lt;1638:DOMIBA&gt;2.3.CO;2]; Bearhop S, 2000, MAR POLLUT BULL, V40, P181, DOI 10.1016/S0025-326X(99)00205-2; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bentley GE, 2006, HORM BEHAV, V49, P550, DOI 10.1016/j.yhbeh.2005.12.005; Blevin P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054508; Bustamante P, 2006, SCI TOTAL ENVIRON, V368, P585, DOI 10.1016/j.scitotenv.2006.01.038; Carravieri A, 2014, ENVIRON POLLUT, V190, P51, DOI 10.1016/j.envpol.2014.03.017; Champoux L, 2006, HYDROBIOLOGIA, V567, P263, DOI 10.1007/s10750-006-0066-7; CHASTEL O, 1993, OECOLOGIA, V94, P278, DOI 10.1007/BF00341328; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; Cherel Y, 2008, MAR BIOL, V154, P813, DOI 10.1007/s00227-008-0974-3; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Cherel Y, 2010, LIMNOL OCEANOGR, V55, P324, DOI 10.4319/lo.2010.55.1.0324; Cossa D, 2011, GEOCHIM COSMOCHIM AC, V75, P4037, DOI 10.1016/j.gca.2011.05.001; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Dietz R, 2000, SCI TOTAL ENVIRON, V245, P25, DOI 10.1016/S0048-9697(99)00431-3; Drevnick PE, 2003, ENVIRON SCI TECHNOL, V37, P4390, DOI 10.1021/es034252m; Evers DC, 2008, ECOTOXICOLOGY, V17, P69, DOI 10.1007/s10646-007-0168-7; FOLLETT BK, 1975, GEN COMP ENDOCR, V26, P126, DOI 10.1016/0016-6480(75)90223-3; Frederick P, 2011, P ROY SOC B-BIOL SCI, V278, P1851, DOI 10.1098/rspb.2010.2189; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; FURNESS R, 1979, ENVIRON POLLUT, V19, P261, DOI 10.1016/0013-9327(79)90118-6; Furness R.W., 1993, P86; FURNESS RW, 1990, ENVIRON POLLUT, V63, P33, DOI 10.1016/0269-7491(90)90101-H; Gabrielsen GW, 2009, POLLUTION BARENTS SE; GOCHFELD M, 1980, MAR POLLUT BULL, V11, P362, DOI 10.1016/0025-326X(80)90284-2; Gonzalez-Solis J, 2002, MAR ECOL PROG SER, V244, P257, DOI 10.3354/meps244257; Goutte A., 2013, ECOLOGY; Goutte A, 2014, P R SOC B; Goutte A, 2011, BIOL LETTERS, V7, P790, DOI 10.1098/rsbl.2011.0196; Goutte A, 2010, GEN COMP ENDOCR, V169, P108, DOI 10.1016/j.ygcen.2010.07.016; Goutte A, 2010, FUNCT ECOL, V24, P1007, DOI 10.1111/j.1365-2435.2010.01712.x; Hallinger KK, 2011, ECOTOXICOLOGY, V20, P39, DOI 10.1007/s10646-010-0554-4; Henny CJ, 2002, ECOTOXICOLOGY, V11, P213, DOI 10.1023/A:1016327602656; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; HOBSON KA, 1993, AUK, V110, P638, DOI 10.2307/4088430; HONDA K, 1986, MAR ENVIRON RES, V20, P143, DOI 10.1016/0141-1136(86)90045-0; HUTTON M, 1981, ENVIRON POLLUT A, V26, P129, DOI 10.1016/0143-1471(81)90043-X; Jaeger A, 2010, RAPID COMMUN MASS SP, V24, P3456, DOI 10.1002/rcm.4792; KOEMAN J H, 1975, Science of the Total Environment, V3, P279, DOI 10.1016/0048-9697(75)90052-2; Lecomte VJ, 2010, P NATL ACAD SCI USA, V107, P6370, DOI 10.1073/pnas.0911181107; Mitro MG, 2008, J WILDLIFE MANAGE, V72, P665, DOI 10.2193/2006-551; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Norris DO, 2013, VERTEBRATE ENDOCRINOLOGY, FIFTH EDITION, P1; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Ramalingam V, 2003, J ENVIRON BIOL, V24, P401; RIDOUX V, 1989, POLAR BIOL, V9, P137, DOI 10.1007/BF00297168; Robinson SA, 2012, ENVIRON SCI TECHNOL, V46, P7094, DOI 10.1021/es204032m; Rowe CL, 2008, BIOSCIENCE, V58, P623, DOI 10.1641/B580709; Scheulhammer AM, 2007, AMBIO, V36, P12, DOI 10.1579/0044-7447(2007)36[12:EOEMOT]2.0.CO;2; Schoech SJ, 1996, BEHAV ECOL SOCIOBIOL, V39, P77, DOI 10.1007/s002650050269; SHARP PJ, 1975, J ENDOCRINOL, V67, P211, DOI 10.1677/joe.0.0670211; Streets DG, 2009, ENVIRON SCI TECHNOL, V43, P2983, DOI 10.1021/es802474j; Tan SW, 2009, CRIT REV TOXICOL, V39, P228, DOI 10.1080/10408440802233259; Tartu S, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0317; Tavares S, 2013, ENVIRON POLLUT, V181, P315, DOI 10.1016/j.envpol.2013.06.032; Thiebot JB, 2014, J ZOOL, V292, P25, DOI 10.1111/jzo.12080; Thiers L, 2014, MAR ECOL PROG SER, V499, P233, DOI 10.3354/meps10620; THOMPSON DR, 1991, J APPL ECOL, V28, P672, DOI 10.2307/2404575; vom Saal F., 1988, PHYSL REPROD, V2nd ed; WAGEMANN R, 1989, CAN J FISH AQUAT SCI, V46, P1558, DOI 10.1139/f89-198; Wayland M, 2001, ENVIRON MONIT ASSESS, V71, P255, DOI 10.1023/A:1011850000360; Wayland M, 2008, ENVIRON TOXICOL CHEM, V27, P698, DOI 10.1897/07-321.1	67	24	24	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103642	10.1371/journal.pone.0103642	http://dx.doi.org/10.1371/journal.pone.0103642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072936	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600076
J	Dixon, LM; Brocklehurst, S; Sandilands, V; Bateson, M; Tolkamp, BJ; D'Eath, RB				Dixon, Laura M.; Brocklehurst, Sarah; Sandilands, Vicky; Bateson, Melissa; Tolkamp, Bert J.; D'Eath, Rick B.			Measuring Motivation for Appetitive Behaviour: Food-Restricted Broiler Breeder Chickens Cross a Water Barrier to Forage in an Area of Wood Shavings without Food	PLOS ONE			English	Article							FEED RESTRICTION; ANIMAL-WELFARE; ETHOLOGICAL NEEDS; LAYING HENS; DEMAND; HUNGER; PREFERENCES; PARAMETERS; EXPERIENCE; GENOTYPE	Broiler breeders (parents of meat chickens) are selected for fast growth and become obese if fed ad libitum. To avoid this and maintain good health and reproductive ability, they are feed restricted to about 1/3 of what they would eat ad libitum. As a result, they experience chronic hunger and exhibit abnormal behaviour patterns that may indicate stress and frustration. One approach to measuring hunger is to observe how much birds will work, such as pecking a key, for access to more or different types of food. However, the sight, smell, and feedback from consumption of the feed reward changes the context and may artificially raise feeding motivation. To avoid this, we tested broiler breeders in an apparatus in which they could work for access to a wooden platform covered in wood shavings by crossing a water runway which increased in length and depth in 8 successive tests. In the wood shavings area, they could perform exploratory and foraging behaviour (the appetitive phase of feeding) but were never rewarded with feed. Sixty birds were divided into three feed quantity treatments: commercial restriction (R), and twice (2R) or three times (3R) this amount. Overall, birds fed R worked harder to reach the wood shavings area (reached it in a larger number of tests) than 2R and 3R birds (P<0.001). More restricted birds took less time to reach the area (P<0.001, R<2R<3R) and spent more time foraging while there (P<0.001, R<2R<3R). This indicates that restricted-fed birds were hungry and willing to work for the opportunity to forage even though food was never provided, suggesting that their motivation to perform the appetitive component of feeding behaviour (foraging/food searching) was sufficient to sustain their response. Thus food restriction in broiler breeders is a welfare concern. However these methods could be used to test alternative feeding regimes to attempt to find ways of alleviating hunger while still maintaining healthy growth and reproduction in these birds.	[Dixon, Laura M.; Sandilands, Vicky; Tolkamp, Bert J.; D'Eath, Rick B.] SRUC, Edinburgh, Midlothian, Scotland; [Brocklehurst, Sarah] Biomathemat & Stat Scotland, Edinburgh, Midlothian, Scotland; [Bateson, Melissa] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Dixon, LM (corresponding author), SRUC, Edinburgh, Midlothian, Scotland.	laura.dixon@sruc.ac.uk	Bateson, Melissa/AAE-7075-2022; Bateson, Melissa/B-1874-2008; Tolkamp, Bert Jan/AGX-2541-2022; Brocklehurst, Sarah/J-3733-2013	Bateson, Melissa/0000-0002-0861-0191; Bateson, Melissa/0000-0002-0861-0191; Brocklehurst, Sarah/0000-0002-1636-1017; Sandilands, Victoria/0000-0003-0806-3535; Dixon, Laura/0000-0002-1781-8795; D'Eath, Rick/0000-0002-1801-254X	UK Department for Environment, Food, and Rural Affairs (Defra) [AW1141]	UK Department for Environment, Food, and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA))	This study was funded by the UK Department for Environment, Food, and Rural Affairs (Defra) as part of a larger project (AW1141) investigating the subjective state of food restricted broiler chickens using behavioural and neurochemical measures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher L, 2009, APPL ANIM BEHAV SCI, V118, P152, DOI 10.1016/j.applanim.2009.02.029; Aviagen, 2013, ROSS 308 PAR MAN HDB; Berridge KC, 2004, PHYSIOL BEHAV, V81, P179, DOI 10.1016/j.physbeh.2004.02.004; Bessei W, 2006, WORLD POULTRY SCI J, V62, P455, DOI 10.1079/WPS2005108; Brown H., 1999, APPL MIXED MODELS ME; Buckley LA, 2011, APPL ANIM BEHAV SCI, V133, P216, DOI 10.1016/j.applanim.2011.06.003; Collett D, 1999, MODELLING BINARY DAT; Cooper J. J., 1994, Modified cages for laying hens. Proceedings of a symposium held at Nobel House, London, UK, 18th January 1993., P11; COOPER JJ, 1995, APPL ANIM BEHAV SCI, V42, P283, DOI 10.1016/0168-1591(94)00543-N; D'Eath RB, 2009, ANIM BEHAV, V77, P275, DOI 10.1016/j.anbehav.2008.10.028; Dawkins MS, 2012, ANIM WELFARE, V21, P147, DOI 10.7120/09627286.21.2.147; Dawkins MS, 2008, ETHOLOGY, V114, P937, DOI 10.1111/j.1439-0310.2008.01557.x; Dawkins MS, 2006, APPL ANIM BEHAV SCI, V100, P4, DOI 10.1016/j.applanim.2006.04.010; Dawkins MS, 2004, ANIM WELFARE, V13, pS3; DAWKINS MS, 1983, ANIM BEHAV, V31, P1195, DOI 10.1016/S0003-3472(83)80026-8; DAWKINS MS, 1990, BEHAV BRAIN SCI, V13, P1, DOI 10.1017/S0140525X00077104; Day JEL, 1996, APPL ANIM BEHAV SCI, V50, P15, DOI 10.1016/0168-1591(96)01072-6; de Jong IC, 2005, APPL ANIM BEHAV SCI, V92, P61, DOI 10.1016/j.applanim.2004.10.022; de Jong IC, 2005, POULTRY SCI, V84, P194, DOI 10.1093/ps/84.2.194; de Jong IC, 2003, PHYSIOL BEHAV, V78, P773, DOI 10.1016/S0031-9384(03)00058-1; de Jong IC, 2002, BRIT POULTRY SCI, V43, P157, DOI 10.1080/00071660120121355; Decuypere E, 2010, BRIT POULTRY SCI, V51, P569, DOI 10.1080/00071668.2010.519121; DEFRA, 2006, STRUCT UK POULTR IND; Dixon LM, 2013, APPL ANIM BEHAV SCI, V148, P164, DOI 10.1016/j.applanim.2013.07.012; Duncan IJH, 1996, ACTA AGR SCAND A-AN, P29; Duncan IJH, 2005, REV SCI TECH OIE, V24, P483, DOI 10.20506/rst.24.2.1587; DUNCAN LJH, 1992, POULTRY SCI, V71, P658, DOI 10.3382/ps.0710658; Dunn IC, 2013, J NEUROENDOCRINOL, V25, P920, DOI 10.1111/jne.12088; FAURE JM, 1994, APPL ANIM BEHAV SCI, V42, P49, DOI 10.1016/0168-1591(94)90006-X; Fraser D., 1997, Animal welfare., P159; Hocking PM, 1996, BRIT POULTRY SCI, V37, P263, DOI 10.1080/00071669608417858; Hocking PM, 2001, BRIT POULTRY SCI, V42, P424, DOI 10.1080/00071660120070677; Jensen MB, 2008, APPL ANIM BEHAV SCI, V113, P340, DOI 10.1016/j.applanim.2008.02.001; Jones EKM, 2004, BRIT POULTRY SCI, V45, P725, DOI 10.1080/00071660400014226; KESTIN SC, 1992, VET REC, V131, P190, DOI 10.1136/vr.131.9.190; Kirkden RD, 2006, APPL ANIM BEHAV SCI, V100, P29, DOI 10.1016/j.applanim.2006.04.009; Mason GJ, 2001, NATURE, V410, P35, DOI 10.1038/35065157; MATTHEWS LR, 1994, ANIM BEHAV, V47, P713, DOI 10.1006/anbe.1994.1096; McFarland D.J., 1974, Advances Study Behav, V5, P201, DOI 10.1016/S0065-3454(08)60023-6; Mench JA, 2002, WORLD POULTRY SCI J, V58, P23, DOI 10.1079/WPS20020004; MENCH JA, 1991, POULTRY SCI, V70, P2547, DOI 10.3382/ps.0702547; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Mills DS., 2010, ENCY APPL ANIMAL BEH, P685; Olsson IAS, 2002, ANIM WELFARE, V11, P11; PROUDFOOT FG, 1984, CAN J ANIM SCI, V64, P759, DOI 10.4141/cjas84-084; Renema RA, 2004, WORLD POULTRY SCI J, V60, P508, DOI 10.1079/WPS200434; Sandilands V, 2006, APPL ANIM BEHAV SCI, V96, P53, DOI 10.1016/j.applanim.2005.04.017; Sandilands V, 2005, PHYSIOL BEHAV, V85, P115, DOI 10.1016/j.physbeh.2005.03.001; SAVORY CJ, 1993, ANIM WELFARE, V2, P131; Savory CJ, 1996, ANIM WELFARE, V5, P105; Savory CJ, 2000, APPL ANIM BEHAV SCI, V69, P135, DOI 10.1016/S0168-1591(00)00123-4; SAVORY CJ, 1992, APPL ANIM BEHAV SCI, V32, P349, DOI 10.1016/S0168-1591(05)80027-9; SAVORY CJ, 1993, BEHAV PROCESS, V29, P179, DOI 10.1016/0376-6357(93)90122-8; Seaman SC, 2008, ANIM BEHAV, V75, P31, DOI 10.1016/j.anbehav.2006.09.031; Toates FM, 1998, CONTROL BEHAV, P15; Verbeek E, 2011, APPL ANIM BEHAV SCI, V132, P121, DOI 10.1016/j.applanim.2011.03.014; Warburton H, 2003, ANIM BEHAV, V65, P755, DOI 10.1006/anbe.2003.2097; Weeks C. A., 2001, British Poultry Science, V42, pS79; Weeks CA, 2002, VET REC, V151, P762	59	21	21	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102322	10.1371/journal.pone.0102322	http://dx.doi.org/10.1371/journal.pone.0102322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068283	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993700006
J	Mendes-da-Cruz, DA; Brignier, AC; Asnafi, V; Baleydier, F; Messias, CV; Lepelletier, Y; Bedjaoui, N; Renand, A; Smaniotto, S; Canioni, D; Milpied, P; Balabanian, K; Bousso, P; Lepretre, S; Bertrand, Y; Dombret, H; Ifrah, N; Dardenne, M; Macintyre, E; Savino, W; Hermine, O				Mendes-da-Cruz, Daniella Areas; Brignier, Anne Colette; Asnafi, Vahid; Baleydier, Frederic; Messias, Carolina Valenca; Lepelletier, Yves; Bedjaoui, Nawel; Renand, Amedee; Smaniotto, Salete; Canioni, Danielle; Milpied, Pierre; Balabanian, Karl; Bousso, Philippe; Lepretre, Stephane; Bertrand, Yves; Dombret, Herve; Ifrah, Norbert; Dardenne, Mireille; Macintyre, Elizabeth; Savino, Wilson; Hermine, Olivier			Semaphorin 3F and Neuropilin-2 Control the Migration of Human T-Cell Precursors	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; HUMAN THYMOCYTE MIGRATION; LYMPHOCYTE EGRESS; THYMUS; EXPRESSION; EMIGRATION; CHEMOKINE; GRADIENTS; TISSUES	Neuropilins and semaphorins are known as modulators of axon guidance, angiogenesis, and organogenesis in the developing nervous system, but have been recently evidenced as also playing a role in the immune system. Here we describe the expression and role of semaphorin 3F (SEMA3F) and its receptor neuropilin-2 (NRP2) in human T cell precursors. NRP2 and SEMA3F are expressed in the human thymus, in both lymphoid and non-lymphoid compartments. SEMA3F have a repulsive effect on thymocyte migration and inhibited CXCL12- and sphingosine-1-phosphate (S1P)-induced thymocyte migration by inhibiting cytoskeleton reorganization prior to stimuli. Moreover, NRP2 and SEMA3F are expressed in human T-cell acute lymphoblastic leukemia/lymphoma primary cells. In these tumor cells, SEMA3F also blocks their migration induced by CXCL12 and S1P. Our data show that SEMA3F and NRP2 are further regulators of human thymocyte migration in physiological and pathological conditions.	[Mendes-da-Cruz, Daniella Areas; Brignier, Anne Colette; Lepelletier, Yves; Renand, Amedee; Milpied, Pierre; Dardenne, Mireille; Hermine, Olivier] Paris Descartes Univ, CNRS UMR8147, Paris, France; [Mendes-da-Cruz, Daniella Areas; Messias, Carolina Valenca; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Brignier, Anne Colette] Necker Childrens Hosp, AP HP, Dept Clin Hematol, Paris, France; [Asnafi, Vahid; Baleydier, Frederic; Bedjaoui, Nawel; Canioni, Danielle; Macintyre, Elizabeth; Hermine, Olivier] Necker Childrens Hosp, AP HP, Lab Oncohematol, INSERM U1151, Paris, France; [Lepelletier, Yves; Hermine, Olivier] Imagine Inst, INSERM U1163, CNRS ERL 8254, Lab Cellular & Mol Basis Hematol Disorders & Thei, Paris, France; [Smaniotto, Salete; Canioni, Danielle] Univ Fed Alagoas, Dept Morphol, Maceio, Brazil; Hop Necker Enfants Malad, Dept Pathol, Paris, France; [Balabanian, Karl] Inst Pasteur, INSERM U819, Paris, France; [Bousso, Philippe] Inst Pasteur, INSERM U668, Paris, France; [Lepretre, Stephane] Ctr Henri Becquerel, Dept Hematol, F-76038 Rouen, France; [Bertrand, Yves] Hop Debrousse, Serv Pediat Hematol, Lyon, France; [Dombret, Herve] Univ Paris 07, Hop St Louis, AP HP, Paris, France; [Dombret, Herve] Univ Paris 07, Inst Univ Hematol EA3518, Paris, France; [Ifrah, Norbert] Ctr Hosp Univ Nantes, Univ Angers, Serv Malad, Pole Rech & Enseignement Super, Angers, France; [Ifrah, Norbert] INSERM U892, Angers, France	UDICE-French Research Universities; Universite Paris Cite; Fundacao Oswaldo Cruz; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade Federal de Alagoas; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UNICANCER; Centre Henri Becquerel; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm)	Mendes-da-Cruz, DA (corresponding author), Paris Descartes Univ, CNRS UMR8147, Paris, France.	daniella@ioc.fiocruz.br; ohermine@gmail.com	Balabanian, Karl/I-2990-2016; Ifrah, Norbert/L-5238-2015; Renand, Amedee/A-9884-2018; Mendes-da-Cruz, Daniella A/E-7875-2016; Milpied, Pierre J/Q-1380-2015; lepelletier, yves/AAF-1546-2020; Balabanian, Karl/S-6250-2019; BOUSSO, Philippe/M-6547-2014; Hermine, Olivier/Q-7072-2018; Mendes-da-Cruz, Daniella/AAN-6644-2020; Smaniotto, Salete/AAT-4056-2020; Baleydier, Frederic/AAX-2554-2020; Smaniotto, Salete/T-3796-2017	Balabanian, Karl/0000-0002-0534-3198; Renand, Amedee/0000-0003-2265-549X; Mendes-da-Cruz, Daniella A/0000-0003-3697-1506; Milpied, Pierre J/0000-0003-1873-5358; lepelletier, yves/0000-0001-7746-5170; Balabanian, Karl/0000-0002-0534-3198; BOUSSO, Philippe/0000-0002-6362-561X; Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Macintyre-Davi, Elizabeth Anne/0000-0003-0520-0493; Smaniotto, Salete/0000-0003-1527-5894; Hermine, Olivier/0000-0003-2574-3874; IFRAH, Norbert/0000-0003-3063-850X	CNRS-Fiocruz Associated Laboratory of Immunology and Immunopathology; CNRS/Fiocruz French/Brazilian conjoint program; CNRS; Foundation for Medical Research (FRM - France); National League against the Cancer (France); National Cancer Institute (France); Fiocruz (Brazil); CNPq (Brazil); Faperj (Brazil); Fund for Structural Convergence of Mercosur (FOCEM/Mercosur)	CNRS-Fiocruz Associated Laboratory of Immunology and Immunopathology; CNRS/Fiocruz French/Brazilian conjoint program(Centre National de la Recherche Scientifique (CNRS)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Foundation for Medical Research (FRM - France); National League against the Cancer (France); National Cancer Institute (France)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fiocruz (Brazil); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj (Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fund for Structural Convergence of Mercosur (FOCEM/Mercosur)	This work was developed in the context of the CNRS-Fiocruz Associated Laboratory of Immunology and Immunopathology. It was partially funded with grants by CNRS/Fiocruz French/Brazilian conjoint program, CNRS, The Foundation for Medical Research (FRM - France), The National League against the Cancer (France), The National Cancer Institute (France); Fiocruz, CNPq, Faperj and CAPES (Brazil); Fund for Structural Convergence of Mercosur (FOCEM/Mercosur). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Annunziato F, 2001, TRENDS IMMUNOL, V22, P277, DOI 10.1016/S1471-4906(01)01889-0; Atwal JK, 2003, J NEUROSCI, V23, P7602; Chalasani SH, 2003, J NEUROSCI, V23, P1360, DOI 10.1523/JNEUROSCI.23-04-01360.2003; Chiba K, 2006, CELL MOL IMMUNOL, V3, P11; Crazzolara R, 2001, BRIT J HAEMATOL, V115, P545, DOI 10.1046/j.1365-2141.2001.03164.x; CRIST WM, 1988, BLOOD, V72, P1891; de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001; Dzhagalov I, 2012, CELL MOL LIFE SCI, V69, P663, DOI 10.1007/s00018-011-0791-6; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Garcia F, 2011, J LEUKOC BIOL; Gaur P, 2009, CLIN CANCER RES, V15, P6763, DOI 10.1158/1078-0432.CCR-09-1810; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Halkias J, 2013, J CLIN INVEST, V123, P2131, DOI 10.1172/JCI67175; Harris NL, 1999, ANN ONCOL, V10, P1419, DOI 10.1023/A:1008375931236; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Lepelletier Y, 2007, P NATL ACAD SCI USA, V104, P5545, DOI 10.1073/pnas.0700705104; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mendes-Da-Cruz DA, 2008, J IMMUNOL, V180, P4639, DOI 10.4049/jimmunol.180.7.4639; Mendes-da-Cruz DA, 2009, ANN NY ACAD SCI, V1153, P20, DOI 10.1111/j.1749-6632.2008.03980.x; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Pascual M, 2005, HIPPOCAMPUS, V15, P184, DOI 10.1002/hipo.20040; Poznansky MC, 2002, J CLIN INVEST, V109, P1101, DOI 10.1172/JCI200213853; Savino W, 2000, Dev Immunol, V7, P279, DOI 10.1155/2000/60247; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Stepanova OI, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1194, DOI 10.1134/S0006297907110041; Takahashi K, 2008, DEV DYNAM, V237, P1699, DOI 10.1002/dvdy.21556; Uckun FM, 1998, BLOOD, V91, P735; Vianello F, 2005, J IMMUNOL, V175, P5115, DOI 10.4049/jimmunol.175.8.5115; Yopp AC, 2006, CLIN TRANSPLANT, V20, P788, DOI 10.1111/j.1399-0012.2006.00570.x	30	31	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103405	10.1371/journal.pone.0103405	http://dx.doi.org/10.1371/journal.pone.0103405			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068647	Green Published, gold			2022-12-25	WOS:000339993700067
J	Sun, ZX; Kang, Y; Norris, MH; Troyer, RM; Son, MS; Schweizer, HP; Dow, SW; Hoang, TT				Sun, Zhenxin; Kang, Yun; Norris, Michael H.; Troyer, Ryan M.; Son, Mike S.; Schweizer, Herbert P.; Dow, Steven W.; Hoang, Tung T.			Blocking Phosphatidylcholine Utilization in Pseudomonas aeruginosa, via Mutagenesis of Fatty Acid, Glycerol and Choline Degradation Pathways, Confirms the Importance of This Nutrient Source In Vivo	PLOS ONE			English	Article							BETAINE ALDEHYDE DEHYDROGENASE; CYSTIC-FIBROSIS; ESCHERICHIA-COLI; LUNG SURFACTANT; PHOSPHORYLCHOLINE PHOSPHATASE; DIFFUSION FACILITATOR; MOUSE MODEL; GENE; OPERON; INFECTION	Pseudomonas aeruginosa can grow to very high-cell-density (HCD) during infection of the cystic fibrosis (CF) lung. Phosphatidylcholine (PC), the major component of lung surfactant, has been hypothesized to support HCD growth of P. aeruginosa in vivo. The phosphorylcholine headgroup, a glycerol molecule, and two long-chain fatty acids (FAs) are released by enzymatic cleavage of PC by bacterial phospholipase C and lipases. Three different bacterial pathways, the choline, glycerol, and fatty acid degradation pathways, are then involved in the degradation of these PC components. Here, we identified five potential FA degradation (Fad) related fadBA-operons (fadBA1-5, each encoding 3-hydroxyacyl-CoA dehydrogenase and acyl-CoA thiolase). Through mutagenesis and growth analyses, we showed that three (fadBA145) of the five fadBA-operons are dominant in medium-chain and long-chain Fad. The triple fadBA145 mutant also showed reduced ability to degrade PC in vitro. We have previously shown that by partially blocking Fad, via mutagenesis of fadBA5 and fadDs, we could significantly reduce the ability of P. aeruginosa to replicate on FA and PC in vitro, as well as in the mouse lung. However, no studies have assessed the ability of mutants, defective in choline and/or glycerol degradation in conjunction with Fad, to grow on PC or in vivo. Hence, we constructed additional mutants (Delta fadBA145 Delta glpD, Delta fadBA145 Delta betAB, and Delta fadBA145 Delta betAB Delta glpD) significantly defective in the ability to degrade FA, choline, and glycerol and, therefore, PC. The analysis of these mutants in the BALB/c mouse lung infection model showed significant inability to utilize PC in vitro, resulted in decreased replication fitness and competitiveness in vivo compared to the complement strain, although there was little to no variation in typical virulence factor production (e.g., hemolysin, lipase, and protease levels). This further supports the hypothesis that lung surfactant PC serves as an important nutrient for P. aeruginosa during CF lung infection.	[Sun, Zhenxin; Kang, Yun; Hoang, Tung T.] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA; [Norris, Michael H.; Hoang, Tung T.] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Son, Mike S.] Plymouth State Univ, Dept Biol Sci, Plymouth, NH USA; [Troyer, Ryan M.; Schweizer, Herbert P.; Dow, Steven W.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University System Of New Hampshire; Plymouth State University; Colorado State University	Hoang, TT (corresponding author), Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA.	tongh@hawaii.edu	Troyer, Ryan/ABE-2221-2021; Sun, Zhenxin/V-3418-2019; Heacock-Kang, Yun/O-9767-2016	Troyer, Ryan/0000-0001-8908-5853; Sun, Zhenxin/0000-0003-3452-3881; Heacock-Kang, Yun/0000-0002-7304-9687; Norris, Michael/0000-0002-5285-0432	National Institute of General Medical Sciences of the National Institutes of Health [P20GM103516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this research was provided by grant number P20GM103516 from the National Institute of General Medical Sciences of the National Institutes of Health. The study design and content are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beassoni PR, 2006, CURR MICROBIOL, V53, P534, DOI 10.1007/s00284-006-0365-2; Bernhard W, 2001, AM J RESP CELL MOL, V25, P725, DOI 10.1165/ajrcmb.25.6.4616; Bernhard W, 1997, THORAX, V52, P723, DOI 10.1136/thx.52.8.723; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Boucher JC, 1997, INFECT IMMUN, V65, P3838, DOI 10.1128/IAI.65.9.3838-3846.1997; Brickman TJ, 2006, INFECT IMMUN, V74, P1741, DOI 10.1128/IAI.74.3.1741-1744.2006; Campbell JW, 2002, J BACTERIOL, V184, P3759, DOI 10.1128/JB.184.13.3759-3764.2002; CLARK D, 1981, J BACTERIOL, V148, P521, DOI 10.1128/JB.148.2.521-526.1981; Coban AY, 2009, MIKROBIYOL BUL, V43, P563; Darch SE, 2012, P NATL ACAD SCI USA, V109, P8259, DOI 10.1073/pnas.1118131109; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Fricks-Lima J, 2011, INT J ANTIMICROB AG, V37, P309, DOI 10.1016/j.ijantimicag.2010.12.017; Hite R.D., 2002, CLIN PULM MED, V9, P39; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hoffmann N, 2005, INFECT IMMUN, V73, P2504, DOI 10.1128/IAI.73.4.2504-2514.2005; HOLLOWAY BW, 1994, MICROBIOL-UK, V140, P2907, DOI 10.1099/13500872-140-11-2907; Kang Y, 2008, MICROBIOL-SGM, V154, P1584, DOI 10.1099/mic.0.2008/018135-0; Kang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013557; Kang Y, 2009, APPL ENVIRON MICROB, V75, P4015, DOI 10.1128/AEM.02733-08; Lode H, 2000, CURR OPIN INFECT DIS, V13, P377, DOI 10.1097/00001432-200008000-00009; Massimelli MJ, 2005, CURR MICROBIOL, V50, P251, DOI 10.1007/s00284-004-4499-9; Miller RM, 2008, J BACTERIOL, V190, P4038, DOI 10.1128/JB.00129-08; NAGASAWA T, 1976, AGR BIOL CHEM TOKYO, V40, P1743, DOI 10.1080/00021369.1976.10862293; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; Pesci EC, 1997, TRENDS MICROBIOL, V5, P132, DOI 10.1016/S0966-842X(97)01008-1; Pompilio A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-145; Postle AD, 1999, AM J RESP CELL MOL, V20, P90, DOI 10.1165/ajrcmb.20.1.3253; PRAMANIK A, 1979, J BACTERIOL, V137, P469, DOI 10.1128/JB.137.1.469-473.1979; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Schweizer HP, 1997, MICROBIOL-SGM, V143, P1287, DOI 10.1099/00221287-143-4-1287; SCHWEIZER HP, 1995, J BACTERIOL, V177, P4801, DOI 10.1128/jb.177.16.4801-4804.1995; SCHWEIZER HP, 1994, J BACTERIOL, V176, P2184, DOI 10.1128/JB.176.8.2184-2193.1994; Schweizer HP, 1996, J BACTERIOL, V178, P5215, DOI 10.1128/jb.178.17.5215-5221.1996; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; Son MS, 2008, PLASMID, V59, P111, DOI 10.1016/j.plasmid.2007.12.002; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; STOREY DG, 1992, INFECT IMMUN, V60, P4687, DOI 10.1128/IAI.60.11.4687-4694.1992; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Velasco-Garcia R, 1999, J BACTERIOL, V181, P1292; Wagner VE, 2008, CLIN REV ALLERG IMMU, V35, P124, DOI 10.1007/s12016-008-8079-9; Wargo MJ, 2008, J BACTERIOL, V190, P2690, DOI 10.1128/JB.01393-07; Wargo MJ, 2009, INFECT IMMUN, V77, P1103, DOI 10.1128/IAI.01008-08; WEISSENBORN DL, 1992, J BIOL CHEM, V267, P6122; Wilson R, 1998, THORAX, V53, P213, DOI 10.1136/thx.53.3.213; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zarzycki-Siek J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064554	50	28	28	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103778	10.1371/journal.pone.0103778	http://dx.doi.org/10.1371/journal.pone.0103778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068317	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700085
J	Tsao, TM; Tsai, MJ; Wang, YN; Lin, HL; Wu, CF; Hwang, JS; Hsu, SHJ; Chao, H; Chuang, KJ; Chou, CCK; Su, TC				Tsao, Tsung-Ming; Tsai, Ming-Jer; Wang, Ya-Nan; Lin, Heng-Lun; Wu, Chang-Fu; Hwang, Jing-Shiang; Hsu, Sandy-H. J.; Chao, Hsing; Chuang, Kai-Jen; Chou, Charles-C. K.; Su, Ta-Chen			The Health Effects of a Forest Environment on Subclinical Cardiovascular Disease and Heath-Related Quality of Life	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; NATURAL-KILLER ACTIVITY; INTIMA-MEDIA THICKNESS; EPIDEMIOLOGIC EVIDENCE; ANTICANCER PROTEINS; ARTERIAL STIFFNESS; PLASMA-FIBRINOGEN; PERSONAL EXPOSURE; TERM EXPOSURE; YOUNG-ADULTS	Background: Assessment of health effects of a forest environment is an important emerging area of public health and environmental sciences. Purpose: To demonstrate the long-term health effects of living in a forest environment on subclinical cardiovascular diseases (CVDs) and health-related quality of life (HRQOL) compared with that in an urban environment. Materials and Methods: This study included the detailed health examination and questionnaire assessment of 107 forest staff members (FSM) and 114 urban staff members (USM) to investigate the long-term health effects of a forest environment. Air quality monitoring between the forest and urban environments was compared. In addition, work-related factors and HRQOL were evaluated. Results: Levels of total cholesterol, low-density lipoprotein cholesterol, and fasting glucose in the USM group were significantly higher than those in the FSM group. Furthermore, a significantly higher intima-media thickness of the internal carotid artery was found in the USM group compared with that in the FSM group. Concentrations of air pollutants, such as NO, NO2, NOx, SO2, CO, PM2.5, and PM10 in the forest environment were significantly lower compared with those in the outdoor urban environment. Working hours were longer in the FSM group; however, the work stress evaluation as assessed by the job content questionnaire revealed no significant differences between FSM and USM. HRQOL evaluated by the World Health Organization Quality of Life-BREF questionnaire showed FSM had better HRQOL scores in the physical health domain. Conclusions: This study provides evidence of the potential beneficial effects of forest environments on CVDs and HRQOL.	[Tsao, Tsung-Ming; Tsai, Ming-Jer; Wang, Ya-Nan] Natl Taiwan Univ, Nantou, Taiwan; [Tsai, Ming-Jer; Wang, Ya-Nan] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10764, Taiwan; [Lin, Heng-Lun; Su, Ta-Chen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lin, Heng-Lun; Su, Ta-Chen] Natl Taiwan Univ Hosp, Cardiovasc Ctr, Taipei, Taiwan; [Wu, Chang-Fu] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan; [Hwang, Jing-Shiang] Acad Sinica, Inst Stat Sci, Taipei 115, Taiwan; [Hsu, Sandy-H. J.] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Chao, Hsing; Chuang, Kai-Jen] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Chou, Charles-C. K.] Acad Sinica, Res Ctr Environm Changes, Taipei 115, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Academia Sinica - Taiwan	Tsai, MJ (corresponding author), Natl Taiwan Univ, Nantou, Taiwan.	tachensu@ntu.edu.tw; tmj@ntu.edu.tw	Chou, Charles C.-K./R-3578-2016; Hwang, Jing-Shiang/AAP-2835-2021; Chao, Hsing Jasmine/AAR-1390-2021	Chou, Charles C.-K./0000-0003-3960-5333; Hwang, Jing-Shiang/0000-0002-5807-7583; Hsu, Sandy Huey-Jen/0000-0002-5539-4858; Wu, Chang-fu/0000-0003-2244-1934; SU, TA-CHEN/0000-0001-7523-7166	Experimental Forest, National Taiwan University [A14]; National Science Council, Taiwan (NSC) [101-2314-B-002-184-NY3]; National Taiwan University [NTU-CESRP-102R7620]	Experimental Forest, National Taiwan University; National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This study was financially supported by the Experimental Forest, National Taiwan University under grant no. A14 and no. 3 projects. National Science Council, Taiwan (NSC 101-2314-B-002-184-NY3) and National Taiwan University (NTU-CESRP-102R7620) also partially supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton PJ, 2006, LANCET ONCOL, V7, P883, DOI 10.1016/S1470-2045(06)70914-7; Bauer M, 2010, J AM COLL CARDIOL, V56, P1803, DOI 10.1016/j.jacc.2010.04.065; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805; Central Weather Bureau (CWB), 2010, MONTHL CLIM DAT; Chen SY, 2014, ENVIRON RES, V131, P1, DOI 10.1016/j.envres.2014.01.009; Chen SY, 2012, EPIDEMIOLOGY, V23, P341, DOI 10.1097/EDE.0b013e3182452f1d; Chiu MH, 2012, ARCH PHYS MED REHAB, V93, P512, DOI 10.1016/j.apmr.2011.11.001; CHOW JC, 1995, J AIR WASTE MANAGE, V45, P320, DOI 10.1080/10473289.1995.10467369; Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC; Elderon L, 2013, PROG CARDIOVASC DIS, V55, P511, DOI 10.1016/j.pcad.2013.03.010; Groessl EJ, 2007, AM J PREV MED, V33, P214, DOI 10.1016/j.amepre.2007.04.031; Horng YS, 2005, SPINE, V30, P551, DOI 10.1097/01.brs.0000154623.20778.f0; Huang CL, 2007, INT J CLIN PRACT, V61, P397, DOI 10.1111/j.1742-1241.2006.01227.x; Hwang HF, 2003, AGE AGEING, V32, P593, DOI 10.1093/ageing/afg102; Ito K, 2011, ENVIRON HEALTH PERSP, V119, P467, DOI 10.1289/ehp.1002667; Jia HM, 2010, AM J PREV MED, V39, P220, DOI 10.1016/j.amepre.2010.03.026; Kim C, 2004, AM J PREV MED, V27, P1, DOI 10.1016/j.amepre.2004.03.008; Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Lee J, 2011, PUBLIC HEALTH, V125, P93, DOI 10.1016/j.puhe.2010.09.005; Lee J, 2009, SCAND J FOREST RES, V24, P227, DOI 10.1080/02827580902903341; Leidy NK, 2006, VALUE HEALTH, V9, P394, DOI 10.1111/j.1524-4733.2006.00132.x; Li Q, 2008, J BIOL REG HOMEOS AG, V22, P45; Li Q, 2008, INT J IMMUNOPATH PH, V21, P117, DOI 10.1177/039463200802100113; Li Q, 2007, Int J Immunopathol Pharmacol, V20, P3; Lin CY, 2013, INT J CARDIOL, V168, P3309, DOI 10.1016/j.ijcard.2013.04.042; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Morita E, 2007, PUBLIC HEALTH, V121, P54, DOI 10.1016/j.puhe.2006.05.024; Mulle JG, 2013, PROG CARDIOVASC DIS, V55, P557, DOI 10.1016/j.pcad.2013.03.005; Ostro B, 2010, ENVIRON HEALTH PERSP, V118, P363, DOI 10.1289/ehp.0901181; Pope CA, 2006, CIRCULATION, V114, P2443, DOI 10.1161/CIRCULATIONAHA.106.636977; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Shin WS, 2007, SCAND J FOREST RES, V22, P248, DOI 10.1080/02827580701262733; Silva RA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034005; Strine TW, 2005, AM J PREV MED, V28, P182, DOI 10.1016/j.amepre.2004.10.002; Su TC, 2006, EUR J CARDIOV PREV R, V13, P849, DOI 10.1097/01.hjr.0000219116.25415.c4; Su TC, 2012, J ATHEROSCLER THROMB, V19, P872, DOI 10.5551/jat.10728; Su TC, 2011, INT J CARDIOL, V153, P100, DOI 10.1016/j.ijcard.2011.09.019; Su TC, 2014, ENV HLTH PE IN PRESS; The World Health Organization, 1955, HDB BAS DOC; Vaccarino V, 2012, BRAUNWALDS HEART DIS; Wu CF, 2012, SCI TOTAL ENVIRON, V431, P176, DOI 10.1016/j.scitotenv.2012.05.015; Wu CF, 2010, AM J EPIDEMIOL, V171, P1299, DOI 10.1093/aje/kwq060; Yao G, 2002, J FORMOS MED ASSOC, V101, P342	45	18	20	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103231	10.1371/journal.pone.0103231	http://dx.doi.org/10.1371/journal.pone.0103231			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068265	gold, Green Published, Green Submitted			2022-12-25	WOS:000339993700049
J	Dinh, J; Angeloni, JT; Pederson, DB; Wang, XX; Cao, M; Dong, YQ				Dinh, Jessica; Angeloni, Joseph T.; Pederson, Daniel B.; Wang, Xiaoxia; Cao, Min; Dong, Yuqing			Cranberry Extract Standardized for Proanthocyanidins Promotes the Immune Response of Caenorhabditis elegans to Vibrio cholerae through the p38 MAPK Pathway and HSF-1	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; EL-TOR BIOTYPE; HEAT-SHOCK; TEMPORAL REQUIREMENTS; MODEL HOST; LIFE-SPAN; GROWTH; MUTANT; PHYTOCHEMICALS; STERILIZATION	Botanicals are rich in bioactive compounds and some offer numerous beneficial effects to animal and human consumed. It is well known that phytochemicals in cranberries have anti-oxidative and antimicrobial activities. Recently, an increasing body of evidence has demonstrated that cranberry phytochemicals may have potential benefits that promote healthy aging. Here, we use Caenarhabditis elegans as a model to show that water-soluble cranberry extract standardized to 4.0% proanthocyanidins (WCESP), a major component of cranberries, can enhance host innate immunity resist against Vibro cholerae (V. cholerae; wild type C6706 (O1 El Tor biotype)) infection. Supplementationof WCESPdid not significantly alter the intestinal colonization of V. cholerae, but upregulated the expression of C. elegans innate immune genes, such as clec-7 clec-71, fmo-2, pqn-5 and C23G10.1. Additionally, WCESP treatment did not affect the growth of V. cholerae and expression of he major bacterial virulence genes, and only slightly reduced bacterial colonization within C. elegans intestine. These findings indicate that the major components Of WCESP, including proanthocyanidins (PACs), may play an important role in enhancing the host innate immunity. Moreover, we engaged C. elegans mutants and identified that the p38 MAPK signaling, insulin/IGF-1 signaling (IIS), and HSF-1 play pivotal roles in the WCESP-mediated host immune response. Considering the level of conservation between the innate immune pathways of C. elegans and humans, the results of this study suggest that WCESP may also play an immunity-promoting role in higher order organism.	[Dinh, Jessica; Angeloni, Joseph T.; Pederson, Daniel B.; Wang, Xiaoxia; Cao, Min; Dong, Yuqing] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Cao, Min; Dong, Yuqing] Clemson Univ, Inst Engaged Aging, Clemson, SC 29634 USA	Clemson University; Clemson University	Cao, M (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	mcao@clemson.edu; ydong@clemson.edu	Cao, Min/A-3532-2013	Cao, Min/0000-0003-1592-8111				ALM RA, 1991, J CLIN MICROBIOL, V29, P2438, DOI 10.1128/JCM.29.11.2438-2445.1991; Blumberg JB, 2013, ADV NUTR, V4, P618, DOI 10.3945/an.113.004473; Bradford PG, 2013, BIOFACTORS, V39, P78, DOI 10.1002/biof.1074; Chiang WC, 2012, CELL, V148, P322, DOI 10.1016/j.cell.2011.12.019; Cinar HN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011558; Cohen E, 2010, AGING CELL, V9, P126, DOI 10.1111/j.1474-9726.2009.00541.x; Engelmann I, 2010, ADV EXP MED BIOL, V708, P105; Ferguson PJ, 2006, NUTR CANCER, V56, P86, DOI 10.1207/s15327914nc5601_12; GANDHI S, 1980, MECH AGEING DEV, V12, P137, DOI 10.1016/0047-6374(80)90090-1; Gardel CL, 1996, INFECT IMMUN, V64, P2246, DOI 10.1128/IAI.64.6.2246-2255.1996; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gonzalez-Vallinas M, 2013, NUTR REV, V71, P585, DOI 10.1111/nure.12051; Guha S, 2014, NUTRIENTS, V6, P911, DOI 10.3390/nu6020911; Guha S, 2013, AGE, V35, P1559, DOI 10.1007/s11357-012-9459-x; HOSONO R, 1978, EXP GERONTOL, V13, P369, DOI 10.1016/0531-5565(78)90047-5; HOSONO R, 1982, EXP GERONTOL, V17, P163, DOI 10.1016/0531-5565(82)90052-3; Howell AB, 2005, PHYTOCHEMISTRY, V66, P2281, DOI 10.1016/j.phytochem.2005.05.022; Hsiao JY, 2013, J MICROBIOL, V51, P367, DOI 10.1007/s12275-013-2589-8; Joshua GWP, 2003, MICROBIOL-SGM, V149, P3221, DOI 10.1099/mic.0.26475-0; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Krueger CG, 2013, ANAL BIOANAL CHEM, V405, P4385, DOI 10.1007/s00216-013-6750-3; Kurz CL, 2003, NAT REV GENET, V4, P380, DOI 10.1038/nrg1067; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Liu Y, 2008, EMBO J, V27, P1049, DOI 10.1038/emboj.2008.42; Liu Z, 2011, P NATL ACAD SCI USA, V108, P810, DOI 10.1073/pnas.1014640108; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Marsh EK, 2012, APPL ENVIRON MICROB, V78, P2075, DOI 10.1128/AEM.07486-11; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Muralidharan S, 2013, J LEUKOCYTE BIOL, V94, P1167, DOI 10.1189/jlb.0313153; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Neto CC, 2007, MOL NUTR FOOD RES, V51, P652, DOI 10.1002/mnfr.200600279; Neto CC, 2007, J NUTR, V137, p186S, DOI 10.1093/jn/137.1.186S; Neto CC, 2011, J SCI FOOD AGR, V91, P2303, DOI 10.1002/jsfa.4621; Pappas E, 2009, CRIT REV FOOD SCI, V49, P741, DOI 10.1080/10408390802145377; Ray S, 2011, INFECT IMMUN, V79, P258, DOI 10.1128/IAI.00663-10; Sacco SM, 2013, BRIT J CLIN PHARMACO, V75, P697, DOI 10.1111/bcp.12033; Sahu SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038200; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulenburg H, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-49; Shivers RP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000892; Shmuely H, 2012, CURR OPIN BIOTECH, V23, P148, DOI 10.1016/j.copbio.2011.10.009; Sies H, 2010, ARCH BIOCHEM BIOPHYS, V501, P2, DOI 10.1016/j.abb.2010.04.006; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Singh V, 2006, CELL CYCLE, V5, P2443, DOI 10.4161/cc.5.21.3434; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Son MS, 2011, J CLIN MICROBIOL, V49, P3739, DOI 10.1128/JCM.01286-11; Sun YN, 2014, EXP GERONTOL, V50, P57, DOI 10.1016/j.exger.2013.11.020; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Volovik Y, 2012, AGING CELL, V11, P491, DOI 10.1111/j.1474-9726.2012.00811.x; Wang C, 2013, J GERONTOL A; Weisberg SP, 2008, ENDOCRINOLOGY, V149, P3549, DOI 10.1210/en.2008-0262; Wilson T, 1998, LIFE SCI, V62, pPL381; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299; Zou S, 2012, AGE, V34, P269, DOI 10.1007/s11357-011-9230-8; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	60	24	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103290	10.1371/journal.pone.0103290	http://dx.doi.org/10.1371/journal.pone.0103290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	25062095	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992600053
J	Sarkissyan, S; Sarkissyan, M; Wu, YY; Cardenas, J; Koeffler, HP; Vadgama, JV				Sarkissyan, Suren; Sarkissyan, Marianna; Wu, Yanyuan; Cardenas, Jessica; Koeffler, H. Phillip; Vadgama, Jaydutt V.			IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion	PLOS ONE			English	Article							GROWTH-FACTOR-I; TRANSCRIPTION FACTOR SNAIL; CCN FAMILY; RACIAL-DIFFERENCES; BINDING PROTEIN-3; INSULIN; PROGRESSION; EXPRESSION; RISK; SURVIVAL	Background: Studies from our laboratory and others have shown that cysteine-rich 61 (Cyr61) may be involved in tumor proliferation and invasion. In earlier studies, we demonstrated increased insulin-like growth factor-I (IGF-1) is associated with breast tumor formation and poor clinical outcomes. In our current study we have investigated IGF-1 regulation of Cyr61 and whether targeting IGF-1 could inhibit Cyr61 induced tumor growth and proliferation. Methods: Several ATCC derived normal and breast cancer cell lines were used in this study: MDA-MB231, BT474, MCF-7, and SKBR3. We also tested cells stably transfected in our laboratory with active Akt1 (pAkt; SKBR3/AA and MCF-7/AA) and dominant negative Akt1 (SKBR3/DN and MCF-7/DN). In addition, we used MCF-7 cells transfected with full length Cyr61 (CYA). Monolayer cultures treated with IGF-1 were analyzed for Cyr61 expression by RT-PCR and immunohistochemical staining. Migration assays and MU based proliferation assays were used to determine invasive characteristics in response to IGF-1/Cyr61 activation. Results: Cells with activated Akt have increased levels of Cyr61. Conversely, cells with inactive Akt have decreased levels of Cyr61. IGF-1 treatment increased Cyr61 expression significantly and cells with high level of Cyr61 demonstrate increased invasiveness and proliferation. Cyr61 overexpression and activation led to decrease in E-cadherin and decrease in FOXO1. Inhibition of the PI3K and MAPK pathways resulted in significant decrease in invasiveness and proliferation, most notably in the PI3K pathway inhibited cells. Conclusion: The findings of this study show that IGF-1 upregulates Cyr61 primarily through activation of the Akt-PI3K pathway. IGF-1 induced MAPK plays a partial role. Increase in Cyr61 leads to increase in breast cancer cell growth and invasion. Hence, targeting Cyr61 and associated pathways may offer an opportunity to inhibit IGF-1 mediated Cyr61 induced breast cancer growth and invasion.	[Sarkissyan, Suren; Sarkissyan, Marianna; Wu, Yanyuan; Cardenas, Jessica; Vadgama, Jaydutt V.] Charles R Drew Univ Med & Sci, Dept Internal Med, Ctr Eliminate Canc Hlth Dispar, Div Canc Res & Training, Los Angeles, CA 90059 USA; [Wu, Yanyuan; Koeffler, H. Phillip; Vadgama, Jaydutt V.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Koeffler, H. Phillip] Cedars Sinai Med Ctr, Dept Internal Med, Div Hematol Oncol, Los Angeles, CA 90048 USA	Charles R. Drew University of Medicine & Science; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Cedars Sinai Medical Center	Vadgama, JV (corresponding author), Charles R Drew Univ Med & Sci, Dept Internal Med, Ctr Eliminate Canc Hlth Dispar, Div Canc Res & Training, 1621 E 120th St, Los Angeles, CA 90059 USA.	jayvadgama@cdrewu.edu		Cardenas, Jessica/0000-0001-5369-5238	National Institute of Health/National Cancer Institute [1U54CA14393, 1U56CA101599, R25DK067105]; Department of Defense [BC043180]; NATIONAL CANCER INSTITUTE [U56CA101599, U54CA143931] Funding Source: NIH RePORTER	National Institute of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Institute of Health/National Cancer Institute 1U54CA14393, 1U56CA101599, R25DK067105, and the Department of Defense BC043180 to J.V. Vadgama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, ADV EXP MED BIOL, V343, P1; ARTEAGA CL, 1989, J CLIN INVEST, V84, P1418, DOI 10.1172/JCI114315; Baglietto L, 2007, CANCER EPIDEM BIOMAR, V16, P763, DOI 10.1158/1055-9965.EPI-06-0960; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chai JY, 2010, LAB INVEST, V90, P1140, DOI 10.1038/labinvest.2010.101; Chlebowski RT, 2005, JNCI-J NATL CANCER I, V97, P439, DOI 10.1093/jnci/dji064; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Fowke JH, 2010, ENDOCR-RELAT CANCER, V17, P51, DOI 10.1677/ERC-09-0023; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KAREY KP, 1988, CANCER RES, V48, P4083; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; LEROITH D, 1995, ANN INTERN MED, V122, P54, DOI 10.7326/0003-4819-122-1-199501010-00009; Leu SJJ, 2013, BIOCHEM BIOPH RES CO, V434, P885, DOI 10.1016/j.bbrc.2013.04.045; Lin JPA, 2012, CANCER IMMUNOL IMMUN, V61, P677, DOI 10.1007/s00262-011-1135-y; Menendez JA, 2005, ONCOGENE, V24, P761, DOI 10.1038/sj.onc.1208238; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; O'Kelly J, 2008, INT J ONCOL, V33, P59; Pinheiro SP, 2005, CANCER EPIDEM BIOMAR, V14, P2147, DOI 10.1158/1055-9965.EPI-04-0944; POLLAK M, 1990, J NATL CANCER I, V82, P1693, DOI 10.1093/jnci/82.21.1693; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Rinaldi S, 2006, ENDOCR-RELAT CANCER, V13, P593, DOI 10.1677/erc.1.01150; Sampath D, 2001, ENDOCRINOLOGY, V142, P2540, DOI 10.1210/en.142.6.2540; SASAKI A, 1995, CANCER RES, V55, P3551; Surmacz E, 1998, BREAST CANCER RES TR, V47, P255, DOI 10.1023/A:1005907101686; Tolia M, 2014, ANTICANCER RES, V34, P23; Tsai MS, 2002, ONCOGENE, V21, P8178, DOI 10.1038/sj.onc.1205682; Vadgama JV, 1999, ONCOLOGY-BASEL, V57, P330, DOI 10.1159/000012052; Wu YY, 2012, AM J CANCER RES, V2, P104; Wu YY, 2010, CANCER RES, V70, P5475, DOI 10.1158/0008-5472.CAN-10-0176; Wu Yu-Huan, 2008, P3; Xie D, 2001, CANCER RES, V61, P8917; Xie D, 2001, J BIOL CHEM, V276, P14187, DOI 10.1074/jbc.M009755200	38	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103534	10.1371/journal.pone.0103534	http://dx.doi.org/10.1371/journal.pone.0103534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	25062088	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992600082
J	Doonan, PJ; Chandramoorthy, HC; Hoffman, NE; Zhang, XQ; Cardenas, C; Shanmughapriya, S; Rajan, S; Vallem, S; Chen, XW; Foskett, JK; Cheung, JY; Houser, SR; Madesh, M				Doonan, Patrick J.; Chandramoorthy, Harish C.; Hoffman, Nicholas E.; Zhang, Xueqian; Cardenas, Cesar; Shanmughapriya, Santhanam; Rajan, Sudarsan; Vallem, Sandhya; Chen, Xiongwen; Foskett, J. Kevin; Cheung, Joseph Y.; Houser, Steven R.; Madesh, Muniswamy			LETM1-dependent mitochondrial Ca2+ flux modulates cellular bioenergetics and proliferation	FASEB JOURNAL			English	Article						Wolf-Hirschhorn syndrome; cell cycle; metabolism; reactive oxygen species	WOLF-HIRSCHHORN-SYNDROME; PERMEABILITY TRANSITION PORE; CALCIUM UNIPORTER; ESSENTIAL COMPONENT; CYCLOPHILIN-D; CYTOCHROME-C; LETM1; PROTEIN; GENE; SUPEROXIDE	Dysregulation of mitochondrial Ca2+-dependent bioenergetics has been implicated in various pathophysiological settings, including neurodegeneration and myocardial infarction. Although mitochondrial Ca2+ transport has been characterized, and several molecules, including LETM1, have been identified, the functional role of LETM1-mediated Ca2+ transport remains unresolved. This study examines LETM1-mediated mitochondrial Ca2+ transport and bioenergetics in multiple cell types, including fibroblasts derived from patients with Wolf-Hirschhorn syndrome (WHS). The results show that both mitochondrial Ca2+ influx and efflux rates are impaired in LETM1 knockdown, and similar phenotypes were observed in EF hand, (D676A D688K)LETM1 mutant-overexpressed cells, and in cells derived from patients with WHS. Although LETM1 levels were lower in WHS-derived fibroblasts, the mitochondrial Ca2+ uniporter components MCU, MCUR1, and MICU1 remain unaltered. In addition, the MCU mitoplast patch-clamp current (I-MCU) was largely unaffected in LETM1-knockdown cells. Silencing of LETM1 also impaired basal mitochondrial oxygen consumption, possibly via complex IV inactivation and ATP production. Remarkably, LETM1 knockdown also resulted in increased reactive oxygen species production. Further, LETM1 silencing promoted AMPK activation, autophagy, and cell cycle arrest. Reconstitution of LETM1 or antioxidant overexpression rescued mitochondrial Ca2+ transport and bioenergetics. These findings reveal the role of LETM1-dependent mitochondrial Ca2+ flux in shaping cellular bioenergetics.Doonan, P J., Chandramoorthy, H. C., Hoffman, N. E., Zhang, X., Cardenas, C., Shanmughapriya, S., Rajan, S., Vallem, S., Chen, X., Foskett, J. K., Cheung, J. Y., Houser, S. R., Madesh, M. LETM1-dependent mitochondrial Ca2+ flux modulates cellular bioenergetics and proliferation.	[Doonan, Patrick J.; Chandramoorthy, Harish C.; Hoffman, Nicholas E.; Shanmughapriya, Santhanam; Rajan, Sudarsan; Vallem, Sandhya; Madesh, Muniswamy] Temple Univ, Dept Biochem, Sch Med, Philadelphia, PA 19140 USA; [Doonan, Patrick J.; Chandramoorthy, Harish C.; Hoffman, Nicholas E.; Zhang, Xueqian; Shanmughapriya, Santhanam; Rajan, Sudarsan; Vallem, Sandhya; Cheung, Joseph Y.; Madesh, Muniswamy] Temple Univ, Ctr Translat Med, Sch Med, Philadelphia, PA 19140 USA; [Chen, Xiongwen; Houser, Steven R.] Temple Univ, Cardiovasc Res Ctr, Sch Med, Philadelphia, PA 19140 USA; [Chen, Xiongwen; Houser, Steven R.] Temple Univ, Dept Physiol, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Cardenas, Cesar] Univ Chile, Inst Biomed Sci, Anat & Dev Biol Program, Santiago, Chile; [Foskett, J. Kevin] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Universidad de Chile; University of Pennsylvania	Madesh, M (corresponding author), Temple Univ, Dept Biochem, 3500 N Broad St,950 MERB, Philadelphia, PA 19140 USA.	madeshm@temple.edu	Chandramoorthy, Harish C/A-6533-2019; Cardenas, Julio C/I-3221-2013; Chen, Xiongwen/D-5988-2012; Shanmughapriya, Santhanam/P-2828-2017	Chen, Xiongwen/0000-0002-3829-5815; Shanmughapriya, Santhanam/0000-0003-1041-8198; Foskett, J. Kevin/0000-0002-8854-0268; Chinna Konda Chandramoorthy, Harish/0000-0002-8780-8971	U.S. National Institutes of Health [R01HL-086699, R01HL-119306, 1S10RR-027327-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027327] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119306, R01HL088243, R01HL086699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056328, R01GM109882] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Drs. Donald L. Gill and Walter J. Koch for their comments on the manuscript. The authors thank Maggie Cheung and Karthik Mallilamkaraman for their cell culture work. This work was supported by the U.S. National Institutes of Health (R01HL-086699, R01HL-119306 and 1S10RR-027327-01 to MM).	Baines CP, 2010, ANNU REV PHYSIOL, V72, P61, DOI 10.1146/annurev-physiol-021909-135929; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Endele S, 1999, GENOMICS, V60, P218, DOI 10.1006/geno.1999.5881; Fieni F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2325; Halestrap A, 2005, NATURE, V434, P578, DOI 10.1038/434578a; Halestrap AP, 1997, MOL CELL BIOCHEM, V174, P167, DOI 10.1023/A:1006879618176; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hanley-Lopez J, 1998, J PEDIATR-US, V133, P141, DOI 10.1016/S0022-3476(98)70194-5; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hawkins BJ, 2007, MOL BIOL CELL, V18, P2002, DOI 10.1091/mbc.E06-09-0830; Hawkins BJ, 2010, J BIOL CHEM, V285, P26494, DOI 10.1074/jbc.M110.143164; HIRSCHHORN K, 1965, HUMANGENETIK, V1, P479; Hoffman NE, 2014, MOL BIOL CELL, V25, P936, DOI 10.1091/mbc.E13-08-0502; Hoffman NE, 2013, CELL REP, V5, P1576, DOI 10.1016/j.celrep.2013.11.026; Irrinki KM, 2011, MOL CELL BIOL, V31, P3745, DOI 10.1128/MCB.05303-11; Jiang DW, 2013, P NATL ACAD SCI USA, V110, pE2249, DOI 10.1073/pnas.1308558110; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Joiner MLA, 2012, NATURE, V491, P269, DOI 10.1038/nature11444; Jones RG, 2007, IMMUNITY, V27, P268, DOI 10.1016/j.immuni.2007.05.023; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022; Madesh M, 2002, J BIOL CHEM, V277, P5651, DOI 10.1074/jbc.M108171200; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Madesh M, 2009, MOL CELL BIOL, V29, P3099, DOI 10.1128/MCB.01845-08; Mallilankaraman K, 2013, NAT CELL BIOL, V15, P123, DOI 10.1038/ncb2669; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; McQuibban AG, 2010, HUM MOL GENET, V19, P987, DOI 10.1093/hmg/ddp563; Miller BA, 2014, J BIOL CHEM, V289, P7615, DOI 10.1074/jbc.M113.533851; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Nowikovsky K, 2012, J GEN PHYSIOL, V139, P445, DOI 10.1085/jgp.201110757; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Santo-Domingo J, 2012, J GEN PHYSIOL, V139, P415, DOI 10.1085/jgp.201110767; Schlickum S, 2004, GENOMICS, V83, P254, DOI 10.1016/j.ygeno.2003.08.013; Sheu SS, 2012, J GEN PHYSIOL, V139, P391, DOI 10.1085/jgp.201210819; Tamai S, 2008, J CELL SCI, V121, P2588, DOI 10.1242/jcs.026625; Tsai MF, 2014, J GEN PHYSIOL, V143, P67, DOI 10.1085/jgp.201311096; Vagnozzi RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006479; Waldeck-Weiermair M, 2011, J BIOL CHEM, V286, P28444, DOI 10.1074/jbc.M111.244517; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302	52	79	79	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4936	4949		10.1096/fj.14-256453	http://dx.doi.org/10.1096/fj.14-256453			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25077561	Green Published			2022-12-25	WOS:000344050900030
J	Husse, J; Leliavski, A; Tsang, AH; Oster, H; Eichele, G				Husse, Jana; Leliavski, Alexei; Tsang, Anthony H.; Oster, Henrik; Eichele, Gregor			The light-dark cycle controls peripheral rhythmicity in mice with a genetically ablated suprachiasmatic nucleus clock	FASEB JOURNAL			English	Article						circadian; synaptotagmin10	GENE-EXPRESSION; CIRCADIAN CLOCK; LOCOMOTOR-ACTIVITY; ADRENAL-GLAND; BEHAVIOR; REVEALS; LESIONS; GLUCOCORTICOIDS; ELIMINATE; PACEMAKER	The mammalian circadian timing system consists of a master pacemaker in the suprachiasmatic nucleus (SCN), which is thought to synchronize peripheral clocks in various organs with each other and with external time. Our knowledge about the role of the SCN clock is based mainly on SCN lesion and transplantation studies. We have now directly deleted the SCN clock using the Cre/LoxP system and investigated how this affects synchronization of peripheral rhythms. Impaired locomotor activity and arrhythmic clock gene expression in the SCN confirm that the SCN clockwork was efficiently abolished in our mouse model. Nonetheless, under light-dark (LD) conditions, peripheral clocks remained rhythmic and synchronized to the LD cycle, and phase relationships between peripheral clocks were sustained. Adaptation to a shifted LD cycle was accelerated in SCN clock-deficient mice. Moreover, under zeitgeber-free conditions, rhythmicity of the peripheral clock gene expression was initially dampened, and after several days peripheral clocks were desynchronized. These findings suggest that the SCN clock is dispensable for the synchronization of peripheral clocks to the LD cycle. A model describing an SCN clock-independent pathway that synchronizes peripheral clocks with the LD cycle is discussed.Husse, J., Leliavski, A., Tsang, A. H., Oster, H., Eichele, G. The light-dark cycle controls peripheral rhythmicity in mice with a genetically ablated suprachiasmatic nucleus clock.	[Husse, Jana; Leliavski, Alexei; Tsang, Anthony H.; Oster, Henrik; Eichele, Gregor] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society	Oster, H (corresponding author), Med Univ Lubeck, Dept Med 1, Chronophysiol Grp, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	henrik.oster@uksh.de	Oster, Henrik/O-4426-2019; Leliavski, Alexei/N-9333-2017	Oster, Henrik/0000-0002-1414-7068; Tsang, Anthony/0000-0002-3673-6365; Leliavski, Alexei/0000-0003-0279-9226	Sleep and Biological Rhythms Toronto (University of Toronto, Toronto, ON, Canada); Max Planck Society	Sleep and Biological Rhythms Toronto (University of Toronto, Toronto, ON, Canada); Max Planck Society(Max Planck SocietyFoundation CELLEX)	H.O. is a Lichtenberg fellow of the Volkswagen Foundation. J.H. was supported by a fellowship from Sleep and Biological Rhythms Toronto (University of Toronto, Toronto, ON, Canada).. This work was supported by the Max Planck Society. The authors declare no conflicts of interest.	Abraham D, 2006, J BIOL RHYTHM, V21, P169, DOI 10.1177/0748730406288040; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Batschelet E, 1981, CIRCULAR STAT BIOL; Brown Steven A, 2013, Handb Exp Pharmacol, P45, DOI 10.1007/978-3-642-25950-0_3; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Guo HG, 2006, J NEUROSCI, V26, P6406, DOI 10.1523/JNEUROSCI.4676-05.2006; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Husse J, 2011, J BIOL RHYTHM, V26, P379, DOI 10.1177/0748730411415363; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Jud C, 2005, BIOL PROCED ONLINE, V7, P101, DOI 10.1251/bpo109; Kalsbeek A, 2010, J NEUROENDOCRINOL, V22, P362, DOI 10.1111/j.1365-2826.2010.01956.x; Kasukawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023228; Kiessling S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092959; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; Ko CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000513; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Maywood ES, 2011, P NATL ACAD SCI USA, V108, P14306, DOI 10.1073/pnas.1101767108; Meyer-Bernstein EL, 1999, ENDOCRINOLOGY, V140, P207, DOI 10.1210/en.140.1.207; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; NIIJIMA A, 1993, PHYSIOL BEHAV, V54, P555, DOI 10.1016/0031-9384(93)90249-F; NIIJIMA A, 1992, J AUTONOM NERV SYST, V40, P155, DOI 10.1016/0165-1838(92)90026-D; Ono D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080615; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Paxinos G., 2008, MOUSE BRAIN STEREOTA; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; REFINETTI R, 1994, J COMP PHYSIOL A, V175, P223, DOI 10.1007/BF00215118; Saini C, 2013, GENE DEV, V27, P1526, DOI 10.1101/gad.221374.113; Sakamoto K, 1998, J BIOL CHEM, V273, P27039, DOI 10.1074/jbc.273.42.27039; Schwartz WJ, 2011, P NATL ACAD SCI USA, V108, P17219, DOI 10.1073/pnas.1107848108; Sellix MT, 2010, CURR BIOL, V20, pR266, DOI 10.1016/j.cub.2010.01.045; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Tahara Y, 2012, CURR BIOL, V22, P1029, DOI 10.1016/j.cub.2012.04.009; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Yao Z, 2014, SCIENCE, V343, P1516, DOI 10.1126/science.1251285; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	47	84	85	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4950	4960		10.1096/fj.14-256594	http://dx.doi.org/10.1096/fj.14-256594			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25063847				2022-12-25	WOS:000344050900031
J	Abrol, N; Smolin, N; Armanious, G; Ceholski, DK; Trieber, CA; Young, HS; Robia, SL				Abrol, Neha; Smolin, Nikolai; Armanious, Gareth; Ceholski, Delaine K.; Trieber, Catharine A.; Young, Howard S.; Robia, Seth L.			Phospholamban C-terminal Residues Are Critical Determinants of the Structure and Function of the Calcium ATPase Regulatory Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LETHAL DILATED CARDIOMYOPATHY; MOLECULAR-DYNAMICS METHOD; PARTICLE MESH EWALD; SARCOPLASMIC-RETICULUM; CARDIAC CONTRACTILITY; HEART-FAILURE; HYPERTROPHIC CARDIOMYOPATHY; ENDOPLASMIC-RETICULUM; FORCE-FIELDS; MUTATION	To determine the structural and regulatory role of the C-terminal residues of phospholamban (PLB) in the membranes of living cells, we fused fluorescent protein tags to PLB and sarco/endoplasmic reticulum calcium ATPase (SERCA). Alanine substitution of PLB C-terminal residues significantly altered fluorescence resonance energy transfer (FRET) from PLB to PLB and SERCA to PLB, suggesting a change in quaternary conformation of PLB pentamer and SERCA-PLB regulatory complex. Val to Ala substitution at position 49 (V49A) had particularly large effects on PLB pentamer structure and PLB-SERCA regulatory complex conformation, increasing and decreasing probe separation distance, respectively. We also quantified a decrease in oligomerization affinity, an increase in binding affinity of V49A-PLB for SERCA, and a gain of inhibitory function as quantified by calcium-dependent ATPase activity. Notably, deletion of only a few C-terminal residues resulted in significant loss of PLB membrane anchoring and mislocalization to the cytoplasm and nucleus. C-terminal truncations also resulted in progressive loss of PLB-PLB FRET due to a decrease in the apparent affinity of PLB oligomerization. We quantified a similar decrease in the binding affinity of truncated PLB for SERCA and loss of inhibitory potency. However, despite decreased SERCA-PLB binding, intermolecular FRET for Val(49)-stop (V49X) truncation mutant was paradoxically increased as a result of an 11.3-angstrom decrease in the distance between donor and acceptor fluorophores. We conclude that PLB C-terminal residues are critical for localization, oligomerization, and regulatory function. In particular, the PLB C terminus is an important determinant of the quaternary structure of the SERCA regulatory complex.	[Abrol, Neha; Smolin, Nikolai; Robia, Seth L.] Loyola Univ, Dept Cell & Mol Physiol, Maywood, IL 60153 USA; [Armanious, Gareth; Ceholski, Delaine K.; Trieber, Catharine A.; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	Loyola University Chicago; University of Alberta	Robia, SL (corresponding author), Loyola Univ, Dept Cell & Mol Physiol, 2160 S First Ave, Maywood, IL 60153 USA.	srobia@luc.edu	Smolin, Nikolai/C-6606-2008	Young, Howard/0000-0002-5990-8422; Trieber, Catharine/0000-0002-1336-1126	National Institutes of Health [R01 HL092321]; National Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Alberta Innovates-Technology Futures; Heart and Stroke Foundation of Canada; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR030939] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Technology Futures; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL092321. This work was also supported by a gift from the McCormick Foundation to Loyola University Chicago.; Supported by a Canada graduate scholarship from the National Sciences and Engineering Research Council of Canada.; Supported by a Canada graduate scholarship from the Canadian Institutes of Health Research and Alberta Innovates-Technology Futures. Present address: Mount Sinai Hospital, Icahn School of Medicine, Leon and Norma Hess Center for Science and Medicine, New York, NY 10029.; Supported by the Heart and Stroke Foundation of Canada.	Akin BL, 2013, J BIOL CHEM, V288, P30181, DOI 10.1074/jbc.M113.501585; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Bluhm WF, 2000, AM J PHYSIOL-HEART C, V278, pH249, DOI 10.1152/ajpheart.2000.278.1.H249; Butler J, 2007, CARDIOVASC RES, V74, P114, DOI 10.1016/j.cardiores.2007.01.006; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Chiu C, 2007, J MOL CELL CARDIOL, V43, P337, DOI 10.1016/j.yjmcc.2007.06.009; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeWitt MM, 2006, J AM COLL CARDIOL, V48, P1396, DOI 10.1016/j.jacc.2006.07.016; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FUJII J, 1989, J BIOL CHEM, V264, P12950; Gadella T. W., 2009, FRET FLIM TECHNIQUES, P193; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Haghighi K, 2001, J BIOL CHEM, V276, P24145, DOI 10.1074/jbc.M102403200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; Karim CB, 1998, BIOCHEMISTRY-US, V37, P12074, DOI 10.1021/bi980642n; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Kimura Akinori, 2008, Circ J, V72 Suppl A, pA38, DOI 10.1253/circj.CJ-08-0050; Kimura Y, 1996, J BIOL CHEM, V271, P21726, DOI 10.1074/jbc.271.36.21726; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Landstrom AP, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.08.001; Li JH, 2004, BIOCHEMISTRY-US, V43, P3870, DOI 10.1021/bi036183u; Lopez-Sendon J., 2011, MEDICOGRAPHIA, V33, P363; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Medeiros A, 2011, AM HEART J, V162, P1088, DOI 10.1016/j.ahj.2011.07.028; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Pallikkuth S, 2013, BIOPHYS J, V105, P1812, DOI 10.1016/j.bpj.2013.08.045; Park WJ, 2013, BMB REP, V46, P237, DOI 10.5483/BMBRep.2013.46.5.077; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Posch MG, 2009, HEART RHYTHM, V6, P480, DOI 10.1016/j.hrthm.2009.01.016; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Stenoien DL, 2007, AM J PHYSIOL-CELL PH, V292, pC2084, DOI 10.1152/ajpcell.00523.2006; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; Towbin Jeffrey A, 2002, Expert Rev Mol Diagn, V2, P587, DOI 10.1586/14737159.2.6.587; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; Trieber CA, 2005, BIOCHEMISTRY-US, V44, P3289, DOI 10.1021/bi047878d; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; Verardi R, 2011, P NATL ACAD SCI USA, V108, P9101, DOI 10.1073/pnas.1016535108; WARREN GB, 1974, P NATL ACAD SCI USA, V71, P622, DOI 10.1073/pnas.71.3.622; Young HS, 1997, BIOPHYS J, V72, P2545, DOI 10.1016/S0006-3495(97)78898-2; Young HS, 2001, BIOPHYS J, V81, P884, DOI 10.1016/S0006-3495(01)75748-7; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5; Zvaritch E, 2000, J BIOL CHEM, V275, P14985, DOI 10.1074/jbc.275.20.14985	65	13	14	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25855	25866		10.1074/jbc.M114.562579	http://dx.doi.org/10.1074/jbc.M114.562579			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074938	hybrid, Green Published			2022-12-25	WOS:000342130800042
J	Saita, S; Shirane, M; Ishitani, T; Shimizu, N; Nakayama, KI				Saita, Shotaro; Shirane, Michiko; Ishitani, Tohru; Shimizu, Nobuyuki; Nakayama, Keiichi I.			Role of the ANKMY2-FKBP38 Axis in Regulation of the Sonic Hedgehog (Shh) Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURITE EXTENSION; MEMBRANE-PROTEIN; TRANSGENIC MICE; PRIMARY CILIUM; GLI PROTEINS; FKBP38; EXPRESSION; P27(KIP1); RECEPTOR; IMMUNOPHILINS	Sonic hedgehog (Shh) is a secreted morphogen that controls the patterning and growth of various tissues in the developing vertebrate embryo, including the central nervous system. Ablation of the FK506-binding protein 38 (FKBP38) gene results in activation of the Shh signaling pathway in mouse embryos, but the molecular mechanism by which FKBP38 suppresses Shh signaling has remained unclear. With the use of a proteomics approach, we have now identified ANKMY2, a protein with three ankyrin repeats and a MYND (myeloid, Nervy, and DEAF-1)-type Zn2+ finger domain, as a molecule that interacts with FKBP38. Co-immunoprecipitation analysis confirmed that endogenous FKBP38 and ANKMY2 interact in the mouse brain. Depletion or overexpression of ANKMY2 resulted in down- and up-regulation of Shh signaling, respectively, in mouse embryonic fibroblasts. Furthermore, combined depletion of both FKBP38 and ANKMY2 attenuated Shh signaling in these cells, suggesting that ANKMY2 acts downstream of FKBP38 to activate the Shh signaling pathway. Targeting of the zebrafish ortholog of mouse Ankmy2 (ankmy2a) in fish embryos with an antisense morpholino oligonucleotide conferred a phenotype reflecting loss of function of the Shh pathway, suggesting that the regulation of Shh signaling by ANKMY2 is conserved between mammals and fish. Our findings thus indicate that the FKBP38-ANKMY2 axis plays a key role in regulation of Shh signaling in vivo.	[Saita, Shotaro; Shirane, Michiko; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Div Cell Biol, Higashi Ku, Fukuoka 8128582, Japan; [Ishitani, Tohru; Shimizu, Nobuyuki] Kyushu Univ, Med Inst Bioregulat, Div Cell Regulat Syst, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University; Kyushu University	Shirane, M (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	smichi@bioreg.kyushu-u.ac.jp	, Tohru/AAH-8979-2020; Ishitani, Tohru/E-9781-2014	, Tohru/0000-0002-6200-7043; Shirane, Michiko/0000-0002-8297-9245; Saita, Shotaro/0000-0002-7406-8361	Japan Society for the Promotion of Science (JSPS) fellowship	Japan Society for the Promotion of Science (JSPS) fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Japan Society for the Promotion of Science (JSPS) fellowship (to S. S.).	Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Cho A, 2008, DEV BIOL, V321, P27, DOI 10.1016/j.ydbio.2008.05.558; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fujiwara M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001211; Hamilton GS, 1998, J MED CHEM, V41, P5119, DOI 10.1021/jm980307x; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Ishitani T, 2005, NAT CELL BIOL, V7, P1106, DOI 10.1038/ncb1311; Jensen VL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001199; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; LAM E, 1995, GENE, V160, P297, DOI 10.1016/0378-1119(95)00216-S; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Matsuzaki F, 2011, MOL BIOL CELL, V22, P4602, DOI 10.1091/mbc.E11-01-0068; MILLER JB, 1989, J BIOL CHEM, V264, P13122; Murdoch JN, 2010, BIRTH DEFECTS RES A, V88, P633, DOI 10.1002/bdra.20686; Nakagawa T, 2007, GENES CELLS, V12, P709, DOI 10.1111/j.1365-2443.2007.01086.x; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nielsen JV, 2004, GENOMICS, V83, P181, DOI 10.1016/j.ygeno.2003.07.001; Ota S, 2012, EMBO J, V31, P1904, DOI 10.1038/emboj.2012.46; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Robertson CP, 2001, DEV BIOL, V238, P157, DOI 10.1006/dbio.2001.0392; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Saita S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2400; Saita S, 2009, J BIOL CHEM, V284, P13766, DOI 10.1074/jbc.M807938200; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Shirane M, 2008, GENES CELLS, V13, P635, DOI 10.1111/j.1365-2443.2008.01194.x; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Susaki E, 2010, J BIOL CHEM, V285, P15538, DOI 10.1074/jbc.M110.105841; Yamamoto T, 2005, J BIOL CHEM, V280, P16979, DOI 10.1074/jbc.M412433200	39	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25639	25654		10.1074/jbc.M114.558635	http://dx.doi.org/10.1074/jbc.M114.558635			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25077969	hybrid, Green Published			2022-12-25	WOS:000342130800024
J	da Silva Giehl, NF; Dias-Silva, K; Juen, L; Batista, JD; Cabette, HSR				da Silva Giehl, Nubia Franca; Dias-Silva, Karina; Juen, Leandro; Batista, Joana Darc; Cabette, Helena Soares Ramos			Taxonomic and Numerical Resolutions of Nepomorpha (Insecta: Heteroptera) in Cerrado Streams	PLOS ONE			English	Article							HABITAT INTEGRITY; SPECIES RICHNESS; WATER-QUALITY; PATTERNS; RIVER; TAXA; MACROINVERTEBRATES; BIOASSESSMENTS; COMMUNITIES; ASSEMBLAGES	Transformations of natural landscapes and their biodiversity have become increasingly dramatic and intense, creating a demand for rapid and inexpensive methods to assess and monitor ecosystems, especially the most vulnerable ones, such as aquatic systems. The speed with which surveys can collect, identify, and describe ecological patterns is much slower than that of the loss of biodiversity. Thus, there is a tendency for higher-level taxonomic identification to be used, a practice that is justified by factors such as the cost-benefit ratio, and the lack of taxonomists and reliable information on species distributions and diversity. However, most of these studies do not evaluate the degree of representativeness obtained by different taxonomic resolutions. Given this demand, the present study aims to investigate the congruence between species-level and genus-level data for the infraorder Nepomorpha, based on taxonomic and numerical resolutions. We collected specimens of aquatic Nepomorpha from five streams of first to fourth order of magnitude in the Pindaiba River Basin in the Cerrado of the state of Mato Grosso, Brazil, totaling 20 sites. A principal coordinates analysis (PCoA) applied to the data indicated that species-level and genus-level abundances were relatively similar (>80% similarity), although this similarity was reduced when compared with the presence/absence of genera (R = 0.77). The presence/absence ordinations of species and genera were similar to those recorded for their abundances (R = 0.95 and R = 0.74, respectively). The results indicate that analyses at the genus level may be used instead of species, given a loss of information of 11 to 19%, although congruence is higher when using abundance data instead of presence/absence. This analysis confirms that the use of the genus level data is a safe shortcut for environmental monitoring studies, although this approach must be treated with caution when the objectives include conservation actions, and faunal complementarity and/or inventories.	[da Silva Giehl, Nubia Franca] Univ Estado de Mato Grosso, Prog Postgrad Ecol & Conservacao, Mato Grosso, Brazil; [Dias-Silva, Karina] Univ Fed Goias, Prog Posgrad Ciencias Ambientais, Goiania, Go, Brazil; [Juen, Leandro] Fed Univ Para, Inst Ciencias Biol, Lab Ecol Conservacao, BR-66059 Belem, Para, Brazil; [da Silva Giehl, Nubia Franca; Batista, Joana Darc; Cabette, Helena Soares Ramos] Univ Estado de Mato Grosso, Entomol Lab, Mato Grosso, Brazil; [Cabette, Helena Soares Ramos] Univ Estado de Mato Grosso, Dept Biol, Mato Grosso, Brazil	Universidade do Estado de Mato Grosso; Universidade Federal de Goias; Universidade Federal do Para; Universidade do Estado de Mato Grosso; Universidade do Estado de Mato Grosso	da Silva Giehl, NF (corresponding author), Univ Estado de Mato Grosso, Prog Postgrad Ecol & Conservacao, Mato Grosso, Brazil.	nubiagiehl@gmail.com	Juen, Leandro/R-4014-2019; Dias-Silva, Karina KDS/H-3164-2014; Dias-Silva, Karina/AAS-5796-2020; Giehl, Nubia F.S./K-8952-2015; Juen, Leandro/I-1338-2012	Juen, Leandro/0000-0002-6188-4386; Giehl, Nubia F.S./0000-0001-5733-2100; Dias-Silva, Karina/0000-0001-5548-4995	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); PELD/CNPq; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT) [Proc. 98/04]; Programa de Apoio a Pos-Graduacao (PROAP); Programa de Cooperacao Tecnica (PROCAD) [109/2007]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PELD/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)); Programa de Apoio a Pos-Graduacao (PROAP); Programa de Cooperacao Tecnica (PROCAD)	The authors thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for a masters scholarship and PELD/CNPq for a DTI-C Scholarship; KDS thanks the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for a doctoral scholarship; JDB thanks PELD/CNPq for PDJ scholarship; to the Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT) (Proc. 98/04), Programa de Apoio a Pos-Graduacao (PROAP) and Programa de Cooperacao Tecnica (PROCAD #109/2007) for financial support for data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armúa de Reyes C. A., 2006, Braz. J. Biol., V66, P1033, DOI 10.1590/S1519-69842006000600009; Bini LM, 2006, DIVERS DISTRIB, V12, P475, DOI 10.1111/j.1366-9516.2006.00286.x; Brown J. H., 1998, BIOGEOGRAPHY; Buss DF, 2010, J N AM BENTHOL SOC, V29, P562, DOI 10.1899/09-095.1; Cabette H. S. R., 2010, GESTAO EDUCACAO AMBI, V2, P113; Carneiro FM, 2013, NAT CONSERVACAO, V11, P43, DOI 10.4322/natcon.2013.006; Carneiro FM, 2010, ECOL INDIC, V10, P249, DOI 10.1016/j.ecolind.2009.05.004; Cortelezzi Agustina, 2011, Acta Limnol. Bras., V23, P412; Couceiro SRM, 2012, ECOL INDIC, V18, P118, DOI 10.1016/j.ecolind.2011.11.001; Couceiro SRM, 2011, AUSTRAL ECOL, V36, P628, DOI 10.1111/j.1442-9993.2010.02198.x; Curry CJ, 2012, FRESHWATER BIOL, V57, P628, DOI 10.1111/j.1365-2427.2011.02724.x; de Souza MAA, 2006, NEOTROP ENTOMOL, V35, P803, DOI 10.1590/S1519-566X2006000600013; Dias-Silva K, 2010, ZOOLOGIA-CURITIBA, V27, P918, DOI 10.1590/S1984-46702010000600013; Dudgeon D, 2012, FRESHWATER BIOL, V57, P1794, DOI 10.1111/j.1365-2427.2012.02839.x; Estevez Ana Lia, 2001, Iheringia Serie Zoologia, V91, P151; Gallego I, 2012, ECOL INDIC, V18, P575, DOI 10.1016/j.ecolind.2012.01.002; GOULART M., 2003, REV FAPAM; Heckman C.W., 2011, ENCY S AM AQUATIC IN; Heino J, 2008, BOREAL ENVIRON RES, V13, P359; Heino J, 2007, BIOL CONSERV, V137, P78, DOI 10.1016/j.biocon.2007.01.017; Heino J, 2010, ECOL INDIC, V10, P112, DOI 10.1016/j.ecolind.2009.04.013; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Ribeiro JRI, 2007, ZOOTAXA, P1; INMET, 2009, PEC ABS MAPA; JACKSON DA, 1995, ECOSCIENCE, V2, P297, DOI 10.1080/11956860.1995.11682297; Jiang XM, 2013, ECOL INDIC, V27, P48, DOI 10.1016/j.ecolind.2012.11.015; Jones FC, 2008, ENVIRON REV, V16, P45, DOI 10.1139/A07-010; Kallimanis AS, 2012, ECOL INDIC, V15, P100, DOI 10.1016/j.ecolind.2011.09.024; Karaouzas I, 2006, HYDROBIOLOGIA, V573, P199, DOI 10.1007/s10750-006-0274-1; Kweka EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052084; Landeiro VL, 2012, ECOL INDIC, V23, P366, DOI 10.1016/j.ecolind.2012.04.023; Lock K, 2013, ANN LIMNOL-INT J LIM, V49, P121, DOI 10.1051/limn/2013047; Lovell S, 2007, BIOL CONSERV, V139, P113, DOI 10.1016/j.biocon.2007.06.008; Marshall JC, 2006, HYDROBIOLOGIA, V572, P171, DOI 10.1007/s10750-005-9007-0; Melo AS, 2005, ARCH HYDROBIOL, V164, P309, DOI 10.1127/0003-9136/2005/0164-0309; Metzeling L, 2003, HYDROBIOLOGIA, V510, P39, DOI 10.1023/B:HYDR.0000008500.34301.a0; Nessimian JL, 2008, HYDROBIOLOGIA, V614, P117, DOI 10.1007/s10750-008-9441-x; Nieser N, 1975, STUDIES FAUNA SURINA, V16, P1, DOI DOI 10.1007/978-94-017-7118-4_1; Nieser N, 1997, HETEROPTEROS AQUATIC; Nieser Nico, 2001, Tijdschrift voor Entomologie, V144, P261; Papacek M, 2001, EUR J ENTOMOL, V98, P1, DOI 10.14411/eje.2001.001; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; PETERSEN RC, 1992, FRESHWATER BIOL, V27, P295, DOI 10.1111/j.1365-2427.1992.tb00541.x; Quiroz-Martinez H, 2007, J AM MOSQUITO CONTR, V23, P110, DOI 10.2987/8756-971X(2007)23[110:AIAPOM]2.0.CO;2; R Development Core Team, 2012, R LANG ENV STAT COMP; Resh Vincent H., 1993, P159; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Sanchez-Moyano JE, 2006, HELGOLAND MAR RES, V60, P243, DOI 10.1007/s10152-006-0039-2; Schiesari L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0378; Schmidt-Kloiber A, 2004, HYDROBIOLOGIA, V516, P269, DOI 10.1023/B:HYDR.0000025270.10807.10; Siqueira T, 2012, ECOGRAPHY, V35, P183, DOI 10.1111/j.1600-0587.2011.06875.x; Strahler A.N., 1957, EOS T AM GEOPHYS UNI, V38, P912, DOI [10.1029/TR038i006p00913, DOI 10.1029/TR038I006P00913]; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wagenhoff A, 2012, J APPL ECOL, V49, P892, DOI 10.1111/j.1365-2664.2012.02162.x; Waite IR, 2004, FRESHWATER BIOL, V49, P474, DOI 10.1111/j.1365-2427.2004.01197.x; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Yoshimura M, 2012, ENTOMOL SCI, V15, P145, DOI 10.1111/j.1479-8298.2011.00511.x	57	17	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103623	10.1371/journal.pone.0103623	http://dx.doi.org/10.1371/journal.pone.0103623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083770	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800060
J	Lin, XC; Li, MG; Wang, M; Zuo, YJ; Zhu, SP; Zheng, YX; Lin, XF; Yu, MB; Lamoureux, EL				Lin, Xianchai; Li, Mingge; Wang, Mei; Zuo, Yajing; Zhu, Siping; Zheng, Yongxin; Lin, Xiaofeng; Yu, Minbin; Lamoureux, Ecosse L.			Validation of Catquest-9SF Questionnaire in a Chinese Cataract Population	PLOS ONE			English	Article							DAILY VISION SCALE; VISUAL FUNCTION; RASCH ANALYSIS; IMPAIRMENT QUESTIONNAIRE; SURGERY CARE; OUTCOMES; RELIABILITY; VALIDITY; IMPACT; VF-14	Purpose: To develop and validate a Chinese version of the Catquest-9SF questionnaire in a cataract population. Methods: The Catquest-9SF Questionnaire was translated and back translated into Chinese. Preoperative patients were recruited at a tertiary eye hospital and their demographic information and visual acuity were documented. Psychometric properties of the Catquest-9SF, including ordered thresholds, the ability to distinguish between different strata of person ability, absence of misfitting items, unidimentionality, differential item functioning (DIF) and construct validity were tested, using Rasch analysis. Results: A total of 102 patients (100% response rate) were enrolled. The participants'mean age was 70.2 year (SD = 12.1) and 46.9% were female. Rasch analysis showed that this version of the questionnaire had ordered response thresholds and was free of DIF. The items fit a single overall construct and unidimensional by principal components analysis of the residuals. Patients with visual impairment had significantly poorer Rasch scores on the Catquest-9SF (mean change, -2.5, p = 0.035, compared with non-visually impaired patients). Conclusion: The Chinese version of Catquest-9SF is a valid and reliable questionnaire for assessing the visual disability outcomes of Chinese patients with cataract, and it may be recommended for routine clinical use.	[Lin, Xianchai; Li, Mingge; Zuo, Yajing; Zhu, Siping; Zheng, Yongxin; Yu, Minbin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Mei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Xiaofeng] Shantou Cent Hosp, Shantou, Peoples R China; [Lamoureux, Ecosse L.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Lamoureux, Ecosse L.] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Lamoureux, Ecosse L.] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia	Sun Yat Sen University; Sun Yat Sen University; National University of Singapore; Singapore National Eye Center; National University of Singapore; Centre for Eye Research Australia; University of Melbourne	Yu, MB (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	yuminbin@126.com	Lamoureux, Ecosse/Z-5482-2019		National Natural Science Foundation of China [81200685]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Dr. Lin Xianchai is funded by National Natural Science Foundation of China 81200685. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbell PA, 2005, LANCET, V365, P599; Chiang PPC, 2011, INVEST OPHTH VIS SCI, V52, P8919, DOI 10.1167/iovs.11-7702; Gothwal VK, 2010, J CATARACT REFR SURG, V36, P1181, DOI 10.1016/j.jcrs.2010.01.029; Gothwal VK, 2010, INVEST OPHTH VIS SCI, V51, P694, DOI 10.1167/iovs.09-3448; Gothwal VK, 2009, CLIN EXP OPHTHALMOL, V37, P785, DOI 10.1111/j.1442-9071.2009.02133.x; He LM, 2011, CURR OPIN OPHTHALMOL, V22, P43, DOI 10.1097/ICU.0b013e3283414f76; Holland PW., 1993, DIFFERENTIAL ITEM FU, DOI DOI 10.4324/9780203357811; Johnson GJ, 2000, LANCET, V355, P158, DOI 10.1016/S0140-6736(99)00404-3; Lamoureux EL, 2007, INVEST OPHTH VIS SCI, V48, P1476, DOI 10.1167/iovs.06-0610; Lamoureux EL, 2007, INVEST OPHTH VIS SCI, V48, P1001, DOI 10.1167/iovs.06-0361; Lamoureux EL, 2006, INVEST OPHTH VIS SCI, V47, P4732, DOI 10.1167/iovs.06-0220; Lamoureux EL, 2011, AM J OPHTHALMOL, V151; Linacre JM., 2012, USERS GUIDE WINSTEPS; Lohr K, 2009, QUAL LIFE RES, V18, P99, DOI 10.1007/s11136-008-9413-7; Lundstrom M, 1998, J CATARACT REFR SURG, V24, P968, DOI 10.1016/S0886-3350(98)80053-9; Lundstrom M, 1997, J CATARACT REFR SURG, V23, P1226, DOI 10.1016/S0886-3350(97)80321-5; Lundstrom M, 2000, J CATARACT REFR SURG, V26, P101, DOI 10.1016/S0886-3350(99)00324-7; Lundstrom M, 2011, ACTA OPHTHALMOL, V89, P718, DOI 10.1111/j.1755-3768.2009.01801.x; Lundstrom M, 2009, J CATARACT REFR SURG, V35, P504, DOI 10.1016/j.jcrs.2008.11.038; MANGIONE CM, 1992, MED CARE, V30, P1111, DOI 10.1097/00005650-199212000-00004; Pesudovs K, 2003, INVEST OPHTH VIS SCI, V44, P2892, DOI 10.1167/iovs.02-1075; Pesudovs K, 2010, J CATARACT REFR SURG, V36, P718, DOI 10.1016/j.jcrs.2009.11.019; Revicki DA, 2010, INVEST OPHTH VIS SCI, V51, P712, DOI 10.1167/iovs.09-3766; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; Smith RM, 1994, UNIDIMENSIONALITY RA, P316; STEINBERG EP, 1994, ARCH OPHTHALMOL-CHIC, V112, P630, DOI 10.1001/archopht.1994.01090170074026; Swanson MW, 2012, OPTOMETRY VISION SCI, V89, pE23, DOI 10.1097/OPX.0b013e31826a3d85; Wong TY, 2014, BRIT J OPHTHALMOL, V98, P599, DOI 10.1136/bjophthalmol-2013-304047	28	10	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103860	10.1371/journal.pone.0103860	http://dx.doi.org/10.1371/journal.pone.0103860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084020	Green Published, gold			2022-12-25	WOS:000339819800092
J	Reyngold, M; Turcan, S; Giri, D; Kannan, K; Walsh, LA; Viale, A; Drobnjak, M; Vahdat, LT; Lee, W; Chan, TA				Reyngold, Marsha; Turcan, Sevin; Giri, Dilip; Kannan, Kasthuri; Walsh, Logan A.; Viale, Agnes; Drobnjak, Marija; Vahdat, Linda T.; Lee, William; Chan, Timothy A.			Remodeling of the Methylation Landscape in Breast Cancer Metastasis	PLOS ONE			English	Article							LYMPH-NODE METASTASES; CLINICAL-IMPLICATIONS; MOLECULAR PORTRAITS; GENE; EXPRESSION; PATTERNS; SUBTYPES; NUMBER; TUMORS; HYPERMETHYLATION	The development of breast cancer metastasis is accompanied by dynamic transcriptome changes and dramatic alterations in nuclear and chromatin structure. The basis of these changes is incompletely understood. The DNA methylome of primary breast cancers contribute to transcriptomic heterogeneity and different metastatic behavior. Therefore we sought to characterize methylome remodeling during regional metastasis. We profiled the DNA methylome and transcriptome of 44 matched primary breast tumors and regional metastases. Striking subtype-specific patterns of metastasis-associated methylome remodeling were observed, which reflected the molecular heterogeneity of breast cancers. These divergent changes occurred primarily in CpG island (CGI)-poor areas. Regions of methylome reorganization shared by the subtypes were also observed, and we were able to identify a metastasis-specific methylation signature that was present across the breast cancer subclasses. These alterations also occurred outside of CGIs and promoters, including sequences flanking CGIs and intergenic sequences. Integrated analysis of methylation and gene expression identified genes whose expression correlated with metastasis-specific methylation. Together, these findings significantly enhance our understanding of the epigenetic reorganization that occurs during regional breast cancer metastasis across the major breast cancer subtypes and reveal the nature of methylome remodeling during this process.	[Reyngold, Marsha; Turcan, Sevin; Kannan, Kasthuri; Walsh, Logan A.; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Reyngold, Marsha; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Giri, Dilip] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core, New York, NY 10021 USA; [Drobnjak, Marija] Mem Sloan Kettering Canc Ctr, Pathol Core, New York, NY 10021 USA; [Vahdat, Linda T.] Weill Cornell Med Ctr, Dept Med, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	chant@mskcc.org	Turcan, Sevin/AAF-1095-2019; Chan, Timothy A/ABD-5850-2021	Turcan, Sevin/0000-0002-0885-5607; Vahdat, Linda/0000-0002-3522-7382; Walsh, Logan/0000-0001-8771-2577; Drobnjak, Marija/0000-0003-0676-4709; Kannan, Kasthuri/0000-0002-8479-0657	Louis Gerstner Foundation; Elsa U. Pardee Foundation; AVON Foundation; STARR Cancer Consortium; Metastasis Research Center; Department of Defense Era of Hope Award; NIH [5T32CA160001]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Louis Gerstner Foundation; Elsa U. Pardee Foundation; AVON Foundation; STARR Cancer Consortium; Metastasis Research Center; Department of Defense Era of Hope Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Louis Gerstner Foundation (T.A.C.); the Elsa U. Pardee Foundation (T.A.C.); the AVON Foundation (T.A.C.); the STARR Cancer Consortium (T.A.C., L.T.V.); the Metastasis Research Center (T.A.C.), and the Department of Defense Era of Hope Award (T.A.C.). S.T. was supported by an NIH T32 grant (5T32CA160001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Ellsworth RE, 2009, CLIN EXP METASTAS, V26, P205, DOI 10.1007/s10585-008-9232-9; Fackler MJ, 2011, CANCER RES, V71, P6195, DOI 10.1158/0008-5472.CAN-11-1630; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Feng YM, 2007, BREAST CANCER RES TR, V103, P319, DOI 10.1007/s10549-006-9385-7; FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hao XS, 2004, CANCER-AM CANCER SOC, V100, P1110, DOI 10.1002/cncr.20095; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Raddatz G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003146; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Suzuki M, 2007, MOL ONCOL, V1, P172, DOI 10.1016/j.molonc.2007.03.005; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Weigman VJ, 2012, BREAST CANCER RES TR, V133, P865, DOI 10.1007/s10549-011-1846-y; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yu HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051239	37	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103896	10.1371/journal.pone.0103896	http://dx.doi.org/10.1371/journal.pone.0103896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083786	gold, Green Submitted, Green Published			2022-12-25	WOS:000339819800100
J	Zheng, N; Yuan, XY; Li, YF; Chi, YY; Gao, HB; Zhao, X; Yu, SB; Sui, HJ; Sharkey, J				Zheng, Nan; Yuan, Xiao-Ying; Li, Yun-Fei; Chi, Yan-Yan; Gao, Hai-Bin; Zhao, Xin; Yu, Sheng-Bo; Sui, Hong-Jin; Sharkey, John			Definition of the To Be Named Ligament and Vertebrodural Ligament and Their Possible Effects on the Circulation of CSF	PLOS ONE			English	Article							SPINAL DURA-MATER; CONNECTIVE-TISSUE; MYODURAL BRIDGE; ANATOMIC RELATION; POSTERIOR MINOR; NUCHAE; MUSCLE; ATTACHMENTS; INTERSPACE; HEADACHE	Few studies have been conducted specifically on the dense connective tissue located in the posterior medial part of the cervical epidural space. This study was undertaken to examine the presence of this connection between the cervical dura mater and the posterior wall of spinal canal at the level of C1-C2. 30 head-neck specimens of Chinese adults were used. Gross dissection was performed on the suboccipital regions of the 20 specimens. Having been treated with the P45 plastination method, 10 specimens were sliced (9 sagittal and 1 horizontal sections). As a result, a dense fibrous band was identified in the nuchal ligament of 29 specimens (except for one horizontal section case). This fascial structure arose from the tissue of the posterior border of the nuchal ligament and then projected anteriorly and superiorly to enter the atlantoaxial interspace. It was termed as to be named ligament (TBNL). In all 30 specimens the existence of a fibrous connection was found between the posterior aspect of the cervical dura mater and the posterior wall of the spinal canal at the level of the atlas to the axis. This fibrous connection was identified as vertebrodural ligament (VDL). The VDL was mainly subdivided into three parts, and five variations of VDL were identified. These two structures, TBNL and VDL, firmly link the posterior aspect of cervical dura mater to the rear of the atlas-axis and the nuchal region. According to these findings, the authors speculated that the movements of the head and neck are likely to affect the shape of the cervical dural sleeve via the TBNL and VDL. It is hypothesized that the muscles directly associated with the cervical dural sleeve, in the suboccipital region, may work as a pump providing an important force required to move the CSF in the spinal canal.	[Zheng, Nan; Yuan, Xiao-Ying; Chi, Yan-Yan; Yu, Sheng-Bo; Sui, Hong-Jin] Dalian Med Univ, Coll Basic Med, Dept Anat, Dalian, Peoples R China; [Li, Yun-Fei] Dalian Med Univ, Zhongshan Coll, Dept Anat, Dalian, Peoples R China; [Gao, Hai-Bin; Sui, Hong-Jin] Dalian Hoffen Biotech Co Ltd, Dalian, Peoples R China; [Zhao, Xin] Dalian Med Univ, Sch Art, Dalian, Peoples R China; [Sharkey, John] Univ Chester, Natl Training Ctr, Dublin, Ireland	Dalian Medical University; Dalian Medical University; Sun Yat Sen University; Dalian Medical University	Yu, SB (corresponding author), Dalian Med Univ, Coll Basic Med, Dept Anat, Dalian, Peoples R China.	ysbdmu@126.com; suihj@hotmail.com			Dalian Hoffen Bio-Technique Co. Ltd	Dalian Hoffen Bio-Technique Co. Ltd	Dalian Hoffen Bio-Technique Co. Ltd freely provided support in making P45 plastination sections (it is a patented technology belonging to this company) and dissecting nuchal specimens. It is confirmed that one or more of the authors employed by this commercial company does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Alix ME, 1999, J MANIP PHYSIOL THER, V22, P534, DOI 10.1016/S0161-4754(99)70006-0; Dean NA, 2002, CLIN ANAT, V15, P182, DOI 10.1002/ca.10001; HACK GD, 1995, SPINE, V20, P2484, DOI 10.1097/00007632-199512000-00003; Hack GD, 2004, HEADACHE, V44, P84, DOI 10.1111/j.1526-4610.2004.04015.x; Hallgren R.C., 1997, AAO J, V7, P30; Hofmann M., 1898, ARCH ANAT PHYSIOL, P403; Humphreys BK, 2003, CLIN ANAT, V16, P152, DOI 10.1002/ca.10109; Johnson GM, 2000, SPINE, V25, P5, DOI 10.1097/00007632-200001010-00003; Kahkeshani K, 2012, CLIN ANAT, V25, P415, DOI 10.1002/ca.21261; KAHN JL, 1992, ACTA ANAT, V144, P65; Lang J, 1987, DIS CRANIO CERVICAL, P27; McPartland J.M., 1999, J BODYW MOV THER, V3, P30, DOI [10.1016/S1360-8592(99)80040-0, DOI 10.1016/S1360-8592(99)80040-0]; Mitchell BS, 1998, J MANIP PHYSIOL THER, V21, P145; Nash L, 2005, SPINE, V30, P1359, DOI 10.1097/01.brs.0000166159.31329.92; Pontell ME, 2013, CLIN ANAT, V26, P450, DOI 10.1002/ca.22134; Rutten HP, 1997, SPINE, V22, P924, DOI 10.1097/00007632-199704150-00018; Scali F, 2013, SPINE J, V13, P558, DOI 10.1016/j.spinee.2013.01.015; Scali F, 2013, CLIN ANAT, V26, P444, DOI 10.1002/ca.22094; Scali F, 2011, SPINE, V36, pE1612, DOI 10.1097/BRS.0b013e31821129df; Sui H.J., 2006, China patent, Patent No. ZL, Patent No. [3 (1), 34109.8, 31341098]; Trolard P., 1888, ARCH PHYSIOL-PARIS, V2, P191; Von Lanz T, 1929, ARCH ENTWICKL MECH O, V118, P252; Zumpano MP, 2006, CLIN ANAT, V19, P522, DOI 10.1002/ca.20220	23	36	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103451	10.1371/journal.pone.0103451	http://dx.doi.org/10.1371/journal.pone.0103451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084162	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800044
J	Figueiredo, CA; Drohomyrecky, PC; McCarthy, SDS; Leontyev, D; Ma, XZ; Branch, DR; Dunn, SE				Figueiredo, Carlyn A.; Drohomyrecky, Paulina C.; McCarthy, Stephen D. S.; Leontyev, Danila; Ma, Xue-Zhong; Branch, Donald R.; Dunn, Shannon E.			Optimal Attenuation of Experimental Autoimmune Encephalomyelitis by Intravenous Immunoglobulin Requires an Intact Interleukin-11 Receptor	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; REGULATORY T-CELLS; GUILLAIN-BARRE-SYNDROME; FC-GAMMA-RIIB; OFF-LABEL USE; MULTIPLE-SCLEROSIS; KAWASAKI-DISEASE; IMMUNE GLOBULIN; MURINE MODEL; IFN-GAMMA	Background: Intravenous immunoglobulin (IVIg) has been used to treat a variety of autoimmune disorders including multiple sclerosis (MS); however its mechanism of action remains elusive. Recent work has shown that interleukin-11 (IL-11) mRNAs are upregulated by IVIg in MS patient T cells. Both IVIg and IL-11 have been shown to ameliorate experimental autoimmune encephalomyelitis (EAE), an animal model of MS. The objective of this study was to determine whether the protective effects of IVIg in EAE occur through an IL-11 and IL-11 receptor (IL-11R)-dependent mechanism. Methods: We measured IL-11 in the circulation of mice and IL-11 mRNA expression in various organs after IVIg treatment. We then followed with EAE studies to test the efficacy of IVIg in wild-type (WT) mice and in mice deficient for the IL-11 receptor (IL-11R alpha(-/-)). Furthermore, we evaluated myelin-specific Th1 and Th17 responses and assessed spinal cord inflammation and demyelination in WT and IL-11R alpha(-/-) mice, with and without IVIg treatment. We also examined the direct effects of mouse recombinant IL-11 on the production of IL-17 by lymph node mononuclear cells. Results: IVIg treatment induced a dramatic surge (>1000-fold increase) in the levels of IL-11 in the circulation and a prominent increase of IL-11 mRNA expression in the liver. Furthermore, we found that IL-11R alpha(-/-) mice, unlike WT mice, although initially protected, were resistant to full protection by IVIg during EAE and developed disease with a similar incidence and severity as control-treated IL-11R alpha(-/-) mice, despite initially showing protection. We observed that Th17 cytokine production by myelin-reactive T cells in the draining lymph nodes was unaffected by IVIg in IL-11R alpha(-/-) mice, yet was downregulated in WT mice. Finally, IL-11 was shown to directly inhibit IL-17 production of lymph node cells in culture. Conclusion: These results implicate IL-11 as an important immune effector of IVIg in the prevention of Th17-mediated autoimmune inflammation during EAE.	[Figueiredo, Carlyn A.; McCarthy, Stephen D. S.; Leontyev, Danila; Ma, Xue-Zhong; Branch, Donald R.] Canadian Blood Serv, Res & Dev, Toronto, ON, Canada; [Figueiredo, Carlyn A.; McCarthy, Stephen D. S.; Branch, Donald R.] Univ Hlth Network, Dept Lab Med, Toronto, ON, Canada; [Figueiredo, Carlyn A.; McCarthy, Stephen D. S.; Branch, Donald R.] Univ Hlth Network, Dept Pathobiol, Toronto, ON, Canada; [Branch, Donald R.; Dunn, Shannon E.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Drohomyrecky, Paulina C.; Dunn, Shannon E.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Drohomyrecky, Paulina C.; Dunn, Shannon E.] Canadian Blood Serv, Ctr Innovat, Toronto, ON, Canada; [Dunn, Shannon E.] Womens Coll Res Inst, Toronto, ON, Canada	Canadian Blood Services; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Canadian Blood Services; University of Toronto; University Toronto Affiliates; Womens College Hospital	Branch, DR (corresponding author), Canadian Blood Serv, Res & Dev, 67 Coll Toronto, Toronto, ON, Canada.	don.branch@utoronto.ca; sdunn@uhnresearch.ca			Canadian Blood Services graduate student fellowship award; Canadian Blood Services/Health Canada Intramural grant [XT00048]; Multiple Sclerosis Society of Canada (MSSC); Canadian Institutes of Health Research (CIHR) Vanier scholarship; MSSC	Canadian Blood Services graduate student fellowship award; Canadian Blood Services/Health Canada Intramural grant; Multiple Sclerosis Society of Canada (MSSC); Canadian Institutes of Health Research (CIHR) Vanier scholarship(Canadian Institutes of Health Research (CIHR)); MSSC	This work was supported by a Canadian Blood Services graduate student fellowship award (C. A. F.) and a Canadian Blood Services/Health Canada Intramural grant, XT00048 (D. R. B.). P. D. was supported by a studentship from the Multiple Sclerosis Society of Canada (MSSC). S. D. S. M. was supported by a Canadian Institutes of Health Research (CIHR) Vanier scholarship. S. E. D. is supported by a Don Paty Award from the MSSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Antonelli A, 1992, Clin Ter, V141, P55; Aslam R, 2012, BLOOD, V120, P2127, DOI 10.1182/blood-2012-02-413526; BERKMAN SA, 1988, SEMIN HEMATOL, V25, P140; Bozza M, 1999, HEPATOLOGY, V30, P1441, DOI 10.1002/hep.510300616; Branch DR, 2013, TRANSFUSION, V53, P242, DOI 10.1111/trf.12053; Busse M, 2012, J IMMUNOL, V189, P1975, DOI 10.4049/jimmunol.1103581; Chi L, 2007, J NEUROIMMUNOL, V192, P206, DOI 10.1016/j.jneuroim.2007.09.034; Chipps E, 1994, J Neurosci Nurs, V26, P8; Cohen JA, 2008, NAT CLIN PRACT NEURO, V4, P588, DOI 10.1038/ncpneuro0923; Crow AR, 2003, BLOOD, V102, P558, DOI 10.1182/blood-2003-01-0023; Curtin F, 2014, EXPERT REV CLIN PHAR, V7, P91, DOI 10.1586/17512433.2014.865517; Dudesek A, 2006, J NEUROL, V253, P50, DOI 10.1007/s00415-006-5007-x; Dunn SE, 2010, J EXP MED, V207, P1599, DOI 10.1084/jem.20091663; Durandy A, 2009, CLIN EXP IMMUNOL, V158, P2, DOI [10.1111/j.1365-2249.2009.04022.X, 10.1111/j.1365-2249.2009.04022.x]; Ephrem A, 2008, BLOOD, V111, P715, DOI 10.1182/blood-2007-03-079947; Fedele G, 2011, J IMMUNOL, V186, P5388, DOI 10.4049/jimmunol.1003765; Foster R, 2010, TRANSFUSION MED, V20, P403, DOI 10.1111/j.1365-3148.2010.01022.x; Gelfand EW, 2012, NEW ENGL J MED, V367, P2015, DOI 10.1056/NEJMra1009433; Guhr T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021246; Gurfein BT, 2009, J IMMUNOL, V183, P4229, DOI 10.4049/jimmunol.0900622; Hirabayashi Y, 2013, EUR J PEDIATR, V172, P833, DOI 10.1007/s00431-013-1937-3; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Ichiyama T, 2005, RHEUMATOLOGY, V44, P314, DOI 10.1093/rheumatology/keh488; IMBACH P, 1981, LANCET, V1, P1228; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jorgensen SH, 2005, J NEUROL SCI, V233, P61, DOI 10.1016/j.jns.2005.03.005; Jorgensen SH, 2005, NEUROL RES, V27, P591, DOI 10.1179/016164105X48798; Katz U, 2011, CURR PHARM DESIGN, V17, P3166, DOI 10.2174/138161211798157540; Keegan BM, 2002, ANNU REV MED, V53, P285, DOI 10.1146/annurev.med.53.082901.103909; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; Kessel A, 2007, J IMMUNOL, V179, P5571, DOI 10.4049/jimmunol.179.8.5571; Leng SX, 1997, INT J BIOCHEM CELL B, V29, P1059, DOI 10.1016/S1357-2725(97)00017-4; Leontyev D, 2012, TRANSFUSION, V52, P1799, DOI 10.1111/j.1537-2995.2011.03517.x; Leontyev D, 2012, BLOOD, V119, P5261, DOI 10.1182/blood-2012-03-415695; Maddur MS, 2011, J ALLERGY CLIN IMMUN, V127, P823, DOI 10.1016/j.jaci.2010.12.1102; Maeshima K, 2004, SHOCK, V21, P134, DOI 10.1097/01.shk.0000103386.98235.f6; Maheshwari A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/685317; Masubachi Y, 2003, BIOCHEM BIOPH RES CO, V304, P207, DOI 10.1016/S0006-291X(03)00572-2; Nishina T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002056; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Oomes PG, 1996, NEUROLOGY, V46, P96, DOI 10.1212/WNL.46.1.96; Othy S, 2013, J IMMUNOL, V190, P4535, DOI 10.4049/jimmunol.1201965; Pashov A, 1997, MULT SCLER, V3, P153, DOI 10.1177/135245859700300218; Pigard N, 2009, J NEUROIMMUNOL, V209, P114, DOI 10.1016/j.jneuroim.2009.01.014; Ramakrishna C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002071; RATKO TA, 1995, JAMA-J AM MED ASSOC, V273, P1865, DOI 10.1001/jama.273.23.1865; Redpath SA, 2013, EUR J IMMUNOL, V43, P705, DOI 10.1002/eji.201242794; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; SCHWARTZ SA, 1990, J CLIN IMMUNOL, V10, P81, DOI 10.1007/BF00918189; SORENSEN PS, 1994, J NEUROL NEUROSUR PS, V57, P62, DOI 10.1136/jnnp.57.Suppl.62; Tjon ASW, 2013, CLIN EXP IMMUNOL, V173, P259, DOI 10.1111/cei.12102; Tran EH, 2000, J IMMUNOL, V164, P2759, DOI 10.4049/jimmunol.164.5.2759; Trepicchio WL, 2001, TOXICOL PATHOL, V29, P242, DOI 10.1080/019262301317052521; Watkatsuki A, 2003, EUR J IMMUNOL, V33, P1859; Zhang MA, 2012, P NATL ACAD SCI USA, V109, P9505, DOI 10.1073/pnas.1118458109; Zhang YT, 2006, J NEUROSCI, V26, P12174, DOI 10.1523/JNEUROSCI.2289-06.2006	57	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e101947	10.1371/journal.pone.0101947	http://dx.doi.org/10.1371/journal.pone.0101947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078447	Green Published, gold, Green Submitted			2022-12-25	WOS:000339954800010
J	Hagemann, UB; Gunnarsson, L; Geraudie, S; Scheffler, U; Griep, RA; Reiersen, H; Duncan, AR; Kiprijanov, SM				Hagemann, Urs B.; Gunnarsson, Lavinia; Geraudie, Solene; Scheffler, Ulrike; Griep, Remko A.; Reiersen, Herald; Duncan, Alexander R.; Kiprijanov, Sergej M.			Fully Human Antagonistic Antibodies against CCR4 Potently Inhibit Cell Signaling and Chemotaxis	PLOS ONE			English	Article							REGULATORY T-CELLS; FOSTERS IMMUNE PRIVILEGE; PHAGE DISPLAY TECHNOLOGY; CHEMOKINE RECEPTOR 4; THERAPEUTIC ANTIBODIES; MONOCLONAL-ANTIBODIES; CANCER-IMMUNOTHERAPY; MOLECULAR TARGET; HODGKIN LYMPHOMA; EXPRESSION	Background: CC chemokine receptor 4 (CCR4) represents a potentially important target for cancer immunotherapy due to its expression on tumor infiltrating immune cells including regulatory T cells (Tregs) and on tumor cells in several cancer types and its role in metastasis. Methodology: Using phage display, human antibody library, affinity maturation and a cell-based antibody selection strategy, the antibody variants against human CCR4 were generated. These antibodies effectively competed with ligand binding, were able to block ligand-induced signaling and cell migration, and demonstrated efficient killing of CCR4-positive tumor cells via ADCC and phagocytosis. In a mouse model of human T-cell lymphoma, significant survival benefit was demonstrated for animals treated with the newly selected anti-CCR4 antibodies. Significance: For the first time, successful generation of anti-G-protein coupled chemokine receptor (GPCR) antibodies using human non-immune library and phage display on GPCR-expressing cells was demonstrated. The generated anti-CCR4 antibodies possess a dual mode of action (inhibition of ligand-induced signaling and antibody-directed tumor cell killing). The data demonstrate that the anti-tumor activity in vivo is mediated, at least in part, through Fc-receptor dependent effector mechanisms, such as ADCC and phagocytosis. Anti-CC chemokine receptor 4 antibodies inhibiting receptor signaling have potential as immunomodulatory antibodies for cancer.	[Hagemann, Urs B.; Gunnarsson, Lavinia; Geraudie, Solene; Scheffler, Ulrike; Griep, Remko A.; Reiersen, Herald; Duncan, Alexander R.; Kiprijanov, Sergej M.] Affitech Res AS, Oslo, Norway		Duncan, AR (corresponding author), Actigen Ltd, Cambridge, England.	alex@actigen.com	Reiersen, Herald/ABA-5161-2020	Reiersen, Herald/0000-0002-3288-554X				Abi-Younes S, 2001, THROMB RES, V101, P279, DOI 10.1016/S0049-3848(00)00402-3; Adams GP, 1999, J IMMUNOL METHODS, V231, P249, DOI 10.1016/S0022-1759(99)00161-1; Adams GP, 1998, IN VIVO, V12, P11; Al Mahmoud R, 2012, J PEDIAT HEMATOL ONC, V34, P611, DOI 10.1097/MPH.0b013e3182707592; Argyriou AA, 2009, MOL MED, V15, P183, DOI 10.2119/molmed.2009.00007; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Beck A, 2012, MABS-AUSTIN, V4, P419, DOI 10.4161/mabs.20996; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Byrne WL, 2011, CANCER RES, V71, P6915, DOI 10.1158/0008-5472.CAN-11-1156; Chang DK, 2012, MOL CANCER THER, V11, P2451, DOI 10.1158/1535-7163.MCT-12-0278; Clemetson KJ, 2000, BLOOD, V96, P4046; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Ferenczi K, 2002, J INVEST DERMATOL, V119, P1405, DOI 10.1046/j.1523-1747.2002.19610.x; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Gear ARL, 2003, MICROCIRCULATION, V10, P335, DOI 10.1038/sj.mn.7800198; Hoogenboom HR, 1999, EUR J BIOCHEM, V260, P774, DOI 10.1046/j.1432-1327.1999.00214.x; Huang LL, 2005, J MOL RECOGNIT, V18, P327, DOI 10.1002/jmr.735; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; Imai T, 1997, J BIOL CHEM, V272, P15036, DOI 10.1074/jbc.272.23.15036; Imai T, 1996, J BIOL CHEM, V271, P21514, DOI 10.1074/jbc.271.35.21514; Imai T, 1998, J BIOL CHEM, V273, P1764, DOI 10.1074/jbc.273.3.1764; Ishida T, 2006, LEUKEMIA, V20, P2162, DOI 10.1038/sj.leu.2404415; Ishida T, 2003, CLIN CANCER RES, V9, P3625; Ishida T, 2006, CANCER SCI, V97, P1139, DOI 10.1111/j.1349-7006.2006.00307.x; Ishida T, 2006, CANCER RES, V66, P5716, DOI 10.1158/0008-5472.CAN-06-0261; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Ishii T, 2010, CLIN CANCER RES, V16, P1520, DOI 10.1158/1078-0432.CCR-09-2697; Kipriyanov SM, 2009, METHODS MOL BIOL, V562, P205, DOI 10.1007/978-1-60327-302-2_16; Kipriyanov SM, 1997, J IMMUNOL METHODS, V200, P69, DOI 10.1016/S0022-1759(96)00188-3; Kurosawa G, 2008, P NATL ACAD SCI USA, V105, P7287, DOI 10.1073/pnas.0712202105; Loset GA, 2005, J IMMUNOL METHODS, V299, P47, DOI 10.1016/j.jim.2005.01.014; Menetrier-Caux C, 2009, CANCER RES, V69, P7895, DOI 10.1158/0008-5472.CAN-09-1642; Mirzabekov T, 2000, NAT BIOTECHNOL, V18, P649, DOI 10.1038/76501; Moghaddam A, 2003, J IMMUNOL METHODS, V280, P139, DOI 10.1016/S0022-1759(03)00109-1; Morimoto Y, 2005, J LEUKOCYTE BIOL, V78, P753, DOI 10.1189/jlb.0305139; Murata K, 2007, INT REV IMMUNOL, V26, P249, DOI 10.1080/08830180701709817; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Niwa R, 2004, CANCER RES, V64, P2127, DOI 10.1158/0008-5472.CAN-03-2068; Norderhaug L, 1997, J IMMUNOL METHODS, V204, P77, DOI 10.1016/S0022-1759(97)00034-3; Overdijk MB, 2012, J IMMUNOL, V189, P3430, DOI 10.4049/jimmunol.1200356; Raman D, 2011, EXP CELL RES, V317, P575, DOI 10.1016/j.yexcr.2011.01.005; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Ravn P, 2013, J BIOL CHEM, V288, P19760, DOI 10.1074/jbc.M112.426288; Ruter J, 2009, FRONT BIOSCI-LANDMRK, V14, P1761, DOI 10.2741/3338; Subramaniam JM, 2012, DRUGS, V72, P1293, DOI 10.2165/11631090-000000000-00000; Sui JH, 2003, EUR J BIOCHEM, V270, P4497, DOI 10.1046/j.1432-1033.2003.03843.x; Tobinai K, 2012, CURR HEMATOL MALIG R, V7, P235, DOI 10.1007/s11899-012-0124-3; Tohidkia MR, 2013, BIODRUGS, V27, P55, DOI 10.1007/s40259-012-0007-0; van Berkel PHC, 2010, BIOTECHNOL BIOENG, V105, P350, DOI 10.1002/bit.22535; van der Horst E, 2009, NEOPLASIA, V11, P355, DOI 10.1593/neo.81536; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Weiner LM, 2012, CELL, V148, P1081, DOI 10.1016/j.cell.2012.02.034; Whittaker S, 2006, SEMIN ONCOL, V33, pS3, DOI 10.1053/j.seminoncol.2005.12.015; Xu C, 2007, J IMMUNOL, V179, P2408, DOI 10.4049/jimmunol.179.4.2408; Zhang Y, 2004, BIOCHEMISTRY-US, V43, P12575, DOI 10.1021/bi0492152; Zhou Q, 2008, BIOTECHNOL BIOENG, V99, P652, DOI 10.1002/bit.21598; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049	60	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103776	10.1371/journal.pone.0103776	http://dx.doi.org/10.1371/journal.pone.0103776			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080123	Green Submitted, gold, Green Published			2022-12-25	WOS:000339954800080
J	Towne, EG; Craine, JM				Towne, E. Gene; Craine, Joseph M.			Ecological Consequences of Shifting the Timing of Burning Tallgrass Prairie	PLOS ONE			English	Article							VEGETATION DYNAMICS; FLINT HILLS; FIRE; VARIABILITY; GRASSLAND; CLIMATE; KANSAS; EMISSIONS; CATTLE; BISON	In the Kansas Flint Hills, grassland burning is conducted during a relatively narrow window because management recommendations for the past 40 years have been to burn only in late spring. Widespread prescribed burning within this restricted time frame frequently creates smoke management issues downwind. A potential remedy for the concentrated smoke production in late spring is to expand burning to times earlier in the year. Yet, previous research suggested that burning in winter or early spring reduces plant productivity and cattle weight gain while increasing the proportion of undesirable plant species. In order to better understand the ecological consequences of burning at different times of the year, plant production and species abundance were measured for 20 years on ungrazed watersheds burned annually in autumn, winter, or spring. We found that there were no significant differences in total grass production among the burns on either upland or lowland topographic positions, although spring burned watersheds had higher grass culm production and lower forb biomass than autumn and winter burned watersheds. Burning in autumn or winter broadened the window of grass productivity response to precipitation, which reduces susceptibility to mid-season drought. Burning in autumn or winter also increased the phenological range of species by promoting cool-season graminoids without a concomitant decrease in warm-season grasses, potentially widening the seasonal window of high-quality forage. Incorporating autumn and winter burns into the overall portfolio of tallgrass prairie management should increase the flexibility in managing grasslands, promote biodiversity, and minimize air quality issues caused by en masse late-spring burning with little negative consequences for cattle production.	[Towne, E. Gene; Craine, Joseph M.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	Kansas State University	Towne, EG (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	egtowne@ksu.edu	Craine, Joseph/D-4569-2009	Craine, Joseph/0000-0001-6561-3244	NSF [DEB-0823341]; Kansas State University	NSF(National Science Foundation (NSF)); Kansas State University	This work was supported in part by an NSF grant to the Konza Prairie Long-Term Ecological Research Program (DEB-0823341). Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous AE, 1934, KANSAS AGR EXPT STAT, V38; ANDERSON KL, 1970, J RANGE MANAGE, V23, P81, DOI 10.2307/3896105; ANDERSON KLING L., 1965, J RANGE MANAGE, V18, P311, DOI 10.2307/3895421; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Augustine JK, 2011, AVIAN CONSERV ECOL, V6, DOI 10.5751/ACE-00429-060102; AXELROD DI, 1985, BOT REV, V51, P163, DOI 10.1007/BF02861083; BAILEY AW, 1968, ECOLOGY, V49, P1, DOI 10.2307/1933554; BENNING TL, 1993, AM MIDL NAT, V130, P127, DOI 10.2307/2426281; BERNARDO DJ, 1988, J RANGE MANAGE, V41, P178, DOI 10.2307/3898959; Bieber GL, 1961, J SOIL WATER CONSERV, V16, P186; Blocksome C, 2011, PRESCRIBED BURNING N; BRAGG TB, 1982, ECOLOGY, V63, P7, DOI 10.2307/1937024; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; BRIGGS JM, 1995, AM J BOT, V82, P1024, DOI 10.2307/2446232; Coppedge BR, 1998, PLANT ECOL, V139, P235, DOI 10.1023/A:1009728104508; Craine JM, 2012, P NATL ACAD SCI USA, V109, P3401, DOI 10.1073/pnas.1118438109; Craine JM, 2012, NEW PHYTOL, V193, P673, DOI 10.1111/j.1469-8137.2011.03953.x; Craine JM, 2010, ECOLOGY, V91, P2132, DOI 10.1890/09-1242.1; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Engle DM, 2001, J RANGE MANAGE, V54, P2, DOI 10.2307/4003519; ERWIN WJ, 1979, AM MIDL NAT, V101, P247, DOI 10.2307/2424922; Hailey A, 2000, BIOL CONSERV, V92, P321, DOI 10.1016/S0006-3207(99)00099-3; HANKS R. J., 1957, Journal of Soil and Water Conservation, V12, P228; Horowitz LW, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002853; HURST DF, 1994, J GEOPHYS RES-ATMOS, V99, P16441, DOI 10.1029/94JD00670; Kansas Department of Health and Environment, 2010, FLINT HILLS SMOK MAN; KEMP PR, 1980, ECOLOGY, V61, P846, DOI 10.2307/1936755; KOLLMORGEN WM, 1965, ANN ASSOC AM GEOGR, V55, P260, DOI 10.1111/j.1467-8306.1965.tb00518.x; Korontzi S, 2003, J ARID ENVIRON, V54, P395, DOI 10.1006/jare.2002.1098; Main MB, 2002, WETLANDS, V22, P430, DOI 10.1672/0277-5212(2002)022[0430:IOSOFO]2.0.CO;2; Mauzerall DL, 2005, ATMOS ENVIRON, V39, P2851, DOI 10.1016/j.atmosenv.2004.12.041; MCMURPHY W. E., 1963, Transactions of the Kansas Academy of Science, V66, P49, DOI 10.2307/3626834; McMURPHY WILFRED E., 1965, J RANGE MANAGE, V18, P265, DOI 10.2307/3895495; Menard C, 2002, J APPL ECOL, V39, P120, DOI 10.1046/j.1365-2664.2002.00693.x; Mohler Rhett L., 2012, Great Plains Research, V22, P15; Odadi WO, 2013, ECOL APPL, V23, P455, DOI 10.1890/12-0878.1; Ohlenbusch PD, 2000, KSU EXTENSION PUBL L, V815; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Owens MK, 2002, J RANGE MANAGE, V55, P509, DOI 10.2307/4003231; OWENSBY CE, 1967, J RANGE MANAGE, V20, P12, DOI 10.2307/3896282; PLUMB GE, 1993, ECOL APPL, V3, P631, DOI 10.2307/1942096; RAO MR, 1973, J RANGE MANAGE, V26, P419, DOI 10.2307/3896976; Reinking Dan L., 2005, Studies in Avian Biology, V30, P116; Robel RJ, 1998, J RANGE MANAGE, V51, P132, DOI 10.2307/4003197; Simoneit BRT, 2002, APPL GEOCHEM, V17, P129, DOI 10.1016/S0883-2927(01)00061-0; STEUTER AA, 1987, J RANGE MANAGE, V40, P27, DOI 10.2307/3899356; Towne E. Gene, 2002, SIDA Contributions to Botany, V20, P269; Towne EG, 2003, J RANGE MANAGE, V56, P185, DOI 10.2307/4003903	48	24	24	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103423	10.1371/journal.pone.0103423	http://dx.doi.org/10.1371/journal.pone.0103423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077487	gold, Green Published, Green Submitted			2022-12-25	WOS:000339954800043
J	Wei, T; Sun, YN; Zhang, B; Wang, RX; Xu, TJ				Wei, Tao; Sun, Yuena; Zhang, Bo; Wang, Rixin; Xu, Tianjun			A Mitogenomic Perspective on the Phylogenetic Position of the Hapalogenys Genus (Acanthopterygii: Perciformes) and the Evolutionary Origin of Perciformes	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; SYSTEMATIC POSITION; TELEOSTEI; FISHES; SEQUENCES; HISTORY	The Hapalogenys genus was the most controversial and problematic in phylogenetic position of Percoidei. In this study, we rechecked the taxonomic status of Hapalogenys in Percoidei using complete mitochondrial genome data. We purposefully added a new complete mitochondrial sequence from chosen species of Hapalogenys and conducted phylogenetic analyses using a large complete mitochondrial data set. The resultant tree topologies were congruent from partitioned Bayesian and Maximum-likelihood methods. The results indicated that Hapalogenys was distantly related to Haemulidae and could be removed from Haemulidae. The results supported the Hapalogeny was upgraded to a family rank titled Hapalogenyidae, and it should be recognized in a separate family of Hapalogenyidae. A relaxed molecular-clock Bayesian analysis indicated that the divergence times of Perciformes groups had a much older than the available old fossil records. The origin of the common ancestral lineage of Perciformes fish was estimated in the late Jurassic about 149 Myr ago.	[Wei, Tao; Sun, Yuena; Zhang, Bo; Wang, Rixin; Xu, Tianjun] Zhejiang Ocean Univ, Coll Marine Sci, Lab Fish Biogenet & Immune Evolut, Zhoushan, Peoples R China	Zhejiang Ocean University	Sun, YN (corresponding author), Zhejiang Ocean Univ, Coll Marine Sci, Lab Fish Biogenet & Immune Evolut, Zhoushan, Peoples R China.	yuenasun@163.com; tianjunxu@163.com			National Natural Science Foundation of China [31272661]; Zhejiang Provincial Natural Science Foundation [LY13C040001]; Young Academic Leaders in Zhejiang Province [PD2013220]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Young Academic Leaders in Zhejiang Province	This study was supported by National Natural Science Foundation of China (31272661), Zhejiang Provincial Natural Science Foundation (LY13C040001), and grant of Young Academic Leaders in Zhejiang Province (PD2013220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-215; Benton M.J., 1993, FOSSIL RECORD; Benton MJ, 1998, ADEQUACY OF THE FOSSIL RECORD, P269; CANTATORE P, 1994, J MOL EVOL, V39, P589, DOI 10.1007/BF00160404; Carroll RL, 1997, PATTERNS PROCESSES V; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Inoue JG, 2009, MOL PHYLOGENET EVOL, V51, P486, DOI 10.1016/j.ympev.2009.01.020; Iwatsuki Yukio, 2006, Memoirs of Museum Victoria, V63, P29; Johnson GD, 1984, AM SOC ICHTHYOL HERP, V1; KUMAZAWA Y, 1993, J MOL EVOL, V37, P380, DOI 10.1007/BF00178868; Kumazawa Y, 1999, BIOL BIODIVERSITY, P35; Lavoue S, 2010, MOL PHYLOGENET EVOL, V56, P480, DOI 10.1016/j.ympev.2009.11.022; Liang RS, 2012, MITOCHONDR DNA, V23, P264, DOI 10.3109/19401736.2012.690746; MADDISON WP, 2000, MACCLADE 4 0 ANAL PH; McKay RJ, 2001, SPECIES IDENTIFICA 3; Miller TL, 2007, MOL PHYLOGENET EVOL, V44, P450, DOI 10.1016/j.ympev.2006.10.029; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Miya M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-58; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; Nelson JS, 1984, FISHES WORLD; Otero O, 2004, ZOOL J LINN SOC-LOND, V141, P81, DOI 10.1111/j.1096-3642.2004.00111.x; PATTERSON C, 1993, B MAR SCI, V52, P29; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Randall JE, 2000, RAFFLES B ZOOL, P569; Ren Gang, 2007, Acta Zootaxonomica Sinica, V32, P835; Ren Gang, 2007, JOURNAL OF TROPICAL OCEANOGRAPHY, V26, P48; Richardson J, 1844, ANN MAGAZINE NATURAL, V13, P462, DOI DOI 10.1080/03745484409442632; Song CB, 1998, MOL PHYLOGENET EVOL, V10, P343, DOI 10.1006/mpev.1998.0542; Springer VG, 1995, AM TOPICAL ASS HDB, V129, P1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavera JJ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-57; Wei T, 2013, J GENET, V92, P247, DOI 10.1007/s12041-013-0259-6; Xu Tian-Jun, 2010, Acta Zootaxonomica Sinica, V35, P530; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389; Zhong BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005297; Zhu SH, 2006, J TROPICAL OCEANOGRA, V4, P42	40	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103011	10.1371/journal.pone.0103011	http://dx.doi.org/10.1371/journal.pone.0103011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077480	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800023
J	Zhu, HW; Chen, X; Chen, B; Chen, B; Song, WB; Sun, DY; Zhao, YG				Zhu, Hongwu; Chen, Xiong; Chen, Bin; Chen, Bei; Song, Weibing; Sun, Dayong; Zhao, Yagang			Activating Transcription Factor 4 Promotes Esophageal Squamous Cell Carcinoma Invasion and Metastasis in Mice and Is Associated with Poor Prognosis in Human Patients	PLOS ONE			English	Article							CANCER; RESECTION; SURVIVAL; REINITIATION; TRANSLATION; EXPRESSION; HYPOXIA	Background: Activating transcription factor 4 (ATF4) is a stress response gene that is involved in homeostasis and cellular protection. However, its expression and function in esophageal squamous cell carcinoma (ESCC) remains unknown. In this study, we aimed to determine the clinicopathologic significance of ATF4 in ESCC and its potential role in ESCC invasion and metastasis. Methodology/Principal Findings: We demonstrated that ATF4 overexpression is correlated with multiple malignant characteristics and indicates poor prognosis in ESCC patients. ATF4 expression was an independent factor that affected the overall survival of patients with ESCC after surgical resection. ATF4 promoted cell invasion and metastasis by promoting matrix metalloproteinase (MMP)-2 and MMP-7 expression, while its silencing significantly attenuated these activities both in vitro and in vivo. Conclusions/Significance: We report that ATF4 is a potential biomarker for ESCC prognosis and that its dysregulation may play a key role in the regulation of invasion and metastasis in ESCC cells. The targeting of ATF4 may provide a new strategy for blocking ESCC metastasis.	[Zhu, Hongwu; Sun, Dayong; Zhao, Yagang] Peoples Liberat Army, Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Chen, Xiong] PLA, Nanjing Mil Command, Fuzhou Gen Hosp, Dept Oncol, Fuzhou, Peoples R China; [Chen, Bin; Chen, Bei] Peoples Liberat Army, Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Song, Weibing] Peoples Liberat Army, Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Gerontol, Guangzhou, Guangdong, Peoples R China	Southern Theater Command General Hospital; Southern Theater Command General Hospital; Southern Theater Command General Hospital	Sun, DY (corresponding author), Peoples Liberat Army, Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China.	sundayong1967@126.com; yagang78@163.com			National Natural Science Foundation of China [81101821, 81101822]; Natural Science Foundation of Guangdong province [10451001002004732]; Ph.D. Start-up Fund of Natural Science Foundation of Guangdong Province [S2011040001277]; Science and Technology Plan Project of Guangdong province [2011B031800317]; Science and Technology Plan Project of Fujian province [2012J05157]; Science and Technology Key Project of Guangzhou, China [11C26090521]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province); Ph.D. Start-up Fund of Natural Science Foundation of Guangdong Province; Science and Technology Plan Project of Guangdong province; Science and Technology Plan Project of Fujian province; Science and Technology Key Project of Guangzhou, China	This study was supported by combined grants from the National Natural Science Foundation of China (No. 81101821, No. 81101822), the Natural Science Foundation of Guangdong province (No. 10451001002004732), the Ph.D. Start-up Fund of Natural Science Foundation of Guangdong Province (No. S2011040001277), the Science and Technology Plan Project of Guangdong province (No. 2011B031800317), the Science and Technology Plan Project of Fujian province (No. 2012J05157), and the Science and Technology Key Project of Guangzhou (No. 11C26090521), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou C, 2006, ANN THORAC SURG, V82, P1073, DOI 10.1016/j.athoracsur.2006.03.012; Ameri K, 2010, BRIT J CANCER, V102, P561, DOI 10.1038/sj.bjc.6605491; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen LL, 2010, J CLIN INVEST, V120, P1178, DOI 10.1172/JCI40665; Chen SB, 2013, J THORAC ONCOL, V8, P495, DOI 10.1097/JTO.0b013e3182829e2c; Chen YZ, 2013, APMIS; Crosby T, 2009, ANN ROY COLL SURG, V91, P366; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Guo W, 2013, CLIN EXP METASTASIS; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lee PC, 2009, ANN THORAC SURG, V88, P186, DOI 10.1016/j.athoracsur.2009.03.079; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060027; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Min S, 2013, CANC GENE THER; Mujcic H, 2009, RADIOTHER ONCOL, V92, P450, DOI 10.1016/j.radonc.2009.08.017; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; Peyre CG, 2008, ANN SURG, V248, P549, DOI 10.1097/SLA.0b013e318188c474; Rice TW, 1998, ANN THORAC SURG, V65, P787, DOI 10.1016/S0003-4975(97)01387-8; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Torres CM, 1999, MODERN PATHOL, V12, P961; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; VAUGHAN TL, 1995, CANCER EPIDEM BIOMAR, V4, P85; Wang HH, 2012, FEBS J, V279, P3652, DOI 10.1111/j.1742-4658.2012.08726.x; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063581; Yu Y, 2013, BIOCH BIOPHYS RES CO; Zhang H, 2013, ASIAN PAC J CANCER P, V14, P2851, DOI 10.7314/APJCP.2013.14.5.2851; Zhu HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031431	29	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103882	10.1371/journal.pone.0103882	http://dx.doi.org/10.1371/journal.pone.0103882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078779	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800092
J	Chou, H; Wu, KG; Yeh, CC; Tai, HY; Tam, MF; Chen, YS; Shen, HD				Chou, Hong; Wu, Keh-Gong; Yeh, Chang-Ching; Tai, Hsiao-Yun; Tam, Ming F.; Chen, Yu-Sen; Shen, Horng-Der			The Transaldolase, a Novel Allergen of Fusarium proliferatum, Demonstrates IgE Cross-Reactivity with Its Human Analogue	PLOS ONE			English	Article							FUNGAL ALLERGENS; MAJOR ALLERGEN; SOLANI; PREVALENCE; ASTHMA; DISEASE; CLONING	Fusarium species are among airborne fungi and recognized as causative agents of human atopic disorders. However, Fusarium allergens have not been well characterized and the lack of information limits clinical diagnosis and treatment of fungal allergy. The purpose of this study is to identify and characterize important allergens of F. proliferatum. IgE-reacting F. proliferatum components were identified by immunoblot using serum samples from patients of respiratory atopic diseases. Characterization of allergens and determination of IgE cross-reactivity were performed by cDNA cloning, then homologous expression and immunoblot inhibition studies. We identified nine different F. proliferatum components that can be recognized by IgE antibodies in 17 (28%) of the 60 atopic sera tested. Components with molecular masses of about 43, 37.5 and 36.5 kDa with IgE-binding frequencies of about 88, 47 and 53%, respectively, were considered as important allergens of F. proliferatum. The 37.5 kDa IgE-binding component was putatively considered as a transaldolase protein of F. proliferatum. The full-length cDNA of F. proliferatum transaldolase was subsequently cloned. It encodes an open reading frame of 312 amino acids and has sequence identifies of 73 and 61%, respectively, with Cladosporium and human transaldolases. The purified recombinant F. proliferatum transaldolase can inhibit the IgE-binding against the 37.5 kDa component of F. proliferatum and the transaldolase allergen from Cladosporium cladosporioides. More importantly, the recombinant F. proliferatum transaldolase can inhibit IgE-binding against human transaldolase in a concentration-dependent manner. Thus, a novel and important F. proliferatum transaldolase allergen was identified. In addition to IgE cross-reactivity between the Fusarium and the Cladosporium transaldolase allergens, IgE cross-reactivity between the Fusarium and the human transaldolases also exists and might contribute to atopic manifestations in the absence of exogenous allergen exposure.	[Chou, Hong; Tai, Hsiao-Yun; Chen, Yu-Sen; Shen, Horng-Der] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan; [Wu, Keh-Gong] Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan; [Wu, Keh-Gong] Natl Yang Ming Univ, Taipei 112, Taiwan; [Yeh, Chang-Ching] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Tam, Ming F.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Carnegie Mellon University	Shen, HD (corresponding author), Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan.	hdshen@vghtpe.gov.tw		YEH, CHANG-CHING/0000-0003-0690-7503	National Science Council [NSC 101-2320-B-075-005-MY2]; Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China [V102C-066]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China(Taipei Veterans General Hospital)	This work was supported by grants from the National Science Council (Grant NSC 101-2320-B-075-005-MY2) and the Taipei Veterans General Hospital (V102C-066), Taipei, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Dieyeh MH, 2010, AEROBIOLOGIA, V26, P263, DOI 10.1007/s10453-010-9162-2; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Appenzeller U, 1999, INT ARCH ALLERGY IMM, V118, P193, DOI 10.1159/000024064; Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; BUSH RK, 1987, CLIN REV ALLERG, V5, P3; Chang HN, 1984, CLIN MED J, V34, P376; Chou H, 2011, CLIN EXP ALLERGY, V41, P739, DOI 10.1111/j.1365-2222.2011.03698.x; Chou H, 2008, INT ARCH ALLERGY IMM, V146, P277, DOI 10.1159/000121462; Crameri R, 2014, ALLERGY, V69, P176, DOI 10.1111/all.12325; Crameri R, 2009, MYCOSES, V52, P99, DOI 10.1111/j.1439-0507.2008.01644.x; Esch RE, 2004, J ALLERGY CLIN IMMUN, V113, P210, DOI 10.1016/j.jaci.2003.11.024; Gonianakis MI, 2006, ALLERGY ASTHMA PROC, V27, P354, DOI 10.2500/aap.2006.27.2918; Hoff M, 2003, MOL IMMUNOL, V39, P965, DOI 10.1016/S0161-5890(03)00026-9; HORNER WE, 1995, CLIN MICROBIOL REV, V8, P161, DOI 10.1128/CMR.8.2.161; Khosravi AR, 2012, ARH HIG RADA TOKSIKO, V63, P1, DOI 10.2478/10004-1254-63-2012-2155; LI CS, 1995, ARCH ENVIRON HEALTH, V50, P38, DOI 10.1080/00039896.1995.9955011; Mayer C, 1999, J EXP MED, V189, P1507, DOI 10.1084/jem.189.9.1507; ONEIL CE, 1986, J ALLERGY CLIN IMMUN, V77, P842, DOI 10.1016/0091-6749(86)90382-9; Prasad R, 2009, LUNG INDIA, V26, P70, DOI 10.4103/0970-2113.53228; Shen HD, 1999, INT ARCH ALLERGY IMM, V119, P259, DOI 10.1159/000024202; SPRENGER GA, 1995, J BACTERIOL, V177, P5930, DOI 10.1128/jb.177.20.5930-5936.1995; Stroud RH, 2001, OTOLARYNG HEAD NECK, V125, P491, DOI 10.1067/mhn.2001.119969; Tai HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071269; Thorell S, 2000, FEBS LETT, V475, P205, DOI 10.1016/S0014-5793(00)01658-6; Valenta R, 2009, TRENDS IMMUNOL, V30, P109, DOI 10.1016/j.it.2008.12.004; VERMA J, 1994, INT ARCH ALLERGY IMM, V104, P175, DOI 10.1159/000236727; Verma J, 2003, INT ARCH ALLERGY IMM, V130, P193, DOI 10.1159/000069518; VERMA J, 1994, ALLERGY, V49, P330, DOI 10.1111/j.1398-9995.1994.tb02277.x; Verma J, 1998, ALLERGY, V53, P311, DOI 10.1111/j.1398-9995.1998.tb03893.x; Wahl P. G. von, 1991, Aerobiologia, V7, P111, DOI 10.1007/BF02270679; Zahran Hatice S., 2011, Morbidity and Mortality Weekly Report, V60, P547	31	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103488	10.1371/journal.pone.0103488	http://dx.doi.org/10.1371/journal.pone.0103488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075521	gold, Green Published, Green Submitted			2022-12-25	WOS:000340028800052
J	Vallverdu, J; Saladie, P; Rosas, A; Huguet, R; Caceres, I; Mosquera, M; Garcia-Tabernero, A; Estalrrich, A; Lozano-Fernandez, I; Pineda-Alcala, A; Carrancho, A; Villalain, JJ; Bourles, D; Braucher, R; Lebatard, A; Vilalta, J; Esteban-Nadal, M; Bennasar, ML; Bastir, M; Lopez-Polin, L; Olle, A; Verges, JM; Ros-Montoya, S; Martinez-Navarro, B; Garcia, A; Martinell, J; Exposito, I; Burjachs, F; Agusti, J; Carbonell, E				Vallverdu, Josep; Saladie, Palmira; Rosas, Antonio; Huguet, Rosa; Caceres, Isabel; Mosquera, Marina; Garcia-Tabernero, Antonio; Estalrrich, Almudena; Lozano-Fernandez, Ivan; Pineda-Alcala, Antonio; Carrancho, Angel; Jose Villalain, Juan; Bourles, Didier; Braucher, Regis; Lebatard, Anne; Vilalta, Jaume; Esteban-Nadal, Montserrat; Lluc Bennasar, Maria; Bastir, Marcus; Lopez-Polin, Lucia; Olle, Andreu; Maria Verges, Josep; Ros-Montoya, Sergio; Martinez-Navarro, Bienvenido; Garcia, Ana; Martinell, Jordi; Exposito, Isabel; Burjachs, Francesc; Agusti, Jordi; Carbonell, Eudald			Age and Date for Early Arrival of the Acheulian in Europe (Barranc de la Boella, la Canonja, Spain)	PLOS ONE			English	Article							PLEISTOCENE HUMAN-SETTLEMENTS; LOIRE RIVER-BASIN; IBERIAN PENINSULA; FLUVIAL DEPOSITS; CENTER REGION; HALF-LIFE; BE-10; AL-26; RADIONUCLIDES; COLONIZATION	The first arrivals of hominin populations into Eurasia during the Early Pleistocene are currently considered to have occurred as short and poorly dated biological dispersions. Questions as to the tempo and mode of these early prehistoric settlements have given rise to debates concerning the taxonomic significance of the lithic assemblages, as trace fossils, and the geographical distribution of the technological traditions found in the Lower Palaeolithic record. Here, we report on the Barranc de la Boella site which has yielded a lithic assemblage dating to similar to 1 million years ago that includes large cutting tools (LCT). We argue that distinct technological traditions coexisted in the Iberian archaeological repertoires of the late Early Pleistocene age in a similar way to the earliest sub-Saharan African artefact assemblages. These differences between stone tool assemblages may be attributed to the different chronologies of hominin dispersal events. The archaeological record of Barranc de la Boella completes the geographical distribution of LCT assemblages across southern Eurasia during the EMPT (Early-Middle Pleistocene Transition, circa 942 to 641 kyr). Up to now, chronology of the earliest European LCT assemblages is based on the abundant Palaeolithic record found in terrace river sequences which have been dated to the end of the EMPT and later. However, the findings at Barranc de la Boella suggest that early LCT lithic assemblages appeared in the SW of Europe during earlier hominin dispersal episodes before the definitive colonization of temperate Eurasia took place.	[Vallverdu, Josep; Saladie, Palmira; Huguet, Rosa; Caceres, Isabel; Mosquera, Marina; Lozano-Fernandez, Ivan; Pineda-Alcala, Antonio; Vilalta, Jaume; Esteban-Nadal, Montserrat; Lluc Bennasar, Maria; Lopez-Polin, Lucia; Olle, Andreu; Maria Verges, Josep; Martinez-Navarro, Bienvenido; Garcia, Ana; Martinell, Jordi; Exposito, Isabel; Burjachs, Francesc; Agusti, Jordi; Carbonell, Eudald] Inst Catala Paleoecol Humana & Evolucio Social IP, Tarragona, Spain; [Vallverdu, Josep; Saladie, Palmira; Huguet, Rosa; Caceres, Isabel; Mosquera, Marina; Lozano-Fernandez, Ivan; Pineda-Alcala, Antonio; Esteban-Nadal, Montserrat; Lopez-Polin, Lucia; Olle, Andreu; Maria Verges, Josep; Martinez-Navarro, Bienvenido; Exposito, Isabel; Burjachs, Francesc; Agusti, Jordi; Carbonell, Eudald] Univ Rovira & Virgili, Fac Lletres, Area Prehist, Dept Hist & Hist Art, E-43007 Tarragona, Spain; [Saladie, Palmira] Univ Coimbra, Grp Quaternario & Prehist, Fac Ciencias & Tecnol, Ctr Geociencias GQP CG, Coimbra, Portugal; [Vallverdu, Josep; Rosas, Antonio; Huguet, Rosa; Garcia-Tabernero, Antonio; Estalrrich, Almudena; Bastir, Marcus; Carbonell, Eudald] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Carrancho, Angel; Jose Villalain, Juan] Univ Burgos UBU, Escuela Politecn Super, Dept Fis, Lab Paleomagnetismo, Burgos, Spain; [Carrancho, Angel] Univ Burgos UBU, Dept Ciencias Hist & Geog, Area Prehist, Burgos, Spain; [Bourles, Didier; Braucher, Regis; Lebatard, Anne] Univ Aix Marseille, CNRS, Ctr Rech & Enseignement Geosci Environem CEREGE, Lab Natl Nucleides Cosmogen,UM34, Aix En Provence, France; [Ros-Montoya, Sergio] Museo Prehist & Paleontol, Granada, Spain; [Martinez-Navarro, Bienvenido; Burjachs, Francesc; Agusti, Jordi] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain; [Martinell, Jordi] Univ Barcelona, Fac Geol, Dept Estratig Paleontol & Geociencies Marines, Barcelona, Spain	Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; Universidade de Coimbra; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universidad de Burgos; Universidad de Burgos; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; ICREA; University of Barcelona	Vallverdu, J (corresponding author), Inst Catala Paleoecol Humana & Evolucio Social IP, Tarragona, Spain.	jvallverdu@iphes.cat; arosas@mncn.csic.es	Saladie, Palmira/AAR-7932-2020; López-Polín, Lucía/AAC-3482-2019; Estalrrich, Almudena/ABF-1891-2020; Mosquera, Marina/B-1140-2014; Burjachs, Francesc/G-2064-2015; Martinez-Navarro, Bienvenido/L-5950-2014; Vergès Bosch, Josep Maria/G-4490-2015; Martínez-Navarro, Bienvenido/ABE-3563-2021; Rosas, Antonio/D-9742-2016; Martinell, Jordi/X-4501-2019; Expósito, Isabel/J-2046-2017; Ros-Montoya, Sergio/AAD-1749-2019; López-Polín, Lucía/C-3087-2016; Huguet, Rosa/H-5713-2015; Poch, Josep Vallverdú i/B-7121-2014; Lozano-Fernández, Iván/AAE-1394-2019; Carrancho, Ángel/R-5077-2018; Ollé, Andreu/D-6837-2013; García-Tabernero, Antonio/AAQ-8382-2020; Ros-Montoya, Sergio/L-6105-2014; Cáceres, Isabel/G-2636-2015; , Braucher/Q-5971-2017; Carbonell, Eudald/G-3003-2015; Martinell, Jordi/K-2981-2014; Montoya, Sergio Ros/M-6189-2015; Saladie, Palmira/G-4019-2015; Bastir, Markus/G-8987-2013	López-Polín, Lucía/0000-0002-5810-4115; Estalrrich, Almudena/0000-0003-2295-5396; Mosquera, Marina/0000-0003-4823-6154; Burjachs, Francesc/0000-0002-7200-9552; Martinez-Navarro, Bienvenido/0000-0002-8374-5109; Vergès Bosch, Josep Maria/0000-0003-1807-7463; Martínez-Navarro, Bienvenido/0000-0002-8374-5109; Rosas, Antonio/0000-0002-5829-9952; Martinell, Jordi/0000-0003-2638-8106; Expósito, Isabel/0000-0002-2084-5487; Ros-Montoya, Sergio/0000-0001-6895-807X; López-Polín, Lucía/0000-0002-5810-4115; Poch, Josep Vallverdú i/0000-0002-3177-3263; Carrancho, Ángel/0000-0001-7119-6424; Ollé, Andreu/0000-0002-8643-5536; García-Tabernero, Antonio/0000-0001-5400-5630; Ros-Montoya, Sergio/0000-0001-6895-807X; Cáceres, Isabel/0000-0001-8487-2591; , Braucher/0000-0002-4637-4302; Martinell, Jordi/0000-0003-2638-8106; Montoya, Sergio Ros/0000-0001-6895-807X; Bennasar, Maria/0000-0003-3780-7505; Pineda Alcala, Antonio/0000-0002-3767-8590; Lozano-Fernandez, Ivan/0000-0003-1036-7634; Saladie, Palmira/0000-0002-1730-8461; Bastir, Markus/0000-0002-3141-3401; VILLALAIN, JUAN JOSE/0000-0001-9948-0953; Bourles, Didier/0000-0001-5991-6126; Lebatard, Anne-Elisabeth/0000-0002-9262-9169	Spanish Ministerio de Economia y Competitividad [CGL2012-36682, CGL2012-38358, CGL2012-38434-C03-03, CGL2010-15326, HAR2009-7223/HIST]; Generalitat de Catalunya; AGAUR agence [2014SGR-901, 2014SGR-899, 2009SGR-324, 2009PBR-0033, 2009SGR-188]; Junta de Castilla y Leon [BU1004A09]; Ajuntament de la Canonja and Departament de Cultura (Servei d'Arqueologia i Paleontologia) de la Generalitat de Catalunya; International Excellence Programme, Reinforcement subprogramme of the Spanish Ministry of Education; Fundacion Atapuerca; ICREA Funding Source: Custom	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); AGAUR agence; Junta de Castilla y Leon(Junta de Castilla y Leon); Ajuntament de la Canonja and Departament de Cultura (Servei d'Arqueologia i Paleontologia) de la Generalitat de Catalunya; International Excellence Programme, Reinforcement subprogramme of the Spanish Ministry of Education; Fundacion Atapuerca; ICREA(ICREA)	The research at Barranc de la Boella has been carried out with the financial support of the Spanish Ministerio de Economia y Competitividad (CGL2012-36682; CGL2012-38358, CGL2012-38434-C03-03 and CGL2010-15326; MICINN project HAR2009-7223/HIST), Generalitat de Catalunya, AGAUR agence ( projects 2014SGR-901; 2014SGR-899; 2009SGR-324, 2009PBR-0033 and 2009SGR-188) and Junta de Castilla y Leon BU1004A09. Financial support for Barranc de la Boella field work and archaeological excavations is provided by the Ajuntament de la Canonja and Departament de Cultura (Servei d'Arqueologia i Paleontologia) de la Generalitat de Catalunya. A. Carrancho's research was funded by the International Excellence Programme, Reinforcement subprogramme of the Spanish Ministry of Education. I. Lozano-Fernandez acknowledges the pre-doctoral grant from the Fundacion Atapuerca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIMEN MH, 1975, ANTHROPOLOGIE, V79, P399; Arnold M, 2010, NUCL INSTRUM METH B, V268, P1954, DOI 10.1016/j.nimb.2010.02.107; ASHTON N, 1994, ANTIQUITY, V68, P585, DOI 10.1017/S0003598X00047074; Bar-Yosef O, 1993, LITHIC ASSEMBLAGES U; Biberson PL., 1961, PALEOLITHIQUE INFERI; Binford L.R., 1982, J ANTHROPOL ARCHAEOL, V1, P5, DOI DOI 10.1016/0278-4165(82)90006-X; Bordes F, 1971, MUNIBE, P5; Braucher R, 2011, EARTH PLANET SC LETT, V309, P1, DOI 10.1016/j.epsl.2011.06.036; Bridgland DR, 2006, J QUATERNARY SCI, V21, P437, DOI 10.1002/jqs.1042; BROWN ET, 1991, GEOCHIM COSMOCHIM AC, V55, P2269, DOI 10.1016/0016-7037(91)90103-C; Bunn H T, 1982, Science, V215, P494, DOI 10.1126/science.215.4532.494; Cac hel S., 1998, EARLY HUMAN BEHAV GL, P108; Carbonell E., 1988, COMPLEX PLISTOCE MIT; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Carbonell E, 2010, QUATERN INT, V223, P36, DOI 10.1016/j.quaint.2010.02.015; Chevrier B, 2006, GALLIA PREHISTOIRE, V48, P207, DOI DOI 10.3406/GALIP.2006.2451; Chmeleff J, 2010, NUCL INSTRUM METH B, V268, P192, DOI 10.1016/j.nimb.2009.09.012; de la Torre I, 2004, ESTRATEGIAS TECNOLOG; de la Torre I, 2011, J HUM EVOL, V60, P768, DOI 10.1016/j.jhevol.2011.01.009; Dennell R, 2005, NATURE, V438, P1099, DOI 10.1038/nature04259; Dennell R, 2003, J HUM EVOL, V45, P421, DOI 10.1016/j.jhevol.2003.09.006; Despriee J, 2011, QUATERNARY SCI REV, V30, P1474, DOI 10.1016/j.quascirev.2011.02.011; Despriee J, 2010, QUATERN INT, V223, P345, DOI 10.1016/j.quaint.2009.07.019; Garcia Sanchez E, 2006, TRABAJOS PREHIST, V63, P47; Goren-Inbar N., 2004, HUMAN PALEOECOLOGY L; Granger DE, 2006, GEOL SOC AM SPEC PAP, V415, P1, DOI 10.1130/2006.2415(01); Granger DE, 2001, EARTH PLANET SC LETT, V188, P269, DOI 10.1016/S0012-821X(01)00309-0; HAYNES G, 1988, J ARCHAEOL SCI, V15, P131, DOI 10.1016/0305-4403(88)90003-9; Isaac G.L., 1977, OLORGESAILIE ARCHEOL; KOHL CP, 1992, GEOCHIM COSMOCHIM AC, V56, P3583, DOI 10.1016/0016-7037(92)90401-4; Korschinek G, 2010, NUCL INSTRUM METH B, V268, P187, DOI 10.1016/j.nimb.2009.09.020; Leakey M. D., 1971, OLDUVAI GORGE EXCAVA; Lozano-Fernandez I, 2013, QUATERNAIRE, V24, P179, DOI 10.4000/quaternaire.6587; Lycett SJ, 2010, WORLD ARCHAEOL, V42, P521, DOI 10.1080/00438243.2010.517667; Madurell-Malapeira J, 2012, J HUM EVOL, V62, P169, DOI 10.1016/j.jhevol.2011.10.005; Jimenez-Arenas JM, 2011, J ARCHAEOL SCI, V38, P3340, DOI 10.1016/j.jas.2011.07.020; Marlowe FW, 2006, FEEDING ECOLOGY APES, P359; Martinez K, 2010, P NATL ACAD SCI USA, V107, P5762, DOI 10.1073/pnas.0913856107; Masana E., 1994, GEOMORFOLOGIA ESPANA, P29; McNabb J, 2005, GEOL SOC SPEC PUBL, V247, P287, DOI 10.1144/GSL.SP.2005.247.01.17; Merchel S, 2004, NUCL INSTRUM METH B, V223, P393, DOI 10.1016/j.nimb.2004.04.076; Merchel S, 1999, RADIOCHIM ACTA, V84, P215; Mgeladze A, 2011, J HUM EVOL, V60, P571, DOI 10.1016/j.jhevol.2010.10.008; Mishra S, 2007, QUATERNARY SCI REV, V26, P2996, DOI 10.1016/j.quascirev.2007.06.035; Moncel MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075529; Moncel MH, 2010, QUATERN INT, V223, P1, DOI 10.1016/j.quaint.2010.02.016; Mosquera M, 2013, QUATERN INT, V295, P130, DOI 10.1016/j.quaint.2012.01.031; Movius HL, 1949, LOWER PALAEOLITHIC C; Nemec W, 1984, SEDIMENTOLOGY GRAVEL, V10, P1; NISHIIZUMI K, 1989, J GEOPHYS RES-SOLID, V94, P17907, DOI 10.1029/JB094iB12p17907; OCONNELL JF, 1988, CURR ANTHROPOL, V29, P356, DOI 10.1086/203648; Pappu S, 2011, SCIENCE, V331, P1596, DOI 10.1126/science.1200183; Parfitt SA, 2010, NATURE, V466, P229, DOI 10.1038/nature09117; Perez Gonzalez A, 1998, B SEMINARIO ESTUDIOS, V64, P9; Perez-Gonzalez A., 2010, CUATERNARIO ARQUEOLO, P45; Petraglia M, 1999, J ANTHROPOL RES, V55, P39, DOI 10.1086/jar.55.1.3630977; Plummer T, 2005, AFRICAN ARCHAEOLOGY, P55; Querol M.A., 1979, EXCAVACIONES ARQUEOL, P181; Rolland Nicolas., 1998, EARLY HUMAN BEHAV GL, P187; Sahnouni M., 2009, CUTTING EDGE NEW APP, P179; SAMWORTH EA, 1972, PHYS REV C, V5, P138, DOI 10.1103/PhysRevC.5.138; Santisteban JI, 2007, QUATERNARY SCI REV, V26, P2738, DOI 10.1016/j.quascirev.2006.12.019; Santonja M., 2006, AXE AGE ACHEULIAN TO, P429; Santonja M, 2000, ZEPHYRUS, V53-54, P27; Santonja M, 2000, ZEPHYRUS, P27; Santonja M, 2010, QUATERN INT, V223, P154, DOI 10.1016/j.quaint.2010.02.010; Schick K., 2003, MULTIPLE APPROACHES, P1; Scott GR, 2009, NATURE, V461, P82, DOI 10.1038/nature08214; Semaw S, 2009, SOURCEBOOK OF PALEOLITHIC TRANSITIONS, P173, DOI 10.1007/978-0-387-76487-0_10; Sharon G, 2011, J HUM EVOL, V60, P387, DOI 10.1016/j.jhevol.2009.11.012; Sharon G, 2011, AFR ARCHAEOL REV, V28, P125, DOI 10.1007/s10437-011-9087-3; Shea JJ, 2010, VERTEBR PALEOBIOL PA, P47, DOI 10.1007/978-90-481-9036-2_4; Silva PG, 2012, ESTUD GEOL-MADRID, V67, P57, DOI DOI 10.3989/EGE0L.40338.134; Sirakov N, 2010, QUATERN INT, V223, P94, DOI 10.1016/j.quaint.2010.02.023; Stone JO, 2000, J GEOPHYS RES-SOL EA, V105, P23753, DOI 10.1029/2000JB900181; Tauxe L, 1996, J GEOPHYS RES-SOL EA, V101, P571, DOI 10.1029/95JB03041; Toro-Moyano I, 2013, J HUM EVOL, V65, P1, DOI 10.1016/j.jhevol.2013.01.012; Valls Bartolome ML, 1987, NEOTECTONICA RED HID, P885; Vilaseca S., 1973, REUS ENTORNO PREHIST; Villa P, 2001, QUATERN INT, V75, P113, DOI 10.1016/S1040-6182(00)00083-5; Villamarin JA, 1999, GEOGACETA, V25, P211; White MJ, 2000, J WORLD PREHIST, V14, P1, DOI 10.1023/A:1007874901792; Zouak M, 2002, QUATERNAIRE, P65	83	120	121	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103634	10.1371/journal.pone.0103634	http://dx.doi.org/10.1371/journal.pone.0103634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AM7EZ	25076416	Green Published, gold, Green Submitted			2022-12-25	WOS:000340028800070
J	Xie, N; Mou, LS; Yuan, JH; Liu, WL; Deng, TT; Li, ZG; Jin, Y; Hu, ZL				Xie, Ni; Mou, Lisha; Yuan, Jianhui; Liu, Wenlan; Deng, Tingting; Li, Zigang; Jin, Yi; Hu, Zhangli			Modulating Drug Resistance by Targeting BCRP/ABCG2 Using Retrovirus-Mediated RNA Interference	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; MULTIDRUG-RESISTANCE; PROTEIN EXPRESSION; BLAST CELLS; IN-VITRO; INHIBITION; TOPOTECAN; MEMBRANE; POTENT	Background: The BCRP/ABCG2 transporter, which mediates drug resistance in many types of cells, depends on energy provided by ATP hydrolysis. Here, a retrovirus encoding a shRNA targeting the ATP-binding domain of this protein was used to screen for highly efficient agents that could reverse drug resistance and improve cell sensitivity to drugs, thus laying the foundation for further studies and applications. Methodology/Principal Findings: To target the ATP-binding domain of BCRP/ABCG2, pLenti6/BCRPsi shRNA recombinant retroviruses, with 20 bp target sequences starting from the 270th, 745th and 939th bps of the 6th exon, were constructed and packaged. The pLenti6/BCRPsi retroviruses (V-BCRPi) that conferred significant knockdown effects were screened using a drug-sensitivity experiment and flow cytometry. The human choriocarcinoma cell line JAR, which highly expresses endogenous BCRP/ABCG2, was injected under the dorsal skin of a hairless mouse to initiate a JAR cytoma. After injecting V-BCRPi-infected JAR tumor cells into the dorsal skin of hairless mice, BCRP/ABCG2 expression in the tumor tissue was determined using immunohistochemistry, fluorescent quantitative RT-PCR and Western blot analyses. After intraperitoneal injection of BCRP/ABCG2-tolerant 5-FU, the tumor volume, weight change, and apoptosis rate of the tumor tissue were determined using in situ hybridization. V-BCRPi increased the sensitivity of the tumor histiocytes to 5-FU and improved the cell apoptosis-promoting effects of 5-FU in the tumor. Conclusions/Significance: The goal of the in vivo and in vitro studies was to screen for an RNA interference recombinant retrovirus capable of stably targeting the ATP-binding domain of BCRP/ABCG2 (V-BCRPi) to inhibit its function. A new method to improve the chemo-sensitivity of breast cancer and other tumor cells was discovered, and this method could be used for gene therapy and functional studies of malignant tumors.	[Xie, Ni; Mou, Lisha; Liu, Wenlan; Jin, Yi] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen, Guangdong, Peoples R China; [Yuan, Jianhui; Deng, Tingting] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China; [Li, Zigang] Peking Univ, Shenzhen Grad Sch, Shenzhen, Guangdong, Peoples R China; [Hu, Zhangli] Shenzhen Univ, Coll Life Sci, Shenzhen, Guangdong, Peoples R China	Shenzhen University; Shenzhen Center for Disease Control & Prevention (SZCDC); Peking University; University Town of Shenzhen; Shenzhen University	Yuan, JH (corresponding author), Shenzhen Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China.	jianhui_yuan@126.com	Mou, Lisha/I-4739-2012	Mou, Lisha/0000-0001-6232-8341; Xie, Ni/0000-0002-7167-9343	National Natural Science Fund [30500599, 81200465]; Guangdong Natural Science Fund Project [9151503102000019]; Shenzhen Science and Technology Plan [201201028]; Shenzhen Technical Research and Development Fund Project [GJHZ20130412153906740, JCYJ20120615085512920, JCYJ20120613171430264, ZYC201006180477A, SW201110060, SW201110018]; Shenzhen Peacock Plan [KQTD201103]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Fund Project; Shenzhen Science and Technology Plan; Shenzhen Technical Research and Development Fund Project; Shenzhen Peacock Plan	Funding provided by National Natural Science Fund (30500599, 81200465); Guangdong Natural Science Fund Project (9151503102000019); Shenzhen Science and Technology Plan (medical treatment and public health) key project (201201028); Shenzhen Technical Research and Development Fund Project (GJHZ20130412153906740, JCYJ20120615085512920, JCYJ20120613171430264, ZYC201006180477A, SW201110060, SW201110018); Shenzhen Peacock Plan (KQTD201103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BL, 2002, BLOOD, V100, P4594, DOI 10.1182/blood-2002-01-0271; Allen JD, 2002, MOL CANCER THER, V1, P417; Allikmets R, 1998, CANCER RES, V58, P5337; Bailey-Dell KJ, 2001, BBA-GENE STRUCT EXPR, V1520, P234, DOI 10.1016/S0167-4781(01)00270-6; Bera TK, 2001, MOL MED, V7, P509, DOI 10.1007/BF03401856; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Ee PLR, 2004, MOL CANCER THER, V3, P1577; Eisenblatter T, 2003, BRAIN RES, V971, P221, DOI 10.1016/S0006-8993(03)02401-6; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Erlichman C, 2001, CANCER RES, V61, P739; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hoffmann U, 2000, PATHOL RES PRACT, V196, P235; Kage K, 2002, INT J CANCER, V97, P626, DOI 10.1002/ijc.10100; Kanzaki A, 2001, JPN J CANCER RES, V92, P452, DOI 10.1111/j.1349-7006.2001.tb01115.x; Kawabata S, 2001, BIOCHEM BIOPH RES CO, V280, P1216, DOI 10.1006/bbrc.2001.4267; Komatani H, 2001, CANCER RES, V61, P2827; Kowalski P, 2001, CANCER GENE THER, V8, P185, DOI 10.1038/sj.cgt.7700294; KRISHNAMACHARY N, 1993, CANCER RES, V53, P3658; Kubota T, 2001, Breast Cancer, V8, P333, DOI 10.1007/BF02967534; Maliepaard M, 2001, CLIN CANCER RES, V7, P935; Minderman H, 2002, CYTOMETRY, V48, P59, DOI 10.1002/cyto.10111; Miyake K, 1999, CANCER RES, V59, P8; Mohan A, 2006, BRIT J OPHTHALMOL, V90, P889, DOI 10.1136/bjo.2005.089219; Nieth C, 2003, FEBS LETT, V545, P144, DOI 10.1016/S0014-5793(03)00523-4; Rabindran SK, 2000, CANCER RES, V60, P47; Ross DD, 2000, BLOOD, V96, P365, DOI 10.1182/blood.V96.1.365.013k46_365_368; Sargent JM, 2001, BRIT J HAEMATOL, V115, P257, DOI 10.1046/j.1365-2141.2001.03122.x; Scheffer GL, 2000, CANCER RES, V60, P2589; SCHUURHUIS GJ, 1991, BRIT J CANCER, V64, P857, DOI 10.1038/bjc.1991.413; Sheng MY, 2001, CHIN J CANCER, V20, P274; Yasumasa H, 2001, CANCER RES, V61, P6635; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	35	17	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103463	10.1371/journal.pone.0103463	http://dx.doi.org/10.1371/journal.pone.0103463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076217	Green Published, gold, Green Submitted			2022-12-25	WOS:000340028800049
J	Melesse, M; Choi, EY; Hall, H; Walsh, MJ; Geer, MA; Hall, MC				Melesse, Michael; Choi, Eunyoung; Hall, Hana; Walsh, Michael J.; Geer, M. Ariel; Hall, Mark C.			Timely Activation of Budding Yeast APC(Cdh1) Involves Degradation of Its Inhibitor, Acm1, by an Unconventional Proteolytic Mechanism	PLOS ONE			English	Article							UBIQUITIN-INDEPENDENT DEGRADATION; ANAPHASE-PROMOTING COMPLEX; ORNITHINE-DECARBOXYLASE; SACCHAROMYCES-CEREVISIAE; PROTEASOMAL DEGRADATION; PSEUDOSUBSTRATE INHIBITION; TUMOR SUPPRESSORS; PROTEINS; SCF; COMPLEX/CYCLOSOME	Regulated proteolysis mediated by the ubiquitin proteasome system is a fundamental and essential feature of the eukaryotic cell division cycle. Most proteins with cell cycle-regulated stability are targeted for degradation by one of two related ubiquitin ligases, the Skp1-cullin-F box protein (SCF) complex or the anaphase-promoting complex (APC). Here we describe an unconventional cell cycle-regulated proteolytic mechanism that acts on the Acm1 protein, an inhibitor of the APC activator Cdh1 in budding yeast. Although Acm1 can be recognized as a substrate by the Cdc20-activated APC (APC(Cdc20)) in anaphase, APC(Cdc20) is neither necessary nor sufficient for complete Acm1 degradation at the end of mitosis. An APC-independent, but 26S proteasome-dependent, mechanism is sufficient for complete Acm1 clearance from late mitotic and G1 cells. Surprisingly, this mechanism appears distinct from the canonical ubiquitin targeting pathway, exhibiting several features of ubiquitin-independent proteasomal degradation. For example, Acm1 degradation in G1 requires neither lysine residues in Acm1 nor assembly of polyubiquitin chains. Acm1 was stabilized though by conditional inactivation of the ubiquitin activating enzyme Uba1, implying some requirement for the ubiquitin pathway, either direct or indirect. We identified an amino terminal predicted disordered region in Acm1 that contributes to its proteolysis in G1. Although ubiquitin-independent proteasome substrates have been described, Acm1 appears unique in that its sensitivity to this mechanism is strictly cell cycle-regulated via cyclin-dependent kinase (Cdk) phosphorylation. As a result, Acm1 expression is limited to the cell cycle window in which Cdk is active. We provide evidence that failure to eliminate Acm1 impairs activation of APC(Cdh1) at mitotic exit, justifying its strict regulation by cell cycle-dependent transcription and proteolytic mechanisms. Importantly, our results reveal that strict cell-cycle expression profiles can be established independent of proteolysis mediated by the APC and SCF enzymes.	[Melesse, Michael; Choi, Eunyoung; Hall, Hana; Walsh, Michael J.; Geer, M. Ariel; Hall, Mark C.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Hall, Mark C.] Purdue Univ, Ctr Canc Res, W Lafayette, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hall, MC (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.	mchall@purdue.edu	Hall, Mark C./D-1698-2011; Melesse, Michael/AAA-9425-2019	Hall, Mark/0000-0001-6429-2506; Melesse Vergara, Michael/0000-0002-3474-6981; Hall, Hana/0000-0002-7544-4437	National Science Foundation [MCB0841748]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by National Science Foundation (www.nsf.gov) grant MCB0841748 to Mark C. Hall. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Bremmer SC, 2012, J BIOL CHEM, V287, P1662, DOI 10.1074/jbc.M111.281105; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; Choi E, 2008, J BIOL CHEM, V283, P23701, DOI 10.1074/jbc.M803695200; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Dial JM, 2007, J BIOL CHEM, V282, P5237, DOI 10.1074/jbc.M606589200; Enquist-Newman M, 2008, MOL CELL, V30, P437, DOI 10.1016/j.molcel.2008.04.004; Ferrara P, 2003, ONCOGENE, V22, P1461, DOI 10.1038/sj.onc.1206266; Forster A, 2003, TRENDS CELL BIOL, V13, P550, DOI 10.1016/j.tcb.2003.09.001; Gandre S, 2002, BIOCHEM BIOPH RES CO, V293, P139, DOI 10.1016/S0006-291X(02)00194-8; Ghaboosi N, 2007, MOL BIOL CELL, V18, P1953, DOI 10.1091/mbc.E06-10-0965; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Hall MC, 2008, J BIOL CHEM, V283, P10396, DOI 10.1074/jbc.M710011200; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; HEINEMEYER W, 1993, J BIOL CHEM, V268, P5115; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jaquenoud M, 2002, EMBO J, V21, P6515, DOI 10.1093/emboj/cdf634; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Leggett David S., 2005, V301, P57; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; Lim SK, 2007, ONCOGENE, V26, P6593, DOI 10.1038/sj.onc.1210482; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Martinez JS, 2006, MOL CELL BIOL, V26, P9162, DOI 10.1128/MCB.00603-06; Martinez JS, 2012, CELL CYCLE, V11, P384, DOI 10.4161/cc.11.2.18944; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; Ostapenko D, 2008, MOL CELL BIOL, V28, P4653, DOI 10.1128/MCB.00055-08; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Robbins JA, 2010, MOL BIOL CELL, V21, P914, DOI 10.1091/mbc.E09-10-0901; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158	56	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103517	10.1371/journal.pone.0103517	http://dx.doi.org/10.1371/journal.pone.0103517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072887	gold, Green Submitted, Green Published			2022-12-25	WOS:000341307600056
J	Zhang, QH; Soderland, D; Steinle, JJ				Zhang, Qiuhua; Soderland, Dylan; Steinle, Jena J.			TNF alpha Inhibits IGFBP-3 through Activation of p38 alpha and Casein Kinase 2 in Human Retinal Endothelial Cells	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; FACTOR-BINDING PROTEIN-3; SIGNALING PATHWAYS; INDUCED APOPTOSIS; PHOSPHORYLATION; SER(307); IRS-1	We recently reported a reciprocal relationship between tumor necrosis factor alpha (TNF alpha) and insulin-like receptor growth factor binding protein 3 (IGFBP-3) in whole retina of normal and IGFBP-3 knockout mice. A similar relationship was also observed in cultured retinal endothelial cells (REC). We found that TNF alpha significantly reduced IGFBP-3 levels and vice-versa, IGFBP-3 can lower TNF alpha and TNF alpha receptor expression. Since IGFBP-3 is protective to the diabetic retina and TNF alpha is causative in the development of diabetic retinopathy, we wanted to better understand the cellular mechanisms by which TNF alpha can reduce IGFBP-3 levels. For these studies, primary human retinal endothelial cells (REC) were used since these cells undergo TNF alpha-mediated apoptosis under conditions of high glucose conditions and contribute to diabetic retinopathy. We first cultured REC in normal or high glucose, treated with exogenous TNF alpha, then measured changes in potential signaling pathways, with a focus on P38 mitogen-activated protein kinase alpha (P38 alpha) and casein kinase 2 (CK2) as these pathways have been linked to both TNF alpha and IGFBP-3. We found that TNF alpha significantly increased phosphorylation of P38 alpha and CK2. Furthermore, specific inhibitors of P38 alpha or CK2 blocked TNF alpha inhibition of IGFBP-3 expression, demonstrating that TNF alpha reduces IGFBP-3 through activation of P38 alpha and CK2. Since TNF alpha and IGFBP-3 are key mediators of retinal damage and protection respectively in diabetic retinopathy, increased understanding of the relationship between these two proteins will offer new therapeutic options for treatment.	[Zhang, Qiuhua; Steinle, Jena J.] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA; [Steinle, Jena J.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA; [Steinle, Jena J.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN USA; [Soderland, Dylan] Cell Syst Corp, Washington, DC USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Steinle, JJ (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA.	jsteinl1@uthsc.edu	zhang, qiu/GXG-5600-2022	Steinle, Jena/0000-0002-7539-2892	National Eye Institute [R01-EY022045]; JDRF [2-2011-597]; Oxnard Foundation; HEI Research to Prevent Blindness Award; NEI Vision Core Grant [PHS 3P30 EY013080]; NATIONAL EYE INSTITUTE [R01EY022045, P30EY013080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); JDRF(Juvenile Diabetes Research Foundation); Oxnard Foundation; HEI Research to Prevent Blindness Award; NEI Vision Core Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Eye Institute R01-EY022045 (JJS), JDRF (2-2011-597 to JJS), Oxnard Foundation (JJS), HEI Research to Prevent Blindness Award (PI: James C. Fleming), and NEI Vision Core Grant: PHS 3P30 EY013080 (PI: Dianna Johnson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Baxter RC, 2001, J CLIN PATHOL-MOL PA, V54, P145, DOI 10.1136/mp.54.3.145; Chen XY, 2006, GROWTH HORM IGF RES, V16, P41, DOI 10.1016/j.ghir.2005.09.003; CONOVER CA, 1992, ENDOCRINOLOGY, V130, P3191, DOI 10.1210/en.130.6.3191; Coverley JA, 1997, MOL CELL ENDOCRINOL, V128, P1, DOI 10.1016/S0303-7207(97)04032-X; Coverley JA, 2000, ENDOCRINOLOGY, V141, P564, DOI 10.1210/en.141.2.564; Granata R, 2004, FASEB J, V18, P1456, DOI 10.1096/fj.04-1618fje; Jiang YD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093788; Jiang YD, 2012, CELL SIGNAL, V24, P1086, DOI 10.1016/j.cellsig.2012.01.003; Jiang YD, 2010, EXP EYE RES, V91, P171, DOI 10.1016/j.exer.2010.04.014; Jiang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065756; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Joussen AM, 2009, MOL VIS, V15, P1418; Leibowitz BJ, 2009, J CELL PHYSIOL, V220, P182, DOI 10.1002/jcp.21748; Markelic M, 2011, EUR J HISTOCHEM, V55, P187, DOI 10.4081/ejh.2011.e34; Mirzaa GM, 2014, NAT GENET, V46, P510, DOI 10.1038/ng.2948; Panjala SR, 2011, MOL VIS, V17, P1822; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; Zhang Q, 2013, INVEST OPHTHALMOL VI; Zhang QH, 2013, INVEST OPHTH VIS SCI, V54, P5376, DOI 10.1167/iovs.13-12497; Zhang QH, 2013, MOL VIS, V19, P796; Zhang QH, 2012, INVEST OPHTH VIS SCI, V53, P3004, DOI 10.1167/iovs.11-8779	23	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103578	10.1371/journal.pone.0103578	http://dx.doi.org/10.1371/journal.pone.0103578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25073020	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600066
J	Ley, CKK; Kuryatov, A; Wang, JY; Lindstrom, JM				Ley, Carson Kai-Kwong; Kuryatov, Alexander; Wang, Jingyi; Lindstrom, Jon Martin			Efficient Expression of Functional (alpha 6 beta 2)(2)beta 3 AChRs in Xenopus Oocytes from Free Subunits Using Slightly Modified alpha 6 Subunits	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; VENTRAL TEGMENTAL AREA; DOPAMINE RELEASE; PHARMACOLOGY; LOCOMOTION; SUBTYPES	Human (alpha 6 beta 2)(alpha 4 beta 2)beta 3 nicotinic acetylcholine receptors (AChRs) are essential for addiction to nicotine and a target for drug development for smoking cessation. Expressing this complex AChR is difficult, but has been achieved using subunit concatamers. In order to determine what limits expression of alpha 6* AChRs and to efficiently express alpha 6* AChRs using free subunits, we investigated expression of the simpler (alpha 6 beta 2)(2)beta 3 AChR. The concatameric form of this AChR assembles well, but is transported to the cell surface inefficiently. Various chimeras of alpha 6 with the closely related alpha 3 subunit increased expression efficiency with free subunits and produced pharmacologically equivalent functional AChRs. A chimera in which the large cytoplasmic domain of alpha 6 was replaced with that of alpha 3 increased assembly with beta 2 subunits and transport of AChRs to the oocyte surface. Another chimera replacing the unique methionine 211 of alpha 6 with leucine found at this position in transmembrane domain 1 of alpha 3 and other alpha subunits increased assembly of mature subunits containing beta 3 subunits within oocytes. Combining both alpha 3 sequences in an alpha 6 chimera increased expression of functional (alpha 6 beta 2)(2)beta 3 AChRs to 12-fold more than with concatamers. This is pragmatically useful, and provides insights on features of alpha 6 subunit structure that limit its expression in transfected cells.	[Ley, Carson Kai-Kwong; Kuryatov, Alexander; Wang, Jingyi; Lindstrom, Jon Martin] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Lindstrom, JM (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.	JSLKK@mail.med.upenn.edu	wang, jing/GRS-7509-2022; WANG, JINGYI/GSJ-1241-2022		National Institute of Neurological Disorders and Stroke [NS11323]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030929] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Neurological Disorders and Stroke [Grant NS11323]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akk Gustav, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS59, DOI 10.1016/j.psyneuen.2009.05.020; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; Crooks PA, 2014, ADV PHARMACOL, V69, P513, DOI 10.1016/B978-0-12-420118-7.00013-5; Cui CH, 2003, J NEUROSCI, V23, P11045; Drenan RM, 2012, PHARMACOL REV, V64, P869, DOI 10.1124/pr.111.004671; Drenan RM, 2010, J NEUROSCI, V30, P9877, DOI 10.1523/JNEUROSCI.2056-10.2010; Gee VJ, 2007, BRIT J PHARMACOL, V152, P501, DOI 10.1038/sj.bjp.0707429; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Jensen AB, 2013, J BIOL CHEM, V288, P33708, DOI 10.1074/jbc.M113.509356; Kracun S, 2008, BRIT J PHARMACOL, V153, P1474, DOI 10.1038/sj.bjp.0707676; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; Letchworth SR, 2011, BIOCHEM PHARMACOL, V82, P862, DOI 10.1016/j.bcp.2011.06.022; Lindstrom J, 2006, MOL PHARMACOL, V70, P5, DOI 10.1124/mol.106.025767.; McCallum SE, 2006, J PHARMACOL EXP THER, V318, P381, DOI 10.1124/jpet.106.104414; Mukherjee J, 2009, J NEUROCHEM, V110, P1885, DOI 10.1111/j.1471-4159.2009.06285.x; Perez XA, 2013, J NEUROCHEM, V127, P762, DOI 10.1111/jnc.12442; Perez XA, 2012, J PHARMACOL EXP THER, V342, P335, DOI 10.1124/jpet.112.194084; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Quik M, 2011, PHARMACOL REV, V63, P938, DOI 10.1124/pr.110.003269; Rasmussen AH, 2014, BRAIN RES, V1542, P1, DOI 10.1016/j.brainres.2013.10.024; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; Salminen O, 2007, MOL PHARMACOL, V71, P1563, DOI 10.1124/mol.106.031492; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Tumkosit P, 2006, MOL PHARMACOL, V70, P1358, DOI 10.1124/mol.106.027326; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918; WHITING PJ, 1988, J NEUROSCI, V8, P3395	32	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103244	10.1371/journal.pone.0103244	http://dx.doi.org/10.1371/journal.pone.0103244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068303	Green Submitted, gold, Green Published			2022-12-25	WOS:000339993700051
J	Kroiss, A; Vincent, S; Decaussin-Petrucci, M; Meugnier, E; Viallet, J; Ruffion, A; Chalmel, F; Samarut, J; Allioli, N				Kroiss, A.; Vincent, S.; Decaussin-Petrucci, M.; Meugnier, E.; Viallet, J.; Ruffion, A.; Chalmel, F.; Samarut, J.; Allioli, N.			Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2	ONCOGENE			English	Article							RECEPTOR; EXPRESSION; GROWTH; RECOGNITION; PATHWAY; KINASE	Androgen signaling, via the androgen receptor (AR), is crucial in mediating prostate cancer (PCa) initiation and progression. Identifying new downstream effectors of the androgens/AR pathway will allow a better understanding of these mechanisms and could reveal novel biomarkers and/or therapeutic agents to improve the rate of patient survival. We compared the microRNA expression profiles in androgen-sensitive LNCaP cells stimulated or not with 1 nM R1881 by performing a high-throughput reverse transcriptase-quantitative PCR and found that miR-135a was upregulated. After androgen stimulation, we showed that AR directly activates the transcription of miR-135a2 gene by binding to an androgen response element in the promoter region. Our findings identify miR-135a as a novel effector in androgens/AR signaling. Using xenograft experiments in chick embryos and adult male mice, we showed that miR-135a overexpression decreases in vivo invasion abilities of prostate PC-3 cells. Through in vitro wound-healing migration and invasion assays, we demonstrated that this effect is mediated through downregulating ROCK1 and ROCK2 expression, two genes that we characterized as miR-135a direct target genes. In human surgical samples from prostatectomy, we observed that miR-135a expression was lower in tumoral compared with paired adjacent normal tissues, mainly in tumors classified with a high Gleason score (>= 8). Moreover, miR-135a expression is lower in invasive tumors, showing extraprostatic extension, as compared with intraprostatic localized tumors. In tumor relative to normal glands, we also showed a more frequently higher ROCK1 protein expression determined using a semi-quantitative immunohistochemistry analysis. Therefore, in tumor cells, the lower miR-135a expression could lead to a higher ROCK1 protein expression, which could explain their invasion abilities. The highlighted relationship between miR-135a expression level and the degree of disease aggressiveness suggests that miR-135a may be considered as a prognostic marker in human PCa.	[Kroiss, A.; Vincent, S.; Decaussin-Petrucci, M.; Ruffion, A.; Samarut, J.; Allioli, N.] Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, F-69365 Lyon, France; [Decaussin-Petrucci, M.; Ruffion, A.; Samarut, J.] Univ Lyon 1, Fac Med & Maieut Lyon Sud Charles Merieux, F-69365 Lyon, France; [Decaussin-Petrucci, M.] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Serv Anat & Cytol Pathol, F-69310 Pierre Benite, France; [Meugnier, E.] Univ Lyon 1, Fac Med & Maieut Lyon Sud Charles Merieux, Lab CarMen, INRA1362,INSERM U1060, Oullins, France; [Viallet, J.] Univ Grenoble, CRI INSERM UJF U823, Inst Albert Bonniot, In Ovo, La Tronche, France; [Ruffion, A.] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Serv Urol, F-69310 Pierre Benite, France; [Chalmel, F.] Univ Rennes 1, GERHM, INSERM Irset U1085, Rennes, France; [Samarut, J.] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Serv Bioch Biol Mol Sud, F-69310 Pierre Benite, France; [Allioli, N.] Univ Lyon 1, Fac Pharm Lyon, Inst Sci Pharmaceut & Biol, F-69365 Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Allioli, N (corresponding author), Inst Genom Fonct Lyon, 32-34 Ave Tony Garnier, F-69007 Lyon, France.	jacques.samarut@ens-lyon.fr; nathalie.allioli@univ-lyon1.fr	Chalmel, Frederic/M-1297-2016; DECAUSSIN PETRUCCI, MYRIAM/GWZ-7373-2022; Chalmel, Frédéric/L-5360-2018; Samarut, Jacques/AAD-2587-2019; Chalmel, Frédéric/AAM-1079-2021	Chalmel, Frédéric/0000-0002-0535-3628; Chalmel, Frédéric/0000-0002-0535-3628; meugnier, emmanuelle/0000-0002-2291-7691	Institut Merieux; Ligue Contre le Cancer	Institut Merieux; Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from the Institut Merieux and the Ligue Contre le Cancer. We thank Julien Dugas (CarMen Lab) for his contribution in statistical analyses, Celine Michaux, Karine Castellano and Beatrice Bancel (Service d'Anatomie et Cytologie Pathologiques, Hospices Civils de Lyon) for providing patient samples and performing IHC staining, Jean Viallet for performing in ovo assay, Christophe Chamot and Claire Lionnet (Microscopy core facility) and Patrick Manas (AniRA-PBES platform) of UMS3444/US8 SFR Biosciences Gerland-Lyon Sud, for assistance in wound-healing assay and performing xenograft assay in mice, respectively.	Allioli N, 2011, PROSTATE, V71, P1239, DOI 10.1002/pros.21340; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bouyssou JMC, 2014, BBA-REV CANCER, V1845, P255, DOI 10.1016/j.bbcan.2014.02.002; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Chen YT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-111; Chen Y, 2009, LANCET ONCOL, V10, P981, DOI 10.1016/S1470-2045(09)70229-3; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; Denayer S, 2010, MOL ENDOCRINOL, V24, P898, DOI 10.1210/me.2009-0310; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fang YX, 2014, ONCOGENE, V33, P135, DOI 10.1038/onc.2013.54; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fendler A, 2011, CLIN CHEM, V57, P954, DOI 10.1373/clinchem.2010.157727; Fletcher CE, 2012, HUM MOL GENET, V21, P3112, DOI 10.1093/hmg/dds139; Golubovskaya VM, 2014, ANTI-CANCER AGENT ME, V14, P18, DOI 10.2174/187152061401140108113435; Gonzalez-Montelongo MC, 2010, MOL ENDOCRINOL, V24, P1007, DOI 10.1210/me.2009-0472; Green SM, 2012, MOL CELL ENDOCRINOL, V360, P3, DOI 10.1016/j.mce.2011.09.046; Hassan O, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-9; Jalava SE, 2012, ONCOGENE, V31, P4460, DOI 10.1038/onc.2011.624; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; Leung CON, 2014, CARCINOGENESIS; Li YW, 2012, EPIGENETICS-US, V7, P940, DOI 10.4161/epi.21236; Ma S, 2011, CANCER RES, V71, P583, DOI 10.1158/0008-5472.CAN-10-2587; Matsumoto T, 2013, ANNU REV PHYSIOL, V75, P201, DOI 10.1146/annurev-physiol-030212-183656; Murata T, 2010, PROSTATE CANCER P D, V13, P356, DOI 10.1038/pcan.2010.32; Nadiminty N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032832; Rao S, 2012, ONCOGENE, V31, P716, DOI 10.1038/onc.2011.273; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Shin JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085205; Somlyo AV, 2000, BIOCHEM BIOPH RES CO, V269, P652, DOI 10.1006/bbrc.2000.2343; Sun D, 2014, ONCOGENE, V33, P1448, DOI 10.1038/onc.2013.77; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Takayama K, 2013, INT J UROL, V20, P756, DOI 10.1111/iju.12146; Waltering KK, 2011, PROSTATE, V71, P604, DOI 10.1002/pros.21276; Wang BD, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/763569; Wang GH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S22; Watahiki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024950; Wen SM, 2013, PROSTATE, V73, P1306, DOI 10.1002/pros.22676; White RWD, 2009, UROL ONCOL-SEMIN ORI, V27, P307, DOI 10.1016/j.urolonc.2009.01.004; Xi Jianzhong Jeff, 2013, Cancer Treat Res, V158, P119, DOI 10.1007/978-3-642-31659-3_5; Zheng C, 2012, MED ONCOL, V29, P815, DOI 10.1007/s12032-011-9934-8; Zhou WW, 2012, ACTA BIOCH BIOPH SIN, V44, P838, DOI 10.1093/abbs/gms071	47	86	90	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 28	2015	34	22					2846	2855		10.1038/onc.2014.222	http://dx.doi.org/10.1038/onc.2014.222			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CJ2OM	25065599	Green Submitted			2022-12-25	WOS:000355324300004
J	Jiang, N; Hjorth-Jensen, K; Hekmat, O; Iglesias-Gato, D; Kruse, T; Wang, C; Wei, W; Ke, B; Yan, B; Niu, Y; Olsen, JV; Flores-Morales, A				Jiang, N.; Hjorth-Jensen, K.; Hekmat, O.; Iglesias-Gato, D.; Kruse, T.; Wang, C.; Wei, W.; Ke, B.; Yan, B.; Niu, Y.; Olsen, J. V.; Flores-Morales, A.			In vivo quantitative phosphoproteomic profiling identifies novel regulators of castration-resistant prostate cancer growth	ONCOGENE			English	Article							ANDROGEN RECEPTOR; HIPPO PATHWAY; LNCAP MODEL; PHOSPHORYLATION; PTEN; MTOR; INHIBITOR; PROGRESSION; ACTIVATION; EXPRESSION	Prostate cancer remains a leading cause of cancer-related mortality worldwide owing to our inability to treat effectively castration-resistant tumors. To understand the signaling mechanisms sustaining castration-resistant growth, we implemented a mass spectrometry-based quantitative proteomic approach and use it to compare protein phosphorylation in orthotopic xenograft tumors grown in either intact or castrated mice. This investigation identified changes in phosphorylation of signaling proteins such as MEK, LYN, PRAS40, YAP1 and PAK2, indicating the concomitant activation of several oncogenic pathways in castration-resistant tumors, a notion that was confirmed by tumor transcriptome analysis. Further analysis demonstrated that the activation of mTORC1, PAK2 and the increased levels of YAP1 in castration-resistant tumors can be explained by the loss of androgen inhibitory actions. The analysis of clinical samples demonstrated elevated levels of PAK2 and YAP1 in castration-resistant tumors, whereas knockdown experiments in androgen-independent cells demonstrated that both YAP1 and PAK2 regulate cell colony formation and cell invasion activity. PAK2 also influenced cell proliferation and mitotic timing. Interestingly, these phenotypic changes occur in the absence of obvious alterations in the activity of AKT, MAPK or mTORC1 pathways, suggesting that PAK2 and YAP1 may represent novel targets for the treatment of castration-resistant prostate cancer. Pharmacologic inhibitors of PAK2 (PF-3758309) and YAP1 (Verteporfin) were able to inhibit the growth of androgen-independent PC3 xenografts. This work demonstrates the power of applying high-resolution mass spectrometry in the proteomic profiling of tumors grown in vivo for the identification of novel and clinically relevant regulatory proteins.	[Jiang, N.; Hjorth-Jensen, K.; Hekmat, O.; Iglesias-Gato, D.; Kruse, T.; Olsen, J. V.; Flores-Morales, A.] Univ Copenhagen, Dept Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth & Med Sci, Copenhagen, Denmark; [Jiang, N.; Wang, C.; Wei, W.; Ke, B.; Yan, B.; Niu, Y.] Tianjin Med Univ, Tianjin Inst Urol, Tianjin, Peoples R China	University of Copenhagen; Tianjin Medical University	Niu, Y (corresponding author), Tianjin Inst Urol, 23 Pingjiang Rd, Tianjin 300211, Peoples R China.	Amilcar.Flores@cpr.ku.dk; niuyuanjie9317@163.com; Amilcar.Flores@cpr.ku.dk	Olsen, Jesper/ABH-4638-2020; Hekmat, Omid/AAU-4182-2021; Iglesias-Gato, Diego/R-1794-2016	Olsen, Jesper/0000-0002-4747-4938; Iglesias-Gato, Diego/0000-0002-8982-9936	Novo Nordisk Foundation, Movember; Danish Council for Independent Research; Science Foundation of Tianjin [11JCZDJC19700, 09ZCZDSF04300]; National Natural Science Foundation of China [2012CB518304, 2012DFG32220]; Novo Nordisk Fonden [NNF12OC0002286] Funding Source: researchfish	Novo Nordisk Foundation, Movember; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Science Foundation of Tianjin(Natural Science Foundation of Tianjin); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants to AF-M from the Novo Nordisk Foundation, Movember and the Danish Council for Independent Research. JN and NY are supported by the Science Foundation of Tianjin (No.: 11JCZDJC19700) and 09ZCZDSF04300 and the National Natural Science Foundation of China Grant numbers: 2012CB518304 and 2012DFG32220.	Balakumaran BS, 2009, CANCER RES, V69, P7803, DOI 10.1158/0008-5472.CAN-09-0910; Blando J, 2009, AM J PATHOL, V174, P1869, DOI 10.2353/ajpath.2009.080055; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chuan YC, 2010, ONCOGENE, V29, P1531, DOI 10.1038/onc.2009.442; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crawford ED, 2009, UROLOGY, V73, P4, DOI 10.1016/j.urology.2009.03.001; D'Antonio JM, 2008, PROSTATE, V68, P698, DOI 10.1002/pros.20677; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Drake JM, 2013, P NATL ACAD SCI USA, V110, pE4762, DOI 10.1073/pnas.1319948110; Geiger T, 2010, NAT METHODS, V7, P383, DOI 10.1038/nmeth.1446; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hekmat O, 2013, J PROTEOME RES, V12, P4136, DOI 10.1021/pr400457u; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lin DL, 2001, PROSTATE, V47, P212, DOI 10.1002/pros.1065; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; LOPEZCASILLAS F, 1988, P NATL ACAD SCI USA, V85, P5784, DOI 10.1073/pnas.85.16.5784; Lundby A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1871; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mukherjee R, 2011, BRIT J CANCER, V104, P1920, DOI 10.1038/bjc.2011.163; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Murray BW, 2010, P NATL ACAD SCI USA, V107, P9446, DOI 10.1073/pnas.0911863107; Nakabayashi M, 2012, BJU INT, V110, P1729, DOI 10.1111/j.1464-410X.2012.11456.x; Nardella C, 2008, GENE DEV, V22, P2172, DOI 10.1101/gad.1699608; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2013, MOL CELL PROTEOMICS, V12, P3444, DOI 10.1074/mcp.O113.034181; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P2796, DOI 10.1074/mcp.M900285-MCP200; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Saramaki O, 2007, FRONT BIOSCI-LANDMRK, V12, P3287, DOI 10.2741/2312; Sato K, 1999, JNCI-J NATL CANCER I, V91, P1574, DOI 10.1093/jnci/91.18.1574; Schaeffer EM, 2008, ONCOGENE, V27, P7180, DOI 10.1038/onc.2008.327; Schayowitz A, 2010, BRIT J CANCER, V103, P1001, DOI 10.1038/sj.bjc.6605882; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; THALMANN GN, 1994, CANCER RES, V54, P2577; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; VISAKORPI T, 1994, EUR J CANCER, V30A, P129, DOI 10.1016/S0959-8049(05)80037-1; Ye Diana Zi, 2012, Cell Logist, V2, P105; Zhang G, 2012, J CELL SCI, V125, P3243, DOI 10.1242/jcs.104208; Zhang WS, 2009, CANCER RES, V69, P7466, DOI 10.1158/0008-5472.CAN-08-4385; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	55	50	52	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2015	34	21					2764	2776		10.1038/onc.2014.206	http://dx.doi.org/10.1038/onc.2014.206			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI7XN	25065596				2022-12-25	WOS:000354979500009
J	Dunford, LJ; Sinclair, KD; Kwong, WY; Sturrock, C; Clifford, BL; Giles, TC; Gardner, DS				Dunford, Louise J.; Sinclair, Kevin D.; Kwong, Wing Y.; Sturrock, Craig; Clifford, Bethan L.; Giles, Tom C.; Gardner, David S.			Maternal protein-energy malnutrition during early pregnancy in sheep impacts the fetal ornithine cycle to reduce fetal kidney microvascular development	FASEB JOURNAL			English	Article						polyamines; renal	INTRAUTERINE GROWTH RESTRICTION; LONG-TERM CONSEQUENCES; BIRTH-WEIGHT; NUTRIENT RESTRICTION; BLOOD-PRESSURE; DNA METHYLATION; POLYAMINES; NUTRITION; DIET; RISK	This paper identifies a common nutritional pathway relating maternal through to fetal protein-energy malnutrition (PEM) and compromised fetal kidney development. Thirty-one twin-bearing sheep were fed either a control (n=15) or low-protein diet (n=16, 17 vs. 8.7 g crude protein/MJ metabolizable energy) from d 0 to 65 gestation (term, approximate to 145 d). Effects on the maternal and fetal nutritional environment were characterized by sampling blood and amniotic fluid. Kidney development was characterized by histology, immunohistochemistry, vascular corrosion casts, and molecular biology. PEM had little measureable effect on maternal and fetal macronutrient balance (glucose, total protein, total amino acids, and lactate were unaffected) or on fetal growth. PEM decreased maternal and fetal urea concentration, which blunted fetal ornithine availability and affected fetal hepatic polyamine production. For the first time in a large animal model, we associated these nutritional effects with reduced micro- but not macrovascular development in the fetal kidney. Maternal PEM specifically impacts the fetal ornithine cycle, affecting cellular polyamine metabolism and microvascular development of the fetal kidney, effects that likely underpin programming of kidney development and function by a maternal low protein diet.Dunford, L. J., Sinclair, K. D., Kwong, W. Y., Sturrock, C., Clifford, B. L., Giles, T. C., Gardner, D. S.. Maternal protein-energy malnutrition during early pregnancy in sheep impacts the fetal ornithine cycle to reduce fetal kidney microvascular development.	[Dunford, Louise J.; Gardner, David S.] Univ Nottingham, Sch Vet Med & Sci, Loughborough LE12 5RD, Leics, England; [Sinclair, Kevin D.; Kwong, Wing Y.; Sturrock, Craig; Clifford, Bethan L.] Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England; [Giles, Tom C.] Univ Nottingham, Adv Data Anal Ctr, Loughborough LE12 5RD, Leics, England	University of Nottingham; University of Nottingham; University of Nottingham	Gardner, DS (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Loughborough LE12 5RD, Leics, England.	david.gardner@nottingham.ac.uk	Gardner, David S/A-7484-2010; Sturrock, Craig/N-6422-2017	Gardner, David S/0000-0002-6490-2412; Sturrock, Craig/0000-0002-5333-8502; Sinclair, Kevin/0000-0002-6375-215X; Dunford, Louise/0000-0003-3739-697X	British Heart Foundation Ph.D. studentship [FS/09/011/26562]; Society for Endocrinology Early Career grant; British Heart Foundation [FS/09/011/26562] Funding Source: researchfish	British Heart Foundation Ph.D. studentship; Society for Endocrinology Early Career grant; British Heart Foundation(British Heart Foundation)	The authors acknowledge Dr. Jim Craigon for statistical advice on the manuscript. L.J.D. was supported by a British Heart Foundation Ph.D. studentship (FS/09/011/26562) and a Society for Endocrinology Early Career grant. The experiments were conducted at the School of Veterinary Medicine and Science (Sutton Bonington Campus, University of Nottingham, Loughborough, UK). D.S.G., LJ.D., and K.D.S conceived and designed the experiments; LJ.D., D.S.G., K.D.S., W.Y.K., C.S., B.L.C., and T.G. conducted research; L.J.D. and D.S.G. analyzed and interpreted research; and D.S.G., L.J.D., and K.D.S. wrote the paper. D.S.G. has primary responsibility for its final content, and all authors have approved the final version of the manuscript.	Agricultural Research Council, 1980, NUTR REQ RUM LIV; Aitken I., 2007, DIS SHEEP, V4th ed.; Alderman G., 1993, ENERGY PROTEIN REQUI; ALEXANDER G, 1964, J REPROD FERTIL, V7, P289, DOI 10.1530/jrf.0.0070289; Barcroft J, 1936, J PHYSIOL-LONDON, V88, P56, DOI 10.1113/jphysiol.1936.sp003422; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Battaglia FC, 2002, PLACENTA, V23, pS3, DOI 10.1053/plac.2002.0812; BATTAGLIA FC, 1978, PHYSIOL REV, V58, P499, DOI 10.1152/physrev.1978.58.2.499; BATTAGLIA FC, 1988, ANNU REV NUTR, V8, P43, DOI 10.1146/annurev.nu.08.070188.000355; Bell AW, 2002, NUTR RES REV, V15, P211, DOI 10.1079/NRR200239; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; BLAXTER KL, 1957, P NUTR SOC, V16, P52, DOI 10.1079/PNS19570013; Boujendar S, 2003, J NUTR, V133, P2820, DOI 10.1093/jn/133.9.2820; Boujendar S, 2002, DIABETOLOGIA, V45, P856, DOI 10.1007/s00125-002-0833-6; Conen D, 2010, CIRCULATION, V122, P764, DOI 10.1161/CIRCULATIONAHA.110.947978; Cowley AW, 1997, AM J PHYSIOL-REG I, V273, pR1, DOI 10.1152/ajpregu.1997.273.1.R1; Cox LA, 2006, J PHYSIOL-LONDON, V572, P67, DOI 10.1113/jphysiol.2006.106872; de Boer MP, 2008, HYPERTENSION, V51, P928, DOI 10.1161/HYPERTENSIONAHA.107.101881; Dubreuil P, 2005, VET REC, V156, P636, DOI 10.1136/vr.156.20.636; EATON SB, 1985, NEW ENGL J MED, V312, P283, DOI 10.1056/NEJM198501313120505; Ekegren T, 2005, ANAL BIOCHEM, V338, P179, DOI 10.1016/j.ab.2004.11.040; Ferraz MLF, 2008, PEDIATR NEPHROL, V23, P257, DOI 10.1007/s00467-007-0654-4; Fowden AL, 1998, P NUTR SOC, V57, P113, DOI 10.1079/PNS19980017; Graham NS, 2011, ANIMAL, V5, P861, DOI 10.1017/S1751731110002533; Guo JK, 2010, ANNU REV PHYSIOL, V72, P357, DOI 10.1146/annurev.physiol.010908.163245; Hammond J, 1932, GROWTH DEV MUTTON QU; Harding JE, 2001, INT J EPIDEMIOL, V30, P15, DOI 10.1093/ije/30.1.15; Heby O, 1995, INT J DEV BIOL, V39, P737; HEBY O, 1981, DIFFERENTIATION, V19, P1, DOI 10.1111/j.1432-0436.1981.tb01123.x; Humphreys BD, 2011, P NATL ACAD SCI USA, V108, P9226, DOI 10.1073/pnas.1100629108; KULHANEK JF, 1974, AM J PHYSIOL, V226, P1257, DOI 10.1152/ajplegacy.1974.226.5.1257; Kunkel PA, 1930, B JOHNS HOPKINS HOSP, V47, P285; Kwon H, 2004, BIOL REPROD, V71, P901, DOI 10.1095/biolreprod.104.029645; Leese HJ, 2012, REPRODUCTION, V143, P417, DOI 10.1530/REP-11-0484; Lemley CO, 2013, ANIMAL, V7, P1500, DOI 10.1017/S1751731113001006; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li YP, 2010, DIABETES, V59, P2400, DOI 10.2337/db10-0385; Lloyd LJ, 2012, J PHYSIOL-LONDON, V590, P377, DOI 10.1113/jphysiol.2011.220186; Luyckx VA, 2005, KIDNEY INT, V68, pS68, DOI 10.1111/j.1523-1755.2005.09712.x; Mandal S, 2013, P NATL ACAD SCI USA, V110, P2169, DOI 10.1073/pnas.1219002110; MCCANCE RA, 1962, LANCET, V2, P621; McDonald TJ, 2013, BRIT J NUTR, V109, P1382, DOI 10.1017/S0007114512003261; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Miller VM, 2012, AM J PHYSIOL-REG I, V302, pR1023, DOI 10.1152/ajpregu.00105.2012; Mondy WL, 2009, TISSUE ENG PART C-ME, V15, P729, DOI [10.1089/ten.tec.2008.0583, 10.1089/ten.TEC.2008.0583]; Nijland MJ, 2007, J PHYSIOL-LONDON, V579, P643, DOI 10.1113/jphysiol.2006.122101; Ojeda NB, 2008, ADV CHRONIC KIDNEY D, V15, P101, DOI 10.1053/j.ackd.2008.01.001; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; PENNELL JP, 1975, J CLIN INVEST, V55, P399, DOI 10.1172/JCI107944; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; RABINOWITZ L, 1973, KIDNEY INT, V4, P188, DOI 10.1038/ki.1973.101; Raznahan A, 2012, P NATL ACAD SCI USA, V109, P11366, DOI 10.1073/pnas.1203350109; Rees WD, 1999, BRIT J NUTR, V81, P243, DOI 10.1017/S0007114599000446; REUSENS B, 1995, NESTLE NUTR WORKS SE, V35, P187; Rhodes P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007393; Ritz E, 2011, NAT REV NEPHROL, V7, P137, DOI 10.1038/nrneph.2011.1; ROBINSON JJ, 1977, J AGR SCI, V88, P539, DOI 10.1017/S0021859600037229; ROBINSON JJ, 1967, BRIT J NUTR, V21, P879, DOI 10.1079/BJN19670088; ROSSO P, 1979, J NUTR, V109, P1887, DOI 10.1093/jn/109.11.1887; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sandovici I, 2011, P NATL ACAD SCI USA, V108, P5449, DOI 10.1073/pnas.1019007108; Sinclair KD, 1998, REPROD FERT DEVELOP, V10, P263, DOI 10.1071/R98021; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Thurner S, 2013, P NATL ACAD SCI USA, V110, P4703, DOI 10.1073/pnas.1215626110; Wagner R, 2011, MICROSC MICROANAL, V17, P215, DOI 10.1017/S1431927610094201; WALLACE LR, 1948, J AGR SCI, V38, P243, DOI 10.1017/S0021859600006079; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Wintour E M, 1997, Equine Vet J Suppl, P51; World Health Organization (WHO), 2011, NUTR LANDSC INF SYST; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Wu GY, 1998, J NUTR, V128, P894, DOI 10.1093/jn/128.5.894; Yamashina S, 2007, J GASTROEN HEPATOL, V22, pS62, DOI 10.1111/j.1440-1746.2006.04655.x; Zandi-Nejad K, 2006, HYPERTENSION, V47, P502, DOI 10.1161/01.HYP.0000198544.09909.1a	75	15	18	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4880	4892		10.1096/fj.14-255364	http://dx.doi.org/10.1096/fj.14-255364			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25077559	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-25	WOS:000344050900025
J	Farrington, GK; Caram-Salas, N; Haqqani, AS; Brunette, E; Eldredge, J; Pepinsky, B; Antognetti, G; Baumann, E; Ding, W; Garber, E; Jiang, SS; Delaney, C; Boileau, E; Sisk, WP; Stanimirovic, DB				Farrington, Graham K.; Caram-Salas, Nadia; Haqqani, Arsalan S.; Brunette, Eric; Eldredge, John; Pepinsky, Blake; Antognetti, Giovanna; Baumann, Ewa; Ding, Wen; Garber, Ellen; Jiang, Susan; Delaney, Christie; Boileau, Eve; Sisk, William P.; Stanimirovic, Danica B.			A novel platform for engineering blood-brain barrier-crossing bispecific biologics	FASEB JOURNAL			English	Article						single-domain antibody; neuropeptides; drug delivery	OPIOID RECEPTOR DESENSITIZATION; SINGLE-DOMAIN ANTIBODIES; HUMAN INSULIN-RECEPTOR; CENTRAL-NERVOUS-SYSTEM; NEONATAL FC-RECEPTOR; CEREBROSPINAL-FLUID; DRUG-DELIVERY; RAT-BRAIN; MONOCLONAL-ANTIBODY; INTERSTITIAL FLUID	The blood-brain barrier (BBB) prevents the access of therapeutic antibodies to central nervous system (CNS) targets. The engineering of bispecific antibodies in which a therapeutic arm is combined with a BBB-transcytosing arm can significantly enhance their brain delivery. The BBB-permeable single-domain antibody FC5 was previously isolated by phenotypic panning of a naive llama single-domain antibody phage display library. In this study, FC5 was engineered as a mono- and bivalent fusion with the human Fc domain to optimize it as a modular brain delivery platform. In vitro studies demonstrated that the bivalent fusion of FC5 with Fc increased the rate of transcytosis (P-app) across brain endothelial monolayer by 25% compared with monovalent fusion. Up to a 30-fold enhanced apparent brain exposure (derived from serum and cerebrospinal fluid pharmacokinetic profiles) of FC5- compared with control domain antibody-Fc fusions after systemic dosing in rats was observed. Systemic pharmacological potency was evaluated in the Hargreaves model of inflammatory pain using the BBB-impermeable neuropeptides dalargin and neuropeptide Y chemically conjugated with FC5-Fc fusion proteins. Improved serum pharmacokinetics of Fc-fused FC5 contributed to a 60-fold increase in pharmacological potency compared with the single-domain version of FC5; bivalent and monovalent FC5 fusions with Fc exhibited similar systemic pharmacological potency. The study demonstrates that modular incorporation of FC5 as the BBB-carrier arm in bispecific antibodies or antibody-drug conjugates offers an avenue to develop pharmacologically active biotherapeutics for CNS indications.Farrington, G. K., Caram-Salas, N., Haqqani, A. S., Brunette, E., Eldredge, J., Pepinsky, B., Antognetti, G., Baumann, E., Ding, W., Garber, E., Jiang, S., Delaney, C., Boileau, E., Sisk, W. P., Stanimirovic, D. B. A novel platform for engineering blood-brain barrier-crossing bispecific biologics.	[Farrington, Graham K.; Eldredge, John; Pepinsky, Blake; Antognetti, Giovanna; Garber, Ellen; Sisk, William P.] Biogen Idec Inc, Cambridge, MA USA; [Caram-Salas, Nadia; Haqqani, Arsalan S.; Brunette, Eric; Baumann, Ewa; Ding, Wen; Jiang, Susan; Delaney, Christie; Boileau, Eve; Stanimirovic, Danica B.] Natl Res Council Canada, Ottawa, ON K1A 0R6, Canada	Biogen; National Research Council Canada	Stanimirovic, DB (corresponding author), Natl Res Council Canada, 1200 Montreal Rd,Bldg M54, Ottawa, ON K1A 0R6, Canada.	graham.farrington@biogenidec.com; danica.stanimirovic@nrc-cnrc.gc.ca	Caram-Salas, Nadia L/F-1977-2019; Salas, Nadia Lizeth Caram/AAG-4767-2020	Salas, Nadia Lizeth Caram/0000-0002-1894-9498	Biogen Idec; National Research Council of Canada	Biogen Idec(Biogen); National Research Council of Canada	The authors thank Luc Tessier (National Research Council of Canada) for maintenance of nanoLC-SRM instruments; Ellen Rohde (Biogen Wet) for running and analyzing PKs of various molecules in rats; Chioma Nwankwo, You Li, and Nels Pederson for cloning of yarious molecules; Jorge Sanchez-Salazar and Tom Cameron for cell line development and expression; and Monika Vecchi, Susan Foley, YuTing Huang, Yaping Sun, and Dingyi Wen for review of mass spectrometry analysis. The study was funded through program support from Biogen Idec based on yearly program reviews and prioritization, and through National Research Council of Canada support for the strategic program Therapeutics Beyond Brain Barriers.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Abulrob A, 2005, J NEUROCHEM, V95, P1201, DOI 10.1111/j.1471-4159.2005.03463.x; ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Boado RJ, 2013, BIOTECHNOL BIOENG, V110, P1456, DOI 10.1002/bit.24795; Boado RJ, 2009, DRUG METAB DISPOS, V37, P2299, DOI 10.1124/dmd.109.028787; Caljon G, 2012, BRIT J PHARMACOL, V165, P2341, DOI 10.1111/j.1476-5381.2011.01723.x; Coloma MJ, 2000, PHARMACEUT RES, V17, P266, DOI 10.1023/A:1007592720793; Couch JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005338; CSERR HF, 1981, AM J PHYSIOL, V240, pF319, DOI 10.1152/ajprenal.1981.240.4.F319; Dang VC, 2012, BRIT J PHARMACOL, V165, P1704, DOI 10.1111/j.1476-5381.2011.01482.x; Dang VC, 2009, J NEUROSCI, V29, P3322, DOI 10.1523/JNEUROSCI.4749-08.2009; de Lange ECM, 2002, CLIN PHARMACOKINET, V41, P691, DOI 10.2165/00003088-200241100-00001; Demeule M, 2008, J NEUROCHEM, V106, P1534, DOI 10.1111/j.1471-4159.2008.05492.x; Dirks NL, 2010, CLIN PHARMACOKINET, V49, P633, DOI 10.2165/11535960-000000000-00000; Farrington G. K., 2009, U. S. patent, Patent No. [20090252729A1, 20090252729]; Fluttert M, 2000, LAB ANIM, V34, P372, DOI 10.1258/002367700780387714; Gan L. S., 2013, INT J CELL BIOL, V2013; Garberg P, 2005, TOXICOL IN VITRO, V19, P299, DOI 10.1016/j.tiv.2004.06.011; Giragossian C, 2013, CURR DRUG METAB, V14, P764, DOI 10.2174/13892002113149990099; Haqqani Arsalan S., 2008, V439, P241, DOI 10.1007/978-1-59745-188-8_17; Haqqani AS, 2013, MOL PHARMACEUT, V10, P1542, DOI 10.1021/mp3004995; Haqqani AS, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-4; Hartz AMS, 2011, CURR PHARM BIOTECHNO, V12, P656; Hristodorov D, 2013, MOL BIOTECHNOL, V54, P1056, DOI 10.1007/s12033-012-9612-x; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Iqbal U, 2010, BRIT J PHARMACOL, V160, P1016, DOI 10.1111/j.1476-5381.2010.00742.x; Iqbal U, 2011, METHODS MOL BIOL, V686, P465, DOI 10.1007/978-1-60761-938-3_24; Johanson CE, 2011, METHODS MOL BIOL, V686, P101, DOI 10.1007/978-1-60761-938-3_4; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; KORNHUBER ME, 1986, J NEUROSCI METH, V17, P63, DOI 10.1016/0165-0270(86)90035-X; Lin D, 2013, J PROTEOME RES, V12, P5996, DOI 10.1021/pr400877e; Lin JH, 2008, CURR DRUG METAB, V9, P46, DOI 10.2174/138920008783331077; MATTSON G, 1993, MOL BIOL REP, V17, P167, DOI 10.1007/BF00986726; Muruganandam A, 2001, FASEB J, V15, P240, DOI 10.1096/fj.01-0343fje; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Nirogi R, 2009, J NEUROSCI METH, V178, P116, DOI 10.1016/j.jneumeth.2008.12.001; Ohshima-Hosoyama S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039036; Pardridge WM, 2002, NEURON, V36, P555, DOI 10.1016/S0896-6273(02)01054-1; PARDRIDGE WM, 1991, J PHARMACOL EXP THER, V259, P66; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Pepinsky RB, 2011, J PHARMACOL EXP THER, V339, P519, DOI 10.1124/jpet.111.183483; Rousselle C, 2003, J PHARMACOL EXP THER, V306, P371, DOI 10.1124/jpet.102.048520; SARNA G, 1984, J PHYSIOL-PARIS, V79, P536; Shen DD, 2004, ADV DRUG DELIVER REV, V56, P1825, DOI 10.1016/j.addr.2004.07.011; Stanimirovic DB, 2012, J CEREBR BLOOD F MET, V32, P1207, DOI 10.1038/jcbfm.2012.25; Strazielle N, 2013, MOL PHARMACEUT, V10, P1473, DOI 10.1021/mp300518e; SZENTISTVANYI I, 1984, AM J PHYSIOL, V246, pF835, DOI 10.1152/ajprenal.1984.246.6.F835; Tanha J, 2002, J IMMUNOL METHODS, V263, P97, DOI 10.1016/S0022-1759(02)00027-3; Tanha Jamshid, 2003, Methods Mol Med, V89, P435; Van Bockstaele F, 2009, CURR OPIN INVEST DR, V10, P1212; Vaughn DE, 1997, BIOCHEMISTRY-US, V36, P9374, DOI 10.1021/bi970841r; Vincke Cecile, 2012, Methods Mol Biol, V911, P15, DOI 10.1007/978-1-61779-968-6_2; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Wolak DJ, 2013, MOL PHARMACEUT, V10, P1492, DOI 10.1021/mp300495e; YAN Q, 1994, EXP NEUROL, V127, P23, DOI 10.1006/exnr.1994.1076; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230	59	84	92	0	50	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4764	4778		10.1096/fj.14-253369	http://dx.doi.org/10.1096/fj.14-253369			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25070367	Green Submitted, Bronze			2022-12-25	WOS:000344050900016
J	Budhidarmo, R; Day, CL				Budhidarmo, Rhesa; Day, Catherine L.			The Ubiquitin-associated Domain of Cellular Inhibitor of Apoptosis Proteins Facilitates Ubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RETICULUM-ASSOCIATED DEGRADATION; ALPHA-DEPENDENT APOPTOSIS; UBA DOMAIN; E3 LIGASE; POLYUBIQUITIN CHAINS; STRUCTURAL BASIS; RING DOMAIN; CUE DOMAIN; MOLECULAR DETERMINANTS	The cellular inhibitor of apoptosis (cIAP) proteins are essential RING E3 ubiquitin ligases that regulate apoptosis and inflammatory responses. cIAPs contain a ubiquitin-associated (UBA) domain that binds ubiquitin and is implicated in the regulation of cell survival and proteasomal degradation. Here we show that mutation of the MGF and LL motifs in the UBA domain of cIAP1 caused unfolding and increased cIAP1 multi-monoubiquitylation. By developing a UBA mutant that disrupted ubiquitin binding but not the structure of the UBA domain, we found that the UBA domain enhances cIAP1 and cIAP2 ubiquitylation. We demonstrate that the UBA domain binds to the UbcH5b similar to Ub conjugate, and this promotes RING domain-dependent monoubiquitylation. This study establishes ubiquitin-binding modules, such as the UBA domain, as important regulatory modules that can fine tune the activity of E3 ligases.	[Budhidarmo, Rhesa; Day, Catherine L.] Univ Otago, Dept Biochem, Otago Sch Med Sci, Dunedin 9054, New Zealand	University of Otago	Day, CL (corresponding author), Univ Otago, Dept Biochem, Otago Sch Med Sci, Dunedin 9054, New Zealand.	catherine.day@otago.ac.nz		Day, Catherine/0000-0003-1571-4367	Otago University Doctoral Scholarship; Marsden Fund (New Zealand)	Otago University Doctoral Scholarship; Marsden Fund (New Zealand)(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by the Otago University Doctoral Scholarship and the Marsden Fund (New Zealand).	Agromayor M, 2012, STRUCTURE, V20, P414, DOI 10.1016/j.str.2011.12.013; Bagola K, 2013, MOL CELL, V50, P528, DOI 10.1016/j.molcel.2013.04.005; Blankenship JW, 2009, BIOCHEM J, V417, P149, DOI 10.1042/BJ20081885; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Feltham R, 2011, J BIOL CHEM, V286, P17015, DOI 10.1074/jbc.M111.222919; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Heinen C, 2010, FEBS LETT, V584, P1585, DOI 10.1016/j.febslet.2010.03.018; Hibbert RG, 2011, P NATL ACAD SCI USA, V108, P5590, DOI 10.1073/pnas.1017516108; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kim HC, 2011, EMBO REP, V12, P334, DOI 10.1038/embor.2011.23; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Liu S, 2012, STRUCTURE, V20, P2138, DOI 10.1016/j.str.2012.09.020; Lopez J, 2011, MOL CELL, V42, P569, DOI 10.1016/j.molcel.2011.04.008; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Metzger MB, 2013, MOL CELL, V50, P516, DOI 10.1016/j.molcel.2013.04.004; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Nakatani Y, 2013, BIOCHEM J, V450, P629, DOI 10.1042/BJ20121702; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Ranaweera RS, 2013, J BIOL CHEM, V288, P18939, DOI 10.1074/jbc.M113.454470; Rojas-Fernandez A, 2014, MOL CELL, V53, P880, DOI 10.1016/j.molcel.2014.02.031; Ronchi VP, 2013, J BIOL CHEM, V288, P10349, DOI 10.1074/jbc.M113.458059; Sasaki T, 2005, BIOCHEM BIOPH RES CO, V336, P530, DOI 10.1016/j.bbrc.2005.08.126; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Schumacher FR, 2013, J MOL BIOL, V425, P4099, DOI 10.1016/j.jmb.2013.06.039; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Stieglitz B, 2013, NATURE, V503, P422, DOI 10.1038/nature12638; Swanson KA, 2006, J MOL BIOL, V358, P713, DOI 10.1016/j.jmb.2006.02.059; Tse MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028511; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Walinda E, 2014, J BIOL CHEM, V289, P13890, DOI 10.1074/jbc.M114.555441; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Williams C, 2012, EMBO J, V31, P391, DOI 10.1038/emboj.2011.411; Williamson A, 2011, MOL CELL, V42, P744, DOI 10.1016/j.molcel.2011.04.022; Wilson RC, 2009, ACTA CRYSTALLOGR F, V65, P440, DOI 10.1107/S1744309109011117; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	59	9	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25721	25736		10.1074/jbc.M113.545475	http://dx.doi.org/10.1074/jbc.M113.545475			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25065467	Green Published, hybrid			2022-12-25	WOS:000342130800031
J	Li, LW; Zhang, YW; Qiao, JJ; Yang, JJ; Liu, ZR				Li, Liangwei; Zhang, Yinwei; Qiao, Jingjuan; Yang, Jenny J.; Liu, Zhi-Ren			Pyruvate Kinase M2 in Blood Circulation Facilitates Tumor Growth by Promoting Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-CELL CARCINOMA; TU M2-PK; MARKER; CANCER; PKM2; TRANSCRIPTION; PROTEIN; PLASMA	It is long known that pyruvate kinase isoform M2 (PKM2) is released into the circulation of cancer patients. The PKM2 levels in patients have been suggested as a diagnostic marker for many types of cancers. However, it is not known how PKM2 is released in the blood, and whether the circulating PKM2 has any physiological function(s) in tumor progression. In this report, we demonstrate that PKM2 in the blood facilitates tumor growth by promoting tumor angiogenesis. Our experiments show that PKM2 promotes tumor angiogenesis by increasing endothelial cell proliferation, migration, and cell-ECM adhesion. Only the dimeric PKM2 possess the activity in promoting tumor angiogenesis, which is consistent with the observations that PKM2 in circulation of cancer patients is a dimer form.	[Li, Liangwei; Zhang, Yinwei; Liu, Zhi-Ren] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Qiao, Jingjuan; Yang, Jenny J.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Liu, ZR (corresponding author), Georgia State Univ, Dept Biol, Univ Plaza, Atlanta, GA 30303 USA.	zliu8@gsu.edu			National Institutes of Health [CA118113]; Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE [R01CA118113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA118113 (to Z.-R. L.). This work was also supported by the Georgia Cancer Coalition (to Z.-R. L.).	Ahmed AS, 2007, EUR J GYNAECOL ONCOL, V28, P83; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Boros LG, 2002, DRUG DISCOV TODAY, V7, P364, DOI 10.1016/S1359-6446(02)02179-7; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Duan HF, 2007, J NATL CANCER I, V99, P1551, DOI 10.1093/jnci/djm132; ELBERS JRJ, 1991, CANCER-AM CANCER SOC, V67, P2552, DOI 10.1002/1097-0142(19910515)67:10<2552::AID-CNCR2820671027>3.0.CO;2-K; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Hacker HJ, 1998, CARCINOGENESIS, V19, P99, DOI 10.1093/carcin/19.1.99; Hathurusinghe HR, 2007, ANN SURG ONCOL, V14, P2714, DOI 10.1245/s10434-007-9481-x; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hugo F, 1999, ANTICANCER RES, V19, P2753; Jiang JK, 2010, BIOORG MED CHEM LETT, V20, P3387, DOI 10.1016/j.bmcl.2010.04.015; Lee JW, 2008, INT J BIOCHEM CELL B, V40, P1043, DOI 10.1016/j.biocel.2007.11.009; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Mazurek S, 2008, ERNST SCHERING FOUND, V4, P99, DOI 10.1007/2789_2008_091; Schneider J, 2006, ADV CLIN CHEM, V42, P1, DOI 10.1016/S0065-2423(06)42001-1; Ugurel S, 2005, INT J CANCER, V117, P825, DOI 10.1002/ijc.21073; Wechsel HW, 1999, ANTICANCER RES, V19, P2583; Weinberger R, 2007, EUR J CANCER CARE, V16, P333, DOI 10.1111/j.1365-2354.2006.00753.x; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598	23	55	56	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25812	25821		10.1074/jbc.M114.576934	http://dx.doi.org/10.1074/jbc.M114.576934			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070887	Green Published, hybrid			2022-12-25	WOS:000342130800038
J	Hatakeyama, D; Shoji, M; Yamayoshi, S; Hirota, T; Nagae, M; Yanagisawa, S; Nakano, M; Ohmi, N; Noda, T; Kawaoka, Y; Kuzuhara, T				Hatakeyama, Dai; Shoji, Masaki; Yamayoshi, Seiya; Hirota, Takenori; Nagae, Monami; Yanagisawa, Shin; Nakano, Masahiro; Ohmi, Naho; Noda, Takeshi; Kawaoka, Yoshihiro; Kuzuhara, Takashi			A Novel Functional Site in the PB2 Subunit of Influenza A Virus Essential for Acetyl-CoA Interaction, RNA Polymerase Activity, and Viral Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE; PROTEIN; TRANSCRIPTION; INHIBITION; BINDING; DOMAIN; AUTOACETYLATION; COENZYME; DEFICIENT; REPRESSES	The PA, PB1, and PB2 subunits, components of the RNA-dependent RNA polymerase of influenza A virus, are essential for viral transcription and replication. The PB2 subunit binds to the host RNA cap (7-methylguanosine triphosphate (m(7)GTP)) and supports the endonuclease activity of PA to "snatch" the cap from host pre-mRNAs. However, the structure of PB2 is not fully understood, and the functional sites remain unknown. In this study, we describe a novel Val/Arg/Gly (VRG) site in the PB2 cap-binding domain, which is involved in interaction with acetyl-CoA found in eukaryotic histone acetyltransferases (HATs). In vitro experiments revealed that the recombinant PB2 cap-binding domain that includes the VRG site interacts with acetyl-CoA; moreover, it was found that this interaction could be blocked by CoA and various HAT inhibitors. Interestingly, m7GTP also inhibited this interaction, suggesting that the same active pocket is capable of interacting with acetyl-CoA and m7GTP. To elucidate the importance of the VRG site on PB2 function and viral replication, we constructed a PB2 recombinant protein and recombinant viruses including several patterns of amino acid mutations in the VRG site. Substitutions of the valine and arginine residues or of all 3 residues of the VRG site to alanine significantly reduced the binding ability of PB2 to acetyl-CoA and its RNA polymerase activity. Recombinant viruses containing the same mutations could not be replicated in cultured cells. These results indicate that the PB2 VRG sequence is a functional site that is essential for acetyl-CoA interaction, RNA polymerase activity, and viral replication.	[Hatakeyama, Dai; Shoji, Masaki; Hirota, Takenori; Nagae, Monami; Yanagisawa, Shin; Ohmi, Naho; Kuzuhara, Takashi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Tokushima 7708514, Japan; [Yamayoshi, Seiya; Nakano, Masahiro; Noda, Takeshi; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Div Virol, Dept Microbiol & Immunol, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens, Tokyo 1088639, Japan; [Nakano, Masahiro; Noda, Takeshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53711 USA	Tokushima Bunri University; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Wisconsin System; University of Wisconsin Madison	Kuzuhara, T (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Tokushima 7708514, Japan.	kuzuhara@ph.bunri-u.ac.jp	Yamayoshi, Seiya/C-1982-2013; Yamayoshi, Seiya/Y-7430-2019; ハタケヤマ, ダイ/HHS-5095-2022	Yamayoshi, Seiya/0000-0001-7768-5157; Yamayoshi, Seiya/0000-0001-7768-5157; ハタケヤマ, ダイ/0000-0001-6047-7124; Kuzuhara, Takashi/0000-0003-0565-6060	Japan Society for the Promotion of Science (JSPS) [26460562, 22590422, 25460574, 23780051, 26860083]; Tokushima Bunri University for Educational Reform and Collaborative Research Grant [TBU2013-2-1]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokushima Bunri University for Educational Reform and Collaborative Research Grant	This work was supported in part by The Japan Society for the Promotion of Science (JSPS), Grants-in-Aid for Scientific Research (C) 26460562 (to D. H.) and 22590422 and 25460574 (to T. K.), Grants-in-Aid for Young Scientists (B) 23780051 (to D. H.) and 26860083 (to M. S.), and Tokushima Bunri University for Educational Reform and Collaborative Research Grant TBU2013-2-1 (to M. S.).	Albaugh BN, 2011, J BIOL CHEM, V286, P24694, DOI 10.1074/jbc.M111.251579; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Bansal S, 2009, APPL BIOCHEM BIOTECH, V157, P285, DOI 10.1007/s12010-008-8357-2; Barak R, 2006, J MOL BIOL, V359, P251, DOI 10.1016/j.jmb.2006.03.033; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Carr SM, 2006, VIROLOGY, V344, P492, DOI 10.1016/j.virol.2005.08.041; Choi CH, 2003, NATURE, V424, P965, DOI 10.1038/nature01899; Choi KC, 2009, CANCER RES, V69, P583, DOI 10.1158/0008-5472.CAN-08-2442; Chuang C, 2010, J PROTEOME RES, V9, P4554, DOI 10.1021/pr100281h; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Galasinski SK, 2000, MOL CELL BIOL, V20, P1923, DOI 10.1128/MCB.20.6.1923-1930.2000; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gastaminza P, 2003, J VIROL, V77, P5098, DOI 10.1128/JVI.77.9.5098-5108.2003; Ghizzoni M, 2012, EUR J MED CHEM, V47, P337, DOI 10.1016/j.ejmech.2011.11.001; Ghizzoni M, 2010, BIOORGAN MED CHEM, V18, P5826, DOI 10.1016/j.bmc.2010.06.089; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hastings JC, 1996, ANTIMICROB AGENTS CH, V40, P1304, DOI 10.1128/AAC.40.5.1304; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V17, P865, DOI 10.1128/AAC.17.5.865; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Hiasa M, 2013, BRIT J PHARMACOL, V169, P115, DOI 10.1111/bph.12102; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Iwai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019825; Iwai Y, 2010, BIOORGAN MED CHEM, V18, P5379, DOI 10.1016/j.bmc.2010.05.035; Jankowska-Kulawy A, 2010, J NEUROCHEM, V115, P333, DOI 10.1111/j.1471-4159.2010.06919.x; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kawakami E, 2011, J VIROL METHODS, V173, P1, DOI 10.1016/j.jviromet.2010.12.014; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Kuzuhara Takashi, 2009, PLoS Curr, V1, pRRN1052; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; Kuzuhara T, 2009, ACTA CRYSTALLOGR F, V65, P144, DOI 10.1107/S1744309108042942; Li T, 2012, P NATL ACAD SCI USA, V109, P10558, DOI 10.1073/pnas.1203447109; LI XQ, 1994, J VIROL, V68, P1245, DOI 10.1128/JVI.68.2.1245-1249.1994; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Lin YX, 1999, NATURE, V400, P86, DOI 10.1038/21922; Maxwell SRJ, 2007, BRIT MED J, V334, P1232, DOI 10.1136/bmj.39240.497025.80; MCALISTER LE, 1981, J BACTERIOL, V146, P200, DOI 10.1128/JB.146.1.200-208.1981; Michno A, 2005, CLIN CHEM, V51, P1673, DOI 10.1373/clinchem.2005.050328; Murakami S, 2008, J VIROL, V82, P1605, DOI 10.1128/JVI.01876-07; Murano K, 2008, MOL CELL BIOL, V28, P3114, DOI 10.1128/MCB.02078-07; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; Pereira JM, 2008, BIOORGAN MED CHEM, V16, P8889, DOI 10.1016/j.bmc.2008.08.057; Ravindra KC, 2009, J BIOL CHEM, V284, P24453, DOI 10.1074/jbc.M109.023861; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Santos-Rosa H, 2003, NUCLEIC ACIDS RES, V31, P4285, DOI 10.1093/nar/gkg655; Shoji M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066337; Sugita Y, 2013, J VIROL, V87, P12879, DOI 10.1128/JVI.02096-13; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Takahashi E, 2012, J VIROL, V86, P10924, DOI 10.1128/JVI.01207-12; Takechi S, 1999, BIOCHEM BIOPH RES CO, V266, P405, DOI 10.1006/bbrc.1999.1836; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Taverna SD, 2007, P NATL ACAD SCI USA, V104, P2086, DOI 10.1073/pnas.0610993104; Tomassini JE, 1996, ANTIMICROB AGENTS CH, V40, P1189, DOI 10.1128/AAC.40.5.1189; Vreede FT, 2007, J VIROL, V81, P2196, DOI 10.1128/JVI.02187-06; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Yang C, 2012, J BIOL CHEM, V287, P34917, DOI 10.1074/jbc.M112.359356; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382; Zhang SJ, 2010, J BIOL CHEM, V285, P41194, DOI 10.1074/jbc.M110.130062	67	14	14	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24980	24994		10.1074/jbc.M114.559708	http://dx.doi.org/10.1074/jbc.M114.559708			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25063805	Green Published, hybrid			2022-12-25	WOS:000341985300023
J	Kwon, H; Bang, K; Cho, S				Kwon, Hyojung; Bang, Kyeongrin; Cho, Saeyoull			Characterization of the Hemocytes in Larvae of Protaetia brevitarsis seulensis: Involvement of Granulocyte-Mediated Phagocytosis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; IMMUNE-RESPONSE; AUTOPHAGY; COLEOPTERA; INSECT; EXPRESSION; APOPTOSIS; PATHWAYS; ATTACIN; TOLL	Hemocytes are key players in the immune response against pathogens in insects. However, the hemocyte types and their functions in the white-spotted flower chafers, Protaetia brevitarsis seulensis (Kolbe), are not known. In this study, we used various microscopes, molecular probes, and flow cytometric analyses to characterize the hemocytes in P. brevitarsis seulensis. The circulating hemocytes were classified based on their size, morphology, and dye-staining properties into six types, including granulocytes, plasmatocytes, oenocytoids, spherulocytes, prohemocytes, and adipohemocytes. The percentages of circulating hemocyte types were as follows: 13% granulocytes, 20% plasmatocytes, 1% oenocytoids, 5% spherulocytes, 17% prohemocytes, and 44% adipohemocytes. Next, we identified the professional phagocytes, granulocytes, which mediate encapsulation and phagocytosis of pathogens. The granulocytes were immunologically or morphologically activated and phagocytosed potentially hazardous substances in vivo. In addition, we showed that the phagocytosis by granulocytes is associated with autophagy, and that the activation of autophagy could be an efficient way to eliminate pathogens in this system. We also observed a high accumulation of autophagic vacuoles in activated granulocytes, which altered their shape and led to autophagic cell death. Finally, the granulocytes underwent mitotic division thus maintaining their number in vivo.	[Kwon, Hyojung; Bang, Kyeongrin; Cho, Saeyoull] Kangwon Natl Univ, Coll Agr & Life Sci, Environm Friendly Agr Ctr, Dept Appl Biol, Chunchon, South Korea	Kangwon National University	Cho, S (corresponding author), Kangwon Natl Univ, Coll Agr & Life Sci, Environm Friendly Agr Ctr, Dept Appl Biol, Chunchon, South Korea.	saeyoullcho@kangwon.ac.kr			National Research Foundation of Korea [NRF-2014R1A1A4A01008545]	National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by National Research Foundation of Korea (Grant Number; NRF-2014R1A1A4A01008545). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MICROBE; Bang K, 2012, MOL BIOL REP, V39, P5151, DOI 10.1007/s11033-011-1311-3; Caruso R. A., 2012, Experimental Oncology, V34, P306; Castillo JC, 2006, INSECT BIOCHEM MOLEC, V36, P891, DOI 10.1016/j.ibmb.2006.08.010; Colombo MI, 2007, IUBMB LIFE, V59, P238, DOI 10.1080/15216540701230503; Colombo MI, 2005, CELL DEATH DIFFER, V12, P1481, DOI 10.1038/sj.cdd.4401767; Duffin R, 2010, IMMUNOL REV, V236, P28, DOI 10.1111/j.1600-065X.2010.00922.x; Firlej A, 2012, ANN ENTOMOL SOC AM, V105, P328, DOI 10.1603/AN11026; Giglio A, 2008, MICRON, V39, P552, DOI 10.1016/j.micron.2007.07.004; Giulianini PG, 2003, TISSUE CELL, V35, P243, DOI 10.1016/S0040-8166(03)00037-5; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gupta A. P., 1979, INSECT HEMOCYTES DEV; Gupta AP, 1985, COMPREHENSIVE INSECT, P85; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; JONES JC, 1962, AM ZOOL, V2, P209; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Kinch G, 2003, J COMP NEUROL, V457, P384, DOI 10.1002/cne.10563; King JG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-55; Kohan R, 2013, SOAJ ENTOMOL STUD, V2, P16; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Kwon Ohseok, 2009, Entomological Research, V39, P152, DOI 10.1111/j.1748-5967.2009.00213.x; Lai Shu-Chin, 2012, Cells, V1, P396, DOI 10.3390/cells1030396; Lee M, 2013, MOL BIOL REP, V40, P3953, DOI 10.1007/s11033-012-2472-4; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Manachini B, 2011, J INVERTEBR PATHOL, V106, P360, DOI 10.1016/j.jip.2010.12.006; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Mihalache CC, 2012, EXP CELL RES, V318, P1187, DOI 10.1016/j.yexcr.2011.12.021; Muller F, 2004, EUR J CELL BIOL, V83, P67, DOI 10.1078/0171-9335-00359; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Oczypok EA, 2013, AM J PATHOL, V182, P612, DOI 10.1016/j.ajpath.2012.12.017; Pandey J. P., 2012, American Journal of Biochemistry and Molecular Biology, V2, P82; Pandey J. P., 2010, Research Journal of Immunology, V3, P169, DOI 10.3923/rji.2010.169.177; Romao S, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13198; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strand MR, 2008, INSECT SCI, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Tsakas S, 2010, ISJ-INVERT SURVIV J, V7, P228; Vernon PJ, 2013, ANTIOXID REDOX SIGN, V18, P677, DOI 10.1089/ars.2012.4810; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Yang YQ, 2012, ANAT REC, V295, P372, DOI 10.1002/ar.21537	46	40	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103620	10.1371/journal.pone.0103620	http://dx.doi.org/10.1371/journal.pone.0103620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083702	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800059
J	Petushkova, NA; Pyatnitskiy, MA; Rudenko, VA; Larina, OV; Trifonova, OP; Kisrieva, JS; Samenkova, NF; Kuznetsova, GP; Karuzina, II; Lisitsa, AV				Petushkova, Natalia A.; Pyatnitskiy, Mikhail A.; Rudenko, Vladislav A.; Larina, Olesya V.; Trifonova, Oxana P.; Kisrieva, Julya S.; Samenkova, Natalia F.; Kuznetsova, Galina P.; Karuzina, Irina I.; Lisitsa, Andrey V.			Applying of Hierarchical Clustering to Analysis of Protein Patterns in the Human Cancer-Associated Liver	PLOS ONE			English	Article							LASER-CAPTURE MICRODISSECTION; SELENIUM-BINDING PROTEIN-1; COLORECTAL-CANCER; PROTEOMIC ANALYSIS; GENE-EXPRESSION; ELECTROPHORESIS; IDENTIFICATION; REPRODUCIBILITY; THERAPIES; BIOMARKER	Background: There are two ways that statistical methods can learn from biomedical data. One way is to learn classifiers to identify diseases and to predict outcomes using the training dataset with established diagnosis for each sample. When the training dataset is not available the task can be to mine for presence of meaningful groups (clusters) of samples and to explore underlying data structure (unsupervised learning). Results: We investigated the proteomic profiles of the cytosolic fraction of human liver samples using two-dimensional electrophoresis (2DE). Samples were resected upon surgical treatment of hepatic metastases in colorectal cancer. Unsupervised hierarchical clustering of 2DE gel images (n = 18) revealed a pair of clusters, containing 11 and 7 samples. Previously we used the same specimens to measure biochemical profiles based on cytochrome P450-dependent enzymatic activities and also found that samples were clearly divided into two well-separated groups by cluster analysis. It turned out that groups by enzyme activity almost perfectly match to the groups identified from proteomic data. Of the 271 reproducible spots on our 2DE gels, we selected 15 to distinguish the human liver cytosolic clusters. Using MALDI-TOF peptide mass fingerprinting, we identified 12 proteins for the selected spots, including known cancer-associated species. Conclusions/Significance: Our results highlight the importance of hierarchical cluster analysis of proteomic data, and showed concordance between results of biochemical and proteomic approaches. Grouping of the human liver samples and/or patients into differing clusters may provide insights into possible molecular mechanism of drug metabolism and creates a rationale for personalized treatment.	[Petushkova, Natalia A.; Pyatnitskiy, Mikhail A.; Larina, Olesya V.; Trifonova, Oxana P.; Kisrieva, Julya S.; Samenkova, Natalia F.; Kuznetsova, Galina P.; Karuzina, Irina I.; Lisitsa, Andrey V.] Russian Acad Med Sci, VN Orekhovich Inst Biomed Chem, Moscow, Russia; [Rudenko, Vladislav A.; Lisitsa, Andrey V.] Postgen Tech LLC, Moscow, Russia	Russian Academy of Medical Sciences; Institute of Biomedical Chemistry	Petushkova, NA (corresponding author), Russian Acad Med Sci, VN Orekhovich Inst Biomed Chem, Moscow, Russia.	natalia.petushkova@ibmc.msk.ru	Petushkova, Natalia/E-9951-2017; Кузнецова, Галина/F-2848-2017; Кисриева, Юлия/F-2823-2017; Лисица, Андрей/ABD-2934-2020; Pyatnitskiy, Mikhail/F-1588-2017; Trifonova, Oxana P/I-9373-2014	Petushkova, Natalia/0000-0002-4101-4607; Pyatnitskiy, Mikhail/0000-0002-4803-8150; Trifonova, Oxana/0000-0002-5803-2529	Ministry of Education and Science of the Russian Federation [16.522.12.2002]	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	The work was supported by the Ministry of Education and Science of the Russian Federation, State Contract No. 16.522.12.2002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrethsen J, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-8; Alfonso P, 2008, J PROTEOME RES, V7, P4247, DOI 10.1021/pr800152u; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breikers G, 2006, PROTEOMICS, V6, P2844, DOI 10.1002/pmic.200500067; Cardona DM, 2009, AM J CLIN PATHOL, V132, P877, DOI 10.1309/AJCP74XGRFWTFLJU; Celis JE, 1999, CURR OPIN BIOTECH, V10, P16, DOI 10.1016/S0958-1669(99)80004-4; Chernobrovkin A L, 2011, Bioorg Khim, V37, P132; Cho-Vega JH, 2007, CANCER EPIDEM BIOMAR, V16, P2615, DOI 10.1158/1055-9965.EPI-07-0684; Choe LH, 2003, ELECTROPHORESIS, V24, P3500, DOI 10.1002/elps.200305614; Corona G, 2010, INT J ONCOL, V36, P93, DOI 10.3892/ijo_00000479; Jain R, 2010, J PROTEOME RES, V9, P737, DOI 10.1021/pr9005525; Jimenez CR, 2010, J PROTEOMICS, V73, P1873, DOI 10.1016/j.jprot.2010.06.004; Karp Natasha A, 2007, Proteomics, V7 Suppl 1, P42, DOI 10.1002/pmic.200700683; Kim H, 2006, PROTEOMICS, V6, P3466, DOI 10.1002/pmic.200500629; Kim J, 2002, ELECTROPHORESIS, V23, P4142, DOI 10.1002/elps.200290032; Kulkarni YM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-291; Kwong KY, 2005, GENOMICS, V86, P142, DOI 10.1016/j.ygeno.2005.03.012; Larina OV, 2012, J PROTEOM BIOINFORM, V5, P40; Lentz F, 2005, AM J PHARMACOGENOMIC, V5, P21, DOI 10.2165/00129785-200505010-00002; Li TH, 2008, MOL NUTR FOOD RES, V52, P1289, DOI 10.1002/mnfr.200700331; Lise M, 2005, FRONT BIOSCI-LANDMRK, V10, P3042, DOI 10.2741/1761; Lohberger B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043664; Macgregor PF, 2002, CLIN CHEM, V48, P1170; Mayer-Kuckuk P, 2002, MOL THER, V5, P492, DOI 10.1006/mthe.2002.0596; Melle C, 2007, J PROTEOME RES, V6, P306, DOI 10.1021/pr060439b; Muto T, 2011, J PROTEOMICS, V74, P858, DOI 10.1016/j.jprot.2011.02.030; Ossipova E, 2006, PROTEOMICS, V6, P2079, DOI 10.1002/pmic.200500484; Peng Y, 2012, MOL BIOSYST, V8, P3077, DOI 10.1039/c2mb25286d; Petushkova NA, 2010, EUR J PHARM SCI, V41, P305, DOI 10.1016/j.ejps.2010.06.014; Pohl NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007774; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Rochat B, 2005, CLIN PHARMACOKINET, V44, P349, DOI 10.2165/00003088-200544040-00002; Ruan DT, 2005, SEMIN ONCOL, V32, P85, DOI 10.1053/j.seminoncol.2004.09.025; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi HJ, 2013, HUM PATHOL, V44, P1089, DOI 10.1016/j.humpath.2012.09.015; Shi HJ, 2011, J PROTEOMICS, V75, P339, DOI 10.1016/j.jprot.2011.07.025; Slany A, 2010, J PROTEOME RES, V9, P6, DOI 10.1021/pr900057t; Techritz S, 2013, PROTEOMICS, V13, P179, DOI 10.1002/pmic.201100539; Voss T, 2000, ELECTROPHORESIS, V21, P3345, DOI 10.1002/1522-2683(20001001)21:16<3345::AID-ELPS3345>3.0.CO;2-Z; Wimmer H, 2009, ELECTROPHORESIS, V30, P2076, DOI 10.1002/elps.200900072; Wray CJ, 2004, EXPERT OPIN INV DRUG, V13, P631, DOI 10.1517/13543784.13.6.631; Yu B, 2004, WORLD J GASTROENTERO, V10, P2652, DOI 10.3748/wjg.v10.i18.2652	42	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103950	10.1371/journal.pone.0103950	http://dx.doi.org/10.1371/journal.pone.0103950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083712	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800109
J	Moyer, GR; Diaz-Ferguson, E; Hill, JE; Shea, C				Moyer, Gregory R.; Diaz-Ferguson, Edgardo; Hill, Jeffrey E.; Shea, Colin			Assessing Environmental DNA Detection in Controlled Lentic Systems	PLOS ONE			English	Article							SITE OCCUPANCY MODELS; EDNA; CONSERVATION; ABUNDANCE; PREY	Little consideration has been given to environmental DNA (eDNA) sampling strategies for rare species. The certainty of species detection relies on understanding false positive and false negative error rates. We used artificial ponds together with logistic regression models to assess the detection of African jewelfish eDNA at varying fish densities (0, 0.32, 1.75, and 5.25 fish/m(3)). Our objectives were to determine the most effective water stratum for eDNA detection, estimate true and false positive eDNA detection rates, and assess the number of water samples necessary to minimize the risk of false negatives. There were 28 eDNA detections in 324, 1-L, water samples collected from four experimental ponds. The best-approximating model indicated that the per-L-sample probability of eDNA detection was 4.86 times more likely for every 2.53 fish/m(3) (1 SD) increase in fish density and 1.67 times less likely for every 1.02 C (1 SD) increase in water temperature. The best section of the water column to detect eDNA was the surface and to a lesser extent the bottom. Although no false positives were detected, the estimated likely number of false positives in samples from ponds that contained fish averaged 3.62. At high densities of African jewelfish, 3-5 L of water provided a > 95% probability for the presence/absence of its eDNA. Conversely, at moderate and low densities, the number of water samples necessary to achieve a > 95% probability of eDNA detection approximated 42-73 and >100 L, respectively. Potential biases associated with incomplete detection of eDNA could be alleviated via formal estimation of eDNA detection probabilities under an occupancy modeling framework; alternatively, the filtration of hundreds of liters of water may be required to achieve a high (e. g., 95%) level of certainty that African jewelfish eDNA will be detected at low densities (i. e <0.32 fish/m(3) or 1.75 g/m(3)).	[Moyer, Gregory R.; Diaz-Ferguson, Edgardo] US Fish & Wildlife Serv, Conservat Genet Lab, Warm Springs, GA 31830 USA; [Hill, Jeffrey E.] Univ Florida, Trop Aquaculture Lab, Program Fisheries & Aquat Sci, Ruskin, FL USA; [Shea, Colin] Tennessee Technol Univ, Dept Biol, Cookeville, TN 38505 USA; [Diaz-Ferguson, Edgardo] Auburn Univ, Dept Fisheries & Allied Aquacultures, Auburn, AL 36849 USA	United States Department of the Interior; US Fish & Wildlife Service; State University System of Florida; University of Florida; Tennessee Technological University; Auburn University System; Auburn University	Moyer, GR (corresponding author), US Fish & Wildlife Serv, Conservat Genet Lab, Warm Springs, GA 31830 USA.	greg_moyer@fws.gov		Diaz-Ferguson, Edgardo/0000-0002-2314-5021	United States Fish and Wildlife Service Region 4 Aquatic Invasive Species Program	United States Fish and Wildlife Service Region 4 Aquatic Invasive Species Program	This work was funded by the United States Fish and Wildlife Service Region 4 Aquatic Invasive Species Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Britton JR, 2013, ECOLOGY, V94, P2558, DOI 10.1890/13-0527.1; Bryk A. S., 2002, HIERARCHICAL LINEAR; Burnham KP, 2002, MULTIMODEL INFERENCE; Congdon P., 2001, BAYESIAN STAT ANAL; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Diaz-Ferguson E, 2014, REV BIOL TR IN PRESS; Diaz-Ferguson E, 2014, MANAG BIOL INVASION, V5, P121, DOI 10.3391/mbi.2014.5.2.05; Dunlop-Hayden KL, 2011, BEHAVIOUR, V148, P795, DOI 10.1163/000579511X577256; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Gelman A, 1996, STAT SINICA, V6, P733; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hines, 2017, OCCUPANCY ESTIMATION; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Hutson AM, 2012, J WORLD AQUACULT SOC, V43, P84, DOI 10.1111/j.1749-7345.2011.00537.x; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Langston JN, 2010, COPEIA, P475, DOI 10.1643/CP-09-069; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Porter-Whitaker AE, 2012, ECOL FRESHW FISH, V21, P375, DOI 10.1111/j.1600-0633.2012.00557.x; Rehage JS, 2013, WETLANDS, P1; RIVAS LUIS R., 1965, QUART J FLORIDA ACAD SCI, V28, P255; Royall R., 1997, STAT EVIDENCE LIKELI; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2006, ECOLOGY, V87, P835, DOI 10.1890/0012-9658(2006)87[835:GSOMAF]2.0.CO;2; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Schofield PJ, 2007, J FISH BIOL, V71, P87, DOI 10.1111/j.1095-8649.2007.01686.x; Snijders TAB, MULTILEVEL ANAL INTR; Sokal R. R., 2012, BIOMETRY; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner C.R., 2014, METHODS ECO IN PRESS; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Woodford DJ, 2013, ECOL APPL, V23, P1926, DOI 10.1890/12-1262.1; Wotton RS, 2001, BIOSCIENCE, V51, P537, DOI 10.1641/0006-3568(2001)051[0537:FIAE]2.0.CO;2; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x	52	78	89	4	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103767	10.1371/journal.pone.0103767	http://dx.doi.org/10.1371/journal.pone.0103767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079969	Green Published, gold, Green Submitted			2022-12-25	WOS:000339954800079
J	Hessamfar, M; Colin, C; Bruyand, M; Decoin, M; Bonnet, F; Mercie, P; Neau, D; Cazanave, C; Pellegrin, JL; Dabis, F; Morlat, P; Chene, G				Hessamfar, Mojgan; Colin, Celine; Bruyand, Mathias; Decoin, Madeleine; Bonnet, Fabrice; Mercie, Patrick; Neau, Didier; Cazanave, Charles; Pellegrin, Jean-Luc; Dabis, Francois; Morlat, Philippe; Chene, Genevieve		GECSA Study Grp	Severe Morbidity According to Sex in the Era of Combined Antiretroviral Therapy: The ANRS CO3 Aquitaine Cohort	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; IMMUNODEFICIENCY-VIRUS-INFECTION; HEALTH-SERVICES UTILIZATION; LONGITUDINAL DATA-ANALYSIS; IN-HOSPITAL ADMISSIONS; AIDS-DEFINING CANCERS; CD4 CELL COUNT; COLLABORATIVE ANALYSIS; MYOCARDIAL-INFARCTION; GENERAL-POPULATION	Objective: To describe trends and determinants of severe morbidity in HIV-infected women and men. Design: A French prospective cohort of HIV-infected patients of both sexes and all transmission categories. Methods: We used hospital admission data from January 2000 to December 2008. A severe morbid event (SME) was defined as a clinical event requiring hospitalization for >= 48 h, several events could be reported during hospitalization. Yearly incidence rates of SME were estimated and compared using Generalized Estimating Equations. Results: Among 4,987 patients (27% women), followed for a median of 8.7 years, 1,473 (30%) were hospitalized (3,049 hospitalizations for 5,963 SME). The yearly incidence rate of hospitalization decreased in men, from 155 in 2000 to 80/1,000 person-years (PY) in 2008 and in women, from 125 to 71/1,000 PY, (p < 0.001). This trend was observed for all SME except for hepatic events, stable in men (15 to 13/1,000 PY) and increasing in women (2.5 to 11.5), cardiovascular events increasing in men (6 to 10/1,000 PY) and in women (6 to 14) and non-AIDS non-hepatic malignancies increasing in men (4 to 7/1,000 PY) and stable in women (2.5). Intraveneous drug users, age >50 years, HIV RNA >10,000 copies, CD4 <500/mm(3), AIDS stage, hepatitis C co-infection and cardiovascular risk factors (diabetes, high blood pressure, and tobacco use) were associated with SME. Conclusions: HIV-infected individuals in care in France require less and less frequently hospitalization. Women are now presenting with severe hepatic and cardio-vascular events. Disparities in SME between men and women are primarily explained by different exposure patterns to risk factors. Women should be targeted to benefit cardiovascular prevention policies as well as men.	[Hessamfar, Mojgan; Colin, Celine; Bruyand, Mathias; Decoin, Madeleine; Bonnet, Fabrice; Mercie, Patrick; Dabis, Francois; Morlat, Philippe; Chene, Genevieve] Univ Bordeaux, Inst Sante Publ Epidemiol & Dev, INSERM U897, Bordeaux, France; [Hessamfar, Mojgan; Colin, Celine; Bruyand, Mathias; Decoin, Madeleine; Bonnet, Fabrice; Mercie, Patrick; Dabis, Francois; Morlat, Philippe; Chene, Genevieve] Univ Bordeaux, Inst Sante Publ Epidemiol & Dev, CIC EC7, Bordeaux, France; [Hessamfar, Mojgan; Bruyand, Mathias; Bonnet, Fabrice; Mercie, Patrick; Neau, Didier; Cazanave, Charles; Pellegrin, Jean-Luc; Dabis, Francois; Morlat, Philippe; Chene, Genevieve] Ctr Hosp Univ CHU Bordeaux, Coordinat Reg Lutte Infect VIH COREVIH Aquitaine, Bordeaux, France; [Hessamfar, Mojgan; Bonnet, Fabrice; Pellegrin, Jean-Luc; Morlat, Philippe] CHU Bordeaux, Serv Med Interne & Malad Infect, Bordeaux, France; [Mercie, Patrick] CHU Bordeaux, Serv Med Interne & Immunol Clin, Bordeaux, France; [Neau, Didier; Cazanave, Charles] CHU Bordeaux, Federat Malad Infect & Trop, Bordeaux, France; [Neau, Didier; Cazanave, Charles; Pellegrin, Jean-Luc] Univ Bordeaux, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Hessamfar, M (corresponding author), Univ Bordeaux, Inst Sante Publ Epidemiol & Dev, INSERM U897, Bordeaux, France.	mojgan.hessamfar@chu-bordeaux.fr	Bruyand, Mathias/AAP-6177-2020; chene, genevieve/H-8665-2014; Bonnet, Fabrice/T-3254-2019; DABIS, FRANCOIS/S-9298-2019; Cazanave, Charles/AHE-5492-2022	chene, genevieve/0000-0002-8368-6460; DABIS, FRANCOIS/0000-0002-1614-8857; 	French Agency for AIDS and hepatitis research (ANRS)	French Agency for AIDS and hepatitis research (ANRS)(ANRS)	This study was supported by grants from the French Agency for AIDS and hepatitis research (ANRS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglaret X, 2012, CLIN INFECT DIS, V54, P714, DOI 10.1093/cid/cir898; [Anonymous], 2013, PRIS CHARG MED PERS; [Anonymous], 1992, MMWR RECOMM REP, V41, P1; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; Benard A, 2007, AIDS PATIENT CARE ST, V21, P458, DOI 10.1089/apc.2006.0142; Benito N, 2001, J ACQ IMMUN DEF SYND, V27, P35, DOI 10.1097/00126334-200105010-00006; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Betz ME, 2005, MED CARE, V43, P3; Blot M, 2012, REV MAL RESPIR, V29, P785, DOI 10.1016/j.rmr.2011.10.974; Bonnet F, 2007, HIV MED, V8, P547, DOI 10.1111/j.1468-1293.2007.00508.x; Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048; Buchacz K, 2008, AIDS, V22, P1345, DOI 10.1097/QAD.0b013e328304b38b; Buchacz K, 2013, ANTIVIR THER, V18, P65, DOI 10.3851/IMP2450; Casau NC, 2005, CLIN INFECT DIS, V41, P855, DOI 10.1086/432797; Crum-Cianflone NF, 2010, JAIDS-J ACQ IMM DEF, V54, P248, DOI 10.1097/QAI.0b013e3181c8ef22; Deeken JF, 2012, CLIN INFECT DIS, V55, P1228, DOI 10.1093/cid/cis613; DREES (Direction de la Recherche dE de l'Evaluation et des Statistiques), 2010, ET SANT POP FRANC SU; Fleishman JA, 2005, MED CARE, V43, P40; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Gebo KA, 2003, JAIDS-J ACQ IMM DEF, V34, P165, DOI 10.1097/00126334-200310010-00006; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V38, P96, DOI 10.1097/00126334-200501010-00017; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Goedert JJ, 2006, BRIT J CANCER, V95, P642, DOI 10.1038/sj.bjc.6603282; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Herida M, 2003, J CLIN ONCOL, V21, P3447, DOI 10.1200/JCO.2003.01.096; Hessamfar-Bonarek M, 2010, INT J EPIDEMIOL, V39, P135, DOI 10.1093/ije/dyp300; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Holmberg SD, 2002, LANCET, V360, P1747, DOI 10.1016/S0140-6736(02)11672-2; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Krentz HB, 2006, HIV MED, V7, P457, DOI 10.1111/j.1468-1293.2006.00408.x; Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f; Levine AM, 2010, J CLIN ONCOL, V28, P1514, DOI 10.1200/JCO.2009.25.6149; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Mocroft A, 2004, HIV MED, V5, P437, DOI 10.1111/j.1468-1293.2004.00250.x; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Monforte AD, 2004, AIDS, V18, P1811, DOI 10.1097/00002030-200409030-00010; Pantanowitz L, 2001, JAMA-J AM MED ASSOC, V285, P3090, DOI 10.1001/jama.285.24.3090; Phillips AN, 2007, AIDS, V21, P1717; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Soriano V, 2001, CLIN INFECT DIS, V33, P1793, DOI 10.1086/323009; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Thiebaut F, 2005, AIDS, V19, P729, DOI 10.1097/01.aids.0000166097.46940.35; Thiebaut R, 2000, AIDS, V14, P971, DOI 10.1097/00002030-200005260-00008; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; UNAIDS, 2012, AIDS EP UPD 2012; Yehia BR, 2010, JAIDS-J ACQ IMM DEF, V53, P397, DOI 10.1097/QAI.0b013e3181bcdc16	48	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102671	10.1371/journal.pone.0102671	http://dx.doi.org/10.1371/journal.pone.0102671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076050	Green Submitted, Green Published, gold			2022-12-25	WOS:000340028800017
J	Robison, B; Seibel, B; Drazen, J				Robison, Bruce; Seibel, Brad; Drazen, Jeffrey			Deep-Sea Octopus (Graneledone boreopacifica) Conducts the Longest-Known Egg-Brooding Period of Any Animal	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; CEPHALOPODA; GROWTH; FISH	Octopuses typically have a single reproductive period and then they die (semelparity). Once a clutch of fertilized eggs has been produced, the female protects and tends them until they hatch. In most shallow-water species this period of parental care can last from 1 to 3 months, but very little is known about the brooding of deep-living species. In the cold, dark waters of the deep ocean, metabolic processes are often slower than their counterparts at shallower depths. Extrapolations from data on shallow-water octopus species suggest that lower temperatures would prolong embryonic development periods. Likewise, laboratory studies have linked lower temperatures to longer brooding periods in cephalopods, but direct evidence has not been available. We found an opportunity to directly measure the brooding period of the deep-sea octopus Graneledone boreopacifica, in its natural habitat. At 53 months, it is by far the longest egg-brooding period ever reported for any animal species. These surprising results emphasize the selective value of prolonged embryonic development in order to produce competitive hatchlings. They also extend the known boundaries of physiological adaptations for life in the deep sea.	[Robison, Bruce] Monterey Bay Aquarium Res Inst, Div Res, Moss Landing, CA 95039 USA; [Seibel, Brad] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [Drazen, Jeffrey] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA	Monterey Bay Aquarium Research Institute; University of Rhode Island; University of Hawaii System	Robison, B (corresponding author), Monterey Bay Aquarium Res Inst, Div Res, Moss Landing, CA 95039 USA.	robr@mbari.org	Drazen, Jeffrey/C-1197-2013	Drazen, Jeffrey/0000-0001-9613-3833	Monterey Bay Aquarium Research Institute [901220]; David and Lucile Packard Foundation	Monterey Bay Aquarium Research Institute; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This research was funded by the Monterey Bay Aquarium Research Institute (www.mbari.org) as a research project (#901220) led by author BR; MBARI is funded by the David and Lucile Packard Foundation (www.packard.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barratt IM, 2007, MAR BIOL, V150, P387, DOI 10.1007/s00227-006-0365-6; Boletzky S.v., 1987, P5; BOLETZKY SV, 1994, ANTARCT SCI, V6, P139, DOI 10.1017/S0954102094000210; Bush SL, 2012, J MAR BIOL ASSOC UK, V92, P1629, DOI 10.1017/S0025315411002165; CALOW P, 1987, CEPHALOPOD LIFE CYCL, V2, P351; CHILDRESS JJ, 1978, MAR BIOL, V50, P47, DOI 10.1007/BF00390541; Corse J, 1799, PHILOS T ROY SOC LON, V1799, P31; DANIELS RA, 1979, SCIENCE, V205, P831, DOI 10.1126/science.205.4408.831; Drazen JC, 2003, BIOL BULL-US, V205, P1, DOI 10.2307/1543439; Hanlon R. T., 1996, CEPHALOPOD BEHAV; Ibanez CM, 2010, REV FISH BIOL FISHER, V20, P123, DOI 10.1007/s11160-009-9129-y; Kirkwood R, 1997, ECOL MONOGR, V67, P155, DOI 10.1890/0012-9615(1997)067[0155:TFEOFE]2.0.CO;2; Mangold K., 1987, P157; Miaud C, 2001, J ZOOL, V254, P251, DOI 10.1017/S0952836901000760; Nesis KN., 1999, RUSS J MAR BIOL+, V25, P499; Paull CK, 2005, GEOL SOC AM BULL, V117, P1134, DOI 10.1130/B25390.1; Pereyra W.T., 1972, P444; Rocha F, 2001, BIOL REV, V76, P291, DOI 10.1017/S1464793101005681; SAUNDERS WB, 1984, SCIENCE, V224, P990, DOI 10.1126/science.224.4652.990; Seibel BA, 2005, NATURE, V438, P929, DOI 10.1038/438929a; TANAKA S, 1990, JPN J ICHTHYOL, V37, P273; Voight JR, 2008, AM MALACOL BULL, V24, P43, DOI 10.4003/0740-2783-24.1.43; Voight JR, 2004, J MOLLUS STUD, V70, P400, DOI 10.1093/mollus/70.4.400; Voight JR, 2000, BIOL BULL, V198, P94, DOI 10.2307/1542807; VOIGHT JR, 2002, B MAR SCI, V71, P1142; Wood JB, 1998, MALACOLOGIA, V39, P11	26	46	48	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103437	10.1371/journal.pone.0103437	http://dx.doi.org/10.1371/journal.pone.0103437			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075745	gold, Green Published, Green Submitted			2022-12-25	WOS:000340028800044
J	Willcox, ML; Dicko, MI; Graz, B; Forster, M; Shinkins, B; Diakite, C; Giani, S; Falquet, J; Diallo, D; Dembele, E				Willcox, Merlin L.; Dicko, Moussa I.; Graz, Bertrand; Forster, Mathieu; Shinkins, Bethany; Diakite, Chiaka; Giani, Sergio; Falquet, Jacques; Diallo, Drissa; Dembele, Eugene			Pre-Hospital Risk Factors for Inpatient Death from Severe Febrile Illness in Malian Children	PLOS ONE			English	Article							LIFE-THREATENING MALARIA; HOME-BASED MANAGEMENT; AFRICAN CHILDREN; TRANSMISSION; MORTALITY; FEATURES; FEVERS; URBAN; AREA	Background: Inpatient case fatality from severe malaria remains high in much of sub-Saharan Africa. The majority of these deaths occur within 24 hours of admission, suggesting that pre-hospital management may have an impact on the risk of case fatality. Methods: Prospective cohort study, including questionnaire about pre-hospital treatment, of all 437 patients admitted with severe febrile illness (presumed to be severe malaria) to the paediatric ward in Sikasso Regional Hospital, Mali, in a two-month period. Findings: The case fatality rate was 17.4%. Coma, hypoglycaemia and respiratory distress at admission were associated with significantly higher mortality. In multiple logistic regression models and in a survival analysis to examine pre-admission risk factors for case fatality, the only consistent and significant risk factor was sex. Girls were twice as likely to die as boys (AOR 2.00, 95% CI 1.08-3.70). There was a wide variety of pre-hospital treatments used, both modern and traditional. None had a consistent impact on the risk of death across different analyses. Reported use of traditional treatments was not associated with post-admission outcome. Interpretation: Aside from well-recognised markers of severity, the main risk factor for death in this study was female sex, but this study cannot determine the reason why. Differences in pre-hospital treatments were not associated with case fatality.	[Willcox, Merlin L.; Shinkins, Bethany] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, Oxon, England; [Dicko, Moussa I.; Diakite, Chiaka; Diallo, Drissa] Inst Natl Rech Sante Publ, Dept Med Traditionnelle, Bamako, Mali; [Graz, Bertrand] Univ Lausanne, Univ Inst Social & Prevent Med, Care Assessment Unit, CAM Group, Lausanne, Switzerland; [Forster, Mathieu] Ungava Tulattavik Hlth Ctr, Kuujjuaq, PQ, Canada; [Giani, Sergio] Aidemet ONG, Bamako, Mali; [Falquet, Jacques] Univ Geneva, Dept Plant Med, Geneva, Switzerland; [Diallo, Drissa] Univ Sci Tech & Technol Bamako, Fac Pharm, Bamako, Mali; [Dembele, Eugene] Sikasso Reg Hosp, Dept Paediat, Sikasso, Mali	University of Oxford; University of Lausanne; University of Geneva; University of Science & Technology of Bamako	Willcox, ML (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, Oxon, England.	merlin.willcox@phc.ox.ac.uk	Willcox, Merlin/I-6255-2019; Shinkins, Bethany/AAX-4045-2020	Willcox, Merlin/0000-0002-5227-3444; Shinkins, Bethany/0000-0001-5350-1018	Swiss Agency for Development and Cooperation (SDC)	Swiss Agency for Development and Cooperation (SDC)	This study was funded by the Swiss Agency for Development and Cooperation (SDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassat Q, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-37; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Biai S, 2007, BRIT MED J, V335, P862, DOI 10.1136/bmj.39345.467813.80; DEFRANCISCO A, 1994, J TROP MED HYG, V97, P69; Diallo D, 2006, T ROY SOC TROP MED H, V100, P515, DOI 10.1016/j.trstmh.2005.08.003; Dzeing-Ella A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-1; Ehrhardt S, 2005, MICROBES INFECT, V7, P1204, DOI 10.1016/j.micinf.2005.04.007; Gemperli A, 2004, AM J EPIDEMIOL, V159, P64, DOI 10.1093/aje/kwh001; Graz B, 2010, T ROY SOC TROP MED H, V104, P33, DOI 10.1016/j.trstmh.2009.07.005; Graz B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-242; Issifou S, 2007, AM J TROP MED HYG, V77, P1015, DOI 10.4269/ajtmh.2007.77.1015; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Nonvignon J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-188; Orimadegun AE, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-143; Ranque S, 2008, PEDIATR INFECT DIS J, V27, P130, DOI 10.1097/INF.0b013e31815988ed; Rasoanaivo P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S4; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Willcox ML, 2009, ANN TROP MED PARASIT, V103, P3, DOI 10.1179/136485909X384983; Willcox ML, 2007, T ROY SOC TROP MED H, V101, P1190, DOI 10.1016/j.trstmh.2007.05.017; Willcox ML, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S8; Willcox ML, 2011, T ROY SOC TROP MED H, V105, P23, DOI 10.1016/j.trstmh.2010.10.003; Willcox ML, 2010, TROP MED INT HEALTH, V15, P232, DOI 10.1111/j.1365-3156.2009.02444.x; Zeidan Z., 2006, Eastern Mediterranean Health Journal, V12, P783	23	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102530	10.1371/journal.pone.0102530	http://dx.doi.org/10.1371/journal.pone.0102530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075623	Green Published, gold, Green Submitted			2022-12-25	WOS:000340028800013
J	Ferrajolo, C; Arcoraci, V; Sullo, MG; Rafaniello, C; Sportiello, L; Ferrara, R; Cannata, A; Pagliaro, C; Tari, MG; Caputi, AP; Rossi, F; Trifiro, G; Capuano, A				Ferrajolo, Carmen; Arcoraci, Vincenzo; Sullo, Maria Giuseppa; Rafaniello, Concetta; Sportiello, Liberata; Ferrara, Rosarita; Cannata, Angelo; Pagliaro, Claudia; Tari, Michele Giuseppe; Caputi, Achille Patrizio; Rossi, Francesco; Trifiro, Gianluca; Capuano, Annalisa			Pattern of Statin Use in Southern Italian Primary Care: Can Prescription Databases Be Used for Monitoring Long-Term Adherence to the Treatment?	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; LIPID-LOWERING DRUGS; PRESCRIBING PATTERN; GENERAL-PRACTICE; PRIMARY PREVENTION; CLINICAL-PRACTICE; INTERACTION RISK; ELDERLY-PATIENTS; THERAPY; PERSISTENCE	Objectives: We sought to evaluate the prescribing pattern of statins according to national and regional health policy interventions and to assess specifically the adherence to the therapy in outpatient setting in Southern Italy. Methods: A population-based study was performed on persons >= 15 years old, living in the catchment area of Caserta (Southern Italy), and registered in Arianna database between 2004 and 2010. Prevalence and incidence of new treatments with statins were calculated for each year and stratified by drug. Adherence to therapy was measured by Medication Possession Ratio. Sub-analyses by individual compound and type of cardiovascular prevention were performed. Results: From 2004 to 2010, the one-year prevalence of statin use increased from 44.9/1,000 inhabitants to 79.8/1,000, respectively, consistently with the incidence of new use from 16.2/1,000 to 19.5/1,000, except a slight decrease after criteria reimbursement revision on 2005 (13.3/1,000). The incidence of new treatments decreased for atorvastatin, and increased for simvastatin over the study years. Overall, 43% of new users were still highly adherent to the treatment (MPR >= 80%) after six months, while 26% after 4-years of follow-up. As compared with highly adherent patients, the probability to be non-adherent (MPR <= 25%) at 4-years of follow-up was 26% higher for women than for men (full adj. odds ratio: 1.26; 95% CI: 1.10-1.45), and 64% higher in patients who started on primary rather than on secondary prevention (1.64; 1.29-2.07). Conclusions: Prevalence and incidence of statin use increased consistently with health policy interventions. Only one-fourth of patients who newly initiated a statin were adherent to the treatment after 4-year of follow-up. Since the benefits of statins in terms of cardiovascular outcome and costs are associated with their chronic use, the identification of patient-related predictors of non-adherence such as gender, primary prevention could be suitable for physicians to improve the patients' compliance.	[Ferrajolo, Carmen; Sullo, Maria Giuseppa; Rafaniello, Concetta; Sportiello, Liberata; Rossi, Francesco; Capuano, Annalisa] Univ Naples 2, Campania Reg Ctr Pharmacovigilance & Pharmacoepid, Dept Expt Med, Pharmacol Sect, Naples, Italy; [Ferrajolo, Carmen; Caputi, Achille Patrizio; Trifiro, Gianluca] Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands; [Arcoraci, Vincenzo; Ferrara, Rosarita; Cannata, Angelo; Trifiro, Gianluca] Univ Messina, Clin & Expt Med Dept, Messina, Italy; [Pagliaro, Claudia; Tari, Michele Giuseppe] Local Hlth Unit Caserta, Caserta, Italy	Universita della Campania Vanvitelli; Erasmus University Rotterdam; Erasmus MC; University of Messina	Ferrajolo, C (corresponding author), Univ Naples 2, Campania Reg Ctr Pharmacovigilance & Pharmacoepid, Dept Expt Med, Pharmacol Sect, Naples, Italy.	Carmen.ferrajolo@unina2.it	Arcoraci, Vincenzo/HGA-3713-2022; Trifiro, Gianluca/K-9744-2016	Arcoraci, Vincenzo/0000-0003-0061-0477; Trifiro, Gianluca/0000-0003-1147-7296; Capuano, Annalisa/0000-0002-8653-2408; Sportiello, Liberata/0000-0002-5884-9889; RAFANIELLO, Concetta/0000-0002-7107-4280; Sullo, Maria Giuseppa/0000-0001-9018-3573				Agenxia Italiana del Farmaco, 2004, 204 AIFA; Alacqua M, 2008, ARTHRIT RHEUM-ARTHR, V59, P568, DOI 10.1002/art.23526; Alacqua M, 2009, EPILEPSY RES, V85, P107, DOI 10.1016/j.eplepsyres.2009.03.002; Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Capuano A, 2004, PHARMACOL RES, V50, P631, DOI 10.1016/j.phrs.2004.05.008; Capuano A, 2009, EUR J CLIN PHARMACOL, V65, P721, DOI 10.1007/s00228-009-0641-8; Catapano AL, 2011, ATHEROSCLEROSIS, V217, P3, DOI 10.1016/j.atherosclerosis.2011.06.028; Corrao G, 2010, CLIN THER, V32, P300, DOI 10.1016/j.clinthera.2010.02.004; Deambrosis P, 2007, EUR J CLIN PHARMACOL, V63, P197, DOI 10.1007/s00228-006-0239-3; Degli Esposti L, 2012, CLIN THER, V34, P190, DOI 10.1016/j.clinthera.2011.12.011; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; Gnavi R, 2007, EUR J PUBLIC HEALTH, V17, P492, DOI 10.1093/eurpub/ckm005; ISLES CG, 1992, LANCET, V339, P702, DOI 10.1016/0140-6736(92)90599-X; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Kozyrskyj A, 2007, EUR J CLIN PHARMACOL, V63, P597, DOI 10.1007/s00228-007-0277-5; Lemstra M, 2012, CAN J CARDIOL, V28, P574, DOI 10.1016/j.cjca.2012.05.007; Mazzitello C, 2013, J PHARMACOL PHARMACO, V4, pS20, DOI 10.4103/0976-500X.120942; Mosca Lori, 2007, Circulation, V115, P1481, DOI 10.1161/CIRCULATIONAHA.107.181546; Naci H, 2013, QJM-INT J MED, V106, P299, DOI 10.1093/qjmed/hct041; Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356; OSMED GdL, 2005, US FARM IT RAPP NAZ; OSMED GdL, 2007, US FARM IT RAPP NAZ; OSMED GdL, 2011, US FARM IT RAPP NAZ; OSMED Gdl, 2012, US FARM IT RAPP NAZ; OSMED GdL, 2010, US FARM IT RAPP NAZ; OSMED GdL, 2009, US FARM IT RAPP NAZ; OSMED GdL, 2006, US FARM IT RAPP NAZ; OSMED GdL, 2008, US FARM IT RAPP NAZ; Oteri A, 2010, BRIT J CLIN PHARMACO, V70, P514, DOI 10.1111/j.1365-2125.2010.03619.x; Palmieri Luigi, 2004, Ann Ist Super Sanita, V40, P393; Peterson AM, 2007, VALUE HEALTH, V10, P3, DOI 10.1111/j.1524-4733.2006.00139.x; Petretta M, 2010, INT J CARDIOL, V138, P25, DOI 10.1016/j.ijcard.2008.08.001; Piacentini N, 2005, EUR J CLIN PHARMACOL, V61, P615, DOI 10.1007/s00228-005-0972-z; Pittman DG, 2011, AM J CARDIOL, V107, P1662, DOI 10.1016/j.amjcard.2011.01.052; Poluzzi E, 2011, EUR J CLIN PHARMACOL, V67, P407, DOI 10.1007/s00228-010-0958-3; Regione Campania, 2008, B UFF PIAN CONT SPES; Roebuck MC, 2011, HEALTH AFFAIR, V30, P91, DOI 10.1377/hlthaff.2009.1087; Saib A, 2013, ARCH CARDIOVASC DIS, V106, P511, DOI 10.1016/j.acvd.2013.06.053; Savoie I, 2002, J CLIN EPIDEMIOL, V55, P95, DOI 10.1016/S0895-4356(01)00436-X; Schedlbauer A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004371.pub3; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Trifiro G, 2008, EUR J CLIN PHARMACOL, V64, P619, DOI 10.1007/s00228-007-0459-1; Trifiro G, 2005, EUR J CLIN PHARMACOL, V61, P47, DOI 10.1007/s00228-004-0868-3; Trifiro G, 2008, J AM GERIATR SOC, V56, P371, DOI 10.1111/j.1532-5415.2007.01522.x; Trifiro G, 2008, J AM GERIATR SOC, V56, P175, DOI 10.1111/j.1532-5415.2007.01486.x; Trifiro G, 2007, PHARMACOEPIDEM DR S, V16, P552, DOI 10.1002/pds.1303; Trifiro G, 2006, BRIT J CLIN PHARMACO, V62, P582, DOI 10.1111/j.1365-2125.2006.02687.x; Trifiro G, 2013, INT J CLIN PHARM-NET, V35, P1053, DOI 10.1007/s11096-013-9822-8; Walley T, 2005, BRIT J CLIN PHARMACO, V60, P543, DOI 10.1111/j.1365-2125.2005.02478.x; Walley T, 2004, BRIT MED J, V328, P385, DOI 10.1136/bmj.328.7436.385; Walsh JME, 2004, JAMA-J AM MED ASSOC, V291, P2243, DOI 10.1001/jama.291.18.2243; Wei MY, 2013, J CLIN LIPIDOL, V7, P472, DOI 10.1016/j.jacl.2013.03.001	53	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e102146	10.1371/journal.pone.0102146	http://dx.doi.org/10.1371/journal.pone.0102146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KU	25072244	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600008
J	Pre, D; Nestor, MW; Sproul, AA; Jacob, S; Koppensteiner, P; Chinchalongporn, V; Zimmer, M; Yamamoto, A; Noggle, SA; Arancio, O				Pre, Deborah; Nestor, Michael W.; Sproul, Andrew A.; Jacob, Samson; Koppensteiner, Peter; Chinchalongporn, Vorapin; Zimmer, Matthew; Yamamoto, Ai; Noggle, Scott A.; Arancio, Ottavio			A Time Course Analysis of the Electrophysiological Properties of Neurons Differentiated from Human Induced Pluripotent Stem Cells (iPSCs)	PLOS ONE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; VOLTAGE-GATED NA+; RAT SPINAL-CORD; DIRECTED DIFFERENTIATION; NEURAL DIFFERENTIATION; FUNCTIONAL MATURATION; SYNAPTIC DYSFUNCTION; DOPAMINERGIC-NEURONS; HUNTINGTONS-DISEASE; PROGENITOR CELLS	Many protocols have been designed to differentiate human embryonic stem cells (ESCs) and human induced pluripotent stem cells (iPSCs) into neurons. Despite the relevance of electrophysiological properties for proper neuronal function, little is known about the evolution over time of important neuronal electrophysiological parameters in iPSC-derived neurons. Yet, understanding the development of basic electrophysiological characteristics of iPSC-derived neurons is critical for evaluating their usefulness in basic and translational research. Therefore, we analyzed the basic electrophysiological parameters of forebrain neurons differentiated from human iPSCs, from day 31 to day 55 after the initiation of neuronal differentiation. We assayed the developmental progression of various properties, including resting membrane potential, action potential, sodium and potassium channel currents, somatic calcium transients and synaptic activity. During the maturation of iPSC-derived neurons, the resting membrane potential became more negative, the expression of voltage-gated sodium channels increased, the membrane became capable of generating action potentials following adequate depolarization and, at day 48-55, 50% of the cells were capable of firing action potentials in response to a prolonged depolarizing current step, of which 30% produced multiple action potentials. The percentage of cells exhibiting miniature excitatory post-synaptic currents increased over time with a significant increase in their frequency and amplitude. These changes were associated with an increase of Ca2+ transient frequency. Co-culturing iPSC-derived neurons with mouse glial cells enhanced the development of electrophysiological parameters as compared to pure iPSC-derived neuronal cultures. This study demonstrates the importance of properly evaluating the electrophysiological status of the newly generated neurons when using stem cell technology, as electrophysiological properties of iPSC-derived neurons mature over time.	[Pre, Deborah; Koppensteiner, Peter; Chinchalongporn, Vorapin; Yamamoto, Ai; Arancio, Ottavio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Pre, Deborah; Koppensteiner, Peter; Chinchalongporn, Vorapin; Arancio, Ottavio] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Pre, Deborah; Koppensteiner, Peter; Chinchalongporn, Vorapin; Arancio, Ottavio] Columbia Univ, Columbia Stem Cell Initiat, New York, NY USA; [Nestor, Michael W.; Sproul, Andrew A.; Jacob, Samson; Zimmer, Matthew; Noggle, Scott A.] New York Stem Cell Fdn, Res Inst, New York, NY USA; [Chinchalongporn, Vorapin] Mahidol Univ, Ctr Res Neurosci, Inst Mol Biosci, Salaya, Nakhonpathom, Thailand; [Yamamoto, Ai] Columbia Univ, Dept Neurol, New York, NY USA	Columbia University; Columbia University; Columbia University; The New York Stem Cell Foundation; Mahidol University; Columbia University	Arancio, O (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.	oa1@columbia.edu	arancio, ottavio/AAB-7959-2019	Sproul, Andrew/0000-0001-6972-1592; arancio, ottavio/0000-0001-6335-164X; Noggle, Scott/0000-0002-0374-2240; Koppensteiner, Peter/0000-0002-3509-1948; PRE, deborah/0000-0002-0163-9514	NIH [NS049442]; Christopher L. Moseley Foundation; Cure Alzheimer's Fund, Charles Evans Foundation, NIH [R21AG042965]; New York Stem Cell Foundation;  [RO1 NS077111]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077111, R01NS049442] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Christopher L. Moseley Foundation; Cure Alzheimer's Fund, Charles Evans Foundation, NIH; New York Stem Cell Foundation; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NIH grant NS049442 and the Christopher L. Moseley Foundation to OA. SAN has been generously supported by the Cure Alzheimer's Fund, Charles Evans Foundation, NIH (R21AG042965) and the New York Stem Cell Foundation. AY was supported by the grant RO1 NS077111. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches E, 2003, BIOTECHNOL LETT, V25, P725, DOI 10.1023/A:1023462832608; Agholme L, 2010, J ALZHEIMERS DIS, V20, P1069, DOI 10.3233/JAD-2010-091363; Aguado F, 2003, DEVELOPMENT, V130, P1267, DOI 10.1242/dev.00351; Anliker B, 2010, NAT METHODS, V7, P929, DOI 10.1038/nmeth.1514; Ascoli GA, 2010, J NEUROSCI, V30, P6434, DOI 10.1523/JNEUROSCI.4066-09.2010; Belinsky GS, 2011, STEM CELLS DEV, V20, P1733, DOI 10.1089/scd.2010.0501; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bertrand S, 1998, J NEUROPHYSIOL, V79, P342, DOI 10.1152/jn.1998.79.1.342; Blondel O, 2000, J NEUROSCI, V20, P8012; Bouron A, 1999, N-S ARCH PHARMACOL, V359, P370, DOI 10.1007/PL00005363; BOUVIER M, 1992, NATURE, V360, P471, DOI 10.1038/360471a0; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; CURRIE DN, 1981, J EXP BIOL, V95, P181; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Enomoto Hideki, 2005, Anatomical Science International, V80, P42; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Feng LY, 1999, MOL BRAIN RES, V66, P62, DOI 10.1016/S0169-328X(99)00015-7; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Gao BX, 1998, J NEUROPHYSIOL, V80, P3047, DOI 10.1152/jn.1998.80.6.3047; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Gingras M, 2007, J CELL PHYSIOL, V210, P498, DOI 10.1002/jcp.20889; Gonzalez-Islas C, 2006, NEURON, V49, P563, DOI 10.1016/j.neuron.2006.01.017; GRACE AA, 1989, J NEUROSCI, V9, P3463; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Hogg RC, 2004, EUR J NEUROSCI, V19, P2410, DOI 10.1111/j.0953-816X.2004.03346.x; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jeon I, 2012, STEM CELLS, V30, P2054, DOI 10.1002/stem.1135; Jin GH, 2005, NEUROSCI LETT, V386, P105, DOI 10.1016/j.neulet.2005.04.065; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kawaguchi A, 2007, NEUROCHEM RES, V32, P1469, DOI 10.1007/s11064-007-9334-9; Kondo T, 2011, NEUROSCI RES, V71, pE191, DOI 10.1016/j.neures.2011.07.825; Lamas JA, 2002, NEUROREPORT, V13, P585, DOI 10.1097/00001756-200204160-00010; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; LEVINE MS, 1982, DEV BRAIN RES, V3, P429, DOI 10.1016/0165-3806(82)90009-8; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Liu RH, 1999, EXP NEUROL, V158, P143, DOI 10.1006/exnr.1999.7078; Lushchekin V S, 1992, Neurosci Behav Physiol, V22, P45, DOI 10.1007/BF01186667; Malarkey EB, 2008, NEUROCHEM INT, V52, P142, DOI 10.1016/j.neuint.2007.06.005; Marchetto MC, 2011, HUM MOL GENET, V20, pR109, DOI 10.1093/hmg/ddr336; Matsumoto S, 2008, NEUROSCI LETT, V439, P241, DOI 10.1016/j.neulet.2008.05.032; Milnerwood AJ, 2006, HUM MOL GENET, V15, P1690, DOI 10.1093/hmg/ddl092; Milnerwood AJ, 2010, TRENDS NEUROSCI, V33, P513, DOI 10.1016/j.tins.2010.08.002; Moe MC, 2005, BRAIN, V128, P2189, DOI 10.1093/brain/awh574; Murai KK, 2007, NEUROSCIENTIST, V13, P657, DOI 10.1177/1073858407304393; MURPHY TH, 1992, J NEUROSCI, V12, P4834; Nemati S, 2011, STEM CELLS DEV, V20, P503, DOI 10.1089/scd.2010.0143; Nestor MW, 2007, J NEUROSCI, V27, P12817, DOI 10.1523/JNEUROSCI.2442-07.2007; Nestor MW, 2013, STEM CELL RES, V10, P454, DOI 10.1016/j.scr.2013.02.001; Ninan I, 2004, NEURON, V42, P129, DOI 10.1016/S0896-6273(04)00143-6; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; Ohyama K, 2005, DEVELOPMENT, V132, P5185, DOI 10.1242/dev.02094; Oswald AMM, 2008, J NEUROPHYSIOL, V99, P2998, DOI 10.1152/jn.01160.2007; Ozair MZ, 2013, STEM CELLS, V31, P35, DOI 10.1002/stem.1246; Pasti L, 1997, J NEUROSCI, V17, P7817; Plowey ED, 2011, NEUROBIOL DIS, V43, P60, DOI 10.1016/j.nbd.2010.10.011; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Rekling JC, 1996, J NEUROPHYSIOL, V75, P795, DOI 10.1152/jn.1996.75.2.795; Rosenberg SS, 2011, COLD SPRING HARBOR P; Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146; Schulz TC, 2004, STEM CELLS, V22, P1218, DOI 10.1634/stemcells.2004-0114; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shi JH, 2010, NEUROSCI RES, V67, P8, DOI 10.1016/j.neures.2010.01.007; Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771; Shimada H, 2009, J BIOSCI BIOENG, V107, P447, DOI 10.1016/j.jbiosc.2008.12.013; Smith R, 2005, CELL MOL LIFE SCI, V62, P1901, DOI 10.1007/s00018-005-5084-5; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Song MK, 2013, STEM CELLS DEV, V22, P1551, DOI 10.1089/scd.2012.0556; Sonoda M, 2003, BIOL REPROD, V68, P947, DOI 10.1095/biolreprod.102.007088; SPITZER NC, 1994, TRENDS NEUROSCI, V17, P115, DOI 10.1016/0166-2236(94)90120-1; Sproul AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084547; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang X, 2013, STEM CELL RES, V11, P743, DOI 10.1016/j.scr.2013.05.002; Teich AF, 2012, BIOCHEM J, V446, P165, DOI 10.1042/BJ20120653; Wada T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006722; WALTON MK, 1993, J NEUROSCI, V13, P2068; Wang DD, 2003, J NEUROPHYSIOL, V90, P2291, DOI 10.1152/jn.01116.2002; Wang L, 2011, J NEUROSCI METH, V194, P274, DOI 10.1016/j.jneumeth.2010.10.025; Warren RA, 1997, J NEUROSCI, V17, P277, DOI 10.1523/JNEUROSCI.17-01-00277.1997; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yamanaka S, 2008, CELL PROLIFERAT, V41, P51, DOI 10.1111/j.1365-2184.2008.00493.x; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	88	76	79	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103418	10.1371/journal.pone.0103418	http://dx.doi.org/10.1371/journal.pone.0103418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072157	Green Submitted, gold, Green Published			2022-12-25	WOS:000341307600047
J	Qin, RQ; LeBoldus, JM				Qin, Ruqian; LeBoldus, Jared M.			The Infection Biology of Sphaerulina musiva: Clues to Understanding a Forest Pathogen	PLOS ONE			English	Article							SEPTORIA-MUSIVA; POPULUS CLONES; HYBRID POPLAR; PINE NEEDLES; LEAF-SPOT; RESISTANCE; DISEASE; INOCULATION; CANKERS; TREES	Trees in the genus Populus and their interspecific hybrids are used across North America for fiber production and as a potential source of biofuel. Plantations of these species are severely impacted by a fungal pathogen, Sphaerulina musiva, the cause of leaf spot and stem canker. An inoculation protocol that does not rely on stem wounding to achieve infection was recently developed. Using this protocol two experiments were conducted to examine infection biology and disease development in the S. musiva-Populus interaction. In the first experiment non-wounded stems of one moderately resistant clone (NM6) and one susceptible clone (NC11505) were inoculated and examined by scanning electron microscopy at six different times (6 h, 12 h, 24 h, 72 h, 1 week, and 3 weeks) post-inoculation. The images indicate that the pathogen appears to enter host tissue through small openings and lenticels and that there are no significant differences in the penetration rate between the moderately resistant (NM6) and susceptible (NC11505) clones at 12 h post-inoculation. In a second experiment a histological comparison of stem cankers for resistant clone DN74 and susceptible clone NC11505 were conducted at three time points (3 weeks, 5 weeks, and 7 weeks) post-inoculation. Distinct differences in disease development were apparent between the resistant and susceptible clones at each time point, with the susceptible clone exhibiting a weak and delayed defense response. These results suggest, that following penetration, the pathogen may be able to interfere with the defense response in the susceptible host.	[Qin, Ruqian; LeBoldus, Jared M.] N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA	North Dakota State University Fargo	LeBoldus, JM (corresponding author), N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA.	jared.leboldus@ndsu.edu			United States Department of Agriculture-National Institutes of Food and Agriculture-RIPM from North Dakota State University-AES and the Department of Plant Pathology [2012-34103-19771]	United States Department of Agriculture-National Institutes of Food and Agriculture-RIPM from North Dakota State University-AES and the Department of Plant Pathology	United States Department of Agriculture-National Institutes of Food and Agriculture-RIPM (2012-34103-19771) GRA to RQ from North Dakota State University-AES and the Department of Plant Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomas A, 2007, TREE PHYSIOL, V27, P1441, DOI 10.1093/treephys/27.10.1441; Barakat A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-38; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; BIER J. E., 1939, CANADIAN JOUR RES SECT C BOT SCI, V17, P195; BIGGS AR, 1983, CAN J BOT, V61, P563, DOI 10.1139/b83-064; BIGGS AR, 1986, ANN BOT-LONDON, V57, P463, DOI 10.1093/oxfordjournals.aob.a087128; BIGGS AR, 1984, CAN J FOREST RES, V14, P351, DOI 10.1139/x84-064; BIGGS AR, 1984, CAN J BOT, V62, P2814, DOI 10.1139/b84-375; Deflorio G, 2011, PHYSIOL MOL PLANT P, V75, P180, DOI 10.1016/j.pmpp.2011.02.002; Enebak SA, 1997, EUR J FOREST PATHOL, V27, P337; Eyles A, 2010, NEW PHYTOL, V185, P893, DOI 10.1111/j.1469-8137.2009.03127.x; Feau N, 2010, CAN J PLANT PATHOL, V32, P122, DOI 10.1080/07060661003740009; GRAM K., 1953, Friesia, V4, P262; HEBARD FV, 1984, PHYTOPATHOLOGY, V74, P140, DOI 10.1094/Phyto-74-140; Kovalchuk A, 2013, ANNU REV PHYTOPATHOL, V51, P221, DOI 10.1146/annurev-phyto-082712-102307; KRUPINSKY JM, 1989, PHYTOPATHOLOGY, V79, P413, DOI 10.1094/Phyto-79-413; LeBoldus JM, 2010, PLANT DIS, V94, P1238, DOI 10.1094/PDIS-02-10-0094; LeBoldus JM, 2009, PLANT DIS, V93, P1146, DOI 10.1094/PDIS-93-11-1146; Liang HY, 2014, PLANT SCI, V223, P69, DOI 10.1016/j.plantsci.2014.03.004; LONG R, 1986, CAN J FOREST RES, V16, P405, DOI 10.1139/x86-072; Mullick D.B., 1977, Recent Advances in Phytochemistry, V11, P395; Newcombe G, 2001, PHYTOPATHOLOGY, V91, P1081, DOI 10.1094/PHYTO.2001.91.11.1081; OSTRY ME, 1985, PLANT DIS, V69, P755, DOI 10.1094/PD-69-755; PATTON RF, 1978, PHYTOPATHOLOGY, V68, P1700, DOI 10.1094/Phyto-68-1700; Pegg GS, 2009, PLANT PATHOL, V58, P642, DOI 10.1111/j.1365-3059.2009.02087.x; PETERSON GW, 1969, PHYTOPATHOLOGY, V59, P1044; Qin RQ, 2014, PLANT DIS, V98, P1106, DOI 10.1094/PDIS-11-13-1152-RE; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Sivanesan A, 1990, CMI DESCRIPTIONS PAT, V988; Smith JA, 2006, PHYTOPATHOLOGY, V96, P171, DOI 10.1094/PHYTO-96-0171; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Ward KT, 2005, PLANT DIS, V89, P1077, DOI 10.1094/PD-89-1077; Waterman AM, 1946, 947 USDA; Weiland JE, 2003, PLANT DIS, V87, P1507, DOI 10.1094/PDIS.2003.87.12.1507; Weiland JE, 2007, PLANT DIS, V91, P1524, DOI 10.1094/PDIS-91-12-1524; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; ZALASKY H, 1978, PHYTOPROTECTION, V59, P43	38	14	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103477	10.1371/journal.pone.0103477	http://dx.doi.org/10.1371/journal.pone.0103477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072596	Green Published, Green Submitted, gold			2022-12-25	WOS:000341307600052
J	Speck, S; Lim, J; Shelake, S; Matka, M; Stoddard, J; Farr, A; Kuchroo, V; Laouar, Y				Speck, Suzanne; Lim, James; Shelake, Sagar; Matka, Marsel; Stoddard, Jonathan; Farr, Alexander; Kuchroo, Vijay; Laouar, Yasmina			TGF-beta Signaling Initiated in Dendritic Cells Instructs Suppressive Effects on Th17 Differentiation at the Site of Neuroinflammation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; REGULATORY T-CELLS; MULTIPLE-SCLEROSIS; TRANSFORMING GROWTH-FACTOR-BETA-1; CNS; PLASTICITY; LINEAGE; INHIBITION	While the role of Transforming Growth Factor beta (TGF-beta) as an intrinsic pathway has been well established in driving de novo differentiation of Th17 cells, no study has directly assessed the capacity of TGF-beta signaling initiated within dendritic cells (DCs) to regulate Th17 differentiation. The central finding of this study is the demonstration that Th17 cell fate during autoimmune inflammation is shaped by TGF-beta extrinsic pathway via DCs. First, we provide evidence that TGF-beta limits at the site of inflammation the differentiation of highly mature DCs as a means of restricting Th17 cell differentiation and controlling autoimmunity. Second, we demonstrate that TGF-beta controls DC differentiation in the inflammatory site but not in the priming site. Third, we show that TGF-beta controls DC numbers at a precursor level but not at a mature stage. While it is undisputable that TGF-beta intrinsic pathway drives Th17 differentiation, our data provide the first evidence that TGF-beta can restrict Th17 differentiation via DC suppression but such a control occurs in the site of inflammation, not at the site of priming. Such a demarcation of the role of TGF-beta in DC lineage is unprecedented and holds serious implications vis-a-vis future DC-based therapeutic targets.	[Speck, Suzanne; Lim, James; Shelake, Sagar; Matka, Marsel; Stoddard, Jonathan; Farr, Alexander; Laouar, Yasmina] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Kuchroo, Vijay] Harvard Univ, Sch Med, Evegrande Ctr Immunol Dis, Boston, MA 02115 USA; [Kuchroo, Vijay] Brigham & Womens Hosp, Boston, MA 02115 USA	University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Laouar, Y (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	ylaouar@umich.edu	Shelake, Sagar/I-8694-2019	Shelake, Sagar/0000-0003-4395-0754; Lim, James Ray/0000-0003-2582-4578	National Multiple Sclerosis Society [RF4106A1/3]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This study was supported by the National Multiple Sclerosis Society RF4106A1/3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; BRABLETZ T, 1993, MOL CELL BIOL, V13, P1155, DOI 10.1128/MCB.13.2.1155; Chen GB, 2013, CRIT REV IMMUNOL, V33, P165, DOI 10.1615/CritRevImmunol.2013006959; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Doisne JM, 2009, J EXP MED, V206, P1365, DOI 10.1084/jem.20090127; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Ifergan I, 2008, BRAIN, V131, P785, DOI 10.1093/brain/awm295; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; JOHNS LD, 1993, J NEUROIMMUNOL, V47, P1, DOI 10.1016/0165-5728(93)90278-7; JOHNS LD, 1991, J IMMUNOL, V147, P1792; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; KURUVILLA AP, 1991, P NATL ACAD SCI USA, V88, P2918, DOI 10.1073/pnas.88.7.2918; Lanz TV, 2010, J CLIN INVEST, V120, P2782, DOI 10.1172/JCI41709; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Laouar Y, 2008, P NATL ACAD SCI USA, V105, P10865, DOI 10.1073/pnas.0805058105; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032705; Lin AH, 2005, J IMMUNOL, V175, P547, DOI 10.4049/jimmunol.175.1.547; Luo J, 2007, J CLIN INVEST, V117, P3306, DOI 10.1172/JCI31763; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marcoe JP, 2012, NAT IMMUNOL, V13, P843, DOI 10.1038/ni.2388; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; RACKE MK, 1991, J IMMUNOL, V146, P3012; RUEGEMER JJ, 1990, J IMMUNOL, V144, P1767; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Segal BM, 2005, J NEUROL SCI, V228, P210, DOI 10.1016/j.jns.2004.10.014; Serafini B, 2006, J NEUROPATH EXP NEUR, V65, P124, DOI 10.1097/01.jnen.0000199572.96472.1c; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang X, 2013, J NEUROSCI RES, V91, P871, DOI 10.1002/jnr.23233; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Yi HF, 2012, J IMMUNOL, V189, P4295, DOI 10.4049/jimmunol.1200086	41	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e102390	10.1371/journal.pone.0102390	http://dx.doi.org/10.1371/journal.pone.0102390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072375	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600010
J	Spiess, B; Postina, P; Reinwald, M; Cornely, OA; Hamprecht, A; Hoenigl, M; Lass-Florl, C; Rath, PM; Steinmann, J; Miethke, T; Lauten, M; Will, S; Merker, N; Hofmann, WK; Buchheidt, D				Spiess, Birgit; Postina, Patricia; Reinwald, Mark; Cornely, Oliver A.; Hamprecht, Axel; Hoenigl, Martin; Lass-Floerl, Cornelia; Rath, Peter-Michael; Steinmann, Joerg; Miethke, Thomas; Lauten, Melchior; Will, Silke; Merker, Natalia; Hofmann, Wolf-Karsten; Buchheidt, Dieter			Incidence of Cyp51 A Key Mutations in Aspergillus fumigatus-A Study on Primary Clinical Samples of Immunocompromised Patients in the Period of 1995-2013	PLOS ONE			English	Article							AZOLE RESISTANCE; TRIAZOLE RESISTANCE; INVASIVE ASPERGILLOSIS; ANTIFUNGAL RESISTANCE; CROSS-RESISTANCE; TR/L98H MUTATION; FRENCH COHORT; PREVALENCE; GUIDELINES; FREQUENCY	As the incidence of azole resistance in Aspergillus fumigatus is rising and the diagnosis of invasive aspergillosis (IA) in immunocompromised patients is rarely based on positive culture yield, we screened our Aspergillus DNA sample collection for the occurrence of azole resistance mediating cyp51 A key mutations. Using two established, a modified and a novel polymerase chain reaction (PCR) assays followed by DNA sequence analysis to detect the most frequent mutations in the A. fumigatus cyp51 A gene conferring azole resistance (TR34 (tandem repeat), L98H and M220 alterations). We analyzed two itraconazole and voriconazole and two multi-azole resistant clinical isolates and screened 181 DNA aliquots derived from clinical samples (blood, bronchoalveolar lavage (BAL), biopsies, cerebrospinal fluid (CSF)) of 155 immunocompromised patients of our Aspergillus DNA sample collection, previously tested positive for Aspergillus DNA and collected between 1995 and 2013. Using a novel PCR assay for the detection of the cyp51 A 46 bp tandem repeat (TR46) directly from clinical samples, we found the alteration in a TR46/Y121F/T289A positive clinical isolate. Fifty stored DNA aliquots from clinical samples were TR46 negative. DNA sequence analysis revealed a single L98H mutation in 2010, two times the L98H alteration combined with TR34 in 2011 and 2012 and a so far unknown N90K mutation in 1998. In addition, four clinical isolates were tested positive for the TR34/L98H combination in the year 2012. We consider our assay of epidemiological relevance to detect A. fumigatus azole resistance in culture-negative clinical samples of immunocompromised patients; a prospective study is ongoing.	[Spiess, Birgit; Postina, Patricia; Reinwald, Mark; Will, Silke; Merker, Natalia; Hofmann, Wolf-Karsten; Buchheidt, Dieter] Heidelberg Univ, Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany; [Cornely, Oliver A.] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Cornely, Oliver A.] ZKS Koln, BMBF 01KN1106, ZKS Koln, Clin Trials Ctr Cologne, Cologne, Germany; [Cornely, Oliver A.] Ctr Integrated Oncol CIO Koln Bonn, Cologne, Germany; [Cornely, Oliver A.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Hamprecht, Axel] Univ Hosp, Inst Med Microbiol Immunol & Hyg, Cologne, Germany; [Hoenigl, Martin] Graz Med Univ, Univ Hosp Internal Med, Sect Infect Dis & Trop Med, Graz, Austria; [Hoenigl, Martin] Graz Med Univ, Univ Hosp Internal Med, Dept Pulmonol, Graz, Austria; [Lass-Floerl, Cornelia] Med Univ Innsbruck, Sect Hyg & Med Microbiol, A-6020 Innsbruck, Austria; [Steinmann, Joerg] Univ Hosp, Inst Med Microbiol, Essen, Germany; [Miethke, Thomas] Univ Hosp, Inst Med Microbiol & Hyg, Mannheim, Germany; [Lauten, Melchior] Univ Hosp Schleswig Holstein, Lubeck, Germany	Ruprecht Karls University Heidelberg; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Medical University of Graz; Medical University of Graz; University of Duisburg Essen; Ruprecht Karls University Heidelberg; University of Kiel; Schleswig Holstein University Hospital	Spiess, B (corresponding author), Heidelberg Univ, Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany.	birgit.spiess@medma.uni-heidelberg.de	Hamprecht, Axel/R-4074-2018; Cornely, Oliver A./J-5095-2013; Hoenigl, Martin/E-8802-2010; Lass-Flörl, Cornelia/AAA-8449-2020	Hamprecht, Axel/0000-0003-1449-5780; Cornely, Oliver A./0000-0001-9599-3137; Hoenigl, Martin/0000-0002-1653-2824; Lass-Florl, Cornelia/0000-0002-2946-7785; Buchheidt, Dieter/0000-0002-4425-6134	German Cancer Aid/Dr. Mildred Scheel Foundation for Cancer Research [109 411]; GILEAD Sciences; Austrian Science Fund (FWF) [I 661, I 656] Funding Source: researchfish	German Cancer Aid/Dr. Mildred Scheel Foundation for Cancer Research; GILEAD Sciences(Gilead Sciences); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The development of the multi-azole resistance PCR assays was supported by a grant of the German Cancer Aid/Dr. Mildred Scheel Foundation for Cancer Research (Project 109 411). An ongoing multicenter prospective clinical study focusing the combined molecular and serologic diagnosis of invasive aspergillosis and multi-azole PCR based detection of cyp51 A alterations in Aspergillus DNA positive clinical samples is supported by a research grant of GILEAD Sciences (ClinicalTrials.gov Identifier: NCT01695512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanio A, 2011, J ANTIMICROB CHEMOTH, V66, P371, DOI 10.1093/jac/dkq450; Bader O, 2013, ANTIMICROB AGENTS CH, V57, P3513, DOI 10.1128/AAC.00167-13; Bueid A, 2010, J ANTIMICROB CHEMOTH, V65, P2116, DOI 10.1093/jac/dkq279; Chowdhary A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052871; Denning DW, 2011, CLIN INFECT DIS, V52, P1123, DOI 10.1093/cid/cir179; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2013, ANT AG BREAKP TABL I; Fischer J, 2014, J ANTIMICROB CH 0131; Garcia-Effron G, 2008, J CLIN MICROBIOL, V46, P1200, DOI 10.1128/JCM.02330-07; Hamprecht A, 2012, EUROSURVEILLANCE, V17, P9; Howard SJ, 2006, INT J ANTIMICROB AG, V28, P450, DOI 10.1016/j.ijantimicag.2006.08.017; Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043; Howard SJ, 2011, MED MYCOL, V49, pS90, DOI 10.3109/13693786.2010.508469; Klaassen CHW, 2010, J ANTIMICROB CHEMOTH, V65, P901, DOI 10.1093/jac/dkq041; Lass-Florl C, 2004, J CLIN MICROBIOL, V42, P4154, DOI 10.1128/JCM.42.9.4154-4157.2004; Lockhart SR, 2011, ANTIMICROB AGENTS CH, V55, P4465, DOI 10.1128/AAC.00185-11; Rodriguez-Tudela JL, 2008, ANTIMICROB AGENTS CH, V52, P2468, DOI 10.1128/AAC.00156-08; Maschmeyer G, 2009, EUR J CANCER, V45, P2462, DOI 10.1016/j.ejca.2009.05.001; Mellado E, 2007, ANTIMICROB AGENTS CH, V51, P1897, DOI 10.1128/AAC.01092-06; Mellado E, 2013, REV IBEROAM MICOL, V30, P64, DOI 10.1016/j.riam.2012.09.002; Morio F, 2012, J ANTIMICROB CHEMOTH, V67, P1870, DOI 10.1093/jac/dks160; Mortensen KL, 2011, J CLIN MICROBIOL, V49, P2243, DOI 10.1128/JCM.00213-11; Rath PM, 2012, ANTIMICROB AGENTS CH, V56, P6060, DOI 10.1128/AAC.01017-12; Reinwald M, 2013, J CLIN MICROBIOL, V51, P4178, DOI 10.1128/JCM.02387-13; Reinwald M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056706; Ruhnke M, 2012, ANN ONCOL, V23, P823, DOI 10.1093/annonc/mdr407; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Skladny H, 1999, J CLIN MICROBIOL, V37, P3865, DOI 10.1128/JCM.37.12.3865-3871.1999; Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219; Snelders E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031801; Spiess B, 2012, ANTIMICROB AGENTS CH, V56, P3905, DOI 10.1128/AAC.05902-11; van der Linden JWM, 2013, CLIN INFECT DIS, V57, P513, DOI 10.1093/cid/cit320; van der Linden JWM, 2011, EMERG INFECT DIS, V17, P1846, DOI 10.3201/eid1710.110226; van der Linden JWM, 2010, J CLIN MICROBIOL, V48, P1478, DOI 10.1128/JCM.02221-09; van der Linden JWM, 2009, CLIN INFECT DIS, V48, P1111, DOI 10.1086/597465; Verweij PE, 2007, NEW ENGL J MED, V356, P1481, DOI 10.1056/NEJMc061720; Verweij PE, 2009, DRUG RESIST UPDATE, V12, P141, DOI 10.1016/j.drup.2009.09.002; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258	37	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103113	10.1371/journal.pone.0103113	http://dx.doi.org/10.1371/journal.pone.0103113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072733	gold, Green Published			2022-12-25	WOS:000341307600024
J	Willner, D; Cohen-Yeshurun, A; Avidan, A; Ozersky, V; Shohami, E; Leker, RR				Willner, Dafna; Cohen-Yeshurun, Ayelet; Avidan, Alexander; Ozersky, Vladislav; Shohami, Esther; Leker, Ronen R.			Short Term Morphine Exposure In Vitro Alters Proliferation and Differentiation of Neural Progenitor Cells and Promotes Apoptosis via Mu Receptors	PLOS ONE			English	Article							ADULT-RAT HIPPOCAMPUS; OPIOID RECEPTORS; CEREBRAL-CORTEX; MOUSE-BRAIN; PYRAMIDAL NEURONS; NERVOUS-SYSTEM; DENTATE GYRUS; NEONATAL-RAT; RADIAL GLIA; GROWTH	Background: Chronic morphine treatment inhibits neural progenitor cell (NPC) progression and negatively effects hippocampal neurogenesis. However, the effect of acute opioid treatment on cell development and its influence on NPC differentiation and proliferation in vitro is unknown. We aim to investigate the effect of a single, short term exposure of morphine on the proliferation, differentiation and apoptosis of NPCs and the mechanism involved. Methods: Cell cultures from 14-day mouse embryos were exposed to different concentrations of morphine and its antagonist naloxone for 24 hours and proliferation, differentiation and apoptosis were studied. Proliferating cells were labeled with bromodeoxyuridine (BrdU) and cell fate was studied with immunocytochemistry. Results: Cells treated with morphine demonstrated decreased BrdU expression with increased morphine concentrations. Analysis of double-labeled cells showed a decrease in cells co-stained for BrdU with nestin and an increase in cells co-stained with BrdU and neuron-specific class III b-tubuline (TUJ1) in a dose dependent manner. Furthermore, a significant increase in caspase-3 activity was observed in the nestin-positive cells. Addition of naloxone to morphine-treated NPCs reversed the anti-proliferative and pro-apoptotic effects of morphine. Conclusions: Short term morphine exposure induced inhibition of NPC proliferation and increased active caspase-3 expression in a dose dependent manner. Morphine induces neuronal and glial differentiation and decreases the expression of nestin- positive cells. These effects were reversed with the addition of the opioid antagonist naloxone. Our results demonstrate the effects of short term morphine administration on the proliferation and differentiation of NPCs and imply a mu-receptor mechanism in the regulation of NPC survival.	[Willner, Dafna; Ozersky, Vladislav] Hadassah Hebrew Univ, Dept Anesthesia & Crit Care Med, Med Ctr, Jerusalem, Israel; [Cohen-Yeshurun, Ayelet; Shohami, Esther] Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, Dept Pharmacol, Jerusalem, Israel; [Avidan, Alexander] Hebrew Univ Jerusalem, Sch Med, Hadassah Hebrew Univ, Dept Anesthesia & Crit Care Med,Med Ctr, Jerusalem, Israel; [Leker, Ronen R.] Hebrew Univ Jerusalem, Sch Med, Hadassah Hebrew Univ Med Ctr, Dept Neurol,Peritz & Chantal Scheinberg Cerebrova, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem	Willner, D (corresponding author), Hadassah Hebrew Univ, Dept Anesthesia & Crit Care Med, Med Ctr, Jerusalem, Israel.	dr.dafna@gmail.com	Leker, Ronen/ABC-6096-2020	Leker, Ronen/0000-0003-4794-0334	Hadassah-Hebrew University Medical Center, Jerusalem, Israel [8017904]	Hadassah-Hebrew University Medical Center, Jerusalem, Israel	This work was funded by an intramural grant (# 8017904) from Hadassah-Hebrew University Medical Center, Jerusalem, Israel to Dr. Willner. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder's URL website is www.hadassah.org.il.	Ammon-Treiber S, 2005, NEUROPHARMACOLOGY, V49, P1160, DOI 10.1016/j.neuropharm.2005.06.016; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Arguello AA, 2008, NEUROSCIENCE, V157, P70, DOI 10.1016/j.neuroscience.2008.08.064; Arguello AA, 2009, NEUROSCIENCE, V159, P1003, DOI 10.1016/j.neuroscience.2009.01.020; Bajic D, 2013, INT J DEV NEUROSCI, V31, P258, DOI 10.1016/j.ijdevneu.2013.02.009; Barash PG, 2009, CLIN ANESTH, P435; Black AM, 2008, BRAIN RES, V1219, P136, DOI 10.1016/j.brainres.2008.04.066; Bramanti Vincenzo, 2010, Front Biosci (Schol Ed), V2, P558; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Cahill CM, 2001, J NEUROSCI, V21, P7598, DOI 10.1523/JNEUROSCI.21-19-07598.2001; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; DiMaggio C, 2012, J NEUROSURG ANESTH, V24, P376, DOI 10.1097/ANA.0b013e31826a038d; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; Drasner K, 2010, ANESTHESIOLOGY, V113, P10, DOI 10.1097/ALN.0b013e3181dcd8b3; Duhrsen L, 2013, NEONATOLOGY, V103, P35, DOI 10.1159/000341769; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Hahn JW, 2010, J NEUROCHEM, V112, P1431, DOI 10.1111/j.1471-4159.2009.06479.x; Hansen HH, 2004, NEUROBIOL DIS, V16, P440, DOI 10.1016/j.nbd.2004.03.013; Hauser KF, 2000, EUR J NEUROSCI, V12, P1281, DOI 10.1046/j.1460-9568.2000.01015.x; Hu SX, 2002, NEUROPHARMACOLOGY, V42, P829, DOI 10.1016/S0028-3908(02)00030-8; Hunt RW, 2008, EARLY HUM DEV, V84, P29, DOI 10.1016/j.earlhumdev.2007.01.013; Iglesias M, 2003, NEUROPHARMACOLOGY, V44, P482, DOI 10.1016/S0028-3908(03)00024-8; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kahn L, 2005, EUR J NEUROSCI, V21, P493, DOI 10.1111/j.1460-9568.2005.03883.x; Kaindl AM, 2008, MOL CELL PROTEOMICS, V7, P2293, DOI 10.1074/mcp.M800030-MCP200; Kim E, 2006, J BIOL CHEM, V281, P33749, DOI 10.1074/jbc.M603862200; Konijnenberg C, 2011, CHILD NEUROPSYCHOL, V17, P495, DOI 10.1080/09297049.2011.553591; Ma DQ, 2007, ANESTHESIOLOGY, V106, P746, DOI 10.1097/01.anes.0000264762.48920.80; Maharajan P, 2000, SYNAPSE, V35, P265, DOI 10.1002/(SICI)1098-2396(20000315)35:4<265::AID-SYN4>3.0.CO;2-6; MANSOUR A, 1994, J COMP NEUROL, V350, P412, DOI 10.1002/cne.903500307; Massa H, 2012, TOXICOL SCI, V130, P168, DOI 10.1093/toxsci/kfs234; MCDOWELL J, 1987, BRAIN RES REV, V12, P397, DOI 10.1016/0165-0173(87)90006-3; McPherson RJ, 2007, NEONATOLOGY, V92, P33, DOI 10.1159/000100084; Mei B, 2009, SYNAPSE, V63, P1154, DOI 10.1002/syn.20694; MERINEY SD, 1991, J NEUROSCI, V11, P3705; Ni Mhuireachtaigh R, 2006, J CLIN ANESTH, V18, P60, DOI 10.1016/j.jclinane.2004.11.009; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Emeterio EPS, 2006, J NEUROSCI RES, V83, P1352, DOI 10.1002/jnr.20812; Reznikov K, 1999, EUR J NEUROSCI, V11, P2711, DOI 10.1046/j.1460-9568.1999.00680.x; RIUS RA, 1991, DEV BRAIN RES, V58, P237, DOI 10.1016/0165-3806(91)90010-G; Roth KA, 2001, MENT RETARD DEV D R, V7, P261, DOI 10.1002/mrdd.1036; Sargeant TJ, 2008, J NEUROCHEM, V107, P883, DOI 10.1111/j.1471-4159.2008.05671.x; Sargeant TJ, 2007, BRAIN RES, V1175, P28, DOI 10.1016/j.brainres.2007.07.091; SEATRIZ JV, 1993, BRAIN RES BULL, V30, P523, DOI 10.1016/0361-9230(93)90078-P; Sen E, 2011, ASN NEURO, V3, DOI 10.1042/AN20100029; Sharm RK, 2008, BRAIN RES, V1243, P19, DOI 10.1016/j.brainres.2008.08.025; STIENEMARTIN A, 1991, DEV BRAIN RES, V60, P1, DOI 10.1016/0165-3806(91)90149-D; STIENEMARTIN A, 1993, DEV BRAIN RES, V76, P189, DOI 10.1016/0165-3806(93)90207-Q; Svensson AL, 2008, P NATL ACAD SCI USA, V105, P7304, DOI 10.1073/pnas.0802531105; Tripathi A, 2008, NEUROSCI RES, V61, P257, DOI 10.1016/j.neures.2008.03.002; van Dorp ELA, 2007, EXPERT OPIN DRUG SAF, V6, P125, DOI 10.1517/14740338.6.2.125; Westin BD, 2010, ANESTHESIOLOGY, V113, P183, DOI 10.1097/ALN.0b013e3181dcd6ec; ZAGON IS, 1983, SCIENCE, V221, P1179, DOI 10.1126/science.6612331; Zhang Y, 2008, NEUROSCIENTIST, V14, P561, DOI 10.1177/1073858408314434; Zhu YX, 1998, J NEUROSCI, V18, P2538	58	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103043	10.1371/journal.pone.0103043	http://dx.doi.org/10.1371/journal.pone.0103043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072277	Green Published, gold, Green Submitted			2022-12-25	WOS:000341307600019
J	Bailey, RR; Klaesner, JW; Lang, CE				Bailey, Ryan R.; Klaesner, Joseph W.; Lang, Catherine E.			An Accelerometry-Based Methodology for Assessment of Real-World Bilateral Upper Extremity Activity	PLOS ONE			English	Article							UPPER-LIMB-ACTIVITY; PHYSICAL-ACTIVITY; ARM ACTIVITY; ADULTS; VARIABILITY; PERFORMANCE; STROKE	Background: The use of both upper extremities (UE) is necessary for the completion of many everyday tasks. Few clinical assessments measure the abilities of the UEs to work together; rather, they assess unilateral function and compare it between affected and unaffected UEs. Furthermore, clinical assessments are unable to measure function that occurs in the real-world, outside the clinic. This study examines the validity of an innovative approach to assess real-world bilateral UE activity using accelerometry. Methods: Seventy-four neurologically intact adults completed ten tasks (donning/doffing shoes, grooming, stacking boxes, cutting playdough, folding towels, writing, unilateral sorting, bilateral sorting, unilateral typing, and bilateral typing) while wearing accelerometers on both wrists. Two variables, the Bilateral Magnitude and Magnitude Ratio, were derived from accelerometry data to distinguish between high-and low-intensity tasks, and between bilateral and unilateral tasks. Estimated energy expenditure and time spent in simultaneous UE activity for each task were also calculated. Results: The Bilateral Magnitude distinguished between high-and low-intensity tasks, and the Magnitude Ratio distinguished between unilateral and bilateral UE tasks. The Bilateral Magnitude was strongly correlated with estimated energy expenditure (p = 0.74, p<0.02), and the Magnitude Ratio was strongly correlated with time spent in simultaneous UE activity (p = 0.93, p<0.01) across tasks. Conclusions: These results demonstrate face validity and construct validity of this methodology to quantify bilateral UE activity during the performance of everyday tasks performed in a laboratory setting, and can now be used to assess bilateral UE activity in real-world environments.	[Bailey, Ryan R.] Washington Univ, Sch Med, Program Phys Therapy, St Louis, MO 63110 USA; [Klaesner, Joseph W.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Dept Biomed Engn,Program Phys Therapy, St Louis, MO 63110 USA; [Lang, Catherine E.] Washington Univ, Sch Med, Dept Neurol, Program Phys Therapy,Program Occupat Therapy, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Lang, CE (corresponding author), Washington Univ, Sch Med, Dept Neurol, Program Phys Therapy,Program Occupat Therapy, St Louis, MO 63110 USA.	langc@wustl.edu	Bailey, Ryan/L-5559-2013; Klaesner, Joseph/ABG-8087-2020	Bailey, Ryan/0000-0002-1662-1800; Lang, Catherine/0000-0002-7120-0136	National Institutes of Health [UL1 TR000448, TL1 TR000449, R01 HD068290]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068290] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000449, UL1TR000448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	National Institutes of Health UL1 TR000448 & TL1 TR000449 (RRB), R01 HD068290 (CEL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Bailey RR, 2013, J REHABIL RES DEV, V50, P1213, DOI 10.1682/JRRD.2012.12.0222; Bao L, 2004, LECT NOTES COMPUT SC, V3001, P1, DOI 10.1007/978-3-540-24646-6_1; Barreca Susan, 2004, Top Stroke Rehabil, V11, P31; BOROD JC, 1984, BRIT J PSYCHOL, V75, P177, DOI 10.1111/j.2044-8295.1984.tb01889.x; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Jobe JB, 2000, SCI SELF REPORT IMPL, P25; Lang CE, 2007, NEUROREHAB NEURAL RE, V21, P279, DOI 10.1177/1545968306296964; Lang CE, 2012, J HAND THER; Michielsen ME, 2012, ARCH PHYS MED REHAB, V93, P1975, DOI 10.1016/j.apmr.2012.03.016; Preece SJ, 2009, IEEE T BIO-MED ENG, V56, P871, DOI 10.1109/TBME.2008.2006190; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Rand D, 2010, AM J OCCUP THER, V64, P877, DOI 10.5014/ajot.2010.09043; Schasfoort FC, 2002, MED BIOL ENG COMPUT, V40, P173, DOI 10.1007/BF02348122; Slifkin AB, 1998, CURR DIR PSYCHOL SCI, V7, P170, DOI 10.1111/1467-8721.ep10836906; Staudenmayer J, 2009, J APPL PHYSIOL, V107, P1300, DOI 10.1152/japplphysiol.00465.2009; Steenhuis R E, 1999, Laterality, V4, P3, DOI 10.1080/135765099397079; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Uswatte G, 2000, STROKE, V31, P662, DOI 10.1161/01.STR.31.3.662; Uswatte G, 2006, ARCH PHYS MED REHAB, V87, P1340, DOI 10.1016/j.apmr.2006.06.006; van der Pas SC, 2011, ARCH PHYS MED REHAB, V92, P1437, DOI 10.1016/j.apmr.2011.02.021; Waller SM, 2008, NEUROREHABILITATION, V23, P29; Welk GJ, 2004, MED SCI SPORT EXER, V36, P1637, DOI 10.1249/01.MSS.0000074670.03001.98	26	80	80	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103135	10.1371/journal.pone.0103135	http://dx.doi.org/10.1371/journal.pone.0103135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068258	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993700038
J	Coderre, EL; van Heuven, WJB				Coderre, Emily L.; van Heuven, Walter J. B.			Electrophysiological Explorations of the Bilingual Advantage: Evidence from a Stroop Task	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; CONFLICT DETECTION; 2 LANGUAGES; EXECUTIVE CONTROL; TIME-COURSE; CONTROL MECHANISMS; RESPONSE CONFLICT; NEURAL MECHANISMS; NATIVE LANGUAGE	Bilinguals have been shown to exhibit a performance advantage on executive control tasks, outperforming their monolingual counterparts. Although a wealth of research has investigated this 'bilingual advantage' behaviourally, electrophysiological correlates are lacking. Using EEG with a Stroop task that manipulated the stimulus onset asynchrony (SOA) of word and colour presentation, the current study addressed two facets of the bilingual advantage. The possibility that bilinguals experience superior conflict processing relative to monolinguals (a 'conflict-specific advantage') was investigated by comparing behavioural interference effects as well as the amplitude of the N-inc, a conflict-related ERP component occurring from approximately 300-500 ms after the onset of conflict. In contrast, the hypothesis that bilinguals experience domain-general, conflict-independent enhancements in executive processing (a 'non-conflict-specific advantage') was evaluated by comparing the control condition (symbol strings) between groups. There was some significant, but inconsistent, evidence for a conflict-specific bilingual advantage. In contrast, strong evidence emerged for a non-conflict-specific advantage, with bilinguals demonstrating faster RTs and reduced ERP amplitudes on control trials compared to monolinguals. Importantly, when the control stimulus was presented before the colour, ERPs to control trials revealed group differences before the onset of conflict, suggesting differences in the ability to ignore or suppress distracting irrelevant information. This indicates that bilinguals experience superior executive processing even in the absence of conflict and semantic salience, and suggests that the advantage extends to more efficient proactive management of the environment.	[Coderre, Emily L.; van Heuven, Walter J. B.] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England	University of Nottingham	Coderre, EL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	ecoderr1@jhmi.edu	van Heuven, Walter J B/K-9034-2013	van Heuven, Walter J B/0000-0003-3183-4449; Coderre, Emily/0000-0002-2762-4994				Abutalebi J, 2012, CEREB CORTEX, V22, P2076, DOI 10.1093/cercor/bhr287; Dunabeitia JA, 2014, EXP PSYCHOL, V61, P234, DOI 10.1027/1618-3169/a000243; Appelbaum LG, 2009, CEREB CORTEX, V19, P2508, DOI 10.1093/cercor/bhp036; Appelbaum LG, 2012, J COGNITIVE NEUROSCI, V24, P1834, DOI 10.1162/jocn_a_00209; ARDAL S, 1990, BRAIN LANG, V39, P187, DOI 10.1016/0093-934X(90)90011-5; Badzakova-Trajkov G, 2009, BRAIN RES, V1253, P139, DOI 10.1016/j.brainres.2008.11.069; Bartholow BD, 2005, PSYCHOPHYSIOLOGY, V42, P33, DOI 10.1111/j.1469-8986.2005.00258.x; Bartolotti J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00324; Bialystok E, 2006, CAN J EXP PSYCHOL, V60, P68, DOI 10.1037/cjep2006008; Bialystok E, 2004, CHILD DEV, V75, P562, DOI 10.1111/j.1467-8624.2004.00693.x; Bialystok E, 2004, DEVELOPMENTAL SCI, V7, P325, DOI 10.1111/j.1467-7687.2004.00351.x; Bialystok E, 1999, CHILD DEV, V70, P636, DOI 10.1111/1467-8624.00046; Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290; Bialystok E, 2005, DEVELOPMENTAL SCI, V8, P595, DOI 10.1111/j.1467-7687.2005.00451.x; Bialystok E, 2005, NEUROIMAGE, V24, P40, DOI 10.1016/j.neuroimage.2004.09.044; Bialystok E, 2008, J EXP PSYCHOL LEARN, V34, P859, DOI 10.1037/0278-7393.34.4.859; Bialystok E, 2006, Q J EXP PSYCHOL, V59, P1968, DOI 10.1080/17470210500482955; Bialystok E, 2006, J EXP PSYCHOL LEARN, V32, P1341, DOI 10.1037/0278-7393.32.6.1341; Bialystok E, 2011, CAN J EXP PSYCHOL, V65, P229, DOI 10.1037/a0025406; Bialystok Ellen, 2009, Psychol Sci Public Interest, V10, P89, DOI 10.1177/1529100610387084; Bialystok E, 2010, DEV PSYCHOL, V46, P93, DOI 10.1037/a0015466; Bialystok E, 2009, BILING-LANG COGN, V12, P3, DOI 10.1017/S1366728908003477; Bialystok E, 2009, J EXP PSYCHOL HUMAN, V35, P565, DOI 10.1037/a0012735; Braet W, 2011, Q J EXP PSYCHOL, V64, P596, DOI 10.1080/17470218.2010.513735; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Brysbaert M, 2010, BILING-LANG COGN, V13, P359, DOI 10.1017/S1366728909990344; Carlson SM, 2008, DEVELOPMENTAL SCI, V11, P282, DOI 10.1111/j.1467-7687.2008.00675.x; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Chouiter L, 2014, BRAIN TOPOGR, V27, P279, DOI 10.1007/s10548-013-0303-0; Coderre E, 2011, BRAIN RES, V1413, P51, DOI 10.1016/j.brainres.2011.07.017; Coderre EL, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-79; Coderre EL, 2013, BILING-LANG COGN, V16, P420, DOI 10.1017/S1366728912000405; Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013; Costa A, 2014, NAT REV NEUROSCI, V15, P336, DOI 10.1038/nrn3709; Costa A, 2009, COGNITION, V113, P135, DOI 10.1016/j.cognition.2009.08.001; De Pisapia N, 2006, NEUROCOMPUTING, V69, P1322, DOI 10.1016/j.neucom.2005.12.100; Degani T, 2010, Q J EXP PSYCHOL, V63, P1266, DOI 10.1080/17470210903377372; Dell'Acqua R, 2007, PSYCHOPHYSIOLOGY, V44, P436, DOI 10.1111/j.1469-8986.2007.00514.x; Dijkstra T, 2002, BILING-LANG COGN, V5, P175, DOI 10.1017/S1366728902003012; DYER FN, 1973, J EXP PSYCHOL, V98, P438, DOI 10.1037/h0034353; DYER FN, 1971, PSYCHON SCI, V25, P229; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Elston-Guttler KE, 2005, J MEM LANG, V52, P256, DOI 10.1016/j.jml.2004.11.002; Garbin G, 2010, NEUROIMAGE, V53, P1272, DOI 10.1016/j.neuroimage.2010.05.078; GLASER MO, 1982, J EXP PSYCHOL HUMAN, V8, P875, DOI 10.1037/0096-1523.8.6.875; GLASER WR, 1989, J EXP PSYCHOL GEN, V118, P13, DOI 10.1037/0096-3445.118.1.13; Goetz P.J., 2003, BILING-LANG COGN, V6, P1, DOI [10.1017/S1366728903001007, DOI 10.1017/S1366728903001007]; Gollan TH, 2005, NEUROPSYCHOLOGY, V19, P278, DOI 10.1037/0894-4105.19.3.278; Gollan TH, 2005, MEM COGNITION, V33, P1220, DOI 10.3758/BF03193224; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Green D., 1998, BILING-LANG COGN, V1, P67, DOI [DOI 10.1017/S1366728998000133, 10.1017/S1366728998000133]; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Heidlmayr K, 2012, COGNITIVE NEUROSCIEN; Hernandez AE, 2006, BILING-LANG COGN, V9, P177, DOI 10.1017/S1366728906002525; Hernandez M, 2012, COGNITION, V122, P37, DOI 10.1016/j.cognition.2011.08.002; Hilchey MD, 2011, PSYCHON B REV, V18, P625, DOI 10.3758/s13423-011-0116-7; Holmes AJ, 2008, NEUROPSYCHOLOGIA, V46, P2904, DOI 10.1016/j.neuropsychologia.2008.05.028; Janse E, 2012, AGING NEUROPSYCHOL C, V19, P741, DOI 10.1080/13825585.2011.652590; Jesse A, 2012, LANG COGNITIVE PROC, V27, P1167, DOI 10.1080/01690965.2011.620335; Kousaie S, 2012, BRAIN RES, V1446, P71, DOI 10.1016/j.brainres.2012.01.052; Kroll JF, 2006, BILING-LANG COGN, V9, P119, DOI 10.1017/S1366728906002483; Kroll JF, 2012, PSYCHOL LEARN MOTIV, V56, P229, DOI 10.1016/B978-0-12-394393-4.00007-8; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Liu Y, 2003, HUM BRAIN MAPP, V18, P167, DOI 10.1002/hbm.10090; Luk G, 2010, BRAIN COGNITION, V74, P347, DOI 10.1016/j.bandc.2010.09.004; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Markela-Lerenc J, 2004, COGNITIVE BRAIN RES, V18, P278, DOI 10.1016/j.cogbrainres.2003.10.013; Martin CD, 2009, NEUROIMAGE, V47, P326, DOI 10.1016/j.neuroimage.2009.04.025; Martin-Rhee MM, 2008, BILING-LANG COGN, V11, P81, DOI 10.1017/S1366728907003227; Melara RD, 2008, BRAIN RES, V1215, P147, DOI 10.1016/j.brainres.2008.03.026; Midgley KJ, 2008, BRAIN RES, V1246, P123, DOI 10.1016/j.brainres.2008.09.078; Morales J, 2013, J COGN PSYCHOL, V25, P531, DOI 10.1080/20445911.2013.807812; Moreno EM, 2005, COGNITIVE BRAIN RES, V22, P205, DOI 10.1016/j.cogbrainres.2004.08.010; Moreno EM, 2008, J NEUROLINGUIST, V21, P477, DOI 10.1016/j.jneuroling.2008.01.003; Naylor LJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00081; Newman AJ, 2012, J COGNITIVE NEUROSCI, V24, P1205, DOI 10.1162/jocn_a_00143; Novick JM, 2009, COGN NEUROPSYCHOL, V26, P527, DOI 10.1080/02643290903519367; Novick JM, 2005, COGN AFFECT BEHAV NE, V5, P263, DOI 10.3758/CABN.5.3.263; Paap KR, 2013, COGNITIVE PSYCHOL, V66, P232, DOI 10.1016/j.cogpsych.2012.12.002; Phillips NA, 2004, J NEUROLINGUIST, V17, P237, DOI 10.1016/S0911-6044(03)00055-1; Phillips NA, 2006, BRAIN RES, V1125, P116, DOI 10.1016/j.brainres.2006.10.002; POULISSE N, 1994, APPL LINGUIST, V15, P36, DOI 10.1093/applin/15.1.36; Prior A, 2010, BILING-LANG COGN, V13, P253, DOI 10.1017/S1366728909990526; Proverbio AM, 2009, BIOL PSYCHOL, V80, P52, DOI 10.1016/j.biopsycho.2008.02.006; Pulvermuller F, 2001, EUR J NEUROSCI, V13, P201, DOI 10.1046/j.0953-816X.2000.01380.x; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rodriguez-Fornells A, 2005, J COGNITIVE NEUROSCI, V17, P422, DOI 10.1162/0898929053279559; Rodriguez-Fornells A, 2002, NATURE, V415, P1026, DOI 10.1038/4151026a; Runnqvist E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00379; Singh N, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00322; Singh N, 2012, BILING-LANG COGN, V15, P771, DOI 10.1017/S1366728912000065; SOARES C, 1984, MEM COGNITION, V12, P380, DOI 10.3758/BF03198298; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sumiya H, 2004, MEM COGNITION, V32, P752, DOI 10.3758/BF03195865; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Tao L, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00123; Thompson-Schill SL, 1998, J MEM LANG, V38, P440, DOI 10.1006/jmla.1997.2559; Tillman CM, 2011, PSYCHOPHYSIOLOGY, V48, P1405, DOI 10.1111/j.1469-8986.2011.01203.x; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104; van Hell JG, 2002, PSYCHON B REV, V9, P780, DOI 10.3758/BF03196335; van Heuven WJB, 2008, CEREB CORTEX, V18, P2706, DOI 10.1093/cercor/bhn030; van Heuven WJB, 2010, BRAIN RES REV, V64, P104, DOI 10.1016/j.brainresrev.2010.03.002; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; West R, 2000, BRAIN RES, V873, P102, DOI 10.1016/S0006-8993(00)02530-0; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; Ye Z, 2009, NEUROIMAGE, V48, P280, DOI 10.1016/j.neuroimage.2009.06.032; Zied KM, 2004, BRAIN COGNITION, V54, P254, DOI 10.1016/j.bandc.2004.02.036	112	32	32	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103424	10.1371/journal.pone.0103424	http://dx.doi.org/10.1371/journal.pone.0103424			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RZ	25068723	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700068
J	Vansteenkiste, P; Van Hamme, D; Veelaert, P; Philippaerts, R; Cardon, G; Lenoir, M				Vansteenkiste, Pieter; Van Hamme, David; Veelaert, Peter; Philippaerts, Renaat; Cardon, Greet; Lenoir, Matthieu			Cycling around a Curve: The Effect of Cycling Speed on Steering and Gaze Behavior	PLOS ONE			English	Article							EYE-MOVEMENTS; VISUAL CONTROL; BICYCLE; MODEL; INFORMATION; VEHICLE; VISION	Although it is generally accepted that visual information guides steering, it is still unclear whether a curvature matching strategy or a 'look where you are going' strategy is used while steering through a curved road. The current experiment investigated to what extent the existing models for curve driving also apply to cycling around a curve, and tested the influence of cycling speed on steering and gaze behavior. Twenty-five participants were asked to cycle through a semicircular lane three consecutive times at three different speeds while staying in the center of the lane. The observed steering behavior suggests that an anticipatory steering strategy was used at curve entrance and a compensatory strategy was used to steer through the actual bend of the curve. A shift of gaze from the center to the inside edge of the lane indicates that at low cycling speed, the 'look where you are going' strategy was preferred, while at higher cycling speeds participants seemed to prefer the curvature matching strategy. Authors suggest that visual information from both steering strategies contributes to the steering system and can be used in a flexible way. Based on a familiarization effect, it can be assumed that steering is not only guided by vision but that a short-term learning component should also be taken into account.	[Vansteenkiste, Pieter; Philippaerts, Renaat; Cardon, Greet; Lenoir, Matthieu] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium; [Van Hamme, David; Veelaert, Peter] Univ Ghent, Dept Telecommun & Informat Proc, B-9000 Ghent, Belgium	Ghent University; Ghent University	Vansteenkiste, P (corresponding author), Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium.	pieter.vansteenkiste@ugent.be	vansteenkiste, pieter/ABE-7819-2021	vansteenkiste, pieter/0000-0001-5053-6864; Van Hamme, David/0000-0003-2112-3475; Cardon, Greet/0000-0003-4983-6557	life line campaign of the Research Foundation of Flanders (FWO) [FWO G.A115.11N]	life line campaign of the Research Foundation of Flanders (FWO)	This research was supported by the life line campaign of the Research Foundation of Flanders (FWO) FWO G.A115.11N http://www.fwo.be/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSAIANTE C, 1992, HUM MOVEMENT SCI, V11, P533, DOI 10.1016/0167-9457(92)90014-3; Authie CN, 2011, VISION RES, V51, P1791, DOI 10.1016/j.visres.2011.06.010; Boer ER, 1996, PROCEEDINGS OF THE 1996 IEEE INTELLIGENT VEHICLES SYMPOSIUM, P7, DOI 10.1109/IVS.1996.566341; Chattington M, 2007, EXP BRAIN RES, V180, P1, DOI 10.1007/s00221-006-0839-2; Chatziastros A, 1999, EFFECT FIELD VIEW SU; Cloete S, 2011, EXP BRAIN RES, V208, P475, DOI 10.1007/s00221-010-2530-x; Coutton-Jean C, 2009, TRANSPORT RES F-TRAF, V12, P483, DOI 10.1016/j.trf.2009.04.006; DONGES E, 1978, HUM FACTORS, V20, P691, DOI 10.1177/001872087802000607; Frissen I, 2014, Q J EXP PSYCHOL, V67, P499, DOI 10.1080/17470218.2013.819518; GAWRON VJ, 1990, APPL ERGON, V21, P33, DOI 10.1016/0003-6870(90)90071-5; GODTHELP H, 1986, HUM FACTORS, V28, P211, DOI 10.1177/001872088602800209; Hatzitaki V, 2002, J MOTOR BEHAV, V34, P161, DOI 10.1080/00222890209601938; Hollands MA, 2002, EXP BRAIN RES, V143, P221, DOI 10.1007/s00221-001-0983-7; Kandil FI, 2010, J VISION, V10, DOI 10.1167/10.4.24; Kandil FI, 2009, J VISION, V9, DOI 10.1167/9.1.11; Kountouriotis GK, 2012, J EXP PSYCHOL HUMAN, V38, P687, DOI 10.1037/a0026123; LAND M, 1995, NATURE, V377, P339, DOI 10.1038/377339a0; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Lappi O., 2013, EYES ROAD EYE MOVEME; Lappi O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068326; Lehtonen E, 2012, TRANSPORT RES F-TRAF, V15, P369, DOI 10.1016/j.trf.2011.08.007; Marigold DS, 2007, NEUROSCIENCE, V144, P302, DOI 10.1016/j.neuroscience.2006.09.006; Marple-Horvat DE, 2005, EXP BRAIN RES, V163, P411, DOI 10.1007/s00221-004-2192-7; Mars F, 2008, J VISION, V8, DOI 10.1167/8.11.10; MCRUER DT, 1977, HUM FACTORS, V19, P381, DOI 10.1177/001872087701900406; Newell K.M., 1986, MOTOR DEV CHILDREN A, VVolume 34, P341, DOI DOI 10.1007/978-94-009-4460-2_19; Patla AE, 1997, NEUROREPORT, V8, P3661, DOI 10.1097/00001756-199712010-00002; Pelz Jeff B., 2007, P661, DOI 10.1016/B978-008044980-7/50033-1; Reymond G, 2001, HUM FACTORS, V43, P483, DOI 10.1518/001872001775898188; Robertshaw KD, 2008, J VISION, V8, DOI 10.1167/8.4.18; Salvucci DD, 2004, PERCEPTION, V33, P1233, DOI 10.1068/p5343; Schepers P, 2011, ERGONOMICS, V54, P315, DOI 10.1080/00140139.2011.558633; Schwab AL, 2012, VEHICLE SYST DYN, V50, P1209, DOI 10.1080/00423114.2011.610898; SensoMotoric Instruments, 2012, BEGAZE MAN VERS 3 1; SHINAR D, 1977, HUM FACTORS, V19, P63, DOI 10.1177/001872087701900107; Tresilian J., 2012, SENSORIMOTOR CONTROL; Van Hamme D, 2011, IEEE INT VEH SYM, P643, DOI 10.1109/IVS.2011.5940453; Vansteenkiste P, 2014, ERGONOMICS IN PRESS; Vansteenkiste P, 2014, TRANSPORT RES F-TRAF, V23, P81, DOI 10.1016/j.trf.2013.12.019; Vansteenkiste P, 2013, ACCIDENT ANAL PREV, V51, P222, DOI 10.1016/j.aap.2012.11.025; Wann JP, 2000, NAT NEUROSCI, V3, P647, DOI 10.1038/76602; Wilkie RM, 2010, EXP BRAIN RES, V204, P539, DOI 10.1007/s00221-010-2321-4; Wilkie RM, 2008, J EXP PSYCHOL HUMAN, V34, P1150, DOI 10.1037/0096-1523.34.5.1150; Wilkie RM, 2003, J VISION, V3, P677, DOI 10.1167/3.11.3; Wilkie RM, 2005, J EXP PSYCHOL HUMAN, V31, P901, DOI 10.1037/0096-1523.31.5.901; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	46	20	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102792	10.1371/journal.pone.0102792	http://dx.doi.org/10.1371/journal.pone.0102792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RZ	25068380	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700019
J	White, SR; Floreth, T; Liao, CH; Bhorade, SM				White, Steven R.; Floreth, Timothy; Liao, Chuanhong; Bhorade, Sangeeta M.			Association of Soluble HLA-G with Acute Rejection Episodes and Early Development of Bronchiolitis Obliterans in Lung Transplantation	PLOS ONE			English	Article							LEUKOCYTE ANTIGEN-G; REGULATORY T-CELLS; BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; CLASS-I MOLECULES; G EXPRESSION; HEART-TRANSPLANTATION; MYELOMONOCYTIC CELLS; INHIBITORY RECEPTOR; POLYMORPHISM	Lung transplantation has evolved into a life-saving therapy for select patients with end age lung diseases. However, longterm survival remains limited because of bronchiolitis obliterans syndrome (BOS). Soluble HLA-G, a mediator of adaptive immunity that modulates regulatory T cells and certain classes of effector T cells, may be a useful marker of survival free of BOS. We conducted a retrospective, single-center, pilot review of 38 lung transplant recipients who underwent collection of rum and bronchoalveolar lavage fluid 3, 6 and 12 months after transplantation, and compared soluble HLA-G concentrations in each to the presence of type A rejection and lymphocytic bronchiolitis in the first 12 months and to the presence of BOS at 24 months after transplantation. Lung soluble HLA-G concentrations were directly related to the presence of type A rejection but not to lymphocytic bronchiolitis. Our data demonstrate that soluble HLA-G concentration bronchoalveolar lavage but not in serum correlates with the number of acute rejection episodes in the first 12 months lung transplantation, and thus may be a reactive marker of rejection	[White, Steven R.; Floreth, Timothy; Liao, Chuanhong] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [White, Steven R.; Floreth, Timothy; Liao, Chuanhong] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Bhorade, Sangeeta M.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA	University of Chicago; University of Chicago; Northwestern University	White, SR (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	swhite@medicine.bsd.uchicago.edu			NHLBI (National Heart, Lung and Blood Institute) [HL-083527]; NIAID (National Institute of Allergy and Infectious Diseases) [AI-095230]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL083527, R43HL083527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083527, U19AI095230] Funding Source: NIH RePORTER	NHLBI (National Heart, Lung and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by HL-083527 by NHLBI (National Heart, Lung and Blood Institute) and AI-095230 by NIAID (National Institute of Allergy and Infectious Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDO K, 1995, J THORAC CARDIOV SUR, V110, P4, DOI 10.1016/S0022-5223(05)80003-0; Basturk B, 2006, TRANSPL P, V38, P571, DOI 10.1016/j.transproceed.2005.12.108; Bhorade SM, 2010, TRANSPLANTATION, V90, P540, DOI 10.1097/TP.0b013e3181e8dabe; Brugiere O, 2009, AM J TRANSPLANT, V9, P1427, DOI 10.1111/j.1600-6143.2009.02650.x; Christie JD, 2008, J HEART LUNG TRANSPL, V27, P957, DOI 10.1016/j.healun.2008.07.018; Colonna M, 1998, J IMMUNOL, V160, P3096; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Contini P, 2003, EUR J IMMUNOL, V33, P125, DOI 10.1002/immu.200390015; Hicheri Y, 2008, J IMMUNOTHER, V31, P806, DOI 10.1097/CJI.0b013e318184908d; Holtzman MJ, 2011, CURR OPIN IMMUNOL, V23, P487, DOI 10.1016/j.coi.2011.05.010; ISHITANI A, 1992, P NATL ACAD SCI USA, V89, P3947, DOI 10.1073/pnas.89.9.3947; La Nasa G, 2007, BRIT J HAEMATOL, V139, P284, DOI 10.1111/j.1365-2141.2007.06779.x; Le Rond S, 2006, J IMMUNOL, V176, P3266, DOI 10.4049/jimmunol.176.5.3266; LeMaoult J, 2004, P NATL ACAD SCI USA, V101, P7064, DOI 10.1073/pnas.0401922101; Lila N, 2002, CIRCULATION, V105, P1949, DOI 10.1161/01.CIR.0000015075.89984.46; Lila N, 2001, P NATL ACAD SCI USA, V98, P12150, DOI 10.1073/pnas.201407398; Luque J, 2006, HUM IMMUNOL, V67, P257, DOI 10.1016/j.humimm.2006.02.034; Naji A, 2007, BLOOD, V110, P3936, DOI 10.1182/blood-2007-04-083139; Nicolae D, 2005, AM J HUM GENET, V76, P349, DOI 10.1086/427763; Noel G, 2008, CLIN IMMUNOL, V129, P241, DOI 10.1016/j.clim.2008.07.019; Pangault C, 2002, HUM IMMUNOL, V63, P83, DOI 10.1016/S0198-8859(01)00373-1; Piancatelli D, 2009, TRANSPL P, V41, P1187, DOI 10.1016/j.transproceed.2009.03.028; Pirri A, 2009, TRANSPL IMMUNOL, V20, P143, DOI 10.1016/j.trim.2008.09.012; Qiu J, 2006, AM J TRANSPLANT, V6, P2152, DOI 10.1111/j.1600-6143.2006.01417.x; Rezvani K, 2006, BLOOD, V108, P1291, DOI 10.1182/blood-2006-02-003996; Riteau B, 2001, J IMMUNOL, V166, P5018, DOI 10.4049/jimmunol.166.8.5018; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Stewart S, 2007, J HEART LUNG TRANSPL, V26, P1229, DOI 10.1016/j.healun.2007.10.017; Todd JL, 2011, CHEST, V140, P502, DOI 10.1378/chest.10-2838	29	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103643	10.1371/journal.pone.0103643	http://dx.doi.org/10.1371/journal.pone.0103643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068264	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993700082
J	Hasbi, A; Perreault, ML; Shen, MYF; Zhang, L; To, R; Fan, T; Nguyen, T; Ji, XD; O'Dowd, BF; George, SR				Hasbi, Ahmed; Perreault, Melissa L.; Shen, Maurice Y. F.; Zhang, Lucia; To, Ryan; Fan, Theresa; Tuan Nguyen; Ji, Xiaodong; O'Dowd, Brian F.; George, Susan R.			A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism	FASEB JOURNAL			English	Article						GPCR oligomerization; heterooligomer; depression; behavioral despair	MEDIATED CALCIUM SIGNAL; D2 RECEPTOR; ELECTROSTATIC INTERACTIONS; D-1; D1; OLIGOMERIZATION; PHARMACOLOGY; ACTIVATION; OCCUPANCY; COMPLEXES	Although the dopamine D1-D2 receptor heteromer has emerging physiological relevance and a postulated role in different neuropsychiatric disorders, such as drug addiction, depression, and schizophrenia, there is a need for pharmacological tools that selectively target such receptor complexes in order to analyze their biological and pathophysiological functions. Since no selective antagonists for the D1-D2 heteromer are available, serial deletions and point mutations were used to precisely identify the amino acids involved in an interaction interface between the receptors, residing within the carboxyl tail of the D1 receptor that interacted with the D2 receptor to form the D1-D2 receptor heteromer. It was determined that D1 receptor carboxyl tail residues (404)Glu and (405)Glu were critical in mediating the interaction with the D2 receptor. Isolated mutation of these residues in the D1 receptor resulted in the loss of agonist activation of the calcium signaling pathway mediated through the D1-D2 receptor heteromer. The physical interaction between the D1 and D2 receptor could be disrupted, as shown by coimmunoprecipitation and BRET analysis, by a small peptide generated from the D1 receptor sequence that contained these amino acids, leading to a switch in G-protein affinities and loss of calcium signaling, resulting in the inhibition of D1-D2 heteromer function. The use of the D1-D2 heteromer-disrupting peptide in vivo revealed a pathophysiological role for the D1-D2 heteromer in the modulation of behavioral despair. This peptide may represent a novel pharmacological tool with potential therapeutic benefits in depression treatment.Hasbi, A., Perreault, M. L., Shen, M. Y. F., Zhang, L., To, R., Fan, T., Nguyen, T., Ji, X., O'Dowd, B. F., George, S. R. A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism.	[Hasbi, Ahmed; Perreault, Melissa L.; Shen, Maurice Y. F.; Fan, Theresa; Tuan Nguyen; O'Dowd, Brian F.; George, Susan R.] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Hasbi, Ahmed; Perreault, Melissa L.; Shen, Maurice Y. F.; Zhang, Lucia; To, Ryan; Fan, Theresa; Tuan Nguyen; Ji, Xiaodong; O'Dowd, Brian F.; George, Susan R.] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada; [George, Susan R.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto	George, SR (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, Med Sci Bldg,1 Kings Coll Cir, Toronto, ON M5S 1A8, Canada.	s.george@utoronto.ca	George, Susan R/P-9669-2018; George, Susan/W-7494-2019; Perreault, Melissa L/N-2867-2017	Perreault, Melissa L/0000-0002-5775-8950	U.S. National Institutes of Health, National Institute on Drug Abuse [DA007223]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007223] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the U.S. National Institutes of Health, National Institute on Drug Abuse (DA007223). S.R.G. is the holder of a Tier 1 Canada Research Chair in Molecular Neuroscience. The authors declare no conflicts of interest..	Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; Andringa G, 1999, EUR J PHARMACOL, V364, P33, DOI 10.1016/S0014-2999(98)00825-5; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Chun LS, 2013, MOL PHARMACOL, V84, P190, DOI 10.1124/mol.113.085175; Ciruela F, 2004, ANAL CHEM, V76, P5354, DOI 10.1021/ac049295f; DEVENEY AM, 1995, BRIT J PHARMACOL, V116, P2120, DOI 10.1111/j.1476-5381.1995.tb16420.x; Fuxe K, 2009, J ACUPUNCT MERIDIAN, V2, P1, DOI 10.1016/S2005-2901(09)60011-X; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; George Susan R, 2007, ScientificWorldJournal, V7, P58; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Hasbi A, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-26; Hasbi A, 2010, CURR OPIN PHARMACOL, V10, P93, DOI 10.1016/j.coph.2009.09.011; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Jackson SN, 2009, J AM SOC MASS SPECTR, V20, P176, DOI 10.1016/j.jasms.2008.08.021; Jackson SN, 2005, J PROTEOME RES, V4, P2360, DOI 10.1021/pr050261d; Jin LQ, 2003, J NEUROCHEM, V85, P378, DOI 10.1046/j.1471-4159.2003.01698.x; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Lee SP, 2003, BIOCHEMISTRY-US, V42, P11023, DOI 10.1021/bi0345539; Lukasiewicz S, 2009, FEBS J, V276, P760, DOI 10.1111/j.1742-4658.2008.06822.x; Maggio R, 2009, PARKINSONISM RELAT D, V15, pS2, DOI 10.1016/S1353-8020(09)70826-0; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Navarro G, 2010, J BIOL CHEM, V285, P27346, DOI 10.1074/jbc.M110.115634; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Ng J, 2010, NEUROSCIENCE, V165, P535, DOI 10.1016/j.neuroscience.2009.10.017; O'Dowd BF, 2013, BIOCHEM BIOPH RES CO, V431, P586, DOI 10.1016/j.bbrc.2012.12.139; O'Dowd BF, 2012, BIOCHEM BIOPH RES CO, V417, P23, DOI 10.1016/j.bbrc.2011.11.027; O'Dowd BF, 2011, EUR J PHARMACOL, V658, P74, DOI 10.1016/j.ejphar.2011.02.030; Pei L, 2010, NAT MED, V16, P1393, DOI 10.1038/nm.2263; Perreault ML, 2014, NEUROPSYCHOPHARMACOL, V39, P156, DOI 10.1038/npp.2013.148; Perreault ML, 2013, INT J NEUROPSYCHOPH, V16, P477, DOI 10.1017/S1461145712000685; Perreault ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033348; Perreault ML, 2010, J BIOL CHEM, V285, P36625, DOI 10.1074/jbc.M110.159954; Rapoport M, 2009, EXPERT OPIN DRUG DEL, V6, P453, DOI [10.1517/17425240902887029, 10.1517/17425240902887029 ]; Rashid AJ, 2007, TRENDS PHARMACOL SCI, V28, P551, DOI 10.1016/j.tips.2007.10.001; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; So CH, 2007, MOL PHARMACOL, V72, P450, DOI 10.1124/mol.107.034884; Verma V, 2010, J BIOL CHEM, V285, P35092, DOI 10.1074/jbc.M109.088625; Woods AS, 2004, J PROTEOME RES, V3, P478, DOI 10.1021/pr034091l	39	40	41	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4806	4820		10.1096/fj.14-254037	http://dx.doi.org/10.1096/fj.14-254037			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25063849	Green Published			2022-12-25	WOS:000344050900019
J	Zhou, W; Ding, WL; Zeng, XL; Dong, LL; Zhao, B; Zhou, M; Scheer, H; Zhao, KH; Yang, XJ				Zhou, Wei; Ding, Wen-Long; Zeng, Xiao-Li; Dong, Liang-Liang; Zhao, Bin; Zhou, Ming; Scheer, Hugo; Zhao, Kai-Hong; Yang, Xiaojing			Structure and Mechanism of the Phycobiliprotein Lyase CpcT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE-MEMBRANE LINKER; CHROMOPHORE ATTACHMENT; BILIN LYASE; FREMYELLA-DIPLOSIPHON; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURE; C-PHYCOCYANIN; PROTEIN; BINDING; PHYCOVIOLOBILIN	Pigmentation of light-harvesting phycobiliproteins of cyanobacteria requires covalent attachment of open-chain tetrapyrroles, bilins, to the apoproteins. Thioether formation via addition of a cysteine residue to the 3-ethylidene substituent of bilins is mediated by lyases. T-type lyases are responsible for attachment to Cys-155 of phycobiliprotein beta-subunits. We present crystal structures of CpcT (All5339) from Nostoc (Anabaena) sp. PCC7120 and its complex with phycocyanobilin at 1.95 and 2.50 angstrom resoluti, respectively. CpcT forms a dimer and adopts a calyx-shaped beta-barrel fold. Although the overall structure of CpcT is largely retained upon chromophore binding, arginine residues at the opening of the binding pocket undergo major rotameric rearrangements anchoring the propionate groups of phycocyanobilin. Based on the structure and mutational analysis, a reaction mechanism is proposed that accounts for chromophore stabilization and regio- and stereospecificity of the addition reaction. At the dimer interface, a loop extending from one subunit partially shields the opening of the phycocyanobilin binding pocket in the other subunit. Deletion of the loop or disruptions of the dimer interface significantly reduce CpcT lyase activity, suggesting functional relevance of the dimer. Dimerization is further enhanced by chromophore binding. The chromophore is largely buried in the dimer, but in the monomer, the 3-ethylidene group is accessible for the apophycobili-protein, preferentially from the chromophore beta-side. Asp-163 and Tyr-65 at the beta- and beta-face near the E-configured ethylidene group, respectively, support the acid-catalyzed nucleo-philic Michael addition of cysteine 155 of the apoprotein to an N-acylimmonium intermediate proposed by Grubmayr and Wagner (Grubmayr, K., and Wagner, U. G. (1988) Monatsh. Chem. 119, 965-983).	[Zhou, Wei; Ding, Wen-Long; Zeng, Xiao-Li; Dong, Liang-Liang; Zhao, Bin; Zhou, Ming; Zhao, Kai-Hong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Scheer, Hugo] Univ Munich, Dept Biol 1, D-80638 Munich, Germany; [Yang, Xiaojing] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Yang, Xiaojing] Univ Illinois, Dept Chem, Chicago, IL 60607 USA	Huazhong Agricultural University; University of Munich; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhao, KH (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	khzhao@163.com; xiaojing@uic.edu		Zeng, Xiaoli/0000-0001-7616-0535	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL EYE INSTITUTE [R01EY024363] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adir N, 2002, BBA-BIOENERGETICS, V1556, P168, DOI 10.1016/S0005-2728(02)00359-6; Alvey RM, 2011, BIOCHEMISTRY-US, V50, P4890, DOI 10.1021/bi200307s; Biswas A, 2011, J BIOL CHEM, V286, P35509, DOI 10.1074/jbc.M111.284281; Biswas A, 2010, APPL ENVIRON MICROB, V76, P2729, DOI 10.1128/AEM.03100-09; Bohm S, 2007, J BIOL CHEM, V282, P25357, DOI 10.1074/jbc.M702669200; Bolte K, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-56; BONNETT R, 1978, PROC R SOC SER B-BIO, V202, P249, DOI 10.1098/rspb.1978.0066; BONNETT R, 1976, NATURE, V262, P326, DOI 10.1038/262326a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRASLAVSKY SE, 1983, ANGEW CHEM INT EDIT, V22, P656, DOI 10.1002/anie.198306561; Bretaudeau A, 2013, NUCLEIC ACIDS RES, V41, pD396, DOI 10.1093/nar/gks1091; Brockmann H., 1978, PORPHYRINS, P288; David L, 2011, J MOL BIOL, V405, P201, DOI 10.1016/j.jmb.2010.10.036; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; DUERRING M, 1991, J MOL BIOL, V217, P577, DOI 10.1016/0022-2836(91)90759-Y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; Falk H., 1989, CHEM LINEAR OLIGOPYR; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Gantt E., 2003, LIGHT HARVESTING ANT, P307, DOI DOI 10.1007/978-94-017-2087-8_10; GLAZER AN, 1984, BIOCHIM BIOPHYS ACTA, V768, P29, DOI 10.1016/0304-4173(84)90006-5; Go YM, 2013, CRIT REV BIOCHEM MOL, V48, P173, DOI 10.3109/10409238.2013.764840; Grossman AR, 1995, ANNU REV GENET, V29, P231, DOI 10.1146/annurev.ge.29.120195.001311; GRUBMAYR K, 1988, MONATSH CHEM, V119, P965, DOI 10.1007/BF00810106; HAIDL E, 1985, J CHEM SOC PERK T 2, P421, DOI 10.1039/p29850000421; HOLDEN HM, 1987, EMBO J, V6, P1565, DOI 10.1002/j.1460-2075.1987.tb02401.x; HUBER R, 1987, J MOL BIOL, V198, P499, DOI 10.1016/0022-2836(87)90296-8; Ishizuka T, 2007, PLANT CELL PHYSIOL, V48, P1385, DOI 10.1093/pcp/pcm106; Ishizuka T, 2011, BIOCHEMISTRY-US, V50, P953, DOI 10.1021/bi101626t; Korndorfer IP, 2003, J MOL BIOL, V330, P385, DOI 10.1016/S0022-2836(03)00573-4; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kronfel CM, 2013, BIOCHEMISTRY-US, V52, P8663, DOI 10.1021/bi401192z; Kumagai A, 2013, CELL, V153, P1602, DOI 10.1016/j.cell.2013.05.038; Kupka M, 2009, J BIOL CHEM, V284, P36405, DOI 10.1074/jbc.M109.056382; Lehner H., 1979, LIEBIGS ANN CHEM, V1979, P1798; Muller K, 2013, CHEM COMMUN, V49, P8970, DOI 10.1039/c3cc45065a; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overkamp KE, 2014, J BIOL CHEM, V289, P26691, DOI 10.1074/jbc.M114.591131; PERSON RV, 1994, J AM CHEM SOC, V116, P42, DOI 10.1021/ja00080a006; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P1449, DOI 10.1021/bi201783j; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHEER H, 1976, Z NATURFORSCH C, V31, P413; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Scheer H., 1982, LIGHT REACTION PATH, P7; SCHIRMER T, 1987, J MOL BIOL, V196, P677, DOI 10.1016/0022-2836(87)90040-4; Schluchter W. M., 1999, PHOTOTROPHIC PROKARY, P83; Schluchter WM, 2010, ADV EXP MED BIOL, V675, P211, DOI 10.1007/978-1-4419-1528-3_12; Schultz LW, 2005, P NATL ACAD SCI USA, V102, P1378, DOI 10.1073/pnas.0409335102; Schuster-Bockler B, 2005, BIOINFORMATICS, V21, P2912, DOI 10.1093/bioinformatics/bti434; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139; Skerra A, 2008, FEBS J, V275, P2677, DOI 10.1111/j.1742-4658.2008.06439.x; Storf M, 2001, BIOCHEMISTRY-US, V40, P12444, DOI 10.1021/bi010776s; Tang K, 2012, BBA-BIOENERGETICS, V1817, P1030, DOI 10.1016/j.bbabio.2012.03.018; Tu JM, 2008, PHOTOSYNTH RES, V95, P163, DOI 10.1007/s11120-007-9251-4; Tu JM, 2009, J AM CHEM SOC, V131, P5399, DOI 10.1021/ja9002348; Vopel S, 2005, BIOL CHEM, V386, P1097, DOI 10.1515/BC.2005.126; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang J, 2012, GENE, V511, P88, DOI 10.1016/j.gene.2012.09.004; Zhao KH, 2007, J BIOL CHEM, V282, P34093, DOI 10.1074/jbc.M703038200; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200; Zhao KH, 2006, FEBS J, V273, P1262, DOI 10.1111/j.1742-4658.2006.05149.x; Zhao KH, 2005, BIOCHEMISTRY-US, V44, P8126, DOI 10.1021/bi0500168; Zhao KH, 2005, BBA-BIOENERGETICS, V1706, P81, DOI 10.1016/j.bbabio.2004.09.008; Zhao KH, 2000, FEBS LETT, V469, P9, DOI 10.1016/S0014-5793(00)01245-X	68	26	28	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26677	26689		10.1074/jbc.M114.586743	http://dx.doi.org/10.1074/jbc.M114.586743			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25074932	Green Published, hybrid			2022-12-25	WOS:000342853900002
J	Guerriero, G; Legay, S; Hausman, JF				Guerriero, Gea; Legay, Sylvain; Hausman, Jean-Francois			Alfalfa Cellulose Synthase Gene Expression under Abiotic Stress: A Hitchhiker's Guide to RT-qPCR Normalization	PLOS ONE			English	Article							REAL-TIME PCR; WALL INTEGRITY MAINTENANCE; SUITABLE REFERENCE GENES; PHENOTYPIC PLASTICITY; NORMAL GROWTH; CELL; SELECTION; PLANTS; HEAT; TOLERANCE	Abiotic stress represents a serious threat affecting both plant fitness and productivity. One of the promptest responses that plants trigger following abiotic stress is the differential expression of key genes, which enable to face the adverse conditions. It is accepted and shown that the cell wall senses and broadcasts the stress signal to the interior of the cell, by triggering a cascade of reactions leading to resistance. Therefore the study of wall-related genes is particularly relevant to understand the metabolic remodeling triggered by plants in response to exogenous stresses. Despite the agricultural and economical relevance of alfalfa (Medicago sativa L.), no study, to our knowledge, has addressed specifically the wall-related gene expression changes in response to exogenous stresses in this important crop, by monitoring the dynamics of wall biosynthetic gene expression. We here identify and analyze the expression profiles of nine cellulose synthases, together with other wall-related genes, in stems of alfalfa plants subjected to different abiotic stresses (cold, heat, salt stress) at various time points (e. g. 0, 24, 72 and 96 h). We identify 2 main responses for specific groups of genes, i.e. a salt/heat-induced and a cold/heat-repressed group of genes. Prior to this analysis we identified appropriate reference genes for expression analyses in alfalfa, by evaluating the stability of 10 candidates across different tissues (namely leaves, stems, roots), under the different abiotic stresses and time points chosen. The results obtained confirm an active role played by the cell wall in response to exogenous stimuli and constitute a step forward in delineating the complex pathways regulating the response of plants to abiotic stresses.	[Guerriero, Gea; Legay, Sylvain; Hausman, Jean-Francois] Ctr Rech Publ, Dept Environm & Agrobiotechnol EVA, Gabriel Lippmann, Belvaux, Luxembourg	Luxembourg Institute of Health; Luxembourg Institute of Science & Technology	Guerriero, G (corresponding author), Ctr Rech Publ, Dept Environm & Agrobiotechnol EVA, Gabriel Lippmann, Belvaux, Luxembourg.	guerrier@lippmann.lu	Guerriero, Gea/B-4883-2013; Hausman, Jean-Francois/AAB-6208-2020	Guerriero, Gea/0000-0001-6586-6997; Hausman, Jean-Francois/0000-0001-6103-7817; Legay, Sylvain/0000-0002-2057-7443	Fonds National de la Recherche Luxembourg (FNR) Project [CANCAN C13/SR/5774202]	Fonds National de la Recherche Luxembourg (FNR) Project(Luxembourg National Research Fund)	Financial support was obtained through the Fonds National de la Recherche Luxembourg (FNR) Project CANCAN C13/SR/5774202 and through internal funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barratt DHP, 2009, P NATL ACAD SCI USA, V106, P13124, DOI 10.1073/pnas.0900689106; Bernal AJ, 2008, PLANT PHYSIOL, V148, P1238, DOI 10.1104/pp.108.121939; Betancur L, 2010, J INTEGR PLANT BIOL, V52, P205, DOI 10.1111/j.1744-7909.2010.00934.x; Bita CE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00273; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carpita NC, 2011, PLANT PHYSIOL, V155, P171, DOI 10.1104/pp.110.163360; Carroll A, 2012, PLANT PHYSIOL, V160, P726, DOI 10.1104/pp.112.199208; Carroll A, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00005; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Coello P, 2011, J EXP BOT, V62, P883, DOI 10.1093/jxb/erq331; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellis C, 2002, PLANT CELL, V14, P1557, DOI 10.1105/tpc.002022; Gonzalez-Verdejo CI, 2008, ANAL BIOCHEM, V379, P176, DOI 10.1016/j.ab.2008.05.003; Gu CS, 2011, MOL BIOTECHNOL, V49, P192, DOI 10.1007/s12033-011-9394-6; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamann T, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00077; Hamann T, 2011, PLANT SIGNAL BEHAV, V6, P1706, DOI 10.4161/psb.6.11.17782; Handakumbura PP, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-131; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Humphrey TV, 2007, NEW PHYTOL, V176, P7, DOI 10.1111/j.1469-8137.2007.02192.x; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kakar K, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-18; Kaushal N, 2013, FUNCT PLANT BIOL, V40, P1334, DOI 10.1071/FP13082; Kumar M, 2009, TRENDS PLANT SCI, V14, P248, DOI 10.1016/j.tplants.2009.02.004; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Li SD, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23179; Lima RB, 2013, CARBOHYD POLYM, V93, P135, DOI 10.1016/j.carbpol.2012.05.015; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Martin RC, 2010, J EXP BOT, V61, P2229, DOI 10.1093/jxb/erq063; Mendu V, 2011, PLANT PHYSIOL, V157, P441, DOI 10.1104/pp.111.179069; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nolan KE, 2006, PLANT CELL REP, V25, P711, DOI 10.1007/s00299-006-0135-4; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Pilling E, 2003, CURR OPIN PLANT BIOL, V6, P611, DOI 10.1016/j.pbi.2003.09.004; Pini F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-78; Prasch CM, 2013, PLANT PHYSIOL, V162, P1849, DOI 10.1104/pp.113.221044; Puijalon S, 2006, AM J BOT, V93, P1090, DOI 10.3732/ajb.93.8.1090; Quiroga M, 2000, PLANT PHYSIOL, V122, P1119, DOI 10.1104/pp.122.4.1119; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sanchez-Aguayo I, 2004, PLANTA, V220, P278, DOI 10.1007/s00425-004-1350-2; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Seifert GJ, 2010, PLANT PHYSIOL, V153, P467, DOI 10.1104/pp.110.153940; Selim M, 2012, PLANT CELL REP, V31, P205, DOI 10.1007/s00299-011-1156-1; Song DL, 2010, NEW PHYTOL, V187, P777, DOI 10.1111/j.1469-8137.2010.03315.x; Sorby LA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-144; Stork J, 2010, PLANT PHYSIOL, V153, P580, DOI 10.1104/pp.110.154062; Sullivan S, 2011, PLANT PHYSIOL, V156, P1725, DOI 10.1104/pp.111.179077; Sultan SE, 2003, EVOL DEV, V5, P25, DOI 10.1046/j.1525-142X.2003.03005.x; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Tesfaye M, 2009, BIOENERG RES, V2, P59, DOI 10.1007/s12155-009-9034-1; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Wang W, 2011, J EXP BOT, V62, P5161, DOI 10.1093/jxb/err221; Wolf S, 2012, CURR BIOL, V22, P1732, DOI 10.1016/j.cub.2012.07.036; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yang SS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-323; Yin YB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-99; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; Zhu JH, 2010, PLANT J, V63, P128, DOI 10.1111/j.1365-313X.2010.04227.x	67	37	39	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103808	10.1371/journal.pone.0103808	http://dx.doi.org/10.1371/journal.pone.0103808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084115	gold, Green Submitted, Green Published			2022-12-25	WOS:000339819800083
J	Kirzin, S; Marisa, L; Guimbaud, R; De Reynies, A; Legrain, M; Laurent-Puig, P; Cordelier, P; Pradere, B; Bonnet, D; Meggetto, F; Portier, G; Brousset, P; Selves, J				Kirzin, Sylvain; Marisa, Laetitia; Guimbaud, Rosine; De Reynies, Aurelien; Legrain, Michele; Laurent-Puig, Pierre; Cordelier, Pierre; Pradere, Bernard; Bonnet, Delphine; Meggetto, Fabienne; Portier, Guillaume; Brousset, Pierre; Selves, Janick			Sporadic Early-Onset Colorectal Cancer Is a Specific Sub-Type of Cancer: A Morphological, Molecular and Genetics Study	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; MICROSATELLITE INSTABILITY; OLDER PATIENTS; RECTAL-CANCER; COLON-CANCER; FEATURES; AGE; PATHWAYS; ADENOCARCINOMA; YOUNG	Sporadic early onset colorectal carcinoma (EOCRC) which has by definition no identified hereditary predisposition is a growing problem that remains poorly understood. Molecular analysis could improve identification of distinct sub-types of colorectal cancers (CRC) with therapeutic implications and thus can help establish that sporadic EOCRC is a distinct entity. From 954 patients resected for CRC at our institution, 98 patients were selected. Patients aged 45-60 years were excluded to help define "young" and "old" groups. Thirty-nine cases of sporadic EOCRC (patients <= 45 years with microsatellite stable tumors) were compared to both microsatellite stable tumors from older patients (36 cases, patients>60 years) and to groups of patients with microsatellite instability. Each group was tested for TP53, KRAS, BRAF, PIK3CA mutations and the presence of a methylator phenotype. Gene expression profiles were also used for pathway analysis. Compared to microsatellite stable CRC from old patients, sporadic EOCRC were characterized by distal location, frequent synchronous metastases and infrequent synchronous adenomas but did not have specific morphological characteristics. A familial history of CRC was more common in sporadic EOCRC patients despite a lack of identified hereditary conditions (p = 0.013). Genetic studies also showed the absence of BRAF mutations (p = 0.022) and the methylator phenotype (p = 0.005) in sporadic EOCRC compared to older patients. Gene expression analysis implicated key pathways such as Wnt/beta catenin, MAP Kinase, growth factor signaling (EGFR, HGF, PDGF) and the TNFR1 pathway in sporadic EOCRC. Wnt/beta catenin signaling activation was confirmed by aberrant nuclear beta catenin immunostaining (p = 0.01). This study strongly suggests that sporadic EOCRC is a distinct clinico-molecular entity presenting as a distal and aggressive disease associated with chromosome instability. Furthermore, several signaling pathways including the TNFR1 pathway have been identified as potential biomarkers for both the diagnosis and treatment of this disease.	[Kirzin, Sylvain; Guimbaud, Rosine; Cordelier, Pierre; Meggetto, Fabienne; Brousset, Pierre; Selves, Janick] Univ Toulouse 3, INSERM 1037, Ctr Rech Cancerol Toulouse, Unite Mixte Rech, F-31062 Toulouse, France; [Kirzin, Sylvain; Pradere, Bernard; Portier, Guillaume] Ctr Hosp Univ Toulouse, Dept Surg, Toulouse, France; [Marisa, Laetitia; De Reynies, Aurelien] Ligue Nationale Canc, Cartes Identite Tumeurs Program, Paris, France; [Guimbaud, Rosine; Bonnet, Delphine] Dept Oncol, Toulouse, France; [Legrain, Michele] Hop Univ Hautepierre, Lab Biochim Biol Mol, Strasbourg, France; [Laurent-Puig, Pierre] Univ Paris 05, INSERM, Bases Mol Response Xenobiot, UMR S775, Paris, France; [Brousset, Pierre; Selves, Janick] Ctr Hosp Univ Toulouse, Dept Pathol, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse	Selves, J (corresponding author), Univ Toulouse 3, INSERM 1037, Ctr Rech Cancerol Toulouse, Unite Mixte Rech, F-31062 Toulouse, France.	selves.j@chu-toulouse.fr	Laurent-Puig, Pierre/K-3641-2019; de Reyniès, Aurélien/Q-8640-2017; Cordelier, Pierre/D-1150-2014; Portier, Guillaume/AAI-9411-2021; laurent-puig, pierre/B-2226-2013; Selves, Janick/M-7719-2014; GUIMBAUD, Rosine/M-7503-2014; MEGGETTO, Fabienne/M-1976-2015	Laurent-Puig, Pierre/0000-0001-8475-5459; de Reyniès, Aurélien/0000-0002-1328-5290; Cordelier, Pierre/0000-0003-2096-7967; Portier, Guillaume/0000-0002-1764-8677; laurent-puig, pierre/0000-0001-8475-5459; BONNET, Delphine/0000-0002-8108-0852	Ligue Regionale Contre le Cancer, Comite du Gers; program Carte d'Identite des Tumeurs from Ligue Nationale Contre le Cancer; Institut National Contre le Cancer	Ligue Regionale Contre le Cancer, Comite du Gers; program Carte d'Identite des Tumeurs from Ligue Nationale Contre le Cancer; Institut National Contre le Cancer	This work was supported by a grant from Ligue Regionale Contre le Cancer, Comite du Gers and the program Carte d'Identite des Tumeurs from Ligue Nationale Contre le Cancer. The authors thank the Institut National Contre le Cancer for their support of the clinical and laboratory geneticist. The authors thank Canceropole Grand Sud-Ouest for providing clinical annotations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1994, CANCER RES, V54, P1645; Agesen TH, 2011, GENES IMMUN, V12, P653, DOI 10.1038/gene.2011.43; Alsop K, 2006, EUR J CANCER, V42, P1357, DOI 10.1016/j.ejca.2006.02.023; Antelo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045357; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Benjamini YH, J ROYAL STAT SOC B, V57, P289; Berg M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013978; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Chang DT, 2012, MODERN PATHOL, V25, P1128, DOI 10.1038/modpathol.2012.61; Chiang JM, 2003, DIS COLON RECTUM, V46, P904, DOI 10.1007/s10350-004-6683-1; Cicek MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038175; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Fairley TL, 2006, CANCER, V107, P1153, DOI 10.1002/cncr.22012; Glaab E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-597; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Goel A, 2010, GASTROENTEROLOGY, V138, P1854, DOI 10.1053/j.gastro.2010.01.035; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; HEIMANN TM, 1989, DIS COLON RECTUM, V32, P473, DOI 10.1007/BF02554500; Hill DA, 2007, J CLIN ONCOL, V25, P5808, DOI 10.1200/JCO.2007.12.6102; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Howlader N, 2012, SEER CANC STAT REV 1; INCA, 2011, POL ASS MUT BIALL GE; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 1999, J CLIN PATHOL, V52, P455, DOI 10.1136/jcp.52.6.455; Kim H, 2004, ONCOGENE, V23, P6218, DOI 10.1038/sj.onc.1207853; Kumar K, 2009, CLIN CANCER RES, V15, P1155, DOI 10.1158/1078-0432.CCR-08-1029; Laurent-Puig P, 2012, J CLIN ONCOL, V30, P1550, DOI 10.1200/JCO.2011.40.1190; Liang JT, 2003, BRIT J SURG, V90, P205, DOI 10.1002/bjs.4015; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Maurel J, 1998, GASTROEN CLIN BIOL, V22, pS90; Mitry E, 2001, DIS COLON RECTUM, V44, P380, DOI 10.1007/BF02234737; Nam S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031685; O'Connell JB, 2004, DIS COLON RECTUM, V47, P2064, DOI 10.1007/s10350-004-0738-1; Onizawa M, 2009, AM J PHYSIOL-GASTR L, V296, pG850, DOI 10.1152/ajpgi.00071.2008; Parramore JB, 1998, AM SURGEON, V64, P563; Perea J, 2010, WORLD J GASTROENTERO, V16, P3697, DOI 10.3748/wjg.v16.i29.3697; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Samowitz WS, 2001, GASTROENTEROLOGY, V121, P830, DOI 10.1053/gast.2001.27996; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Siegel RL, 2009, CANCER EPIDEM BIOMAR, V18, P1695, DOI 10.1158/1055-9965.EPI-09-0186; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; Toyota M, 1999, SEMIN CANCER BIOL, V9, P349, DOI 10.1006/scbi.1999.0135; Varma J R, 1990, J Am Board Fam Pract, V3, P54; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b	48	84	84	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103159	10.1371/journal.pone.0103159	http://dx.doi.org/10.1371/journal.pone.0103159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083765	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800020
J	Rugelj, D; Gomiscek, G; Sevsek, F				Rugelj, Darja; Gomiscek, Gregor; Sevsek, France			The Influence of Very Low Illumination on the Postural Sway of Young and Elderly Adults	PLOS ONE			English	Article							BODY SWAY; SENSORIMOTOR INTEGRATION; HEALTHY-YOUNG; AGE; STABILITY; STEADINESS; VISION; RELIABILITY; ORIENTATION; ADAPTATION	The purpose of the present study was to evaluate the influence of very low ambient illumination and complete darkness on the postural sway of young and elderly adults. Eighteen healthy young participants aged 23.8 +/- 1.5 years and 26 community-dwelling elderly aged 69.8 +/- 5.6 years were studied. Each participant performed four tests while standing on a force platform in the following conditions: in normal light (215 lx) with open eyes and with closed eyes, in very low illumination (0.25 lx) with open eyes, and in complete darkness with open eyes. The sequences of the tests in the altered visual conditions were determined by random blocs. Postural sway was assessed by means of the force platform measurements. The centre of pressure variables: the medio-lateral and antero-posterior path lengths, mean velocities, sway areas, and fractal dimensions were analysed. Very low illumination resulted in a statistically significant increase in postural sway in both the young and elderly groups compared to normal light, although the increase was significantly smaller than those observed in the eyes closed and complete darkness condition, and no significant effects of illumination on fractal dimensions were detected. The gains of the sways in the very low or no illumination conditions relative to the normal light condition were significantly larger in the group of young participants than in the group of elderly participants (up to 50% and 25%, respectively). However, the response patterns to changes in illumination were similar in the young and elderly participants, with the exception of the short-range fractal dimension of the medio-lateral sway. In conclusion, very low illumination resulted in increased postural sway compared to normal illumination; however, in the closed eye and complete darkness conditions, postural sway was significantly higher than in the very low illumination condition regardless of the age of the participants.	[Rugelj, Darja; Gomiscek, Gregor; Sevsek, France] Univ Ljubljana, Fac Hlth Sci, Biomech Lab, Ljubljana, Slovenia; [Gomiscek, Gregor] Univ Ljubljana, Fac Med, Inst Biophys, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Rugelj, D (corresponding author), Univ Ljubljana, Fac Hlth Sci, Biomech Lab, Ljubljana, Slovenia.	darja.rugelj@zf.uni-lj.si			Faculty of Health Sciences at University of Ljubljana	Faculty of Health Sciences at University of Ljubljana	No external sources of funding were received. The trial was supported by the existing resources of the Faculty of Health Sciences at University of Ljubljana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard Y, 2007, GAIT POSTURE, V26, P442, DOI 10.1016/j.gaitpost.2006.10.009; Brooke-Wavell K, 2002, GERONTOLOGY, V48, P293, DOI 10.1159/000065252; Brouwer B, 1998, SCAND J REHABIL MED, V30, P131; Doyle Tim L A, 2004, Int J Med Sci, V1, P11; EDWARDS AS, 1946, J EXP PSYCHOL, V36, P526, DOI 10.1037/h0059909; Figueiro MG, 2008, LIGHTING RES TECHNOL, V40, P111, DOI 10.1177/1477153507084198; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P173, DOI 10.1113/jphysiol.1994.sp020240; HIGUCHI T, 1988, PHYSICA D, V31, P277, DOI 10.1016/0167-2789(88)90081-4; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Jackson GR, 1999, VISION RES, V39, P3975, DOI 10.1016/S0042-6989(99)00092-9; Johnson EG, 2012, J GERIATR PHYS THER, V35, P15, DOI 10.1519/JPT.0b013e31821cb0ed; Kim J, 2012, INT J PRECIS ENG MAN, V13, P969, DOI 10.1007/s12541-012-0126-z; Kim S, 2008, J BIOMECH, V41, P406, DOI 10.1016/j.jbiomech.2007.08.011; Kinsella-Shaw JM, 2006, J MOTOR BEHAV, V38, P251, DOI 10.3200/JMBR.38.4.251-264; KOLLEGGER H, 1992, EUR NEUROL, V32, P253, DOI 10.1159/000116836; Lanska DJ, 2002, SEMIN NEUROL, V22, P409, DOI 10.1055/s-2002-36763; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Lord SR, 2000, GERONTOLOGY, V46, P306, DOI 10.1159/000022182; LORD SR, 1994, AGE AGEING, V23, P452, DOI 10.1093/ageing/23.6.452; Lord SR, 2001, J AM GERIATR SOC, V49, P508, DOI 10.1046/j.1532-5415.2001.49107.x; Marucchi C, 1987, Agressologie, V28, P947; Massion J, 2004, PROG BRAIN RES, V143, P13, DOI 10.1016/S0079-6123(03)43002-1; Moe-Nilssen R, 2006, J MOTOR BEHAV, V38, P118, DOI 10.3200/JMBR.38.2.118-125; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Poulain I, 2008, GAIT POSTURE, V27, P1, DOI 10.1016/j.gaitpost.2007.02.007; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Rougier P, 2003, NEUROSCI RES, V47, P73, DOI 10.1016/S0168-0102(03)00187-1; Rugelj Darja, 2007, WSEAS Transactions on Signal Processing, V3, P213; Rugelj D, 2011, APPL ERGON, V42, P860, DOI 10.1016/j.apergo.2011.02.002; Santos BR, 2008, GAIT POSTURE, V27, P408, DOI 10.1016/j.gaitpost.2007.05.008; Sevsek F, 2004, COMPUT METH PROG BIO, V73, P189, DOI 10.1016/S0169-2607(03)00065-8; Sevsek F, 2009, STAB V 1 0; Sevsek F, 2011, 23 C INT SOC BIOM BR, P174; SIMONEAU GG, 1992, J GERONTOL, V47, pM151, DOI 10.1093/geronj/47.5.M151; Sozzi S, 2011, HUM MOVEMENT SCI, V30, P172, DOI 10.1016/j.humov.2010.06.002; Springer Barbara A, 2007, J Geriatr Phys Ther, V30, P8; Stambolieva K, 2001, J PHYSIOL SCI, V61, P123; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; TIPTON DA, 1984, AVIAT SPACE ENVIR MD, V55, P145; Wang Z, 2012, EXP BRAIN RES, V222, P333, DOI 10.1007/s00221-012-3212-7	43	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103903	10.1371/journal.pone.0103903	http://dx.doi.org/10.1371/journal.pone.0103903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084015	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800102
J	Boltong, A; Aranda, S; Keast, R; Wynne, R; Francis, PA; Chirgwin, J; Gough, K				Boltong, Anna; Aranda, Sanchia; Keast, Russell; Wynne, Rochelle; Francis, Prudence A.; Chirgwin, Jacqueline; Gough, Karla			A Prospective Cohort Study of the Effects of Adjuvant Breast Cancer Chemotherapy on Taste Function, Food Liking, Appetite and Associated Nutritional Outcomes	PLOS ONE			English	Article							PERCEPTION; HEDONICS; FLAVOR; NAUSEA	Background: 'Taste' changes are commonly reported during chemotherapy. It is unclear to what extent this relates to actual changes in taste function or to changes in appetite and food liking and how these changes affect dietary intake and nutritional status. Patients and methods: This prospective, repeated measures cohort study recruited participants from three oncology clinics. Women (n = 52) prescribed adjuvant chemotherapy underwent standardised testing of taste perception, appetite and food liking at six time points to measure change from baseline. Associations between taste and hedonic changes and nutritional outcomes were examined. Results: Taste function was significantly reduced early in chemotherapy cycles (p<0.05) but showed recovery by late in the cycle. Ability to correctly identify salty, sour and umami tastants was reduced. Liking of sweet food decreased early and mid-cycle (p<0.01) but not late cycle. Liking of savory food was not significantly affected. Appetite decreased early in the cycle (p<0.001). Reduced taste function was associated with lowest kilojoule intake (r = 0.31; p = 0.008) as was appetite loss with reduced kilojoule (r = 0.34; p = 0.002) and protein intake (r = 0.36; p = 0.001) early in the third chemotherapy cycle. Decreased appetite early in the third and final chemotherapy cycles was associated with a decline in BMI (p = <0.0005) over the study period. Resolution of taste function, food liking and appetite was observed 8 weeks after chemotherapy completion. There was no association between taste change and dry mouth, oral mucositis or nausea. Conclusion: The results reveal, for the first time, the cyclical yet transient effects of adjuvant chemotherapy on taste function and the link between taste and hedonic changes, dietary intake and nutritional outcomes. The results should be used to inform reliable pre-chemotherapy education.	[Boltong, Anna] Canc Council Victoria, Melbourne, Vic, Australia; [Aranda, Sanchia] Canc Inst NSW, Eveleigh, NSW, Australia; [Aranda, Sanchia; Gough, Karla] Peter MacCallum Canc Ctr, Dept Canc Experiences Res, East Melbourne, Vic, Australia; [Aranda, Sanchia; Wynne, Rochelle] Univ Melbourne, Melbourne Sch Hlth Sci, Carlton, Vic 3053, Australia; [Keast, Russell] Deakin Univ, Ctr Phys Act & Nutr Res, Burwood, Vic, Australia; [Francis, Prudence A.] Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia; [Chirgwin, Jacqueline] Eastern Hlth, Melbourne, Vic, Australia	Cancer Council Victoria; Peter Maccallum Cancer Center; University of Melbourne; Deakin University; Peter Maccallum Cancer Center	Boltong, A (corresponding author), Canc Council Victoria, Melbourne, Vic, Australia.	anna.boltong@cancervic.org.au	Wynne, Rochelle/AAC-8333-2019; Francis, Prudence A/J-4003-2012; Wynne, Rochelle M/G-6984-2017; Aranda, Sanchia/ABC-3840-2021; Keast, Russell S/P-1899-2017	Wynne, Rochelle/0000-0003-1814-3416; Francis, Prudence A/0000-0002-7207-9286; Wynne, Rochelle M/0000-0003-1814-3416; Keast, Russell S/0000-0003-2147-7687; Gough, Karla/0000-0003-2819-4217; Aranda, Sanchia/0000-0003-4170-9799	Victorian Cancer Agency [SCS08Resub_04_Boltong]	Victorian Cancer Agency	The contribution by first author Dr. Boltong was funded by a Victorian Cancer Agency Supportive Care in Cancer PhD Scholarship (SCS08Resub_04_Boltong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer J, 2002, EUR J CLIN NUTR, V56, P779, DOI 10.1038/sj.ejcn.1601412; Bernhardson BM, 2007, J PAIN SYMPTOM MANAG, V34, P403, DOI 10.1016/j.jpainsymman.2006.12.010; Bernhardson Britt-Marie, 2003, Evid Based Nurs, V6, P62, DOI 10.1136/ebn.6.2.62; Blundell J., 1979, NUTR LIFESTYLES APPL, P21; BOAKES RA, 1993, EUR J CANCER, V29A, P866, DOI 10.1016/S0959-8049(05)80427-7; Boltong A, 2011, CANCER FORUM, V35, P81; Boltong A, 2012, SUPPORT CARE CANCER, V20, P2765, DOI 10.1007/s00520-012-1398-7; Boltong A, 2012, CANCER TREAT REV, V38, P152, DOI 10.1016/j.ctrv.2011.04.008; Breslin PAS, 2008, CURR BIOL, V18, pR148, DOI 10.1016/j.cub.2007.12.017; COHEN J, 1988, APPL PSYCH MEAS, V12, P425, DOI 10.1177/014662168801200410; Doty RL, 2008, DRUG SAFETY, V31, P199, DOI 10.2165/00002018-200831030-00002; Garcia-Granero M, 2011, 2 PROPORTIONS TEST R; HEASMAN KZ, 1985, BREAST CANCER RES TR, V5, P195, DOI 10.1007/BF01805994; International Organization for Standardization, 2011, 39722011 ISO; Knight KRG, 2005, J CLIN ONCOL, V23, P8588, DOI 10.1200/JCO.2004.00.5355; McQuestion M, 2011, EUR J ONCOL NURS, V15, P145, DOI 10.1016/j.ejon.2010.07.006; Mela DJ, 2006, APPETITE, V47, P10, DOI 10.1016/j.appet.2006.02.006; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ottery F, 2000, CLIN GUIDE ONCOLOGY, P11; PERYAM DR, 1957, FOOD TECHNOL-CHICAGO, V11, P32; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; Raper N, 2004, J FOOD COMPOS ANAL, V17, P545, DOI 10.1016/j.jfca.2004.02.013; Schiffman SS, 2007, J NUTR HEALTH AGING, V11, P439; Schiffman SS, 2000, EUR J CLIN NUTR, V54, pS54, DOI 10.1038/sj.ejcn.1601026; Schiffman SS, 2007, P NUTR SOC, V66, P331, DOI 10.1017/S0029665107005599; Schwartz MD, 1996, PHYSIOL BEHAV, V59, P659, DOI 10.1016/0031-9384(95)02096-9; Steinbach S, 2009, J CLIN ONCOL, V27, P1899, DOI 10.1200/JCO.2008.19.2690; TRANT AS, 1982, AM J CLIN NUTR, V36, P45, DOI 10.1093/ajcn/36.1.45; Zabernigg A, 2010, ONCOLOGIST, V15, P913, DOI 10.1634/theoncologist.2009-0333	29	71	74	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103512	10.1371/journal.pone.0103512	http://dx.doi.org/10.1371/journal.pone.0103512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078776	Green Published, gold, Green Submitted			2022-12-25	WOS:000339954800052
J	Dasgupta, S; Castro, LM; Dulman, R; Yang, CY; Schmidt, M; Ferro, ES; Fricker, LD				Dasgupta, Sayani; Castro, Leandro M.; Dulman, Russell; Yang, Ciyu; Schmidt, Marion; Ferro, Emer S.; Fricker, Lloyd D.			Proteasome Inhibitors Alter Levels of Intracellular Peptides in HEK293T and SH-SY5Y Cells	PLOS ONE			English	Article							THIMET OLIGOPEPTIDASE; NATURAL REGULATORS; DEGRADATION; AMINOPEPTIDASE; GENERATION; PEPTIDOMICS; SPECIFICITY; PROTECTION; PRODUCTS; PROTEINS	The proteasome cleaves intracellular proteins into peptides. Earlier studies found that treatment of human embryonic kidney 293T (HEK293T) cells with epoxomicin (an irreversible proteasome inhibitor) generally caused a decrease in levels of intracellular peptides. However, bortezomib (an antitumor drug and proteasome inhibitor) caused an unexpected increase in the levels of most intracellular peptides in HEK293T and SH-SY5Y cells. To address this apparent paradox, quantitative peptidomics was used to study the effect of a variety of other proteasome inhibitors on peptide levels in HEK293T and SH-SY5Y cells. Inhibitors tested included carfilzomib, MG132, MG262, MLN2238, AM114, and clasto-Lactacystin beta-lactone. Only MG262 caused a substantial elevation in peptide levels that was comparable to the effect of bortezomib, although carfilzomib and MLN2238 elevated the levels of some peptides. To explore off-target effects, the proteosome inhibitors were tested with various cellular peptidases. Bortezomib did not inhibit tripeptidyl peptidase 2 and only weakly inhibited cellular aminopeptidase activity, as did some of the other proteasome inhibitors. However, potent inhibitors of tripeptidyl peptidase 2 (butabindide) and cellular aminopeptidases (bestatin) did not substantially alter the peptidome, indicating that the increase in peptide levels due to proteasome inhibitors is not a result of peptidase inhibition. Although we cannot exclude other possibilities, we presume that the paradoxical increase in peptide levels upon treatment with bortezomib and other inhibitors is the result of allosteric effects of these compounds on the proteasome. Because intracellular peptides are likely to be functional, it is possible that some of the physiologic effects of bortezomib and carfilzomib arise from the perturbation of peptide levels inside the cell.	[Dasgupta, Sayani; Dulman, Russell; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Castro, Leandro M.; Ferro, Emer S.] Univ Sao Paulo, Inst Biomed Sci, Support Ctr Res Proteolysis & Cell Signaling, Dept Pharmacol, Sao Paulo, Brazil; [Yang, Ciyu; Schmidt, Marion] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Universidade de Sao Paulo; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Fricker, LD (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	lloyd.fricker@einstein.yu.edu	Ferro, Emer S/D-3908-2012; Castro, Leandro/ABI-5520-2020; Castro, Leandro/O-6762-2019	Ferro, Emer S/0000-0003-1651-9192; Castro, Leandro/0000-0002-7156-2006; Castro, Leandro/0000-0002-7156-2006; Dasgupta, Sayani/0000-0003-4782-7956; Dulman, Russell/0000-0003-2899-7984	National Institutes of Health [R01-DA-004494, R01-GM-43601]; CNPq; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health R01-DA-004494 (LDF) and National Institutes of Health R01-GM-43601 (MS). ESF is funded by a CNPq research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Arastu-Kapur S, 2011, CLIN CANCER RES, V17, P2734, DOI 10.1158/1078-0432.CCR-10-1950; Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Beck P, 2012, BIOL CHEM, V393, P1101, DOI 10.1515/hsz-2012-0212; Berkers CR, 2005, NAT METHODS, V2, P357, DOI 10.1038/nmeth759; Berti DA, 2012, PROTEOMICS, V12, P2668, DOI 10.1002/pmic.201200051; Berti DA, 2009, J BIOL CHEM, V284, P14105, DOI 10.1074/jbc.M807916200; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Chauhan D, 2011, CLIN CANCER RES, V17, P5311, DOI 10.1158/1078-0432.CCR-11-0476; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; Crawford LJA, 2006, CANCER RES, V66, P6379, DOI 10.1158/0008-5472.CAN-06-0605; Cunha FM, 2008, J BIOL CHEM, V283, P24448, DOI 10.1074/jbc.M801252200; Dange T, 2011, J BIOL CHEM, V286, P42830, DOI 10.1074/jbc.M111.300178; de Araujo CB, 2014, J BIOL CHEM; Ferro ES, 2004, J NEUROCHEM, V91, P769, DOI 10.1111/j.1471-4159.2004.02757.x; Fricker LD, 2012, J PROTEOME RES, V11, P1981, DOI 10.1021/pr2012076; Fricker LD, 2010, MOL BIOSYST, V6, P1355, DOI 10.1039/c003317k; Gaedicke S, 2002, CANCER RES, V62, P6901; Garcia-Medel N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011486; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Gelman JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053263; Gelman JS, 2012, METHODS MOL BIOL, V829, P487, DOI 10.1007/978-1-61779-458-2_31; Gelman JS, 2011, J PROTEOME RES, V10, P1583, DOI 10.1021/pr100952f; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Kessler BM, 2002, MOL IMMUNOL, V39, P171, DOI 10.1016/S0161-5890(02)00100-1; Kisselev AF, 2002, J BIOL CHEM, V277, P22260, DOI 10.1074/jbc.M112360200; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kuhn DJ, 2007, BLOOD, V110, P3281, DOI 10.1182/blood-2007-01-065888; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lightcap ES, 2000, CLIN CHEM, V46, P673; Lyons P. J., 2011, CURRENT PROTOCOLS PR; Marcilla M, 2008, EUR J IMMUNOL, V38, P631, DOI 10.1002/eji.200737444; Marcilla M, 2007, MOL CELL PROTEOMICS, V6, P923, DOI 10.1074/mcp.M600302-MCP200; Milner E, 2013, MOL CELL PROTEOMICS, V12, P1853, DOI 10.1074/mcp.M112.026013; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; Moravec RA, 2009, ANAL BIOCHEM, V387, P294, DOI 10.1016/j.ab.2009.01.016; Nolte WM, 2009, BIOCHEMISTRY-US, V48, P11971, DOI 10.1021/bi901637c; Nussbaum AK, 1998, P NATL ACAD SCI USA, V95, P12504, DOI 10.1073/pnas.95.21.12504; Ostrowska H, 1997, BIOCHEM BIOPH RES CO, V234, P729, DOI 10.1006/bbrc.1997.6434; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rubinstein M, 2009, BIOPOLYMERS, V91, P505, DOI 10.1002/bip.21164; Russo LC, 2012, PROTEOMICS, V12, P2641, DOI 10.1002/pmic.201200032; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Smulski PA, 2009, STRUCTURE, V17, P1137, DOI 10.1016/j.str.2009.06.011; Tagore DM, 2009, NAT CHEM BIOL, V5, P23, DOI 10.1038/nchembio.126; Towne CF, 2005, J IMMUNOL, V175, P6605, DOI 10.4049/jimmunol.175.10.6605; Towne CF, 2008, J IMMUNOL, V180, P1704, DOI 10.4049/jimmunol.180.3.1704; Zhang X, 2008, J NEUROCHEM, V107, P1596, DOI 10.1111/j.1471-4159.2008.05722.x	52	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103604	10.1371/journal.pone.0103604	http://dx.doi.org/10.1371/journal.pone.0103604			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079948	Green Submitted, gold, Green Published			2022-12-25	WOS:000339954800059
J	Skowronki, K; Andrews, J; Rodenhiser, DI; Coomber, BL				Skowronki, Karolina; Andrews, Joseph; Rodenhiser, David I.; Coomber, Brenda L.			Genome-Wide Analysis in Human Colorectal Cancer Cells Reveals Ischemia-Mediated Expression of Motility Genes via DNA Hypomethylation	PLOS ONE			English	Article							CPG-BINDING-PROTEIN; PLASMINOGEN-ACTIVATOR; PROSTATE-CANCER; THERAPEUTIC IMPLICATIONS; CHROMOSOMAL INSTABILITY; RECEPTOR EXPRESSION; GASTRIC-CANCER; BREAST-CANCER; TUMOR HYPOXIA; METHYLATION	DNA hypomethylation is an important epigenetic modification found to occur in many different cancer types, leading to the upregulation of previously silenced genes and loss of genomic stability. We previously demonstrated that hypoxia and hypoglycaemia (ischemia), two common micro-environmental changes in solid tumours, decrease DNA methylation through the downregulation of DNMTs in human colorectal cancer cells. Here, we utilized a genome-wide cross-platform approach to identify genes hypomethylated and upregulated by ischemia. Following exposure to hypoxia or hypoglycaemia, methylated DNA from human colorectal cancer cells (HCT116) was immunoprecipitated and analysed with an Affymetrix promoter array. Additionally, RNA was isolated and analysed in parallel with an Affymetrix expression array. Ingenuity pathway analysis software revealed that a significant proportion of the genes hypomethylated and upregulated were involved in cellular movement, including PLAUR and CYR61. A Matrigel invasion assay revealed that indeed HCT116 cells grown in hypoxic or hypoglycaemic conditions have increased mobility capabilities. Confirmation of upregulated expression of cellular movement genes was performed with qPCR. The correlation between ischemia and metastasis is well established in cancer progression, but the molecular mechanisms responsible for this common observation have not been clearly identified. Our novel data suggests that hypoxia and hypoglycaemia may be driving changes in DNA methylation through downregulation of DNMTs. This is the first report to our knowledge that provides an explanation for the increased metastatic potential seen in ischemic cells; i.e. that ischemia could be driving DNA hypomethylation and increasing expression of cellular movement genes.	[Skowronki, Karolina; Coomber, Brenda L.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Andrews, Joseph; Rodenhiser, David I.] Univ Western Ontario, Dept Biochem, London Reg Canc Ctr, London, ON, Canada; [Andrews, Joseph; Rodenhiser, David I.] Univ Western Ontario, Dept Oncol, London Reg Canc Ctr, London, ON, Canada; [Andrews, Joseph; Rodenhiser, David I.] Univ Western Ontario, Dept Paediat, London Reg Canc Ctr, London, ON, Canada; [Andrews, Joseph; Rodenhiser, David I.] Childrens Hlth Res Inst, London, ON, Canada	University of Guelph; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Coomber, BL (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	bcoomber@uoguelph.ca			Canadian Cancer Society Research Institute [020094]	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was funded by a Research Grant # 020094 to BLC and DR from the Canadian Cancer Society Research Institute (http://www.cancer.ca/research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman WM, 2001, P NATL ACAD SCI USA, V98, P2538, DOI 10.1073/pnas.041603298; Andrews J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008665; Avni R, 2011, NMR BIOMED, V24, P569, DOI 10.1002/nbm.1632; Barrow C, 2006, CLIN CANCER RES, V12, P764, DOI 10.1158/1078-0432.CCR-05-1544; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; Buechler P, 2009, NEOPLASIA, V11, P196, DOI 10.1593/neo.08734; Cui HM, 2002, CANCER RES, V62, P6442; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Eskandarpour M, 2009, INT J CANCER, V124, P16, DOI 10.1002/ijc.23876; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; FEINBERG AP, 1988, CANCER RES, V48, P1159; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frigola J, 2005, HUM MOL GENET, V14, P319, DOI 10.1093/hmg/ddi028; Fromigue O, 2011, J BONE MINER RES, V26, P1533, DOI 10.1002/jbmr.343; Fyles A, 2002, J CLIN ONCOL, V20, P680, DOI 10.1200/JCO.20.3.680; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Graham CH, 1999, INT J CANCER, V80, P617, DOI 10.1002/(SICI)1097-0215(19990209)80:4<617::AID-IJC22>3.0.CO;2-C; Gravina GL, 2013, ONCOL REP, V29, P1189, DOI 10.3892/or.2012.2192; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Guo YJ, 2002, J BIOL CHEM, V277, P41571, DOI 10.1074/jbc.M201864200; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; Herath NI, 2010, INT J CANCER, V126, P2003, DOI 10.1002/ijc.25147; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Horiuchi A, 2012, INT J CANC; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Jung EJ, 2005, ANTICANCER RES, V25, P2105; Kanai Y, 2007, CARCINOGENESIS, V28, P2434, DOI 10.1093/carcin/bgm206; Kim KH, 2006, WORLD J GASTROENTERO, V12, P5651, DOI 10.3748/wjg.v12.i35.5651; Kita Y, 2009, EJSO-EUR J SURG ONC, V35, P52, DOI 10.1016/j.ejso.2008.01.025; Klein R, 2012, REPROD FERT DEVELOP, V24, P482, DOI 10.1071/RD10335; Krishnamachary B, 2003, CANCER RES, V63, P1138; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; Kwon OH, 2011, BIOCHEM BIOPH RES CO, V406, P539, DOI 10.1016/j.bbrc.2011.02.082; Laner T, 2005, ONCOL RES, V15, P257, DOI 10.3727/096504005776404607; Leone G, 2002, HAEMATOLOGICA, V87, P1324; Liu J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-261; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Pakneshan P, 2005, CURR CANCER DRUG TAR, V5, P471, DOI 10.2174/156800905774574011; Phipps KD, 2011, CANCER RES, V71, P6676, DOI 10.1158/0008-5472.CAN-11-1748; PYKE C, 1995, CANCER RES, V55, P4132; Rabbani S A, 2001, Surg Oncol Clin N Am, V10, P393; Raghunand N, 2003, BRIT J RADIOL, V76, pS11, DOI 10.1259/bjr/12913493; Roschke AV, 2002, NEOPLASIA, V4, P19, DOI 10.1038/sj.neo.7900197; Shahrzad S, 2007, EPIGENETICS-US, V2, P119, DOI 10.4161/epi.2.2.4613; Shimozaki K, 2005, J NEUROCHEM, V93, P432, DOI 10.1111/j.1471-4159.2005.03031.x; Skowronski K, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12400; Snyder BN, 2011, EUR J CELL BIOL, V90, P376, DOI 10.1016/j.ejcb.2010.11.016; Subarsky P, 2003, CLIN EXP METASTAS, V20, P237, DOI 10.1023/A:1022939318102; Suzuki S, 1998, GUT, V43, P798, DOI 10.1136/gut.43.6.798; Takeuchi T, 2011, INT J EXP PATHOL, V92, P79, DOI 10.1111/j.1365-2613.2010.00740.x; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; Xiao J, 2004, WORLD J GASTROENTERO, V10, P1849; Xie JJ, 2011, INT J MOL MED, V27, P429, DOI 10.3892/ijmm.2011.603; Yanagawa N, 2011, ANTICANCER RES, V31, P171; Yonemura Y, 2000, CLIN CANCER RES, V6, P4234	62	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103243	10.1371/journal.pone.0103243	http://dx.doi.org/10.1371/journal.pone.0103243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079072	gold, Green Published, Green Submitted			2022-12-25	WOS:000339954800034
J	Sohn, H; Kim, B; Kim, KH; Kim, MK; Choi, TK; Lee, SH				Sohn, Hoyoung; Kim, Borah; Kim, Keun Hyang; Kim, Min-Kyoung; Choi, Tai Kiu; Lee, Sang-Hyuk			Effects of VRK2 (rs2312147) on White Matter Connectivity in Patients with Schizophrenia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COGNITIVE IMPAIRMENT; CONFERRING RISK; COMMON VARIANTS; 1ST-EPISODE; HYPOXIA; SUSCEPTIBILITY; PERFORMANCE; APOPTOSIS	Recent genome-wide association studies of schizophrenia reported a novel risk variant, rs2312147 at vaccinia-related kinase 2 gene (VRK2), in multiple Asian and European samples. However, its effect on the brain structure in schizophrenia is little known. We analyzed the brain structure of 36 schizophrenia patients and 18 healthy subjects with regard to rs2312147 genotype groups. Brain magnetic resonance scans for gray matter (GM) and white matter (WM) analysis, and genotype analysis for VRK2 rs2312147, were conducted. The Positive and Negative Syndrome Scale and the Digit Symbol Test were assessed for schizophrenia patients. There was no significant difference in either GM volume or WM connectivity with regard to rs2312147 genotype in healthy subjects. In contrast, we found significant differences in the WM connectivity between rs2312147 CC and CT/TT genotype groups of schizophrenia patients. The related brain areas included the splenium of corpus callosum, the left occipital lobe WM, the internal capsule (left anterior limb and right retrolenticular part), the bilateral temporal lobe WM, the left fornix/stria terminalis, the left cingulate gyrus WM, and the left parietal lobe WM. Voxelwise correlation analysis revealed that the Digit Symbol Test scores (age corrected) correlated with the fractional anisotropy in WM tracts that previously showed significant group differences between the CT/TT and CC genotypes in the rs2312147 CT/TT genotype group, while no significant correlation was found in the CC genotype group. Our data may provide evidence for the effect of VRK2 on WM connectivity in patients with schizophrenia.	[Sohn, Hoyoung; Kim, Borah; Kim, Keun Hyang; Kim, Min-Kyoung; Choi, Tai Kiu; Lee, Sang-Hyuk] CHA Univ, CHA Bundang Med Ctr, Dept Psychiat, Songnam, Gyeonggi Do, South Korea	Pochon Cha University	Lee, SH (corresponding author), CHA Univ, CHA Bundang Med Ctr, Dept Psychiat, Songnam, Gyeonggi Do, South Korea.	leesanghyuk@yahoo.com		Sohn, Hoyoung/0000-0002-1856-8636				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Blanco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001660; Blanco S, 2007, MOL CELL BIOL, V27, P7273, DOI 10.1128/MCB.00025-07; Burdick KE, 2010, AM J PSYCHIAT, V167, P436, DOI 10.1176/appi.ajp.2009.09050615; Chabchoub E, 2008, J MED GENET, V45, P189, DOI 10.1136/jmg.2007.056176; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Dajas-Ballador F, 2008, CURR BIOL, V18, P221, DOI 10.1016/j.cub.2008.01.025; Dickinson D, 2008, BRIT J PSYCHIAT, V193, P354, DOI 10.1192/bjp.bp.108.049387; Dickinson D, 2007, ARCH GEN PSYCHIAT, V64, P532, DOI 10.1001/archpsyc.64.5.532; Dong ZH, 2005, MOL BRAIN RES, V134, P282, DOI 10.1016/j.molbrainres.2004.10.039; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; First M. B., 1997, STRUCTURED CLIN INTE; Friedman JI, 2008, AM J PSYCHIAT, V165, P1024, DOI 10.1176/appi.ajp.2008.07101640; Gasso P, 2014, J PSYCHIATR RES, V48, P94, DOI 10.1016/j.jpsychires.2013.09.017; Gibbons LE, 2012, BRAIN IMAGING BEHAV, V6, P517, DOI 10.1007/s11682-012-9176-1; Gonzalez-Blanch C, 2011, ARCH CLIN NEUROPSYCH, V26, P48, DOI 10.1093/arclin/acq086; Han DH, 2008, J PSYCHIATR RES, V42, P399, DOI 10.1016/j.jpsychires.2007.03.002; Hoyer WJ, 2004, PSYCHOL AGING, V19, P211, DOI 10.1037/0882-7974.19.1.211; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Knochel C, 2012, SCHIZOPHR RES, V140, P129, DOI 10.1016/j.schres.2012.06.001; Li LY, 2006, J GEN VIROL, V87, P2869, DOI 10.1099/vir.0.81953-0; Li M, 2012, SCHIZOPHR RES, V142, P200, DOI 10.1016/j.schres.2012.10.008; Rodriguez-Sanchez JM, 2007, BRIT J PSYCHIAT, V191, pS107, DOI 10.1192/bjp.191.51.s107; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Peled S, 2006, MAGN RESON IMAGING, V24, P1263, DOI 10.1016/j.mri.2006.07.009; Price G, 2005, J NEUROL NEUROSUR PS, V76, P585, DOI 10.1136/jnnp.2004.042952; Prontera P, 2011, AM J MED GENET A, V155A, P2473, DOI 10.1002/ajmg.a.33875; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rajcan-Separovic E, 2007, J MED GENET, V44, P269, DOI 10.1136/jmg.2006.045013; Rietschel M, 2012, MOL PSYCHIATR, V17, P906, DOI 10.1038/mp.2011.80; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Schmidt-Kastner R, 2012, MOL PSYCHIATR, V17, P1194, DOI 10.1038/mp.2011.183; Schmidt-Kastner R, 2006, SCHIZOPHR RES, V84, P253, DOI 10.1016/j.schres.2006.02.022; Shirts BH, 2006, SCHIZOPHR RES, V88, P235, DOI 10.1016/j.schres.2006.06.037; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steffens M, 2012, HUM MOL GENET, V21, P5359, DOI 10.1093/hmg/dds373; Steinberg S, 2011, HUM MOL GENET, V20, P4076, DOI 10.1093/hmg/ddr325; Strange A, 2012, BIOL PSYCHIAT, V72, P620, DOI 10.1016/j.biopsych.2012.05.035; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; Usui N, 2009, NEUROSCI LETT, V463, P1, DOI 10.1016/j.neulet.2009.07.048; Wechsler D., 1981, WAIS R WECHSLER ADUL; WILLIAMS H, 2011, TLS TIMES LIT S 0114, P16; Yu HJ, 2012, NEUROIMAGE, V59, P3713, DOI 10.1016/j.neuroimage.2011.10.053; Yum TH, 1992, MANUAL KOREAN WECHSL	52	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103519	10.1371/journal.pone.0103519	http://dx.doi.org/10.1371/journal.pone.0103519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079070	Green Published, Green Submitted, gold			2022-12-25	WOS:000339954800054
J	Li, JH; Yang, YJ; Li, BW; Li, WJ; Wang, G; Knops, JMH				Li, Jin Hua; Yang, Yu Jie; Li, Bo Wen; Li, Wen Jin; Wang, Gang; Knops, Johannes M. H.			Effects of Nitrogen and Phosphorus Fertilization on Soil Carbon Fractions in Alpine Meadows on the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; ORGANIC-CARBON; GRASSLAND SOILS; STORAGE; MINERALIZATION; SEQUESTRATION; BIODIVERSITY; DEPOSITION; ABUNDANCE; BIOMASS	In grassland ecosystems, N and P fertilization often increase plant productivity, but there is no concensus if fertilization affects soil C fractions. We tested effects of N, P and N+P fertilization at 5, 10, 15 g m(-2) yr(-1) (N-5, N-10, N-15, P-5, P-10, P-15, N5P5, N10P10, and N15P15) compared to unfertilized control on soil C, soil microbial biomass and functional diversity at the 0-20 cm and 20-40 cm depth in an alpine meadow after 5 years of continuous fertilization. Fertilization increased total aboveground biomass of community and grass but decreased legume and forb biomass compared to no fertilization. All fertilization treatments decreased the C:N ratios of legumes and roots compared to control, however fertilization at rates of 5 and 15 g m(-2) yr(-1) decreased the C:N ratios of the grasses. Compared to the control, soil microbial biomass C increased in N-5, N-10, P-5, and P-10 in 0-20 cm, and increased in N-10 and P-5 while decreased in other treatments in 20-40 cm. Most of the fertilization treatments decreased the respiratory quotient (qCO(2)) in 0-20 cm but increased qCO(2) in 20-40 cm. Fertilization increased soil microbial functional diversity (except N-15) but decreased cumulative C mineralization (except in N-15 in 0-20 cm and N-5 in 20-40 cm). Soil organic C (SOC) decreased in P-5 and P-15 in 0-20 cm and for most of the fertilization treatments (except N15P15) in 20-40 cm. Overall, these results suggested that soils will not be a C sink (except N15P15). Nitrogen and phosphorus fertilization may lower the SOC pool by altering the plant biomass composition, especially the C:N ratios of different plant functional groups, and modifying C substrate utilization patterns of soil microbial communities. The N+P fertilization at 15 g m(-2) yr(-1) may be used in increasing plant aboveground biomass and soil C accumulation under these meadows.	[Li, Jin Hua; Yang, Yu Jie; Li, Bo Wen; Li, Wen Jin; Wang, Gang] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China; [Knops, Johannes M. H.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA	Lanzhou University; University of Nebraska System; University of Nebraska Lincoln	Li, JH (corresponding author), Lanzhou Univ, Sch Life Sci, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China.	lijinhuap@sohu.com	Knops, Johannes/AAA-8546-2020		New Century Excellent Talents in University [NCET-11-0210]; Fundamental Research Funds for the Central Universities [LZUJBKY-2013-K12]; National Natural Science Foundation of China [30871823]	New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Program for New Century Excellent Talents in University (NCET-11-0210), the Fundamental Research Funds for the Central Universities (LZUJBKY-2013-K12) and National Natural Science Foundation of China (No. 30871823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2013, ECOLOGY, V94, P714, DOI 10.1890/12-1243.1; ANDERSON TH, 1990, SOIL BIOL BIOCHEM, V22, P251, DOI 10.1016/0038-0717(90)90094-G; [白洁冰 BAI Jiebing], 2011, [生态环境学报, Ecology and Environmental Sciences], V20, P855; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Biudes MS, 2012, SOIL SCI SOC AM J, V76, P2068, DOI 10.2136/sssaj2012.0101n; Bradford MA, 2008, GLOBAL CHANGE BIOL, V14, P1113, DOI 10.1111/j.1365-2486.2008.01564.x; Bradley K, 2006, SOIL BIOL BIOCHEM, V38, P1583, DOI 10.1016/j.soilbio.2005.11.011; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Chen LY, 2010, THESIS LANZHOU U; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Fornara DA, 2013, GLOBAL CHANGE BIOL, V19, P3848, DOI 10.1111/gcb.12323; Fornara DA, 2012, ECOLOGY, V93, P2030, DOI 10.1890/12-0292.1; Garland JL, 1996, SOIL BIOL BIOCHEM, V28, P213, DOI 10.1016/0038-0717(95)00112-3; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Gong Z., 2014, CHINESE SOIL GEOGRAP; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Insam H, 1997, MICROBIAL COMMUNITIES, P259; Isbell F, 2013, ECOL LETT, V16, P454, DOI 10.1111/ele.12066; KALEMBASA SJ, 1973, J SCI FOOD AGR, V24, P1085, DOI 10.1002/jsfa.2740240910; Keeler BL, 2009, ECOSYSTEMS, V12, P1, DOI 10.1007/s10021-008-9199-z; Koyama A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077212; Li JH, 2012, ENVIRON MANAGE, V50, P1193, DOI 10.1007/s00267-012-9958-7; Li LJ, 2010, BIOL FERT SOILS, V46, P653, DOI 10.1007/s00374-010-0463-y; Li Ying-chen, 2010, Shengtaixue Zazhi, V29, P2091; Liu K, 2009, J ENVIRON QUAL, V38, P2267, DOI 10.2134/jeq2008.0387; Liu LL, 2010, ECOL LETT, V13, P819, DOI 10.1111/j.1461-0248.2010.01482.x; LOVELL RD, 1995, SOIL BIOL BIOCHEM, V27, P969, DOI 10.1016/0038-0717(94)00241-R; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Malhi SS, 2003, NUTR CYCL AGROECOSYS, V66, P33, DOI 10.1023/A:1023376905096; Ni J, 2002, J ARID ENVIRON, V50, P205, DOI 10.1006/jare.2001.0902; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Qi R, 2013, THESIS LANZHOU U; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ren ZW, 2010, J PLANT ECOL, V3, P25, DOI 10.1093/jpe/rtp034; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; Song MH, 2010, EUR J SOIL BIOL, V46, P375, DOI 10.1016/j.ejsobi.2010.09.003; Stapleton LM, 2005, SOIL BIOL BIOCHEM, V37, P2088, DOI 10.1016/j.soilbio.2005.03.016; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vourlitis GL, 2007, BIOL FERT SOILS, V43, P611, DOI 10.1007/s00374-006-0137-y; Vourlitis GL, 2009, ECOSYSTEMS, V12, P473, DOI 10.1007/s10021-009-9236-6; Wang GX, 2002, SCI TOTAL ENVIRON, V291, P207, DOI 10.1016/S0048-9697(01)01100-7; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wedin DA, 1996, SCIENCE, V274, P1720, DOI 10.1126/science.274.5293.1720; Xin XJ, 2011, THESIS LANZHOU U; [杨红飞 YANG Hongfei], 2011, [中国草地学报, Chinese Journal of Grassland], V33, P107; Zhang CB, 2010, ECOL ENG, V36, P62, DOI 10.1016/j.ecoleng.2009.09.010; [张金霞 Zhang Jinxia], 2003, [生态学报, Acta Ecologica Sinica], V23, P627; Zhang RY, 2011, POL J ECOL, V59, P105	52	22	28	18	179	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103266	10.1371/journal.pone.0103266	http://dx.doi.org/10.1371/journal.pone.0103266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075624	Green Published, gold			2022-12-25	WOS:000340028800033
J	Pisano, F; Heine, W; Rosenheinrich, M; Schweer, J; Nuss, AM; Dersch, P				Pisano, Fabio; Heine, Wiebke; Rosenheinrich, Maik; Schweer, Janina; Nuss, Aaron M.; Dersch, Petra			Influence of PhoP and Intra-Species Variations on Virulence of Yersinia pseudotuberculosis during the Natural Oral Infection Route	PLOS ONE			English	Article							RESPONSE REGULATOR PHOP; INVASIN EXPRESSION; IMMUNE-RESPONSE; OUTER PROTEINS; PESTIS; ENTEROCOLITICA; MACROPHAGES; SURVIVAL; SYSTEMS; HOST	The two-component regulatory system PhoP/PhoQ has been shown to (i) control expression of virulence-associated traits, (ii) confer survival and growth within macrophages and (iii) play a role in Yersinia infections. However, the influence of PhoP on virulence varied greatly between different murine models of infection and its role in natural oral infections with frequently used representative isolates of Y. pseudotuberculosis was unknown. To address this issue, we constructed an isogenic set of phoP(+) and phoP-2 variants of strain IP32953 and YPIII and analyzed the impact of PhoP using in vitro functionality experiments and a murine oral infection model, whereby we tested for bacterial dissemination and influence on the host immune response. Our results revealed that PhoP has a low impact on virulence, lymphatic and systemic organ colonization, and on immune response modulation by IP32953 and YPIII, indicating that PhoP is not absolutely essential for oral infections but may be involved in fine-tuning the outcome. Our work further revealed certain strain-specific differences in virulence properties, which do not strongly rely on the function of PhoP, but affect tissue colonization, dissemination and/or persistence of the bacteria. Highlighted intra-species variations may provide a potential means to rapidly adjust to environmental changes inside and outside of the host.	[Pisano, Fabio; Heine, Wiebke; Rosenheinrich, Maik; Schweer, Janina; Nuss, Aaron M.; Dersch, Petra] Helmholtz Ctr Infect Res, Dept Mol Infect Biol, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Dersch, P (corresponding author), Helmholtz Ctr Infect Res, Dept Mol Infect Biol, Braunschweig, Germany.	petra.dersch@helmholtz-hzi.de			Deutsche Forschungsgemeinschaft [DE616/4-2 (SPP1316)]; President's Initiative and Network Fund of the Helmholtz Association of German Research Centres (HGF) [VH-GS-202]; DFG [IRTG1273]; Deutsche Zentrum fur Infektionsforschung (DZIF); Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); President's Initiative and Network Fund of the Helmholtz Association of German Research Centres (HGF); DFG(German Research Foundation (DFG)); Deutsche Zentrum fur Infektionsforschung (DZIF); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft Grants DE616/4-2 (SPP1316) for AN, a stipend of the President's Initiative and Network Fund of the Helmholtz Association of German Research Centres (HGF) (VH-GS-202) for WH, a stipend of the DFG funded IRTG1273, the Deutsche Zentrum fur Infektionsforschung (DZIF) for FP and PD, and the Fonds der Chemischen Industrie for PD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand RD, 2004, BIOTECHNIQUES, V36, P982, DOI 10.2144/04366ST03; AUTENRIETH IB, 1993, IMMUNOBIOLOGY, V187, P1; AUTENRIETH IB, 1992, INFECT IMMUN, V60, P1140, DOI 10.1128/IAI.60.3.1140-1149.1992; Balada-Llasat JM, 2006, PLOS PATHOG, V2, P816, DOI 10.1371/journal.ppat.0020086; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; Bergman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000573; Bliska JB, 2013, CELL MICROBIOL, V15, P1622, DOI 10.1111/cmi.12164; BOLIN I, 1982, INFECT IMMUN, V37, P506; Bozue J, 2011, MICROB PATHOGENESIS, V50, P314, DOI 10.1016/j.micpath.2011.02.005; Brzostek K, 2003, FEMS MICROBIOL LETT, V228, P265, DOI 10.1016/S0378-1097(03)00779-1; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; FINEGOLD MJ, 1969, AM J PATHOL, V54, P167; Fisher ML, 2007, INFECT IMMUN, V75, P429, DOI 10.1128/IAI.01287-06; Flamez C, 2008, INT J MED MICROBIOL, V298, P193, DOI 10.1016/j.ijmm.2007.05.005; Fujimura Yoshinori, 1992, Journal of Clinical Electron Microscopy, V25, P35; Galindo CL, 2011, J PATHOG, V2011, DOI 10.4061/2011/182051; Grabenstein JP, 2006, INFECT IMMUN, V74, P3727, DOI 10.1128/IAI.00255-06; Grabenstein JP, 2004, INFECT IMMUN, V72, P4973, DOI 10.1128/IAI.72.9.4973-4984.2004; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Groisman EA, 2006, NAT REV MICROBIOL, V4, P705, DOI 10.1038/nrmicro1478; HANSKI C, 1991, INFECT IMMUN, V59, P1106, DOI 10.1128/IAI.59.3.1106-1111.1991; HANSKI C, 1989, INFECT IMMUN, V57, P673, DOI 10.1128/IAI.57.3.673-678.1989; Heise T, 2006, P NATL ACAD SCI USA, V103, P3375, DOI 10.1073/pnas.0507749103; HIGUCHI K, 1957, J BACTERIOL, V73, P122, DOI 10.1128/JB.73.1.122-129.1957; Koornhof HJ, 1999, EUR J CLIN MICROBIOL, V18, P87, DOI 10.1007/s100960050237; Kumar S, 2009, ANTON LEEUW INT J G, V95, P91, DOI 10.1007/s10482-008-9292-5; Laukkanen-Ninios R, 2011, ENVIRON MICROBIOL, V13, P3114, DOI 10.1111/j.1462-2920.2011.02588.x; Lejona S, 2003, J BACTERIOL, V185, P6287, DOI 10.1128/JB.185.21.6287-6294.2003; Lockman HA, 2002, INFECT IMMUN, V70, P2708, DOI 10.1128/IAI.70.5.2708-2714.2002; Maldonado-Arocho FJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003415; Marceau M, 2005, CURR ISSUES MOL BIOL, V7, P151; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x; O'Loughlin JL, 2010, INFECT IMMUN, V78, P773, DOI 10.1128/IAI.00718-09; Oyston PCF, 2000, INFECT IMMUN, V68, P3419, DOI 10.1128/IAI.68.6.3419-3425.2000; Paczosa MK, 2013, CELLULAR MICROBIOLOG; Palonen E, 2013, FOODBORNE PATHOG DIS, V10, P21, DOI 10.1089/fpd.2012.1247; Perez JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000428; Pisano F, 2012, INFECT IMMUN, V80, P1050, DOI 10.1128/IAI.05715-11; Pujol C, 2005, P NATL ACAD SCI USA, V102, P12909, DOI 10.1073/pnas.0502849102; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Sambrook J, 2001, MOL CLONING LAB MANU; Schaake J, 2013, INFECT IMMUN, V81, P4013, DOI 10.1128/IAI.00572-13; Schweer J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003746; SIMONET M, 1990, INFECT IMMUN, V58, P841, DOI 10.1128/IAI.58.3.841-845.1990; SIMONET M, 1992, INFECT IMMUN, V60, P4414, DOI 10.1128/IAI.60.10.4414-4417.1992; Smego RA, 1999, EUR J CLIN MICROBIOL, V18, P1, DOI 10.1007/s100960050219; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Sun YC, 2009, FEMS MICROBIOL LETT, V290, P85, DOI 10.1111/j.1574-6968.2008.01409.x; Svanborg C, 1999, CURR OPIN MICROBIOL, V2, P99, DOI 10.1016/S1369-5274(99)80017-4; Uliczka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020425; UNE T, 1977, MICROBIOL IMMUNOL, V21, P349, DOI 10.1111/j.1348-0421.1977.tb00300.x; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wershil BK, 2008, J ALLERGY CLIN IMMUN, V121, pS380, DOI 10.1016/j.jaci.2007.10.023; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Yamamoto T, 1996, INFECT IMMUN, V64, P2980, DOI 10.1128/IAI.64.8.2980-2987.1996	59	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103541	10.1371/journal.pone.0103541	http://dx.doi.org/10.1371/journal.pone.0103541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075520	Green Published, Green Submitted, gold			2022-12-25	WOS:000340028800062
J	Rakotoarinivo, M; Dransfield, J; Bachman, SP; Moat, J; Baker, WJ				Rakotoarinivo, Mijoro; Dransfield, John; Bachman, Steven P.; Moat, Justin; Baker, William J.			Comprehensive Red List Assessment Reveals Exceptionally High Extinction Risk to Madagascar Palms	PLOS ONE			English	Article							CONSERVATION PRIORITIES; BIODIVERSITY HOTSPOTS; FOREST FRAGMENTATION; PLANT CONSERVATION; DIVERSITY; DEFORESTATION; EASTERN; THREAT; GENUS; AREA	The establishment of baseline IUCN Red List assessments for plants is a crucial step in conservation planning. Nowhere is this more important than in biodiversity hotspots that are subject to significant anthropogenic pressures, such as Madagascar. Here, all Madagascar palm species are assessed using the IUCN Red List categories and criteria, version 3.1. Our results indicate that 83% of the 192 endemic species are threatened, nearly four times the proportion estimated for plants globally and exceeding estimates for all other comprehensively evaluated plant groups in Madagascar. Compared with a previous assessment in 1995, the number of Endangered and Critically Endangered species has substantially increased, due to the discovery of 28 new species since 1995, most of which are highly threatened. The conservation status of most species included in both the 1995 and the current assessments has not changed. Where change occurred, more species have moved to lower threat categories than to higher categories, because of improved knowledge of species and their distributions, rather than a decrease in extinction risk. However, some cases of genuine deterioration in conservation status were also identified. Palms in Madagascar are primarily threatened by habitat loss due to agriculture and biological resource use through direct exploitation or collateral damage. The recent extension of Madagascar's protected area network is highly beneficial for palms, substantially increasing the number of threatened species populations included within reserves. Notably, three of the eight most important protected areas for palms are newly designated. However, 28 threatened and data deficient species are not protected by the expanded network, including some Critically Endangered species. Moreover, many species occurring in protected areas are still threatened, indicating that threatening processes persist even in reserves. Definitive implementation of the new protected areas combined with local community engagement are essential for the survival of Madagascar's palms.	[Rakotoarinivo, Mijoro] Ambodivoanjo Ivandry, Kew Madagascar Conservat Ctr, Antananarivo, Madagascar; [Dransfield, John; Bachman, Steven P.; Moat, Justin; Baker, William J.] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England	Royal Botanic Gardens, Kew	Rakotoarinivo, M (corresponding author), Ambodivoanjo Ivandry, Kew Madagascar Conservat Ctr, Antananarivo, Madagascar.	mrakotoarinivo.rbgkew@moov.mg	Rakotoarinivo, Mijoro/AAE-6975-2020; Sambri, Vittorio/H-5372-2019; Baker, William/B-1244-2011	Sambri, Vittorio/0000-0002-5012-7355; rakotoarinivo, mijoro/0000-0001-6644-5107; Moat, Justin/0000-0002-5513-3615; Baker, William/0000-0001-6727-1831; Bachman, Steven/0000-0003-1085-6075	Friends of Kew through the Threatened Plants Appeal; Bentham-Moxon Trust at the Royal Botanic Gardens, Kew	Friends of Kew through the Threatened Plants Appeal; Bentham-Moxon Trust at the Royal Botanic Gardens, Kew	This work was funded by the Friends of Kew through the Threatened Plants Appeal and by the Bentham-Moxon Trust at the Royal Botanic Gardens, Kew. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allnutt TF, 2013, TROP CONSERV SCI, V6, P1, DOI 10.1177/194008291300600101; Allnutt TF, 2008, CONSERV LETT, V1, P173, DOI 10.1111/j.1755-263X.2008.00027.x; Andreone F, 2005, CONSERV BIOL, V19, P1790, DOI 10.1111/j.1523-1739.2005.00249.x; Association Nationale pour la Gestion des Aires Protegees [ANGAP], 2001, MAD PROT AR SYST MAN; Bachman S, 2011, ZOOKEYS, P117, DOI 10.3897/zookeys.150.2109; Battistini R, 1996, COLLOQ SEMI, P1; Bennett B., 2011, ENCY LIFE SUPPORT SY; Borrini-Feyerabend G., 2005, AIRES PROTEGEES MADA; Brummitt N, 2010, PLANTS PRESSURE GLOB; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Butchart SHM, 2006, CONSERV BIOL, V20, P579, DOI 10.1111/j.1523-1739.2006.00410.x; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Byg A, 2001, BIODIVERS CONSERV, V10, P951, DOI 10.1023/A:1016640713643; Byg Anja, 2003, Palms, V47, P37; Callmander MW, 2007, ORYX, V41, P168, DOI 10.1017/S0030605307001731; Callmander MW, 2005, TAXON, V54, P1047, DOI 10.2307/25065491; Couvreur TLP, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-48; Couvreur TLP, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-44; Davies N., 2013, LEMURS MADAGASCAR ST, P13; Dransfield J, 1999, ACTA HORTIC, P21, DOI 10.17660/ActaHortic.1999.486.1; Dransfield J., 1995, PALMS MADAGASCAR; Dransfield J, 2008, GENERA PALMARUM EVOL; Dransfield J, 2006, FIELD GUIDE PALMS MA; Dransfield J, 2008, BOT J LINN SOC, V156, P79, DOI 10.1111/j.1095-8339.2007.00742.x; Fattorini S, 2012, ACTA OECOL, V40, P27, DOI 10.1016/j.actao.2012.02.006; Fleischmann K, 2005, AFR J ECOL, V43, P291, DOI 10.1111/j.1365-2028.2005.00567.x; Foibe Taosarintanin'i Madagasikara [FTM], 2006, MAD SES 22 REG; Gaston KJ, 2009, J APPL ECOL, V46, P1, DOI 10.1111/j.1365-2664.2008.01596.x; Good TC, 2006, CONSERV BIOL, V20, P1099, DOI 10.1111/j.1523-1739.2006.00473.x; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Google, 2010, GOOGL EARTH VERS 5 2; Govaerts R, 2012, WORLD CHECKLIST AREC; Groupe des Specialistes des Plantes Malgaches [GSPM], 2011, LIST ROUG PLANT VASC; Hannah L, 2008, BIOL LETTERS, V4, P590, DOI 10.1098/rsbl.2008.0270; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hobbs RJ, 2007, RESTOR ECOL, V15, P354, DOI 10.1111/j.1526-100X.2007.00225.x; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; International Union for Conservation of Nature [IUCN], 1998, 1997 IUCN RED LIST T; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; IUCN, 2011, GUID US IUCN RED LIS; IUCN, 2013, IUCN RED LIST THREAT; IUCN, 2012, IUCN RED LIST CATEGO, VSecond; IUCN, 1994, IUCN RED LIST CAT CR; IUCN, 2012, IUCN RED LIST THREAT; IUCN, 2012, THREATS CLASS SCHEM; Joppa LN, 2011, P NATL ACAD SCI USA, V108, P13171, DOI 10.1073/pnas.1109389108; Jury MR., 2003, NATURAL HIST MADAGAS, P75; Kissling WD, 2012, P NATL ACAD SCI USA, V109, P7379, DOI 10.1073/pnas.1120467109; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Marcot BG, 2013, NAT RESOUR MODEL, V26, P194, DOI 10.1111/j.1939-7445.2012.00134.x; Mittermeier RA., 2005, INT J WILDERNESS, V11, P42; Moat J., 2007, ATLAS VEGETATION MAD; Moat J., 2007, CONSERVATION ASSESSM; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nicoll ME, 2003, NATURAL HIST MADAGAS, P1432; Norris S, 2006, BIOSCIENCE, V56, P960, DOI 10.1641/0006-3568(2006)56[960:MD]2.0.CO;2; Rakotoarinivo M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3048; Rakotoarinivo Mijoro, 2010, Palms, V54, P141; Rakotoarinivo Mijoro, 2010, Kew Bulletin, V65, P279, DOI 10.1007/s12225-010-9210-7; Rakotoarinivo Mijoro, 2009, Palms, V53, P125; Ramananjanahary RH, 2010, MADAGASCARS ENDEMIC; Richard D, 2006, TAXONOMY PLANT CONSE, P163; Rivers MC, 2010, BIODIVERS CONSERV, V19, P2071, DOI 10.1007/s10531-010-9826-9; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rojas-Sandoval J, 2012, ACTA OECOL, V41, P30, DOI 10.1016/j.actao.2012.04.004; Scariot A, 1999, J ECOL, V87, P66, DOI 10.1046/j.1365-2745.1999.00332.x; Schatz G. E., 2003, GAZETTEER MALAGASY B; Systeme des Aires Protegees de Madagascar [SAPM], 2011, ATL NUM SAPM; Thiers B., 2012, INDEX HERBARIORUM GL; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Vie J.C., 2008, IUCN RED LIST KEY CO; Willis F, 2003, BIODIVERS CONSERV, V12, P1537, DOI 10.1023/A:1023679329093; WorldBank, 2013, POP DENS	75	20	26	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103684	10.1371/journal.pone.0103684	http://dx.doi.org/10.1371/journal.pone.0103684			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075612	Green Published, gold			2022-12-25	WOS:000340028800073
J	Lv, ZY; Wei, Y; Wang, D; Zhang, CY; Zen, K; Li, LM				Lv, Zhiyuan; Wei, Yao; Wang, Dong; Zhang, Chen-Yu; Zen, Ke; Li, Limin			Argonaute 2 in Cell-Secreted Microvesicles Guides the Function of Secreted miRNAs in Recipient Cells	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; MICRORNA; COMMUNICATION; DROSOPHILA; APOPTOSIS; EXOSOMES; GROWTH; RNAS	MicroRNAs (miRNAs) secreted by cells into microvesicles (MVs) form a novel class of signal molecules that mediate intercellular communication. However, several fundamental aspects of secreted miRNAs remain unknown, particularly the mechanism that governs the function or fate of exogenous miRNAs in recipient cells. In the present study, we provide evidence indicating that Argonaute 2 (Ago2) plays a role in stabilizing miRNAs and facilitating the packaging of secreted miRNAs into MVs. More importantly, Ago2 in origin cell-secreted MVs (but not in recipient cells) directs the function of secreted miRNAs. First, Ago2 overexpression clearly increased the level of miR-16 in cells transfected with a miR-16 mimic by protecting the miRNAs from degradation in lysosomes. Second, Ago2 overexpression increased the level of miR-16 in cell-secreted MVs, suggesting that Ago2 may facilitate the packaging of secreted miRNAs into MVs. Third, exogenous miR-16 delivered by MVs within the origin cells significantly reduced the Bcl2 protein level in recipient cells, and miR-16 and Bcl2 mRNA were physically associated with exogenous HA-tagged Ago2 (HA-Ago2). Finally, the effect of MV-delivered miR-16 on the production of the Bcl2 protein in recipient cells was not abolished by knocking down Ago2 in the recipient cells.	[Lv, Zhiyuan; Wei, Yao; Wang, Dong; Zhang, Chen-Yu; Zen, Ke; Li, Limin] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Zhang, CY (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	cyzhang@nju.edu.cn; kzen@nju.edu.cn; bixuehan2005@163.com			National Basic Research Program of China (973 Program) [2012CB517603, 2011CB504803]; National Natural Science Foundation of China [31301061]; Natural Science Foundation of Jiangsu Province [BK2011013, BK20130564]; Specialized Research Fund for the Doctoral Program of Higher Education [20130091120037]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the National Basic Research Program of China (973 Program, 2012CB517603 and 2011CB504803), the National Natural Science Foundation of China (No. 31301061), the Natural Science Foundation of Jiangsu Province (No. BK2011013, BK20130564) and the Specialized Research Fund for the Doctoral Program of Higher Education (20130091120037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bhattacharyya SN, 2007, CELL, V128, P1027, DOI 10.1016/j.cell.2007.02.033; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dugas DV, 2004, CURR OPIN PLANT BIOL, V7, P512, DOI 10.1016/j.pbi.2004.07.011; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Pan Y, 2014, J IMMUNOL, V192, P437, DOI 10.4049/jimmunol.1301790; Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Thomson DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055214; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Balkom BWM, 2013, BLOOD, V121, P3997, DOI 10.1182/blood-2013-02-478925; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Wei Y, 2014, J BIOL CHEM; Xu J, 2013, J NEUROCHEM, V124, P15, DOI 10.1111/jnc.12057; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zhang QP, 2013, PROTEIN CELL, V4, P243, DOI 10.1007/s13238-013-3006-0; Zhang YQ, 2014, BIOMATERIALS, V35, P4390, DOI 10.1016/j.biomaterials.2014.02.003; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	27	32	34	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103599	10.1371/journal.pone.0103599	http://dx.doi.org/10.1371/journal.pone.0103599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072345	Green Submitted, Green Published, gold			2022-12-25	WOS:000341307600069
J	Carlson, AE; Hoffmayer, ER; Tribuzio, CA; Sulikowski, JA				Carlson, Amy E.; Hoffmayer, Eric R.; Tribuzio, Cindy A.; Sulikowski, James A.			The Use of Satellite Tags to Redefine Movement Patterns of Spiny Dogfish (Squalus acanthias) along the US East Coast: Implications for Fisheries Management	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; ATLANTIC BLUEFIN TUNA; SHARKS CARCHARODON-CARCHARIAS; DIEL VERTICAL MIGRATION; LIGHT-BASED GEOLOCATION; STATE-SPACE MODEL; HORIZONTAL MOVEMENTS; POPULATION-STRUCTURE; NORTHWEST ATLANTIC; SPATIAL DYNAMICS	Spiny dogfish (Squalus acanthias) are assumed to be a highly migratory species, making habitual north-south migrations throughout their northwestern Atlantic United States (U.S.) range. Also assumed to be a benthic species, spiny dogfish stock structure is estimated through Northeast Fisheries Science Center (NEFSC) bottom-trawl surveys. Recent anomalies in population trends, including a recent four-fold increase in estimated spawning stock biomass, suggest alternative movement patterns could exist for this shark species. To obtain a better understanding of the horizontal and vertical movement dynamics of this species, Microwave Telemetry pop-up satellite archival X-Tags were attached to forty adult spiny dogfish at the northern (Gulf of Maine) and southern (North Carolina) extents of their core U.S. geographic range. Reconstructed geolocation tracks ranging in lengths from two to 12 months suggest that the seasonal migration patterns appear to be local in nature to each respective northern and southern deployment site, differing from previously published migration paradigms. Differences in distance and direction traveled between seasonal geolocations possibly indicate separate migratory patterns between groups. Kernel utilization distribution models also suggest strong separate core home ranges. Significant differences in seasonal temperature and depths between the two regions further substantiate the possibility of separate regional movement patterns between the two groups. Vertical utilization also suggests distinct diel patterns and that this species may not utilize the benthos as previously thought, potentially decreasing availability to benthic gear.	[Carlson, Amy E.; Sulikowski, James A.] Univ New England, Ctr Marine Sci, Biddeford, ME 04005 USA; [Hoffmayer, Eric R.] Southeast Fisheries Sci Ctr, Mississippi Labs, Natl Marine Fisheries Serv, Pascagoula, MS USA; [Tribuzio, Cindy A.] Alaska Fisheries Sci Ctr, Auke Bay Labs, Natl Marine Fisheries Serv, Juneau, AK USA	University of New England - Maine; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Carlson, AE (corresponding author), Univ New England, Ctr Marine Sci, Biddeford, ME 04005 USA.	acarlson1@une.edu			Saltonstall-Kennedy (S-K) Grant Program [NA09NMF4270099, NA10NMF4270203]; Sturdivant Island Tuna Association	Saltonstall-Kennedy (S-K) Grant Program; Sturdivant Island Tuna Association	This project was supported by awards from the Saltonstall-Kennedy (S-K) Grant Program (NA09NMF4270099 and NA10NMF4270203) and Sturdivant Island Tuna Association to J.A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KS, 2009, ANIM BEHAV, V78, P525, DOI 10.1016/j.anbehav.2009.05.027; ASIH (American Society of Tchthyologists and Herpetologists) - AFS (American Fisheries Society) - AIFRB (American Institute of Fisheries Research Biologists), 2003, GUID US FISH FIELD R; Atlantic States Marine Fisheries Commission (ASMFC), 2002, 40 ATL STAT MAR FISH; Atlantic States Marine Fisheries Commission (ASMFC), 2009, INT FISH MAN PLAN SP; Atlantic States Marine Fisheries Commission (ASMFC), 2008, EXC ASMFC FISH FOC, V17, P1; Azarovitz T.R., 1981, Canadian Special Publication of Fisheries and Aquatic Sciences, V58, P62; Benoit HP, 2003, ICES J MAR SCI, V60, P1298, DOI 10.1016/S1054-3139(03)00124-3; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Boustany AM, 2010, PROG OCEANOGR, V86, P94, DOI 10.1016/j.pocean.2010.04.015; Brill RW, 2001, AM FISH S S, V25, P179; Bubley WJ, 2013, FISH RES, V147, P202, DOI 10.1016/j.fishres.2013.06.004; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Campana SE, 2009, BIOL MANAGEMENT DOGF; Campana SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016854; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; Castro J. I, 2011, SHARKS N AM; Collette B. B, 2002, BIGELOW SCHROEDERS F, V3rd; Compagno L. J. V., 1984, FAO Fisheries Synopsis, P251; Demirhan Sefa Ayhan, 2006, Turkish Journal of Zoology, V30, P433; DESPRESPATANJO LI, 1988, MAR FISH REV, V50, P69; Domeier M. L., 2013, Animal Biotelemetry, V1, P1; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Ewer, 1968, ETHOLOGY MAMMALS; Farrugia TJ, 2011, MAR FRESHWATER RES, V62, P648, DOI 10.1071/MF10173; Fisk AT, 2012, MAR ECOL PROG SER, V468, P255, DOI 10.3354/meps09962; Fraser HM, 2007, ICES J MAR SCI, V64, P1800, DOI 10.1093/icesjms/fsm145; Galuardi B, 2008, MAR ECOL PROG SER, V365, P35, DOI 10.3354/meps07497; Galuardi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037829; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Godo OR, 1999, ICES J MAR SCI, V56, P292, DOI 10.1006/jmsc.1999.0444; Graham RT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036834; Greene CH, 2009, OCEANOGRAPHY, V22, P210, DOI 10.5670/oceanog.2009.21; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; HISAW FL, 1947, BIOL BULL-US, V92, P187, DOI 10.2307/1538305; Hoffmayer ER, 2013, B MAR SCI, V89, P551, DOI 10.5343/bms.2012.1048; Hoolihan JP, 2005, MAR BIOL, V146, P1015, DOI 10.1007/s00227-004-1488-2; Howey-Jordan LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056588; Jensen AC, 1966, FISHERY B, V65, P537; Johnston R, 2013, ECOSYSTEMS SURVEYS B; JONSSON B, 1985, T AM FISH SOC, V114, P182, DOI 10.1577/1548-8659(1985)114<182:LHPOFR>2.0.CO;2; Jorgensen SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047819; KAUFMANN JOHN H., 1962, UNIV CALIF PUBL ZOOL, V60, P95; Klein-MacPhee G., 2002, BIGELOW SCHROEDERS F, P54; KOHLER N. E., 1998, MAR FISH REV, V60, P1, DOI DOI 10.7755/MFR.81.2.1; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Lam CH, 2010, MAR ECOL PROG SER, V419, P71, DOI 10.3354/meps08862; Luo JG, 2006, FISH OCEANOGR, V15, P208, DOI 10.1111/j.1365-2419.2006.00360.x; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; MABEC, 2019, MABEC; McFarlane GA, 2003, FISH B-NOAA, V101, P358; Michalsen K, 1996, ICES J MAR SCI, V53, P389, DOI 10.1006/jmsc.1996.0054; Mid-Atlantic Fishery Management Council (MAFMC), 2012, AM 2 SPIN DOGF FISH; Miklos P, 2003, ENVIRON BIOL FISH, V66, P15, DOI 10.1023/A:1023287123495; Moore T.M., 1998, THESIS ACADIA U WOLF; Murdy EO, 1997, FISHES CHESAPEAKE BA; Musick JA, 1999, AM FISH S S, V23, P1; Musyl MK, 2011, FISH B-NOAA, V109, P341; NAMMACK MF, 1985, T AM FISH SOC, V114, P367, DOI 10.1577/1548-8659(1985)114<367:LHOSDO>2.0.CO;2; Nasby-Lucas N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008163; National Oceanic and Atmospheric Administration (NOAA), 2011, CRUIS RES NOAA FSV 1; National Oceanic and Atmospheric Administration (NOAA), 2010, CRUIS RES NOAA FSV 1; National Oceanic and Atmospheric Administration (NOAA), 2009, CRUIS RES NOAA FSV 1; *NEFSC, 1998, 26 NE REG STOCK ASS, P98; NEFSC, 2006, 43 NE REG STOCK ASS; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; Nielsen CK, 2001, AM MIDL NAT, V146, P43, DOI 10.1674/0003-0031(2001)146[0043:SOOBLR]2.0.CO;2; Northeast Fishery Science Center (NEFSC), 2009, NOAA FISH SCI CTR RE; Northeast Fishery Science Center (NEFSC), 2010, NOAA FISH SCI CTR RE; Northeast Fishery Science Center (NEFSC), 2011, NOAA FISH SCI CTR RE; Northeast Fishery Science Center ( NEFSC), 2003, INT FISH MAN PLAN SP; Northeast Fishery Science Center (NEFSC), 2012, NOAA FISH SCI CTR RE; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Ortiz M, 2003, MAR FRESHWATER RES, V54, P489, DOI 10.1071/MF02028; R Core Development Team, 2008, R LANG ENV STAT COMP; Rago P, 2012, UPDATE STATUS SPINY; Rago PJ, 1998, FISH RES, V39, P165, DOI 10.1016/S0165-7836(98)00181-7; Rago PJ, 2010, 1006 NE FISH SCI CTR; Rago PJ, 1994, 9419 NE FISH SCI CTR, P94; Register KE, 2007, 05FEG07 N CAR SEA GR; Rogers PJ, 2013, MAR FRESHWATER RES, V64, P20, DOI 10.1071/MF11234; Royer F, 2005, OIKOS, V109, P473, DOI 10.1111/j.0030-1299.2005.13777.x; Rulifson RA, 2002, BIOL CHARACTERIZATIO; Rulifson RA, 2009, BIOLOGY AND MANAGEMENT OF DOGFISH SHARKS, P133; SCOTT JS, 1982, CAN J FISH AQUAT SCI, V39, P943, DOI 10.1139/f82-128; Shafer TC, 1970, THESIS U RHODE ISLAN; Shepherd T, 2002, FISH OCEANOGR, V11, P78, DOI 10.1046/j.1365-2419.2002.00191.x; Sibert JR, 2003, FISH OCEANOGR, V12, P141, DOI 10.1046/j.1365-2419.2003.00228.x; Sims DW, 2005, J ANIM ECOL, V74, P755, DOI 10.1111/j.1365-2656.2005.00971.x; Soldat VT, 1979, 796102 INT COMM NW A; Sorte CJB, 2010, OIKOS, V119, P1909, DOI 10.1111/j.1600-0706.2010.18663.x; Sosebee K, 2006, SPINY DOGFISH STATUS; Stehlik L.L., 2007, NOAA TECHNICAL MEMOR; Stevens JD, 2010, MAR BIOL, V157, P575, DOI 10.1007/s00227-009-1343-6; Sulikowski JA, 2013, FISH RES, V137, P59, DOI 10.1016/j.fishres.2012.08.018; Sulikowski JA, 2010, MAR ECOL PROG SER, V418, P249, DOI 10.3354/meps08821; Templeman W, 1944, RES B DEV FISH RESOU, V15; Teo S, 2003, MAR ECOL PROG SER, V283, P81; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; TRAC (Transboundary Resources Assessment Committee), 2010, 201002 TRAC; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; WENG K, 2013, J MAR BIOL, V2013, pNIL1, DOI DOI 10.1155/2013/598745; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616; Weng KC, 2004, FISH B-NOAA, V102, P221; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Wilson J, 1999, ECOL ECON, V31, P243, DOI 10.1016/S0921-8009(99)00082-8; WOOD CC, 1979, J FISH RES BOARD CAN, V36, P647, DOI 10.1139/f79-094; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3	112	27	28	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103384	10.1371/journal.pone.0103384	http://dx.doi.org/10.1371/journal.pone.0103384			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068584	Green Published, gold			2022-12-25	WOS:000339993700066
J	Han, X; Cui, Y; Yang, CH; Sun, WL; Wu, JH; Gao, YJ; Xue, HB; Li, XB; Shen, L; Peng, YS; Zhang, HH; Hu, Y; Zhong, LY; Chen, XY; Ge, ZZ				Han, Xiao; Cui, Yun; Yang, Chuanhua; Sun, Weili; Wu, Jianghong; Gao, Yunjie; Xue, Hanbing; Li, Xiaobo; Shen, Lei; Peng, Yanshen; Zhang, Hanhui; Hu, Yan; Zhong, Liying; Chen, Xiaoyu; Ge, Zhizheng			Endoscopic Biopsy in Gastrointestinal Neuroendocrine Neoplasms: A Retrospective Study	PLOS ONE			English	Article							RECTAL CARCINOID-TUMORS; DIMINUTIVE POLYPS; SUBMUCOSAL DISSECTION; RESECTION	Background: Gastrointestinal neuroendocrine neoplasms (GI-NENs) are often located in the deep mucosa or submucosa, and the efficacy of endoscopic biopsy for diagnosis and treatment of GI-NENs is not fully understood. Objective: The current study analyzed GI-NENs, especially those diagnosed pathologically and resected endoscopically, and focused on the biopsy and cold biopsy forceps polypectomy (CBP) to analyze their roles in diagnosing and treating GI-NENs. Methods: Clinical data of all GI-NENs were reviewed from January 2006 to March 2012. Histopathology was used to diagnose GI-NENs, which were confirmed by immunohistochemistry. Results: 67.96% GI-NENs were diagnosed pathologically by endoscopy. Only 26.21% were diagnosed pathologically by biopsies before treatment. The diagnostic rate was significantly higher in polypoid (76.47%) and submucosal lesions (68.75%), than in ulcerative lesions (12.00%). However, biopsies were only taken in 56.31% patients, including 51.52% of polypoid lesions, 35.56% of submucosal lesions and 100.00% of ulcerative lesions. Endoscopic resection removed 61.76% of GI-NENs, including six by CBP, 14 by snare polypectomy with electrocauterization, 28 by endoscopic mucosal resection (EMR) and 15 by endoscopic submucosal dissection (ESD). 51.52% polypoid GI-NENs had infiltrated the submucosa under microscopic examination. CBP had a significantly higher rate of remnant (33.33%) than snare polypectomy with electrocauterization, EMR and ESD (all 0.00%). Conclusions: Biopsies for all polypoid and submucosal lesions will improve pre-operative diagnosis. The high rate of submucosal infiltration of polypoid GI-NENs determined that CBP was inadequate in the treatment of GI-NENs. Diminutive polypoid GI-NENs that disappeared after CBP had a high risk of remnant and should be closely followed up over the long term.	[Han, Xiao; Cui, Yun; Yang, Chuanhua; Sun, Weili; Wu, Jianghong; Gao, Yunjie; Xue, Hanbing; Li, Xiaobo; Shen, Lei; Peng, Yanshen; Zhang, Hanhui; Hu, Yan; Zhong, Liying; Chen, Xiaoyu; Ge, Zhizheng] Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Sch Med, Div Gastroenterol & Hepatol,Ren Ji Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Yang, CH (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Sch Med, Div Gastroenterol & Hepatol,Ren Ji Hosp, Shanghai 200030, Peoples R China.	dryangch3@163.com			National Natural Science Foundation of China [81370509]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by National Natural Science Foundation of China (81370509) (http://www.nsfc.gov.cn/publish/portal1/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosman T.F., 2010, WHO CLASSIFICATION T, P13; Efthymiou M, 2011, ENDOSCOPY, V43, P312, DOI 10.1055/s-0030-1256086; Hirabayashi K, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00002; Jung YS, 2013, ENDOSCOPY, V45, P1024, DOI 10.1055/s-0033-1344394; Kobayashi K, 2005, DIS COLON RECTUM, V48, P285, DOI 10.1007/s10350-004-0765-y; Lee DS, 2010, ENDOSCOPY, V42, P647, DOI 10.1055/s-0030-1255591; Modlin IM, 2008, LANCET ONCOL, V9, P61, DOI 10.1016/S1470-2045(07)70410-2; Niederle MB, 2011, ONCOLOGIST, V16, P602, DOI 10.1634/theoncologist.2011-0002; Onozato Y, 2010, DIS COLON RECTUM, V53, P169, DOI 10.1007/DCR.0b013e3181b9db7b; Park CH, 2011, ENDOSCOPY, V43, P790, DOI 10.1055/s-0030-1256414; Park HW, 2010, GASTROINTEST ENDOSC, V72, P143, DOI 10.1016/j.gie.2010.01.040; Ramage JK, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2011-300831; Remes SM, 2012, AM J SURG PATHOL, V36, P1359, DOI 10.1097/PAS.0b013e3182632038; Scherubl H, 2011, WORLD J GASTRO ENDOS, V3, P133, DOI 10.4253/wjge.v3.i7.133; Suzuki S, 2012, SURG ENDOSC, V26, P759, DOI 10.1007/s00464-011-1948-y; WOODS A, 1989, GASTROINTEST ENDOSC, V35, P536, DOI 10.1016/S0016-5107(89)72906-0	16	2	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103210	10.1371/journal.pone.0103210	http://dx.doi.org/10.1371/journal.pone.0103210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068592	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993700045
J	Kaiyala, KJ				Kaiyala, Karl J.			Mathematical Model for the Contribution of Individual Organs to Non-Zero Y-Intercepts in Single and Multi-Compartment Linear Models of Whole-Body Energy Expenditure	PLOS ONE			English	Article							BASAL METABOLIC-RATE; FAT-FREE MASS; MAJOR ORGANS; ALLOMETRIC CASCADE; TISSUE MASS; WEIGHT-LOSS; OBESE; SIZE; RATES; THERMOGENESIS	Mathematical models for the dependence of energy expenditure (EE) on body mass and composition are essential tools in metabolic phenotyping. EE scales over broad ranges of body mass as a non-linear allometric function. When considered within restricted ranges of body mass, however, allometric EE curves exhibit 'local linearity.' Indeed, modern EE analysis makes extensive use of linear models. Such models typically involve one or two body mass compartments (e.g., fat free mass and fat mass). Importantly, linear EE models typically involve a non-zero (usually positive) y-intercept term of uncertain origin, a recurring theme in discussions of EE analysis and a source of confounding in traditional ratio-based EE normalization. Emerging linear model approaches quantify whole-body resting EE (REE) in terms of individual organ masses (e.g., liver, kidneys, heart, brain). Proponents of individual organ REE modeling hypothesize that multi-organ linear models may eliminate non-zero y-intercepts. This could have advantages in adjusting REE for body mass and composition. Studies reveal that individual organ REE is an allometric function of total body mass. I exploit first-order Taylor linearization of individual organ REEs to model the manner in which individual organs contribute to whole-body REE and to the non-zero y-intercept in linear REE models. The model predicts that REE analysis at the individual organ-tissue level will not eliminate intercept terms. I demonstrate that the parameters of a linear EE equation can be transformed into the parameters of the underlying 'latent' allometric equation. This permits estimates of the allometric scaling of EE in a diverse variety of physiological states that are not represented in the allometric EE literature but are well represented by published linear EE analyses.	Univ Washington, Sch Dent, Dept Oral Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kaiyala, KJ (corresponding author), Univ Washington, Sch Dent, Dept Oral Hlth Sci, Seattle, WA 98195 USA.	kkaiyala@UW.edu			National Institutes of Health [P30 DK035816, U24DK076169]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076169, P30DK035816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health Grants P30 DK035816, U24DK076169. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON DB, 1995, INT J OBESITY, V19, P644; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Bishop CM, 1999, P ROY SOC B-BIOL SCI, V266, P2275, DOI 10.1098/rspb.1999.0919; Bitz C, 2004, DIABETES CARE, V27, P2416, DOI 10.2337/diacare.27.10.2416; BOGARDUS C, 1986, DIABETES, V35, P1, DOI 10.2337/diabetes.35.1.1; Bosy-Westphal A, 2013, INT J OBESITY, V37, P1371, DOI 10.1038/ijo.2013.1; Bosy-Westphal A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00047; Breslow MJ, 1999, AM J PHYSIOL-ENDOC M, V276, pE443, DOI 10.1152/ajpendo.1999.276.3.E443; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Butte NF, 2007, J NUTR, V137, P2660, DOI 10.1093/jn/137.12.2660; Choi SJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE1031, DOI 10.1152/ajpendo.00656.2010; Clarke A, 2010, J ANIM ECOL, V79, P610, DOI 10.1111/j.1365-2656.2010.01672.x; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; DOBELN W. V., 1956, Acta Physiologica Scandinavica, V38, P193, DOI 10.1111/j.1748-1716.1957.tb01383.x; FONTVIEILLE AM, 1992, DIABETOLOGIA, V35, P753; FRANSSILAKALLUNKI A, 1992, DIABETOLOGIA, V35, P962, DOI 10.1007/BF00401426; Fuite J, 2006, COMMUN COMPUT PHYS, V2, P87; Gallagher D, 1998, AM J PHYSIOL-ENDOC M, V275, pE249, DOI 10.1152/ajpendo.1998.275.2.E249; Gallagher D, 2000, ANN NY ACAD SCI, V904, P449; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Hayes JP, 2006, PHYSIOL BIOCHEM ZOOL, V79, P665, DOI 10.1086/502814; Heil DP, 1997, MED SCI SPORT EXER, V29, P1602, DOI 10.1097/00005768-199712000-00009; HEUSNER AA, 1982, RESP PHYSIOL, V48, P1, DOI 10.1016/0034-5687(82)90046-9; HEUSNER AA, 1985, ANNU REV NUTR, V5, P267, DOI 10.1146/annurev.nu.05.070185.001411; HEUSNER AA, 1991, J NUTR, V121, pS8, DOI 10.1093/jn/121.suppl_11.S8; Heymsfield SB, 2012, OBES REV, V13, P1001, DOI 10.1111/j.1467-789X.2012.01019.x; Hochachka PW, 2003, COMP BIOCHEM PHYS A, V134, P675, DOI 10.1016/S1095-6433(02)00364-1; HOLLIDAY MA, 1967, PEDIATR RES, V1, P185, DOI 10.1203/00006450-196705000-00005; Hsu A, 2003, AM J CLIN NUTR, V77, P1506, DOI 10.1093/ajcn/77.6.1506; Javed F, 2010, AM J CLIN NUTR, V91, P907, DOI 10.3945/ajcn.2009.28512; Kaitaniemi P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001932; Kaiyala KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041473; Kaiyala KJ, 2011, DIABETES, V60, P17, DOI 10.2337/db10-0909; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Kaiyala KJ, 2014, WHAT DOES INDIRECT C; KATCH V, 1972, ERGONOMICS, V15, P671, DOI 10.1080/00140137208924467; KATCH VL, 1973, MED SCI SPORT EXER, V5, P253; KEESEY RE, 1990, INT J OBESITY, V14, P1079; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; Kleiber M., 1975, FIRE LIFE INTRO ANIM; KRONMAL RA, 1993, J ROY STAT SOC A STA, V156, P379, DOI 10.2307/2983064; Later W, 2008, AM J CLIN NUTR, V88, P1004, DOI 10.1093/ajcn/88.4.1004; Levine James A., 1999, Science (Washington D C), V283, P212, DOI 10.1126/science.283.5399.212; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Makimattila S, 1999, DIABETOLOGIA, V42, P406, DOI 10.1007/s001250051172; Muller MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022732; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; NELSON KM, 1992, AM J CLIN NUTR, V56, P848, DOI 10.1093/ajcn/56.5.848; Nise N. S., 2004, CONTROL SYSTEMS ENG; Novak CM, 2006, J NEUROENDOCRINOL, V18, P594, DOI 10.1111/j.1365-2826.2006.01454.x; POEHLMAN ET, 1995, AM J CLIN NUTR, V61, P482, DOI 10.1093/ajcn/61.3.482; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Rubner M., 1883, Z BIOL, V19, P535; Selman C, 2001, J EXP BIOL, V204, P777; Sieg AE, 2009, AM NAT, V174, P720, DOI 10.1086/606023; Speakman JR, 2013, DIS MODEL MECH, V6, P293, DOI 10.1242/dmm.009860; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; TANNER JM, 1949, J APPL PHYSIOL, V2, P1; TANNER JM, 1952, ARCH DIS CHILD, V27, P10, DOI 10.1136/adc.27.131.10; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; VONDOBELN W, 1956, ACTA PHYSIOL SCAND, V37, P1; Wang ZiMian, 2012, ISRN Zoology, P1; Wang ZM, 2012, OBESITY, V20, P95, DOI 10.1038/oby.2011.256; Wang ZM, 2011, AM J HUM BIOL, V23, P333, DOI 10.1002/ajhb.21137; Wang ZM, 2010, AM J CLIN NUTR, V92, P1369, DOI 10.3945/ajcn.2010.29885; Wang ZM, 2000, AM J PHYSIOL-ENDOC M, V279, pE539, DOI 10.1152/ajpendo.2000.279.3.E539; Wang ZM, 2001, J NUTR, V131, P2967, DOI 10.1093/jn/131.11.2967; Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548; WEINSIER RL, 1992, AM J CLIN NUTR, V55, P790, DOI 10.1093/ajcn/55.4.790; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Weyer C, 1999, DIABETES, V48, P1607, DOI 10.2337/diabetes.48.8.1607; White CR, 2005, J EXP BIOL, V208, P1611, DOI 10.1242/jeb.01501; White CR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P929, DOI 10.1086/425186; White CR, 2003, PHYSIOL BIOCHEM ZOOL, V76, P135, DOI 10.1086/367939; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2011, COMP BIOCHEM PHYS A, V158, P346, DOI 10.1016/j.cbpa.2010.10.004; White CR, 2009, EVOLUTION, V63, P2658, DOI 10.1111/j.1558-5646.2009.00747.x; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Zakeri I, 2006, J NUTR, V136, P1371, DOI 10.1093/jn/136.5.1371	81	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103301	10.1371/journal.pone.0103301	http://dx.doi.org/10.1371/journal.pone.0103301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068692	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993700056
J	Mich, JK; Payumo, AY; Rack, PG; Chen, JK				Mich, John K.; Payumo, Alexander Y.; Rack, Paul G.; Chen, James K.			In Vivo Imaging of Hedgehog Pathway Activation with a Nuclear Fluorescent Reporter	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; SONIC-HEDGEHOG; VERTEBRATE DEVELOPMENT; TRANSGENIC ZEBRAFISH; NEURAL-TUBE; MODEL; GENES; REVEALS; DOMAINS; CELLS	The Hedgehog (Hh) pathway is essential for embryonic develop to birth defects and tumorigenesis. Understanding how this these processes would benefit from an ability to visualize Hedgehog pathway activity in g h single-cell resolution. We report here the generation of transgenic zebrafish lines that express nuclear-localized mCherry fluorescent protein in a Gli transcription factor-dependent manner. As demonstrated by chemical and genetic perturbations, these lines faitfully report Hedgehog pathway state in individual cells and with high detection sensitivity. They will be valuable tools for studying dynamic Gli dependent processes in vertebrates and for identifying new chemical and genetic regulators of the Hh pathway.	[Mich, John K.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Payumo, Alexander Y.; Rack, Paul G.; Chen, James K.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Chen, James K.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Chen, JK (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	jameschen@stanford.edu	Chen, James/G-9972-2011	Chen, James/0000-0002-9220-8436; Rack, Philip/0000-0002-9964-3254	National Institutes of Health [DP1 HD075622]; American Cancer Society Research Scholar [RSG-08-041-01-DDC]; California Institute for Regenerative Medicine Scholar Award [T1-0001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar(American Cancer Society); California Institute for Regenerative Medicine Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (DP1 HD075622 to JKC), an American Cancer Society Research Scholar Grant (RSG-08-041-01-DDC to JKC), and a California Institute for Regenerative Medicine Scholar Award (T1-0001 to JKM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen WB, 2001, DEVELOPMENT, V128, P2385; Clark KJ, 2011, REV NEUROSCIENCE, V22, P49, DOI 10.1515/RNS.2011.007; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Gibert Y, 2013, CURR MED CHEM, V20, P2458, DOI 10.2174/0929867311320190005; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Huang P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002762; Iovine MK, 2007, NAT CHEM BIOL, V3, P613, DOI 10.1038/nchembio.2007.36; Karlstrom RO, 2003, DEVELOPMENT, V130, P1549, DOI 10.1242/dev.00364; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Ke ZY, 2005, DEV DYNAM, V232, P479, DOI 10.1002/dvdy.20242; Kokel D, 2012, TRENDS BIOTECHNOL, V30, P421, DOI 10.1016/j.tibtech.2012.05.001; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Laforest L, 1998, DEVELOPMENT, V125, P4175; Laux DW, 2011, DEV DYNAM, V240, P682, DOI 10.1002/dvdy.22558; Lawson ND, 2011, DEV CELL, V21, P48, DOI 10.1016/j.devcel.2011.06.007; Lewis KE, 1999, DEV BIOL, V208, P14, DOI 10.1006/dbio.1998.9169; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; LOETSCHER P, 1991, J BIOL CHEM, V266, P11213; Meijer AH, 2011, CURR DRUG TARGETS, V12, P1000; Mich JK, 2011, DEVELOPMENT, V138, P5113, DOI 10.1242/dev.066225; Molina GA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-62; Moro E, 2012, DEV BIOL, V366, P327, DOI 10.1016/j.ydbio.2012.03.023; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schwend T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014396; Sekimizu K, 2004, DEVELOPMENT, V131, P2521, DOI 10.1242/dev.01059; Seth A, 2013, DIS MODEL MECH, V6, P1080, DOI 10.1242/dmm.011346; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shimizu N, 2012, DEV BIOL, V370, P71, DOI 10.1016/j.ydbio.2012.07.016; Shkumatava A, 2004, DEVELOPMENT, V131, P3849, DOI 10.1242/dev.01247; Tal TL, 2010, GERONTOLOGY, V56, P231, DOI 10.1159/000259327; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Tyurina OV, 2005, DEV BIOL, V277, P537, DOI 10.1016/j.ydbio.2004.10.003; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Weber T, 2013, METHODS, V62, P279, DOI 10.1016/j.ymeth.2013.07.028; White R, 2013, NAT REV CANCER, V13, P624, DOI 10.1038/nrc3589; Wolff C, 2004, GENE DEV, V18, P1565, DOI 10.1101/gad.296004; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Yang HB, 2009, J BIOL CHEM, V284, P20876, DOI 10.1074/jbc.M807648200; Zhang J, 2012, DEV BIOL, V365, P424, DOI 10.1016/j.ydbio.2012.03.008	47	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103661	10.1371/journal.pone.0103661	http://dx.doi.org/10.1371/journal.pone.0103661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068273	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993700083
J	Park, SM; Cha, JM; Nam, J; Kim, MS; Park, SJ; Park, ES; Lee, H; Kim, HR				Park, Sun Min; Cha, Jae Min; Nam, Jungyong; Kim, Min Sang; Park, Sang-Jun; Park, Eun Sung; Lee, Hwankyu; Kim, Hyun Ryoung			Formulation Optimization and in Vivo Proof-of-Concept Study of Thermosensitive Liposomes Balanced by Phospholipid, Elastin-Like Polypeptide, and Cholesterol	PLOS ONE			English	Article							COARSE-GRAINED MODEL; DRUG-DELIVERY SYSTEMS; MOLECULAR SIMULATION; LOCAL HYPERTHERMIA; ENHANCED DELIVERY; MILD HYPERTHERMIA; LIPID-BILAYERS; FORCE-FIELD; DOXORUBICIN; RELEASE	One application of nanotechnology in medicine that is presently being developed involves a drug delivery system (DDS) employing nanoparticles to deliver drugs to diseased sites in the body avoiding damage of healthy tissue. Recently, the mild hyperthermia-triggered drug delivery combined with anticancer agent-loaded thermosensitive liposomes was widely investigated. In this study, thermosensitive liposomes (TSLs), composed of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-2000] (DSPE-PEG), cholesterol, and a fatty acid conjugated elastin-like polypeptide (ELP),were developed and optimized for triggered drug release, controlled by external heat stimuli. We introduced modified ELP, tunable for various biomedical purposes, to our thermosensitive liposome (e-TSL) to convey a high thermoresponsive property. We modulated thermosensitivity and stability by varying the ratios of e-TSL components, such as phospholipid, ELP, and cholesterol. Experimental data obtained in this study corresponded to results from a simulation study that demonstrated, through the calculation of the lateral diffusion coefficient, increased permeation of the lipid bilayer with higher ELP concentrations, and decreased permeation in the presence of cholesterol. Finally, we identified effective drug accumulation in tumor tissues and antitumor efficacy with our optimized e-TSL, while adjusting lag-times for systemic accumulation.	[Park, Sun Min; Cha, Jae Min; Nam, Jungyong; Kim, Min Sang; Park, Sang-Jun; Park, Eun Sung; Kim, Hyun Ryoung] SAIT, Bio Res Ctr, Drug Delivery Syst Grp, Yongin, Gyeonggi Do, South Korea; [Lee, Hwankyu] Dankook Univ, Dept Chem Engn, Yongin, Gyeonggi Do, South Korea	Samsung; Dankook University	Kim, HR (corresponding author), SAIT, Bio Res Ctr, Drug Delivery Syst Grp, Yongin, Gyeonggi Do, South Korea.	hyunryoung.kim@samsung.com		Lee, Hwankyu/0000-0002-2036-1490	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2012R1A1A1001196]; National Institute of Supercomputing and Networking/Korea Institute of Science and Technology Information with supercomputing resources [KSC-2013-C2-18]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology; National Institute of Supercomputing and Networking/Korea Institute of Science and Technology Information with supercomputing resources	The simulation part of this research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, and Technology (2012R1A1A1001196), and by the National Institute of Supercomputing and Networking/Korea Institute of Science and Technology Information with supercomputing resources, including technical support (KSC-2013-C2-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; BAE YH, 1987, MAKROMOL CHEM-RAPID, V8, P481; Banno B, 2010, J PHARM SCI-US, V99, P2295, DOI 10.1002/jps.21988; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071; Dreher MR, 2003, J CONTROL RELEASE, V91, P31, DOI 10.1016/S0168-3659(03)00216-5; GABIZON AA, 1992, CANCER RES, V52, P891; Haidar ZS, 2010, POLYMERS-BASEL, V2, P323, DOI 10.3390/polym2030323; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HUANG SK, 1994, CANCER RES, V54, P2186; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218; Kong G, 2000, CANCER RES, V60, P6950; Koo OM, 2005, NANOMED-NANOTECHNOL, V1, P193, DOI 10.1016/j.nano.2005.06.004; Koynova R, 1998, BBA-REV BIOMEMBRANES, V1376, P91, DOI 10.1016/S0304-4157(98)00006-9; Lee H, 2012, MACROMOLECULES, V45, P7304, DOI 10.1021/ma301327j; Li L, 2013, J CONTROL RELEASE, V168, P142, DOI 10.1016/j.jconrel.2013.03.011; Li L, 2013, J CONTROL RELEASE, V167, P130, DOI 10.1016/j.jconrel.2013.01.026; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Liu WE, 2006, J CONTROL RELEASE, V116, P170, DOI 10.1016/j.jconrel.2006.06.026; Manzoor AA, 2012, CANCER RES, V72, P5566, DOI 10.1158/0008-5472.CAN-12-1683; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2005, CHEM PHYS LIPIDS, V135, P223, DOI 10.1016/j.chemphyslip.2005.03.001; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; MARUYAMA K, 1993, BIOCHIM BIOPHYS ACTA, V1149, P209, DOI 10.1016/0005-2736(93)90203-C; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Nettles DL, 2010, ADV DRUG DELIVER REV, V62, P1479, DOI 10.1016/j.addr.2010.04.002; Park SM, 2013, J CONTROL RELEASE, V170, P373, DOI 10.1016/j.jconrel.2013.06.003; Salata OV, 2004, J Nanobiotechnology, V2, P3, DOI 10.1186/1477-3155-2-3; Sandstrom MC, 2005, J CONTROL RELEASE, V107, P131, DOI 10.1016/j.jconrel.2005.06.001; Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus; Tagami T, 2011, J CONTROL RELEASE, V152, P303, DOI 10.1016/j.jconrel.2011.02.009; UNEZAKI S, 1994, PHARMACEUT RES, V11, P1180, DOI 10.1023/A:1018949218380; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291	35	16	22	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e103116	10.1371/journal.pone.0103116	http://dx.doi.org/10.1371/journal.pone.0103116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25068721	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993700035
J	Rondeau, EB; Minkley, DR; Leong, JS; Messmer, AM; Jantzen, JR; von Schalburg, KR; Lemon, C; Bird, NH; Koop, BF				Rondeau, Eric B.; Minkley, David R.; Leong, Jong S.; Messmer, Amber M.; Jantzen, Johanna R.; von Schalburg, Kristian R.; Lemon, Craig; Bird, Nathan H.; Koop, Ben F.			The Genome and Linkage Map of the Northern Pike (Esox lucius): Conserved Synteny Revealed between the Salmonid Sister Group and the Neoteleostei	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RAY-FINNED FISHES; TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; REPETITIVE ELEMENTS; TELEOST FISHES; DNA-SEQUENCES; EVOLUTION; DUPLICATION; GENES	The northern pike is the most frequently studied member of the Esociformes, the closest order to the diverse and economically important Salmoniformes. The ancestor of all salmonids purportedly experienced a whole-genome duplication (WGD) event, making salmonid species ideal for studying the early impacts of genome duplication while complicating their use in wider analyses of teleost evolution. Studies suggest that the Esociformes diverged from the salmonid lineage prior to the WGD, supporting the use of northern pike as a pre-duplication outgroup. Here we present the first genome assembly, reference transcriptome and linkage map for northern pike, and evaluate the suitability of this species to provide a representative pre-duplication genome for future studies of salmonid and teleost evolution. The northern pike genome sequence is composed of 94,267 contigs (N50 = 16,909 bp) contained in 5,688 scaffolds (N50 = 700,535 bp); the total scaffolded genome size is 878 million bases. Multiple lines of evidence suggest that over 96% of the protein-coding genome is present in the genome assembly. The reference transcriptome was constructed from 13 tissues and contains 38,696 transcripts, which are accompanied by normalized expression data in all tissues. Gene-prediction analysis produced a total of 19,601 northern pike-specific gene models. The first-generation linkage map identifies 25 linkage groups, in agreement with northern pike's diploid karyotype of 2N = 50, and facilitates the placement of 46% of assembled bases onto linkage groups. Analyses reveal a high degree of conserved synteny between northern pike and other model teleost genomes. While conservation of gene order is limited to smaller syntenic blocks, the wider conservation of genome organization implies the northern pike exhibits a suitable approximation of a non-duplicated Protacanthopterygiian genome. This dataset will facilitate future studies of esocid biology and empower ongoing examinations of the Atlantic salmon and rainbow trout genomes by facilitating their comparison with other major teleost groups. Citation:	[Rondeau, Eric B.; Minkley, David R.; Leong, Jong S.; Messmer, Amber M.; Jantzen, Johanna R.; von Schalburg, Kristian R.; Bird, Nathan H.; Koop, Ben F.] Univ Victoria, Dept Biol, Ctr Biomed Res, Victoria, BC V8W 2Y2, Canada; [Lemon, Craig] Charles O Hayford Hackettstown State Fish Hatcher, Hackettstown, NJ USA	University of Victoria	Koop, BF (corresponding author), Univ Victoria, Dept Biol, Ctr Biomed Res, POB 1700, Victoria, BC V8W 2Y2, Canada.	bkoop@uvic.ca	Koop, Ben F./A-8151-2008	Koop, Ben F./0000-0003-0045-5200; Leong, Jong/0000-0001-6521-9239	Natural Sciences and Engineering Research Council of Canada; NSERC; government of British Columbia	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); government of British Columbia	This study was primarily supported by a grant from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) to BFK; additional resources were provided by the University of Victoria (www.uvic.ca). Support was provided by NSERC through a postgraduate scholarship to EBR and by the government of British Columbia to support DRM. Compute Canada (www.computecanada.ca) contributed computing resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F.W., 1984, P1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; BEAMISH RJ, 1971, CHROMOSOMA, V34, P436, DOI 10.1007/BF00326315; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Betancur R R, 2013, PLOS CURR, V5, DOI DOI 10.3389/fmars.2019.00628; Blacket MJ, 2012, MOL ECOL RESOUR, V12, P456, DOI 10.1111/j.1755-0998.2011.03104.x; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Campbell MA, 2013, GENE, V530, P57, DOI 10.1016/j.gene.2013.07.068; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Craig JF, 2008, HYDROBIOLOGIA, V601, P5, DOI 10.1007/s10750-007-9262-3; Crossman EJ, 2001, COPEIA, P860; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; de Boer JG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-422; Dittmar K, 2011, EVOLUTION GENE DUPLI; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gonen S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-166; Gotoh RO, 2013, MOL ECOL RESOUR, V13, P461, DOI 10.1111/1755-0998.12070; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gregory T. R., 2013, ANIMAL GENOME SIZE D; Hardie DC, 2004, CAN J FISH AQUAT SCI, V61, P1636, DOI 10.1139/F04-106; Hardie DC, 2003, GENOME, V46, P683, DOI 10.1139/G03-040; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Howe K., 2013, NATURE, V496, P498, DOI DOI 10.1038/NATURE12111; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Katju Vaishali, 2013, Frontiers in Genetics, V4, P273, DOI 10.3389/fgene.2013.00273; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Launey S, 2003, MOL ECOL NOTES, V3, P366, DOI 10.1046/j.1471-8286.2003.00452.x; Leong JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-279; Li J, 2010, MOL PHYLOGENET EVOL, V57, P932, DOI 10.1016/j.ympev.2010.07.016; Lien S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-615; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lu JG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-246; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Macqueen DJ, 2014, P BIOL SCI, P281; Mank JE, 2006, GENETICA, V127, P321, DOI 10.1007/s10709-005-5248-0; Messmer AM, 2011, AQUACULTURE, V320, P183, DOI 10.1016/j.aquaculture.2010.09.033; Miller LM, 2003, N AM J FISH MANAGE, V23, P297, DOI 10.1577/1548-8675(2003)023&lt;0297:ARONPP&gt;2.0.CO;2; Miller LM, 1996, T AM FISH SOC, V125, P971, DOI 10.1577/1548-8659(1996)125&lt;0971:NMDMRN&gt;2.3.CO;2; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Nelson JS, 1984, FISHES WORLD; Nilsson PA, 2008, HYDROBIOLOGIA, V601, P137, DOI 10.1007/s10750-007-9260-5; Nordine RN, 1985, PEACE RIVER AREA CHA; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ouellet-Cauchon G, 2014, CONSERV GENET RESOUR, V6, P451, DOI 10.1007/s12686-013-0123-2; Palaiokostas C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-566; Poptsova MS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04532; Raat A.J.P., 1988, FAO FISHERIES SYNOPS, V30, P1; RAB P, 1994, CAN J ZOOL, V72, P1951, DOI 10.1139/z94-265; Rexroad CE, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-74; Roche Applied Science, 2006, GMBHUSM0022B ROCH DI; Rondeau EB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-452; Sambrook J, 2001, MOL CLONING LAB MANU; Semon M, 2008, P NATL ACAD SCI USA, V105, P8333, DOI 10.1073/pnas.0708705105; Shiina T, 2005, IMMUNOGENETICS, V56, P878, DOI 10.1007/s00251-004-0755-1; Singer A, 2002, GENETICS, V160, P649; Smit A, 1996, REPEATMASKER OPEN 30; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Talevich E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-209; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Thorgaard GH, 2002, COMP BIOCHEM PHYS B, V133, P609, DOI 10.1016/S1096-4959(02)00167-7; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Vinogradov AE, 1998, CYTOMETRY, V31, P100, DOI 10.1002/(SICI)1097-0320(19980201)31:2<100::AID-CYTO5>3.0.CO;2-Q; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-96; Wang J, 2011, GENET MOL BIOL, V34, P169, DOI 10.1590/S1415-47572010005000114; Wegrzyn JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072439; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wolfe K, 2000, NAT GENET, V25, P3, DOI 10.1038/75560; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Zou M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00665	93	87	91	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2014	9	7							e102089	10.1371/journal.pone.0102089	http://dx.doi.org/10.1371/journal.pone.0102089			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RZ	25069045	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993700004
J	Zhang, B; Chen, SY; He, XY; Liu, WJ; Zhao, Q; Zhao, L; Tian, CJ				Zhang, Bin; Chen, Shengyun; He, Xingyuan; Liu, Wenjie; Zhao, Qian; Zhao, Lin; Tian, Chunjie			Responses of Soil Microbial Communities to Experimental Warming in Alpine Grasslands on the Qinghai-Tibet Plateau	PLOS ONE			English	Article							CLIMATE-CHANGE MANIPULATIONS; CARBON-CYCLE FEEDBACK; DYNAMICS; BACTERIA; FUNGI; MICROORGANISMS; TEMPERATURE; MOISTURE; LITTER; GROWTH	Global surface temperature is predicted to increase by at least 1.5 degrees C by the end of this century. However, the response of soil microbial communities to global warming is still poorly understood, especially in high-elevation grasslands. We therefore conducted an experiment on three types of alpine grasslands on the Qinghai-Tibet Plateau to study the effect of experimental warming on abundance and composition of soil microbial communities at 0-10 and 10-20 cm depths. Plots were passively warmed for 3 years using open-top chambers and compared to adjacent control plots at ambient temperature. Soil microbial communities were assessed using phospholipid fatty acid (PLFA) analysis. We found that 3 years of experimental warming consistently and significantly increased microbial biomass at the 0-10 cm soil depth of alpine swamp meadow (ASM) and alpine steppe (AS) grasslands, and at both the 0-10 and 10-20 cm soil depths of alpine meadow (AM) grasslands, due primarily to the changes in soil temperature, moisture, and plant coverage. Soil microbial community composition was also significantly affected by warming at the 0-10 cm soil depth of ASM and AM and at the 10-20 cm soil depth of AM. Warming significantly decreased the ratio of fungi to bacteria and thus induced a community shift towards bacteria at the 0-10 cm soil depth of ASM and AM. While the ratio of arbuscular mycorrhizal fungi to saprotrophic fungi (AMF/SF) was significantly decreased by warming at the 0-10 cm soil depth of ASM, it was increased at the 0-10 cm soil depth of AM. These results indicate that warming had a strong influence on soil microbial communities in the studied high-elevation grasslands and that the effect was dependent on grassland type.	[Zhang, Bin; He, Xingyuan; Tian, Chunjie] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China; [Chen, Shengyun; Liu, Wenjie; Zhao, Qian; Zhao, Lin] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, State Key Lab Cryospher Sci, Lanzhou, Peoples R China; [Zhao, Lin] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Observat & Res Stn Qinghai Tibet Plateau, Golmud, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Tian, CJ (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China.	tiancj@iga.ac.cn	Cai, Guanjing/GZK-7070-2022; Zhang, Bangzhou/CAG-9625-2022; Zhao, Lin/M-9536-2018	Zhao, Lin/0000-0003-0245-8413	National Basic Research Program of China (973 program) [2013CBA01807]; Science Foundation of Chinese Academy of Sciences [KZZD-EW-TZ-16]; National Natural Science Foundation of China [Y4E1041001, 40901040]; Natural Science Foundation of Jilin Province [20130101080JC]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Science Foundation of Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province	This work was financially supported by the National Basic Research Program of China (973 program, 2013CBA01807, http://www.973.gov.cn/Default_3.aspx), the Science Foundation of Chinese Academy of Sciences (KZZD-EW-TZ-16, http://www.cas.cn/), the National Natural Science Foundation of China (Y4E1041001,40901040, http://www.nsfc.gov.cn/) and the Natural Science Foundation of Jilin Province (20130101080JC, http://kjt.jl.gov.cn/kjt/4/tindex.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP; [Anonymous], 2013, CLIM CHANG 2013 PHYS; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Berg N, 2008, SOIL BIOL BIOCHEM, V40, P2686, DOI 10.1016/j.soilbio.2008.07.019; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; [陈生云 Chen Shengyun], 2012, [冰川冻土, Journal of Glaciology and Geocryology], V34, P1142; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Crowther TW, 2012, ISME J, V6, P1992, DOI 10.1038/ismej.2012.53; Deslippe JR, 2012, FEMS MICROBIOL ECOL, V82, P303, DOI 10.1111/j.1574-6941.2012.01350.x; Eklof JS, 2012, ECOL LETT, V15, P864, DOI 10.1111/j.1461-0248.2012.01810.x; Frey SD, 2008, SOIL BIOL BIOCHEM, V40, P2904, DOI 10.1016/j.soilbio.2008.07.020; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Grimm NB, 2013, FRONT ECOL ENVIRON, V11, P474, DOI 10.1890/120282; Guo DL, 2012, INT J CLIMATOL, V32, P1775, DOI 10.1002/joc.2388; Haugwitz MS, 2014, PLANT SOIL, V374, P211, DOI 10.1007/s11104-013-1855-1; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Posada RH, 2012, FUNGAL BIOL-UK, V116, P747, DOI 10.1016/j.funbio.2012.04.003; Institute of Soil Sciences Chinese Academy of Sciences, 1978, PHYS CHEM AN METH SO, P7; IUSS Working Group WRB, 2006, WORLD REFERENCE BASE, V103; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jackson RB, 2007, ECOLOGY, V88, P1343, DOI 10.1890/06-1882; KIEFT TL, 1994, APPL ENVIRON MICROB, V60, P3292, DOI 10.1128/AEM.60.9.3292-3299.1994; Klein JA, 2005, GLOBAL CHANGE BIOL, V11, P1440, DOI 10.1111/j.1365-2486.2005.00994.x; Liang C, 2012, APPL SOIL ECOL, V54, P24, DOI 10.1016/j.apsoil.2011.11.015; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Liu WJ, 2014, ENV RES LET IN PRESS; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Luo CY, 2010, GLOBAL CHANGE BIOL, V16, P1606, DOI 10.1111/j.1365-2486.2009.02026.x; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Margesin R, 2009, FEMS MICROBIOL ECOL, V67, P208, DOI 10.1111/j.1574-6941.2008.00620.x; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; Mille-Lindblom C, 2006, OIKOS, V113, P233, DOI 10.1111/j.2006.0030-1299.14337.x; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Rinnan R, 2007, GLOBAL CHANGE BIOL, V13, P28, DOI 10.1111/j.1365-2486.2006.01263.x; Rousk J, 2011, FEMS MICROBIOL ECOL, V78, P17, DOI 10.1111/j.1574-6941.2011.01106.x; Sheik CS, 2011, ISME J, V5, P1692, DOI 10.1038/ismej.2011.32; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Wen Z, 2014, ENVIRON EARTH SCI, V71, P1195, DOI 10.1007/s12665-013-2523-8; Wixon DL, 2013, SOIL BIOL BIOCHEM, V57, P769, DOI 10.1016/j.soilbio.2012.08.016; Yergeau E, 2012, ISME J, V6, P692, DOI 10.1038/ismej.2011.124; Yuan YL, 2014, FEMS MICROBIOL ECOL, V87, P121, DOI 10.1111/1574-6941.12197; Zhang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066184; Zhang B, 2012, SOIL TILL RES, V124, P153, DOI 10.1016/j.still.2012.05.011; Zhang NL, 2013, OECOLOGIA, V173, P1125, DOI 10.1007/s00442-013-2685-9; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078616; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	51	64	80	11	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103859	10.1371/journal.pone.0103859	http://dx.doi.org/10.1371/journal.pone.0103859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	24675867	Green Submitted, Green Published, gold			2022-12-25	WOS:000339819800091
J	Ward, ME; McMahon, G; St Pourcain, B; Evans, DM; Rietveld, CA; Benjamin, DJ; Koellinger, PD; Cesarini, D; Smith, GD; Timpson, NJ				Ward, Mary E.; McMahon, George; St Pourcain, Beate; Evans, David M.; Rietveld, Cornelius A.; Benjamin, Daniel J.; Koellinger, Philipp D.; Cesarini, David; Smith, George Davey; Timpson, Nicholas J.		Social Sci Genetic Assoc Consortiu	Genetic Variation Associated with Differential Educational Attainment in Adults Has Anticipated Associations with School Performance in Children	PLOS ONE			English	Article							HERITABILITY	Genome-wide association study results have yielded evidence for the association of common genetic variants with crude measures of completed educational attainment in adults. Whilst informative, these results do not inform as to the mechanism of these effects or their presence at earlier ages and where educational performance is more routinely and more precisely assessed. Single nucleotide polymorphisms exhibiting genome-wide significant associations with adult educational attainment were combined to derive an unweighted allele score in 5,979 and 6,145 young participants from the Avon Longitudinal Study of Parents and Children with key stage 3 national curriculum test results (SATS results) available at age 13 to 14 years in English and mathematics respectively. Standardised (z-scored) results for English and mathematics showed an expected relationship with sex, with girls exhibiting an advantage over boys in English (0.433 SD (95%CI 0.395, 0.470), p<10(-10)) with more similar results (though in the opposite direction) in mathematics (0.042 SD (95%CI 0.004, 0.080), p = 0.030). Each additional adult educational attainment increasing allele was associated with 0.041 SD (95%CI 0.020, 0.063), p = 1.79 x 10(-04) and 0.028 SD (95%CI 0.007, 0.050), p = 0.01 increases in standardised SATS score for English and mathematics respectively. Educational attainment is a complex multifactorial behavioural trait which has not had heritable contributions to it fully characterised. We were able to apply the results from a large study of adult educational attainment to a study of child exam performance marking events in the process of learning rather than realised adult end product. Our results support evidence for common, small genetic contributions to educational attainment, but also emphasise the likely lifecourse nature of this genetic effect. Results here also, by an alternative route, suggest that existing methods for child examination are able to recognise early life variation likely to be related to ultimate educational attainment.	[Ward, Mary E.; McMahon, George; St Pourcain, Beate; Evans, David M.; Smith, George Davey; Timpson, Nicholas J.] Univ Bristol, Sch Social & Community Med, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [St Pourcain, Beate] Univ Bristol, Sch Oral & Dent Sci, Bristol, Avon, England; [St Pourcain, Beate] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Evans, David M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Rietveld, Cornelius A.; Koellinger, Philipp D.] Erasmus Univ, Erasmus Sch Econ, Dept Appl Econ, Rotterdam, Netherlands; [Rietveld, Cornelius A.; Koellinger, Philipp D.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Benjamin, Daniel J.] Cornell Univ, Dept Econ, Ithaca, NY 14853 USA; [Koellinger, Philipp D.] Univ Amsterdam, Amsterdam Business Sch, Amsterdam, Netherlands; [Cesarini, David] NYU, Dept Econ, Ctr Expt Social Sci, New York, NY 10003 USA; [Cesarini, David] New York Univ Abu Dhabi, Div Social Sci, Abu Dhabi, U Arab Emirates; [Cesarini, David] Res Inst Ind Econ, Stockholm, Sweden	University of Bristol; University of Bristol; University of Bristol; University of Queensland; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Cornell University; University of Amsterdam; New York University; Research Institute of Industrial Economics (IFN)	Timpson, NJ (corresponding author), Univ Bristol, Sch Social & Community Med, MRC, Integrat Epidemiol Unit, Bristol, Avon, England.	n.j.timpson@bris.ac.uk	Evans, David M/H-6325-2013; Fox, Laura J/C-6249-2016; Davey Smith, George/A-7407-2013; Attrill, Lauren/V-1688-2018; St Pourcain, Beate/K-8004-2017; Timpson, Nicholas John/O-7548-2015	Evans, David M/0000-0003-0663-4621; Davey Smith, George/0000-0002-1407-8314; St Pourcain, Beate/0000-0002-4680-3517; Timpson, Nicholas John/0000-0002-7141-9189; Koellinger, Philipp/0000-0001-7413-0412; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Cesarini, David/0000-0002-0043-009X; Munafo, Marcus/0000-0002-4049-993X; s, hema/0000-0002-3440-9475	Wellcome Trust PhD studentship award [099873/Z/12/Z]; Wellcome Trust [092731]; MRC [MC_UU_12013/4, MC_UU_12013/1, MC_UU_12013/3] Funding Source: UKRI; Medical Research Council [MC_UU_12013/4, MC_UU_12013/1, MC_UU_12013/3, MC_PC_15018] Funding Source: researchfish	Wellcome Trust PhD studentship award(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MEW is funded through a Wellcome Trust PhD studentship award (grant ref. 099873/Z/12/Z) (http://www.wellcome.ac.uk/). NJT, DME and GDS work in the UK Medical Research Council and University of Bristol Integrative Epidemiology Unit. The UK Medical Research Council (http://www.mrc.ac.uk/) and the Wellcome Trust (grant ref: 092731) and the University of Bristol (http://www.bristol.ac.uk/) provide core support for ALSPAC. The authors have declared that no competing interests exist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Bartels M, 2002, TWIN RES, V5, P544, DOI 10.1375/136905202762342017; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Branigan AR, 2013, SOC FORCES, V92, P109, DOI 10.1093/sf/sot076; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; de Moor MHM, 2012, MOL PSYCHIATR, V17, P337, DOI 10.1038/mp.2010.128; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Johnson W, 2011, AM J EPIDEMIOL, V173, P55, DOI 10.1093/aje/kwq333; Levacic R, 2005, RR679 DFES DEP ED SK; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Miller P, 2001, ECON EDUC REV, V20, P211, DOI 10.1016/S0272-7757(00)00018-2; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Shakeshaft NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080341; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; TAUBMAN P, 1976, AM ECON REV, V66, P858; UNESCO, 2006, INT STAND CLASS ED; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	25	48	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100248	10.1371/journal.pone.0100248	http://dx.doi.org/10.1371/journal.pone.0100248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8VR	25032841	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300008
J	Zhang, DP; Chen, L; Li, DH; Lv, B; Chen, Y; Chen, JG; Yan, XJ; Liang, JS				Zhang, Dongping; Chen, Li; Li, Dahong; Lv, Bing; Chen, Yun; Chen, Jingui; Yan, Xuejiao; Liang, Jiansheng			OsRACK1 Is Involved in Abscisic Acid- and H2O2-Mediated Signaling to Regulate Seed Germination in Rice (Oryza sativa, L.)	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; PROTEOMIC ANALYSIS; INNATE IMMUNITY; ABA CATABOLISM; RACK1; DORMANCY; PROTEIN; GENE; TRANSCRIPTION; NETWORKS	The receptor for activated C kinase 1 (RACK1) is one member of the most important WD repeat-containing family of proteins found in all eukaryotes and is involved in multiple signaling pathways. However, compared with the progress in the area of mammalian RACK1, our understanding of the functions and molecular mechanisms of RACK1 in the regulation of plant growth and development is still in its infancy. In the present study, we investigated the roles of rice RACK1A gene (OsRACK1A) in controlling seed germination and its molecular mechanisms by generating a series of transgenic rice lines, of which OsRACK1A was either over-expressed or under-expressed. Our results showed that OsRACK1A positively regulated seed germination and negatively regulated the responses of seed germination to both exogenous ABA and H2O2. Inhibition of ABA biosynthesis had no enhancing effect on germination, whereas inhibition of ABA catabolism significantly suppressed germination. ABA inhibition on seed germination was almost fully recovered by exogenous H2O2 treatment. Quantitative analyses showed that endogenous ABA levels were significantly higher and H2O2 levels significantly lower in OsRACK1A-down regulated transgenic lines as compared with those in wildtype or OsRACK1A-up regulated lines. Quantitative real-time PCR analyses showed that the transcript levels of OsRbohs and amylase genes, RAmy1A and RAmy3D, were significantly lower in OsRACK1A-down regulated transgenic lines. It is concluded that OsRACK1A positively regulates seed germination by controlling endogenous levels of ABA and H2O2 and their interaction.	[Zhang, Dongping; Chen, Li; Lv, Bing; Chen, Yun; Yan, Xuejiao; Liang, Jiansheng] Yangzhou Univ, Coll Biosci & Biotechnol, Dept Biotechnol, Yangzhou, Jiangsu, Peoples R China; [Li, Dahong] Huanghuai Univ, Dept Biol Engn, Zhumadian City, Henan Province, Peoples R China; [Chen, Jingui] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	Yangzhou University; Huanghuai University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Liang, JS (corresponding author), Yangzhou Univ, Coll Biosci & Biotechnol, Dept Biotechnol, Yangzhou, Jiangsu, Peoples R China.	jsliang@yzu.edu.cn	Chen, Jin-Gui/AFV-6337-2022; Chen, Jin-Gui/A-4773-2011; Zhang, Dongping/AAD-9164-2019	Chen, Jin-Gui/0000-0002-1752-4201; Chen, Jin-Gui/0000-0002-1752-4201; Zhang, Dongping/0000-0001-8564-8348; Yu, Jianming/0000-0001-5326-3099	National Science Foundation of China [31271622]; Hi-Tech Research and Development Program ("863" project) from the Ministry of Science and Technology of China [2008AA10Z120]; College Postgraduate Research and Innovation Project in Jiangsu Province; University Innovation Training Program of Jiangsu Province	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program ("863" project) from the Ministry of Science and Technology of China; College Postgraduate Research and Innovation Project in Jiangsu Province; University Innovation Training Program of Jiangsu Province	This work was supported by the National Science Foundation of China (grant no: 31271622 to JSL) and the Hi-Tech Research and Development Program ("863" project) from the Ministry of Science and Technology of China (grant no: 2008AA10Z120 to JSL), and by the College Postgraduate Research and Innovation Project in Jiangsu Province (to DPZ) and University Innovation Training Program of Jiangsu Province (to SJY) for research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DR, 2011, CELL COMMUN SIGNAL, V9, P823; Bahin E, 2011, PLANT CELL ENVIRON, V34, P980, DOI 10.1111/j.1365-3040.2011.02298.x; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Bailly C, 2008, CR BIOL, V331, P806, DOI 10.1016/j.crvi.2008.07.022; Barba-Espin G, 2010, PLANT CELL ENVIRON, V33, P981, DOI 10.1111/j.1365-3040.2010.02120.x; Bassel GW, 2008, PLANT PHYSIOL, V147, P143, DOI 10.1104/pp.107.110841; Bassel GW, 2011, P NATL ACAD SCI USA, V108, P9709, DOI 10.1073/pnas.1100958108; Belmonte MF, 2013, P NATL ACAD SCI USA, V110, pE435, DOI 10.1073/pnas.1222061110; Chaudhuri A., 2013, J PLANT BIOCH PHYSL, DOI [10.4172/jpbp.1000103, DOI 10.4172/JPBP.1000103]; Chen JG, 2006, J EXP BOT, V57, P2697, DOI 10.1093/jxb/erl035; Chen SH, 2004, J BIOL CHEM, V279, P17861, DOI 10.1074/jbc.M313727200; Chen Y, 2006, PLANT PHYSIOL, V140, P302, DOI 10.1104/pp.105.069872; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Diaz-Vivancos P, 2013, PLANT CELL REP, V32, P1491, DOI 10.1007/s00299-013-1473-7; El-Maarouf-Bouteau H, 2008, PLANT SIGNAL BEHAV, V3, P175, DOI 10.4161/psb.3.3.5539; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Gallardo K, 2001, PLANT PHYSIOL, V126, P835, DOI 10.1104/pp.126.2.835; Guo J., 2007, INT J PLANT DEV BIOL, V1, P95; Guo JJ, 2011, PLANT PHYSIOL, V155, P370, DOI 10.1104/pp.110.160663; Guo JJ, 2009, J EXP BOT, V60, P3819, DOI 10.1093/jxb/erp221; He DL, 2011, PROTEOMICS, V11, P2693, DOI 10.1002/pmic.201000598; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Howell KA, 2009, PLANT PHYSIOL, V149, P961, DOI 10.1104/pp.108.129874; Ishibashi Yushi, 2013, Ann Bot, V111, P95, DOI 10.1093/aob/mcs240; Ishibashi Y, 2008, PLANT SIGNAL BEHAV, V3, P183, DOI 10.4161/psb.3.3.5540; Ishida S, 1996, PLANT CELL PHYSIOL, V37, P439, DOI 10.1093/oxfordjournals.pcp.a028965; ISHIDA S, 1993, P NATL ACAD SCI USA, V90, P11152, DOI 10.1073/pnas.90.23.11152; Islas-Flores T, 2012, PLANT SIGNAL BEHAV, V7, P132, DOI 10.4161/psb.7.1.18485; Islas-Flores T, 2009, PHYSIOL PLANTARUM, V137, P264, DOI 10.1111/j.1399-3054.2009.01280.x; IWASAKI Y, 1995, PLANT CELL PHYSIOL, V36, P505, DOI 10.1093/oxfordjournals.pcp.a078786; Kim ST, 2008, PROTEOMICS, V8, P3577, DOI 10.1002/pmic.200800183; Kundu N, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24012; Leymarie J, 2012, PLANT CELL PHYSIOL, V53, P96, DOI 10.1093/pcp/pcr129; Li Da-hong, 2008, Zhongguo Shuidao Kexue, V22, P447; Li DC, 2011, ENZYM RES, V2011, DOI DOI 10.1016/J.CATT0D.2011.04.007; Liu Jian, 2012, PLoS One, V7, pe33817, DOI 10.1371/journal.pone.0033817; Liu YG, 2010, J EXP BOT, V61, P2979, DOI 10.1093/jxb/erq125; Muller K, 2010, PROTEOMICS, V10, P406, DOI 10.1002/pmic.200900548; Muller K, 2009, NEW PHYTOL, V184, P885, DOI 10.1111/j.1469-8137.2009.03005.x; Nakashima A, 2008, PLANT CELL, V20, P2265, DOI 10.1105/tpc.107.054395; Nonogaki H, 2010, PLANT SCI, V179, P574, DOI 10.1016/j.plantsci.2010.02.010; Okamoto M, 2010, PLANT J, V62, P39, DOI 10.1111/j.1365-313X.2010.04135.x; Oracz K, 2007, PLANT J, V50, P452, DOI 10.1111/j.1365-313X.2007.03063.x; Oracz K, 2009, PLANT PHYSIOL, V150, P494, DOI 10.1104/pp.109.138107; QUARRIE SA, 1988, PLANTA, V173, P330, DOI 10.1007/BF00401020; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Wamaitha MJ, 2012, RICE, V5, DOI 10.1186/1939-8433-5-35; Wang PT, 2008, NEW PHYTOL, V178, P703, DOI 10.1111/j.1469-8137.2008.02431.x; Yang PF, 2007, PROTEOMICS, V7, P3358, DOI 10.1002/pmic.200700207; Ye NH, 2012, J EXP BOT, V63, P1809, DOI 10.1093/jxb/err336; Zhu GH, 2009, PLANT CELL PHYSIOL, V50, P644, DOI 10.1093/pcp/pcp022	53	33	37	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97120	10.1371/journal.pone.0097120	http://dx.doi.org/10.1371/journal.pone.0097120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	25072699	Green Published, gold			2022-12-25	WOS:000336914100011
J	Lin, YF; Nagasawa, H; Little, JB; Kato, TA; Shih, HY; Xie, XJ; Wilson, PF; Brogan, JR; Kurimasa, A; Chen, DJ; Bedford, JS; Chen, BPC				Lin, Yu-Fen; Nagasawa, Hatsumi; Little, John B.; Kato, Takamitsu A.; Shih, Hung-Ying; Xie, Xian-Jin; Wilson, Paul F., Jr.; Brogan, John R.; Kurimasa, Akihiro; Chen, David J.; Bedford, Joel S.; Chen, Benjamin P. C.			Differential Radiosensitivity Phenotypes of DNA-PKcs Mutations Affecting NHEJ and HRR Systems following Irradiation with Gamma-Rays or Very Low Fluences of Alpha Particles	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; SISTER-CHROMATID EXCHANGES; RADIATION-SENSITIVE MUTANT; POTENTIALLY LETHAL DAMAGE; CELL-CYCLE PROGRESSION; DOUBLE-STRAND BREAKS; ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; CHROMOSOME-ABERRATIONS; CATALYTIC SUBUNIT	We have examined cell-cycle dependence of chromosomal aberration induction and cell killing after high or low dose-rate gamma irradiation in cells bearing DNA-PKcs mutations in the S2056 cluster, the T2609 cluster, or the kinase domain. We also compared sister chromatid exchanges (SCE) production by very low fluences of alpha-particles in DNA-PKcs mutant cells, and in homologous recombination repair (HRR) mutant cells including Rad51C, Rad51D, and Fancg/xrcc9. Generally, chromosomal aberrations and cell killing by gamma-rays were similarly affected by mutations in DNA-PKcs, and these mutant cells were more sensitive in G(1) than in S/G(2) phase. In G(1)-irradiated DNA-PKcs mutant cells, both chromosome- and chromatid-type breaks and exchanges were in excess than wild-type cells. For cells irradiated in late S/G(2) phase, mutant cells showed very high yields of chromatid breaks compared to wild-type cells. Few exchanges were seen in DNA-PKcs-null, Ku80-null, or DNA-PKcs kinase dead mutants, but exchanges in excess were detected in the S2506 or T2609 cluster mutants. SCE induction by very low doses of alpha-particles is resulted from bystander effects in cells not traversed by alpha-particles. SCE seen in wild-type cells was completely abolished in Rad51C- or Rad51D-deficient cells, but near normal in Fancg/xrcc9 cells. In marked contrast, very high levels of SCEs were observed in DNA-PKcs-null, DNA-PKcs kinase-dead and Ku80-null mutants. SCE induction was also abolished in T2609 cluster mutant cells, but was only slightly reduced in the S2056 cluster mutant cells. Since both non-homologous end-joining (NHEJ) and HRR systems utilize initial DNA lesions as a substrate, these results suggest the possibility of a competitive interference phenomenon operating between NHEJ and at least the Rad51C/D components of HRR; the level of interaction between damaged DNA and a particular DNA-PK component may determine the level of interaction of such DNA with a relevant HRR component.	[Lin, Yu-Fen; Shih, Hung-Ying; Chen, David J.; Chen, Benjamin P. C.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Nagasawa, Hatsumi; Kato, Takamitsu A.; Brogan, John R.; Bedford, Joel S.] Colorado State Univ, Dept & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Little, John B.] Harvard Univ, Sch Med, Dept Genet & Complex Dis, Boston, MA USA; [Xie, Xian-Jin] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Wilson, Paul F., Jr.] Brookhaven Natl Lab, Dept Biosci, Upton, NY 11973 USA; [Kurimasa, Akihiro] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Tottori 680, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; Colorado State University; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; United States Department of Energy (DOE); Brookhaven National Laboratory	Chen, BPC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	benjamin.chen@utsouthwestern.edu	Kato, Takamitsu A/D-7969-2015; Lin, Yu-Fen/A-2570-2016	Kato, Takamitsu/0000-0002-6263-600X	National Cancer Institute/National Institutes of Health [CA166677]; U.S. Department of Energy Low Dose Radiation Research Program [DE-FG02-07ER64350, DE-FG02-05ER64089]; Cancer Prevention Research Institute of Texas [RP110465-P1]; NATIONAL CANCER INSTITUTE [R01CA162804, R01CA166677] Funding Source: NIH RePORTER	National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Energy Low Dose Radiation Research Program(United States Department of Energy (DOE)); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CA166677 from the National Cancer Institute/National Institutes of Health, DE-FG02-07ER64350 and DE-FG02-05ER64089 from the U.S. Department of Energy Low Dose Radiation Research Program, and RP110465-P1 from the Cancer Prevention Research Institute of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARLETT CF, 1980, CANCER RES, V40, P926; Bedford JS, 2002, RADIAT RES, V158, P251, DOI 10.1667/0033-7587(2002)158[0251:HACHIR]2.0.CO;2; BEDFORD JS, 1978, RADIAT RES, V76, P573, DOI 10.2307/3574806; CARRANO AV, 1973, MUTAT RES, V17, P341, DOI 10.1016/0027-5107(73)90006-7; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; CORNFORTH MN, 1987, RADIAT RES, V111, P385, DOI 10.2307/3576926; COX R, 1978, ARCH DIS CHILD, V53, P386, DOI 10.1136/adc.53.5.386; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; DEWEY WC, 1971, P NATL ACAD SCI USA, V68, P667, DOI 10.1073/pnas.68.3.667; DEWEY WC, 1962, RADIAT RES, V16, P503, DOI 10.2307/3571085; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; DRITSCHILO A, 1984, RADIAT RES, V100, P387, DOI 10.2307/3576359; FORNACE AJ, 1980, MUTAT RES, V70, P323, DOI 10.1016/0027-5107(80)90022-6; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; HALL EJ, 1964, RADIAT RES, V22, P305, DOI 10.2307/3571661; Hashimoto M, 2001, J BIOL CHEM, V276, P12827, DOI 10.1074/jbc.M010906200; HIGURASHI M, 1973, CANCER-AM CANCER SOC, V32, P380, DOI 10.1002/1097-0142(197308)32:2<380::AID-CNCR2820320214>3.0.CO;2-2; Hinz JM, 2006, NUCLEIC ACIDS RES, V34, P1358, DOI 10.1093/nar/gkl020; Hsu FM, 2012, TRANSL CANCER RES, V1, P22, DOI 10.3978/j.issn.2218-676X.2012.04.01; HSU TC, 1958, J NATL CANCER I, V21, P437; ILIAKIS GE, 1991, INT J RADIAT BIOL, V59, P321, DOI 10.1080/09553009114550311; JEGGO PA, 1982, BIOCHIMIE, V64, P713, DOI 10.1016/S0300-9084(82)80116-8; Jeggo PA, 2006, DNA REPAIR, V5, P1192, DOI 10.1016/j.dnarep.2006.05.011; JONES NJ, 1987, MUTAT RES, V183, P279, DOI 10.1016/0167-8817(87)90011-3; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Kurimasa A, 1999, MOL CELL BIOL, V19, P3877; Leenhouts HP, 1978, ADV RADIAT BIOL, P55; Lin JYD, 1997, RADIAT RES, V147, P166, DOI 10.2307/3579417; LITTLE JB, 1985, RADIAT RES, V101, P81, DOI 10.2307/3576305; METTING NF, 1995, HEALTH PHYS, V68, P710, DOI 10.1097/00004032-199505000-00012; NAGASAWA H, 1985, MUTAT RES, V148, P71, DOI 10.1016/0027-5107(85)90209-X; Nagasawa H, 2005, RADIAT RES, V164, P141, DOI 10.1667/RR3420; NAGASAWA H, 1981, RADIAT RES, V87, P538, DOI 10.2307/3575519; NAGASAWA H, 1989, RADIAT RES, V118, P559, DOI 10.2307/3577413; NAGASAWA H, 1983, MUTAT RES, V107, P315, DOI 10.1016/0027-5107(83)90173-2; NAGASAWA H, 1994, INT J RADIAT BIOL, V66, P373, DOI 10.1080/09553009414551311; NAGASAWA H, 1992, CANCER RES, V52, P6394; NAGASAWA H, 1992, RADIAT RES, V132, P375, DOI 10.2307/3578247; NAGASAWA H, 1983, MUTAT RES, V109, P297, DOI 10.1016/0027-5107(83)90054-4; Nagasawa H, 2008, DNA REPAIR, V7, P515, DOI 10.1016/j.dnarep.2007.11.014; Nagasawa H, 2011, RADIAT RES, V175, P83, DOI 10.1667/RR2092.1; Nagasawa H, 2010, MUTAT RES-GEN TOX EN, V701, P12, DOI 10.1016/j.mrgentox.2010.03.003; NATARAJAN AT, 1979, HUM GENET, V52, P127; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; PARSHAD R, 1983, P NATL ACAD SCI-BIOL, V80, P5612, DOI 10.1073/pnas.80.18.5612; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Perryman LE, 2004, VET PATHOL, V41, P95, DOI 10.1354/vp.41-2-95; Priestley A, 1998, NUCLEIC ACIDS RES, V26, P1965, DOI 10.1093/nar/26.8.1965; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Revell SH., 1983, RAD INDUCED CHROMOSO, P215; Roberts SA, 2010, NATURE, V464, P1214, DOI 10.1038/nature08926; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Scott D, 1993, ATAXIA TELANGIECTASI, P101; Shao ZP, 2012, DNA REPAIR, V11, P310, DOI 10.1016/j.dnarep.2011.12.007; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; STACKHOUSE MA, 1993, RADIAT RES, V136, P241, DOI 10.2307/3578617; STACKHOUSE MA, 1994, INT J RADIAT BIOL, V65, P571, DOI 10.1080/09553009414550661; STACKHOUSE MA, 1993, RADIAT RES, V136, P250, DOI 10.2307/3578618; Sun J, 2012, J BIOL CHEM, V287, P4936, DOI 10.1074/jbc.M111.306167; TAYLOR AMR, 1976, NATURE, V260, P441, DOI 10.1038/260441a0; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; Tebbs RS, 2005, DNA REPAIR, V4, P11, DOI 10.1016/j.dnarep.2004.06.013; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; THOMPSON LH, 1980, MUTAT RES, V74, P21, DOI 10.1016/0165-1161(80)90188-0; TOBEY RA, 1971, CANCER RES, V31, P46; Wang XS, 2008, CANCER RES, V68, P971, DOI 10.1158/0008-5472.CAN-07-6272; WEICHSELBAUM RR, 1978, NATURE, V271, P261, DOI 10.1038/271261a0; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; WHITMORE GF, 1989, INT J RADIAT BIOL, V56, P657, DOI 10.1080/09553008914551881; ZAMPETTIBOSSELER F, 1981, INT J RADIAT BIOL, V39, P547, DOI 10.1080/09553008114550651; ZDZIENICKA MZ, 1987, MUTAT RES, V178, P235, DOI 10.1016/0027-5107(87)90274-0; Zhang SC, 2011, J CELL BIOL, V193, P295, DOI 10.1083/jcb.201009074	74	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93579	10.1371/journal.pone.0093579	http://dx.doi.org/10.1371/journal.pone.0093579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714417	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900037
J	Xie, JF; Ma, XD; Huang, YZ; Mo, M; Guo, FM; Yang, Y; Qiu, HB				Xie, Jianfeng; Ma, Xudong; Huang, Yingzi; Mo, Min; Guo, Fengmei; Yang, Yi; Qiu, Haibo			Value of American Thoracic Society Guidelines in Predicting Infection or Colonization with Multidrug-Resistant Organisms in Critically III Patients	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE UNITS; RISK-FACTORS; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; SEVERE SEPSIS; IMPACT; BACTERIA; CHINA; EPIDEMIOLOGY	Background: The incidence rate of infection by multidrug-resistant organisms (MDROs) can affect the accuracy of etiological diagnosis when using American Thoracic Society (ATS) guidelines. We determined the accuracy of the ATS guidelines in predicting infection or colonization by MDROs over 18 months at a single ICU in eastern China. Methods: This prospective observational study examined consecutive patients who were admitted to an intensive care unit (ICU) in Nanjing, China. MDROs were defined as bacteria that were resistant to at least three antimicrobial classes, such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), Pseudomonas aeruginosa, Acinetobacter baumannii. Screening for MDROs was performed at ICU admission and discharge. Risk factors for infection or colonization with MDROs were recorded, and the accuracy of the ATS guidelines in predicting infection or colonization with MDROs was documented. Results: There were 610 patients, 225 (37%) of whom were colonized or infected with MDROs at ICU admission, and this increased to 311 (51%) at discharge. At admission, the sensitivity (70.0%), specificity (31.6%), positive predictive value (38.2%), and negative predictive value (63.5%), all based on ATS guidelines for infection or colonization with MDROs were low. The negative predictive value was greater in patients from departments with MDRO infection rates of 31-40% than in patients from departments with MDRO infection rates of 30% or less and from departments with MDRO infection rates more than 40%. Conclusion: ATS criteria were not reliable in predicting infection or colonization with MDROs in our ICU. The negative predictive value was greater in patients from departments with intermediate rates of MDRO infection than in patients from departments with low or high rates of MDRO infection.	[Xie, Jianfeng; Huang, Yingzi; Mo, Min; Guo, Fengmei; Yang, Yi; Qiu, Haibo] Southeast Univ, Dept Crit Care Med, Zhong Da Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China; [Ma, Xudong] Huazhong Univ Sci & Technol, Sch Med & Hlth Management, Tongji Med Coll, Wuhan 430074, Peoples R China	Southeast University - China; Huazhong University of Science & Technology	Qiu, HB (corresponding author), Southeast Univ, Dept Crit Care Med, Zhong Da Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China.	haiboq2000@gmail.com	Lang, Ming/HIK-0758-2022; yang, yang/HGT-7999-2022; yang, yang/GVT-5210-2022; Qiu, Haibo/AAS-9047-2021; Odle, Jack/K-9660-2017	Qiu, Haibo/0000-0001-8589-4717; Odle, Jack/0000-0003-4965-2096; Ma, Xudong/0000-0002-5943-0879; Xi, Lin/0000-0003-3911-9677	Major Special Projects of Ministry of Health of China [201202011]; Fund of the Key Discipline of Jiangsu Province [KJXW11.3]	Major Special Projects of Ministry of Health of China; Fund of the Key Discipline of Jiangsu Province	This research was supported by the Major Special Projects of Ministry of Health of China (grant number: 201202011), and the Fund of the Key Discipline of Jiangsu Province (grant number KJXW11.3.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Bertrand X, 2012, CLIN THER, V34, P124, DOI 10.1016/j.clinthera.2011.11.023; Cao B, 2010, CLIN INFECT DIS, V51, P189, DOI 10.1086/653535; Chastre J, 2008, CLIN MICROBIOL INFEC, V14, P3, DOI 10.1111/j.1469-0691.2008.01958.x; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dong LF, 2008, J ANTIMICROB CHEMOTH, V62, P410, DOI 10.1093/jac/dkn153; Ewig S, 2010, LANCET INFECT DIS, V10, P279, DOI 10.1016/S1473-3099(10)70032-3; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Harris AD, 2007, EMERG INFECT DIS, V13, P1144, DOI 10.3201/eid1308.070071; Heddini A, 2009, LANCET, V373, P30, DOI 10.1016/S0140-6736(08)61956-X; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hoo GWS, 2005, CHEST, V128, P2778, DOI 10.1378/chest.128.4.2778; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Liang XY, 2011, INT J CLIN PHARM-NET, V33, P750, DOI 10.1007/s11096-011-9535-9; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Maragakis LL, 2010, CRIT CARE MED, V38, pS345, DOI 10.1097/CCM.0b013e3181e6cbc5; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Nachtigall I, 2009, CRIT CARE MED, V37, P159, DOI 10.1097/CCM.0b013e3181934f1b; Nseir S, 2010, CLIN MICROBIOL INFEC, V16, P902, DOI 10.1111/j.1469-0691.2009.03027.x; Nseir S, 2008, J INFECTION, V56, P319, DOI 10.1016/j.jinf.2008.02.012; Parker CM, 2008, J CRIT CARE, V23, P18, DOI 10.1016/j.jcrc.2008.02.001; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Reynolds L, 2009, HEALTH POLICY, V90, P32, DOI 10.1016/j.healthpol.2008.09.002; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Teixeira PJZ, 2007, J HOSP INFECT, V65, P361, DOI 10.1016/j.jhin.2006.12.019; Thomson T, 2011, INFECT CONT HOSP EP, V32, P626, DOI 10.1086/660199; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Warren DK, 2007, CRIT CARE MED, V35, P430, DOI 10.1097/01.CCM.0000253813.98431.28; Zhang RF, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-6	34	41	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89687	10.1371/journal.pone.0089687	http://dx.doi.org/10.1371/journal.pone.0089687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	25072282	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500008
J	Zhang, BZ; Cai, GJ; Wang, HT; Li, D; Yang, XJ; An, XL; Zheng, XW; Tian, Y; Zheng, W; Zheng, TL				Zhang, Bangzhou; Cai, Guanjing; Wang, Haitao; Li, Dong; Yang, Xujun; An, Xinli; Zheng, Xiaowei; Tian, Yun; Zheng, Wei; Zheng, Tianling			Streptomyces alboflavus RPS and Its Novel and High Algicidal Activity against Harmful Algal Bloom Species Phaeocystis globosa	PLOS ONE			English	Article							TOXIC DINOFLAGELLATE; MICROCYSTIS-AERUGINOSA; POPULATION-DYNAMICS; MARINE; BACTERIUM; IDENTIFICATION; CYANOBACTERIA; ACTINOMYCETE; MECHANISMS; COMPOUND	Phaeocystis globosa blooms have frequently occurred along coastal waters and exerted serious impacts on ecological environments by releasing toxic hemolytic substances, forming nuisance foam, and causing oxygen depletion. An actinomycete strain RPS with high algicidal activity against P. globosa was isolated and identified as Streptomyces alboflavus, based on morphology, physiological and biochemical characteristics, and 16S rDNA sequence analysis. RPS lysed 95% of P. globosa within 48 h by releasing an extracellular active substance into the growth medium. The activity of RPS supernatant was sensitive to temperature at and above 50 degrees C and insensitive to pH from 3 to 11. The molecular weight of the active substance was between 100 Da and 1000 Da, and approximately 90% of it was extracted by ethyl acetate. It was presumed that the active component efficiently inhibited the movement of P. globosa, caused the flagella to fall off the algae, and finally lysed the algal cells. RPS showed a wide target range against harmful algae. S. alboflavus RPS with high algicidal activity and such novel features of temperature and pH sensitivity, low molecular weight, algicidal process, and target range possesses great potential in the biological control of P. globosa blooms.	[Zheng, Wei] Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Zheng, W (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.	jedi@xmu.edu.cn; microzh@xmu.edu.cn	Cai, Guanjing/GZK-7070-2022; Zhang, Bangzhou/CAG-9625-2022; Zhao, Lin/M-9536-2018	Zhao, Lin/0000-0003-0245-8413	National Natural Science Foundation of China [40930847, 41376119]; Public Science and Technology Research Funds Projects of Ocean [201305016]; Special Fund for Ph.D. Programs in the University [20120121130001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Science and Technology Research Funds Projects of Ocean; Special Fund for Ph.D. Programs in the University	This work was supported by the National Natural Science Foundation of China (40930847, 41376119) (http://www.nsfc.gov.cn/publish/portal0/default.htm), the Public Science and Technology Research Funds Projects of Ocean (201305016) (http://www.soa.gov.cn/), and the Special Fund for Ph.D. Programs in the University (20120121130001) (http://www.cutech.edu.cn/cn/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actinomycete Classification Group of CAS, 1975, MAN STREPT ID, P13; Amin SA, 2012, MICROBIOL MOL BIOL R, V76, P667, DOI 10.1128/MMBR.00007-12; Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; Anderson DM, 2009, OCEAN COAST MANAGE, V52, P342, DOI 10.1016/j.ocecoaman.2009.04.006; Arnoux P, 2009, PLANT CELL, V21, P2036, DOI 10.1105/tpc.109.068007; Bai SJJ, 2011, CURR MICROBIOL, V62, P1774, DOI 10.1007/s00284-011-9927-z; Banin E, 2001, APPL ENVIRON MICROB, V67, P1536, DOI 10.1128/AEM.67.4.1536-1541.2001; Baudoux AC, 2005, VIROLOGY, V341, P80, DOI 10.1016/j.virol.2005.07.002; Blauw AN, 2010, J MARINE SYST, V83, P115, DOI 10.1016/j.jmarsys.2010.05.003; Cai WW, 2011, APPL ENVIRON MICROB, V77, P7837, DOI 10.1128/AEM.05783-11; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; Hai DN, 2010, J MARINE SYST, V83, P253, DOI 10.1016/j.jmarsys.2010.04.015; Fei XG, 2004, HYDROBIOLOGIA, V512, P145, DOI 10.1023/B:HYDR.0000020320.68331.ce; Gumbo RJ, 2008, AFR J BIOTECHNOL, V7, P4765; Guo ZY, 2009, J ANTIBIOT, V62, P201, DOI 10.1038/ja.2009.15; Jeong HJ, 2008, HARMFUL ALGAE, V7, P368, DOI 10.1016/j.hal.2007.12.004; Jessup DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004550; Kodama M, 2006, ECOL STU AN, V189, P243, DOI 10.1007/978-3-540-32210-8_19; Kodani S, 2002, J APPL PHYCOL, V14, P109, DOI 10.1023/A:1019533414018; Kong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057654; Lamy D, 2009, AQUAT MICROB ECOL, V58, P95, DOI 10.3354/ame01359; Lee SO, 2000, APPL ENVIRON MICROB, V66, P4334, DOI 10.1128/AEM.66.10.4334-4339.2000; Lee SW, 2013, J HAZARD MATER, V263, P20, DOI 10.1016/j.jhazmat.2013.08.017; Lee YJ, 2008, HARMFUL ALGAE, V7, P154, DOI 10.1016/j.hal.2007.06.004; Li FM, 2005, APPL ENVIRON MICROB, V71, P6545, DOI 10.1128/AEM.71.11.6545-6553.2005; Li L, 2013, ENVIRON SCI TECHNOL, V47, P4555, DOI 10.1021/es305234d; Li PN, 2011, ENVIRON SCI TECHNOL, V45, P4521, DOI 10.1021/es200057g; LISS PS, 1994, J MARINE SYST, V5, P41, DOI 10.1016/0924-7963(94)90015-9; Manset KJV, 2013, J ENVIRON SCI MANAG, P11; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; Mayali X, 2002, HARMFUL ALGAE, V1, P277, DOI 10.1016/S1568-9883(02)00032-X; Meuser D, 1999, FEBS LETT, V462, P447, DOI 10.1016/S0014-5793(99)01579-3; Monchy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039924; Nakashima T, 2006, AQUAT MICROB ECOL, V45, P255, DOI 10.3354/ame045255; Nayak BB, 2000, WORLD J MICROB BIOT, V16, P99, DOI 10.1023/A:1008934406780; Ni LX, 2012, CHEMOSPHERE, V88, P1051, DOI 10.1016/j.chemosphere.2012.05.009; Nishitarumizu S, 2011, FISHERIES SCI, P1; Orton JH, 1923, NATURE, V111, P773, DOI 10.1038/111773a0; Ozaki K, 2008, CHEMOSPHERE, V71, P1531, DOI 10.1016/j.chemosphere.2007.11.052; Paul C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021032; Peng XC, 2005, J INTEGR PLANT BIOL, V47, P165, DOI 10.1111/j.1744-7909.2005.00039.x; Peperzak L, 2008, J SEA RES, V60, P220, DOI 10.1016/j.seares.2008.06.001; Qi YZ, 2004, HYDROBIOLOGIA, V512, P209, DOI 10.1023/B:HYDR.0000020329.06666.8c; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Schoemann V, 2005, J SEA RES, V53, P43, DOI 10.1016/j.seares.2004.01.008; Seong Kyeong Ah, 2011, Ocean Science Journal, V46, P105, DOI 10.1007/s12601-011-0010-2; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Skerratt JH, 2002, MAR ECOL PROG SER, V244, P1, DOI 10.3354/meps244001; Su RQ, 2007, HARMFUL ALGAE, V6, P799, DOI 10.1016/j.hal.2007.04.004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Wang BX, 2010, LETT APPL MICROBIOL, V51, P552, DOI 10.1111/j.1472-765X.2010.02936.x; Wang BX, 2012, HARMFUL ALGAE, V13, P83, DOI 10.1016/j.hal.2011.10.006; Wang XL, 2005, HARMFUL ALGAE, V4, P433, DOI 10.1016/j.hal.2004.06.001; Yamamoto Y, 1998, J APPL PHYCOL, V10, P391, DOI 10.1023/A:1008077414808; Yan Rong-jun, 2011, Huanjing Kexue, V32, P225; Yang CY, 2012, HARMFUL ALGAE, V20, P132, DOI 10.1016/j.hal.2012.09.002; Yoshikawa K, 2000, APPL ENVIRON MICROB, V66, P718, DOI 10.1128/AEM.66.2.718-722.2000; Zhang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063018; Zhang SJ, 2012, ENVIRON SCI TECHNOL, V46, P8764, DOI 10.1021/es301000m; Zheng XW, 2013, APPL MICROBIOL BIOT, V97, P9207, DOI 10.1007/s00253-012-4617-8; Zhou LH, 2007, HARMFUL ALGAE, V6, P354, DOI 10.1016/j.hal.2006.10.002	62	64	80	11	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92907	10.1371/journal.pone.0092907	http://dx.doi.org/10.1371/journal.pone.0092907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675867	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677500054
J	Deng, Y; Sun, MZ; Lin, PH; Ma, JJ; Shaevitz, JW				Deng, Yi; Sun, Mingzhai; Lin, Pei-Hui; Ma, Jianjie; Shaevitz, Joshua W.			Spatial Covariance Reconstructive (SCORE) Super-Resolution Fluorescence Microscopy	PLOS ONE			English	Article							LOCALIZATION; RESOLUTION; BLINKING; PROTEIN; BREAKING; LIMIT	Super-resolution fluorescence microscopy has become a powerful tool to resolve structural information that is not accessible to traditional diffraction-limited imaging techniques such as confocal microscopy. Stochastic optical reconstruction microscopy (STORM) and photoactivation localization microscopy (PALM) are promising super-resolution techniques due to their relative ease of implementation and instrumentation on standard microscopes. However, the application of STORM is critically limited by its long sampling time. Several recent works have been focused on improving the STORM imaging speed by making use of the information from emitters with overlapping point spread functions (PSF). In this work, we present a fast and efficient algorithm that takes into account the blinking statistics of independent fluorescence emitters. We achieve sub-diffraction lateral resolution of 100 nm from 5 to 7 seconds of imaging. Our method is insensitive to background and can be applied to different types of fluorescence sources, including but not limited to the organic dyes and quantum dots that we demonstrate in this work.	[Deng, Yi; Shaevitz, Joshua W.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Sun, Mingzhai; Shaevitz, Joshua W.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Lin, Pei-Hui; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	Princeton University; Princeton University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Shaevitz, JW (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	shaevitz@princeton.edu	Sun, Mingzhai/B-4945-2012; Deng, Yi/F-9358-2015; Lin, Pei-Hui/I-3011-2015; cui, xiao yong/B-3669-2016	Deng, Yi/0000-0002-6822-6343; Lin, Pei-Hui/0000-0002-3894-5099; Hernandez, Marcela/0000-0002-1041-785X; cui, xiao yong/0000-0001-7592-5866; Dumont, Marc/0000-0002-7347-8668	National Science Foundation [PHY-0844466]; National Institutes of Health [P50GM071508]; Pew Charitable Trusts; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028614] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Science Foundation (PHY-0844466) (www.nsf.gov), the National Institutes of Health (P50GM071508) (www.nih.gov), and The Pew Charitable Trusts (www.pewtrusts.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Cordes T, 2009, OPTICAL SOC AM, V7367, p1D; Cox S, 2012, NAT METHODS, V9, P195, DOI [10.1038/NMETH.1812, 10.1038/nmeth.1812]; Dedecker P, 2012, P NATL ACAD SCI USA, V109, P10909, DOI 10.1073/pnas.1204917109; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Dertinger T, 2009, P NATL ACAD SCI USA, V106, P22287, DOI 10.1073/pnas.0907866106; Dertinger T, 2010, OPT EXPRESS, V18, P18875, DOI 10.1364/OE.18.018875; Geissbuehler S, 2011, BIOMED OPT EXPRESS, V2, P408, DOI 10.1364/BOE.2.000408; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Holden SJ, 2011, NAT METHODS, V8, P279, DOI 10.1038/nmeth0411-279; Hu YS, 2013, NAT METHODS, V10, P96, DOI 10.1038/nmeth.2335; Klar TA, 1999, OPT LETT, V24, P954, DOI 10.1364/OL.24.000954; Lidke KA, 2005, OPT EXPRESS, V13, P7052, DOI 10.1364/OPEX.13.007052; MAUPIN P, 1983, J CELL BIOL, V96, P51, DOI 10.1083/jcb.96.1.51; Mukamel EA, 2012, BIOPHYS J, V102, P2391, DOI 10.1016/j.bpj.2012.03.070; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; Rosten E, 2013, NAT METHODS, V10, P97, DOI 10.1038/nmeth.2342; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shimizu KT, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.205316; Stiel AC, 2008, BIOPHYS J, V95, P2989, DOI 10.1529/biophysj.108.130146; Subach FV, 2010, CHEM BIOL, V17, P745, DOI 10.1016/j.chembiol.2010.05.022; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Wang Y, 2013, NANO LETT, V13, P5233, DOI 10.1021/nl4026665; Wolter S, 2012, NAT METHODS, V9, P1040, DOI 10.1038/nmeth.2224; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Zhu L, 2012, NAT METHODS, V9, P721, DOI [10.1038/NMETH.1978, 10.1038/nmeth.1978]	34	39	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e94807	10.1371/journal.pone.0094807	http://dx.doi.org/10.1371/journal.pone.0094807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788039	Green Published, Green Submitted, gold			2022-12-25	WOS:000338917300006
J	Liu, WQ; Zhang, SW; Zhao, D; Zou, HW; Sun, NY; Liang, X; Dard, M; Lanske, B; Yuan, Q				Liu, Weiqing; Zhang, Shiwen; Zhao, Dan; Zou, Huawei; Sun, Ningyuan; Liang, Xing; Dard, Michel; Lanske, Beate; Yuan, Quan			Vitamin D Supplementation Enhances the Fixation of Titanium Implants in Chronic Kidney Disease Mice	PLOS ONE			English	Article							POSITION STATEMENT; RENAL-FAILURE; OSSEOINTEGRATION; PREVALENCE; BONE; DEFICIENCY; ASSOCIATION; ADOLESCENTS; CHILDREN; PATIENT	Vitamin D (Vit D) deficiency is a common condition in chronic kidney disease (CKD) patients that negatively affects bone regeneration and fracture healing. Previous study has shown that timely healing of titanium implants is impaired in CKD. This study aimed to investigate the effect of Vit D supplementation on implant osseointegration in CKD mice. Uremia was induced by 5/6 nephrectomy in C57BL mice. Eight weeks after the second renal surgery, animals were given 1,25(OH)(2)D-3 three times a week intraperitoneally for four weeks. Experimental titanium implants were inserted into the distal end of femurs two weeks later. Serum measurements confirmed decreased 1,25(OH)(2)D levels in CKD mice, which could be successfully corrected by Vit D injections. Moreover, the hyperparathyroidism observed in CKD mice was also corrected. Xray examination and histological sections showed successful osseointegration in these mice. Histomorphometrical analysis revealed that the bone-implant contact (BIC) ratio and bone volume (BV/TV) around the implant were significantly increased in the Vit D-supplementation group. In addition, resistance of the implant, as measured by a push-in method, was significantly improved compared to that in the vehicle group. These results demonstrate that Vit D supplementation is an effective approach to improve the fixation of titanium implants in CKD.	[Liu, Weiqing; Zhang, Shiwen; Zhao, Dan; Zou, Huawei; Sun, Ningyuan; Liang, Xing; Yuan, Quan] Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China; [Dard, Michel] NYU, Coll Dent, Dept Periodontol & Implant Dent, New York, NY USA; [Lanske, Beate] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	Sichuan University; New York University; Harvard University; Harvard School of Dental Medicine	Yuan, Q (corresponding author), Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China.	yuanquan@scu.edu.cn	yuan, quan/GZM-5597-2022	Yuan, Quan/0000-0002-2836-1081; Lanske, Beate/0000-0003-4638-804X; zhao, dan/0000-0002-0037-1464	National Natural Science Foundation of China [NSFC 81371173]; New Century Excellent Talents in University [NCET-12-0379]; International Team of Implantology [ITI 717_2010]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01-073944]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); International Team of Implantology; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Natural Science Foundation of China (NSFC 81371173), New Century Excellent Talents in University (NCET-12-0379) and International Team of Implantology (ITI 717_2010) to Q.Y., and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, R01-073944) to B.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan Ali, 2012, Dent Res J (Isfahan), V9, P582; Alvim-Pereira F, 2008, CLIN ORAL IMPLAN RES, V19, P786, DOI 10.1111/j.1600-0501.2008.01532.x; Andress DL, 2008, KIDNEY INT, V73, P1345, DOI 10.1038/ki.2008.60; Andress DL, 2005, SEMIN DIALYSIS, V18, P315, DOI 10.1111/j.1525-139X.2005.18408.x; Bayraktar G, 2007, ORAL DIS, V13, P393, DOI 10.1111/j.1601-0825.2006.01297.x; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Brinker MR, 2007, J ORTHOP TRAUMA, V21, P557, DOI 10.1097/BOT.0b013e31814d4dc6; Chandra Prakash, 2008, Endocr Pract, V14, P10; Cho YJ, 2011, INT J ORAL MAX IMPL, V26, P1225; Choukroun J, 2013, J ORAL IMPLANTOL; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Craig RG, 2007, NEPHROL DIAL TRANSPL, V22, P312, DOI 10.1093/ndt/gfl604; Davidovich E, 2005, PEDIATR DENT, V27, P98; Davidovich E, 2005, J CLIN PERIODONTOL, V32, P1076, DOI 10.1111/j.1600-051X.2005.00812.x; DeRossi SS, 1996, J AM DENT ASSOC, V127, P211, DOI 10.14219/jada.archive.1996.0171; Dijakiewicz M, 2007, NEPHROL DIAL TRANSPL, V22, P2722, DOI 10.1093/ndt/gfm317; Dvorak G, 2012, CLIN ORAL IMPLAN RES, V23, P1308, DOI 10.1111/j.1600-0501.2011.02346.x; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Gonzalez EA, 2004, AM J NEPHROL, V24, P503, DOI 10.1159/000081023; Hasegawa H, 2010, KIDNEY INT, V78, P975, DOI 10.1038/ki.2010.313; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Ishimura E, 1999, KIDNEY INT, V55, P1019, DOI 10.1046/j.1523-1755.1999.0550031019.x; Jingushi S, 1998, ENDOCRINOLOGY, V139, P1467, DOI 10.1210/en.139.4.1467; Cervero AJ, 2008, MED ORAL PATOL ORAL, V13, pE419; Kandula P, 2011, CLIN J AM SOC NEPHRO, V6, P50, DOI 10.2215/CJN.03940510; Kelly J, 2009, J PROSTHODONT, V18, P473, DOI 10.1111/j.1532-849X.2009.00446.x; Kimura Genjiro, 2007, Clin Exp Nephrol, V11, P188, DOI 10.1007/s10157-007-0474-7; LaClair RE, 2005, AM J KIDNEY DIS, V45, P1026, DOI 10.1053/j.ajkd.2005.02.029; Lee MM, 2010, J PERIODONTOL, V81, P300, DOI 10.1902/jop.2009.090379; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Mengatto CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015848; Messier MD, 2012, J PERIODONTOL, V83, P602, DOI 10.1902/jop.2011.110306; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Nickolas TL, 2010, J AM SOC NEPHROL, V21, P1371, DOI 10.1681/ASN.2009121208; Pillar R, 2013, HYPERTENS RES, V36, P428, DOI 10.1038/hr.2012.230; Rouached M, 2008, KIDNEY INT, V74, P389, DOI 10.1038/ki.2008.169; Ruospo M, 2013, NEPHROL DIAL TRANSPL; Saran R, 2010, ADV CHRONIC KIDNEY D, V17, P271, DOI 10.1053/j.ackd.2010.03.001; Stellingsma C, 2004, CRIT REV ORAL BIOL M, V15, P240, DOI 10.1177/154411130401500406; Wu YY, 2013, BONE, V52, P1, DOI 10.1016/j.bone.2012.09.005; Xu B, 2009, J DENT RES, V88, P1003, DOI 10.1177/0022034509346928; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhou CC, 2012, OR SURG OR MED OR PA, V114, pS174, DOI 10.1016/j.oooo.2011.09.030; Zou HW, 2013, BONE, V56, P410, DOI 10.1016/j.bone.2013.07.014	46	38	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95689	10.1371/journal.pone.0095689	http://dx.doi.org/10.1371/journal.pone.0095689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24752599	Green Published, gold			2022-12-25	WOS:000335227400101
J	Yang, YC; Huang, YT; Hsieh, CW; Yang, PM; Wung, BS				Yang, Yan-Chang; Huang, Yu-Ting; Hsieh, Chia-Wen; Yang, Po-Min; Wung, Being-Sun			Carbon Monoxide Induces Heme Oxygenase-1 to Modulate STAT3 Activation in Endothelial Cells via S-Glutathionylation	PLOS ONE			English	Article							NF-KAPPA-B; ENDOPLASMIC-RETICULUM-STRESS; CO-RELEASING MOLECULES; THERAPEUTIC APPLICATIONS; GENE-EXPRESSION; UP-REGULATION; JNK PATHWAY; PHOSPHORYLATION; INHIBITION; APOPTOSIS	IL-6/STAT3 pathway is involved in a variety of biological responses, including cell proliferation, differentiation, apoptosis, and inflammation. In our present study, we found that CO releasing molecules (CORMs) suppress IL-6-induced STAT3 phosphorylation, nuclear translocation and transactivity in endothelial cells (ECs). CO is a byproduct of heme degradation mediated by heme oxygenase (HO-1). However, CORMs can induce HO-1 expression and then inhibit STAT3 phosphorylation. CO has been found to increase a low level ROS and which may induce protein glutathionylation. We hypothesized that CORMs increases protein glutathionylation and inhibits STAT3 activation. We found that CORMs increase the intracellular GSSG level and induce the glutathionylation of multiple proteins including STAT3. GSSG can inhibit STAT3 phosphorylation and increase STAT3 glutathionylation whereas the antioxidant enzyme catalase can suppress the glutathionylation. Furthermore, catalase blocks the inhibition of STAT3 phosphorylation by CORMs treatment. The inhibition of glutathione synthesis by BSO was also found to attenuate STAT3 glutathionylation and its inhibition of STAT3 phosphorylation. We further found that HO-1 increases STAT3 glutathionylation and that HO-1 siRNA attenuates CORM-induced STAT3 glutathionylation. Hence, the inhibition of STAT3 activation is likely to occur via a CO-mediated increase in the GSSG level, which augments protein glutathionylation, and CO-induced HO-1 expression, which may enhance and maintain its effects in IL-6-treated ECs.	[Yang, Yan-Chang; Huang, Yu-Ting; Hsieh, Chia-Wen; Wung, Being-Sun] Natl Chiayi Univ, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan; [Yang, Po-Min] Chiayi Christian Hosp, Dept Ophthalmol, Chiayi, Taiwan	National Chiayi University; Chia-Yi Christian Hospital	Wung, BS (corresponding author), Natl Chiayi Univ, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan.	bswung@mail.ncyu.edu.tw	; Herrup, Karl/C-5313-2014	Chen, Ji-hua/0000-0002-1151-0693; wung, being sun/0000-0002-9378-2798; Hsieh, Chia-Wen/0000-0003-1188-1934; Herrup, Karl/0000-0001-7786-5844; Li, Jiali/0000-0002-0039-3671	National Science Council, Taiwan [102-2320-B-415-002-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants (102-2320-B-415-002-MY3) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EMG, 2012, ANTIOXID REDOX SIGN, V17, P1748, DOI 10.1089/ars.2012.4644; Bannenberg GL, 2009, EXPERT OPIN THER PAT, V19, P663, DOI 10.1517/13543770902858824; Brennan JP, 2006, MOL CELL PROTEOMICS, V5, P215, DOI 10.1074/mcp.M500212-MCP200; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Butturini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020174; Carballo M, 1999, J BIOL CHEM, V274, P17580, DOI 10.1074/jbc.274.25.17580; Clark JE, 2000, AM J PHYSIOL-HEART C, V278, pH643, DOI 10.1152/ajpheart.2000.278.2.H643; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; GOSPODAROWICZ D, 1976, P NATL ACAD SCI USA, V73, P4120, DOI 10.1073/pnas.73.11.4120; GYLLENHAMMAR H, 1987, J IMMUNOL METHODS, V97, P209, DOI 10.1016/0022-1759(87)90461-3; Kamencic H, 2000, ANAL BIOCHEM, V286, P35, DOI 10.1006/abio.2000.4765; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Lian KC, 2010, TOXICOL APPL PHARM, V245, P21, DOI 10.1016/j.taap.2010.01.003; Liao BC, 2010, TOXICOL SCI, V116, P151, DOI 10.1093/toxsci/kfq098; Liu YC, 2007, LIFE SCI, V80, P1420, DOI 10.1016/j.lfs.2006.12.040; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Morita T, 2005, ARTERIOSCL THROM VAS, V25, P1786, DOI 10.1161/01.ATV.0000178169.95781.49; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Pimentel D, 2012, ANTIOXID REDOX SIGN, V16, P524, DOI 10.1089/ars.2011.4336; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schipper HM, 2004, FREE RADICAL BIO MED, V37, P1995, DOI 10.1016/j.freeradbiomed.2004.09.015; Schuringa JJ, 2001, J BIOL CHEM, V276, P27709, DOI 10.1074/jbc.M009821200; Schwer CI, 2010, MOL PHARMACOL, V77, P660, DOI 10.1124/mol.109.059519; Shin DY, 2012, BLOOD, V119, P2523, DOI 10.1182/blood-2011-07-366690; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Wu CC, 2006, TOXICOL APPL PHARM, V214, P244, DOI 10.1016/j.taap.2005.12.013; Wu CC, 2006, LIFE SCI, V78, P2889, DOI 10.1016/j.lfs.2005.11.013; Wung BS, 2006, LIFE SCI, V78, P3035, DOI 10.1016/j.lfs.2005.12.013; Wung BS, 2005, LIFE SCI, V78, P389, DOI 10.1016/j.lfs.2005.04.052; Wung BS, 2005, J BIOMED SCI, V12, P91, DOI 10.1007/s11373-004-8170-z; Wung BS, 1997, CIRC RES, V81, P1, DOI 10.1161/01.RES.81.1.1; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Yeh PY, 2014, FREE RADICAL BIO MED, V70, P1, DOI 10.1016/j.freeradbiomed.2014.01.042; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	40	112	121	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e100677	10.1371/journal.pone.0100677	http://dx.doi.org/10.1371/journal.pone.0100677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	24498369	Green Submitted, Green Published, gold			2022-12-25	WOS:000341307600004
